PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Singh, M; Kishore, A; Maity, D; Sunanda, P; Krishnarjuna, B; Vappala, S; Raghothama, S; Kenyon, LC; Pal, D; Das Sarma, J				Singh, Manmeet; Kishore, Abhinoy; Maity, Dibyajyoti; Sunanda, Punnepalli; Krishnarjuna, Bankala; Vappala, Sreeparna; Raghothama, Srinivasarao; Kenyon, Lawrence C.; Pal, Debnath; Das Sarma, Jayasri			A proline insertion-deletion in the spike glycoprotein fusion peptide of mouse hepatitis virus strongly alters neuropathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fusion protein; membrane fusion; plus-stranded RNA virus; neuroinflammation; neurodegeneration; central proline; fusion peptide; mouse hepatitis virus; spike glycoprotein; viral titer; syncytia formation; demyelination; neuropathology	MEMBRANE-FUSION; STRAIN A59; NONDEMYELINATING STRAINS; HYDROPHOBIC REGIONS; CORONAVIRUS; PROTEIN; IDENTIFICATION; DEMYELINATION; MODEL; SUBSTITUTION	Fusion peptides (FPs) in spike proteins are key players mediating early events in cell-to-cell fusion, vital for intercellular viral spread. A proline residue located at the central FP region has often been suggested to have a distinctive role in this fusion event. The spike glycoprotein from strain RSA59 (PP) of mouse hepatitis virus (MHV) contains two central, consecutive prolines in the FP. Here, we report that deletion of one of these proline residues, resulting in RSA59 (P), significantly affected neural cell syncytia formation and viral titers postinfection in vitro. Transcranial inoculation of C57Bl/6 mice with RSA59 (PP) or RSA59 (P) yielded similar degrees of necrotizing hepatitis and meningitis, but only RSA59 (PP) produced widespread encephalitis that extended deeply into the brain parenchyma. By day 6 postinfection, both virus variants were mostly cleared from the brain. Interestingly, inoculation with the RSA59 (P)-carrying MHV significantly reduced demyelination at the chronic stage. We also found that the presence of two consecutive prolines in FP promotes a more ordered, compact, and rigid structure in the spike protein. These effects on FP structure were due to proline's unique stereochemical properties intrinsic to its secondary amino acid structure, revealed by molecular dynamics and NMR experiments. We therefore propose that the differences in the severity of encephalitis and demyelination between RSA59 (PP) and RSA59 (P) arise from the presence or absence, respectively, of the two consecutive prolines in FP. Our studies define a structural determinant of MHV entry in the brain parenchyma important for altered neuropathogenesis.	[Singh, Manmeet; Kishore, Abhinoy; Vappala, Sreeparna; Das Sarma, Jayasri] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur 741246, W Bengal, India; [Maity, Dibyajyoti] Indian Inst Sci, IISc Math Initiat, Bengaluru 560012, Karnataka, India; [Sunanda, Punnepalli; Krishnarjuna, Bankala; Raghothama, Srinivasarao] Indian Inst Sci, NMR Res Ctr, Bengaluru 560012, Karnataka, India; [Pal, Debnath] Indian Inst Sci, Dept Computat & Data Sci, Bengaluru 560012, Karnataka, India; [Kenyon, Lawrence C.] Thomas Jefferson Univ, Dept Anat Pathol & Cell Biol, Philadelphia, PA 19107 USA	Indian Institute of Science Education & Research (IISER) - Kolkata; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Jefferson University	Das Sarma, J (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur 741246, W Bengal, India.; Pal, D (corresponding author), Indian Inst Sci, Dept Computat & Data Sci, Bengaluru 560012, Karnataka, India.	dpal@iisc.ac.in; dassarmaj@iiserkol.ac.in	Sarma, Jayasri Das/AAS-3837-2020; kishore, abhinoy/AAD-8748-2021; SINGH, MANMEET/HFZ-9743-2022; Krishnarjuna, Bankala/H-4562-2013; Maity, Dibyajyoti/M-4818-2017	SINGH, MANMEET/0000-0003-0917-8844; Krishnarjuna, Bankala/0000-0002-4575-0011; Raghothama, S/0000-0002-1289-3382; Maity, Dibyajyoti/0000-0002-8032-646X; Vappala, Sreeparna/0000-0002-1207-4248; PAL, DEBNATH/0000-0002-3591-5978; Kenyon, Lawrence/0000-0002-3719-9565	University Grant Commission, New Delhi; DuPre fellowship, Multiple Sclerosis Society International Federation (MSIF), UK; Department of Biotechnology (DBT), New Delhi; Council of Scientific and Industrial Research, New Delhi; DBT, New Delhi	University Grant Commission, New Delhi(University Grants Commission, India); DuPre fellowship, Multiple Sclerosis Society International Federation (MSIF), UK; Department of Biotechnology (DBT), New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); DBT, New Delhi(Department of Biotechnology (DBT) India)	This work was supported by the University Grant Commission, New Delhi, and DuPre fellowship, Multiple Sclerosis Society International Federation (MSIF), UK (to M. S.); fellowships from the Department of Biotechnology (DBT), New Delhi, and Council of Scientific and Industrial Research, New Delhi (to A. K. and D. M., respectively); and funding support for the experiments from the DBT, New Delhi (to J. D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The funders had no role in the study design, data collection, and interpretation, or the decision to publish the work.	Chakrabarti P, 2001, PROG BIOPHYS MOL BIO, V76, P1, DOI 10.1016/S0079-6107(01)00005-0; CHAMBERS P, 1990, J GEN VIROL, V71, P3075, DOI 10.1099/0022-1317-71-12-3075; COMPTON SR, 1995, J VIROL METHODS, V52, P301, DOI 10.1016/0166-0934(94)00161-9; Das Sarma J, 2000, J VIROL, V74, P9206, DOI 10.1128/JVI.74.19.9206-9213.2000; Das Sarma J, 2002, J NEUROVIROL, V8, P381, DOI [10.1080/13550280290100815, 10.1080/13550280260422686]; Das Sarma J, 2001, J NEUROVIROL, V7, P432; Das Sarma J, 2001, EXP MOL PATHOL, V71, P1; Das Sarma J, 2008, J VIROL, V82, P5519, DOI 10.1128/JVI.01488-07; Das Sarma J, 2009, J NEUROSCI, V29, P10272, DOI 10.1523/JNEUROSCI.1975-09.2009; Delos SE, 2000, J VIROL, V74, P1686, DOI 10.1128/JVI.74.4.1686-1693.2000; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Drummer HE, 2004, J BIOL CHEM, V279, P30066, DOI 10.1074/jbc.M405098200; Durell SR, 1997, MOL MEMBR BIOL, V14, P97, DOI 10.3109/09687689709048170; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Eifart P, 2007, J VIROL, V81, P10758, DOI 10.1128/JVI.00725-07; FREDERICKSEN BL, 1995, J VIROL, V69, P1435, DOI 10.1128/JVI.69.3.1435-1443.1995; Gomara MJ, 2004, FEBS LETT, V569, P261, DOI 10.1016/j.febslet.2004.06.006; Hingley ST, 1998, J VIROL, V72, P1606, DOI 10.1128/JVI.72.2.1606-1609.1998; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaufman G, 2014, VIRUS RES, V189, P177, DOI 10.1016/j.virusres.2014.05.023; KECK JG, 1988, J VIROL, V62, P1989, DOI 10.1128/JVI.62.6.1989-1998.1988; Kenyon LC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00488; KOOI C, 1991, VIROLOGY, V180, P108, DOI 10.1016/0042-6822(91)90014-3; Kuo LL, 2000, J VIROL, V74, P1393, DOI 10.1128/JVI.74.3.1393-1406.2000; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAVI E, 1988, LAB INVEST, V58, P31; LAVI E, 1984, NEUROLOGY, V34, P597, DOI 10.1212/WNL.34.5.597; Leparc-Goffart I, 1997, VIROLOGY, V239, P1, DOI 10.1006/viro.1997.8877; Lontok E, 2004, J VIROL, V78, P5913, DOI 10.1128/JVI.78.11.5913-5922.2004; Luo ZL, 1998, VIROLOGY, V244, P483, DOI 10.1006/viro.1998.9121; Luo ZL, 1998, ADV EXP MED BIOL, V440, P17; Martin I, 2000, BIOSCIENCE REP, V20, P483, DOI 10.1023/A:1010454803579; McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Nash TC, 1997, VIROLOGY, V233, P1, DOI 10.1006/viro.1997.8609; Ou XY, 2016, J VIROL, V90, P5586, DOI 10.1128/JVI.00015-16; Pecheur EI, 1999, J MEMBRANE BIOL, V167, P1, DOI 10.1007/s002329900466; Phillips JJ, 1999, J VIROL, V73, P7752, DOI 10.1128/JVI.73.9.7752-7760.1999; Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06; Sadasivan J, 2017, J BIOSCIENCES, V42, P231, DOI 10.1007/s12038-017-9676-7; Sainz B, 2005, J VIROL, V79, P7195, DOI 10.1128/JVI.79.11.7195-7206.2005; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Tiwari V, 2010, PHYTOTHER RES, V24, P1132, DOI 10.1002/ptr.3085; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Walls AC, 2016, NATURE, V531, P114, DOI 10.1038/nature16988; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	48	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8064	8087		10.1074/jbc.RA118.004418	http://dx.doi.org/10.1074/jbc.RA118.004418			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30824541	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000470656500009
J	Jung, Y; Ryu, HG; Kim, SW; Lee, KH; Gu, S; Yi, H; Ku, HO; Jang, SK; Kim, KT				Jung, Youngseob; Ryu, Hye Guk; Kim, Sung Wook; Lee, Kyung-Ha; Gu, Sohyun; Yi, Hee; Ku, Hyun-Ok; Jang, Sung Key; Kim, Kyong-Tai			The RNA-binding protein hnRNP Q represses translation of the clock gene Bmal1 in murine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian rhythm; translation control; RNA-protein interaction; RNA-binding protein; heterogeneous nuclear ribonucleoprotein (hnRNP); Bmal1; hnRNP Q	REV-ERB-ALPHA; CIRCADIAN CLOCK; MESSENGER-RNA; INDIVIDUAL FIBROBLASTS; TRANSCRIPTION; COMPONENT; EXPRESSION; PTB; PHOSPHORYLATES; DEGRADATION	Most living creatures have a circadian rhythm that is generated by a precisely regulated transcriptional-translational feedback loop of clock genes. Brain and muscle ARNT-like 1 (BMAL1) is one of the core clock genes and transcription factors that represents a positive arm of this autoregulatory circadian clock system. Despite the indispensable role of BMAL1 in the circadian rhythm, the molecular mechanisms underlying translational control of BMAL1 are largely unknown. Here, using murine NIH-3T3 cells, gene constructs, and a variety of biochemical approaches, including RNAi- and luciferase reporter gene-based assays, along with immunoblotting, in vitro transcription, quantitative real-time PCR, and real-time bioluminescence experiments, we show that translation of Bmal1 is negatively regulated by an RNA-binding protein, heterogeneous nuclear ribonucleoprotein Q (hnRNP Q). Interestingly, we found that hnRNP Q rhythmically binds to a specific region of the Bmal1 mRNA 5 UTR and controls its time-dependent expression. Moreover, we demonstrate that knockdown of hnRNP Q modulates BMAL1 protein oscillation amplitude without affecting mRNA rhythmic patterns. Furthermore, hnRNP Q depletion increases the mRNA oscillation amplitudes of BMAL1-regulated target genes. Together, our results suggest that hnRNP Q plays a pivotal role in both Bmal1 translation and BMAL1-regulated gene expression.	[Jung, Youngseob; Kim, Sung Wook; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 37673, Gyeongbuk, South Korea; [Ryu, Hye Guk; Gu, Sohyun; Jang, Sung Key; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea; [Lee, Kyung-Ha] Daegu Haany Univ, Div Cosmet Sci & Technol, Gyongsan 38610, Gyeongbuk, South Korea; [Yi, Hee; Ku, Hyun-Ok] Anim & Plant Quarantine Agcy, Vet Drugs & Biol Div, Gimcheon 39660, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Daegu Haany University; Animal & Plant Quarantine Agency	Kim, KT (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 37673, Gyeongbuk, South Korea.; Kim, KT (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea.	ktk@postech.ac.kr	Lee, Kyung-Ha/GRY-2640-2022	Lee, Kyung-Ha/0000-0003-0515-7392; Kim, Sung Wook/0000-0001-9572-4762; KIM, KYONG-TAI/0000-0001-7292-2627	Bio & Medical Technology Development Program from the National Research Foundation - Korean government (Ministry of Science and ICT, Ministry of Education) [2017M3C7A1023478, 2019R1A2C2009440]; Cooperative Research Program for Agriculture Science and Technology Development of the Rural Development Administration [PJ01324801]; Ministry of Education, Korea [10Z20130012243]	Bio & Medical Technology Development Program from the National Research Foundation - Korean government (Ministry of Science and ICT, Ministry of Education); Cooperative Research Program for Agriculture Science and Technology Development of the Rural Development Administration; Ministry of Education, Korea	This work was supported by Bio & Medical Technology Development Program Grant 2017M3C7A1023478 and Grant 2019R1A2C2009440 from the National Research Foundation funded by the Korean government (Ministry of Science and ICT, Ministry of Education), the Cooperative Research Program for Agriculture Science and Technology Development (Project PJ01324801) of the Rural Development Administration, and BK21 Plus Grant 10Z20130012243 funded by the Ministry of Education, Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gossan NC, 2014, NUCLEIC ACIDS RES, V42, P5765, DOI 10.1093/nar/gku225; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Harvey RF, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1465; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Kaminski A, 1995, RNA, V1, P924; Kim DY, 2010, NUCLEIC ACIDS RES, V38, P7068, DOI 10.1093/nar/gkq569; Kim HJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42882; Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507; Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Lau PP, 2001, BIOCHEM BIOPH RES CO, V282, P977, DOI 10.1006/bbrc.2001.4679; Lee HR, 2015, J PINEAL RES, V59, P518, DOI 10.1111/jpi.12284; Lee KH, 2014, NUCLEIC ACIDS RES, V42, P3590, DOI 10.1093/nar/gkt1379; Lee KH, 2012, MOL CELL BIOL, V32, P717, DOI 10.1128/MCB.06177-11; Lim C, 2013, NAT NEUROSCI, V16, P1544, DOI 10.1038/nn.3543; Lim I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159018; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yang ZT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3006	43	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7682	7691		10.1074/jbc.RA118.006947	http://dx.doi.org/10.1074/jbc.RA118.006947			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30948510	Green Published, hybrid			2022-12-28	WOS:000470153300014
J	Nagy, N; Gurevich, I; Kuipers, HF; Ruppert, SM; Marshall, PL; Xie, BJ; Sun, WC; Malkovskiy, AV; Rajadas, J; Grandoch, M; Fischer, JW; Frymoyer, AR; Kaber, G; Bollyky, PL				Nagy, Nadine; Gurevich, Irina; Kuipers, Hedwich F.; Ruppert, Shannon M.; Marshall, Payton L.; Xie, Bryan J.; Sun, Wenchao; Malkovskiy, Andrey V.; Rajadas, Jayakumar; Grandoch, Maria; Fischer, Jens W.; Frymoyer, Adam R.; Kaber, Gernot; Bollyky, Paul L.			4-Methylumbelliferyl glucuronide contributes to hyaluronan synthesis inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hyaluronan; diabetes; extracellular matrix; autoimmune disease; immunology; 2-photon imaging; 4-methylumbelliferone; 4-methylumbelliferyl glucuronide; glycosaminoglycan; N-acetylglucosamine (GlcNAc)	EXTRACELLULAR-MATRIX; IMMUNE TOLERANCE; PROMOTES; PHARMACOKINETICS; ACCUMULATION; AUTOIMMUNITY; RECOGNITION; MAINTENANCE; PERSISTENCE; EXPRESSION	4-Methylumbelliferone (4-MU) inhibits hyaluronan (HA) synthesis and is an approved drug used for managing biliary spasm. However, rapid and efficient glucuronidation is thought to limit its utility for systemically inhibiting HA synthesis. In particular, 4-MU in mice has a short half-life, causing most of the drug to be present as the metabolite 4-methylumbelliferyl glucuronide (4-MUG), which makes it remarkable that 4-MU is effective at all. We report here that 4-MUG contributes to HA synthesis inhibition. We observed that oral administration of 4-MUG to mice inhibits HA synthesis, promotes FoxP3(+) regulatory T-cell expansion, and prevents autoimmune diabetes. Mice fed either 4-MUG or 4-MU had equivalent 4-MU:4-MUG ratios in serum, liver, and pancreas, indicating that 4-MU and 4-MUG reach an equilibrium in these tissues. LC-tandem MS experiments revealed that 4-MUG is hydrolyzed to 4-MU in serum, thereby greatly increasing the effective bioavailability of 4-MU. Moreover, using intravital 2-photon microscopy, we found that 4-MUG (a nonfluorescent molecule) undergoes conversion into 4-MU (a fluorescent molecule) and that 4-MU is extensively tissue bound in the liver, fat, muscle, and pancreas of treated mice. 4-MUG also suppressed HA synthesis independently of its conversion into 4-MU and without depletion of the HA precursor UDP-glucuronic acid (GlcUA). Together, these results indicate that 4-MUG both directly and indirectly inhibits HA synthesis and that the effective bioavailability of 4-MU is higher than previously thought. These findings greatly alter the experimental and therapeutic possibilities for HA synthesis inhibition.	[Nagy, Nadine; Kuipers, Hedwich F.; Ruppert, Shannon M.; Marshall, Payton L.; Xie, Bryan J.; Kaber, Gernot; Bollyky, Paul L.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Gurevich, Irina] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA; [Sun, Wenchao; Malkovskiy, Andrey V.; Rajadas, Jayakumar] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery BioADD Lab, Palo Alto, CA 94304 USA; [Grandoch, Maria; Fischer, Jens W.] Univ Clin Dusseldorf, Pharmacol & Clin Pharmacol, Univ Str 1, D-40225 Dusseldorf, Germany; [Frymoyer, Adam R.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Stanford University	Nagy, N (corresponding author), Beckman Ctr, 279 Campus Dr,Rm B237, Stanford, CA 94305 USA.	nnagy@stanford.edu	Rajadas, Jayakumar/AHC-0630-2022; Sun, Wenchao/H-7738-2017; Kuipers, Hedwich F./AAF-1925-2021	Sun, Wenchao/0000-0003-4306-2896; Kuipers, Hedwich F./0000-0002-7275-5889; gurevich, irina/0000-0001-9576-0456; Nagy, Nadine/0000-0002-2638-2436; Rajadas, Jayakumar/0000-0001-6520-3923; Xie, Bryan/0000-0002-8625-5981	National Institutes of Health [NS069375]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, U01AI101984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114174, P30DK116074, R01DK096087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We appreciate the use of the Stanford Neuroscience Microscopy Service Center, supported by National Institutes of Health Grant NS069375, and we thank Dr. Andrew Olson for helpful discussions and advice regarding 2-photon measurements.	Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bollyky PL, 2012, CURR DIABETES REP, V12, P471, DOI 10.1007/s11892-012-0297-0; Bollyky PL, 2011, P NATL ACAD SCI USA, V108, P7938, DOI 10.1073/pnas.1017360108; Bollyky PL, 2010, CELL MOL IMMUNOL, V7, P211, DOI 10.1038/cmi.2010.9; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Coulson-Thomas V., 2016, BIO-PROTOCOL, V4, DOI [10.21769/bioprotoc.1236, DOI 10.21769/BIOPROTOC.1236, 10.21769/BioProtoc.1236]; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; GARRETT ER, 1993, BIOPHARM DRUG DISPOS, V14, P13, DOI 10.1002/bdd.2510140103; Hull RL, 2015, J HISTOCHEM CYTOCHEM, V63, P592, DOI 10.1369/0022155415576542; Hull RL, 2012, J HISTOCHEM CYTOCHEM, V60, P749, DOI 10.1369/0022155412457048; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Kuipers HF, 2016, CLIN EXP IMMUNOL, V185, P372, DOI 10.1111/cei.12815; Kuipers HF, 2016, P NATL ACAD SCI USA, V113, P1339, DOI 10.1073/pnas.1525086113; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Lee-Sayer SSM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00150; Mahaffey CL, 2007, J IMMUNOL, V179, P8191, DOI 10.4049/jimmunol.179.12.8191; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Medina CO, 2018, CURR OPIN IMMUNOL, V55, P22, DOI 10.1016/j.coi.2018.09.006; Mine S, 2006, ENDOCR J, V53, P761, DOI 10.1507/endocrj.K05-119; Mueller AM, 2014, J BIOL CHEM, V289, P22888, DOI 10.1074/jbc.M114.559583; MULDER GJ, 1985, BIOCHEM PHARMACOL, V34, P1325, DOI 10.1016/0006-2952(85)90513-1; Nagy N, 2015, J CLIN INVEST, V125, P3928, DOI 10.1172/JCI79271; Nagy N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00123; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Ruppert Shannon M, 2015, Int J Cell Biol, V2015, P614297, DOI 10.1155/2015/614297; TAKEDA S, 1981, J PHARMACOBIO-DYNAM, V4, P724, DOI 10.1248/bpb1978.4.724; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Termeer C, 2003, TRENDS IMMUNOL, V24, P112, DOI 10.1016/S1471-4906(03)00029-2; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2014, MATRIX BIOL, V35, P8, DOI 10.1016/j.matbio.2013.10.002; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Yoshioka Y, 2013, ARTHRITIS RHEUM-US, V65, P1160, DOI 10.1002/art.37861; Yung SS, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/207190	45	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7864	7877		10.1074/jbc.RA118.006166	http://dx.doi.org/10.1074/jbc.RA118.006166			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30914479	Green Published, hybrid			2022-12-28	WOS:000470153300027
J	Parsons, LM; Bouwman, KM; Azurmendi, H; de Vries, RP; Cipollo, JF; Verheije, MH				Parsons, Lisa M.; Bouwman, Kim M.; Azurmendi, Hugo; de Vries, Robert P.; Cipollo, John F.; Verheije, Monique H.			Glycosylation of the viral attachment protein of avian coronavirus is essential for host cell and receptor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; cell-surface receptor; glycomics; computational biology; glycoprotein; sialic acid; glycosylation; avian infectious bronchitis virus; coronavirus; receptor-binding; spike protein; viral envelope	SPIKE PROTEIN; SECONDARY STRUCTURE; MOLECULAR-GRAPHICS; SIALIC-ACID; VIRUS; DOMAIN; IBV	Avian coronaviruses, including infectious bronchitis virus (IBV), are important respiratory pathogens of poultry. The heavily glycosylated IBV spike protein is responsible for binding to host tissues. Glycosylation sites in the spike protein are highly conserved across viral genotypes, suggesting an important role for this modification in the virus life cycle. Here, we analyzed the N-glycosylation of the receptor-binding domain (RBD) of IBV strain M41 spike protein and assessed the role of this modification in host receptor binding. Ten single Asn-to-Ala substitutions at the predicted N-glycosylation sites of the M41-RBD were evaluated along with two control Val-to-Ala substitutions. CD analysis revealed that the secondary structure of all variants was retained compared with the unmodified M41-RBD construct. Six of the 10 glycosylation variants lost binding to chicken trachea tissue and an ELISA-presented 2,3-linked sialic acid oligosaccharide ligand. LC/MSE glycomics analysis revealed that glycosylation sites have specific proportions of N-glycan subtypes. Overall, the glycosylation patterns of most variant RBDs were highly similar to those of the unmodified M41-RBD construct. In silico docking experiments with the recently published cryo-EM structure of the M41 IBV spike protein and our glycosylation results revealed a potential ligand receptor site that is ringed by four glycosylation sites that dramatically impact ligand binding. Combined with the results of previous array studies, the glycosylation and mutational analyses presented here suggest a unique glycosylation-dependent binding modality for the M41 spike protein.	[Parsons, Lisa M.; Azurmendi, Hugo; Cipollo, John F.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Bouwman, Kim M.; Verheije, Monique H.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Div Pathol, NL-3584 CL Utrecht, Netherlands; [de Vries, Robert P.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Chem Biol & Drug Discovery, NL-3512 JE Utrecht, Netherlands	US Food & Drug Administration (FDA); Utrecht University; Utrecht University	Cipollo, JF (corresponding author), US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	john.cipollo@fda.hhs.gov		, Hugo/0000-0003-3540-4585; Bouwman, Kim/0000-0003-1794-6735; de Vries, Robert/0000-0002-1586-4464; Azurmendi, Hugo/0000-0002-5773-9127	Netherlands Organisation for Scientific Research (NWO); National Institutes of Health, Health and Human Services, Food and Drug Administration [Z01 BJ 02044-04 LBP]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health, Health and Human Services, Food and Drug Administration	This work was supported by The Netherlands Organisation for Scientific Research (NWO) with VENI Grants (to R. P. dV.) and MEERVOUD (to M. H. V.) and National Institutes of Health, Health and Human Services, Food and Drug Administration Grant Z01 BJ 02044-04 LBP (to L. M. P. and J. F. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An YM, 2015, J PROTEOME RES, V14, P3957, DOI 10.1021/acs.jproteome.5b00416; An YM, 2011, ANAL BIOCHEM, V415, P67, DOI 10.1016/j.ab.2011.04.018; BINNS MM, 1985, J GEN VIROL, V66, P719, DOI 10.1099/0022-1317-66-4-719; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Bucior I, 2004, GLYCOCONJUGATE J, V21, P111, DOI 10.1023/B:GLYC.0000044843.72595.7d; CAVANAGH D, 1983, J GEN VIROL, V64, P2577, DOI 10.1099/0022-1317-64-12-2577; CAVANAGH D, 1983, J GEN VIROL, V64, P1187, DOI 10.1099/0022-1317-64-5-1187; Cheng K, 2017, GLYCOBIOLOGY, V27, P200, DOI 10.1093/glycob/cww115; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432; DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; GEILHAUSEN HE, 1973, ARCH GES VIRUSFORSCH, V40, P285, DOI 10.1007/BF01242547; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Lewicki DN, 2002, J BIOL CHEM, V277, P19727, DOI 10.1074/jbc.M201837200; Lorenz B, 2012, J AM CHEM SOC, V134, P3326, DOI 10.1021/ja210304j; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Masters PS, 2013, FIELDS VIROLOGY, V6, P825; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Parsons LM, 2017, J PROTEOME RES, V16, P398, DOI 10.1021/acs.jproteome.6b00175; Peng GQ, 2012, J BIOL CHEM, V287, P41931, DOI 10.1074/jbc.M112.418210; Promkuntod N, 2014, VIROLOGY, V448, P26, DOI 10.1016/j.virol.2013.09.018; Radziejewska I, 2013, ADV CLIN EXP MED, V22, P347; Raman R, 2016, CURR OPIN STRUC BIOL, V40, P153, DOI 10.1016/j.sbi.2016.10.003; Shang J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007009; Sletmoen M, 2018, GLYCOBIOLOGY, V28, P437, DOI 10.1093/glycob/cwy032; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wickramasinghe INA, 2015, J VIROL, V89, P8783, DOI 10.1128/JVI.00745-15; Wickramasinghe INA, 2014, VIRUS RES, V194, P37, DOI 10.1016/j.virusres.2014.10.009; Wickramasinghe INA, 2011, J VIROL, V85, P8903, DOI 10.1128/JVI.05112-11; Winter C, 2006, J GEN VIROL, V87, P1209, DOI 10.1099/vir.0.81651-0; Woods Group, 2005, GLYCAM WEB; Zheng J, 2018, VIROLOGY, V513, P65, DOI 10.1016/j.virol.2017.10.003	39	42	44	3	29	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7797	7809		10.1074/jbc.RA119.007532	http://dx.doi.org/10.1074/jbc.RA119.007532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30902814	hybrid, Green Published			2022-12-28	WOS:000470153300022
J	Liu, LL; Qi, L; Knifley, T; Piecoro, DW; Rychahou, P; Liu, JP; Mitov, MI; Martin, J; Wang, C; Wu, JR; Weiss, HL; Butterfield, DA; Evers, BM; O'Connor, KL; Chen, M				Liu, Lili; Qi, Lei; Knifley, Teresa; Piecoro, Dava W.; Rychahou, Piotr; Liu, Jinpeng; Mitov, Mihail I.; Martin, Jeremiah; Wang, Chi; Wu, Jianrong; Weiss, Heidi L.; Butterfield, D. Allan; Evers, B. Mark; O'Connor, Kathleen L.; Chen, Min			S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						S100 proteins; lung cancer; mitochondria; invasion; metastasis; mitochondrial respiratory chain complex; glycolysis; energy metabolism; fibroblast-specific protein-1; metastasin-1; mitochondrial complex I; NADH:ubiquinone oxidoreductase core subunit S2 (NDUFS2); S100 calcium-binding protein A4 (S100A4); cellular respiration; non-small cell lung cancer (NSCLC)	CALCIUM-BINDING PROTEIN; TUMOR PROGRESSION; GLYCOLYSIS; EXPRESSION; BIOENERGETICS; NICLOSAMIDE; INHIBITION; PGC1-ALPHA; PHENOTYPE; METFORMIN	It is generally accepted that alterations in metabolism are critical for the metastatic process; however, the mechanisms by which these metabolic changes are controlled by the major drivers of the metastatic process remain elusive. Here, we found that S100 calcium-binding protein A4 (S100A4), a major metastasis-promoting protein, confers metabolic plasticity to drive tumor invasion and metastasis of non-small cell lung cancer cells. Investigating how S100A4 regulates metabolism, we found that S100A4 depletion decreases oxygen consumption rates, mitochondrial activity, and ATP production and also shifts cell metabolism to higher glycolytic activity. We further identified that the 49-kDa mitochondrial complex I subunit NADH dehydrogenase (ubiquinone) Fe-S protein 2 (NDUFS2) is regulated in an S100A4-dependent manner and that S100A4 and NDUFS2 exhibit co-occurrence at significant levels in various cancer types as determined by database-driven analysis of genomes in clinical samples using cBioPortal for Cancer Genomics. Importantly, we noted that S100A4 or NDUFS2 silencing inhibits mitochondrial complex I activity, reduces cellular ATP level, decreases invasive capacity in three-dimensional growth, and dramatically decreases metastasis rates as well as tumor growth in vivo. Finally, we provide evidence that cells depleted in S100A4 or NDUFS2 shift their metabolism toward glycolysis by up-regulating hexokinase expression and that suppressing S100A4 signaling sensitizes lung cancer cells to glycolysis inhibition. Our findings uncover a novel S100A4 function and highlight its importance in controlling NDUFS2 expression to regulate the plasticity of mitochondrial metabolism and thereby promote the invasive and metastatic capacity in lung cancer.	[Liu, Lili; Qi, Lei; Knifley, Teresa; Rychahou, Piotr; Liu, Jinpeng; Mitov, Mihail I.; Martin, Jeremiah; Wang, Chi; Wu, Jianrong; Weiss, Heidi L.; Butterfield, D. Allan; Evers, B. Mark; O'Connor, Kathleen L.; Chen, Min] Univ Kentucky, Markey Canc Ctr, 760 Press Ave,Res Bldg 2,Rm B344, Lexington, KY 40536 USA; [Piecoro, Dava W.] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40536 USA; [Rychahou, Piotr; Martin, Jeremiah; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40536 USA; [Liu, Jinpeng; Wang, Chi; Wu, Jianrong; Weiss, Heidi L.] Univ Kentucky, Dept Biostat, Lexington, KY 40536 USA; [Butterfield, D. Allan] Univ Kentucky, Dept Chem, Lexington, KY 40536 USA; [O'Connor, Kathleen L.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Chen, Min] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA; [Liu, Lili] Guangdong Prov Hosp Occupat Dis Prevent & Treatme, Guangzhou 510300, Guangdong, Peoples R China	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	O'Connor, KL; Chen, M (corresponding author), Univ Kentucky, Markey Canc Ctr, 760 Press Ave,Res Bldg 2,Rm B344, Lexington, KY 40536 USA.	kloconnor@uky.edu; min.chen@uky.edu	O'Connor, Kathleen/H-2569-2013	O'Connor, Kathleen/0000-0002-1088-9734	American Cancer Society Institutional Research Grant [IRG-85-001-25]; Kentucky Lung Cancer Research program; National Institutes of Health COBRE Pilot Grant [P20 GM121327]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000117]; Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment Grant [2017B030314152]; National Cancer Institute, National Institutes of Health [R01 CA109136, R01 CA195573]; NATIONAL CANCER INSTITUTE [R01CA195573, P30CA177558, R01CA109136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121327] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); Kentucky Lung Cancer Research program; National Institutes of Health COBRE Pilot Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment Grant; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society Institutional Research Grant IRG-85-001-25 (to M. C.); the Kentucky Lung Cancer Research program (to M. C.); the National Institutes of Health COBRE Pilot Grant P20 GM121327 (to M. C.); National Center for Advancing Translational Sciences, National Institutes of Health, Grant UL1TR000117 (to M. C.); Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment Grant 2017B030314152 (to L. L.); National Cancer Institute, National Institutes of Health Grant R01 CA109136 (to K. L. O.); and National Cancer Institute, National Institutes of Health, Grant R01 CA195573 (to B. M. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam MM, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0082-9; Bettum IJ, 2015, CANCER LETT, V366, P71, DOI 10.1016/j.canlet.2015.06.006; Bhowmik SK, 2015, ONCOTARGET, V6, P42651, DOI 10.18632/oncotarget.4765; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Fernandez-Aguera MC, 2015, CELL METAB, V22, P825, DOI 10.1016/j.cmet.2015.09.004; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen M, 2013, ONCOGENE, V32, P3754, DOI 10.1038/onc.2012.383; Chen M, 2011, AM J PHYSIOL-CELL PH, V300, pC1155, DOI 10.1152/ajpcell.00407.2010; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Elia I, 2016, HANDB EXP PHARMACOL, V233, P321, DOI 10.1007/164_2015_10; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; Fei F, 2017, ONCOTARGET, V8, P73219, DOI 10.18632/oncotarget.18016; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grigorian M, 1996, INT J CANCER, V67, P831, DOI 10.1002/(SICI)1097-0215(19960917)67:6<831::AID-IJC13>3.0.CO;2-4; Grotterod I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hou XB, 2016, BIOMED PHARMACOTHER, V84, P1575, DOI 10.1016/j.biopha.2016.10.037; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Li LD, 2016, NEOPLASMA, V63, P548, DOI 10.4149/neo_2016_408; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Maelandsmo GM, 1996, CANCER RES, V56, P5490; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; MOREADITH RW, 1987, J CLIN INVEST, V79, P463, DOI 10.1172/JCI112834; Moreno-Sanchez R, 2009, BIOFACTORS, V35, P209, DOI 10.1002/biof.31; Ngu LH, 2012, BBA-MOL BASIS DIS, V1822, P168, DOI 10.1016/j.bbadis.2011.10.012; Orre LM, 2013, ONCOGENE, V32, P5531, DOI 10.1038/onc.2013.213; Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Ramanujan V. K, 2015, J CELL SCI R, V6, P211, DOI [10.4172/2157-7013.1000211, DOI 10.4172/2157-7013.1000211]; Sack U, 2011, JNCI-J NATL CANCER I, V103, P1018, DOI 10.1093/jnci/djr190; Stewart RL, 2016, ONCOTARGET, V7, P34630, DOI 10.18632/oncotarget.8969; Suhane S, 2013, BIOL OPEN, V2, P295, DOI 10.1242/bio.20133244; Takenaga K, 1997, ONCOGENE, V14, P331, DOI 10.1038/sj.onc.1200820; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wen SJ, 2013, FUTURE MED CHEM, V5, P53, DOI 10.4155/fmc.12.190; Xiong XP, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2016.103; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	48	31	32	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7516	7527		10.1074/jbc.RA118.004365	http://dx.doi.org/10.1074/jbc.RA118.004365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30885944	hybrid, Green Published			2022-12-28	WOS:000468402900034
J	Ahmad, I; Li, SN; Li, RR; Chai, QQ; Zhang, LX; Wang, B; Yu, CQ; Zheng, YH				Ahmad, Iqbal; Li, Sunan; Li, Rongrong; Chai, Qingqing; Zhang, Lixin; Wang, Bin; Yu, Chongqing; Zheng, Yong-Hui			The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virus; virus entry; host-pathogen interaction; innate immunity; viral protein; EIAV S2; HIV Nef; MLV glycoGag; restriction factor; SERINC5	EQUINE INFECTIOUS-ANEMIA; HIV-1 NEF; DOWN-REGULATION; FEBRILE EPISODES; VIRUS; GENE; FAMILY	Serine incorporator 5 (SERINC5) is a recently identified restriction factor that blocks virus entry but is antagonized by three unrelated retroviral accessory proteins. The S2 protein from equine infectious anemia virus (EIAV) has been reported to reduce SERINC5 expression at steady-state levels likely via the endocytic pathway; however, the precise mechanism is still unclear. Here, we investigated how EIAV S2 protein down-regulates SERINC5 compared with down-regulation induced by Nef from HIV-1 and glycoMA proteins from murine leukemia virus (MLV). Using bimolecular fluorescence complementation (BiFC) assay and immunoprecipitation (IP), we detected an interaction between S2 and SERINC5. We found that this interaction relies on the S2 myristoylation site, indicating that it may occur on the plasma membrane. S2 internalized SERINC5 via receptor-mediated endocytosis and targeted it to endosomes and lysosomes, resulting in a ubiquitination-dependent decrease in SERINC5 expression at steady-state levels. Both BiFC and IP detected a glycoMA-SERINC5 interaction, but a Nef-SERINC5 interaction was detected only by BiFC. Moreover, S2 and glycoMA down-regulated SERINC5 more effectively than did Nef. We further show that unlike Nef, both S2 and glycoMA effectively down-regulate SERINC2 and also SERINC5 from Xenopus tropicalis (xSERINC5). Moreover, we detected expression of the equine SERINC5 (eSERINC5) protein and observed that its expression is much weaker than expression levels of SERINC5 from other species. Nonetheless, eSERINC5 had a strong antiviral activity that was effectively counteracted by S2. We conclude that HIV-1, EIAV, and MLV share a similar mechanism to antagonize viral restriction by host SERINC5.	[Ahmad, Iqbal; Li, Sunan; Li, Rongrong; Zhang, Lixin; Wang, Bin; Yu, Chongqing; Zheng, Yong-Hui] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, CAAS Michigan State Univ Joint Lab Innate Immun, Harbin Vet Res Inst, Harbin 150069, Heilongjiang, Peoples R China; [Chai, Qingqing; Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Michigan State University	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Zheng, Yong-Hui/AAP-4492-2021	Zheng, Yong-Hui/0000-0002-1098-7385; Yu, Changqing/0000-0002-9548-7151	National Natural Science Foundation of China [31700138, 31702270, 31873013]; Natural Science Foundation of Heilongjiang Province Grant [QC2018037]; China Postdoctoral Science Foundation [2017M620980]; Chinese Academy of Agricultural Sciences; NIAID, National Institutes of Health [AI120189, AI122863, AI138707]; Beijing Government scholarships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122863, R01AI120189, R21AI138707] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province Grant(Natural Science Foundation of Heilongjiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Agricultural Sciences; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Beijing Government scholarships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China Grants 31700138 (to S. L.), 31702270 (to C. Y.), and 31873013 (to B. W.); Natural Science Foundation of Heilongjiang Province Grant QC2018037 and China Postdoctoral Science Foundation Grant 2017M620980 (to S. L.); Chinese Academy of Agricultural Sciences and Beijing Government scholarships (to I. A.); and NIAID, National Institutes of Health Grants AI120189, AI122863, and AI138707 (to Y.-H. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahi YS, 2016, MBIO, V7, DOI 10.1128/mBio.01985-16; Alvarado JJ, 2014, J BIOL CHEM, V289, P28539, DOI 10.1074/jbc.M114.600031; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Chande A, 2016, P NATL ACAD SCI USA, V113, P13197, DOI 10.1073/pnas.1612044113; Cook RF, 2013, VET MICROBIOL, V167, P181, DOI 10.1016/j.vetmic.2013.09.031; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Dai WW, 2018, CELL REP, V22, P869, DOI 10.1016/j.celrep.2017.12.082; de Sousa-Pereira P, 2019, J GEN VIROL, V100, P278, DOI 10.1099/jgv.0.001201; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Fagerness AJ, 2006, VIROLOGY, V349, P22, DOI 10.1016/j.virol.2005.12.041; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Inuzuka M, 2005, J BIOL CHEM, V280, P35776, DOI 10.1074/jbc.M505712200; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Li F, 2000, J VIROL, V74, P573, DOI 10.1128/JVI.74.1.573-579.2000; Li F, 2003, J VIROL, V77, P7244, DOI 10.1128/JVI.77.13.7244-7253.2003; Li SN, 2019, J VIROL, V93, DOI 10.1128/JVI.01651-18; Park SY, 2014, BIOSCIENCE REP, V34, P381, DOI 10.1042/BSR20140069; PAYNE SL, 1994, J GEN VIROL, V75, P425, DOI 10.1099/0022-1317-75-2-425; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Shi J, 2018, J VIROL, V92, DOI 10.1128/JVI.00196-18; Sood C, 2017, J BIOL CHEM, V292, P6014, DOI 10.1074/jbc.M117.777714; Trautz B, 2016, J VIROL, V90, P10915, DOI 10.1128/JVI.01246-16; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Zhang XF, 2017, J VIROL, V91, DOI 10.1128/JVI.00137-17; Zheng YH, 1997, J GEN VIROL, V78, P807, DOI 10.1099/0022-1317-78-4-807; Zheng YH, 2000, VIRUS RES, V68, P93, DOI 10.1016/S0168-1702(00)00147-7; Zheng YH, 1997, J VIROL, V71, P5031, DOI 10.1128/JVI.71.7.5031-5039.1997	29	17	17	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7013	7024		10.1074/jbc.RA119.007662	http://dx.doi.org/10.1074/jbc.RA119.007662			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30862674	Green Published, hybrid			2022-12-28	WOS:000467394700033
J	Chen, HT; Gao, L; Yang, D; Xiao, YY; Zhang, MH; Li, CM; Wang, AH; Jin, YP				Chen, Huatao; Gao, Lei; Yang, Dan; Xiao, Yaoyao; Zhang, Manhui; Li, Cuimei; Wang, Aihua; Jin, Yaping			Coordination between the circadian clock and androgen signaling is required to sustain rhythmic expression of Elovl3 in mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen; circadian clock; liver; mouse; clock gene; Elovl3	GENE; ALPHA; TRANSCRIPTION; RECRUITMENT; DIMORPHISM; COMPONENT; HORMONES; SYSTEM; TISSUE; MODEL	ELOVL3 is a very long-chain fatty acid elongase, and its mRNA levels display diurnal rhythmic changes exclusively in adult male mouse livers. This cyclical expression of hepatic Elovl3 is potentially controlled by the circadian clock, related hormones, and transcriptional factors. It remains unknown, however, whether the circadian clock, in conjunction with androgen signaling, functions in maintaining the rhythmic expression of Elovl3 in a sexually dimorphic manner. Under either zeitgeber or circadian time, WT mouse livers exhibited a robust circadian rhythmicity in the expression of circadian clock genes and Elovl3. In contrast, male Bmal1(-/-) mice displayed severely weakened expression of hepatic circadian clock genes, resulting in relatively high, but nonrhythmic, Elovl3 expression levels. ChIP assays revealed that NR1D1 binds to the Elovl3 promoter upon circadian change in WT mouse livers in vivo, and a diminished binding was observed in male Bmal1(-/-) mouse livers. Additionally, female mouse livers exhibited constant low levels of Elovl3 expression. Castration markedly reduced Elovl3 expression levels in male mouse livers but did not disrupt circadian variation of Elovl3. Injection of female mice with 5-dihydrotestosterone induced Elovl3 rhythmicity in the liver. In AML12 cells, 5-dihydrotestosterone also elevated Elovl3 expression in a time-dependent manner. In contrast, flutamide efficiently attenuated this induction effect. In conclusion, a lack of either the circadian clock or androgen signaling impairs hepatic Elovl3 expression, highlighting the observation that coordination between the circadian clock and androgen signaling is required to sustain the rhythmic expression of Elovl3 in mouse liver.	[Chen, Huatao; Gao, Lei; Yang, Dan; Xiao, Yaoyao; Zhang, Manhui; Li, Cuimei; Jin, Yaping] Northwest A&F Univ, Coll Vet Med, Dept Clin Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Wang, Aihua] Northwest A&F Univ, Coll Vet Med, Dept Prevent Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Chen, Huatao; Gao, Lei; Yang, Dan; Xiao, Yaoyao; Zhang, Manhui; Li, Cuimei; Wang, Aihua; Jin, Yaping] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China; [Yang, Dan] Kyushu Univ, Grad Sch Agr, Lab Regulat Metab & Behav, Fukuoka, Fukuoka, Japan	Northwest A&F University - China; Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Kyushu University	Chen, HT; Jin, YP (corresponding author), Northwest A&F Univ, Coll Vet Med, Dept Clin Vet Med, Yangling 712100, Shaanxi, Peoples R China.	htchen@nwafu.edu.cn; yapingjin@163.com	Chen, Huatao/H-3755-2011	Chen, Huatao/0000-0002-3800-5013	National Natural Science Foundation of China [31771301, 31602125, 31772817]; China Postdoctoral Science Foundation [2017M61065, 2018T111112]; Shaanxi Postdoctoral Science Foundation [2017BSHEDZZ105]; Fundamental Research Funds for the Central Universities [2452017292]; Scientific Research Foundation for Talents of Shaanxi [A279021712]; Scientific Research Foundation for Talents of Northwest AF University [Z11021601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shaanxi Postdoctoral Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation for Talents of Shaanxi; Scientific Research Foundation for Talents of Northwest AF University	This work was supported by National Natural Science Foundation of China Grants 31771301 and 31602125 (to H. C.) and 31772817 (to Y. J.), China Postdoctoral Science Foundation Grants 2017M61065 and 2018T111112 (to H. C.), Shaanxi Postdoctoral Science Foundation Grant 2017BSHEDZZ105 (to H. C.), Fundamental Research Funds for the Central Universities Grant 2452017292 (to H. C.), Scientific Research Foundation for Talents of Shaanxi Grant A279021712 (to H. C.), and Scientific Research Foundation for Talents of Northwest A&F University Grant Z11021601 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Anzulovich A, 2006, J LIPID RES, V47, P2690, DOI 10.1194/jlr.M600230-JLR200; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bur IM, 2009, J BIOL CHEM, V284, P9066, DOI 10.1074/jbc.M808360200; Chao HW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02207-7; Coste H, 2002, J BIOL CHEM, V277, P27120, DOI 10.1074/jbc.M203421200; De Giorgio MR, 2010, J STEROID BIOCHEM, V122, P53, DOI 10.1016/j.jsbmb.2010.02.023; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gilardi F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004155; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Ilagan R, 2005, MOL CANCER THER, V4, P1662, DOI 10.1158/1535-7163.MCT-05-0197; Jakobsson A, 2005, AM J PHYSIOL-ENDOC M, V289, pE517, DOI 10.1152/ajpendo.00045.2005; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Ji LJ, 2016, ENDOCRINOLOGY, V157, P91, DOI 10.1210/en.2015-1674; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kobayashi T, 2012, AM J PHYSIOL-ENDOC M, V302, pE1461, DOI 10.1152/ajpendo.00623.2011; LABRIE F, 1993, CANCER-AM CANCER SOC, V72, P3816, DOI 10.1002/1097-0142(19931215)72:12+<3816::AID-CNCR2820721711>3.0.CO;2-3; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pilorz V, 2018, PFLUG ARCH EUR J PHY, V470, P227, DOI 10.1007/s00424-017-2103-y; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Xiong YJ, 2017, AM J PHYSIOL-CELL PH, V312, pC341, DOI 10.1152/ajpcell.00222.2016; Xu JH, 2018, CELL TISSUE RES, V373, P499, DOI 10.1007/s00441-018-2812-3; Yang DQ, 2018, BIOL REPROD, V98, P713, DOI 10.1093/biolre/ioy044; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; Zheng DS, 2018, MOL CELL ENDOCRINOL, V471, P33, DOI 10.1016/j.mce.2017.05.025	45	17	18	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7046	7056		10.1074/jbc.RA118.005950	http://dx.doi.org/10.1074/jbc.RA118.005950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30862677	Green Published, hybrid			2022-12-28	WOS:000467394700036
J	Li, AQ; Sun, ZP; Liu, X; Yang, JS; Jin, F; Zhu, L; Jia, WH; De Vos, S; Van Stappen, G; Bossier, P; Yang, WJ				Li, An-Qi; Sun, Zhan-Peng; Liu, Xu; Yang, Jin-Shu; Jin, Feng; Zhu, Lin; Jia, Wen-Huan; De Vos, Stephanie; Van Stappen, Gilbert; Bossier, Peter; Yang, Wei-Jun			The chloride channel cystic fibrosis transmembrane conductance regulator (CFTR) controls cellular quiescence by hyperpolarizing the cell membrane during diapause in the crustacean Artemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis transmembrane conductance regulator (CFTR); cell proliferation; cell cycle; chloride channel; channel activation; Artemia; cellular quiescence; diapause embryo; dormancy maintenance; hyperpolarization	RIBOSOMAL S6 KINASE; CYCLE ARREST; ION CHANNELS; PROLIFERATION; PROTEIN; INHIBITION; CURRENTS; INVOLVEMENT; PROGRESSION; EMBRYOS	Cellular quiescence, a reversible state in which growth, proliferation, and other cellular activities are arrested, is important for self-renewal, differentiation, development, regeneration, and stress resistance. However, the physiological mechanisms underlying cellular quiescence remain largely unknown. In the present study, we used embryos of the crustacean Artemia in the diapause stage, in which these embryos remain quiescent for prolonged periods, as a model to explore the relationship between cell-membrane potential (V-mem) and quiescence. We found that V-mem is hyperpolarized and that the intracellular chloride concentration is high in diapause embryos, whereas V-mem is depolarized and intracellular chloride concentration is reduced in postdiapause embryos and during further embryonic development. We identified and characterized the chloride ion channel protein cystic fibrosis transmembrane conductance regulator (CFTR) of Artemia (Ar-CFTR) and found that its expression is silenced in quiescent cells of Artemia diapause embryos but remains constant in all other embryonic stages. Ar-CFTR knockdown and GlyH-101-mediated chemical inhibition of Ar-CFTR produced diapause embryos having a high V-mem and intracellular chloride concentration, whereas control Artemia embryos released free-swimming nauplius larvae. Transcriptome analysis of embryos at different developmental stages revealed that proliferation, differentiation, and metabolism are suppressed in diapause embryos and restored in postdiapause embryos. Combined with RNA sequencing (RNA-Seq) of GlyH-101-treated MCF-7 breast cancer cells, these analyses revealed that CFTR inhibition down-regulates the Wnt and Aurora Kinase A (AURKA) signaling pathways and up-regulates the p53 signaling pathway. Our findings provide insight into CFTR-mediated regulation of cellular quiescence and V-mem in the Artemia model.	[Li, An-Qi; Sun, Zhan-Peng; Liu, Xu; Yang, Jin-Shu; Jin, Feng; Zhu, Lin; Jia, Wen-Huan; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [De Vos, Stephanie; Van Stappen, Gilbert; Bossier, Peter] Univ Ghent, Dept Anim Prod, Lab Aquaculture, B-9000 Ghent, Belgium; [De Vos, Stephanie; Van Stappen, Gilbert; Bossier, Peter] Univ Ghent, Dept Anim Prod, Artemia Reference Ctr, B-9000 Ghent, Belgium; [Yang, Wei-Jun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266000, Shandong, Peoples R China	Zhejiang University; Ghent University; Ghent University; Qingdao National Laboratory for Marine Science & Technology	Yang, WJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@zju.edu.cn	; Bossier, Peter/A-8118-2008	Yang, Wei-Jun/0000-0002-4591-8830; Bossier, Peter/0000-0002-6165-9111; Yang, Jin-Shu/0000-0001-6680-7737	National Major Research and Development Projects of China [2016YFA0101201]; National Natural Science Foundation of China [31730084, 41711530710]	National Major Research and Development Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Major Research and Development Projects of China Grant 2016YFA0101201 and National Natural Science Foundation of China Grants 31730084 and 41711530710. The authors declare that they have no conflicts of interest with the contents of this article.	Abatzopoulos T. J., 2002, ARTEMIA BASIC APPL B, P129; Barman PP, 2011, BIOCHEM BIOPH RES CO, V408, P12, DOI 10.1016/j.bbrc.2011.03.089; Baylie RL, 2010, J PHYSIOL PHARMACOL, V61, P543; BINGGELI R, 1986, J THEOR BIOL, V123, P377, DOI 10.1016/S0022-5193(86)80209-0; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Bordey A, 1997, J NEUROPHYSIOL, V78, P461, DOI 10.1152/jn.1997.78.1.461; BRODWICK MS, 1983, SCIENCE, V222, P1115, DOI 10.1126/science.222.4628.1115; Brown JA, 2017, CELL STEM CELL, V21, P650, DOI 10.1016/j.stem.2017.10.001; Browne R. A., 1991, ARTEMIA BIOL, P37; Chen DF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0239-4; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Chittajallu R, 2002, P NATL ACAD SCI USA, V99, P2350, DOI 10.1073/pnas.042698399; CLEGG JS, 1995, EXP CELL RES, V219, P1, DOI 10.1006/excr.1995.1197; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai L, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00453-16; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; Goddard ET, 2018, NAT CELL BIOL, V20, P1240, DOI 10.1038/s41556-018-0214-0; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; INAGAKI C, 1992, FOLIA PHARMACOL JPN, V99, P307, DOI 10.1254/fpj.99.307; Kito H, 2014, J PHARMACOL SCI, V125, P227, DOI 10.1254/jphs.14002SC; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Konig J, 2001, EMBO REP, V2, P1047, DOI 10.1093/embo-reports/kve232; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Li R, 2012, J BIOL CHEM, V287, P15923, DOI 10.1074/jbc.M111.312413; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Liang WB, 2009, HYPERTENSION, V54, P286, DOI 10.1161/HYPERTENSIONAHA.109.130138; Lirakis M, 2018, J INSECT PHYSIOL, V107, P175, DOI 10.1016/j.jinsphys.2018.04.006; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lubzens E, 2010, TOP CURR GENET, V21, P1, DOI 10.1007/978-3-642-12422-8_1; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Nakamura-Ishizu A, 2014, DEVELOPMENT, V141, P4656, DOI 10.1242/dev.106575; NOVAK I, 1992, PFLUG ARCH EUR J PHY, V422, P151, DOI 10.1007/BF00370414; Petrik D, 2018, CELL STEM CELL, V22, P865, DOI 10.1016/j.stem.2018.04.016; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; RANSOM CB, 1995, J NEUROPHYSIOL, V73, P333, DOI 10.1152/jn.1995.73.1.333; Reddy MM, 2005, J MEMBRANE BIOL, V207, P23, DOI 10.1007/s00232-005-0798-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Scriver C.R., 1995, METABOLIC MOL BASES; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Stuart JA, 2006, COMP BIOCHEM PHYS A, V143, P12, DOI 10.1016/j.cbpa.2005.11.002; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Tang YB, 2008, CELL PROLIFERAT, V41, P775, DOI 10.1111/j.1365-2184.2008.00551.x; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Wang W, 2014, SCI WORLD J, DOI 10.1155/2014/785140; Wei L, 1999, PFLUG ARCH EUR J PHY, V438, P635, DOI 10.1007/s004240051087; WOODFORK KA, 1995, J CELL PHYSIOL, V162, P163, DOI 10.1002/jcp.1041620202; Wright SH, 2004, ADV PHYSIOL EDUC, V28, P139, DOI 10.1152/advan.00029.2004; Yang F, 2012, CELL STRESS CHAPERON, V17, P577, DOI 10.1007/s12192-012-0333-7; Yang M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00185; Yao G, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0074; Yasuda T, 2008, MOL CELL NEUROSCI, V37, P284, DOI 10.1016/j.mcn.2007.10.003; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; Zheng YJ, 2003, J CELL PHYSIOL, V194, P376, DOI 10.1002/jcp.10218; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068374; Zhu L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24460-6	62	2	2	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6598	6611		10.1074/jbc.RA118.005900	http://dx.doi.org/10.1074/jbc.RA118.005900			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30765604	Green Published, hybrid			2022-12-28	WOS:000468402000033
J	Mohtar, O; Ozdemir, C; Roy, D; Shantaram, D; Emili, A; Kandror, KV				Mohtar, Omar; Ozdemir, Cafer; Roy, Debasish; Shantaram, Dharti; Emili, Andrew; Kandror, Konstantin V.			Egr1 mediates the effect of insulin on leptin transcription in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						leptin; early growth response protein 1 (Egr1); mTOR complex (mTORC); insulin; adipocyte	MAMMALIAN TARGET; MESSENGER-RNA; INHIBITS LIPOLYSIS; GENE-EXPRESSION; OBESE GENE; RAPAMYCIN; PATHWAY; MTORC1; TRANSLATION; INTEGRATION	In mammals, leptin production in adipocytes is up-regulated by feeding and insulin. Although this regulatory connection is central to all physiological effects of leptin, its molecular mechanism remains unknown. Here, we show that the transcription factor early growth response 1, Egr1, is rapidly but transiently induced by insulin in adipose cells both in vitro and in vivo, and its induction is followed by an increase in leptin transcription. ChIP and luciferase assays demonstrate that Egr1 directly binds to and activates the leptin promoter. Interestingly, the lipid droplet protein FSP27 may work as a co-factor for Egr1 in regulating leptin expression. By using siRNA-mediated knockout of Egr1 along with its overexpression in adipocytes, we demonstrate that Egr1 is both necessary and sufficient for the stimulatory effect of insulin on leptin transcription.	[Mohtar, Omar; Ozdemir, Cafer; Roy, Debasish; Shantaram, Dharti; Emili, Andrew; Kandror, Konstantin V.] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St, Boston, MA 02118 USA	Boston University	Kandror, KV (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St, Boston, MA 02118 USA.	kkandror@bu.edu		Kandror, Konstantin/0000-0002-8601-9313; Roy, Debasish/0000-0001-7516-8615; SHANTARAM, DHARTI/0000-0003-2637-8039	National Institutes of Health Institutional Training Grant [T32DK007201]; National Institutes of Health Research Grants [DK52057, DK107498]; American Diabetes Association Research Grant [1-18-IBS-266]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052057, R01DK107498, T32DK007201] Funding Source: NIH RePORTER	National Institutes of Health Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Research Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Research Grant(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Institutional Training Grant T32DK007201 (to O. M.); National Institutes of Health Research Grants DK52057, DK107498 (to K. V. K.); and American Diabetes Association Research Grant 1-18-IBS-266 (to K. V. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Cardamone MD, 2018, JOVE-J VIS EXP, DOI 10.3791/58682; Carnevalli LS, 2010, DEV CELL, V18, P763, DOI 10.1016/j.devcel.2010.02.018; Chakrabarti P, 2008, MOL ENDOCRINOL, V22, P2260, DOI 10.1210/me.2008-0148; Chakrabarti P, 2013, MOL CELL BIOL, V33, P3659, DOI 10.1128/MCB.01584-12; Chakrabarti P, 2010, DIABETES, V59, P775, DOI 10.2337/db09-1602; Dalamaga M, 2013, CELL METAB, V18, P29, DOI 10.1016/j.cmet.2013.05.010; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Gallardo-Montejano VI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12723; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; Kandror K. V., 2016, POSTTRANSCRIPTIONAL, P221; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kim J, 2019, MOL BIOL REP, V46, P317, DOI 10.1007/s11033-018-4474-3; Labun K, 2019, GENOME RES, V29, P843, DOI 10.1101/gr.244293.118; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee MJ, 2007, J BIOL CHEM, V282, P72, DOI 10.1074/jbc.M609518200; Lee MJ, 2006, J LIPID RES, V47, P1984, DOI 10.1194/jlr.M600065-JLR200; Lee MJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1230, DOI 10.1152/ajpendo.90927.2008; Levy R, 1997, BIOCHEM BIOPH RES CO, V237, P98, DOI 10.1006/bbrc.1997.7086; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Roh C, 2003, AM J PHYSIOL-ENDOC M, V284, pE322, DOI 10.1152/ajpendo.00230.2002; Russell CD, 2001, AM J PHYSIOL-ENDOC M, V280, pE399, DOI 10.1152/ajpendo.2001.280.3.E399; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Singh M, 2015, J BIOL CHEM, V290, P17331, DOI 10.1074/jbc.M114.631895; Singh M, 2014, J BIOL CHEM, V289, P14481, DOI 10.1074/jbc.C114.563080; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang CY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000143; Wang WS, 2012, NAT MED, V18, P235, DOI 10.1038/nm.2614; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Zeng WW, 2015, CELL, V163, P84, DOI 10.1016/j.cell.2015.08.055; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	42	10	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5784	5789		10.1074/jbc.AC119.007855	http://dx.doi.org/10.1074/jbc.AC119.007855			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30846562	Green Published, hybrid			2022-12-28	WOS:000465077500005
J	Stancill, JS; Broniowska, KA; Oleson, BJ; Naatz, A; Corbett, JA				Stancill, Jennifer S.; Broniowska, Katarzyna A.; Oleson, Bryndon J.; Naatz, Aaron; Corbett, John A.			Pancreatic beta-cells detoxify H2O2 through the peroxiredoxin/thioredoxin antioxidant system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; beta-cell; oxidative stress; thioredoxin reductase; reactive oxygen species (ROS); diabetes; metabolic dysfunction; oxidative phosphorylation; ROS detoxification	OXIDATIVE STRESS; DNA-DAMAGE; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; INSULIN-SECRETION; RINM5F CELLS; NITRIC-OXIDE; GLUCOSE; EXPRESSION; TOXICITY	Oxidative stress is thought to promote pancreatic beta-cell dysfunction and contribute to both type 1 and type 2 diabetes. Reactive oxygen species (ROS), such as superoxide and hydrogen peroxide, are mediators of oxidative stress that arise largely from electron leakage during oxidative phosphorylation. Reports that beta-cells express low levels of antioxidant enzymes, including catalase and GSH peroxidases, have supported a model in which beta-cells are ill-equipped to detoxify ROS. This hypothesis seems at odds with the essential role of beta-cells in the control of metabolic homeostasis and organismal survival through exquisite coupling of oxidative phosphorylation, a prominent ROS-producing pathway, to insulin secretion. Using glucose oxidase to deliver H2O2 continuously over time and Amplex Red to measure extracellular H2O2 concentration, we found here that beta-cells can remove micromolar levels of this oxidant. This detoxification pathway utilizes the peroxiredoxin/thioredoxin antioxidant system, as selective chemical inhibition or siRNA-mediated depletion of thioredoxin reductase sensitized beta-cells to continuously generated H2O2. In contrast, when delivered as a bolus, H2O2 induced the DNA damage response, depleted cellular energy stores, and decreased beta-cell viability independently of thioredoxin reductase inhibition. These findings show that beta-cells have the capacity to detoxify micromolar levels of H2O2 through a thioredoxin reductase-dependent mechanism and are not as sensitive to oxidative damage as previously thought.	[Stancill, Jennifer S.; Broniowska, Katarzyna A.; Oleson, Bryndon J.; Naatz, Aaron; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu		Stancill, Jennifer/0000-0002-1612-4695	NIDDK, National Institutes of Health [DK-052194]; Division of Intramural Research, NIAID, National Institutes of Health [AI-044458]; NHLBI, National Institutes of Health [T32 HL134643]; American Heart Association Fellowship [14PRE20380585]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL134643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grant DK-052194; Division of Intramural Research, NIAID, National Institutes of Health Grant AI-044458; and a gift from the Forest County Potawatomi Foundation (to J. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the NHLBI, National Institutes of Health Grant T32 HL134643.; Supported by American Heart Association Fellowship 13POST16940076.; Supported by American Heart Association Fellowship 14PRE20380585.	Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053; Alfar EA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03873-9; Bast A, 2002, DIABETOLOGIA, V45, P867, DOI 10.1007/s00125-002-0846-1; Benhamou PY, 1998, DIABETOLOGIA, V41, P1093, DOI 10.1007/s001250051035; Broniowska KA, 2015, J BIOL CHEM, V290, P7952, DOI 10.1074/jbc.M114.627869; Broniowska KA, 2013, BIOCHEMISTRY-US, V52, P4364, DOI 10.1021/bi400342t; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; GHISELLI A, 1992, FREE RADICAL BIO MED, V13, P621, DOI 10.1016/0891-5849(92)90036-G; GOPAUL NK, 1995, FEBS LETT, V368, P225, DOI 10.1016/0014-5793(95)00649-T; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hotta M, 1998, J EXP MED, V188, P1445, DOI 10.1084/jem.188.8.1445; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kalyanaraman B, 2017, ARCH BIOCHEM BIOPHYS, V617, P38, DOI 10.1016/j.abb.2016.08.021; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Khan P, 2014, APPL BIOCHEM BIOTECH, V173, P333, DOI 10.1007/s12010-014-0850-1; KUBISCH HM, 1994, P NATL ACAD SCI USA, V91, P9956, DOI 10.1073/pnas.91.21.9956; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Lenzen S, 2017, BBA-GEN SUBJECTS, V1861, P1929, DOI 10.1016/j.bbagen.2017.05.013; Long LH, 2009, BIOCHEM BIOPH RES CO, V388, P700, DOI 10.1016/j.bbrc.2009.08.069; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Marinho HS, 2013, METHOD ENZYMOL, V526, P159, DOI 10.1016/B978-0-12-405883-5.00010-7; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Mehmeti I, 2014, J BIOL CHEM, V289, P26904, DOI 10.1074/jbc.M114.568329; Munro D, 2017, J EXP BIOL, V220, P1170, DOI 10.1242/jeb.132142; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; NOUROOZZADEH J, 1995, DIABETES, V44, P1054, DOI 10.2337/diabetes.44.9.1054; Olahova M, 2015, AGING CELL, V14, P558, DOI 10.1111/acel.12321; Oleson BJ, 2016, MOL CELL BIOL, V36, P2067, DOI 10.1128/MCB.00262-16; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Paula FMM, 2013, MOL CELL ENDOCRINOL, V374, P56, DOI 10.1016/j.mce.2013.04.009; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rehman A, 1999, FEBS LETT, V448, P120, DOI 10.1016/S0014-5793(99)00339-7; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shin CS, 2001, DIABETES CARE, V24, P733, DOI 10.2337/diacare.24.4.733; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; STOCCHI V, 1987, ANAL BIOCHEM, V167, P181, DOI 10.1016/0003-2697(87)90150-3; Stocker S, 2018, NAT CHEM BIOL, V14, P148, DOI 10.1038/nchembio.2536; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Tiedge M, 1998, DIABETES, V47, P1578, DOI 10.2337/diabetes.47.10.1578; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wolf G, 2010, J ENDOCRINOL, V207, P163, DOI 10.1677/JOE-09-0455; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xu B, 1999, FREE RADICAL BIO MED, V27, P830, DOI 10.1016/S0891-5849(99)00130-6; Zhao F, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-22	57	39	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4843	4853		10.1074/jbc.RA118.006219	http://dx.doi.org/10.1074/jbc.RA118.006219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30659092	hybrid, Green Published			2022-12-28	WOS:000463985600010
J	Unciuleac, MC; Goldgur, Y; Shuman, S				Unciuleac, Mihaela-Carmen; Goldgur, Yehuda; Shuman, Stewart			Structures of ATP-bound DNA ligase D in a closed domain conformation reveal a network of amino acid and metal contacts to the ATP phosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; enzyme structure; ATP; metal ion-protein interaction; catalysis; Mycobacterium tuberculosis; covalent nucleotidyltransferase; DNA ligase; lysyl-AMP; two metal mechanism	END-JOINING FUNCTION; CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; RNA; REPAIR; MECHANISM; COMPONENT; RECOGNITION; DISPLAYS; 2-METAL	DNA ligases are the sine qua non of genome integrity and essential for DNA replication and repair in all organisms. DNA ligases join 3'-OH and 5'-PO4 ends via a series of three nucleotidyl transfer steps. In step 1, ligase reacts with ATP or NAD(+) to form a covalent ligase-(lysyl-N zeta)-AMP intermediate and release pyrophosphate (PPi) or nicotinamide mononucleotide. In step 2, AMP is transferred from ligase-adenylate to the 5'-PO4 DNA end to form a DNA-adenylate intermediate (AppDNA). In step 3, ligase catalyzes attack by a DNA 3'-OH on the DNA-adenylate to seal the two ends via a phosphodiester bond and release AMP. Eukaryal, archaeal, and many bacterial and viral DNA ligases are ATP-dependent. The catalytic core of ATP-dependent DNA ligases consists of an N-terminal nucleotidyltransferase domain fused to a C-terminal OB domain. Here we report crystal structures at 1.4-1.8 angstrom resolution of Mycobacterium tuberculosis LigD, an ATP-dependent DNA ligase dedicated to nonhomologous end joining, in complexes with ATP that highlight large movements of the OB domain (similar to 50 angstrom), from a closed conformation in the ATP complex to an open conformation in the covalent ligase-AMP intermediate. The LigD center dot ATP structures revealed a network of amino acid contacts to the ATP phosphates that stabilize the transition state and orient the PPi leaving group. Acomplex with ATP and magnesium suggested a two-metal mechanism of lysine adenylylation driven by a catalytic Mg2+ that engages the ATP alpha phosphate and a second metal that bridges the ATP beta and gamma phosphates.	[Unciuleac, Mihaela-Carmen; Shuman, Stewart] Sloan Kettering Inst, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA; [Goldgur, Yehuda] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM126945, AI64693]; NCI, National Institutes of Health [P30-CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P41GM103403, R35GM126945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM126945 and AI64693. The Memorial Sloan Kettering Cancer Center structural biology core laboratory is supported by NCI, National Institutes of Health Grant P30-CA008748. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akey D, 2006, J BIOL CHEM, V281, P13412, DOI 10.1074/jbc.M513550200; Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Banerjee A, 2019, NUCLEIC ACIDS RES, V47, P1428, DOI 10.1093/nar/gky1275; Chakravarty AK, 2011, J BIOL CHEM, V286, P4117, DOI 10.1074/jbc.M110.196766; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; El Omari K, 2006, J BIOL CHEM, V281, P1573, DOI 10.1074/jbc.M509658200; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Gong CL, 2004, J BIOL CHEM, V279, P20594, DOI 10.1074/jbc.M401841200; Gu HQ, 2016, NUCLEIC ACIDS RES, V44, P2337, DOI 10.1093/nar/gkw094; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaminski AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05024-8; Kim DJ, 2009, ACTA CRYSTALLOGR F, V65, P544, DOI 10.1107/S1744309109017485; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nair PA, 2010, P NATL ACAD SCI USA, V107, P12822, DOI 10.1073/pnas.1005830107; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Nandakumar J, 2006, CELL, V127, P71, DOI 10.1016/j.cell.2006.08.038; Nishida H, 2006, J MOL BIOL, V360, P956, DOI 10.1016/j.jmb.2006.05.062; Ochi T, 2013, STRUCTURE, V21, P672, DOI 10.1016/j.str.2013.02.014; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2008, CURR OPIN STRUC BIOL, V18, P96, DOI 10.1016/j.sbi.2007.12.008; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Petrova T, 2012, ACTA CRYSTALLOGR F, V68, P1440, DOI 10.1107/S1744309112043394; Piserchio A, 2010, J MOL BIOL, V395, P291, DOI 10.1016/j.jmb.2009.11.007; Pitcher RS, 2007, J MOL BIOL, V366, P391, DOI 10.1016/j.jmb.2006.10.046; Sawaya R, 2003, BIOCHEMISTRY-US, V42, P8240, DOI 10.1021/bi034396d; Shi K, 2018, NUCLEIC ACIDS RES, V46, P10474, DOI 10.1093/nar/gky776; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Smith P, 2012, P NATL ACAD SCI USA, V109, P2296, DOI 10.1073/pnas.1116827109; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; Unciuleac MC, 2017, P NATL ACAD SCI USA, V114, P2592, DOI 10.1073/pnas.1619220114; Unciuleac MC, 2015, P NATL ACAD SCI USA, V112, P13868, DOI 10.1073/pnas.1516536112; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang P, 2012, P NATL ACAD SCI USA, V109, P13248, DOI 10.1073/pnas.1209805109; Williamson A, 2018, NUCLEIC ACIDS RES, V46, P8616, DOI 10.1093/nar/gky622; Williamson A, 2014, ACTA CRYSTALLOGR D, V70, P3043, DOI 10.1107/S1399004714021099; Zhu H, 2006, P NATL ACAD SCI USA, V103, P1711, DOI 10.1073/pnas.0509083103; Zhu H, 2008, J BIOL CHEM, V283, P8331, DOI 10.1074/jbc.M705476200; Zhu H, 2007, NUCLEIC ACIDS RES, V35, P3631, DOI 10.1093/nar/gkm145	43	7	7	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5094	5104		10.1074/jbc.RA119.007445	http://dx.doi.org/10.1074/jbc.RA119.007445			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718283	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000463985600031
J	Liu, Y; Xu, XF; Lin, P; He, YM; Zhang, YW; Cao, BY; Zhang, ZB; Sethi, G; Liu, JB; Zhou, XM; Mao, XL				Liu, Yan; Xu, Xiaofeng; Lin, Peng; He, Yuanming; Zhang, Yawen; Cao, Biyin; Zhang, Zubin; Sethi, Gautam; Liu, Jinbao; Zhou, Xiumin; Mao, Xinliang			Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; drug resistance; ubiquitylation (ubiquitination); deubiquitylation (deubiquitination); cancer; apoptosis; pre-B cell leukemia homeobox-1; prostate cancer; protein degradation; USP9x	PROLIFERATION; CHEMORESISTANCE; TARGET	Chemoresistance is a leading obstacle in effective management of advanced prostate cancer (PCa). A better understanding of the molecular mechanisms involved in PCa chemoresistance could improve treatment of patients with PCa. In the present study, using immune histochemical, chemistry, and precipitation assays with cells from individuals with benign or malignant prostate cancer or established PCa cell lines, we found that the oncogenic transcription factor pre-B cell leukemia homeobox-1 (PBX1) promotes PCa cell proliferation and confers to resistance against common anti-cancer drugs such as doxorubicin and cisplatin. We observed that genetic PBX1 knockdown abrogates this resistance, and further experiments revealed that PBX1 stability was modulated by the ubiquitin-proteasomal pathway. To directly probe the impact of this pathway on PBX1 activity, we screened for PBX1-specific deubiquitinases (Dubs) and found that ubiquitin-specific peptidase 9 X-linked (USP9x) interacted with and stabilized the PBX1 protein by attenuating its Lys-48-linked polyubiquitination. Moreover, the USP9x inhibitor WP1130 markedly induced PBX1 degradation and promoted PCa cell apoptosis. The results in this study indicate that PBX1 confers to PCa chemoresistance and identify USP9x as a Dub of PBX1. We concluded that targeting the USP9x/PBX1 axis could be a potential therapeutic strategy for managing advanced prostate cancer.	[Liu, Yan; Zhang, Zubin; Liu, Jinbao; Mao, Xinliang] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Sch Basic Med Sci, Key Lab Prot Modificat & Degradat, Guangzhou 511436, Guangdong, Peoples R China; [Liu, Yan; Lin, Peng; He, Yuanming; Zhang, Yawen; Cao, Biyin; Zhang, Zubin; Mao, Xinliang] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Xiaofeng] Nanjing Univ, Sch Med, Nanjing Jinling Hosp, Dept Urol, Nanjing 21002, Jiangsu, Peoples R China; [Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117600, Singapore; [Zhou, Xiumin] Soochow Univ, Affiliated Hosp 1, Dept Oncol, Suzhou 215006, Jiangsu, Peoples R China; [Liu, Yan] Sichuan Kelun Pharmaceut Co Ltd, Chengdu 610071, Sichuan, Peoples R China	Guangzhou Medical University; Soochow University - China; Nanjing University; National University of Singapore; Soochow University - China	Zhou, XM (corresponding author), Soochow Univ, Affiliated Hosp 1, 188 Shizi St, Suzhou 215006, Jiangsu, Peoples R China.; Mao, XL (corresponding author), Guangzhou Med Univ, Key Lab Prot Modificat & Degradat, Guangzhou 511436, Guangdong, Peoples R China.	alice-xm@163.com; xinliangmao@gzhmu.edu.cn	Sethi, Gautam/F-2372-2011	Sethi, Gautam/0000-0002-8677-8475	National Natural Science Foundation of China [81770154, 30901716, 81320108023, 81770215]; Natural Science Foundation of Jiangsu Higher Education Institutes of China [17KJA180010]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Key Laboratory of Neuropsychiatric Diseases [BK2013003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Higher Education Institutes of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Key Laboratory of Neuropsychiatric Diseases	This work was supported by National Natural Science Foundation of China Grants 81770154 (to X. M.), 30901716 (to X. X.), 81320108023 (to X. M.), and 81770215 (to B. C.), Natural Science Foundation of Jiangsu Higher Education Institutes of China Grant 17KJA180010 (to X. M.), the Priority Academic Program Development of Jiangsu Higher Education Institutions (to X. M.), and Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant BK2013003 (to X. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Boutros PC, 2015, NAT GENET, V47, P736, DOI 10.1038/ng.3315; Chang AJ, 2014, NAT REV CLIN ONCOL, V11, P308, DOI 10.1038/nrclinonc.2014.68; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; He CY, 2017, ONCOTARGET, V8, P46818, DOI 10.18632/oncotarget.17473; Jiang N, 2017, ONCOTARGET, V8; Jung JG, 2016, CANCER RES, V76, P6351, DOI 10.1158/0008-5472.CAN-16-0980; KAMPS MP, 1991, GENE DEV, V5, P358, DOI 10.1101/gad.5.3.358; Li L, 2018, ONCOGENE, V37, P2422, DOI 10.1038/s41388-018-0134-2; Lin CL, 2017, BBA-MOL CELL RES, V1864, P1867, DOI 10.1016/j.bbamcr.2017.07.015; Magnani L, 2015, ONCOTARGET, V6, P21878, DOI 10.18632/oncotarget.4243; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Mao XL, 2011, MOL PHARMACOL, V79, P672, DOI 10.1124/mol.110.068122; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517; Ramberg H, 2016, INT J CANCER, V139, P1810, DOI 10.1002/ijc.30220; Risolino M, 2014, P NATL ACAD SCI USA, V111, pE3775, DOI 10.1073/pnas.1407074111; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shen JJ, 2018, CANCER RES, V78, P359, DOI 10.1158/0008-5472.CAN-17-1805; Sun HS, 2011, BLOOD, V117, P3151, DOI 10.1182/blood-2010-03-276477; Sykes DB, 2004, MOL CELL BIOL, V24, P1256, DOI 10.1128/MCB.24.3.1256-1269.2004; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; Trivigno D, 2012, NEOPLASIA, V14, P893, DOI 10.1593/neo.12598; Wade CA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030904; Wang S, 2014, P NATL ACAD SCI USA, V111, P4251, DOI 10.1073/pnas.1322198111; Xu X, 2016, J BIOL CHEM, V291, P9617, DOI 10.1074/jbc.M115.701979; Xu YJ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0499-7; Zhang W, 2015, INT J BIOL SCI, V11, P1160, DOI 10.7150/ijbs.11439; Zhang ZB, 2016, BLOOD, V127, P1676, DOI 10.1182/blood-2015-07-658203; Zhu XM, 2017, AM J CANCER RES, V7, P1642	31	23	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4572	4582		10.1074/jbc.RA118.006057	http://dx.doi.org/10.1074/jbc.RA118.006057			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30718275	Green Published, hybrid			2022-12-28	WOS:000462969500024
J	Gonzalez-Magana, A; de Opakua, AI; Romano-Moreno, M; Murciano-Calles, J; Merino, N; Luque, I; Rojas, AL; Onesti, S; Blanco, FJ; De Biasio, A				Gonzalez-Magana, Amaia; Ibanez de Opakua, Alain; Romano-Moreno, Miguel; Murciano-Calles, Javier; Merino, Nekane; Luque, Irene; Rojas, Adriana L.; Onesti, Silvia; Blanco, Francisco J.; De Biasio, Alfredo			The p12 subunit of human polymerase uses an atypical PIP box for molecular recognition of proliferating cell nuclear antigen (PCNA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; DNA polymerase; proliferating cell nuclear antigen (PCNA); protein-protein interaction; processivity; protein structure; PCNA interacting sequence; PIP-box	DNA-POLYMERASE; UBIQUITIN LIGASE; DELTA; REPLICATION; PROTEIN; DAMAGE; DEGRADATION; PREDICTION; COMPLEX; MOTIFS	Human DNA polymerase is essential for DNA replication and acts in conjunction with the processivity factor proliferating cell nuclear antigen (PCNA). In addition to its catalytic subunit (p125), pol comprises three regulatory subunits (p50, p68, and p12). PCNA interacts with all of these subunits, but only the interaction with p68 has been structurally characterized. Here, we report solution NMR-, isothermal calorimetry-, and X-ray crystallography-based analyses of the p12-PCNA interaction, which takes part in the modulation of the rate and fidelity of DNA synthesis by pol . We show that p12 binds with micromolar affinity to the classical PIP-binding pocket of PCNA via a highly atypical PIP box located at the p12 N terminus. Unlike the canonical PIP box of p68, the PIP box of p12 lacks the conserved glutamine; binds through a 2-fork plug made of an isoleucine and a tyrosine residue at +3 and +8 positions, respectively; and is stabilized by an aspartate at +6 position, which creates a network of intramolecular hydrogen bonds. These findings add to growing evidence that PCNA can bind a diverse range of protein sequences that may be broadly grouped as PIP-like motifs as has been previously suggested.	[Gonzalez-Magana, Amaia; Ibanez de Opakua, Alain; Romano-Moreno, Miguel; Merino, Nekane; Rojas, Adriana L.; Blanco, Francisco J.] CIC bioGUNE, Parque Tecnol Bizkaia Edificio 800, Derio 48160, Spain; [Murciano-Calles, Javier; Luque, Irene] Univ Granada, Dept Phys Chem, E-18071 Granada, Spain; [Murciano-Calles, Javier; Luque, Irene] Univ Granada, Inst Biotechnol, E-18071 Granada, Spain; [Onesti, Silvia; De Biasio, Alfredo] Elettra Sincrotrone Trieste SCpA, Struct Biol Lab, I-34149 Trieste, Italy; [Blanco, Francisco J.] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain; [De Biasio, Alfredo] Univ Leicester, Leicester Inst Struct & Chem Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England; [De Biasio, Alfredo] Univ Leicester, Dept Mol & Cell Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England; [Ibanez de Opakua, Alain] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany	CIC bioGUNE; University of Granada; University of Granada; Elettra Sincrotrone Trieste; Basque Foundation for Science; University of Leicester; University of Leicester; Max Planck Society	Blanco, FJ (corresponding author), CIC bioGUNE, Parque Tecnol Bizkaia Edificio 800, Derio 48160, Spain.; De Biasio, A (corresponding author), Univ Leicester, Leicester Inst Struct & Chem Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England.; De Biasio, A (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England.	fblanco@cicbiogune.es; adb43@leicester.ac.uk	Blanco, Francisco J/D-4401-2009; Luque, Irene/K-4758-2012; Ibáñez de Opakua, Alain/H-5081-2018; Murciano-Calles, Javier/J-8897-2012; Rojas, Adriana L./G-2403-2011	Blanco, Francisco J/0000-0003-2545-4319; Luque, Irene/0000-0003-2757-4779; Ibáñez de Opakua, Alain/0000-0003-1700-9354; Murciano-Calles, Javier/0000-0002-8667-1651; Gonzalez Magana, Amaia/0000-0002-6007-8390; Rojas, Adriana L./0000-0002-7358-3505; Onesti, Silvia/0000-0002-0612-7948; De Biasio, Alfredo/0000-0003-2139-2958	Italian Association for Cancer Research (iCARE fellowship from AIRC); Italian Association for Cancer Research (European Commission); Italian Association for Cancer Research (AIRC Grant) [IG14718]; MINECO/FEDER, UE [CTQ2017-83810-R]; MINECO Fellowship [BES-2015-075847]; Basque Government Predoctoral Fellowship [PRE_2016_2_0249]	Italian Association for Cancer Research (iCARE fellowship from AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Association for Cancer Research (European Commission); Italian Association for Cancer Research (AIRC Grant)(Fondazione AIRC per la ricerca sul cancro); MINECO/FEDER, UE(Spanish Government); MINECO Fellowship(Spanish Government); Basque Government Predoctoral Fellowship	This work was supported by the Italian Association for Cancer Research (iCARE fellowship from AIRC and the European Commission to A. D. B. and AIRC Grant IG14718 to S. O.), by Grant CTQ2017-83810-R (MINECO/FEDER, UE; to F. J. B.), by MINECO Fellowship BES-2015-075847 (to A. G.-M.), and by Basque Government Predoctoral Fellowship PRE_2016_2_0249 (to M. R.-M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Boehm EM, 2016, BIOESSAYS, V38, P1117, DOI 10.1002/bies.201600116; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Choe KN, 2017, MOL CELL, V65, P380, DOI 10.1016/j.molcel.2016.12.020; De Biasio A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7439; De Biasio A, 2013, ADV PROTEIN CHEM STR, V91, P1, DOI 10.1016/B978-0-12-411637-5.00001-9; De Biasio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048390; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hara K, 2018, ACTA CRYSTALLOGR F, V74, P214, DOI 10.1107/S2053230X18003242; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Hedglin M, 2016, ELIFE, V5, DOI 10.7554/eLife.19788; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hoffmann S, 2016, J CELL BIOL, V212, P63, DOI 10.1083/jcb.201506071; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Kaufmann T, 2017, NUCLEIC ACIDS RES, V45, P9741, DOI 10.1093/nar/gkx604; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Lee MYWT, 2017, GENES-BASEL, V8, DOI 10.3390/genes8070190; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Mo JY, 2000, BIOCHEMISTRY-US, V39, P7245, DOI 10.1021/bi0000871; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishida H, 2009, P NATL ACAD SCI USA, V106, P20693, DOI 10.1073/pnas.0907780106; Olaisen C, 2018, FEBS OPEN BIO, V8, P1135, DOI 10.1002/2211-5463.12442; Palacios A, 2008, J BIOL CHEM, V283, P15956, DOI 10.1074/jbc.M710020200; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; Rahmeh AA, 2012, BIOCHEMISTRY-US, V51, P416, DOI 10.1021/bi201638e; Sebesta M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15847; Tahirov Tahir H, 2012, Subcell Biochem, V62, P217, DOI 10.1007/978-94-007-4572-8_12; TAN CK, 1986, J BIOL CHEM, V261, P2310; Urban V, 2016, J CELL BIOL, V214, P401, DOI 10.1083/jcb.201507099; Wang Y, 2016, BIOCHEM BIOPH RES CO, V474, P264, DOI 10.1016/j.bbrc.2016.04.053; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027092; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; Zhang P, 1999, J BIOL CHEM, V274, P26647, DOI 10.1074/jbc.274.38.26647; ZHANG SJ, 1995, J BIOL CHEM, V270, P7988, DOI 10.1074/jbc.270.14.7988; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhang SF, 2013, J BIOL CHEM, V288, P29550, DOI 10.1074/jbc.M113.490466; Zhou YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039156	54	10	10	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3947	3956		10.1074/jbc.RA118.006391	http://dx.doi.org/10.1074/jbc.RA118.006391			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655288	Green Published, hybrid			2022-12-28	WOS:000461854400012
J	Sanchez-Lozada, LG; Andres-Hernando, A; Garcia-Arroyo, FE; Cicerchi, C; Li, NX; Kuwabara, M; Roncal-Jimenez, CA; Johnson, RJ; Lanaspa, MA				Sanchez-Lozada, Laura G.; Andres-Hernando, Ana; Garcia-Arroyo, Fernando E.; Cicerchi, Christina; Li, Nanxing; Kuwabara, Masanari; Roncal-Jimenez, Carlos A.; Johnson, Richard J.; Lanaspa, Miguel A.			Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fructose; uric acid; metabolic syndrome; liver metabolism; fatty acid; aldose reductase; polyol pathway; sorbitol	TRANSCRIPTIONAL ACTIVATOR; CELL-PROLIFERATION; METABOLIC SYNDROME; HYPERTONIC STRESS; DIETARY FRUCTOSE; OXIDATIVE STRESS; EXPRESSION; DISEASE; CONSUMPTION; CHILDREN	Dietary, fructose-containing sugars have been strongly associated with the development of nonalcoholic fatty liver disease (NAFLD). Recent studies suggest that fructose also can be produced via the polyol pathway in the liver, where it may induce hepatic fat accumulation. Moreover, fructose metabolism yields uric acid, which is highly associated with NAFLD. Here, using biochemical assays, reporter gene expression, and confocal fluorescence microscopy, we investigated whether uric acid regulates aldose reductase, a key enzyme in the polyol pathway. We evaluated whether soluble uric acid regulates aldose reductase expression both in cultured hepatocytes (HepG2 cells) and in the liver of hyperuricemic rats and whether this stimulation is associated with endogenous fructose production and fat accumulation. Uric acid dose-dependently stimulated aldose reductase expression in the HepG2 cells, and this stimulation was associated with endogenous fructose production and triglyceride accumulation. This stimulatory mechanism was mediated by uric acid-induced oxidative stress and stimulation of the transcription factor nuclear factor of activated T cells 5 (NFAT5). Uric acid also amplified the effects of elevated glucose levels to stimulate hepatocyte triglyceride accumulation. Hyperuricemic rats exhibited elevated hepatic aldose reductase expression, endogenous fructose accumulation, and fat buildup that was significantly reduced by co-administration of the xanthine oxidase inhibitor allopurinol. These results suggest that uric acid generated during fructose metabolism may act as a positive feedback mechanism that stimulates endogenous fructose production by stimulating aldose reductase in the polyol pathway. Our findings suggest an amplifying mechanism whereby soft drinks rich in glucose and fructose can induce NAFLD.	[Sanchez-Lozada, Laura G.; Garcia-Arroyo, Fernando E.] Inst Nacl Cardiol Ignacio Chavez, Lab Renal Physiopathol, Mexico City 14080, DF, Mexico; [Andres-Hernando, Ana; Cicerchi, Christina; Li, Nanxing; Kuwabara, Masanari; Roncal-Jimenez, Carlos A.; Johnson, Richard J.; Lanaspa, Miguel A.] Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA	National Institute of Cardiology - Mexico; University of Colorado System; University of Colorado Anschutz Medical Campus	Lanaspa, MA (corresponding author), Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.	miguel.lanaspagarcia@ucdenver.edu	Lanaspa, Miguel/AAO-4971-2020; Sanchez-Lozada, Laura/AAS-2104-2021; Kuwabara, Masanari/O-9844-2017	Kuwabara, Masanari/0000-0002-6601-4347; Andres-Hernando, Ana/0000-0002-0676-0188; Lanaspa, Miguel/0000-0002-1163-1831; Garcia, Fernando/0000-0003-1545-9765; Sanchez-Lozada, Laura-Gabriela/0000-0003-0348-9617	National Institutes of Health [NIDDK 1R01DK109408-01A1, NIDDK R01 DK108859-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095930, R01DK108859, R01DK109408, P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants NIDDK 1R01DK109408-01A1 and NIDDK R01 DK108859-01. Some of the authors are members of Colorado Research Partners LLC, a start-up company developing inhibitors of fructose metabolism (M. A. L., A. A.-H., C. A. R.-J., R. J. J., and L. G. S.-L.). Dr. Johnson also has equity with a start-up company (XORT Therapeutics) developing novel xanthine oxidase inhibitors. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741; Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abid A, 2009, J HEPATOL, V51, P918, DOI 10.1016/j.jhep.2009.05.033; Ackerman Z, 2005, HYPERTENSION, V45, P1012, DOI 10.1161/01.HYP.0000164570.20420.67; Al-attar R, 2017, PEERJ, V5, DOI 10.7717/peerj.2797; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Andres-Hernando A, 2008, J BIOL CHEM, V283, P25082, DOI 10.1074/jbc.M802381200; Brown KE, 2005, HISTOL HISTOPATHOL, V20, P429, DOI 10.14670/HH-20.429; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Collison KS, 2009, OBESITY, V17, P2003, DOI 10.1038/oby.2009.58; Ferreira VSG, 2010, ARQ BRAS ENDOCRINOL, V54, P362, DOI 10.1590/S0004-27302010000400004; Garcia-Arroyo FE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202901; Gersch C, 2009, NUCLEOS NUCLEOT NUCL, V28, P118, DOI 10.1080/15257770902736400; Hodgkinson AD, 2001, KIDNEY INT, V60, P211, DOI 10.1046/j.1523-1755.2001.00788.x; Huang ZY, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-016-0158-6; Imaram W, 2010, FREE RADICAL BIO MED, V49, P275, DOI 10.1016/j.freeradbiomed.2010.04.010; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Jensen T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30267-2; Jensen T, 2018, J HEPATOL, V68, P1063, DOI 10.1016/j.jhep.2018.01.019; Jin R, 2012, J CLIN ENDOCR METAB, V97, pE1088, DOI 10.1210/jc.2012-1370; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; Kim NH, 2014, EUR J IMMUNOL, V44, P2721, DOI 10.1002/eji.201343669; Kuwabara M, 2018, INT J CARDIOL, V261, P183, DOI 10.1016/j.ijcard.2018.03.045; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Lanaspa MA, 2018, P NATL ACAD SCI USA, V115, P3138, DOI 10.1073/pnas.1713837115; Lanaspa MA, 2014, J AM SOC NEPHROL, V25, P2526, DOI 10.1681/ASN.2013080901; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048801; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Lanaspa MA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047948, 10.1371/journal.pone.0048801]; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; LIN LR, 1993, INVEST OPHTH VIS SCI, V34, P2352; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Mohandas R, 2014, EXP CELL RES, V326, P136, DOI 10.1016/j.yexcr.2014.05.025; Mosca A, 2017, J HEPATOL, V66, P1031, DOI 10.1016/j.jhep.2016.12.025; Na KY, 2003, J AM SOC NEPHROL, V14, P283, DOI 10.1097/01.ASN.0000045050.19544.B2; Nakatsu Y, 2015, AM J PHYSIOL-GASTR L, V309, pG42, DOI 10.1152/ajpgi.00443.2014; Nomura K, 2012, J NUTR BIOCHEM, V23, P203, DOI 10.1016/j.jnutbio.2011.09.006; O'Connor T, 1999, BIOCHEM J, V343, P487, DOI 10.1042/0264-6021:3430487; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Paschos P, 2018, CURR VASC PHARMACOL, V16, P269, DOI 10.2174/1570161115666170621082237; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Qiu LX, 2012, EXP DIABETES RES, DOI 10.1155/2012/789730; Rittner HL, 1999, J CLIN INVEST, V103, P1007, DOI 10.1172/JCI4711; Ruepp B, 1996, P NATL ACAD SCI USA, V93, P8624, DOI 10.1073/pnas.93.16.8624; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; Sanchez-Lozada LG, 2012, NEPHRON EXP NEPHROL, V121, pE71, DOI 10.1159/000345509; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schwarz JM, 2017, GASTROENTEROLOGY, V153, P743, DOI 10.1053/j.gastro.2017.05.043; Shah VO, 1997, J CLIN ENDOCR METAB, V82, P2294, DOI 10.1210/jc.82.7.2294; Sirota JC, 2013, METABOLISM, V62, P392, DOI 10.1016/j.metabol.2012.08.013; Sylvia S., 2016, 9 EUR GASTR C OCT 24; Vos MB, 2012, J PEDIATR GASTR NUTR, V54, P90, DOI 10.1097/MPG.0b013e318229da1a; Woo SK, 2002, PFLUG ARCH EUR J PHY, V444, P579, DOI 10.1007/s00424-002-0849-2; Xu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011578; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Zhou XM, 2005, AM J PHYSIOL-RENAL, V289, pF377, DOI 10.1152/ajprenal.00463.2004	63	49	54	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4272	4281		10.1074/jbc.RA118.006158	http://dx.doi.org/10.1074/jbc.RA118.006158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30651350	Green Published, hybrid			2022-12-28	WOS:000461854400036
J	Chakroborty, D; Kurppa, KJ; Paatero, I; Ojala, VK; Koivu, M; Tamirat, MZ; Koivunen, JP; Janne, PA; Johnson, MS; Elo, LL; Elenius, K				Chakroborty, Deepankar; Kurppa, Kari J.; Paatero, Ilkka; Ojala, Veera K.; Koivu, Marika; Tamirat, Mahlet Z.; Koivunen, Jussi P.; Jaenne, Pasi A.; Johnson, Mark S.; Elo, Laura L.; Elenius, Klaus			An unbiased in vitro screen for activating epidermal growth factor receptor mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor receptor (EGFR); mutagenesis in vitro; cancer biology; tyrosine-protein kinase (tyrosine kinase); directed evolution; cancer; oncogene; clonal selection; driver mutations; passenger mutations; somatic evolution; tyrosine kinase inhibitors; ERBB; targeted therapies; tyrosine kinase inhibitors	CELL LUNG-CANCER; MOLECULAR-DYNAMICS; EGFR MUTATIONS; KINASE DOMAIN; BA/F3 CELLS; GEFITINIB; MECHANISM; ERLOTINIB	Cancer tissues harbor thousands of mutations, and a given oncogene may be mutated at hundreds of sites, yet only a few of these mutations have been functionally tested. Here, we describe an unbiased platform for the functional characterization of thousands of variants of a single receptor tyrosine kinase (RTK) gene in a single assay. Our in vitroscreen for activating mutations (iSCREAM) platform enabled rapid analysis of mutations conferring gain-of-function RTK activity promoting clonal growth. The screening strategy included a somatic model of cancer evolution and utilized a library of 7,216 randomly mutated epidermal growth factor receptor (EGFR) single-nucleotide variants that were tested in murine lymphoid Ba/F3 cells. These cells depend on exogenous interleukin-3 (IL-3) for growth, but this dependence can be compensated by ectopic EGFR overexpression, enabling selection for gain-of-function EGFR mutants. Analysis of the enriched mutants revealed EGFR A702V, a novel activating variant that structurally stabilized the EGFR kinase dimer interface and conferred sensitivity to kinase inhibition by afatinib. As proof of concept for our approach, we recapitulated clinical observations and identified the EGFR L858R as the major enriched EGFR variant. Altogether, iSCREAM enabled robust enrichment of 21 variants from a total of 7,216 EGFR mutations. These findings indicate the power of this screening platform for unbiased identification of activating RTK variants that are enriched under selection pressure in a model of cancer heterogeneity and evolution.	[Chakroborty, Deepankar; Kurppa, Kari J.; Ojala, Veera K.; Koivu, Marika; Elenius, Klaus] Univ Turku, Inst Biomed, FIN-20520 Turku, Finland; [Chakroborty, Deepankar; Kurppa, Kari J.; Ojala, Veera K.; Koivu, Marika; Elenius, Klaus] Univ Turku, Med Res Labs, Tykistokatu 6A, FIN-20520 Turku, Finland; [Chakroborty, Deepankar; Ojala, Veera K.; Koivu, Marika] Univ Turku, Turku Doctoral Programme Mol Med, FIN-20520 Turku, Finland; [Chakroborty, Deepankar; Paatero, Ilkka; Ojala, Veera K.; Koivu, Marika; Elo, Laura L.; Elenius, Klaus] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Chakroborty, Deepankar; Paatero, Ilkka; Ojala, Veera K.; Koivu, Marika; Elo, Laura L.; Elenius, Klaus] Abo Akad Univ, FIN-20520 Turku, Finland; [Kurppa, Kari J.; Jaenne, Pasi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02215 USA; [Tamirat, Mahlet Z.; Johnson, Mark S.] Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, SF-20500 Turku, Finland; [Koivunen, Jussi P.] Oulu Univ Hosp, Dept Radiotherapy & Oncol, Oulu 90220, Finland; [Koivunen, Jussi P.] MRC Oulu, Oulu 90220, Finland; [Elenius, Klaus] Turku Univ Hosp, Dept Oncol, Turku 20521, Finland	University of Turku; University of Turku; University of Turku; University of Turku; Abo Akademi University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Abo Akademi University; University of Oulu; University of Turku	Elenius, K (corresponding author), Univ Turku, Med Res Labs, Tykistokatu 6A, FIN-20520 Turku, Finland.	klaele@utu.fi	Paatero, Ilkka/AAE-7542-2019; Elenius, Klaus/AAI-7594-2021	Paatero, Ilkka/0000-0001-5926-2396; Elenius, Klaus/0000-0001-5700-0827; Ojala, Veera/0000-0001-5204-8899; Kurppa, Kari/0000-0001-8286-2429; Chakroborty, Deepankar/0000-0002-3458-0205; Koivu, Marika/0000-0002-4371-2142; Koivunen, Jussi/0000-0001-6425-1640	University of Turku; University of Turku Graduate School (Turku Doctoral Program in Molecular Medicine); Finnish Cultural Foundation; Graduate School of Abo Akademi University (Informational and Structural Biology Doctoral Network); Joe, Pentti, and Tor Borg Memorial Fund; Sigrid Juselius Foundation; European Research Council; Academy of Finland [274728, 316796]; Cancer Foundation of Finland; Turku University Central Hospital; Academy of Finland	University of Turku; University of Turku Graduate School (Turku Doctoral Program in Molecular Medicine); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Graduate School of Abo Akademi University (Informational and Structural Biology Doctoral Network); Joe, Pentti, and Tor Borg Memorial Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Research Council(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Cancer Foundation of Finland; Turku University Central Hospital; Academy of Finland(Academy of Finland)	Supported by the University of Turku and University of Turku Graduate School (Turku Doctoral Program in Molecular Medicine).; Supported by the University of Turku and the Finnish Cultural Foundation.; Supported by the Graduate School of Abo Akademi University (Informational and Structural Biology Doctoral Network).; Supported by the Joe, Pentti, and Tor Borg Memorial Fund and Sigrid Juselius Foundation.; Supported by the European Research Council, Academy of Finland, and Sigrid Juselius Foundation.; Supported by Academy of Finland Grants 274728 and 316796, the Cancer Foundation of Finland, the Sigrid Juselius Foundation, and Turku University Central Hospital (to K.E.).	Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; [Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beau-Faller M, 2014, ANN ONCOL, V25, P126, DOI 10.1093/annonc/mdt418; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Case D. A., 2018, AMBER 2019; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Dienstmann R, 2015, CANCER DISCOV, V5, P118, DOI 10.1158/2159-8290.CD-14-1118; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Galli G, 2018, LUNG CANCER, V115, P135, DOI 10.1016/j.lungcan.2017.12.002; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyman DM, 2017, CELL, V168, P584, DOI 10.1016/j.cell.2016.12.015; Jiang JR, 2005, CANCER RES, V65, P8968, DOI 10.1158/0008-5472.CAN-05-1829; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; O'Kane GM, 2017, LUNG CANCER, V109, P137, DOI 10.1016/j.lungcan.2017.04.016; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park JH, 2012, BIOCHEM J, V448, P417, DOI 10.1042/BJ20121513; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RCore Team, 2018, R LANG ENV STAT COMP; Reckamp KL, 2006, CLIN CANCER RES, V12, P3381, DOI 10.1158/1078-0432.CCR-06-0112; Regales L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000810; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Sievert C., 2018, PLOTLY R; Solca F, 2012, J PHARMACOL EXP THER, V343, P342, DOI 10.1124/jpet.112.197756; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; van Lengerich B, 2017, P NATL ACAD SCI USA, V114, pE2836, DOI 10.1073/pnas.1617994114; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	52	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2019	294	24					9377	9389		10.1074/jbc.RA118.006336	http://dx.doi.org/10.1074/jbc.RA118.006336			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IE9QZ	30952700	Green Published, hybrid			2022-12-28	WOS:000472713000008
J	Irani, S; Sipe, SN; Yang, WJ; Burkholder, NT; Lin, B; Sim, K; Matthews, WL; Brodbelt, JS; Zhang, Y				Irani, Seema; Sipe, Sarah N.; Yang, Wanjie; Burkholder, Nathaniel T.; Lin, Brian; Sim, Kelly; Matthews, Wendy L.; Brodbelt, Jennifer S.; Zhang, Yan			Structural determinants for accurate dephosphorylation of RNA polymerase II by its cognate C-terminal domain (CTD) phosphatase during eukaryotic transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase II; phosphatase; mass spectrometry (MS); X-ray crystallography; DNA transcription; intrinsically disordered protein; CTD code; phosphoryl motif; proline isomerization; tyrosine phosphorylation	PHOSPHORYLATION; SSU72; PROTEIN; TOOLS; ELONGATION; SITE	The C-terminal domain (CTD) of RNA polymerase II contains a repetitive heptad sequence (YSPTSPS) whose phosphorylation states coordinate eukaryotic transcription by recruiting protein regulators. The precise placement and removal of phosphate groups on specific residues of the CTD are critical for the fidelity and effectiveness of RNA polymerase II-mediated transcription. During transcriptional elongation, phosphoryl-Ser(5) (pSer(5)) is gradually dephosphorylated by CTD phosphatases, whereas Ser(2) phosphorylation accumulates. Using MS, X-ray crystallography, protein engineering, and immunoblotting analyses, here we investigated the structure and function of SSU72 homolog, RNA polymerase II CTD phosphatase (Ssu72, from Drosophila melanogaster), an essential CTD phosphatase that dephosphorylates pSer(5) at the transition from elongation to termination, to determine the mechanism by which Ssu72 distinguishes the highly similar pSer(2) and pSer(5) CTDs. We found that Ssu72 dephosphorylates pSer(5) effectively but only has low activities toward pSer(7) and pSer(2). The structural analysis revealed that Ssu72 requires that the proline residue in the substrate's SP motif is in the cis configuration, forming a tight -turn for recognition by Ssu72. We also noted that residues flanking the SP motif, such as the bulky Tyr(1) next to Ser(2), prevent the formation of such configuration and enable Ssu72 to distinguish among the different SP motifs. The phosphorylation of Tyr(1) further prohibited Ssu72 binding to pSer(2) and thereby prevented untimely Ser(2) dephosphorylation. Our results reveal critical roles for Tyr(1) in differentiating the phosphorylation states of Ser(2)/Ser(5) of CTD in RNA polymerase II that occur at different stages of transcription.	[Irani, Seema] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Irani, Seema; Yang, Wanjie; Burkholder, Nathaniel T.; Lin, Brian; Sim, Kelly; Matthews, Wendy L.; Zhang, Yan] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Sipe, Sarah N.; Brodbelt, Jennifer S.] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Zhang, Yan] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Zhang, Y (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Zhang, Y (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	jzhang@cm.utexas.edu	Irani, Seema/R-5077-2019	Zhang, Yan/0000-0002-9360-5388; Sipe, Sarah/0000-0003-4554-7571; Burkholder, Nathaniel/0000-0002-1769-3750	UT System; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104896, R01GM125882] Funding Source: NIH RePORTER	UT System; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. J. E. Mayfield for critical comments on the manuscript. Voyager DE-PROT MALDI MS data were collected in the University of Texas (UT) at Austin Proteomics Facility. Funding from the UT System for support of the UT System Proteomics Core Facility Network is gratefully acknowledged.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; [Anonymous], R LANG ENV STAT COMP; Bartkowiak B, 2011, TRANSCR-AUSTIN, V2, P115, DOI 10.4161/trns.2.3.15004; Brodbelt JS, 2014, CHEM SOC REV, V43, P2757, DOI 10.1039/c3cs60444f; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; CARTER SG, 1982, J BIOCHEM BIOPH METH, V7, P7, DOI 10.1016/0165-022X(82)90031-8; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; Collin P, 2019, MOL CELL, V73, P655, DOI 10.1016/j.molcel.2018.12.002; Corden JL, 2013, CHEM REV, V113, P8423, DOI 10.1021/cr400158h; Descostes N, 2014, ELIFE, V3, DOI 10.7554/eLife.02105; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghazy MA, 2009, MOL CELL BIOL, V29, P2296, DOI 10.1128/MCB.01514-08; Harlen KM, 2017, NAT REV MOL CELL BIO, V18, P263, DOI 10.1038/nrm.2017.10; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Hsin JP, 2014, ELIFE, V3, DOI 10.7554/eLife.02112; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Jeronimo C, 2013, CHEM REV, V113, P8491, DOI 10.1021/cr4001397; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Luo YH, 2013, ACS CHEM BIOL, V8, P2042, DOI 10.1021/cb400229c; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Mayfield JE, 2017, ACS CHEM BIOL, V12, P153, DOI 10.1021/acschembio.6b00729; Mayfield JE, 2015, ACS CHEM BIOL, V10, P2405, DOI 10.1021/acschembio.5b00296; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Rosado-Lugo JD, 2014, J BIOL CHEM, V289, P33916, DOI 10.1074/jbc.M114.608695; Schauer T, 2009, CELL MOL LIFE SCI, V66, P909, DOI 10.1007/s00018-009-8670-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuller R, 2016, MOL CELL, V61, P305, DOI 10.1016/j.molcel.2015.12.003; Shah N, 2018, MOL CELL, V69, P48, DOI 10.1016/j.molcel.2017.12.009; Suh H, 2016, MOL CELL, V61, P297, DOI 10.1016/j.molcel.2015.12.021; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; Xiang KH, 2012, GENE DEV, V26, P2265, DOI 10.1101/gad.198853.112; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Zhang Y, 2011, BIOCHEM J, V434, P435, DOI 10.1042/BJ20101471	44	7	8	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8592	8605		10.1074/jbc.RA119.007697	http://dx.doi.org/10.1074/jbc.RA119.007697			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30971428	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000471108200026
J	Tashjian, TF; Danilowicz, C; Molza, AE; Nguyen, BH; Prevost, C; Prentiss, M; Godoy, VG				Tashjian, Tommy F.; Danilowicz, Claudia; Molza, Anne-Elizabeth; Nguyen, Brian H.; Prevost, Chantal; Prentiss, Mara; Godoy, Veronica G.			Residues in the fingers domain of the translesion DNA polymerase DinB enable its unique participation in error-prone double-strand break repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA synthesis; DNA damage; DNA repair; homologous recombination; DinB; DNA polymerase IV; RecA	HOMOLOGOUS RECOMBINATION; RECBCD ENZYME; MOLECULAR-DYNAMICS; ACCURATE BYPASS; HIGH-FIDELITY; RECA PROTEIN; IN-VITRO; IV; COMPLEX; MUTAGENESIS	The evolutionarily conserved Escherichia coli translesion DNA polymerase IV (DinB) is one of three enzymes that can bypass potentially deadly DNA lesions on the template strand during DNA replication. Remarkably, however, DinB is the only known translesion DNA polymerase active in RecA-mediated strand exchange during error-prone double-strand break repair. In this process, a single-stranded DNA (ssDNA)-RecA nucleoprotein filament invades homologous dsDNA, pairing the ssDNA with the complementary strand in the dsDNA. When exchange reaches the 3 end of the ssDNA, a DNA polymerase can add nucleotides onto the end, using one strand of dsDNA as a template and displacing the other. It is unknown what makes DinB uniquely capable of participating in this reaction. To explore this topic, we performed molecular modeling of DinB's interactions with the RecA filament during strand exchange, identifying key contacts made with residues in the DinB fingers domain. These residues are highly conserved in DinB, but not in other translesion DNA polymerases. Using a novel FRET-based assay, we found that DinB variants with mutations in these conserved residues are less effective at stabilizing RecA-mediated strand exchange than native DinB. Furthermore, these variants are specifically deficient in strand displacement in the absence of RecA filament. We propose that the amino acid patch of highly conserved residues in DinB-like proteins provides a mechanistic explanation for DinB's function in strand exchange and improves our understanding of recombination by providing evidence that RecA plays a role in facilitating DinB's activity during strand exchange.	[Tashjian, Tommy F.; Nguyen, Brian H.; Godoy, Veronica G.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Danilowicz, Claudia; Prentiss, Mara] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Molza, Anne-Elizabeth; Prevost, Chantal] CNRS UPR9080, Lab Biochim Theor, F-75005 Paris, France; [Molza, Anne-Elizabeth; Prevost, Chantal] Univ Paris Diderot, IBPC, F-75005 Paris, France	Northeastern University; Harvard University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Godoy, VG (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	v.godoycarter@northeastern.edu	Prentiss, Mara/AAU-2940-2021	Tashjian, Tommy/0000-0001-5675-1151; Chantal, Prevost/0000-0003-3516-6687	National Institutes of Health NIGMS [RO1GM088230]; Northeastern University; Graduate Research and Dissertation Grant, Northeastern University College of Science; Initiative d'Excellence Program of the French State Grant DYNAMO [ANR-11 - LABX-0011-01]	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Northeastern University; Graduate Research and Dissertation Grant, Northeastern University College of Science; Initiative d'Excellence Program of the French State Grant DYNAMO	This work was supported in part by National Institutes of Health NIGMS Grant RO1GM088230 (to V. G. G.) and Northeastern University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Graduate Research and Dissertation Grant, Northeastern University College of Science. Present address: Dept. of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA 01003.; Supported by Initiative d'Excellence Program of the French State Grant DYNAMO, ANR-11 - LABX-0011-01.	Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Bazemore LR, 1997, P NATL ACAD SCI USA, V94, P11863, DOI 10.1073/pnas.94.22.11863; Benson RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019944; Berdichevsky A, 2002, MOL CELL, V10, P917, DOI 10.1016/S1097-2765(02)00679-2; Beuning PJ, 2006, METHOD ENZYMOL, V408, P318, DOI 10.1016/S0076-6879(06)08020-7; Bjedov I, 2007, GENETICS, V176, P1431, DOI 10.1534/genetics.107.072405; Boudsocq F, 1997, J MOL BIOL, V270, P201, DOI 10.1006/jmbi.1997.1098; Boyer B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116414; Cafarelli TM, 2014, ENVIRON MOL MUTAGEN, V55, P92, DOI 10.1002/em.21826; Cafarelli TM, 2013, J BACTERIOL, V195, P1179, DOI 10.1128/JB.01349-12; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox M.M., 2007, TOPICS CURRENT GENET, P53; Danilowicz C, 2015, NUCLEIC ACIDS RES, V43, P6473, DOI 10.1093/nar/gkv610; DeLano W.L, PYMOL MOL GRAPHICS S; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Duan GL, 2001, MOL PHYS, V99, P1689, DOI 10.1080/00268970110063917; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Greene EC, 2016, J BIOL CHEM, V291, P11572, DOI 10.1074/jbc.R116.724807; Henrikus SS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007161; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Jarosz DF, 2007, CELL CYCLE, V6, P817, DOI 10.4161/cc.6.7.4065; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Kottur J, 2015, STRUCTURE, V23, P56, DOI 10.1016/j.str.2014.10.019; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; LAM ST, 1974, GENETICS, V77, P425; Lee JY, 2016, J BIOL CHEM, V291, P22218, DOI 10.1074/jbc.M116.740563; Liu J, 2011, METHODS MOL BIOL, V745, P363, DOI 10.1007/978-1-61779-129-1_21; Lovett S, 2006, DNA REPAIR, V5, P1421, DOI 10.1016/j.dnarep.2006.06.008; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mallik S, 2015, J BACTERIOL, V197, P2792, DOI 10.1128/JB.00101-15; MALONE RE, 1978, J MOL BIOL, V121, P473, DOI 10.1016/0022-2836(78)90395-9; Molza AE, 2014, FARADAY DISCUSS, V169, P45, DOI 10.1039/c3fd00134b; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pomerantz RT, 2013, NAT STRUCT MOL BIOL, V20, P748, DOI 10.1038/nsmb.2573; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Rehrauer WM, 1998, J BIOL CHEM, V273, P32384, DOI 10.1074/jbc.273.49.32384; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Sharma A, 2013, NUCLEIC ACIDS RES, V41, P5104, DOI 10.1093/nar/gkt146; Shee C, 2011, P NATL ACAD SCI USA, V108, P13659, DOI 10.1073/pnas.1104681108; Sholder G, 2015, DNA REPAIR, V35, P144, DOI 10.1016/j.dnarep.2015.09.020; Smith GR, 2012, MICROBIOL MOL BIOL R, V76, P217, DOI 10.1128/MMBR.05026-11; SOMMER S, 1993, MOL MICROBIOL, V10, P963, DOI 10.1111/j.1365-2958.1993.tb00968.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Tashjian TF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00288; Thomason L. C., 2007, CURRENT PROTOCOLS MO, V79, P1, DOI [DOI 10.1002/0471142727.mb0117s79, 10.1002/0471142727.mb0117s79, DOI 10.1002/0471142727.MB0117S79]; Yang DR, 2015, NUCLEIC ACIDS RES, V43, P10251, DOI 10.1093/nar/gkv883; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105	56	8	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7588	7600		10.1074/jbc.RA118.006233	http://dx.doi.org/10.1074/jbc.RA118.006233			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30872406	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000470153300007
J	Yang, Y; Liu, Z; He, XQ; Yang, JJ; Wu, J; Yang, HL; Li, M; Qian, Q; Lai, R; Xu, W; Wei, L				Yang, Yang; Liu, Zhen; He, Xiaoqin; Yang, Juanjuan; Wu, Jing; Yang, Hailong; Li, Min; Qian, Qian; Lai, Ren; Xu, Wei; Wei, Lin			A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); peptides; structure-function; amino acid; drug action; drug resistance; -helix; anti-mycobacterial peptide; hydrophobic moment; mycobacteriophage; antibiotic; endolysin; immune regulation; Mycobacterium tuberculosis	ALPHA-HELICAL PEPTIDES; ANTIMICROBIAL PEPTIDES; ANTIMYCOBACTERIAL ACTIVITIES; HYDROPHOBIC MOMENT; IDENTIFICATION; TUBERCULOSIS; COMBINATION; SELECTIVITY; TRYPTOPHAN; RESISTANCE	Mycobacteriophages express various peptides/proteins to infect Mycobacterium tuberculosis (M. tb). Particular attention has been paid to mycobacteriophage-derived endolysin proteins. We herein characterized a small mycobacteriophage-derived peptide designated AK15 with potent anti-M. tb activity. AK15 adopted cationic amphiphilic -helical structure, and on the basis of this structure, we designed six isomers with increased hydrophobic moment by rearranging amino acid residues of the helix. We found that one of these isomers, AK15-6, exhibits enhanced anti-mycobacterial efficiency. Both AK15 and AK15-6 directly inhibited M. tb by trehalose 6,6-dimycolate (TDM) binding and membrane disruption. They both exhibited bactericidal activity, cell selectivity, and synergistic effects with rifampicin, and neither induced drug resistance to M. tb. They efficiently attenuated mycobacterial load in the lungs of M. tb-infected mice. We observed that lysine, arginine, tryptophan, and an -helix are key structural requirements for their direct anti-mycobacterial action. Of note, they also exhibited immunomodulatory effects, including inhibition of proinflammatory response in TDM-stimulated or M. tb-infected murine bone marrow-derived macrophages (BMDMs) and M.tb-infected mice and induction of only a modest level of cytokine (tumor necrosis factor (TNF-) and interleukin-6 (IL-6)) production in murine BMDMs and a T-cell cytokine (interferin- (IFN-) and TNF-) response in murine lung and spleen. In summary, characterization of a small mycobacteriophage-derived peptide and its improved isomer revealed that both efficiently restrain M. tb infection via dual mycobactericidal-immunoregulatory activities. Our work provides clues for identifying small mycobacteriophage-derived anti-mycobacterial peptides and improving those that have cationic amphiphilic -helices.	[Yang, Yang; Liu, Zhen; Li, Min; Qian, Qian; Xu, Wei; Wei, Lin] Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China; [Yang, Yang; Liu, Zhen; Li, Min; Qian, Qian; Xu, Wei; Wei, Lin] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China; [He, Xiaoqin; Lai, Ren] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [He, Xiaoqin] Jiangsu Inst Parasit Dis, Natl Hlth Commiss Key Lab Parasit Dis Control & P, Jiangsu Prov Key Lab Parasite & Vector Control Te, Wuxi 214064, Jiangsu, Peoples R China; [Yang, Juanjuan] Fuzhou Univ, Coll Biol Sci & Technol, Inst Pharmaceut Biotechnol & Engn, Fuzhou 350108, Fujian, Peoples R China; [Wu, Jing; Yang, Hailong] Kunming Med Univ, Sch Basic Med Sci, Kunming 650500, Yunnan, Peoples R China	Soochow University - China; Soochow University - China; Chinese Academy of Sciences; Kunming Institute of Zoology; Fuzhou University; Kunming Medical University	Xu, W; Wei, L (corresponding author), Soochow Univ, Inst Biol, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China.; Xu, W; Wei, L (corresponding author), Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Jiangsu, Peoples R China.; Lai, R (corresponding author), Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.	rlai@mail.kiz.ac.cn; xuweifd828@126.com; weilin1005@126.com	yang, hailong/GXH-9625-2022; Wei, Lin/AAE-3043-2022	Wei, Lin/0000-0003-3359-2471; Xu, Wei/0000-0003-2652-8244	National Natural Science Foundation of China [81402830, 31870868, 81603080, 31670930, 31700656, 81802023]; China Postdoctoral Science Foundation [2015M571815]; Ministry of Science and Technology of China [2018ZX10731301-001-006]; Natural Science Foundation of Jiangsu Province [BK20140362]; Fujian Province [2017J05050]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRTIRT1075]; Science and Technology Development of Suzhou [SNG2017050, sys2018017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fujian Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Science and Technology Development of Suzhou	This work was supported by National Natural Science Foundation of China Grants 81402830, 31870868, 81603080, 31670930, 31700656, and 81802023; China Postdoctoral Science Foundation Grant 2015M571815; Ministry of Science and Technology of China Grant 2018ZX10731301-001-006; Natural Science Foundation of Jiangsu Province Grant BK20140362 and Fujian Province Grant 2017J05050; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University Grant PCSIRTIRT1075; and Science and Technology Development of Suzhou Grants SNG2017050 and sys2018017. The authors declare that they have no conflicts of interest with the contents of this article.	Abedinzadeh M, 2015, J ANTIMICROB CHEMOTH, V70, P1285, DOI 10.1093/jac/dku570; Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Anantharaman A, 2010, ANTIMICROB AGENTS CH, V54, P1693, DOI 10.1128/AAC.01231-09; Arranz-Trullen J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01499; BARRIERE SL, 1992, PHARMACOTHERAPY, V12, P397; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Etna MP, 2014, SEMIN IMMUNOL, V26, P543, DOI 10.1016/j.smim.2014.09.011; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Genoula M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00459; Gil F, 2008, MICROBIOL-SGM, V154, P1364, DOI 10.1099/mic.0.2007/014621-0; Gutsmann T, 2016, BBA-BIOMEMBRANES, V1858, P1034, DOI 10.1016/j.bbamem.2016.01.031; Haas W, 2010, J ANTIMICROB CHEMOTH, V65, P1441, DOI 10.1093/jac/dkq127; Hatfull GF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003953; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Jin L, 2016, J MED CHEM, V59, P1791, DOI 10.1021/acs.jmedchem.5b01264; Khara JS, 2014, BIOMATERIALS, V35, P2032, DOI 10.1016/j.biomaterials.2013.11.035; Khara JS, 2015, ACTA BIOMATER, V28, P99, DOI 10.1016/j.actbio.2015.09.015; Khusro A, 2016, ASIAN PAC J TROP MED, V9, P1001, DOI 10.1016/j.apjtm.2016.09.005; Lai MJ, 2015, MOLECULES, V20, P19277, DOI 10.3390/molecules201019277; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Lee E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12048; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Oh D, 2000, BIOCHEMISTRY-US, V39, P11855, DOI 10.1021/bi000453g; Payne KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034052; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Phoenix DA, 2003, CURR PROTEIN PEPT SC, V4, P357, DOI 10.2174/1389203033487090; Pohane AA, 2015, FEBS LETT, V589, P695, DOI 10.1016/j.febslet.2015.01.036; Pohane AA, 2014, J BIOL CHEM, V289, P12085, DOI 10.1074/jbc.M113.529594; RAND KH, 1993, ANTIMICROB AGENTS CH, V37, P613, DOI 10.1128/AAC.37.3.613; Rybniker J, 2006, J MED MICROBIOL, V55, P37, DOI 10.1099/jmm.0.46238-0; Teng TS, 2015, CELL PHYSIOL BIOCHEM, V35, P452, DOI 10.1159/000369711; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang F, 2013, P NATL ACAD SCI USA, V110, pE2510, DOI 10.1073/pnas.1309171110; Wang Y, 2014, BIOMATERIALS, V35, P3102, DOI 10.1016/j.biomaterials.2013.12.049; Wei L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1149-y; Wei L, 2015, J BIOL CHEM, V290, P16633, DOI 10.1074/jbc.M115.642645; Wei L, 2013, FASEB J, V27, P3067, DOI 10.1096/fj.13-227454; Wei L, 2013, J MED CHEM, V56, P3546, DOI 10.1021/jm4004158; Welsh KJ, 2010, TRANSL RES, V156, P207, DOI 10.1016/j.trsl.2010.06.001; WHO, 2017, GLOB TUB REP 2017; Wu ML, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00445; Wu YL, 1999, J ANTIMICROB CHEMOTH, V44, P389, DOI 10.1093/jac/44.3.389	45	8	8	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7615	7631		10.1074/jbc.RA118.006968	http://dx.doi.org/10.1074/jbc.RA118.006968			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30894414	Green Published, hybrid			2022-12-28	WOS:000470153300009
J	Elbaum-Garfinkle, S				Elbaum-Garfinkle, Shana			Matter over mind: Liquid phase separation and neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						neurodegeneration; protein aggregation; intrinsically disordered protein; Alzheimer disease; biomaterials; amyloid; Parkinson disease; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); material properties; phase separation	HEXANUCLEOTIDE REPEAT; DISORDERED PROTEINS; ALPHA-SYNUCLEIN; MESSENGER-RNA; AGGREGATION; TRANSITION; C9ORF72; ALS; DROPLETS; GRANULES	Phase separation of biomolecules leading to the formation of assemblies with distinct material properties has recently emerged as a new paradigm underlying subcellular organization. The discovery that disordered proteins, long associated with aggregation in neurodegenerative disease, are also implicated in driving liquid phase separation has galvanized significant interest in exploring the relationship between misregulated phase transitions and disease. This review summarizes recent work linking liquid phase separation to neurodegeneration, highlighting a pathological role for altered phase behavior and material properties of proteins assembled via liquid phase separation. The techniques that recent and current work in this area have deployed are also discussed, as is the potential for these discoveries to promote new research directions for investigating the molecular etiologies of neurodegenerative diseases.	[Elbaum-Garfinkle, Shana] CUNY, Struct Biol Initiat, Adv Sci Res Ctr, New York, NY 10031 USA; [Elbaum-Garfinkle, Shana] CUNY, PhD Program Biochem, Grad Ctr, New York, NY 10031 USA	City University of New York (CUNY) System; City University of New York (CUNY) System	Elbaum-Garfinkle, S (corresponding author), CUNY, Struct Biol Initiat, Adv Sci Res Ctr, New York, NY 10031 USA.	shana.elbaum@asrc.cuny.edu		Elbaum, Shana/0000-0002-3953-7329	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS096217] Funding Source: NIH RePORTER; NINDS NIH HHS [R00 NS096217] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Audas TE, 2016, DEV CELL, V39, P155, DOI 10.1016/j.devcel.2016.09.002; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Berchowitz LE, 2015, CELL, V163, P406, DOI 10.1016/j.cell.2015.08.060; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; Boke E, 2017, CELL CYCLE, V16, P153, DOI 10.1080/15384101.2016.1241605; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Ceballos AV, 2018, METHOD ENZYMOL, V611, P31, DOI 10.1016/bs.mie.2018.09.037; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng H, 2014, NAT REV NEUROL, V10, P337, DOI 10.1038/nrneurol.2014.78; Dolgin E, 2018, NATURE, V555, P300, DOI 10.1038/d41586-018-03070-2; Eggers J, 1999, J FLUID MECH, V401, P293, DOI 10.1017/S002211209900662X; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Hubstenberger A, 2013, DEV CELL, V27, P161, DOI 10.1016/j.devcel.2013.09.024; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Larsen TH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.146001; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Ling H, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.011; Mackenzie IR, 2017, NEURON, V95, P808, DOI 10.1016/j.neuron.2017.07.025; Malmos KG, 2017, AMYLOID, V24, P1, DOI 10.1080/13506129.2017.1304905; MASON TG, 1995, PHYS REV LETT, V75, P2770, DOI 10.1103/PhysRevLett.75.2770; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peskett TR, 2018, MOL CELL, V70, P588, DOI 10.1016/j.molcel.2018.04.007; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Smith J, 2016, ELIFE, V5, DOI 10.7554/eLife.21337; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Vernon RM, 2018, ELIFE, V7, DOI 10.7554/eLife.31486; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wei MT, 2017, NAT CHEM, V9, P1118, DOI [10.1038/NCHEM.2803, 10.1038/nchem.2803]; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183; Zhou LJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15295; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	77	109	111	9	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7160	7168		10.1074/jbc.REV118.001188	http://dx.doi.org/10.1074/jbc.REV118.001188			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30914480	hybrid, Green Published			2022-12-28	WOS:000468402900006
J	Morgan, JLW; Evans, EGB; Zagotta, WN				Morgan, Jacob L. W.; Evans, Eric G. B.; Zagotta, William N.			Functional characterization and optimization of a bacterial cyclic nucleotide-gated channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; potassium channel; cyclic nucleotide; allosteric regulation; channel activation; bacteria; cyclic nucleotide gating; prokaryotic ion channel; voltage-gated ion channel; allostery	LIGAND-BINDING DOMAIN; ESCHERICHIA-COLI; TERMINAL REGION; PATCH-CLAMP; K+ CHANNEL; MODULATION; MECHANISM; GENE; HCN2; REARRANGEMENTS	Cyclic nucleotide-gated (CNG) channels produce the initial electrical signal in mammalian vision and olfaction. They open in response to direct binding of cyclic nucleotide (cAMP or cGMP) to a cytoplasmic region of the channel. However, the conformational rearrangements occurring upon binding to produce pore opening (i.e. gating) are not well understood. SthK is a bacterial CNG channel that has the potential to serve as an ideal model for structure-function studies of gating but is currently limited by its toxicity, native cysteines, and low open probability (P-o). Here, we expressed SthK in giant Escherichia coli spheroplasts and performed patch-clamp recordings to characterize SthK gating in a bacterial membrane. We demonstrated that the P-o in cAMP is higher than has been previously published and that cGMP acts as a weak partial SthK agonist. Additionally, we determined that SthK expression is toxic to E. coli because of gating by cytoplasmic cAMP. We overcame this toxicity by developing an adenylate cyclase-knockout E. coli cell line. Finally, we generated a cysteine-free SthK construct and introduced mutations that further increase the P-o in cAMP. We propose that this SthK model will help elucidate the gating mechanism of CNG channels.	[Morgan, Jacob L. W.; Evans, Eric G. B.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	Zagotta@uw.edu		Evans, Eric/0000-0002-8669-2663	National Institutes of Health [R01EY010329, R01MH102378, R01GM127325]; Raymond and Beverly Sackler Scholars Program; National Institutes of Health Vision Training Grant [T32EY007031]; National Institutes of Health Cardiovascular Pathology Training Grant [T32HL007312]; NATIONAL EYE INSTITUTE [R01EY010329, T32EY007031] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120553, R01GM127325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Raymond and Beverly Sackler Scholars Program; National Institutes of Health Vision Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cardiovascular Pathology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants R01EY010329, R01MH102378, and R01GM127325; National Institutes of Health Cardiovascular Pathology Training Grant T32HL007312 (to J. L. W. M.); and the Raymond and Beverly Sackler Scholars Program and National Institutes of Health Vision Training Grant T32EY007031 (to E. G. B. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Auerbach Anthony, 2003, Sci STKE, V2003, pre11, DOI 10.1126/stke.2003.188.re11; Brams M, 2014, P NATL ACAD SCI USA, V111, P7855, DOI 10.1073/pnas.1401917111; BRICKMAN E, 1973, J BACTERIOL, V116, P582, DOI 10.1128/JB.116.2.582-587.1973; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Carranza G, 2017, BBA-BIOMEMBRANES, V1859, P1124, DOI 10.1016/j.bbamem.2017.03.006; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Corey RA, 2018, P NATL ACAD SCI USA, V115, P7967, DOI 10.1073/pnas.1721536115; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeBerg HA, 2016, J BIOL CHEM, V291, P371, DOI 10.1074/jbc.M115.696450; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Gordon SE, 1996, BIOCHEMISTRY-US, V35, P3994, DOI 10.1021/bi952607b; GORDON SE, 1995, NEURON, V14, P177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; James ZM, 2018, J GEN PHYSIOL, V150, P225, DOI 10.1085/jgp.201711898; James ZM, 2017, P NATL ACAD SCI USA, V114, P4430, DOI 10.1073/pnas.1700248114; Jensen SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep17874; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kesters D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116369; Kuo MMC, 2007, J BIOL CHEM, V282, P24294, DOI 10.1074/jbc.M703618200; Laage S, 2015, BBA-BIOMEMBRANES, V1848, P260, DOI 10.1016/j.bbamem.2014.08.021; Li MH, 2017, NATURE, V542, P60, DOI 10.1038/nature20819; Martinac Boris, 2013, Methods Mol Biol, V966, P367, DOI 10.1007/978-1-62703-245-2_23; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Paoletti P, 1999, J GEN PHYSIOL, V113, P17, DOI 10.1085/jgp.113.1.17; PERLMAN RL, 1969, BIOCHEM BIOPH RES CO, V37, P151, DOI 10.1016/0006-291X(69)90893-6; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Rheinberger J, 2018, ELIFE, V7, DOI 10.7554/eLife.39775; Santos JS, 2006, J GEN PHYSIOL, V128, P283, DOI 10.1085/jgp.200609572; Schmidpeter PAM, 2018, J GEN PHYSIOL, V150, P821, DOI 10.1085/jgp.201812023; SHIBUYA I, 1992, PROG LIPID RES, V31, P245, DOI 10.1016/0163-7827(92)90010-G; Sunderman ER, 1999, J GEN PHYSIOL, V113, P621, DOI 10.1085/jgp.113.5.621; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; TAKAHASHI M, 1989, J MOL BIOL, V207, P783, DOI 10.1016/0022-2836(89)90244-1; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	49	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7503	7515		10.1074/jbc.RA119.007699	http://dx.doi.org/10.1074/jbc.RA119.007699			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30885945	Green Published, hybrid			2022-12-28	WOS:000468402900033
J	Wu, YL; Li, YL; Li, YY; Ma, YZ; Zhao, YL; Wang, CZ; Chi, HB; Chen, M; Ding, YH; Guo, XP; Min, L; Zhang, XL				Wu, Yuanlong; Li, Yanlong; Li, Yaoyao; Ma, Yizan; Zhao, Yunlong; Wang, Chaozhi; Chi, Huabin; Chen, Miao; Ding, Yuanhao; Guo, Xiaoping; Min, Ling; Zhang, Xianlong			Proteomic analysis reveals that sugar and fatty acid metabolisms play a central role in sterility of the male-sterile line 1355A of cotton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein expression; proteomics; glycolysis; fatty acid metabolism; pyruvate; artificial emasculation; carbohydrate metabolism; Gossypium; heterosis; male sterility	POLLEN WALL DEVELOPMENT; ACYL CARRIER PROTEIN; SPOROPOLLENIN SYNTHESIS; ANTHER DEVELOPMENT; EXINE FORMATION; COA SYNTHETASE; BIOSYNTHESIS; MICROSPOROGENESIS; PATHWAYS; TAPETUM	Cotton (Gossypium spp.) is one of the most important economic crops and exhibits yield-improving heterosis in specific hybrid combinations. The genic male-sterility system is the main strategy used for producing heterosis in cotton. To better understand the mechanisms of male sterility in cotton, we carried out two-dimensional electrophoresis (2-DE) and label-free quantitative proteomics analysis in the anthers of two near-isogenic lines, the male-sterile line 1355A and the male-fertile line 1355B. We identified 39 and 124 proteins that were significantly differentially expressed between these two lines in the anthers at the tetrad stage (stage 7) and uninucleate pollen stage (stage 8), respectively. Gene ontology-based analysis revealed that these differentially expressed proteins were mainly associated with pyruvate, carbohydrate, and fatty acid metabolism. Biochemical analysis revealed that in the anthers of line 1355A, glycolysis was activated, which was caused by a reduction in fructose, glucose, and other soluble sugars, and that accumulation of acetyl-CoA was increased along with a significant increase in C14:0 and C18:1 free fatty acids. However, the activities of pyruvate dehydrogenase and fatty acid biosynthesis were inhibited and fatty acid -oxidation was activated at the translational level in 1355A. We speculate that in the 1355A anther, high rates of glucose metabolism may promote fatty acid synthesis to enable anther growth. These results provide new insights into the molecular mechanism of genic male sterility in upland cotton.	[Wu, Yuanlong; Li, Yanlong; Li, Yaoyao; Ma, Yizan; Zhao, Yunlong; Wang, Chaozhi; Chi, Huabin; Chen, Miao; Ding, Yuanhao; Min, Ling; Zhang, Xianlong] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China; [Guo, Xiaoping] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Min, L (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China.	lingmin@mail.hzau.edu.cn	wu, yuanlong/GSD-8393-2022	Chi, Huabin/0000-0002-2945-6664; wu, yuanlong/0000-0002-3677-8936	National Key Research and Development Program of China [2016YFD0101402]	National Key Research and Development Program of China	This work was supported by the National Key Research and Development Program of China (2016YFD0101402). The authors declare that they have no conflicts of interest with the contents of this article.	Ahlers F, 1999, PHYTOCHEMISTRY, V50, P1095, DOI 10.1016/S0031-9422(98)00225-8; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; Blackmore S, 2007, NEW PHYTOL, V174, P483, DOI 10.1111/j.1469-8137.2007.02060.x; Chang HS, 2012, PLANT PHYSIOL, V158, P264, DOI 10.1104/pp.111.184853; Chawla M, 2017, HISTOCHEM CELL BIOL, V147, P103, DOI 10.1007/s00418-016-1481-0; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Chen WW, 2011, PLANT PHYSIOL, V157, P842, DOI 10.1104/pp.111.181693; Datta R, 2002, PLANT PHYSIOL, V130, P1645, DOI 10.1104/pp.006908; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Gao W, 2013, MOL CELL PROTEOMICS, V12, P3690, DOI 10.1074/mcp.M113.031013; Geng XX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020324; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Goff SA, 2013, CURR OPIN PLANT BIOL, V16, P221, DOI 10.1016/j.pbi.2013.03.009; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Gonzalez-Fernandez R, 2013, J PROTEOME RES, V12, P3042, DOI 10.1021/pr3010937; Grienenberger E, 2010, PLANT CELL, V22, P4067, DOI 10.1105/tpc.110.080036; GUILFORD WJ, 1988, PLANT PHYSIOL, V86, P134, DOI 10.1104/pp.86.1.134; Hafidh S, 2016, PLANT REPROD, V29, P31, DOI 10.1007/s00497-015-0272-4; Hirsche J, 2017, PLANT CELL PHYSIOL, V58, P691, DOI 10.1093/pcp/pcx020; Huang L, 2009, J EXP BOT, V60, P301, DOI 10.1093/jxb/ern295; Jia QS, 2015, MOL PLANT, V8, P251, DOI 10.1016/j.molp.2014.10.001; Jiang J, 2013, PLANT BIOLOGY, V15, P249, DOI 10.1111/j.1438-8677.2012.00706.x; Kim SS, 2013, J PLANT BIOL, V56, P1, DOI 10.1007/s12374-012-0385-3; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Li JJ, 2016, J PROTEOMICS, V138, P72, DOI 10.1016/j.jprot.2016.02.017; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Lin H, 2017, PLANT J, V92, P1076, DOI 10.1111/tpj.13744; Lou Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4855; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; Matsuda H., 2016, Tropical Agriculture and Development, V60, P155; Min L, 2014, PLANT PHYSIOL, V164, P1293, DOI 10.1104/pp.113.232314; Min L, 2013, PLANT J, V75, P823, DOI 10.1111/tpj.12245; Morant M, 2007, PLANT CELL, V19, P1473, DOI 10.1105/tpc.106.045948; OHLROGGE JB, 1979, P NATL ACAD SCI USA, V76, P1194, DOI 10.1073/pnas.76.3.1194; Oliver SN, 2007, PLANT CELL PHYSIOL, V48, P1319, DOI 10.1093/pcp/pcm100; OWEN HA, 1995, PROTOPLASMA, V185, P7, DOI 10.1007/BF01272749; Piffanelli P, 1998, SEX PLANT REPROD, V11, P65, DOI 10.1007/s004970050122; Quilichini TD, 2015, PHYTOCHEMISTRY, V113, P170, DOI 10.1016/j.phytochem.2014.05.002; Quilichini TD, 2014, PLANT CELL, V26, P4483, DOI 10.1105/tpc.114.130484; Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.3.CO;2-I; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rounds CM, 2013, ANNU REV PLANT BIOL, V64, P243, DOI 10.1146/annurev-arplant-050312-120150; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Souza CD, 2009, PLANT CELL, V21, P507, DOI 10.1105/tpc.108.062513; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Suzuki T, 2008, PLANT CELL PHYSIOL, V49, P1465, DOI 10.1093/pcp/pcn131; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00092; Wang XL, 2009, PLANT J, V57, P473, DOI 10.1111/j.1365-313X.2008.03700.x; Wiermann R, 2001, BIOPOLYMERS, V1, P209, DOI DOI 10.1002/3527600035.BPOL1007; Wilson ZA, 2011, J EXP BOT, V62, P1633, DOI 10.1093/jxb/err014; Wu YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09608; Xu J, 2014, PLANT CELL, V26, P1544, DOI 10.1105/tpc.114.122986; Xu ZP, 2016, SCI REP-UK, V6, DOI 10.1038/srep33342; Yang ZN, 2016, SCI CHINA LIFE SCI, V59, P1335, DOI 10.1007/s11427-016-0338-y; Yi B, 2010, PLANT J, V63, P925, DOI 10.1111/j.1365-313X.2010.04289.x; Zamariola L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00279; Zhang DS, 2008, MOL PLANT, V1, P599, DOI 10.1093/mp/ssn028; Zhang DB, 2016, SUBCELL BIOCHEM, V86, P315, DOI 10.1007/978-3-319-25979-6_13; Zhang DB, 2014, CURR OPIN PLANT BIOL, V17, P49, DOI 10.1016/j.pbi.2013.11.001; Zheng BB, 2014, J PROTEOME RES, V13, P2998, DOI 10.1021/pr500126g; Zhu W, 2008, EUPHYTICA, V164, P283, DOI 10.1007/s10681-008-9732-3	63	10	13	7	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7057	7067		10.1074/jbc.RA118.006878	http://dx.doi.org/10.1074/jbc.RA118.006878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30862676	Green Published, hybrid			2022-12-28	WOS:000467394700037
J	Landemaine, A; Ramirez-Martinez, A; Monestier, O; Sabin, N; Rescan, PY; Olson, EN; Gabillard, JC				Landemaine, Aurelie; Ramirez-Martinez, Andres; Monestier, Olivier; Sabin, Nathalie; Rescan, Pierre-Yves; Olson, Eric N.; Gabillard, Jean-Charles			Trout myomaker contains 14 minisatellites and two sequence extensions but retains fusogenic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phylogenetics; myogenesis; skeletal muscle; hyperplasia; membrane fusion; cell fusion; fish; minisatellite; muscle-specific protein; myoblast	SKELETAL-MUSCLE; MYOBLAST FUSION; DIFFERENTIATION; HYBRIDIZATION; DYNAMICS; MYOCYTES; INSIGHTS; PROTEIN; GROWTH; GENES	The formation of new myofibers in vertebrates occurs by myoblast fusion and requires fusogenic activity of the muscle-specific membrane protein myomaker. Here, using in silico (BLAST) genome analyses, we show that the myomaker gene from trout includes 14 minisatellites, indicating that it has an unusual structure compared with those of other animal species. We found that the trout myomaker gene encodes a 434-amino acid (aa) protein, in accordance with its apparent molecular mass (approximate to 40 kDa) observed by immunoblotting. The first half of the trout myomaker protein (1-220 aa) is similar to the 221-aa mouse myomaker protein, whereas the second half (222-234 aa) does not correspond to any known motifs and arises from two protein extensions. The first extension (approximate to 70 aa) apparently appeared with the radiation of the bony fish clade Euteleostei, whereas the second extension (up to 236 aa) is restricted to the superorder Protacanthopterygii (containing salmonids and pike) and corresponds to the insertion of minisatellites having a length of 30 nucleotides. According to gene expression analyses, trout myomaker expression is consistently associated with the formation of new myofibers during embryonic development, postlarval growth, and muscle regeneration. Using cell-mixing experiments, we observed that trout myomaker has retained the ability to drive the fusion of mouse fibroblasts with C2C12 myoblasts. Our work reveals that trout myomaker has fusogenic function despite containing two protein extensions.	[Landemaine, Aurelie; Sabin, Nathalie; Rescan, Pierre-Yves; Gabillard, Jean-Charles] INRA, UR1037 Lab Fish Physiol & Genom, F-35000 Rennes, France; [Ramirez-Martinez, Andres; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dept Mol Biol, Dallas, TX 75390 USA; [Monestier, Olivier] Univ Libre Bruxelles, Inst Interdisciplinary Res Human & Mol Biol, B-1070 Brussels, Belgium	INRAE; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universite Libre de Bruxelles	Gabillard, JC (corresponding author), INRA, UR1037 Lab Fish Physiol & Genom, F-35000 Rennes, France.	Jean-Charles.Gabillard@inra.fr	Monestier, Olivier/AAB-2220-2020; Monestier, Olivier/E-2926-2013	Monestier, Olivier/0000-0002-3236-0807; Monestier, Olivier/0000-0002-3236-0807; Ramirez-Martinez, Andres/0000-0003-1300-1101	National Institutes of Health [AR-067294, HL-130253, DK-099653, HD-087351]; French National Research Agency [ANR-12-JSV7-0001-01]; Brittany region funds; Robert A. Welch Foundation [1-0025]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French National Research Agency(French National Research Agency (ANR)); Brittany region funds; Robert A. Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants AR-067294, HL-130253, DK-099653, and HD-087351. This study was also supported by French National Research Agency Grant ANR-12-JSV7-0001-01, by Brittany region funds (to A.L.), and by Robert A. Welch Foundation Grant 1-0025 (to E.N.O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barresi MJF, 2001, CURR BIOL, V11, P1432, DOI 10.1016/S0960-9822(01)00428-6; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Bi PP, 2018, P NATL ACAD SCI USA, V115, P3864, DOI 10.1073/pnas.1800052115; Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361; Di Gioia SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16077; Dumont E, 2008, J EXP BIOL, V211, P1163, DOI 10.1242/jeb.015461; Durcan PJ, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.44; FRENCH BA, 1991, MOL CELL BIOL, V11, P2439, DOI 10.1128/MCB.11.5.2439; Froehlich JM, 2014, JOVE-J VIS EXP, DOI 10.3791/51354; Gabillard JC, 2010, CELL TISSUE RES, V342, P471, DOI 10.1007/s00441-010-1071-8; Gabillard JC, 2006, J ENDOCRINOL, V191, P15, DOI 10.1677/joe.1.06869; Gamage DG, 2017, J BIOL CHEM, V292, P17272, DOI 10.1074/jbc.M117.811372; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Ingerslev HC, 2010, FISH SHELLFISH IMMUN, V29, P440, DOI 10.1016/j.fsi.2010.05.002; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Landemaine A, 2014, BIOCHEM BIOPH RES CO, V451, P480, DOI 10.1016/j.bbrc.2014.07.093; Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216; Quinn ME, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15665; Rescan PY, 2008, J EXP ZOOL PART B, V310B, P541, DOI 10.1002/jez.b.21230; Rescan PY, 2015, J EXP BIOL, V218, P1137, DOI 10.1242/jeb.113704; Rowlerson A, 1997, CELL TISSUE RES, V289, P311, DOI 10.1007/s004410050878; Shi J, 2017, P NATL ACAD SCI USA, V114, P11950, DOI 10.1073/pnas.1715229114; Sohn RL, 2009, P NATL ACAD SCI USA, V106, P9274, DOI 10.1073/pnas.0904398106; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; Steinbacher P, 2007, DEV DYNAM, V236, P1106, DOI 10.1002/dvdy.21103; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WEATHERLEY AH, 1979, CAN J ZOOL, V57, P2385, DOI 10.1139/z79-310; Zhang WB, 2017, DEV BIOL, V423, P24, DOI 10.1016/j.ydbio.2017.01.019; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6364	6374		10.1074/jbc.RA118.006047	http://dx.doi.org/10.1074/jbc.RA118.006047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30819805	Green Published, hybrid			2022-12-28	WOS:000468402000014
J	Lehane, AM; Dennis, ASM; Bray, KO; Li, DD; Rajendran, E; McCoy, JM; McArthur, HM; Winterberg, M; Rahimi, F; Tonkin, CJ; Kirk, K; van Dooren, GG				Lehane, Adele M.; Dennis, Adelaide S. M.; Bray, Katherine O.; Li, Dongdi; Rajendran, Esther; McCoy, James M.; McArthur, Hillary M.; Winterberg, Markus; Rahimi, Farid; Tonkin, Christopher J.; Kirk, Kiaran; van Dooren, Giel G.			Characterization of the ATP4 ion pump in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toxoplasma gondii; membrane transport; drug action; ATPase; malaria; cipargamin; Na+ pump; protozoan parasite; sodium transporter; TgATP4	INTRAERYTHROCYTIC MALARIA PARASITE; X-RAY-MICROANALYSIS; PLASMODIUM-FALCIPARUM; CATION ATPASE; NA+; SPIROINDOLONE; EXTRUSION; PROTEIN; PFATP4; SURVIVAL	The Plasmodium falciparum ATPase PfATP4 is the target of a diverse range of antimalarial compounds, including the clinical drug candidate cipargamin. PfATP4 was originally annotated as a Ca2+ transporter, but recent evidence suggests that it is a Na+ efflux pump, extruding Na+ in exchange for H+. Here we demonstrate that ATP4 proteins belong to a clade of P-type ATPases that are restricted to apicomplexans and their closest relatives. We employed a variety of genetic and physiological approaches to investigate the ATP4 protein of the apicomplexan Toxoplasma gondii, TgATP4. We show that TgATP4 is a plasma membrane protein. Knockdown of TgATP4 had no effect on resting pH or Ca2+ but rendered parasites unable to regulate their cytosolic Na+ concentration ([Na+](cyt)). PfATP4 inhibitors caused an increase in [Na+](cyt) and a cytosolic alkalinization in WT but not TgATP4 knockdown parasites. Parasites in which TgATP4 was knocked down or disrupted exhibited a growth defect, attributable to reduced viability of extracellular parasites. Parasites in which TgATP4 had been disrupted showed reduced virulence in mice. These results provide evidence for ATP4 proteins playing a key conserved role in Na+ regulation in apicomplexan parasites.	[Lehane, Adele M.; Dennis, Adelaide S. M.; Bray, Katherine O.; Li, Dongdi; Rajendran, Esther; McArthur, Hillary M.; Winterberg, Markus; Rahimi, Farid; Kirk, Kiaran; van Dooren, Giel G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [McCoy, James M.; Tonkin, Christopher J.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [McCoy, James M.; Tonkin, Christopher J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Winterberg, Markus] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Winterberg, Markus] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok, Thailand	Australian National University; Walter & Eliza Hall Institute; University of Melbourne; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Lehane, AM; Kirk, K; van Dooren, GG (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia.	adele.lehane@anu.edu.au; kiaran.kirk@anu.edu.au; giel.vandooren@anu.edu.au	Kirk, Kiaran/C-8299-2009; Lehane, Adele M/B-4127-2012; Bray, Kate/ABE-4038-2021; Rahimi, Farid/E-6522-2018; van Dooren, Giel/A-8896-2012; Tonkin, Christopher/J-2580-2016	Kirk, Kiaran/0000-0002-5613-2622; Lehane, Adele M/0000-0002-0050-9101; Bray, Kate/0000-0002-3990-2429; Rahimi, Farid/0000-0002-0920-8188; van Dooren, Giel/0000-0003-2455-9821; Tonkin, Christopher/0000-0002-7036-6222	National Health and Medical Research Council [1042272]; Australian Research Council [DP150102883, LP150101226, DE160101035, DP110103144, FT120100164]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council Grant 1042272 (to K. K.) and Australian Research Council Discovery Project Grant DP150102883 (to K. K. and G. G. v. D.), Linkage Project Grant LP150101226 (to K. K.), Discovery Early Career Researcher Award DE160101035 (to A. M. L.), QEII Fellowship DP110103144 (to G. G. v. D.), and Future Fellowship FT120100164 (to C. J. T.). C. J. T. is grateful for institutional support from the Victorian State Government Operational Infrastructure Support Program and the National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme. The authors declare that they have no conflicts of interest with the contents of this article.	Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Alleva LM, 2001, MOL BIOCHEM PARASIT, V117, P121, DOI 10.1016/S0166-6851(01)00338-3; Arrizabalaga G, 2004, J CELL BIOL, V165, P653, DOI 10.1083/jcb.200309097; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BARNES H, 1954, J EXP BIOL, V31, P582; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Blaustein M. P., 2004, CELLULAR PHYSL, P37; Borel E, 1998, PARASITE, V5, P371, DOI 10.1051/parasite/1998054371; Carey KL, 2000, MOL BIOCHEM PARASIT, V105, P25, DOI 10.1016/S0166-6851(99)00160-7; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; Das S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005647; Dennis ASM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26819-1; Dennis ASM, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00087-18, 10.1128/aac.00087-18]; Diarra A, 2001, AM J PHYSIOL-CELL PH, V280, pC1623, DOI 10.1152/ajpcell.2001.280.6.C1623; Dyer M, 1996, MOL BIOCHEM PARASIT, V78, P1, DOI 10.1016/S0166-6851(96)02593-5; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; Foth Bernardo J., 2007, V390, P467; Francia ME, 2011, EXP CELL RES, V317, P1382, DOI 10.1016/j.yexcr.2011.03.020; Goldgof GM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27806; Gornik SG, 2015, P NATL ACAD SCI USA, V112, P5767, DOI 10.1073/pnas.1423400112; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; Hewitt SN, 2017, ACS INFECT DIS, V3, P34, DOI 10.1021/acsinfecdis.6b00078; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; Katris NJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004074; Kirk K, 2015, ANNU REV MICROBIOL, V69, P341, DOI 10.1146/annurev-micro-091014-104506; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; LEE P, 1988, AM J TROP MED HYG, V39, P157, DOI 10.4269/ajtmh.1988.39.157; Lehane AM, 2014, MOL MICROBIOL, V94, P327, DOI 10.1111/mmi.12765; Mauritz JMA, 2011, BIOPHYS J, V100, P1438, DOI 10.1016/j.bpj.2011.02.007; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Moreno SNJ, 1998, BIOCHEM J, V330, P853; Rajendran E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14455; Rodriguez-Navarro A, 2010, BBA-BIOMEMBRANES, V1798, P1841, DOI 10.1016/j.bbamem.2010.07.009; Rosling JEO, 2018, J BIOL CHEM, V293, P13327, DOI 10.1074/jbc.RA118.003640; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; SIBLEY LD, 1986, J CELL BIOL, V103, P867, DOI 10.1083/jcb.103.3.867; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Spillman NJ, 2008, MOL BIOCHEM PARASIT, V162, P96, DOI 10.1016/j.molbiopara.2008.07.001; Spillman NJ, 2013, MOL BIOCHEM PARASIT, V189, P1, DOI 10.1016/j.molbiopara.2013.04.004; Spillman NJ, 2013, CELL HOST MICROBE, V13, P227, DOI 10.1016/j.chom.2012.12.006; Staines HM, 2001, AM J PHYSIOL-CELL PH, V280, pC1576, DOI 10.1152/ajpcell.2001.280.6.C1576; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TROTTEIN F, 1995, GENE, V158, P133, DOI 10.1016/0378-1119(95)00158-3; Vaidya AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6521; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Dooren GG, 2016, J BIOL CHEM, V291, P19335, DOI 10.1074/jbc.M116.725069; van Dooren GG, 2013, ANNU REV MICROBIOL, V67, P271, DOI 10.1146/annurev-micro-092412-155741; Van Voorhis WC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005763; Winterberg M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29241; Zhou Y, 2014, ANTIMICROB AGENTS CH, V58, P1789, DOI 10.1128/AAC.02225-13	59	8	8	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5720	5734		10.1074/jbc.RA118.006706	http://dx.doi.org/10.1074/jbc.RA118.006706			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30723156	Green Published, hybrid			2022-12-28	WOS:000464517500038
J	Hedglin, M; Aitha, M; Pedley, A; Benkovic, SJ				Hedglin, Mark; Aitha, Mahesh; Pedley, Anthony; Benkovic, Stephen J.			Replication protein A dynamically regulates monoubiquitination of proliferating cell nuclear antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proliferating cell nuclear antigen (PCNA); ubiquitin-conjugating enzyme (E2 enzyme); E3 ubiquitin ligase; ubiquitylation (ubiquitination); DNA damage; DNA replication; PCNA monoubiquitination; posttranslational modification (PTM); Rad6; Rad18; replication protein A (RPA); translesion DNA synthesis (TLS); DNA polymerase; DNA-binding protein; sliding clamp; cell cycle	SINGLE-STRANDED-DNA; LAGGING STRANDS; DAMAGE BYPASS; LIGASE RAD18; PCNA; BINDING; UBIQUITIN; REPAIR; CYCLE; P53	DNA damage tolerance permits bypass of DNA lesions encountered during S-phase and may be carried out by translesion DNA synthesis (TLS). Human TLS requires selective monoubiquitination of proliferating cell nuclear antigen (PCNA) sliding clamps encircling damaged DNA. This posttranslational modification (PTM) is catalyzed by Rad6/Rad18. Recent studies revealed that replication protein A (RPA), the major ssDNA-binding protein, is involved in the regulation of PCNA monoubiquitination and interacts directly with Rad18 on chromatin and in the nucleoplasm. However, it is unclear how RPA regulates this critical PTM and what functional role(s) these interactions serve. Here, we developed an in vitro assay to quantitatively monitor PCNA monoubiquitination under in vivo scenarios. Results from extensive experiments revealed that RPA regulates Rad6/Rad18 activity in an ssDNA-dependent manner. We found that "DNA-free" RPA inhibits monoubiquitination of free PCNA by directly interacting with Rad18. This interaction is promoted under native conditions when there is an overabundance of free RPA in the nucleoplasm where Rad6/Rad18 and a significant fraction of PCNA reside. During DNA replication stress, RPA binds the ssDNA exposed downstream of stalled primer/template (P/T) junctions, releasing Rad6/Rad18. RPA restricted the resident PCNAs to the upstream duplex regions by physically blocking diffusion of PCNA along ssDNA, and this activity was required for efficient monoubiquitination of PCNA on DNA. Furthermore, upon binding ssDNA, RPA underwent a conformational change that increased its affinity for Rad18. Rad6/Rad18 complexed with ssDNA-bound RPA was active, and this interaction may selectively promote monoubiquitination of PCNA on long RPA-coated ssDNA.	[Hedglin, Mark; Aitha, Mahesh; Pedley, Anthony; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hedglin, M (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	muh218@psu.edu		Pedley, Anthony/0000-0003-1034-5072; Hedglin, Mark/0000-0003-2599-1691	National Institute of General Medical Sciences (NIGMS), National Institutes of Health [R01 GM013306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences (NIGMS), National Institutes of Health Grant R01 GM013306. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramova NA, 1997, P NATL ACAD SCI USA, V94, P7186, DOI 10.1073/pnas.94.14.7186; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Brown S, 2009, CELL CYCLE, V8, P689, DOI 10.4161/cc.8.5.7707; Cooper GM., 2016, CELL MOL APPROACH, V89, P424; Cotto-Rios XM, 2011, J CELL BIOL, V194, P177, DOI 10.1083/jcb.201101062; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Diamant N, 2012, NUCLEIC ACIDS RES, V40, P170, DOI 10.1093/nar/gkr596; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; Elia AEH, 2015, MOL CELL, V60, P280, DOI 10.1016/j.molcel.2015.09.011; Flynn RL, 2010, CRIT REV BIOCHEM MOL, V45, P266, DOI 10.3109/10409238.2010.488216; Game JC, 2009, DNA REPAIR, V8, P470, DOI 10.1016/j.dnarep.2009.01.007; HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F; Hedglin M, 2017, BIOCHEMISTRY-US, V56, P3415, DOI 10.1021/acs.biochem.7b00386; Hedglin M, 2017, CHEM REV, V117, P7857, DOI 10.1021/acs.chemrev.7b00046; Hedglin M, 2017, BIOCHEMISTRY-US, V56, P1824, DOI 10.1021/acs.biochem.6b01213; Hedglin M, 2015, ANNU REV BIOPHYS, V44, P207, DOI 10.1146/annurev-biophys-060414-033841; Hedglin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010165; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang AD, 2011, J MOL BIOL, V410, P424, DOI 10.1016/j.jmb.2011.04.051; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Huttner D, 2008, CELL CYCLE, V7, P3629, DOI 10.4161/cc.7.23.7166; KIM C, 1995, BIOCHEMISTRY-US, V34, P2058, DOI 10.1021/bi00006a028; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Li FF, 2018, CURR GENET, V64, P459, DOI 10.1007/s00294-017-0753-0; LI R, 1993, CELL, V73, P1207, DOI 10.1016/0092-8674(93)90649-B; Lin YL, 1996, J BIOL CHEM, V271, P17190, DOI 10.1074/jbc.271.29.17190; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Masuyama S, 2005, GENES CELLS, V10, P753, DOI 10.1111/j.1365-2443.2005.00874.x; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Miller SD, 1997, MOL CELL BIOL, V17, P2194, DOI 10.1128/MCB.17.4.2194; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Nguyen B, 2014, J MOL BIOL, V426, P3246, DOI 10.1016/j.jmb.2014.07.014; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Notenboom V, 2007, NUCLEIC ACIDS RES, V35, P5819, DOI 10.1093/nar/gkm615; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Prakash Aishwarya, 2012, Subcell Biochem, V62, P171, DOI 10.1007/978-94-007-4572-8_10; SASAKI K, 1993, CYTOMETRY, V14, P876, DOI 10.1002/cyto.990140805; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Soria G, 2006, ONCOGENE, V25, P2829, DOI 10.1038/sj.onc.1209315; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Tateishi S, 2000, P NATL ACAD SCI USA, V97, P7927, DOI 10.1073/pnas.97.14.7927; Tsuji Y, 2008, GENES CELLS, V13, P343, DOI 10.1111/j.1365-2443.2008.01176.x; Waldman VM, 2016, NUCLEIC ACIDS RES, V44, P4317, DOI 10.1093/nar/gkw262; Wang ZF, 2016, J CELL SCI, V129, P1223, DOI 10.1242/jcs.179408; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang Y, 2013, NUCLEIC ACIDS RES, V41, P2296, DOI 10.1093/nar/gks1325; Yoon JH, 2012, P NATL ACAD SCI USA, V109, P7799, DOI 10.1073/pnas.1204105109; Yu CH, 2014, MOL CELL, V56, P551, DOI 10.1016/j.molcel.2014.09.017; Zessin PJM, 2016, SCI REP-UK, V6, DOI 10.1038/srep18779	58	15	15	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5157	5168		10.1074/jbc.RA118.005297	http://dx.doi.org/10.1074/jbc.RA118.005297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30700555	Green Published, hybrid			2022-12-28	WOS:000463985600036
J	Graber, TG; Fry, CS; Brightwell, CR; Moro, T; Maroto, R; Bhattarai, N; Porter, C; Wakamiya, M; Rasmussen, BB				Graber, Ted G.; Fry, Christopher S.; Brightwell, Camille R.; Moro, Tatiana; Maroto, Rosario; Bhattarai, Nisha; Porter, Craig; Wakamiya, Maki; Rasmussen, Blake B.			Skeletal muscle-specific knockout of DEP domain containing 5 protein increases mTORC1 signaling, muscle cell hypertrophy, and mitochondrial respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GATOR1 (GTPase-activating protein (GAP) activity toward Rags-1); gene knockout; muscle; muscle hypertrophy; translation control; transgenic mice; mTOR complex (mTORC); amino acid sensing; muscle contractility	ACTIVATION; COMPLEX; CAPACITY; STRENGTH; EXERCISE; MODEL; MICE	mTORC1 regulates protein synthesis and in turn is regulated by growth factors, energy status, and amino acid availability. In kidney cell (HEK293-T) culture, the GAP activity toward RAG (GATOR1) protein complex suppresses activation of the RAG A/B-RAG C/D heterodimer when amino acids are insufficient. During amino acid sufficiency, the RAG heterodimer recruits mTORC1 to the lysosomal membrane where its interaction with Ras homolog enriched in brain (Rheb) stimulates mTORC1's kinase activity. The DEP domain containing 5 (DEPDC5) protein, a GATOR1 subunit, causes familial focal epilepsy when mutated, and global knockout of the Depdc5 gene is embryonically lethal. To study the function of DEPDC5 in skeletal muscle, we generated a muscle-specific inducible Depdc5 knockout mouse, hypothesizing that knocking out Depdc5 in muscle would make mTORC1 constitutively active, causing hypertrophy and improving muscle function. Examining mTORC1 signaling, morphology, mitochondrial respiratory capacity, contractile function, and applied physical function (e.g. rotarod, treadmill, grip test, and wheel running), we observed that mTORC1 activity was significantly higher in knockout (KO) mice, indicated by the increased phosphorylation of mTOR and its downstream effectors (by 118% for p-mTOR/mTOR, 114% for p-S6K1/S6K1, and 35% for p-4E-BP1/4E-BP1). The KO animals also exhibited soleus muscle cell hypertrophy and a 2.5-fold increase in mitochondrial respiratory capacity. However, contrary to our hypothesis, neither physical nor contractile function improved. In conclusion, DEPDC5 depletion in adult skeletal muscle removes GATOR1 inhibition of mTORC1, resulting in muscle hypertrophy and increased mitochondrial respiration, but does not improve overall muscle quality and function.	[Graber, Ted G.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Graber, Ted G.; Fry, Christopher S.; Moro, Tatiana; Maroto, Rosario; Rasmussen, Blake B.] Univ Texas Med Branch, Dept Nutr & Metab, 301 Univ Blvd, Galveston, TX 77555 USA; [Brightwell, Camille R.] Univ Texas Med Branch, Program Cell Biol, Galveston, TX 77555 USA; [Bhattarai, Nisha; Porter, Craig] Univ Texas Med Branch, Dept Surg Burn Metab, Galveston, TX 77555 USA; [Wakamiya, Maki] Univ Texas Med Branch, Transgen Core Facil, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Rasmussen, BB (corresponding author), Univ Texas Med Branch, Dept Nutr & Metab, 301 Univ Blvd, Galveston, TX 77555 USA.	blrasmus@utmb.edu	Moro, Tatiana/N-6669-2019; Fry, Christopher/U-2216-2019; Brightwell, Camille R./X-8718-2019	Moro, Tatiana/0000-0002-1404-1511; Brightwell, Camille R./0000-0001-6334-3789; Graber, Ted/0000-0002-5332-7838; Rasmussen, Blake/0000-0001-7854-5375	National Institutes of Health NCATS CTSA [TL1TR001440 NSRA]; NIA [P30 AG024832, R56 AG051267, T32 AG000270]; NIAMS [R01 AR072061]; Shriners Hospitals for Children Grant [84090]; NCATSS CTSA KL2 scholar award [KL2TR001441]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001441, TL1TR001440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832, T32AG000270] Funding Source: NIH RePORTER	National Institutes of Health NCATS CTSA; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Shriners Hospitals for Children Grant; NCATSS CTSA KL2 scholar award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health NCATS CTSA TL1TR001440 NSRA Fellowship and NIA P30 AG024832 Pilot/Developmental grants (to T. G. G.), NIA R56 AG051267 (to B. B. R.), NIAMS R01 AR072061 (to C. S. F.), NIA T32 AG000270 (to C. R. B.), and NCATSS CTSA KL2 scholar award KL2TR001441 (to C. P.) and by Shriners Hospitals for Children Grant 84090 (to C. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrigo J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2063179; ALNAQEEB MA, 1984, J ANAT, V139, P677; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chen CNJ, 2014, J MUSCLE RES CELL M, V35, P191, DOI 10.1007/s10974-014-9385-x; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Dutchak PA, 2018, CELL REP, V23, P1907, DOI 10.1016/j.celrep.2018.04.058; Dutchak PA, 2015, CELL REP, V12, P371, DOI 10.1016/j.celrep.2015.06.042; Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710; Graber TG, 2018, EXP GERONTOL, V106, P88, DOI 10.1016/j.exger.2018.02.002; Graber TG, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0187-1; Graber TG, 2015, AGE, V37, DOI 10.1007/s11357-015-9773-1; Graber TG, 2013, J GERONTOL A-BIOL, V68, P1326, DOI 10.1093/gerona/glt032; Guridi M, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0084-8; Haizlip KM, 2015, PHYSIOLOGY, V30, P30, DOI 10.1152/physiol.00024.2014; Hughes J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12574-2; Kappel S, 2017, ANIMALS, V7, DOI 10.3390/ani7120088; Kimball SR, 2014, AM J CLIN NUTR, V99, p237S, DOI 10.3945/ajcn.113.068387; Kowalczyk MS, 2012, MAMM GENOME, V23, P404, DOI 10.1007/s00335-012-9398-y; Marsan E, 2016, NEUROBIOL DIS, V89, P180, DOI 10.1016/j.nbd.2016.02.010; Matsakas A, 2012, EXP PHYSIOL, V97, P125, DOI 10.1113/expphysiol.2011.063008; MAUGHAN RJ, 1984, SPORTS MED, V1, P263, DOI 10.2165/00007256-198401040-00002; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Porter C, 2016, CELL METAB, V24, P246, DOI 10.1016/j.cmet.2016.07.004; Porter C, 2015, AM J PHYSIOL-ENDOC M, V309, pE224, DOI 10.1152/ajpendo.00125.2015; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; SALE DG, 1992, EUR J APPL PHYSIOL O, V64, P51, DOI 10.1007/BF00376440; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Van Loo PLP, 2004, LAB ANIM-UK, V38, P178, DOI 10.1258/002367704322968867; Webers EM, 2017, LAB ANIMAL, V46, P157, DOI 10.1038/laban.1219; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Yang HJ, 2017, NATURE, V552, P368, DOI 10.1038/nature25023; Yuskaitis CJ, 2018, NEUROBIOL DIS, V111, P91, DOI 10.1016/j.nbd.2017.12.010	38	15	15	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4091	4102		10.1074/jbc.RA118.005970	http://dx.doi.org/10.1074/jbc.RA118.005970			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30635399	hybrid, Green Published			2022-12-28	WOS:000461854400022
J	Alimov, I; Menon, S; Cochran, N; Maher, R; Wang, Q; Alford, J; Concannon, JB; Yang, ZE; Harrington, E; Llamas, L; Lindeman, A; Hoffman, G; Schuhmann, T; Russ, C; Reece-Hoyes, J; Canham, SM; Cai, XM				Alimov, Irina; Menon, Suchithra; Cochran, Nadire; Maher, Rob; Wang, Qiong; Alford, John; Concannon, John B.; Yang, Zinger; Harrington, Edmund; Llamas, Luis; Lindeman, Alicia; Hoffman, Gregory; Schuhmann, Tim; Russ, Carsten; Reece-Hoyes, John; Canham, Stephen M.; Cai, Xinming			Bile acid analogues are activators of pyrin inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; CRISPR; Cas; microbiome; mucosal immunology; bile acid; pyrin; familial Mediterranean fever; CRISPR screen; microbiota; biotransformation; immune response; gut homeostasis; autoimmune disease	FAMILIAL MEDITERRANEAN FEVER; NLRP3 INFLAMMASOME; DEOXYCHOLIC-ACID; CULTURE-SYSTEM; MICROBIOTA; DISEASE; GENE; EPIMERIZATION; MECHANISM; COLITIS	Bile acids are critical metabolites in the gastrointestinal tract and contribute to maintaining intestinal immune homeostasis through cross-talk with the gut microbiota. The conversion of bile acids by the gut microbiome is now recognized as a factor affecting both host metabolism and immune responses, but its physiological roles remain unclear. We conducted a screen for microbiome metabolites that would function as inflammasome activators and herein report the identification of 12-oxo-lithocholic acid (BAA485), a potential microbiome-derived bile acid metabolite. We demonstrate that the more potent analogue 11-oxo-12S-hydroxylithocholic acid methyl ester (BAA473) can induce secretion of interleukin-18 (IL-18) through activation of the inflammasome in both myeloid and intestinal epithelial cells. Using a genome-wide CRISPR screen with compound induced pyroptosis in THP-1 cells, we identified that inflammasome activation by BAA473 is pyrin-dependent (MEFV). To our knowledge, the bile acid analogues BAA485 and BAA473 are the first small molecule activators of the pyrin inflammasome. We surmise that pyrin inflammasome activation through microbiota-modified bile acid metabolites such as BAA473 and BAA485 plays a role in gut microbiota regulated intestinal immune response. The discovery of these two bioactive compounds may help to further unveil the importance of pyrin in gut homeostasis and autoimmune diseases.	[Alimov, Irina; Menon, Suchithra; Cochran, Nadire; Maher, Rob; Wang, Qiong; Alford, John; Concannon, John B.; Yang, Zinger; Harrington, Edmund; Llamas, Luis; Lindeman, Alicia; Hoffman, Gregory; Schuhmann, Tim; Russ, Carsten; Reece-Hoyes, John; Canham, Stephen M.; Cai, Xinming] Novartis Inst Biomed Res, 181 Massachusetts Ave, Cambridge, MA 02139 USA; [Schuhmann, Tim] Novartis Pharma AG, Novartis Inst Biomed Res, Forum 1 Novartis Campus, CH-4056 Basel, Switzerland	Novartis; Novartis	Canham, SM; Cai, XM (corresponding author), Novartis Inst Biomed Res, 181 Massachusetts Ave, Cambridge, MA 02139 USA.; Cai, XM (corresponding author), Sanofi US, 270 Albany St, Cambridge, MA 02139 USA.	steve.canham@novartis.com; xinming.cai@sanofi.com		Reece-Hoyes, John/0000-0001-5251-5813; Canham, Stephen/0000-0003-4750-8066; Yang Loureiro, Zinger/0000-0001-8543-4841				Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Batu ED, 2016, ARTHRIT CARE RES, V68, P1859, DOI 10.1002/acr.22901; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]; Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]; EDENHARDER R, 1985, SYST APPL MICROBIOL, V6, P18, DOI 10.1016/S0723-2020(85)80005-9; EDENHARDER R, 1985, APPL ENVIRON MICROB, V49, P964, DOI 10.1128/AEM.49.4.964-968.1985; EDENHARDER R, 1984, SYST APPL MICROBIOL, V5, P287, DOI 10.1016/S0723-2020(84)80031-4; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fidder H, 2005, AM J GASTROENTEROL, V100, P338, DOI 10.1111/j.1572-0241.2005.40810.x; GALLAGHER TF, 1946, J BIOL CHEM, V162, P539; Gao WQ, 2016, P NATL ACAD SCI USA, V113, pE4857, DOI 10.1073/pnas.1601700113; GROH H, 1993, J BASIC MICROB, V33, P59, DOI 10.1002/jobm.3620330115; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; HERSHBERG EB, 1952, J AM CHEM SOC, V74, P2585, DOI 10.1021/ja01130a036; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; KELSEY MI, 1976, J STEROID BIOCHEM, V7, P641, DOI 10.1016/0022-4731(76)90059-5; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Ktsoyan ZA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00776; Ktsoyan ZA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00002; Kubosaki A, 2010, MOL IMMUNOL, V47, P2295, DOI 10.1016/j.molimm.2010.05.289; Lei-Leston AC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01168; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Liberzon A, 2014, METHODS MOL BIOL, V1150, P153, DOI 10.1007/978-1-4939-0512-6_9; MACDONALD IA, 1983, J LIPID RES, V24, P675; Marker RE, 1938, J AM CHEM SOC, V60, P1334, DOI 10.1021/ja01273a017; Moon C, 2014, MUCOSAL IMMUNOL, V7, P818, DOI 10.1038/mi.2013.98; Ozen S, 2009, ANN RHEUM DIS, V68, P246, DOI 10.1136/ard.2008.092031; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; SCHWABE AD, 1974, MEDICINE, V53, P453, DOI 10.1097/00005792-197411000-00005; Sharma D, 2018, GASTROENTEROLOGY, V154, P948, DOI 10.1053/j.gastro.2017.11.276; Van Gijn ME, 2018, J MED GENET, V55, P530, DOI 10.1136/jmedgenet-2017-105216; VanDussen KL, 2015, GUT, V64, P911, DOI 10.1136/gutjnl-2013-306651; Villani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007154; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yao LN, 2018, ELIFE, V7, DOI 10.7554/eLife.37182; Yepiskoposyan L, 2007, EUR J HUM GENET, V15, P911, DOI 10.1038/sj.ejhg.5201869; Zhernakova A, 2008, AM J HUM GENET, V82, P1202, DOI 10.1016/j.ajhg.2008.03.016	42	25	25	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3359	3366		10.1074/jbc.RA118.005103	http://dx.doi.org/10.1074/jbc.RA118.005103			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30647128	hybrid, Green Published			2022-12-28	WOS:000461853900004
J	Wilson, IBH; Schabussova, I				Wilson, Iain B. H.; Schabussova, Irma			Sweet and CRISP(R)y parasite engineering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Toxoplasma gondii is an intracellular parasite that is highly prevalent within human populations. Its genome encodes a range of enzymes involved in glycan biosynthesis and metabolism. A new study presents a library of CRISPR/Cas9-based glyco-relevant gene knockouts and their examination in glycomic and functional assays. This new resource can pave the way for a better understanding of the role of carbohydrates in infection and immunomodulation by this significant protozoan parasite.	[Wilson, Iain B. H.] Univ Bodenkultur, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria; [Schabussova, Irma] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Kinderspitalgasse 15, A-1090 Vienna, Austria	Medical University of Vienna	Wilson, IBH (corresponding author), Univ Bodenkultur, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria.; Schabussova, I (corresponding author), Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Kinderspitalgasse 15, A-1090 Vienna, Austria.	iain.wilson@boku.ac.at; irma.schabussova@meduniwien.ac.at	Wilson, Iain/B-3326-2009	Wilson, Iain/0000-0001-8996-1518; Schabussova, Irma/0000-0002-2109-2640	Austrian Science Fund [P29466, F4612]	Austrian Science Fund(Austrian Science Fund (FWF))	Research in the authors' laboratories is funded by the Austrian Science Fund (FWF Grants P29466 and F4612). The authors declare that they have no conflicts of interest with the contents of this article.	Bandini G, 2019, J BIOL CHEM, V294, P1967, DOI 10.1074/jbc.RA118.005179; Drinic M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15663-4; Gas-Pascual E, 2019, J BIOL CHEM, V294, P1104, DOI 10.1074/jbc.RA118.006072; Khurana S, 2019, J BIOL CHEM, V294, P1541, DOI 10.1074/jbc.RA118.005357; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Rahman K, 2017, J BIOL CHEM, V292, P18644, DOI 10.1074/jbc.M117.809301; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003	7	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1126	1127		10.1074/jbc.H118.007210	http://dx.doi.org/10.1074/jbc.H118.007210			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30807998	hybrid, Green Published			2022-12-28	WOS:000457879500005
J	Mathiesen, SB; Lunde, M; Aronsen, JM; Romaine, A; Kaupang, A; Martinsen, M; de Souza, GA; Nyman, TA; Sjaastad, I; Christensen, G; Carlson, CR				Mathiesen, Sabrina Bech; Lunde, Marianne; Aronsen, Jan Magnus; Romaine, Andreas; Kaupang, Anita; Martinsen, Marita; de Souza, Gustavo Antonio; Nyman, Tuula A.; Sjaastad, Ivar; Christensen, Geir; Carlson, Cathrine Rein			The cardiac syndecan-4 interactome reveals a role for syndecan-4 in nuclear translocation of muscle LIM protein (MLP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteoglycan; heart; cardiomyopathy; protein-protein interaction; nuclear translocation; protein complex; biomechanics; cysteine and glycine rich protein 3 (CSRP3); muscle LIM protein (MLP); syndecan-4	TIGHT JUNCTION; HEART-FAILURE; CARDIOMYOCYTES; PROTEOGLYCAN; DOMAIN; GENE; LOCALIZATION; ASSOCIATION; ACTIVATION; MUTATIONS	Costameres are signaling hubs at the sarcolemma and important contact points between the extracellular matrix and cell interior, sensing and transducing biomechanical signals into a cellular response. The transmembrane proteoglycan syndecan-4 localizes to these attachment points and has been shown to be important in the initial stages of cardiac remodeling, but its mechanistic function in the heart remains insufficiently understood. Here, we sought to map the cardiac interactome of syndecan-4 to better understand its function and downstream signaling mechanisms. By combining two different affinity purification methods with MS analysis, we found that the cardiac syndecan-4 interactome consists of 21 novel and 29 previously described interaction partners. Nine of the novel partners were further validated to bind syndecan-4 in HEK293 cells (i.e. CAVIN1/PTRF, CCT5, CDK9, EIF2S1, EIF4B, MPP7, PARVB, PFKM, and RASIP). We also found that 19 of the 50 interactome partners bind differently to syndecan-4 in the left ventricle lysate from aortic-banded heart failure (ABHF) rats compared with SHAM-operated animals. One of these partners was the well-known mechanotransducer muscle LIM protein (MLP), which showed direct and increased binding to syndecan-4 in ABHF. Nuclear translocation is important in MLP-mediated signaling, and we found less MLP in the nuclear-enriched fractions from syndecan-4(-/-) mouse left ventricles but increased nuclear MLP when syndecan-4 was overexpressed in a cardiomyocyte cell line. In the presence of a cell-permeable syndecan-4-MLP disruptor peptide, the nuclear MLP level was reduced. These findings suggest that syndecan-4 mediates nuclear translocation of MLP in the heart.	[Mathiesen, Sabrina Bech; Lunde, Marianne; Aronsen, Jan Magnus; Romaine, Andreas; Kaupang, Anita; Martinsen, Marita; Sjaastad, Ivar; Christensen, Geir; Carlson, Cathrine Rein] Univ Oslo, Oslo Univ Hosp, Inst Expt Med Res, N-0450 Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, N-0456 Oslo, Norway; [Romaine, Andreas; Sjaastad, Ivar; Christensen, Geir] Univ Oslo, KG Jebsen Ctr Cardiac Res, N-0450 Oslo, Norway; [de Souza, Gustavo Antonio; Nyman, Tuula A.] Univ Oslo, Dept Immunol, Inst Clin Med, N-0372 Oslo, Norway; [de Souza, Gustavo Antonio; Nyman, Tuula A.] Rikshosp Oslo, N-0372 Oslo, Norway; [Aronsen, Jan Magnus] Univ Oslo, Dept Pharmacol, Fac Med, Sognsvannsveien 20, N-0372 Oslo, Norway; [Aronsen, Jan Magnus] Oslo Univ Hosp, Sognsvannsveien 20, N-0372 Oslo, Norway; [de Souza, Gustavo Antonio] Campus Univ UFRN, Dept Biochem, Ctr Biociencias, Av Sen Salgado Filho,3000 Lagoa Nova, BR-59064741 Natal, RN, Brazil	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Carlson, CR (corresponding author), Univ Oslo, Oslo Univ Hosp, Inst Expt Med Res, N-0450 Oslo, Norway.	c.r.carlson@medisin.uio.no	de Souza, Gustavo A/J-1502-2015; Center, Norwegian Transgenic/T-2512-2018	de Souza, Gustavo A/0000-0001-8372-9451; Romaine, Andreas/0000-0002-4952-7052	Core Facilities Program of the South-Eastern Norway Regional Health Authority	Core Facilities Program of the South-Eastern Norway Regional Health Authority	We thank Solveig Sirnes, Hilde Jarstadmarken, Tone Lian, and Dina Behmen for help with transfections, cell isolation, and general technical assistance. We thank Astrid Tutturen and Maria Stensland for technical assistance regarding MS. We also thank Professor John R. Couchman for helpful advice on antibody selection. The Proteomics Core Facility is supported by the Core Facilities Program of the South-Eastern Norway Regional Health Authority.	Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Boateng SY, 2007, AM J PHYSIOL-HEART C, V292, pH259, DOI 10.1152/ajpheart.00766.2006; Boateng SY, 2009, J MOL CELL CARDIOL, V47, P426, DOI 10.1016/j.yjmcc.2009.04.006; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Choi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep36818; Christensen G, 2019, MATRIX BIOL, V75-76, P286, DOI 10.1016/j.matbio.2018.01.001; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Elfenbein A, 2013, J CELL SCI, V126, P3799, DOI 10.1242/jcs.124636; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finsen AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028302; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frank R, 1996, EPITOPE MAPPING PROT, P149, DOI [10.1385/0896033759, DOI 10.1385/0896033759]; Gehmlich K, 2004, CELL TISSUE RES, V317, P129, DOI 10.1007/s00441-004-0873-y; Geier C, 2003, CIRCULATION, V107, P1390, DOI 10.1161/01.CIR.0000056522.82563.5F; Geier C, 2008, HUM MOL GENET, V17, P2753, DOI 10.1093/hmg/ddn160; Granes F, 2003, FEBS LETT, V547, P212, DOI 10.1016/S0014-5793(03)00712-9; Hallhuber M, 2006, CIRC RES, V99, P626, DOI 10.1161/01.RES.0000243208.59795.d8; Haque ZK, 2017, CELL MOL LIFE SCI, V74, P983, DOI 10.1007/s00018-016-2373-0; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Herum KM, 2015, CARDIOVASC RES, V106, P217, DOI 10.1093/cvr/cvv002; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hirokawa M, 2015, EUR J HUM GENET, V23, P374, DOI 10.1038/ejhg.2014.110; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Li A, 2012, PROTEOMICS, V12, P203, DOI 10.1002/pmic.201100492; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Mezzano V, 2012, LIFE SCI, V90, P313, DOI 10.1016/j.lfs.2011.12.009; Mlynarcik P, 2012, J PROTEOMICS, V75, P4529, DOI 10.1016/j.jprot.2012.03.001; Murakami M, 2002, J BIOL CHEM, V277, P20367, DOI 10.1074/jbc.M202501200; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Pandey P, 2018, DEV CELL, V44, P326, DOI 10.1016/j.devcel.2017.12.024; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Riley KN, 2003, MOL BIOL CELL, V14, P4155, DOI 10.1091/mbc.e02-11-0726; Ronning SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129288; Roper JA, 2012, CURR OPIN STRUC BIOL, V22, P583, DOI 10.1016/j.sbi.2012.07.003; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schallus T, 2009, FEBS LETT, V583, P1017, DOI 10.1016/j.febslet.2009.02.021; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Stucke VM, 2007, MOL BIOL CELL, V18, P1744, DOI 10.1091/mbc.E06-11-0980; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; van Putten S, 2016, J MOL CELL CARDIOL, V93, P133, DOI 10.1016/j.yjmcc.2015.11.025; VanWinkle WB, 2002, ANAT RECORD, V268, P38, DOI 10.1002/ar.10130; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zong F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007346	56	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8717	8731		10.1074/jbc.RA118.006423	http://dx.doi.org/10.1074/jbc.RA118.006423			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30967474	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000470971100009
J	Singh, A; Mia, MM; Cibi, DM; Arya, AK; Bhadada, SK; Singh, MK				Singh, Anamika; Mia, Masum M.; Cibi, Dasan Mary; Arya, Ashutosh Kumar; Bhadada, Sanjay Kumar; Singh, Manvendra K.			Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						developmental factor; development; proliferation; cell proliferation; signaling; epidermal growth factor receptor (EGFR); parathyroid hormone; cancer; receptor tyrosine kinase; hormone; ERBB signaling; extracellular signaling; hyperparathyroidism; parathyroid hyperplasia; semaphorin signaling	FACTOR RECEPTOR EGFR; CYCLIN D1; TYROSINE KINASES; ERBB/HER FAMILY; HORMONE 1-34; EXPRESSION; CANCER; THYMUS; GROWTH; HYPERPLASIA	Primary hyperparathyroidism (PHPT) is a common endocrinopathy characterized by hypercalcemia and elevated levels of parathyroid hormone. The primary cause of PHPT is a benign overgrowth of parathyroid tissue causing excessive secretion of parathyroid hormone. However, the molecular etiology of PHPT is incompletely defined. Here, we demonstrate that semaphorin3d (Sema3d), a secreted glycoprotein, is expressed in the developing parathyroid gland in mice. We also observed that genetic deletion of Sema3d leads to parathyroid hyperplasia, causing PHPT. In vivo and in vitro experiments using histology, immunohistochemistry, biochemical, RT-qPCR, and immunoblotting assays revealed that Sema3d inhibits parathyroid cell proliferation by decreasing the epidermal growth factor receptor (EGFR)/Erb-B2 receptor tyrosine kinase (ERBB) signaling pathway. We further demonstrate that EGFR signaling is elevated in Sema3d(-/-) parathyroid glands and that pharmacological inhibition of EGFR signaling can partially rescue the parathyroid hyperplasia phenotype. We propose that because Sema3d is a secreted protein, it may be possible to use recombinant Sema3d or derived peptides to inhibit parathyroid cell proliferation causing hyperplasia and hyperparathyroidism. Collectively, these findings identify Sema3d as a negative regulator of parathyroid growth.	[Singh, Anamika; Mia, Masum M.; Cibi, Dasan Mary; Singh, Manvendra K.] Duke NUS Med Sch Singapore, Program Cardiovasc & Metab Disorders, Singapore 169857, Singapore; [Singh, Manvendra K.] Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore 169609, Singapore; [Arya, Ashutosh Kumar; Bhadada, Sanjay Kumar] Postgrad Inst Med Educ & Res PGIMER, Dept Endocrinol, Chandigarh 160012, India	National University of Singapore; National Heart Centre Singapore; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Singh, MK (corresponding author), Duke NUS Med Sch Singapore, Program Cardiovasc & Metab Disorders, Singapore 169857, Singapore.	manvendra.singh@duke-nus.edu.sg	Singh, Manvendra K./AHE-0676-2022; Arya, Ashutosh/AAC-9569-2020	Arya, Ashutosh/0000-0003-2717-8872; Singh, Manvendra K./0000-0002-2884-0074; Mia, Md Masum/0000-0001-8281-6377; Singh, Anamika/0000-0002-1699-3671	Duke-NUS Medical School Singapore; Goh Foundation; Singapore National Research Foundation (NRF) [NRF-NRFF2016-01]	Duke-NUS Medical School Singapore(National University of Singapore); Goh Foundation; Singapore National Research Foundation (NRF)(National Research Foundation, Singapore)	This work was supported by funds from Duke-NUS Medical School Singapore, the Goh Foundation, and Singapore National Research Foundation (NRF) Fellowship NRF-NRFF2016-01 (to M. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aghajanian H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12038; Aghajanian H, 2014, J BIOL CHEM, V289, P17971, DOI 10.1074/jbc.M113.544833; Arcidiacono MV, 2008, J AM SOC NEPHROL, V19, P310, DOI 10.1681/ASN.2007040406; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bandeira Leonardo, 2016, F1000Res, V5, DOI 10.12688/f1000research.7039.1; Bednarz N, 2009, ACTA BIOCHIM POL, V56, P83; Bilezikian JP, 2018, LANCET, V391, P168, DOI 10.1016/S0140-6736(17)31430-7; Bilezikian JP, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.33; Bjorklund P, 2007, BIOCHEM BIOPH RES CO, V352, P532, DOI 10.1016/j.bbrc.2006.11.056; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Burk K, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms14508; Cagnoni G, 2014, ONCOGENE, V33, P4795, DOI 10.1038/onc.2013.474; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; Cozzolino M, 2005, AM J PHYSIOL-RENAL, V289, pF1096, DOI 10.1152/ajprenal.00167.2005; Cusano NE, 2013, J CLIN DENSITOM, V16, P33, DOI 10.1016/j.jocd.2012.12.001; Degenhardt K, 2013, NAT MED, V19, P760, DOI 10.1038/nm.3185; Dempster DW, 2001, J BONE MINER RES, V16, P1846, DOI 10.1359/jbmr.2001.16.10.1846; DIETRICH S, 1995, DEV BIOL, V167, P529, DOI 10.1006/dbio.1995.1047; Dong Y, 1997, INT J CANCER, V74, P57, DOI 10.1002/(SICI)1097-0215(19970220)74:1<57::AID-IJC10>3.0.CO;2-F; Epstein JA, 2015, CELL METAB, V21, P163, DOI 10.1016/j.cmet.2014.12.015; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Feiner L, 2001, DEVELOPMENT, V128, P3061; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Furnari FB, 2015, NAT REV CANCER, V15, P302, DOI 10.1038/nrc3918; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Greicius G, 2018, P NATL ACAD SCI USA, V115, pE3173, DOI 10.1073/pnas.1713510115; Grigorieva IV, 2010, J CLIN INVEST, V120, P2144, DOI 10.1172/JCI42021; Gulkesen KH, 2001, APMIS, V109, P870, DOI 10.1034/j.1600-0463.2001.091210.x; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Hsi ED, 1996, J CLIN ENDOCR METAB, V81, P1736, DOI 10.1210/jc.81.5.1736; Imanishi Y, 2001, J CLIN INVEST, V107, P1093, DOI 10.1172/JCI10523; Karayan-Tapon L, 2008, BRIT J CANCER, V99, P1153, DOI 10.1038/sj.bjc.6604641; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Lee KY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9054; Lenferink AEG, 2001, CANCER RES, V61, P6583; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; Manley NR, 1998, DEV BIOL, V195, P1, DOI 10.1006/dbio.1997.8827; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; Marcocci C, 2008, J BONE MINER RES, V23, P1869, DOI 10.1359/JBMR.081018; Meadows SM, 2013, DEV DYNAM, V242, P580, DOI 10.1002/dvdy.23949; Moore-Scott BA, 2005, DEV BIOL, V278, P323, DOI 10.1016/j.ydbio.2004.10.027; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Neufeld G, 2016, DRUG RESIST UPDATE, V29, P1, DOI 10.1016/j.drup.2016.08.001; Offterdinger M, 2008, TRAFFIC, V9, P147, DOI 10.1111/j.1600-0854.2007.00665.x; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Peacock JW, 2018, EMBO MOL MED, V10, P219, DOI 10.15252/emmm.201707689; Prescott JD, 2009, WORLD J SURG, V33, P2324, DOI 10.1007/s00268-009-9962-0; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sadler GP, 1996, WORLD J SURG, V20, P736, DOI 10.1007/s002689900112; Sakanyan V, 2014, SCI REP-UK, V4, DOI 10.1038/srep03977; Singh A, 2016, CELL REP, V15, P1384, DOI 10.1016/j.celrep.2016.04.027; Singh MK, 2011, J BIOL CHEM, V286, P41036, DOI 10.1074/jbc.M111.268573; Singh N, 2013, DEV BIOL, V377, P333, DOI 10.1016/j.ydbio.2013.03.008; Stewart AF, 2000, J BONE MINER RES, V15, P1517, DOI 10.1359/jbmr.2000.15.8.1517; Takahashi K, 2008, DEV DYNAM, V237, P1699, DOI 10.1002/dvdy.21556; Tamagnone L, 2012, CANCER CELL, V22, P145, DOI 10.1016/j.ccr.2012.06.031; Tominaga Y, 1999, KIDNEY INT, V55, P1375, DOI 10.1046/j.1523-1755.1999.00396.x; Tong JF, 2014, MOL CELL PROTEOMICS, V13, P1644, DOI 10.1074/mcp.M114.038596; Torres PU, 2006, J RENAL NUTR, V16, P87, DOI 10.1053/j.jrn.2006.01.011; Walker MD, 2018, NAT REV ENDOCRINOL, V14, P115, DOI 10.1038/nrendo.2017.104; Wallin J, 1996, DEVELOPMENT, V122, P23; Worzfeld T, 2014, NAT REV DRUG DISCOV, V13, P603, DOI 10.1038/nrd4337; Worzfeld T, 2012, J CLIN INVEST, V122, P1296, DOI 10.1172/JCI60568	67	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8336	8347		10.1074/jbc.RA118.007063	http://dx.doi.org/10.1074/jbc.RA118.007063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30979723	Green Published, hybrid			2022-12-28	WOS:000471108200002
J	Thada, V; Cortez, D				Thada, Vaughn; Cortez, David			Common motifs in ETAA1 and TOPBP1 required for ATR kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage response; cell cycle; serine; threonine protein kinase; DNA replication; signaling; cancer; ATR; ATR activation domain (AAD); DNA topoisomerase II binding protein 1 (TOPBP1); ETAA1 activator of ATR kinase (ETAA1); PI3K-related protein kinase (PIKK)	DNA-DAMAGE RESPONSE; C-TERMINAL TAIL; COILED COILS; CHECKPOINT; PROTEIN; REPLICATION; MEC1/ATR; COMPLEX; RHINO; CLAMP	DNA damage response Ser/Thr kinases, including ataxia telangiectasia-mutated (ATM) and Rad3-related (ATR), control cell cycle progression, DNA repair, and apoptosis. ATR is activated by ETAA1 activator of ATR kinase (ETAA1) or DNA topoisomerase II binding protein 1 (TOPBP1). Both ETAA1 and TOPBP1 contain experimentally defined ATR activation domains (AADs) that are mostly unstructured and have minimal sequence similarity. A tryptophan residue in both AADs is required for ATR activation, but the other features of these domains and the mechanism by which they activate ATR are unknown. In this study, using bioinformatic analyses, kinase assays, co-immunoprecipitation, and immunofluorescence measures of signaling, we more specifically defined the TOPBP1 and ETAA1 AADs and identified additional features of the AADs needed for ATR activation. We found that both ETAA1 and TOPBP1 contain a predicted coiled-coil motif that is required for ATR activation in vitro and in cells. Mutation of the predicted coiled coils does not alter AAD oligomerization but does impair binding of the AADs to ATR. These results suggest that TOPBP1 and ETAA1 activate ATR using similar motifs and mechanisms.	[Thada, Vaughn; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu			National Institutes of Health [CA102729, CA239161]; NIEHS, National Institutes of Health [5T32ES007028]; NIGMS, National Institutes of Health [1F31GM128334-01]; NATIONAL CANCER INSTITUTE [R01CA239161, R01CA102729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM128334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health grants CA102729 and CA239161 (to D.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIEHS, National Institutes of Health training grant 5T32ES007028 and NIGMS, National Institutes of Health grant 1F31GM128334-01.	Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bass TE, 2019, J CELL BIOL, V218, P1235, DOI 10.1083/jcb.201810058; Bass TE, 2016, NAT CELL BIOL, V18, P1185, DOI 10.1038/ncb3415; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Forment JV, 2018, PHARMACOL THERAPEUT, V188, P155, DOI 10.1016/j.pharmthera.2018.03.005; Haahr P, 2016, NAT CELL BIOL, V18, P1196, DOI 10.1038/ncb3422; Kobayashi M, 2013, GENES CELLS, V18, P238, DOI 10.1111/gtc.12031; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lee YC, 2016, CURR BIOL, V26, P3257, DOI 10.1016/j.cub.2016.10.030; Lindsey-Boltz LA, 2015, CELL CYCLE, V14, P99, DOI 10.4161/15384101.2014.967076; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2011, J BIOL CHEM, V286, P40999, DOI 10.1074/jbc.M111.283994; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Rappas M, 2011, NUCLEIC ACIDS RES, V39, P313, DOI 10.1093/nar/gkq743; Saldivar JC, 2018, SCIENCE, V361, P806, DOI 10.1126/science.aap9346; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Wanrooij PH, 2016, J BIOL CHEM, V291, P393, DOI 10.1074/jbc.M115.687145; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	31	21	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8395	8402		10.1074/jbc.RA119.008154	http://dx.doi.org/10.1074/jbc.RA119.008154			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30940728	Green Published, hybrid			2022-12-28	WOS:000471108200010
J	Caballero, A; Mahn, SA; Ali, MS; Rogers, MR; Marchese, A				Caballero, Adriana; Mahn, Sarah A.; Ali, Mudassir S.; Rogers, M. Rose; Marchese, Adriano			Heterologous regulation of CXCR4 lysosomal trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); CXC chemokine receptor type 4 (CXCR4); receptor desensitization; receptor internalization; receptor protein serine; threonine kinase; phorbol ester; receptor modification; chemokine; lysosomal trafficking; receptor down-regulation; heterotrimeric G protein; receptor endocytosis; receptor degradation; signal transduction; protein kinase C (PKC); cyclic AMP (cAMP)	CHEMOKINE RECEPTOR CXCR4; C-TERMINAL TAIL; ARRESTIN-2 INTERACTS; MOLECULAR-CLONING; WHIM-SYNDROME; GENE CXCR4; CHEMOTAXIS; INTERNALIZATION; UBIQUITINATION; PHOSPHORYLATION	G protein-coupled receptor (GPCR) signaling is regulated by members of the protein kinase C (PKC) and GPCR kinase (GRK) families, although the relative contribution of each to GPCR function varies among specific GPCRs. The CXC motif receptor 4 (CXCR4) is a member of the GPCR superfamily that binds the CXC motif chemokine ligand 12 (CXCL12), initiating signaling that is subsequently terminated in part by internalization and lysosomal degradation of CXCR4. The purpose of this study is to define the relative contribution of PKC and GRK to CXCR4 signaling attenuation by studying their effects on CXCR4 lysosomal trafficking and degradation. Our results demonstrate that direct activation of PKC via the phorbol ester phorbol 12-myristate 13-acetate (PMA) mimics CXCL12-mediated desensitization, internalization, ubiquitination, and lysosomal trafficking of CXCR4. In agreement, heterologous activation of PKC by stimulating the chemokine receptor CXCR5 with its ligand, CXCL13, also mimics CXCL12-mediated desensitization, internalization, ubiquitination, and lysosomal degradation of CXCR4. Similar to CXCL12, PMA promotes PKC-dependent phosphorylation of serine residues within CXCR4 C-tail that are required for binding and ubiquitination by the E3 ubiquitin ligase AIP4 (atrophin-interacting protein 4). However, inhibition of PKC activity does not alter CXCL12-mediated ubiquitination and degradation of CXCR4, suggesting that other kinases are also required. Accordingly, siRNA-mediated depletion of GRK6 results in decreased degradation and ubiquitination of CXCR4. Overall, these results suggest that PKC and GRK6 contribute to unique aspects of CXCR4 phosphorylation and lysosomal degradation to ensure proper signal propagation and termination.	[Caballero, Adriana; Marchese, Adriano] Loyola Univ Chicago, Dept Pharmacol, Maywood, IL 60153 USA; [Mahn, Sarah A.; Ali, Mudassir S.; Rogers, M. Rose; Marchese, Adriano] Med Coll Wisconsin, Dept Biochem, TBRC C3850,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Caballero, Adriana] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Loyola University Chicago; Medical College of Wisconsin; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Marchese, A (corresponding author), Med Coll Wisconsin, Dept Biochem, TBRC C3850,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	amarchese@mcw.edu		Wedemeyer, Sarah/0000-0003-4787-4672; Caballero, Adriana/0000-0001-7052-7594	National Institutes of Health [GM122889]; Loyola University Chicago; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loyola University Chicago; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM122889 (to A. M.). This work was also supported in part by institutional funds at Loyola University Chicago. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Ustwani O, 2014, BRIT J HAEMATOL, V164, P15, DOI 10.1111/bjh.12574; Alekhina O, 2016, J BIOL CHEM, V291, P26083, DOI 10.1074/jbc.M116.757138; Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Binkowski BF, 2011, METHODS MOL BIOL, V756, P263, DOI 10.1007/978-1-61779-160-4_14; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Caballero A, 2011, METHODS MOL BIOL, V746, P251, DOI 10.1007/978-1-61779-126-0_13; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; El-Haibi CP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-64; English EJ, 2018, J BIOL CHEM, V293, P11470, DOI 10.1074/jbc.RA118.001872; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Grimsey N, 2014, METHOD ENZYMOL, V535, P389, DOI 10.1016/B978-0-12-397925-4.00022-5; Guinamard R, 1999, J EXP MED, V189, P1461, DOI 10.1084/jem.189.9.1461; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hezareh Marjan, 2004, Antiviral Chemistry & Chemotherapy, V15, P207; Holm NT, 2007, J SURG RES, V141, P53, DOI 10.1016/j.jss.2007.03.015; Horuk R, 1997, METHOD ENZYMOL, V288, P326; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Luo JS, 2017, MOL PHARMACOL, V91, P554, DOI 10.1124/mol.116.106468; Luttrell LM, 2002, J CELL SCI, V115, P455; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2016, METHOD ENZYMOL, V570, P281, DOI 10.1016/bs.mie.2015.10.004; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Mueller W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064975; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Newton AC, 2018, CRIT REV BIOCHEM MOL, V53, P208, DOI 10.1080/10409238.2018.1442408; Obara B, 2013, HISTOCHEM CELL BIOL, V139, P391, DOI 10.1007/s00418-012-1068-3; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Richardson RM, 2003, J BIOL CHEM, V278, P15867, DOI 10.1074/jbc.M211745200; Schuller U, 2005, INT J CANCER, V117, P82, DOI 10.1002/ijc.21116; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Verma R, 2015, J BIOL CHEM, V290, P6810, DOI 10.1074/jbc.M114.606699; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P698, DOI 10.1189/jlb.0703320; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Worz S, 2010, IEEE T MED IMAGING, V29, P1474, DOI 10.1109/TMI.2010.2049857	53	8	8	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8023	8036		10.1074/jbc.RA118.005991	http://dx.doi.org/10.1074/jbc.RA118.005991			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30936203	Green Published, hybrid			2022-12-28	WOS:000470656500006
J	Salom, D; Jin, H; Gerken, TA; Yu, C; Huang, L; Palczewski, K				Salom, David; Jin, Hui; Gerken, Thomas A.; Yu, Clinton; Huang, Lan; Palczewski, Krzysztof			Human red and green cone opsins are O-glycosylated at an N-terminal Ser/Thr-rich domain conserved in vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); receptor; receptor structure-function; retinal metabolism; rhodopsin	PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; RHODOPSIN; GALNAC; REGENERATION; EXPRESSION; STABILITY; PIGMENTS	There are fundamental differences in the structures of outer segments between rod and cone photoreceptor cells in the vertebrate retina. Visual pigments are the only essential membrane proteins that differ between rod and cone outer segments, making it likely that they contribute to these structural differences. Human rhodopsin is N-glycosylated on Asn(2) and Asn(15), whereas human (h) red and green cone opsins (hOPSR and hOPSG, respectively) are N-glycosylated at Asn(34). Here, utilizing a monoclonal antibody (7G8 mAB), we demonstrate that hOPSR and hOPSG from human retina also are O-glycosylated with full occupancy. We determined that 7G8 mAB recognizes the N-terminal sequence (21)DSTQSSIF(28) of hOPSR and hOPSG from extracts of human retina, but only after their O-glycans have been removed with O-glycosidase treatment, thus revealing this post-translational modification of red and green cone opsins. In addition, we show that hOPSR and hOPSG from human retina are recognized by jacalin, a lectin that binds to O-glycans, preferentially to Gal-GalNAc. Next, we confirmed the presence of O-glycans on OPSR and OPSG from several vertebrate species, including mammals, birds, and amphibians. Finally, the analysis of bovine OPSR by MS identified an O-glycan on Ser(22), a residue that is semi-conserved (Ser or Thr) among vertebrate OPSR and OPSG. These results suggest that O-glycosylation is a fundamental feature of red and green cone opsins, which may be relevant to their function or to cone cell development, and that differences in this post-translational modification also could contribute to the different morphologies of rod and cone photoreceptors.	[Salom, David; Palczewski, Krzysztof] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA; [Salom, David; Palczewski, Krzysztof] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA; [Salom, David; Jin, Hui; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Gerken, Thomas A.] Case Western Reserve Univ, Dept Biochem & Chem, Cleveland, OH 44106 USA; [Yu, Clinton; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Case Western Reserve University; Case Western Reserve University; University of California System; University of California Irvine	Salom, D (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA.; Salom, D (corresponding author), Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA.; Salom, D (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.; Palczewski, K (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, Irvine, CA 92697 USA.	dsalom1@uci.edu; kpalczew@uci.edu		Salom, David/0000-0002-3208-1509	Research to Prevent Blindness (RPB) grant; NATIONAL EYE INSTITUTE [R24EY027283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113534, R01GM130144, R01GM074830] Funding Source: NIH RePORTER	Research to Prevent Blindness (RPB) grant(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially carried out at the Department of Pharmacology, Case Western Reserve University, Cleveland, OH. This work was supported by a Research to Prevent Blindness (RPB) grant to the Department of Ophthalmology at the University of California, Irvine. We are grateful for the help provided by Dr. Wenyu Sun (Polgenix, Inc.). We also thank our colleagues at Case Western Reserve University who helped obtain retina samples: Drs. Les Kallestad and Tim Owen (13LGS retinas); Elliot Choi and Dr. Henri Leinonen (mouse retinas); David Peck (porcine retinas); Dr. Sahil Gulati (bovine and chicken COS/ROS); Dr. Natalia Mast (human retinas); Dr. Jianye Zhang (macaque retinas); and Philip Ropelewski (Xenopus retinas). Our thanks to Remy Zimmerman and Drs. Angele Nalbandian, Tim Kern, and Philip Kiser (University of California, Irvine) for their insightful comments on this manuscript.	Alexander NS, 2017, J BIOL CHEM, V292, P10983, DOI 10.1074/jbc.M117.780478; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bourne HR, 2000, SCIENCE, V289, P733, DOI 10.1126/science.289.5480.733; Craig SEL, 2010, INVEST OPHTH VIS SCI, V51, P3244, DOI 10.1167/iovs.09-4879; Cummings RD., 2015, ESSENTIALS GLYCOBIOL, DOI DOI 10.1101/GLYCOBIOLOGY.3E.036; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Goth CK, 2018, TRENDS BIOCHEM SCI, V43, P269, DOI 10.1016/j.tibs.2018.02.005; Goth CK, 2017, J BIOL CHEM, V292, P4714, DOI 10.1074/jbc.M116.730614; Hofmann L, 2017, BIOCHEMISTRY-US, V56, P2338, DOI 10.1021/acs.biochem.7b00165; Jacobs GH, 2015, HANDBOOK OF COLOR PSYCHOLOGY, P110; JACOBS GH, 1976, J COMP NEUROL, V165, P209, DOI 10.1002/cne.901650207; Jones BW, 2011, J COMP NEUROL, V519, P2713, DOI 10.1002/cne.22703; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Lackman JJ, 2018, CELL SIGNAL, V42, P184, DOI 10.1016/j.cellsig.2017.10.016; Lopez M, 1999, BBA-GEN SUBJECTS, V1427, P49, DOI 10.1016/S0304-4165(98)00176-7; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; Murray AR, 2015, HUM MOL GENET, V24, P2709, DOI 10.1093/hmg/ddv031; Nakagawa M, 2001, FEBS LETT, V496, P19, DOI 10.1016/S0014-5793(01)02392-4; Opefi CA, 2013, J BIOL CHEM, V288, P33912, DOI 10.1074/jbc.M113.483032; Owen TS, 2018, BIOCHEMISTRY-US, V57, P1022, DOI 10.1021/acs.biochem.7b01118; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Salom D, 2006, J STRUCT BIOL, V156, P497, DOI 10.1016/j.jsb.2006.05.003; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steiner L., 1988, ANTIBODIES LAB MANUA, P726; Stenkamp RE, 2002, BBA-BIOMEMBRANES, V1565, P168, DOI 10.1016/S0005-2736(02)00567-9; Tachibana K, 2006, GLYCOBIOLOGY, V16, P46, DOI 10.1093/glycob/cwj038; Visiers I, 2002, METHOD ENZYMOL, V343, P329; Vissers PMAM, 1996, FEBS LETT, V396, P26, DOI 10.1016/0014-5793(96)01064-2	33	5	5	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8123	8133		10.1074/jbc.RA118.006835	http://dx.doi.org/10.1074/jbc.RA118.006835			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30948514	Green Published, hybrid			2022-12-28	WOS:000470656500012
J	Labourel, A; Basle, A; Munoz-Munoz, J; Ndeh, D; Booth, S; Nepogodiev, SA; Field, RA; Cartmell, A				Labourel, Aurore; Basle, Arnaud; Munoz-Munoz, Jose; Ndeh, Didier; Booth, Simon; Nepogodiev, Sergey A.; Field, Robert A.; Cartmell, Alan			Structural and functional analyses of glycoside hydrolase 138 enzymes targeting chain A galacturonic acid in the complex pectin rhamnogalacturonan II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme; enzyme catalysis; enzyme mechanism; carbohydrate; carbohydrate metabolism; crystallography; enzyme kinetics; glycoside hydrolase (GH); pectin; gut microbe; complex glycan; carbohydrate-active enzyme (CAZyme); rhamnogalacturonan II	GUT MICROBIOTA; PLANT-CELL; POLYSACCHARIDE; HYDROLYSIS; DATABASE; REVEALS; FAMILY	The metabolism of carbohydrate polymers drives microbial diversity in the human gut microbiome. The selection pressures in this environment have spurred the evolution of a complex reservoir of microbial genes encoding carbohydrate-active enzymes (CAZymes). Previously, we have shown that the human gut bacterium Bacteroides thetaiotaomicron (Bt) can depolymerize the most structurally complex glycan, the plant pectin rhamnogalacturonan II (RGII), commonly found in the human diet. Previous investigation of the RGII-degrading apparatus in Bt identified BT0997 as a new CAZyme family, classified as glycoside hydrolase 138 (GH138). The mechanism of substrate recognition by GH138, however, remains unclear. Here, using synthetic substrates and biochemical assays, we show that BT0997 targets the d-galacturonic acid--1,2-l-rhamnose linkage in chain A of RGII and that it absolutely requires the presence of a second d-galacturonic acid side chain (linked -1,3 to l-rhamnose) for activity. NMR analysis revealed that BT0997 operates through a double displacement retaining mechanism. We also report the crystal structure of a BT0997 homolog, BPA0997 from Bacteroides paurosaccharolyticus, in complex with ligands at 1.6 angstrom resolution. The structure disclosed that the enzyme comprises four domains, including a catalytic TIM (/)(8) barrel. Characterization of several BT0997 variants identified Glu-294 and Glu-361 as the catalytic acid/base and nucleophile, respectively, and we observed a chloride ion close to the active site. The three-dimensional structure and bioinformatic analysis revealed that two arginines, Arg-332 and Arg-521, are key specificity determinants of BT0997 in targeting d-galacturonic acid residues. In summary, our study reports the first structural and mechanistic analyses of GH138 enzymes.	[Labourel, Aurore; Basle, Arnaud; Munoz-Munoz, Jose; Ndeh, Didier; Booth, Simon; Cartmell, Alan] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Nepogodiev, Sergey A.; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Labourel, Aurore] Aix Marseille Univ, BBF, UMR1163, F-13009 Marseille, France; [Munoz-Munoz, Jose] Northumbria Univ, Fac Hlth & Life Sci, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UDICE-French Research Universities; Aix-Marseille Universite; Northumbria University	Cartmell, A (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	alan.cartmell2@newcastle.ac.uk	; Munoz-Munoz, Jose/G-3506-2016	Ndeh, Didier/0000-0001-7875-1638; Cartmell, Alan/0000-0002-5512-249X; Munoz-Munoz, Jose/0000-0003-0010-948X; Booth, Simon/0000-0001-5585-022X; Basle, Arnaud/0000-0002-4899-3086; Labourel, Aurore/0000-0002-4762-5804	Priority Excellent Science, H2020 European Research Council [322820]; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI	Priority Excellent Science, H2020 European Research Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Priority Excellent Science, H2020 European Research Council Grant 322820. The authors declare that they have no conflicts of interest with the contents of this article.	Aghajari N, 2002, PROTEIN SCI, V11, P1435, DOI 10.1110/ps.0202602; Apolinar-Valiente R, 2013, J AGR FOOD CHEM, V61, P2538, DOI 10.1021/jf304987m; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Carugo O, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0019-8; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Chauvin AL, 2005, J ORG CHEM, V70, P960, DOI 10.1021/jo0482864; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feller G, 1996, J BIOL CHEM, V271, P23836, DOI 10.1074/jbc.271.39.23836; Hickey CA, 2015, CELL HOST MICROBE, V17, P672, DOI 10.1016/j.chom.2015.04.002; Jiang CM, 2017, J ALZHEIMERS DIS, V58, P1, DOI 10.3233/JAD-161141; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Munoz-Munoz J, 2017, J BIOL CHEM, V292, P13271, DOI 10.1074/jbc.M117.794578; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Nepogodiev SA, 2011, ORG BIOMOL CHEM, V9, P6670, DOI 10.1039/c1ob05587a; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pitson SM, 1998, BIOCHEM BIOPH RES CO, V242, P552, DOI 10.1006/bbrc.1997.8009; Porter NT, 2017, ANNU REV MICROBIOL, V71, P349, DOI 10.1146/annurev-micro-102215-095316; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	35	6	6	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7711	7721		10.1074/jbc.RA118.006626	http://dx.doi.org/10.1074/jbc.RA118.006626			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30877196	hybrid, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000470153300016
J	Bazilevsky, GA; Affronti, HC; Wei, XP; Campbell, SL; Wellen, KE; Marmorstein, R				Bazilevsky, Gleb A.; Affronti, Hayley C.; Wei, Xuepeng; Campbell, Sydney L.; Wellen, Kathryn E.; Marmorstein, Ronen			ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); coenzyme A (CoA); protein assembly; enzyme mechanism; metabolism; ATP-citrate lyase; citrate synthase	ACETYL-COENZYME; HISTONE ACETYLATION; RAT-LIVER; ACYL-COA; CELL; SYNTHASE; IDENTIFICATION; PHOSPHORYLATION; DENATURATION; METABOLISM	ATP-citrate lyase (ACLY) is a major source of nucleocytosolic acetyl-CoA, a fundamental building block of carbon metabolism in eukaryotes. ACLY is aberrantly regulated in many cancers, cardiovascular disease, and metabolic disorders. However, the molecular mechanisms determining ACLY activity and function are unclear. To this end, we investigated the role of the uncharacterized ACLY C-terminal citrate synthase homology domain in the mechanism of acetyl-CoA formation. Using recombinant, purified ACLY and a suite of biochemical and biophysical approaches, including analytical ultracentrifugation, dynamic light scattering, and thermal stability assays, we demonstrated that the C terminus maintains ACLY tetramerization, a conserved and essential quaternary structure in vitro and likely also in vivo. Furthermore, we show that the C terminus, only in the context of the full-length enzyme, is necessary for full ACLY binding to CoA. Together, we demonstrate that ACLY forms a homotetramer through the C terminus to facilitate CoA binding and acetyl-CoA production. Our findings highlight a novel and unique role of the C-terminal citrate synthase homology domain in ACLY function and catalysis, adding to the understanding of the molecular basis for acetyl-CoA synthesis by ACLY. This newly discovered means of ACLY regulation has implications for the development of novel ACLY modulators to target acetyl-CoA-dependent cellular processes for potential therapeutic use.	[Bazilevsky, Gleb A.; Campbell, Sydney L.; Wellen, Kathryn E.; Marmorstein, Ronen] Univ Penn, Grad Grp Cell & Mol Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bazilevsky, Gleb A.; Affronti, Hayley C.; Wei, Xuepeng; Campbell, Sydney L.; Wellen, Kathryn E.; Marmorstein, Ronen] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, 421 Curie Blvd,Biomed Res Bldg 2-3,Rm 454, Philadelphia, PA 19104 USA; [Wei, Xuepeng; Marmorstein, Ronen] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, 421 Curie Blvd,Biomed Res Bldg 2-3,Rm 454, Philadelphia, PA 19104 USA; [Affronti, Hayley C.; Campbell, Sydney L.; Wellen, Kathryn E.] Univ Penn, Dept Canc Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Marmorstein, R (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, 421 Curie Blvd,Biomed Res Bldg 2-3,Rm 454, Philadelphia, PA 19104 USA.; Marmorstein, R (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, 421 Curie Blvd,Biomed Res Bldg 2-3,Rm 454, Philadelphia, PA 19104 USA.	marmor@upenn.edu		Bazilevsky, Gleb/0000-0001-5300-0643; Wellen, Kathryn/0000-0002-2281-0042; Campbell, Sydney/0000-0002-7861-5609; Marmorstein, Ronen/0000-0003-4373-4752	National Institutes of Health [R35 GM118090, P01 AG 031862, R01-CA228339, F31CA189559-01, F31CA217070, 4K00CA212455-03]; NATIONAL CANCER INSTITUTE [K00CA212455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118090, T32GM008275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R35 GM118090 and P01 AG 031862 (to R. M.), R01-CA228339 (to K. E. W.), F31CA189559-01 (to G. B.), F31CA217070 (to S. L. C.), and 4K00CA212455-03 (to H. C. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALEXANDER MC, 1982, J BIOL CHEM, V257, P2049; Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; [Anonymous], 2017, J VIS EXP; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Bilen O, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0611-4; Bond DR, 2005, APPL ENVIRON MICROB, V71, P3858, DOI 10.1128/AEM.71.7.3858-3865.2005; Burke AC, 2017, CURR OPIN LIPIDOL, V28, P193, DOI 10.1097/MOL.0000000000000390; Carrer A, 2017, J BIOL CHEM, V292, P3312, DOI 10.1074/jbc.M116.750620; Chervenka C. H., 1969, MANUAL METHODS ANAL, P28; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Fan F, 2012, BIOCHEMISTRY-US, V51, P5198, DOI 10.1021/bi300611s; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Gawryluk RMR, 2015, MOL PHYLOGENET EVOL, V91, P12, DOI 10.1016/j.ympev.2015.05.010; Grinberg VY, 2000, J BIOTECHNOL, V79, P269, DOI 10.1016/S0168-1656(00)00243-1; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; INOUE H, 1966, J BIOCHEM, V60, P543, DOI 10.1093/oxfordjournals.jbchem.a128474; Kanamori E, 2015, BIOPHYS PHYSICOBIOL, V12, P47, DOI 10.2142/biophysico.12.0_47; Kostanski LK, 2004, J BIOCHEM BIOPH METH, V58, P159, DOI 10.1016/j.jbbm.2003.10.001; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee Joyce V, 2013, Drug Discov Today Dis Mech, V10, pe55; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Lin RT, 2013, MOL CELL, V51, P506, DOI 10.1016/j.molcel.2013.07.002; LINN TC, 1979, J BIOL CHEM, V254, P1691; MCEVILY AJ, 1986, J BIOL CHEM, V261, P2593; McRorie D. K., 2004, SELF ASSOCIATING SYS, P8; Michnik A, 2005, BIOPHYS CHEM, V118, P93, DOI 10.1016/j.bpc.2005.06.012; Moore V, 2011, EXTREMOPHILES, V15, P327, DOI 10.1007/s00792-011-0363-6; Murphy JR, 2015, ACTA CRYSTALLOGR F, V71, P1292, DOI 10.1107/S2053230X15015939; Nguyen NT, 2001, BIOCHEMISTRY-US, V40, P13177, DOI 10.1021/bi010408o; Peleg S, 2016, EMBO REP, V17, P455, DOI 10.15252/embr.201541132; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Pinkosky SL, 2017, TRENDS MOL MED, V23, P1047, DOI 10.1016/j.molmed.2017.09.001; Potapova IA, 2000, BIOCHEMISTRY-US, V39, P1169, DOI 10.1021/bi992159y; Sanchez LB, 2000, J BIOL CHEM, V275, P5794, DOI 10.1074/jbc.275.8.5794; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SINGH M, 1976, J BIOL CHEM, V251, P5242; SRERE PA, 1953, J AM CHEM SOC, V75, P4874, DOI 10.1021/ja01115a547; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stetefeld Jorg, 2016, Biophys Rev, V8, P409, DOI 10.1007/s12551-016-0218-6; Sun TJ, 2010, J BIOL CHEM, V285, P27418, DOI 10.1074/jbc.M109.078667; Wang DY, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698338; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Zaidi N, 2012, MOL CANCER THER, V11, P1925, DOI 10.1158/1535-7163.MCT-12-0095	49	12	12	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7259	7268		10.1074/jbc.RA118.006685	http://dx.doi.org/10.1074/jbc.RA118.006685			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877197	hybrid, Green Published			2022-12-28	WOS:000468402900015
J	Howard, MJ; Foley, KG; Shock, DD; Batra, VK; Wilson, SH				Howard, Michael J.; Foley, K. Grace; Shock, David D.; Batra, Vinod K.; Wilson, Samuel H.			Molecular basis for the faithful replication of 5-methylcytosine and its oxidized forms by DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; DNA repair; DNA polymerase; base excision repair (BER); enzyme kinetics; 5-methylcytosine	MAMMALIAN DNA; KINETIC-ANALYSIS; 5-FORMYLCYTOSINE; BETA; 5-HYDROXYMETHYLCYTOSINE; EXCISION; CPG; 5-CARBOXYLCYTOSINE; OLIGONUCLEOTIDES; 8-OXOGUANINE	DNA methylation is an epigenetic mark that regulates gene expression in mammals. One method of methylation removal is through ten-eleven translocation-catalyzed oxidation and the base excision repair pathway. The iterative oxidation of 5-methylcytosine catalyzed by ten-eleven translocation enzymes produces three oxidized forms of cytosine: 5-hydroxmethylcytosine, 5-formylcytosine, and 5-carboxycytosine. The effect these modifications have on the efficiency and fidelity of the base excision repair pathway during the repair of opposing base damage, and in particular DNA polymerization, remains to be elucidated. Using kinetic assays, we show that the catalytic efficiency for the incorporation of dGTP catalyzed by human DNA polymerase is not affected when 5-methylcytosine, 5-hydroxmethylcytosine, and 5-formylcytosine are in the DNA template. In contrast, the catalytic efficiency of dGTP insertion decreases approximate to 20-fold when 5-carboxycytosine is in the templating position, as compared with unmodified cytosine. However, DNA polymerase fidelity is unaltered when these modifications are in the templating position. Structural analysis reveals that the methyl, hydroxymethyl, and formyl modifications are easily accommodated within the polymerase active site. However, to accommodate the carboxyl modification, the phosphate backbone on the templating nucleotide shifts approximate to 2.5 to avoid a potential steric/repulsive clash. This altered conformation is stabilized by lysine 280, which makes a direct interaction with the carboxyl modification and the phosphate backbone of the templating strand. This work provides the molecular basis for the accommodation of epigenetic base modifications in a polymerase active site and suggests that these modifications are not mutagenically copied during base excision repair.	[Howard, Michael J.; Foley, K. Grace; Shock, David D.; Batra, Vinod K.; Wilson, Samuel H.] NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233 MD F1-12, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233 MD F1-12, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel/E-6644-2019	Wilson, Samuel/0000-0002-1702-5293	National Institutes of Health [Z01ES50158, Z01ES050159, Z01ES050161]; Intramural Research Program of the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050159, ZIAES050158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants Z01ES50158, Z01ES050159, and Z01ES050161 (to S. H. W.) from the Intramural Research Program of the NIEHS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Batra VK, 2012, P NATL ACAD SCI USA, V109, P113, DOI 10.1073/pnas.1112235108; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 2014, J BIOL CHEM, V289, P31411, DOI 10.1074/jbc.M114.607432; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cavanaugh NA, 2011, J BIOL CHEM, V286, P31650, DOI 10.1074/jbc.M111.253401; Dai Q, 2016, ACS CHEM BIOL, V11, P470, DOI 10.1021/acschembio.5b00762; DOETSCH PW, 1986, BIOCHEMISTRY-US, V25, P2212, DOI 10.1021/bi00356a054; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Howard MJ, 2017, J BIOL CHEM, V292, P17473, DOI 10.1074/jbc.M117.801860; Howard MJ, 2017, NUCLEIC ACIDS RES, V45, P3822, DOI 10.1093/nar/gkx047; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iwan K, 2018, NAT CHEM BIOL, V14, P72, DOI [10.1038/NCHEMBIO.2531, 10.1038/nchembio.2531]; Jabbari K, 2004, GENE, V333, P143, DOI 10.1016/j.gene.2004.02.043; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Kamiya H, 2002, J BIOCHEM, V132, P551, DOI 10.1093/oxfordjournals.jbchem.a003256; Karino N, 2001, NUCLEIC ACIDS RES, V29, P2456, DOI 10.1093/nar/29.12.2456; Kasymov RD, 2013, FEBS LETT, V587, P3129, DOI 10.1016/j.febslet.2013.08.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Moon AF, 2014, NAT STRUCT MOL BIOL, V21, P253, DOI 10.1038/nsmb.2766; Munzel M, 2011, CHEM-EUR J, V17, P13782, DOI 10.1002/chem.201102782; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Sassa A, 2014, J BIOL CHEM, V289, P13996, DOI 10.1074/jbc.M114.557769; Shibutani T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05220; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Szulik MW, 2015, BIOCHEMISTRY-US, V54, P1294, DOI 10.1021/bi501534x; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Werneburg BG, 1996, BIOCHEMISTRY-US, V35, P7041, DOI 10.1021/bi9527202; Xing XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072993; Zhu CX, 2017, CELL STEM CELL, V20, P720, DOI 10.1016/j.stem.2017.02.013; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	42	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7194	7201		10.1074/jbc.RA118.006809	http://dx.doi.org/10.1074/jbc.RA118.006809			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30885943	Green Published, hybrid			2022-12-28	WOS:000468402900009
J	Nishi, C; Yanagihashi, Y; Segawa, K; Nagata, S				Nishi, Chihiro; Yanagihashi, Yuichi; Segawa, Katsumori; Nagata, Shigekazu			MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; macrophage; signal transduction; phosphatidylserine; phosphorylation; cell death; cell signaling; cancer; efferocytosis; kinase	APOPTOTIC CELLS; LUNG-CANCER; CLEARANCE; PHAGOCYTOSIS; ACTIVATION; INHIBITOR; ENGULFMENT; PROTEIN; DEATH; IDENTIFICATION	Apoptotic cells expose phosphatidylserine (PtdSer) on their surface, leading to efferocytosis, i.e. their engulfment by resident macrophages that express the PtdSer receptor T cell immunoglobulin mucin receptor 4 (TIM4) and TAM family receptor tyrosine kinase receptors (MERTK, AXL, and TYRO3). TAM family receptors stimulate cell proliferation, and the many aspects of the growth signaling pathway downstream of TAM family receptors have been elucidated previously. However, the signaling cascade for TAM receptor-mediated efferocytosis has been elusive. Here we observed that efferocytosis by mouse-resident peritoneal macrophages was blocked by inhibitors against the MERTK, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK), AKT Ser/Thr kinase (AKT), focal adhesion kinase (FAK), or STAT6 pathway. Accordingly, apoptotic cells stimulated the phosphorylation of MERTK, ERK, AKT, FAK, and STAT6, but not of IB or STAT5. A reconstituted efferocytosis system using MERTK- and TIM4-expressing NIH3T3-derived cells revealed that the juxtamembrane and C-terminal regions of MERTK have redundant roles in efferocytosis. The transformation of murine IL-3-dependent Ba/F3 cells (a pro-B cell line) with MERTK and TIM4 enabled them to proliferate in response to apoptotic cells in a PtdSer-dependent manner. This apoptotic cell-induced MERTK-mediated proliferation required both MERTK's juxtamembrane and C-terminal regions and was blocked by inhibitors of not only ERK, AKT, FAK, and STAT6 but also of NF-B and STAT5 signaling. These results suggest that apoptotic cells stimulate distinct sets of signal transduction pathways via MERTK to induce either efferocytosis or proliferation.	[Nishi, Chihiro; Yanagihashi, Yuichi; Segawa, Katsumori; Nagata, Shigekazu] Osaka Univ, Lab Biochem & Immunol, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Osaka University	Nagata, S (corresponding author), Osaka Univ, Lab Biochem & Immunol, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan.	snagata@ifrec.osaka-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science (JSPS) [16H06943]; JSPS [15H05785]; Japan Science and Technology Agency [JPMJCR14M4]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by Grant-in-Aid for Research Activity Start-Up from Japan Society for the Promotion of Science (JSPS) 16H06943 (to C. N.) and Grants-in-Aid for Scientific Research (S) from JSPS 15H05785 and Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency JPMJCR14M4 (to S. N.). The authors declare that they have no conflicts of interest with the contents of this article.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Birge RB, 2016, CELL DEATH DIFFER, V23, P962, DOI 10.1038/cdd.2016.11; Chen YZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3726; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cummings CT, 2015, MOL CANCER THER, V14, P2014, DOI 10.1158/1535-7163.MCT-15-0116; Cummings CT, 2013, CLIN CANCER RES, V19, P5275, DOI 10.1158/1078-0432.CCR-12-1451; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Dorfman DM, 2010, HUM PATHOL, V41, P1486, DOI 10.1016/j.humpath.2010.04.005; Elliott MR, 2016, DEV CELL, V38, P147, DOI 10.1016/j.devcel.2016.06.029; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Georgescu MM, 1999, MOL CELL BIOL, V19, P1171; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Haftchenary S, 2013, ACS MED CHEM LETT, V4, P1102, DOI 10.1021/ml4003138; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hedger G, 2015, SCI REP-UK, V5, DOI 10.1038/srep09198; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hinz M, 2014, EMBO REP, V15, P46, DOI 10.1002/embr.201337983; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Kang YY, 2012, GENE DEV, V26, P1339, DOI 10.1101/gad.187815.112; Kasikara C, 2017, MOL CANCER RES, V15, P753, DOI 10.1158/1541-7786.MCR-16-0350; Kawano M, 2018, P NATL ACAD SCI USA, V115, P2132, DOI 10.1073/pnas.1720732115; Lemke G, 2017, TRENDS BIOCHEM SCI, V42, P738, DOI 10.1016/j.tibs.2017.06.004; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; McIver AL, 2017, CHEMMEDCHEM, V12, P207, DOI 10.1002/cmdc.201600589; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nagashima S, 2007, BIOORGAN MED CHEM, V15, P1044, DOI 10.1016/j.bmc.2006.10.015; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Nishi C, 2014, MOL CELL BIOL, V34, P1512, DOI 10.1128/MCB.01394-13; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Pettazzoni P, 2015, CANCER RES, V75, P1091, DOI 10.1158/0008-5472.CAN-14-1854; Pinto SM, 2012, CURR OPIN CELL BIOL, V24, P881, DOI 10.1016/j.ceb.2012.11.002; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Reich N. C., 2013, JAK STAT, V2; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Schlegel J, 2013, J CLIN INVEST, V123, P2257, DOI 10.1172/JCI67816; Schoumacher M, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0579-4; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sehgal Pravin B, 2013, JAKSTAT, V2, pe24860, DOI 10.4161/jkst.24860; Shiraishi T, 2004, BIOCHEM BIOPH RES CO, V322, P197, DOI 10.1016/j.bbrc.2004.07.098; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Stanford JC, 2014, J CLIN INVEST, V124, P4737, DOI 10.1172/JCI76375; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Tanimura S, 2017, J BIOCHEM, V162, P145, DOI 10.1093/jb/mvx048; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; Toda S, 2012, MOL CELL BIOL, V32, P118, DOI 10.1128/MCB.05993-11; Todt JC, 2004, J LEUKOCYTE BIOL, V75, P705, DOI 10.1189/jlb.0903439; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Xu LS, 2011, J BIOL CHEM, V286, P36694, DOI 10.1074/jbc.M111.292540; Yanagihashi Y, 2017, P NATL ACAD SCI USA, V114, P8800, DOI 10.1073/pnas.1705365114; Zhang QQ, 2015, BRIT J CANCER, V113, P1484, DOI 10.1038/bjc.2015.323	70	27	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7221	7230		10.1074/jbc.RA118.006628	http://dx.doi.org/10.1074/jbc.RA118.006628			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30846565	hybrid, Green Published			2022-12-28	WOS:000468402900012
J	Bajpai, P; Koc, E; Sonpavde, G; Singh, R; Singh, KK				Bajpai, Prachi; Koc, Emine; Sonpavde, Guru; Singh, Rajender; Singh, Keshav K.			Mitochondrial localization, import, and mitochondrial function of the androgen receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen receptor; mitochondria; prostate cancer; cell signaling; gene transcription; genomic signaling; mitochondrial localization sequence; nongenomic signaling; oxidative phosphorylation; retrograde signaling; castration-resistant; nuclear receptor	OXIDATIVE-PHOSPHORYLATION SYSTEM; SPLICE VARIANTS; HORMONE-RECEPTORS; SIGNALING PATHWAY; NUCLEAR IMPORT; TARGET GENES; CELL-GROWTH; ACTIVATION; STRESS; PROGRESSION	Nuclear localization of androgen receptor (AR) directs transcriptional regulation of a host of genes, referred to as genomic signaling. Additionally, nonnuclear or nongenomic activities of the AR have long been described, but understanding of these activities remains elusive. Here, we report that AR is imported into and localizes to mitochondria and has a novel role in regulating multiple mitochondrial processes. Employing complementary experimental approaches of AR knockdown in AR-expressing cells and ectopic AR expression in AR-deficient cells, we demonstrate an inverse relationship between AR expression and mitochondrial DNA (mtDNA) content and transcription factor A, mitochondrial (TFAM), a regulator of mtDNA content. We show that AR localizes to mitochondria in prostate tissues and cell lines and is imported into mitochondria in vitro. We also found that AR contains a 36-amino-acid-long mitochondrial localization sequence (MLS) capable of targeting a passenger protein (GFP) to the mitochondria and that deletion of the MLS abolishes the import of AR into the mitochondria. Ectopic AR expression reduced the expression of oxidative phosphorylation (OXPHOS) subunits. Interestingly, AR also controlled translation of mtDNA-encoded genes by regulating expression of multiple nuclear DNA-encoded mitochondrial ribosomal proteins. Consistent with these observations, OXPHOS supercomplexes were destabilized, and OXPHOS enzymatic activities were reduced in AR-expressing cells and restored upon AR knockdown. Moreover, mitochondrial impairment induced AR expression and increased its translocation into mitochondria. We conclude that AR localizes to mitochondria, where it controls multiple mitochondrial functions and mitonuclear communication. Our studies also suggest that mitochondria are novel players in nongenomic activities of AR.	[Bajpai, Prachi; Singh, Rajender; Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Environm Hlth, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA; [Koc, Emine] Marshall Univ, Joan C Edwards Sch Med, Dept Biomed Sci, Huntington, WV 25701 USA; [Sonpavde, Guru] Dana Farber Canc Inst, Boston, MA 02215 USA; [Singh, Keshav K.] Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Marshall University; Harvard University; Dana-Farber Cancer Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Singh, KK (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Genet, Kaul Genetics Bldg,Suite 620,720 20th St, Birmingham, AL 35294 USA.	kksingh@uab.edu	Singh, Rajender/ABE-3512-2020	Rajender, Singh/0000-0002-4592-6566	National Institutes of Health [R01 CA204430]; Mike Slive Foundation for Prostate Cancer Research; Indo-US Science and Technology Forum (IUSSTF) [2016/120]; NATIONAL CANCER INSTITUTE [R01CA204430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mike Slive Foundation for Prostate Cancer Research; Indo-US Science and Technology Forum (IUSSTF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health Grant R01 CA204430 and a grant from the Mike Slive Foundation for Prostate Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Indo-US Science and Technology Forum (IUSSTF) Grant 2016/120.	Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Bajpai P, 2014, J BIOL CHEM, V289, P29614, DOI 10.1074/jbc.M114.583062; Barbour Jayne Alexandra, 2014, Int J Cell Biol, V2014, P156020, DOI 10.1155/2014/156020; BHAT NK, 1985, BIOCHEMISTRY-US, V24, P8107, DOI 10.1021/bi00348a041; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Caino MC, 2016, CLIN CANCER RES, V22, P540, DOI 10.1158/1078-0432.CCR-15-0460; Carden T, 2017, J BIOL CHEM, V292, P20694, DOI 10.1074/jbc.M117.797001; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; Chan Siu Chiu, 2014, Adv Pharmacol, V70, P327, DOI 10.1016/B978-0-12-417197-8.00011-0; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Choudhury AR, 2017, SEMIN CANCER BIOL, V47, P125, DOI 10.1016/j.semcancer.2017.05.001; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Dudkina NV, 2008, J BIOENERG BIOMEMBR, V40, P419, DOI 10.1007/s10863-008-9167-5; Efstathiou E, 2015, EUR UROL, V67, P53, DOI 10.1016/j.eururo.2014.05.005; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; GASSER SM, 1982, J BIOL CHEM, V257, P3034; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; Higuchi M, 2006, ONCOGENE, V25, P1437, DOI 10.1038/sj.onc.1209190; Higuchi M, 2002, ANTIOXID REDOX SIGN, V4, P945, DOI 10.1089/152308602762197489; Higuchi M, 2007, MITOCHONDRION, V7, P53, DOI 10.1016/j.mito.2006.12.001; Jagla M, 2007, ENDOCRINOLOGY, V148, P4334, DOI 10.1210/en.2007-0446; Jernberg E, 2017, ENDOCR CONNECT, V6, pR146, DOI 10.1530/EC-17-0118; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Koochekpour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074688; Lamb LE, 2011, CANCER RES, V71, P2739, DOI 10.1158/0008-5472.CAN-10-2745; Leung JK, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00002; Levin ER, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2016.122; Li J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20984; Liao RS, 2013, TRANSL ANDROL UROL, V2, P187, DOI 10.3978/j.issn.2223-4683.2013.09.07; Lorin T, 2015, G3-GENES GENOM GENET, V5, P2275, DOI 10.1534/g3.115.020685; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; Morrish F, 2006, MITOCHONDRION, V6, P143, DOI 10.1016/j.mito.2006.04.002; Ni L, 2013, MOL CELL BIOL, V33, P4766, DOI 10.1128/MCB.00647-13; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; Rimler A, 2002, NEUROENDOCRINOL LETT, V23, P45; Ritch CR, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4405; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scheller K, 2000, EUR J CELL BIOL, V79, P299, DOI 10.1078/S0171-9335(04)70033-3; Sepuri NBV, 2017, HANDB EXP PHARMACOL, V240, P3, DOI 10.1007/164_2016_3; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139846; Singh KK, 2017, SEMIN CANCER BIOL, V47, pIV, DOI 10.1016/j.semcancer.2017.10.013; Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71; Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; van Gisbergen MW, 2015, MUTAT RES-REV MUTAT, V764, P16, DOI 10.1016/j.mrrev.2015.01.001; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Xu J, 2016, ASIAN J UROL, V3, P177, DOI 10.1016/j.ajur.2016.08.003; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yang YJ, 2010, J BIOL CHEM, V285, P7417, DOI 10.1074/jbc.M109.053421; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Zarif JC, 2016, CELL SIGNAL, V28, P348, DOI 10.1016/j.cellsig.2016.01.013; Zarif JC, 2015, ONCOTARGET, V6, P6862, DOI 10.18632/oncotarget.3119; Zhou Y, 2015, J MOL ENDOCRINOL, V54, pR15, DOI 10.1530/JME-14-0203	71	39	39	3	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6621	6634		10.1074/jbc.RA118.006727	http://dx.doi.org/10.1074/jbc.RA118.006727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30792308	Green Published, hybrid			2022-12-28	WOS:000468402000035
J	Conteh, AM; Reissaus, CA; Hernandez-Perez, M; Nakshatri, S; Anderson, RM; Mirmira, RG; Tersey, SA; Linnemann, AK				Conteh, Abass M.; Reissaus, Christopher A.; Hernandez-Perez, Marimar; Nakshatri, Swetha; Anderson, Ryan M.; Mirmira, Raghavendra G.; Tersey, Sarah A.; Linnemann, Amelia K.			Platelet-type 12-lipoxygenase deletion provokes a compensatory 12/15-lipoxygenase increase that exacerbates oxidative stress in mouse islet cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoxygenase pathway; pancreatic islet; diabetes; reactive oxygen species (ROS); oxidative stress	INFLAMMATION; DYSFUNCTION; INHIBITORS; CHEMISTRY; APOPTOSIS; CYTOKINES; PRODUCTS; PROTECTS; MODEL; MICE	In type 1 diabetes, an autoimmune event increases oxidative stress in islet cells, giving rise to cellular dysfunction and apoptosis. Lipoxygenases are enzymes that catalyze the oxygenation of polyunsaturated fatty acids that can form lipid metabolites involved in several biological functions, including oxidative stress. 12-Lipoxygenase and 12/15-lipoxygenase are related but distinct enzymes that are expressed in pancreatic islets, but their relative contributions to oxidative stress in these regions are still being elucidated. In this study, we used mice with global genetic deletion of the genes encoding 12-lipoxygenase (arachidonate 12-lipoxygenase, 12S type [Alox12]) or 12/15-lipoxygenase (Alox15) to compare the influence of each gene deletion on cell function and survival in response to the cell toxin streptozotocin. Alox12(-/-) mice exhibited greater impairment in glucose tolerance following streptozotocin exposure than WT mice, whereas Alox15(-/-) mice were protected against dysglycemia. These changes were accompanied by evidence of islet oxidative stress in Alox12(-/-) mice and reduced oxidative stress in Alox15(-/-) mice, consistent with alterations in the expression of the antioxidant response enzymes in islets from these mice. Additionally, islets from Alox12(-/-) mice displayed a compensatory increase in Alox15 gene expression, and treatment of these mice with the 12/15-lipoxygenase inhibitor ML-351 rescued the dysglycemic phenotype. Collectively, these results indicate that Alox12 loss activates a compensatory increase in Alox15 that sensitizes mouse cells to oxidative stress.	[Conteh, Abass M.; Mirmira, Raghavendra G.; Linnemann, Amelia K.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Conteh, Abass M.; Anderson, Ryan M.; Mirmira, Raghavendra G.; Linnemann, Amelia K.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Reissaus, Christopher A.; Hernandez-Perez, Marimar; Nakshatri, Swetha; Anderson, Ryan M.; Mirmira, Raghavendra G.; Tersey, Sarah A.; Linnemann, Amelia K.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Reissaus, Christopher A.; Hernandez-Perez, Marimar; Nakshatri, Swetha; Anderson, Ryan M.; Mirmira, Raghavendra G.; Tersey, Sarah A.; Linnemann, Amelia K.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Reissaus, Christopher A.; Hernandez-Perez, Marimar; Nakshatri, Swetha; Anderson, Ryan M.; Mirmira, Raghavendra G.; Tersey, Sarah A.; Linnemann, Amelia K.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Tersey, SA (corresponding author), 1044 W Walnut St,R4-325, Indianapolis, IN 46202 USA.; Linnemann, AK (corresponding author), 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	stersey@iu.edu; aklinnem@iu.edu	Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Nakshatri, Swetha/0000-0002-7627-1953; Linnemann, Amelia/0000-0001-7356-4876	NIDDK, National Institutes of Health [R01 DK105588, P30 DK097512, K01 DK102492, R03 DK115990]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK115990, P30DK097512, R01DK105588, K01DK102492, R01DK060581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM077229] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIDDK, National Institutes of Health Grants R01 DK105588 and P30 DK097512 (to R. G. M.) and K01 DK102492 and R03 DK115990 (to A. K. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackermann JA, 2017, BBA-MOL CELL BIOL L, V1862, P371, DOI 10.1016/j.bbalip.2016.07.014; Al Nahdi AMT, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7054272; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bleich D, 1999, J CLIN INVEST, V103, P1431, DOI 10.1172/JCI5241; Cabrera SM, 2013, CLIN EXP IMMUNOL, V172, P375, DOI 10.1111/cei.12068; Delmastro MM, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/593863; Eleazu CO, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-60; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564; Hernandez-Perez M, 2017, DIABETES, V66, P2875, DOI 10.2337/db17-0215; Hu CY, 2018, MEDCHEMCOMM, V9, P212, DOI 10.1039/c7md00390k; Ikei KN, 2012, J LIPID RES, V53, P2546, DOI 10.1194/jlr.M026385; Johnson EN, 1999, J INVEST DERMATOL, V112, P861, DOI 10.1046/j.1523-1747.1999.00595.x; JOHNSON MB, 1993, DIABETES, V42, P1179, DOI 10.2337/diabetes.42.8.1179; KUBISCH HM, 1994, P NATL ACAD SCI USA, V91, P9956, DOI 10.1073/pnas.91.21.9956; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Lei XY, 2014, ENDOCRINOLOGY, V155, P3352, DOI 10.1210/en.2013-2134; Lenzen S, 2017, BBA-GEN SUBJECTS, V1861, P1929, DOI 10.1016/j.bbagen.2017.05.013; Lismont C, 2017, METHODS MOL BIOL, V1595, P151, DOI 10.1007/978-1-4939-6937-1_14; Lukic M L, 1998, Dev Immunol, V6, P119, DOI 10.1155/1998/92198; Ma K, 2010, J CLIN ENDOCR METAB, V95, P887, DOI 10.1210/jc.2009-1102; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Marasco MR, 2018, DIABETES, V67, P1576, DOI 10.2337/db17-1280; Mashima R, 2015, REDOX BIOL, V6, P297, DOI 10.1016/j.redox.2015.08.006; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Miki A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196570; Muller A, 2017, FREE RADICAL BIO MED, V106, P329, DOI 10.1016/j.freeradbiomed.2017.02.044; Neuman JC, 2017, DIABETES, V66, P1572, DOI 10.2337/db16-1362; Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626; Neyestani TR, 2012, EUR J CLIN NUTR, V66, P1054, DOI 10.1038/ejcn.2012.81; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; Prasad KMR, 2003, BIOCHEM BIOPH RES CO, V308, P427, DOI 10.1016/S0006-291X(03)01418-9; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Subramanian S., 2000, ENDOTEXT; Tersey SA, 2015, MOL ENDOCRINOL, V29, P791, DOI 10.1210/me.2015-1041; Tersey SA, 2014, MOL CELL BIOL, V34, P3735, DOI 10.1128/MCB.00157-14; Ward DT, 2001, J AM SOC NEPHROL, V12, P779, DOI 10.1681/ASN.V124779; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909; Zarkovic K, 2017, FREE RADICAL BIO MED, V111, P110, DOI 10.1016/j.freeradbiomed.2016.12.009; Zhang XJ, 2018, NAT MED, V24, P73, DOI 10.1038/nm.4451; Zhou YP, 1998, J CLIN INVEST, V101, P1623, DOI 10.1172/JCI1245	45	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6612	6620		10.1074/jbc.RA118.007102	http://dx.doi.org/10.1074/jbc.RA118.007102			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30792307	hybrid, Green Published			2022-12-28	WOS:000468402000034
J	Garcia, A; Lev, B; Hossain, KR; Gorman, A; Diaz, D; Pham, THN; Cornelius, F; Allen, TW; Clarke, RJ				Garcia, Alvaro; Lev, Bogdan; Hossain, Khondker R.; Gorman, Amy; Diaz, Dil; Thi Hanh Nguyen Pham; Cornelius, Flemming; Allen, Toby W.; Clarke, Ronald J.			Cholesterol depletion inhibits Na+,K+-ATPase activity in a near-native membrane environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid-protein interaction; molecular dynamics; Na+; K+-ATPase; pre-steady-state kinetics; cholesterol; lipid-protein interactions; methyl--cyclodextrin; molecular dynamics; partial reaction kinetics; steady-state activity	LIPID-PROTEIN INTERACTIONS; NA+/K+-ATPASE ACTIVITY; CRYSTAL-STRUCTURE; CONFORMATIONAL TRANSITIONS; MOLECULAR-DYNAMICS; STEADY-STATE; SODIUM-PUMP; K+-ATPASE; NA,K-ATPASE; MODULATION	Cholesterol's effects on Na , K -ATPase reconstituted in phospholipid vesicles have been extensively studied. However, previous studies have reported both cholesterol-mediated stimulation and inhibition of Na , K -ATPase activity. Here, using partial reaction kinetics determined via stopped-flow experiments, we studied cholesterol's effect on Na , K -ATPase in a near-native environment in which purified membrane fragments were depleted of cholesterol with methyl- -cyclodextrin (m CD). Them CD-treated Na , K -ATPase had significantly reduced overall activity and exhibited decreased observed rate constants forATPphosphorylation(ENa 3 3E2P, i. e. phosphorylation by ATP and Na occlusion from the cytoplasm) and K deocclusion with subsequent intracellular Na binding (E2K 2 3E1Na 3 ). However, cholesterol depletion did not affect the observed rate constant for K occlusion by phosphorylated Na , K -ATPase on the extracellular face and subsequent dephosphorylation (E2P3E2K 2 ). Thus, partial reactions involving cation binding and release at the protein's intracellular side were most dependent on cholesterol. Fluorescence measurements with the probe eosin indicated that cholesterol depletion stabilizes the unphosphorylated E2 state relative to E1, and the cholesterol depletion-induced slowing of ATP phosphorylation kinetics was consistent with partial conversion of Na , K ATPase into the E2 state, requiring a slow E2 3 E1 transition before the phosphorylation. Molecular dynamics simulations of Na , K -ATPase in membranes with 40 mol % cholesterol revealed cholesterol interaction sites that differ markedly among protein conformations. They further indicated state-dependent effects on membrane shape, with the E2 state being likely disfavored in cholesterol-rich bilayers relative to the E1P state because of a greater hydrophobic mismatch. In summary, cholesterol extraction from membranes significantly decreases Na , K -ATPase steady-state activity.	[Garcia, Alvaro; Hossain, Khondker R.; Gorman, Amy; Diaz, Dil; Thi Hanh Nguyen Pham; Clarke, Ronald J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Garcia, Alvaro; Clarke, Ronald J.] Univ Sydney, Nano Inst, Sydney, NSW 2006, Australia; [Lev, Bogdan; Allen, Toby W.] RMIT Univ, Sch Sci, Melbourne, Vic 3001, Australia; [Gorman, Amy] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Cornelius, Flemming] Univ Aarhus, Dept Biomed, DK-8000 Aarhus C, Denmark; [Allen, Toby W.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Garcia, Alvaro] Univ Technol Sydney, Sch Life Sci, Ultimo, NSW 2007, Australia	University of Sydney; University of Sydney; Royal Melbourne Institute of Technology (RMIT); University of York - UK; Aarhus University; University of California System; University of California Davis; University of Technology Sydney	Clarke, RJ (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	ronald.clarke@sydney.edu.au	Hossain, Khondker/C-1814-2019; Hossain, Khondker Rufaka/AAR-6301-2020; Clarke, Ronald J/L-5259-2016; Garcia, Alvaro/E-6573-2015	Hossain, Khondker/0000-0003-4506-1491; Hossain, Khondker Rufaka/0000-0003-4506-1491; Clarke, Ronald J/0000-0002-0950-8017; Garcia, Alvaro/0000-0002-1159-4567; allen, toby/0000-0002-3521-7950; Gorman, Amy/0000-0002-6039-9100; Lev, Bogdan/0000-0002-7631-9400	Australian Research Council [DP121003548, DP150101112, DP170101732]; NHMRC [App1104259]; National Institutes of Health [U01-HL126273-02]; Medical Advances Without Animals Trust; Danish Medical Research Council; Novo Nordisk Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL126273] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Advances Without Animals Trust; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Australian Research Council Discovery Grants DP121003548 (to R. J. C. and T. W. A.), DP150101112 (to R. J. C. and F. C.), and DP170101732 (to R. J. C., T. W. A., and F. C.), NHMRC Grant App1104259 (to T. W. A.), National Institutes of Health Grant U01-HL126273-02, the Medical Advances Without Animals Trust, the Danish Medical Research Council, and The Novo Nordisk Foundation (to F. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alwarawrah M, 2010, J PHYS CHEM B, V114, P7516, DOI 10.1021/jp101415g; Asano S, 2000, JPN J PHYSIOL, V50, P419, DOI 10.2170/jjphysiol.50.419; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Balut C, 2006, AM J PHYSIOL-CELL PH, V290, pC87, DOI 10.1152/ajpcell.00184.2005; CLARET M, 1978, J PHYSIOL-LONDON, V274, P247, DOI 10.1113/jphysiol.1978.sp012145; Clarke RJ, 2015, BIOPHYS J, V109, P1513, DOI 10.1016/j.bpj.2015.08.022; Clarke RJ, 2013, BBA-BIOENERGETICS, V1827, P1205, DOI 10.1016/j.bbabio.2013.06.010; Cornelius F, 2005, BIOCHEMISTRY-US, V44, P13051, DOI 10.1021/bi0504456; Cornelius F, 2015, BBA-BIOMEMBRANES, V1848, P1729, DOI 10.1016/j.bbamem.2015.03.012; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2003, BIOPHYS J, V84, P1690, DOI 10.1016/S0006-3495(03)74977-7; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Cornelius F, 1999, BIOPHYS J, V77, P934, DOI 10.1016/S0006-3495(99)76944-4; Cornelius F, 1998, BIOCHEMISTRY-US, V37, P16686, DOI 10.1021/bi981571v; Cornelius F, 2008, BIOCHEMISTRY-US, V47, P1652, DOI 10.1021/bi702128x; Cuevas FJ, 2006, BIOCHEMISTRY-US, V45, P13855, DOI 10.1021/bi061351e; Daly SE, 1996, J BIOL CHEM, V271, P23683, DOI 10.1074/jbc.271.39.23683; DEPONT JJHHM, 1978, BIOCHIM BIOPHYS ACTA, V508, P464, DOI 10.1016/0005-2736(78)90092-5; ESMANN M, 1985, BIOCHEMISTRY-US, V24, P1386, DOI 10.1021/bi00327a016; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FORBUSH B, 1991, SOC GEN PHY, V46, P211; Garcia A, 2017, BBA-BIOMEMBRANES, V1859, P813, DOI 10.1016/j.bbamem.2017.01.022; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; Grossfield A, 2006, P NATL ACAD SCI USA, V103, P4888, DOI 10.1073/pnas.0508352103; Habeck M, 2017, P NATL ACAD SCI USA, V114, P2904, DOI 10.1073/pnas.1620799114; Habeck M, 2015, J BIOL CHEM, V290, P4829, DOI 10.1074/jbc.M114.611384; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Han M, 2017, SCI REP-UK, V7, DOI 10.1038/srep39829; Humphrey PA, 2002, BIOCHEMISTRY-US, V41, P9496, DOI 10.1021/bi025836o; Hung WC, 2007, BIOPHYS J, V92, P3960, DOI 10.1529/biophysj.106.099234; Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g; Jiang QC, 2017, BIOPHYS J, V112, P288, DOI 10.1016/j.bpj.2016.12.008; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN PL, 1982, BIOCHIM BIOPHYS ACTA, V694, P27, DOI 10.1016/0304-4157(82)90013-2; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; JORGENSEN PL, 1982, ANN NY ACAD SCI, V402, P207, DOI 10.1111/j.1749-6632.1982.tb25743.x; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kane DJ, 1997, BIOCHEMISTRY-US, V36, P13406, DOI 10.1021/bi970598w; Khalid M, 2010, BIOPHYS J, V98, P2290, DOI 10.1016/j.bpj.2010.01.038; KIMELBERG HK, 1974, J BIOL CHEM, V249, P1071; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; Lambropoulos N, 2016, J MEMBRANE BIOL, V249, P251, DOI 10.1007/s00232-015-9864-z; Lauger P., 1991, ELECTROGENIC ION PUM; Lopez CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCIO FJ, 1991, EXP PHYSIOL, V76, P437, DOI 10.1113/expphysiol.1991.sp003510; LUNDKATZ S, 1988, BIOCHEMISTRY-US, V27, P3416, DOI 10.1021/bi00409a044; Lupfert C, 2001, BIOPHYS J, V81, P2069, DOI 10.1016/S0006-3495(01)75856-0; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MARIN R, 1985, BIOCHEM PHARMACOL, V34, P4197, DOI 10.1016/0006-2952(85)90274-6; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Myers SL, 2011, BIOPHYS J, V100, P70, DOI 10.1016/j.bpj.2010.11.038; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Pan J, 2008, BIOPHYS J, V94, P117, DOI 10.1529/biophysj.107.115691; PETERS WHM, 1981, BIOCHIM BIOPHYS ACTA, V649, P541, DOI 10.1016/0005-2736(81)90158-9; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pilotelle-Bunner A, 2009, BIOPHYS J, V96, P3753, DOI 10.1016/j.bpj.2009.01.042; Pucadyil TJ, 2004, BBA-BIOMEMBRANES, V1663, P188, DOI 10.1016/j.bbamem.2004.03.010; Pytel M, 2006, BRIT J PHARMACOL, V148, P413, DOI 10.1038/sj.bjp.0706747; Razavi AM, 2017, J BIOL CHEM, V292, P12412, DOI 10.1074/jbc.M117.779090; Reddy ST, 2016, BBA-BIOMEMBRANES, V1858, P2611, DOI 10.1016/j.bbamem.2016.07.007; ROBINSON JD, 1993, BIOCHIM BIOPHYS ACTA, V1154, P83, DOI 10.1016/0304-4157(93)90018-J; Sarkar P, 2016, CHEM PHYS LIPIDS, V195, P34, DOI 10.1016/j.chemphyslip.2015.11.005; Sarkar P, 2015, CHEM PHYS LIPIDS, V191, P91, DOI 10.1016/j.chemphyslip.2015.08.016; Scanzano R, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705899200; SCHVARTZ PG, 2005, J GEN PHYSIOL, V31, pA32; Schwartz A. K., 1971, METHOD PHARMACOL, V1, P361; SHIN YK, 1990, BIOPHYS J, V57, P445, DOI 10.1016/S0006-3495(90)82561-3; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; SKOU JC, 1983, BIOCHIM BIOPHYS ACTA, V746, P101, DOI 10.1016/0167-4838(83)90016-X; SKOU JC, 1981, BIOCHIM BIOPHYS ACTA, V647, P232, DOI 10.1016/0005-2736(81)90251-0; Sotomayor CP, 2000, BIOCHEMISTRY-US, V39, P10928, DOI 10.1021/bi000717z; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; STURMER W, 1991, J MEMBRANE BIOL, V121, P163, DOI 10.1007/BF01870530; YEAGLE PL, 1983, BIOCHIM BIOPHYS ACTA, V727, P39, DOI 10.1016/0005-2736(83)90366-8; YEAGLE PL, 1988, BIOCHEMISTRY-US, V27, P6449, DOI 10.1021/bi00417a037; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	87	18	18	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5956	5969		10.1074/jbc.RA118.006223	http://dx.doi.org/10.1074/jbc.RA118.006223			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30770471	Green Published, hybrid			2022-12-28	WOS:000465077500027
J	Bahudhanapati, H; Tan, JN; Dutta, JA; Strock, SB; Sembrat, J; Alvarez, D; Rojas, M; Jager, B; Prasse, A; Zhang, YZ; Kass, DJ				Bahudhanapati, Harinath; Tan, Jiangning; Dutta, Justin A.; Strock, Stephen B.; Sembrat, John; Alvarez, Diana; Rojas, Mauricio; Jaeger, Benedikt; Prasse, Antje; Zhang, Yingze; Kass, Daniel J.			MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						relaxin; fibroblast; myofibroblast; microRNA (miRNA); pulmonary fibrosis; transforming growth factor (TGF-B); post-transcriptional regulation; epigenetics; idiopathic pulmonary fibrosis; lung disease; lung fibroblasts; miR-144-3p; relaxin; insulin-like family peptide receptor 1 (RXFP1)	RELAXIN RECEPTOR; ACTIVATION; AP-1; PATHOGENESIS; INFLAMMATION; PROGRESSION; MECHANISM; FOS	The hormone relaxin is considered a potential therapy for idiopathic pulmonary fibrosis (IPF). We have previously shown that a potential limitation to relaxin-based IPF therapy is decreased expression of a relaxin receptor, relaxin/insulin-like family peptide receptor 1 (RXFP1), in IPF fibroblasts. The mechanism that down-regulates RXFP1 in IPF remains unclear. To determine whether microRNAs (miRs) regulate RXFP1 gene expression, here we employed a bioinformatics approach to identify miRs predicted to target RXFP1 and identified a putative miR-144-3p target site in the RXFP1 mRNA. In situ hybridization of IPF lung biopsies revealed that miR-144-3p is expressed in fibroblastic foci. Furthermore, we found that miR-144-3p is up-regulated in IPF fibroblasts compared with lung fibroblasts from healthy donors. Transforming growth factor beta increased miR-144-3p expression in both healthy and IPF lung fibroblasts in a SMAD family 2/3 (SMAD2/3)-dependent manner, and Jun proto-oncogene AP-1 transcription factor subunit (AP-1) was required for constitutive miR-144-3p expression. Overexpression of an miR-144-3p mimic significantly reduced RXFP1 mRNA and protein levels and increased expression of the myofibroblast marker alpha-smooth muscle actin (alpha-SMA) in healthy lung fibroblasts. IPF lung fibroblasts transfected with anti-miR-144-3p had increased RXFP1 expression and reduced alpha-SMA expression. Of note, a lentiviral luciferase reporter carrying the WT 3' UTR of RXFP1 was significantly repressed in IPF lung fibroblasts, whereas a reporter carrying a mutated miR-144-3p-binding site exhibited less sensitivity toward endogenous miR-144-3p expression, indicating that miR-144-3p down-regulates RXFP1 in IPF lung fibroblasts by targeting its 3' UTR. We conclude that miR-144-3p directly represses RXFP1 mRNA and protein expression.	[Bahudhanapati, Harinath; Tan, Jiangning; Dutta, Justin A.; Strock, Stephen B.; Sembrat, John; Alvarez, Diana; Rojas, Mauricio; Zhang, Yingze; Kass, Daniel J.] Univ Pittsburgh, Sch Med, Dorothy P & Richard P Simmons Ctr Interstitial Lu, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Prasse, Antje] Hannover Med Sch, Dept Pulmonol, DZL, BREATH, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Jaeger, Benedikt; Prasse, Antje] Fraunhofer ITEM, DZL, BREATH, Nicolai Fuchs Str 1, D-30625 Hannover, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hannover Medical School	Kass, DJ (corresponding author), Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Simmons Ctr Interstitial Lung Disease, 200 Lothrop St, Pittsburgh, PA 15260 USA.	kassd2@upmc.edu	Prasse, Antje/AAY-6279-2020; Prasse, Antje/AAM-7521-2021	Prasse, Antje/0000-0002-7336-7458; Zhang, YIngze/0000-0001-8042-6105; Dutta, Justin/0000-0002-1740-0639	National Institutes of Health [R01 HL126990, P50AR060780]; Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126990, R01HL123766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in whole or part by National Institutes of Health Grants R01 HL126990 and P50AR060780 (to D. J. K.) and the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alvarez D, 2017, AM J PHYSIOL-LUNG C, V313, pL1164, DOI 10.1152/ajplung.00220.2017; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bahudhanapati H, 2017, AM J RESP CELL MOL, V57, P10, DOI 10.1165/rcmb.2017-0079ED; Baig S, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0315-6; Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bridges RS, 2009, AM J PATHOL, V175, P2351, DOI 10.2353/ajpath.2009.080954; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; Chen SL, 2014, J CELL MOL MED, V18, P415, DOI 10.1111/jcmm.12218; Cheng C, 2013, J BIOL CHEM, V288, P13748, DOI 10.1074/jbc.M112.381392; CHIHAL HJ, 1973, ENDOCRINOLOGY, V93, P1441, DOI 10.1210/endo-93-6-1441; Christmann RB, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1054-6; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Dehghan F, 2014, INT J MED SCI, V11, P180, DOI 10.7150/ijms.6283; Fallowfield JA, 2014, HEPATOLOGY, V59, P1492, DOI 10.1002/hep.26627; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Huang XW, 2011, AM J PATHOL, V179, P2751, DOI 10.1016/j.ajpath.2011.08.018; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Li HN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27914; Li YR, 2018, J BIOCHEM MOL TOXIC, V32, DOI 10.1002/jbt.22044; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Mazella J, 2004, HUM REPROD, V19, P1513, DOI 10.1093/humrep/deh274; Mercer PF, 2016, THORAX, V71, P701, DOI 10.1136/thoraxjnl-2015-207429; Mizuno K, 2017, J HUM GENET, V62, P57, DOI 10.1038/jhg.2016.98; Montgomery RL, 2014, EMBO MOL MED, V6, P1347, DOI 10.15252/emmm.201303604; Moore XL, 2014, CARDIOVASC DRUG THER, V28, P221, DOI 10.1007/s10557-014-6525-x; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; O'Dwyer DN, 2016, AM J PHYSIOL-LUNG C, V311, pL590, DOI 10.1152/ajplung.00221.2016; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Parikh Victoria N, 2013, Methods Mol Biol, V1024, P157, DOI 10.1007/978-1-62703-453-1_12; Raghu G, 2014, LANCET RESP MED, V2, P277, DOI 10.1016/S2213-2600(14)70011-6; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Samuel CS, 2005, ANN NY ACAD SCI, V1041, P182, DOI 10.1196/annals.1282.026; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Snowdon VK, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002248; Tan JN, 2017, J IMMUNOL, V198, P2269, DOI 10.4049/jimmunol.1600610; Tan JN, 2016, AM J RESP CRIT CARE, V194, P1392, DOI 10.1164/rccm.201509-1865OC; UNEMORI EN, 1992, J INVEST DERMATOL, V99, P337, DOI 10.1111/1523-1747.ep12616665; Wu C, 2018, CELL PHYSIOL BIOCHEM, V48, P2493, DOI 10.1159/000492687; Xu ZP, 2015, J HEART LUNG TRANSPL, V34, P1154, DOI 10.1016/j.healun.2015.03.021; Yong K L, 2013, Ital J Anat Embryol, V118, P10	48	16	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5008	5022		10.1074/jbc.RA118.004910	http://dx.doi.org/10.1074/jbc.RA118.004910			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30709904	hybrid, Green Published			2022-12-28	WOS:000463985600024
J	Gregg, T; Sdao, SM; Dhillon, RS; Rensvold, JW; Lewandowski, SL; Pagliarini, DJ; Denu, JM; Merrins, MJ				Gregg, Trillian; Sdao, Sophia M.; Dhillon, Rashpal S.; Rensvold, Jarred W.; Lewandowski, Sophie L.; Pagliarini, David J.; Denu, John M.; Merrins, Matthew J.			Obesity-dependent CDK1 signaling stimulates mitochondrial respiration at complex I in pancreatic -cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial metabolism; complex I; insulin secretion; obesity; calcium; cyclin B1; cyclin-dependent kinase 1 (CDK1); ob; ob mice; pancreatic cell; RO-3306	GLUCOSE-REGULATED ANAPLEROSIS; BETA-CELLS; INSULIN-SECRETION; NADH FLUORESCENCE; ISLETS; DEHYDROGENASE; EXPRESSION; RELEASE; MODEL; MICE	beta-Cell mitochondria play a central role in coupling glucose metabolism with insulin secretion. Here, we identified a metabolic function of cyclin-dependent kinase 1 (CDK1)/cyclin B1the activation of mitochondrial respiratory complex Ithat is active in quiescent adult -cells and hyperactive in -cells from obese (ob/ob) mice. In WT islets, respirometry revealed that 65% of complex I flux and 49% of state 3 respiration is sensitive to CDK1 inhibition. Islets from ob/ob mice expressed more cyclin B1 and exhibited a higher sensitivity to CDK1 blockade, which reduced complex I flux by 76% and state 3 respiration by 79%. The ensuing reduction in mitochondrial NADH utilization, measured with two-photon NAD(P)H fluorescence lifetime imaging (FLIM), was matched in the cytosol by a lag in citrate cycling, as shown with a FRET reporter targeted to -cells. Moreover, time-resolved measurements revealed that in ob/ob islets, where complex I flux dominates respiration, CDK1 inhibition is sufficient to restrict the duty cycle of ATP/ADP and calcium oscillations, the parameter that dynamically encodes -cell glucose sensing. Direct complex I inhibition with rotenone mimicked the restrictive effects of CDK1 inhibition on mitochondrial respiration, NADH turnover, ATP/ADP, and calcium influx. These findings identify complex I as a critical mediator of obesity-associated metabolic remodeling in -cells and implicate CDK1 as a regulator of complex I that enhances -cell glucose sensing.	[Gregg, Trillian; Sdao, Sophia M.; Lewandowski, Sophie L.; Merrins, Matthew J.] Univ Wisconsin, Dept Med, Div Endocrinol Diabet & Metab, Madison, WI 53705 USA; [Dhillon, Rashpal S.; Denu, John M.; Merrins, Matthew J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53705 USA; [Rensvold, Jarred W.; Pagliarini, David J.] Univ Wisconsin, Morgridge Inst Res, Madison, WI 53715 USA; [Rensvold, Jarred W.; Pagliarini, David J.] Univ Wisconsin, Dept Biochem, Madison, WI 53715 USA; [Merrins, Matthew J.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Merrins, MJ (corresponding author), Med Fdn Centennial Bldg,1600 Overlook Terrace, Madison, WI 53705 USA.	merrins@wisc.edu		Merrins, Matthew J./0000-0003-1599-9227; LEWANDOWSKI, SOPHIE/0000-0002-2838-7054; Pagliarini, David J./0000-0002-0001-0087	American Diabetes Association Grant [1-16-IBS-212]; NIDDK, National Institutes of Health [R01DK098672, R01DK113103]; NIA, National Institutes of Health [R21AG050135]; New Investigator Award from the Wisconsin Partnership Program; Central Society for Clinical and Translational Research; National Institutes of Health Molecular Biophysics Training Grant [T32GM08293]; Laboratory for Optical and Computational Instrumentation; Wisconsin Alumni Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113103, R01DK098672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG050135] Funding Source: NIH RePORTER	American Diabetes Association Grant(American Diabetes Association); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New Investigator Award from the Wisconsin Partnership Program; Central Society for Clinical and Translational Research; National Institutes of Health Molecular Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laboratory for Optical and Computational Instrumentation; Wisconsin Alumni Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work in the Merrins laboratory was supported by American Diabetes Association Grant 1-16-IBS-212; NIDDK, National Institutes of Health Grant R01DK113103; NIA, National Institutes of Health Grant R21AG050135; a New Investigator Award from the Wisconsin Partnership Program; and an Early Career Development Award from the Central Society for Clinical and Translational Research. The work in the Pagliarini laboratory was supported by NIDDK, National Institutes of Health Grant R01DK098672. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of additional support from National Institutes of Health Molecular Biophysics Training Grant T32GM08293, the Laboratory for Optical and Computational Instrumentation, and a Wisconsin Alumni Research Foundation dissertation fellowship.	Affourtit C, 2018, BIOCHEM SOC T, V46, P555, DOI 10.1042/BST20170505; Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021; Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; Blinova K, 2008, BIOCHEMISTRY-US, V47, P9636, DOI 10.1021/bi800307y; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Ewald JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028245; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Ferdaoussi M, 2015, J CLIN INVEST, V125, P3847, DOI 10.1172/JCI82498; Forstner H., 1983, POLAROGRAPHIC OXYGEN, P321; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/bst0300252; Gregg T, 2016, DIABETES, V65, P2700, DOI 10.2337/db16-0432; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Irles E, 2015, MOL CELL ENDOCRINOL, V404, P46, DOI 10.1016/j.mce.2015.01.033; Jorda R, 2018, J MED CHEM, V61, P9105, DOI 10.1021/acs.jmedchem.8b00049; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02664-0; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kim SY, 2017, J BIOL CHEM, V292, P3841, DOI 10.1074/jbc.M116.754077; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; LAKOWICZ JR, 1992, P NATL ACAD SCI USA, V89, P1271, DOI 10.1073/pnas.89.4.1271; Li HB, 2016, DNA CELL BIOL, V35, P680, DOI 10.1089/dna.2016.3271; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; MIURA RM, 1995, B MATH BIOL, V57, P229, DOI 10.1016/0092-8240(94)00035-B; Nicholls DG, 2016, PHYSIOL REV, V96, P1385, DOI 10.1152/physrev.00009.2016; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Qin LL, 2015, CELL REP, V13, P2056, DOI 10.1016/j.celrep.2015.11.015; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Shirakawa J, 2017, CELL METAB, V25, P868, DOI 10.1016/j.cmet.2017.02.004; Solaki M, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00093; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; van der Meulen T, 2015, NAT MED, V21, P769, DOI 10.1038/nm.3872; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; de Tudela MVP, 2015, J NEUROSCI, V35, P9287, DOI 10.1523/JNEUROSCI.4712-14.2015; Votion DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034890; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; Zhao C, 2001, DIABETES, V50, P361, DOI 10.2337/diabetes.50.2.361	46	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4656	4666		10.1074/jbc.RA118.006085	http://dx.doi.org/10.1074/jbc.RA118.006085			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30700550	hybrid, Green Published			2022-12-28	WOS:000462969500031
J	Jendroszek, A; Madsen, JB; Chana-Munoz, A; Dupont, DM; Christensen, A; Panitz, F; Fuchtbauer, EM; Lovell, SC; Jensen, JK				Jendroszek, Agnieszka; Madsen, Jeppe B.; Chana-Munoz, Andres; Dupont, Daniel M.; Christensen, Anni; Panitz, Frank; Fuchtbauer, Ernst-Martin; Lovell, Simon C.; Jensen, Jan K.			Biochemical and structural analyses suggest that plasminogen activators coevolved with their cognate protein substrates and inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine protease; serpin; substrate specificity; protein evolution; surface plasmon resonance (SPR)	UROKINASE-TYPE; CRYSTAL-STRUCTURE; IMMUNOHISTOCHEMICAL LOCALIZATION; MECHANISM; SPECIFICITY; BINDING; RECEPTOR; TYPE-1	Protein sequences of members of the plasminogen activation system are present throughout the entire vertebrate phylum. This important and well-described proteolytic cascade is governed by numerous protease-substrate and protease-inhibitor interactions whose conservation is crucial to maintaining unchanged protein function throughout evolution. The pressure to preserve protein-protein interactions may lead to either co-conservation or covariation of binding interfaces. Here, we combined covariation analysis and structure-based prediction to analyze the binding interfaces of urokinase (uPA):plasminogen activator inhibitor-1 (PAI-1) and uPA:plasminogen complexes. We detected correlated variation between the S3-pocket-lining residues of uPA and the P3 residue of both PAI-1 and plasminogen. These residues are known to form numerous polar interactions in the human uPA:PAI-1 Michaelis complex. To test the effect of mutations that correlate with each other and have occurred during mammalian diversification on protein-protein interactions, we produced uPA, PAI-1, and plasminogen from human and zebrafish to represent mammalian and nonmammalian orthologs. Using single amino acid point substitutions in these proteins, we found that the binding interfaces of uPA:plasminogen and uPA:PAI-1 may have coevolved to maintain tight interactions. Moreover, we conclude that although the interaction areas between protease-substrate and protease-inhibitor are shared, the two interactions are mechanistically different. Compared with a protease cleaving its natural substrate, the interaction between a protease and its inhibitor is more complex and involves a more fine-tuned mechanism. Understanding the effects of evolution on specific protein interactions may help further pharmacological interventions of the plasminogen activation system and other proteolytic systems.	[Jendroszek, Agnieszka; Madsen, Jeppe B.; Chana-Munoz, Andres; Dupont, Daniel M.; Christensen, Anni; Panitz, Frank; Fuchtbauer, Ernst-Martin; Jensen, Jan K.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Lovell, Simon C.] Univ Manchester, Sch Biol Sci, Manchester M13 9PL, Lancs, England	Aarhus University; University of Manchester	Jensen, JK (corresponding author), Aarhus Univ, Ny Munkegade 116,Bygning 1521,418, DK-8000 Aarhus, Denmark.	jkj@mbg.au.dk	Dupont, Daniel M./H-7556-2019; Panitz, Frank/A-3281-2017	Panitz, Frank/0000-0002-6909-5162; Dupont, Daniel Miotto/0000-0003-1378-1670	Danish Research Council	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by The Danish Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDREASEN PA, 1990, MOL CELL ENDOCRINOL, V68, P1, DOI 10.1016/0303-7207(90)90164-4; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bager R, 2013, J MOL BIOL, V425, P2867, DOI 10.1016/j.jmb.2013.05.007; Bager R, 2012, J BIOL CHEM, V287, P27526, DOI 10.1074/jbc.M112.369207; Blouse GE, 2003, BIOCHEMISTRY-US, V42, P12260, DOI 10.1021/bi034737n; CHIBBER BAK, 1985, BIOCHEMISTRY-US, V24, P3429, DOI 10.1021/bi00335a006; Christensen L, 1996, INT J CANCER, V66, P441; Coombs GS, 1996, J BIOL CHEM, V271, P4461; DING L, 1995, P NATL ACAD SCI USA, V92, P7627, DOI 10.1073/pnas.92.17.7627; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; ELLIS V, 1987, J BIOL CHEM, V262, P14998; Gong LH, 2015, J BIOL CHEM, V290, P25795, DOI 10.1074/jbc.M115.677567; GRONDAHLHANSEN J, 1987, J INVEST DERMATOL, V88, P28, DOI 10.1111/1523-1747.ep12464827; Harms MJ, 2013, NAT REV GENET, V14, P559, DOI 10.1038/nrg3540; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hong ZB, 2016, J BIOL CHEM, V291, P14340, DOI 10.1074/jbc.M115.707240; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Ibarra CA, 2004, J BIOL CHEM, V279, P3643, DOI 10.1074/jbc.M310601200; Im H, 2000, PROTEIN SCI, V9, P934, DOI 10.1110/ps.9.5.934; Jendroszek A, 2017, THROMB HAEMOSTASIS, V117, P1688, DOI 10.1160/TH17-02-0102; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kaslik G, 1997, BIOCHEMISTRY-US, V36, P5455, DOI 10.1021/bi962931m; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Li W., 2015, NUCLEIC ACIDS RES, V43, pW58, DOI DOI 10.1093/nar/gkv316; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; MADISON EL, 1995, J BIOL CHEM, V270, P7558, DOI 10.1074/jbc.270.13.7558; Medynski D, 2007, PROTEIN EXPRES PURIF, V52, P395, DOI 10.1016/j.pep.2006.10.012; MILES LA, 1983, THROMB RES, V29, P407, DOI 10.1016/0049-3848(83)90244-X; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333; ROBBINS KC, 1973, J BIOL CHEM, V248, P7242; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; Tom R, 2008, COLD SPRING HARB PRO, V2008, P1, DOI DOI 10.1101/PDB.PR0T4977	40	2	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3794	3805		10.1074/jbc.RA118.005419	http://dx.doi.org/10.1074/jbc.RA118.005419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30651349	hybrid, Green Published			2022-12-28	WOS:000461853900039
J	Takaya, A; Takeda, H; Tashiro, S; Kawashima, H; Yamamoto, T				Takaya, Akiko; Takeda, Hikari; Tashiro, Shogo; Kawashima, Hiroto; Yamamoto, Tomoko			Chaperone-mediated secretion switching from early to middle substrates in the type III secretion system encoded by Salmonella pathogenicity island 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; type III secretion system (T3SS); protein secretion; protein assembly; protein folding; Salmonella enterica; virulence factor; effector protein; protein secretion switching; Salmonella pathogenicity island 2; SsaE; SsaH	NEEDLE PROTEIN YSCF; ESCHERICHIA-COLI; COMPLEX; LENGTH; SPECIFICITY; IDENTIFICATION; VIRULENCE; EXPORT; GENES; TYPHIMURIUM	The bacterial type III secretion system (T3SS) delivers virulence proteins, called effectors, into eukaryotic cells. T3SS comprises a transmembrane secretion apparatus and a complex network of specialized chaperones that target protein substrates to this secretion apparatus. However, the regulation of secretion switching from early (needle and inner rod) to middle (tip/filament and translocators) substrates is incompletely understood. Here, we investigated chaperone-mediated secretion switching from early to middle substrates in the T3SS encoded by Salmonella pathogenicity island 2 (SPI2), essential for systemic infection. Our findings revealed that the protein encoded by ssaH regulates the secretion of an inner rod and early substrate, SsaI. Structural modeling revealed that SsaH is structurally similar to class III chaperones, known to associate with proteins in various pathogenic bacteria. The SPI2 protein SsaE was identified as a class V chaperone homolog and partner of SsaH. A pulldown analysis disclosed that SsaH and SsaE form a heterodimer, which interacted with another early substrate, the needle protein SsaG. Moreover, SsaE also helped stabilize SsaH and a middle substrate, SseB. We also found that SsaE regulates cellular SsaH levels to translocate the early substrates SsaG and SsaI and then promotes the translocation of SseB by stabilizing it. In summary, our results indicate that the class III chaperone SsaH facilitates SsaI secretion, and a heterodimer of SsaH and the type V chaperone SsaE then switches secretion to SsaG. This is the first report of a chaperone system that regulates both early and middle substrates during substrate switching for T3SS assembly.	[Takaya, Akiko; Takeda, Hikari; Tashiro, Shogo; Kawashima, Hiroto] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Microbiol & Immunol, Chiba 2608675, Japan; [Yamamoto, Tomoko] Chiba Univ, Med Mycol Res Ctr, Chiba 2608673, Japan	Chiba University; Chiba University	Takaya, A (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Microbiol & Immunol, Chiba 2608675, Japan.	akiko@faculty.chiba-u.jp	Takaya, Akiko/H-2769-2017	Takaya, Akiko/0000-0003-1726-7150	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants [16K15272, 18K07102]; Institute for Global Prominent Research, Chiba University	Japan Society for the Promotion of Science (JSPS) KAKENHI Grants; Institute for Global Prominent Research, Chiba University	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 16K15272 and 18K07102 (to A. T.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Institute for Global Prominent Research, Chiba University.	Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x; Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Allison SE, 2014, J BIOL CHEM, V289, P23734, DOI 10.1074/jbc.M114.578476; Bergeron JRC, 2016, J BIOL CHEM, V291, P1676, DOI 10.1074/jbc.M115.684423; Betts HJ, 2008, J BACTERIOL, V190, P1680, DOI 10.1128/JB.01671-07; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Cao SY, 2017, J BIOL CHEM, V292, P5488, DOI 10.1074/jbc.M116.743591; Chatterjee C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019208; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Darboe N, 2006, PROTEIN SCI, V15, P543, DOI 10.1110/ps.051733506; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day JB, 2000, INFECT IMMUN, V68, P6466, DOI 10.1128/IAI.68.11.6466-6471.2000; Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20; Diepold A, 2011, MOL MICROBIOL, V82, P502, DOI 10.1111/j.1365-2958.2011.07830.x; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Feria JVM, 2015, MBIO, V6, DOI 10.1128/mBio.01459-15; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; GULIG PA, 1987, INFECT IMMUN, V55, P2891, DOI 10.1128/IAI.55.12.2891-2901.1987; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Ho O, 2017, J BIOL CHEM, V292, P3299, DOI 10.1074/jbc.M116.770255; Izore T, 2011, STRUCTURE, V19, P603, DOI 10.1016/j.str.2011.03.015; Jennings E, 2017, CELL HOST MICROBE, V22, P217, DOI 10.1016/j.chom.2017.07.009; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Klein JR, 2001, INFECT IMMUN, V69, P737, DOI 10.1128/IAI.69.2.737-743.2001; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lefebre MD, 2014, P NATL ACAD SCI USA, V111, P817, DOI 10.1073/pnas.1319698111; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Miki T, 2009, J BACTERIOL, V191, P6843, DOI 10.1128/JB.00863-09; Feria JM, 2012, J BACTERIOL, V194, P6029, DOI 10.1128/JB.01215-12; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Phan J, 2005, PROTEIN SCI, V14, P2759, DOI 10.1110/ps.051706105; Portaliou AG, 2016, TRENDS BIOCHEM SCI, V41, P175, DOI 10.1016/j.tibs.2015.09.005; Quinaud M, 2005, J BIOL CHEM, V280, P36293, DOI 10.1074/jbc.M508089200; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Sal-Man N, 2013, J BACTERIOL, V195, P2481, DOI 10.1128/JB.00118-13; Souza CD, 2018, MICROBIOL-SGM, V164, P338, DOI 10.1099/mic.0.000610; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Tan YW, 2008, PROTEIN SCI, V17, P1748, DOI 10.1110/ps.036798.108; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wilharm G, 2007, INT J MED MICROBIOL, V297, P27, DOI 10.1016/j.ijmm.2006.10.003; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Yoshida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094347; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	53	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3783	3793		10.1074/jbc.RA118.005072	http://dx.doi.org/10.1074/jbc.RA118.005072			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30651351	Green Published, hybrid			2022-12-28	WOS:000461853900038
J	Chiu, J; Hogg, PJ				Chiu, Joyce; Hogg, Philip J.			Allosteric disulfides: Sophisticated molecular structures enabling flexible protein regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						disulfide; protein chemistry; protein conformation; protein dynamic; protein disulfide isomerase; drug discovery; oxidation-reduction (redox); post-translational modification; protein chemical modification; thiol; allosteric; cysteine; cystine; disulfide bond; oxidoreductase	TISSUE TRANSGLUTAMINASE; THROMBUS FORMATION; GROWTH-FACTOR; REDOX-SWITCH; PDI FAMILY; ISOMERASE; PLATELET; REDUCTION; BONDS; IDENTIFICATION	Protein disulfide bonds link pairs of cysteine residues in polypeptide chains. Many of these bonds serve a purely structural or energetic role, but a growing subset of cleavable disulfide bonds has been shown to control the function of the mature protein in which they reside. These allosteric disulfides and the factors that cleave these bonds are being identified across biological systems and life forms and have been shown to control hemostasis, the immune response, and viral infection in mammals. The discovery of these functional disulfides and a rationale for their facile nature has been aided by the emergence of a conformational signature for allosteric bonds. This post-translational modification mostly occurs extracellularly, making these chemical events prime drug targets. Indeed, a membrane-impermeable inhibitor of one of the cleaving factors is currently being trialed as an antithrombotic agent in cancer patients. Allosteric disulfides are firmly established as a sophisticated means by which a protein's shape and function can be altered; however, the full scope of this biological regulation will not be realized without new tools and techniques to study this regulation and innovative ways of targeting it.	[Chiu, Joyce; Hogg, Philip J.] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney Med Sch, Centenary Inst, Camperdown, NSW 2006, Australia	University of Sydney; Centenary Institute	Hogg, PJ (corresponding author), Univ Sydney, Charles Perkins Ctr, ACRF Centenary Canc Res Ctr, Level 4 West,Educ & Res Hub D17, Camperdown, NSW 2006, Australia.	phil.hogg@sydney.edu.au	Chiu, Joyce/H-7772-2017	Chiu, Joyce/0000-0001-8910-8664; Hogg, Philip/0000-0001-6486-2863	National Health and Medical Research Council of Australia; Helen and Robert Ellis postdoctoral fellowship from the Sydney Medical School Foundation; Tony Basten postdoctoral fellowship from the Sydney Medical School Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Helen and Robert Ellis postdoctoral fellowship from the Sydney Medical School Foundation; Tony Basten postdoctoral fellowship from the Sydney Medical School Foundation	This work was supported by the National Health and Medical Research Council of Australia (to P. J. H.), Helen and Robert Ellis postdoctoral fellowship, and Tony Basten postdoctoral fellowship from the Sydney Medical School Foundation (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Andersen JF, 1997, BIOCHEMISTRY-US, V36, P13979, DOI 10.1021/bi971004s; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Auwerx J, 2009, INT J BIOCHEM CELL B, V41, P1269, DOI 10.1016/j.biocel.2008.10.031; Azimi I, 2010, J BIOL CHEM, V285, P40072, DOI 10.1074/jbc.M110.185371; Baldus IB, 2012, BIOPHYS J, V102, P622, DOI 10.1016/j.bpj.2011.12.039; Banerji S, 2016, J BIOL CHEM, V291, P25004, DOI 10.1074/jbc.M116.736926; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Bekendam RH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12579; Bowley SR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14151; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brooks DJ, 2002, MOL BIOL EVOL, V19, P1645, DOI 10.1093/oxfordjournals.molbev.a003988; Butera D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq1477; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Butera D, 2014, J BIOL CHEM, V289, P2992, DOI 10.1074/jbc.M113.539924; Cerutti N, 2010, J BIOL CHEM, V285, P25743, DOI 10.1074/jbc.M110.144121; Chen VM, 2006, BIOCHEMISTRY-US, V45, P12020, DOI 10.1021/bi061271a; Chiu J, 2014, J BIOL CHEM, V289, P15035, DOI 10.1074/jbc.M114.554253; Chiu J, 2014, BIOCHEMISTRY-US, V53, P7, DOI 10.1021/bi401518b; Chmura AJ, 2001, P NATL ACAD SCI USA, V98, P8480, DOI 10.1073/pnas.151260298; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Churchfield LA, 2016, J AM CHEM SOC, V138, P13163, DOI 10.1021/jacs.6b08458; Cook KM, 2013, J BIOL CHEM, V288, P34920, DOI 10.1074/jbc.M113.523506; Creighton TE, 1996, FASEB J, V10, P110, DOI 10.1096/fasebj.10.1.8566531; CREIGHTON TE, 1979, J MOL BIOL, V129, P411, DOI 10.1016/0022-2836(79)90504-7; CREIGHTON TE, 1977, J MOL BIOL, V113, P329, DOI 10.1016/0022-2836(77)90145-0; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Flaumenhaft R, 2016, BLOOD, V128, P893, DOI 10.1182/blood-2016-04-636456; FRECH C, 1995, J MOL BIOL, V251, P135, DOI 10.1006/jmbi.1995.0421; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Giannakopoulos B, 2012, J AUTOIMMUN, V39, P121, DOI 10.1016/j.jaut.2012.05.005; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Gonzalez-Perez P, 2015, GENE, V566, P158, DOI 10.1016/j.gene.2015.04.035; Gopalan G, 2004, P NATL ACAD SCI USA, V101, P13945, DOI 10.1073/pnas.0405240101; Hogg PJ, 2013, NAT REV CANCER, V13, P425, DOI 10.1038/nrc3519; Hogg PJ, 1997, BIOCHEM J, V326, P709, DOI 10.1042/bj3260709; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Holbrook LM, 2012, J THROMB HAEMOST, V10, P278, DOI 10.1111/j.1538-7836.2011.04593.x; Holbrook LM, 2010, BRIT J HAEMATOL, V148, P627, DOI 10.1111/j.1365-2141.2009.07994.x; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hotchkiss KA, 1996, BIOCHEMISTRY-US, V35, P9761, DOI 10.1021/bi9603938; Hotchkiss KA, 1998, BBA-PROTEIN STRUCT M, V1388, P478, DOI 10.1016/S0167-4838(98)00211-8; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Jordan PA, 2005, BLOOD, V105, P1500, DOI 10.1182/blood-2004-02-0608; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Kellett-Clarke H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138137; Kim S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9410; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Kozlov G, 2010, J MOL BIOL, V401, P618, DOI 10.1016/j.jmb.2010.06.045; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Li J., 2018, CIRCULATION, V2018, DOI [10.1161/CIRCULATIONAHA.118.03632330586735, DOI 10.1161/CIRCULATI0NAHA.118.03632]; Li WJ, 2010, J AM CHEM SOC, V132, P16790, DOI 10.1021/ja104763q; Lin L, 2015, J BIOL CHEM, V290, P23543, DOI 10.1074/jbc.M115.666180; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Malojcic G, 2010, ANTIOXID REDOX SIGN, V13, P1247, DOI 10.1089/ars.2010.3119; Martin G, 2011, J BIOL CHEM, V286, P21706, DOI 10.1074/jbc.M111.232272; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Mauney CH, 2017, ANTIOXID REDOX SIGN, V27, P1317, DOI 10.1089/ars.2016.6888; Metcalfe C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110036; Mohammad A, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010030; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Nishii W, 2015, NAT CHEM BIOL, V11, P46, DOI 10.1038/nchembio.1688; Oka OBV, 2015, BIOCHEM J, V469, P279, DOI 10.1042/BJ20141423; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Pasquarello C, 2004, RAPID COMMUN MASS SP, V18, P117, DOI 10.1002/rcm.1286; Passam F, 2018, ELIFE, V7, DOI 10.7554/eLife.34843; Passam FH, 2015, BLOOD, V125, P2276, DOI 10.1182/blood-2013-12-547208; Pijning AE, 2018, CHEM BIO, V9, P152; Pijning AE, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171058; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Plugis NM, 2018, P NATL ACAD SCI USA, V115, P8781, DOI 10.1073/pnas.1805288115; Plugis NM, 2017, J BIOL CHEM, V292, P2000, DOI 10.1074/jbc.M116.767988; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; Reiser K, 2012, INT J BIOCHEM CELL B, V44, P556, DOI 10.1016/j.biocel.2011.12.015; Sagong HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42318; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Sobierajska K, 2014, J BIOL CHEM, V289, P5758, DOI 10.1074/jbc.M113.479477; SPEZIALE MV, 1990, J BIOL CHEM, V265, P17859; STALEY JP, 1994, PROTEIN SCI, V3, P1822, DOI 10.1002/pro.5560031021; Stopa JD, 2017, J BIOL CHEM, V292, P9063, DOI 10.1074/jbc.M116.771832; Stopa JD, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89373; SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Swiatkowska M, 2010, J BIOL CHEM, V285, P29874, DOI 10.1074/jbc.M109.092486; VANMIERLO CPM, 1994, J MOL BIOL, V235, P1044, DOI 10.1006/jmbi.1994.1056; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Woehlbier U, 2016, EMBO J, V35, P845, DOI 10.15252/embj.201592224; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Wong JWH, 2011, MOL BIOL EVOL, V28, P327, DOI 10.1093/molbev/msq194; Wouters MA, 2004, BIOESSAYS, V26, P73, DOI 10.1002/bies.10413; Yi MC, 2018, J BIOL CHEM, V293, P2640, DOI 10.1074/jbc.RA117.001382; Zhao ZH, 2018, MATH PROBL ENG, V4, P1; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; Zhou BF, 2017, BIOPHYS J, V112, P78, DOI 10.1016/j.bpj.2016.12.003; Zhou BF, 2014, BIOPHYS J, V107, P672, DOI 10.1016/j.bpj.2014.06.025; Zhou JS, 2017, BLOOD, V130, P817, DOI 10.1182/blood-2016-12-755587	110	59	59	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2949	2960		10.1074/jbc.REV118.005604	http://dx.doi.org/10.1074/jbc.REV118.005604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30635401	Green Published, hybrid			2022-12-28	WOS:000459601600033
J	Shen, K; Valenstein, ML; Gu, X; Sabatini, DM				Shen, Kuang; Valenstein, Max L.; Gu, Xin; Sabatini, David M.			Arg-78 of Nprl2 catalyzes GATOR1-stimulated GTP hydrolysis by the Rag GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR complex (mTORC); GATOR1 (GTPase-activating protein (GAP) activity toward Rags-1); Rag GTPase; GTPase activating protein (GAP); enzyme mechanism; amino acid; arginine finger; Nprl2 (NPR2-like GATOR1 complex subunit); nutrient sensing	BINDING PROTEINS; CELL-GROWTH; RHEB; EPILEPSY; COMPLEX	mTOR complex 1 (mTORC1) is a major regulator of cell growth and proliferation that coordinates nutrient inputs with anabolic and catabolic processes. Amino acid signals are transmitted to mTORC1 through the Rag GTPases, which directly recruit mTORC1 onto the lysosomal surface, its site of activation. The Rag GTPase heterodimer has a unique architecture that consists of two GTPase subunits, RagA or RagB bound to RagC or RagD. Their nucleotide-loading states are strictly controlled by several lysosomal or cytosolic protein complexes that directly detect and transmit the amino acid signals. GATOR1 (GTPase-activating protein (GAP) activity toward Rags-1), a negative regulator of the cytosolic branch of the nutrient-sensing pathway, comprises three subunits, Depdc5 (DEP domain-containing protein 5), Nprl2 (NPR2-like GATOR1 complex subunit), and Nprl3 (NPR3-like GATOR1 complex subunit), and is a GAP for RagA. GATOR1 binds the Rag GTPases via two modes: an inhibitory mode that holds the Rag GTPase heterodimer and has previously been captured by structural determination, and a GAP mode that stimulates GTP hydrolysis by RagA but remains structurally elusive. Here, using site-directed mutagenesis, GTP hydrolysis assays, coimmunoprecipitation experiments, and structural analysis, we probed the GAP mode and found that a critical residue on Nprl2, Arg-78, is the arginine finger that carries out GATOR1's GAP function. Substitutions of this arginine residue rendered mTORC1 signaling insensitive to amino acid starvation and are found frequently in cancers such as glioblastoma. Our results reveal the biochemical bases of mTORC1 inactivation through the GATOR1 complex.	[Shen, Kuang; Valenstein, Max L.; Gu, Xin] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shen, Kuang; Valenstein, Max L.; Gu, Xin; Sabatini, David M.] MIT, Dept Biol, 455 Main St, Cambridge, MA 02142 USA; [Shen, Kuang; Valenstein, Max L.; Gu, Xin] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Shen, Kuang; Valenstein, Max L.; Gu, Xin] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Shen, Kuang; Valenstein, Max L.; Gu, Xin] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Sabatini, David M.] Howard Hughes Med Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Sabatini, DM (corresponding author), MIT, Dept Biol, 455 Main St, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 455 Main St, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		Valenstein, Max/0000-0001-7616-0148	National Institutes of Health [R01 CA103866, R01 CA129105, R37 AI047389]; Department of Defense [W81XWH-15-1-0230]; Lustgarten Foundation; National Institutes of Health Fellowship [F30 CA228229, T32 GM007753]; Ludwig Center for Molecular Oncology; Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE [R01CA103866, F30CA228229, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Lustgarten Foundation; National Institutes of Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center for Molecular Oncology; Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 CA103866, R01 CA129105, and R37 AI047389, Department of Defense Grant W81XWH-15-1-0230, and the Lustgarten Foundation (to D. M. S.); National Institutes of Health Fellowship Grants F30 CA228229 and T32 GM007753 (to M. L. V.); a fellowship from the Ludwig Center for Molecular Oncology (to X. G.); and a fellowship from the Life Sciences Research Foundation (to K. S.), where he is a Pfizer Fellow. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Baldassari S, 2019, GENET MED, V21, P398, DOI 10.1038/s41436-018-0060-2; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Baulac S, 2015, ANN NEUROL, V77, P675, DOI 10.1002/ana.24368; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Hirose E, 1998, J CELL SCI, V111, P11; Mossmann D, 2018, NAT REV CANCER, V18, P744, DOI 10.1038/s41568-018-0074-8; Nakashima N, 1996, J CELL SCI, V109, P2311; Panchaud N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004112; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Shen K, 2018, P NATL ACAD SCI USA, V115, P9545, DOI 10.1073/pnas.1811727115; Shen K, 2018, NATURE, V556, P64, DOI 10.1038/nature26158; Shen K, 2017, MOL CELL, V68, P552, DOI 10.1016/j.molcel.2017.09.026; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Yuskaitis CJ, 2018, NEUROBIOL DIS, V111, P91, DOI 10.1016/j.nbd.2017.12.010; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	23	35	36	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2970	2975		10.1074/jbc.AC119.007382	http://dx.doi.org/10.1074/jbc.AC119.007382			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30651352	hybrid, Green Published			2022-12-28	WOS:000459601600035
J	Punch, EK; Hover, S; Blest, HTW; Fuller, J; Hewson, R; Fontana, J; Mankouri, J; Barr, JN				Punch, Emma K.; Hover, Samantha; Blest, Henry T. W.; Fuller, Jack; Hewson, Roger; Fontana, Juan; Mankouri, Jamel; Barr, John N.			Potassium is a trigger for conformational change in the fusion spike of an enveloped RNA virus (vol 293, pg 9937, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction												J.Fontana@leeds.ac.uk; J.Mankouri@leeds.ac.uk						Punch EK, 2018, J BIOL CHEM, V293, P9937, DOI 10.1074/jbc.RA118.002494	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2579	2579		10.1074/jbc.AAC119.007718	http://dx.doi.org/10.1074/jbc.AAC119.007718			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30765512	hybrid, Green Published			2022-12-28	WOS:000458895400031
J	Gottesfeld, JM				Gottesfeld, Joel M.			Milestones in transcription and chromatin published in the Journal of Biological Chemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						RNA polymerase; transcription; chromatin; nucleosome; epigenetics; transcription factor; histone acetyltransferase; nucleoprotein; TATA-binding protein	RNA-POLYMERASE-II; TATA-BINDING PROTEIN; CARBOXYL-TERMINAL DOMAIN; RIBONUCLEIC-ACID POLYMERASE; IN-VITRO; HISTONE H3; SUBUNIT STRUCTURE; MULTIPLE FORMS; PROMOTER RECOGNITION; PARTIAL-PURIFICATION	During Herbert Tabor's tenure as Editor-in-Chief from 1971 to 2010, JBC has published many seminal papers in the fields of chromatin structure, epigenetics, and regulation of transcription in eukaryotes. As of this writing, more than 21,000 studies on gene transcription at the molecular level have been published in JBC since 1971. This brief review will attempt to highlight some of these ground-breaking discoveries and show how early studies published in JBC have influenced current research. Papers published in the Journal have reported the initial discovery of multiple forms of RNA polymerase in eukaryotes, identification and purification of essential components of the transcription machinery, and identification and mechanistic characterization of various transcriptional activators and repressors and include studies on chromatin structure and post-translational modifications of the histone proteins. The large body of literature published in the Journal has inspired current research on how chromatin organization and epigenetics impact regulation of gene expression.	[Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Gottesfeld, Joel M.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Gottesfeld, JM (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.; Gottesfeld, JM (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	joelg@scripps.edu			National Institutes of Health [5R01-NS062856, 5R01-EY026490, 1R01-EY029166]; BioMarin Pharmaceutical; NATIONAL EYE INSTITUTE [R01EY029166, R01EY026490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioMarin Pharmaceutical(Johnson & Johnson); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants 5R01-NS062856, 5R01-EY026490, and 1R01-EY029166 and by BioMarin Pharmaceutical. This JBC Review is part of a collection honoring Herbert Tabor on the occasion of his 100th birthday. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott DW, 2001, J BIOL CHEM, V276, P41945, DOI 10.1074/jbc.M108217200; Ali M, 2015, J BIOL CHEM, V290, P22919, DOI 10.1074/jbc.M115.669333; Allis CD, 2015, J BIOL CHEM, V290, P15904, DOI 10.1074/jbc.X115.663229; Altaf M, 2010, J BIOL CHEM, V285, P15966, DOI 10.1074/jbc.M110.117069; An WJ, 2003, J BIOL CHEM, V278, P1504, DOI 10.1074/jbc.M209355200; Appikonda S, 2018, J BIOL CHEM, V293, P7476, DOI 10.1074/jbc.RA118.002233; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; BIEKER JJ, 1986, J BIOL CHEM, V261, P9732; BIEKER JJ, 1985, CELL, V40, P119, DOI 10.1016/0092-8674(85)90315-0; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; Brehove M, 2015, J BIOL CHEM, V290, P22612, DOI 10.1074/jbc.M115.661363; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; CADENA DL, 1987, J BIOL CHEM, V262, P12468; CAREY MF, 1986, J BIOL CHEM, V261, P4309; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; CHAMBERS RS, 1994, J BIOL CHEM, V269, P26243; CHAMBON P, 1975, ANNU REV BIOCHEM, V44, P613, DOI 10.1146/annurev.bi.44.070175.003145; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; COLEMAN RA, 1995, J BIOL CHEM, V270, P13850, DOI 10.1074/jbc.270.23.13850; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; Coussens NP, 2018, J BIOL CHEM, V293, P13750, DOI 10.1074/jbc.RA118.004274; Dhall A, 2014, J BIOL CHEM, V289, P33827, DOI 10.1074/jbc.M114.591644; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Feigerle JT, 2016, J BIOL CHEM, V291, P22721, DOI 10.1074/jbc.M116.751107; Fishburn J, 2016, J BIOL CHEM, V291, P13040, DOI 10.1074/jbc.M116.724583; FITZGERALD PC, 1985, J BIOL CHEM, V260, P5318; FLANAGAN PM, 1990, J BIOL CHEM, V265, P11105; FLORES O, 1992, J BIOL CHEM, V267, P2786; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Friedrich JK, 2005, J BIOL CHEM, V280, P29551, DOI 10.1074/jbc.M501595200; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Furukawa T, 2000, J BIOL CHEM, V275, P29847, DOI 10.1074/jbc.M002989200; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; Gates LA, 2017, J BIOL CHEM, V292, P14456, DOI 10.1074/jbc.M117.802074; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Gustafsson CM, 1998, J BIOL CHEM, V273, P30851, DOI 10.1074/jbc.273.47.30851; HANSEN JC, 1991, J BIOL CHEM, V266, P4276; Harper TM, 2018, J BIOL CHEM, V293, P13778, DOI 10.1074/jbc.R117.794438; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; IMAI BS, 1986, J BIOL CHEM, V261, P8784; IMBALZANO AN, 1994, J BIOL CHEM, V269, P8280; JAEHNING JA, 1977, J BIOL CHEM, V252, P8753; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jiang W, 2000, J BIOL CHEM, V275, P39819, DOI 10.1074/jbc.C000713200; Jung M, 2014, J BIOL CHEM, V289, P9304, DOI 10.1074/jbc.M113.523019; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Khuong MT, 2017, J BIOL CHEM, V292, P19478, DOI 10.1074/jbc.M117.815365; KILLEEN M, 1992, J BIOL CHEM, V267, P9463; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Librizzi MD, 1998, J BIOL CHEM, V273, P4563, DOI 10.1074/jbc.273.8.4563; Liu JX, 2013, J BIOL CHEM, V288, P10890, DOI 10.1074/jbc.M113.460238; Lomberk G, 2012, J BIOL CHEM, V287, P13026, DOI 10.1074/jbc.M112.342634; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; MARVIN KW, 1990, J BIOL CHEM, V265, P19839; MATSUI T, 1980, J BIOL CHEM, V255, P1992; McCullough LL, 2018, J BIOL CHEM, V293, P6121, DOI 10.1074/jbc.RA117.000199; Mizuguchi G, 2001, J BIOL CHEM, V276, P14773, DOI 10.1074/jbc.M100125200; Moritz LE, 2018, J BIOL CHEM, V293, P13805, DOI 10.1074/jbc.R117.800367; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; PARVIN JD, 1994, J BIOL CHEM, V269, P18414; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; PAYNE JM, 1993, J BIOL CHEM, V268, P80; Pazin MJ, 1998, J BIOL CHEM, V273, P34653, DOI 10.1074/jbc.273.51.34653; PERRY M, 1981, J BIOL CHEM, V256, P3313; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; POON D, 1993, J BIOL CHEM, V268, P15325; RANISH JA, 1991, J BIOL CHEM, V266, P19320; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; RIGGS DL, 1995, J BIOL CHEM, V270, P6205, DOI 10.1074/jbc.270.11.6205; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; ROEDER RG, 1974, J BIOL CHEM, V249, P241; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; SCHNAPP A, 1991, J BIOL CHEM, V266, P24588; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; SCHWARTZ LB, 1975, J BIOL CHEM, V250, P3221; SCHWARTZ LB, 1974, J BIOL CHEM, V249, P5898; SCHWARTZ LB, 1974, J BIOL CHEM, V249, P5889; SEGALL J, 1980, J BIOL CHEM, V255, P1986; Sekine S, 2012, CURR OPIN STRUC BIOL, V22, P110, DOI 10.1016/j.sbi.2011.11.006; SERIZAWA H, 1994, J BIOL CHEM, V269, P20750; SKLAR VEF, 1976, J BIOL CHEM, V251, P1064; SOBEL RE, 1994, J BIOL CHEM, V269, P18576; SVEJSTRUP JQ, 1994, J BIOL CHEM, V269, P28044; SWANSON ME, 1983, J BIOL CHEM, V258, P3242; Szerlong HJ, 2010, J BIOL CHEM, V285, P31954, DOI 10.1074/jbc.M110.148718; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2003, J BIOL CHEM, V278, P43897, DOI 10.1074/jbc.C300417200; TRAVIS GH, 1984, J BIOL CHEM, V259, P4406; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Urvalek AM, 2014, J BIOL CHEM, V289, P19519, DOI 10.1074/jbc.M114.556555; WAMPLER SL, 1990, J BIOL CHEM, V265, P21223; Wang J, 2017, J BIOL CHEM, V292, P11873, DOI 10.1074/jbc.M116.770412; WEIL PA, 1979, J BIOL CHEM, V254, P6163; WHITE RJ, 1992, TRENDS GENET, V8, P284, DOI 10.1016/0168-9525(92)90255-3; WIKTOROWICZ JE, 1982, J BIOL CHEM, V257, P2893; WILKINSON JK, 1982, J BIOL CHEM, V257, P4375; WOOD WI, 1982, J BIOL CHEM, V257, P7730; Wu C, 1997, J BIOL CHEM, V272, P28171, DOI 10.1074/jbc.272.45.28171; Wu SY, 2001, J BIOL CHEM, V276, P34235, DOI 10.1074/jbc.M102463200; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047	124	3	3	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1652	1660		10.1074/jbc.TM118.004162	http://dx.doi.org/10.1074/jbc.TM118.004162			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710013	Green Published, hybrid			2022-12-28	WOS:000457879200024
J	Wang, DD; Zhang, ZM; Cui, S; Zhao, YC; Craft, S; Fikrig, E; You, FP				Wang, Dandan; Zhang, Zeming; Cui, Shuang; Zhao, Yingchi; Craft, Samuel; Fikrig, Erol; You, Fuping			ELF4 facilitates innate host defenses against Plasmodium by activating transcription of Pf4 and Ppbp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						malaria; mouse; Plasmodium; innate immunity; transcription regulation; ELF4; PF4; PPBP	PATTERN-RECOGNITION RECEPTORS; GENOME-WIDE ANALYSIS; I INTERFERON; MALARIA; QUIESCENCE; EXPRESSION; FALCIPARUM; PRODUCTS; IMMUNITY; CELLS	Platelet factor 4 (PF4) is an anti-Plasmodium component of platelets. It is expressed in megakaryocytes and released from platelets following infection with Plasmodium. Innate immunity is crucial for the host anti-Plasmodium response, in which type I interferon plays an important role. Whether there is cross-talk between innate immune signaling and the production of anti-Plasmodium defense peptides is unknown. Here we demonstrate that E74, like ETS transcription factor 4 (ELF4), a type I interferon activator, can help protect the host from Plasmodium yoelii infection. Mechanically, ELF4 binds to the promoter of genes of two C-X-C chemokines, Pf4 and pro-platelet basic protein (Ppbp), initiating the transcription of these two genes, thereby enhancing PF4-mediated killing of parasites from infected erythrocytes. Elf4(-/-) mice are much more susceptible to Plasmodium infection than WT littermates. The expression level of Pf4 and Ppbp in megakaryocytes from Elf4(-/-) mice is much lower than in those from control animals, resulting in increased parasitemia. In conclusion, our study uncovered a distinct role of ELF4, an innate immune molecule, in host defense against malaria.	[Wang, Dandan; Zhang, Zeming; Zhao, Yingchi; You, Fuping] Peking Univ, Hlth Sci Ctr, Dept Immunol, Inst Syst Biomed, Beijing 100191, Peoples R China; [Wang, Dandan; Zhang, Zeming; Zhao, Yingchi; You, Fuping] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing Key Lab Tumor Syst Biol, Beijing 100191, Peoples R China; [Cui, Shuang] Peking Univ, Neurosci Res Inst, Key Lab Neurosci, Beijing 100191, Peoples R China; [Cui, Shuang] Minist Educ, Natl Hlth & Family Planning Commiss Peoples Repub, Beijing 100083, Peoples R China; [Craft, Samuel; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, 333 Cedar St, New Haven, CT 06520 USA; [Craft, Samuel] RI Hosp, Hasbro Childrens Hosp, Dept Emergency Med, Providence, RI 02903 USA	Peking University; Peking University; Peking University; Yale University; Hasbro Children's Hospital	You, FP (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Immunol, Inst Syst Biomed, Beijing 100191, Peoples R China.; You, FP (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing Key Lab Tumor Syst Biol, Beijing 100191, Peoples R China.	erol.fikrig@yale.edu; fupingyou@hsc.pku.edu.cn		wang, Dandan/0000-0001-8643-2514	National Natural Science Foundation of China [31570891, 31872736]; National Key Research and Development Program of China [2016YFA0500302]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Natural Science Foundation of China Grant 31570891 and 31872736 National Key Research and Development Program of China Grant 2016YFA0500302. The authors declare that they have no conflicts of interest with the contents of this article.	Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338; Brouwers J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064850; Brown AJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01248; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fernandez-Arias C, 2016, CELL HOST MICROBE, V19, P194, DOI 10.1016/j.chom.2016.01.009; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Head MG, 2017, LANCET GLOB HEALTH, V5, pE772, DOI 10.1016/S2214-109X(17)30245-0; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Krijgsveld J, 2000, J BIOL CHEM, V275, P20374, DOI 10.1074/jbc.275.27.20374; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Liehl P, 2014, NAT MED, V20, P47, DOI 10.1038/nm.3424; Love MS, 2012, CELL HOST MICROBE, V12, P815, DOI 10.1016/j.chom.2012.10.017; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Okada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024837; Palomo J, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12502; RAVID K, 1991, P NATL ACAD SCI USA, V88, P1521, DOI 10.1073/pnas.88.4.1521; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Souza MC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/168937; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; Suico MA, 2017, J MOL CELL BIOL, V9, P168, DOI 10.1093/jmcb/mjw051; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unver N, 2015, CYTOKINE, V75, P330, DOI 10.1016/j.cyto.2015.07.018; Vigario AM, 2001, BLOOD, V97, P3966, DOI 10.1182/blood.V97.12.3966; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; World Health Organization, 2015, GUID TREATM MAL, Vthird; Wu J, 2015, CELL REP, V12, P661, DOI 10.1016/j.celrep.2015.06.058; Xu LL, 2013, AM J TRANSL RES, V5, P235; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756; Yu X, 2016, IMMUNITY, V45, P1093, DOI 10.1016/j.immuni.2016.10.001; Zhang CY, 1997, J BIOL CHEM, V272, P26236, DOI 10.1074/jbc.272.42.26236; Zhang CY, 2001, BLOOD, V98, P610, DOI 10.1182/blood.V98.3.610	38	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7787	7796		10.1074/jbc.RA118.006321	http://dx.doi.org/10.1074/jbc.RA118.006321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30898878	Green Published, hybrid			2022-12-28	WOS:000470153300021
J	Jones, JL; Hofmann, KB; Cowan, AT; Temiakov, D; Cramer, P; Anikin, M				Jones, Julia L.; Hofmann, Katharina B.; Cowan, Andrew T.; Temiakov, Dmitry; Cramer, Patrick; Anikin, Michael			Yeast mitochondrial protein Pet111p binds directly to two distinct targets in COX2 mRNA, suggesting a mechanism of translational activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; cytochrome c oxidase (Complex IV); gene expression; RNA-protein interaction; translation regulation; PAR-CLIP; pentatricopeptide repeat (PPR) protein; respiratory complex; translational activator	5-UNTRANSLATED LEADER; NUCLEOTIDE-SEQUENCE; INNER MEMBRANE; ORGANIZATION; EXPRESSION	The genes in mitochondrial DNA code for essential subunits of the respiratory chain complexes. In yeast, expression of mitochondrial genes is controlled by a group of gene-specific translational activators encoded in the nucleus. These factors appear to be part of a regulatory system that enables concerted expression of the necessary genes from both nuclear and mitochondrial genomes to produce functional respiratory complexes. Many of the translational activators are believed to act on the 5-untranslated regions of target mRNAs, but the molecular mechanisms involved in this regulation remain obscure. In this study, we used a combination of in vivo and in vitro analyses to characterize the interactions of one of these translational activators, the pentatricopeptide repeat protein Pet111p, with its presumed target, COX2 mRNA, which encodes subunit II of cytochrome c oxidase. Using photoactivatable ribonucleoside-enhanced cross-linking and immunoprecipitation analysis, we found that Pet111p binds directly and specifically to a 5-end proximal region of the COX2 transcript. Further, we applied in vitro RNase footprinting and mapped two binding targets of the protein, of which one is located in the 5-untranslated leader and the other is within the coding sequence. Combined with the available genetic data, these results suggest a plausible mechanism of translational activation, in which binding of Pet111p may prevent inhibitory secondary structures from forming in the translation initiation region, thus rendering the mRNA available for interaction with the ribosome.	[Jones, Julia L.] Rowan Univ, Sch Osteopath Med, Grad Sch Biomed Sci, Grad Program Cell & Mol Biol, Stratford, NJ 08084 USA; [Jones, Julia L.; Cowan, Andrew T.; Anikin, Michael] Rowan Univ, Sch Osteopath Med, Dept Cell Biol & Neurosci, 42 East Laurel Rd,UDP 2200, Stratford, NJ 08084 USA; [Hofmann, Katharina B.; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany; [Temiakov, Dmitry] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Cowan, Andrew T.] Thomas Jefferson Univ Hosp, Dept Pharm, 111 South 11th St,Suite 2260, Philadelphia, PA 19107 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rowan University; Rowan University School of Osteopathic Medicine; Max Planck Society; Jefferson University; Jefferson University	Anikin, M (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Cell Biol & Neurosci, 42 East Laurel Rd,UDP 2200, Stratford, NJ 08084 USA.	anikinmi@rowan.edu		Hofmann, Katharina/0000-0002-0683-6277	New Jersey Health Foundation [PC127-13]; Rowan University Graduate School of Biomedical Sciences	New Jersey Health Foundation; Rowan University Graduate School of Biomedical Sciences	This work was supported by New Jersey Health Foundation Grant PC127-13 (to M.A.) and by the Rowan University Graduate School of Biomedical Sciences (to J.L.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Baejen C, 2014, MOL CELL, V55, P745, DOI 10.1016/j.molcel.2014.08.005; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bonnefoy N, 2001, MOL CELL BIOL, V21, P2359, DOI 10.1128/MCB.21.7.2359-2372.2001; CORUZZI G, 1981, J BIOL CHEM, V256, P2780; Costanzo MC, 2000, GENETICS, V154, P999; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunstan HM, 1997, GENETICS, V147, P87; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Green-Willms NS, 2001, J BIOL CHEM, V276, P6392, DOI 10.1074/jbc.M009856200; Henzel WJ, 2003, J AM SOC MASS SPECTR, V14, P931, DOI 10.1016/S1044-0305(03)00214-9; Herbert CJ, 2013, RNA BIOL, V10, P1477, DOI 10.4161/rna.25392; Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007; Kehrein K, 2015, CELL REP, V10, P843, DOI 10.1016/j.celrep.2015.01.012; Krause K, 2004, MOL BIOL CELL, V15, P2674, DOI 10.1091/mbc.E04-02-0126; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lipinski KA, 2011, MOL BIOL EVOL, V28, P2935, DOI 10.1093/molbev/msr120; MEADOR J, 1990, EUR J BIOCHEM, V187, P549, DOI 10.1111/j.1432-1033.1990.tb15336.x; MULERO JJ, 1993, MOL BIOL CELL, V4, P1327, DOI 10.1091/mbc.4.12.1327; MULERO JJ, 1993, GENETICS, V133, P509; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Nilsen Timothy W, 2014, Cold Spring Harb Protoc, V2014, P677, DOI 10.1101/pdb.prot080788; OSINGA KA, 1984, EMBO J, V3, P829, DOI 10.1002/j.1460-2075.1984.tb01892.x; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; PAPADOPOULOU B, 1990, EMBO J, V9, P4135, DOI 10.1002/j.1460-2075.1990.tb07636.x; POUTRE CG, 1987, GENETICS, V115, P637; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Richman TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11884; Sanchirico ME, 1998, EMBO J, V17, P5796, DOI 10.1093/emboj/17.19.5796; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Strecker V, 2016, BBA-MOL CELL RES, V1863, P1643, DOI 10.1016/j.bbamcr.2016.04.012; STRICK CA, 1987, MOL CELL BIOL, V7, P2728, DOI 10.1128/MCB.7.8.2728; Wiesenberger G, 1997, MOL CELL BIOL, V17, P2816, DOI 10.1128/MCB.17.5.2816; Williams EH, 2003, RNA, V9, P419, DOI 10.1261/rna.2182903	38	9	9	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7528	7536		10.1074/jbc.RA118.005355	http://dx.doi.org/10.1074/jbc.RA118.005355			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30910813	Green Published, hybrid			2022-12-28	WOS:000468402900035
J	Babinchak, WM; Haider, R; Dumm, BK; Sarkar, P; Surewicz, K; Choi, JK; Surewicz, WK				Babinchak, W. Michael; Haider, Raza; Dumm, Benjamin K.; Sarkar, Prottusha; Surewicz, Krystyna; Choi, Jin-Kyu; Surewicz, Witold K.			The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TAR DNA-binding protein 43 (TDP-43) (TARDBP); amyloid; protein aggregation; intrinsically disordered protein; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); neurodegeneration; fibrillation; liquid-liquid phase separation	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; C-TERMINAL FRAGMENTS; AMYLOID FIBRILS; ALS; DISEASE; INCLUSIONS; PEPTIDE; MECHANISMS	Pathological aggregation of the transactive response DNA-binding protein of 43 kDa (TDP-43) is associated with several neurodegenerative disorders, including ALS, frontotemporal dementia, chronic traumatic encephalopathy, and Alzheimer's disease. TDP-43 aggregation appears to be largely driven by its low-complexity domain (LCD), which also has a high propensity to undergo liquid-liquid phase separation (LLPS). However, the mechanism of TDP-43 LCD pathological aggregation and, most importantly, the relationship between the aggregation process and LLPS remains largely unknown. Here, we show that amyloid formation by the LCD is controlled by electrostatic repulsion. We also demonstrate that the liquid droplet environment strongly accelerates LCD fibrillation and that its aggregation under LLPS conditions involves several distinct events, culminating in rapid assembly of fibrillar aggregates that emanate from within mature liquid droplets. These combined results strongly suggest that LLPS may play a major role in pathological TDP-43 aggregation, contributing to pathogenesis in neurodegenerative diseases.	[Babinchak, W. Michael; Haider, Raza; Dumm, Benjamin K.; Sarkar, Prottusha; Surewicz, Krystyna; Choi, Jin-Kyu; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu		Dumm, Benjamin/0000-0001-8824-7160; Babinchak, William/0000-0002-8299-287X	National Institutes of Health [F30 AG059350, T32 NS077888, T32 GM 007250, P01 AI106705, R01 NS103848, RF1 AG061797]; National Institutes of Health Office of Research Infrastructure Programs [S10 OD024996]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077888, R01NS103848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG061797, F30AG059350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Office of Research Infrastructure Programs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants F30 AG059350 (to W. M. B.), T32 NS077888, T32 GM 007250, P01 AI106705 (to W. K. S.), R01 NS103848 (to W. K. S.), and RF1 AG061797 (to W. K. S.). Microscopy work was supported by National Institutes of Health Office of Research Infrastructure Programs Grant S10 OD024996. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afroz T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00062-0; Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Chang XL, 2016, MOL NEUROBIOL, V53, P3349, DOI 10.1007/s12035-015-9264-5; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chen YJ, 2019, J BIOL CHEM, V294, P3696, DOI 10.1074/jbc.RA118.006351; Choi KJ, 2018, BIOCHEMISTRY-US, V57, P6822, DOI 10.1021/acs.biochem.8b01051; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Elbaum-Garfinkle S, 2015, DEV CELL, V35, P531, DOI 10.1016/j.devcel.2015.11.014; Fatima M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0226-y; Francis DJ, 2012, APPL MAGN RESON, V43, P405, DOI 10.1007/s00723-012-0369-y; Guenther EL, 2018, NAT STRUCT MOL BIOL, V25, P463, DOI 10.1038/s41594-018-0064-2; Guo M, 2005, FEBS LETT, V579, P3574, DOI 10.1016/j.febslet.2005.05.036; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Jiang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23928; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Josephs KA, 2016, ACTA NEUROPATHOL, V131, P571, DOI 10.1007/s00401-016-1537-1; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Li HR, 2018, J BIOL CHEM, V293, P6090, DOI 10.1074/jbc.AC117.001037; Li HR, 2018, BBA-PROTEINS PROTEOM, V1866, P214, DOI 10.1016/j.bbapap.2017.10.001; Li Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7183; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu GCH, 2013, CHEM COMMUN, V49, P11212, DOI 10.1039/c3cc46762g; Liu-Yesucevitz L, 2014, J NEUROSCI, V34, P4167, DOI 10.1523/JNEUROSCI.2350-13.2014; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; McGurk L, 2018, BIOCHEMISTRY-US, V57, P6923, DOI 10.1021/acs.biochem.8b00910; McGurk L, 2018, MOL CELL, V71, P703, DOI 10.1016/j.molcel.2018.07.002; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mompean M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002447; Mompean M, 2016, FEBS J, V283, P1242, DOI 10.1111/febs.13651; Mompean M, 2014, ARCH BIOCHEM BIOPHYS, V545, P53, DOI 10.1016/j.abb.2014.01.007; Nelson PT, 2016, J NEUROPATH EXP NEUR, V75, P482, DOI 10.1093/jnen/nlw033; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Prasad A, 2018, BIOCHIMIE, V150, P76, DOI 10.1016/j.biochi.2018.05.003; Robinson JL, 2013, ACTA NEUROPATHOL, V125, P121, DOI 10.1007/s00401-012-1055-8; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Sekiguchi T, 2014, J NEUROL NEUROSUR PS, V85, P85, DOI 10.1136/jnnp-2013-305617; Shimonaka S, 2016, J BIOL CHEM, V291, P8896, DOI 10.1074/jbc.M115.713552; Smethurst P, 2015, NEUROPATH APPL NEURO, V41, P578, DOI 10.1111/nan.12206; St George-Hyslop P, 2018, BRAIN RES, V1693, P11, DOI 10.1016/j.brainres.2018.04.036; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Stoll S, 2007, BIOL MAGN RESON, V27, P299; Stsiapura VI, 2008, J PHYS CHEM B, V112, P15893, DOI 10.1021/jp805822c; Sun YL, 2017, BIOCHEMISTRY-US, V56, P809, DOI 10.1021/acs.biochem.6b01088; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Wang L, 2018, BIOCHEM BIOPH RES CO, V499, P189, DOI 10.1016/j.bbrc.2018.03.121; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wiesner D, 2018, EXP NEUROL, V299, P15, DOI 10.1016/j.expneurol.2017.09.011; Williams TL, 2015, ACS CHEM NEUROSCI, V6, P1972, DOI 10.1021/acschemneuro.5b00229; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhu L, 2014, HUM MOL GENET, V23, P6863, DOI 10.1093/hmg/ddu409; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	68	122	122	10	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6306	6317		10.1074/jbc.RA118.007222	http://dx.doi.org/10.1074/jbc.RA118.007222			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30814253	Green Published, hybrid			2022-12-28	WOS:000468402000009
J	Golob-Urbanc, A; Rajcevic, U; Strmsek, Z; Jerala, R				Golob-Urbanc, Anja; Rajcevic, Uros; Strmsek, Ziga; Jerala, Roman			Design of split superantigen fusion proteins for cancer immunotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; T cell; antibody engineering; protein chimera; protein engineering; protein splicing; cancer immunotherapy; split protein; superantigen; T cell activation	STAPHYLOCOCCAL-ENTEROTOXIN-A; NAPTUMOMAB ESTAFENATOX; ANTIBODY; THERAPY; AGENTS; SITES; LINE	Several antibody-targeting cancer immunotherapies have been developed based on T cell activation at the target cells. One of the most potent activators of T cells are bacterial superantigens, which bind to major histocompatibility complex class II on antigen-presenting cells and activate T cells through T cell receptor. Strong T cell activation is also one of the main weaknesses of this strategy as it may lead to systemic T cell activation. To overcome the limitation of conventional antibody-superantigen fusion proteins, we have split a superantigen into two fragments, individually inactive, until both fragments came into close proximity and reassembled into a biologically active form capable of activating T cell response. A screening method based on fusion between SEA and coiled-coil heterodimers was developed that enabled detection of functional split SEA designs. The split SEA design that demonstrated efficacy in fusion with coiled-coil dimer forming polypeptides was fused to a single chain antibody specific for tumor antigen CD20. This design selectively activated T cells by split SEA-scFv fusion binding to target cells.	[Golob-Urbanc, Anja; Strmsek, Ziga; Jerala, Roman] Natl Inst Chem, Dept Synthet Biol & Immunol, Hajdrihova 19, Ljubljana 1000, Slovenia; [Golob-Urbanc, Anja; Strmsek, Ziga] Univ Ljubljana, Grad Sch Biomed, Ljubljana 1000, Slovenia; [Rajcevic, Uros] Blood Transfus Ctr Slovenia, Dept Res & Dev, Slajmerjeva 6, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Dept Synthet Biol & Immunol, Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si	Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251	Slovenian Research Agency [P4-0176]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency Grant P4-0176 (to R. J.) and for the Ph.D. study (to A. G.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHMSEN L, 1995, EMBO J, V14, P2978, DOI 10.1002/j.1460-2075.1995.tb07300.x; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Baker MD, 2004, INT J MED MICROBIOL, V293, P529, DOI 10.1078/1438-4221-00298; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Brodin TN, 1998, ADV DRUG DELIVER REV, V31, P131, DOI 10.1016/S0169-409X(97)00097-5; Chen Y, 2009, PROTEIN SCI, V18, P399, DOI 10.1002/pro.42; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; DOHLSTEN M, 1991, P NATL ACAD SCI USA, V88, P9287, DOI 10.1073/pnas.88.20.9287; DOHLSTEN M, 1994, P NATL ACAD SCI USA, V91, P8945, DOI 10.1073/pnas.91.19.8945; DOHLSTEN M, 1995, CANCER IMMUNOL IMMUN, V41, P162, DOI 10.1007/s002620050214; DOHLSTEN M, 1993, INT J CANCER, V54, P482, DOI 10.1002/ijc.2910540321; Drobnak I, 2017, J AM CHEM SOC, V139, P8229, DOI 10.1021/jacs.7b01690; Erlandsson E, 2003, J MOL BIOL, V333, P893, DOI 10.1016/j.jmb.2003.09.009; Forsberg G, 2001, BRIT J CANCER, V85, P129, DOI 10.1054/bjoc.2001.1891; Forsberg G, 2010, J IMMUNOTHER, V33, P492, DOI 10.1097/CJI.0b013e3181d75820; Fraser J, 2000, MOL MED TODAY, V6, P125, DOI 10.1016/S1357-4310(99)01657-3; Giantonio BJ, 1997, J CLIN ONCOL, V15, P1994, DOI 10.1200/JCO.1997.15.5.1994; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gidlof C, 1997, BLOOD, V89, P2089, DOI 10.1182/blood.V89.6.2089; Gradisar H, 2013, NAT CHEM BIOL, V9, P362, DOI 10.1038/nchembio.1248; Hansen H., 2006, U. S. Patent, Patent No. [7,151,164, 7151164]; Hawkins RE, 2016, CLIN CANCER RES, V22, P3172, DOI 10.1158/1078-0432.CCR-15-0580; HEDLUND G, 1990, CELL IMMUNOL, V129, P426, DOI 10.1016/0008-8749(90)90218-G; Kang Ju-Seop, 2009, Korean Journal of Internal Medicine, V24, P1, DOI 10.3904/kjim.2009.24.1.1; Kent KP, 2008, J AM CHEM SOC, V130, P9664, DOI 10.1021/ja803782x; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Litton MJ, 1997, AM J PATHOL, V150, P1607; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Rosendahl A, 2000, METH MOL B, V145, P241; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Shaw DM, 2007, BRIT J CANCER, V96, P567, DOI 10.1038/sj.bjc.6603567; Shekhawat SS, 2011, CURR OPIN CHEM BIOL, V15, P789, DOI 10.1016/j.cbpa.2011.10.014; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989	38	6	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6294	6305		10.1074/jbc.RA118.006742	http://dx.doi.org/10.1074/jbc.RA118.006742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30782846	Green Published, hybrid			2022-12-28	WOS:000468402000008
J	Grimsey, NJ; Lin, Y; Narala, R; Rada, CC; Mejia-Pena, H; Trejo, J				Grimsey, Neil J.; Lin, Ying; Narala, Rachan; Rada, Cara C.; Mejia-Pena, Hilda; Trejo, JoAnn			G protein-coupled receptors activate p38 MAPK via a non-canonical TAB1-TAB2-and TAB1-TAB3-dependent pathway in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenosine; endothelial dysfunction; histamine; inflammation; prostaglandin; purinergic receptor; thrombin; protease-activated receptor	KINASE ACTIVATION; INDEPENDENT ACTIVATION; BARRIER FUNCTION; P38-ALPHA; MECHANISM; BINDING; PERMEABILITY; MIGRATION; INHIBIT; ROLES	Endothelial dysfunction is induced by inflammatory mediators including multiple G protein-coupled receptor (GPCR) agonists. However, the GPCR signaling pathways that promote endothelial dysfunction are incompletely understood. We previously showed that thrombin promotes endothelial barrier disruption through autophosphorylation and activation of p38 mitogen-activated protein kinase (MAPK) via a non-canonical transforming growth factor--activated protein kinase-1-binding protein-1 (TAB1) and TAB2-dependent pathway rather than the canonical three-tiered kinase cascade. Here, we sought to determine whether other GPCR agonists stimulate p38 MAPK activation via this non-canonical pathway in human endothelial cells derived from different vascular beds. Using primary human umbilical vein endothelial cells (HUVECs), HUVEC-derived EA.hy926 cells, and human dermal microvascular endothelial cells (HDMECs), we found that both non-canonical and canonical p38 activation pathways components are expressed in these various endothelial cell types, including TAB3, a structurally-related TAB2 homolog. Moreover, multiple GPCRs agonists, including thrombin, histamine, prostaglandin E-2, and ADP, stimulated robust p38 autophosphorylation, whereas phosphorylation of the upstream MAPKs MAP kinase kinase 3 (MKK3) and MKK6, was virtually undetectable, indicating that non-canonical p38 activation may exist for other GPCRs. Indeed, in EA.hy926 cells, thrombin- and histamine-stimulated p38 activation depended on TAB1-TAB2, whereas in primary HUVECs, both TAB1-TAB2 and TAB1-TAB3 were required for p38 activation. In HDMECs, thrombin-induced p38 activation depended on TAB1-TAB3, but histamine-induced p38 activation required TAB1-TAB2. Moreover, thrombin- and histamine-stimulated interleukin-6 production required both TAB1-TAB2 and TAB1-TAB3 in HUVEC. We conclude that multiple GPCR agonists utilize non-canonical TAB1-TAB2 and TAB1-TAB3-dependent p38 activation to promote endothelial inflammatory responses.	[Grimsey, Neil J.; Lin, Ying; Narala, Rachan; Rada, Cara C.; Mejia-Pena, Hilda; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Rada, Cara C.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Grimsey, Neil J.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Georgia; University of Georgia	Trejo, J (corresponding author), Biomed Sci Bldg 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu	Grimsey, Neil/AAB-9153-2020	Grimsey, Neil/0000-0002-0481-4920; Lin, Ying/0000-0002-5619-1104; TREJO, JOANN/0000-0003-4405-6228	University of California Tobacco-related Disease Research Program Predoctoral Fellowship; National Institutes of Health, NIGMS Initiative for Maximizing Student Development Grant [R25 GM083275]; National Institutes of Health NIGMS Grant [R35 GM127121]; University of California [TRDRP 26IP-0050]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM127121, R25GM083275, T32GM007752] Funding Source: NIH RePORTER	University of California Tobacco-related Disease Research Program Predoctoral Fellowship; National Institutes of Health, NIGMS Initiative for Maximizing Student Development Grant; National Institutes of Health NIGMS Grant; University of California(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a University of California Tobacco-related Disease Research Program Predoctoral Fellowship (to C. C. R.), National Institutes of Health, NIGMS Initiative for Maximizing Student Development Grant R25 GM083275 (to H. M.-P.), National Institutes of Health NIGMS Grant R35 GM127121 (to J. T.), and a University of California TRDRP 26IP-0050 High Impact Pilot Award (to J. T.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adderley SP, 2015, MICROCIRCULATION, V22, P237, DOI 10.1111/micc.12189; Bernatchez PN, 2001, BRIT J PHARMACOL, V134, P1253, DOI 10.1038/sj.bjp.0704367; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; De Nicola GF, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121144; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Grimsey NJ, 2018, CELL REP, V24, P3312, DOI 10.1016/j.celrep.2018.08.061; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Gupta J, 2015, FEBS J, V282, P1841, DOI 10.1111/febs.13250; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Jean-Charles PY, 2016, PROG MOL BIOL TRANSL, V141, P1, DOI 10.1016/bs.pmbts.2016.05.001; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Konya V, 2013, J ALLERGY CLIN IMMUN, V131, P532, DOI 10.1016/j.jaci.2012.05.008; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Li HG, 2003, CIRCULATION, V107, P2348, DOI 10.1161/01.CIR.0000066697.19571.AF; Li Y, 2001, MICROVASC RES, V61, P253, DOI 10.1006/mvre.2001.2304; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Perrot CY, 2018, FASEB J; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Remy G, 2010, CELL SIGNAL, V22, P660, DOI 10.1016/j.cellsig.2009.11.020; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Shen JZ, 2008, CIRC RES, V102, P448, DOI 10.1161/CIRCRESAHA.107.165795; Stolwijk JA, 2016, J BIOL CHEM, V291, P22894, DOI 10.1074/jbc.M116.756114; Stolwijk JA, 2015, PFLUG ARCH EUR J PHY, V467, P2193, DOI 10.1007/s00424-014-1674-0; Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Theivanthiran B, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005903; Wang QY, 2013, MOL THER, V21, P1668, DOI 10.1038/mt.2013.90; Weis SM, 2008, CURR OPIN HEMATOL, V15, P243, DOI 10.1097/MOH.0b013e3282f97d86; Yamauchi J, 2001, J BIOL CHEM, V276, P23362, DOI 10.1074/jbc.M011752200; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P5620, DOI 10.1073/pnas.0801453105	44	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5867	5878		10.1074/jbc.RA119.007495	http://dx.doi.org/10.1074/jbc.RA119.007495			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30760523	hybrid, Green Published			2022-12-28	WOS:000465077500018
J	Ries, LK; Sander, B; Deol, KK; Letzelter, MA; Strieter, ER; Lorenz, S				Ries, Lena K.; Sander, Bodo; Deol, Kirandeep K.; Letzelter, Marie-Annick; Strieter, Eric Robert; Lorenz, Sonja			Analysis of ubiquitin recognition by the HECT ligase E6AP provides insight into its linkage specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin ligase; ubiquitylation (ubiquitination); post-translational modification; enzyme mechanism	E3 LIGASE; STRUCTURAL BASIS; CHAIN ELONGATION; MOLECULAR-BASIS; POLYUBIQUITIN; MECHANISM; REVEALS; DOMAIN; COMPLEX; BINDING	Deregulation of the HECT-type ubiquitin ligase E6AP (UBE3A) is implicated in human papilloma virus-induced cervical tumorigenesis and several neurodevelopmental disorders. Yet the structural underpinnings of activity and specificity in this crucial ligase are incompletely understood. Here, we unravel the determinants of ubiquitin recognition by the catalytic domain of E6AP and assign them to particular steps in the catalytic cycle. We identify a functionally critical interface that is specifically required during the initial formation of a thioester-linked intermediate between the C terminus of ubiquitin and the ligase-active site. This interface resembles the one utilized by NEDD4-type enzymes, indicating that it is widely conserved across HECT ligases, independent of their linkage specificities. Moreover, we uncover surface regions in ubiquitin and E6AP, both in the N- and C-terminal portions of the catalytic domain, that are important for the subsequent reaction step of isopeptide bond formation between two ubiquitin molecules. We decipher key elements of linkage specificity, including the C-terminal tail of E6AP and a hydrophilic surface region of ubiquitin in proximity to the acceptor site Lys-48. Intriguingly, mutation of Glu-51, a single residue within this region, permits formation of alternative chain types, thus pointing to a key role of ubiquitin in conferring linkage specificity to E6AP. We speculate that substrate-assisted catalysis, as described previously for certain RING-associated ubiquitin-conjugating enzymes, constitutes a common principle during linkage-specific ubiquitin chain assembly by diverse classes of ubiquitination enzymes, including HECT ligases.	[Ries, Lena K.; Sander, Bodo; Letzelter, Marie-Annick; Lorenz, Sonja] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Deol, Kirandeep K.; Strieter, Eric Robert] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Strieter, Eric Robert] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Wurzburg; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Lorenz, S (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany.	sonja.lorenz@virchow.uni-wuerzburg.de	Lorenz, Sonja/AAL-4499-2020	Lorenz, Sonja/0000-0002-9639-2381	National Institutes of Health [1S10OD010645-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Lorenz laboratory for insightful discussions; Julia Haubenreisser for technical assistance; and Kristian Schweimer at the Northern Bavaria NMR Center for excellent support. Data collected on the Orbitrap Fusion mass spectrometer were funded by National Institutes of Health Grant 1S10OD010645-01A1.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Al-Maawali A, 2013, J CHILD NEUROL, V28, P392, DOI 10.1177/0883073812443591; Attali I, 2017, EMBO J, V36, P425, DOI 10.15252/embj.201694314; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Brown NG, 2016, CELL, V165, P1440, DOI 10.1016/j.cell.2016.05.037; Brown NG, 2014, MOL CELL, V56, P246, DOI 10.1016/j.molcel.2014.09.009; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen D, 2018, CHEMBIOCHEM, V19, P2123, DOI 10.1002/cbic.201800321; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Fajner V, 2017, FEBS LETT, V591, P2636, DOI 10.1002/1873-3468.12775; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; French ME, 2017, J BIOL CHEM, V292, P10398, DOI 10.1074/jbc.M117.789479; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hong JH, 2015, PROTEOMICS, V15, P2910, DOI 10.1002/pmic.201500058; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Jackl M, 2018, J MOL BIOL, V430, P3218, DOI 10.1016/j.jmb.2018.06.044; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kathman SG, 2015, J AM CHEM SOC, V137, P12442, DOI 10.1021/jacs.5b06839; Kelly A, 2014, MOL CELL, V56, P232, DOI 10.1016/j.molcel.2014.09.010; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Koch JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4041; Kristariyanto YA, 2015, BIOCHEM J, V467, P345, DOI 10.1042/BJ20141502; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lee YS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1469; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Lorenz S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147550; Lorenz S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-65; Martinez-Noel G, 2018, J MOL BIOL, V430, P1024, DOI 10.1016/j.jmb.2018.01.021; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Mevissen TET, 2016, NATURE, V538, P402, DOI 10.1038/nature19836; Michel MA, 2017, MOL CELL, V68, P233, DOI 10.1016/j.molcel.2017.08.020; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Middleton AJ, 2017, J MOL BIOL, V429, P3430, DOI 10.1016/j.jmb.2017.06.008; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Mortensen F, 2015, P NATL ACAD SCI USA, V112, P9872, DOI 10.1073/pnas.1505923112; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Ronchi VP, 2017, J BIOL CHEM, V292, P18006, DOI 10.1074/jbc.M117.813477; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Sadikovic B, 2014, HUM MUTAT, V35, P1407, DOI 10.1002/humu.22687; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Sander B, 2017, ELIFE, V6, DOI 10.7554/eLife.21036; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Stieglitz B, 2013, NATURE, V503, P422, DOI 10.1038/nature12638; Streich FC, 2016, NATURE, V536, P304, DOI 10.1038/nature19071; TAYLOR WR, 1995, NATURE, V375, P372, DOI 10.1038/375372a0; Todaro DR, 2018, J BIOL CHEM, V293, P18192, DOI 10.1074/jbc.RA118.003716; Todaro DR, 2017, J BIOL CHEM, V292, P19521, DOI 10.1074/jbc.M117.817882; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu YS, 2001, J BIOMOL NMR, V21, P285, DOI 10.1023/A:1012916731276; Yang Y, 2013, P NATL ACAD SCI USA, V110, P5115, DOI 10.1073/pnas.1220271110; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhu K, 2017, EMBO REP, V18, P1618, DOI 10.15252/embr.201744454	94	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6113	6129		10.1074/jbc.RA118.007014	http://dx.doi.org/10.1074/jbc.RA118.007014			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30737286	Green Published, hybrid			2022-12-28	WOS:000465077500040
J	Beliakova-Bethell, N; Mukim, A; White, CH; Deshmukh, S; Abewe, H; Richman, DD; Spina, CA				Beliakova-Bethell, Nadejda; Mukim, Amey; White, Cory H.; Deshmukh, Savitha; Abewe, Hosiana; Richman, Douglas D.; Spina, Celsa A.			Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug action; human immunodeficiency virus (HIV); gene expression; transcriptomics; histone deacetylase inhibitor (HDAC inhibitor) (HDI); T cell; transcription regulation; latency reversal; maturation phenotypes; primary CD4+T cell; romidepsin; SAHA	HYDROXAMIC ACID SAHA; B P-TEFB; GENE-EXPRESSION; LATENT HIV; TRANSCRIPTION; RNA; DEPSIPEPTIDE; ACETYLATION; PATHWAY; CELLS	Histone deacetylase (HDAC) inhibitors (HDACis) have been widely tested in clinical trials for their ability to reverse HIV latency but have yielded only limited success. One HDACi, suberoylanilide hydroxamic acid (SAHA), exhibits off-target effects on host gene expression predicted to interfere with induction of HIV transcription. Romidepsin (RMD) has higher potency and specificity for class I HDACs implicated in maintaining HIV provirus in the latent state. More robust HIV reactivation has indeed been achieved with RMD use ex vivo than with SAHA; however, reduction of viral reservoir size has not been observed in clinical trials. Therefore, using RNA-Seq, we sought to compare the effects of SAHA and RMD on gene expression in primary CD4(+) T cells. Among the genes whose expression was modulated by both HDACi agents, we identified genes previously implicated in HIV latency. Two genes, SMARCB1 and PARP1, whose modulation by SAHA and RMD is predicted to inhibit HIV reactivation, were evaluated in the major maturation subsets of CD4(+) T cells and were consistently either up- or down-regulated by both HDACi compounds. Our results indicate that despite having different potencies and HDAC specificities, SAHA and RMD modulate an overlapping set of genes, implicated in HIV latency regulation. Some of these genes merit exploration as additional targets to improve the therapeutic outcomes of shock and kill strategies. The overall complexity of HDACi-induced responses among host genes with predicted stimulatory or inhibitory effects on HIV expression likely contributes to differential HDACi potencies and dictates the outcome of HIV reactivation.	[Beliakova-Bethell, Nadejda; Mukim, Amey; Deshmukh, Savitha; Abewe, Hosiana; Richman, Douglas D.; Spina, Celsa A.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Beliakova-Bethell, Nadejda; Mukim, Amey; Deshmukh, Savitha; Abewe, Hosiana; Richman, Douglas D.; Spina, Celsa A.] Vet Med Res Fdn, San Diego, CA 92161 USA; [Beliakova-Bethell, Nadejda; White, Cory H.; Abewe, Hosiana; Richman, Douglas D.; Spina, Celsa A.] Univ Calif San Diego, Stein Clin Res Bldg,Rm 304,9500 Gilman Dr,0679, La Jolla, CA 92093 USA; [White, Cory H.] Merck Res Labs, Merck Exploratory Sci Ctr, Cambridge, MA 02141 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Veterans Medical Research Foundation; University of California System; University of California San Diego; Merck & Company	Beliakova-Bethell, N (corresponding author), Univ Calif San Diego, Stein Clin Res Bldg,Rm 304,9500 Gilman Dr,0679, La Jolla, CA 92093 USA.	nbeliako@ucsd.edu		Mukim, Amey/0000-0002-7777-3728	NIAID, National Institutes of Health, San Diego CFAR Developmental Grant [AI036214]; Office of Research and Development, Veterans Health Administration, Career Developmental Award [II IK2 BX002731]; NIAID, National Institutes of Health, CARE Collaboratory for AIDS Research on Eradication Grants [U19 AI096113, 1UM1 AI126619]; James B. Pendleton Charitable Trust; Molecular Biology Program, University of Utah, Salt Lake City, UT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI126619, P30AI036214] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002731] Funding Source: NIH RePORTER	NIAID, National Institutes of Health, San Diego CFAR Developmental Grant; Office of Research and Development, Veterans Health Administration, Career Developmental Award; NIAID, National Institutes of Health, CARE Collaboratory for AIDS Research on Eradication Grants; James B. Pendleton Charitable Trust; Molecular Biology Program, University of Utah, Salt Lake City, UT; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIAID, National Institutes of Health, San Diego CFAR Developmental Grant AI036214 (to N. B.-B.); Office of Research and Development, Veterans Health Administration, Career Developmental Award-II IK2 BX002731 (to N. B.-B.); NIAID, National Institutes of Health, CARE Collaboratory for AIDS Research on Eradication Grants U19 AI096113 and 1UM1 AI126619 (to D. D. R.) and U19 AI096113 (to C. A. S.); and the James B. Pendleton Charitable Trust. D. D. R. has consulted for Gilead, Inc., Antiva Biosciences, Inc., and Monogram Biosciences, Inc. C. H. W. is currently employed by Merck, Inc. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The sponsors of this research were not involved in the study design, collection or interpretation of the data, manuscript preparation, or the decision to submit the article for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a merit-based scholarship from H. E. president of Rwanda, Paul Kagame. Present address: Molecular Biology Program, University of Utah, Salt Lake City, UT 84112.	Abdel-Mohsen M, 2015, AIDS, V29, P411, DOI 10.1097/QAD.0000000000000572; Ako-Adjei D, 2015, NUCLEIC ACIDS RES, V43, pD566, DOI 10.1093/nar/gku1126; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2014, J INFECT DIS, V210, P728, DOI 10.1093/infdis/jiu155; Beliakova-Bethell N, 2014, CYTOM PART A, V85A, P94, DOI 10.1002/cyto.a.22352; Beliakova-Bethell N, 2013, AIDS, V27, P29, DOI 10.1097/QAD.0b013e32835b3e26; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Chavez L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004955; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Das B, 2018, P NATL ACAD SCI USA, V115, pE7795, DOI 10.1073/pnas.1803468115; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Furumai R, 2002, CANCER RES, V62, P4916; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hlubek F, 2001, J BIOCHEM-TOKYO, V129, P635, DOI 10.1093/oxfordjournals.jbchem.a002901; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; LaBonte MJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-67; Lada SM, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01158-18; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; Leth S, 2016, LANCET HIV, V3, pE463, DOI 10.1016/S2352-3018(16)30055-8; Li ZC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007012; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Mensah AA, 2015, ONCOTARGET, V6, P5059; Michaels KK, 2015, J IMMUNOL, V194, P3267, DOI 10.4049/jimmunol.1402581; Mohammadi P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004156; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Pan XY, 2016, J BIOL CHEM, V291, P26177, DOI 10.1074/jbc.M116.743906; Parent M, 2005, J BIOL CHEM, V280, P448, DOI 10.1074/jbc.M408435200; Park J, 2014, AIDS, V28, P1719, DOI 10.1097/QAD.0000000000000309; Rajgolikar G, 1998, BREAST CANCER RES TR, V51, P29, DOI 10.1023/A:1006091014092; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruiz A, 2014, J BIOL CHEM, V289, P27665, DOI 10.1074/jbc.M114.570341; Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Sung JA, 2017, EBIOMEDICINE, V23, P52, DOI 10.1016/j.ebiom.2017.07.019; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2007, BIOCHEM BIOPH RES CO, V356, P998, DOI 10.1016/j.bbrc.2007.03.076; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; White CH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006026; White CH, 2015, ANTIVIR RES, V123, P78, DOI 10.1016/j.antiviral.2015.09.002; Wightman F, 2013, AIDS, V27, P2853, DOI 10.1097/QAD.0000000000000067; Wozniak MB, 2010, HAEMATOL-HEMATOL J, V95, P613, DOI 10.3324/haematol.2009.013870; Wu GX, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92901; Yang XA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002350; Yu D, 2018, CELL REP, V23, P3741, DOI 10.1016/j.celrep.2018.05.084; Yucha RW, 2017, EBIOMEDICINE, V20, P217, DOI 10.1016/j.ebiom.2017.05.006; Yukl SA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9927; Zaikos TD, 2018, J VIROL, V92, DOI 10.1128/JVI.02110-17	59	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5576	5589		10.1074/jbc.RA118.005185	http://dx.doi.org/10.1074/jbc.RA118.005185			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30745362	Green Published, hybrid			2022-12-28	WOS:000464517500027
J	Shekhar, R; Priyanka, P; Kumar, P; Ghosh, T; Khan, MM; Nagarajan, P; Saxena, S				Shekhar, Ritu; Priyanka, Priyanka; Kumar, Praveen; Ghosh, Tanushree; Khan, Md. Muntaz; Nagarajan, Perumal; Saxena, Sandeep			The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); cell cycle; cyclin; tumor suppressor gene; osteosarcoma (OS); bone cancer; CCNA2; cyclin A2; non-coding RNA; oncogenesis; posttranscriptional regulation	FUNCTIONAL-CHARACTERIZATION; TUMOR-SUPPRESSOR; DOWN-REGULATION; CELL-LINES; S-PHASE; INVASION; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; ARREST	MicroRNAs of the miR-16 and miR-34 families have been reported to inhibit cell cycle progression, and their loss has been linked to oncogenic transformation. Utilizing a high-throughput, genome-wide screen for miRNAs and mRNAs that are differentially regulated in osteosarcoma (OS) cell lines, we report that miR-449a and miR-424, belonging to the miR-34 and miR-16 families, respectively, target the major S/G(2) phase cyclin, cyclin A2 (CCNA2), in a bipartite manner. We found that the 3-UTR of CCNA2 is recognized by miR-449a, whereas the CCNA2 coding region is targeted by miR-424. Of note, we observed loss of both miR-449a and miR-424 in OS, resulting in derepression of CCNA2 and appearance of aggressive cancer phenotypes. Ectopic expression of miR-449a and miR-424 significantly decreased cyclin A2 levels and inhibited proliferation rate, migratory potential, and colony-forming ability of OS cells. To further probe the roles of miR-449a and miR-424 in OS, we developed an OS mouse model by intraosseous injection of U2OS cells into the tibia bone of NOD-scid mice, which indicated that miR-449a and miR-424 co-expression suppresses tumor growth. On the basis of this discovery, we analyzed the gene expression of human OS biopsy samples, revealing that miR-449a and miR-424 are both down-regulated, whereas cyclin A2 is significantly up-regulated in these OS samples. In summary, the findings in our study highlight that cyclin A2 repression by miRNAs of the miR-16 and miR-34 families is lost in aggressive OS.	[Shekhar, Ritu; Priyanka, Priyanka; Kumar, Praveen; Ghosh, Tanushree; Khan, Md. Muntaz; Nagarajan, Perumal; Saxena, Sandeep] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Saxena, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sandeep@nii.res.in	Nagarajan, Perumal/AAJ-8599-2021	Nagarajan, Perumal/0000-0003-4557-4633; Ghosh, Tanushree/0000-0002-0988-2367; Priyanka, Fnu/0000-0001-7933-3809	Government of India [BT/PR22824/BRB/10/1578/2016, EMR/2016/001702]	Government of India	This study was supported in part by Government of India Projects BT/PR22824/BRB/10/1578/2016 and EMR/2016/001702. The authors declare that they have no conflicts of interest with the contents of this article.	Achari C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-538; Allen-Rhoades W, 2015, CANCER MED-US, V4, P977, DOI 10.1002/cam4.438; Bae YJ, 2012, HUM MOL GENET, V21, P2991, DOI 10.1093/hmg/dds129; Beg MS, 2017, INVEST NEW DRUG, V35, P180, DOI 10.1007/s10637-016-0407-y; Bueno MJ, 2011, BLOOD, V117, P6255, DOI 10.1182/blood-2010-10-315432; Cai CK, 2012, ONCOL REP, V28, P1764, DOI 10.3892/or.2012.1995; Chen J, 2015, TUMOR BIOL, V36, P8221, DOI 10.1007/s13277-015-3568-y; Deng NA, 2018, BIOCHEM BIOPH RES CO, V495, P189, DOI 10.1016/j.bbrc.2017.11.028; Fotedar A, 1996, J BIOL CHEM, V271, P31627, DOI 10.1074/jbc.271.49.31627; Ge L, 2016, ONCOL LETT, V11, P2207, DOI 10.3892/ol.2016.4162; Ghosh T, 2017, J BIOL CHEM, V292, P21264, DOI 10.1074/jbc.M117.808287; Gopinathan L, 2014, CANCER RES, V74, P3870, DOI 10.1158/0008-5472.CAN-13-3440; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu YL, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180375; Jiang QQ, 2013, ASIAN PAC J CANCER P, V14, P4127, DOI 10.7314/APJCP.2013.14.7.4127; Kobayashi Eisuke, 2012, Sarcoma, V2012, P359739, DOI 10.1155/2012/359739; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Lewis IJ, 2007, JNCI-J NATL CANCER I, V99, P112, DOI 10.1093/jnci/djk015; Li JQ, 2002, HUM PATHOL, V33, P1006, DOI 10.1053/hupa.2002.125774; Li Q, 2017, INT J BIOL SCI, V13, P1038, DOI 10.7150/ijbs.19476; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long XH, 2013, EXP THER MED, V5, P1048, DOI 10.3892/etm.2013.959; Lulla Rishi R., 2011, Sarcoma, V2011, P732690, DOI 10.1155/2011/732690; Lv T, 2018, CANCER BIOMARK, V23, P315, DOI 10.3233/CBM-170906; Mao JH, 2012, ONCOL LETT, V4, P1125, DOI 10.3892/ol.2012.863; Miller CW, 1996, J CANCER RES CLIN, V122, P559, DOI 10.1007/BF01213553; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Otto T, 2017, P NATL ACAD SCI USA, V114, P10660, DOI 10.1073/pnas.1702914114; Patel N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02800-2; Perdigao-Henriques R, 2016, ONCOGENE, V35, P158, DOI 10.1038/onc.2015.69; Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6; Ren XS, 2014, CANCER LETT, V344, P195, DOI 10.1016/j.canlet.2013.10.031; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Stahlhut C, 2015, CELL CYCLE, V14, P2171, DOI 10.1080/15384101.2014.1003008; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; van der Deen M, 2013, J BIOL CHEM, V288, P21307, DOI 10.1074/jbc.M112.445890; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xiao X, 2015, ARCH BIOCHEM BIOPHYS, V566, P49, DOI 10.1016/j.abb.2014.12.007; Xu M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0972-x; Yang F, 2015, J BIOL CHEM, V290, P6507, DOI 10.1074/jbc.M114.620369; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yasmeen A, 2003, EXPERT REV MOL DIAGN, V3, P617, DOI 10.1586/14737159.3.5.617; Yin D, 2013, ONCOGENE, V32, P1155, DOI 10.1038/onc.2012.132; Zhao ZZ, 2015, RNA BIOL, V12, P538, DOI 10.1080/15476286.2015.1023495	51	41	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4381	4400		10.1074/jbc.RA118.005778	http://dx.doi.org/10.1074/jbc.RA118.005778			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30679313	hybrid, Green Published			2022-12-28	WOS:000462969500009
J	Ziegler, CS; Bouchab, L; Tramier, M; Durand, D; Fieschi, F; Dupre-Crochet, S; Merola, F; Nusse, O; Erard, M				Ziegler, Cornelia S.; Bouchab, Leila; Tramier, Marc; Durand, Dominique; Fieschi, Franck; Dupre-Crochet, Sophie; Merola, Fabienne; Nusse, Oliver; Erard, Marie			Quantitative live-cell imaging and 3D modeling reveal critical functional features in the cytosolic complex of phagocyte NADPH oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); fluorescence correlation spectroscopy (FCS); protein complex; NADPH oxidase; structural model; FCCS; fluorescent protein; FRET-FLIM; intrinsically disordered proteins; protein-protein interaction	PROTEIN-PROTEIN INTERACTIONS; X-RAY-SCATTERING; FLUORESCENT PROTEIN; P47(PHOX); CYAN; P67(PHOX); BINDING; DOMAIN; MACROMOLECULES; SPECTROSCOPY	Phagocyte NADPH oxidase produces superoxide anions, a precursor of reactive oxygen species (ROS) critical for host responses to microbial infections. However, uncontrolled ROS production contributes to inflammation, making NADPH oxidase a major drug target. It consists of two membranous (Nox2 and p22(phox)) and three cytosolic subunits (p40(phox), p47(phox), and p67(phox)) that undergo structural changes during enzyme activation. Unraveling the interactions between these subunits and the resulting conformation of the complex could shed light on NADPH oxidase regulation and help identify inhibition sites. However, the structures and the interactions of flexible proteins comprising several well-structured domains connected by intrinsically disordered protein segments are difficult to investigate by conventional techniques such as X-ray crystallography, NMR, or cryo-EM. Here, we developed an analytical strategy based on FRET-fluorescence lifetime imaging (FLIM) and fluorescence cross-correlation spectroscopy (FCCS) to structurally and quantitatively characterize NADPH oxidase in live cells. We characterized the inter- and intramolecular interactions of its cytosolic subunits by elucidating their conformation, stoichiometry, interacting fraction, and affinities in live cells. Our results revealed that the three subunits have a 1:1:1 stoichiometry and that nearly 100% of them are present in complexes in living cells. Furthermore, combining FRET data with small-angle X-ray scattering (SAXS) models and published crystal structures of isolated domains and subunits, we built a 3D model of the entire cytosolic complex. The model disclosed an elongated complex containing a flexible hinge separating two domains ideally positioned at one end of the complex and critical for oxidase activation and interactions with membrane components.	[Ziegler, Cornelia S.; Bouchab, Leila; Dupre-Crochet, Sophie; Merola, Fabienne; Nusse, Oliver; Erard, Marie] Univ Paris Saclay, Univ Paris Sud, CNRS, Lab Chim Phys, F-91405 Orsay, France; [Tramier, Marc] Univ Rennes, CNRS, Inst Genet & Dev Rennes, UMR 6290,BIOSIT UMS 3480, F-35000 Rennes, France; [Durand, Dominique] Univ Paris Saclay, Univ Paris Sud, CNRS UMR 9198, Inst Integrat Biol Cell,CEA, F-91190 Gif Sur Yvette, France; [Fieschi, Franck] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct, F-38044 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Nusse, O; Erard, M (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Lab Chim Phys, F-91405 Orsay, France.	oliver.nusse@u-psud.fr; marie.erard@u-psud.fr	ERARD, Marie/L-9089-2019; Erard, Marie/G-7478-2012; Nüsse, Oliver/J-8645-2013; Dupré-Crochet, Sophie/J-8607-2013; Fieschi, Franck/W-2748-2019	ERARD, Marie/0000-0002-4063-365X; Erard, Marie/0000-0002-4063-365X; Nüsse, Oliver/0000-0003-0068-8346; Dupré-Crochet, Sophie/0000-0002-6405-3748; FIESCHI, Franck/0000-0003-1194-8107; Tramier, Marc/0000-0001-8200-6446	Foundation for Medical Research Grant [DCM20121225747]; IDEX Paris Saclay (IRS BioProbe); IDEX Paris-Saclay; Region Ile-de-France (DIM Malinf); LabExPALMGrant [ANR-10-LABX-0039-PALM]	Foundation for Medical Research Grant; IDEX Paris Saclay (IRS BioProbe); IDEX Paris-Saclay; Region Ile-de-France (DIM Malinf)(Region Ile-de-France); LabExPALMGrant	This work was supported by "The Foundation for Medical Research Grant DCM20121225747," by LabExPALMGrant ANR-10-LABX-0039-PALM, and by the IDEX Paris Saclay (IRS BioProbe). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a doctoral grant from IDEX Paris-Saclay.; Supported by a doctoral grant from Region Ile-de-France (DIM Malinf).	Betolngar DB, 2015, ANAL BIOANAL CHEM, V407, P4183, DOI 10.1007/s00216-015-8636-z; Bohmer M, 2002, CHEM PHYS LETT, V353, P439, DOI 10.1016/S0009-2614(02)00044-1; Boura E, 2011, P NATL ACAD SCI USA, V108, P9437, DOI 10.1073/pnas.1101763108; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Cifuentes-Pagano ME, 2015, CURR PHARM DESIGN, V21, P6023, DOI 10.2174/1381612821666151029112013; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; Demeautis C, 2017, SCI REP-UK, V7, DOI 10.1038/srep41026; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Erard M, 2013, MOL BIOSYST, V9, P258, DOI 10.1039/c2mb25303h; Espagne A, 2011, BIOCHEMISTRY-US, V50, P437, DOI 10.1021/bi1015875; Faure MC, 2013, BIOL CELL, V105, P501, DOI 10.1111/boc.201300010; Foo YH, 2012, BIOPHYS J, V102, P1174, DOI 10.1016/j.bpj.2012.01.040; Fuertes G, 2017, P NATL ACAD SCI USA, V114, pE6342, DOI 10.1073/pnas.1704692114; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Grailhe R, 2006, CHEMPHYSCHEM, V7, P1442, DOI 10.1002/cphc.200600057; Greife A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36792; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Herbomel G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45058; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Karimi G, 2014, BBA-GEN SUBJECTS, V1840, P3277, DOI 10.1016/j.bbagen.2014.07.022; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kofoed EM, 2010, J BIOL CHEM, V285, P2428, DOI 10.1074/jbc.M109.045203; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Laraia L, 2015, CHEM BIOL, V22, P689, DOI 10.1016/j.chembiol.2015.04.019; Marcoux J, 2010, J BIOL CHEM, V285, P28980, DOI 10.1074/jbc.M110.139824; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Merola F, 2016, METHODS APPL FLUORES, V4, DOI 10.1088/2050-6120/4/1/012001; Moore BL, 2013, J COMPUT CHEM, V34, P1881, DOI 10.1002/jcc.23330; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Padilla-Parra S, 2014, METHODS MOL BIOL, V1076, P683, DOI 10.1007/978-1-62703-649-8_31; Padilla-Parra S, 2011, MICROSC RES TECHNIQ, V74, P788, DOI 10.1002/jemt.21015; Pauwels K, 2017, CELL MOL LIFE SCI, V74, P3185, DOI 10.1007/s00018-017-2561-6; Peti W, 2018, METHODS MOL BIOL, V1688, P375, DOI 10.1007/978-1-4939-7386-6_17; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Piovesan D, 2018, NUCLEIC ACIDS RES, V46, pD471, DOI 10.1093/nar/gkx1071; Poea-Guyon S, 2013, ANAL BIOANAL CHEM, V405, P3983, DOI 10.1007/s00216-013-6860-y; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Song ZM, 2017, J LEUKOCYTE BIOL, V101, P1155, DOI 10.1189/jlb.1A0716-305R; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; STEINBERG IZ, 1968, J CHEM PHYS, V48, P2411, DOI 10.1063/1.1669461; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Uversky VN, 2016, J BIOL CHEM, V291, P6681, DOI 10.1074/jbc.R115.685859; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Valeur B., 2006, MOL FLUORESCENCE PRI; Vogel Steven S, 2006, Sci STKE, V2006, pre2; Vogel SS, 2014, METHODS, V66, P131, DOI 10.1016/j.ymeth.2013.06.021; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Yuzawa S, 2009, J INNATE IMMUN, V1, P543, DOI 10.1159/000235656; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zachariassen LG, 2016, P NATL ACAD SCI USA, V113, pE3950, DOI 10.1073/pnas.1601747113	62	16	16	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3824	3836		10.1074/jbc.RA118.006864	http://dx.doi.org/10.1074/jbc.RA118.006864			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30630949	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000461854400003
J	Byun, J; Del Re, DP; Zhai, PY; Ikeda, S; Shirakabe, A; Mizushima, W; Miyamoto, S; Brown, JH; Sadoshima, J				Byun, Jaemin; Del Re, Dominic P.; Zhai, Peiyong; Ikeda, Shohei; Shirakabe, Akihiro; Mizushima, Wataru; Miyamoto, Shigeki; Brown, Joan H.; Sadoshima, Junichi			Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; signal transduction; cardiomyocyte; cardiovascular disease; heart failure; YAP	HIPPO PATHWAY; TISSUE HOMEOSTASIS; MOUSE HEART; PROMOTES; GROWTH; ACTIVATION; SURVIVAL; MYOCYTES; YAP/TAZ; KINASE	Cardiovascular disease (CVD) remains the leading cause of death globally, and heart failure is a major component of CVD-related morbidity and mortality. The development of cardiac hypertrophy in response to hemodynamic overload is initially considered to be beneficial; however, this adaptive response is limited and, in the presence of prolonged stress, will transition to heart failure. Yes-associated protein (YAP), the central downstream effector of the Hippo signaling pathway, regulates proliferation and survival in mammalian cells. Our previous work demonstrated that cardiac-specific loss of YAP leads to increased cardiomyocyte (CM) apoptosis and impaired CM hypertrophy during chronic myocardial infarction (MI) in the mouse heart. Because of its documented cardioprotective effects, we sought to determine the importance of YAP in response to acute pressure overload (PO). Our results indicate that endogenous YAP is activated in the heart during acute PO. YAP activation that depended upon RhoA was also observed in CMs subjected to cyclic stretch. To examine the function of endogenous YAP during acute PO, Yap(+/flox);Cre(-MHC) (YAP-CHKO) and Yap(+/flox) mice were subjected to transverse aortic constriction (TAC). We found that YAP-CHKO mice had attenuated cardiac hypertrophy and significant increases in CM apoptosis and fibrosis that correlated with worsened cardiac function after 1 week of TAC. Loss of CM YAP also impaired activation of the cardioprotective kinase Akt, which may underlie the YAP-CHKO phenotype. Together, these data indicate a prohypertrophic, prosurvival function of endogenous YAP and suggest a critical role for CM YAP in the adaptive response to acute PO.	[Byun, Jaemin; Del Re, Dominic P.; Zhai, Peiyong; Ikeda, Shohei; Shirakabe, Akihiro; Mizushima, Wataru; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Miyamoto, Shigeki; Brown, Joan H.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California San Diego	Sadoshima, J (corresponding author), Rutgers New Jersey Med Sch, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA.	sadoshju@njms.rutgers.edu		Del Re, Dominic/0000-0002-5504-9114	National Institutes of Health [HL127339, HL135726, HL097037, HL080101, HL105242, HL028143, HL067724, HL091469, HL112330, HL138720, AG023039]; Tobacco-related Disease Research Program (TRDRP) [26IP-0040]; Foundation Leducq Transatlantic Network of Excellence [15CBD04]; American Heart Association [11SDG7240067, 15GRNTZ297009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138720, R15HL135726, R01HL127339, R01HL145459, R01HL067724, R01HL091469, R37HL028143, R01HL112330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-related Disease Research Program (TRDRP)(University of California System); Foundation Leducq Transatlantic Network of Excellence; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants HL127339 and HL135726 (to D. P. D.), HL097037 (to S. M.), HL080101, HL105242, and HL028143 (to J. H. B.), and HL067724, HL091469, HL112330, HL138720, and AG023039 (to J. S.), Tobacco-related Disease Research Program (TRDRP) Grant 26IP-0040 (to J. H. B.), the Foundation Leducq Transatlantic Network of Excellence 15CBD04 (to J. S.), and American Heart Association Grant 11SDG7240067 (to D. P. D.) and 15GRNTZ297009 (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Astone M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27657-x; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Del Re DP, 2013, J BIOL CHEM, V288, P3977, DOI 10.1074/jbc.M112.436311; Del Re DP, 2008, J BIOL CHEM, V283, P35622, DOI 10.1074/jbc.M804036200; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; He MJ, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0013-6; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Ikeda S, 2019, CIRC RES, V124, P292, DOI 10.1161/CIRCRESAHA.118.314048; Lauriol J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005262; Li CZ, 2013, BIOCHEM BIOPH RES CO, V438, P607, DOI 10.1016/j.bbrc.2013.08.008; Lin ZQ, 2014, CIRC RES, V115, P354, DOI 10.1161/CIRCRESAHA.115.303632; Lorell BH, 2000, CIRCULATION, V102, P470; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Morikawa Y, 2017, NATURE, V547, P227, DOI 10.1038/nature22979; Nakamura M, 2018, NAT REV CARDIOL, V15, P387, DOI 10.1038/s41569-018-0007-y; Ohgushi M, 2015, CELL STEM CELL, V17, P448, DOI 10.1016/j.stem.2015.07.009; Reddy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073763; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Tao G, 2016, NATURE, V534, P119, DOI 10.1038/nature17959; Tsika RW, 2010, J BIOL CHEM, V285, P13721, DOI 10.1074/jbc.M109.063057; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Wackerhage H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005096; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang XH, 2018, CELL DEATH DIFFER, V25, P966, DOI 10.1038/s41418-017-0036-9; Xiang SY, 2011, J CLIN INVEST, V121, P3269, DOI 10.1172/JCI44371; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yang YF, 2015, CIRC RES, V117, P891, DOI 10.1161/CIRCRESAHA.115.306624; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	52	42	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3603	3617		10.1074/jbc.RA118.006123	http://dx.doi.org/10.1074/jbc.RA118.006123			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30635403	Green Published, hybrid			2022-12-28	WOS:000461853900024
J	Li, ZK; Qi, DL; Singh, HP; Zou, Y; Shen, BH; Cobrinik, D				Li, Zhengke; Qi, Dong-Lai; Singh, Hardeep P.; Zou, Yue; Shen, Binghui; Cobrinik, David			A novel thyroid hormone receptor isoform, TR beta 2-46, promotes SKP2 expression and retinoblastoma cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor cell biology; retina; translation initiation; cell cycle; proliferation; retinoblastoma; thyroid hormone receptor beta 2	DEPENDENT REGULATION; S-PHASE; BETA-2; RB; PHOSPHORYLATION; LOCALIZATION; IDENTIFICATION; DEGRADATION; MECHANISM; BINDING	Retinoblastoma is a childhood retinal tumor that develops from cone photoreceptor precursors in response to inactivating RB1 mutations and loss of functional RB protein. The cone precursor's response to RB loss involves cell type-specific signaling circuitry that helps to drive tumorigenesis. One component of the cone precursor circuitry, the thyroid hormone receptor beta 2 (TR beta 2), enables the aberrant proliferation of diverse RB-deficient cells in part by opposing the down-regulation of S-phase kinase-associated protein 2 (SKP2) by the more widely expressed and tumor-suppressive TR beta 1. However, it is unclear how TR beta 2 opposes TR beta 1 to enable SKP2 expression and cell proliferation. Here, we show that in human retinoblastoma cells TR beta 2 mRNA encodes two TR beta 2 protein isoforms: a predominantly cytoplasmic 54-kDa protein (TR beta 2-54) corresponding to the well-characterized full-length murine Tr beta 2 and an N-terminally truncated and exclusively cytoplasmic 46-kDa protein (TR beta 2-46) that starts at Met-79. Whereas TR beta 2 knockdown decreased SKP2 expression and impaired retinoblastoma cell cycle progression, re-expression of TR beta 2-46 but not TR beta 2-54 stabilized SKP2 and restored proliferation to an extent similar to that of ectopic SKP2 restoration. We conclude that TR beta 2-46 is an oncogenic thyroid hormone receptor isoform that promotes SKP2 expression and SKP2-dependent retinoblastoma cell proliferation.	[Li, Zhengke; Qi, Dong-Lai; Singh, Hardeep P.; Cobrinik, David] Childrens Hosp Los Angeles, Vis Ctr, Los Angeles, CA 90027 USA; [Li, Zhengke; Qi, Dong-Lai; Singh, Hardeep P.; Cobrinik, David] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Li, Zhengke; Shen, Binghui] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA; [Li, Zhengke; Zou, Yue] East Tennessee State Univ, Dept Biomed Sci, Quillen Coll Med, Johnson City, TN 37614 USA; [Cobrinik, David] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Med, Los Angeles, CA 90033 USA; [Cobrinik, David] Univ Southern Calif, Keck Sch Med, USC Roski Eye Inst, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; City of Hope; Beckman Research Institute of City of Hope; East Tennessee State University; University of Southern California; University of Southern California	Li, ZK (corresponding author), East Tennessee State Univ, Quillen Coll Med, Johnson City, TN 37614 USA.; Cobrinik, D (corresponding author), Childrens Hosp Los Angeles, 4650 Sunset Blvd,MS 163, Los Angeles, CA 90027 USA.	LIZ01@mail.etsu.edu; dcobrinik@chla.usc.edu	Li, Zhengke/J-8527-2016; Zou, Yue/ABA-8429-2020	Li, Zhengke/0000-0001-5560-343X; Singh, Hardeep/0000-0002-9586-8544; Shen, Binghui/0000-0002-4408-407X	Larry and Celia Moh Foundation; Neonatal Blindness Research Fund; Research to Prevent Blindness; Saban Research Institute research career development fellowship; National Institutes of Health [R01CA085344, P30CA014089, R01EY026661, R01CA137124]; NATIONAL CANCER INSTITUTE [P30CA014089, R01CA137124, R01CA219342, R01CA085344] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY026661] Funding Source: NIH RePORTER	Larry and Celia Moh Foundation; Neonatal Blindness Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Saban Research Institute research career development fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Larry and Celia Moh Foundation, the Neonatal Blindness Research Fund, an unrestricted grant from Research to Prevent Blindness (to the University of Southern California Department of Ophthalmology), a Saban Research Institute research career development fellowship (to D.-L. Q.), and National Institutes of Health Grants R01CA085344 (to B. H. S.), P30CA014089, R01EY026661, and R01CA137124 (to D. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anyetei-Anum CS, 2018, J ENDOCRINOL, V237, pR19, DOI 10.1530/JOE-17-0708; Aranda A, 2009, TRENDS ENDOCRIN MET, V20, P318, DOI 10.1016/j.tem.2009.03.011; BRADLEY DJ, 1994, P NATL ACAD SCI USA, V91, P439, DOI 10.1073/pnas.91.2.439; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Clement E, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao3810; Davis PJ, 2008, STEROIDS, V73, P1013, DOI 10.1016/j.steroids.2007.12.030; Dimaras H, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.21; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Hahm JB, 2013, MOL ENDOCRINOL, V27, P840, DOI 10.1210/me.2012-1117; Hilton BA, 2015, MOL CELL, V60, P35, DOI 10.1016/j.molcel.2015.08.008; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; Hones GS, 2017, P NATL ACAD SCI USA, V114, pE11323, DOI 10.1073/pnas.1706801115; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; Lee TC, 2006, INVEST OPHTH VIS SCI, V47, P5590, DOI 10.1167/iovs.06-0063; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lu ZL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4463; Martin NP, 2014, ENDOCRINOLOGY, V155, P3713, DOI 10.1210/en.2013-2058; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Maruvada P, 2004, MOL BIOL CELL, V15, P1895, DOI 10.1091/mbc.e03-09-0636; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; Oberste-Berghaus C, 2000, J BIOL CHEM, V275, P1787, DOI 10.1074/jbc.275.3.1787; Onishi A, 2010, NAT NEUROSCI, V13, P1059, DOI 10.1038/nn.2618; Privalsky ML, 2009, J BIOL CHEM, V284, P19554, DOI 10.1074/jbc.M109.007542; Qi DL, 2017, ONCOGENE, V36, P1760, DOI 10.1038/onc.2016.350; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Singh HP, 2018, P NATL ACAD SCI USA, V115, pE9391, DOI 10.1073/pnas.1808903115; SJOBERG M, 1995, MOL CELL BIOL, V15, P4718; SJOBERG M, 1992, DEVELOPMENT, V114, P39; Song GJ, 2015, J BIOL CHEM, V290, P2879, DOI 10.1074/jbc.M114.609768; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tamarkin-Ben-Harush A, 2017, ELIFE, V6, DOI 10.7554/eLife.21907; Wan W, 2005, MOL ENDOCRINOL, V19, P1529, DOI 10.1210/me.2005-0014; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Wang X, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166941; WOOD WM, 1994, MOL ENDOCRINOL, V8, P1605, DOI 10.1210/me.8.12.1605; Xu XLL, 2017, CANCER RES, V77, P6838, DOI 10.1158/0008-5472.CAN-16-3299; Xu XLL, 2014, NATURE, V514, P385, DOI 10.1038/nature13813; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang SH, 2017, CANCER CELL, V31, P669, DOI 10.1016/j.ccell.2017.04.004	45	4	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2961	2969		10.1074/jbc.AC118.006041	http://dx.doi.org/10.1074/jbc.AC118.006041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30643022	Green Published, hybrid			2022-12-28	WOS:000459601600034
J	Diaz-Perales, A; Quesada, V; Sanchez, LM; Ugalde, AP; Suarez, MF; Fueyo, A; Lopez-Otin, C				Diaz-Perales, Araceli; Quesada, Victor; Sanchez, Luis M.; Ugalde, Alejandro P.; Suarez, Maria F.; Fueyo, Antonio; Lopez-Otin, Carlos			RETRACTION: Withdrawal: Identification of human aminopeptidase O, a novel metalloprotease with structural similarity to aminopeptidase B and leukotriene A(4) hydrolase. (Retraction of Vol 280, Pg 14310, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Díaz-Perales, Araceli/D-8433-2016; Suárez, María Fernanda Valencia/F-8200-2019; Lopez-Otin, Carlos/AAB-2106-2020; Pineiro Ugalde, Alejandro/AAB-5229-2020	Díaz-Perales, Araceli/0000-0002-1093-3627; Suárez, María Fernanda Valencia/0000-0001-8987-8431; Lopez-Otin, Carlos/0000-0001-6964-1904; Pineiro Ugalde, Alejandro/0000-0003-2522-0627				Diaz-Perales A, 2005, J BIOL CHEM, V280, P14310, DOI 10.1074/jbc.M413222200	1	0	0	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1433	1433		10.1074/jbc.W118.007327	http://dx.doi.org/10.1074/jbc.W118.007327			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30808004	hybrid, Green Published			2022-12-28	WOS:000457879500036
J	Rose, T; Pillet, AH; Lavergne, V; Tamarit, B; Lenormand, P; Rousselle, JC; Namane, A; Theze, J				Rose, Thierry; Pillet, Anne-Helene; Lavergne, Vincent; Tamarit, Blanche; Lenormand, Pascal; Rousselle, Jean-Claude; Namane, Abdelkader; Theze, Jacques			RETRACTION: Withdrawal: Interleukin-7 compartmentalizes its receptor signaling complex to initiate CD4 T lymphocyte response. (Retraction of Vol 285, Pg 14898, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Rose T, 2010, J BIOL CHEM, V285, P14898, DOI 10.1074/jbc.M110.104232	1	0	0	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1436	1436		10.1074/jbc.W118.007350	http://dx.doi.org/10.1074/jbc.W118.007350			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30808007	hybrid, Green Published			2022-12-28	WOS:000457879500039
J	Engelhart, EA; Hoppins, S				Engelhart, Emily A.; Hoppins, Suzanne			A catalytic domain variant of mitofusin requiring a wildtype paralog for function uncouples mitochondrial outer-membrane tethering and fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Charcot-Marie-Tooth disease (CMT); fusion protein; membrane fusion; GTPase; mitochondria; organelle; structure-function; dynamin related protein (DRP); mitochondrial network; tethering	STRUCTURAL BASIS; ENDOPLASMIC-RETICULUM; PROVIDE INSIGHT; MFN1; OPA1; DYNAMICS; FISSION; DIMERIZATION; MORPHOLOGY; FORM	Mitofusins (Mfns) are dynamin-related GTPases that mediate mitochondrial outer-membrane fusion, a process that is required for mitochondrial and cellular health. In Mfn1 and Mfn2 paralogs, a conserved phenylalanine (Phe-202 (Mfn1) and Phe-223 (Mfn2)) located in the GTPase domain on a conserved strand is part of an aromatic network in the core of this domain. To gain insight into the poorly understood mechanism of Mfn-mediated membrane fusion, here we characterize a Mitofusin mutant variant etiologically linked to Charcot-Marie-Tooth syndrome. From analysis of mitochondrial structure in cells and mitochondrial fusion in vitro, we found that conversion of Phe-202 to leucine in either Mfn1 or Mfn2 diminishes the fusion activity of heterotypic complexes with both Mfn1 and Mfn2 and abolishes fusion activity of homotypic complexes. Using coimmunoprecipitation and native gel analysis, we further dissect the steps of mitochondrial fusion and demonstrate that the mutant variant has normal tethering activity but impaired higher-order nucleotide-dependent assembly. The defective coupling of tethering to membrane fusion observed here suggests that nucleotide-dependent self-assembly of Mitofusin is required after tethering to promote membrane fusion.	[Engelhart, Emily A.; Hoppins, Suzanne] Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hoppins, S (corresponding author), Univ Washington, Dept Biochem, 1959 NE Pacific St,Hlth Sci Bldg,J383, Seattle, WA 98195 USA.	shoppins@uw.edu		Hoppins, Suzanne/0000-0002-8070-3560	University of Washington Department of Biochemistry; NIGMS, National Institutes of Health [R01 GM118509, T32GM008268]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118509, T32GM008268] Funding Source: NIH RePORTER	University of Washington Department of Biochemistry; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Washington Department of Biochemistry and NIGMS, National Institutes of Health Grants R01 GM118509 (to S. H.) and T32GM008268 (to E. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Ban T, 2017, NAT CELL BIOL, V19, P856, DOI 10.1038/ncb3560; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Brandt T, 2016, ELIFE, V5, DOI 10.7554/eLife.14618; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Cao YL, 2017, NATURE, V542, P372, DOI 10.1038/nature21077; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Daumke O, 2017, CURR BIOL, V27, pR353, DOI 10.1016/j.cub.2017.03.024; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dorn GW, 2019, ANNU REV PHYSIOL, V81, P1, DOI 10.1146/annurev-physiol-020518-114358; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Hu JJ, 2016, SEMIN CELL DEV BIOL, V60, P105, DOI 10.1016/j.semcdb.2016.06.001; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160; Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Qi YB, 2016, J CELL BIOL, V215, P621, DOI 10.1083/jcb.201609019; Santel A, 2001, J CELL SCI, V114, P867; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Steffen J, 2017, MOL BIOL CELL, V28, P600, DOI 10.1091/mbc.E16-07-0545; Stuppia G, 2015, J NEUROL SCI, V356, P7, DOI 10.1016/j.jns.2015.05.033; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Yan LM, 2018, NAT STRUCT MOL BIOL, V25, P233, DOI 10.1038/s41594-018-0034-8; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	37	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8001	8014		10.1074/jbc.RA118.006347	http://dx.doi.org/10.1074/jbc.RA118.006347			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30936207	Green Published, hybrid			2022-12-28	WOS:000470656500004
J	Mazumder, S; De, R; Debsharma, S; Bindu, S; Maity, P; Sarkar, S; Saha, SJ; Siddiqui, AA; Banerjee, C; Nag, S; Saha, D; Pramanik, S; Mitra, K; Bandyopadhyay, U				Mazumder, Somnath; De, Rudranil; Debsharma, Subhashis; Bindu, Samik; Maity, Pallab; Sarkar, Souvik; Saha, Shubhra Jyoti; Siddiqui, Asim Azhar; Banerjee, Chinmoy; Nag, Shiladitya; Saha, Debanjan; Pramanik, Saikat; Mitra, Kalyan; Bandyopadhyay, Uday			Indomethacin impairs mitochondrial dynamics by activating the PKC-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; apoptosis; oxidative stress; mitochondrial membrane potential; mitochondrial respiratory chain complex; dynamin-related protein 1 (DRP1); kinase signaling	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NF-KAPPA-B; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; SIGNALING PATHWAY; FISSION; DEATH; DRP1; NSAIDS; INJURY	The subcellular mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) induce apoptosis in gastric cancer and normal mucosal cells is elusive because of the diverse cyclooxygenase-independent effects of these drugs. Using human gastric carcinoma cells (AGSs) and a rat gastric injury model, here we report that the NSAID indomethacin activates the protein kinase C (PKC)-p38 MAPK (p38)-dynamin-related protein 1 (DRP1) pathway and thereby disrupts the physiological balance of mitochondrial dynamics by promoting mitochondrial hyper-fission and dysfunction leading to apoptosis. Notably, DRP1 knockdown or SB203580-induced p38 inhibition reduced indomethacin-induced damage to AGSs. Indomethacin impaired mitochondrial dynamics by promoting fissogenic activation and mitochondrial recruitment of DRP1 and down-regulating fusogenic optic atrophy 1 (OPA1) and mitofusins in rat gastric mucosa. Consistent with OPA1 maintaining cristae architecture, its down-regulation resulted in EM-detectable cristae deformity. Deregulated mitochondrial dynamics resulting in defective mitochondria were evident from enhanced Parkin expression and mitochondrial proteome ubiquitination. Indomethacin ultimately induced mitochondrial metabolic and bioenergetic crises in the rat stomach, indicated by compromised fatty acid oxidation, reduced complex I- associated electron transport chain activity, and ATP depletion. Interestingly, Mdivi-1, a fission-preventing mito-protective drug, reversed indomethacin-induced DRP1 phosphorylation on Ser-616, mitochondrial proteome ubiquitination, and mitochondrial metabolic crisis. Mdivi-1 also prevented indomethacin-induced mitochondrial macromolecular damage, caspase activation, mucosal inflammation, and gastric mucosal injury. Our results identify mitochondrial hyper-fission as a critical and common subcellular event triggered by indomethacin that promotes apoptosis in both gastric cancer and normal mucosal cells, thereby contributing to mucosal injury.	[Mazumder, Somnath; De, Rudranil; Debsharma, Subhashis; Maity, Pallab; Sarkar, Souvik; Saha, Shubhra Jyoti; Siddiqui, Asim Azhar; Banerjee, Chinmoy; Nag, Shiladitya; Saha, Debanjan; Pramanik, Saikat; Bandyopadhyay, Uday] CSIR Indian Inst Chem Biol, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India; [Bindu, Samik] Cooch Behar Panchanan Barma Univ, Dept Zool, Cooch Behar 736101, W Bengal, India; [Mitra, Kalyan] CSIR Cent Drug Res Inst, Sophisticated Analyt Instrument Facil, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Bandyopadhyay, U (corresponding author), CSIR Indian Inst Chem Biol, Div Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Maity, Pallab/L-3896-2017	Maity, Pallab/0000-0001-9769-3533; Mazumder, Somnath/0000-0003-3588-4283; De, Rudranil/0000-0001-5846-3479; Bindu, Samik/0000-0003-1416-2003	Council of Scientific and Industrial Research, New Delhi, India [BSC 0206]; DST (J. C. Bose Fellowship) [SB/S2/JCB-54/2014]	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); DST (J. C. Bose Fellowship)(Department of Science & Technology (India))	This work was supported by a Council of Scientific and Industrial Research, New Delhi, India, fellowship (to S. M. and R. D.), Research Grants BEnD, BSC 0206, and DST (J. C. Bose Fellowship) Grant SB/S2/JCB-54/2014. The authors declare that they have no conflicts of interest with the contents of this article.	Akita M, 2014, INT J ONCOL, V45, P1901, DOI 10.3892/ijo.2014.2608; Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32; Anderson EJ, 2012, CLIN EXP PHARMACOL P, V39, P179, DOI 10.1111/j.1440-1681.2011.05641.x; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Atchison JW, 2013, J MANAGE CARE PHARM, V19, pS3; Barbato F, 1997, J PHARM SCI, V86, P225, DOI 10.1021/js960233h; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Biswas D, 2016, FASEB J, V30, P3822, DOI 10.1096/fj.201600571RR; Blair IA, 2008, J BIOL CHEM, V283, P15545, DOI 10.1074/jbc.R700051200; Bordt EA, 2017, DEV CELL, V40, P583, DOI 10.1016/j.devcel.2017.02.020; Boring MA, 2017, MMWR-MORBID MORTAL W, V66, pS27; Brook Robert D., 2000, J Clin Hypertens (Greenwich), V2, P319; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Burian M, 2005, PHARMACOL THERAPEUT, V107, P139, DOI 10.1016/j.pharmthera.2005.02.004; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Carrasco-Pozo C, 2011, J AGR FOOD CHEM, V59, P11501, DOI 10.1021/jf202621d; Chowdhury SR, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.77; Chuang YC, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0262-3; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; Crofford LJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4174; Cryer B, 2001, CURR OPIN GASTROEN, V17, P503, DOI 10.1097/00001574-200111000-00005; da Costa BR, 2017, LANCET, V390, pE21, DOI 10.1016/S0140-6736(17)31744-0; de Groot DJA, 2007, CRIT REV ONCOL HEMAT, V61, P52, DOI 10.1016/j.critrevonc.2006.07.001; Dey S, 2009, FREE RADICAL BIO MED, V46, P271, DOI 10.1016/j.freeradbiomed.2008.10.032; Dey S, 2014, INFECT IMMUN, V82, P3113, DOI 10.1128/IAI.01598-14; Dey S, 2012, J BIOL CHEM, V287, P26630, DOI 10.1074/jbc.M112.341255; Dong YH, 2018, BRIT J CLIN PHARMACO, V84, P1045, DOI 10.1111/bcp.13537; Fernandez-Checa JC, 2010, SIGNALING PATHWAYS IN LIVER DISEASES, SECOND EDITION, P439, DOI 10.1007/978-3-642-00150-5_29; Ferreira-da-Silva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122308; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; FROMM D, 1987, CLIN INVEST MED, V10, P251; Gargaun Serghei, 2014, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V13, P121, DOI 10.2174/1871523012666131229132519; Gharanei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077713; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Gurpinar E, 2014, CLIN CANCER RES, V20, P1104, DOI 10.1158/1078-0432.CCR-13-1573; Gurpinar E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00181; Handa O, 2014, J CLIN BIOCHEM NUTR, V54, P2, DOI 10.3164/jcbn.13-84; Horl WH, 2010, PHARMACEUTICALS, V3, P2291, DOI 10.3390/ph3072291; Huang QC, 2016, AUTOPHAGY, V12, P999, DOI 10.1080/15548627.2016.1166318; Huang SB, 2015, DIABETES, V64, P1728, DOI 10.2337/db14-0758; Hung CHL, 2018, REDOX BIOL, V14, P7, DOI 10.1016/j.redox.2017.08.010; Hunter TS, 2015, AM J MANAG CARE, V21, pS139; Isaya G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00029; IVEY K J, 1988, American Journal of Medicine, V84, P41, DOI 10.1016/0002-9343(88)90253-7; Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010013; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Ki YW, 2013, TOXICOL LETT, V218, P235, DOI 10.1016/j.toxlet.2013.02.003; Kim TI, 2002, ANN NY ACAD SCI, V973, P241, DOI 10.1111/j.1749-6632.2002.tb04641.x; Ko AR, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00124; Ko SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12692-x; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Lee S, 2014, TOX RESEARCH, V30, P243, DOI 10.5487/TR.2014.30.4.243; Lethaby A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000400.pub2; Li XY, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-19; Li YF, 2012, HUM REPROD, V27, P2096, DOI 10.1093/humrep/des110; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lim S, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0089-3; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Luczaj W, 2003, CELL MOL BIOL LETT, V8, P391; LUNDHOLM K, 1994, CANCER RES, V54, P5602; Luo C, 2013, J CELL BIOCHEM, V114, P212, DOI 10.1002/jcb.24356; Manczak M, 2019, HUM MOL GENET, V28, P177, DOI 10.1093/hmg/ddy335; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Mao K, 2013, CELL CYCLE, V12, P3131, DOI 10.4161/cc.26352; Marcum Zachary A, 2010, Ann Longterm Care, V18, P24; Marin-Garcia J, 2016, HEART FAIL REV, V21, P123, DOI 10.1007/s10741-016-9530-2; Matsui H, 2011, J CLIN BIOCHEM NUTR, V48, P107, DOI 10.3164/jcbn.10-79; Mazumder S, 2016, BIOCHEM PHARMACOL, V121, P33, DOI 10.1016/j.bcp.2016.09.027; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mercadante S, 2001, CANCER TREAT REV, V27, P51, DOI 10.1053/ctrv.2000.0192; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Mohanty K, 2016, ASIA-PAC J OPHTHALMO, V5, P293, DOI 10.1097/APO.0000000000000203; Monnier Yan, 2005, Current Drug Targets - Inflammation and Allergy, V4, P31, DOI 10.2174/1568010053622975; Moris D, 2016, BREAST CARE, V11, P339, DOI 10.1159/000452315; Munoz E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198952; Musumba C, 2009, ALIMENT PHARM THER, V30, P517, DOI 10.1111/j.1365-2036.2009.04086.x; Ong CKS, 2007, CLIN MED RES, V5, P17, DOI 10.3121/cmr.2007.698; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pantziarka P, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.610; Parameyong A, 2015, MITOCHONDRION, V24, P1, DOI 10.1016/j.mito.2015.07.004; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Pradere JP, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aab2820; Renault TT, 2014, CHEM BIOL, V21, P114, DOI 10.1016/j.chembiol.2013.10.009; Rosdah AA, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.235; Sanchis-Gomar F, 2016, TRENDS MOL MED, V22, P267, DOI 10.1016/j.molmed.2016.02.007; SCHAFER AI, 1995, J CLIN PHARMACOL, V35, P209, DOI 10.1002/j.1552-4604.1995.tb04050.x; Scholz CC, 2013, P NATL ACAD SCI USA, V110, P18490, DOI 10.1073/pnas.1309718110; Shimura T, 2016, CELL CYCLE, V15, P1099, DOI 10.1080/15384101.2016.1156276; Shorrock C J, 1989, Scand J Rheumatol Suppl, V78, P5; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Smith G, 2017, DEV NEUROBIOL, V77, P1260, DOI 10.1002/dneu.22519; SMOLINSKE SC, 1990, DRUG SAFETY, V5, P252, DOI 10.2165/00002018-199005040-00003; Soh JW, 2003, PROG EXP TUMOR RES, V37, P261; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tang WX, 2013, J NEPHROL, V26, P1073, DOI 10.5301/jn.5000268; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tarnawski AS, 2003, J MOL MED, V81, P627, DOI 10.1007/s00109-003-0479-y; Thakre-Nighot M, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1187325; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Traverso N, 2004, J GERONTOL A-BIOL, V59, P890, DOI 10.1093/gerona/59.9.B890; Vallecillo-Hernandez J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21455-1; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; van Laar Mart, 2012, Open Rheumatol J, V6, P320, DOI 10.2174/1874312901206010320; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wakabayashi Keiji, 2000, Asian Pac J Cancer Prev, V1, P97; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Wang JN, 2015, BIOCHEM BIOPH RES CO, V456, P7, DOI 10.1016/j.bbrc.2014.11.010; Wang LG, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170942; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wigdal SS, 2002, J NEUROCHEM, V82, P1029, DOI 10.1046/j.1471-4159.2002.01049.x; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133; Xu S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.7; Xu SC, 2016, J PINEAL RES, V60, P291, DOI 10.1111/jpi.12310; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2014, J BIOL CHEM, V289, P34074, DOI 10.1074/jbc.M114.588616; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhang H, 2013, SCAND J IMMUNOL, V77, P230, DOI 10.1111/sji.12030; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zhang N, 2013, NEUROSCI LETT, V535, P104, DOI 10.1016/j.neulet.2012.12.049; Zhao XP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01644-0; Zhou X, 2017, ONCOTARGET, V8, P44682, DOI 10.18632/oncotarget.17967	137	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8238	8258		10.1074/jbc.RA118.004415	http://dx.doi.org/10.1074/jbc.RA118.004415			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30940726	Green Published, hybrid			2022-12-28	WOS:000470656500021
J	Szakacs, D; Kocsis, A; Szasz, R; Gal, P; Pal, G				Szakacs, David; Kocsis, Andrea; Szasz, Robert; Gal, Peter; Pal, Gabor			Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; complement system; phage display; serine protease; directed evolution; ischemia; protease inhibitor; complement-targeted therapy; MASP-2; lectin pathway; ischemia-reperfusion injury; serine proteinase	ISCHEMIA-REPERFUSION INJURY; SERINE PROTEASE-1 MASP-1; COMPLEMENT PATHWAY; MYOCARDIAL INJURY; ACTIVATION; PROTEIN; COAGULATION; SYSTEM; AND-2; ASSOCIATION	The lectin pathway (LP) of the complement system is an important antimicrobial defense mechanism, but it also contributes significantly to ischemia reperfusion injury (IRI) associated with myocardial infarct, stroke, and several other clinical conditions. Mannan-binding lectin-associated serine proteinase 2 (MASP-2) is essential for LP activation, and therefore, it is a potential drug target. We have previously developed the first two generations of MASP-2 inhibitors by in vitro evolution of two unrelated canonical serine proteinase inhibitors. These inhibitors were selective LP inhibitors, but their nonhuman origin rendered them suboptimal lead molecules for drug development. Here, we present our third-generation MASP-2 inhibitors that were developed based on a human inhibitor scaffold. We subjected the second Kunitz domain of human tissue factor pathway inhibitor 1 (TFPI1 D2) to directed evolution using phage display to yield inhibitors against human and rat MASP-2. These novel TFPI1-based MASP-2 inhibitor (TFMI-2) variants are potent and selective LP inhibitors in both human and rat serum. Directed evolution of the first Kunitz domain of TFPI1 had already yielded the potent kallikrein inhibitor, Kalbitor (R) (ecallantide), which is an FDA-approved drug to treat acute attacks of hereditary angioedema. Like hereditary angioedema, acute IRI is also related to the uncontrolled activation of a specific plasma serine proteinase. Therefore, TFMI-2 variants are promising lead molecules for drug development against IRI.	[Szakacs, David; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary; [Kocsis, Andrea; Gal, Peter] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary; [Szasz, Robert] Univ Debrecen, Inst Internal Med, Dept Hematol, Nagyerdei Krt 98, H-4032 Debrecen, Hungary; [Pal, Gabor] EvolVeritas Biotechnol Ltd, Somogyi Bela U 17, H-6600 Szentes, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Debrecen	Pal, G (corresponding author), Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.	gabor.pal@ttk.elte.hu	Szakacs, David/K-1985-2018	Szakacs, David/0000-0002-8758-6387; Szasz, Robert/0000-0003-1343-6017; Pal, Gabor/0000-0001-7868-7971	National Research, Development, and Innovation Office (Hungarian Scientific Research Fund) [K119374, K119386]; European Union; State of Hungary; European Regional Development Fund [VEKOP-2.3.2-16-2017-00014]; National Development Agency [KMOP-4.2.1/B-10-2011-0002]	National Research, Development, and Innovation Office (Hungarian Scientific Research Fund); European Union(European Commission); State of Hungary; European Regional Development Fund(European Commission); National Development Agency	This work was supported by National Research, Development, and Innovation Office (Hungarian Scientific Research Fund) Grants K119374 and K119386 and by the European Union and the State of Hungary and co-financed by the European Regional Development Fund within the project VEKOP-2.3.2-16-2017-00014 as well as by National Development Agency Grant KMOP-4.2.1/B-10-2011-0002. David Szakacs, Peter Gal, and Gabor Pal are inventors on the patent application WO2018127719A3 filed by EvolVeritas Biotechnology Ltd. for the TFMI inhibitors. Gabor Pal is a CEO of EvolVeritas Biotechnology Ltd.	Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Asgari E, 2014, FASEB J, V28, P3996, DOI 10.1096/fj.13-246306; Berger N, 2018, J MED CHEM, V61, P6153, DOI 10.1021/acs.jmedchem.8b00560; Boros E, 2019, J MOL BIOL, V431, P557, DOI 10.1016/j.jmb.2018.12.003; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Burgering MJM, 1997, J MOL BIOL, V269, P395, DOI 10.1006/jmbi.1997.1029; Bussiere JL, 2008, EXPERT OPIN DRUG MET, V4, P871, DOI 10.1517/17425255.4.7.871 ; Bussiere JL, 2009, INT J TOXICOL, V28, P230, DOI 10.1177/1091581809337262; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dobo J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01851; Dobo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31877; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Gal P, 2007, IMMUNOBIOLOGY, V212, P267, DOI 10.1016/j.imbio.2006.11.002; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; Harrison RA, 2018, SEMIN IMMUNOPATHOL, V40, P15, DOI 10.1007/s00281-017-0661-x; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; James EC, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2017-000652; Jenny L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191292; Keizer MP, 2015, EUR J IMMUNOL, V45, P544, DOI 10.1002/eji.201445070; Kelly CA, 2005, PROTEIN PEPTIDE LETT, V12, P465, DOI 10.2174/0929866054395383; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lachmann PJ, 2018, IMMUNOBIOLOGY, V223, P519, DOI 10.1016/j.imbio.2018.02.001; Le Quintrec M, 2010, SEMIN THROMB HEMOST, V36, P641, DOI 10.1055/s-0030-1262886; Lunn M, 2011, CLIN MED INSIGHTS-CA, V5, P49, DOI 10.4137/CMC.S4434; Maibaum J, 2016, NAT CHEM BIOL, V12, P1105, DOI [10.1038/NCHEMBIO.2208, 10.1038/nchembio.2208]; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Nayak A, 2010, IMMUNOL LETT, V131, P139, DOI 10.1016/j.imlet.2010.03.012; NOVOTNY WF, 1991, BLOOD, V78, P387; Oroszlan G, 2016, J IMMUNOL, V196, P857, DOI 10.4049/jimmunol.1501717; Orsini F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0684-6; Osthoff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021338; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Palarasah Y, 2010, J CLIN MICROBIOL, V48, P908, DOI 10.1128/JCM.01985-09; Panagiotou A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01151; Parej K, 2018, J IMMUNOL, V200, P2247, DOI 10.4049/jimmunol.1701421; Pavlov VI, 2015, AM J PATHOL, V185, P347, DOI 10.1016/j.ajpath.2014.10.015; Pavlov VI, 2012, CIRCULATION, V126, P2227, DOI 10.1161/CIRCULATIONAHA.112.123968; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Presumey J, 2017, ADV IMMUNOL, V135, P53, DOI 10.1016/bs.ai.2017.06.004; Qasim MA, 1997, BIOCHEMISTRY-US, V36, P1598, DOI 10.1021/bi9620870; Ricklin D, 2018, NAT REV NEPHROL, V14, P26, DOI 10.1038/nrneph.2017.156; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schoos MM, 2013, MOL IMMUNOL, V54, P408, DOI 10.1016/j.molimm.2013.01.008; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Tan PL, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0079-x; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Tuzun E, 2013, AUTOIMMUN REV, V12, P904, DOI 10.1016/j.autrev.2013.03.003; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Zani ML, 2010, BIOCHIMIE, V92, P1689, DOI 10.1016/j.biochi.2010.05.003; Zhang M, 2013, INT J CARDIOL, V166, P499, DOI 10.1016/j.ijcard.2011.11.032; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zuraw B, 2010, NAT REV DRUG DISCOV, V9, P189, DOI 10.1038/nrd3125	67	5	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8227	8237		10.1074/jbc.RA119.008315	http://dx.doi.org/10.1074/jbc.RA119.008315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30952698	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000470656500020
J	Chung, J; Karkhanis, V; Baiocchi, RA; Sif, S				Chung, Jihyun; Karkhanis, Vrajesh; Baiocchi, Robert A.; Sif, Said			Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/beta-catenin and AKT/GSK3 beta proliferative signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein arginine N-methyltransferase 5 (PRMT5); Wnt signaling; Akt PKB; lymphoma; histone; non-Hodgkin's lymphoma; protein arginine methyltransferase 5 (PRMT5); protein kinase B (AKT); glycogen synthase kinase 3; WNT antagonists; WNT; beta-catenin signaling	AKT KINASE TARGETS; HISTONE H3; GENE; METHYLATION; EXPRESSION; INHIBITION; PATHWAY; PHOSPHORYLATION; TRANSLOCATION; ACETYLATION	Epigenetic regulation by the type II protein arginine methyltransferase, PRMT5, plays an essential role in the control of cancer cell proliferation and tumorigenesis. In this report, we investigate the relationship between PRMT5 and WNT/-CATENIN as well as AKT/GSK3 proliferative signaling in three different types of non-Hodgkin's lymphoma cell lines, clinical samples, and mouse primary lymphoma cells. We show that PRMT5 stimulates WNT/-CATENIN signaling through direct epigenetic silencing of pathway antagonists, AXIN2 and WIF1, and indirect activation of AKT/GSK3 signaling. PRMT5 inhibition with either shRNA-mediated knockdown or a specific small molecule PRMT5 inhibitor, CMP-5, not only leads to derepression of WNT antagonists and decreased levels of active phospho-AKT (Thr-450 and Ser-473) and inactive phospho-GSK3 (Ser-9) but also results in decreased transcription of WNT/-CATENIN target genes, CYCLIN D1, c-MYC, and SURVIVIN, and enhanced lymphoma cell death. Furthermore, PRMT5 inhibition leads to reduced recruitment of co-activators CBP, p300, and MLL1, as well as enhanced recruitment of co-repressors HDAC2 and LSD1 to the WNT/-CATENIN target gene promoters. These results indicate that PRMT5 governs expression of prosurvival genes by promoting WNT/-CATENIN and AKT/GSK3 proliferative signaling and that its inhibition induces lymphoma cell death, which warrants further clinical evaluation.	[Chung, Jihyun; Karkhanis, Vrajesh; Baiocchi, Robert A.] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Sif, Said] Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar	University System of Ohio; Ohio State University; Qatar University	Sif, S (corresponding author), Qatar Univ, Coll Arts & Sci, Dept Biol & Environm Sci, Doha, Qatar.	ssif@qu.edu.qa	Sif, Said/AAE-5554-2019	Sif, Said/0000-0001-6268-1145	Leukemia and Lymphoma Society Award [MCL7001-18]; National Research Fund (a member of Qatar Foundation) [NPRP8-617-3-131]; NATIONAL CANCER INSTITUTE [P01CA214274] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society Award(Leukemia and Lymphoma Society); National Research Fund (a member of Qatar Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Leukemia and Lymphoma Society Award MCL7001-18 (to R. A. B.) and National Priorities Research Program Grant NPRP8-617-3-131 from the National Research Fund (a member of Qatar Foundation) (to S. S). The authors declare that they have no conflicts of interest with the contents of this article.	Alinari L, 2015, BLOOD, V125, P2530, DOI 10.1182/blood-2014-12-619783; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Chung JH, 2013, J BIOL CHEM, V288, P35534, DOI 10.1074/jbc.M113.510669; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; Li Y, 2015, CANCER DISCOV, V5, P288, DOI 10.1158/2159-8290.CD-14-0625; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin SY, 2004, ONCOL REP, V11, P341; Liu Y, 2013, FEBS LETT, V587, P847, DOI 10.1016/j.febslet.2013.02.023; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McCubrey JA, 2014, LEUKEMIA, V28, P15, DOI 10.1038/leu.2013.184; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Motllo C, 2010, CANCER GENET CYTOGEN, V203, P328, DOI 10.1016/j.cancergencyto.2010.08.018; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nogai H, 2011, J CLIN ONCOL, V29, P1803, DOI 10.1200/JCO.2010.33.3252; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; PEZZELLA F, 1989, LANCET, V1, P779; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Shailesh Harshita, 2018, Oncotarget, V9, P36705, DOI 10.18632/oncotarget.26404; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Srivastava S, 2017, CELL CYCLE, V16, P1515, DOI 10.1080/15384101.2017.1339846; Stevenson FK, 2001, ADV CANCER RES, V83, P81, DOI 10.1016/S0065-230X(01)83004-9; Swerdlow SH, 2008, WHO CLASSIFICATION T, P229; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Thorvaldsen TE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170508; Torres C Hernandez, 2018, J Assoc Genet Technol, V44, P141; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wang JF, 2017, AM J PATHOL, V187, P1700, DOI 10.1016/j.ajpath.2017.04.009; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wang Q, 2016, MOL ENDOCRINOL, V30, P856, DOI 10.1210/me.2015-1310; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yang LH, 2013, TUMOR BIOL, V34, P749, DOI 10.1007/s13277-012-0604-z; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhang P, 2015, GENE DEV, V29, P123, DOI 10.1101/gad.254870.114; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	51	44	46	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7692	7710		10.1074/jbc.RA119.007640	http://dx.doi.org/10.1074/jbc.RA119.007640			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30885941	hybrid, Green Published			2022-12-28	WOS:000470153300015
J	Ejaz, A; Goldgur, Y; Shuman, S				Ejaz, Anam; Goldgur, Yehuda; Shuman, Stewart			Activity and structure of Pseudomonas putida MPE, a manganese-dependent single-strand DNA endonuclease encoded in a nucleic acid repair gene cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA endonuclease; DNA repair; enzyme structure; manganese; metalloenzyme; phosphodiesterases	ESCHERICHIA-COLI; MRE11 NUCLEASE; PROTEIN; BREAK; PHOSPHODIESTERASE; RECOGNITION; INSIGHTS; HELICASE; FAMILY; LHR	A recently identified and widely prevalent prokaryal gene cluster encodes a suite of enzymes with imputed roles in nucleic acid repair. The enzymes are as follows: MPE, a DNA endonuclease; Lhr-Core, a 3-5 DNA helicase; LIG, an ATP-dependent DNA ligase; and Exo, a metallo--lactamase-family nuclease. Bacterial and archaeal MPE proteins belong to the binuclear metallophosphoesterase superfamily that includes the well-studied DNA repair nucleases Mre11 and SbcD. Here, we report that the Pseudomonas putida MPE protein is a manganese-dependent DNA endonuclease that incises either linear single strands or the single-strand loops of stem-loop DNA structures. MPE has feeble activity on duplex DNA. A crystal structure of MPE at 2.2 resolution revealed that the active site includes two octahedrally coordinated manganese ions. Seven signature amino acids of the binuclear metallophosphoesterase superfamily serve as the enzymic metal ligands in MPE: Asp(33), His(35), Asp(78), Asn(112), His(124), His(146), and His(158). A swath of positive surface potential on either side of the active site pocket suggests a binding site for the single-strand DNA substrate. The structure of MPE differs from Mre11 and SbcD in several key respects: (i) MPE is a monomer, whereas Mre11 and SbcD are homodimers; (ii) MPE lacks the capping domain present in Mre11 and SbcD; and (iii) the topology of the sandwich that comprises the core of the metallophosphoesterase fold differs in MPE vis-a-vis Mre11 and SbcD. We surmise that MPE exemplifies a novel clade of DNA endonuclease within the binuclear metallophosphoesterase superfamily.	[Ejaz, Anam; Shuman, Stewart] Sloan Kettering Inst, Mol Biol Program, New York, NY 10065 USA; [Goldgur, Yehuda] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			NCI, National Institutes of Health [P30-CA008748]; NIGMS, National Institutes of Health [P41GM103403, P41GM103473, P41GM111244]; NIH-ORIP [HEI S10RR029205]; Department of Energy [DE-AC02-06CH11357, DE-AC02-98CH10886, E-SC0012704]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P41GM103403, R35GM126945] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP; Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Memorial Sloan Kettering Cancer Center structural biology core laboratory is supported by NCI, National Institutes of Health, Grant P30-CA008748. X-ray diffraction data were collected at synchrotron facilities supported by grants and contracts from NIGMS, National Institutes of Health (P41GM103403, P41GM103473, and P41GM111244), NIH-ORIP (HEI S10RR029205), and the Department of Energy (DE-AC02-06CH11357, DE-AC02-98CH10886, and E-SC0012704).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chen SF, 2004, J BIOL CHEM, V279, P31854, DOI 10.1074/jbc.M401059200; Connelly JC, 1997, J BIOL CHEM, V272, P19819, DOI 10.1074/jbc.272.32.19819; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; Ejaz A, 2018, J BIOL CHEM, V293, P17491, DOI 10.1074/jbc.RA118.005296; Ejaz A, 2018, NUCLEIC ACIDS RES, V46, P442, DOI 10.1093/nar/gkx1163; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Liu S, 2014, ACTA CRYSTALLOGR D, V70, P299, DOI 10.1107/S139900471302693X; Matange N, 2015, BIOCHEM J, V467, P201, DOI 10.1042/BJ20150028; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Okada C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32822; Ordonez H, 2013, J BIOL CHEM, V288, P14125, DOI 10.1074/jbc.M113.466854; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Paull TT, 2018, MOL CELL, V71, P419, DOI 10.1016/j.molcel.2018.06.033; Schiller CB, 2012, NAT STRUCT MOL BIOL, V19, P693, DOI 10.1038/nsmb.2323; Seifert FU, 2015, ACTA CRYSTALLOGR F, V71, P752, DOI 10.1107/S2053230X15007566; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sung S, 2014, EMBO J, V33, P2422, DOI 10.15252/embj.201488299; Uson ML, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00304-17; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017	25	4	4	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7931	7941		10.1074/jbc.RA119.008049	http://dx.doi.org/10.1074/jbc.RA119.008049			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30894417	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000470153300032
J	McGregor, NE; Murat, M; Elango, J; Poulton, IJ; Walker, EC; Crimeen-Irwin, B; Ho, PWM; Gooi, JH; Martin, TJ; Sims, NA				McGregor, Narelle E.; Murat, Melissa; Elango, Jeevithan; Poulton, Ingrid J.; Walker, Emma C.; Crimeen-Irwin, Blessing; Ho, Patricia W. M.; Gooi, Jonathan H.; Martin, T. John; Sims, Natalie A.			IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoblast; osteocyte; osteoclast; interleukin 6 (IL-6); STAT3; cell signaling; bone; cytokine; inflammation; bone growth; osteopenia	SOLUBLE INTERLEUKIN-6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; DESIGNER CYTOKINE; IN-VIVO; DIFFERENTIATION; EXPRESSION; ACTIVATOR; CELLS; BLOCKADE	Interleukin 6 (IL-6) supports development of bone-resorbing osteoclasts by acting early in the osteoblast lineage via membrane-bound (cis) or soluble (trans) receptors. Here, we investigated how IL-6 signals and modifies gene expression in differentiated osteoblasts and osteocytes and determined whether these activities can promote bone formation or support osteoclastogenesis. Moreover, we used a genetically altered mouse with circulating levels of the pharmacological IL-6 trans-signaling inhibitor sgp130-Fc to determine whether IL-6 trans-signaling is required for normal bone growth and remodeling. We found that IL-6 increases suppressor of cytokine signaling 3 (Socs3) and CCAAT enhancer-binding protein (Cebpd) mRNA levels and promotes signal transducer and activator of transcription 3 (STAT3) phosphorylation by both cis- and trans-signaling in cultured osteocytes. In contrast, RANKL (Tnfsf11) mRNA levels were elevated only by trans-signaling. Furthermore, we observed soluble IL-6 receptor release and ADAM metallopeptidase domain 17 (ADAM17) sheddase expression by osteocytes. Despite the observation that IL-6 cis-signaling occurs, IL-6 stimulated bone formation in vivo only via trans-signaling. Although IL-6 stimulated RANKL (Tnfsf11) mRNA in osteocytes, these cells did not support osteoclast formation in response to IL-6 alone; binucleated TRAP+ cells formed, and only in response to trans-signaling. Finally, pharmacological, sgp130-Fc-mediated inhibition of IL-6 trans-signaling did not impair bone growth or remodeling unless mice had circulating sgp130-Fc levels > 10 g/ml. At those levels, osteopenia and impaired bone growth occurred, reducing bone strength. We conclude that high sgp130-Fc levels may have detrimental off-target effects on the skeleton.	[McGregor, Narelle E.; Murat, Melissa; Elango, Jeevithan; Poulton, Ingrid J.; Walker, Emma C.; Crimeen-Irwin, Blessing; Ho, Patricia W. M.; Martin, T. John; Sims, Natalie A.] St Vincents Inst Med Res, Bone Cell Biol & Dis Unit, Melbourne, Vic 3065, Australia; [Elango, Jeevithan] Shanghai Ocean Univ, Coll Food Sci & Technol, Dept Marine Biopharmacol, Shanghai 201306, Peoples R China; [Murat, Melissa] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia; [Gooi, Jonathan H.; Martin, T. John; Sims, Natalie A.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic 3065, Australia; [Gooi, Jonathan H.] St Vincents Inst Med Res, Struct Biol Unit, Melbourne, Vic 3065, Australia	St. Vincent's Institute of Medical Research; Shanghai Ocean University; La Trobe University; St Vincent's Hospital Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research	Sims, NA (corresponding author), St Vincents Inst Med Res, Bone Biol & Dis Unit, 9 Princes St, Fitzroy, Vic 3065, Australia.	nsims@svi.edu.au	Gooi, Jonathan/AAS-7982-2020; Elango, Jeevithan/Y-8106-2019; Sims, Natalie Ann/A-7192-2012	Gooi, Jonathan/0000-0002-8839-1602; Elango, Jeevithan/0000-0003-4115-9918; Sims, Natalie Ann/0000-0003-1421-8468	National Health and Medical Research Council (Australia); Victorian State Government Operational Infrastructure Support scheme	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support scheme	This work was supported by the National Health and Medical Research Council (Australia) through project grant funding (to N. A. S. and T. J. M.). St. Vincent's Institute is supported by the Victorian State Government Operational Infrastructure Support scheme. The authors declare that they have no conflicts of interest with the contents of this article.	Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bakker AD, 2014, J DENT RES, V93, P394, DOI 10.1177/0022034514522485; Bellido T, 1996, J CLIN INVEST, V97, P431, DOI 10.1172/JCI118432; Bellido T, 1997, ENDOCRINOLOGY, V138, P3666, DOI 10.1210/en.138.9.3666; Chia LY, 2015, BONE, V72, P34, DOI 10.1016/j.bone.2014.11.005; Cho DC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00920-x; CORNISH J, 1993, ENDOCRINOLOGY, V132, P1359, DOI 10.1210/en.132.3.1359; Dallas DJ, 1999, BONE, V25, P9, DOI 10.1016/S8756-3282(99)00099-X; Dame JB, 2000, EARLY HUM DEV, V58, P25, DOI 10.1016/S0378-3782(00)00064-5; Dreymueller D, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9621724; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Gao Y, 1998, BONE, V22, P487, DOI 10.1016/S8756-3282(98)00040-4; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Girasole G, 1999, CLIN ENDOCRINOL, V51, P801, DOI 10.1046/j.1365-2265.1999.00896.x; Hall KC, 2013, MOL CELL BIOL, V33, P3077, DOI 10.1128/MCB.00291-13; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; HONDA M, 1992, J IMMUNOL, V148, P2175; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Johnson RW, 2015, BONE, V81, P343, DOI 10.1016/j.bone.2015.08.005; Johnson RW, 2014, J BONE MINER RES, V29, P1492, DOI 10.1002/jbmr.2159; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kartsogiannis V, 2008, J BIOL CHEM, V283, P30850, DOI 10.1074/jbc.M801761200; Kotake S, 1996, J BONE MINER RES, V11, P88; Kyrtsonis MC, 1996, BRIT J HAEMATOL, V93, P398, DOI 10.1046/j.1365-2141.1996.4721018.x; Lazzaro L, 2018, BONE, V112, P120, DOI 10.1016/j.bone.2018.04.015; Li Y, 2008, CYTOKINE, V43, P165, DOI 10.1016/j.cyto.2008.05.007; LITTLEWOOD AJ, 1991, ENDOCRINOLOGY, V129, P1513, DOI 10.1210/endo-129-3-1513; MARTIN TJ, 1987, METHOD ENZYMOL, V145, P324; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; MITSUYAMA K, 1995, GUT, V36, P45, DOI 10.1136/gut.36.1.45; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Poulton IJ, 2012, J BONE MINER RES, V27, P586, DOI 10.1002/jbmr.1485; Quinn JMW, 2008, J IMMUNOL, V181, P5720, DOI 10.4049/jimmunol.181.8.5720; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Rakemann T, 1999, J BIOL CHEM, V274, P1257, DOI 10.1074/jbc.274.3.1257; Richards CD, 2000, CYTOKINE, V12, P613, DOI 10.1006/cyto.1999.0635; ROODMAN GD, 1992, J CLIN INVEST, V89, P46, DOI 10.1172/JCI115584; Rose-John S, 2017, CLIN PHARMACOL THER, V102, P591, DOI 10.1002/cpt.782; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; SUDA T, 1995, BONE, V17, pS87, DOI 10.1016/8756-3282(95)00185-G; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; UDAGAWA N, 1995, J EXP MED, V182, P1461, DOI 10.1084/jem.182.5.1461; Walker EC, 2016, J BIOL CHEM, V291, P21703, DOI 10.1074/jbc.M116.748483; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; Wong PKK, 2006, ARTHRITIS RHEUM-US, V54, P158, DOI 10.1002/art.21537; Wu Andy C, 2014, Bonekey Rep, V3, P571, DOI 10.1038/bonekey.2014.66; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	61	38	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7850	7863		10.1074/jbc.RA119.008074	http://dx.doi.org/10.1074/jbc.RA119.008074			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30923130	Green Published, hybrid			2022-12-28	WOS:000470153300026
J	Chatterjee, BK; Jayaraj, A; Kumar, V; Blagg, B; Davis, RE; Jayaram, B; Deep, S; Chaudhuri, TK				Chatterjee, Bhaskar K.; Jayaraj, Abhilash; Kumar, Vinay; Blagg, Brian; Davis, Rachel E.; Jayaram, B.; Deep, Shashank; Chaudhuri, Tapan K.			Stimulation of heat shock protein 90 chaperone function through binding of a novobiocin analog KU-32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; heat shock protein 90 (Hsp90); molecular dynamics; conformational change; protein-drug interaction; allosteric modulation; chaperone-assisted protein folding; KU-32; novobiocin; neuropathy	MOLECULAR-DYNAMICS; HSP90 INHIBITOR; ATP HYDROLYSIS; COMPUTATIONAL PROTOCOL; CANCER-CELLS; NUCLEOTIDE; AGGREGATION; AFFINITIES; DOCKING; CYCLE	Heat shock protein 90 (Hsp90) is a eukaryotic chaperone responsible for the folding and functional activation of numerous client proteins, many of which are oncoproteins. Thus, Hsp90 inhibition has been intensely pursued, resulting in the development of many potential Hsp90 inhibitors, not all of which are well-characterized. Hsp90 inhibitors not only abrogate its chaperone functions, but also could help us gain insight into the structure-function relationship of this chaperone. Here, using biochemical and cell-based assays along with isothermal titration calorimetry, we investigate KU-32, a derivative of the Hsp90 inhibitor novobiocin (NB), for its ability to modulate Hsp90 chaperone function. Although NB and KU-32 differ only slightly in structure, we found that upon binding, they induce completely opposite conformational changes in Hsp90. We observed that NB and KU-32 both bind to the C-terminal domain of Hsp90, but surprisingly, KU-32 stimulated the chaperone functions of Hsp90 via allosteric modulation of its N-terminal domain, responsible for the chaperone's ATPase activity. In vitro and in silico studies indicated that upon KU-32 binding, Hsp90 undergoes global structural changes leading to the formation of a partially closed intermediate that selectively binds ATP and increases ATPase activity. We also report that KU-32 promotes HeLa cell survival and enhances the refolding of an Hsp90 substrate inside the cell. This discovery explains the effectiveness of KU-32 analogs in the management of neuropathies and may facilitate the design of molecules that promote cell survival by enhancing Hsp90 chaperone function and reducing the load of misfolded proteins in cells.	[Chatterjee, Bhaskar K.; Chaudhuri, Tapan K.] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, Hauz Khas, New Delhi 110016, India; [Jayaraj, Abhilash; Jayaram, B.] Indian Inst Technol Delhi, Supercomp Facil Bioinformat & Computat Biol, Hauz Khas, New Delhi 110016, India; [Kumar, Vinay; Deep, Shashank] Indian Inst Technol Delhi, Dept Chem, Hauz Khas, New Delhi 110016, India; [Blagg, Brian; Davis, Rachel E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Kumar, Vinay] Indian Inst Technol Delhi, Clensta Int Private Ltd, FITT BBIF Bldg,Hauz Khas, New Delhi 110016, India; [Blagg, Brian; Davis, Rachel E.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46554 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Kansas; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Notre Dame	Chaudhuri, TK (corresponding author), Indian Inst Technol Delhi, Kusuma Sch Biol Sci, Hauz Khas, New Delhi 110016, India.	tkchaudhuri@bioschool.iitd.ac.in	Chatterjee, Bhaskar Kumar/AAZ-5204-2021; blagg, brian s j/X-7770-2018; Davis, Rachel/P-5448-2017	Chatterjee, Bhaskar Kumar/0000-0003-2626-5763; blagg, brian s j/0000-0002-6200-3480; Jayaram, B/0000-0002-5495-2213; Davis, Rachel/0000-0003-0359-381X	Indian Institute of Technology (Delhi, India); Kusuma Trust	Indian Institute of Technology (Delhi, India); Kusuma Trust	B. K. C. and T. K. C. thank Prof. Johannes Buchner and Dr. William Kaelin Jr. for providing the Hsp90 beta and firefly luciferase plasmids, respectively, and for answering certain queries related to this work. The authors would also like to thank Jon Tally for carefully reading the manuscript and providing valuable suggestions. B. K. C. thanks Harsha Rohira and Ashutosh Pastor for constant support, encouragement, andtechnical advice. B. K. C., A. J., V. K., B. J., S. D., and T. K. C. thank the Indian Institute of Technology (Delhi, India) and Kusuma Trust for their financial support and for providing the infrastructure required to execute this project.	Ahsan A, 2012, NEOPLASIA, V14, P670, DOI 10.1593/neo.12986; Ansar S, 2007, BIOORG MED CHEM LETT, V17, P1984, DOI 10.1016/j.bmcl.2007.01.017; Bagatell R, 2004, MOL CANCER THER, V3, P1021; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cohen SM, 2012, ANN SURG ONCOL, V19, pS483, DOI 10.1245/s10434-011-1971-1; Colombo G, 2008, P NATL ACAD SCI USA, V105, P7976, DOI 10.1073/pnas.0802879105; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Daturpalli S, 2013, J MOL BIOL, V425, P4614, DOI 10.1016/j.jmb.2013.08.006; Didenko T, 2012, BBA-MOL CELL RES, V1823, P636, DOI 10.1016/j.bbamcr.2011.11.009; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Eskew JD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-468; Farmer K, 2012, EXP DIABETES RES, DOI 10.1155/2012/671673; French JB, 2013, P NATL ACAD SCI USA, V110, P2528, DOI 10.1073/pnas.1300173110; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Gupta A, 2007, PROTEIN PEPTIDE LETT, V14, P632; Hiss DC, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-5; Jain T, 2005, FEBS LETT, V579, P6659, DOI 10.1016/j.febslet.2005.10.031; Jain T, 2007, PROTEINS, V67, P1167, DOI 10.1002/prot.21332; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krukenberg KA, 2009, J MOL BIOL, V390, P278, DOI 10.1016/j.jmb.2009.04.080; Lee Samuel M, 2012, Commun Integr Biol, V5, P107; Li J, 2012, ACTA BIOCH BIOPH SIN, V44, P300, DOI 10.1093/abbs/gms001; Li PF, 2016, J CHEM INF MODEL, V56, P599, DOI 10.1021/acs.jcim.5b00674; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Maiti P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/495091; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Matts RL, 2011, ACS CHEM BIOL, V6, P800, DOI 10.1021/cb200052x; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2015, ANNU REV PHARMACOL, V55, P353, DOI 10.1146/annurev-pharmtox-010814-124332; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Shelton SN, 2009, MOL PHARMACOL, V76, P1314, DOI 10.1124/mol.109.058545; Singh T, 2015, MOL BIOSYST, V11, P1041, DOI 10.1039/c5mb00003c; Solarova Z, 2015, INT J ONCOL, V46, P907, DOI 10.3892/ijo.2014.2791; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Vital A, 2014, J PERIPHER NERV SYST, V19, P44, DOI 10.1111/jns5.12056; Wang J, 2014, AMBER14 REFERENCE MA; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Yu XM, 2005, J AM CHEM SOC, V127, P12778, DOI 10.1021/ja0535864; Zhang HQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09542; Zhang XY, 2018, ACS CHEM NEUROSCI, V9, P381, DOI 10.1021/acschemneuro.7b00377; Zhao HP, 2012, ACS MED CHEM LETT, V3, P327, DOI 10.1021/ml300018e	56	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6450	6467		10.1074/jbc.RA118.002502	http://dx.doi.org/10.1074/jbc.RA118.002502			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30792306	hybrid, Green Published			2022-12-28	WOS:000468402000022
J	Miao, R; Lung, SC; Li, X; Li, XD; Chye, ML				Miao, Rui; Lung, Shiu-Cheung; Li, Xin; Li, Xiang David; Chye, Mee-Len			Thermodynamic insights into an interaction between ACYL-CoA-BINDING PROTEIN2 and LYSOPHOSPHOLIPASE2 in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lysophospholipid; thermodynamics; isothermal titration calorimetry (ITC); enzyme mutation; structural model; molecular docking; ankyrin; lipid metabolism; lysophosphatidylcholine; protein-protein interaction	CATALYTIC TRIAD; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; NITRIC-OXIDE; HEAVY-METAL; CADMIUM; GENE; EXPRESSION; TOLERANCE; LIPASE	Lysophospholipids (LPLs) are important lipid-signaling molecules in plants, of which lysophosphatidylcholine (lysoPC) is one of the most well-characterized LPLs, having important roles in plant stress responses. It is broken down by lysophospholipases, but the molecular mechanism involved in lysoPC degradation is unclear. Recombinant Arabidopsis thaliana ACYL-CoA-BINDING PROTEIN2 (AtACBP2) has been reported to bind lysoPC via its acyl-CoA-binding domain and also LYSOPHOSPHOLIPASE 2 (AtLYSOPL2) via its ankyrin repeats in vitro. To investigate the interactions of AtACBP2 with AtLYSOPL2 and lysoPC in more detail, we conducted isothermal titration calorimetry with AtACBP2(70-354), an AtACBP2 derivative consisting of amino acids 70-354, containing both the acyl-CoA-binding domain and ankyrin repeats. We observed that the interactions of AtACBP2(70-354) with AtLYSOPL2 and lysoPC were both endothermic, favored by solvation entropy and opposed by enthalpy, with dissociation constants in the micromolar range. Of note, three AtLYSOPL2 catalytic triad mutant proteins (S147A, D268A, and H298A) bound lysoPC only weakly, with an exothermic burst and dissociation constants in the millimolar range. Furthermore, the binding affinity of lysoPC-premixed AtACBP2(70-354) to AtLYSOPL2 was 10-fold higher than that of AtACBP2(70-354) alone to AtLYSOPL2. We conclude that AtACBP2 may play a role in facilitating a direct interaction between AtLYSOPL2 and lysoPC. Our results suggest that AtACBP2(70-354) probably binds to lysoPC through a hydrophobic interface that enhances a hydrotropic interaction of AtACBP2(70-354) with AtLYSOPL2 and thereby facilitates AtLYSOPL2's lysophospholipase function.	[Miao, Rui; Lung, Shiu-Cheung; Chye, Mee-Len] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China; [Li, Xin; Li, Xiang David] Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Peoples R China; [Chye, Mee-Len] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong	Chye, ML (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China.	mlchye@hku.hk	Lung, Shiu-Cheung/I-6597-2019; Li, Xin/X-5971-2018; Li, Xin/U-2944-2019; Li, Xiang/ABG-9385-2020; Miao, Rui/AAD-4159-2020	Lung, Shiu-Cheung/0000-0002-6433-4988; Li, Xin/0000-0001-9698-1883; Li, Xin/0000-0001-9698-1883; Li, Xiang/0000-0002-2797-4134; Miao, Rui/0000-0003-0956-6310	Wilson and Amelia Wong Endowment Fund; Research Grants Council of the Hong Kong Special Administrative Region, China [17101818, AoE/M-05/12, AoE/M-403/16]; Innovation Technology Fund of the Innovation Technology Commission	Wilson and Amelia Wong Endowment Fund; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Innovation Technology Fund of the Innovation Technology Commission	This work was supported by the Wilson and Amelia Wong Endowment Fund, Research Grants Council of the Hong Kong Special Administrative Region, China, Grants 17101818, AoE/M-05/12, and AoE/M-403/16, and Innovation Technology Fund of the Innovation Technology Commission (Funding Support to State Key Laboratory of Agrobiotechnology in Hong Kong). The authors declare that they have no conflicts of interest with the contents of this article.	Abdullah N, 2014, BIOPHYS J, V106, P382, DOI 10.1016/j.bpj.2013.11.4492; ASAOKA Y, 1992, P NATL ACAD SCI USA, V89, P6447, DOI 10.1073/pnas.89.14.6447; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Clemens S, 2016, ANNU REV PLANT BIOL, V67, P489, DOI 10.1146/annurev-arplant-043015-112301; D'Arrigo P, 2010, MOLECULES, V15, P1354, DOI 10.3390/molecules15031354; DalCorso G, 2008, J INTEGR PLANT BIOL, V50, P1268, DOI 10.1111/j.1744-7909.2008.00737.x; de Kroon AIPM, 2013, PROG LIPID RES, V52, P374, DOI 10.1016/j.plipres.2013.04.006; De Michele R, 2009, PLANT PHYSIOL, V150, P217, DOI 10.1104/pp.108.133397; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fong YH, 2011, J BIOL CHEM, V286, P43241, DOI 10.1074/jbc.M111.296830; Gao W, 2009, NEW PHYTOL, V181, P89, DOI 10.1111/j.1469-8137.2008.02631.x; Gao W, 2010, PLANT J, V62, P989, DOI 10.1111/j.1365-313X.2010.04209.x; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; Gutierrez-Fernandez J, 2014, J STRUCT BIOL, V187, P215, DOI 10.1016/j.jsb.2014.07.007; Hariharan P, 2015, P NATL ACAD SCI USA, V112, P2407, DOI 10.1073/pnas.1500891112; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hong YW, 2000, P NATL ACAD SCI USA, V97, P8717, DOI 10.1073/pnas.140213697; Hsu KH, 2010, J APPL MICROBIOL, V108, P1712, DOI 10.1111/j.1365-2672.2009.04569.x; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Kawaguchi M, 2011, J AM CHEM SOC, V133, P12021, DOI 10.1021/ja201028t; Khairnar NP, 2013, J BACTERIOL, V195, P2880, DOI 10.1128/JB.01503-12; Kim RJ, 2016, PLANT J, V85, P758, DOI 10.1111/tpj.13146; Kulik A, 2012, PLANT PHYSIOL, V160, P868, DOI 10.1104/pp.112.194472; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Li MY, 2011, PLANT CELL, V23, P1107, DOI 10.1105/tpc.110.081240; Lung SC, 2018, NEW PHYTOL, V218, P183, DOI 10.1111/nph.14965; Lung SC, 2017, PLANT PHYSIOL, V174, P1420, DOI 10.1104/pp.17.00412; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murohara T, 1996, CIRC RES, V78, P780, DOI 10.1161/01.RES.78.5.780; Park J, 2012, PLANT J, V69, P278, DOI 10.1111/j.1365-313X.2011.04789.x; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Ryu SB, 2004, TRENDS PLANT SCI, V9, P229, DOI 10.1016/j.tplants.2004.03.004; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanchez R, 2000, METH MOL B, V143, P97; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Suzuki T, 2016, ANAL SCI, V32, P741, DOI 10.2116/analsci.32.741; Taskinen JP, 2007, PROTEINS, V66, P229, DOI 10.1002/prot.21124; Torkhovskaya TI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P125, DOI 10.1134/S0006297907020010; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Vijayaraj P, 2012, PLANT PHYSIOL, V160, P667, DOI 10.1104/pp.112.202135; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1439, P1, DOI 10.1016/S1388-1981(99)00063-3; Wang AJ, 1997, J BIOL CHEM, V272, P22030, DOI 10.1074/jbc.272.35.22030; Wang AJ, 1997, J BIOL CHEM, V272, P12723, DOI 10.1074/jbc.272.19.12723; Wang XM, 2004, CURR OPIN PLANT BIOL, V7, P329, DOI 10.1016/j.pbi.2004.03.012; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wi SJ, 2014, PHYTOCHEMISTRY, V104, P48, DOI 10.1016/j.phytochem.2014.04.009; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x; Wuhanqimuge, 2013, FEBS OPEN BIO, V3, P243, DOI 10.1016/j.fob.2013.05.003; Zabela MD, 2002, MOL PLANT MICROBE IN, V15, P808, DOI 10.1094/MPMI.2002.15.8.808; Zhai ZY, 2014, PLANT CELL, V26, P2249, DOI 10.1105/tpc.114.123737	63	15	15	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6214	6226		10.1074/jbc.RA118.006876	http://dx.doi.org/10.1074/jbc.RA118.006876			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30782848	Green Published, hybrid			2022-12-28	WOS:000468402000002
J	Li, Y; Inoki, K; Vacratsis, P; Guan, KL				Li, Yong; Inoki, Ken; Vacratsis, Panayiotis; Guan, Kun-Liang			The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3 (vol 278, pg 13663, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Guan, Kun-Liang/ADK-7088-2022					Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5807	5807		10.1074/jbc.AAC119.008435	http://dx.doi.org/10.1074/jbc.AAC119.008435			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30979849	Green Published, hybrid			2022-12-28	WOS:000465077500008
J	Das, AK; Kudlacek, O; Baumgart, F; Jaentsch, K; Stockner, T; Sitte, HH; Schutz, GJ				Das, Anand Kant; Kudlacek, Oliver; Baumgart, Florian; Jaentsch, Kathrin; Stockner, Thomas; Sitte, Harald H.; Schuetz, Gerhard J.			Dopamine transporter forms stable dimers in the live cell plasma membrane in a phosphatidylinositol 4,5-bisphosphate-independent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; dopamine transporter; single-molecule biophysics; dimerization; inositol phospholipid; protein-protein interaction; neurotransmitter; single-molecule brightness analysis; synaptic transmission	SINGLE-MOLECULE ANALYSIS; SEROTONIN-TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; MONOAMINE TRANSPORTERS; OLIGOMER FORMATION; CHOLESTEROL OXIDASES; CROSS-LINKING; LIVING CELLS; AMPHETAMINE; COCAINE	The human dopamine transporter (hDAT) regulates the level of the neurotransmitter dopamine (DA) in the synaptic cleft and recycles DA for storage in the presynaptic vesicular pool. Many neurotransmitter transporters exist as oligomers, but the physiological role of oligomerization remains unclear; for example, it has been speculated to be a prerequisite for amphetamine-induced release and protein trafficking. Previous studies point to an oligomeric quaternary structure of hDAT; however, the exact stoichiometry and the fraction of co-existing oligomeric states are not known. Here, we used single-molecule brightness analysis to quantify the degree of oligomerization of heterologously expressed hDAT fused to monomeric GFP (mGFP-hDAT) in Chinese hamster ovary (CHO) cells. We observed that monomers and dimers of mGFP-hDAT co-exist and that higher-order molecular complexes of mGFP-hDAT are absent at the plasma membrane. The mGFP-hDAT dimers were stable over several minutes, and the fraction of dimers was independent of the mGFP-hDAT surface density. Furthermore, neither oxidation nor depletion of cholesterol had any effect on the fraction of dimers. Unlike for the human serotonin transporter (hSERT), in which direct binding of phosphatidylinositol 4,5-bisphosphate (PIP2) stabilized the oligomers, the stability of mGFP-hDAT dimers was PIP2 independent.	[Das, Anand Kant; Baumgart, Florian; Schuetz, Gerhard J.] TU Wien, Inst Appl Phys, Getreidemarkt 9, A-1060 Vienna, Austria; [Kudlacek, Oliver; Jaentsch, Kathrin; Stockner, Thomas; Sitte, Harald H.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria	Technische Universitat Wien; Medical University of Vienna	Schutz, GJ (corresponding author), TU Wien, Inst Appl Phys, Getreidemarkt 9, A-1060 Vienna, Austria.; Sitte, HH (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13a, A-1090 Vienna, Austria.	harald.sitte@meduniwien.ac.at; schuetz@iap.tuwien.ac.at	Sitte, Harald/O-7025-2019; Stockner, Thomas/A-9509-2014	Sitte, Harald/0000-0002-1339-7444; Stockner, Thomas/0000-0002-7071-8283; Das, Anand/0000-0003-0740-8140; Kudlacek, Oliver/0000-0002-3086-8551	Austrian Science Fund/FWF; Vienna Science and Technology Fund [CS15-033]	Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Vienna Science and Technology Fund	This work was supported by Austrian Science Fund/FWF F35 (to T. S., H. H. S., and G. J. S) and Vienna Science and Technology Fund Grant CS15-033 (to H. H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Akiva E, 2008, P NATL ACAD SCI USA, V105, P13292, DOI 10.1073/pnas.0801207105; Alguel Y, 2016, BIOCHEM SOC T, V44, P1737, DOI 10.1042/BST20160217; Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Anderluh A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14089; Anderluh A, 2014, J BIOL CHEM, V289, P4387, DOI 10.1074/jbc.M113.531632; Barrera NP, 2013, TRENDS CELL BIOL, V23, P1, DOI 10.1016/j.tcb.2012.08.007; Baucum AJ, 2004, J NEUROSCI, V24, P3436, DOI 10.1523/JNEUROSCI.0387-04.2004; BERGER SP, 1994, MOL PHARMACOL, V46, P726; Block ER, 2015, J NEUROSCI, V35, P12845, DOI 10.1523/JNEUROSCI.1391-15.2015; Brameshuber M, 2012, METHOD ENZYMOL, V505, P159, DOI 10.1016/B978-0-12-388448-0.00017-6; Buchmayer F, 2013, P NATL ACAD SCI USA, V110, P11642, DOI 10.1073/pnas.1220552110; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Christian AE, 1997, J LIPID RES, V38, P2264; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Das AK, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0187; de Meyer FJM, 2008, BIOPHYS J, V95, P1851, DOI 10.1529/biophysj.107.124164; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Fjorback AW, 2009, BIOCHEM BIOPH RES CO, V380, P724, DOI 10.1016/j.bbrc.2009.01.128; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hamilton PJ, 2014, NAT CHEM BIOL, V10, P582, DOI [10.1038/NCHEMBIO.1545, 10.1038/nchembio.1545]; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Javanainen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187936; Jayaraman K, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006229; Jess U, 1996, FEBS LETT, V394, P44, DOI 10.1016/0014-5793(96)00916-7; Jones KT, 2012, J NEUROCHEM, V123, P700, DOI 10.1111/jnc.12007; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Kocabas AM, 2003, J NEUROCHEM, V85, P1513, DOI 10.1046/j.1471-4159.2003.01793.x; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; Ma SQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05637-x; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Masson J, 1999, PHARMACOL REV, V51, P439; METZGER H, 1992, J IMMUNOL, V149, P1477; MILNER HE, 1994, BBA-BIOMEMBRANES, V1190, P185, DOI 10.1016/0005-2736(94)90051-5; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; MOLNAR I, 1993, MOL MICROBIOL, V7, P419, DOI 10.1111/j.1365-2958.1993.tb01133.x; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pizzo AB, 2013, MOL PSYCHIATR, V18, P824, DOI 10.1038/mp.2012.82; Rahbek-Clemmensen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00790-3; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sampson NS, 2003, ACCOUNTS CHEM RES, V36, P713, DOI 10.1021/ar9800587; Sarkar B, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00084; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Sevcsik E, 2016, BIOESSAYS, V38, P129, DOI 10.1002/bies.201500150; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sucic S, 2013, J BIOL CHEM, V288, P5330, DOI 10.1074/jbc.M112.408237; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sweeney CG, 2017, J BIOL CHEM, V292, P1302, DOI 10.1074/jbc.M116.762872; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Zahniser NR, 2009, SEMIN CELL DEV BIOL, V20, P411, DOI 10.1016/j.semcdb.2009.01.004; Zhen J, 2018, J NEUROCHEM, V144, P162, DOI 10.1111/jnc.14259	77	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5632	5642		10.1074/jbc.RA118.006178	http://dx.doi.org/10.1074/jbc.RA118.006178			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30705091	Green Published, hybrid			2022-12-28	WOS:000464517500031
J	Musier-Forsyth, K				Musier-Forsyth, Karin			Aminoacyl-tRNA synthetases and tRNAs in human disease: an introduction to the JBC Reviews thematic series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						aminoacyl tRNA synthetase; transfer RNA (tRNA); neurological disease; cancer; Charcot-Marie-Tooth disease (CMT); human disease; human immunodeficiency virus (HIV); mitochondrial tRNA-synthetases; multisynthetase complex; therapeutic targets		Aminoacyl-tRNA synthetases (ARSs) catalyze the attachment of specific amino acids to cognate tRNAs for use in protein synthesis. This historical function of ARSs and tRNAs is fairly well understood. However, ARSs and tRNAs also perform noncanonical functions that are continuing to be unveiled at a rapid pace. The expanded functions of these essential molecules of life range from roles in retroviral replication to stimulation of mammalian target of rapamycin (mTOR) activity; DNA repair, splicing, and transcriptional and translational regulation; and other aspects of cellular homeostasis. Furthermore, mutations in tRNAs and synthetases are known to drive human maladies, such as the neurodegenerative disorder Charcot-Marie-Tooth disease along with other central nervous system dysfunctions and cancer. This series of reviews focuses on the diseases that result from natural variations in human cytoplasmic tRNAs, as well as from mutations in mitochondrial tRNAs and ARSs. Ultimately, the exciting work in this rapidly emerging area may lead to new therapies for microbial and parasitic infections, cancer, and neurodegenerative diseases.	[Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol, Columbus, OH 43210 USA; [Musier-Forsyth, Karin] Ohio State Univ, Ctr Retroviral Res, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Musier-Forsyth, K (corresponding author), Ohio State Univ, 100 West 18th Ave, Columbus, OH 43210 USA.	musier-forsyth.1@osu.edu						Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Francklyn CS, 2019, J BIOL CHEM, V294, P5365, DOI 10.1074/jbc.REV118.002956; Gonzalez-Serrano LE, 2019, J BIOL CHEM, V294, P5309, DOI 10.1074/jbc.REV118.002953; Hyeon DY, 2019, J BIOL CHEM, V294, P5340, DOI 10.1074/jbc.REV118.002958; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jin DN, 2019, J BIOL CHEM, V294, P5352, DOI 10.1074/jbc.REV118.002957; Lant JT, 2019, J BIOL CHEM, V294, P5294, DOI 10.1074/jbc.REV118.002982; Wei N, 2019, J BIOL CHEM, V294, P5321, DOI 10.1074/jbc.REV118.002955	9	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5292	5293		10.1074/jbc.REV119.007721	http://dx.doi.org/10.1074/jbc.REV119.007721			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30799306	Green Published, hybrid			2022-12-28	WOS:000464517500005
J	Cho, E; Kang, H; Kang, DK; Lee, Y				Cho, Eunjin; Kang, HyunJun; Kang, Dae-Ki; Lee, Youngsook			Myocardial-specific ablation of Jumonji and AT-rich interaction domain-containing 2 (Jarid2) leads to dilated cardiomyopathy in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heart failure; cardiomyopathy; gene regulation; cardiomyocyte; gene expression; Cardiomyocyte maturation; Dilated cardiomyopathy; Jarid2; Jumonji family; muscle contraction	CARDIAC DEVELOPMENT; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; HEART-FAILURE; JUMONJI; PROTEIN; TRANSCRIPTION; REGENERATION; MUSCLE; ROLES	Cardiomyopathy is a common myocardial disease that can lead to sudden death. However, molecular mechanisms underlying cardiomyopathy remain unclear. Jumonji and AT-rich interaction domain-containing 2 (Jarid2) is necessary for embryonic heart development, but functions of Jarid2 after birth remain to be elucidated. Here, we report that myocardial-specific deletion of Jarid2 using alpha MHC::Cre mice (Jarid2(alpha MHC)) causes dilated cardiomyopathy (DCM) and premature death 6-9 months after birth. To determine functions of Jarid2 in the adult heart and DCM, we analyzed gene expression in the heart at postnatal day (p)10 (neonatal) and 7 months (DCM). Pathway analyses revealed that dysregulated genes in Jarid2(alpha MHC) hearts at p10, prior to cardiomyopathy, represented heart development and muscle contraction pathways. At 7 months, down-regulated genes in Jarid2(alpha MHC) hearts were enriched in metabolic process and ion channel activity pathways and up-regulated genes in extracellular matrix components. In normal hearts, expression levels of contractile genes were increased from p10 to 7 months but were not sufficiently increased in Jarid2(alpha MHC) hearts. Moreover, Jarid2 was also necessary to repress fetal contractile genes such as TroponinI1, slow skeletal type (Tnni1) and Actin alpha 2, smooth muscle (Acta2) in neonatal stages through ErbB2-receptor tyrosine kinase 4 (ErbB4) signaling. Interestingly, Ankyrin repeat domain 1 (Ankrd1) and Neuregulin 1 (Nrg1), whose expression levels are known to be increased in the failing heart, were already elevated in Jarid2(alpha MHC) hearts within 1 month of birth. Thus, we demonstrate that ablation of Jarid2 in cardiomyocytes results in DCM and suggest that Jarid2 plays important roles in cardiomyocyte maturation during neonatal stages.	[Cho, Eunjin; Lee, Youngsook] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53705 USA; [Cho, Eunjin; Lee, Youngsook] Univ Wisconsin, Mol & Cellular Pharmacol Grad Program, Madison, WI 53705 USA; [Kang, HyunJun] Univ Wisconsin, Natl Primate Res Ctr, Madison, WI 53705 USA; [Kang, Dae-Ki] Dongseo Univ, Dept Comp Engn, Busan 47011, South Korea	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Dongseo University	Lee, Y (corresponding author), Univ Wisconsin, Wisconsin Inst Med Res 2, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, 1111 Highland Ave, Madison, WI 53705 USA.	youngsooklee@wisc.edu	Kang, Dae-Ki/AAL-2185-2020	Kang, Dae-Ki/0000-0002-4147-2835	National Institutes of Health [HL067050]; American Heart Association [12GRNT12070021]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported in part by National Institutes of Health Grant HL067050 and American Heart Association Grant 12GRNT12070021 (to Y. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker AH, 2016, CELL STEM CELL, V19, P563, DOI 10.1016/j.stem.2016.10.011; Bang ML, 2017, J CELL PHYSIOL, V232, P38, DOI 10.1002/jcp.25424; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bovill E, 2008, J THORAC CARDIOV SUR, V136, P709, DOI 10.1016/j.jtcvs.2008.02.020; Brody MJ, 2013, J MOL CELL CARDIOL, V62, P237, DOI 10.1016/j.yjmcc.2013.05.020; Brody MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051621; Burke MA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86898; Camacho P, 2016, AM J CARDIOVASC DIS, V6, P70; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104040; Cho EJ, 2018, J BIOL CHEM, V293, P11659, DOI 10.1074/jbc.RA118.002482; Costa-Silva J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190152; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Dupays L, 2009, DEV BIOL, V333, P121, DOI 10.1016/j.ydbio.2009.06.025; Elahi MM, 2014, MOL BIOL REP, V41, P7209, DOI 10.1007/s11033-014-3605-8; Fahrenbach JP, 2014, FASEB J, V28, P2804, DOI 10.1096/fj.13-244459; Ghosh AK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063825, 10.1371/journal.pone.0069949]; Goldbergova MP, 2012, GENET TEST MOL BIOMA, V16, P1172, DOI 10.1089/gtmb.2012.0120; Gorsi B, 2010, DEV DYNAM, V239, P3312, DOI 10.1002/dvdy.22456; Hafver TL, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600417; Hall DD, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92476; Harvey RP, 2016, HEART LUNG CIRC, V25, P4, DOI 10.1016/j.hlc.2015.08.014; He AB, 2012, CIRC RES, V110, P406, DOI 10.1161/CIRCRESAHA.111.252205; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hou N, 2017, EXP MOL PATHOL, V103, P267, DOI 10.1016/j.yexmp.2017.11.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang DD, 2018, BIOCHEM BIOPH RES CO, V499, P403, DOI 10.1016/j.bbrc.2018.03.052; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Kumar D, 2016, J MOL ENDOCRINOL, V56, pT63, DOI 10.1530/JME-15-0266; Laforet P, 2017, CURR OPIN NEUROL, V30, P449, DOI 10.1097/WCO.0000000000000484; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2000, CIRC RES, V86, P932, DOI 10.1161/01.RES.86.9.932; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li L, 2018, MATRIX BIOL, V68-69, P490, DOI 10.1016/j.matbio.2018.01.013; Ling SSM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071362; Louzao-Martinez L, 2016, INT J CARDIOL, V220, P634, DOI 10.1016/j.ijcard.2016.06.253; Major JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170066; Mao X, 2017, J NEUROPHYSIOL, V117, P28, DOI 10.1152/jn.00307.2016; Maurer SF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17704; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Mercurio V, 2016, J CARD FAIL, V22, P449, DOI 10.1016/j.cardfail.2016.04.008; Mizuta K, 2015, DEV DYNAM, V244, P31, DOI 10.1002/dvdy.24216; Morton SU, 2016, CLIN PERINATOL, V43, P395, DOI 10.1016/j.clp.2016.04.001; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Mysliwiec MR, 2006, GENESIS, V44, P407, DOI 10.1002/dvg.20221; Mysliwiec MR, 2012, J BIOL CHEM, V287, P1235, DOI 10.1074/jbc.M111.315945; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Nevil M, 2017, GENETICS, V205, P605, DOI 10.1534/genetics.116.195685; O'Donnell PJ, 2003, J MOL CELL CARDIOL, V35, P915, DOI 10.1016/S0022-2828(03)00171-8; Perez-Serra A, 2016, INT J CARDIOL, V224, P461, DOI 10.1016/j.ijcard.2016.09.068; Porayette P, 2014, PEDIATR DEVEL PATHOL, V17, P209, DOI 10.2350/13-08-1370-CR.1; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Rupert CE, 2015, BIOMARK INSIGHTS, V10, P1, DOI [10.4137/BMI.S20061, 10.4137/BMIMI.S20061]; Seok HY, 2014, CIRC RES, V114, P1585, DOI 10.1161/CIRCRESAHA.114.303784; Shameem K, 2015, INT J CARDIOL, V189, P73, DOI 10.1016/j.ijcard.2015.04.069; Smith SJ, 2016, DEV BIOL, V416, P373, DOI 10.1016/j.ydbio.2016.05.006; Somekawa S, 2012, P NATL ACAD SCI USA, V109, P12064, DOI 10.1073/pnas.1207210109; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Talukder MAH, 2007, AM J PHYSIOL-HEART C, V293, pH2418, DOI 10.1152/ajpheart.00663.2007; Tzahor E, 2017, SCIENCE, V356, P1035, DOI 10.1126/science.aam5894; Ujfalusi Z, 2018, J BIOL CHEM, V293, P9017, DOI 10.1074/jbc.RA118.001938; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Vogel P, 2010, VET PATHOL, V47, P703, DOI 10.1177/0300985810363485; Wang F, 2012, MOL BIOL REP, V39, P9075, DOI 10.1007/s11033-012-1778-6; Yin ZY, 2015, BBA-MOL BASIS DIS, V1852, P47, DOI 10.1016/j.bbadis.2014.11.003; Young P, 2005, MOL CELL NEUROSCI, V30, P238, DOI 10.1016/j.mcn.2005.07.015; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhao J, 2016, METHOD ENZYMOL, V568, P477, DOI 10.1016/bs.mie.2015.09.012; Zhong L, 2015, CARDIOVASC RES, V106, P261, DOI 10.1093/cvr/cvv108; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	79	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4981	4996		10.1074/jbc.RA118.005634	http://dx.doi.org/10.1074/jbc.RA118.005634			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30700554	Green Published, hybrid			2022-12-28	WOS:000463985600022
J	Strogolova, V; Hoang, NH; Hosler, J; Stuart, RA				Strogolova, Vera; Hoang, Ngoc H.; Hosler, Jonathan; Stuart, Rosemary A.			The yeast mitochondrial proteins Rcf1 and Rcf2 support the enzymology of the cytochrome c oxidase complex and generation of the proton motive force	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; proton motive force; cytochrome oxidase; bioenergetics; mitochondrial respiratory chain complex; OXPHOS; Rcf1; Rcf2	SUBUNIT-III; SACCHAROMYCES-CEREVISIAE; RHODOBACTER-SPHAEROIDES; SUICIDE INACTIVATION; REGULATORY ROLE; MEMBRANE; SUPERCOMPLEX; MODULATION; SAFRANINE; GLUCOSE	The yeast mitochondrial proteins Rcf1 and Rcf2 are associated with a subpopulation of the cytochrome bc(1)-cytochrome c oxidase supercomplex and have been proposed to play a role in the assembly and/or modulation of the activity of the cytochrome c oxidase (complex IV, CIV). Yeast mutants deficient in either Rcf1 or Rcf2 proteins can use aerobic respiration-based metabolism for growth, but the absence of both proteins results in a strong growth defect. In this study, using assorted biochemical and biophysical analyses of Rcf1/Rcf2 single and double null-mutant yeast cells and mitochondria, we further explored how Rcf1 and Rcf2 support aerobic respiration and growth. We show that the absence of Rcf1 physically reduces the levels of CIV and diminishes the ability of the CIV that is present to maintain a normal mitochondrial proton motive force (PMF). Although the absence of Rcf2 did not noticeably affect the physical content of CIV, the PMF generated by CIV was also lower than normal. Our results indicate that the detrimental effects of the absence of Rcf1 and Rcf2 proteins on the CIV complex are distinct in terms of CIV assembly/accumulation and additive in terms of the ability of CIV to generate PMF. Thus, the combined absence of Rcf1 and Rcf2 alters both CIV physiology and assembly. We conclude that the slow aerobic growth of the Rcf1/Rcf2 double null mutant results from diminished generation of mitochondrial PMF by CIV and limits the level of CIV activity required for maintenance of the PMF and growth under aerobic conditions.	[Strogolova, Vera; Stuart, Rosemary A.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Hoang, Ngoc H.; Hosler, Jonathan] Univ Mississippi, Med Ctr, Dept Cell & Mol Biol, Jackson, MS 39216 USA	Marquette University; University of Mississippi; University of Mississippi Medical Center	Stuart, RA (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	rosemary.stuart@marquette.edu		Stuart, Rosemary/0000-0002-9751-5494	National Science Foundation [MCB-1157722]; National Institutes of Health [R15GM101594, R15GM117551, P20GM121334]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121334] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB-1157722 and National Institutes of Health Grants R15GM101594 and R15GM117551 (to R. A. S.) and P20GM121334 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Ameri Kurosh, 2015, Mol Cell Oncol, V2, pe1030537, DOI 10.1080/23723556.2015.1030537; Ameri K, 2015, CELL REP, V10, P891, DOI 10.1016/j.celrep.2015.01.020; Ameri K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062758; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Blomberg MRA, 2012, BBA-BIOENERGETICS, V1817, P495, DOI 10.1016/j.bbabio.2011.09.014; Bratton MR, 1999, BIOCHEMISTRY-US, V38, P16236, DOI 10.1021/bi9914107; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Ferguson-Miller S., 2018, MECH PRIMARY ENERGY, P215; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Garlich J, 2017, J BIOL CHEM, V292, P5216, DOI 10.1074/jbc.M116.758045; Gilderson G, 2003, BIOCHEMISTRY-US, V42, P7400, DOI 10.1021/bi0341298; HILL BC, 1986, J BIOL CHEM, V261, P5356; KOVAC L, 1982, BIOCHIM BIOPHYS ACTA, V721, P341, DOI 10.1016/0167-4889(82)90088-X; Krumschnabel G, 2014, METHOD ENZYMOL, V542, P163, DOI 10.1016/B978-0-12-416618-9.00009-1; Lee HJ, 2010, J AM CHEM SOC, V132, P16225, DOI 10.1021/ja107244g; Liang RB, 2017, P NATL ACAD SCI USA, V114, P5924, DOI 10.1073/pnas.1703654114; Lundin CR, 2017, FEBS LETT, V591, P4049, DOI 10.1002/1873-3468.12918; Lundin CR, 2016, P NATL ACAD SCI USA, V113, pE4476, DOI 10.1073/pnas.1601196113; Nguyen XT, 2002, PROTEIN EXPRES PURIF, V26, P122, DOI 10.1016/S1046-5928(02)00503-X; Rompler K, 2016, J BIOL CHEM, V291, P23769, DOI 10.1074/jbc.M116.734665; SARTI P, 1985, P NATL ACAD SCI USA, V82, P4876, DOI 10.1073/pnas.82.15.4876; Schafer J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29567-4; Schafer J, 2018, BBA-BIOENERGETICS, V1859, P699, DOI 10.1016/j.bbabio.2018.05.004; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Su CH, 2014, MOL BIOL CELL, V25, P965, DOI [10.1091/mbc.E13-0-0575, 10.1091/mbc.E13-10-0575]; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Varanasi L, 2006, BIOCHEMISTRY-US, V45, P14896, DOI 10.1021/bi061390q; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; Wikstrom M, 2018, CHEM REV, V118, P2469, DOI 10.1021/acs.chemrev.7b00664; Winge DR, 2012, MOL CELL BIOL, V32, P2647, DOI 10.1128/MCB.00573-12; Yoshikawa S, 2012, BBA-BIOENERGETICS, V1817, P579, DOI 10.1016/j.bbabio.2011.12.012	36	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4867	4877		10.1074/jbc.RA118.006888	http://dx.doi.org/10.1074/jbc.RA118.006888			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30683696	Green Published, hybrid			2022-12-28	WOS:000463985600012
J	Wang, L; Ferrao, R; Li, QB; Hatcher, JM; Choi, HG; Buhrlage, SJ; Gray, NS; Wu, H				Wang, Li; Ferrao, Ryan; Li, Qiubai; Hatcher, John M.; Choi, Hwan Geun; Buhrlage, Sara J.; Gray, Nathanael S.; Wu, Hao			Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor-associated kinase 4 (IRAK4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; structural biology; crystal structure; Toll-like receptor (TLR); drug development; inactive conformation; inflammation; IRAK4; kinase; type II inhibition	CRYSTAL-STRUCTURES; ACTIVATION; DISCOVERY; INNATE; MYD88; MODEL; OPTIMIZATION; INFECTIONS; MECHANISM; MUTATION	Interleukin-1 receptor-associated kinase 4 (IRAK4) is a key player in innate immune and inflammatory responses, performing a critical role in signal transduction downstream of Toll-like receptors and interleukin-1 (IL-1) receptors. Upon ligand binding and via its N-terminal death domain, IRAK4 is recruited to an oligomeric receptor that is proximal to the Myddosome signaling complex, inducing IRAK4 kinase domain dimerization, autophosphorylation, and activation. To date, all known IRAK4 structures are in the active conformation, precluding a good understanding of IRAK4's conformational dynamics. To address this issue, here we first solved three crystal structures of the IRAK4 kinase domain (at 2.6 resolution), in its unphosphorylated, inactive state bound to either the ATP analog AMP-PNP or to one of the two small-molecule inhibitors JH-I-25 and JH-I-17. The structures disclosed that although the structure in complex with AMP-PNP is in an C-out inactive conformation, those in complex with type I inhibitors assume an active Asp-Phe-Gly (DFG)-in and C-in conformation. The ability of unphosphorylated IRAK4 to take on variable conformations prompted us to screen for small-molecule inhibitors that bind preferentially to unphosphorylated IRAK4, leading to the identification of ponatinib and HG-12-6. Solving the structures of unphosphorylated IRAK4 in complex with these two inhibitors, we found that they both bind as type II inhibitors with IRAK4 in a DFG-out conformation. Collectively, these structures reveal conformational flexibility of unphosphorylated IRAK4 and provide unexpected insights into the potential use of small molecules to modulate IRAK4 activity in cancer, autoimmunity, and inflammation.	[Wang, Li; Ferrao, Ryan; Li, Qiubai; Hatcher, John M.; Choi, Hwan Geun; Buhrlage, Sara J.; Gray, Nathanael S.; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wang, Li; Ferrao, Ryan; Li, Qiubai; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Hatcher, John M.; Choi, Hwan Geun; Buhrlage, Sara J.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Dana-Farber Cancer Institute	Wu, H (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	wu@crystal.harvard.edu		, Hao/0000-0002-7281-8579	NIH-ORIP HEI Grant [S10 RR029205]; Department of Energy Office of Science [DE-AC02-06CH11357]; NIGMS, National Institutes of Health [P41 GM103403]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD087988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	NIH-ORIP HEI Grant; Department of Energy Office of Science(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Qun Liu for collecting data of IRAK4 bound to JH-I-25. The Pilatus 6M detector on 24-ID-C beam line is funded by NIH-ORIP HEI Grant S10 RR029205. This research used resources of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. This work was partially based upon research conducted at the Northeastern Collaborative Access Team Beamlines, which are funded by NIGMS, National Institutes of Health Grant P41 GM103403.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Buckley GM, 2008, BIOORG MED CHEM LETT, V18, P3211, DOI 10.1016/j.bmcl.2008.04.058; Cameron B, 2012, J NEUROSCI, V32, P15112, DOI 10.1523/JNEUROSCI.1729-12.2012; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Hanisak J, 2016, BIOORG MED CHEM LETT, V26, P4250, DOI 10.1016/j.bmcl.2016.07.048; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kim TW, 2011, J IMMUNOL, V186, P2871, DOI 10.4049/jimmunol.1002242; Koziczak-Holbro M, 2009, ARTHRITIS RHEUM-US, V60, P1661, DOI 10.1002/art.24552; Kuglstatter A, 2007, J IMMUNOL, V178, P2641, DOI 10.4049/jimmunol.178.5.2641; Lee KL, 2017, J MED CHEM, V60, P5521, DOI 10.1021/acs.jmedchem.7b00231; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Lim J, 2015, ACS MED CHEM LETT, V6, P683, DOI 10.1021/acsmedchemlett.5b00107; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lye E, 2008, EUR J IMMUNOL, V38, P870, DOI 10.1002/eji.200737429; McElroy WT, 2015, ACS MED CHEM LETT, V6, P677, DOI 10.1021/acsmedchemlett.5b00106; McElroy WT, 2015, BIOORG MED CHEM LETT, V25, P1836, DOI 10.1016/j.bmcl.2015.03.043; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; RAea Laskowski, 1993, J APPL CRYST, V26; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Schneider EV, 2011, J MOL BIOL, V412, P251, DOI 10.1016/j.jmb.2011.07.020; SchulzeGahmen U, 1996, J MED CHEM, V39, P4540, DOI 10.1021/jm960402a; Seganish WM, 2015, ACS MED CHEM LETT, V6, P942, DOI 10.1021/acsmedchemlett.5b00279; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Smith GF, 2017, BIOORG MED CHEM LETT, V27, P2721, DOI 10.1016/j.bmcl.2017.04.050; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	44	6	6	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4511	4519		10.1074/jbc.RA118.005428	http://dx.doi.org/10.1074/jbc.RA118.005428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30679311	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000462969500019
J	Chen, YJ; Cohen, TJ				Chen, Youjun; Cohen, Todd J.			Aggregation of the nucleic acid-binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TAR DNA-binding protein 43 (TDP-43) (TARDBP); stress granule; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); post-translational modification (PTM); histone deacetylase 6 (HDAC6); neurodegeneration; amyloid; protein aggregation; amyloid; motor neuron disease; neurodegeneration; oxidative stress; protein aggregation	MENTAL-RETARDATION PROTEIN; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; DEACETYLASE HDAC6; PHASE-TRANSITION; RNA TRANSLATION; MESSENGER-RNA; MUTATIONS; FUS; ACETYLATION	TAR DNA-binding protein 43 (TDP-43) is a nucleic acid-binding protein, and its aggregation represents the defining pathology in amyotrophic lateral sclerosis (ALS) and related proteinopathies. Recent studies implicate cytoplasmic stress granules (SGs) as hubs that may facilitate TDP-43 aggregation. Here, using cellular fractionation, biochemical analyses, and histological assays, we show that TDP-43 targeted to the cytoplasm has multiple fates. Whereas a TDP-43 subpopulation is indeed recruited to SGs, mature aggregated TDP-43, produced with aggregate-prone TDP-43 variants or exposure to oxidative stress, generates distinct TDP-43 inclusions that are surprisingly devoid of SGs. Consistent with this observation, we found that SG components are predominantly excluded from TDP-43 pathology in motor neurons from individuals with ALS. We generated de novo SGs by expressing the fragile X protein (FMRP) and found that rather than directly engaging TDP-43 aggregates, SGs can sequester the proteostasis factor histone deacetylase 6 (HDAC6) and thereby impede TDP-43 clearance from cells. These findings indicate that SGs form distinct cytoplasmic structures that can indirectly enhance TDP-43 aggregation. Therapeutic approaches that inhibit SG formation may therefore be effective at suppressing TDP-43-mediated toxicity in patients with ALS and related TDP-43 proteinopathies.	[Chen, Youjun; Cohen, Todd J.] Univ N Carolina, Neurosci Ctr, Dept Neurol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Cohen, TJ (corresponding author), Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA.	toddcohen@neurology.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; , Pathology Services Core/CEZ-2246-2022		National Institutes of Health [R00 NS080985, R01NS105981]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105981, R00NS080985, P30NS045892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R00 NS080985 (to T. J. C.) and R01NS105981 (to T. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Aulas A, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00423, 10.3389/fncel.2015.00423]; Bhandare VV, 2018, J BIOMOL STRUCT DYN, V36, P1075, DOI 10.1080/07391102.2017.1310670; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Coyne AN, 2015, HUM MOL GENET, V24, P6886, DOI 10.1093/hmg/ddv389; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; DEWEY CM, 2011, J BACTERIOL, V193, P1098, DOI DOI 10.1128/MCB.01279-10; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gal J, 2013, J BIOL CHEM, V288, P15035, DOI 10.1074/jbc.M112.431957; Gopal PP, 2017, P NATL ACAD SCI USA, V114, pE2466, DOI 10.1073/pnas.1614462114; Guo WT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00911-y; Hirsch-Reinshagen V, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0493-x; Hwang AW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168913; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kametani F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23281; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023075; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu-Yesucevitz L, 2011, J NEUROSCI, V31, P16086, DOI 10.1523/JNEUROSCI.4105-11.2011; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IR, 2017, NEURON, V95, P808, DOI 10.1016/j.neuron.2017.07.025; Majumder P, 2016, ACTA NEUROPATHOL, V132, P721, DOI 10.1007/s00401-016-1603-8; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; McGurk L, 2018, MOL CELL, V71, P703, DOI 10.1016/j.molcel.2018.07.002; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Monahan Z, 2016, BRAIN RES, V1649, P189, DOI 10.1016/j.brainres.2016.05.022; Moreno F, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0190-6; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Shelkovnikova TA, 2014, HUM MOL GENET, V23, P5211, DOI 10.1093/hmg/ddu243; Taes I, 2013, HUM MOL GENET, V22, P1783, DOI 10.1093/hmg/ddt028; Valle C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00005; Wang P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00088-4; Yu ZP, 2012, J BIOL CHEM, V287, P22560, DOI 10.1074/jbc.M112.357582; Zhang LL, 2015, PROTEIN CELL, V6, P42, DOI 10.1007/s13238-014-0102-8; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	55	47	47	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3696	3706		10.1074/jbc.RA118.006351	http://dx.doi.org/10.1074/jbc.RA118.006351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30630951	Green Published, hybrid			2022-12-28	WOS:000461853900031
J	Witkowski, A; Carta, S; Lu, R; Yokoyama, S; Rubartelli, A; Cavigiolio, G				Witkowski, Andrzej; Carta, Sonia; Lu, Rui; Yokoyama, Shinji; Rubartelli, Anna; Cavigiolio, Giorgio			Oxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; amyloid; atherosclerosis; cytokine induction; inflammation; interleukin; macrophage; oxidation-reduction (redox); Toll-like receptor (TLR); methionine oxidation; apolipoprotein A-I; cytokines; DAMP; inflammation; methionine oxidation	HIGH-DENSITY-LIPOPROTEIN; TOLL-LIKE RECEPTORS; NLRP3 INFLAMMASOME; STERILE INFLAMMATION; ALZHEIMERS-DISEASE; CHOLESTEROL EFFLUX; INTERLEUKIN-1-BETA; ACTIVATION; PROTEIN; ATHEROSCLEROSIS	Amyloid deposits of apolipoprotein A-I (apoA-I) and inflammation are common in atherosclerotic arteries. In this study, we investigated the interplay between oxidation of apoA-I methionine residues (Met(O)-ApoA-I), a known amyloidogenic modification of apoA-I, and the inflammatory response of immune cells. Soluble pre-fibrillar Met(O)-ApoA-I, but not apoA-I, induced intracellular accumulation of pro-interleukin (IL)-1 and secretion of the pro-inflammatory cytokines tumor necrosis factor (TNF) and IL-6 in mouse bone marrow-derived macrophages (BMDMs) and human primary monocytes. Additionally, secretion of mature IL-1 was also activated in human monocytes. The pro-inflammatory activity of Met(O)-ApoA-I was Toll-like receptor 4 (TLR4)-dependent and CD36-independent and was solely determined by oxidation of apoA-I methionine residues, in particular Met-86 and Met-148. In contrast, amyloid fibrils or reconstituted high-density lipoproteins (HDLs) generated from Met(O)-ApoA-I did not induce cytokine production in BMDMs. Although lipid-free Met(O)-ApoA-I remained functional in extracting lipids from cells and generating HDL, it gained strong pro-inflammatory properties that may aggravate local inflammation in the arteries and atherosclerosis. Our study indicates that oxidation of apoA-I methionine residues produces a potent danger-associated molecular pattern capable of stimulating pro-inflammatory cytokine secretion at levels similar to those induced by known pathogen-associated molecular patterns, such as lipopolysaccharide.	[Witkowski, Andrzej; Cavigiolio, Giorgio] UCSF Benioff Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; [Carta, Sonia; Rubartelli, Anna] Osped Policlin San Martino, Cell Biol Unit, I-16132 Genoa, Italy; [Lu, Rui; Yokoyama, Shinji] Chubu Univ, Food & Nutr Sci, Kasugai, Aichi 4878501, Japan	Chubu University	Cavigiolio, G (corresponding author), UCSF Benioff Childrens Hosp Oakland UCSF BCHO Res, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gcavigiolio@chori.org	Rubartelli, Anna/AAA-1259-2021; carta, sonia/AAB-3799-2020	carta, sonia/0000-0002-1278-9761; Cavigiolio, Giorgio/0000-0002-1622-0628; Witkowski, Andrzej/0000-0002-0442-4586	National Institutes of Health [R01 HL113059]; Japan Society for the Promotion of Science's Invitation Fellowship Program for Research in Japan [L-14559]; Associazione Italiana per la Ricerca sul Cancro [IG 2016-15434]; Fondazione Telethon [GGP14144]; Italian Ministry of Health "Young Investigators" Grant [GR-2016-02363630]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1201007]; MEXT Japan [24614018, 26461370, 15H02903]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113059] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science's Invitation Fellowship Program for Research in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Telethon(Fondazione TelethonEuropean Commission); Italian Ministry of Health "Young Investigators" Grant; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or part by National Institutes of Health Grant R01 HL113059 (to G. C.); Japan Society for the Promotion of Science's Invitation Fellowship Program for Research in Japan (L-14559) (to G. C. and S. Y.); Associazione Italiana per la Ricerca sul Cancro (IG 2016-15434) and Fondazione Telethon (GGP14144) (to A. R.); Italian Ministry of Health "Young Investigators" Grant GR-2016-02363630 (to S. C.); MEXT-Supported Program for the Strategic Research Foundation at Private Universities Grant S1201007; and MEXT Japan Grants-in-Aid 24614018, 26461370, and 15H02903 (to S. Y. and R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Arpaia N, 2011, CELL, V144, P675, DOI 10.1016/j.cell.2011.01.031; Audet A, 2012, HISTOPATHOLOGY, V61, P610, DOI 10.1111/j.1365-2559.2012.04265.x; Balducci C, 2017, BRAIN BEHAV IMMUN, V60, P188, DOI 10.1016/j.bbi.2016.10.012; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434; Chan GKL, 2015, J BIOL CHEM, V290, P10958, DOI 10.1074/jbc.M114.630442; Clark IA, 2015, BRIT J PHARMACOL, V172, P3714, DOI 10.1111/bph.13181; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Eren E, 2015, CLIN CHIM ACTA, V439, P18, DOI 10.1016/j.cca.2014.09.024; Estruch M, 2015, BBA-MOL CELL BIOL L, V1851, P1442, DOI 10.1016/j.bbalip.2015.08.009; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Gardella S, 2001, BLOOD, V98, P2152, DOI 10.1182/blood.V98.7.2152; Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080; Goulopoulou S, 2016, PHARMACOL REV, V68, P142, DOI 10.1124/pr.114.010090; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Hirata Y, 2013, ATHEROSCLEROSIS, V231, P227, DOI 10.1016/j.atherosclerosis.2013.09.010; Hoshino K, 1999, J IMMUNOL, V162, P3749; Howlett GJ, 2006, CURR OPIN LIPIDOL, V17, P541, DOI 10.1097/01.mol.0000245260.63505.4f; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Jayaraman S, 2011, J BIOL CHEM, V286, P35610, DOI 10.1074/jbc.M111.262485; Jiang YG, 2012, BIOCHEM BIOPH RES CO, V425, P121, DOI 10.1016/j.bbrc.2012.07.011; Kee P, 2002, ARTERIOSCL THROM VAS, V22, P1912, DOI 10.1161/01.ATV.0000038485.94020.7F; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Kristen AV, 2010, CARDIOVASC PATHOL, V19, P228, DOI 10.1016/j.carpath.2009.04.005; Kusters PJH, 2015, METHODS MOL BIOL, V1339, P17, DOI 10.1007/978-1-4939-2929-0_2; Lavieri R, 2014, J IMMUNOL, V192, P5373, DOI 10.4049/jimmunol.1303480; LIANG HQ, 1995, BBA-LIPID LIPID MET, V1257, P31, DOI 10.1016/0005-2760(95)00055-H; LIANG HQ, 1994, J LIPID RES, V35, P1187; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Miyazaki O, 2014, J LIPID RES, V55, P214, DOI 10.1194/jlr.M041038; Molteni M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6978936; MUCCHIANO G, 1992, AM J PATHOL, V140, P871; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; Navab Mohamad, 2007, Curr Atheroscler Rep, V9, P244, DOI 10.1007/s11883-007-0026-3; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nicholls SJ, 2005, TRENDS CARDIOVAS MED, V15, P212, DOI 10.1016/j.tcm.2005.06.004; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Rocken C, 2006, ARTERIOSCL THROM VAS, V26, P676, DOI 10.1161/01.ATV.0000201930.10103.be; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Ryan J., 2008, CORNING TECHNICAL B, VTC-305; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Semino C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1121-9; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stewart CR, 2005, BIOCHEMISTRY-US, V44, P9108, DOI 10.1021/bi050497v; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Ueno H, 2010, ATHEROSCLEROSIS, V211, P431, DOI 10.1016/j.atherosclerosis.2010.04.006; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang MY, 2014, TRENDS ENDOCRIN MET, V25, P72, DOI 10.1016/j.tem.2013.10.002; WESTERMARK P, 1995, AM J PATHOL, V147, P1186; Witkowski A, 2018, FASEB J, V32, P3149, DOI 10.1096/fj.201701127R; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200	80	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3634	3646		10.1074/jbc.RA118.005663	http://dx.doi.org/10.1074/jbc.RA118.005663			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30635405	Green Published, hybrid			2022-12-28	WOS:000461853900026
J	Yang, DX; Xiao, P; Li, Q; Fu, XL; Pan, C; Lu, D; Wen, SS; Xia, WY; He, DF; Li, H; Fang, H; Shen, YM; Xu, ZG; Lin, A; Wang, C; Yu, X; Wu, JW; Sun, JP				Yang, Duxiao; Xiao, Peng; Li, Qing; Fu, Xiaolei; Pan, Chang; Lu, Di; Wen, Shishuai; Xia, Wanying; He, Dongfang; Li, Hui; Fang, Hao; Shen, Yuemao; Xu, Zhigang; Lin, Amy; Wang, Chuan; Yu, Xiao; Wu, Jiawei; Sun, Jinpeng			Allosteric modulation of the catalytic VYD loop in Slingshot by its N-terminal domain underlies both Slingshot auto-inhibition and activation (vol 293, pg 16226, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Yang DX, 2018, J BIOL CHEM, V293, P16226, DOI 10.1074/jbc.RA118.004175	1	1	1	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2947	2947		10.1074/jbc.AAC119.007803	http://dx.doi.org/10.1074/jbc.AAC119.007803			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30796175	Green Published, hybrid			2022-12-28	WOS:000459601600031
J	Buchner, J				Buchner, Johannes			Molecular chaperones and protein quality control: an introduction to the JBC Reviews thematic series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						chaperone; protein assembly; protein folding; ribosome function; chemical biology; drug design		Protein folding is a spontaneous process. However, under physiological conditions, proteins are inherently unstable, and the protein concentrations in living cells favor unspecific interactions between partially folded proteins. Thus, the cellular proteome requires the assistance of helper factors, the molecular chaperones, for quality control and the maintenance of protein homeostasis. This series of reviews delves into how these molecular machines work in the eukaryotic cell, how they convey resilience to life, how these functions have allowed expansion of the protein universe, and how we can target them for therapeutic purposes. Together, they present the progress made in recent years in our understanding of one of the most fundamental aspects of life.	[Buchner, Johannes] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany	Technical University of Munich	Buchner, J (corresponding author), Tech Univ Munich, Tech Univ Munchen Chem, Lichenbergr 4, D-85758 Garching, Germany.	johannes.buchner@tum.de	Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737				Genest O, 2019, J BIOL CHEM, V294, P2109, DOI 10.1074/jbc.REV118.002806; Gestwicki JE, 2019, J BIOL CHEM, V294, P2151, DOI 10.1074/jbc.TM118.002813; Haslbeck M, 2019, J BIOL CHEM, V294, P2121, DOI 10.1074/jbc.REV118.002809; Ito S, 2019, J BIOL CHEM, V294, P2133, DOI 10.1074/jbc.TM118.002812; Mayer MP, 2019, J BIOL CHEM, V294, P2085, DOI 10.1074/jbc.REV118.002810; Pobre KFR, 2019, J BIOL CHEM, V294, P2098, DOI 10.1074/jbc.REV118.002804; Rizzolo K, 2019, J BIOL CHEM, V294, P2142, DOI 10.1074/jbc.TM118.002805; Stein KC, 2019, J BIOL CHEM, V294, P2076, DOI 10.1074/jbc.REV118.002814; Wang T, 2019, J BIOL CHEM, V294, P2162, DOI 10.1074/jbc.REV118.002811; Xie LH, 2019, J BIOL CHEM, V294, P2180, DOI 10.1074/jbc.REV118.002808	10	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2074	2075		10.1074/jbc.REV118.006739	http://dx.doi.org/10.1074/jbc.REV118.006739			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30626733	Green Published, hybrid			2022-12-28	WOS:000459711400025
J	Chen, MK; Du, Y; Sun, LL; Hsu, JL; Wang, YH; Gao, Y; Huang, JX; Hung, MC				Chen, Mei-Kuang; Du, Yi; Sun, Linlin; Hsu, Jennifer L.; Wang, Yu-Han; Gao, Yuan; Huang, Jiaxing; Hung, Mien-Chie			H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleus; nuclear transport; reactive oxygen species (ROS); receptor tyrosine kinase; breast cancer; c-MET; hepatocyte growth factor receptor (HGFR); hydrogen peroxide; vesicle trafficking	GROWTH-FACTOR RECEPTOR; HYDROGEN-PEROXIDE; EGF RECEPTOR; OXIDATIVE STRESS; RESISTANCE; PROTEIN; PHOSPHORYLATION; KINESIN; KU; TRANSLOCATION	Reactive oxygen species (ROS) are cellular by-products produced from metabolism and also anticancer agents, such as ionizing irradiation and chemotherapy drugs. The ROS H2O2 has high rates of production in cancer cells because of their rapid proliferation. ROS oxidize DNA, protein, and lipids, causing oxidative stress in cancer cells and making them vulnerable to other stresses. Therefore, cancer cell survival relies on maintaining ROS-induced stress at tolerable levels. Hepatocyte growth factor receptor (c-MET) is a receptor tyrosine kinase overexpressed in malignant cancer types, including breast cancer. Full-length c-MET triggers a signal transduction cascade from the plasma membrane that, through downstream signaling proteins, up-regulates cell proliferation and migration. Recently, c-MET was shown to interact and phosphorylate poly(ADP-ribose) polymerase 1 in the nucleus and to induce poly(ADP-ribose) polymerase inhibitor resistance. However, it remains unclear how c-MET moves from the cell membrane to the nucleus. Here, we demonstrate that H2O2 induces retrograde transport of membrane-associated full-length c-MET into the nucleus of human MCF10A and MCF12A or primary breast cancer cells. We further show that knocking down either coatomer protein complex subunit 1 (COPG1) or Sec61 translocon subunit (SEC61) attenuates the accumulation of full-length nuclear c-MET. However, a c-MET kinase inhibitor did not block nuclear c-MET transport. Moreover, nuclear c-MET interacted with KU proteins in breast cancer cells, suggesting a role of full-length nuclear c-MET in ROS-induced DNA damage repair. We conclude that a membrane-bound retrograde vesicle transport mechanism facilitates membrane-to-nucleus transport of c-MET in breast cancer cells.	[Chen, Mei-Kuang; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, UTHlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Chen, Mei-Kuang; Du, Yi; Sun, Linlin; Hsu, Jennifer L.; Wang, Yu-Han; Gao, Yuan; Huang, Jiaxing; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Sun, Linlin] Tianjin Med Univ, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Gen Hosp, Lung Canc Inst, Tianjin 300052, Peoples R China; [Wang, Yu-Han] China Med Univ, Grad Inst Biomed Sci, Taichung 402, Taiwan; [Gao, Yuan] China Med Univ, Ctr Mol Med, Taichung 402, Taiwan; [Huang, Jiaxing] Shanghai Jiao Tong Univ, Sch Med, Dept Gen Surg, Xinhua Hosp, Shanghai 200092, Peoples R China; [Hung, Mien-Chie] Sichuan Univ, West China Hosp, Canc Ctr, Dept Med Oncol, Chengdu 610041, Sichuan, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical University; China Medical University Taiwan; China Medical University Taiwan; Shanghai Jiao Tong University; Sichuan University	Hung, MC (corresponding author), China Med Univ, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.	mhung@mail.cmu.edu.tw	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Du, Yi/0000-0002-3969-2652; Yuan, Gao/0000-0003-2224-5538; CHEN, MEI-KUANG/0000-0001-8027-8990	 [NCI CA016672]; NATIONAL CANCER INSTITUTE [R01CA211615, P30CA016672] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	STR DNA fingerprinting was done by the Cancer Center Support Grant-funded Characterized Cell Line core under Grant NCI CA016672.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BJORKMAN U, 1995, MOL CELL ENDOCRINOL, V111, P99, DOI 10.1016/0303-7207(95)03552-I; Bradley CA, 2017, NAT REV CLIN ONCOL, V14, P562, DOI 10.1038/nrclinonc.2017.40; Chae YK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152585; Chen MK, 2016, AM J CANCER RES, V6, P827; Chen MK, 2015, FEBS J, V282, P3693, DOI 10.1111/febs.13342; Chen R, 2013, J CELL BIOCHEM, V114, P816, DOI 10.1002/jcb.24420; Couto CAM, 2011, J CELL BIOL, V194, P367, DOI 10.1083/jcb.201012132; Dahm-Daphi J, 2000, INT J RADIAT BIOL, V76, P67, DOI 10.1080/095530000139023; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; Di Meo S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1245049; Dittmann K, 2009, RADIOTHER ONCOL, V92, P379, DOI 10.1016/j.radonc.2009.06.003; Du Y, 2014, ONCOGENE, V33, P756, DOI 10.1038/onc.2013.1; Du Y, 2016, NAT MED, V22, P194, DOI 10.1038/nm.4032; Galadari S, 2017, FREE RADICAL BIO MED, V104, P144, DOI 10.1016/j.freeradbiomed.2017.01.004; Gelsomino F, 2014, CRIT REV ONCOL HEMAT, V89, P284, DOI 10.1016/j.critrevonc.2013.11.006; GIORDANO S, 1989, ONCOGENE, V4, P1383; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Grossman EN, 2013, GENETICS, V195, P899, DOI 10.1534/genetics.113.154393; Groth-Pedersen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045381; Guo G, 2017, CURR CANCER DRUG TAR, V17, P297, DOI 10.2174/1568009616666161215162515; Habold C, 2008, J CELL MOL MED, V12, P607, DOI 10.1111/j.1582-4934.2007.00136.x; HAGIWARA H, 1994, J BIOL CHEM, V269, P3581; Han JA, 1999, EXP MOL MED, V31, P83, DOI 10.1038/emm.1999.14; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Hsu YH, 2014, CANCER RES, V74, P4822, DOI 10.1158/0008-5472.CAN-14-0584; Inanc M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0801-7; Kasahara M, 2016, ONCOL LETT, V12, P1909, DOI 10.3892/ol.2016.4823; Kodiha M., 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/208650; Lee HH, 2015, AM J CANCER RES, V5, P2944; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045465; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lisanti MP, 2011, CELL CYCLE, V10, P2440, DOI 10.4161/cc.10.15.16870; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lucanus AJ, 2018, ONCOGENE, V37, P833, DOI 10.1038/onc.2017.406; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Myers JM, 2003, J CELL BIOCHEM, V88, P1273, DOI 10.1002/jcb.10476; Ortiz-Zapater E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170798; Pellett PA, 2013, ELIFE, V2, DOI 10.7554/eLife.01296; Pozner-Moulis S, 2006, CANCER RES, V66, P7976, DOI 10.1158/0008-5472.CAN-05-4335; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Rodriguez-Gabriel MA, 2005, EUKARYOT CELL, V4, P1396, DOI 10.1128/EC.4.8.1396-1402.2005; Romano P, 2009, NUCLEIC ACIDS RES, V37, pD925, DOI 10.1093/nar/gkn730; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Shimizu S, 1997, RES COMMUN MOL PATH, V95, P227; Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035; Spang A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013391; Telikicherla Deepthi, 2012, J Proteomics Bioinform, V5, P122; Troiani T, 2013, CLIN CANCER RES, V19, P6751, DOI 10.1158/1078-0432.CCR-13-0423; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061640; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-13; Wang YN, 2012, J BIOL CHEM, V287, P16869, DOI 10.1074/jbc.M111.314799; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Wei H, 2017, FOLIA HISTOCHEM CYTO, V55, P43, DOI 10.5603/FHC.a2017.0007; Weinstain R, 2014, J AM CHEM SOC, V136, P874, DOI 10.1021/ja411547j; Yang G, 2018, NUCLEIC ACIDS RES, V46, P3446, DOI 10.1093/nar/gky088; Yang WY, 2014, DRUG DEVELOP RES, V75, P331, DOI 10.1002/ddr.21216; Yuan Y, 2013, ACS NANO, V7, P10502, DOI 10.1021/nn4033294; Zagouri F, 2013, BRIT J CANCER, V108, P1100, DOI 10.1038/bjc.2013.31; Zhao S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.36	71	9	9	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8516	8528		10.1074/jbc.RA118.005953	http://dx.doi.org/10.1074/jbc.RA118.005953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30962283	Green Published, hybrid			2022-12-28	WOS:000471108200020
J	Huang, TW; Gonzalez, YR; Qu, DB; Huang, E; Safarpour, F; Wang, E; Joselin, A; Im, DS; Callaghan, SM; Boonying, W; Julian, L; Dunwoodie, SL; Slack, RS; Park, DS				Huang, Tianwen; Gonzalez, Yasmilde Rodriguez; Qu, Dianbo; Huang, En; Safarpour, Farzaneh; Wang, Eugene; Joselin, Alvin; Im, Doo Soon; Callaghan, Steve M.; Boonying, Wassamon; Julian, Lisa; Dunwoodie, Sally L.; Slack, Ruth S.; Park, David S.			The pro-death role of Cited2 in stroke is regulated by E2F1/4 transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stroke; ischemia; neuron; hypoxia; E2F transcription factor; brain injury; Cbp; P300-interacting transactivator with Glu; Asp-rich carboxyl-terminal domain 2; cell death; gene promoter; gene regulation	CYCLIN-DEPENDENT KINASES; CELL-CYCLE; NEURONAL DEATH; HEART DEVELOPMENT; FOCAL ISCHEMIA; FAMILY-MEMBERS; MICE LACKING; EXPRESSION; GENE; PROLIFERATION	We previously reported that the cell cycle-related cyclin-dependent kinase 4-retinoblastoma (RB) transcriptional corepressor pathway is essential for stroke-induced cell death both in vitro and in vivo. However, how this signaling pathway induces cell death is unclear. Previously, we found that the cyclin-dependent kinase 4 pathway activates the pro-apoptotic transcriptional co-regulator Cited2 in vitro after DNA damage. In the present study, we report that Cited2 protein expression is also dramatically increased following stroke/ischemic insult. Critically, utilizing conditional knockout mice, we show that Cited2 is required for neuronal cell death, both in culture and in mice after ischemic insult. Importantly, determining the mechanism by which Cited2 levels are regulated, we found that E2F transcription factor (E2F) family members participate in Cited2 regulation. First, E2F1 expression induced Cited2 transcription, and E2F1 deficiency reduced Cited2 expression. Moreover, determining the potential E2F-binding regions on the Cited2 gene regulatory sequence by ChIP analysis, we provide evidence that E2F1/4 proteins bind to this DNA region. A luciferase reporter assay to probe the functional outcomes of this interaction revealed that E2F1 activates and E2F4 inhibits Cited2 transcription. Moreover, we identified the functional binding motif for E2F1 in the Cited2 gene promoter by demonstrating that mutation of this site dramatically reduces E2F1-mediated Cited2 transcription. Finally, E2F1 and E2F4 regulated Cited2 expression in neurons after stroke-related insults. Taken together, these results indicate that the E2F-Cited2 regulatory pathway is critically involved in stroke injury.	[Huang, Tianwen; Gonzalez, Yasmilde Rodriguez; Qu, Dianbo; Huang, En; Safarpour, Farzaneh; Wang, Eugene; Joselin, Alvin; Im, Doo Soon; Callaghan, Steve M.; Boonying, Wassamon; Julian, Lisa; Slack, Ruth S.; Park, David S.] Univ Ottawa, Brain & Mind Res Inst, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Huang, Tianwen] Fujian Med Univ, Union Hosp, Dept Neurol, Fuzhou 350001, Fujian, Peoples R China; [Huang, Tianwen] Fujian Med Univ, Union Hosp, Fujian Key Lab Mol Neurol, Fuzhou 350001, Fujian, Peoples R China; [Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Dunwoodie, Sally L.] Univ New South Wales, Fac Med, Kensington, NSW 2033, Australia; [Dunwoodie, Sally L.] Univ New South Wales, Fac Sci, Kensington, NSW 2033, Australia; [Qu, Dianbo; Joselin, Alvin; Im, Doo Soon; Park, David S.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, HRIC 1A10,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada	University of Ottawa; Fujian Medical University; Fujian Medical University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of Calgary	Park, DS (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, HRIC 1A10,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	david.park1@ucalgary.ca	, Dianbo/AAU-8480-2021	, Dianbo/0000-0002-0435-9585; Park, David/0000-0002-4490-3784	Canadian Institute of Health Research; Heart and Stroke Foundation of Ontario; Canadian Stroke Network; Centre for Stroke Recovery	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Stroke Network; Centre for Stroke Recovery	This work was supported by grants from the Canadian Institute of Health Research, the Heart and Stroke Foundation of Ontario, the Canadian Stroke Network, and the Centre for Stroke Recovery. The authors declare that they have no conflicts of interest with the contents of this article.	Andrusiak MG, 2013, CELL CYCLE, V12, P1416, DOI 10.4161/cc.24527; Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Barbera JPM, 2002, HUM MOL GENET, V11, P283, DOI 10.1093/hmg/11.3.283; Bentham J, 2010, HUM MOL GENET, V19, P3394, DOI 10.1093/hmg/ddq251; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Biswas SC, 2010, J NEUROSCI, V30, P3973, DOI 10.1523/JNEUROSCI.6421-09.2010; Buaas FW, 2009, HUM MOL GENET, V18, P2989, DOI 10.1093/hmg/ddp237; Combes AN, 2010, INT J DEV BIOL, V54, P683, DOI 10.1387/ijdb.092920ac; DeGregori J, 2006, CURR MOL MED, V6, P739; Demyanenko S, 2017, MOL NEUROBIOL, V54, P6839, DOI 10.1007/s12035-016-0191-x; Du JW, 2013, CURR OPIN HEMATOL, V20, P301, DOI 10.1097/MOH.0b013e3283606022; Fame RM, 2016, J NEUROSCI, V36, P6403, DOI 10.1523/JNEUROSCI.4067-15.2016; Floro KL, 2011, HUM MOL GENET, V20, P1097, DOI 10.1093/hmg/ddq554; Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011; Gonzalez YR, 2008, J NEUROSCI, V28, P5559, DOI 10.1523/JNEUROSCI.1014-08.2008; Haase M, 2007, J ENDOCRINOL, V192, P459, DOI 10.1677/JOE-06-0083; Herrup K, 2004, J NEUROSCI, V24, P9232, DOI 10.1523/JNEUROSCI.3347-04.2004; Iyirhiaro GO, 2017, J NEUROSCI, V37, P6729, DOI 10.1523/JNEUROSCI.3017-16.2017; Iyirhiaro GO, 2014, J BIOL CHEM, V289, P18202, DOI 10.1074/jbc.M114.574145; Fonseca DJ, 2012, TRANSL RES, V160, P384, DOI 10.1016/j.trsl.2012.05.006; Jayaraman S, 2016, MOL CANCER RES, V14, P730, DOI 10.1158/1541-7786.MCR-16-0081; Julian LM, 2013, CELL STEM CELL, V12, P440, DOI 10.1016/j.stem.2013.02.001; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Leung MK, 1999, GENOMICS, V61, P307, DOI 10.1006/geno.1999.5970; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Liu YC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv934; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; MacManus JP, 1999, NEUROREPORT, V10, P2711, DOI 10.1097/00001756-199909090-00004; MacManus JP, 2003, J CEREBR BLOOD F MET, V23, P1020, DOI 10.1097/01.WCB.0000084249.20114.FA; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; O'Hare MJ, 2000, J BIOL CHEM, V275, P25358, DOI 10.1074/jbc.M001725200; Osman AM, 2011, STROKE, V42, P3559, DOI 10.1161/STROKEAHA.111.627802; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Preis JI, 2006, GENESIS, V44, P579, DOI 10.1002/dvg.20251; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; Sakai M, 2012, NAT MED, V18, P612, DOI 10.1038/nm.2691; SOTO AM, 1985, J STEROID BIOCHEM, V23, P87, DOI 10.1016/0022-4731(85)90265-1; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Sun W, 2006, BRAIN RES, V1072, P15, DOI 10.1016/j.brainres.2005.12.016; Timsit Serge, 2007, Biotechnology Journal, V2, P958, DOI 10.1002/biot.200700072; Tschop K, 2011, CELL CYCLE, V10, P3814, DOI 10.4161/cc.10.22.18225; Tschop K, 2011, GENE DEV, V25, P814, DOI 10.1101/gad.2000211; Val P, 2007, DEVELOPMENT, V134, P2349, DOI 10.1242/dev.004390; Volcik KA, 2004, AM J MED GENET A, V126A, P324, DOI 10.1002/ajmg.a.20578; Wang Fuhu, 2001, Expert Opin Ther Targets, V5, P557; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; Xu B, 2008, DEV BIOL, V317, P95, DOI 10.1016/j.ydbio.2008.02.019; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013; Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006; Zhang Y, 2010, J NEUROCHEM, V112, P497, DOI 10.1111/j.1471-4159.2009.06476.x	62	11	11	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8617	8629		10.1074/jbc.RA119.007941	http://dx.doi.org/10.1074/jbc.RA119.007941			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30967472	Green Published, hybrid			2022-12-28	WOS:000471108200028
J	Tapia, VS; Daniels, MJD; Palazon-Riquelme, P; Dewhurst, M; Luheshi, NM; Rivers-Auty, J; Green, J; Redondo-Castro, E; Kaldis, P; Lopez-Castejon, G; Brough, D				Tapia, Victor S.; Daniels, Michael J. D.; Palazon-Riquelme, Pablo; Dewhurst, Matthew; Luheshi, Nadia M.; Rivers-Auty, Jack; Green, Jack; Redondo-Castro, Elena; Kaldis, Philipp; Lopez-Castejon, Gloria; Brough, David			The three cytokines IL-1, IL-18, and IL-1 share related but distinct secretory routes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; inflammation; interleukin 1 (IL-1); NLRP3; caspase 1 (CASP1); calpain; cytokine; immunology; immune cell; neutrophil	NLRP3 INFLAMMASOME; GASDERMIN-D; IL-1-BETA SECRETION; RELEASE; INTERLEUKIN-1-ALPHA; SENESCENCE; MECHANISM; MEMBRANE; ACTIVATION; EFFECTORS	Interleukin (IL)-1 family cytokines potently regulate inflammation, with the majority of the IL-1 family proteins being secreted from immune cells via unconventional pathways. In many cases, secretion of IL-1 cytokines appears to be closely coupled to cell death, yet the secretory mechanisms involved remain poorly understood. Here, we studied the secretion of the three best-characterized members of the IL-1 superfamily, IL-1, IL-1, and IL-18, in a range of conditions and cell types, including murine bone marrow-derived and peritoneal macrophages, human monocyte-derived macrophages, HeLa cells, and mouse embryonic fibroblasts. We discovered that IL-1 and IL-18 share a common secretory pathway that depends upon membrane permeability and can operate in the absence of complete cell lysis and cell death. We also found that the pathway regulating the trafficking of IL-1 is distinct from the pathway regulating IL-1 and IL-18. Although the release of IL-1 could also be dissociated from cell death, it was independent of the effects of the membrane-stabilizing agent punicalagin, which inhibited both IL-1 and IL-18 release. These results reveal that in addition to their role as danger signals released from dead cells, IL-1 family cytokines can be secreted in the absence of cell death. We propose that models used in the study of IL-1 release should be considered context-dependently.	[Tapia, Victor S.; Rivers-Auty, Jack; Green, Jack; Lopez-Castejon, Gloria; Brough, David] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester M13 9PT, Lancs, England; [Tapia, Victor S.; Daniels, Michael J. D.; Dewhurst, Matthew; Luheshi, Nadia M.; Rivers-Auty, Jack; Green, Jack; Redondo-Castro, Elena; Brough, David] Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Neurosci & Expt Psychol, Sch Biol Sci,Fac Biol Med & Hlth, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Daniels, Michael J. D.] Univ Edinburgh, UK Dementia Res Inst, Coll Med & Vet Med, 49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland; [Palazon-Riquelme, Pablo; Lopez-Castejon, Gloria] Univ Manchester, Manchester Acad Hlth Sci Ctr, Core Technol Facil,Div Infect Immun & Resp Med, Sch Biol Sci,Fac Biol Med & Hlth,Manchester Colla, Manchester M13 9PT, Lancs, England; [Palazon-Riquelme, Pablo] Claude Bernard Lyon 1 Univ, Ecole Normale Super Lyon, CNRS, UMR5308,INSERM,U1111,Int Ctr Infectiol Res, F-69100 Lyon, France; [Luheshi, Nadia M.] MedImmune Ltd, Aaron Klug Bldg,Granta Pk, Cambridge CB21 6GH, England; [Dewhurst, Matthew; Kaldis, Philipp] NUS, A STAR, IMCB, Dept Biochem, Singapore 119007, Singapore	University of Manchester; University of Manchester; University of Edinburgh; University of Manchester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; AstraZeneca; Medimmune; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Lopez-Castejon, G; Brough, D (corresponding author), Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Manchester M13 9PT, Lancs, England.; Brough, D (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Div Neurosci & Expt Psychol, Sch Biol Sci,Fac Biol Med & Hlth, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Gloria.lopez-castejon@manchester.ac.uk; david.brough@manchester.ac.uk	Green, Jack/AAV-7447-2021; Lopez-Castejon, Gloria/F-6985-2015; Kaldis, Philipp/G-2714-2010; Palazon-Riquelme, Pablo/G-5449-2019	Lopez-Castejon, Gloria/0000-0002-8585-3381; Kaldis, Philipp/0000-0002-7247-7591; Dewhurst, Matthew/0000-0003-4667-4070; Tapia, Victor/0000-0001-5009-4779; Green, Jack/0000-0003-1108-3422; Palazon-Riquelme, Pablo/0000-0001-6799-2698; Daniels, Michael/0000-0001-7489-5626; Rivers-Auty, Jack/0000-0001-5321-2347; Brough, David/0000-0002-2250-2381	Medical Research Council [MR/N029992/1]; Wellcome Trust [104192/Z/14/Z]; Royal Society [104192/Z/14/Z]; CONICYT (Becas Chile) [721704488]; MRC DTP Studentship [MR/K501311/1]; Manchester Collaborative Centre for Inflammation Research, an initiative of the University of Manchester; Manchester Collaborative Centre for Inflammation Research, an initiative of AstraZeneca; Manchester Collaborative Centre for Inflammation Research, an initiative of GlaxoSmithKline; BBSRC [BB/P01061X/1]; MRC [MR/N029992/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); CONICYT (Becas Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); MRC DTP Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Manchester Collaborative Centre for Inflammation Research, an initiative of the University of Manchester; Manchester Collaborative Centre for Inflammation Research, an initiative of AstraZeneca; Manchester Collaborative Centre for Inflammation Research, an initiative of GlaxoSmithKline; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant MR/N029992/1 (to D. B.) and a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 104192/Z/14/Z (to G. L.-C)).; Supported by CONICYT (Becas Chile 721704488).; Supported by MRC DTP Studentship MR/K501311/1.; Supported by the Manchester Collaborative Centre for Inflammation Research, as a joint initiative of the University of Manchester, AstraZeneca, and GlaxoSmithKline.; Supported by BBSRC Grant BB/P01061X/1.	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Baldwin AG, 2017, CELL CHEM BIOL, V24, P1321, DOI 10.1016/j.chembiol.2017.08.011; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Brough D, 2017, J CELL SCI, V130, P3197, DOI 10.1242/jcs.204206; Chen KWW, 2014, CELL REP, V8, P569, DOI 10.1016/j.celrep.2014.06.028; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Clancy DM, 2018, CELL REP, V22, P2937, DOI 10.1016/j.celrep.2018.02.062; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; England H, 2014, J BIOL CHEM, V289, P15942, DOI 10.1074/jbc.M114.557561; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gardner SE, 2015, ARTERIOSCL THROM VAS, V35, P1963, DOI 10.1161/ATVBAHA.115.305896; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Green JP, 2018, P NATL ACAD SCI USA, V115, pE9371, DOI 10.1073/pnas.1812744115; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Martin SJ, 2016, FEBS J, V283, P2599, DOI 10.1111/febs.13775; Martin-Sanchez F, 2016, CELL DEATH DIFFER, V23, P1219, DOI 10.1038/cdd.2015.176; Monteleone M, 2018, CELL REP, V24, P1425, DOI 10.1016/j.celrep.2018.07.027; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Perregaux DG, 1998, J IMMUNOL, V160, P2469; Redondo-Castro E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24029-3; Rivers-Auty J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03362-1; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Semino C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1121-9; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shirasaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04736; Stoffels M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00054; Swanton T, 2018, SLAS DISCOV, V23, P991, DOI 10.1177/2472555218786210; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Xu X, 2015, MEDIAT INFLAMM, V2015, DOI [10.1155/2015/810798, 10.1155/2015/380218]; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	44	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8325	8335		10.1074/jbc.RA119.008009	http://dx.doi.org/10.1074/jbc.RA119.008009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30940725	Green Published, hybrid			2022-12-28	WOS:000471108200001
J	Abe, M; Saito, M; Tsukahara, A; Shiokawa, S; Ueno, K; Shimamura, H; Nagano, M; Toshima, JY; Toshima, J				Abe, Michiko; Saito, Mayu; Tsukahara, Ayana; Shiokawa, Shuka; Ueno, Kazuma; Shimamura, Hiroki; Nagano, Makoto; Toshima, Junko Y.; Toshima, Jiro			Functional complementation reveals that 9 of the 13 human V-ATPase subunits can functionally substitute for their yeast orthologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; yeast genetics; vacuole; Saccharomyces cerevisiae; human	VACUOLAR H+-ATPASE; SITE-DIRECTED MUTAGENESIS; RENAL TUBULAR-ACIDOSIS; PLASMA-MEMBRANE; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; PROTON PUMPS; A3 ISOFORM; ACIDIFICATION; PH	Vacuolar-type H+-ATPase (V-ATPase) is a highly conserved proton pump responsible for acidification of intracellular organelles and potential drug target. It is a multisubunit complex comprising a cytoplasmic V-1 domain responsible for ATP hydrolysis and a membrane-embedded V-o domain that contributes to proton translocation across the membrane. Saccharomyces cerevisiae V-ATPase is composed of 14 subunits, deletion of any one of which results in well-defined growth defects. As the structure of V-ATPase and the function of each subunit have been well-characterized in yeast, this organism has been recognized as a preferred model for studies of V-ATPases. In this study, to assess the functional relatedness of the yeast and human V-ATPase subunits, we investigated whether human V-ATPase subunits can complement calcium- or pH-sensitive growth, acidification of the vacuolar lumen, assembly of the V-ATPase complex, and protein sorting in yeast mutants lacking the equivalent yeast genes. These assessments revealed that 9 of the 13 human V-ATPase subunits can partially or fully complement the function of the corresponding yeast subunits. Importantly, sequence similarity was not necessarily correlated with functional complementation. We also found that besides all V-o domain subunits, the V-1 F subunit is required for proper assembly of the V-o domain at the endoplasmic reticulum. Furthermore, the human H subunit fully restored the level of vacuolar acidification, but only partially rescued calcium-sensitive growth, suggesting a specific role of the H subunit in V-ATPase activity. These findings provide important insights into functional homologies between yeast and human V-ATPases.	[Abe, Michiko; Saito, Mayu; Tsukahara, Ayana; Shiokawa, Shuka; Ueno, Kazuma; Shimamura, Hiroki; Nagano, Makoto; Toshima, Jiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, 6-3-1 Niijyuku, Tokyo 1258585, Japan; [Toshima, Junko Y.] Tokyo Univ Technol, Sch Hlth Sci, Ota Ku, Tokyo 1448535, Japan	Tokyo University of Science; Tokyo University of Technology	Toshima, J (corresponding author), Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, 6-3-1 Niijyuku, Tokyo 1258585, Japan.; Toshima, JY (corresponding author), Tokyo Univ Technol, Sch Hlth Sci, Ota Ku, Tokyo 1448535, Japan.	toshimajk@srf.teu.ac.jp; jtosiscb@rs.noda.tus.ac.jp	純子, 十島 Y/GRS-7321-2022		JSPS KAKENHI [18K06229, 6K07303]; Takeda Science Foundation; Novartis Foundation, Japan; Uehara Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novartis Foundation, Japan(Novartis); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by JSPS KAKENHI Grant 18K06229, the Takeda Science Foundation, the Novartis Foundation, Japan (to J. Y. T.), JSPS KAKENHI Grant 6K07303, the Uehara Memorial Foundation, and the Takeda Science Foundation (to J. T.). The authors declare that they have no conflicts of interest with the contents of this article.	ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; Bodzeta A, 2017, CELL REP, V20, P1348, DOI 10.1016/j.celrep.2017.07.040; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cotter K, 2015, J BIOL CHEM, V290, P3680, DOI 10.1074/jbc.M114.611210; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Finnigan GC, 2011, MOL BIOL CELL, V22, P3176, DOI 10.1091/mbc.E11-03-0244; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Inoue H, 1999, BBA-BIOENERGETICS, V1413, P130, DOI 10.1016/S0005-2728(99)00096-1; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawamura S, 2014, BIOCHEM BIOPH RES CO, V450, P519, DOI 10.1016/j.bbrc.2014.06.002; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Liu Q, 1996, J BIOL CHEM, V271, P2018, DOI 10.1074/jbc.271.4.2018; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MELLMAN I, 1992, J EXP BIOL, V172, P39; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miles AL, 2017, ELIFE, V6, DOI 10.7554/eLife.22693; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Oot RA, 2016, EMBO J, V35, P1694, DOI 10.15252/embj.201593447; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Padilla-Lopez S, 2006, J BIOL CHEM, V281, P10273, DOI 10.1074/jbc.M510625200; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; PENA A, 1995, J BACTERIOL, V177, P1017, DOI 10.1128/jb.177.4.1017-1022.1995; Piao HL, 2007, MOL BIOL CELL, V18, P57, DOI 10.1091/mbc.e06-08-0721; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; Prosser DC, 2010, TRAFFIC, V11, P1141, DOI 10.1111/j.1600-0854.2010.01088.x; Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; Thudium CS, 2012, CURR PROTEIN PEPT SC, V13, P141; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Tomashek JJ, 1996, J BIOL CHEM, V271, P10397, DOI 10.1074/jbc.271.17.10397; Toshima J, 2005, NAT CELL BIOL, V7, P246, DOI 10.1038/ncb1229; Toshima JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4498; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Ueno K, 2014, BIOCHEM BIOPH RES CO, V443, P549, DOI 10.1016/j.bbrc.2013.12.008; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	59	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8273	8285		10.1074/jbc.RA118.006192	http://dx.doi.org/10.1074/jbc.RA118.006192			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30952699	Green Published, hybrid			2022-12-28	WOS:000470656500023
J	Kochert, BA; Fleischhacker, AS; Wales, TE; Becker, DF; Engen, JR; Ragsdale, SW				Kochert, Brent A.; Fleischhacker, Angela S.; Wales, Thomas E.; Becker, Donald F.; Engen, John R.; Ragsdale, Stephen W.			Dynamic and structural differences between heme oxygenase-1 and-2 are due to differences in their C-terminal regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme oxygenase; enzyme catalysis; enzyme mechanism; protein dynamics; membrane protein; hydrogen exchange mass spectrometry; enzyme kinetics; conformational change; heme homeostasis; membrane anchor	THIOL/DISULFIDE REDOX SWITCH; SIGNAL PEPTIDE PEPTIDASE; BOUND CRYSTAL-STRUCTURES; REV-ERB-BETA; REGULATORY MOTIFS; BINDING; PROTEIN; DEGRADATION; AFFINITY; COMPLEX	Heme oxygenase (HO) catalyzes heme degradation, a process crucial for regulating cellular levels of this vital, but cytotoxic, cofactor. Two HO isoforms, HO1 and HO2, exhibit similar catalytic mechanisms and efficiencies. They also share catalytic core structures, including the heme-binding site. Outside their catalytic cores are two regions unique to HO2: a 20-amino acid-long N-terminal extension and a C-terminal domain containing two heme regulatory motifs (HRMs) that bind heme independently of the core. Both HO isoforms contain a C-terminal hydrophobic membrane anchor; however, their sequences diverge. Here, using hydrogen-deuterium exchange MS, size-exclusion chromatography, and sedimentation velocity, we investigated how these divergent regions impact the dynamics and structure of the apo and heme-bound forms of HO1 and HO2. Our results reveal that heme binding to the catalytic cores of HO1 and HO2 causes similar dynamic and structural changes in regions (proximal, distal, and A6 helices) within and linked to the heme pocket. We observed that full-length HO2 is more dynamic than truncated forms lacking the membrane-anchoring region, despite sharing the same steady-state activity and heme-binding properties. In contrast, the membrane anchor of HO1 did not influence its dynamics. Furthermore, although residues within the HRM domain facilitated HO2 dimerization, neither the HRM region nor the N-terminal extension appeared to affect HO2 dynamics. In summary, our results highlight significant dynamic and structural differences between HO2 and HO1 and indicate that their dissimilar C-terminal regions play a major role in controlling the structural dynamics of these two proteins.	[Kochert, Brent A.; Wales, Thomas E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Fleischhacker, Angela S.; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Becker, Donald F.] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA; [Kochert, Brent A.] Merck & Co Inc, Prot Mass Spectrometry, Analyt R&D, Proc R&D, 2000 Galloping Hill Rd, Kenilworth, NJ 07033 USA	Northeastern University; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln; Merck & Company	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, Sch Med, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu	Fleischhacker, Angela/AAN-3275-2021	Engen, John R./0000-0002-6918-9476; Wales, Thomas E./0000-0001-6133-5689	National Institutes of Health [R01-GM123513, P30GM103335, GM061068]; Waters Corp.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335, R01GM123513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waters Corp.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-GM123513 (to S. W. R.) and P30GM103335 and GM061068 (to D. F. B.) and a research collaboration with Waters Corp. (to J. R. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bagai I, 2015, BIOCHEMISTRY-US, V54, P2693, DOI 10.1021/bi501489r; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Carter EL, 2017, J BIOL CHEM, V292, P11280, DOI 10.1074/jbc.M117.783118; Carter EL, 2016, J BIOL CHEM, V291, P2196, DOI 10.1074/jbc.M115.670281; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dawson R.M., 1969, DATA BIOCH RES, P316; DWYER BE, 1992, GLIA, V5, P300, DOI 10.1002/glia.440050407; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fleischhacker AS, 2018, ANTIOXID REDOX SIGN, V29, P1841, DOI 10.1089/ars.2017.7368; Fleischhacker AS, 2015, BIOCHEMISTRY-US, V54, P2709, DOI 10.1021/acs.biochem.5b00266; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Hsu FF, 2015, ONCOGENE, V34, P2360, DOI 10.1038/onc.2014.166; Huber WJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI 10.1021/bi701496z; Huber WJ, 2009, BIOCHEMISTRY-US, V48, P190, DOI 10.1021/bi801912z; Hwang HW, 2009, J BIOL CHEM, V284, P22672, DOI 10.1074/jbc.M109.028001; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Linnenbaum M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035483; Lou XW, 2004, J CHROMATOGR A, V1029, P67, DOI 10.1016/j.chroma.2003.12.023; MAINES MD, 1986, J BIOL CHEM, V261, P411; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Schaefer B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188344; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Spencer ALM, 2014, J BIOL CHEM, V289, P29836, DOI 10.1074/jbc.M114.582783; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; Yu CM, 2006, J CHROMATOGR A, V1132, P99, DOI 10.1016/j.chroma.2006.07.017	35	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8259	8272		10.1074/jbc.RA119.008592	http://dx.doi.org/10.1074/jbc.RA119.008592			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30944174	hybrid, Green Published			2022-12-28	WOS:000470656500022
J	Zhang, ZM; Huang, Q; Tao, X; Song, GB; Zheng, P; Li, HY; Sun, HZ; Xia, W				Zhang, Zhemin; Huang, Qi; Tao, Xuan; Song, Guobing; Zheng, Peng; Li, Hongyan; Sun, Hongzhe; Xia, Wei			The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Helicobacter pylori; secretion; serine protease; virulence factor; protein structure; PDZ domain; high-temperature requirement A (HtrA)	PROTEIN-QUALITY-CONTROL; ESCHERICHIA-COLI; IV SECRETION; SERINE-PROTEASE; E-CADHERIN; CRYSTAL-STRUCTURE; STRESS SENSOR; CHAPERONE; FAMILY; DEGS	Knowledge of the molecular mechanisms of specific bacterial virulence factors can significantly contribute to antibacterial drug discovery. Helicobacter pylori is a Gram-negative microaerophilic bacterium that infects almost half of the world's population, leading to gastric disorders and even gastric cancer. H. pylori expresses a series of virulence factors in the host, among which high-temperature requirement A (HpHtrA) is a newly identified serine protease secreted by H. pylori. HpHtrA cleaves the extracellular domain of the epithelial cell surface adhesion protein E-cadherin and disrupts gastric epithelial cell junctions, allowing H. pylori to access the intercellular space. Here we report the first crystal structure of HpHtrA at 3.0 resolution. The structure revealed a new type of HtrA protease trimer stabilized by unique N-terminal domain swapping distinct from other known HtrA homologs. We further observed that truncation of the N terminus completely abrogates HpHtrA trimer formation as well as protease activity. In the presence of unfolded substrate, HpHtrA assembled into cage-like 12-mers or 24-mers. Combining crystallographic, biochemical, and mutagenic data, we propose a mechanistic model of how HpHtrA recognizes and cleaves the well-folded E-cadherin substrate. Our study provides a fundamental basis for the development of anti-H. pylori agents by using a previously uncharacterized HtrA protease as a target.	[Zhang, Zhemin; Huang, Qi; Tao, Xuan; Xia, Wei] Sun Yat Sen Univ, MOE Key Lab Bioinorgan & Synthet Chem, Sch Chem, Guangzhou 510275, Guangdong, Peoples R China; [Song, Guobing; Zheng, Peng] Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Peoples R China; [Li, Hongyan; Sun, Hongzhe] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210023, Jiangsu, Peoples R China	Sun Yat Sen University; University of Hong Kong; Nanjing University	Xia, W (corresponding author), Sun Yat Sen Univ, MOE Key Lab Bioinorgan & Synthet Chem, Sch Chem, Guangzhou 510275, Guangdong, Peoples R China.	xiawei5@mail.sysu.edu.cn	xia, wei/C-2628-2015; /D-3123-2009	xia, wei/0000-0001-6480-3265; /0000-0001-6697-6899	National Natural Science Foundation of China [21671203, 21771103, 21877131]; Science and Technology Program of Guangzhou, China [201707010038]; RGC of Hong Kong [17305415, 17333616, 17307017]; Ministry of Education of China [IRT-17R111]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Jiangsu Province [BK20160639]; Shuangchuang Program of Jiangsu Province; Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou, China; RGC of Hong Kong(Hong Kong Research Grants Council); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Shuangchuang Program of Jiangsu Province; Sun Yat-sen University	This work was supported by grants from the National Natural Science Foundation of China (21671203, 21771103, and 21877131); the Science and Technology Program of Guangzhou, China (201707010038); RGC of Hong Kong (17305415, 17333616, and 17307017); the Ministry of Education of China (IRT-17R111); Fundamental Research Funds for the Central Universities, Natural Science Foundation of Jiangsu Province (BK20160639); the Shuangchuang Program of Jiangsu Province; and startup funding from Sun Yat-sen University. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alba BM, 2001, MOL MICROBIOL, V40, P1323, DOI 10.1046/j.1365-2958.2001.02475.x; Albrecht N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00642; Ausiello G, 1997, PROTEINS, V28, P556, DOI 10.1002/(SICI)1097-0134(199708)28:4<556::AID-PROT9>3.3.CO;2-C; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Bai XC, 2011, STRUCTURE, V19, P1328, DOI 10.1016/j.str.2011.06.013; Boehm M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-3; Bonsor DA, 2015, J BIOL CHEM, V290, P12929, DOI 10.1074/jbc.M115.641829; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Dickey SW, 2017, NAT REV DRUG DISCOV, V16, P457, DOI 10.1038/nrd.2017.23; DOIG P, 1994, INFECT IMMUN, V62, P4526, DOI 10.1128/IAI.62.10.4526-4533.1994; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foegeding NJ, 2016, TOXINS, V8, DOI 10.3390/toxins8060173; Frees Dorte, 2013, Subcell Biochem, V66, P161, DOI 10.1007/978-94-007-5940-4_7; Gloeckl S, 2013, MOL MICROBIOL, V89, P676, DOI 10.1111/mmi.12306; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Grohmann E, 2018, MOL MICROBIOL, V107, P455, DOI 10.1111/mmi.13896; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hoy B, 2013, J BASIC MICROB, V53, P402, DOI 10.1002/jobm.201200074; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Iwanczyk J, 2007, J BACTERIOL, V189, P3176, DOI 10.1128/JB.01788-06; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Kaplan-Turkoz B, 2012, P NATL ACAD SCI USA, V109, P14640, DOI 10.1073/pnas.1206098109; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lower M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003510; Maurizi MR, 2002, NAT STRUCT BIOL, V9, P410, DOI 10.1038/nsb0602-410; MEGRAUD F, 1992, INFECT IMMUN, V60, P1858; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perna AM, 2015, ANGEW CHEM INT EDIT, V54, P10244, DOI 10.1002/anie.201504035; Perna AM, 2014, CHEM SCI, V5, P3583, DOI 10.1039/c4sc01443j; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Raju RM, 2012, NAT REV DRUG DISCOV, V11, P777, DOI 10.1038/nrd3846; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rieder G, 2005, CURR OPIN MICROBIOL, V8, P67, DOI 10.1016/j.mib.2004.12.004; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Schmidt TP, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0112-6; Schmidt TP, 2016, SCI REP-UK, V6, DOI 10.1038/srep23264; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; Skorko-Glonek J, 2013, CURR PHARM DESIGN, V19, P977, DOI 10.2174/1381612811319060003; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; SWAISGOOD HE, 1993, J DAIRY SCI, V76, P3054, DOI 10.3168/jds.S0022-0302(93)77645-6; Tarsia C, 2018, BBA-GEN SUBJECTS, V1862, P2245, DOI 10.1016/j.bbagen.2018.07.020; Tegtmeyer N, 2017, CELL HOST MICROBE, V22, P552, DOI 10.1016/j.chom.2017.09.005; Tegtmeyer N, 2016, MOL MICROBIOL, V99, P925, DOI 10.1111/mmi.13276; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Yang XM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003887; Zhang L, 2017, CELL RES, V27, P582, DOI 10.1038/cr.2017.5	69	9	9	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					7990	8000		10.1074/jbc.RA119.007387	http://dx.doi.org/10.1074/jbc.RA119.007387			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30936204	Green Published, hybrid			2022-12-28	WOS:000470656500003
J	Kuckelkorn, U; Stubler, S; Textoris-Taube, K; Kilian, C; Niewienda, A; Henklein, P; Janek, K; Stumpf, MPH; Mishto, M; Liepe, J				Kuckelkorn, Ulrike; Stuebler, Sabine; Textoris-Taube, Kathrin; Kilian, Christiane; Niewienda, Agathe; Henklein, Petra; Janek, Katharina; Stumpf, Michael P. H.; Mishto, Michele; Liepe, Juliane			Proteolytic dynamics of human 20S thymoproteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; protein degradation; antigen processing; computational biology; bioinformatics; thymoproteasome; thymus; proteolysis	MYELIN BASIC-PROTEIN; T-CELL RESPONSES; APPROXIMATE BAYESIAN COMPUTATION; MODEL SELECTION; PARAMETER-ESTIMATION; EXPRESSION; PROTEASOMES; CLEAVAGE; SYSTEMS; SUBUNIT	An efficient immunosurveillance of CD8(+) T cells in the periphery depends on positive/negative selection of thymocytes and thus on the dynamics of antigen degradation and epitope production by thymoproteasome and immunoproteasome in the thymus. Although studies in mouse systems have shown how thymoproteasome activity differs from that of immunoproteasome and strongly impacts the T cell repertoire, the proteolytic dynamics and the regulation of human thymoproteasome are unknown. By combining biochemical and computational modeling approaches, we show here that human 20S thymoproteasome and immunoproteasome differ not only in the proteolytic activity of the catalytic sites but also in the peptide transport. These differences impinge upon the quantity of peptide products rather than where the substrates are cleaved. The comparison of the two human 20S proteasome isoforms depicts different processing of antigens that are associated to tumors and autoimmune diseases.	[Kuckelkorn, Ulrike; Textoris-Taube, Kathrin; Kilian, Christiane; Niewienda, Agathe; Henklein, Petra; Janek, Katharina; Mishto, Michele] Charite Univ Med Berlin, D-10117 Berlin, Germany; [Kuckelkorn, Ulrike; Textoris-Taube, Kathrin; Kilian, Christiane; Niewienda, Agathe; Henklein, Petra; Janek, Katharina; Mishto, Michele] Free Univ Berlin, D-10117 Berlin, Germany; [Kuckelkorn, Ulrike; Kilian, Christiane; Henklein, Petra] Humboldt Univ, Inst Biochem, D-10117 Berlin, Germany; [Stuebler, Sabine; Stumpf, Michael P. H.; Liepe, Juliane] Imperial Coll London, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England; [Stuebler, Sabine] Univ Potsdam, Inst Math, Math Modelling & Syst Biol, D-14469 Potsdam, Germany; [Textoris-Taube, Kathrin; Niewienda, Agathe; Janek, Katharina; Mishto, Michele] Humboldt Univ, D-10117 Berlin, Germany; [Textoris-Taube, Kathrin; Niewienda, Agathe; Janek, Katharina; Mishto, Michele] Berlin Inst Hlth, Inst Biochem, D-10117 Berlin, Germany; [Textoris-Taube, Kathrin; Niewienda, Agathe; Janek, Katharina] Berlin Inst Hlth, Shared Facil Mass Spectrometry, D-10117 Berlin, Germany; [Mishto, Michele] Kings Coll London, Sch Immunol & Microbial Sci, CIBCI, London SE1 1UL, England; [Mishto, Michele] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London SE1 1UL, England; [Liepe, Juliane] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Stumpf, Michael P. H.] Univ Melbourne, Sch BioSci, Melbourne Integrat Genom, Parkville, Vic 3010, Australia; [Stumpf, Michael P. H.] Univ Melbourne, Sch BioSci, Sch Math & Stat, Parkville, Vic 3010, Australia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Imperial College London; University of Potsdam; Humboldt University of Berlin; Berlin Institute of Health; Berlin Institute of Health; University of London; King's College London; University of London; King's College London; Max Planck Society; University of Melbourne; University of Melbourne	Mishto, M (corresponding author), Charite Univ Med Berlin, D-10117 Berlin, Germany.; Mishto, M (corresponding author), Free Univ Berlin, D-10117 Berlin, Germany.; Liepe, J (corresponding author), Imperial Coll London, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England.; Mishto, M (corresponding author), Humboldt Univ, D-10117 Berlin, Germany.; Mishto, M (corresponding author), Berlin Inst Hlth, Inst Biochem, D-10117 Berlin, Germany.; Mishto, M (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, CIBCI, London SE1 1UL, England.; Mishto, M (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, London SE1 1UL, England.; Liepe, J (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	michele.mishto@kcl.ac.uk; juliane.liepe@mpibpc.mpg.de	mishto, michele/A-5592-2010	mishto, michele/0000-0003-3042-2792; Kuckelkorn, Ulrike/0000-0002-3085-9161; Liepe, Juliane/0000-0003-2515-9707; Henklein, Petra/0000-0001-7468-8926	Cancer Research UK King's Health Partners Centre at King's College London; Berlin Institute of Health [CRG1-TP1]	Cancer Research UK King's Health Partners Centre at King's College London; Berlin Institute of Health	This work was supported in part by Cancer Research UK King's Health Partners Centre at King's College London (Development Fund 2018) (to M. M.), Berlin Institute of Health Grant CRG1-TP1 (to P. M. Kloetzel). The authors declare that they have no conflicts of interest with the contents of this article.	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; [Anonymous], 2014, R LANG ENV STAT COMP; Berthelot L, 2008, EUR J IMMUNOL, V38, P1889, DOI 10.1002/eji.200838023; Deol P, 2007, J IMMUNOL, V178, P7557, DOI 10.4049/jimmunol.178.12.7557; Ebner F, 2014, ALLERGY, V69, P1489, DOI 10.1111/all.12496; Ebstein F, 2016, SCI REP-UK, V6, DOI 10.1038/srep24032; Erguler K, 2011, MOL BIOSYST, V7, P1593, DOI 10.1039/c0mb00107d; Faridi P, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3947; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Jaravine V, 2017, BIOINFORMATICS, V33, P104, DOI 10.1093/bioinformatics/btw567; Jurewicz A, 1998, J IMMUNOL, V160, P3056; Keller M, 2015, EUR J IMMUNOL, V45, P3257, DOI 10.1002/eji.201445243; Kincaid EZ, 2016, NAT IMMUNOL, V17, P938, DOI 10.1038/ni.3480; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Liepe J, 2019, CANCER IMMUNOL RES, V7, P62, DOI 10.1158/2326-6066.CIR-18-0424; Liepe J, 2018, CURR OPIN IMMUNOL, V52, P81, DOI 10.1016/j.coi.2018.04.016; Liepe J, 2016, SCIENCE, V354, P354, DOI 10.1126/science.aaf4384; Liepe J, 2015, ELIFE, V4, DOI 10.7554/eLife.07545; Liepe J, 2014, NAT PROTOC, V9, P439, DOI 10.1038/nprot.2014.025; Liepe J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002888; Liepe J, 2010, BIOINFORMATICS, V26, P1797, DOI 10.1093/bioinformatics/btq278; Liepe J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000830; Mishto M, 2006, BIOL CHEM, V387, P417, DOI 10.1515/BC.2006.056; Mishto M, 2017, TRENDS IMMUNOL, V38, P904, DOI 10.1016/j.it.2017.07.011; Mishto M, 2015, BRAIN BEHAV IMMUN, V49, P188, DOI 10.1016/j.bbi.2015.05.007; Mishto M, 2014, EUR J IMMUNOL, V44, P3508, DOI 10.1002/eji.201444902; Mishto M, 2012, MOL CELL PROTEOMICS, V11, P1008, DOI 10.1074/mcp.M112.020164; Mishto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009287; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nil A, 2004, EUR J IMMUNOL, V34, P2681, DOI 10.1002/eji.200425032; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Nurse P, 2011, CELL, V144, P850, DOI 10.1016/j.cell.2011.02.045; Olshina MA, 2018, CELL CYCLE, V17, P393, DOI 10.1080/15384101.2017.1414682; Pearson H, 2016, J CLIN INVEST, V126, P4690, DOI 10.1172/JCI88590; Perchellet A, 2004, NAT IMMUNOL, V5, P606, DOI 10.1038/ni1073; Perchellet A, 2008, P NATL ACAD SCI USA, V105, P14040, DOI 10.1073/pnas.0804970105; Peters B, 2002, J MOL BIOL, V318, P847, DOI 10.1016/S0022-2836(02)00167-5; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Putter H, 2002, STAT MED, V21, P2199, DOI 10.1002/sim.1211; Sasaki K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8484; Schrader J, 2016, SCIENCE, V353, P594, DOI 10.1126/science.aaf8993; Solomon H, 2017, CELL DEATH DIFFER, V24, P2187, DOI 10.1038/cdd.2017.139; Takada K, 2015, NAT IMMUNOL, V16, P1069, DOI 10.1038/ni.3237; Takase H, 2005, INT IMMUNOL, V17, P1131, DOI 10.1093/intimm/dxh275; Textoris-Taube K, 2015, J BIOL CHEM, V290, P30417, DOI 10.1074/jbc.M115.695189; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; TSUCHIDA T, 1994, P NATL ACAD SCI USA, V91, P10859, DOI 10.1073/pnas.91.23.10859; Vyshemirsky V, 2008, BIOINFORMATICS, V24, P833, DOI 10.1093/bioinformatics/btm607; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Yamada Y, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201930; Yamada Y, 2011, AM J SURG PATHOL, V35, P1296, DOI 10.1097/PAS.0b013e3182237f5d; Zang YCQ, 2004, J IMMUNOL, V172, P5120, DOI 10.4049/jimmunol.172.8.5120; Zanker D, 2013, J IMMUNOL, V191, P52, DOI 10.4049/jimmunol.1300802; Zhou YX, 2011, BIOINFORMATICS, V27, P874, DOI 10.1093/bioinformatics/btr015	61	19	19	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7740	7754		10.1074/jbc.RA118.007347	http://dx.doi.org/10.1074/jbc.RA118.007347			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30914481	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000470153300018
J	Charlton, FW; Hover, S; Fuller, J; Hewson, R; Fontana, J; Barr, JN; Mankouri, J				Charlton, Frank W.; Hover, Samantha; Fuller, Jack; Hewson, Roger; Fontana, Juan; Barr, John N.; Mankouri, Jamel			Cellular cholesterol abundance regulates potassium accumulation within endosomes and is an important determinant in bunyavirus entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virology; potassium channel; potassium transport; cholesterol; endosome; virus entry	VIRUS ENTRY; TRANSPORT INHIBITOR; DENGUE VIRUS; PROTEIN; ENDOCYTOSIS; CLATHRIN; U18666A; CELLS; REPLICATION; TRAFFICKING	The Bunyavirales order of segmented negative-sense RNA viruses includes more than 500 isolates that infect insects, animals, and plants and are often associated with severe and fatal disease in humans. To multiply and cause disease, bunyaviruses must translocate their genomes from outside the cell into the cytosol, achieved by transit through the endocytic network. We have previously shown that the model bunyaviruses Bunyamwera virus (BUNV) and Hazara virus (HAZV) exploit the changing potassium concentration ([K+]) of maturing endosomes to release their genomes at the appropriate endosomal location. K+ was identified as a biochemical cue to activate the viral fusion machinery, promoting fusion between viral and cellular membranes, consequently permitting genome release. In this study, we further define the biochemical prerequisites for BUNV and HAZV entry and their K+ dependence. Using drug-mediated cholesterol extraction along with viral entry and K+ uptake assays, we report three major findings: BUNV and HAZV require cellular cholesterol during endosomal escape; cholesterol depletion from host cells impairs K+ accumulation in maturing endosomes, revealing new insights into endosomal K+ homeostasis; and priming BUNV and HAZV virions with K+ before infection alleviates their cholesterol requirement. Taken together, our findings suggest a model in which cholesterol abundance influences endosomal K+ levels and, consequently, the efficiency of bunyavirus infection. The ability to inhibit bunyaviruses with existing cholesterol-lowering drugs may offer new options for future antiviral interventions for pathogenic bunyaviruses.	[Charlton, Frank W.; Hover, Samantha; Fontana, Juan; Barr, John N.; Mankouri, Jamel] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Fontana, Juan; Barr, John N.; Mankouri, Jamel] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Fuller, Jack; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England	University of Leeds; University of Leeds; Public Health England	Barr, JN; Mankouri, J (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.; Barr, JN; Mankouri, J (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	j.n.barr@leeds.ac.uk; j.mankouri@leeds.ac.uk	; Fontana, Juan/A-9138-2009	Fuller, Jack/0000-0002-8922-5032; Hover, Samantha/0000-0001-9190-5670; Mankouri, Jamel/0000-0002-4325-3687; Fontana, Juan/0000-0002-9084-2927; Charlton, Frank/0000-0003-2892-3555	Wellcome Trust [090932/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The FEI Tecnai G<SUP>2</SUP>-Spirit was funded by the Wellcome Trust (090932/Z/09/Z). We thank Xiaohong Shi (CVR Glasgow) for the kind gift of GFP-BUNV.	Bajimaya S, 2017, VIROLOGY, V510, P234, DOI 10.1016/j.virol.2017.07.024; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chlanda P, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.50, 10.1038/nmicrobiol.2016.50]; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Elgner F, 2016, J VIROL, V90, P11181, DOI 10.1128/JVI.01053-16; Elliott RM, 1997, MOL MED, V3, P572, DOI 10.1007/BF03401814; FULLER F, 1983, J GEN VIROL, V64, P1705, DOI 10.1099/0022-1317-64-8-1705; Garry Courtney E, 2004, Theor Biol Med Model, V1, P10, DOI 10.1186/1742-4682-1-10; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Hollidge BS, 2012, J VIROL, V86, P7988, DOI 10.1128/JVI.00140-12; Hover S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006845; Hover S, 2017, J GEN VIROL, V98, P345, DOI 10.1099/jgv.0.000712; Hover S, 2016, J BIOL CHEM, V291, P3411, DOI 10.1074/jbc.M115.692673; Jin M, 2002, VIROLOGY, V294, P60, DOI 10.1006/viro.2001.1303; KIELIAN MC, 1984, J VIROL, V52, P281, DOI 10.1128/JVI.52.1.281-283.1984; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lee AG, 2018, BIOPHYS J, V115, P522, DOI 10.1016/j.bpj.2018.06.022; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615; Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014; Punch EK, 2018, J BIOL CHEM, V293, P9937, DOI 10.1074/jbc.RA118.002494; Shi XH, 2010, J VIROL, V84, P8460, DOI 10.1128/JVI.00902-10; Shi XH, 2009, J GEN VIROL, V90, P2483, DOI 10.1099/vir.0.013540-0; Simon M, 2009, J GEN VIROL, V90, P210, DOI 10.1099/vir.0.006387-0; SIMONS JF, 1990, J VIROL, V64, P247, DOI 10.1128/JVI.64.1.247-255.1990; Soldan SS, 2005, J NEUROVIROL, V11, P412, DOI 10.1080/13550280591002496; Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; Vera-Otarola J, 2012, J VIROL, V86, P2176, DOI 10.1128/JVI.06223-11; VONBONSDORFF CH, 1975, J VIROL, V16, P141, DOI 10.1128/JVI.16.1.141-145.1975; VONBONSDORFF CH, 1975, J VIROL, V16, P1296, DOI 10.1128/JVI.16.5.1296-1307.1975; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5; Wolf Y., 2018, INT COMM TAXON VIRUS	41	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7335	7347		10.1074/jbc.RA119.007618	http://dx.doi.org/10.1074/jbc.RA119.007618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30804209	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000468402900021
J	Harding, RJ; Loppnau, P; Ackloo, S; Lemak, A; Hutchinson, A; Hunt, B; Holehouse, AS; Ho, JC; Fan, LX; Toledo-Sherman, L; Seitova, A; Arrowsmith, CH				Harding, Rochel J.; Loppnau, Peter; Ackloo, Suzanne; Lemak, Alexander; Hutchinson, Ashley; Hunt, Brittany; Holehouse, Alex S.; Ho, Jolene C.; Fan, Lixin; Toledo-Sherman, Leticia; Seitova, Alma; Arrowsmith, Cheryl H.			Design and characterization of mutant and wildtype huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Huntington disease; neurodegeneration; protein expression; protein purification; biophysics; small-angle X-ray scattering (SAXS); molecular dynamics	DNA-DAMAGE; PHOSPHOPROTEOMIC ANALYSIS; MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; QUANTITATIVE PHOSPHOPROTEOMICS; MITOCHONDRIAL DYSFUNCTION; PHOSPHORYLATION ANALYSIS; POLYGLUTAMINE EXPANSION; REVEALS; DISEASE	The gene mutated in individuals with Huntington's disease (HD) encodes the 348-kDa huntingtin (HTT) protein. Pathogenic HD CAG-expansion mutations create a polyglutamine (polyQ) tract at the N terminus of HTT that expands above a critical threshold of approximate to 35 glutamine residues. The effect of these HD mutations on HTT is not well understood, in part because it is difficult to carry out biochemical, biophysical, and structural studies of this large protein. To facilitate such studies, here we have generated expression constructs for the scalable production of HTT in multiple eukaryotic expression systems. Our set of HTT expression clones comprised both N- and C-terminally FLAG-tagged HTT constructs with polyQ lengths representative of the general population, HD patients, and juvenile HD patients, as well as the more extreme polyQ expansions used in some HD tissue and animal models. Our expression system yielded milligram quantities of pure recombinant HTT protein, including many of the previously mapped post-translational modifications. We characterized both apo and HTT-HTT-associated protein 40 (HAP40) complex samples produced with this HD resource, demonstrating that this toolkit can be used to generate physiologically meaningful HTT complexes. We further demonstrate that these resources can produce sufficient material for protein-intensive experiments, such as small-angle X-ray scattering, providing biochemical insight into full-length HTT protein structure. The work outlined and the tools generated here lay a foundation for further biochemical and structural work on the HTT protein and for studying its functional interactions with other biomolecules.	[Harding, Rochel J.; Loppnau, Peter; Ackloo, Suzanne; Hutchinson, Ashley; Hunt, Brittany; Ho, Jolene C.; Seitova, Alma; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Lemak, Alexander; Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Lemak, Alexander; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Holehouse, Alex S.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Holehouse, Alex S.] Washington Univ, Ctr Biol Syst Engn, St Louis, MO 63130 USA; [Fan, Lixin] NCI, Basic Sci Program, Frederick Natl Lab Canc Res, SAXS Core,NIH, Frederick, MD 21701 USA; [Toledo-Sherman, Leticia] CHDI Fdn, Los Angeles, CA 90045 USA; [Hunt, Brittany] Custom Biol, 115 Skyway Ave, Toronto, ON M9W 4Z4, Canada; [Holehouse, Alex S.] Washington Univ, Lab RV Pappu, St Louis, MO 63130 USA; [Toledo-Sherman, Leticia] Rainwater Charitable Fdn, Tau Consortium, 777 Main St,Ste 2250, Ft Worth, TX 76102 USA	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL)	Harding, RJ; Arrowsmith, CH (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.; Arrowsmith, CH (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada.; Arrowsmith, CH (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.	Rachel.Harding@utoronto.ca; Cheryl.Arrowsmith@uhnresearch.ca	Holehouse, Alex/ABE-8308-2020	Holehouse, Alex/0000-0002-4155-5729; Ho, Jolene/0000-0001-5908-0007; Ackloo, Suzanne/0000-0002-9696-1839; Arrowsmith, Cheryl/0000-0002-4971-3250; Harding, Rachel/0000-0002-1134-391X	National Institutes of Health, NCI [HHSN26120080001E]; Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; Huntington's Disease Society of America Berman/Topper Family Career Development Fellowship; Natural Sciences and Engineering Research Council of Canada; Huntington Society of Canada [RGPIN-2015-05939]; CHDI Foundation; SGC; AbbVie [1097737]; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute [OGI-055]; Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant [115766]; Janssen; Merck KGaA, Darmstadt, Germany; MSD; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer; Sao Paulo Research Foundation (FAPESP); Takeda; Wellcome Trust	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; Huntington's Disease Society of America Berman/Topper Family Career Development Fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Huntington Society of Canada; CHDI Foundation; SGC; AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck KGaA, Darmstadt, Germany; MSD; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science (MRIS); Pfizer(Pfizer); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by National Institutes of Health, NCI, under Contract HHSN26120080001E, by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research, a Huntington's Disease Society of America Berman/Topper Family Career Development Fellowship (to R. J. H.), the Natural Sciences and Engineering Research Council of Canada (to C. H. A.), Huntington Society of Canada Grant RGPIN-2015-05939 (to C. H. A.), the CHDI Foundation (to L. T. S. and C. H. A.), the SGC, a registered charity (No. 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute Grant OGI-055, Innovative Medicines Initiative (EU/EFPIA) ULTRA-DD Grant 115766, Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, Sao Paulo Research Foundation (FAPESP), Takeda, and The Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackloo S, 2017, EPIGENETICS-US, V12, P378, DOI 10.1080/15592294.2017.1279371; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Ayala-Pena S, 2013, FREE RADICAL BIO MED, V62, P102, DOI 10.1016/j.freeradbiomed.2013.04.017; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Berlin K, 2013, J AM CHEM SOC, V135, P16595, DOI 10.1021/ja4083717; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boeing S, 2016, CELL REP, V15, P1597, DOI 10.1016/j.celrep.2016.04.047; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Britton D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090948; Cariulo C, 2017, P NATL ACAD SCI USA, V114, pE10809, DOI 10.1073/pnas.1705372114; Carrier M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157290; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dong GF, 2012, PROTEOMICS, V12, P2060, DOI 10.1002/pmic.201100380; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Feigin L A, 1987, STRUCTURE ANAL SMALL, DOI DOI 10.1007/978-1-4757-6624-0; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franz-Wachtel M, 2012, MOL CELL PROTEOMICS, V11, P160, DOI 10.1074/mcp.M111.016014; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Gundry Rebekah L, 2009, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1025s88; Guo Q, 2018, NATURE, V555, P117, DOI 10.1038/nature25502; Han GH, 2010, ELECTROPHORESIS, V31, P1080, DOI 10.1002/elps.200900493; Holehouse AS, 2017, BIOPHYS J, V112, P16, DOI 10.1016/j.bpj.2016.11.3200; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121055; Huesgen PF, 2015, NAT METHODS, V12, P55, DOI 10.1038/nmeth.3177; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Imami K, 2012, MOL CELL PROTEOMICS, V11, P1741, DOI 10.1074/mcp.M112.019919; Johri A, 2013, FREE RADICAL BIO MED, V62, P37, DOI 10.1016/j.freeradbiomed.2013.04.016; Ju TC, 2012, CELL MOL LIFE SCI, V69, P4107, DOI 10.1007/s00018-012-1025-2; Junger MA, 2014, WIRES DEV BIOL, V3, P83, DOI 10.1002/wdev.121; Kay C, 2014, HUNTINGTONS DIS, P131; Kay C, 2017, HAND CLINIC, V144, P31, DOI 10.1016/B978-0-12-801893-4.00003-1; Keil B., 1992, SPECIFICITY PROTEOLY, P43, DOI DOI 10.1007/978-3-642-48380-6_5; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kim M, 1999, J NEUROSCI, V19, P964; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Kim YC, 2008, J MOL BIOL, V375, P1416, DOI 10.1016/j.jmb.2007.11.063; Klammer M, 2012, MOL CELL PROTEOMICS, V11, P651, DOI 10.1074/mcp.M111.016410; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200; Luerman GC, 2014, J NEUROCHEM, V128, P561, DOI 10.1111/jnc.12483; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maiuri T, 2017, HUM MOL GENET, V26, P395, DOI 10.1093/hmg/ddw395; Marion S, 2014, J BIOL CHEM, V289, P11715, DOI 10.1074/jbc.M113.544312; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Meyer JG, 2014, MOL CELL PROTEOMICS, V13, P823, DOI 10.1074/mcp.M113.034710; Michalik A, 2001, BIOTECHNIQUES, V31, P250, DOI 10.2144/01312bm02; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Naia L, 2015, MOL NEUROBIOL, V51, P331, DOI 10.1007/s12035-014-8735-4; Nithianantharajah J, 2013, NEUROSCIENCE, V251, P66, DOI 10.1016/j.neuroscience.2012.05.043; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P2796, DOI 10.1074/mcp.M900285-MCP200; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Peters MF, 2001, J BIOL CHEM, V276, P3188, DOI 10.1074/jbc.M008099200; Posey AE, 2018, J BIOL CHEM, V293, P3734, DOI 10.1074/jbc.RA117.000357; Raijmakers R, 2010, ANAL CHEM, V82, P824, DOI 10.1021/ac901764g; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Ratovitski T, 2017, J PROTEOME RES, V16, P2692, DOI 10.1021/acs.jproteome.6b00991; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P101, DOI 10.1016/j.bbadis.2011.10.016; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Rolland D, 2014, AM J PATHOL, V184, P1331, DOI 10.1016/j.ajpath.2014.01.036; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Rui YN, 2015, NAT CELL BIOL, V17, P262, DOI 10.1038/ncb3101; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schreiber TB, 2010, MOL CELL PROTEOMICS, V9, P1047, DOI 10.1074/mcp.M900486-MCP200; Schweppe DK, 2013, J PROTEOMICS, V91, P286, DOI 10.1016/j.jprot.2013.07.023; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Seredenina T, 2012, NEUROBIOL DIS, V45, P83, DOI 10.1016/j.nbd.2011.07.001; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Stuart SA, 2015, MOL CELL PROTEOMICS, V14, P1599, DOI 10.1074/mcp.M114.047233; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Trevisiol S, 2016, PROTEOMICS, V16, P715, DOI 10.1002/pmic.201500379; Vieweg S, 2016, J BIOL CHEM, V291, P12074, DOI 10.1074/jbc.M116.713982; Vijayvargia R, 2016, ELIFE, V5, DOI 10.7554/eLife.11184; Wang R, 2014, AM J PHYSIOL-CELL PH, V307, pC442, DOI 10.1152/ajpcell.00379.2013; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Watkin EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088284; Weber C, 2012, J PROTEOMICS, V75, P1343, DOI 10.1016/j.jprot.2011.11.004; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yi TF, 2014, P NATL ACAD SCI USA, V111, pE2182, DOI 10.1073/pnas.1404943111; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zheng ZQ, 2012, PROG MOL BIOL TRANSL, V107, P189, DOI 10.1016/B978-0-12-385883-2.00010-2; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k	106	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6986	7001		10.1074/jbc.RA118.007204	http://dx.doi.org/10.1074/jbc.RA118.007204			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30842263	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000467394700031
J	Smith, CP; Lee, WK; Haley, M; Poulsen, SB; Thevenod, F; Fenton, RA				Smith, Craig P.; Lee, Wing-Kee; Haley, Matthew; Poulsen, Soren B.; Thevenod, Frank; Fenton, Robert A.			Proximal tubule transferrin uptake is modulated by cellular iron and mediated by apical membrane megalin-cubilin complex and transferrin receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transferrin; kidney; iron; membrane transport; epithelial cell; renal physiology; chelation; cubilin; endocytosis; megalin; transferrin receptor	EXPRESSION; KIDNEY; TRANSPORTER; IMMORTALIZATION; LOCALIZATION; REABSORPTION; METABOLISM; PROTEINS; CELLS; IMAGE	Receptor-mediated endocytosis is responsible for reabsorption of transferrin (Tf) in renal proximal tubules (PTs). Although the role of the megalin-cubilin receptor complex (MCRC) in this process is unequivocal, modalities independent of this complex are evident but as yet undefined. Here, using immunostaining and Tf-flux assays, FACS analysis, and fluorescence imaging, we report localization of Tf receptor 1 (TfR1), the cognate Tf receptor mediating cellular holo-Tf (hTf) acquisition, to the apical brush border of the PT, with expression gradually declining along the PT in mouse and rat kidneys. In functional studies, hTf uptake across the apical membrane of cultured PT epithelial cell (PTEC) monolayers increased in response to decreased cellular iron after desferrioxamine (DFO) treatment. We also found that apical hTf uptake under basal conditions is receptor-associated protein (RAP)-sensitive and therefore mediated by the MCRC but becomes RAP-insensitive under DFO treatment, with concomitantly decreased megalin and cubilin expression levels and increased TfR1 expression. Thus, as well as the MCRC, TfR1 mediates hTf uptake across the PT apical brush border, but in conditions of decreased cellular iron, hTf uptake is predominated by augmented apical TfR1. In conclusion, both the MCRC and TfR1 mediate hTf uptake across apical brush border membranes of PTECs and reciprocally respond to decreased cellular iron. Our findings have implications for renal health, whole-body iron homeostasis, and pathologies arising from disrupted iron balance.	[Smith, Craig P.; Haley, Matthew] Univ Manchester, Sch Med Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England; [Lee, Wing-Kee; Thevenod, Frank] Univ Witten Herdecke, Physiol Pathophysiol & Toxicol, D-58453 Witten, Germany; [Poulsen, Soren B.; Fenton, Robert A.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	University of Manchester; Witten Herdecke University; Aarhus University	Smith, CP (corresponding author), Univ Manchester, Sch Med Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	craig.smith@manchester.ac.uk	Fenton, Robert/AFR-6983-2022; Fenton, Robert A/ABD-9824-2021	Fenton, Robert/0000-0003-1623-199X; Poulsen, Soren Brandt/0000-0002-0082-3934; Lee, Wing-Kee/0000-0002-7352-4679; Thevenod, Frank/0000-0001-8663-3498	Biotechnology and Biological Sciences Research Council (BBSRC); Bundesministerium fur Bildung und Forschung (BMBF) [01DN16039]; ZBAF (Center for Biomedical Education and Research); Independent Research Fund Denmark; Novo Nordisk Foundation; Faculty of Health, Witten/Herdecke University [IFF2017-14, IFF2018-52]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); ZBAF (Center for Biomedical Education and Research); Independent Research Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Faculty of Health, Witten/Herdecke University	This work was supported in part by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship (to M. H.), Bundesministerium fur Bildung und Forschung (BMBF) Grant 01DN16039 and ZBAF (Center for Biomedical Education and Research) (to F. T.), Independent Research Fund Denmark and the Novo Nordisk Foundation (to R. A. F.), and the Faculty of Health, Witten/Herdecke University internal grant program (Projects IFF2017-14 and IFF2018-52) (to W. K. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abouhamed M, 2006, AM J PHYSIOL-RENAL, V290, pF1525, DOI 10.1152/ajprenal.00359.2005; Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Barasch J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12973; Betten R, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0285-3; Breuer W, 2000, BLOOD, V95, P2975, DOI 10.1182/blood.V95.9.2975.009k03_2975_2982; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Canonne-Hergaux FS, 2002, KIDNEY INT, V62, P147, DOI 10.1046/j.1523-1755.2002.00405.x; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; Fenton RA, 2015, AM J PHYSIOL-RENAL, V308, pF1409, DOI 10.1152/ajprenal.00129.2015; Ferguson CJ, 2001, AM J PHYSIOL-RENAL, V280, pF803, DOI 10.1152/ajprenal.2001.280.5.F803; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Haldar S, 2015, J BIOL CHEM, V290, P5512, DOI 10.1074/jbc.M114.607507; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; Langelueddecke C, 2012, J BIOL CHEM, V287, P159, DOI 10.1074/jbc.M111.308296; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LU JP, 1989, ACTA PATHOL JAPON, V39, P759; Martines AMF, 2013, NAT REV NEPHROL, V9, P385, DOI 10.1038/nrneph.2013.98; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Ohno Y, 2005, NEPHRON EXP NEPHROL, V99, pE17, DOI 10.1159/000081794; Orosz DE, 2004, IN VITRO CELL DEV-AN, V40, P22; Rieg T, 2013, AM J PATHOL, V182, P96, DOI 10.1016/j.ajpath.2012.09.014; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sanchez-Gonzalez C, 2014, SCI WORLD J, DOI 10.1155/2014/706074; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith CP, 2009, BBA-GEN SUBJECTS, V1790, P724, DOI 10.1016/j.bbagen.2008.10.010; Thevenod F, 2016, METALLOMICS, V8, P17, DOI 10.1039/c5mt00215j; van Raaij S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27107-8; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Ward DT, 2005, BBA-MOL BASIS DIS, V1740, P79, DOI 10.1016/j.bbadis.2005.01.008; Wareing M, 2003, AM J PHYSIOL-RENAL, V285, pF1050, DOI 10.1152/ajprenal.00064.2003; Wareing M, 2000, J PHYSIOL-LONDON, V524, P581, DOI 10.1111/j.1469-7793.2000.00581.x; Weiss G, 1997, BIOCHEM PHARMACOL, V53, P1419, DOI 10.1016/S0006-2952(96)00894-5; Wolff NA, 2011, J CELL MOL MED, V15, P209, DOI 10.1111/j.1582-4934.2009.00985.x; Woost PG, 1996, KIDNEY INT, V50, P125, DOI 10.1038/ki.1996.295; Zhang DL, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00124; Zhang DL, 2007, J AM SOC NEPHROL, V18, P401, DOI 10.1681/ASN.2006080908	39	19	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7025	7036		10.1074/jbc.RA118.006390	http://dx.doi.org/10.1074/jbc.RA118.006390			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30833328	Green Published, hybrid			2022-12-28	WOS:000467394700034
J	Eggink, D; Bontjer, I; de Taeye, SW; Langedijk, JPM; Berkhout, B; Sanders, RW				Eggink, Dirk; Bontjer, Ilja; de Taeye, Steven W.; Langedijk, Johannes P. M.; Berkhout, Ben; Sanders, Rogier W.			HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); drug resistance; inhibition mechanism; virus entry; fusion protein; membrane fusion; peptides; anchor inhibitor; antiviral drug; fusion peptide (FP)	TYPE-1 GP41; PROMISCUOUS BINDING; 6-HELIX BUNDLE; ENFUVIRTIDE; RESISTANCE; MUTATIONS; PEPTIDE; INTERMEDIATE; EMERGENCE; DOMAIN	HIV-1 entry into cells is mediated by the envelope glycoprotein (Env) and represents an attractive target for therapeutic intervention. Two drugs that inhibit HIV entry are approved for clinical use: the membrane fusion-inhibitor T20 (Fuzeon, enfuvirtide) and the C-C chemokine receptor type 5 (CCR5) blocker maraviroc (Selzentry). Another class of entry inhibitors supposedly target the fusion peptide (FP) and are termed anchor inhibitors. These include the VIRIP peptide and VIRIP derivatives such as VIR165, VIR353, and VIR576. Here, we investigated the mechanism of inhibition by VIR165. We show that substitutions within the FP modulate sensitivity to VIR165, consistent with the FP being the drug target. Our results also revealed that VIR165 acts during an intermediate post-CD4-binding entry step that is overlapping but not identical to the step inhibited by fusion inhibitors such as T20. We found that some but not all resistance mutations to heptad repeat 2 (HR2)-targeting fusion inhibitors can provide cross-resistance to VIR165. In contrast, resistance mutations in the HR1-binding site for the fusion inhibitors did not cause cross-resistance to VIR165. However, Env with mutations located outside this binding site and thought to affect fusion kinetics, exhibited decreased sensitivity to VIR165. Although we found a strong correlation between Env stability and resistance to HR2-based fusion inhibitors, such correlation was not observed for Env stability and VIR165 resistance. We conclude that VIRIP analogs target the FP during an intermediate, post-CD4-binding entry step that overlaps with but is distinct from the step(s) inhibited by HR2-based fusion inhibitors.	[Eggink, Dirk; Bontjer, Ilja; de Taeye, Steven W.; Berkhout, Ben; Sanders, Rogier W.] Univ Amsterdam, Amsterdam Univ Med Ctr Amsterdam UMC, Locat AMC, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Langedijk, Johannes P. M.] Pepscan Therapeut BV, Zuidersluisweg 2, NL-8243 RC Lelystad, Netherlands; [Langedijk, Johannes P. M.] Janssen Vaccines & Prevent, Archimedesweg 4-6, NL-2333 Leiden, Netherlands	University of Amsterdam; Cornell University; Pepscan Therapeutics B.V.	Sanders, RW (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr Amsterdam UMC, Locat AMC, Lab Expt Virol,Dept Med Microbiol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl		Eggink, Dirk/0000-0002-4248-6008	Aids Fonds Netherlands [2005021, 2008013]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) [OPP1111923, OPP1132237]; National Institutes of Health [P01 AI110657]; European Union's Horizon 2020 research and innovation program [68113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI110657] Funding Source: NIH RePORTER	Aids Fonds Netherlands; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union's Horizon 2020 research and innovation program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Aids Fonds Netherlands Grants 2005021 and 2008013, the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) Grants OPP1111923 and OPP1132237, National Institutes of Health Grant P01 AI110657, and the European Union's Horizon 2020 research and innovation program under Grant 68113. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrahamyan LG, 2003, J VIROL, V77, P5829, DOI 10.1128/JVI.77.10.5829-5836.2003; Agrawal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021339; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Baldwin C, 2008, J VIROL, V82, P7735, DOI 10.1128/JVI.02524-07; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; BUCHSCHACHER GL, 1995, J VIROL, V69, P1344, DOI 10.1128/JVI.69.2.1344-1348.1995; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Das AT, 1999, J VIROL, V73, P81, DOI 10.1128/JVI.73.1.81-91.1999; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Delahunty MD, 1996, VIROLOGY, V218, P94, DOI 10.1006/viro.1996.0169; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Dingens AS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007159; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2016, J VIROL, V90, P10587, DOI 10.1128/JVI.01616-16; Eggink D, 2011, J VIROL, V85, P10785, DOI 10.1128/JVI.05331-11; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Ekins S, 2004, DRUG DISCOV TODAY, V9, P276, DOI 10.1016/S1359-6446(03)03008-3; Forssmann WG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001697; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; FREED EO, 1992, P NATL ACAD SCI USA, V89, P70, DOI 10.1073/pnas.89.1.70; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Gonzalez E, 2011, AIDS, V25, P1575, DOI 10.1097/QAD.0b013e328348a733; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Gustchina E, 2008, J VIROL, V82, P10032, DOI 10.1128/JVI.01050-08; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Henderson HI, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-36; Herold N, 2014, J VIROL, V88, P13956, DOI 10.1128/JVI.01543-14; Huang K, 1998, STRUCTURE, V6, P697, DOI 10.1016/S0969-2126(98)00072-0; James LC, 2003, PROTEIN SCI, V12, P2183, DOI 10.1110/ps.03172703; Jeeninga RE, 2001, VIROLOGY, V283, P294, DOI 10.1006/viro.2001.0888; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kong R, 2016, SCIENCE, V352, P828, DOI 10.1126/science.aae0474; Konuma T, 2007, J MOL BIOL, V368, P209, DOI 10.1016/j.jmb.2007.01.077; Lalezari Jacob P, 2003, AIDS Read, V13, pS9; Leaman DP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003184; Leitner T., 2008, HIV SEQUENCE COMPEND; Melby T, 2006, AIDS RES HUM RETROV, V22, P375, DOI 10.1089/aid.2006.22.375; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2006, J VIROL, V80, P3249, DOI 10.1128/JVI.80.7.3249-3258.2006; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; Pritsker M, 1999, BIOCHEMISTRY-US, V38, P11359, DOI 10.1021/bi990232e; Quinones-Mateu ME, 2011, AIDS, V25, P1663, DOI 10.1097/QAD.0b013e32834a36ea; Raviv Y, 2002, VIROLOGY, V293, P243, DOI 10.1006/viro.2001.1237; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Reynes J, 2007, AIDS PATIENT CARE ST, V21, P533, DOI 10.1089/apc.2006.0174; Sanders Rogier W, 2004, Retrovirology, V1, P3, DOI 10.1186/1742-4690-1-3; Sanders RW, 2014, NATURE, V514, P437, DOI 10.1038/nature13926; Sanders RW, 2004, AIDS RES HUM RETROV, V20, P742, DOI 10.1089/0889222041524544; SANDERS RW, 2002, HIV SEQUENCE COMPEND, P43; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Shafer RW, 2008, AIDS REV, V10, P67; Tolstrup M, 2007, AIDS, V21, P519, DOI 10.1097/QAD.0b013e3280187558; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; van Gils MJ, 2018, IMMUNITY, V49, P14, DOI 10.1016/j.immuni.2018.07.003; van Gils MJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.199; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005	75	14	14	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5736	5746		10.1074/jbc.RA119.007360	http://dx.doi.org/10.1074/jbc.RA119.007360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30696772	Green Published, hybrid			2022-12-28	WOS:000465077500001
J	Eisa, NH; Jilani, Y; Kainth, K; Redd, P; Lu, S; Bougrine, O; Sater, HA; Patwardhan, CA; Shull, A; Shi, HD; Liu, KB; Elsherbiny, NM; Eissa, LA; El-Shishtawy, MM; Horuzsko, A; Bollag, R; Maihle, N; Roig, J; Korkaya, H; Cowell, JK; Chadli, A				Eisa, Nada H.; Jilani, Yasmeen; Kainth, Kashish; Redd, Priscilla; Lu, Su; Bougrine, Oulia; Sater, Houssein Abdul; Patwardhan, Chaitanya A.; Shull, Austin; Shi, Huidong; Liu, Kebin; Elsherbiny, Nehal M.; Eissa, Laila A.; El-Shishtawy, Mamdouh M.; Horuzsko, Anatolij; Bollag, Roni; Maihle, Nita; Roig, Joan; Korkaya, Hasan; Cowell, John K.; Chadli, Ahmed			The co-chaperone UNC45A is essential for the expression of mitotic kinase NEK7 and tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; mitosis; molecular chaperone; centrosome; glucocorticoid receptor; Heat shock protein 90; Hsp90; KEK7; UNC-45A; UNC45A	NIMA-FAMILY KINASE; MYOSIN CHAPERONE; UNC-45 CHAPERONE; KINESIN EG5; UCS DOMAIN; CANCER; PROLIFERATION; CENTROSOMES; SEPARATION; PROTEINS	Cumulative evidence suggests that the heat shock protein 90 (Hsp90) co-chaperone UNC-45 myosin chaperone A (UNC45A) contributes to tumorigenesis and that its expression in cancer cells correlates with proliferation and metastasis of solid tumors. However, the molecular mechanism by which UNC45A regulates cancer cell proliferation remains largely unknown. Here, using siRNA-mediated gene silencing and various human cells, we report that UNC45A is essential for breast cancer cell growth, but is dispensable for normal cell proliferation. Immunofluorescence microscopy, along with gene microarray and RT-quantitative PCR analyses, revealed that UNC45A localizes to the cancer cell nucleus, where it up-regulates the transcriptional activity of the glucocorticoid receptor and thereby promotes expression of the mitotic kinase NIMA-related kinase 7 (NEK7). We observed that UNC45A-deficient cancer cells exhibit extensive pericentrosomal material disorganization, as well as defects in centrosomal separation and mitotic chromosome alignment. Consequently, these cells stalled in metaphase and cytokinesis and ultimately underwent mitotic catastrophe, phenotypes that were rescued by heterologous NEK7 expression. Our results identify a key role for the co-chaperone UNC45A in cell proliferation and provide insight into the regulatory mechanism. We propose that UNC45A represents a promising new therapeutic target to inhibit cancer cell growth in solid tumor types.	[Eisa, Nada H.; Jilani, Yasmeen; Kainth, Kashish; Redd, Priscilla; Lu, Su; Patwardhan, Chaitanya A.; Shull, Austin; Shi, Huidong; Horuzsko, Anatolij; Bollag, Roni; Maihle, Nita; Korkaya, Hasan; Cowell, John K.; Chadli, Ahmed] Augusta Univ, Georgia Canc Ctr, 1410 Laney Walker Blvd,CN-3151, Augusta, GA 30912 USA; [Bougrine, Oulia; Sater, Houssein Abdul] Augusta Univ, Dept Pathol, CN-3151, Augusta, GA 30912 USA; [Liu, Kebin; Elsherbiny, Nehal M.; Eissa, Laila A.; El-Shishtawy, Mamdouh M.; Bollag, Roni] Mansoura Univ, Biochem Dept, Fac Pharm, Mansoura 35516, Egypt; [Bollag, Roni] Augusta Univ, Georgia Canc Ctr, Biorepository, Augusta, GA 30912 USA; [Roig, Joan] CSIC, IBMB, Parc Cient Barcelona,C Baldiri & Reixac 10-12, E-08028 Barcelona, Spain	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Egyptian Knowledge Bank (EKB); Mansoura University; University System of Georgia; Augusta University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Chadli, A (corresponding author), Augusta Univ, Georgia Canc Ctr, 1410 Laney Walker Blvd,CN-3151, Augusta, GA 30912 USA.	achadli@augusta.edu	Eisa, Nada H./AAR-4359-2021; El-Shishtawy, Mamdouh M./O-6626-2018; Elsherbiny, Nehal/AAF-9206-2019; Korkaya, Hasan/GRY-1016-2022; Eissa, Laila Ahmed/O-3010-2018; Korkaya, Hasan/ABD-6282-2020; Eisa, Nada H./N-5111-2018; Roig, Joan/E-2836-2017	El-Shishtawy, Mamdouh M./0000-0002-7888-354X; Elsherbiny, Nehal/0000-0001-5167-3377; Eissa, Laila Ahmed/0000-0003-4470-0263; Korkaya, Hasan/0000-0002-0719-5862; Shi, Huidong/0000-0003-1137-3390; Abdul Sater, Houssein/0000-0003-1975-3726; Eisa, Nada H./0000-0001-8630-0693; Roig, Joan/0000-0002-3872-4712; Shull, Austin/0000-0001-5111-2908	National Institutes of Health [R01 GM102443-01]; Augusta University Startup Funds; Egyptian Cultural and Educational Bureau	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Augusta University Startup Funds; Egyptian Cultural and Educational Bureau(Egyptian Cultural & Educational Bureau)	This work was supported by National Institutes of Health Grant R01 GM102443-01 and Augusta University Startup Funds (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the government scholarship fund from the Egyptian Cultural and Educational Bureau.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bazzaro M, 2007, AM J PATHOL, V171, P1640, DOI 10.2353/ajpath.2007.070325; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; BRENNER S, 1974, GENETICS, V77, P71; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chadli A, 2008, J BIOL CHEM, V283, P9509, DOI 10.1074/jbc.C800017200; Cohen S, 2013, BBA-MOL CELL RES, V1833, P1104, DOI 10.1016/j.bbamcr.2012.12.021; Comyn SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048861; Cullati SN, 2017, J CELL BIOL, V216, P2339, DOI 10.1083/jcb.201512055; Epping MT, 2009, MOL CANCER RES, V7, P1861, DOI 10.1158/1541-7786.MCR-09-0187; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Feige E, 2002, MECH DEVELOP, V110, P219, DOI 10.1016/S0925-4773(01)00573-1; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Fu JY, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015800; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; GILMORE TD, 1986, CELL, V44, P791, DOI 10.1016/0092-8674(86)90845-7; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Guo W, 2011, J MOL BIOL, V412, P365, DOI 10.1016/j.jmb.2011.07.012; Gupta A, 2017, MOL BIOL CELL, V28, P2123, DOI 10.1091/mbc.E16-09-0643; Iizuka Y, 2017, MOL BIOL CELL, V28, P1337, DOI 10.1091/mbc.E16-06-0381; Iizuka Y, 2015, J IMMUNOL, V195, P4760, DOI 10.4049/jimmunol.1500979; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jilani Y, 2015, CANCER LETT, V357, P114, DOI 10.1016/j.canlet.2014.11.009; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kim S, 2007, BIOCHEM BIOPH RES CO, V360, P56, DOI 10.1016/j.bbrc.2007.05.206; Kim S, 2011, J CELL SCI, V124, P3760, DOI 10.1242/jcs.078089; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lee CF, 2011, STRUCTURE, V19, P397, DOI 10.1016/j.str.2011.01.002; Lehtimaki JI, 2017, J CELL BIOL, V216, P4053, DOI 10.1083/jcb.201703107; Minoguchi S, 2003, BIOCHEM BIOPH RES CO, V301, P899, DOI 10.1016/S0006-291X(03)00049-4; Mooneyham A, 2019, MOL CANCER RES, V17, P370, DOI 10.1158/1541-7786.MCR-18-0670; Ni WM, 2011, J CELL SCI, V124, P3164, DOI 10.1242/jcs.087320; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Roig J, 2002, GENE DEV, V16, P1640, DOI 10.1101/gad.972202; Salem H, 2010, ONCOGENE, V29, P4046, DOI 10.1038/onc.2010.162; Sampson J, 2017, CANCER RES, V77, P4785, DOI 10.1158/0008-5472.CAN-16-3233; Sdelci S, 2011, CELL CYCLE, V10, P3816, DOI 10.4161/cc.10.22.18226; Shi H, 2010, P NATL ACAD SCI USA, V107, P21382, DOI 10.1073/pnas.1013038107; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Walker Michael G., 2001, Mini-Reviews in Medicinal Chemistry, V1, P197, DOI 10.2174/1389557013407034; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069	49	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5246	5260		10.1074/jbc.RA118.006597	http://dx.doi.org/10.1074/jbc.RA118.006597			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30737284	Green Published, hybrid			2022-12-28	WOS:000464517500002
J	Sachdeva, M; Duchateau, P; Depil, S; Poirot, L; Valton, J				Sachdeva, Mohit; Duchateau, Philippe; Depil, Stephane; Poirot, Laurent; Valton, Julien			Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunotherapy; cancer therapy; gene knockout; gene transfer; T-cell; CAR T-cell therapy; cytokine release syndrome (CRS); granulocyte-macrophage colony-stimulating factor (GMCSF); interleukin signaling	TARGETING GM-CSF; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; RECEPTOR; ACTIVATION	Chimeric antigen receptor T-cell (CAR T-cell) therapy has been shown to be clinically effective for managing a variety of hematological cancers. However, CAR T-cell therapy is associated with multiple adverse effects, including neurotoxicity and cytokine release syndrome (CRS). CRS arises from massive cytokine secretion and can be life-threatening, but it is typically managed with an anti-IL-6Ra mAb or glucocorticoid administration. However, these treatments add to a patient's medication burden and address only the CRS symptoms. Therefore, alternative strategies that can prevent CRS and neurotoxicity associated with CAR T-cell treatment are urgently needed. Here, we explored a therapeutic route aimed at preventing CRS rather than limiting its consequences. Using a cytokine-profiling assay, we show that granulocyte-macrophage colony-stimulating factor (GMCSF) is a key CRS-promoting protein. Through a combination of in vitro experiments and gene-editing technology, we further demonstrate that antibody-mediated neutralization or TALEN-mediated genetic inactivation of GMCSF in CAR T-cells drastically decreases available GMCSF and abolishes macrophage-dependent secretion of CRS biomarkers, including monocyte chemoattractant protein 1 (MCP-1), interleukin (IL) 6, and IL-8. Of note, we also found that the genetic inactivation of GMCSF does not impair the antitumor function or proliferative capacity of CAR T-cells in vitro. We conclude that it is possible to prevent CRS by using all-in-one GMCSF-knockout CAR T-cells. This approach may eliminate the need for anti-CRS treatment and may improve the overall safety of CAR T-cell therapies for cancer patients.	[Sachdeva, Mohit; Valton, Julien] Cellectis Inc, 430 East 29th St, New York, NY 10016 USA; [Duchateau, Philippe; Depil, Stephane; Poirot, Laurent] Cellectis, 8 Rue Croix Jarry, F-75013 Paris, France		Sachdeva, M; Valton, J (corresponding author), Cellectis Inc, 430 East 29th St, New York, NY 10016 USA.	mohit.sachdeva@cellectis.com; julien.valton@cellectis.com		Valton, Julien/0000-0003-0826-5401				[Anonymous], 2014, BLOOD, DOI DOI 10.1182/BLOOD.V124.21.2296.2296; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Bonifant CL, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.11; Burmester GR, 2011, ANN RHEUM DIS, V70, P1542, DOI 10.1136/ard.2010.146225; CHEN BDM, 1988, BLOOD, V71, P997; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; FIEHN C, 1992, Z RHEUMATOL, V51, P121; Fitzgerald JC, 2017, CRIT CARE MED, V45, pE124, DOI 10.1097/CCM.0000000000002053; Frey N, 2017, BEST PRACT RES CL HA, V30, P336, DOI 10.1016/j.beha.2017.09.002; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Hamilton JA, 2015, EXPERT REV CLIN IMMU, V11, P457, DOI 10.1586/1744666X.2015.1024110; Huizinga TWJ, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1267-3; Jones G, 2010, CLIN MED INSIGHTS-AR, V3, P81, DOI 10.4137/CMAMD.S4864; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Papp KA, 2019, BRIT J DERMATOL, V180, P1352, DOI 10.1111/bjd.17195; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Postiglione L, 1998, LIFE SCI, V63, P327, DOI 10.1016/S0024-3205(98)00281-1; Russo RC, 2014, EXPERT REV CLIN IMMU, V10, P593, DOI 10.1586/1744666X.2014.894886; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Sentman ML, 2016, J IMMUNOL, V197, P4674, DOI 10.4049/jimmunol.1600769; Singh N, 2017, CYTOTHERAPY, V19, P867, DOI 10.1016/j.jcyt.2017.04.001; Sterner RM, 2019, BLOOD, V133, P697, DOI 10.1182/blood-2018-10-881722; Tang XY, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013904; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Valton J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27264-w; Vogel DYS, 2015, EUR J IMMUNOL, V45, P1808, DOI 10.1002/eji.201444960; Wicks IP, 2016, NAT REV RHEUMATOL, V12, P37, DOI 10.1038/nrrheum.2015.161; WILLIAMSON DJ, 1988, CLIN EXP IMMUNOL, V72, P67; XU WD, 1989, J CLIN INVEST, V83, P876, DOI 10.1172/JCI113971	39	77	90	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5430	5437		10.1074/jbc.AC119.007558	http://dx.doi.org/10.1074/jbc.AC119.007558			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30804212	hybrid, Green Published			2022-12-28	WOS:000464517500016
J	Wang, HB; Lu, J; Kulkarni, S; Zhang, WQ; Gorka, JE; Mandel, JA; Goetzman, ES; Prochownik, EV				Wang, Huabo; Lu, Jie; Kulkarni, Sucheta; Zhang, Weiqi; Gorka, Joanna E.; Mandel, Jordan A.; Goetzman, Eric S.; Prochownik, Edward V.			Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Myc (c-Myc); fatty acid oxidation; pyruvate carboxylase (PC); Warburg effect; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); glutaminolysis; reverse carboxylation	GREEN FLUORESCENT PROTEIN; C-MYC; LACTATE-DEHYDROGENASE; REDUCTIVE CARBOXYLATION; DNA-DAMAGE; DEFICIENT CELLS; RAT-LIVER; CANCER; GLUTAMINE; INHIBITION	Eukaryotic cell metabolism consists of processes that generate available energy, such as glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation (Oxphos), and those that consume it, including macromolecular synthesis, the maintenance of ionic gradients, and cellular detoxification. By converting pyruvate to acetyl-CoA (AcCoA), the pyruvate dehydrogenase (PDH) complex (PDC) links glycolysis and the TCA cycle. Surprisingly, disrupting the connection between glycolysis and the TCA cycle by inactivation of PDC has only minor effects on cell replication. However, the molecular basis for this metabolic re-equilibration is unclear. We report here that CRISPR/Cas9-generated PDH-knockout (PDH-KO) rat fibroblasts reprogrammed their metabolism and their response to short-term c-Myc (Myc) oncoprotein overexpression. PDH-KO cells replicated normally but produced surprisingly little lactate. They also exhibited higher rates of glycolysis and Oxphos. In addition, PDH-KO cells showed altered cytoplasmic and mitochondrial pH, redox states, and mitochondrial membrane potential (M). Conditionally activated Myc expression affected some of these parameters in a PDH-dependent manner. PDH-KO cells had increased oxygen consumption rates in response to glutamate, but not to malate, and were depleted in all TCA cycle substrates between -ketoglutarate and malate despite high rates of glutaminolysis, as determined by flux studies with isotopically labeled glutamine. Malate and pyruvate were diverted to produce aspartate, thereby potentially explaining the failure to accumulate lactate. We conclude that PDH-KO cells maintain proliferative capacity by utilizing glutamine to supply high rates of AcCoA-independent flux through the bottom portion of the TCA cycle while accumulating pyruvate and aspartate that rescue their redox defects.	[Wang, Huabo; Lu, Jie; Kulkarni, Sucheta; Zhang, Weiqi; Gorka, Joanna E.; Mandel, Jordan A.; Prochownik, Edward V.] UPMC, Childrens Hosp Pittsburgh, Sect Hematol Oncol, Pittsburgh, PA 15224 USA; [Goetzman, Eric S.] UPMC, Childrens Hosp Pittsburgh, Div Med Genet, Pittsburgh, PA USA; [Prochownik, Edward V.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA; [Prochownik, Edward V.] UPMC, Hillman Canc Ctr, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), UPMC, Hillman Canc Ctr, Pittsburgh, PA 15232 USA.; Prochownik, EV (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Hematol Oncol, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	procev@chp.edu		Gorka, Joanna/0000-0001-9871-7664	National Institutes of Health [DK090242, RO1CA174713]; Hyundai Hope on Wheels Scholar Grant; NATIONAL CANCER INSTITUTE [R01CA174713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels Scholar Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1CA174713, Hyundai Hope on Wheels Scholar Grant (to E. V. P.), and National Institutes of Health Grant DK090242 (to E. S. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberghina L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.513; Augoff K, 2015, CANCER LETT, V358, P1, DOI 10.1016/j.canlet.2014.12.035; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; BURTON BK, 1984, PEDIATR RES, V18, P1242, DOI 10.1203/00006450-198412000-00003; BUSTO F, 1984, INT J BIOCHEM, V16, P171, DOI 10.1016/0020-711X(84)90068-5; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COULSON CJ, 1969, FEBS LETT, V3, P333, DOI 10.1016/0014-5793(69)80171-7; Covarrubias L, 2008, DEV BIOL, V320, P1, DOI 10.1016/j.ydbio.2008.04.041; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; Dean JM, 2018, PROTEIN CELL, V9, P196, DOI 10.1007/s13238-017-0423-5; DESANCHEZ VC, 1977, FEBS LETT, V83, P321, DOI 10.1016/0014-5793(77)81032-6; Dolezal JM, 2017, J BIOL CHEM, V292, P10068, DOI 10.1074/jbc.M117.782052; Edmunds LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134049; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; Eszes CM, 1996, FEBS LETT, V399, P193, DOI 10.1016/S0014-5793(96)01317-8; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Green K, 2004, DIABETES, V53, pS110, DOI 10.2337/diabetes.53.2007.S110; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HASLAM JM, 1968, BIOCHEM J, V109, P921, DOI 10.1042/bj1090921; Hsieh AL, 2015, SEMIN CELL DEV BIOL, V43, P11, DOI 10.1016/j.semcdb.2015.08.003; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Idelchik MDS, 2017, SEMIN CANCER BIOL, V47, P57, DOI 10.1016/j.semcancer.2017.04.005; Indo HP, 2017, HANDB EXP PHARMACOL, V240, P439, DOI 10.1007/164_2016_117; Jackson LE, 2017, CANCER RES, V77, P5795, DOI 10.1158/0008-5472.CAN-17-1325; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Jiang K, 2006, PLANT PHYSIOL, V141, P397, DOI 10.1104/pp.106.078246; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Johnson MT, 2001, MOL GENET METAB, V74, P293, DOI 10.1006/mgme.2001.3249; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; KLEFSTROM J, 1994, EMBO J, V13, P5442, DOI 10.1002/j.1460-2075.1994.tb06879.x; Kulkarni S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182705; Landay M, 2000, CELL DEATH DIFFER, V7, P697, DOI 10.1038/sj.cdd.4400701; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Li M, 2012, ARCH BIOCHEM BIOPHYS, V519, P69, DOI 10.1016/j.abb.2011.10.015; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Lindsay DP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00058; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; MAFTAH A, 1989, BIOCHEM BIOPH RES CO, V164, P185, DOI 10.1016/0006-291X(89)91700-2; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Moloney JN, 2018, SEMIN CELL DEV BIOL, V80, P50, DOI 10.1016/j.semcdb.2017.05.023; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nakae Y, 1997, J HISTOCHEM CYTOCHEM, V45, P1427, DOI 10.1177/002215549704501011; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Obrosova IG, 2005, ANTIOXID REDOX SIGN, V7, P1543, DOI 10.1089/ars.2005.7.1543; Patel KP, 2012, MOL GENET METAB, V105, P34, DOI 10.1016/j.ymgme.2011.09.032; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104; Perez-Escuredo J, 2016, CELL CYCLE, V15, P72, DOI 10.1080/15384101.2015.1120930; Perl A, 2004, TRENDS IMMUNOL, V25, P360, DOI 10.1016/j.it.2004.05.001; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Prochownik EV, 2008, CURR MOL MED, V8, P446, DOI 10.2174/156652408785747988; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Sarin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.201; Scalise M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00306; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Shirmanova MV, 2015, BBA-GEN SUBJECTS, V1850, P1905, DOI 10.1016/j.bbagen.2015.05.001; Sofou K, 2017, J INHERIT METAB DIS, V40, P237, DOI 10.1007/s10545-016-0011-5; Stacpoole PW, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx071; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Swietach P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0099; Talaiezadeh A, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0171-7; Tao JY, 2014, GASTROENTEROLOGY, V147, P690, DOI 10.1053/j.gastro.2014.05.004; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Van Vranken JG, 2015, CELL, V162, P471, DOI 10.1016/j.cell.2015.07.027; VANANTWERP ME, 1992, P NATL ACAD SCI USA, V89, P9010, DOI 10.1073/pnas.89.19.9010; Wahlstrom T, 2015, BBA-GENE REGUL MECH, V1849, P563, DOI 10.1016/j.bbagrm.2014.07.004; Wang HB, 2016, J BIOL CHEM, V291, P26241, DOI 10.1074/jbc.M116.754218; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Whitaker AM, 2017, FRONT BIOSCI-LANDMRK, V22, P1493, DOI 10.2741/4555; White C, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00171; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; WOJTCZAK L, 1969, BIOCHIM BIOPHYS ACTA, V191, P10, DOI 10.1016/0005-2744(69)90310-6; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yang LF, 2017, ANNU REV BIOMED ENG, V19, P163, DOI 10.1146/annurev-bioeng-071516-044546; Yao CH, 2016, CELL CHEM BIOL, V23, P483, DOI 10.1016/j.chembiol.2016.03.007; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2001, CANCER RES, V61, P6487; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	114	10	11	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5466	5486		10.1074/jbc.RA118.005200	http://dx.doi.org/10.1074/jbc.RA118.005200			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30755479	Green Published, hybrid			2022-12-28	WOS:000464517500019
J	Bucki, R; Wang, YH; Yang, CS; Kandy, SK; Fatunmbi, O; Bradley, R; Pogoda, K; Svitkina, T; Radhakrishnan, R; Janmey, PA				Bucki, Robert; Wang, Yu-Hsiu; Yang, Changsong; Kandy, Sreeja Kutti; Fatunmbi, Ololade; Bradley, Ryan; Pogoda, Katarzyna; Svitkina, Tatyana; Radhakrishnan, Ravi; Janmey, Paul A.			Lateral distribution of phosphatidylinositol 4,5-bisphosphate in membranes regulates formin- and ARP2/3-mediated actin nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid; phosphatidylinositol; membrane; actin; cell biology; actin assembly; biological membrane; cholesterol; formins; PI(4; 5)P2	CLUSTER FORMATION; PLASMA-MEMBRANE; PROTEIN; CHOLESTEROL; MODEL; PHOSPHOINOSITIDES; POLYMERIZATION; ORGANIZATION; CYTOSKELETON; INHIBITOR	Spatial and temporal control of actin polymerization is fundamental for many cellular processes, including cell migration, division, vesicle trafficking, and response to agonists. Many actin-regulatory proteins interact with phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) and are either activated or inactivated by local PI(4,5)P-2 concentrations that form transiently at the cytoplasmic face of cell membranes. The molecular mechanisms of these interactions and how the dozens of PI(4,5)P-2-sensitive actin-binding proteins are selectively recruited to membrane PI(4,5)P-2 pools remains undefined. Using a combination of biochemical, imaging, and cell biologic studies, combined with molecular dynamics and analytical theory, we test the hypothesis that the lateral distribution of PI(4,5)P-2 within lipid membranes and native plasma membranes alters the capacity of PI(4,5)P-2 to nucleate actin assembly in brain and neutrophil extracts and show that activities of formins and the Arp2/3 complex respond to PI(4,5)P-2 lateral distribution. Simulations and analytical theory show that cholesterol promotes the cooperative interaction of formins with multiple PI(4,5)P-2 headgroups in the membrane to initiate actin nucleation. Masking PI(4,5)P-2 with neomycin or disrupting PI(4,5)P-2 domains in the plasma membrane by removing cholesterol decreases the ability of these membranes to nucleate actin assembly in cytoplasmic extracts.	[Bucki, Robert; Pogoda, Katarzyna; Janmey, Paul A.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Wang, Yu-Hsiu] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Yang, Changsong; Svitkina, Tatyana] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kandy, Sreeja Kutti; Fatunmbi, Ololade; Bradley, Ryan; Radhakrishnan, Ravi] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Bucki, Robert] Med Univ Bialystok, Dept Microbiol & Nanobiomed Engn, PL-15089 Bialystok, Poland; [Pogoda, Katarzyna] Polish Acad Sci, Inst Nucl Phys, PL-31342 Krakow, Poland; [Wang, Yu-Hsiu; Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Medical University of Bialystok; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; University of Pennsylvania; Pennsylvania Medicine	Bucki, R (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.; Bucki, R (corresponding author), Med Univ Bialystok, Dept Microbiol & Nanobiomed Engn, PL-15089 Bialystok, Poland.	buckirobert@gmail.com	Pogoda, Katarzyna/AAD-2057-2020; Wang, Yu-Hsiu/N-8094-2013	Pogoda, Katarzyna/0000-0001-6994-3435; Wang, Yu-Hsiu/0000-0001-9753-5535; Bradley, Ryan/0000-0001-9190-8409; Radhakrishnan, Ravi/0000-0003-0686-2851; Bucki, Robert/0000-0001-7664-9226	National Institutes of Health [GM111942]; National Science Center, Poland [UMO-2015/17/B/NZ6/03473]; NATIONAL CANCER INSTITUTE [U54CA193417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Center, Poland(National Science Centre, Poland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM111942 (to P. A. J.) and the National Science Center, Poland, under Grant UMO-2015/17/B/NZ6/03473 (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alwarawrah M, 2017, J PHYS CHEM B, V121, P78, DOI 10.1021/acs.jpcb.6b10188; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bilkova E, 2017, J AM CHEM SOC, V139, P4019, DOI 10.1021/jacs.6b11760; Bradley RP, 2016, P NATL ACAD SCI USA, V113, pE5117, DOI 10.1073/pnas.1605259113; Bucki R, 2004, ANTIMICROB AGENTS CH, V48, P1526, DOI 10.1128/AAC.48.5.1526-1533.2004; Chierico L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06056; Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048; DeLano W.L, PYMOL MOL GRAPHICS S; DOGTEROM M, 1993, PHYS REV LETT, V70, P1347, DOI 10.1103/PhysRevLett.70.1347; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Huang MZ, 2005, CELL MOTIL CYTOSKEL, V62, P232, DOI 10.1002/cm.20097; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janmey PA, 2018, BIOCHEM BIOPH RES CO, V506, P307, DOI 10.1016/j.bbrc.2018.07.155; Jungmichel S, 2014, CELL REP, V6, P578, DOI 10.1016/j.celrep.2013.12.038; Kang JK, 2017, P NATL ACAD SCI USA, V114, P11926, DOI 10.1073/pnas.1706489114; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LASSING I, 1988, EXP CELL RES, V174, P1, DOI 10.1016/0014-4827(88)90136-X; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Lee S, 2014, J PHYS CHEM B, V118, P547, DOI 10.1021/jp410344g; Levental I, 2008, BIOPHYS J, V95, P1199, DOI 10.1529/biophysj.107.126615; Lewis AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003376; Ma L, 1998, J CELL BIOL, V140, P1125; Mahammad S, 2015, METHODS MOL BIOL, V1232, P91, DOI 10.1007/978-1-4939-1752-5_8; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ramakrishnan N, 2014, PHYS REP, V543, P1, DOI 10.1016/j.physrep.2014.05.001; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Rusinova R, 2013, J GEN PHYSIOL, V141, P673, DOI 10.1085/jgp.201310960; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Senju Y, 2017, P NATL ACAD SCI USA, V114, pE8977, DOI 10.1073/pnas.1705032114; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Stocker U, 2000, PROTEINS, V40, P145, DOI 10.1002/(SICI)1097-0134(20000701)40:1<145::AID-PROT160>3.0.CO;2-Y; Suetsugu S, 2001, J CELL SCI, V114, P4533; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Wang YH, 2016, BIOCHEMISTRY-US, V55, P3361, DOI 10.1021/acs.biochem.5b01363; Wang YH, 2014, CHEM PHYS LIPIDS, V182, P38, DOI 10.1016/j.chemphyslip.2014.01.001; Wang YH, 2012, J AM CHEM SOC, V134, P3387, DOI 10.1021/ja208640t; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zigmond SH, 1998, J CELL BIOL, V142, P1001, DOI 10.1083/jcb.142.4.1001	55	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4704	4722		10.1074/jbc.RA118.005552	http://dx.doi.org/10.1074/jbc.RA118.005552			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30692198	Green Published, hybrid			2022-12-28	WOS:000462969500035
J	Cho, H; Shen, GQ; Wang, XF; Wang, F; Archacki, S; Li, YB; Yu, G; Chakrabarti, S; Chen, QY; Wang, QK				Cho, Hyosuk; Shen, Gong-Qing; Wang, Xiaofeng; Wang, Fan; Archacki, Stephen; Li, Yabo; Yu, Gang; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth			Long noncoding RNA ANRIL regulates endothelial cell activities associated with coronary artery disease by up-regulating CLIP1, EZR, and LYVE1 genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						long noncoding RNA (long ncRNA; lncRNA); gene regulation; EZR (ezrin); endothelial cell; cell adhesion; ANRIL (CDKN2B-AS1); CLIP1 (CLIP-170); coronary artery disease; LYVE1 (LYVE-1); transendothelial migration of monocytes (TEM); monocyte adhesion	EXPRESSION; LOCUS; ANGIOGENESIS; ADTRP; ATHEROSCLEROSIS; IDENTIFICATION; PROLIFERATION; INFLAMMATION; PATHWAY; PROTEIN	Coronary artery disease (CAD) is the leading cause of death worldwide. Long noncoding RNAs (lncRNAs) are a class of noncoding transcripts of > 200 nucleotides and are increasingly recognized as playing functional roles in physiology and disease. ANRIL is an lncRNA gene mapped to the chromosome 9p21 genetic locus for CAD identified by the first series of genome-wide association studies (GWAS). However, ANRIL's role in CAD and the underlying molecular mechanism are unknown. Here, we show that the major ANRIL transcript in endothelial cells (ECs) is DQ485454 with a much higher expression level in ECs than in THP-1 monocytes. Of note, DQ485454 expression was down-regulated in CAD coronary arteries compared with non-CAD arteries. DQ485454 overexpression significantly reduced monocyte adhesion to ECs, transendothelial monocyte migration (TEM), and EC migration, which are critical cellular processes involved in CAD initiation, whereas siRNA-mediated ANRIL knockdown (KD) had the opposite effect. Microarray and follow-up quantitative RT-PCR analyses revealed that the ANRIL KD down-regulated expression of AHNAK2, CLIP1, CXCL11, ENC1, EZR, LYVE1, WASL, and TNFSF10 genes and up-regulated TMEM100 and TMEM106B genes. Mechanistic studies disclosed that overexpression of CLIP1, EZR, and LYVE1 reversed the effects of ANRIL KD on monocyte adhesion to ECs, TEM, and EC migration. These findings indicate that ANRIL regulates EC functions directly related to CAD, supporting the hypothesis that ANRIL is involved in CAD pathogenesis at the 9p21 genetic locus and identifying a molecular mechanism underlying lncRNA-mediated regulation of EC function and CAD development.	[Cho, Hyosuk; Wang, Qing Kenneth] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Cho, Hyosuk; Shen, Gong-Qing; Wang, Fan; Archacki, Stephen; Li, Yabo; Yu, Gang; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44195 USA; [Wang, Xiaofeng] Cleveland Clin, Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Cho, Hyosuk; Shen, Gong-Qing; Wang, Fan; Archacki, Stephen; Li, Yabo; Yu, Gang; Chakrabarti, Susmita; Chen, Qiuyun; Wang, Qing Kenneth] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA; [Yu, Gang; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Cardio X Ctr,Coll Life Sci & Technol, Wuhan 430073, Peoples R China; [Yu, Gang; Wang, Qing Kenneth] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan 430073, Peoples R China	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, QY; Wang, QK (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44195 USA.	chenq3@ccf.org; wangq2@ccf.org	Chakrabarti, Susmita/CAH-2331-2022	Chakrabarti, Susmita/0000-0003-1197-2780; Wang, Qing/0000-0002-5639-8519; Wang, Qing Kenneth/0000-0002-2235-6572; WANG, FAN/0000-0001-9806-5037; Cho, Hyosuk/0000-0003-0592-9102	NHLBI, National Institutes of Health [R01 HL121358, R01 HL126729]; American Heart Association Innovative Research Grant [11IRG5570046]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121358, R01HL126729] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Innovative Research Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NHLBI, National Institutes of Health, Grants R01 HL121358 and R01 HL126729; American Heart Association Innovative Research Grant 11IRG5570046. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archacki Stephen, 2004, Human Genomics, V1, P355; Bai Y, 2014, STROKE, V45, P383, DOI 10.1161/STROKEAHA.113.003393; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cheng XA, 2011, DIABETES, V60, P680, DOI 10.2337/db10-0185; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Fan C, 2009, J BIOL CHEM, V284, P25653, DOI 10.1074/jbc.M109.041368; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Holdt LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003588; Holdt LM, 2012, ARTERIOSCL THROM VAS, V32, P196, DOI 10.1161/ATVBAHA.111.232678; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; Holdt LM, 2011, ATHEROSCLEROSIS, V214, P264, DOI 10.1016/j.atherosclerosis.2010.06.029; Hu WT, 2018, ATHEROSCLEROSIS, V278, P39, DOI 10.1016/j.atherosclerosis.2018.09.018; Johnson LA, 2017, NAT IMMUNOL, V18, P762, DOI 10.1038/ni.3750; Kong YH, 2016, DIABETOLOGIA, V59, P1579, DOI 10.1007/s00125-016-3967-7; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Luo CY, 2017, BBA-MOL BASIS DIS, V1863, P2319, DOI 10.1016/j.bbadis.2017.06.015; Luo CY, 2017, BBA-MOL BASIS DIS, V1863, P1640, DOI 10.1016/j.bbadis.2017.03.010; Luo CY, 2016, PHYSIOL GENOMICS, V48, P554, DOI 10.1152/physiolgenomics.00028.2016; Matsuzawa Y, 2014, CORONARY ARTERY DIS, V25, P713, DOI 10.1097/MCA.0000000000000178; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Nishida-Fukuda H, 2016, J BIOL CHEM, V291, P10490, DOI 10.1074/jbc.M115.683201; Rey-Gallardo A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215541; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Sun XD, 2013, PROTEIN CELL, V4, P266, DOI 10.1007/s13238-013-3007-z; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Xie SB, 2014, ATHEROSCLEROSIS, V233, P403, DOI 10.1016/j.atherosclerosis.2014.01.009; Ye J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34034; Zhang T, 2016, HUM MOL GENET, V25, P5094, DOI 10.1093/hmg/ddw273; Zhao LP, 2016, J HUAZHONG U SCI-MED, V36, P243, DOI 10.1007/s11596-016-1574-y; Zhao YY, 2015, BBA-MOL BASIS DIS, V1852, P2024, DOI 10.1016/j.bbadis.2015.07.016; Zhou X, 2016, RNA BIOL, V13, P98, DOI 10.1080/15476286.2015.1122164	35	34	34	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3881	3898		10.1074/jbc.RA118.005050	http://dx.doi.org/10.1074/jbc.RA118.005050			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655286	Green Published, hybrid			2022-12-28	WOS:000461854400007
J	Klinker, S; Stindt, S; Gremer, L; Bode, JG; Gertzen, CGW; Gohlke, H; Weiergraber, OH; Hoffmann, S; Willbold, D				Klinker, Stefan; Stindt, Sabine; Gremer, Lothar; Bode, Johannes G.; Gertzen, Christoph G. W.; Gohlke, Holger; Weiergraeber, Oliver H.; Hoffmann, Silke; Willbold, Dieter			Phosphorylated tyrosine 93 of hepatitis C virus nonstructural protein 5A is essential for interaction with host c-Src and efficient viral replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis C virus (HCV); Src; Src homology 2 domain (SH2 domain); phosphotyrosine; viral replication; liver disease; nonstructural protein 5A; NS5A; virion assembly	PARTICLE MESH EWALD; NS5A PROTEIN; RNA REPLICATION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; SH2 DOMAINS; CELL-LINES; IN-VIVO; BINDING; PARAMETERS	The hepatitis C virus (HCV) nonstructural protein 5A (NS5A) plays a key role in viral replication and virion assembly, and the regulation of the assembly process critically depends on phosphorylation of both serine and threonine residues in NS5A. We previously identified SRC proto-oncogene, nonreceptor tyrosine kinase (c-Src), as an essential host component of the HCV replication complex consisting of NS5A, the RNA-dependent RNA polymerase NS5B, and c-Src. Pulldown assays revealed an interaction between NS5A and the Src homology 2 (SH2) domain of c-Src; however, the precise binding mode remains undefined. In this study, using a variety of biochemical and biophysical techniques, along with molecular dynamics simulations, we demonstrate that the interaction between NS5A and the c-Src SH2 domain strictly depends on an intact phosphotyrosine-binding competent SH2 domain and on tyrosine phosphorylation within NS5A. Detailed analysis of c-Src SH2 domain binding to a panel of phosphorylation-deficient NS5A variants revealed that phosphorylation of Tyr-93 located within domain 1 of NS5A, but not of any other tyrosine residue, is crucial for complex formation. In line with these findings, effective replication of subgenomic HCV replicons as well as production of infectious virus particles in mammalian cell culture models were clearly dependent on the presence of tyrosine at position 93 of NS5A. These findings indicate that phosphorylated Tyr-93 in NS5A plays an important role during viral replication by facilitating NS5A's interaction with the SH2 domain of c-Src.	[Klinker, Stefan; Gremer, Lothar; Willbold, Dieter] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany; [Stindt, Sabine; Bode, Johannes G.] Heinrich Heine Univ Dusseldorf, Dept Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany; [Gremer, Lothar; Gertzen, Christoph G. W.; Gohlke, Holger; Weiergraeber, Oliver H.; Hoffmann, Silke; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst Struct Biochem ICS 6, D-52425 Julich, Germany; [Gertzen, Christoph G. W.; Gohlke, Holger] Forschungszentrum Julich, John von Neumann Inst Comp NIC, D-52425 Julich, Germany; [Gertzen, Christoph G. W.; Gohlke, Holger] Forschungszentrum Julich, JSC, D-52425 Julich, Germany; [Gertzen, Christoph G. W.; Gohlke, Holger] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany.	d.willbold@fz-juelich.de	Gremer, Lothar/H-9128-2013; Hoffmann, Silke/H-5059-2013; Weiergräber, Oliver H./G-8940-2013; Willbold, Dieter/A-6280-2013	Gremer, Lothar/0000-0001-7065-5027; Hoffmann, Silke/0000-0003-1414-8957; Weiergräber, Oliver H./0000-0002-2410-3691; Willbold, Dieter/0000-0002-0065-7366	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [190586431-SFB 974]; Deutsche Forschungsgemeinschaft [267205415-SFB 1208]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Projektnummer 190586431-SFB 974 (to D. W. and J. G. B) and by Deutsche Forschungsgemeinschaft-Projektnummer 267205415-SFB 1208 (to D. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Aladag A, 2014, J PEPT SCI, V20, P334, DOI 10.1002/psc.2618; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Ascher DB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04765; Badillo A, 2017, BIOCHEMISTRY-US, V56, P3029, DOI 10.1021/acs.biochem.7b00212; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bode JG, 2009, BIOL CHEM, V390, P1013, DOI 10.1515/BC.2009.118; Case D., 2015, AMBER, V14; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Feuerstein S, 2012, J MOL BIOL, V420, P310, DOI 10.1016/j.jmb.2012.04.023; Feuerstein S, 2012, J MAGN RESON, V214, P329, DOI 10.1016/j.jmr.2011.10.019; Feuerstein S, 2011, BIOMOL NMR ASSIGN, V5, P241, DOI 10.1007/s12104-011-9309-2; Hierholzer J, 1996, VIROLOGY METHODS MAN, P24; Hiyoshi M, 2012, J CELL PHYSIOL, V227, P1090, DOI 10.1002/jcp.22825; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456; Lee JH, 2018, EBIOMEDICINE, V28, P151, DOI 10.1016/j.ebiom.2018.01.004; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Li PF, 2013, J CHEM THEORY COMPUT, V9, P2733, DOI 10.1021/ct400146w; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakashima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046634; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Pfannkuche A, 2011, HEPATOLOGY, V53, P1127, DOI 10.1002/hep.24214; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pietschmann T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000475; Romero-Brey I, 2015, MBIO, V6, DOI 10.1128/mBio.00759-15; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Rosnoblet C, 2012, J BIOL CHEM, V287, P44249, DOI 10.1074/jbc.M112.392209; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Ross-Thriepland D, 2015, J VIROL, V89, P3123, DOI 10.1128/JVI.02995-14; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schwarten M, 2013, BIOCHEMISTRY-US, V52, P6160, DOI 10.1021/bi400363v; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Solyom Z, 2015, BIOPHYS J, V109, P1483, DOI 10.1016/j.bpj.2015.06.040; Solyom Z, 2013, J BIOMOL NMR, V55, P311, DOI 10.1007/s10858-013-9715-0; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; Vieyres G, 2013, METHODS, V59, P233, DOI 10.1016/j.ymeth.2012.09.005; Wagner MJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008987; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yamauchi S, 2015, J BIOL CHEM, V290, P21857, DOI 10.1074/jbc.M115.666859; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	67	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7388	7402		10.1074/jbc.RA119.007656	http://dx.doi.org/10.1074/jbc.RA119.007656			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30862675	Green Published, hybrid			2022-12-28	WOS:000468402900025
J	French, RL; Grese, ZR; Aligireddy, H; Dhavale, DD; Reeb, AN; Kedia, N; Kotzbauer, PT; Bieschke, J; Ayala, YM				French, Rachel L.; Grese, Zachary R.; Aligireddy, Himani; Dhavale, Dhruva D.; Reeb, Ashley N.; Kedia, Niraja; Kotzbauer, Paul T.; Bieschke, Jan; Ayala, Yuna M.			Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); TAR DNA-binding protein 43 (TDP-43) (TARDBP); RNA binding protein; protein aggregation; neurodegeneration; ribonuclear protein (RNP); ALS mutation; frontotemporal dementia (FTD); liquid droplet; liquid-liquid phase separation	FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; PHASE-SEPARATION; FIBRIL FORMATION; AMYLOID-BETA; HEAT-SHOCK; REGULATES TDP-43; RNA RECOGNITION; YEAST PRION; KDA TDP-43	Aggregates of the RNA-binding protein TDP-43 (TAR DNA-binding protein) are a hallmark of the overlapping neurodegenerative disorders amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. The process of TDP-43 aggregation remains poorly understood, and whether it includes formation of intermediate complexes is unknown. Here, we analyzed aggregates derived from purified TDP-43 under semidenaturing conditions, identifying distinct oligomeric complexes at the initial time points before the formation of large aggregates. We found that this early oligomerization stage is primarily driven by TDP-43's RNA-binding region. Specific binding to GU-rich RNA strongly inhibited both TDP-43 oligomerization and aggregation, suggesting that RNA interactions are critical for maintaining TDP-43 solubility. Moreover, we analyzed TDP-43 liquid-liquid phase separation and detected similar detergent-resistant oligomers upon maturation of liquid droplets into solid-like fibrils. These results strongly suggest that the oligomers form during the early steps of TDP-43 misfolding. Importantly, the ALS-linked TDP-43 mutations A315T and M337V significantly accelerate aggregation, rapidly decreasing the monomeric population and shortening the oligomeric phase. We also show that aggregates generated from purified TDP-43 seed intracellular aggregation detected by established TDP-43 pathology markers. Remarkably, cytoplasmic aggregate seeding was detected earlier for the A315T and M337V variants and was 50% more widespread than for WT TDP-43 aggregates. We provide evidence for an initial step of TDP-43 self-assembly into intermediate oligomeric complexes, whereby these complexes may provide a scaffold for aggregation. This process is altered by ALS-linked mutations, underscoring the role of perturbations in TDP-43 homeostasis in protein aggregation and ALS-FTD pathogenesis.	[French, Rachel L.; Grese, Zachary R.; Aligireddy, Himani; Reeb, Ashley N.; Ayala, Yuna M.] St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63103 USA; [Dhavale, Dhruva D.; Kotzbauer, Paul T.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Kedia, Niraja; Bieschke, Jan] UCL, MRC Prion Unit, London W1W 7FF, England; [Reeb, Ashley N.] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL); University of London; University College London; Washington University (WUSTL)	Ayala, YM (corresponding author), St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63103 USA.	yuna.ayala@health.slu.edu	Dhavale, Dhruva/AAI-3934-2021; Bieschke, Jan/AAG-2705-2019	Dhavale, Dhruva/0000-0002-0096-1085; Bieschke, Jan/0000-0002-3485-9767	Saint Louis University Grant [230230]; Amyotrophic Lateral Sclerosis Association and ALS Finding a Cure; NINDS, National Institutes of Health [K01 NS082391]; Alzheimer's Disease Core Center Grant from NIA, National Institutes of Health [P30AG013854]; MRC [MR/M02492X/1, MC_UU_00024/6] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [P30AG013854] Funding Source: NIH RePORTER	Saint Louis University Grant; Amyotrophic Lateral Sclerosis Association and ALS Finding a Cure; NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Disease Core Center Grant from NIA, National Institutes of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the President's Research Fund of Saint Louis University Grant 230230, by Amyotrophic Lateral Sclerosis Association and ALS Finding a Cure, and by NINDS, National Institutes of Health Grant K01 NS082391. This work study was also supported in part by Alzheimer's Disease Core Center Grant P30AG013854 from NIA, National Institutes of Health to Northwestern University (Chicago, IL). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afroz T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00062-0; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6; Bosque PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062301; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2015, ADV GENET, V91, P1, DOI 10.1016/bs.adgen.2015.07.001; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chen HJ, 2016, BRAIN, V139, P1417, DOI 10.1093/brain/aww028; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Dhavale DD, 2017, J BIOL CHEM, V292, P9034, DOI 10.1074/jbc.M116.767053; Dulle JE, 2013, J CELL BIOL, V203, P197, DOI 10.1083/jcb.201307040; Fang YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5824; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gopal PP, 2017, P NATL ACAD SCI USA, V114, pE2466, DOI 10.1073/pnas.1614462114; Guenther EL, 2018, NAT STRUCT MOL BIOL, V25, P311, DOI 10.1038/s41594-018-0045-5; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedia N, 2017, PHYS CHEM CHEM PHYS, V19, P18036, DOI 10.1039/c7cp02849k; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li W, 2017, J BIOL CHEM, V292, P5089, DOI 10.1074/jbc.M116.753913; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Mackenzie IR, 2017, NEURON, V95, P808, DOI 10.1016/j.neuron.2017.07.025; Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mompean M, 2017, J BIOL CHEM, V292, P11992, DOI 10.1074/jbc.M117.775965; Mompean M, 2015, J PHYS CHEM LETT, V6, P2608, DOI 10.1021/acs.jpclett.5b00918; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Porta S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06548-9; Robinson JL, 2013, ACTA NEUROPATHOL, V125, P121, DOI 10.1007/s00401-012-1055-8; Saini A, 2014, LANGMUIR, V30, P3845, DOI 10.1021/la404710w; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sanders DW, 2016, NEURON, V89, P433, DOI 10.1016/j.neuron.2016.01.026; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Schmidt HB, 2016, CELL REP, V16, P1228, DOI 10.1016/j.celrep.2016.06.088; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Shimonaka S, 2016, J BIOL CHEM, V291, P8896, DOI 10.1074/jbc.M115.713552; Tavella D, 2018, BIOPHYS J, V115, P1673, DOI 10.1016/j.bpj.2018.09.011; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Udan-Johns M, 2014, HUM MOL GENET, V23, P157, DOI 10.1093/hmg/ddt408; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Vogler TO, 2018, NATURE, V563, P508, DOI 10.1038/s41586-018-0665-2; Walker AK, 2015, ACTA NEUROPATHOL, V130, P643, DOI 10.1007/s00401-015-1460-x; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Wang YT, 2013, J BIOL CHEM, V288, P9049, DOI 10.1074/jbc.M112.438564; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wobst HJ, 2015, FEBS LETT, V589, P77, DOI 10.1016/j.febslet.2014.11.026; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	87	48	48	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6696	6709		10.1074/jbc.RA118.005889	http://dx.doi.org/10.1074/jbc.RA118.005889			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30824544	Green Published, hybrid			2022-12-28	WOS:000467394700009
J	Giles, AC; Desbois, M; Opperman, KJ; Tavora, R; Maroni, MJ; Grill, B				Giles, Andrew C.; Desbois, Muriel; Opperman, Karla J.; Tavora, Rubens; Maroni, Marissa J.; Grill, Brock			A complex containing the O-GlcNAc transferase OGT-1 and the ubiquitin ligase EEL-1 regulates GABA neuron function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans (C; elegans); O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); E3 ubiquitin ligase; gamma-aminobutyric acid (GABA); synapse; proteomics; EEL-1; GABAergic transmission; HUWE1; motor neuron; OGT-1; proteomics; neurotransmission	NEUROTRANSMITTER RELEASE; INHIBITORY SYNAPSES; HECT FAMILY; NEUROLIGIN 2; ELEGANS; HUWE1; PROTEINS; DEGRADATION; GLCNACYLATION; PROLIFERATION	Inhibitory GABAergic transmission is required for proper circuit function in the nervous system. However, our understanding of molecular mechanisms that preferentially influence GABAergic transmission, particularly presynaptic mechanisms, remains limited. We previously reported that the ubiquitin ligase EEL-1 preferentially regulates GABAergic presynaptic transmission. To further explore how EEL-1 functions, here we performed affinity purification proteomics using Caenorhabditis elegans and identified the O-GlcNAc transferase OGT-1 as an EEL-1 binding protein. This observation was intriguing, as we know little about how OGT-1 affects neuron function. Using C. elegans biochemistry, we confirmed that the OGT-1/EEL-1 complex forms in neurons in vivo and showed that the human orthologs, OGT and HUWE1, also bind in cell culture. We observed that, like EEL-1, OGT-1 is expressed in GABAergic motor neurons, localizes to GABAergic presynaptic terminals, and functions cell-autonomously to regulate GABA neuron function. Results with catalytically inactive point mutants indicated that OGT-1 glycosyltransferase activity is dispensable for GABA neuron function. Consistent with OGT-1 and EEL-1 forming a complex, genetic results using automated, behavioral pharmacology assays showed that ogt-1 and eel-1 act in parallel to regulate GABA neuron function. These findings demonstrate that OGT-1 and EEL-1 form a conserved signaling complex and function together to affect GABA neuron function.	[Giles, Andrew C.; Desbois, Muriel; Opperman, Karla J.; Maroni, Marissa J.; Grill, Brock] Scripps Res Inst, Dept Neurosci, Scripps Florida, 130 Scripps Way, Jupiter, FL 33458 USA; [Tavora, Rubens] Florida Atlantic Univ, Harriet L Wilkes Honors Coll, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida; State University System of Florida; Florida Atlantic University	Grill, B (corresponding author), Scripps Res Inst, Dept Neurosci, Scripps Florida, 130 Scripps Way, Jupiter, FL 33458 USA.	bgrill@scripps.edu	Desbois, Muriel/AAD-3598-2022	Desbois, Muriel/0000-0002-8070-2525; Tavora, Rubens/0000-0002-6392-7095; Maroni, Marissa/0000-0001-5295-8307; Grill, Brock/0000-0002-0379-3267; Giles, Andrew/0000-0002-0875-0696	NINDS, National Institutes of Health [R01 NS072129]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072129] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health, Grant R01 NS072129 (to B. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Andres LM, 2017, ACS CHEM BIOL, V12, P2030, DOI 10.1021/acschembio.7b00232; Barclay JW, 2012, CELL CALCIUM, V52, P289, DOI 10.1016/j.ceca.2012.03.005; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; BRENNER S, 1974, GENETICS, V77, P71; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; de Groot REA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004985; Feng J, 2002, J NEUROSCI, V22, P4372, DOI 10.1523/JNEUROSCI.22-11-04372.2002; Forget A, 2014, DEV CELL, V29, P649, DOI 10.1016/j.devcel.2014.05.014; Friez MJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009537; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hart GW, 2019, J BIOL CHEM, V294, P2211, DOI 10.1074/jbc.AW119.003226; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Ko J, 2015, TRENDS MOL MED, V21, P256, DOI 10.1016/j.molmed.2015.01.004; Kowalski JR, 2014, MOL CELL NEUROSCI, V58, P62, DOI 10.1016/j.mcn.2013.12.001; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Krueger-Burg D, 2017, CURR OPIN NEUROBIOL, V45, P66, DOI 10.1016/j.conb.2017.04.003; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Levine ZG, 2016, ANNU REV BIOCHEM, V85, P631, DOI 10.1146/annurev-biochem-060713-035344; Li J, 2017, NEURON, V96, P808, DOI 10.1016/j.neuron.2017.10.003; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Mariappa D, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150234; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moortgat S, 2018, EUR J HUM GENET, V26, P64, DOI 10.1038/s41431-017-0038-6; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Opperman KJ, 2017, CELL REP, V19, P822, DOI 10.1016/j.celrep.2017.04.003; Orivoli S, 2016, NEUROPEDIATRICS, V47, P51, DOI 10.1055/s-0035-1566233; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Ramamoorthi K, 2011, TRENDS MOL MED, V17, P452, DOI 10.1016/j.molmed.2011.03.003; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Schuske K, 2004, TRENDS NEUROSCI, V27, P407, DOI 10.1016/j.tins.2004.05.005; Senyilmaz D, 2015, NATURE, V525, P124, DOI 10.1038/nature14601; Singh JP, 2015, CANCER LETT, V356, P244, DOI 10.1016/j.canlet.2014.04.014; Stiernagle Theresa, 2006, WormBook, P1; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059132; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Urban N, 2016, SCIENCE, V353, P292, DOI 10.1126/science.aaf4802; Vaidyanathan K, 2017, J BIOL CHEM, V292, P8948, DOI 10.1074/jbc.M116.771030; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Vaughan L, 2015, CELL REP, V10, P88, DOI 10.1016/j.celrep.2014.12.012; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Wani WY, 2017, BRAIN RES BULL, V133, P80, DOI 10.1016/j.brainresbull.2016.08.002; Willems AP, 2017, J BIOL CHEM, V292, P12621, DOI 10.1074/jbc.M117.790097; Yamasaki T, 2017, NEURON, V93, P1138, DOI 10.1016/j.neuron.2017.02.023; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhen M, 2015, CURR OPIN NEUROBIOL, V33, P117, DOI 10.1016/j.conb.2015.03.009	67	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6843	6856		10.1074/jbc.RA119.007406	http://dx.doi.org/10.1074/jbc.RA119.007406			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30858176	hybrid, Green Published			2022-12-28	WOS:000467394700021
J	Baath, JA; Mazurkewich, S; Poulsen, JCN; Olsson, L; Lo Leggio, L; Larsbrink, J				Baath, Jenny Arnling; Mazurkewich, Scott; Poulsen, Jens-Christian Navarro; Olsson, Lisbeth; Lo Leggio, Leila; Larsbrink, Johan			Structure-function analyses reveal that a glucuronoyl esterase from Teredinibacter turnerae interacts with carbohydrates and aromatic compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; enzyme kinetics; carbohydrate; plant cell wall; enzyme structure; enzyme mechanism; enzyme mutation; biotechnology; carbohydrate esterase; carbohydrate-active enzymes; CE15; glucuronoyl esterase; lignin-carbohydrate complexes; uronic acid	STRUCTURE REFINEMENT; MODEL; DEGRADATION; EXPRESSION	Glucuronoyl esterases (GEs) catalyze the cleavage of ester linkages found between lignin and glucuronic acid moieties on glucuronoxylan in plant biomass. As such, GEs represent promising biochemical tools in industrial processing of these recalcitrant resources. However, details on how GEs interact with their natural substrates are sparse, calling for thorough structure-function studies. Presented here is the structure and biochemical characterization of a GE, TtCE15A, from the bacterium Teredinibacter turnerae, a symbiont of wood-boring shipworms. To gain deeper insight into enzyme-substrate interactions, inhibition studies were performed with both the WT TtCE15A and variants in which we, by using site-directed mutagenesis, substituted residues suggested to have key roles in binding to or interacting with the aromatic and carbohydrate structures of its uronic acid ester substrates. Our results support the hypothesis that two aromatic residues (Phe-174 and Trp-376), conserved in bacterial GEs, interact with aromatic and carbohydrate structures of these substrates in the enzyme active site, respectively. The solved crystal structure of TtCE15A revealed features previously not observed in either fungal or bacterial GEs, with a large inserted N-terminal region neighboring the active site and a differently positioned residue of the catalytic triad. The findings highlight key interactions between GEs and complex lignin-carbohydrate ester substrates and advance our understanding of the substrate specificities of these enzymes in biomass conversion.	[Baath, Jenny Arnling; Mazurkewich, Scott; Olsson, Lisbeth; Larsbrink, Johan] Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Wallenberg Wood Sci Ctr, SE-41296 Gothenburg, Sweden; [Poulsen, Jens-Christian Navarro; Lo Leggio, Leila] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark	Chalmers University of Technology; University of Copenhagen	Larsbrink, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Kemivagen 10, SE-41296 Gothenburg, Sweden.	johan.larsbrink@chalmers.se	Larsbrink, Johan/A-3053-2013; Lo Leggio, Leila/B-4287-2015	Larsbrink, Johan/0000-0001-8386-2914; Mazurkewich, Scott/0000-0002-9238-0615; Arnling Baath, Jenny/0000-0001-7973-9577; Lo Leggio, Leila/0000-0002-5135-0882	Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center; MAX4ESSFUN: Cross Border Science and Society Program [CTH-003]; Novo Nordisk Foundation [NNF17OC0027698]	Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center(Knut & Alice Wallenberg Foundation); MAX4ESSFUN: Cross Border Science and Society Program; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The work performed at Chalmers University of Technology was supported by the Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center. The collaborative work between Chalmers University of Technology and Copenhagen University was supported by MAX4ESSFUN: Cross Border Science and Society Program Grant CTH-003 and Novo Nordisk Foundation Grant NNF17OC0027698 (Biotechnology-based Synthesis and Production Research). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Baath JA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1213-x; Baath JA, 2016, FEBS LETT, V590, P2611, DOI 10.1002/1873-3468.12290; Biely P, 2015, FEBS LETT, V589, P2334, DOI 10.1016/j.febslet.2015.07.019; Charavgi MD, 2013, ACTA CRYSTALLOGR D, V69, P63, DOI 10.1107/S0907444912042400; d'Errico C, 2016, J BIOTECHNOL, V219, P117, DOI 10.1016/j.jbiotec.2015.12.024; d'Errico C, 2015, BIOTECHNOL BIOENG, V112, P914, DOI 10.1002/bit.25508; De Santi C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17677-4; De Santi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159345; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Duranova M, 2009, BIOSCI BIOTECH BIOCH, V73, P2483, DOI 10.1271/bbb.90486; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Huynh HH, 2016, J GEN APPL MICROBIOL, V62, P217, DOI 10.2323/jgam.2016.03.004; Huttner S, 2017, APPL MICROBIOL BIOT, V101, P5301, DOI 10.1007/s00253-017-8266-9; Huynh H, 2018, APPL MICROBIOL BIOT, V102, P2191, DOI 10.1007/s00253-018-8739-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katsimpouras C, 2014, APPL MICROBIOL BIOT, V98, P5507, DOI 10.1007/s00253-014-5542-9; Lin MI, 2018, APPL MICROBIOL BIOT, V102, P9635, DOI 10.1007/s00253-018-9318-5; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monrad RN, 2018, CRIT REV BIOTECHNOL, V38, P1121, DOI 10.1080/07388551.2018.1468316; Mosbech C, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1075-2; Pokkuluri PR, 2011, PROTEINS, V79, P2588, DOI 10.1002/prot.23088; Spanikova S, 2007, ARCH MICROBIOL, V188, P185, DOI 10.1007/s00203-007-0241-x; Spanikova S, 2006, FEBS LETT, V580, P4597, DOI 10.1016/j.febslet.2006.07.033; Sunner H, 2015, MOLECULES, V20, P17807, DOI 10.3390/molecules201017807; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Topakas E, 2010, APPL MICROBIOL BIOT, V87, P1765, DOI 10.1007/s00253-010-2655-7; Tsai AYL, 2012, PLANT BIOTECHNOL J, V10, P1077, DOI 10.1111/j.1467-7652.2012.00735.x; Vafiadi C, 2009, FEMS MICROBIOL LETT, V296, P178, DOI 10.1111/j.1574-6968.2009.01631.x; Wong D. W., 2012, BIOTECHNOL RES INT, V2012, DOI 10.1155/2012/951267; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085	38	14	14	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6635	6644		10.1074/jbc.RA119.007831	http://dx.doi.org/10.1074/jbc.RA119.007831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30814248	Green Published, hybrid			2022-12-28	WOS:000468402000036
J	Eyre, DR; Weis, M; Rai, J				Eyre, David R.; Weis, MaryAnn; Rai, Jyoti			Analyses of lysine aldehyde cross-linking in collagen reveal that the mature cross-link histidinohydroxylysinonorleucine is an artifact	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; cornea; protein cross-linking; lysyl oxidase; mass spectrometry (MS); skin; tendon; connective tissue; allysine aldol	I COLLAGEN; PEPTIDYL ALDEHYDES; BONE-COLLAGEN; HISTIDINE; HYDROXYLATION; CHEMISTRY; TELOPEPTIDES; QUANTITATION; SPECIFICITY; INHIBITORS	Lysyl oxidase-generated intermolecular cross-links are essential for the tensile strength of collagen fibrils. Two cross-linking pathways can be defined, one based on telopeptide lysine aldehydes and another on telopeptide hydroxylysine aldehydes. Since the 1970s it has been accepted that the mature cross-linking structures on the lysine aldehyde pathway, which dominates in skin and cornea, incorporate histidine residues. Here, using a range of MS-based methods, we re-examined this conclusion and found that telopeptide aldol dimerization is the primary mechanism for stable cross-link formation. The C-telopeptide aldol dimers formed labile addition products with glucosylgalactosyl hydroxylysine at 1(I)K87 in adjacent collagen molecules that resisted borohydride reduction and after acid hydrolysis produced histidinohydroxylysinonorleucine (HHL), but only from species with a histidine in their 1(I) C-telopeptide sequence. Peptide MS analyses and the lack of HHL formation in rat and mouse skin, species that lack an 1(I) C-telopeptide histidine, revealed that HHL is a laboratory artifact rather than a natural cross-linking structure. Our experimental results also establish that histidinohydroxymerodesmosine is produced by borohydride reduction of N-telopeptide allysine aldol dimers in aldimine intermolecular linkage to nonglycosylated 1(I) K930. Borohydride reduction of the aldimine promotes an accompanying base-catalyzed Michael addition of 1(I) H932 imidazole to the ,-unsaturated aldol. These aldehydes are intramolecular at the N terminus but at the C terminus they can be both intramolecular and intermolecular according to present and earlier findings.	[Eyre, David R.; Weis, MaryAnn; Rai, Jyoti] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eyre, DR (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	deyre@uw.edu			National Institutes of Health NIAMS [AR037318, AR036794]; NICHD [HD070394]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318] Funding Source: NIH RePORTER	National Institutes of Health NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in whole or in part by National Institutes of Health NIAMS Grants AR037318 and AR036794 (to D. E.) and NICHD Grant HD070394 (to D. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amar A, 2010, CR CHIM, V13, P553, DOI 10.1016/j.crci.2009.11.009; BAILEY AJ, 1970, BIOCHEM J, V117, P819, DOI 10.1042/bj1170819; BAILEY AJ, 1976, BIOCHEM J, V153, P211, DOI 10.1042/bj1530211; BAILEY AJ, 1969, BIOCHEM J, V111, pP12, DOI 10.1042/bj1110012Pb; Belin MW, 2018, CORNEA, V37, P1218, DOI 10.1097/ICO.0000000000001707; Bella J, 2017, SUBCELL BIOCHEM, V82, P457, DOI 10.1007/978-3-319-49674-0_14; BERNSTEIN PH, 1980, J BIOL CHEM, V255, P414; BORNSTEIN P, 1966, P NATL ACAD SCI USA, V55, P417, DOI 10.1073/pnas.55.2.417; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; EYRE DR, 1973, BIOCHIM BIOPHYS ACTA, V295, P301, DOI 10.1016/0005-2795(73)90097-4; FAIRWEATHER RB, 1972, BIOCHEM BIOPH RES CO, V48, P1311, DOI 10.1016/0006-291X(72)90854-6; Giger L, 2013, NAT CHEM BIOL, V9, P494, DOI 10.1038/nchembio.1276; Gjaltema RAF, 2017, CRIT REV BIOCHEM MOL, V52, P74, DOI 10.1080/10409238.2016.1269716; HANSON DA, 1992, J BONE MINER RES, V7, P1251; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Heard ME, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006002; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; HENKEL W, 1976, EUR J BIOCHEM, V69, P223, DOI 10.1111/j.1432-1033.1976.tb10877.x; Holmes DF, 2018, CURR TOP DEV BIOL, V130, P107, DOI 10.1016/bs.ctdb.2018.02.004; HOUSLEY T, 1975, BIOCHEM BIOPH RES CO, V67, P824, DOI 10.1016/0006-291X(75)90887-6; Hudson DM, 2017, J BIOL CHEM, V292, P3877, DOI 10.1074/jbc.M116.762245; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Inani H, 2017, CHEMISTRYSELECT, V2, P11666, DOI 10.1002/slct.201702502; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; KANG AH, 1970, P NATL ACAD SCI USA, V67, P1307, DOI 10.1073/pnas.67.3.1307; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malone JP, 2004, BIOCHEMISTRY-US, V43, P15358, DOI 10.1021/bi048304b; McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738; MECHANIC GL, 1987, BIOCHEMISTRY-US, V26, P3500, DOI 10.1021/bi00386a038; Naffa R, 2016, J CHROMATOGR A, V1478, P60, DOI 10.1016/j.chroma.2016.11.060; Park J, 2004, BIOORG MED CHEM LETT, V14, P685, DOI 10.1016/j.bmcl.2003.11.027; Park JU, 2003, BIOCHEMISTRY-US, V42, P5159, DOI 10.1021/bi034076u; Paul RG, 1997, INT J BIOCHEM CELL B, V29, P211, DOI 10.1016/S1357-2725(96)00134-3; REISER KM, 1994, J GERONTOL, V49, pB71, DOI 10.1093/geronj/49.2.B71; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; ROBINS SP, 1973, BIOCHEM J, V135, P657, DOI 10.1042/bj1350657; ROBINS SP, 1977, BIOCHIM BIOPHYS ACTA, V492, P408, DOI 10.1016/0005-2795(77)90092-7; Rodriguez-Pascual F, 2016, SCI REP-UK, V6, DOI 10.1038/srep37374; ROJKIND M, 1966, J BIOL CHEM, V241, P1530; SIMS TJ, 1992, J CHROMATOGR-BIOMED, V582, P49, DOI 10.1016/0378-4347(92)80301-6; TANZER ML, 1973, J BIOL CHEM, V248, P393; TANZER ML, 1973, SCIENCE, V180, P561, DOI 10.1126/science.180.4086.561; WOODLEY DT, 1991, J INVEST DERMATOL, V97, P580, DOI 10.1111/1523-1747.ep12481920; YAMAUCHI M, 1988, BIOCHEM BIOPH RES CO, V152, P898, DOI 10.1016/S0006-291X(88)80124-4; YAMAUCHI M, 1987, J BIOL CHEM, V262, P11428; Yamauchi M, 2018, METHOD CELL BIOL, V143, P115, DOI 10.1016/bs.mcb.2017.08.006; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/bse0520113, 10.1042/BSE0520113]; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	51	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6578	6590		10.1074/jbc.RA118.007202	http://dx.doi.org/10.1074/jbc.RA118.007202			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30733334	Green Published, hybrid			2022-12-28	WOS:000468402000031
J	Luu, K; Rajagopalan, N; Ching, JCH; Loewen, MC; Loewen, ME				Luu, Khanh; Rajagopalan, Nandhakishore; Ching, John C. H.; Loewen, Michele C.; Loewen, Matthew E.			The malate-activated ALMT12 anion channel in the grass Brachypodium distachyon is co-activated by Ca2+/calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; patch clamp; isothermal titration calorimetry (ITC); calmodulin (CaM); calcium; plant physiology; protein-protein interaction; structure-function; stomatal function	ABSCISIC-ACID ACTIVATION; GUARD-CELLS; STOMATAL MOVEMENT; ION CHANNELS; CALMODULIN; ARABIDOPSIS; KINASE; SLAC1; EXPRESSION; CALCIUM	In plants, strict regulation of stomatal pores is critical for modulation of CO2 fixation and transpiration. Under certain abiotic and biotic stressors, pore closure is initiated through anionic flux, with calcium (Ca2+) playing a central role. The aluminum-activated malate transporter 12 (ALMT12) is a malate-activated, voltage-dependent member of the aluminum-activated malate transporter family that has been implicated in anionic flux from guard cells controlling the stomatal aperture. Herein, we report the characterization of the regulatory mechanisms mediating channel activities of an ALMT from the grass Brachypodium distachyon (BdALMT12) that has the highest sequence identity to Arabidopsis thaliana ALMT12. Electrophysiological studies in a heterologous cell system confirmed that this channel is malate- and voltage-dependent. However, this was shown to be true only in the presence of Ca2+. Although a general kinase inhibitor increased the current density of BdALMT12, a calmodulin (CaM) inhibitor reduced the Ca2+-dependent channel activation. We investigated the physiological relevance of the CaM-based regulation in planta, where stomatal closure, induced by exogenous Ca2+ ionophore and malate, was shown to be inhibited by exogenous application of a CaM inhibitor. Subsequent analyses revealed that the double substitutions R335A/R338A and R335A/K342A, within a predicted BdALMT12 CaM-binding domain (CBD), also decreased the channels' ability to activate. Using isothermal titration calorimetry and CBD-mimetic peptides, as well as CaM-agarose affinity pulldown of full-length recombinant BdALMT12, we confirmed the physical interaction between the CBD and CaM. Together, these findings support a co-regulatory mechanism of BdALMT12 activation by malate, and Ca2+/CaM, emphasizing that a complex regulatory network modulates BdALMT12 activity.	[Luu, Khanh; Ching, John C. H.; Loewen, Matthew E.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK S7N 1B8, Canada; [Rajagopalan, Nandhakishore; Loewen, Michele C.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Loewen, Michele C.] Natl Res Council Canada, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Loewen, Michele C.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 0N6, Canada	University of Saskatchewan; National Research Council Canada; National Research Council Canada; Queens University - Canada	Loewen, MC (corresponding author), Natl Res Council Canada, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	michele.loewen@nrc.ca			Natural Sciences and Engineering Discovery Grants [261683-2012, 371364-2010]; National Research Council of Canada	Natural Sciences and Engineering Discovery Grants; National Research Council of Canada	This work was supported by Natural Sciences and Engineering Discovery Grants 261683-2012 (to M.C.L.) and 371364-2010 (to M.E.L.) and by a grant from the National Research Council of Canada, Wheat Flagship Program to M.C.L. This manuscript is NRCC no. 53630. The authors declare that they have no conflicts of interest with the contents of this article.	Alaimo A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13811-4; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Berger D, 2000, GENE DEV, V14, P1119; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; CAO YW, 1995, PLANT PHYSIOL, V109, P1093, DOI 10.1104/pp.109.3.1093; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COUSSON A, 1995, PLANT PHYSIOL, V109, P491, DOI 10.1104/pp.109.2.491; DESILVA DLR, 1985, NEW PHYTOL, V101, P555, DOI 10.1111/j.1469-8137.1985.tb02861.x; DONOVAN N, 1985, J PLANT PHYSIOL, V118, P177, DOI 10.1016/S0176-1617(85)80146-2; Dreyer I, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00263; Edlund M, 1996, J BIOL CHEM, V271, P1393, DOI 10.1074/jbc.271.3.1393; ERDAHL WL, 1994, BIOPHYS J, V66, P1678, DOI 10.1016/S0006-3495(94)80959-2; Geiger D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001346; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Hedrich R, 2012, PHYSIOL REV, V92, P1777, DOI 10.1152/physrev.00038.2011; HIDAKA H, 1983, METHOD ENZYMOL, V102, P185; HILU KW, 1984, TAXON, V33, P413, DOI 10.2307/1220980; Imes D, 2013, PLANT J, V74, P372, DOI 10.1111/tpj.12133; Ivashikina N, 2005, J GEN PHYSIOL, V125, P483, DOI 10.1085/jgp.200409211; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Leng Q, 1999, PLANT PHYSIOL, V121, P753, DOI 10.1104/pp.121.3.753; Leng Q, 2002, PLANT PHYSIOL, V128, P400, DOI 10.1104/pp.010832; Ligaba A, 2009, PLANT J, V60, P411, DOI 10.1111/j.1365-313X.2009.03964.x; LINDER B, 1992, FEBS LETT, V313, P27, DOI 10.1016/0014-5793(92)81176-M; Maierhofer T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005703; Mann DGJ, 2012, PLANT BIOTECHNOL J, V10, P226, DOI 10.1111/j.1467-7652.2011.00658.x; Marten H, 2007, PLANT PHYSIOL, V143, P28, DOI 10.1104/pp.106.092643; Medeiros DB, 2016, PLANT PHYSIOL, V170, P86, DOI 10.1104/pp.15.01053; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Minhas FUA, 2012, BIOINFORMATICS, V28, pI416, DOI 10.1093/bioinformatics/bts416; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Mruk K, 2014, J GEN PHYSIOL, V144, P103, DOI 10.1085/jgp.201311140; Mumm P, 2013, MOL PLANT, V6, P1550, DOI 10.1093/mp/sst008; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; Palmer AJ, 2016, BIOCHEM SOC T, V44, P856, DOI 10.1042/BST20160027; Peterson FC, 2010, NAT STRUCT MOL BIOL, V17, P1109, DOI 10.1038/nsmb.1898; Pilot G, 2001, J BIOL CHEM, V276, P3215, DOI 10.1074/jbc.M007303200; Reichow SL, 2013, NAT STRUCT MOL BIOL, V20, P1085, DOI 10.1038/nsmb.2630; Reisser S, 2014, BIOPHYS J, V106, P2385, DOI 10.1016/j.bpj.2014.04.020; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Sasaki T, 2010, PLANT CELL PHYSIOL, V51, P354, DOI 10.1093/pcp/pcq016; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Scherzer S, 2012, MOL PLANT, V5, P1409, DOI 10.1093/mp/sss084; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHROEDER JI, 1992, P NATL ACAD SCI USA, V89, P5025, DOI 10.1073/pnas.89.11.5025; SHIMAZAKI K, 1992, PLANT PHYSIOL, V99, P1416, DOI 10.1104/pp.99.4.1416; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Szabo I, 2000, BIOCHEM BIOPH RES CO, V274, P130, DOI 10.1006/bbrc.2000.3095; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Weiner SA, 2018, GENOME, V61, P266, DOI 10.1139/gen-2017-0066; Zhou YP, 2012, PLANT MOL BIOL, V79, P333, DOI 10.1007/s11103-012-9915-0; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	58	7	7	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6142	6156		10.1074/jbc.RA118.005301	http://dx.doi.org/10.1074/jbc.RA118.005301			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30770467	hybrid, Green Published			2022-12-28	WOS:000465077500042
J	Gao, Y; Liu, JF; Bai, ZZ; Sink, S; Zhao, CT; Lorenzo, FR; McClain, DA				Gao, Yan; Liu, Jingfang; Bai, Zhenzhong; Sink, Sandy; Zhao, Chengyu; Lorenzo, Felipe Ramos; McClain, Donald A.			Iron down-regulates leptin by suppressing protein O-GlcNAc modification in adipocytes, resulting in decreased levels of O-glycosylated CREB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc); leptin; iron; adipocyte; diabetes	GENE-EXPRESSION; GLUCOSE-HOMEOSTASIS; TRANSFERASE; KINASE; PHOSPHORYLATION; ADIPOGENESIS; MECHANISMS; MUSCLE; C/EBP; LIVER	We previously reported that iron down-regulates transcription of the leptin gene by increasing occupancy of phosphorylated cAMP response element-binding protein (pCREB) at two sites in the leptin gene promoter. Several nutrient-sensing pathways including O-GlcNAcylation also regulate leptin. We therefore investigated whether O-glycosylation plays a role in iron- and CREB-mediated regulation of leptin. We found that high iron decreases protein O-GlcNAcylation both in cultured 3T3-L1 adipocytes and in mice fed high-iron diets and down-regulates leptin mRNA and protein levels. Glucosamine treatment, which bypasses the rate-limiting step in the synthesis of substrate for glycosylation, increased both O-GlcNAc and leptin, whereas inhibition of O-glycosyltransferase (OGT) decreased O-GlcNAc and leptin. The increased leptin levels induced by glucosamine were susceptible to the inhibition by iron, but in the case of OGT inhibition, iron did not further decrease leptin. Mice with deletion of the O-GlcNAcase gene, either via whole-body heterozygous deletion or through adipocyte-targeted homozygous deletion, exhibited increased O-GlcNAc levels in adipose tissue and increased leptin levels that were inhibited by iron. Of note, iron increased the occupancy of pCREB and decreased the occupancy of O-GlcNAcylated CREB on the leptin promoter. These patterns observed in our experimental models suggest that iron exerts its effects on leptin by decreasing O-glycosylation and not by increasing protein deglycosylation and that neither O-GlcNAcase nor OGT mRNA and protein levels are affected by iron. We conclude that iron down-regulates leptin by decreasing CREB glycosylation, resulting in increased CREB phosphorylation and leptin promoter occupancy by pCREB.	[Gao, Yan; Liu, Jingfang; Bai, Zhenzhong; Sink, Sandy; Zhao, Chengyu; Lorenzo, Felipe Ramos; McClain, Donald A.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [McClain, Donald A.] WG Hefner Vet Affairs Med Ctr, Salisbury, NC 28144 USA; [Gao, Yan] Univ Illinois Chicago & Rockford, Sch Pharm, 1601 Parkview Ave, Rockford, IL 61107 USA; [Bai, Zhenzhong; Zhao, Chengyu] Qinghai Sch Med, Inst High Altitude Med, Xining 820012, Qinghai, Peoples R China	Wake Forest University	McClain, DA (corresponding author), 1 Med Ctr Dr,Meads Bldg,1st Floor, Winston Salem, NC 27157 USA.	dmcclain@wakehealth.edu		McClain, Don/0000-0002-3310-2359	National Institutes of Health [1R01 DK081842]; Research Service of the Department of Veterans Affairs Grant [2I01 BX001140]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081842] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Department of Veterans Affairs Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant 1R01 DK081842 and Research Service of the Department of Veterans Affairs Grant 2I01 BX001140. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azuma Y, 2007, BIOL PHARM BULL, V30, P2284, DOI 10.1248/bpb.30.2284; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; BRISSOT P, 1981, GASTROENTEROLOGY, V80, P557; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Considine RV, 2000, J CLIN ENDOCR METAB, V85, P3551, DOI 10.1210/jc.85.10.3551; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Gao Y, 2015, J CLIN INVEST, V125, P3681, DOI 10.1172/JCI81860; Groussaud D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006518; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Huang JH, 2007, J BIOL CHEM, V282, P37501, DOI 10.1074/jbc.M703625200; Huang JY, 2013, FASEB J, V27, P2845, DOI 10.1096/fj.12-216929; Jin NN, 2018, BIOCHEM BIOPH RES CO, V497, P194, DOI 10.1016/j.bbrc.2018.02.053; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; Katai E, 2016, J CELL MOL MED, V20, P2269, DOI 10.1111/jcmm.12910; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; Levine ZG, 2016, ANNU REV BIOCHEM, V85, P631, DOI 10.1146/annurev-biochem-060713-035344; Fernandez-Real JM, 2015, DIABETES CARE, V38, P2169, DOI 10.2337/dc14-3082; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McClain DA, 2000, ENDOCRINOLOGY, V141, P1999, DOI 10.1210/en.141.6.1999; Ortiz-Meoz RF, 2015, ACS CHEM BIOL, V10, P1392, DOI 10.1021/acschembio.5b00004; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Roh C, 2003, AM J PHYSIOL-ENDOC M, V284, pE322, DOI 10.1152/ajpendo.00230.2002; Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whisenhunt TR, 2006, GLYCOBIOLOGY, V16, P551, DOI 10.1093/glycob/cwj096; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Zachara N, 2015, ESSENTIALS GLYCOBIOL, P239; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhang PL, 2002, ENDOCRINOLOGY, V143, P99, DOI 10.1210/en.143.1.99; Zhang X, 2018, CELL REP, V24, P3180, DOI 10.1016/j.celrep.2018.08.055	43	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5487	5495		10.1074/jbc.RA118.005183	http://dx.doi.org/10.1074/jbc.RA118.005183			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30709903	hybrid, Green Published			2022-12-28	WOS:000464517500020
J	Lant, JT; Berg, MD; Heinemann, IU; Brandl, CJ; O'Donoghue, P				Lant, Jeremy T.; Berg, Matthew D.; Heinemann, Ilka U.; Brandl, Christopher J.; O'Donoghue, Patrick			Pathways to disease from natural variations in human cytoplasmic tRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						transfer RNA (tRNA); human genetics; cancer; neurodegeneration; protein synthesis; cytoplasmic tRNA; human genome; mistranslation; nucleotide modification	GENETIC-CODE; MISTRANSLATION; TRANSLATION; MUTATION; EXPRESSION; BINDING; PROTEOME; DATABASE; GENOME; YEAST	Perfectly accurate translation of mRNA into protein is not a prerequisite for life. Resulting from errors in protein synthesis, mistranslation occurs in all cells, including human cells. The human genome encodes >600 tRNA genes, providing both the raw material for genetic variation and a buffer to ensure that resulting translation errors occur at tolerable levels. On the basis of data from the 1000 Genomes Project, we highlight the unanticipated prevalence of mistranslating tRNA variants in the human population and review studies on synthetic and natural tRNA mutations that cause mistranslation or de-regulate protein synthesis. Although mitochondrial tRNA variants are well known to drive human diseases, including developmental disorders, few studies have revealed a role for human cytoplasmic tRNA mutants in disease. In the context of the unexpectedly large number of tRNA variants in the human population, the emerging literature suggests that human diseases may be affected by natural tRNA variants that cause mistranslation or de-regulate tRNA expression and nucleotide modification. This review highlights examples relevant to genetic disorders, cancer, and neurodegeneration in which cytoplasmic tRNA variants directly cause or exacerbate disease and disease-linked phenotypes in cells, animal models, and humans. In the near future, tRNAs may be recognized as useful genetic markers to predict the onset or severity of human disease.	[Lant, Jeremy T.; Berg, Matthew D.; Heinemann, Ilka U.; Brandl, Christopher J.; O'Donoghue, Patrick] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [O'Donoghue, Patrick] Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	O'Donoghue, P (corresponding author), Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada.	patrick.odonoghue@uwo.ca	Berg, Matthew/P-6311-2019	Berg, Matthew/0000-0002-7924-9241; O'Donoghue, Patrick/0000-0002-9500-8640	Natural Sciences and Engineering Research Council of Canada [RGPIN 04282-2014, 530175-2018, RGPIN-2015-04394]; Canada Foundation for Innovation Grant [229917]; Ontario Research Fund [229917]; Canada Research Chairs [950-229917]; Ontario Centres of Excellence Grant [28922]; Postgraduate Studies Doctoral Scholarship; Canada Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation Grant(Canada Foundation for Innovation); Ontario Research Fund; Canada Research Chairs(Canada Research ChairsCGIAR); Ontario Centres of Excellence Grant; Postgraduate Studies Doctoral Scholarship; Canada Graduate Scholarship	This work was supported in part by Natural Sciences and Engineering Research Council of Canada Grants RGPIN 04282-2014 (to P. O.), 530175-2018 (to P. O.), and RGPIN-2015-04394 (to C. J. B.); Canada Foundation for Innovation Grant 229917 (to P. O.); the Ontario Research Fund 229917 (to P. O.); Canada Research Chairs 950-229917 (to P. O.); and the Ontario Centres of Excellence Grant 28922 (to P. O.). This is the first article in the "tRNAs and aminoacyl-tRNA synthetases in human disease" JBC Reviews series. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Postgraduate Studies Doctoral Scholarship and supported by the Natural Sciences and Engineering Research Council of Canada.; Recipient of a(Canada Graduate Scholarship and supported by the Natural Sciences and Engineering Research Council of Canada and by generous donations from Graham Wright and James Robertson.	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Agris Paul F, 2017, Enzymes, V41, P1, DOI 10.1016/bs.enz.2017.03.005; Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Alvarez A, 2014, JOVE-J VIS EXP, DOI 10.3791/51742; BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Bednarova A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00135; Berg MD, 2017, GENETICS, V206, P1865, DOI 10.1534/genetics.117.203232; Berry MJ, 2002, METHOD ENZYMOL, V347, P17; Betat H, 2014, INT J MOL SCI, V15, P23975, DOI 10.3390/ijms151223975; Bezerra AR, 2013, P NATL ACAD SCI USA, V110, P11079, DOI 10.1073/pnas.1302094110; Biddle W, 2016, NUCLEIC ACIDS RES, V44, P10042, DOI 10.1093/nar/gkw948; Biddle W, 2015, BIOCHEMISTRY-US, V54, P7355, DOI 10.1021/acs.biochem.5b00870; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Bock A, 1988, Biofactors, V1, P245; Bour T, 2016, P NATL ACAD SCI USA, V113, P4717, DOI 10.1073/pnas.1600476113; Brocker MJ, 2014, ANGEW CHEM INT EDIT, V53, P319, DOI 10.1002/anie.201308584; Campbell JH, 2013, P NATL ACAD SCI USA, V110, P5540, DOI 10.1073/pnas.1303090110; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; CARBON J, 1966, COLD SPRING HARB SYM, V31, P487, DOI 10.1101/SQB.1966.031.01.063; Carlson BA, 2009, MOLECULES, V14, P3509, DOI 10.3390/molecules14093509; Casper J, 2018, NUCLEIC ACIDS RES, V46, pD762, DOI 10.1093/nar/gkx1020; Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chatterjee K, 2018, BBA-GENE REGUL MECH, V1861, P373, DOI 10.1016/j.bbagrm.2017.11.007; Crick F. H. C., 1955, NOTE RNA TIE CLUB, P1; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Dedon PC, 2014, CHEM RES TOXICOL, V27, P330, DOI 10.1021/tx400438d; Ding Y, 2018, GENE, V642, P299, DOI 10.1016/j.gene.2017.11.049; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Endres L, 2015, RNA BIOL, V12, P603, DOI 10.1080/15476286.2015.1031947; Fechter P, 2001, EUR J BIOCHEM, V268, P761, DOI 10.1046/j.1432-1327.2001.01931.x; Fernandez-Calero Tamara, 2016, Life-Basel, V6, P9, DOI 10.3390/life6010009; Foreman MG, 2011, AM J RESP CELL MOL, V44, P316, DOI 10.1165/rcmb.2009-0360OC; Frumkin I, 2018, P NATL ACAD SCI USA, V115, pE4940, DOI 10.1073/pnas.1719375115; Torres AG, 2015, NUCLEIC ACIDS RES, V43, P5145, DOI 10.1093/nar/gkv277; Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008; GARDNER RS, 1962, P NATL ACAD SCI USA, V48, P2087, DOI 10.1073/pnas.48.12.2087; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Girstmair H, 2013, CELL REP, V3, P148, DOI 10.1016/j.celrep.2012.12.019; Gogakos T, 2017, CELL REP, V20, P1463, DOI 10.1016/j.celrep.2017.07.029; Gomes AC, 2016, RNA, V22, P467, DOI 10.1261/rna.054163.115; Goodarzi H, 2016, CELL, V165, P1416, DOI 10.1016/j.cell.2016.05.046; Goodenbour JM, 2006, NUCLEIC ACIDS RES, V34, P6137, DOI 10.1093/nar/gkl725; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Gu WF, 2005, MOL CELL BIOL, V25, P8191, DOI 10.1128/MCB.25.18.8191-8201.2005; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Hatfield DL, 2009, BBA-GEN SUBJECTS, V1790, P1541, DOI 10.1016/j.bbagen.2009.03.001; Heinemann IU, 2012, NUCLEIC ACIDS RES, V40, P333, DOI 10.1093/nar/gkr696; HOAGLAND MB, 1958, J BIOL CHEM, V231, P241; Hoffman KS, 2017, NUCLEIC ACIDS RES, V45, P3407, DOI 10.1093/nar/gkw1021; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; HOLLEY RW, 1965, J BIOL CHEM, V240, P2122; Hopper AK, 2013, GENETICS, V194, P43, DOI 10.1534/genetics.112.147470; Hopper AK, 2010, FEBS LETT, V584, P310, DOI 10.1016/j.febslet.2009.11.053; Horjales S, 2007, ARCH BIOCHEM BIOPHYS, V467, P139, DOI 10.1016/j.abb.2007.07.029; HOU YM, 1989, TRENDS BIOCHEM SCI, V14, P233, DOI 10.1016/0968-0004(89)90033-9; Hrabeta-Robinson E, 2017, METHODS MOL BIOL, V1562, P231, DOI 10.1007/978-1-4939-6807-7_15; Huang SQ, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0745-z; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Iben JR, 2014, GENE, V536, P376, DOI 10.1016/j.gene.2013.11.049; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256; Jinks-Robertson S, 2014, ANNU REV GENET, V48, P341, DOI 10.1146/annurev-genet-120213-092015; Josefson R, 2017, ESSAYS BIOCHEM, V61, P317, DOI 10.1042/EBC20160085; Joshi K, 2018, NUCLEIC ACIDS RES, V46, P10331, DOI 10.1093/nar/gky664; Kapur M, 2018, TRENDS GENET, V34, P218, DOI 10.1016/j.tig.2017.12.007; Kessler AC, 2018, RNA BIOL, V15, P554, DOI 10.1080/15476286.2017.1371402; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirchner S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000779; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; Kuncha SK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02204-w; Kutter C, 2011, NAT GENET, V43, P948, DOI 10.1038/ng.906; Kwon NH, 2018, RNA BIOL, V15, P635, DOI 10.1080/15476286.2017.1356563; Lant JT, 2018, RNA BIOL, V15, P567, DOI 10.1080/15476286.2017.1379645; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li HY, 2018, BIOCHEM BIOPH RES CO, V495, P574, DOI 10.1016/j.bbrc.2017.11.061; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Ling JQ, 2015, NAT REV MICROBIOL, V13, P707, DOI 10.1038/nrmicro3568; Lorenz C, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7020035; Mahlab S, 2012, RNA, V18, P640, DOI 10.1261/rna.030775.111; Martinez A, 2017, NUCLEIC ACIDS RES, V45, P5423, DOI 10.1093/nar/gkx051; de Toda IM, 2016, EXP GERONTOL, V84, P21, DOI 10.1016/j.exger.2016.08.013; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530; Meyer-Schuman R, 2017, HUM MOL GENET, V26, pR114, DOI 10.1093/hmg/ddx231; Moghal A, 2014, FEBS LETT, V588, P4305, DOI 10.1016/j.febslet.2014.08.035; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; NIRENBERG M, 1965, P NATL ACAD SCI USA, V53, P1161, DOI 10.1073/pnas.53.5.1161; NISHIMURA S, 1965, J MOL BIOL, V13, P302, DOI 10.1016/S0022-2836(65)80098-5; O'Donoghue P, 2012, FEBS LETT, V586, P3931, DOI 10.1016/j.febslet.2012.09.033; ONEILL VA, 1985, J BIOL CHEM, V260, P2501; Parisien M, 2013, RNA BIOL, V10, P1853, DOI 10.4161/rna.27361; Parmeggiani A, 2006, J BIOL CHEM, V281, P2893, DOI 10.1074/jbc.M505951200; Pavlov MY, 2018, ANNU REV BIOPHYS, V47, P525, DOI 10.1146/annurev-biophys-060414-034148; Pavon-Eternod M, 2013, RNA, V19, P461, DOI 10.1261/rna.037507.112; Payea MJ, 2018, RNA, V24, P410, DOI 10.1261/rna.064642.117; Pezo V, 2004, P NATL ACAD SCI USA, V101, P8593, DOI 10.1073/pnas.0402893101; Preston MA, 2013, RNA, V19, P243, DOI 10.1261/rna.035808.112; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Rapino F, 2018, NATURE, V558, P605, DOI 10.1038/s41586-018-0243-7; Rauscher R, 2018, BIOCHEM SOC T, V46, P937, DOI 10.1042/BST20170422; RIYASATY S, 1968, J MOL BIOL, V34, P541, DOI 10.1016/0022-2836(68)90179-4; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; Santesmasses D, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005383; Santos M, 2018, RNA BIOL, V15, P773, DOI 10.1080/15476286.2018.1454244; Schimmel P, 2018, NAT REV MOL CELL BIO, V19, P45, DOI 10.1038/nrm.2017.77; Schoenmakers E, 2016, J CLIN INVEST, V126, P992, DOI 10.1172/JCI84747; Schwartz MH, 2017, CRIT REV BIOCHEM MOL, V52, P205, DOI 10.1080/10409238.2016.1274284; Schweizer U, 2016, FASEB J, V30, P3669, DOI 10.1096/fj.201600424; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SOLL D, 1966, J MOL BIOL, V19, P556; SOLL D, 1965, P NATL ACAD SCI USA, V54, P1378, DOI 10.1073/pnas.54.5.1378; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Sun LT, 2016, J AM CHEM SOC, V138, P12948, DOI 10.1021/jacs.6b07121; Thornlow BP, 2018, P NATL ACAD SCI USA, V115, P8996, DOI 10.1073/pnas.1801240115; Tomita K, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00305; Towns WL, 2012, DNA CELL BIOL, V31, P434, DOI 10.1089/dna.2011.1437; Tukenmez H, 2015, NUCLEIC ACIDS RES, V43, P9489, DOI 10.1093/nar/gkv832; Umu SU, 2018, RNA BIOL, V15, P242, DOI 10.1080/15476286.2017.1403003; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Wilusz JE, 2015, WIRES RNA, V6, P453, DOI 10.1002/wrna.1287; Wilusz JE, 2011, SCIENCE, V334, P817, DOI 10.1126/science.1213671; Wu J, 2014, NUCLEIC ACIDS RES, V42, P6523, DOI 10.1093/nar/gku271; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794; Zimmerman SM, 2018, NUCLEIC ACIDS RES, V46, P7831, DOI 10.1093/nar/gky623	142	26	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5294	5308		10.1074/jbc.REV118.002982	http://dx.doi.org/10.1074/jbc.REV118.002982			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30643023	hybrid, Green Published			2022-12-28	WOS:000464517500006
J	Summers, KC; Bogard, AS; Tavalin, SJ				Summers, Kyle C.; Bogard, Amy S.; Tavalin, Steven J.			Preferential generation of Ca2+-permeable AMPA receptors by AKAP79-anchored protein kinase C proceeds via GluA1 subunit phosphorylation at Ser-831	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase anchoring protein (AKAP); alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor; AMPAR); phosphorylation; synaptic plasticity; protein kinase C (PKC); calcineurin; protein kinase A (PKA); calcium; ion channel; subunit composition	LONG-TERM POTENTIATION; SYNAPTIC INCORPORATION; AKAP150-ANCHORED PKA; GLUR1 SUBUNIT; CINGULATE CORTEX; TRAFFICKING; PLASTICITY; MEMBRANE; AKAP79; NMDA	AMPA-type glutamate receptors (AMPARs) mediate fast excitatory neurotransmission in the mammalian central nervous system. Preferential AMPAR subunit assembly favors heteromeric GluA1/GluA2 complexes. The presence of the GluA2 subunit generates Ca2+-impermeable (CI) AMPARs that have linear current-voltage (I-V) relationships. However, diverse forms of synaptic plasticity and pathophysiological conditions are associated with shifts from CI to inwardly rectifying, GluA2-lacking, Ca2+-permeable (CP) AMPARs on time scales ranging from minutes to days. These shifts have been linked to GluA1 phosphorylation at Ser-845, a protein kinase A (PKA)-targeted site within its intracellular C-terminal tail, often in conjunction with protein kinase A anchoring protein 79 (AKAP79; AKAP150 in rodents), which targets PKA to GluA1. However, AKAP79 may impact GluA1 phosphorylation at other sites by interacting with other signaling enzymes. Here, we evaluated the ability of AKAP79, its signaling components, and GluA1 phosphorylation sites to induce CP-AMPARs under conditions in which CI-AMPARs normally predominate. We found that GluA1 phosphorylation at Ser-831 is sufficient for the appearance of CP-AMPARs and that AKAP79-anchored protein kinase C (PKC) primarily drives the appearance of these receptors via this site. In contrast, other AKAP79-signaling components and C-terminal tail GluA1 phosphorylation sites exhibited a permissive role, limiting the extent to which AKAP79 promotes CP-AMPARs. This may reflect the need for these sites to undergo active phosphorylation/dephosphorylation cycles that control their residency within distinct subcellular compartments. These findings suggest that AKAP79, by orchestrating phosphorylation, represents a key to a GluA1 phosphorylation passcode, which allows the GluA1 subunit to escape GluA2 dominance and promote the appearance of CP-AMPARs.	[Summers, Kyle C.; Bogard, Amy S.; Tavalin, Steven J.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, 71 S Manassas St, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center	Tavalin, SJ (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, 71 S Manassas St, Memphis, TN 38103 USA.	stavalin@uthsc.edu			National Institutes of Health [NS076637]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant NS076637 (to S. J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee B, 2013, NEUROGASTROENT MOTIL, V25, P973, DOI 10.1111/nmo.12233; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Brooks IM, 2011, J BIOL CHEM, V286, P6697, DOI 10.1074/jbc.M110.183558; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chen T, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0076-8; Chung HJ, 2000, J NEUROSCI, V20, P7258; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Clem RL, 2010, J NEUROSCI, V30, P6360, DOI 10.1523/JNEUROSCI.6276-09.2010; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Diering GH, 2018, NEURON, V100, P314, DOI 10.1016/j.neuron.2018.10.018; Diering GH, 2016, P NATL ACAD SCI USA, V113, pE4920, DOI 10.1073/pnas.1610631113; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Dittmer PJ, 2014, CELL REP, V7, P1410, DOI 10.1016/j.celrep.2014.04.039; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ferrario CR, 2011, NEUROPHARMACOLOGY, V61, P1141, DOI 10.1016/j.neuropharm.2011.01.021; Goel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018264; Gray EE, 2014, J BIOL CHEM, V289, P14600, DOI 10.1074/jbc.M114.553537; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hanley JG, 2014, SEMIN CELL DEV BIOL, V27, P14, DOI 10.1016/j.semcdb.2013.12.002; Hosokawa T, 2015, NEURON, V85, P60, DOI 10.1016/j.neuron.2014.11.026; Huie JR, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0091-15.2015; Incontro S, 2013, BBA-MOL CELL RES, V1833, P1820, DOI 10.1016/j.bbamcr.2013.03.021; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jenkins MA, 2014, MOL PHARMACOL, V85, P618, DOI 10.1124/mol.113.091488; Jenkins MA, 2012, CHANNELS, V6, P60, DOI 10.4161/chan.18648; Jones TL, 2005, PAIN, V117, P259, DOI 10.1016/j.pain.2005.06.003; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Kim S, 2015, P NATL ACAD SCI USA, V112, P3122, DOI 10.1073/pnas.1417498112; Kim S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001900; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00017; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee S, 2013, NAT NEUROSCI, V16, P1436, DOI 10.1038/nn.3491; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Lussier MP, 2015, J BIOL CHEM, V290, P28596, DOI 10.1074/jbc.R115.652750; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Martinez-Rivera A, 2017, MOL PSYCHIATR, V22, P1735, DOI 10.1038/mp.2017.9; McDonald BJ, 2001, NEUROPHARMACOLOGY, V41, P672, DOI 10.1016/S0028-3908(01)00129-0; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Park K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100108; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Purkey AM, 2018, CELL REP, V25, P974, DOI 10.1016/j.celrep.2018.09.085; Qiu S, 2014, J NEUROSCI, V34, P13505, DOI 10.1523/JNEUROSCI.1431-14.2014; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sanderson JL, 2018, J NEUROSCI, V38, P2863, DOI 10.1523/JNEUROSCI.2362-17.2018; Sanderson JL, 2016, NEURON, V89, P1000, DOI 10.1016/j.neuron.2016.01.043; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shen GF, 2009, BIOCHEM SOC T, V37, P1394, DOI 10.1042/BST0371394; Shukla K, 2007, J BIOL CHEM, V282, P18100, DOI 10.1074/jbc.M702906200; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tang YY, 2018, NEUROPHARMACOLOGY, V133, P462, DOI 10.1016/j.neuropharm.2018.02.026; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Toda AMA, 2015, P NATL ACAD SCI USA, V112, P6712, DOI 10.1073/pnas.1507229112; Tukey DS, 2013, J BIOL CHEM, V288, P35297, DOI 10.1074/jbc.M113.516690; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Whitcomb DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10934; Whitehead G, 2013, BRAIN, V136, P3753, DOI 10.1093/brain/awt293; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wigerblad G, 2017, EXP NEUROL, V293, P144, DOI 10.1016/j.expneurol.2017.04.004; Yi ES, 2017, BIOCHEM BIOPH RES CO, V486, P671, DOI 10.1016/j.bbrc.2017.03.093; Yoo SW, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.254	82	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5521	5535		10.1074/jbc.RA118.004340	http://dx.doi.org/10.1074/jbc.RA118.004340			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30737285	Green Published, hybrid			2022-12-28	WOS:000464517500023
J	Wei, N; Zhang, Q; Yang, XL				Wei, Na; Zhang, Qian; Yang, Xiang-Lei			Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						aminoacyl tRNA synthetase; animal model; drug development; genetic disease; neurodegenerative disease; transfer RNA (tRNA); protein synthesis; protein structure; pathogenesis; translation	ANTICODON-BINDING DOMAIN; SPINAL MUSCULAR-ATROPHY; C-ALA DOMAIN; CRYSTAL-STRUCTURE; NONCANONICAL FUNCTION; PROTEIN TRANSLATION; FUNCTION MUTATIONS; MAJOR DETERMINANT; AARS MUTATION; GENETIC-CODE	Aminoacyl-tRNA synthetases (aaRSs) are essential enzymes that catalyze the first reaction in protein biosynthesis, namely the charging of transfer RNAs (tRNAs) with their cognate amino acids. aaRSs have been increasingly implicated in dominantly and recessively inherited human diseases. The most common aaRS-associated monogenic disorder is the incurable neurodegenerative disease Charcot-Marie-Tooth neuropathy (CMT), caused by dominant mono-allelic mutations in aaRSs. With six currently known members (GlyRS, TyrRS, AlaRS, HisRS, TrpRS, and MetRS), aaRSs represent the largest protein family implicated in CMT etiology. After the initial discovery linking aaRSs to CMT, the field has progressed from understanding whether impaired tRNA charging is a critical component of this disease to elucidating the specific pathways affected by CMT-causing mutations in aaRSs. Although many aaRS CMT mutants result in loss of tRNA aminoacylation function, animal genetics studies demonstrated that dominant mutations in GlyRS cause CMT through toxic gain-of-function effects, which also may apply to other aaRS-linked CMT subtypes. The CMT-causing mechanism is likely to be multifactorial and involves multiple cellular compartments, including the nucleus and the extracellular space, where the normal WT enzymes also appear. Thus, the association of aaRSs with neuropathy is relevant to discoveries indicating that aaRSs also have nonenzymatic regulatory functions that coordinate protein synthesis with other biological processes. Through genetic, functional, and structural analyses, commonalities among different mutations and different aaRS-linked CMT subtypes have begun to emerge, providing insights into the nonenzymatic functions of aaRSs and the pathogenesis of aaRS-linked CMT to guide therapeutic development to treat this disease.	[Wei, Na; Zhang, Qian; Yang, Xiang-Lei] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA	Scripps Research Institute	Yang, XL (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.	xlyang@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [R01 GM088278]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM088278 and a fellowship from National Foundation for Cancer Research. This is the third article in the "tRNAs and aminoacyl-tRNA synthetases in human disease" JBC Reviews series. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott JA, 2018, HUM MUTAT, V39, P415, DOI 10.1002/humu.23380; Achilli F, 2009, DIS MODEL MECH, V2, P359, DOI 10.1242/dmm.002527; Alexandrova J, 2015, RNA BIOL, V12, P1301, DOI 10.1080/15476286.2015.1086866; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Bansagi B, 2015, J NEUROL, V262, P1899, DOI 10.1007/s00415-015-7778-4; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Benoy V, 2018, BRAIN, V141, P673, DOI 10.1093/brain/awx375; Blocquel D, 2017, NUCLEIC ACIDS RES, V45, P8091, DOI 10.1093/nar/gkx455; Boczonadi V, 2018, HUM MOL GENET, V27, P2187, DOI 10.1093/hmg/ddy127; Boczonadi V, 2018, FEBS LETT, V592, P703, DOI 10.1002/1873-3468.12962; Brozkova DS, 2015, BRAIN, V138, P2161, DOI 10.1093/brain/awv158; Cader MZ, 2007, FEBS LETT, V581, P2959, DOI 10.1016/j.febslet.2007.05.046; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Chihara T, 2007, NAT NEUROSCI, V10, P828, DOI 10.1038/nn1910; CHRISTODOULOU K, 1995, HUM MOL GENET, V4, P1629, DOI 10.1093/hmg/4.9.1629; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; Debard S, 2017, METHODS, V113, P91, DOI 10.1016/j.ymeth.2016.09.017; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Ermanoska B, 2014, NEUROBIOL DIS, V68, P180, DOI 10.1016/j.nbd.2014.04.020; Eskuri JM, 2012, J PERIPHER NERV SYST, V17, P132, DOI 10.1111/j.1529-8027.2012.00370.x; Froelich CA, 2011, BIOCHEMISTRY-US, V50, P7132, DOI 10.1021/bi200989h; Fu GS, 2012, J BIOL CHEM, V287, P9330, DOI 10.1074/jbc.C111.325902; Gonzaga-Jauregui C, 2015, CELL REP, V12, P1169, DOI 10.1016/j.celrep.2015.07.023; Gonzalez M, 2013, J NEUROL NEUROSUR PS, V84, P1247, DOI 10.1136/jnnp-2013-305049; Grice SJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00055; Grice SJ, 2015, HUM MOL GENET, V24, P4397, DOI 10.1093/hmg/ddv176; Griffin LB, 2014, HUM MUTAT, V35, P1363, DOI 10.1002/humu.22681; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Gutmann L, 2015, CURR OPIN NEUROL, V28, P462, DOI 10.1097/WCO.0000000000000237; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108; Hirano M, 2016, J PERIPHER NERV SYST, V21, P370, DOI 10.1111/jns.12193; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Hyun YS, 2014, CLIN GENET, V86, P592, DOI 10.1111/cge.12327; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; James PA, 2006, NEUROLOGY, V67, P1710, DOI 10.1212/01.wnl.0000242619.52335.bc; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Kim Young Kwan, 2014, Biodesign, V2, P142; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Leitao-Goncalves R, 2012, AMINO ACIDS, V42, P1661, DOI 10.1007/s00726-011-0868-4; Liao YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133423; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029393; McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; McMillan HJ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-36; Meyer-Schuman R, 2017, HUM MOL GENET, V26, pR114, DOI 10.1093/hmg/ddx231; Mo ZY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03461-z; Motley WW, 2015, NEUROLOGY, V84, P2040, DOI 10.1212/WNL.0000000000001583; Motley WW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002399; Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nafisinia M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178125; Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106; Nam SH, 2016, MOL CELLS, V39, P382, DOI 10.14348/molcells.2016.2288; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Niehues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8520; Oprescu SN, 2017, METHODS, V113, P139, DOI 10.1016/j.ymeth.2016.11.013; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Qin XJ, 2016, J MOL BIOL, V428, P3603, DOI 10.1016/j.jmb.2016.05.018; Qin XJ, 2014, J BIOL CHEM, V289, P20359, DOI 10.1074/jbc.M114.557249; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; Rips J, 2018, EUR J MED GENET, V61, P616, DOI 10.1016/j.ejmg.2018.04.005; Rossor AM, 2016, CURR OPIN NEUROL, V29, P537, DOI 10.1097/WCO.0000000000000373; Rossor AM, 2013, NAT REV NEUROL, V9, P562, DOI 10.1038/nrneurol.2013.179; Sagi-Dain L, 2018, J PERIPHER NERV SYST, V23, P138, DOI 10.1111/jns.12264; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Schimmel P, 2018, NAT REV MOL CELL BIO, V19, P45, DOI 10.1038/nrm.2017.77; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Shen YJ, 2018, J MOL MED, V96, P1167, DOI 10.1007/s00109-018-1693-y; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Sleigh JN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10005-w; Sleigh JN, 2017, P NATL ACAD SCI USA, V114, pE3324, DOI 10.1073/pnas.1614557114; Sleigh JN, 2014, HUM MOL GENET, V23, P2639, DOI 10.1093/hmg/ddt659; Spaulding EL, 2016, J NEUROSCI, V36, P3254, DOI 10.1523/JNEUROSCI.1762-15.2016; Storkebaum E, 2016, BIOESSAYS, V38, P818, DOI 10.1002/bies.201600052; Storkebaum E, 2009, P NATL ACAD SCI USA, V106, P11782, DOI 10.1073/pnas.0905339106; Stum M, 2011, MOL CELL NEUROSCI, V46, P432, DOI 10.1016/j.mcn.2010.11.006; Sun LT, 2016, P NATL ACAD SCI USA, V113, P14300, DOI 10.1073/pnas.1617316113; Sun LT, 2016, J AM CHEM SOC, V138, P12948, DOI 10.1021/jacs.6b07121; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Tsai PC, 2017, BRAIN, V140, P1252, DOI 10.1093/brain/awx058; Venkova K, 2014, J NEUROPATH EXP NEUR, V73, P702, DOI 10.1097/NEN.0000000000000086; Vester A, 2013, HUM MUTAT, V34, P191, DOI 10.1002/humu.22210; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wallen RC, 2013, CURR OPIN GENET DEV, V23, P302, DOI 10.1016/j.gde.2013.02.002; Wei N, 2014, MOL CELL, V56, P323, DOI 10.1016/j.molcel.2014.09.006; Weterman MAJ, 2018, HUM MOL GENET, V27, P4036, DOI 10.1093/hmg/ddy290; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686; Yang XL, 2013, CHEM BIOL, V20, P1093, DOI 10.1016/j.chembiol.2013.07.013; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhao HT, 2018, J CLIN INVEST, V128, P359, DOI 10.1172/JCI96499; Zhao Z, 2012, NEUROLOGY, V78, P1644, DOI 10.1212/WNL.0b013e3182574f8f; Zhou JJ, 2014, J BIOL CHEM, V289, P19269, DOI 10.1074/jbc.C114.571026; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	112	38	43	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5321	5339		10.1074/jbc.REV118.002955	http://dx.doi.org/10.1074/jbc.REV118.002955			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30643024	hybrid, Green Published			2022-12-28	WOS:000464517500008
J	Zou, J; Li, WJ; Misra, A; Yue, F; Song, K; Chen, Q; Guo, GH; Yi, JL; Kimata, JT; Liu, LY				Zou, Jing; Li, Wenjiao; Misra, Anisha; Yue, Fei; Song, Kun; Chen, Qi; Guo, Guanghua; Yi, Jinglin; Kimata, Jason T.; Liu, Leyuan			The viral restriction factor Tetherin prevents leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) from association with Beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and enhances autophagy and mitophagy (vol 290, pg 7269, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Kimata, Jason/0000-0002-0504-0090	NCI NIH HHS [R01 CA142862] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Zou J, 2015, J BIOL CHEM, V290, P7269, DOI 10.1074/jbc.M114.627679	1	1	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5211	5211		10.1074/jbc.AAC119.008256	http://dx.doi.org/10.1074/jbc.AAC119.008256			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30926759	hybrid, Green Published			2022-12-28	WOS:000463985600043
J	Le, T; Le, SC; Yang, HH				Le, Trieu; Le, Son C.; Yang, Huanghe			Drosophila Subdued is a moonlighting transmembrane protein 16 (TMEM16) that transports ions and phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; membrane biophysics; ion channel; Drosophila; calcium-binding protein; Anoctamin; CaCC; phospholipid scramblase; protein moonlighting; TMEM16	PHOSPHATIDYLSERINE EXPOSURE; WEB TOOL; CHANNEL; SCRAMBLASE; CHOPCHOP	Transmembrane protein 16 (TMEM16) family members play numerous important physiological roles, ranging from controlling membrane excitability and secretion to mediating blood coagulation and viral infection. These diverse functions are largely due to their distinct biophysical properties. Mammalian TMEM16A and TMEM16B are Ca2+-activated Cl- channels (CaCCs), whereas mammalian TMEM16F, fungal afTMEM16, and nhTMEM16 are moonlighting (multifunctional) proteins with both Ca2+-activated phospholipid scramblase (CaPLSase) and Ca2+-activated, nonselective ion channel (CAN) activities. To further understand the biological functions of the enigmatic TMEM16 proteins in different organisms, here, by combining an improved annexin V-based CaPLSase-imaging assay with inside-out patch clamp technique, we thoroughly characterized Subdued, a Drosophila TMEM16 ortholog. We show that Subdued is also a moonlighting transport protein with both CAN and CaPLSase activities. Using a TMEM16F-deficient HEK293T cell line to avoid strong interference from endogenous CaPLSases, our functional characterization and mutagenesis studies revealed that Subdued is a bona fide CaPLSase. Our finding that Subdued is a moonlighting TMEM16 expands our understanding of the molecular mechanisms of TMEM16 proteins and their evolution and physiology in both Drosophila and humans.	[Le, Trieu; Le, Son C.; Yang, Huanghe] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Yang, Huanghe] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Yang, HH (corresponding author), DUMC, Box 3711, Durham, NC 27710 USA.	huanghe.yang@duke.edu		Le, Son/0000-0002-7647-5307; Yang, Huanghe/0000-0001-9521-9328	National Institutes of Health [DP2 GM126898, R00-NS086916]; Whitehead Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM126898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS086916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehead Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants DP2 GM126898 (to H. Y.) and R00-NS086916 (to H. Y.) and by funds from the Whitehead Foundation (to H. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bethel NP, 2016, P NATL ACAD SCI USA, V113, P14049, DOI 10.1073/pnas.1607574113; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Copley SD, 2014, BIOCHEM SOC T, V42, P1684, DOI 10.1042/BST20140245; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Falzone ME, 2018, J GEN PHYSIOL, V150, P933, DOI 10.1085/jgp.201711957; Gyobu S, 2017, P NATL ACAD SCI USA, V114, P6274, DOI 10.1073/pnas.1703391114; Hu Y, 2016, J EXP MED, V213, P2759, DOI 10.1084/jem.20160612; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2016, J PROTEOMICS, V134, P19, DOI 10.1016/j.jprot.2015.10.003; Jiang T, 2017, ELIFE, V6, DOI 10.7554/eLife.28671; Kmit A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.135; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lee BC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05724-1; Lee BC, 2016, BIOPHYS J, V111, P1919, DOI 10.1016/j.bpj.2016.09.032; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Medrano-Soto A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192851; Milenkovic VM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-319; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pelz T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191219; Sapar ML, 2018, CELL REP, V24, P2273, DOI 10.1016/j.celrep.2018.07.095; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Whitlock JM, 2018, J GEN PHYSIOL, V150, P1498, DOI 10.1085/jgp.201812097; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Wong XM, 2013, ELIFE, V2, DOI 10.7554/eLife.00862; Yang H, 2016, PERSP TRANS CELL BIO, P165, DOI 10.1016/B978-0-12-802002-9.00007-8; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901	41	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4529	4537		10.1074/jbc.AC118.006530	http://dx.doi.org/10.1074/jbc.AC118.006530			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30700552	Green Published, hybrid			2022-12-28	WOS:000462969500021
J	Llavero, F; Montoro, ML; Sastre, AA; Fernandez-Moreno, D; Lacerda, HM; Parada, LA; Lucia, A; Zugaza, JL				Llavero, Francisco; Luque Montoro, Miriam; Arrazola Sastre, Alazne; Fernandez-Moreno, David; Lacerda, Hadriano M.; Parada, Luis A.; Lucia, Alejandro; Zugaza, Jose L.			Epidermal growth factor receptor controls glycogen phosphorylase in T cells through small GTPases of the RAS family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor receptor (EGFR); RAS protein; phosphorylase; adenylate cyclase (adenylyl cyclase); Raf kinase; glycogen phosphorylase; adaptive immunity; GTPase; cAMP-regulated guanine nucleotide exchange factor II (EPAC2); cell signaling	NUCLEOTIDE-EXCHANGE FACTOR; PROTEIN-KINASE-C; ALLOSTERIC TRANSITIONS; TUMOR-GROWTH; CYCLIC-AMP; ACTIVATION; CANCER; EGFR; EPAC; RAP1	We recently uncovered a regulatory pathway of the muscle isoform of glycogen phosphorylase (PYGM) that plays an important role in regulating immune function in T cells. Here, using various enzymatic, pulldown, and immunoprecipitation assays, we describe signaling cross-talk between the small GTPases RAS and RAP1A, member of RAS oncogene family (RAP1) in human Kit 225 lymphoid cells, which, in turn, is regulated by the epidermal growth factor receptor (EGFR). We found that this communication bridge is essential for glycogen phosphorylase (PYG) activation through the canonical pathway because this enzyme is inactive in the absence of adenylyl cyclase type 6 (ADCY6). PYG activation required stimulation of both exchange protein directly activated by cAMP 2 (EPAC2) and RAP1 via RAS and ADCY6 phosphorylation, with the latter being mediated by Raf-1 proto-oncogene, Ser/Thr kinase (RAF1). Consistent with this model, PYG activation was EGFR-dependent and may be initiated by the constitutively active form of RAS. Consequently, PYG activation in Kit 225 T cells could be blocked with specific inhibitors of RAS, EPAC, RAP1, RAF1, ADCY6, and cAMP-dependent protein kinase. Our results establish a new paradigm for the mechanism of PYG activation, which depends on the type of receptor involved.	[Llavero, Francisco; Luque Montoro, Miriam; Arrazola Sastre, Alazne; Zugaza, Jose L.] Univ Basque Country, Achucarro Basque Ctr Neurosci, Sci Pk, E-48940 Leioa, Spain; [Arrazola Sastre, Alazne; Zugaza, Jose L.] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Fac Sci & Technol, E-48940 Leioa, Spain; [Fernandez-Moreno, David; Lucia, Alejandro] Hosp 12 Octubre I 12, Res Inst, Madrid 28041, Spain; [Fernandez-Moreno, David; Lucia, Alejandro] Univ Europea Madrid, Fac Sports Sci, Madrid 28670, Spain; [Lacerda, Hadriano M.] Univ Basque Country, Three R Labs, Sci Pk, E-48940 Leioa, Spain; [Parada, Luis A.] Univ Nacl Salta, Inst Patol Expt, A4400, Salta, Argentina; [Zugaza, Jose L.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain	University of Basque Country; University of Basque Country; Hospital Universitario 12 de Octubre; European University of Madrid; University of Basque Country; Basque Foundation for Science	Zugaza, JL (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain.; Llavero, F; Zugaza, JL (corresponding author), Univ Basque Country, Lab Small GTPases & Neurosignalling, Achucarro Basque Ctr Neurosci, Sci Pk,Sede Bldg,Third Floor,Barrio Sarriena S-N, E-48940 Leioa, Spain.	francisco.llavero@ehu.eus; joseluis.zugaza@ehu.es	; Zugaza, Jose L/B-8331-2012	Lucia, Alejandro/0000-0002-5565-0997; Zugaza, Jose L/0000-0002-9000-6398	Foundation "Jesus de Gangoiti y Barrera"; Basque Government Predoctoral Fellowship [PRE-2017-0016]; Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias (FIS)) [PI15/00558, PI18/00139]; Department of Economic Development and Competitiveness of the Basque Government [KK-2017/00084]; FIS [PI18/00207]	Foundation "Jesus de Gangoiti y Barrera"; Basque Government Predoctoral Fellowship; Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias (FIS)); Department of Economic Development and Competitiveness of the Basque Government; FIS(Instituto de Salud Carlos III)	Recipient of a fellowship from Foundation "Jesus de Gangoiti y Barrera."; Recipient of Basque Government Predoctoral Fellowship PRE-2017-0016.; Supported by Spanish Ministry of Economy and Competitiveness (Fondo de Investigaciones Sanitarias (FIS)) Grants PI15/00558 and PI18/00139.; Supported by the Department of Economic Development and Competitiveness of the Basque Government Grant KK-2017/00084 and FIS Grant PI18/00207.	Andersen B, 2002, BIOCHEM J, V367, P443, DOI 10.1042/BJ20020153; Arrizabalaga O, 2012, J BIOL CHEM, V287, P11878, DOI 10.1074/jbc.M111.297804; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Beazely MA, 2005, MOL PHARMACOL, V67, P250, DOI 10.1124/mol.104.001370; BECKNER SK, 1986, J BIOL CHEM, V261, P3043; BECKNER SK, 1988, J IMMUNOL, V140, P208; BLACK WJ, 1970, BIOCHIM BIOPHYS ACTA, V212, P257, DOI 10.1016/0005-2744(70)90206-8; Caloca MJ, 2008, J BIOL CHEM, V283, P36454, DOI 10.1074/jbc.M803814200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Chan G, 2009, P NATL ACAD SCI USA, V106, P22369, DOI 10.1073/pnas.0908787106; Chen HJ, 2013, TETRAHEDRON LETT, V54, P1546, DOI 10.1016/j.tetlet.2013.01.024; Chiluiza D, 2013, J BIOL CHEM, V288, P18407, DOI 10.1074/jbc.M113.463059; DAVID ES, 1986, BIOCHIM BIOPHYS ACTA, V880, P78, DOI 10.1016/0304-4165(86)90122-4; de Luna N, 2014, NEUROMUSCULAR DISORD, V24, P1079, DOI 10.1016/j.nmd.2014.08.002; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fuld S, 2005, EXP CELL RES, V309, P161, DOI 10.1016/j.yexcr.2005.05.016; Goldberg L, 2009, J MED CHEM, V52, P197, DOI 10.1021/jm801165r; Hariharan IK, 2005, DEV CELL, V8, P303, DOI 10.1016/j.devcel.2005.02.006; HORI T, 1987, BLOOD, V70, P1069; Imperial R, 2019, SEMIN CANCER BIOL, V54, P14, DOI 10.1016/j.semcancer.2017.11.016; KEPPENS S, 1975, FEBS LETT, V51, P29, DOI 10.1016/0014-5793(75)80848-9; Kesanakurti D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.182; Krebs E G, 1981, Curr Top Cell Regul, V18, P401; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Lim SC, 2017, KOREAN J PHYSIOL PHA, V21, P397, DOI 10.4196/kjpp.2017.21.4.397; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Llavero F, 2016, CELL SIGNAL, V28, P1713, DOI 10.1016/j.cellsig.2016.07.014; Llavero F, 2015, J BIOL CHEM, V290, P9171, DOI 10.1074/jbc.M114.608414; MADSEN NB, 1978, J BIOL CHEM, V253, P9097; Mahtouk K, 2005, ONCOGENE, V24, P3512, DOI 10.1038/sj.onc.1208536; Maillet M, 2003, NAT CELL BIOL, V5, P633, DOI 10.1038/ncb1007; Martinelli E, 2017, CANCER TREAT REV, V53, P61, DOI 10.1016/j.ctrv.2016.12.001; McInerney M, 2002, BBA-GEN SUBJECTS, V1570, P53, DOI 10.1016/S0304-4165(02)00154-X; Minutti CM, 2017, IMMUNITY, V47, P710, DOI 10.1016/j.immuni.2017.09.013; Miquel K, 1997, CANCER RES, V57, P1846; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Muller MS, 2015, GLIA, V63, P154, DOI 10.1002/glia.22741; Riely GJ, 2011, J THORAC ONCOL, V6, P1435, DOI 10.1097/JTO.0b013e318223c099; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Scholes AGM, 2001, ARCH OPHTHALMOL-CHIC, V119, P373, DOI 10.1001/archopht.119.3.373; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Slack Cathy, 2017, Nutr Healthy Aging, V4, P195, DOI 10.3233/NHA-160021; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; WANG JH, 1968, J BIOL CHEM, V243, P4641; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wery-Zennaro S, 2000, ONCOGENE, V19, P1596, DOI 10.1038/sj.onc.1203458; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zaldua N, 2007, FEBS LETT, V581, P5814, DOI 10.1016/j.febslet.2007.11.053; Zhu YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09344; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768; Zundelevich A, 2007, MOL CANCER THER, V6, P1765, DOI 10.1158/1535-7163.MCT-06-0706	58	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4345	4358		10.1074/jbc.RA118.005997	http://dx.doi.org/10.1074/jbc.RA118.005997			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30647127	Green Published, hybrid			2022-12-28	WOS:000462969500006
J	Torcato, IM; Kasal, MR; Brito, PH; Miller, ST; Xavier, KB				Torcato, Ines M.; Kasal, Meghann R.; Brito, Patricia H.; Miller, Stephen T.; Xavier, Karina B.			Identification of novel autoinducer-2 receptors in Clostridia reveals plasticity in the binding site of the LsrB receptor family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						quorum sensing; isothermal titration calorimetry (ITC); microbiome; cell signaling; crystal structure; ABC transporters; autoinducer-2; Clostridium autoethanogenum; Clostridium saccharobutylicum; LsrB receptors	QUORUM-SENSING SIGNAL; ESCHERICHIA-COLI; VIBRIO-HARVEYI; SALMONELLA-TYPHIMURIUM; ABC TRANSPORTER; SP-NOV; AI-2; EXPRESSION; SEQUENCE; SYSTEMS	Autoinducer-2 (AI-2) is unique among quorum-sensing signaling molecules, as it is produced and recognized by a wide variety of bacteria and thus facilitates interspecies communication. To date, two classes of AI-2 receptors have been identified: the LuxP-type, present in the Vibrionales, and the LsrB-type, found in a number of phylogenetically distinct bacterial families. Recently, AI-2 was shown to affect the colonization levels of a variety of bacteria in the microbiome of the mouse gut, including members of the genus Clostridium, but no AI-2 receptor had been identified in this genus. Here, we identify a noncanonical, functional LsrB-type receptor in Clostridium saccharobutylicum. This novel LsrB-like receptor is the first one reported with variations in the binding-site amino acid residues that interact with AI-2. The crystal structure of the C. saccharobutylicum receptor determined at 1.35 resolution revealed that it binds the same form of AI-2 as the other known LsrB-type receptors, and isothermal titration calorimetry (ITC) assays showed that binding of AI-2 occurs at a submicromolar concentration. Using phylogenetic analysis, we inferred that the newly identified noncanonical LsrB receptor shares a common ancestor with known LsrB receptors and that noncanonical receptors are present in bacteria from different phyla. This led us to identify putative AI-2 receptors in bacterial species in which no receptors were known, as in bacteria belonging to the Spirochaetes and Actinobacteria phyla. Thus, this work represents a significant step toward understanding how AI-2-mediated quorum sensing influences bacterial interactions in complex biological niches.	[Torcato, Ines M.; Brito, Patricia H.; Xavier, Karina B.] Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal; [Torcato, Ines M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Ave Republ, P-2780157 Oeiras, Portugal; [Miller, Stephen T.] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA; [Brito, Patricia H.] Univ Nova Lisboa, Chron Dis Res Ctr CEDOC, NOVA Med Sch, Rua Camara Pestana 6, P-1150082 Lisbon, Portugal; [Kasal, Meghann R.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa; Swarthmore College; Universidade Nova de Lisboa; Massachusetts Institute of Technology (MIT)	Xavier, KB (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.; Miller, ST (corresponding author), 500 Coll Ave, Swarthmore, PA 19081 USA.	smiller1@swarthmore.edu; kxavier@igc.gulbenkian.pt	Brito, Patricia H./ABD-8695-2020; Xavier, Karina/B-9425-2008	Torcato, Ines/0000-0001-8311-1096; Xavier, Karina/0000-0001-5210-1434; Brito, Patricia H./0000-0002-2457-7520	Portuguese National funds Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-MIC/4188/14]; Swarthmore College; FCT [PD/BD/105736/2014, PD/00133/2012, IF/00831/2015]; Mayer Davidson '57 Womens Science research fellowship; Frances Velay Womens Science research fellowship	Portuguese National funds Fundacao para a Ciencia e Tecnologia (FCT); Swarthmore College; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Mayer Davidson '57 Womens Science research fellowship; Frances Velay Womens Science research fellowship	This work was supported by Portuguese National funds Fundacao para a Ciencia e Tecnologia (FCT) Grant PTDC/BIA-MIC/4188/14 (to K. B. X.) and the Swarthmore College (to S. T. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by FCT Grant PD/BD/105736/2014, within the scope of Ph.D. program Molecular Biosciences Grant PD/00133/2012.; Supported by Mayer Davidson '57 and Frances Velay Womens Science research fellowships.; Supported by FCT Grant IF/00831/2015.	ABRINI J, 1994, ARCH MICROBIOL, V161, P345, DOI 10.1007/BF00303591; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alou M. T., 2018, New Microbes and New Infections, V21, P128, DOI 10.1016/j.nmni.2017.11.003; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; Ascenso OS, 2011, BIOORGAN MED CHEM, V19, P1236, DOI 10.1016/j.bmc.2010.12.036; Bansal T, 2008, APPL MICROBIOL BIOT, V78, P811, DOI 10.1007/s00253-008-1359-8; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bin Darwish N, 2015, DESALINATION, V370, P1, DOI 10.1016/j.desal.2015.05.009; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Duncan SH, 2006, INT J SYST EVOL MICR, V56, P2437, DOI 10.1099/ijs.0.64098-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Ha JH, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar7063; Hegde M, 2011, J BACTERIOL, V193, P768, DOI 10.1128/JB.01196-10; Jani S, 2017, MICROBIOL-SGM, V163, P1778, DOI 10.1099/mic.0.000567; Jung SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004837; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kavanaugh JS, 2011, ACTA CRYSTALLOGR F, V67, P1501, DOI 10.1107/S1744309111042953; Laganenka L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12984; Lee ASY, 2005, BIOCHEM BIOPH RES CO, V335, P659, DOI 10.1016/j.bbrc.2005.07.131; Li J, 2007, J BACTERIOL, V189, P6011, DOI 10.1128/JB.00014-07; Marques JC, 2014, P NATL ACAD SCI USA, V111, P14235, DOI 10.1073/pnas.1408691111; Marques JC, 2011, J BIOL CHEM, V286, P18331, DOI 10.1074/jbc.M111.230227; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x; Pereira CS, 2012, MOL MICROBIOL, V84, P93, DOI 10.1111/j.1365-2958.2012.08010.x; Pereira CS, 2009, J BACTERIOL, V191, P6975, DOI 10.1128/JB.00976-09; Pereira CS, 2008, MOL MICROBIOL, V70, P1223, DOI 10.1111/j.1365-2958.2008.06477.x; Rivers DMR, 2015, J BACTERIOL, V197, P3812, DOI 10.1128/JB.00510-15; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Solbach P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196977; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Thompson JA, 2015, CELL REP, V10, P1861, DOI 10.1016/j.celrep.2015.02.049; van Sambeek DM, 2016, J ANIM SCI, V94, P387, DOI 10.2527/jas.2015-9861; Wang B, 2009, J MEMBRANE BIOL, V231, P1, DOI 10.1007/s00232-009-9200-6; Wang L, 2005, J BACTERIOL, V187, P8350, DOI 10.1128/JB.187.24.8350-8360.2005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Whiteley M, 2017, NATURE, V551, P313, DOI 10.1038/nature24624; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Wu MH, 2013, J BIOL CHEM, V288, P15878, DOI 10.1074/jbc.M112.417634; Xavier KB, 2007, ACS CHEM BIOL, V2, P128, DOI 10.1021/cb600444h; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Xue T, 2009, CELL RES, V19, P1258, DOI 10.1038/cr.2009.91; Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493; Zhu JG, 2008, ACS CHEM BIOL, V3, P110, DOI 10.1021/cb7002048	57	14	15	5	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4450	4463		10.1074/jbc.RA118.006938	http://dx.doi.org/10.1074/jbc.RA118.006938			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30696769	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000462969500014
J	Wang, Z; Song, YD; Li, SB; Kurian, S; Xiang, R; Chiba, T; Wu, XH				Wang, Zi; Song, Yadong; Li, Shibo; Kurian, Sunil; Xiang, Rong; Chiba, Takuya; Wu, Xiaohua			DNA polymerase (POLQ) is important for repair of DNA double-strand breaks caused by fork collapse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; DNA replication stress; genomic instability; breast cancer; inhibitor; ATR kinase; microhomology-mediated end joining; POLQ; DNA double-strand break repair; cancer; genome integrity	END RESECTION; CANCER-CELLS; THETA; REPLICATION; ATR; PATHWAYS; INHIBITION; MECHANISMS; DEFICIENT; LETHAL	DNA polymerase (POLQ) plays an important role in alternative nonhomologous end joining or microhomology-mediated end joining (alt-NHEJ/MMEJ). Here, we show that POLQ is not only required for MMEJ to repair DNA double-strand breaks (DSBs) generated by endonucleases such as I-SceI or Cas9, but is also needed for repair of DSBs derived from DNA nicks generated by Cas9 nickase. Consistently, we found that POLQ deficiency leads to sensitivity to topoisomerase inhibitors that cause DNA single-strand break (SSB) accumulation at replication forks and to ATR inhibitors that induce replication fork collapse. These studies support the function of POLQ in coping with replication stress and repairing DSBs upon fork collapse. POLQ overexpression is present in many cancer types and is associated with poor prognosis, including breast cancer regardless of BRCA1 status. We provide proof-of-concept evidence to support a novel cancer treatment strategy that combines POLQ inhibition with administration of topoisomerase or ATR inhibitors, which induces replication stress and fork collapse. Given the prevalence of POLQ overexpression in tumors, such strategy may have a significant impact on developing targeted cancer treatment.	[Wang, Zi; Song, Yadong; Li, Shibo; Wu, Xiaohua] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Wang, Zi; Chiba, Takuya] Waseda Univ, Fac Human Sci, Biomed Gerontol Lab, 2-579-15 Mikajima, Tokorozawa, Saitama 3591192, Japan; [Song, Yadong; Xiang, Rong] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Kurian, Sunil] Scripps Hlth, Div Organ Transplant, La Jolla, CA 92037 USA	Scripps Research Institute; Waseda University; Nankai University	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu	Kurian, Sunil/C-4493-2008	Kurian, Sunil/0000-0002-7782-7263	California Breast Cancer Research Program (CBCRP) [23IB]; National Institutes of Health [CA187052, CA197995, GM080677]; NATIONAL CANCER INSTITUTE [R01CA187052, R01CA197995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	California Breast Cancer Research Program (CBCRP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by California Breast Cancer Research Program (CBCRP) Grant 23IB and National Institutes of Health Grants CA187052, CA197995, and GM080677 (to X. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander JL, 2016, P NATL ACAD SCI USA, V113, P13809, DOI 10.1073/pnas.1617110113; Anand RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010397; Black SJ, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090067; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; de Rugy TG, 2016, BIOL OPEN, V5, P1485, DOI 10.1242/bio.018028; Goff JP, 2009, RADIAT RES, V172, P165, DOI 10.1667/RR1598.1; Higgins GS, 2018, SCIENCE, V359, P1217, DOI 10.1126/science.aar5149; Higgins GS, 2010, ONCOTARGET, V1, P175, DOI 10.18632/oncotarget.124; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karnitz LM, 2015, CLIN CANCER RES, V21, P4780, DOI 10.1158/1078-0432.CCR-15-0479; Kawamura K, 2004, INT J CANCER, V109, P9, DOI 10.1002/ijc.11666; Lemee F, 2010, P NATL ACAD SCI USA, V107, P13390, DOI 10.1073/pnas.0910759107; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Livraghi L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0425-1; Mateos-Gomez PA, 2017, NAT STRUCT MOL BIOL, V24, P1116, DOI 10.1038/nsmb.3494; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Mohni KN, 2014, CANCER RES, V74, P2835, DOI 10.1158/0008-5472.CAN-13-3229; Morgado-Palacin I, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8243; Nieto-Soler M, 2016, ONCOTARGET, V7, P58759, DOI 10.18632/oncotarget.11643; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Quinet A, 2017, MOL CELL, V68, P830, DOI 10.1016/j.molcel.2017.11.022; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Roerink SF, 2014, GENOME RES, V24, P954, DOI 10.1101/gr.170431.113; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Seol JH, 2018, MUTAT RES-FUND MOL M, V809, P81, DOI 10.1016/j.mrfmmm.2017.07.002; Shima N, 2004, MOL CELL BIOL, V24, P10381, DOI 10.1128/MCB.24.23.10381-10389.2004; Shima N, 2003, GENETICS, V163, P1031; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Sultana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057098; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Truong LN, 2013, P NATL ACAD SCI USA, V110, P7720, DOI 10.1073/pnas.1213431110; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Williamson CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13837; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	41	47	48	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3909	3919		10.1074/jbc.RA118.005188	http://dx.doi.org/10.1074/jbc.RA118.005188			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655289	hybrid, Green Published			2022-12-28	WOS:000461854400009
J	Wang, MX; Yuan, ZL; Xie, R; Ma, YL; Liu, XH; Yu, XC				Wang, Mengxi; Yuan, Zenglin; Xie, Rong; Ma, Yinliang; Liu, Xiuhua; Yu, Xiaochun			Structure-function analyses reveal the mechanism of the ARH3-dependent hydrolysis of ADP-ribosylation (vol 29, pg 14470, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Yu, Xiaochun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Yu, XC (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA 91010 USA.							Wang MX, 2018, J BIOL CHEM, V293, P14470, DOI 10.1074/jbc.RA118.004284	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					874	874		10.1074/jbc.AAC118.007258	http://dx.doi.org/10.1074/jbc.AAC118.007258			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30659162	hybrid, Green Published			2022-12-28	WOS:000458670200013
J	Julian, MC; Rabia, LA; Desai, AA; Arsiwala, A; Gerson, JE; Paulson, HL; Kane, RS; Tessier, PM				Julian, Mark C.; Rabia, Lilia A.; Desai, Alec A.; Arsiwala, Ammar; Gerson, Julia E.; Paulson, Henry L.; Kane, Ravi S.; Tessier, Peter M.			Nature-inspired design and evolution of anti-amyloid antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; monoclonal antibody; amyloid; amyloid- (A); directed evolution; fibril; neurodegeneration; Alzheimer's disease; aggregate; conformation; gammabody; scFv; yeast surface display	ALPHA-SYNUCLEIN STRAINS; NONSPECIFIC-BINDING; BETA; AFFINITY; DOMAIN; SELECTION; SEQUENCE; AMYLOID-BETA(1-42); PHARMACOKINETICS; OPTIMIZATION	Antibodies that recognize amyloidogenic aggregates with high conformational and sequence specificity are important for detecting and potentially treating a wide range of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. However, these types of antibodies are challenging to generate because of the large size, hydrophobicity, and heterogeneity of protein aggregates. To address this challenge, we developed a method for generating antibodies specific for amyloid aggregates. First, we grafted amyloidogenic peptide segments from the target polypeptide [Alzheimer's amyloid- (A) peptide] into the complementarity-determining regions (CDRs) of a stable antibody scaffold. Next, we diversified the grafted and neighboring CDR sites using focused mutagenesis to sample each WT or grafted residue, as well as one to five of the most commonly occurring amino acids at each site in human antibodies. Finally, we displayed these antibody libraries on the surface of yeast cells and selected antibodies that strongly recognize A-amyloid fibrils and only weakly recognize soluble A. We found that this approach enables the generation of monovalent and bivalent antibodies with nanomolar affinity for A fibrils. These antibodies display high conformational and sequence specificity as well as low levels of nonspecific binding and recognize a conformational epitope at the extreme N terminus of human A. We expect that this systematic approach will be useful for generating antibodies with conformational and sequence specificity against a wide range of peptide and protein aggregates associated with neurodegenerative disorders.	[Julian, Mark C.; Rabia, Lilia A.; Tessier, Peter M.] Rensselaer Polytech Inst, Isermann Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rabia, Lilia A.; Tessier, Peter M.] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Rabia, Lilia A.; Desai, Alec A.; Tessier, Peter M.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Rabia, Lilia A.; Desai, Alec A.; Tessier, Peter M.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Tessier, Peter M.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Gerson, Julia E.; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Paulson, Henry L.; Tessier, Peter M.] Univ Michigan, Prot Folding Dis Initiat, Ann Arbor, MI 48109 USA; [Paulson, Henry L.] Univ Michigan, Michigan Alzheimers Dis Ctr, Ann Arbor, MI 48109 USA; [Arsiwala, Ammar; Kane, Ravi S.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Rensselaer Polytechnic Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Georgia; Georgia Institute of Technology	Tessier, PM (corresponding author), Univ Michigan, Dept Chem Engn, Biointerfaces Inst, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Dept Pharmaceut Sci, Biointerfaces Inst, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Dept Biomed Engn, Biointerfaces Inst, Ann Arbor, MI 48109 USA.	ptessier@umich.edu	Arsiwala, Ammar/J-4892-2015; Tessier, Peter/GPP-3396-2022		National Institutes of Health [R01GM104130, RF1AG059723]; National Science Foundation [CBET 1159943, 1605266, 1813963]; Albert M. Mattocks Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG053760, RF1AG059723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Albert M. Mattocks Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01GM104130 (to P. M. T.) and RF1AG059723 (to P. M. T. and R. S. K.,), National Science Foundation Grants CBET 1159943, 1605266, and 1813963 (to P. M. T.), Graduate Research Fellowships (to M. C. J. and L. A. R.), and the Albert M. Mattocks Chair (to P. M. T). P. M. T. has received consulting fees and/or honorariums for presentations of this and/or related research findings at Pfizer, Adimab, Roche Applied Science, Boehringer Ingelheim, Bayer, and Novo Nordisk. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174; Alam ME, 2018, MOL PHARMACEUT, V15, P150, DOI 10.1021/acs.molpharmaceut.7b00779; Arndt JW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24501-0; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Bohrmann B, 2012, J ALZHEIMERS DIS, V28, P49, DOI 10.3233/JAD-2011-110977; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brannstrom K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090857; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Datta-Mannan A, 2015, MABS-AUSTIN, V7, P1084, DOI 10.1080/19420862.2015.1075109; Datta-Mannan A, 2015, MABS-AUSTIN, V7, P483, DOI 10.1080/19420862.2015.1016696; Dobson CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38644; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; Feinberg H, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt261; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Jain T, 2017, P NATL ACAD SCI USA, V114, P944, DOI 10.1073/pnas.1616408114; Julian MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45259; Julian MC, 2015, PROTEIN ENG DES SEL, V28, P339, DOI 10.1093/protein/gzv050; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kehoe JW, 2014, PROTEIN ENG DES SEL, V27, P199, DOI 10.1093/protein/gzu012; Kelly RL, 2018, J MOL BIOL, V430, P119, DOI 10.1016/j.jmb.2017.11.008; Kelly RL, 2017, MABS-AUSTIN, V9, P1029, DOI 10.1080/19420862.2017.1356528; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Lee CC, 2016, J BIOL CHEM, V291, P2858, DOI 10.1074/jbc.M115.682336; Li B, 2014, MABS-AUSTIN, V6, P1255, DOI 10.4161/mabs.29809; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Perchiacca JM, 2012, PROTEIN ENG DES SEL, V25, P591, DOI 10.1093/protein/gzs042; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Rabia LA, 2018, PROTEIN ENG DES SEL, V31, P409, DOI 10.1093/protein/gzz002; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Starr CG, 2019, CURR OPIN BIOTECH, V60, P119, DOI 10.1016/j.copbio.2019.01.008; Stern LA, 2016, BIOTECHNOL BIOENG, V113, P2328, DOI 10.1002/bit.26001; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Tiller KE, 2017, J BIOL CHEM, V292, P16638, DOI 10.1074/jbc.M117.783837; Tiller KE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00986; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Yadav DB, 2015, J BIOL CHEM, V290, P29732, DOI 10.1074/jbc.M115.692434; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	57	13	13	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8438	8451		10.1074/jbc.RA118.004731	http://dx.doi.org/10.1074/jbc.RA118.004731			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30918024	hybrid, Green Published			2022-12-28	WOS:000471108200014
J	Kukurugya, MA; Mendonca, CM; Solhtalab, M; Wilkes, RA; Thannhauser, TW; Aristilde, L				Kukurugya, Matthew A.; Mendonca, Caroll M.; Solhtalab, Mina; Wilkes, Rebecca A.; Thannhauser, Theodore W.; Aristilde, Ludmilla			Multi-omics analysis unravels a segregated metabolic flux network that tunes co-utilization of sugar and aromatic carbons in Pseudomonas putida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas; bacterial metabolism; metabolomics; proteomics; glucose; benzoate; fluxomics; metabolic flux; metabolic regulation; mixed carbon metabolism	ISOCITRATE DEHYDROGENASE; CATABOLITE REPRESSION; GLUCOSE; DEGRADATION; CRC; PATHWAYS; BENZOATE; SEQUENCE; TOLUENE; GENOME	Pseudomonas species thrive in different nutritional environments and can catabolize divergent carbon substrates. These capabilities have important implications for the role of these species in natural and engineered carbon processing. However, the metabolic phenotypes enabling Pseudomonas to utilize mixed substrates remain poorly understood. Here, we employed a multi-omics approach involving stable isotope tracers, metabolomics, fluxomics, and proteomics in Pseudomonas putida KT2440 to investigate the constitutive metabolic network that achieves co-utilization of glucose and benzoate, respectively a monomer of carbohydrate polymers and a derivative of lignin monomers. Despite nearly equal consumption of both substrates, metabolite isotopologues revealed nonuniform assimilation throughout the metabolic network. Gluconeogenic flux of benzoate-derived carbons from the tricarboxylic acid cycle did not reach the upper Embden-Meyerhof-Parnas pathway nor the pentose-phosphate pathway. These latter two pathways were populated exclusively by glucose-derived carbons through a cyclic connection with the Entner-Doudoroff pathway. We integrated the C-13-metabolomics data with physiological parameters for quantitative flux analysis, demonstrating that the metabolic segregation of the substrate carbons optimally sustained biosynthetic flux demands and redox balance. Changes in protein abundance partially predicted the metabolic flux changes in cells grown on the glucose:benzoate mixture versus on glucose alone. Notably, flux magnitude and directionality were also maintained by metabolite levels and regulation of phosphorylation of key metabolic enzymes. These findings provide new insights into the metabolic architecture that affords adaptability of P. putida to divergent carbon substrates and highlight regulatory points at different metabolic nodes that may underlie the high nutritional flexibility of Pseudomonas species.	[Kukurugya, Matthew A.; Mendonca, Caroll M.; Solhtalab, Mina; Wilkes, Rebecca A.; Aristilde, Ludmilla] Cornell Univ, Coll Agr & Life Sci, Dept Biol & Environm Engn, Ithaca, NY 14853 USA; [Thannhauser, Theodore W.] ARS, USDA, Ithaca, NY 14853 USA	Cornell University; United States Department of Agriculture (USDA)	Aristilde, L (corresponding author), Cornell Univ, 214 Riley Robb Hall, Ithaca, NY 14850 USA.	ludmilla@cornell.edu	Solhtalab, Mina/ABG-4811-2020; Aristilde, Ludmilla/V-7611-2019	Mendonca, Caroll/0000-0001-6692-2911; Wilkes, Rebecca/0000-0002-4628-0170; Aristilde, Ludmilla/0000-0002-8566-1486	Integrative Graduate Education and Research Traineeship Fellowship from the National Science Foundation; Cornell University	Integrative Graduate Education and Research Traineeship Fellowship from the National Science Foundation; Cornell University	This work was supported by an Integrative Graduate Education and Research Traineeship Fellowship from the National Science Foundation (to M. A. K.), graduate fellowships from Cornell University (to M. S. and R. A. W.), and a start-up package from Cornell University. The authors declare that they have no conflicts of interest with the contents of this article.	Akkaya O, 2018, MBIO, V9, DOI 10.1128/mBio.01512-18; [Anonymous], 1967, HDB METHODS APPL STA; Aristilde L, 2017, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00034; Aristilde L, 2015, APPL ENVIRON MICROB, V81, P1452, DOI 10.1128/AEM.03199-14; Basu A, 2006, APPL ENVIRON MICROB, V72, P2226, DOI 10.1128/AEM.72.3.2226-2230.2006; Belda E, 2016, ENVIRON MICROBIOL, V18, P3403, DOI 10.1111/1462-2920.13230; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; BURLAGE RS, 1989, APPL ENVIRON MICROB, V55, P1323, DOI 10.1128/AEM.55.6.1323-1328.1989; Cao B, 2008, BIOTECHNOL BIOENG, V101, P1297, DOI 10.1002/bit.21997; Chen JW, 2013, J PROTEOME RES, V12, P1151, DOI 10.1021/pr3007528; del Castillo T, 2007, J BACTERIOL, V189, P6602, DOI 10.1128/JB.00679-07; Dvorak P, 2018, METAB ENG, V48, P94, DOI 10.1016/j.ymben.2018.05.019; Fang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050312; George KW, 2012, MICROBIOL-SGM, V158, P2781, DOI 10.1099/mic.0.058230-0; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hackett SR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf2786; Hester KL, 2000, J BACTERIOL, V182, P1144, DOI 10.1128/JB.182.4.1144-1149.2000; Johnson Christopher W, 2016, Metab Eng Commun, V3, P111, DOI 10.1016/j.meteno.2016.04.002; Johnson GR, 2003, APPL MICROBIOL BIOT, V62, P110, DOI 10.1007/s00253-003-1341-4; Kim J, 2016, ENVIRON MICROBIOL, V18, P3327, DOI 10.1111/1462-2920.13054; Kleiber C, 2008, ECON STUD INEQUAL SO, V5, P97, DOI 10.1007/978-0-387-72796-7_6; Kohlstedt M, 2019, METAB ENG, V54, P35, DOI 10.1016/j.ymben.2019.01.008; La Rosa R, 2015, ENVIRON MICROBIOL, V17, P3362, DOI 10.1111/1462-2920.12812; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; Lassek C, 2016, PROTEOMICS, V16, P1381, DOI 10.1002/pmic.201500228; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Moreno R, 2009, NUCLEIC ACIDS RES, V37, P7678, DOI 10.1093/nar/gkp825; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nikel PI, 2015, J BIOL CHEM, V290, P25920, DOI 10.1074/jbc.M115.687749; Nikel PI, 2014, ENVIRON MICROBIOL, V16, P239, DOI 10.1111/1462-2920.12224; Palazzolo MA, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2128-y; Park JO, 2016, NAT CHEM BIOL, V12, P482, DOI [10.1038/NCHEMBIO.2077, 10.1038/nchembio.2077]; Poblete-Castro I, 2012, APPL MICROBIOL BIOT, V93, P2279, DOI 10.1007/s00253-012-3928-0; ROJO F, 1987, SCIENCE, V238, P1395, DOI 10.1126/science.3479842; Ruiz-Manzano A, 2005, J BACTERIOL, V187, P3678, DOI 10.1128/JB.187.11.3678-3686.2005; Sasnow SS, 2016, MICROBIOLOGYOPEN, V5, P3, DOI 10.1002/mbo3.287; Silva-Rocha R, 2013, ISME J, V7, P229, DOI 10.1038/ismej.2012.98; SMITH CM, 1974, J BIOL CHEM, V249, P1497; Snedecor G.W., 1989, AMES IOWA STATE U PR; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Sudarsan Suresh, 2016, Metab Eng Commun, V3, P97, DOI 10.1016/j.meteno.2016.03.005; Sudarsan S, 2014, APPL ENVIRON MICROB, V80, P5292, DOI 10.1128/AEM.01643-14; Tepper N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075370; Thomas CJ, 2017, ANAL BIOCHEM, V525, P46, DOI 10.1016/j.ab.2017.02.011; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; van Duuren JBJH, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-93; van Duuren JBJH, 2012, BIOTECHNOL PROGR, V28, P85, DOI 10.1002/btpr.709; Vardon DR, 2015, ENERG ENVIRON SCI, V8, P617, DOI [10.1039/C4EE03230F, 10.1039/c4ee03230f]; WALSH K, 1985, J BIOL CHEM, V260, P8430; Weitzel M, 2013, BIOINFORMATICS, V29, P143, DOI 10.1093/bioinformatics/bts646; Wilkes RA, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02084-18; WORSEY MJ, 1975, J BACTERIOL, V124, P7, DOI 10.1128/JB.124.1.7-13.1975; Yang Shuping, 2018, Oncotarget, V9, P11352, DOI 10.18632/oncotarget.24250; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	57	23	23	4	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8464	8479		10.1074/jbc.RA119.007885	http://dx.doi.org/10.1074/jbc.RA119.007885			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30936206	Green Published, hybrid			2022-12-28	WOS:000471108200016
J	Lu, D; Danilowicz, C; Tashjian, TF; Prevost, C; Godoy, VG; Prentiss, M				Lu, Daniel; Danilowicz, Claudia; Tashjian, Tommy F.; Prevost, Chantal; Godoy, Veronica G.; Prentiss, Mara			Slow extension of the invading DNA strand in a D-loop formed by RecA-mediated homologous recombination may enhance recognition of DNA homology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA recombination; DNA polymerase; cooperativity; fluorescence resonance energy transfer (FRET); molecular dynamics; DNA damage; double-strand break (DSB); heteroduplex formation; RecA; strand displacement synthesis	ESCHERICHIA-COLI; POLYMERASE; EXCHANGE; HYDROLYSIS; MECHANISM; ALLOWS; REPAIR; IV	DNA recombination resulting from RecA-mediated strand exchange aided by RecBCD proteins often enables accurate repair of DNA double-strand breaks. However, the process of recombinational repair between short DNA regions of accidental similarity can lead to fatal genomic rearrangements. Previous studies have probed how effectively RecA discriminates against interactions involving a short similar sequence that is embedded in otherwise dissimilar sequences but have not yielded fully conclusive results. Here, we present results of in vitro experiments with fluorescent probes strategically located on the interacting DNA fragments used for recombination. Our findings suggest that DNA synthesis increases the stability of the recombination products. Fluorescence measurements can also probe the homology dependence of the extension of invading DNA strands in D-loops formed by RecA-mediated strand exchange. We examined the slow extension of the invading strand in a D-loop by DNA polymerase (Pol) IV and the more rapid extension by DNA polymerase LF-Bsu. We found that when DNA Pol IV extends the invading strand in a D-loop formed by RecA-mediated strand exchange, the extension afforded by 82 bp of homology is significantly longer than the extension on 50 bp of homology. In contrast, the extension of the invading strand in D-loops by DNA LF-Bsu Pol is similar for intermediates with 50 bp of homology. These results suggest that fatal genomic rearrangements due to the recombination of small regions of accidental homology may be reduced if RecA-mediated strand exchange is immediately followed by DNA synthesis by a slow polymerase.	[Lu, Daniel; Danilowicz, Claudia; Prentiss, Mara] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Tashjian, Tommy F.; Godoy, Veronica G.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Prevost, Chantal] CNRS, UMR 9080, IBPC, Lab Biochim Theor, F-75005 Paris, France	Harvard University; Northeastern University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Prentiss, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	prentiss@fas.harvard.edu	Prentiss, Mara/AAU-2940-2021	Tashjian, Tommy/0000-0001-5675-1151; Chantal, Prevost/0000-0003-3516-6687	Northeastern University; the "Initiative d'Excellence" program of the French State ("DYNAMO") [ANR-11-LABX-0011-01]; Program for Research in Science and Engineering of Harvard University; Harvard University	Northeastern University; the "Initiative d'Excellence" program of the French State ("DYNAMO"); Program for Research in Science and Engineering of Harvard University; Harvard University	This work was supported by Northeastern University (to V. G. G.), the "Initiative d'Excellence" program of the French State ("DYNAMO," Grant ANR-11-LABX-0011-01) (to C. P.), the Program for Research in Science and Engineering of Harvard University (to D. L.), and Harvard University (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Bazemore LR, 1997, P NATL ACAD SCI USA, V94, P11863, DOI 10.1073/pnas.94.22.11863; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Cafarelli TM, 2013, J BACTERIOL, V195, P1179, DOI 10.1128/JB.01349-12; Cockram CA, 2015, P NATL ACAD SCI USA, V112, pE4735, DOI 10.1073/pnas.1424269112; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Danilowicz C, 2017, NUCLEIC ACIDS RES, V45, P8448, DOI 10.1093/nar/gkx582; Danilowicz C, 2015, NUCLEIC ACIDS RES, V43, P6473, DOI 10.1093/nar/gkv610; Henrikus SS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007161; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Janion C, 2008, INT J BIOL SCI, V4, P338; Kates-Harbeck J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012702; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Le Chatelier E, 2004, J BIOL CHEM, V279, P1757, DOI 10.1074/jbc.M310719200; Li C, 2019, NUCLEIC ACIDS RES, V47, P1836, DOI 10.1093/nar/gky1252; Lovett ST, 2002, GENETICS, V160, P851; Pomerantz RT, 2013, NAT STRUCT MOL BIOL, V20, P748, DOI 10.1038/nsmb.2573; Prentiss M, 2015, CRIT REV BIOCHEM MOL, V50, P453, DOI 10.3109/10409238.2015.1092943; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Savir Y, 2010, MOL CELL, V40, P388, DOI 10.1016/j.molcel.2010.10.020; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P5616, DOI 10.1021/bi00392a006; SHEN P, 1986, GENETICS, V112, P441; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tashjian TF, 2019, J BIOL CHEM, V294, P7588, DOI 10.1074/jbc.RA118.006233; Tashjian TF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00288; WATT VM, 1985, P NATL ACAD SCI USA, V82, P4768, DOI 10.1073/pnas.82.14.4768; Xiao J, 2006, CHEMBIOCHEM, V7, P1265, DOI 10.1002/cbic.200600038; Yang DR, 2015, NUCLEIC ACIDS RES, V43, P10251, DOI 10.1093/nar/gkv883	32	4	5	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8606	8616		10.1074/jbc.RA119.007554	http://dx.doi.org/10.1074/jbc.RA119.007554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30975899	Green Published, hybrid			2022-12-28	WOS:000471108200027
J	Putri, DDP; Kawasaki, T; Murase, M; Sueyoshi, T; Deguchi, T; Ori, D; Suetsugu, S; Kawai, T				Putri, Dyaningtyas Dewi Pamungkas; Kawasaki, Takumi; Murase, Motoya; Sueyoshi, Takuya; Deguchi, Tomoya; Ori, Daisuke; Suetsugu, Shiro; Kawai, Taro			PtdIns3P phosphatases MTMR3 and MTMR4 negatively regulate innate immune responses to DNA through modulating STING trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylinositol; phosphatidylinositol phosphatase; innate immunity; DNA viruses; interferon regulatory factor; IRF; DNA sensor; MTM; MTMR; PtdIns3P; STING; type I IFNs	MYOTUBULARIN; PROTEIN; 2ND-MESSENGER; AUTOPHAGY; PATHWAY	The innate immune system plays an essential role in initial recognition of pathogen infection by producing inflammatory cytokines and type I interferons. cGAS is a cytoplasmic sensor for DNA derived from DNA viruses. cGAS binding with DNA induces the production of cGAMP, a second messenger that associates with STING in endoplasmic reticulum (ER). STING changes its cellular distribution from ER to perinuclear Golgi, where it activates the protein kinase TBK1 that catalyzes the phosphorylation of IRF3. Here we found that STING trafficking is regulated by myotubularin-related protein (MTMR) 3 and MTMR4, members of protein tyrosine phosphatases that dephosphorylate 3 position in phosphatidylinositol (PtdIns) and generate PtdIns5P from PtdIns3,5P(2) and PtdIns from PtdIns3P. We established MTMR3 and MTMR4 double knockout (DKO) RAW264.7 macrophage cells and found that they exhibited increased type I interferon production after interferon-stimulatory DNA (ISD) stimulation and herpes simplex virus 1 infection concomitant with enhanced IRF3 phosphorylation. In DKO cells, STING rapidly trafficked from ER to Golgi after ISD stimulation. Notably, DKO cells exhibited enlarged cytosolic puncta positive for PtdIns3P and STING was aberrantly accumulated in this puncta. Taken together, these results suggest that MTMR3 and MTMR4 regulate the production of PtdIns3P, which plays a critical role in suppressing DNA-mediated innate immune responses via modulating STING trafficking.	[Putri, Dyaningtyas Dewi Pamungkas; Kawasaki, Takumi; Murase, Motoya; Sueyoshi, Takuya; Deguchi, Tomoya; Ori, Daisuke; Kawai, Taro] Nara Inst Sci & Technol NAIST, Lab Mol Immunobiol, Grad Sch Sci & Technol, Nara 6300192, Japan; [Suetsugu, Shiro] Nara Inst Sci & Technol NAIST, Lab Mol Med & Cell Biol, Grad Sch Sci & Technol, Div Biol Sci, Nara 6300192, Japan	Nara Institute of Science & Technology; Nara Institute of Science & Technology	Kawasaki, T; Kawai, T (corresponding author), 8916-5 Takayama Cho, Nara 6300192, Japan.	kawast01@bs.naist.jp; tarokawai@bs.naist.jp	Suetsugu, Shiro/B-3300-2010; Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/AAF-4427-2019; -, Dyaningtyas Dewi Pamungkas Putri/GLV-3044-2022	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; -, Dyaningtyas Dewi Pamungkas Putri/0000-0002-1235-4346; Kawai, Taro/0000-0001-7510-4662	MEXT KAKENHI [17H04066, 17K15598]; Takeda Science Foundation	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by MEXT KAKENHI Grant-in-Aid for Scientific Research B 17H04066 and Young Scientist B 17K15598 and by Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn J, 2014, CURR OPIN IMMUNOL, V31, P121, DOI 10.1016/j.coi.2014.10.009; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Guittard G, 2010, FEBS LETT, V584, P2455, DOI 10.1016/j.febslet.2010.04.051; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2013, CELL HOST MICROBE, V14, P148, DOI 10.1016/j.chom.2013.07.011; Lahiri A, 2015, P NATL ACAD SCI USA, V112, P10461, DOI 10.1073/pnas.1501752112; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Ma Z, 2016, CELL HOST MICROBE, V19, P150, DOI 10.1016/j.chom.2016.01.010; Marat AL, 2016, EMBO J, V35, P561, DOI 10.15252/embj.201593564; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Murase M, 2018, J IMMUNOL, V200, P2798, DOI 10.4049/jimmunol.1701390; Nascimbeni AC, 2017, EMBO J, V36, P2018, DOI 10.15252/embj.201797006; Naughtin MJ, 2010, J CELL SCI, V123, P3071, DOI 10.1242/jcs.060103; Oppelt A, 2013, EMBO REP, V14, P57, DOI 10.1038/embor.2012.183; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Seo GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02936-3; Sueyoshi T, 2018, J IMMUNOL, V200, P3814, DOI 10.4049/jimmunol.1701282; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Takahama M, 2017, CELL REP, V20, P2944, DOI 10.1016/j.celrep.2017.08.085; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Teo WX, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00091; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608	34	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8412	8423		10.1074/jbc.RA118.005731	http://dx.doi.org/10.1074/jbc.RA118.005731			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30944173	hybrid, Green Published			2022-12-28	WOS:000471108200012
J	Chen, JL; Smaardijk, S; Mattelaer, CA; Pamula, F; Vandecaetsbeek, I; Vanoevelen, J; Wuytack, F; Lescrinier, E; Eggermont, J; Vangheluwe, P				Chen, Jialin; Smaardijk, Susanne; Mattelaer, Charles-Alexandre; Pamula, Filip; Vandecaetsbeek, Ilse; Vanoevelen, Jo; Wuytack, Frank; Lescrinier, Eveline; Eggermont, Jan; Vangheluwe, Peter			An N-terminal Ca2+-binding motif regulates the secretory pathway Ca2+/Mn2+-transport ATPase SPCA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Golgi; calcium ATPase; protein purification; membrane transporter reconstitution; calcium transport; manganese; breast cancer; Hailey-Hailey disease; ion homeostasis; proteoliposomes	PLASMA-MEMBRANE; BREAST-CANCER; ION-TRANSPORT; CALCIUM-PUMP; STEADY-STATE; MOUSE-BRAIN; CA2+; YEAST; LOCALIZATION; MN2+-ATPASE	The Ca2+/Mn2+ transport ATPases 1a and 2 (SPCA1a/2) are closely related to the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) and are implicated in breast cancer and Hailey-Hailey skin disease. Here, we purified the human SPCA1a/2 isoforms from a yeast recombinant expression system and compared their biochemical properties after reconstitution. We observed that the purified SPCA1a displays a lower Ca2+ affinity and slightly lower Mn2+ affinity than SPCA2. Remarkably, the turnover rates of SPCA1a in the presence of Mn2+ and SPCA2 incubated with Ca2+ and Mn2+ were comparable, whereas the turnover rate of SPCA1a in Ca2+ was 2-fold higher. Moreover, we noted an unusual biphasic activation curve for the SPCA1a ATPase and autophosphorylation activity, not observed with SPCA2. We also found that the biphasic pattern and low apparent ion affinity of SPCA1a critically depends on ATP concentration. We further show that the specific properties of SPCA1a at least partially depend on an N-terminal EF-hand-like motif, which is present only in the SPCA1a isoform and absent in SPCA2. This motif binds Ca2+, and its mutation lowered the Ca2+ turnover rate relative to that of Mn2+, increased substrate affinity, and reduced the level of biphasic activation of SPCA1a. A biochemical analysis indicated that Ca2+ binding to the N-terminal EF-hand-like motif promotes the activity of SPCA1a by facilitating autophosphorylation. We propose that this regulation may be physiologically relevant in cells with a high Ca2+ load, such as mammary gland cells during lactation, or in cells with a low ATP content, such as keratinocytes.	[Chen, Jialin; Smaardijk, Susanne; Pamula, Filip; Vandecaetsbeek, Ilse; Vanoevelen, Jo; Wuytack, Frank; Eggermont, Jan; Vangheluwe, Peter] Katholieke Univ Leuven, Rega Inst, Dept Cellular & Mol Med, Lab Cellular Transport Syst, Leuven, Belgium; [Mattelaer, Charles-Alexandre; Lescrinier, Eveline] Katholieke Univ Leuven, Rega Inst, Dept Pharmaceut & Pharmacol Sci, Med Chem, Leuven, Belgium	KU Leuven; KU Leuven	Vangheluwe, P (corresponding author), Katholieke Univ Leuven, ON1 Campus Gasthuisberg,Herestr 49 Box 802, B-3000 Leuven, Belgium.	peter.vangheluwe@kuleuven.be	Lescrinier, Eveline/G-9339-2016; Vanoevelen, Jo M/F-2686-2013; Vangheluwe, Peter/P-5476-2017	Lescrinier, Eveline/0000-0001-7066-4329; Vanoevelen, Jo M/0000-0003-1830-8858; Mattelaer, Charles-Alexandre/0000-0002-8801-062X; Pamula, Filip/0000-0002-1765-8218; Eggermont, Jan/0000-0002-8497-1159; Vangheluwe, Peter/0000-0002-7822-2944	Flanders Research Foundation FWO [G044212N, G0B1115N]; Inter-University Attraction Poles program [P7/13]	Flanders Research Foundation FWO(FWO); Inter-University Attraction Poles program(Belgian Federal Science Policy Office)	This work was supported by Flanders Research Foundation FWO Grants G044212N and G0B1115N (to P. V.) and Inter-University Attraction Poles program P7/13. The authors declare that they have no conflicts of interest with the contents of this article.	Aronchik I, 2003, J INVEST DERMATOL, V121, P681, DOI 10.1046/j.1523-1747.2003.12472.x; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Baron S, 2009, BBA-MOL CELL RES, V1793, P1041, DOI 10.1016/j.bbamcr.2008.11.005; BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bolton EC, 2002, MOL CELL, V9, P879, DOI 10.1016/S1097-2765(02)00495-1; Chen JL, 2017, J BIOL CHEM, V292, P6938, DOI 10.1074/jbc.M117.778431; Cross BM, 2014, AM J PHYSIOL-CELL PH, V306, pC515, DOI 10.1152/ajpcell.00330.2013; Cross BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067348; Dang DN, 2017, MOL CARCINOGEN, V56, P2474, DOI 10.1002/mc.22695; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; Dode L, 2006, J BIOL CHEM, V281, P3182, DOI 10.1074/jbc.M511547200; Dode L, 2005, J BIOL CHEM, V280, P39124, DOI 10.1074/jbc.M506181200; Elias PM, 2002, J INVEST DERMATOL, V119, P1269, DOI 10.1046/j.1523-1747.2002.19622.x; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Gong DS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06075-7; Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Holemans T, 2015, P NATL ACAD SCI USA, V112, P9040, DOI 10.1073/pnas.1508220112; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Leitch S, 2011, BIOMETALS, V24, P159, DOI 10.1007/s10534-010-9384-3; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lopreiato R, 2014, J BIOL CHEM, V289, P10261, DOI 10.1074/jbc.O114.555565; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Mandal D, 2000, J BIOL CHEM, V275, P23933, DOI 10.1074/jbc.M002619200; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Moody B. J., 1991, COMP INORGANIC CHEM, p[xiii, 562]; POST RL, 1973, J BIOL CHEM, V248, P6993; Prebil SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27383; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Rule G. S., 2006, FOCUS STRUCTURAL BIO, P530; Sepulveda MR, 2012, CONTRAST MEDIA MOL I, V7, P426, DOI 10.1002/cmmi.1469; Sepulveda MR, 2008, MOL CELL NEUROSCI, V38, P461, DOI 10.1016/j.mcn.2008.02.012; Sitsel A, 2019, EMBO J, V38, DOI 10.15252/embj.2018100020; Smaardijk S, 2018, BBA-MOL CELL RES, V1865, P855, DOI 10.1016/j.bbamcr.2018.03.007; Smaardijk S, 2017, TISSUE CELL, V49, P141, DOI 10.1016/j.tice.2016.09.004; Ton VK, 2002, J BIOL CHEM, V277, P6422, DOI 10.1074/jbc.M110612200; Vandecaetsbeek Ilse, 2014, Cold Spring Harb Protoc, V2014, P865, DOI 10.1101/pdb.prot076885; Vangheluwe P, 2009, CHEM REV, V109, P4733, DOI 10.1021/cr900013m; Vanoevelen J, 2005, J BIOL CHEM, V280, P22800, DOI 10.1074/jbc.M501026200; Wei Y, 1999, BIOCHEMISTRY-US, V38, P14534, DOI 10.1021/bi9911233; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200; Yamamoto S, 2016, BIOCHEM BIOPH RES CO, V477, P266, DOI 10.1016/j.bbrc.2016.06.055; Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005	46	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7878	7891		10.1074/jbc.RA118.006250	http://dx.doi.org/10.1074/jbc.RA118.006250			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30923126	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000470153300028
J	Podolnikova, NP; Hlavackova, M; Wu, YF; Yakubenko, VP; Faust, J; Balabiyev, A; Wang, X; Ugarova, TP				Podolnikova, Nataly P.; Hlavackova, Marketa; Wu, Yifei; Yakubenko, Valentin P.; Faust, James; Balabiyev, Arnat; Wang, Xu; Ugarova, Tatiana P.			Interaction between the integrin Mac-1 and signal regulatory protein (SIRP) mediates fusion in heterologous cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrin; cell adhesion; cell-cell interaction; structure-function; macrophage; cell-cell fusion; chronic inflammation; Mac-1 (M2; CD11b; CD18); multinucleated giant cell; SIRP	MULTINUCLEATED GIANT-CELLS; BINDING-SITE; ALPHA(M)BETA(2) MAC-1; INTERFERON-GAMMA; GROWTH-FACTOR; A-DOMAIN; I-DOMAIN; IDENTIFICATION; RECEPTOR; LIGAND	Macrophage fusion leading to the formation of multinucleated giant cells is a hallmark of chronic inflammation. Several membrane proteins have been implicated in mediating cell-cell attachment during fusion, but their binding partners remain unknown. Recently, we demonstrated that interleukin-4 (IL-4)-induced fusion of mouse macrophages depends on the integrin macrophage antigen 1 (Mac-1). Surprisingly, the genetic deficiency of intercellular adhesion molecule 1 (ICAM-1), an established ligand of Mac-1, did not impair macrophage fusion, suggesting the involvement of other counter-receptors. Here, using various approaches, including signal regulatory protein (SIRP) knockdown, recombinant proteins, adhesion and fusion assays, biolayer interferometry, and peptide libraries, we show that SIRP, which, similar to ICAM-1, belongs to the Ig superfamily and has previously been implicated in cell fusion, interacts with Mac-1. The following results support the conclusion that SIRP is a ligand of Mac-1: (a) recombinant ectodomain of SIRP supports adhesion of Mac-1-expressing cells; (b) Mac-1-SIRP interaction is mediated through the ligand-binding I-M-domain of Mac-1; (c) recognition of SIRP by the I-M-domain conforms to general principles governing binding of Mac-1 to many of its ligands; (d) SIRP reportedly binds CD47; however, anti-CD47 function-blocking mAb produced only a limited inhibition of macrophage adhesion to SIRP; and (e) co-culturing of SIRP- and Mac-1-expressing HEK293 cells resulted in the formation of multinucleated cells. Taken together, these results identify SIRP as a counter-receptor for Mac-1 and suggest that the Mac-1-SIRP interaction may be involved in macrophage fusion.	[Podolnikova, Nataly P.; Hlavackova, Marketa; Wu, Yifei; Faust, James; Balabiyev, Arnat; Ugarova, Tatiana P.] Arizona State Univ, Sch Life Sci, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA; [Wang, Xu] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Yakubenko, Valentin P.] East Tennessee State Univ, Coll Med, Johnson City, TN 37614 USA; [Hlavackova, Marketa] Czech Acad Sci, Inst Physiol, Dept Dev Cardiol, Videnska 1083, Prague 14220 4, Czech Republic; [Faust, James] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37240 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; East Tennessee State University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Vanderbilt University	Ugarova, TP (corresponding author), Arizona State Univ, 530 E Orange St,ISTB 1,Mail Code 4501, Tempe, AZ 85287 USA.	tatiana.ugarova@asu.edu	Hlavackova, Marketa/N-5632-2015	Hlavackova, Marketa/0000-0003-3842-6907; Balabiyev, Arnat/0000-0002-8904-598X	National Institutes of Health [HL63199, DK102020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants HL63199 (to T. P. U.) and DK102020 (to V. P. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Chiozzi P, 1997, J CELL BIOL, V138, P697, DOI 10.1083/jcb.138.3.697; Cui WG, 2007, P NATL ACAD SCI USA, V104, P14436, DOI 10.1073/pnas.0702811104; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DUFF JL, 1995, J BIOL CHEM, V270, P7161, DOI 10.1074/jbc.270.13.7161; FAIS S, 1994, LAB INVEST, V71, P737; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kramer A, 1998, METH MOL B, V87, P25; KURACHI T, 1993, BIOCHIM BIOPHYS ACTA, V1178, P259, DOI 10.1016/0167-4889(93)90202-Z; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Lee WY, 2010, J BIOL CHEM, V285, P37953, DOI 10.1074/jbc.M110.180018; Lishko VK, 2016, RES REP BIOCHEM, V6, P39, DOI 10.2147/RRBC.S107070; Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200; Lishko VK, 2003, EXP CELL RES, V283, P116, DOI 10.1016/S0014-4827(02)00024-1; Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Milde R, 2015, CELL REP, V13, P1937, DOI 10.1016/j.celrep.2015.10.065; MOST J, 1990, EUR J IMMUNOL, V20, P1661, DOI 10.1002/eji.1830200807; Oldenborg Per-Arne, 2013, ISRN Hematol, V2013, P614619, DOI 10.1155/2013/614619; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Podolnikova NP, 2016, AM J PATHOL, V186, P2105, DOI 10.1016/j.ajpath.2016.04.001; Podolnikova NP, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0027-0; Podolnikova NP, 2015, BIOCHEMISTRY-US, V54, P1408, DOI 10.1021/bi5013782; Quinn MT, 2009, J INNATE IMMUN, V1, P509, DOI 10.1159/000228158; Saginario C, 1995, P NATL ACAD SCI USA, V92, P12210, DOI 10.1073/pnas.92.26.12210; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; Schober JM, 2003, J BIOL CHEM, V278, P25808, DOI 10.1074/jbc.M301534200; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Shen D, 2017, J BIOL CHEM, V292, P18848, DOI 10.1074/jbc.M116.773713; Shilagardi K, 2013, SCIENCE, V340, P359, DOI 10.1126/science.1234781; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519; Vernon-Wilson EF, 2000, EUR J IMMUNOL, V30, P2130; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yakubenko VP, 2002, J BIOL CHEM, V277, P48635, DOI 10.1074/jbc.M208877200; Yakubenko VP, 2001, J BIOL CHEM, V276, P13995, DOI 10.1074/jbc.M010174200; Yalamanchili P, 2000, J BIOL CHEM, V275, P21877, DOI 10.1074/jbc.M908868199; Zhang L, 1997, J BIOL CHEM, V272, P17558, DOI 10.1074/jbc.272.28.17558	53	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7833	7849		10.1074/jbc.RA118.006314	http://dx.doi.org/10.1074/jbc.RA118.006314			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30910815	hybrid, Green Published			2022-12-28	WOS:000470153300025
J	Yu, ZY; Chiara, DC; Savechenkov, PY; Bruzik, KS; Cohen, JB				Yu, Zhiyi; Chiara, David. C.; Savechenkov, Pavel Y.; Bruzik, Karol S.; Cohen, Jonathan B.			A photoreactive analog of allopregnanolone enables identification of steroid-binding sites in a nicotinic acetylcholine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); GABA receptor; anesthetic; steroid; ion channel; lipid-protein interaction; ligand-gated ion channel; neurosteroid allopregnanolone; neurotransmitter receptor; perfluorophenyl azide; photolabeling	GAMMA-AMINOBUTYRIC-ACID; ION-CHANNEL; NONCOMPETITIVE ANTAGONISTS; STRUCTURAL BASIS; AMINO-ACIDS; NEUROSTEROIDS; MODULATION; ACTIVATION; CHOLESTEROL; ANESTHETICS	Many neuroactive steroids potently and allosterically modulate pentameric ligand-gated ion channels, including GABA(A) receptors (GABA(A)R) and nicotinic acetylcholine receptors (nAChRs). Allopregnanolone and its synthetic analog alphaxalone are GABA(A)R-positive allosteric modulators (PAMs), whereas alphaxalone and most neuroactive steroids are nAChR inhibitors. In this report, we used 11-(p-azidotetrafluorobenzoyloxy)allopregnanolone (F(4)N(3)Bzoxy-AP), a general anesthetic and photoreactive allopregnanolone analog that is a potent GABA(A)R PAM, to characterize steroid-binding sites in the Torpedo (2) nAChR in its native membrane environment. We found that F(4)N(3)Bzoxy-AP (IC50 = 31 m) is 7-fold more potent than alphaxalone in inhibiting binding of the channel blocker [H-3]tenocyclidine to nAChRs in the desensitized state. At 300 m, neither steroid inhibited binding of [H-3]tetracaine, a closed-state selective channel blocker, or of [H-3]acetylcholine. Photolabeling identified three distinct [H-3]F(4)N(3)Bzoxy-AP-binding sites in the nAChR transmembrane domain: 1) in the ion channel, identified by photolabeling in the M2 helices of Val-261 and Val-269 (position M2-13); 2) at the interface between the M1 and M4 helices, identified by photolabeling in M1 (Cys-222/Leu-223); and 3) at the lipid-protein interface involving Trp-453 (M4), a residue photolabeled by small lipophilic probes and promegestone, a steroid nAChR antagonist. Photolabeling in the ion channel and M1 was higher in the nAChR-desensitized state than in the resting state and inhibitable by promegestone. These results directly indicate a steroid-binding site in the nAChR ion channel and identify additional steroid-binding sites also occupied by other lipophilic nAChR antagonists.	[Yu, Zhiyi; Chiara, David. C.; Cohen, Jonathan B.] Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA; [Savechenkov, Pavel Y.; Bruzik, Karol S.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cohen, JB (corresponding author), Harvard Med Sch, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu			National Institutes of Health [GM-58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM-58448. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akk G, 2007, PHARMACOL THERAPEUT, V116, P35, DOI 10.1016/j.pharmthera.2007.03.004; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Arias HR, 2003, BIOCHEMISTRY-US, V42, P7358, DOI 10.1021/bi034052n; Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Baenziger JE, 2017, CURR TOP MEMBR, V80, P95, DOI 10.1016/bs.ctm.2017.05.002; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Blanco MJ, 2018, BIOORG MED CHEM LETT, V28, P61, DOI 10.1016/j.bmcl.2017.11.043; Blanton MP, 1998, J BIOL CHEM, V273, P8659, DOI 10.1074/jbc.273.15.8659; Blanton MP, 1999, MOL PHARMACOL, V55, P269, DOI 10.1124/mol.55.2.269; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Blanton MP, 2001, BBA-BIOMEMBRANES, V1512, P215, DOI 10.1016/S0005-2736(01)00321-2; Bouzat C, 1996, J BIOL CHEM, V271, P25835, DOI 10.1074/jbc.271.42.25835; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Cheng WWL, 2018, J BIOL CHEM, V293, P3013, DOI 10.1074/jbc.RA117.000359; Chiara DC, 2009, BIOCHEMISTRY-US, V48, P10066, DOI 10.1021/bi901271w; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Cline MR, 2007, BIOCHEMISTRY-US, V46, P1981, DOI 10.1021/bi061269j; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Forman SA, 2016, ANESTH ANALG, V123, P1263, DOI 10.1213/ANE.0000000000001368; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Gallagher MJ, 1999, MOL PHARMACOL, V56, P300, DOI 10.1124/mol.56.2.300; Garbus I, 2002, NEUROPHARMACOLOGY, V43, P65, DOI 10.1016/S0028-3908(02)00068-0; Garbus I, 2001, NEUROREPORT, V12, P227, DOI 10.1097/00001756-200102120-00010; Garcia G, 2007, BIOCHEMISTRY-US, V46, P10296, DOI 10.1021/bi7008163; Hamouda AK, 2014, J MOL NEUROSCI, V53, P480, DOI 10.1007/s12031-013-0150-1; Hamouda AK, 2014, MOL PHARMACOL, V85, P735, DOI 10.1124/mol.113.090985; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; HAWKINSON JE, 1994, MOL PHARMACOL, V46, P977; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Ke L, 1996, J NEUROCHEM, V67, P1100; KEANA JFW, 1990, J ORG CHEM, V55, P3640, DOI 10.1021/jo00298a048; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mnatsakanyan N, 2013, J NEUROCHEM, V125, P843, DOI 10.1111/jnc.12260; MOORE MA, 1995, BBA-BIOMEMBRANES, V1235, P336, DOI 10.1016/0005-2736(95)80022-8; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Nirthanan S, 2005, BIOCHEMISTRY-US, V44, P13447, DOI 10.1021/bi051209y; Nirthanan S, 2008, J BIOL CHEM, V283, P22051, DOI 10.1074/jbc.M801332200; Olsen Richard W, 2015, Adv Pharmacol, V73, P167, DOI 10.1016/bs.apha.2014.11.005; Paradiso K, 2000, MOL PHARMACOL, V58, P341, DOI 10.1124/mol.58.2.341; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Purohit P, 2015, J PHYSIOL-LONDON, V593, P2851, DOI 10.1113/JP270223; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Reddy DS, 2016, TRENDS PHARMACOL SCI, V37, P543, DOI 10.1016/j.tips.2016.04.003; Santiago J, 2001, J BIOL CHEM, V276, P46523, DOI 10.1074/jbc.M104563200; Savechenkov PY, 2017, EUR J MED CHEM, V136, P334, DOI 10.1016/j.ejmech.2017.04.043; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2017, IUCRJ, V4, P393, DOI 10.1107/S2052252517005243; WACHTEL RE, 1992, BRIT J PHARMACOL, V106, P623, DOI 10.1111/j.1476-5381.1992.tb14385.x; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Yu ZY, 2017, J BIOL CHEM, V292, P17258, DOI 10.1074/jbc.M117.808592	63	1	1	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7892	7903		10.1074/jbc.RA118.007172	http://dx.doi.org/10.1074/jbc.RA118.007172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30923128	Green Published, hybrid			2022-12-28	WOS:000470153300029
J	Horsthemke, M; Nutter, LMJ; Bachg, AC; Skryabin, BV; Honnert, U; Zobel, T; Bogdan, S; Stoll, M; Seidl, MD; Muller, FU; Ravens, U; Unger, A; Linke, WA; van Gorp, PRR; de Vries, AAF; Bahler, M; Hanley, PJ				Horsthemke, Markus; Nutter, Lauryl M. J.; Bachg, Anne C.; Skryabin, Boris V.; Honnert, Ulrike; Zobel, Thomas; Bogdan, Sven; Stoll, Monika; Seidl, Matthias D.; Mueller, Frank U.; Ravens, Ursula; Unger, Andreas; Linke, Wolfgang A.; van Gorp, Pim R. R.; de Vries, Antoine A. F.; Baehler, Martin; Hanley, Peter J.			A novel isoform of myosin 18A (Myo18A) is an essential sarcomeric protein in mouse heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene knockout; myosin; molecular motor; heart; macrophage	PDZ-CONTAINING MYOSIN; GENOME-WIDE; F-ACTIN; GENE; EXPRESSION; GOLGI; MICE; ACTOMYOSIN; RESOLUTION; RESOURCE	Whereas myosin 18B (Myo18B) is known to be a critical sarcomeric protein, the function of myosin 18A (Myo18A) is unclear, although it has been implicated in cell motility and Golgi shape. Here, we show that homozygous deletion (homozygous tm1a, tm1b, or tm1d alleles) of Myo18a in mouse is embryonic lethal. Reminiscent of Myo18b, Myo18a was highly expressed in the embryo heart, and cardiac-restricted Myo18a deletion in mice was embryonic lethal. Surprisingly, using Western blot analysis, we were unable to detect the known isoforms of Myo18A, Myo18A and Myo18A, in mouse heart using a custom C-terminal antibody. However, alternative anti-Myo18A antibodies detected a larger than expected protein, and RNA-Seq analysis indicated that a novel Myo18A transcript is expressed in mouse ventricular myocytes (and human heart). Cloning and sequencing revealed that this cardiac isoform, denoted Myo18A, lacks the PDZ-containing N terminus of Myo18A but includes an alternative N-terminal extension and a long serine-rich C terminus. EGFP-tagged Myo18A expressed in ventricular myocytes localized to the level of A-bands in sarcomeres, and Myo18a knockout embryos at day 10.5 exhibited disorganized sarcomeres with wavy thick filaments. We additionally generated myeloid-restricted Myo18a knockout mice to investigate the role of Myo18A in nonmuscle cells, exemplified by macrophages, which express more Myo18A than Myo18A, but no defects in cell shape, motility, or Golgi shape were detected. In summary, we have identified a previously unrecognized sarcomere component, a large novel isoform (denoted Myo18A) of Myo18A. Thus, both members of class XVIII myosins are critical components of cardiac sarcomeres.	[Horsthemke, Markus; Bachg, Anne C.; Honnert, Ulrike; Baehler, Martin; Hanley, Peter J.] Westfalische Wilhelms Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany; [Skryabin, Boris V.] Westfalische Wilhelms Univ Munster, Dept Med Transgen Anim & Genet Engn Models TRAM, D-48149 Munster, Germany; [Stoll, Monika] Westfalische Wilhelms Univ Munster, Inst Humangenet, D-48149 Munster, Germany; [Seidl, Matthias D.; Mueller, Frank U.] Westfalische Wilhelms Univ Munster, Inst Pharmakol & Toxikol, D-48149 Munster, Germany; [Nutter, Lauryl M. J.] Hosp Sick Children, Ctr Phenogen, Toronto, ON M5T 3H7, Canada; [Zobel, Thomas] Heinrich Heine Univ Dusseldorf, Ctr Adv Imaging, D-40225 Dusseldorf, Germany; [Bogdan, Sven] Philipps Univ Marburg, Inst Physiol & Pathophysiol, Abt Mol Zellphysiol, D-35037 Marburg, Germany; [Ravens, Ursula] Univ Klinikum Freiburg, Inst Expt Kardiovaskulare Med, D-79110 Freiburg, Germany; [Unger, Andreas; Linke, Wolfgang A.] Westfalische Wilhelms Univ Munster, Inst Physiol 2, Robert Koch Str 27b, D-48149 Munster, Germany; [van Gorp, Pim R. R.; de Vries, Antoine A. F.] Leiden Univ, Med Ctr, Dept Cardiol, Lab Expt Cardiol, Albinusdreef 2, NL-2300 RC Leiden, Netherlands	University of Munster; University of Munster; University of Munster; University of Munster; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Heinrich Heine University Dusseldorf; Philipps University Marburg; University of Freiburg; University of Munster; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hanley, PJ (corresponding author), Westfalische Wilhelms Univ Munster, Inst Mol Zellbiol, D-48149 Munster, Germany.	hanley@uni-muenster.de	de Vries, Antoine/ABG-5787-2021; Skryabin, Boris/AAL-3100-2020	Skryabin, Boris/0000-0002-4392-185X; Nutter, Lauryl/0000-0001-9619-146X; Linke, Wolfgang/0000-0003-0801-3773	Deutsche Forschungsgemeinschaft (DFG) [Mu1376/11-3, HA 3271/3-1, HA 3271/4-1, EXC 1003]; Cells in Motion (CiM); Genome Canada; Ontario Genomics Institute [OGI-059]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cells in Motion (CiM); Genome Canada(Genome Canada); Ontario Genomics Institute	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants Mu1376/11-3 (to F. U. M.), HA 3271/3-1 (to P. J. H.), HA 3271/4-1 (to P. J. H.), and EXC 1003 (Cluster of Excellence 1003), Cells in Motion (CiM), and the NorCOMM2 project was funded by Genome Canada and Ontario Genomics Institute Grant OGI-059. The authors declare that they have no conflicts of interest with the contents of this article.	Adams NC, 2006, PRIN PRACT, P131; Ajima R, 2008, GENES CELLS, V13, P987, DOI 10.1111/j.1365-2443.2008.01226.x; Askar SFA, 2011, CARDIOVASC RES, V90, P295, DOI 10.1093/cvr/cvr011; Berger J, 2017, HUM MOL GENET, V26, P1146, DOI 10.1093/hmg/ddx025; Billington N, 2015, CURR BIOL, V25, P942, DOI 10.1016/j.cub.2015.02.012; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Birling MC, 2012, GENESIS, V50, P482, DOI 10.1002/dvg.20826; Bruun K, 2017, CYTOSKELETON, V74, P205, DOI 10.1002/cm.21364; Cao JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep36768; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; Desgrange A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162776; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Engels MC, 2015, CARDIOVASC RES, V107, P601, DOI 10.1093/cvr/cvv191; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Isfort K, 2011, J BIOL CHEM, V286, P44776, DOI 10.1074/jbc.M111.289793; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lee I, 2014, P NATL ACAD SCI USA, V111, P1849, DOI 10.1073/pnas.1323895111; Maravillas-Montero JL, 2012, J LEUKOCYTE BIOL, V91, P35, DOI 10.1189/jlb.0711335; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Nenoi M, 1996, GENE, V175, P179, DOI 10.1016/0378-1119(96)00145-X; Nishioka M, 2002, P NATL ACAD SCI USA, V99, P12269, DOI 10.1073/pnas.192445899; Perez-Garcia V, 2018, NATURE, V555, P463, DOI 10.1038/nature26002; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taft MH, 2013, J BIOL CHEM, V288, P30029, DOI 10.1074/jbc.M113.497180; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tuck E, 2015, DIS MODEL MECH, V8, P1467, DOI 10.1242/dmm.021238; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Yang CH, 2005, J BIOL CHEM, V280, P34447, DOI 10.1074/jbc.M505229200; Yu ZY, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003439; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	46	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7202	7218		10.1074/jbc.RA118.004560	http://dx.doi.org/10.1074/jbc.RA118.004560			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30737279	hybrid, Green Published			2022-12-28	WOS:000468402900010
J	Berry, JL; Gurung, I; Anonsen, JH; Spielman, I; Harper, E; Hall, AMJ; Goosens, VJ; Raynaud, C; Koomey, M; Biais, N; Matthews, S; Pelicic, V				Berry, Jamie-Lee; Gurung, Ishwori; Anonsen, Jan Haug; Spielman, Ingrid; Harper, Elliot; Hall, Alexander M. J.; Goosens, Vivianne J.; Raynaud, Claire; Koomey, Michael; Biais, Nicolas; Matthews, Steve; Pelicic, Vladimir			Global biochemical and structural analysis of the type IV pilus from the Gram-positive bacterium Streptococcus sanguinis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gram-positive bacteria; protein structure; type IV pili; virulence factor; molecular motor; pilin; Streptococcus sanguinis; twitching motility; type IV filaments	II SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; MINOR PILINS; STRUCTURE/FUNCTION ANALYSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; LEADER PEPTIDE; REVEALS; PREPILIN; VISUALIZATION	Type IV pili (Tfp) are functionally versatile filaments, widespread in prokaryotes, that belong to a large class of filamentous nanomachines known as type IV filaments (Tff). Although Tfp have been extensively studied in several Gram-negative pathogens where they function as key virulence factors, many aspects of their biology remain poorly understood. Here, we performed a global biochemical and structural analysis of Tfp in a recently emerged Gram-positive model, Streptococcus sanguinis. In particular, we focused on the five pilins and pilin-like proteins involved in Tfp biology in S. sanguinis. We found that the two major pilins, PilE1 and PilE2, (i) follow widely conserved principles for processing by the prepilin peptidase PilD and for assembly into filaments; (ii) display only one of the post-translational modifications frequently found in pilins, i.e. a methylated N terminus; (iii) are found in the same heteropolymeric filaments; and (iv) are not functionally equivalent. The 3D structure of PilE1, solved by NMR, revealed a classical pilin-fold with a highly unusual flexible C terminus. Intriguingly, PilE1 more closely resembles pseudopilins forming shorter Tff than bona fide Tfp-forming major pilins, underlining the evolutionary relatedness among different Tff. Finally, we show that S. sanguinis Tfp contain a low abundance of three additional proteins processed by PilD, the minor pilins PilA, PilB, and PilC. These findings provide the first global biochemical and structural picture of a Gram-positive Tfp and have fundamental implications for our understanding of a widespread class of filamentous nanomachines.	[Berry, Jamie-Lee; Gurung, Ishwori; Harper, Elliot; Hall, Alexander M. J.; Goosens, Vivianne J.; Raynaud, Claire; Pelicic, Vladimir] Imperial Coll London, Med Res Council, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Anonsen, Jan Haug] Univ Oslo, Prote & Mass Spectrometry Unit, Dep Biol Sci, N-0371 Oslo, Norway; [Anonsen, Jan Haug; Koomey, Michael] Univ Oslo, Ctr Integrat Microbial Evolut, Dept Biol Sci, N-0371 Oslo, Norway; [Spielman, Ingrid; Biais, Nicolas] CUNY, Brooklyn Coll, Dept Biol, New York, NY 11210 USA; [Spielman, Ingrid; Biais, Nicolas] CUNY, Grad Ctr, New York, NY 10016 USA; [Matthews, Steve] Imperial Coll London, Ctr Struct Biol, London SW7 2AZ, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oslo; University of Oslo; City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; Imperial College London; University of London; Institute of Cancer Research - UK	Pelicic, V (corresponding author), Imperial Coll London, Med Res Council, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	v.pelicic@imperial.ac.uk	Anonsen, Jan Haug/H-8786-2016; Pelicic, Vladimir/ABD-3102-2021; Pelicic, Vladimir/N-3755-2017	Anonsen, Jan Haug/0000-0003-0304-3404; Pelicic, Vladimir/0000-0002-9456-4995; Pelicic, Vladimir/0000-0002-9456-4995; Raynaud, Claire/0000-0002-7121-8424; Goosens, Vivianne/0000-0002-7808-5185	Medical Research Council [MR/L008408/1, MR/P022197/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC2AI116566] Funding Source: NIH RePORTER; MRC [MR/P022197/1, MR/L008408/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants MR/L008408/1 and MR/P022197/1 (to V. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Aly KA, 2013, MICROBIOLOGYOPEN, V2, P94, DOI 10.1002/mbo3.51; Anonsen JH, 2017, GLYCOBIOLOGY, V27, P888, DOI 10.1093/glycob/cwx032; Anonsen JH, 2016, J BACTERIOL, V198, P256, DOI 10.1128/JB.00620-15; Anonsen JH, 2012, J PROTEOME RES, V11, P5781, DOI 10.1021/pr300584x; Arts J, 2007, J BACTERIOL, V189, P2069, DOI 10.1128/JB.01236-06; Bernard SC, 2014, NAT MED, V20, P725, DOI 10.1038/nm.3563; Berry JL, 2016, STRUCTURE, V24, P926, DOI 10.1016/j.str.2016.04.001; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Biais N, 2010, P NATL ACAD SCI USA, V107, P11358, DOI 10.1073/pnas.0911328107; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Chang YW, 2016, SCIENCE, V351, DOI 10.1126/science.aad2001; Chaudhury P, 2018, MOL MICROBIOL, V107, P298, DOI 10.1111/mmi.13889; Cisneros DA, 2012, MOL MICROBIOL, V86, P805, DOI 10.1111/mmi.12033; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Gold VAM, 2015, ELIFE, V4, DOI 10.7554/eLife.07380; Goosens VJ, 2017, P NATL ACAD SCI USA, V114, pE4978, DOI 10.1073/pnas.1618539114; Gurung I, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1177; Gurung I, 2016, MOL MICROBIOL, V99, P380, DOI 10.1111/mmi.13237; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Horiuchi T, 1998, J BACTERIOL, V180, P4613, DOI 10.1128/JB.180.17.4613-4620.1998; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Imam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028919; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kolappan S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13015; Koo J, 2016, STRUCTURE, V24, P1778, DOI 10.1016/j.str.2016.08.007; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Lopez-Castilla A, 2017, NAT MICROBIOL, V2, P1686, DOI 10.1038/s41564-017-0041-2; Maier B, 2004, P NATL ACAD SCI USA, V101, P10961, DOI 10.1073/pnas.0402305101; Mancl JM, 2016, STRUCTURE, V24, P1886, DOI 10.1016/j.str.2016.08.010; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Piepenbrink KH, 2015, STRUCTURE, V23, P385, DOI 10.1016/j.str.2014.11.018; PUGSLEY AP, 1993, MOL MICROBIOL, V9, P295, DOI 10.1111/j.1365-2958.1993.tb01691.x; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Sambrook J., 2001, MOL CLONING LAB MANU; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; STROM MS, 1991, J BIOL CHEM, V266, P1656; Thomas NA, 2001, ARCH MICROBIOL, V175, P263, DOI 10.1007/s002030100254; Varga JJ, 2006, MOL MICROBIOL, V62, P680, DOI 10.1111/j.1365-2958.2006.05414.x; Wang FB, 2017, STRUCTURE, V25, P1423, DOI 10.1016/j.str.2017.07.016; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762	56	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6796	6808		10.1074/jbc.RA118.006917	http://dx.doi.org/10.1074/jbc.RA118.006917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30837269	Green Published, hybrid			2022-12-28	WOS:000467394700017
J	Dhar, SK; Batinic-Haberle, I; St Clair, DK				Dhar, Sanjit K.; Batinic-Haberle, Ines; St Clair, Daret K.			UVB-induced inactivation of manganese-containing superoxide dismutase promotes mitophagy via ROS-mediated mTORC2 pathway activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; mitophagy; metabolism; cancer; reactive oxygen species (ROS); oxidative stress; MnSOD; mTOR; mTOR complex 2 (mTOR C2); rictor	AUTOPHAGY; SURVIVAL; PROTEIN; OVEREXPRESSION; MECHANISMS; CANCER; OXYGEN; CELLS	Mitochondria are major sites of energy metabolism that influence numerous cellular events, including immunity and cancer development. Previously, we reported that the mitochondrion-specific antioxidant enzyme, manganese-containing superoxide dismutase (MnSOD), has dual roles in early- and late-carcinogenesis stages. However, how defective MnSOD impacts the chain of events that lead to cell transformation in pathologically normal epidermal cells that have been exposed to carcinogens is unknown. Here, we show that UVB radiation causes nitration and inactivation of MnSOD leading to mitochondrial injury and mitophagy. In keratinocytes, exposure to UVB radiation decreased mitochondrial oxidative phosphorylation, increased glycolysis and the expression of autophagy-related genes, and enhanced AKT Ser/Thr kinase (AKT) phosphorylation and cell growth. Interestingly, UVB initiated a prosurvival mitophagy response by mitochondria-mediated reactive oxygen species (ROS) signaling via the mammalian target of the mTOR complex 2 (mTORC2) pathway. Knockdown of rictor but not raptor abrogated UVB-induced mitophagy responses. Furthermore, fractionation and proximity-ligation assays reveal that ROS-mediated mTOC2 activation in mitochondria is necessary for UVB-induced mitophagy. Importantly, pretreatment with the MnSOD mimic MnTnBuOE-2-PyP5+ (MnP) attenuates mTORC2 activation and suppresses UVB-induced mitophagy. UVB radiation exposure also increased cell growth as assessed by soft-agar colony survival and cell growth assays, and pretreatment with MnP or the known autophagy inhibitor 3-methyladenine abrogated UVB-induced cell growth. These results indicate that MnSOD is a major redox regulator that maintains mitochondrial health and show that UVB-mediated MnSOD inactivation promotes mitophagy and thereby prevents accumulation of damaged mitochondria.	[Dhar, Sanjit K.; St Clair, Daret K.] Univ Kentucky, Dept Toxicol & Canc Biol, 1095 VA Dr, Lexington, KY 40536 USA; [Batinic-Haberle, Ines] Duke Univ, Dept Radiat Oncol, Med Ctr, Durham, NC 27710 USA	University of Kentucky; Duke University	St Clair, DK (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, 1095 VA Dr, Lexington, KY 40536 USA.	dstcl00@uky.edu			National Institutes of Health [CA 214638]; NATIONAL CANCER INSTITUTE [R01CA214638, P30CA177558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA 214638. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aitken GR, 2007, CLIN EXP DERMATOL, V32, P722, DOI 10.1111/j.1365-2230.2007.02474.x; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Aoki H, 2008, AUTOPHAGY, V4, P467, DOI 10.4161/auto.5668; Bakthavatchalu V, 2012, ONCOGENE, V31, P2129, DOI 10.1038/onc.2011.407; Batinic-Haberle I, 2018, ANTIOXID REDOX SIGN, V29, P1691, DOI 10.1089/ars.2017.7453; Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; Chinnadurai G, 2008, ONCOGENE, V27, pS114, DOI 10.1038/onc.2009.49; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; Dangi A, 2016, J CELL PHYSIOL, V231, P94, DOI 10.1002/jcp.25055; Dhar SK, 2018, ONCOGENE, V37, P6225, DOI 10.1038/s41388-018-0404-z; Dhar SK, 2011, CANCER RES, V71, P6684, DOI 10.1158/0008-5472.CAN-11-1233; Dhar SK, 2010, J BIOL CHEM, V285, P9835, DOI 10.1074/jbc.M109.060715; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Duan HY, 2015, EXP CELL RES, V335, P99, DOI 10.1016/j.yexcr.2015.05.003; Fan QW, 2011, AUTOPHAGY, V7, P536, DOI 10.4161/auto.7.5.14779; GREGORY EM, 1973, J BACTERIOL, V114, P1193, DOI 10.1128/JB.114.3.1193-1197.1973; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lippolis R, 2015, BBA-MOL BASIS DIS, V1852, P1960, DOI 10.1016/j.bbadis.2015.06.015; MacMillan-Crow LA, 1999, ARCH BIOCHEM BIOPHYS, V366, P82, DOI 10.1006/abbi.1999.1202; Maglio DHG, 2005, PHOTODERMATOL PHOTO, V21, P311, DOI 10.1111/j.1600-0781.2005.00185.x; Matsuda-Lennikov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079795; Matsuzawa Y, 2015, AUTOPHAGY, V11, P1052, DOI 10.1080/15548627.2015.1055439; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; Moldogazieva NT, 2018, CANCER RES, V78, P6040, DOI 10.1158/0008-5472.CAN-18-0980; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Rajic Z, 2012, FREE RADICAL BIO MED, V52, P1828, DOI 10.1016/j.freeradbiomed.2012.02.006; Rodriguez-Rocha H, 2011, MUTAT RES-FUND MOL M, V711, P158, DOI 10.1016/j.mrfmmm.2011.03.007; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Spitz D.R., 2001, CURRENT PROTOCOLS TO, V8, DOI [10.1002/0471140856.tx0705s08, DOI 10.1002/0471140856.TX0705S08]; St Clair D, 2005, BIOMED PHARMACOTHER, V59, P209, DOI 10.1016/j.biopha.2005.03.004; STCLAIR DK, 1992, MOL CARCINOGEN, V6, P238, DOI 10.1002/mc.2940060404; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang P, 2013, MOL CELL BIOCHEM, V372, P161, DOI 10.1007/s11010-012-1457-x; Wu SY, 2010, PHOTOCHEM PHOTOBIOL, V86, P389, DOI 10.1111/j.1751-1097.2009.00682.x; Zhao YF, 2002, ONCOGENE, V21, P3836, DOI 10.1038/sj.onc.1205477	41	14	14	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6831	6842		10.1074/jbc.RA118.006595	http://dx.doi.org/10.1074/jbc.RA118.006595			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30858178	Green Published, hybrid			2022-12-28	WOS:000467394700020
J	Dierschke, SK; Miller, WP; Favate, JS; Shah, P; Kawasawa, YI; Salzberg, AC; Kimball, SR; Jefferson, LS; Dennis, MD				Dierschke, Sadie K.; Miller, William P.; Favate, John S.; Shah, Premal; Kawasawa, Yuka Imamura; Salzberg, Anna C.; Kimball, Scot R.; Jefferson, Leonard S.; Dennis, Michael D.			O-GlcNAcylation alters the selection of mRNAs for translation and promotes 4E-BP1-dependent mitochondrial dysfunction in the retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-linked N-acetylglucosamine (O-GlcNAc); eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1); eukaryotic translation initiation; diabetes; retina; oxidative stress; post-translational modification (PTM); RiboSeq; ribosome foot printing	LINKED N-ACETYLGLUCOSAMINE; PROTEIN-SYNTHESIS; GENE-EXPRESSION; SUPEROXIDE-DISMUTASE; DIABETIC-RETINOPATHY; DNA-DAMAGE; CELL-DEATH; GLCNAC; BINDING; PHOSPHORYLATION	Diabetes promotes the posttranslational modification of proteins by O-linked addition of GlcNAc (O-GlcNAcylation) to Ser/Thr residues of proteins and thereby contributes to diabetic complications. In the retina of diabetic mice, the repressor of mRNA translation, eIF4E-binding protein 1 (4E-BP1), is O-GlcNAcylated, and sequestration of the cap-binding protein eukaryotic translation initiation factor (eIF4E) is enhanced. O-GlcNAcylation has also been detected on several eukaryotic translation initiation factors and ribosomal proteins. However, the functional consequence of this modification is unknown. Here, using ribosome profiling, we evaluated the effect of enhanced O-GlcNAcylation on retinal gene expression. Mice receiving thiamet G (TMG), an inhibitor of the O-GlcNAc hydrolase O-GlcNAcase, exhibited enhanced retinal protein O-GlcNAcylation. The principal effect of TMG on retinal gene expression was observed in ribosome-associated mRNAs (i.e. mRNAs undergoing translation), as less than 1% of mRNAs exhibited changes in abundance. Remarkably, approximate to 19% of the transcriptome exhibited TMG-induced changes in ribosome occupancy, with 1912 mRNAs having reduced and 1683 mRNAs having increased translational rates. In the retina, the effect of O-GlcNAcase inhibition on translation of specific mitochondrial proteins, including superoxide dismutase 2 (SOD2), depended on 4E-BP1/2. O-GlcNAcylation enhanced cellular respiration and promoted mitochondrial superoxide levels in WT cells, and 4E-BP1/2 deletion prevented O-GlcNAcylation-induced mitochondrial superoxide in cells in culture and in the retina. The retina of diabetic WT mice exhibited increased reactive oxygen species levels, an effect not observed in diabetic 4E-BP1/2-deficient mice. These findings provide evidence for a mechanism whereby diabetes-induced O-GlcNAcylation promotes oxidative stress in the retina by altering the selection of mRNAs for translation.	[Dierschke, Sadie K.; Miller, William P.; Kimball, Scot R.; Jefferson, Leonard S.; Dennis, Michael D.] Penn State Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA; [Favate, John S.; Shah, Premal] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Kawasawa, Yuka Imamura] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Salzberg, Anna C.] Penn State Coll Med, Dept Biochem & Mol Biol, Inst Personalized Med, Hershey, PA 17033 USA; [Salzberg, Anna C.] Ipsen Biosci Inc, 650 E Kendall St, Cambridge, MA 02142 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Dennis, MD (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	mdennis@psu.edu		Favate, John/0000-0001-6344-4854; MILLER, WILLIAM PHILLIP/0000-0003-0157-6389; Shah, Premal/0000-0002-8424-4218; Dennis, Michael/0000-0002-0645-6864	American Diabetes Association Pathway to Stop Diabetes Grant [1-14-INI-04]; NEI, National Institutes of Health [EY023612]; Penn State Eye Center Frontiers in Eye and Vision Research Award; Human Genetics Institute of New Jersey; NIGMS, National Institutes of Health Grant [GM124976]; NIDDK, National Institute of Health Grants [DK13499, DK15658]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002016, UL1TR002014] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R00EY023612] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015658, R01DK013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124976] Funding Source: NIH RePORTER	American Diabetes Association Pathway to Stop Diabetes Grant; NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Penn State Eye Center Frontiers in Eye and Vision Research Award; Human Genetics Institute of New Jersey; NIGMS, National Institutes of Health Grant; NIDDK, National Institute of Health Grants; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-04; NEI, National Institutes of Health Grant EY023612 and the Penn State Eye Center Frontiers in Eye and Vision Research Award (to M. D. D.); startup funds from the Human Genetics Institute of New Jersey and NIGMS, National Institutes of Health Grant GM124976 (to P. S.); and NIDDK, National Institute of Health Grants DK13499 and DK15658 (to S. R. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Dai WW, 2018, BBA-MOL BASIS DIS, V1864, P3568, DOI 10.1016/j.bbadis.2018.09.006; Dennis MD, 2015, J BIOL CHEM, V290, P3865, DOI 10.1074/jbc.M114.623058; Dennis MD, 2013, DIABETES, V62, P2204, DOI 10.2337/db12-1453; Dennis MD, 2011, J BIOL CHEM, V286, P34286, DOI 10.1074/jbc.M111.259457; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Duverger E, 1996, GLYCOBIOLOGY, V6, P381, DOI 10.1093/glycob/6.4.381; Fort PE, 2014, DIABETES, V63, P3077, DOI 10.2337/db14-0235; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gurel Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095561; Gurel Z, 2013, MOL VIS, V19, P1047; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; Kern TS, 2000, INVEST OPHTH VIS SCI, V41, P3972; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kim SJ, 2016, CURR EYE RES, V41, P249, DOI 10.3109/02713683.2015.1006372; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kowluru RA, 2006, INVEST OPHTH VIS SCI, V47, P1594, DOI 10.1167/iovs.05-1276; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Kowluru RA, 2006, FREE RADICAL BIO MED, V41, P1191, DOI 10.1016/j.freeradbiomed.2006.01.012; Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2; Li WZ, 2017, BIOINFORMATICS, V33, P1735, DOI 10.1093/bioinformatics/btx047; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma JF, 2016, J PROTEOME RES, V15, P2254, DOI 10.1021/acs.jproteome.6b00250; Ma JF, 2015, J BIOL CHEM, V290, P29141, DOI 10.1074/jbc.M115.691741; MADER S, 1995, MOL CELL BIOL, V15, P4990; Madsen-Bouterse SA, 2010, ANTIOXID REDOX SIGN, V13, P797, DOI 10.1089/ars.2009.2932; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Rodriguez JM, 2013, NUCLEIC ACIDS RES, V41, pD110, DOI 10.1093/nar/gks1058; Miller WP, 2016, INVEST OPHTH VIS SCI, V57, P1327, DOI 10.1167/iovs.15-18719; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Ptushkina M, 1999, EMBO J, V18, P4068, DOI 10.1093/emboj/18.14.4068; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schrufer TL, 2010, DIABETES, V59, P2107, DOI 10.2337/db10-0148; Schuller AP, 2017, MOL CELL, V66, P194, DOI 10.1016/j.molcel.2017.03.003; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Semba RD, 2014, PROTEOM CLIN APPL, V8, P218, DOI 10.1002/prca.201300076; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Tan EP, 2017, J BIOL CHEM, V292, P14940, DOI 10.1074/jbc.M117.797944; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Young TA, 2002, ARCH BIOCHEM BIOPHYS, V405, P65, DOI 10.1016/S0003-9861(02)00338-7; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhong Q, 2011, INVEST OPHTH VIS SCI, V52, P8739, DOI 10.1167/iovs.11-8045; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	68	14	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5508	5520		10.1074/jbc.RA119.007494	http://dx.doi.org/10.1074/jbc.RA119.007494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30733333	Green Published, hybrid			2022-12-28	WOS:000464517500022
J	Novoa-Aponte, L; Ramirez, D; Arguello, JM				Novoa-Aponte, Lorena; Ramirez, David; Arguello, Jose M.			The interplay of the metallosensor CueR with two distinct CopZ chaperones defines copper homeostasis in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; Pseudomonas; homeostasis; metal ion-protein interaction; metalloprotein; metal sensor; metallochaperone; stress response; transcriptional regulation	BACILLUS-SUBTILIS; MERR-FAMILY; WEB SERVER; ATPASES; EFFLUX; SELECTIVITY; ACTIVATION; MECHANISMS; EXPRESSION; RESISTANCE	Copper homeostasis in pathogenic bacteria is critical for cuproprotein assembly and virulence. However, in vivo biochemical analyses of these processes are challenging, which has prevented defining and quantifying the homeostatic interplay between Cu+-sensing transcriptional regulators, chaperones, and sequestering molecules. The cytoplasm of Pseudomonas aeruginosa contains a Cu+-sensing transcriptional regulator, CueR, and two homologous metal chaperones, CopZ1 and CopZ2, forming a unique system for studying Cu+ homeostasis. We found here that both chaperones exchange Cu+, albeit at a slow rate, reaching equilibrium after 3 h, a time much longer than P. aeruginosa duplication time. Therefore, they appeared as two separate cellular Cu+ pools. Although both chaperones transferred Cu+ to CueR in vitro, experiments in vivo indicated that CopZ1 metallates CueR, eliciting the translation of Cu+ efflux transporters involved in metal tolerance. Although this observation was consistent with the relative Cu+ affinities of the three proteins (CopZ1 < CueR < CopZ2), in vitro and in silico analyses also indicated a stronger interaction between CopZ1 and CueR that was independent of Cu+. In contrast, CopZ2 function was defined by its distinctly high abundance during Cu2+ stress. Under resting conditions, CopZ2 remained largely in its apo form. Metal stress quickly induced CopZ2 expression, and its holo form predominated, reaching levels commensurate with the cytoplasmic Cu+ levels. In summary, these results show that CopZ1 acts as chaperone delivering Cu+ to the CueR sensor, whereas CopZ2 functions as a fast-response Cu+-sequestering storage protein. We propose that equivalent proteins likely play similar roles in most bacterial systems.	[Novoa-Aponte, Lorena; Ramirez, David; Arguello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01605 USA	Worcester Polytechnic Institute	Arguello, JM (corresponding author), 60 Prescott St, Worcester, MA 01605 USA.	arguello@wpi.edu	Ramirez, David/X-4233-2019	Ramirez, David/0000-0003-0002-1189; Novoa-Aponte, Lorena/0000-0003-3348-8383	National Institutes of Health [R01GM114949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM114949 (to J. M. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Arguello JM, 2016, METALLOMICS, V8, P906, DOI 10.1039/c6mt00089d; Banci L, 2003, BIOCHEMISTRY-US, V42, P2467, DOI 10.1021/bi0205810; Banci L, 2010, NAT PROD REP, V27, P695, DOI 10.1039/b906678k; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Brunori M, 2005, J INORG BIOCHEM, V99, P324, DOI 10.1016/j.jinorgbio.2004.10.011; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Chaplin AK, 2015, METALLOMICS, V7, P145, DOI 10.1039/c4mt00250d; Chen P, 2013, BIOCHEMISTRY-US, V52, P7170, DOI 10.1021/bi400597v; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cobine P, 1999, FEBS LETT, V445, P27, DOI 10.1016/S0014-5793(99)00091-5; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cubillas C, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.452; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L, PYMOL MOL GRAPHICS S; Dennison C, 2018, J BIOL CHEM, V293, P4616, DOI 10.1074/jbc.TM117.000180; Desideri A, 2003, BIOCHEM SOC T, V31, P1322; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Ekici S, 2012, MBIO, V3, DOI 10.1128/mBio.00293-11; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fu Y, 2013, NAT CHEM BIOL, V9, P177, DOI [10.1038/NCHEMBIO.1168, 10.1038/nchembio.1168]; Gaballa A, 2003, BIOMETALS, V16, P497, DOI 10.1023/A:1023425321617; Glauninger H, 2018, CHEM SCI, V9, P105, DOI 10.1039/c7sc04396a; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; Hearnshaw S, 2009, BIOCHEMISTRY-US, V48, P9324, DOI 10.1021/bi9011995; Hernandez-Montes G, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-249; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Joshi CP, 2012, P NATL ACAD SCI USA, V109, P15121, DOI 10.1073/pnas.1208508109; Kay KL, 2016, METALLOMICS, V8, P709, DOI 10.1039/c6mt00036c; Kihlken MA, 2002, BIOCHEM J, V368, P729, DOI 10.1042/BJ20021036; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LaBauve AE., 2012, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259.mc06e01s25, DOI 10.1002/9780471729259.MC06E01S25]; Ladomersky E, 2015, METALLOMICS, V7, P957, DOI 10.1039/c4mt00327f; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Nawapan S, 2009, J BACTERIOL, V191, P5159, DOI 10.1128/JB.00384-09; NEUBERT M, 2017, COPPER, V2, pe0037, DOI DOI 10.1128/MSPHERE.00372-17; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; Osman D, 2015, J BIOL CHEM, V290, P19806, DOI 10.1074/jbc.M115.663427; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Parmar JH, 2018, MOL MICROBIOL, V110, P357, DOI 10.1111/mmi.14086; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philips SJ, 2015, SCIENCE, V349, P877, DOI 10.1126/science.aaa9809; Quintana J, 2017, J BIOL CHEM, V292, P15691, DOI 10.1074/jbc.M117.804492; Radford DS, 2003, FEMS MICROBIOL LETT, V220, P105, DOI 10.1016/S0378-1097(03)00095-8; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrodinger, 2017, MAESTR REL 2017 3; Thaden JT, 2010, J BACTERIOL, V192, P2557, DOI 10.1128/JB.01528-09; Urvoas A, 2004, EUR J BIOCHEM, V271, P993, DOI 10.1111/j.1432-1033.2004.04001.x; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei W, 2015, J AM CHEM SOC, V137, P15358, DOI 10.1021/jacs.5b09895; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zhang XX, 2008, ENVIRON MICROBIOL, V10, P3284, DOI 10.1111/j.1462-2920.2008.01720.x	66	13	13	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4934	4945		10.1074/jbc.RA118.006316	http://dx.doi.org/10.1074/jbc.RA118.006316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718281	hybrid, Green Published			2022-12-28	WOS:000463985600018
J	de Cozar, JMG; Gerards, M; Teeri, E; George, J; Dufour, E; Jacobs, HT; Joers, P				Gonzalez de Cozar, Jose M.; Gerards, Mike; Teeri, Eveliina; George, Jack; Dufour, Eric; Jacobs, Howard T.; Joers, Priit			RNase H1 promotes replication fork progression through oppositely transcribed regions of Drosophila mitochondrial DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; DNA replication; RNA; genomic instability; ribonuclease; heteroduplex; locomotor dysfunction; mtDNA; replication fork; RNase H; genome stability; insect rnh1	R-LOOPS; ALTERNATIVE OXIDASE; ACCESSORY SUBUNIT; POLYMERASE-GAMMA; BINDING PROTEIN; MTDNA; TFAM; EMBRYOGENESIS; MAINTENANCE; REGRESSION	Mitochondrial DNA (mtDNA) replication uses a simple core machinery similar to those of bacterial viruses and plasmids, but its components are challenging to unravel. Here, we found that, as in mammals, the single Drosophila gene for RNase H1 (rnh1) has alternative translational start sites, resulting in two polypeptides, targeted to either mitochondria or the nucleus. RNAi-mediated rnh1 knockdown did not influence growth or viability of S2 cells, but compromised mtDNA integrity and copy number. rnh1 knockdown in intact flies also produced a phenotype of impaired mitochondrial function, characterized by respiratory chain deficiency, locomotor dysfunction, and decreased lifespan. Its overexpression in S2 cells resulted in cell lethality after 5-9 days, attributable to the nuclearly localized isoform. rnh1 knockdown and overexpression produced opposite effects on mtDNA replication intermediates. The most pronounced effects were seen in genome regions beyond the major replication pauses where the replication fork needs to progress through a gene cluster that is transcribed in the opposite direction. RNase H1 deficiency led to an accumulation of replication intermediates in these zones, abundant mtDNA molecules joined by four-way junctions, and species consistent with fork regression from the origin. These findings indicate replication stalling due to the presence of unprocessed RNA/DNA heteroduplexes, potentially leading to the degradation of collapsed forks or to replication restart by a mechanism involving strand invasion. Both mitochondrial RNA and DNA syntheses were affected by rnh1 knockdown, suggesting that RNase H1 also plays a role in integrating or coregulating these processes in Drosophila mitochondria.	[Gonzalez de Cozar, Jose M.; Gerards, Mike; Teeri, Eveliina; George, Jack; Dufour, Eric; Jacobs, Howard T.; Joers, Priit] Tampere Univ, Fac Med & Hlth Technol, FI-33014 Tampere, Finland; [Gonzalez de Cozar, Jose M.; Gerards, Mike; Teeri, Eveliina; George, Jack; Dufour, Eric; Jacobs, Howard T.; Joers, Priit] Tampere Univ, Tampere Univ Hosp, FI-33014 Tampere, Finland; [Jacobs, Howard T.] Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland; [Joers, Priit] Univ Tartu, Inst Mol & Cell Biol, Riia 23, EE-51010 Tartu, Estonia; [Gerards, Mike] Maastricht Univ, Maastricht Ctr Syst Biol MaCSBio, NL-6229 ER Maastricht, Netherlands	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; University of Tartu; Maastricht University	Jacobs, HT (corresponding author), Tampere Univ, Fac Med & Hlth Technol, FI-33014 Tampere, Finland.; Jacobs, HT (corresponding author), Tampere Univ, Tampere Univ Hosp, FI-33014 Tampere, Finland.; Jacobs, HT (corresponding author), Univ Helsinki, Inst Biotechnol, FI-00014 Helsinki, Finland.	howard.jacobs@tuni.fi	Dufour, Eric/AAF-6210-2020	Gonzalez de Cozar, Jose M./0000-0002-2487-8585; Joers, Priit/0000-0002-9248-1774; Jacobs, Howard/0000-0003-1895-6003; Dufour, Eric/0000-0001-6690-5329; Morikka, Jack/0000-0002-0053-4171	Academy of Finland Centre of Excellence Grant [272376]; Estonian Research Council Grant [PUT573]; University of Tampere; Tampere University Hospital Medical Research Fund; Sigrid Juselius Foundation;  [256615]	Academy of Finland Centre of Excellence Grant; Estonian Research Council Grant(Estonian Research Council); University of Tampere; Tampere University Hospital Medical Research Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); 	This work was supported by Academy of Finland Centre of Excellence Grant 272376 and Academy Professorship Grant 256615 (to H. T. J.), Estonian Research Council Grant PUT573 (to P. J.), the University of Tampere, the Tampere University Hospital Medical Research Fund, and the Sigrid Juselius Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Akman G, 2016, P NATL ACAD SCI USA, V113, pE4276, DOI 10.1073/pnas.1600537113; Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; Amon JD, 2016, ELIFE, V5, DOI 10.7554/eLife.20533; Arora R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6220; Bolt EL, 2002, MOL CELL, V10, P187, DOI 10.1016/S1097-2765(02)00560-9; Bugreev DV, 2011, NUCLEIC ACIDS RES, V39, P2153, DOI 10.1093/nar/gkq1139; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Ciesielski GL, 2016, ENZYMES, V39, P255, DOI 10.1016/bs.enz.2016.03.006; Ciesielski GL, 2018, NUCLEIC ACIDS RES, V46, P3034, DOI 10.1093/nar/gky094; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; El Hage A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004716; Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Filippov V, 2001, MOL GENET GENOMICS, V265, P771, DOI 10.1007/s004380100483; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; Fukuoh A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145117; Fuste JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; HOGREFE HH, 1990, J BIOL CHEM, V265, P5561; Holmes JB, 2015, P NATL ACAD SCI USA, V112, P9334, DOI 10.1073/pnas.1503653112; Holt IJ, 2016, METHODS MOL BIOL, V1351, P95, DOI 10.1007/978-1-4939-3040-1_8; Humble MM, 2013, HUM MOL GENET, V22, P1017, DOI 10.1093/hmg/dds506; Joers P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003800; Joers P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053249; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Kasiviswanathan R, 2012, BBA-GENE REGUL MECH, V1819, P970, DOI 10.1016/j.bbagrm.2011.12.005; Kemppainen KK, 2014, HUM MOL GENET, V23, P2078, DOI 10.1093/hmg/ddt601; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LEWIS DL, 1994, MOL BIOL EVOL, V11, P523; Lima WF, 2016, NUCLEIC ACIDS RES, V44, P5299, DOI 10.1093/nar/gkw350; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Maric C, 2014, CHROMOSOMA, V123, P577, DOI 10.1007/s00412-014-0471-z; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; Maul RW, 2017, J MOL BIOL, V429, P3255, DOI 10.1016/j.jmb.2016.12.020; Nelson SW, 2010, J MOL BIOL, V401, P743, DOI 10.1016/j.jmb.2010.06.027; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; Parajuli S, 2017, J BIOL CHEM, V292, P15216, DOI 10.1074/jbc.M117.787473; Petzold C, 2015, J BIOL CHEM, V290, P14626, DOI 10.1074/jbc.M115.655134; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Reyes A, 2015, AM J HUM GENET, V97, P186, DOI 10.1016/j.ajhg.2015.05.013; Reyes A, 2013, NUCLEIC ACIDS RES, V41, P5837, DOI 10.1093/nar/gkt196; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shen W, 2017, NUCLEIC ACIDS RES, V45, P10672, DOI 10.1093/nar/gkx710; Shi YH, 2016, NUCLEIC ACIDS RES, V44, P5732, DOI 10.1093/nar/gkw302; Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007; Stiles AR, 2016, MOL GENET METAB, V119, P91, DOI 10.1016/j.ymgme.2016.07.001; Sugimoto T, 2008, EXP CELL RES, V314, P103, DOI 10.1016/j.yexcr.2007.08.015; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; Tannous E, 2015, SCI REP-UK, V5, DOI 10.1038/srep09969; Wang YE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074513; Watanabe A, 2011, CARDIOVASC RES, V90, P57, DOI 10.1093/cvr/cvq374; Wu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071006; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yang Z, 2017, PLANT CELL, V29, P2478, DOI 10.1105/tpc.17.00305; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005; Young SK, 2016, J BIOL CHEM, V291, P16927, DOI 10.1074/jbc.R116.733899	62	9	9	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4331	4344		10.1074/jbc.RA118.007015	http://dx.doi.org/10.1074/jbc.RA118.007015			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30635398	Green Published, hybrid			2022-12-28	WOS:000462969500005
J	Khan, CA; Meisburger, SP; Ando, N; Fitzpatrick, PF				Khan, Crystal A.; Meisburger, Steve P.; Ando, Nozomi; Fitzpatrick, Paul F.			The phenylketonuria-associated substitution R68S converts phenylalanine hydroxylase to a constitutively active enzyme but reduces its stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; small-angle X-ray scattering (SAXS); enzyme kinetics; analytical ultracentrifugation; hydroxylase; protein conformation; enzyme stability; phenylalanine hydroxylase; phenylketonuria; allostery; protein structure	BIOLOGICAL MACROMOLECULES; PHOSPHORYLATION STATE; LIMITED PROTEOLYSIS; STRUCTURAL BASIS; ACTIVATION; DOMAIN; MUTATIONS; MECHANISM; BINDING; LYSOLECITHIN	The naturally occurring R68S substitution of phenylalanine hydroxylase (PheH) causes phenylketonuria (PKU). However, the molecular basis for how the R68S variant leads to PKU remains unclear. Kinetic characterization of R68S PheH establishes that the enzyme is fully active in the absence of allosteric binding of phenylalanine, in contrast to the WT enzyme. Analytical ultracentrifugation establishes that the isolated regulatory domain of R68S PheH is predominantly monomeric in the absence of phenylalanine and dimerizes in its presence, similar to the regulatory domain of the WT enzyme. Fluorescence and small-angle X-ray scattering analyses establish that the overall conformation of the resting form of R68S PheH is different from that of the WT enzyme. The data are consistent with the substitution disrupting the interface between the catalytic and regulatory domains of the enzyme, shifting the equilibrium between the resting and activated forms approximate to 200-fold, so that the resting form of R68S PheH is approximate to 70% in the activated conformation. However, R68S PheH loses activity 2 orders of magnitude more rapidly than the WT enzyme at 37 degrees C and is significantly more sensitive to proteolysis. We propose that, even though this substitution converts the enzyme to a constitutively active enzyme, it results in PKU because of the decrease in protein stability.	[Khan, Crystal A.; Fitzpatrick, Paul F.] UT Hlth San Antonio, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Meisburger, Steve P.; Ando, Nozomi] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	University of Texas System; University of Texas Health San Antonio; Cornell University	Fitzpatrick, PF (corresponding author), UT Hlth San Antonio, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	fitzpatrickp@uthscsa.edu		Meisburger, Steve/0000-0001-6577-8719; Olivas, Crystal/0000-0001-7805-914X	Office of the Vice President for Research at UT Health San Antonio; National Science Foundation (NSF); National Institutes of Health (NIH)/NIGMS via NSF Grant [DMR-1332208]; NIH/NIGMS [GM-103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM124847, F31GM116452, P41GM103485, F32GM117757] Funding Source: NIH RePORTER	Office of the Vice President for Research at UT Health San Antonio; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)/NIGMS via NSF Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Gregory Reinhart for helpful discussion during this work. Support for the Center for Macromolecular Interactions from the Office of the Vice President for Research at UT Health San Antonio is gratefully acknowledged. CHESS is supported by the National Science Foundation (NSF) and National Institutes of Health (NIH)/NIGMS via NSF Grant DMR-1332208, and the Mac-CHESS resource is supported by NIH/NIGMS Grant GM-103485.	ABITA JP, 1984, J BIOL CHEM, V259, P4560; Acerbo AS, 2015, J SYNCHROTRON RADIAT, V22, P180, DOI 10.1107/S1600577514020360; Arturo EC, 2016, P NATL ACAD SCI USA, V113, P2394, DOI 10.1073/pnas.1516967113; Bueno MA, 2012, METABOLISM, V61, P1809, DOI 10.1016/j.metabol.2012.07.015; CHANG N, 1979, J BIOL CHEM, V254, P2665; Couce ML, 2013, GENE, V521, P100, DOI 10.1016/j.gene.2013.03.004; Daubner SC, 1997, BIOCHEMISTRY-US, V36, P11574, DOI 10.1021/bi9711137; Daubner SC, 1997, ARCH BIOCHEM BIOPHYS, V348, P295, DOI 10.1006/abbi.1997.0435; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Eisensmith Randy C., 1992, Human Mutation, V1, P13, DOI 10.1002/humu.1380010104; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FISHER DB, 1973, J BIOL CHEM, V248, P4345; FISHER DB, 1972, J BIOL CHEM, V247, P2250; Fitzpatrick PF, 2015, CURR OPIN STRUC BIOL, V35, P1, DOI 10.1016/j.sbi.2015.07.004; Fitzpatrick PF, 2012, ARCH BIOCHEM BIOPHYS, V519, P194, DOI 10.1016/j.abb.2011.09.012; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Flydal MI, 2013, IUBMB LIFE, V65, P341, DOI 10.1002/iub.1150; GIBBS BS, 1991, BIOCHEMISTRY-US, V30, P6795, DOI 10.1021/bi00241a024; Gjetting T, 2001, AM J HUM GENET, V68, P1353, DOI 10.1086/320604; Jennings IG, 2001, FEBS LETT, V488, P196, DOI 10.1016/S0014-5793(00)02426-1; Khan CA, 2018, BIOCHEMISTRY-US, V57, P6274, DOI 10.1021/acs.biochem.8b00919; Knappskog PM, 1997, FEBS LETT, V409, P7, DOI 10.1016/S0014-5793(97)00465-1; KNAPPSKOG PM, 1995, BIOCHEMISTRY-US, V34, P11790, DOI 10.1021/bi00037a017; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Li J, 2011, ARCH BIOCHEM BIOPHYS, V505, P250, DOI 10.1016/j.abb.2010.10.009; McCulloch RI, 1999, ARCH BIOCHEM BIOPHYS, V367, P143, DOI 10.1006/abbi.1999.1259; Meisburger SP, 2016, J AM CHEM SOC, V138, P6506, DOI 10.1021/jacs.6b01563; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Parker MJ, 2018, P NATL ACAD SCI USA, V115, pE4594, DOI 10.1073/pnas.1800356115; PARNIAK MA, 1981, J BIOL CHEM, V256, P6876; Patel D, 2016, SCI REP-UK, V6, DOI 10.1038/srep23748; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PHILLIPS RS, 1984, J BIOL CHEM, V259, P2474; Roberts KM, 2014, BIOCHEMISTRY-US, V53, P7846, DOI 10.1021/bi501183x; SHIMAN R, 1990, J BIOL CHEM, V265, P11633; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Thorolfsson M, 2003, BIOCHEMISTRY-US, V42, P3419, DOI 10.1021/bi034021s; Tyree TJ, 2018, ACTA CRYSTALLOGR D, V74, P471, DOI 10.1107/S2059798318003078; Williams Robin A, 2008, Clin Biochem Rev, V29, P31; Zhang SN, 2016, J BIOL CHEM, V291, P7418, DOI 10.1074/jbc.M115.709998; Zhang SN, 2014, BIOCHEMISTRY-US, V53, P6625, DOI 10.1021/bi501109s	42	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4359	4367		10.1074/jbc.RA118.006477	http://dx.doi.org/10.1074/jbc.RA118.006477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30674554	hybrid, Green Published			2022-12-28	WOS:000462969500007
J	Khan, Z; Cao, DY; Giani, JF; Bernstein, EA; Veiras, LC; Fuchs, S; Wang, YZ; Peng, ZZ; Kalkum, M; Liu, GY; Bernstein, KE				Khan, Zakir; Cao, Duo-Yao; Giani, Jorge F.; Bernstein, Ellen A.; Veiras, Luciana C.; Fuchs, Sebastien; Wang, Yizhou; Peng, Zhenzi; Kalkum, Markus; Liu, George Y.; Bernstein, Kenneth E.			Overexpression of the C-domain of angiotensin-converting enzyme reduces melanoma growth by stimulating M1 macrophage polarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						melanoma; macrophage; NF-kappa B (NF-KB); tumor necrosis factor (TNF); cellular immune response; ACE; Macrophage polarization; STAT	NECROSIS-FACTOR-ALPHA; TERMINAL CATALYTIC DOMAIN; EXPRESSION; ACE; INFLAMMATION; PROGRESSION; RESISTANT; ROLES	Angiotensin-converting enzyme (ACE) can hydrolyze many peptides and plays a central role in controlling blood pressure. Moreover, ACE overexpression in monocytes and macrophages increases resistance of mice to tumor growth. ACE is composed of two independent catalytic domains. Here, to investigate the specific role of each domain in tumor resistance, we overexpressed either WT ACE (Tg-ACE mice) or ACE lacking N- or C-domain catalytic activity (Tg-NKO and Tg-CKO mice) in the myeloid cells of mice. Tg-ACE and Tg-NKO mice exhibited strongly suppressed growth of B16-F10 melanoma because of increased ACE expression in macrophages, whereas Tg-CKO mice resisted melanoma no better than WT animals. The effect of ACE overexpression reverted to that of the WT enzyme with an ACE inhibitor but not with an angiotensin II type 1 (AT1) receptor antagonist. ACE C-domain overexpression in macrophages drove them toward a pronounced M1 phenotype upon tumor stimulation, with increased activation of NF-B and signal transducer and activator of transcription 1 (STAT1) and decreased STAT3 and STAT6 activation. Tumor necrosis factor (TNF) is important for M1 activation, and TNF blockade reverted Tg-NKO macrophages to a WT phenotype. Increased ACE C-domain expression increased the levels of reactive oxygen species (ROS) and of the transcription factor C/EBP in macrophages, important stimuli for TNF expression, and decreased expression of several M2 markers, including interleukin-4R. Natural ACE C-domain-specific substrates are not well-described, and we propose that the peptide(s) responsible for the striking ACE-mediated enhancement of myeloid function are substrates/products of the ACE C-domain.	[Khan, Zakir; Cao, Duo-Yao; Giani, Jorge F.; Bernstein, Ellen A.; Veiras, Luciana C.; Wang, Yizhou; Peng, Zhenzi; Liu, George Y.; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Biomed Sci, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA; [Khan, Zakir; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Pathol, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA; [Wang, Yizhou] Cedars Sinai Med Ctr, Dept Genom Core, Los Angeles, CA 90048 USA; [Liu, George Y.] Cedars Sinai Med Ctr, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Liu, George Y.] Cedars Sinai Med Ctr, Div Immunol Res, Los Angeles, CA 90048 USA; [Fuchs, Sebastien] Western Univ Hlth Sci, Dept Basic Med Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA; [Kalkum, Markus] City Hope Natl Med Ctr, Dept Mol Imaging & Therapy, Beckman Res Inst, Duarte, CA 91010 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Western University of Health Sciences; City of Hope; Beckman Research Institute of City of Hope	Bernstein, KE (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA.; Bernstein, KE (corresponding author), Cedars Sinai Med Ctr, Dept Pathol, Davis Res Bldg,Rm 2021,110 N George Burns Rd, Los Angeles, CA 90048 USA.	Kenneth.Bernstein@cshs.org	wang, yizhou/CAJ-3518-2022	wang, yizhou/0000-0002-9378-745X; Kalkum, Markus/0000-0002-9506-671X; Cao, DuoYao/0000-0002-0455-4655; Veiras, Luciana/0000-0002-4635-7772	National Institutes of Health [P01HL129941, AI143599, R21AI114965, R01HL142672, P30DK063491]; American Heart Association [17GRNT33661206, 16SDG30130015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL129941, R01HL142672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI134714, R21AI114965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P01HL129941 (to K. E. B.), AI143599 (to K. E. B.), R21AI114965 (to K. E. B.), R01HL142672 (to J. F. G.), and P30DK063491 (to J. F. G.) and American Heart Association Grants 17GRNT33661206 (to K. E. B.) and 16SDG30130015 (to J. F. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bernstein KE, 2018, NAT REV NEPHROL, V14, P325, DOI 10.1038/nrneph.2018.15; Bernstein KE, 2014, BIOL CHEM, V395, P1173, DOI 10.1515/hsz-2013-0295; Bernstein KE, 2014, J CLIN INVEST, V124, P1000, DOI 10.1172/JCI66541; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Diet F, 1996, CIRCULATION, V94, P2756, DOI 10.1161/01.CIR.94.11.2756; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; Fuchs S, 2004, CURR HYPERTENS REP, V6, P124, DOI 10.1007/s11906-004-0087-4; Fuchs S, 2004, J BIOL CHEM, V279, P15946, DOI 10.1074/jbc.M400149200; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Hiyama A, 2016, J ORTHOP RES, V34, P865, DOI 10.1002/jor.23085; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Khan Z, 2017, BLOOD, V130, P328, DOI 10.1182/blood-2016-11-752006; Kim S, 2000, PHARMACOL REV, V52, P11; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Lin CT, 2011, FASEB J, V25, P1145, DOI 10.1096/fj.10-169433; Ma L, 2014, J BIOL CHEM, V289, P12457, DOI 10.1074/jbc.M113.521708; Ohishi M, 1997, J HYPERTENS, V15, P1295, DOI 10.1097/00004872-199715110-00014; OKABE T, 1985, J CLIN INVEST, V75, P911, DOI 10.1172/JCI111791; Okwan-Duodu D, 2010, J BIOL CHEM, V285, P39051, DOI 10.1074/jbc.M110.163782; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Romer F K, 1984, Acta Med Scand Suppl, V690, P3; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Savov JD, 2002, AM J PHYSIOL-LUNG C, V283, pL952, DOI 10.1152/ajplung.00420.2001; Schleicher U, 2016, CELL REP, V15, P1062, DOI 10.1016/j.celrep.2016.04.001; Shah KH, 2015, CIRC RES, V117, P858, DOI 10.1161/CIRCRESAHA.115.306539; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Shen XZ, 2014, LAB INVEST, V94, P536, DOI 10.1038/labinvest.2014.41; Shen XZ, 2011, NAT IMMUNOL, V12, P1078, DOI 10.1038/ni.2107; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Zhao TT, 2017, LAB INVEST, V97, P764, DOI 10.1038/labinvest.2017.32	37	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4368	4380		10.1074/jbc.RA118.006275	http://dx.doi.org/10.1074/jbc.RA118.006275			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30670595	Green Published, hybrid			2022-12-28	WOS:000462969500008
J	Broer, A; Gauthier-Coles, G; Rahimi, F; van Geldermalsen, M; Dorsch, D; Wegener, A; Holst, J; Broer, S				Broer, Angelika; Gauthier-Coles, Gregory; Rahimi, Farid; van Geldermalsen, Michelle; Dorsch, Dieter; Wegener, Ansgar; Holst, Jeff; Broer, Stefan			Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid transport; stress response; glutamine; homeostasis; signal transduction; amino acid harmonizer; ASCT1; GCN2; SNAT1; SNAT2; cancer; starvation response	GLUTAMINE UPTAKE; TUMOR-GROWTH; ASCT2/SLC1A5; INHIBITION; PATHWAY; PROTEIN; LAT1	The neutral amino acid transporter solute carrier family 1 member 5 (SLC1A5 or ASCT2) is overexpressed in many cancers. To identify its roles in tumors, we employed 143B osteosarcoma cells and HCC1806 triple-negative breast cancer cells with or without ASCT2 deletion. ASCT2ko 143B cells grew well in standard culture media, but ASCT2 was required for optimal growth at <0.5 mm glutamine, with tumor spheroid growth and monolayer migration of 143B ASCT2ko cells being strongly impaired at lower glutamine concentrations. However, the ASCT2 deletion did not affect matrix-dependent invasion. ASCT2ko 143B xenografts in nude mice exhibited a slower onset of growth and a higher number of small tumors than ASCT2wt 143B xenografts, but did not differ in average tumor size 25 days after xenotransplantation. ASCT2 deficiency was compensated by increased levels of sodium neutral amino acid transporter 1 (SNAT1 or SLC38A1) and SNAT2 (SLC38A2) in ASCT2ko 143B cells, mediated by a GCN2 EIF2 kinase (GCN2)-dependent pathway, but this compensation was not observed in ASCT2ko HCC1806 cells. Combined SNAT1 silencing and GCN2 inhibition significantly inhibited growth of ASCT2ko HCC1806 cells, but not of ASCT2ko 143B cells. Similarly, pharmacological inhibition of l-type amino acid transporter 1 (LAT1) and GCN2 significantly inhibited growth of ASCT2ko HCC1806 cells, but not of ASCT2ko 143B cells. We conclude that cancer cells with reduced transporter plasticity are more vulnerable to disruption of amino acid homeostasis than cells with a full capacity to up-regulate redundant transporters by an integrated stress response.	[Broer, Angelika; Gauthier-Coles, Gregory; Rahimi, Farid; Broer, Stefan] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [van Geldermalsen, Michelle] Univ Sydney, Centenary Inst, Origins Canc Program, Sydney, NSW, Australia; [van Geldermalsen, Michelle] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Dorsch, Dieter; Wegener, Ansgar] Merck KGaA, D-64293 Darmstadt, Germany; [Holst, Jeff] Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Holst, Jeff] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia	Australian National University; University of Sydney; Centenary Institute; University of Sydney; Merck KGaA; University of New South Wales Sydney; University of New South Wales Sydney	Broer, S (corresponding author), Australian Natl Univ, Coll Sci, Res Sch Biol, Bldg 134, Canberra, ACT 2601, Australia.	stefan.broeer@anu.edu.au	Holst, Jeff/H-7634-2012; Rahimi, Farid/E-6522-2018; Broer, Stefan/A-1286-2008	Holst, Jeff/0000-0002-0377-9318; Rahimi, Farid/0000-0002-0920-8188; Broer, Stefan/0000-0002-8040-1634; Gauthier-Coles, Gregory/0000-0002-4725-5313	Merck KGaA speed grant; Australian Research Council [DP180101702]; Cancer Council New South Wales [RG17-04, RG18-06]	Merck KGaA speed grant; Australian Research Council(Australian Research Council); Cancer Council New South Wales(Cancer Council New South Wales)	This work was supported in part by a Merck KGaA speed grant (to S. B.), Australian Research Council Discovery Project Grant DP180101702 (to S. B.), and Cancer Council New South Wales Grants RG17-04 and RG18-06 (to J. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bhutia YD, 2015, CANCER RES, V75, P1782, DOI 10.1158/0008-5472.CAN-14-3745; Bothwell PJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072093; Broer A, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00785; Broer A, 2016, J BIOL CHEM, V291, P13194, DOI 10.1074/jbc.M115.700534; Broer S, 2017, BIOCHEM J, V474, P1935, DOI 10.1042/BCJ20160822; Bror S, 2014, PFLUG ARCH EUR J PHY, V466, P155, DOI 10.1007/s00424-013-1393-y; Chen EY, 2014, P NATL ACAD SCI USA, V111, P5349, DOI 10.1073/pnas.1317731111; Chiu M, 2017, AMINO ACIDS, V49, P1365, DOI 10.1007/s00726-017-2436-z; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cormerais Y, 2018, J BIOL CHEM, V293, P2877, DOI 10.1074/jbc.RA117.001342; Deitmer JW, 2003, J NEUROCHEM, V87, P127, DOI 10.1046/j.1471-4159.2003.01981.x; Dorsch D., 2014, Patent No. [WO/2014/135244, 2014135244]; Dorsch D., 2016, AM CHEM SOC M PHIL A; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Fuchs BC, 2004, AM J PHYSIOL-GASTR L, V286, pG467, DOI 10.1152/ajpgi.00344.2003; Hassanein M, 2015, INT J CANCER, V137, P1587, DOI 10.1002/ijc.29535; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Hosios AM, 2016, DEV CELL, V36, P540, DOI 10.1016/j.devcel.2016.02.012; KALLINOWSKI F, 1987, J CANCER RES CLIN, V113, P209, DOI 10.1007/BF00396375; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Lu HQ, 2016, CANCER LETT, V381, P23, DOI 10.1016/j.canlet.2016.07.020; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Nakamura A, 2018, P NATL ACAD SCI USA, V115, pE7776, DOI 10.1073/pnas.1805523115; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Ren P, 2015, J PATHOL, V235, P90, DOI 10.1002/path.4429; Scalise M, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00243; Schulte ML, 2018, NAT MED, V24, P194, DOI 10.1038/nm.4464; Schulte ML, 2016, BIOORG MED CHEM LETT, V26, P1044, DOI 10.1016/j.bmcl.2015.12.031; Suzuki M, 2017, BIOCHEM BIOPH RES CO, V482, P651, DOI 10.1016/j.bbrc.2016.11.089; van Geldermalsen M, 2016, ONCOGENE, V35, P3201, DOI 10.1038/onc.2015.381; van Geldermalsen M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4599-8; Wang Q, 2015, AM J CANCER RES, V5, P1281; Wang Q, 2015, J PATHOL, V236, P278, DOI 10.1002/path.4518	36	35	37	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4012	4026		10.1074/jbc.RA118.006378	http://dx.doi.org/10.1074/jbc.RA118.006378			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30635397	Green Published, hybrid			2022-12-28	WOS:000461854400017
J	Zurawski, Z; Yim, YY; Alford, S; Hamm, HE				Zurawski, Zack; Yim, Yun Young; Alford, Simon; Hamm, Heidi E.			The expanding roles and mechanisms of G protein-mediated presynaptic inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						G protein; G protein-coupled receptor (GPCR); neuroscience; pharmacology; SNARE proteins	BETA-GAMMA-SUBUNITS; ADENYLATE-CYCLASE ACTIVITY; GTP-BINDING PROTEINS; NUCLEOTIDE REGULATORY PROTEIN; GABA-B RECEPTORS; ADRENERGIC-RECEPTOR; GUANINE-NUCLEOTIDES; SYNAPTIC-TRANSMISSION; AMINOBUTYRIC-ACID; CALCIUM CURRENTS	Throughout the past five decades, tremendous advancements have been made in our understanding of G protein signaling and presynaptic inhibition, many of which were published in the Journal of Biological Chemistry under the tenure of Herb Tabor as Editor-in-Chief. Here, we identify these critical advances, including the formulation of the ternary complex model of G protein-coupled receptor signaling and the discovery of G beta gamma as a critical signaling component of the heterotrimeric G protein, along with the nature of presynaptic inhibition and its physiological role. We provide an overview for the discovery and physiological relevance of the two known G beta gamma-mediated mechanisms for presynaptic inhibition: first, the action of G beta gamma on voltage-gated calcium channels to inhibit calcium influx to the presynaptic active zone and, second, the direct binding of G beta gamma to the SNARE complex to displace synaptotagmin downstream of calcium entry, which has been demonstrated to be important in neurons and secretory cells. These two mechanisms act in tandem with each other in a synergistic manner to provide more complete spatiotemporal control over neurotransmitter release.	[Zurawski, Zack; Yim, Yun Young; Hamm, Heidi E.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg,23rd Ave South Pierce, Nashville, TN 37232 USA; [Zurawski, Zack; Alford, Simon] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Vanderbilt University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hamm, HE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg,23rd Ave South Pierce, Nashville, TN 37232 USA.	heidi.hamm@vanderbilt.edu		Alford, Simon/0000-0002-0454-4246; /0000-0002-0061-6820	NIDDK NIH HHS [R01 DK109204] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109204] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albert PR, 2002, CELL SIGNAL, V14, P407, DOI 10.1016/S0898-6568(01)00259-5; ALFORD S, 1991, EUR J NEUROSCI, V3, P107, DOI 10.1111/j.1460-9568.1991.tb00071.x; ALFORD S, 1991, J NEUROSCI, V11, P3718; ANDERSEN P, 1962, NATURE, V194, P740, DOI 10.1038/194740a0; ANDRADE R, 1986, SCIENCE, V234, P1261, DOI 10.1126/science.2430334; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; BARBER RP, 1978, BRAIN RES, V141, P35, DOI 10.1016/0006-8993(78)90615-7; Bark C, 2004, J NEUROSCI, V24, P8796, DOI 10.1523/JNEUROSCI.1940-04.2004; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BARK IC, 1993, J MOL BIOL, V233, P67, DOI 10.1006/jmbi.1993.1485; BARK IC, 1995, P NATL ACAD SCI USA, V92, P1510, DOI 10.1073/pnas.92.5.1510; Barron DH, 1938, J PHYSIOL-LONDON, V92, P276, DOI 10.1113/jphysiol.1938.sp003603; BAZEMORE A, 1956, NATURE, V178, P1052, DOI 10.1038/1781052a0; Belardetti F, 2008, CURR OPIN INVEST DR, V9, P707; BERRIE CP, 1979, BIOCHEM BIOPH RES CO, V87, P1000, DOI 10.1016/S0006-291X(79)80006-6; Betke KM, 2012, PROG NEUROBIOL, V96, P304, DOI 10.1016/j.pneurobio.2012.01.009; Betty M, 1998, NEUROSCIENCE, V85, P475, DOI 10.1016/S0306-4522(97)00623-4; BINZ T, 1994, J BIOL CHEM, V269, P1617; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; BOURNE HR, 1986, NATURE, V321, P814, DOI 10.1038/321814a0; BOWERY NG, 1979, BRIT J PHARMACOL, V66, pP108; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; BOYER JL, 1992, J BIOL CHEM, V267, P25451; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P4357, DOI 10.1021/bi00288a002; CERIONE RA, 1984, BIOCHEMISTRY-US, V23, P4519, DOI 10.1021/bi00315a003; CERIONE RA, 1984, J BIOL CHEM, V259, P9979; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chen SR, 2005, J PHARMACOL EXP THER, V312, P120, DOI 10.1124/jpet.104.073817; CODINA J, 1987, SCIENCE, V236, P442, DOI 10.1126/science.2436299; CONRADI S, 1983, BRAIN RES, V265, P31, DOI 10.1016/0006-8993(83)91330-6; DADO RJ, 1993, NEUROREPORT, V5, P341, DOI 10.1097/00001756-199312000-00041; Daraio T, 2018, NEUROSCI LETT, V674, P75, DOI 10.1016/j.neulet.2018.03.024; Degtiar VE, 1996, FEBS LETT, V380, P137, DOI 10.1016/0014-5793(96)00047-6; Delaney AJ, 2007, NEURON, V56, P880, DOI 10.1016/j.neuron.2007.10.022; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Depuy SD, 2006, P NATL ACAD SCI USA, V103, P14590, DOI 10.1073/pnas.0603945103; Dingus J, 2005, BIOCHEMISTRY-US, V44, P11882, DOI 10.1021/bi0504254; DOLPHIN AC, 1986, BRIT J PHARMACOL, V88, P213, DOI 10.1111/j.1476-5381.1986.tb09489.x; DUBOCOVICH ML, 1974, J PHYSIOL-LONDON, V237, P505, DOI 10.1113/jphysiol.1974.sp010495; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; DUNLAP K, 1984, NEUROSCI LETT, V47, P265, DOI 10.1016/0304-3940(84)90524-X; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; ECCLES JC, 1962, J PHYSIOL-LONDON, V160, P62, DOI 10.1113/jphysiol.1962.sp006835; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; ENERO MA, 1972, BRIT J PHARMACOL, V44, P672, DOI 10.1111/j.1476-5381.1972.tb07306.x; FLOREY E, 1961, COMP BIOCHEM PHYSIOL, V3, P92, DOI 10.1016/0010-406X(61)90135-9; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; FRANK K, 1957, FED PROC, V16, P39; Gasser HS, 1933, AM J PHYSIOL, V103, P303, DOI 10.1152/ajplegacy.1933.103.2.303; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Glitsch M, 2006, J NEUROPHYSIOL, V96, P86, DOI 10.1152/jn.01282.2005; Hamid E, 2014, J NEUROSCI, V34, P260, DOI 10.1523/JNEUROSCI.3633-12.2014; HEGSTRAND LR, 1979, J PHARMACOL EXP THER, V210, P215; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hildebrandt JD, 1997, BIOCHEM PHARMACOL, V54, P325, DOI 10.1016/S0006-2952(97)00269-4; Hohmann AG, 1999, BRAIN RES, V822, P17, DOI 10.1016/S0006-8993(98)01321-3; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; Huang CC, 2001, J PHYSIOL-LONDON, V532, P731, DOI 10.1111/j.1469-7793.2001.0731e.x; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Iremonger KJ, 2009, J NEUROSCI, V29, P7349, DOI 10.1523/JNEUROSCI.0381-09.2009; JOHNSTON GA, 1972, NATURE-NEW BIOL, V240, P219, DOI 10.1038/newbio240219a0; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; KIRSCH GE, 1988, AM J PHYSIOL, V254, pH1200, DOI 10.1152/ajpheart.1988.254.6.H1200; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; Kobayashi S, 1999, PFLUG ARCH EUR J PHY, V438, P750, DOI 10.1007/s004240051102; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KRAVITZ EA, 1963, J NEUROPHYSIOL, V26, P739, DOI 10.1152/jn.1963.26.5.739; KUFFLER SW, 1958, J NEUROPHYSIOL, V21, P589, DOI 10.1152/jn.1958.21.6.589; KURACHI Y, 1989, PFLUG ARCH EUR J PHY, V413, P325, DOI 10.1007/BF00583550; LEFKOWITZ RJ, 1976, J BIOL CHEM, V251, P4686; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; Lim WK, 2001, BIOCHEMISTRY-US, V40, P10532, DOI 10.1021/bi010950c; LIMBIRD LE, 1980, P NATL ACAD SCI-BIOL, V77, P775, DOI 10.1073/pnas.77.2.775; Lindorfer MA, 1998, J BIOL CHEM, V273, P34429, DOI 10.1074/jbc.273.51.34429; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LUCAS M, 1977, MOL PHARMACOL, V13, P314; MAEKAWA K, 1994, NEUROSCI LETT, V168, P97, DOI 10.1016/0304-3940(94)90425-1; MAGUIRE ME, 1976, MOL PHARMACOL, V12, P335; MAXWELL DJ, 1983, BRAIN RES, V288, P297, DOI 10.1016/0006-8993(83)90106-3; MAY DC, 1985, J BIOL CHEM, V260, P5829; McCool BA, 2001, BRIT J PHARMACOL, V132, P879, DOI 10.1038/sj.bjp.0703884; Mizutani H, 2006, EUR J NEUROSCI, V24, P1946, DOI 10.1111/j.1460-9568.2006.05063.x; Noguchi J, 2000, J PHYSIOL-LONDON, V526, P313, DOI 10.1111/j.1469-7793.2000.00313.x; NORTHUP JK, 1980, P NATL ACAD SCI-BIOL, V77, P6516, DOI 10.1073/pnas.77.11.6516; Okae H, 2010, DEV DYNAM, V239, P1089, DOI 10.1002/dvdy.22256; Pan YZ, 2002, J NEUROPHYSIOL, V87, P1938, DOI 10.1152/jn.00575.2001; Petrovski S, 2016, AM J HUM GENET, V98, P1001, DOI 10.1016/j.ajhg.2016.03.011; Photowala H, 2006, P NATL ACAD SCI USA, V103, P4281, DOI 10.1073/pnas.0600509103; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Prescott GR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-35; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; RODBELL M, 1971, J BIOL CHEM, V246, P1872; ROSS EM, 1977, P NATL ACAD SCI USA, V74, P3715, DOI 10.1073/pnas.74.9.3715; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schwindinger WF, 2004, MOL CELL BIOL, V24, P7758, DOI 10.1128/MCB.24.17.7758-7768.2004; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Schwindinger WF, 2012, J BIOL CHEM, V287, P7121, DOI 10.1074/jbc.M111.308395; Schwindinger WF, 2010, J BIOL CHEM, V285, P29787, DOI 10.1074/jbc.M110.142620; SCOTT RH, 1986, NEUROSCI LETT, V69, P59, DOI 10.1016/0304-3940(86)90414-3; SCOTT RH, 1987, NATURE, V330, P760, DOI 10.1038/330760a0; SHORR RGL, 1982, P NATL ACAD SCI-BIOL, V79, P2778, DOI 10.1073/pnas.79.9.2778; SHORR RGL, 1982, J BIOL CHEM, V257, P2341; SHORR RGL, 1981, J BIOL CHEM, V256, P5820; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SILINSKY EM, 1992, J PHYSIOL-LONDON, V457, P315, DOI 10.1113/jphysiol.1992.sp019380; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; STADEL JM, 1980, J BIOL CHEM, V255, P1436; STARKE K, 1972, N-S ARCH PHARMACOL, V275, P11, DOI 10.1007/BF00505064; STARKE K, 1971, NATURWISSENSCHAFTEN, V58, P420, DOI 10.1007/BF00591535; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STERNWEIS PC, 1981, J BIOL CHEM, V256, P1517; Takahashi M, 2001, J PHYSIOL-LONDON, V532, P323, DOI 10.1111/j.1469-7793.2001.0323f.x; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TSAI BS, 1979, MOL PHARMACOL, V16, P61; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Van Hook MJ, 2017, J NEUROSCI, V37, P4618, DOI 10.1523/JNEUROSCI.2948-16.2017; Vanderbeld B, 2000, BIOCHEM CELL BIOL, V78, P537, DOI 10.1139/o00-075; Wells CA, 2012, MOL PHARMACOL, V82, P1136, DOI 10.1124/mol.112.080507; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; WU LG, 1995, J PHYSIOL-LONDON, V485, P649, DOI 10.1113/jphysiol.1995.sp020759; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; Yim YY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37222-1; Yim YY, 2017, BIOCHEMISTRY-US, V56, P5405, DOI 10.1021/acs.biochem.7b00433; Yoon EJ, 2008, J NEUROPHYSIOL, V100, P2929, DOI 10.1152/jn.90839.2008; Yoon EJ, 2007, MOL PHARMACOL, V72, P1210, DOI 10.1124/mol.107.039446; Yost EA, 2007, MOL PHARMACOL, V72, P812, DOI 10.1124/mol.107.038075; ZAHNISER NR, 1978, NATURE, V275, P453, DOI 10.1038/275453a0; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x; Zhang SY, 1996, J BIOL CHEM, V271, P33575, DOI 10.1074/jbc.271.52.33575; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020500; Zhao Y, 2010, J PHYSIOL-LONDON, V588, P3485, DOI 10.1113/jphysiol.2010.190090; Zurawski Z, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aat8595; Zurawski Z, 2017, J BIOL CHEM, V292, P12165, DOI 10.1074/jbc.M116.773523; Zurawski Z, 2016, MOL PHARMACOL, V89, P75, DOI 10.1124/mol.115.101600	142	11	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1661	1670		10.1074/jbc.TM118.004163	http://dx.doi.org/10.1074/jbc.TM118.004163			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710014	Green Published, hybrid			2022-12-28	WOS:000457879200025
J	Zhao, LY; Pascual, F; Bacudio, L; Suchanek, AL; Young, PA; Li, LO; Martin, SA; Camporez, JP; Perry, RJ; Shulman, GI; Klett, EL; Coleman, RA				Zhao, Liyang; Pascual, Florencia; Bacudio, Lawrence; Suchanek, Amanda L.; Young, Pamela A.; Li, Lei O.; Martin, Sarah A.; Camporez, Joao-Paulo; Perry, Rachel J.; Shulman, Gerald I.; Klett, Eric L.; Coleman, Rosalind A.			Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid oxidation; protein synthesis; skeletal muscle; amino acid; muscle regeneration; acyl-CoA synthetase isoform-1 (ACSL1); gastrocnemius; myopathy; soleus	SKELETAL-MUSCLE; FIBER-TYPE; PROTEIN-SYNTHESIS; LIPID-METABOLISM; MDX MICE; EXERCISE; CARNITINE; MYOPATHY; INSULIN; ACCUMULATION	Loss of long-chain acyl-CoA synthetase isoform-1 (ACSL1) in mouse skeletal muscle (Acsl1(M-/-)) severely reduces acyl-CoA synthetase activity and fatty acid oxidation. However, the effects of decreased fatty acid oxidation on skeletal muscle function, histology, use of alternative fuels, and mitochondrial function and morphology are unclear. We observed that Acsl1(M-/-) mice have impaired voluntary running capacity and muscle grip strength and that their gastrocnemius muscle contains myocytes with central nuclei, indicating muscle regeneration. We also found that plasma creatine kinase and aspartate aminotransferase levels in Acsl1(M-/-) mice are 3.4- and 1.5-fold greater, respectively, than in control mice (Acsl1(flox/flox)), indicating muscle damage, even without exercise, in the Acsl1(M-/-) mice. Moreover, caspase-3 protein expression exclusively in Acsl1(M-/-) skeletal muscle and the presence of cleaved caspase-3 suggested myocyte apoptosis. Mitochondria in Acsl1(M-/-) skeletal muscle were swollen with abnormal cristae, and mitochondrial biogenesis was increased. Glucose uptake did not increase in Acsl1(M-/-) skeletal muscle, and pyruvate oxidation was similar in gastrocnemius homogenates from Acsl1(M-/-) and control mice. The rate of protein synthesis in Acsl1(M-/-) glycolytic muscle was 2.1-fold greater 30 min after exercise than in the controls, suggesting resynthesis of proteins catabolized for fuel during the exercise. At this time, mTOR complex 1 was activated, and autophagy was blocked. These results suggest that fatty acid oxidation is critical for normal skeletal muscle homeostasis during both rest and exercise. We conclude that ACSL1 deficiency produces an overall defect in muscle fuel metabolism that increases protein catabolism, resulting in exercise intolerance, muscle weakness, and myocyte apoptosis.	[Zhao, Liyang; Pascual, Florencia; Bacudio, Lawrence; Suchanek, Amanda L.; Young, Pamela A.; Li, Lei O.; Coleman, Rosalind A.] Univ N Carolina, Dept Nutr, 2301 Michael Hooker Res Ctr,Dauer Dr, Chapel Hill, NC 27599 USA; [Klett, Eric L.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Martin, Sarah A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet & Internal Med, Dallas, TX 75390 USA; [Camporez, Joao-Paulo; Perry, Rachel J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Perry, Rachel J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University	Coleman, RA (corresponding author), Univ N Carolina, Dept Nutr, 2301 Michael Hooker Res Ctr,Dauer Dr, Chapel Hill, NC 27599 USA.	rcoleman@unc.edu	Shulman, Gerald I./P-7176-2019; , Histology Research Core Facility/ABF-6317-2021; Suchanek, Amanda/HCI-3855-2022	Shulman, Gerald I./0000-0003-1529-5668; Zhao, Liyang/0000-0003-1960-0199; Camporez, Joao Paulo/0000-0003-3486-4301; Perry, Rachel/0000-0003-0748-8064	National Institutes of Health [DK59935, DK56598, DK107481, CA-215315, DK116774, DK045735]; NATIONAL CANCER INSTITUTE [K99CA215315, R00CA215315] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107481, R56DK056598, R01DK056598, P30DK056350, R01DK116774, P30DK045735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK59935 and DK56598 (to R. A. C.), DK107481 (to E. L. K.), CA-215315 (to R. J. P.), and DK116774 and DK045735 (to G. I. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Argiles JM, 2016, J AM MED DIR ASSOC, V17, P789, DOI 10.1016/j.jamda.2016.04.019; Atherton PJ, 2012, J PHYSIOL-LONDON, V590, P1049, DOI 10.1113/jphysiol.2011.225003; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosma M, 2016, EXP CELL RES, V340, P180, DOI 10.1016/j.yexcr.2015.10.023; Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Corti S, 2008, J NEUROL SCI, V266, P97, DOI 10.1016/j.jns.2007.09.015; DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frezza Christian, 2007, Methods Mol Biol, V372, P405, DOI 10.1007/978-1-59745-365-3_29; Fukao T, 2001, PEDIATR RES, V49, P227, DOI 10.1203/00006450-200102000-00016; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Grevengoed TJ, 2015, FASEB J, V29, P4641, DOI 10.1096/fj.15-272732; Grevengoed TJ, 2015, J LIPID RES, V56, P1572, DOI 10.1194/jlr.M059717; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Harber MP, 2010, AM J PHYSIOL-REG I, V299, pR1254, DOI 10.1152/ajpregu.00348.2010; Hargreaves M, 2000, CLIN EXP PHARMACOL P, V27, P225, DOI 10.1046/j.1440-1681.2000.03225.x; Hauerslev S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066929; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Heden TD, 2016, TRENDS ENDOCRIN MET, V27, P553, DOI 10.1016/j.tem.2016.05.007; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x; Kelly SA, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43086; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Komiya Y, 2017, J MUSCLE RES CELL M, V38, P163, DOI 10.1007/s10974-017-9468-6; Li LO, 2015, DIABETES, V64, P23, DOI 10.2337/db13-1070; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; MACLEAN DA, 1994, AM J PHYSIOL-ENDOC M, V267, pE1010, DOI 10.1152/ajpendo.1994.267.6.E1010; MACLENNAN PA, 1990, BIOCHEM J, V268, P795, DOI 10.1042/bj2680795; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; Padanad MS, 2016, CELL REP, V16, P1614, DOI 10.1016/j.celrep.2016.07.009; Pascual F, 2016, BBA-MOL CELL BIOL L, V1861, P1425, DOI 10.1016/j.bbalip.2016.03.014; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Radley-Crabb HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089277; Rennie MJ, 2000, ANNU REV NUTR, V20, P457, DOI 10.1146/annurev.nutr.20.1.457; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Rocchi A, 2016, ACTA NEUROPATHOL, V132, P127, DOI 10.1007/s00401-016-1550-4; Ruest LB, 2002, J CELL BIOCHEM, V86, P21, DOI 10.1002/jcb.10211; Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302; Schatz UA, 2010, J INHERIT METAB DIS, V33, P513, DOI 10.1007/s10545-010-9115-5; Schuler A Michele, 2002, ILAR J, V43, P57; Shadrach JL, 2011, PHILOS T R SOC B, V366, P2297, DOI 10.1098/rstb.2011.0027; Shimomura Y, 2004, J NUTR, V134, p1583S, DOI 10.1093/jn/134.6.1583S; Shimomura Y, 2006, J NUTR, V136, p529S, DOI 10.1093/jn/136.2.529S; SMITH OLK, 1982, AM J PHYSIOL, V242, pR109, DOI 10.1152/ajpregu.1982.242.1.R109; Spiekerkoetter U, 2004, EUR J CLIN INVEST, V34, P191, DOI 10.1111/j.1365-2362.2004.01308.x; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092; Tucci S, 2018, FEBS LETT, V592, P219, DOI 10.1002/1873-3468.12940; Tucci S, 2013, BBA-MOL BASIS DIS, V1832, P509, DOI 10.1016/j.bbadis.2013.01.006; Vergeade A, 2016, MITOCHONDRION, V28, P88, DOI 10.1016/j.mito.2016.04.002; Vissing J, 2016, REV NEUROL-FRANCE, V172, P559, DOI 10.1016/j.neurol.2016.08.005; Wagenmakers AJM, 1998, EXERCISE SPORT SCI R, V26, P287; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1315, DOI 10.1152/ajpendo.00561.2011; Weber-Carstens S, 2013, AM J RESP CRIT CARE, V187, P387, DOI 10.1164/rccm.201209-1649OC; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wicks SE, 2015, P NATL ACAD SCI USA, V112, pE3300, DOI 10.1073/pnas.1418560112; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200	68	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8819	8833		10.1074/jbc.RA118.006790	http://dx.doi.org/10.1074/jbc.RA118.006790			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30975900	hybrid, Green Published			2022-12-28	WOS:000470971100017
J	Wang, X; Plachetzki, DC; Cote, RH				Wang, Xin; Plachetzki, David C.; Cote, Rick H.			The N termini of the inhibitory -subunits of phosphodiesterase-6 (PDE6) from rod and cone photoreceptors differentially regulate transducin-mediated PDE6 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phototransduction; G protein; photoreceptor; vision; protein structure; inhibition mechanism; -subunit; PDE6; phosphodiesterase (PDE); retinal protein; transducin	GAMMA-SUBUNIT; CGMP-PHOSPHODIESTERASE; G-PROTEIN; ALPHA-SUBUNIT; CYCLIC-GMP; VERTEBRATE PHOTORECEPTORS; BINDING-SITES; DARK NOISE; PHOTOTRANSDUCTION; EVOLUTION	Phosphodiesterase-6 (PDE6) plays a central role in both rod and cone phototransduction pathways. In the dark, PDE6 activity is suppressed by its inhibitory -subunit (P). Rhodopsin-catalyzed activation of the G protein transducin relieves this inhibition and enhances PDE6 catalysis. We hypothesized that amino acid sequence differences between rod- and cone-specific Ps underlie transducin's ability to more effectively activate cone-specific PDE6 than rod PDE6. To test this, we analyzed rod and cone P sequences from all major vertebrate and cyclostome lineages and found that rod P loci are far more conserved than cone P sequences and that most of the sequence differences are located in the N-terminal region. Next we reconstituted rod PDE6 catalytic dimer (P) with various rod or cone P variants and analyzed PDE6 activation upon addition of the activated transducin -subunit (Gt*-GTPS). This analysis revealed a rod-specific P motif (amino acids 9-18) that reduces the ability of Gt*-GTPS to activate the reconstituted PDE6. In cone P, Asn-13 and Gln-14 significantly enhanced Gt*-GTPS activation of cone P truncation variants. Moreover, we observed that the first four amino acids of either rod or cone P contribute to Gt*-GTPS-mediated activation of PDE6. We conclude that physiological differences between rod and cone photoreceptor light responsiveness can be partially ascribed to ancient, highly conserved amino acid differences in the N-terminal regions of P isoforms, demonstrating for the first time a functional role for this region of P in the differential activation of rod and cone PDE6 by transducin.	[Wang, Xin; Plachetzki, David C.; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick/G-3363-2013	Cote, Rick/0000-0002-1573-6526	NEI, National Institutes of Health [1R01EY05798-29]; NIGMS, National Institutes of Health [P20GM113131]; National Science Foundation IOS Award [1755337]; United States Department of Agriculture-National Institute of Food and Agriculture Hatch Project [00654]; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113131] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation IOS Award(National Science Foundation (NSF)); United States Department of Agriculture-National Institute of Food and Agriculture Hatch Project; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NEI, National Institutes of Health Grant 1R01EY05798-29 and NIGMS, National Institutes of Health Grant P20GM113131 (to R. H. C.) and National Science Foundation IOS Award 1755337 and United States Department of Agriculture-National Institute of Food and Agriculture Hatch Project 00654 (to D. C. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arshavsky VY, 2013, INVEST OPHTH VIS SCI, V54, P7725, DOI 10.1167/iovs.13-13281; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; Artemyev NO, 1997, BIOCHEMISTRY-US, V36, P4188, DOI 10.1021/bi963002y; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; Asteriti S, 2015, ELIFE, V4, DOI 10.7554/eLife.07166; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; Cote RH, 2000, METHOD ENZYMOL, V315, P646; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Gopalakrishna KN, 2017, CELL SIGNAL, V37, P74, DOI 10.1016/j.cellsig.2017.06.002; Gopalakrishna KN, 2012, BIOCHEMISTRY-US, V51, P1617, DOI 10.1021/bi3000935; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Guo LW, 2010, J BIOL CHEM, V285, P15209, DOI 10.1074/jbc.M109.086116; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Ingram NT, 2016, J PHYSIOL-LONDON, V594, P5415, DOI 10.1113/JP272556; Kefalov VJ, 2012, J BIOL CHEM, V287, P1635, DOI 10.1074/jbc.R111.303008; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; Korenbrot JI, 2012, PROG RETIN EYE RES, V31, P442, DOI 10.1016/j.preteyeres.2012.05.002; Lagman D, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0695-z; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lamb TD, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180076; Lamb TD, 2016, MOL BIOL EVOL, V33, P2064, DOI 10.1093/molbev/msw095; Lamb TD, 2013, PROG RETIN EYE RES, V36, P52, DOI 10.1016/j.preteyeres.2013.06.001; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; Mao W, 2013, J BIOL CHEM, V288, P5257, DOI 10.1074/jbc.M112.430058; Mirarab S, 2015, J COMPUT BIOL, V22, P377, DOI 10.1089/cmb.2014.0156; Morshedian A, 2017, J PHYSIOL-LONDON, V595, P4947, DOI 10.1113/JP274211; Morshedian A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0074; Morshedian A, 2015, CURR BIOL, V25, P484, DOI 10.1016/j.cub.2014.12.031; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2007, BIOCHEMISTRY-US, V46, P9992, DOI 10.1021/bi700535s; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Pentia Dana C., 2005, V307, P125; Pugh EN, 2018, J GEN PHYSIOL, V150, P383, DOI 10.1085/jgp.201711970; Qureshi BM, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180075; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Rotov AY, 2017, MOL VIS, V23, P416; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; Wensel Theodore G., 2005, V307, P289; Zeng-Elmore X, 2014, J MOL BIOL, V426, P3713, DOI 10.1016/j.jmb.2014.07.033; Zhang XJ, 2012, J BIOL CHEM, V287, P26312, DOI 10.1074/jbc.M112.377333; Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406	51	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8351	8360		10.1074/jbc.RA119.007520	http://dx.doi.org/10.1074/jbc.RA119.007520			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30962282	Green Published, hybrid			2022-12-28	WOS:000471108200006
J	Tanaka, N; Nakajima, M; Narukawa-Nara, M; Matsunaga, H; Kamisuki, S; Aramasa, H; Takahashi, Y; Sugimoto, N; Abe, K; Terada, T; Miyanaga, A; Yamashita, T; Sugawara, F; Kamakura, T; Komba, S; Nakai, H; Taguchi, H				Tanaka, Nobukiyo; Nakajima, Masahiro; Narukawa-Nara, Megumi; Matsunaga, Hiroki; Kamisuki, Shinji; Aramasa, Hiroki; Takahashi, Yuta; Sugimoto, Naohisa; Abe, Koichi; Terada, Tohru; Miyanaga, Akimasa; Yamashita, Tetsuro; Sugawara, Fumio; Kamakura, Takashi; Komba, Shiro; Nakai, Hiroyuki; Taguchi, Hayao			Identification, characterization, and structural analyses of a fungal endo-beta-1,2-glucanase reveal a new glycoside hydrolase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fungi; oligosaccharide; enzyme catalysis; enzyme structure; glycoside hydrolase; -1; 2-glucan; -1; 2-gluco-oligosaccharide; endo--1; 2-glucanase; novel glycoside hydrolase family; Talaromyces funiculosus	ACTIVE-SITE; CRYSTAL-STRUCTURE; N-ACETYLGLUCOSAMINIDASES; SECONDARY-STRUCTURE; MOLECULAR-DYNAMICS; ENZYME; MECHANISM; AGROBACTERIUM; COMPLEX; POLYSACCHARIDE	endo--1,2-Glucanase (SGL) is an enzyme that hydrolyzes -1,2-glucans, which play important physiological roles in some bacteria as a cyclic form. To date, no eukaryotic SGL has been identified. We purified an SGL from Talaromyces funiculosus (TfSGL), a soil fungus, to homogeneity and then cloned the complementary DNA encoding the enzyme. TfSGL shows no significant sequence similarity to any known glycoside hydrolase (GH) families, but shows significant similarity to certain eukaryotic proteins with unknown functions. The recombinant TfSGL (TfSGLr) specifically hydrolyzed linear and cyclic -1,2-glucans to sophorose (Glc--1,2-Glc) as a main product. TfSGLr hydrolyzed reducing-end-modified -1,2-gluco-oligosaccharides to release a sophoroside with the modified moiety. These results indicate that TfSGL is an endo-type enzyme that preferably releases sophorose from the reducing end of substrates. Stereochemical analysis demonstrated that TfSGL is an inverting enzyme. The overall structure of TfSGLr includes an (/)(6) toroid fold. The substrate-binding mode was revealed by the structure of a Michaelis complex of an inactive TfSGLr mutant with a -1,2-glucoheptasaccharide. Mutational analysis and action pattern analysis of -1,2-gluco-oligosaccharide derivatives revealed an unprecedented catalytic mechanism for substrate hydrolysis. Glu-262 (general acid) indirectly protonates the anomeric oxygen at subsite -1 via the 3-hydroxy group of the Glc moiety at subsite +2, and Asp-446 (general base) activates the nucleophilic water via another water. TfSGLr is apparently different from a GH144 SGL in the reaction and substrate recognition mechanism based on structural comparison. Overall, we propose that TfSGL and closely-related enzymes can be classified into a new family, GH162.	[Tanaka, Nobukiyo; Nakajima, Masahiro; Narukawa-Nara, Megumi; Matsunaga, Hiroki; Kamisuki, Shinji; Abe, Koichi; Sugawara, Fumio; Kamakura, Takashi; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan; [Kamisuki, Shinji] Azabu Univ, Sch Vet Med, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2525201, Japan; [Aramasa, Hiroki; Takahashi, Yuta; Sugimoto, Naohisa; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Abe, Koichi; Terada, Tohru] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Miyanaga, Akimasa] Tokyo Inst Technol, Sch Sci, Dept Chem, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528551, Japan; [Yamashita, Tetsuro] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Komba, Shiro] Natl Agr & Food Res Org, Food Res Inst, Food Component Anal Unit, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan	Tokyo University of Science; Azabu University; Niigata University; University of Tokyo; Tokyo Institute of Technology; Iwate University; National Agriculture & Food Research Organization - Japan	Nakajima, M (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	m-nakajima@rs.tus.ac.jp	Terada, Tohru/W-2956-2019; komba, shiro/GPJ-9657-2022; Miyanaga, Akimasa/C-1472-2015	Terada, Tohru/0000-0002-7091-0646; komba, shiro/0000-0002-6716-7409; Miyanaga, Akimasa/0000-0003-2219-6051; Nakajima, Masahiro/0000-0002-3182-0859; Taguchi, Hayao/0000-0001-5270-581X	Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED [JP18am0101107]	Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED	This work was supported in part by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under Grant JP18am0101107. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Abe K., 2015, J APPL GLYCOSCI, V62, P47, DOI [DOI 10.5458/JAG.JAG, 10.5458/jag.jag.JAG-2014_011, DOI 10.5458/JAG.JAG.JAG-2014_011]; Abe K, 2018, J BIOL CHEM, V293, P8812, DOI 10.1074/jbc.RA117.001536; Abe K, 2017, J BIOL CHEM, V292, P7487, DOI 10.1074/jbc.M116.762724; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; ALTABE S, 1990, J BACTERIOL, V172, P2563, DOI 10.1128/jb.172.5.2563-2567.1990; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bianchetti CM, 2015, J BIOL CHEM, V290, P11819, DOI 10.1074/jbc.M114.623579; BREEDVELD MW, 1995, MICROBIOL-SGM, V141, P583, DOI 10.1099/13500872-141-3-583; BUNDLE DR, 1988, INFECT IMMUN, V56, P1101, DOI 10.1128/IAI.56.5.1101-1106.1988; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case D. A., 2018, AMBER 2019; Castro LDS, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-41; Ciocchini AE, 2007, P NATL ACAD SCI USA, V104, P16492, DOI 10.1073/pnas.0708025104; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004; DELL A, 1983, CARBOHYD RES, V117, P185, DOI 10.1016/0008-6215(83)88086-0; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; DYLAN T, 1990, J BACTERIOL, V172, P1400, DOI 10.1128/jb.172.3.1400-1408.1990; DYLAN T, 1990, J BACTERIOL, V172, P1409, DOI 10.1128/jb.172.3.1409-1417.1990; DYLAN T, 1986, P NATL ACAD SCI USA, V83, P4403, DOI 10.1073/pnas.83.12.4403; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ficko-Blean E, 2011, PROTEINS, V79, P2771, DOI 10.1002/prot.23116; Furtado GP, 2013, PROTEIN ENG DES SEL, V26, P15, DOI 10.1093/protein/gzs057; Gregg KJ, 2015, J BIOL CHEM, V290, P25657, DOI 10.1074/jbc.M115.680470; Guidolin LS, 2009, J BACTERIOL, V191, P1230, DOI 10.1128/JB.01108-08; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hehemann JH, 2012, J BIOL CHEM, V287, P13985, DOI 10.1074/jbc.M112.345645; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HISAMATSU M, 1992, CARBOHYD RES, V231, P137, DOI 10.1016/0008-6215(92)84014-J; Hisamatsu M., 1984, J JPN SOC STARCH SCI, V31, P117, DOI [10.5458/jag1972.31.117, DOI 10.5458/JAG1972.31.117]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishiguro R, 2017, FEBS LETT, V591, P3926, DOI 10.1002/1873-3468.12911; Ito T, 2014, BIOCHEM BIOPH RES CO, V447, P32, DOI 10.1016/j.bbrc.2014.03.096; Javvadi S, 2018, EMBO REP, V19, P172, DOI 10.15252/embr.201744650; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karakashian M. W, 1975, Symposia Soc exp Biol, VNo. 29, P145; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KITAHATA S, 1987, AGR BIOL CHEM TOKYO, V51, P2701; Kobayashi K, 2018, ANAL BIOCHEM, V560, P1, DOI 10.1016/j.ab.2018.08.021; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; KOIZUMI K, 1984, J CHROMATOGR, V299, P215, DOI 10.1016/S0021-9673(01)97833-1; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel EB, 2004, SOFTWARE PRACT EXPER, V34, P591, DOI 10.1002/spe.588; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Macdonald SS, 2015, J BIOL CHEM, V290, P4887, DOI 10.1074/jbc.M114.621110; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Miao F, 2012, MOLECULES, V17, P14091, DOI 10.3390/molecules171214091; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Miyatake H, 2006, ACTA CRYSTALLOGR D, V62, P280, DOI 10.1107/S0907444905041909; Miyazaki T, 2016, J STRUCT BIOL, V196, P479, DOI 10.1016/j.jsb.2016.09.015; Munoz-Munoz J, 2017, P NATL ACAD SCI USA, V114, P4936, DOI 10.1073/pnas.1701130114; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nakae S, 2013, J MOL BIOL, V425, P4468, DOI 10.1016/j.jmb.2013.08.002; Nakajima M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42671; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nakamura A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500263; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; REESE ET, 1961, CAN J MICROBIOL, V7, P309, DOI 10.1139/m61-038; Reid CW, 2007, FEBS LETT, V581, P4988, DOI 10.1016/j.febslet.2007.09.037; Rigano LA, 2007, PLANT CELL, V19, P2077, DOI 10.1105/tpc.106.047944; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roset MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101279; Shimizu H, 2018, BIOCHEMISTRY-US, V57, P3849, DOI 10.1021/acs.biochem.8b00385; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Suarez ER, 2008, CARBOHYD RES, V343, P2623, DOI 10.1016/j.carres.2008.07.009; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Tanaka N, 2018, CARBOHYD RES, V468, P13, DOI 10.1016/j.carres.2018.08.005; Terada T, 2012, J PHYS CHEM B, V116, P6810, DOI 10.1021/jp2125558; Tiels P, 2012, NAT BIOTECHNOL, V30, P1225, DOI 10.1038/nbt.2427; TUOHY MG, 1993, BIOCHEM J, V290, P515, DOI 10.1042/bj2900515; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Yamada C, 2017, CELL CHEM BIOL, V24, P515, DOI 10.1016/j.chembiol.2017.03.012	92	5	5	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7942	7965		10.1074/jbc.RA118.007087	http://dx.doi.org/10.1074/jbc.RA118.007087			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30926603	Green Published, hybrid			2022-12-28	WOS:000470153300033
J	Jing, J; Sun, YN				Jing, Jian; Sun, Yanna			An (IIb3)- and phosphatidylserine (PS)-binding recombinant fusion protein promotes PS-dependent anticoagulation and integrin-dependent antithrombosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						annexin; drug design; fusion protein; phosphatidylserine; protein chimera; protein engineering; protein expression; protein motif; protein-lipid interaction; thrombosis	BOUND ANNEXIN-V; PLATELET-AGGREGATION; CHIMERIC PROTEIN; BINDING; EXPRESSION; EXPOSURE; INHIBITORS; BLOOD; PURIFICATION; PROCOAGULANT	Blood platelets are required for normal wound healing, but they are also involved in thrombotic diseases, which are usually managed with anticoagulant drugs. Here, using genetic engineering, we coupled the disintegrin protein echistatin, which specifically binds to the platelet integrin (IIb3) receptor, to annexin V, which binds platelet membrane-associated phosphatidylserine (PS), to create the bifunctional antithrombotic molecule recombinant echistatin-annexin V fusion protein (r-EchAV). Lipid binding and plasma coagulation studies revealed that r-EchAV dose-dependently binds PS and delays plasma clotting time. Moreover, r-EchAV inhibited ADP-induced platelet aggregation in a dose-dependent manner and exhibited potent antiplatelet aggregation effects. r-EchAV significantly prolonged activated partial thromboplastin time, suggesting that it primarily affects the in vivo coagulation pathway. Flow cytometry results indicated that r-EchAV could effectively bind to the platelet (IIb3) receptor, indicating that r-EchAV retains echistatin's receptor-recognition region. In vivo experiments in mice disclosed that r-EchAV significantly prolongs bleeding time, indicating a significant anticoagulant effect in vivo resulting from the joint binding of r-EchAV to both PS and the (IIb3) receptor. We also report optimization of the r-EchAV production steps and its purification for high purity and yield. Our findings indicate that r-EchAV retains the active structural regions of echistatin and annexin V and that the whole molecule exhibits multitarget-binding ability arising from the dual functions of echistatin and annexin V. Therefore, r-EchAV represents a new class of anticoagulant that specifically targets the anionic membrane-associated coagulation enzyme complexes at thrombogenesis sites and may be a potentially useful antithrombotic agent.	[Jing, Jian; Sun, Yanna] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Genet Engn & Biotechnol, Xinwai St 19, Beijing 100875, Peoples R China	Beijing Normal University	Jing, J (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Genet Engn & Biotechnol, Xinwai St 19, Beijing 100875, Peoples R China.	jjing@bnu.edu.cn			Joint Construction Project of the Beijing Education Committee [2017110651103]; Young Scholars Fund of Beijing Normal University [BNU10300104977]	Joint Construction Project of the Beijing Education Committee; Young Scholars Fund of Beijing Normal University	This work was supported by Joint Construction Project of the Beijing Education Committee to Beijing Normal University No. 2017110651103 and Grant BNU10300104977 (to J.J.) from the Young Scholars Fund of Beijing Normal University. The authors declare that they have no conflicts of interest with the contents of this article.	ANDREE HAM, 1992, J BIOL CHEM, V267, P17907; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Chen HH, 2005, BLOOD, V105, P3902, DOI 10.1182/blood-2004-11-4435; Chen YC, 2012, TOXICON, V60, P1342, DOI 10.1016/j.toxicon.2012.08.009; Choo HJ, 2017, ARTERIOSCL THROM VAS, V37, P1503, DOI 10.1161/ATVBAHA.117.309473; DEJANA E, 1982, THROMB HAEMOSTASIS, V48, P108; FLAHERTY MJ, 1990, J LAB CLIN MED, V115, P174; Fox SC, 2004, PLATELETS, V15, P85, DOI 10.1080/09537100310001645979; GAN ZR, 1988, J BIOL CHEM, V263, P19827; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Huang X, 2006, BLOOD, V107, P980, DOI 10.1182/blood-2005-07-2733; HUBER R, 1990, EMBO J, V9, P3867, DOI 10.1002/j.1460-2075.1990.tb07605.x; Kenis H, 2009, CURR PHARM DESIGN, V15, P2719, DOI 10.2174/138161209788923903; Kuypers FA, 2007, THROMB HAEMOSTASIS, V97, P478, DOI 10.1160/TH06-08-0436; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LEWITBENTLEY A, 1992, EUR J BIOCHEM, V210, P73, DOI 10.1111/j.1432-1033.1992.tb17392.x; Li C., 2001, J NANJING MED U, V21, P277; [梁盼盼 LIANG Panpan], 2009, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University. Natural Science], V45, P378; Lord ST, 2007, CURR OPIN HEMATOL, V14, P236, DOI 10.1097/MOH.0b013e3280dce58c; Marder LS, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-33; MAURERFOGY I, 1988, EUR J BIOCHEM, V174, P585, DOI 10.1111/j.1432-1033.1988.tb14139.x; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Nagata S, 2016, CELL DEATH DIFFER, V23, P952, DOI 10.1038/cdd.2016.7; Nguyen-Ho P, 2001, Curr Atheroscler Rep, V3, P139, DOI 10.1007/s11883-001-0050-7; Obydennyy SI, 2016, J THROMB HAEMOST, V14, P1867, DOI 10.1111/jth.13395; Oling F, 2001, J STRUCT BIOL, V133, P55, DOI 10.1006/jsbi.2000.4337; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; REUTELINGSPERGER CPM, 1985, EUR J BIOCHEM, V151, P625, DOI 10.1111/j.1432-1033.1985.tb09150.x; REUTELINGSPERGER CPM, 1988, EUR J BIOCHEM, V173, P171, DOI 10.1111/j.1432-1033.1988.tb13981.x; Sambrock J, 2001, MOL CLONING LAB MANU, V3rd; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAIT JF, 1994, THROMB RES, V75, P491, DOI 10.1016/0049-3848(94)90224-0; TAIT JF, 1995, J BIOL CHEM, V270, P21594, DOI 10.1074/jbc.270.37.21594; Tanaka K, 1996, BIOCHEMISTRY-US, V35, P922, DOI 10.1021/bi951528x; Tcheng JE, 1996, AM J CARDIOL, V78, P35, DOI 10.1016/S0002-9149(96)00490-0; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; THIAGARAJAN P, 1991, J BIOL CHEM, V266, P24302; Uchman B, 2015, CLIN APPL THROMB-HEM, V21, P584, DOI 10.1177/1076029613512417; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; VANHEERDE WL, 1994, BIOCHEM J, V302, P305, DOI 10.1042/bj3020305; Verlinden NJ, 2017, J CARDIOVASC PHARM T, V22, P546, DOI 10.1177/1074248417698042; VOGES D, 1994, J MOL BIOL, V238, P199, DOI 10.1006/jmbi.1994.1281; Vorchheimer DA, 2006, MAYO CLIN PROC, V81, P59, DOI 10.4065/81.1.59; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Xu Q, 2013, INT J CARDIOL, V162, P210, DOI 10.1016/j.ijcard.2012.06.001; Yang Chao, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P1130; Yi XY, 2013, ANAL CHEM, V85, P3660, DOI 10.1021/ac303624z; Yuan H, 2004, MICROBIOL RES, V159, P147, DOI 10.1016/j.micres.2004.02.002; Zhao L, 2017, J NEUROSURG, V127, P1041, DOI 10.3171/2016.8.JNS16996	56	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6670	6684		10.1074/jbc.RA118.006044	http://dx.doi.org/10.1074/jbc.RA118.006044			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30803987	Green Published, hybrid			2022-12-28	WOS:000467394700002
J	Liou, AY; Molday, LL; Wang, J; Andersen, JP; Molday, RS				Liou, Angela Y.; Molday, Laurie L.; Wang, Jiao; Andersen, Jens Peter; Molday, Robert S.			Identification and functional analyses of disease-associated P4-ATPase phospholipid flippase variants in red blood cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylserine; lipid transport; ATPase; cell biology; erythrocyte; ATP11C; disease mechanisms; lipid flippases; P4-ATPases; CDC50A	P-TYPE ATPASES; PUTATIVE AMINOPHOSPHOLIPID TRANSLOCASE; SUBCELLULAR-LOCALIZATION; ERYTHROCYTE-MEMBRANE; CDC50 PROTEINS; TRANSPORT; PHOSPHATIDYLSERINE; ATP11C; EXPRESSION; BINDING	ATP-dependent phospholipid flippase activity crucial for generating lipid asymmetry was first detected in red blood cell (RBC) membranes, but the P4-ATPases responsible have not been directly determined. Using affinity-based MS, we show that ATP11C is the only abundant P4-ATPase phospholipid flippase in human RBCs, whereas ATP11C and ATP8A1 are the major P4-ATPases in mouse RBCs. We also found that ATP11A and ATP11B are present at low levels. Mutations in the gene encoding ATP11C are responsible for blood and liver disorders, but the disease mechanisms are not known. Using heterologous expression, we show that the T415N substitution in the phosphorylation motif of ATP11C, responsible for congenital hemolytic anemia, reduces ATP11C expression, increases retention in the endoplasmic reticulum, and decreases ATPase activity by 61% relative to WT ATP11C. The I355K substitution in the transmembrane domain associated with cholestasis and anemia in mice was expressed at WT levels and trafficked to the plasma membrane but was devoid of activity. We conclude that the T415N variant causes significant protein misfolding, resulting in low protein expression, cellular mislocalization, and reduced functional activity. In contrast, the I355K variant folds and traffics normally but lacks key contacts required for activity. We propose that the loss in ATP11C phospholipid flippase activity coupled with phospholipid scramblase activity results in the exposure of phosphatidylserine on the surface of RBCs, decreasing RBC survival and resulting in anemia.	[Liou, Angela Y.; Molday, Laurie L.; Wang, Jiao; Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Andersen, Jens Peter] Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark; [Wang, Jiao] Shanghai Univ, Sch Life Sci, Lab Mol Neural Biol, Shanghai 200444, Peoples R China	University of British Columbia; Aarhus University; Shanghai University	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	molday@mail.ubc.ca		Andersen, Jens Peter/0000-0003-0654-4300; Molday, Robert/0000-0002-4479-1831	Canadian Institutes of Health Research Grant [PJT 148649]; National Institutes of Health [EY002422]; Danish Council for Independent Research Grant [DFF-6110-00271]; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Canadian Institutes of Health Research Grant PJT 148649 (to R. S. M.), National Institutes of Health Grant EY002422 (to R. S. M.), and Danish Council for Independent Research Grant DFF-6110-00271 (to J. P. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Arashiki N, 2016, HAEMATOLOGICA, V101, P559, DOI 10.3324/haematol.2016.142273; AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Bryk AH, 2017, J PROTEOME RES, V16, P2752, DOI 10.1021/acs.jproteome.7b00025; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Coleman JA, 2014, J CELL SCI, V127, P1138, DOI 10.1242/jcs.145052; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; DALEKE DL, 1985, BIOCHEMISTRY-US, V24, P5406, DOI 10.1021/bi00341a019; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Katoh Y, 2004, ONCOL REP, V12, P939; Kobayashi T, 2018, CURR BIOL, V28, pR386, DOI 10.1016/j.cub.2018.01.007; Lee S, 2015, EMBO J, V34, P669, DOI 10.15252/embj.201489703; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Lopez-Marques RL, 2015, BBA-GEN SUBJECTS, V1850, P461, DOI 10.1016/j.bbagen.2014.04.008; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; MARUYAMA K, 1989, J BIOL CHEM, V264, P13038; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; McMillan HJ, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0825-3; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; MORROT G, 1989, BIOCHEMISTRY-US, V28, P3456, DOI 10.1021/bi00434a046; Mouro I, 1999, BIOCHEM BIOPH RES CO, V257, P333, DOI 10.1006/bbrc.1999.0347; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Pasini EM, 2008, MOL CELL PROTEOMICS, V7, P1317, DOI 10.1074/mcp.M700458-MCP200; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Quazi F, 2013, J BIOL CHEM, V288, P34414, DOI 10.1074/jbc.M113.508812; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Segawa K, 2016, J BIOL CHEM, V291, P762, DOI 10.1074/jbc.M115.690727; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Soupene E, 2008, J RECEPT LIGAND CH R, V1, P1; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Vilsen B, 1998, BIOCHEMISTRY-US, V37, P10961, DOI 10.1021/bi9802925; Wang J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29108-z; Williamson Patrick, 2015, Lipid Insights, V8, P41, DOI 10.4137/LPI.S31785; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; ZACHOWSKI A, 1986, BIOCHEMISTRY-US, V25, P2585, DOI 10.1021/bi00357a046; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	59	9	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6809	6821		10.1074/jbc.RA118.007270	http://dx.doi.org/10.1074/jbc.RA118.007270			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30850395	Green Published, hybrid			2022-12-28	WOS:000467394700018
J	Shi, W; Wang, YJ; Peng, JZ; Qi, SJ; Vitale, N; Kaneda, N; Murata, T; Luo, HY; Wu, JP				Shi, Wei; Wang, Yujia; Peng, Junzheng; Qi, Shijie; Vitale, Nicolas; Kaneda, Norio; Murata, Tomiyasu; Luo, Hongyu; Wu, Jiangping			EPHB6 controls catecholamine biosynthesis by up-regulating tyrosine hydroxylase transcription in adrenal gland chromaffin cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor tyrosine kinase; catecholamine; c-JUN transcription factor; early growth response protein 1 (EGR1); adrenal; chromaffin cells; tyrosine hydroxylase	SIGNAL-TRANSDUCTION; BLOOD-PRESSURE; CROSS-LINKING; PROTEIN; PHOSPHORYLATION; CONTRACTILITY; ACTIVATION; EPHRINB1; EFNB1; ELK-1	EPHB6 is a member of the erythropoietin-producing hepatocellular kinase (EPH) family and a receptor tyrosine kinase with a dead kinase domain. It is involved in blood pressure regulation and adrenal gland catecholamine (CAT) secretion, but several facets of EPHB6-mediated CAT regulation are unclear. In this study, using biochemical, quantitative RT-PCR, immunoblotting, and gene microarray assays, we found that EPHB6 up-regulates CAT biosynthesis in adrenal gland chromaffin cells (AGCCs). We observed that epinephrine content is reduced in the AGCCs from male Ephb6-KO mice, caused by decreased expression of tyrosine hydroxylase, the rate-limiting enzyme in CAT biosynthesis. We demonstrate that the signaling pathway from EPHB6 to tyrosine hydroxylase expression in AGCCs involves Rac family small GTPase 1 (RAC1), MAP kinase kinase 7 (MKK7), c-Jun N-terminal kinase (JNK), proto-oncogene c-Jun, activator protein 1 (AP1), and early growth response 1 (EGR1). On the other hand, signaling via extracellular signal-regulated kinase (ERK1/2), p38 mitogen-activated protein kinase, and ELK1, ETS transcription factor (ELK1) was not affected by EPHB6 deletion. We further report that EPHB6's effect on AGCCs was via reverse signaling through ephrin B1 and that EPHB6 acted in concert with the nongenomic effect of testosterone to control CAT biosynthesis. Our findings elucidate the mechanisms by which EPHB6 modulates CAT biosynthesis and identify potential therapeutic targets for diseases, such as hypertension, caused by dysfunctional CAT biosynthesis.	[Shi, Wei; Wang, Yujia; Peng, Junzheng; Qi, Shijie; Luo, Hongyu; Wu, Jiangping] Univ Montreal, Ctr Hosp, Res Ctr, Montreal, PQ H2X 0A9, Canada; [Wu, Jiangping] Univ Montreal, Ctr Hosp, Nephrol Dept, Montreal, PQ H2X 0A9, Canada; [Wang, Yujia] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Vitale, Nicolas] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, UPR 3212, CNRS, 5 Rue Blaise Pascal, F-67000 Strasbourg, France; [Kaneda, Norio; Murata, Tomiyasu] Meijo Univ, Fac Pharm, Dept Analyt Neurobiol, Tempaku Ku, Nagoya, Aichi 4688503, Japan	Universite de Montreal; Universite de Montreal; Zhejiang University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Meijo University	Luo, HY; Wu, JP (corresponding author), CRCHUM, 900 Rue St Denis,R12-426, Montreal, PQ H2X 0A9, Canada.	hongyu.luo@umontreal.ca; jianping.wu@umontreal.ca	Vitale, Nicolas/G-5967-2014	Vitale, Nicolas/0000-0002-4752-4907	Fonds de Recherche du Quebec-Sante; J.-Louis Levesque Foundation; Canadian Institutes of Health Research [MOP272014]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-04790]; Juvenile Diabetes Research Foundation [17-2013-440]	Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); J.-Louis Levesque Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by the Fonds de Recherche du Quebec-Sante (to J. W. and H. L.) and the J.-Louis Levesque Foundation (to J. W.). It was also funded in part by grants from the Canadian Institutes of Health Research (MOP272014 to J. W.) and the Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-04790) and the Juvenile Diabetes Research Foundation (17-2013-440) (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1997, CELL, V90, P403, DOI DOI 10.1016/S0092-8674(00)80500-0; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DECHAMPLAIN J, 1976, CIRC RES, V38, P109, DOI 10.1161/01.RES.38.2.109; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Foltz IN, 1998, J BIOL CHEM, V273, P9344, DOI 10.1074/jbc.273.15.9344; Gasman S, 2003, CELL SIGNAL, V15, P893, DOI 10.1016/S0898-6568(03)00052-4; Gregg Jennifer, 2011, Genes Cancer, V2, P900, DOI 10.1177/1947601911431885; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Hoffmann E, 2008, J BIOL CHEM, V283, P12120, DOI 10.1074/jbc.M800583200; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Hu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1778, DOI 10.1002/art.39116; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; James GD, 1997, ANNU REV ANTHROPOL, V26, P313, DOI 10.1146/annurev.anthro.26.1.313; Jin W, 2014, MOL IMMUNOL, V58, P1, DOI 10.1016/j.molimm.2013.10.008; Kohno S, 2011, CELL BIOL INT, V35, P325, DOI 10.1042/CBI20090344; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; Luo HY, 2016, NEUROBIOL DIS, V91, P292, DOI 10.1016/j.nbd.2016.03.013; Luo HY, 2012, J BIOL CHEM, V287, P6819, DOI 10.1074/jbc.M111.293365; Luo HY, 2011, J BIOL CHEM, V286, P44976, DOI 10.1074/jbc.M111.316414; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Luo HY, 2001, J IMMUNOL, V167, P1362, DOI 10.4049/jimmunol.167.3.1362; Luo HY, 2002, J CLIN INVEST, V110, P1141, DOI 10.1172/JCI200215883; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; Nakada M, 2006, CANCER RES, V66, P8492, DOI 10.1158/0008-5472.CAN-05-4211; Nakayama A, 2013, GENE DEV, V27, P2576, DOI 10.1101/gad.224089.113; O'Neill AK, 2016, J CELL BIOL, V215, P217, DOI 10.1083/jcb.201604097; Papanikolaou NA, 2000, J BIOL CHEM, V275, P26683; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; Schreck I, 2011, BIOCHEM BIOPH RES CO, V407, P735, DOI 10.1016/j.bbrc.2011.03.092; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Tremblay J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44114; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Wang YY, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.603.9125; Wang YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19215-2; Wang YJ, 2016, EUR J HUM GENET, V24, P1817, DOI 10.1038/ejhg.2016.105; Wang YJ, 2016, AM J PHYSIOL-HEART C, V310, pH861, DOI 10.1152/ajpheart.00873.2015; Wang YJ, 2015, J BIOL CHEM, V290, P14235, DOI 10.1074/jbc.M114.621615; Wong DL, 2007, STRESS, V10, P121, DOI 10.1080/10253890701393529; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Wu T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32836-x; Wu ZH, 2012, J BIOL CHEM, V287, P15557, DOI 10.1074/jbc.M112.340869; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200; Yu G, 2003, J IMMUNOL, V171, P106, DOI 10.4049/jimmunol.171.1.106; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200; Zhang ZQ, 2019, J HYPERTENS, V37, P775, DOI 10.1097/HJH.0000000000001948	54	6	6	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6871	6887		10.1074/jbc.RA118.005767	http://dx.doi.org/10.1074/jbc.RA118.005767			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30824540	hybrid, Green Published			2022-12-28	WOS:000467394700023
J	Fernandes, VC; Golubeva, VA; Di Pietro, G; Shields, C; Amankwah, K; Nepomuceno, TC; de Gregoriis, G; Abreu, RBV; Harro, C; Gomes, TT; Silva, RF; Suarez-Kurtz, G; Couch, FJ; Iversen, ES; Monteiro, ANA; Carvalho, MA				Fernandes, Vanessa C.; Golubeva, Volha A.; Di Pietro, Giuliano; Shields, Cara; Amankwah, Kwabena; Nepomuceno, Thales C.; de Gregoriis, Giuliana; Abreu, Renata B. V.; Harro, Carly; Gomes, Thiago T.; Silva, Ricceli F.; Suarez-Kurtz, Guilherme; Couch, Fergus J.; Iversen, Edwin S.; Monteiro, Alvaro N. A.; Carvalho, Marcelo A.			Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BRCA1; cancer prevention; human genetics; protein conformation; breast cancer; BRCT domains; breast cancer risk; clinical annotation; clinical risk assessment; VarCall	SEQUENCE VARIANTS; MISSENSE VARIANTS; FUNCTIONAL-ANALYSIS; CLASSIFICATION; BREAST; TRANSCRIPTION; MUTATIONS; PROTEIN; ASSAY; REGION	Genetic testing for BRCA1, a DNA repair protein, can identify carriers of pathogenic variants associated with a substantially increased risk for breast and ovarian cancers. However, an association with increased risk is unclear for a large fraction of BRCA1 variants present in the human population. Most of these variants of uncertain clinical significance lead to amino acid changes in the BRCA1 protein. Functional assays are valuable tools to assess the potential pathogenicity of these variants. Here, we systematically probed the effects of substitutions in the C terminus of BRCA1: the N- and C-terminal borders of its tandem BRCT domain, the BRCT-[N-C] linker region, and the 1 and 1 helices in BRCT-[N] and -[C]. Using a validated transcriptional assay based on a fusion of the GAL4 DNA-binding domain to the BRCA1 C terminus (amino acids 1396-1863), we assessed the functional impact of 99 missense variants of BRCA1. We include the data obtained for these 99 missense variants in a joint analysis to generate the likelihood of pathogenicity for 347 missense variants in BRCA1 using VarCall, a Bayesian integrative statistical model. The results from this analysis increase our understanding of BRCA1 regions less tolerant to changes, identify functional borders of structural domains, and predict the likelihood of pathogenicity for 98% of all BRCA1 missense variants in this region recorded in the population. This knowledge will be critical for improving risk assessment and clinical treatment of carriers of BRCA1 variants.	[Fernandes, Vanessa C.; Nepomuceno, Thales C.; de Gregoriis, Giuliana; Abreu, Renata B. V.; Suarez-Kurtz, Guilherme; Carvalho, Marcelo A.] Inst Nacl Canc, Programa Pesquisa Clin, BR-20231050 Rio De Janeiro, Brazil; [Golubeva, Volha A.; Di Pietro, Giuliano; Shields, Cara; Amankwah, Kwabena; Nepomuceno, Thales C.; Harro, Carly; Monteiro, Alvaro N. A.] H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA; [Di Pietro, Giuliano] Univ Fed Sergipe, Campus Sao Cristovao, BR-49100000 Sao Cristovao, Brazil; [Harro, Carly] Univ S Florida, Canc Biol PhD Program, Coll Arts & Sci, Dept Cell Biol,Microbiol, Tampa, FL 33612 USA; [Couch, Fergus J.] Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA; [Iversen, Edwin S.] Duke Univ, Dept Stat, Durham, NC 27710 USA; [Gomes, Thiago T.; Silva, Ricceli F.] Inst Fed Rio de Janeiro, BR-20270021 Rio De Janeiro, Brazil	National Cancer Institute (Inca); H Lee Moffitt Cancer Center & Research Institute; Universidade Federal de Sergipe; State University System of Florida; University of South Florida; Mayo Clinic; Duke University; Instituto Federal do Rio de Janeiro (IFRJ)	Carvalho, MA (corresponding author), Inst Fed Rio de Janeiro, BR-20270021 Rio De Janeiro, Brazil.; Monteiro, ANA (corresponding author), 12902 Magnolia Dr, Tampa, FL 33612 USA.	alvaro.monteiro@moffitt.org; marcelo.carvalho@ifrj.edu.br	De Gregoriis, Giuliana/AAC-9864-2022; Carvalho, Marcelo A/J-7144-2012; Carvalho, Marcelo/T-2014-2019; Torres Gomes, Thiago/GRR-2203-2022; Monteiro, Alvaro N. A./A-7566-2009; Suarez-Kurtz, Guilherme/J-6648-2012; Nepomuceno, Thales/Y-8018-2019; Barbosa Vahia de Abreu, Renata/V-5594-2018	Carvalho, Marcelo A/0000-0002-7053-0053; Monteiro, Alvaro N. A./0000-0002-8448-4801; Suarez-Kurtz, Guilherme/0000-0002-1115-8319; Nepomuceno, Thales/0000-0002-1171-1030; Fernandes, Vanessa C./0000-0003-4130-8215; Harro, Carly/0000-0002-0683-217X; Shields, Cara/0000-0002-3791-8259; Golubeva, Volha/0000-0001-5430-3507; Barbosa Vahia de Abreu, Renata/0000-0002-3183-1195; Torres Gomes, Thiago/0000-0001-7669-3980	National Institutes of Health [U01 CA116167]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao do Cancer (Programa de Oncobiologia); Molecular Genomics Core Facilities at the Moffitt Cancer Center through National Institutes of Health NCI CCSG Grant [P30-CA76292]; NATIONAL CANCER INSTITUTE [P30CA076292, U01CA116167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao do Cancer (Programa de Oncobiologia); Molecular Genomics Core Facilities at the Moffitt Cancer Center through National Institutes of Health NCI CCSG Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant U01 CA116167, the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao do Cancer (Programa de Oncobiologia), and in part by the Molecular Genomics Core Facilities at the Moffitt Cancer Center through National Institutes of Health NCI CCSG Grant P30-CA76292. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anantha RW, 2017, ELIFE, V6, DOI 10.7554/eLife.21350; Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Bouwman P, 2013, CANCER DISCOV, V3, P1142, DOI 10.1158/2159-8290.CD-13-0094; Brzovic PS, 2001, J BIOL CHEM, V276, P41399, DOI 10.1074/jbc.M106551200; Carvalho MA, 2002, CANCER BIOL THER, V1, P502, DOI 10.4161/cbt.1.5.165; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Cline MS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007752; Coyne RS, 2004, CANCER BIOL THER, V3, P453, DOI 10.4161/cbt.3.5.809; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Hayes F, 2000, CANCER RES, V60, P2411; Iversen ES, 2011, CANCER EPIDEM BIOMAR, V20, P1078, DOI 10.1158/1055-9965.EPI-10-1214; Karchin R, 2007, PLOS COMPUT BIOL, V3, P268, DOI 10.1371/journal.pcbi.0030026; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Lindor NM, 2012, HUM MUTAT, V33, P8, DOI 10.1002/humu.21627; Lu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10086; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Nadeau G, 2000, EMBO REP, V1, P260, DOI 10.1093/embo-reports/kvd059; Petitalot A., 2018, MOL CANCER RES, V17, P54, DOI [10.1186/s12943-018-0790-4, DOI 10.1186/S12943-018-0790-4]; Phelan CM, 2005, J MED GENET, V42, P138, DOI 10.1136/jmg.2004.024711; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Starita LM, 2017, AM J HUM GENET, V101, P315, DOI 10.1016/j.ajhg.2017.07.014; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Thouvenot P, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006096; Toland AE, 2017, J MED GENET, V54, P721, DOI 10.1136/jmedgenet-2017-104707; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Woods NT, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.1; Worley T, 2002, CANCER BIOL THER, V1, P497, DOI 10.4161/cbt.1.5.164	42	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5980	5992		10.1074/jbc.RA118.005274	http://dx.doi.org/10.1074/jbc.RA118.005274			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30765603	Green Published, hybrid			2022-12-28	WOS:000465077500029
J	Katayama, K; Gulati, S; Ortega, JT; Alexander, NS; Sun, WY; Shenouda, MM; Palczewski, K; Jastrzebska, B				Katayama, Kota; Gulati, Sahil; Ortega, Joseph T.; Alexander, Nathan S.; Sun, Wenyu; Shenouda, Marina M.; Palczewski, Krzysztof; Jastrzebska, Beata			Specificity of the chromophore-binding site in human cone opsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); membrane protein; photoreceptor; retinoid; rhodopsin; 11-cis-6mr-retinal; protein structure; retinal pigment; vision	CRYSTAL-STRUCTURE; VISUAL PIGMENTS; RECEPTOR ACTIVATION; WATER-MOLECULES; SCHIFF-BASE; RHODOPSIN; ISOMERIZATION; GREEN; ROD; PHOTOSENSITIVITIES	The variable composition of the chromophore-binding pocket in visual receptors is essential for vision. The visual phototransduction starts with the cis-trans isomerization of the retinal chromophore upon absorption of photons. Despite sharing the common 11-cis-retinal chromophore, rod and cone photoreceptors possess distinct photochemical properties. Thus, a detailed molecular characterization of the chromophore-binding pocket of these receptors is critical to understanding the differences in the photochemistry of vision between rods and cones. Unlike for rhodopsin (Rh), the crystal structures of cone opsins remain to be determined. To obtain insights into the specific chromophore-protein interactions that govern spectral tuning in human visual pigments, here we harnessed the unique binding properties of 11-cis-6-membered-ring-retinal (11-cis-6mr-retinal) with human blue, green, and red cone opsins. To unravel the specificity of the chromophore-binding pocket of cone opsins, we applied 11-cis-6mr-retinal analog-binding analyses to human blue, green, and red cone opsins. Our results revealed that among the three cone opsins, only blue cone opsin can accommodate the 11-cis-6mr-retinal in its chromophore-binding pocket, resulting in the formation of a synthetic blue pigment (B6mr) that absorbs visible light. A combination of primary sequence alignment, molecular modeling, and mutagenesis experiments revealed the specific amino acid residue 6.48 (Tyr-262 in blue cone opsins and Trp-281 in green and red cone opsins) as a selectivity filter in human cone opsins. Altogether, the results of our study uncover the molecular basis underlying the binding selectivity of 11-cis-6mr-retinal to the cone opsins.	[Katayama, Kota; Ortega, Joseph T.; Alexander, Nathan S.; Shenouda, Marina M.; Jastrzebska, Beata] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Gulati, Sahil; Palczewski, Krzysztof] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA; [Gulati, Sahil; Palczewski, Krzysztof] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA; [Katayama, Kota] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi 4668555, Japan; [Katayama, Kota] Nagoya Inst Technol, OptoBio Technol Res Ctr, Showa Ku, Nagoya, Aichi 4668555, Japan; [Sun, Wenyu; Palczewski, Krzysztof] Polgenix Inc, Cleveland, OH 44106 USA	Case Western Reserve University; University of California System; University of California Irvine; University of California System; University of California Irvine; Nagoya Institute of Technology; Nagoya Institute of Technology	Palczewski, K (corresponding author), Gavin Herbert Eye Inst, Dept Ophthalmol, 850 Hlth Sci Rd, Irvine, CA 92697 USA.; Palczewski, K (corresponding author), Gavin Herbert Eye Inst, Dept Physiol & Biophys, 850 Hlth Sci Rd, Irvine, CA 92697 USA.; Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kpalczewski@uci.edu; bxj27@case.edu	Ortega, Joseph/AFN-8883-2022	Katayama, Kota/0000-0001-8498-4374; Shenouda, Marina/0000-0002-6074-2327; Jastrzebska, Beata/0000-0001-5209-8685	National Institutes of Health [EY025214, EY027283, EY024864, EY009339, EY025451, P30EY011373]; CORE grant for Vision Research; Research to Prevent Blindness (RPB) grant; Canadian Institute for Advanced Research (CIFAR); Alcon Research Institute (ARI); NATIONAL EYE INSTITUTE [R24EY024864, U01EY025451, P30EY011373, R01EY009339, R24EY027283, R01EY025214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CORE grant for Vision Research; Research to Prevent Blindness (RPB) grant(Research to Prevent Blindness (RPB)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Alcon Research Institute (ARI); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants EY025214 (to B. J.), EY027283, EY024864, EY009339, EY025451 (all to K. P.), and P30EY011373, CORE grant for Vision Research awarded to the Visual Sciences Research Center (VSRC) at Case Western Reserve University; a Research to Prevent Blindness (RPB) grant (to the Department of Ophthalmology at University of California Irvine); the Canadian Institute for Advanced Research (CIFAR); and Alcon Research Institute (ARI). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja S, 2009, J AM CHEM SOC, V131, P15160, DOI 10.1021/ja9034768; Alexander NS, 2017, J BIOL CHEM, V292, P10983, DOI 10.1074/jbc.M117.780478; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; BHATTACHARYA S, 1992, J BIOL CHEM, V267, P6763; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brown MF, 2010, BBA-BIOMEMBRANES, V1798, P177, DOI 10.1016/j.bbamem.2009.08.013; Chen Yuanyuan, 2015, Methods Mol Biol, V1271, P369, DOI 10.1007/978-1-4939-2330-4_24; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; DARTNALL HJ, 1968, VISION RES, V8, P339, DOI 10.1016/0042-6989(68)90104-1; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Fasick JI, 1999, BIOCHEMISTRY-US, V38, P11593, DOI 10.1021/bi991600h; Furutani Y, 2003, BIOCHEMISTRY-US, V42, P9619, DOI 10.1021/bi034592k; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Gulati S, 2017, P NATL ACAD SCI USA, V114, pE2608, DOI 10.1073/pnas.1617446114; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; Imamoto Y, 2013, BIOCHEMISTRY-US, V52, P3010, DOI 10.1021/bi3015967; Isayama T, 2006, VISUAL NEUROSCI, V23, P899, DOI 10.1017/S0952523806230256; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Katayama K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05177-4; Katayama K, 2015, J PHYS CHEM LETT, V6, P1130, DOI 10.1021/acs.jpclett.5b00291; Katayama K, 2012, BIOCHEMISTRY-US, V51, P1126, DOI 10.1021/bi201676y; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kim JE, 2003, BIOCHEMISTRY-US, V42, P5169, DOI 10.1021/bi030026d; Kim JE, 2001, BIOCHEMISTRY-US, V40, P13774, DOI 10.1021/bi0116137; Kono M, 2011, J NAT PROD, V74, P391, DOI 10.1021/np100749j; Kuksa V, 2002, J BIOL CHEM, V277, P42315, DOI 10.1074/jbc.M206014200; Kuwayama S, 2002, BIOCHEMISTRY-US, V41, P15245, DOI 10.1021/bi026444k; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; Mertz B, 2012, BBA-BIOMEMBRANES, V1818, P241, DOI 10.1016/j.bbamem.2011.08.003; NAKANISHI K, 1976, J AM CHEM SOC, V98, P236, DOI 10.1021/ja00417a040; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; OKANO T, 1992, PHOTOCHEM PHOTOBIOL, V56, P995, DOI 10.1111/j.1751-1097.1992.tb09722.x; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, VISION RES, V46, P4425, DOI 10.1016/j.visres.2006.10.009; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pope A, 2014, BBA-BIOENERGETICS, V1837, P683, DOI 10.1016/j.bbabio.2013.10.007; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; SHICHIDA Y, 1988, BIOCHEMISTRY-US, V27, P6495, DOI 10.1021/bi00417a044; SPALINK JD, 1983, P NATL ACAD SCI-BIOL, V80, P1887, DOI 10.1073/pnas.80.7.1887; Stenkamp RE, 2002, BBA-BIOMEMBRANES, V1565, P168, DOI 10.1016/S0005-2736(02)00567-9; Stenkamp RE, 2002, CHEMBIOCHEM, V3, P963, DOI 10.1002/1439-7633(20021004)3:10<963::AID-CBIC963>3.0.CO;2-9; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; Van Hooser JP, 2000, METHOD ENZYMOL, V316, P565; Vogel R, 2000, CURR OPIN CHEM BIOL, V4, P518, DOI 10.1016/S1367-5931(00)00125-3; Vogel R, 2005, BIOCHEMISTRY-US, V44, P11684, DOI 10.1021/bi0508587; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Yan ECY, 2004, BIOCHEMISTRY-US, V43, P10867, DOI 10.1021/bi0400148; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733	61	7	8	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6082	6093		10.1074/jbc.RA119.007587	http://dx.doi.org/10.1074/jbc.RA119.007587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30770468	Green Published, hybrid			2022-12-28	WOS:000465077500038
J	Wagner, EK; Qerqez, AN; Stevens, CA; Nguyen, AW; Delidakis, G; Maynard, JA				Wagner, Ellen K.; Qerqez, Ahlam N.; Stevens, Christopher A.; Nguyen, Annalee W.; Delidakis, George; Maynard, Jennifer A.			Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression using mammalian cell display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; antibody engineering; protein engineering; recombinant protein expression; immunoglobulin fold; affinity; antiviral treatment; cytomegalovirus; T-cell receptor	MAJOR HISTOCOMPATIBILITY COMPLEXES; DIRECTED EVOLUTION; IN-VITRO; TCR; RECOGNITION; SELECTION; PROTEIN; LEVEL; SECRETION; FREQUENCY	T-cell receptors (TCR) have considerable potential as therapeutics and antibody-like reagents to monitor disease progression and vaccine efficacy. Whereas antibodies recognize only secreted and surface-bound proteins, TCRs recognize otherwise inaccessible disease-associated intracellular proteins when they are presented as processed peptides bound to major histocompatibility complexes (pMHC). TCRs have been primarily explored for cancer therapy applications but could also target infectious diseases such as cytomegalovirus (CMV). However, TCRs are more difficult to express and engineer than antibodies, and advanced methods are needed to enable their widespread use. Here, we engineered the human CMV-specific TCR RA14 for high-affinity and robust soluble expression. To achieve this, we adapted our previously reported mammalian display system to present TCR extracellular domains and used this to screen CDR3 libraries for clones with increased pMHC affinity. After three rounds of selection, characterized clones retained peptide specificity and activation when expressed on the surface of human Jurkat T cells. We obtained high yields of soluble, monomeric protein by fusing the TCR extracellular domains to antibody hinge and Fc constant regions, adding a stabilizing disulfide bond between the constant domains and disrupting predicted glycosylation sites. One variant exhibited 50 nm affinity for its cognate pMHC, as measured by surface plasmon resonance, and specifically stained cells presenting this pMHC. Our work has identified a human TCR with high affinity for the immunodominant CMV peptide and offers a new strategy to rapidly engineer soluble TCRs for biomedical applications.	[Wagner, Ellen K.; Qerqez, Ahlam N.; Stevens, Christopher A.; Nguyen, Annalee W.; Delidakis, George; Maynard, Jennifer A.] Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Maynard, JA (corresponding author), Univ Texas Austin, 200 E Dean Keeton,MC0400, Austin, TX 78712 USA.	maynard@che.utexas.edu		Nguyen, Annalee/0000-0003-1268-7164	Welch Foundation [F-1767]; Clayton Foundation for Biomedical Research; National Institutes of Health NRSA [F32GM111018]; National Science Foundation GRFP fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI144719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM111018] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Clayton Foundation for Biomedical Research; National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation GRFP fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Welch Foundation Grant F-1767 (to J. A. M.), the Clayton Foundation for Biomedical Research (to G. D.), National Institutes of Health NRSA Grant F32GM111018 (to A. W. N.), and National Science Foundation GRFP fellowships (to E. K. W. and A. N. Q.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggen DH, 2011, PROTEIN ENG DES SEL, V24, P361, DOI 10.1093/protein/gzq113; Anikeeva N, 2009, CLIN IMMUNOL, V130, P98, DOI 10.1016/j.clim.2008.08.025; Borroto A, 1999, J IMMUNOL, V163, P25; Bossi G, 2014, CANCER IMMUNOL IMMUN, V63, P437, DOI 10.1007/s00262-014-1525-z; Bossi G, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26840; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Chervin AS, 2008, J IMMUNOL METHODS, V339, P175, DOI 10.1016/j.jim.2008.09.016; Chng J, 2015, MABS-AUSTIN, V7, P403, DOI 10.1080/19420862.2015.1008351; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Colby DW, 2004, METHOD ENZYMOL, V388, P348; Cole DK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00168; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; Foss S, 2016, J CONTROL RELEASE, V223, P42, DOI 10.1016/j.jconrel.2015.12.033; Gakamsky DM, 2007, P NATL ACAD SCI USA, V104, P16639, DOI 10.1073/pnas.0707061104; Gonzalez-Galarza FF, 2018, METHODS MOL BIOL, V1802, P49, DOI 10.1007/978-1-4939-8546-3_4; Goyarts EC, 1998, MOL IMMUNOL, V35, P593, DOI 10.1016/S0161-5890(98)00056-X; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; GREGOIRE C, 1991, P NATL ACAD SCI USA, V88, P8077, DOI 10.1073/pnas.88.18.8077; Gunnarsen KS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01162; Harris DT, 2016, TRENDS PHARMACOL SCI, V37, P220, DOI 10.1016/j.tips.2015.11.004; Ho SKN, 1998, J CLIN MICROBIOL, V36, P638, DOI 10.1128/JCM.36.3.638-640.1998; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; KAGEYAMA S, 1995, J IMMUNOL, V154, P567; Kessels HWHC, 2000, P NATL ACAD SCI USA, V97, P14578, DOI 10.1073/pnas.97.26.14578; Kuball J, 2009, J EXP MED, V206, P463, DOI 10.1084/jem.20082487; Kunaparaju R, 2005, BIOTECHNOL BIOENG, V91, P670, DOI 10.1002/bit.20534; Lebowitz MS, 1999, CELL IMMUNOL, V192, P175, DOI 10.1006/cimm.1999.1441; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Lunde E, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-61; Makler O, 2010, EUR J IMMUNOL, V40, P1552, DOI 10.1002/eji.200939875; Malecek K, 2013, J IMMUNOL METHODS, V392, P1, DOI 10.1016/j.jim.2013.02.018; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Mosquera LA, 2005, J IMMUNOL, V174, P4381, DOI 10.4049/jimmunol.174.7.4381; Nguyen AW, 2018, PROTEIN ENG DES SEL, V31, P91, DOI 10.1093/protein/gzy004; Nguyen AW, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0966; Oates J, 2015, MOL IMMUNOL, V67, P67, DOI 10.1016/j.molimm.2015.01.024; Ozawa T, 2012, BIOCHEM BIOPH RES CO, V422, P245, DOI 10.1016/j.bbrc.2012.04.134; Plotkin SA, 2019, VACCINE, V37, P7437, DOI 10.1016/j.vaccine.2018.02.089; RIDDELL SR, 1991, J IMMUNOL, V146, P2795; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Saulquin X, 2000, EUR J IMMUNOL, V30, P2531, DOI 10.1002/1521-4141(200009)30:9<2531::AID-IMMU2531>3.0.CO;2-O; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; van Boxel GI, 2009, J IMMUNOL METHODS, V350, P14, DOI 10.1016/j.jim.2009.08.008; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Walseng E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119559; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wang XL, 2015, CLIN CANCER RES, V21, P2993, DOI 10.1158/1078-0432.CCR-14-2920; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; WULFING C, 1994, J MOL BIOL, V242, P655, DOI 10.1006/jmbi.1994.1615; Yang HB, 2016, MOL THER, V24, P1913, DOI 10.1038/mt.2016.114; Yang XB, 2015, J BIOL CHEM, V290, P29106, DOI 10.1074/jbc.M115.691311; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845	61	16	17	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5790	5804		10.1074/jbc.RA118.007187	http://dx.doi.org/10.1074/jbc.RA118.007187			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30796163	Green Published, hybrid			2022-12-28	WOS:000465077500006
J	Iwama, R; Ohsumi, Y				Iwama, Ryo; Ohsumi, Yoshinori			Analysis of autophagy activated during changes in carbon source availability in yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; physiology; yeast; glucose; mitophagy; autophagy-related protein 8 (Atg8); diauxie; ER-phagy; ethanol; nutrient starvation	SACCHAROMYCES-CEREVISIAE; TRIACYLGLYCEROL LIPASE; TAGS PEROXISOMES; DIAUXIC SHIFT; DEGRADATION; GENES; STARVATION; RECEPTOR; PROTEIN; MECHANISMS	Autophagy is a conserved intracellular degradation system in eukaryotes. Recent studies have revealed that autophagy can be induced not only by nitrogen starvation but also by many other stimuli. However, questions persist regarding the types of conditions that induce autophagy, as well as the particular kinds of autophagy that are induced under these specific conditions. In experimental studies, abrupt nutrient changes are often used to induce autophagy. In this study, we investigated autophagy induction in batch culture on low-glucose medium, in which growth of yeast (Saccharomyces cerevisiae) cells is clearly reflected exclusively by carbon source state. In this medium, cells pass sequentially through three stages: glucose-utilizing, ethanol-utilizing, and ethanol-depleted phases. Using GFP cleavage assay by immunoblotting methods, fluorescence microscopy, and transmission electron microscopy ultrastructural analysis, we found that bulk autophagy and endoplasmic reticulum-phagy are induced starting at the ethanol-utilizing phase, and bulk autophagy is activated to a greater extent in the ethanol-depleted phase. Furthermore, we found that mitophagy is induced by ethanol depletion. Microautophagy occurred after glucose depletion and involved incorporation of cytosolic components and lipid droplets into the vacuolar lumen. Moreover, we observed that autophagy-deficient cells grow more slowly in the ethanol-utilizing phase and exhibit a delay in growth resumption when they are shifted to fresh medium from the ethanol-depleted phase. Our findings suggest that distinct types of autophagy are induced in yeast cells undergoing gradual changes in carbon source availability.	[Iwama, Ryo; Ohsumi, Yoshinori] Tokyo Inst Technol, Inst Innovat Res, Ctr Cell Biol, Midori Ku, 4259-S2-12 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Ctr Cell Biol, Midori Ku, 4259-S2-12 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009; IWAMA, Ryo/AAY-4462-2021; Iwama, Ryo/W-2769-2017	Ohsumi, Yoshinori/0000-0003-2384-2166; IWAMA, Ryo/0000-0002-0466-6593; Iwama, Ryo/0000-0002-0466-6593	JSPS KAKENHI [JP23000015, JP16H06375, JP17K15245]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants JP23000015, JP16H06375, and JP17K15245. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi A, 2017, J BIOL CHEM, V292, P19905, DOI 10.1074/jbc.M117.817510; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Dickinson J. R., 1999, METABOLISM MOL PHYSL; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; FIECHTER A, 1981, ADV MICROB PHYSIOL, V22, P123, DOI 10.1016/S0065-2911(08)60327-6; Frankel D. G., 2011, YEAST INTERMEDIARY M; Fukuda T, 2018, MOL CELLS, V41, P35, DOI 10.14348/molcells.2018.2214; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Horie T, 2017, J BIOL CHEM, V292, P8533, DOI 10.1074/jbc.M116.762963; Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kawamata T, 2017, J BIOL CHEM, V292, P8520, DOI 10.1074/jbc.M116.762948; Kayikci O, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov068; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Medeiros TC, 2018, J CELL BIOL, V217, P1601, DOI 10.1083/jcb.201801168; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; MOELLER CH, 1979, J ULTRA MOL STRUCT R, V68, P38, DOI 10.1016/S0022-5320(79)90140-0; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Muller O, 2000, J CELL BIOL, V151, P519, DOI 10.1083/jcb.151.3.519; Murphy JP, 2015, MOL CELL PROTEOMICS, V14, P2454, DOI 10.1074/mcp.M114.045849; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2015, ANNU REV BIOPHYS, V44, P101, DOI 10.1146/annurev-biophys-060414-034248; Noda T, 2008, METHOD ENZYMOL, V451, P27, DOI 10.1016/S0076-6879(08)03202-3; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Oku M, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800008; Oku M, 2017, J CELL BIOL, V216, P3263, DOI 10.1083/jcb.201611029; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Ploier B, 2013, J BIOL CHEM, V288, P36061, DOI 10.1074/jbc.M113.509927; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Sibirny AA, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow038; Stahl G, 2004, EUKARYOT CELL, V3, P331, DOI 10.1128/EC.3.2.331-338.2004; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2013, CELL DEATH DIFFER, V20, P43, DOI 10.1038/cdd.2012.73; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Tsuji T, 2017, ELIFE, V6, DOI 10.7554/eLife.25960; VANDIJKEN JP, 1993, ANTON LEEUW INT J G, V63, P343, DOI 10.1007/BF00871229; Yokota H, 2017, BIOCHEM BIOPH RES CO, V483, P522, DOI 10.1016/j.bbrc.2016.12.112	53	16	16	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5590	5603		10.1074/jbc.RA118.005698	http://dx.doi.org/10.1074/jbc.RA118.005698			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30755486	hybrid, Green Published			2022-12-28	WOS:000464517500028
J	Jin, DN; Musier-Forsyth, K				Jin, Danni; Musier-Forsyth, Karin			Role of host tRNAs and aminoacyl-tRNA synthetases in retroviral replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						transfer RNA (tRNA); aminoacyl tRNA synthetase; retrovirus; human immunodeficiency virus (HIV); transposable element; RNA-binding protein; tRNA fragment (tRF)	HUMAN-IMMUNODEFICIENCY-VIRUS; CELL LEUKEMIA-VIRUS; PROTEIN-PROTEIN INTERACTIONS; BINDING-SITE COMPLEMENTARY; PRIMER ACTIVATION SIGNAL; ACID CHAPERONE ACTIVITY; TYPE-1 GAG POLYPROTEIN; SMALL NONCODING RNAS; HIV-1 GAG; REVERSE TRANSCRIPTION	The lifecycle of retroviruses and retrotransposons includes a reverse transcription step, wherein dsDNA is synthesized from genomic RNA for subsequent insertion into the host genome. Retroviruses and retrotransposons commonly appropriate major components of the host cell translational machinery, including cellular tRNAs, which are exploited as reverse transcription primers. Nonpriming functions of tRNAs have also been proposed, such as in HIV-1 virion assembly, and tRNA-derived fragments may also be involved in retrovirus and retrotransposon replication. Moreover, host cellular proteins regulate retroviral replication by binding to tRNAs and thereby affecting various steps in the viral lifecycle. For example, in some cases, tRNA primer selection is facilitated by cognate aminoacyl-tRNA synthetases (ARSs), which bind tRNAs and ligate them to their corresponding amino acids, but also have many known nontranslational functions. Multi-omic studies have revealed that ARSs interact with both viral proteins and RNAs and potentially regulate retroviral replication. Here, we review the currently known roles of tRNAs and their derivatives in retroviral and retrotransposon replication and shed light on the roles of tRNA-binding proteins such as ARSs in this process.	Ohio State Univ, Dept Chem & Biochem, Ctr Retrovirus Res, Columbus, OH 43210 USA; Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem & Biochem, 140 W 18th Ave,3033B McPherson Lab, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu		Jin, Danni/0000-0002-2878-9950	National Institutes of Health [R01 GM113887, GM065056, U54 GM103368]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI150472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103368, R01GM113887, R01GM065056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM113887, GM065056, and U54 GM103368. This is the fifth article in the "tRNAs and aminoacyl-tRNA synthetases in human disease" JBC Reviews series. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdel-Mohsen M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-106; Alfadhli A, 2011, J MOL BIOL, V410, P653, DOI 10.1016/j.jmb.2011.04.063; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; Anderson P, 2014, FEBS LETT, V588, P4297, DOI 10.1016/j.febslet.2014.09.001; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Beerens N, 2002, J VIROL, V76, P2329, DOI 10.1128/JVI.76.5.2329-2339.2002; Beerens N, 2002, RNA, V8, P357, DOI 10.1017/S1355838202028194; Borner K, 2010, BIOTECHNOL J, V5, P39, DOI 10.1002/biot.200900226; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burniston MT, 1999, J VIROL, V73, P8527, DOI 10.1128/JVI.73.10.8527-8540.1999; Carlson LA, 2016, ELIFE, V5, DOI 10.7554/eLife.14663; Cen S, 2000, J VIROL, V74, P10796, DOI 10.1128/JVI.74.22.10796-10800.2000; Cen S, 2004, J VIROL, V78, P1595, DOI 10.1128/JVI.78.3.1595-1601.2004; Cen S, 2002, J VIROL, V76, P13111, DOI 10.1128/JVI.76.24.13111-13115.2002; Cen S, 2001, J VIROL, V75, P5043, DOI 10.1128/JVI.75.11.5043-5048.2001; Chukkapalli V, 2013, J VIROL, V87, P7155, DOI 10.1128/JVI.00075-13; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Coffin J. M., 1997, RETROVIRUSES, P1; Comandur R, 2017, RNA, V23, P1850, DOI 10.1261/rna.062182.117; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/NMETH.3508, 10.1038/nmeth.3508]; DAS AT, 1995, J VIROL, V69, P3090, DOI 10.1128/JVI.69.5.3090-3097.1995; Dewan V, 2012, J BIOL CHEM, V287, P41955, DOI 10.1074/jbc.M112.421842; Dewan V, 2012, ACS CHEM BIOL, V7, P761, DOI 10.1021/cb200450w; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Duchon A. A., 2018, NONCODING RNAS RETRO, P421; Duchon AA, 2017, J VIROL, V91, DOI 10.1128/JVI.01240-17; Eckwahl MJ, 2016, RNA, V22, P1228, DOI 10.1261/rna.057299.116; Eckwahl MJ, 2015, GENE DEV, V29, P646, DOI 10.1101/gad.258731.115; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Engeland CE, 2014, VIROLOGY, V460, P194, DOI 10.1016/j.virol.2014.04.038; Feng YX, 1999, J VIROL, V73, P4251, DOI 10.1128/JVI.73.5.4251-4256.1999; Finnegan DJ, 2012, CURR BIOL, V22, pR432, DOI 10.1016/j.cub.2012.04.025; Gabor J, 2002, J VIROL, V76, P9096, DOI 10.1128/JVI.76.18.9096-9102.2002; Garcia-Lopez J, 2014, BBA-GENE REGUL MECH, V1839, P463, DOI 10.1016/j.bbagrm.2014.04.006; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gogakos T, 2017, CELL REP, V20, P1463, DOI 10.1016/j.celrep.2017.07.029; Goldschmidt V, 2004, J BIOL CHEM, V279, P35923, DOI 10.1074/jbc.M404473200; Goldschmidt V, 2003, NUCLEIC ACIDS RES, V31, P850, DOI 10.1093/nar/gkg187; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; Guo F, 2005, J BIOL CHEM, V280, P26018, DOI 10.1074/jbc.M502454200; Guo F, 2003, J VIROL, V77, P9817, DOI 10.1128/JVI.77.18.9817-9822.2003; Guo F, 2009, J VIROL, V83, P8099, DOI 10.1128/JVI.00488-09; Halwani R, 2004, J VIROL, V78, P7553, DOI 10.1128/JVI.78.14.7553-7564.2004; Hughes SH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0027-2014; ISEL C, 1993, J BIOL CHEM, V268, P25269; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Javanbakht H, 2003, J BIOL CHEM, V278, P27644, DOI 10.1074/jbc.M301840200; Javanbakht H, 2002, J BIOL CHEM, V277, P17389, DOI 10.1074/jbc.M112479200; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jones CP, 2014, P NATL ACAD SCI USA, V111, P3395, DOI 10.1073/pnas.1319658111; Jones CP, 2013, RNA, V19, P219, DOI 10.1261/rna.036681.112; Jones CP, 2011, J VIROL, V85, P1594, DOI 10.1128/JVI.01809-10; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kaminska M, 2007, J VIROL, V81, P68, DOI 10.1128/JVI.01267-06; Katsyv I, 2016, ONCOTARGET, V7, P69592, DOI 10.18632/oncotarget.11870; Ke N, 1999, RNA, V5, P929, DOI 10.1017/S1355838299990015; Keating CP, 2009, NUCLEIC ACIDS RES, V37, P945, DOI 10.1093/nar/gkn1015; KIKUCHI Y, 1986, NATURE, V323, P824, DOI 10.1038/323824a0; Kim DG, 2012, FASEB J, V26, P4142, DOI 10.1096/fj.12-207639; Kim JH, 2014, TOP CURR CHEM, V344, P119, DOI 10.1007/128_2013_479; Kleiman L, 2010, FEBS LETT, V584, P359, DOI 10.1016/j.febslet.2009.11.038; Knoener RA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16793-5; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kovaleski BJ, 2006, J BIOL CHEM, V281, P19449, DOI 10.1074/jbc.M601189200; Kumar P, 2016, TRENDS BIOCHEM SCI, V41, P679, DOI 10.1016/j.tibs.2016.05.004; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Larsen KP, 2018, NATURE, V557, P118, DOI 10.1038/s41586-018-0055-9; Le Grice SFJ, 2003, BIOCHEMISTRY-US, V42, P14349, DOI 10.1021/bi030201q; Lee EY, 2018, BIOCHEM PHARMACOL, V154, P424, DOI 10.1016/j.bcp.2018.06.009; Lee EY, 2016, NAT IMMUNOL, V17, P1252, DOI 10.1038/ni.3542; Lee MS, 2016, J MICROBIOL BIOTECHN, V26, P432, DOI 10.4014/jmb.1511.11056; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Levin HL, 1996, MOL CELL BIOL, V16, P5645; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; LI XG, 1994, J VIROL, V68, P6198, DOI 10.1128/JVI.68.10.6198-6206.1994; Lin YZ, 2016, VIROLOGY, V495, P112, DOI 10.1016/j.virol.2016.04.024; Liu JM, 2004, NUCLEIC ACIDS RES, V32, P719, DOI 10.1093/nar/gkh240; Liu S, 2016, RNA, V22, P1828, DOI 10.1261/rna.058081.116; MAK J, 1994, J VIROL, V68, P2065, DOI 10.1128/JVI.68.4.2065-2072.1994; Martinez G, 2017, NUCLEIC ACIDS RES, V45, P5142, DOI 10.1093/nar/gkx103; Martrus G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-78; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Mishima E, 2014, J AM SOC NEPHROL, V25, P2316, DOI 10.1681/ASN.2013091001; Mita P, 2016, CURR OPIN GENET DEV, V37, P90, DOI 10.1016/j.gde.2016.01.001; Mohammadi P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003161; Nathanson L, 2000, J BIOL CHEM, V275, P31559, DOI 10.1074/jbc.C000385200; Nogales V, 2016, ONCOTARGET, V7, P3084, DOI 10.18632/oncotarget.6413; Olson ED, 2019, SEMIN CELL DEV BIOL, V86, P129, DOI 10.1016/j.semcdb.2018.03.015; Palmer MT, 2007, J VIROL, V81, P4397, DOI 10.1128/JVI.02643-06; Parisien M, 2013, CELL REP, V3, P1703, DOI 10.1016/j.celrep.2013.04.010; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Peterlin BM, 2017, J VIROL, V91, DOI 10.1128/JVI.00237-17; Piras G, 1996, J BIOL CHEM, V271, P20501, DOI 10.1074/jbc.271.34.20501; PUTNEY SD, 1981, NATURE, V291, P632, DOI 10.1038/291632a0; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Rein A, 2010, RNA BIOL, V7, P700, DOI 10.4161/rna.7.6.13685; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Roldan A, 2005, J BIOL CHEM, V280, P17488, DOI 10.1074/jbc.M501310200; ROTHNIE HM, 1991, NUCLEIC ACIDS RES, V19, P279, DOI 10.1093/nar/19.2.279; Ruggero K, 2014, J VIROL, V88, P3612, DOI 10.1128/JVI.02823-13; Ruggero K, 2010, MOL ASPECTS MED, V31, P367, DOI 10.1016/j.mam.2010.05.001; Saadatmand J, 2012, VIRUS RES, V169, P340, DOI 10.1016/j.virusres.2012.06.001; Saikia M, 2012, J BIOL CHEM, V287, P42708, DOI 10.1074/jbc.M112.371799; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; SANDMEYER SB, 1990, ANNU REV GENET, V24, P491; SAWYER RC, 1973, J VIROL, V12, P1226, DOI 10.1128/JVI.12.6.1226-1237.1973; Schorn AJ, 2017, CELL, V170, P61, DOI 10.1016/j.cell.2017.06.013; Seif E, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0171-7; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Sobala A, 2013, RNA BIOL, V10, P553, DOI 10.4161/rna.24285; Stake M, 2015, VIROLOGY, V486, P307, DOI 10.1016/j.virol.2015.06.001; Tian L, 2014, ANTI-CANCER DRUG, V25, P1175, DOI 10.1097/CAD.0000000000000151; Todd GC, 2017, RNA, V23, P395, DOI 10.1261/rna.058453.116; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-92; van Weringh A, 2011, MOL BIOL EVOL, V28, P1827, DOI 10.1093/molbev/msr005; VANHEMERT FJ, 1995, J MOL EVOL, V41, P132, DOI 10.1007/BF00170664; Vogt V., 1997, RETROVIRUSES, P42; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; WAKEFIELD JK, 1995, J VIROL, V69, P6021, DOI 10.1128/JVI.69.10.6021-6029.1995; Wakefield JK, 1996, J VIROL, V70, P966, DOI 10.1128/JVI.70.2.966-975.1996; Wang QR, 2013, MOL THER, V21, P368, DOI 10.1038/mt.2012.237; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; Wu H, 2010, RNA BIOL, V7, P712, DOI 10.4161/rna.7.6.13776; Xing L, 2012, J VIROL, V86, P13272, DOI 10.1128/JVI.01993-12; Xing L, 2011, J VIROL, V85, P1847, DOI 10.1128/JVI.02010-10; Yang JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03544-x; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Zaitseva L, 2006, PLOS BIOL, V4, P1689, DOI 10.1371/journal.pbio.0040332; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	142	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5352	5364		10.1074/jbc.REV118.002957	http://dx.doi.org/10.1074/jbc.REV118.002957			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30700559	Green Published, hybrid			2022-12-28	WOS:000464517500010
J	Etichetti, CB; Di Benedetto, C; Rossi, C; Baglioni, MV; Bicciato, S; Del Sal, G; Menacho-Marquez, M; Girardini, J				Borini Etichetti, Carla; Di Benedetto, Carolina; Rossi, Carolina; Virginia Baglioni, Maria; Bicciato, Silvio; Del Sal, Giannino; Menacho-Marquez, Mauricio; Girardini, Javier			Isoprenylcysteine carboxy methyltransferase (ICMT) is associated with tumor aggressiveness and its expression is controlled by the p53 tumor suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein isoprenylation; protein carboxylation; p53; cytoskeleton; breast cancer; lung cancer; cell signaling; gene regulation; post-translational modification (PTM); mutant p53	MUTANT P53; CELL-MIGRATION; K-RAS; CANCER; CARBOXYLMETHYLTRANSFERASE; RHO; TRANSFORMATION; METHYLATION; METASTASIS; DEFICIENCY	Isoprenyl cysteine carboxyl methyltransferase (ICMT) plays a key role in post-translational regulation of prenylated proteins. On the basis of previous results, we hypothesized that the p53 pathway and ICMT expression may be linked in cancer cells. Here, we studied whether WT p53 and cancer-associated p53 point mutants regulate ICMT levels and whether ICMT overexpression affects tumor progression. Studying the effect of p53 variants on ICMT mRNA and protein levels in cancer cells, we found that WT p53 and p53 mutants differentially affect ICMT expression, indicating that p53 status influences ICMT levels in tumors. To investigate the underlying mechanisms, we constructed ICMT-luciferase reporters and found that WT p53 represses ICMT transcription. In contrast, p53 mutants showed a positive effect on ICMT expression. Promoter truncation analyses pinpointed the repressive effect of WT p53 to the -209 and -14 region on the ICMT promoter, and ChIP assays indicated that WT p53 is recruited to this region. Instead, a different promoter region was identified as responsible for the mutant p53 effect. Studying the effect of ICMT overexpression on tumor-associated phenotypes in vitro and in vivo, and analyzing breast and lung cancer databases, we identified a correlation between p53 status and ICMT expression in breast and lung cancers. Moreover, we observed that ICMT overexpression is correlated with negative clinical outcomes. Our work unveils a link between postprenylation protein processing and the p53 pathway, indicating that the functional interplay between WT and mutant p53 alters ICMT levels, thereby affecting tumor aggressiveness.	[Borini Etichetti, Carla; Di Benedetto, Carolina; Rossi, Carolina; Girardini, Javier] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario IBR, Fac Ciencias Med,Inst Genet Ex, RA-2000 Rosario, Santa Fe, Argentina; [Virginia Baglioni, Maria] Univ Nacl Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Del Sal, Giannino] Lab Nazl CIB, Area Sci Pk Padriciano, I-34149 Trieste, Italy; [Del Sal, Giannino] Univ Trieste, Dipartimento Sci Vita, I-34127 Trieste, Italy; [Menacho-Marquez, Mauricio] Univ Nacl Rosario, CONICET, IIDEFAR, Inst Invest El Descubrimiento Farmacos Rosario, RA-2000 Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universita di Modena e Reggio Emilia; University of Trieste; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Girardini, J (corresponding author), Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina.	girardini@ibr-conicet.gov.ar	Bicciato, Silvio/C-9825-2009	Bicciato, Silvio/0000-0002-1944-7078; BORINI ETICHETTI, CARLA/0000-0002-1632-2819; Baglioni, Maria Virginia/0000-0002-1329-2757	Instituto Nacional del Cancer (INC) Asistencia Financiera III; Agencia Nacional de Promocion Cientifica y Tecnologica Grant ANPCyT [PICT 1221]	Instituto Nacional del Cancer (INC) Asistencia Financiera III; Agencia Nacional de Promocion Cientifica y Tecnologica Grant ANPCyT	This work was supported by Instituto Nacional del Cancer (INC) Asistencia Financiera III, 2015 grants (to J. G.) and Agencia Nacional de Promocion Cientifica y Tecnologica Grant ANPCyT. PICT 1221. The authors declare that they have no conflicts of interest with the contents of this article.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; BROWN MS, 1980, J LIPID RES, V21, P505; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Court H, 2013, J CLIN INVEST, V123, P4681, DOI 10.1172/JCI65764; Cushman I, 2011, CELL ADHES MIGR, V5, P11, DOI 10.4161/cam.5.1.13196; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Do MT, 2017, ONCOGENE, V36, P5757, DOI 10.1038/onc.2017.183; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gentry LR, 2015, J BIOL CHEM, V290, P22851, DOI 10.1074/jbc.M115.656710; Girardini Javier E, 2014, Subcell Biochem, V85, P41, DOI 10.1007/978-94-017-9211-0_3; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Guida E, 2008, CANCER RES, V68, P6550, DOI 10.1158/0008-5472.CAN-08-0137; HABENICHT AJR, 1980, J BIOL CHEM, V255, P5134; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jansen S, 2018, PHARMACOL THERAPEUT, V183, P1, DOI 10.1016/j.pharmthera.2017.09.002; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Lau HY, 2017, ONCOGENE, V36, P3934, DOI 10.1038/onc.2016.508; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Manolaridis I, 2013, NATURE, V504, P301, DOI 10.1038/nature12754; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; QUESNEYHUNEEUS V, 1979, P NATL ACAD SCI USA, V76, P5056, DOI 10.1073/pnas.76.10.5056; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; SMELAND TE, 1994, P NATL ACAD SCI USA, V91, P10712, DOI 10.1073/pnas.91.22.10712; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang B, 2010, CELL CYCLE, V9, P870, DOI 10.4161/cc.9.5.10825; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Zandvakili I, 2017, ONCOGENE, V36, P3213, DOI 10.1038/onc.2016.473; Zhou HC, 2014, ONCOTARGET, V5, P12177, DOI 10.18632/oncotarget.2601	49	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5060	5073		10.1074/jbc.RA118.006037	http://dx.doi.org/10.1074/jbc.RA118.006037			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30655292	Green Published, hybrid			2022-12-28	WOS:000463985600028
J	Cardenas, EI; Gonzalez, R; Breaux, K; Da, Q; Gutierrez, BA; Ramos, MA; Cardenas, RA; Burns, AR; Rumbaut, RE; Adachi, R				Cardenas, Eduardo I.; Gonzalez, Ricardo; Breaux, Keegan; Da, Qi; Gutierrez, Berenice A.; Ramos, Marco A.; Cardenas, Rodolfo A.; Burns, Alan R.; Rumbaut, Rolando E.; Adachi, Roberto			Munc18-2, but not Munc18-1 or Munc18-3, regulates platelet exocytosis, hemostasis, and thrombosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exocytosis; SNARE proteins; platelet; hemostasis; thrombosis; secretion; Munc18	MOLECULAR-MECHANISMS; ALPHA-GRANULE; SYNTAXIN; SECRETION; PROTEINS; SNARE; RELEASE; ACTIVATION; ROLES; MICE	Platelet degranulation, a form of regulated exocytosis, is crucial for hemostasis and thrombosis. Exocytosis in platelets is mediated by SNARE proteins, and in most mammalian cells this process is controlled by Munc18 (mammalian homolog of Caenorhabditis elegans uncoordinated gene 18) proteins. Platelets express all Munc18 paralogs (Munc18-1, -2, and -3), but their roles in platelet secretion and function have not been fully characterized. Using Munc18-1, -2, and -3 conditional knockout mice, here we deleted expression of these proteins in platelets and assessed granule exocytosis. We measured products secreted by each type of platelet granule and analyzed EM platelet profiles by design-based stereology. We observed that the removal of Munc18-2 ablates the release of alpha, dense, and lysosomal granules from platelets, but we found no exocytic role for Munc18-1 or -3 in platelets. In vitro, Munc18-2-deficient platelets exhibited defective aggregation at low doses of collagen and impaired thrombus formation under shear stress. In vivo, megakaryocyte-specific Munc18-2 conditional knockout mice had a severe hemostatic defect and prolonged arterial and venous bleeding times. They were also protected against arterial thrombosis in a chemically induced model of arterial injury. Taken together, our results indicate that Munc18-2, but not Munc18-1 or Munc18-3, is essential for regulated exocytosis in platelets and platelet participation in thrombosis and hemostasis.	[Cardenas, Eduardo I.; Gonzalez, Ricardo; Breaux, Keegan; Gutierrez, Berenice A.; Ramos, Marco A.; Cardenas, Rodolfo A.; Burns, Alan R.; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Cardenas, Eduardo I.; Gonzalez, Ricardo; Gutierrez, Berenice A.] Inst Tecnol Monterrey, Escuela Ingn & Ciencias, Monterrey 64849, Nuevo Leon, Mexico; [Da, Qi; Rumbaut, Rolando E.] Michael E DeBakey VA Med Ctr, CTRID, Houston, TX 77030 USA; [Da, Qi; Rumbaut, Rolando E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Cardenas, Rodolfo A.] Inst Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey 64710, Nuevo Leon, Mexico; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; Baylor College of Medicine; Baylor College of Medicine; Tecnologico de Monterrey; University of Houston System; University of Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	radachi@mdanderson.org		Cardenas, Eduardo/0000-0001-5973-5675; Adachi, Roberto/0000-0002-0146-0768; Rumbaut, Rolando/0000-0002-8486-1013	National Institutes of Health [AI093533A, AI137319, CA016672, HL116524, EY007551]; U.S. Dept. of Veterans Affairs [I01 BX002551]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [352566, 446906, 448085]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY007551] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI137319] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Veterans Affairs(US Department of Veterans Affairs); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This project was supported by National Institutes of Health Grants AI093533A, AI137319, and CA016672 (to R. A.), HL116524 (to R. E. R.), and EY007551 (to A. R. B.). This project was also supported by Merit Review Award I01 BX002551 (to R. E. R.) from the U.S. Dept. of Veterans Affairs. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Department of Veterans Affairs, or the United States government.; These authors were supported by PhD Grant Scholarships 352566 (to E. I. C.), 446906 (to R. G.), and 448085 (to B. A. G.) from the Consejo Nacional de Ciencia y Tecnologia (CONACyT).	Adhikari P, 2018, INFLAMM RES, V67, P1, DOI 10.1007/s00011-017-1097-4; Al Hawas R, 2012, BLOOD, V120, P2493, DOI 10.1182/blood-2012-05-430629; Bin NR, 2013, P NATL ACAD SCI USA, V110, P4610, DOI 10.1073/pnas.1214887110; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Brochetta C, 2008, BBA-MOL CELL RES, V1783, P1781, DOI 10.1016/j.bbamcr.2008.05.023; Cardenas EI, 2018, HAEMATOLOGICA, V103, P1235, DOI 10.3324/haematol.2017.185637; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; Ciferri S, 2000, THROMB HAEMOSTASIS, V83, P157; Da Q, 2015, BLOOD, V126, P2338, DOI 10.1182/blood-2015-05-648030; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Flaumenhaft R, 2005, BLOOD, V105, P3879, DOI 10.1182/blood-2004-04-1392; Flaumenhaft R, 1999, J BIOL CHEM, V274, P2492, DOI 10.1074/jbc.274.4.2492; Graham GJ, 2009, BLOOD, V114, P1083, DOI 10.1182/blood-2009-03-210211; Gutierrez BA, 2018, J BIOL CHEM, V293, P7148, DOI 10.1074/jbc.RA118.002455; Heeroma JH, 2004, EUR J NEUROSCI, V20, P623, DOI 10.1111/j.1460-9568.2004.03503.x; Houng A, 2003, J BIOL CHEM, V278, P19627, DOI 10.1074/jbc.M212465200; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jaramillo AM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124815; Jarvis GE, 2004, PLATELETS, V15, P303, DOI 10.1080/09537100410001710254; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Khan AH, 2001, J BIOL CHEM, V276, P4063, DOI 10.1074/jbc.M007419200; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Lai Y, 2017, NEURON, V95, P591, DOI 10.1016/j.neuron.2017.07.004; Lemons PP, 2000, BIOCHEM BIOPH RES CO, V267, P875, DOI 10.1006/bbrc.1999.2039; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Oh E, 2012, J BIOL CHEM, V287, P25821, DOI 10.1074/jbc.M112.361501; Pagel J, 2012, BLOOD, V119, P6016, DOI 10.1182/blood-2011-12-398958; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Reed GL, 1999, BLOOD, V93, P2617, DOI 10.1182/blood.V93.8.2617.408k19_2617_2626; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Rodarte EM, 2018, J BIOL CHEM, V293, P345, DOI 10.1074/jbc.M117.816884; Sandrock K, 2010, BLOOD, V116, P6148, DOI 10.1182/blood-2010-08-302943; Schneider JP, 2012, METHOD CELL BIOL, V113, P257, DOI 10.1016/B978-0-12-407239-8.00012-4; Schraw TD, 2004, THROMB HAEMOSTASIS, V92, P829, DOI 10.1160/TH04-04-0263; Schraw TD, 2003, BIOCHEM J, V374, P207, DOI 10.1042/BJ20030610; Shen C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9852; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Zhu D, 2015, MOL METAB, V4, P418, DOI 10.1016/j.molmet.2015.02.004	50	5	6	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4784	4792		10.1074/jbc.RA118.006922	http://dx.doi.org/10.1074/jbc.RA118.006922			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30696774	Green Published, hybrid			2022-12-28	WOS:000463985600005
J	Pearce, FG				Pearce, F. Grant			An unexpected sticking point for carboxysome assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RUBISCO; MECHANISM	In order to improve photosynthetic efficiency, bacteria often enclose RubisCO and carbonic anhydrase into microcompartments called carboxysomes. Assembly of these complexes requires a protein called CcmM. It had previously been thought that CcmM mediated RubisCO assembly by displacing one of the RubisCO subunits, Ryan et al. show that despite having a three-dimensional structure that closely resembles the RubisCO small subunit, CcmM does not dislodge it, leading to a proposal for an alternative binding location. These results provide a new model for carboxysome assembly with implications for photosynthetic engineering.	[Pearce, F. Grant] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Pearce, F. Grant] Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8140, New Zealand	University of Canterbury; University of Canterbury	Pearce, FG (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8140, New Zealand.	grant.pearce@canterbury.ac.nz						Bhat JY, 2017, MOL CELL, V67, P744, DOI 10.1016/j.molcel.2017.07.004; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Lin MT, 2014, PLANT J, V79, P1, DOI 10.1111/tpj.12536; Long BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06044-0; Long BM, 2011, PHOTOSYNTH RES, V109, P33, DOI 10.1007/s11120-011-9659-8; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Rae BD, 2017, J EXP BOT, V68, P3717, DOI 10.1093/jxb/erx133; Rae BD, 2013, MICROBIOL MOL BIOL R, V77, P357, DOI 10.1128/MMBR.00061-12; Raunser S, 2009, P NATL ACAD SCI USA, V106, P3160, DOI 10.1073/pnas.0810563106; Ryan P, 2019, J BIOL CHEM, V294, P2593, DOI 10.1074/jbc.RA118.006330	10	0	0	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2604	2605		10.1074/jbc.H119.007530	http://dx.doi.org/10.1074/jbc.H119.007530			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30796174	hybrid, Green Published			2022-12-28	WOS:000459601600003
J	Ramana, KV; Fadl, AA; Tammali, R; Reddy, ABM; Chopra, AK; Srivastava, SK				Ramana, Kota V.; Fadl, Amin A.; Tammali, Ravinder; Reddy, Aramati B. M.; Chopra, Ashok K.; Srivastava, Satish K.			Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages (Expression of Concern of Vol 281, Pg 33019, 2006)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Ramana KV, 2006, J BIOL CHEM, V281, P33019, DOI 10.1074/jbc.M603819200	1	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1633	1633		10.1074/jbc.EC119.007462	http://dx.doi.org/10.1074/jbc.EC119.007462			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710008	hybrid, Green Published			2022-12-28	WOS:000457879200019
J	Sack, J				Sack, John			How Herb Tabor's vision for timely and accessible research led scientific publishing into the online age	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						history; JBC; scientific publishing; web		There was a time not that long ago when scientific communication happened only in print, with research papers, letters to the editor, and all other exchanges just appearing in issues mailed weeks or months after the papers were formally accepted. Learning about this research required a personal subscription to specific journals, a well-funded library, or attendance at conferences to hear the latest results and read newly released journal issues. Even as the web came into existence, the idea of using this new platform to make a scientific journal available around the country or even the world was simply not considered. That is, until the JBC-then under the leadership of Dr. Herb Tabor-decided they must find a way. Working with professors at Stanford and the newly formed Stanford service group, Highwire Press, "JBC Online" was born in 1995. In this article, as a tribute to Dr. Tabor's 100th birthday, I share my perspective and those of others involved in this transition as to what is so remarkable about the JBC going online. Specifically, I describe how Dr. Tabor's governance and leadership of the JBC, and within the American Society for Biochemistry and Molecular Biology, brought together many threads in the research, society, publishing, and technological context of the time to make sure that the JBC not only made this remarkable leap, but made it first and farthest, and paved a path for many other, and now virtually all, journals to follow.	[Sack, John] HighWire Press, Los Gatos, CA 95032 USA		Sack, J (corresponding author), HighWire Press, Los Gatos, CA 95032 USA.	sack@highwirepress.com		Sack, John/0000-0001-7113-5250				Oldach L., 2018, WHO IS H TABOR ASBMB; Sack J, 2005, LEARN PUBL, V18, P131, DOI 10.1087/0953151053584948; Simoni RD, 2005, LEARN PUBL, V18, P127, DOI 10.1087/0953151053584993; The Editor and the Associate Editors, 1999, J BIOL CHEM, V274, P36825	4	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1721	1728		10.1074/jbc.TME118.005088	http://dx.doi.org/10.1074/jbc.TME118.005088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710019	Green Published, hybrid			2022-12-28	WOS:000457879200032
J	Diaz-Perales, A; Quesada, V; Peinado, JR; Ugalde, AP; Alvarez, J; Suarez, MF; Gomis-Ruth, FX; Lopez-Otin, C				Diaz-Perales, Araceli; Quesada, Victor; Peinado, Juan R.; Ugalde, Alejandro P.; Alvarez, Jesus; Suarez, Maria F.; Gomis-Ruth, F. Xavier; Lopez-Otin, Carlos			RETRACTION: Withdrawal: Identification and characterization of human archaemetzincin-1 and-2, two novel members of a family of metalloproteases widely distributed in Archaea. (Retraction of Vol 280, Pg 30367, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Suárez, María Fernanda Valencia/F-8200-2019; Díaz-Perales, Araceli/D-8433-2016; Lopez-Otin, Carlos/AAB-2106-2020; Pineiro Ugalde, Alejandro/AAB-5229-2020	Suárez, María Fernanda Valencia/0000-0001-8987-8431; Díaz-Perales, Araceli/0000-0002-1093-3627; Lopez-Otin, Carlos/0000-0001-6964-1904; Pineiro Ugalde, Alejandro/0000-0003-2522-0627				Diaz-Perales A, 2005, J BIOL CHEM, V280, P30367, DOI 10.1074/jbc.M504533200	1	0	0	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1434	1434		10.1074/jbc.W118.007328	http://dx.doi.org/10.1074/jbc.W118.007328			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30808005	hybrid, Green Published			2022-12-28	WOS:000457879500037
J	Nielsen, LD; Foged, MM; Albert, A; Bertelsen, AB; Soltoft, CL; Robinson, SD; Petersen, SV; Purcell, AW; Olivera, BM; Norton, RS; Vasskog, T; Safavi-Hemami, H; Teilum, K; Ellgaard, L				Nielsen, Lau D.; Foged, Mads M.; Albert, Anastasia; Bertelsen, Andreas B.; Soltoft, Cecilie L.; Robinson, Samuel D.; Petersen, Steen V.; Purcell, Anthony W.; Olivera, Baldomero M.; Norton, Raymond S.; Vasskog, Terje; Safavi-Hemami, Helena; Teilum, Kaare; Ellgaard, Lars			y The three-dimensional structure of an H-superfamily conotoxin reveals a granulin fold arising from a common ICK cysteine framework	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						toxin; protein structure; protein-disulfide isomerase; protein conformation; protein evolution; protein expression; disulfide; conotoxin; inhibitor cystine knot; antistasin; -hairpin; CD spectroscopy; disulfide bond; granulin; NMR spectroscopy; toxin	2 BETA-HAIRPINS; CYSTINE KNOT; VENOM PEPTIDES; CHEMICAL-SHIFTS; PROTEIN; STACK; FAMILY; PHASE; THERAPEUTICS; COEFFICIENTS	Venomous marine cone snails produce peptide toxins (conotoxins) that bind ion channels and receptors with high specificity and therefore are important pharmacological tools. Conotoxins contain conserved cysteine residues that form disulfide bonds that stabilize their structures. To gain structural insight into the large, yet poorly characterized conotoxin H-superfamily, we used NMR and CD spectroscopy along with MS-based analyses to investigate H-Vc7.2 from Conus victoriae, a peptide with a VI/VII cysteine framework. This framework has Cys(I)-Cys(IV)/Cys(II)-Cys(V)/Cys(III)-Cys(VI) connectivities, which have invariably been associated with the inhibitor cystine knot (ICK) fold. However, the solution structure of recombinantly expressed and purified H-Vc7.2 revealed that although it displays the expected cysteine connectivities, H-Vc7.2 adopts a different fold consisting of two stacked -hairpins with opposing -strands connected by two parallel disulfide bonds, a structure homologous to the N-terminal region of the human granulin protein. Using structural comparisons, we subsequently identified several toxins and nontoxin proteins with this mini-granulin fold. These findings raise fundamental questions concerning sequence-structure relationships within peptides and proteins and the key determinants that specify a given fold.	[Nielsen, Lau D.; Foged, Mads M.; Bertelsen, Andreas B.; Soltoft, Cecilie L.; Safavi-Hemami, Helena; Teilum, Kaare; Ellgaard, Lars] Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr Prot Sci, DK-2200 Copenhagen N, Denmark; [Albert, Anastasia; Vasskog, Terje] Norut Northern Res Inst, N-9294 Tromso, Norway; [Robinson, Samuel D.; Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Robinson, Samuel D.; Norton, Raymond S.] Monash Univ, Med Chem, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Petersen, Steen V.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Purcell, Anthony W.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Purcell, Anthony W.] Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Safavi-Hemami, Helena] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	University of Copenhagen; Utah System of Higher Education; University of Utah; Monash University; Aarhus University; Monash University; Monash University; Utah System of Higher Education; University of Utah	Ellgaard, L (corresponding author), Univ Copenhagen, Dept Biol, Linderstrom Lang Ctr Prot Sci, DK-2200 Copenhagen N, Denmark.	lellgaard@bio.ku.dk	Ellgaard, Lars/I-9034-2014; Søltoft, Cecilie L/B-4901-2015; Purcell, Anthony/AAH-1942-2019; Robinson, Samuel/E-5602-2018; Teilum, Kaare/K-4340-2014	Ellgaard, Lars/0000-0002-7018-0137; Søltoft, Cecilie L/0000-0002-3194-0287; Purcell, Anthony/0000-0003-0532-8331; Robinson, Samuel/0000-0002-3518-0377; Nielsen, Lau/0000-0001-5352-0809; Norton, Raymond/0000-0001-8893-0584; Vang Petersen, Steen/0000-0002-9338-911X; Teilum, Kaare/0000-0001-6919-1982	Tromso County Council [1 S10 OD018210 01A1];  [TFK2013-252]	Tromso County Council; 	We thank Nick Williamson, University of Melbourne, and the Mass Spectrometry and Proteomics Core Facility at the University of Utah (spectrometry equipment obtained through a Shared Instrumentation Grant 1 S10 OD018210 01A1) for technical assistance with MS. Norut Northern Research Institute was supported by Tromso County Council Grant TFK2013-252.	Albert A, 2016, ANAL CHEM, V88, P9539, DOI 10.1021/acs.analchem.6b02115; Balsara R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122840; Bansal PS, 2017, J MED CHEM, V60, P4258, DOI 10.1021/acs.jmedchem.7b00047; Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Cash JN, 2012, J BIOL CHEM, V287, P1043, DOI 10.1074/jbc.M111.270801; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gaciarz A, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0419-5; Gao B, 2013, BIOSCIENCE REP, V33, P513, DOI 10.1042/BSR20130052; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; Jin AH, 2017, ANGEW CHEM INT EDIT, V56, P14973, DOI 10.1002/anie.201708927; Kaas Q, 2010, TOXICON, V55, P1491, DOI 10.1016/j.toxicon.2010.03.002; Khoo KK, 2012, AMINO ACIDS, PEPTIDES AND PROTEINS IN ORGANIC CHEMISTRY, VOL 5: ANALYSIS AND FUNCTION OF AMINO ACIDS AND PEPTIDES, P395; Klint JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063865; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lavergne V, 2015, RSC DRUG DISCOV, V42, P37; Lu SY, 1999, J PROTEIN CHEM, V18, P609, DOI 10.1023/A:1020663619657; Menting JG, 2016, NAT STRUCT MOL BIOL, V23, P916, DOI 10.1038/nsmb.3292; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Moilanen A, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800090; Nguyen MN, 2011, NUCLEIC ACIDS RES, V39, pW24, DOI 10.1093/nar/gkr393; Nguyen MN, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr348; Nguyen VD, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-1; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; O'Brien H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113418; Olivera B. M., 2017, CHEM BIOL NATURAL PR, P425; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Palfree RGE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133749; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Pennington MW, 2018, BIOORGAN MED CHEM, V26, P2738, DOI 10.1016/j.bmc.2017.09.029; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Postic G, 2018, NUCLEIC ACIDS RES, V46, pD454, DOI 10.1093/nar/gkx1084; Ram N, 2008, J BIOL CHEM, V283, P27048, DOI 10.1074/jbc.M804727200; Rester U, 1999, J MOL BIOL, V293, P93, DOI 10.1006/jmbi.1999.3162; Robinson SD, 2017, NEUROPHARMACOLOGY, V127, P79, DOI 10.1016/j.neuropharm.2017.07.001; Robinson SD, 2017, EXPERT REV PROTEOMIC, V14, P931, DOI 10.1080/14789450.2017.1377613; Robinson SD, 2015, J PROTEOMICS, V114, P38, DOI 10.1016/j.jprot.2014.11.003; Robinson SD, 2014, MAR DRUGS, V12, P6058, DOI 10.3390/md12126058; Robinson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087648; Rogov VV, 2012, CHEMBIOCHEM, V13, P959, DOI 10.1002/cbic.201200045; Safavi-Hemami H, 2019, J PROTEOMICS, V190, P12, DOI 10.1016/j.jprot.2018.05.009; Safavi-Hemami H, 2016, P NATL ACAD SCI USA, V113, P3227, DOI 10.1073/pnas.1525790113; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Tolkatchev D, 2001, J PEPT RES, V57, P227, DOI 10.1046/j.1397-002X.2000.00828.x; Tolkatchev D, 2000, BIOCHEMISTRY-US, V39, P2878, DOI 10.1021/bi992130u; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Turchetto J, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-016-0617-1; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Undheim EAB, 2016, BIOESSAYS, V38, P539, DOI 10.1002/bies.201500165; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Vranken WF, 1999, J PEPT RES, V53, P590, DOI 10.1034/j.1399-3011.1999.00048.x; WOODWARD SR, 1990, EMBO J, V9, P1015, DOI 10.1002/j.1460-2075.1990.tb08204.x; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Xu SQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14261; Yao SG, 2000, J BIOMOL NMR, V16, P109, DOI 10.1023/A:1008382624724	64	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8745	8759		10.1074/jbc.RA119.007491	http://dx.doi.org/10.1074/jbc.RA119.007491			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30975904	Green Published, hybrid			2022-12-28	WOS:000470971100011
J	Peng, ZS; Chen, JY; Drachenberg, CB; Raufman, JP; Xie, GF				Peng, Zhongsheng; Chen, Jiayan; Drachenberg, Cinthia B.; Raufman, Jean-Pierre; Xie, Guofeng			Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; matrix metalloproteinase (MMP); colorectal cancer; tumor suppressor gene; bile acid; FXR response element; gene promoter; oncogenesis; transcriptional regulation; transcriptional repression	BILE-ACIDS; INDUCED PROLIFERATION; FXR; GENE; TRANSACTIVATION; RISK; CHOLECYSTECTOMY; IDENTIFICATION; ACTIVATION; INHIBITORS	The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily of bile acid-activated transcription factors and an important regulator of cell proliferation, apoptosis, and Wnt signaling. Down-regulated expression of FXR plays an important role in some malignancies such as colon cancer, and in rodent models of intestinal neoplasia, FXR knockout increases the size and number of colon tumors. These previous observations implicate FXR as a tumor suppressor, but the underlying molecular mechanisms are unclear. Employing complementary experimental approaches and using human colon cancer specimens, human and murine colon cancer cell lines, and FXR transgenic mice, here we identified an additional, potentially important role for FXR. We observed an inverse relationship between the expression of FXR and matrix metalloproteinase-7 (MMP7), a collagenase and signaling molecule consistently associated with colon cancer progression. We noted that FXR gene ablation increases MMP7 expression. Consistent with this finding, FXR overexpression and a dominant-negative FXR mutation reduced and augmented, respectively, MMP7 expression. Of note, MMP7 was the only MMP gene family member whose expression was down-regulated after FXR activation. FXR-mediated regulation of MMP7 transcription did not require heterodimerization with the retinoid X receptor (RXR), indicating that FXR represses MMP7 expression independently of RXR. Last, we uncovered that FXR suppresses MMP7 transcription by binding to a negative FXR-responsive element in the 5 MMP7 promoter, an event that inhibited colon cancer cell proliferation and invasion. These findings identify the FXR-MMP7 axis as a potential therapeutic target for managing colon cancer.	[Peng, Zhongsheng; Chen, Jiayan; Raufman, Jean-Pierre; Xie, Guofeng] Univ Maryland, Sch Med, Vet Affairs Maryland Healthcare Syst, Dept Med,Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA; [Peng, Zhongsheng; Chen, Jiayan; Raufman, Jean-Pierre; Xie, Guofeng] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Drachenberg, Cinthia B.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Xie, GF (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA.	gxie@som.umaryland.edu		Raufman, Jean-Pierre/0000-0002-6340-4382	Veterans Affairs Merit Awards from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program [BX002777, BX002129]; Veterans Affairs [I01BX002129, I01BX002777] Funding Source: NIH RePORTER	Veterans Affairs Merit Awards from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Awards BX002777 (to G. X.) and BX002129 (to J. P. R.) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program. The contents do not represent the views of the United States Department of Veterans Affairs or the United States Government. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi Y, 1999, GUT, V45, P252, DOI 10.1136/gut.45.2.252; Alaseem A, 2019, SEMIN CANCER BIOL, V56, P100, DOI 10.1016/j.semcancer.2017.11.008; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Bailey AM, 2014, AM J PHYSIOL-GASTR L, V306, pG48, DOI 10.1152/ajpgi.00234.2013; Bajor A, 2010, SCAND J GASTROENTERO, V45, P645, DOI 10.3109/00365521003702734; Barbier O, 2003, GASTROENTEROLOGY, V124, P1926, DOI 10.1016/S0016-5085(03)00388-3; Belo A, 2011, AM J PHYSIOL-GASTR L, V300, pG749, DOI 10.1152/ajpgi.00306.2010; BERG A, 1973, POPUL BULL, V29, P3; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; BIANCHINI F, 1989, J NUTR, V119, P1617, DOI 10.1093/jn/119.11.1617; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Ceulemans LJ, 2016, ACTA CHIR BELG, V116, P156, DOI 10.1080/00015458.2016.1215953; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; Cheng KR, 2005, BIOCHEM PHARMACOL, V70, P1035, DOI 10.1016/j.bcp.2005.07.023; Cheng KR, 2003, CANCER RES, V63, P6744; Cheng KR, 2002, BBA-MOL BASIS DIS, V1588, P48, DOI 10.1016/S0925-4439(02)00115-1; Cheng KR, 2007, BIOCHEM PHARMACOL, V73, P1001, DOI 10.1016/j.bcp.2006.11.028; Cheng KR, 2017, ONCOTARGET, V8, P21106, DOI 10.18632/oncotarget.15500; Cheng KR, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-77; Claudel T, 2002, J CLIN INVEST, V109, P961; Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; De Gottardi A, 2004, DIGEST DIS SCI, V49, P982; Degirolamo C, 2011, TRENDS MOL MED, V17, P564, DOI 10.1016/j.molmed.2011.05.010; Dussault I, 2003, J BIOL CHEM, V278, P7027, DOI 10.1074/jbc.M209863200; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; Fiorucci S, 2005, J PHARMACOL EXP THER, V313, P604, DOI 10.1124/jpet.104.079665; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Gadaleta RM, 2017, MOL ASPECTS MED, V56, P66, DOI 10.1016/j.mam.2017.04.002; GAIRE M, 1994, J BIOL CHEM, V269, P2032; GIOVANNUCCI E, 1993, GASTROENTEROLOGY, V105, P130, DOI 10.1016/0016-5085(93)90018-8; Grivas PD, 2013, CANCER-AM CANCER SOC, V119, P1120, DOI 10.1002/cncr.27908; Hasegawa S, 1998, INT J CANCER, V76, P812, DOI 10.1002/(SICI)1097-0215(19980610)76:6<812::AID-IJC8>3.0.CO;2-0; Kirkegaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5504; Kowdley KV, 2018, HEPATOLOGY, V67, P1890, DOI 10.1002/hep.29569; Lagergren J, 2001, GASTROENTEROLOGY, V121, P542, DOI 10.1053/gast.2001.27083; Lax S, 2012, INT J CANCER, V130, P2232, DOI 10.1002/ijc.26293; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lian F, 2011, BIOCHEM J, V438, P315, DOI 10.1042/BJ20102096; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Marshall DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127063; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Modjtahedi H, 2009, ANTI-CANCER DRUG, V20, P851, DOI 10.1097/CAD.0b013e3283330590; MORI M, 1995, CANCER, V75, P1516, DOI 10.1002/1097-0142(19950315)75:6+<1516::AID-CNCR2820751522>3.0.CO;2-7; Overman MJ, 2007, DIS COLON RECTUM, V50, P1259, DOI 10.1007/s10350-007-0228-3; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Peng ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048461; Popowski K, 2005, MOL PHARMACOL, V67, P1629, DOI 10.1124/mol.104.010223; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Raufman JP, 2015, CARCINOGENESIS, V36, P1193, DOI 10.1093/carcin/bgv107; Raufman JP, 2003, DIGEST DIS SCI, V48, P1431, DOI 10.1023/A:1024733500950; REDDY BS, 1978, CANCER-AM CANCER SOC, V42, P2832, DOI 10.1002/1097-0142(197812)42:6<2832::AID-CNCR2820420644>3.0.CO;2-L; Said AH, 2014, CANCERS, V6, P366, DOI 10.3390/cancers6010366; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Sipples Rebecca, 2006, Semin Oncol Nurs, V22, P28, DOI 10.1016/j.soncn.2006.01.013; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Venook AP, 2005, CANCER-AM CANCER SOC, V103, P2435, DOI 10.1002/cncr.21123; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; WITTY JP, 1994, CANCER RES, V54, P4805; Xie GF, 2009, AM J PHYSIOL-GASTR L, V296, pG755, DOI 10.1152/ajpgi.90519.2008; Yasumitsu H, 2017, METHODS MOL BIOL, V1626, P13, DOI 10.1007/978-1-4939-7111-4_2; Zucker S, 2004, CANCER METAST REV, V23, P101, DOI 10.1023/A:1025867130437	71	24	24	7	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8529	8542		10.1074/jbc.RA118.004361	http://dx.doi.org/10.1074/jbc.RA118.004361			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30967475	Green Published, hybrid			2022-12-28	WOS:000471108200021
J	Pedchenko, V; Bauer, R; Pokidysheva, EN; Al-Shaer, A; Forde, NR; Fidler, AL; Hudson, BG; Boudko, SP				Pedchenko, Vadim; Bauer, Ryan; Pokidysheva, Elena N.; Al-Shaer, Alaa; Forde, Nancy R.; Fidler, Aaron L.; Hudson, Billy G.; Boudko, Sergei P.			A chloride ring is an ancient evolutionary innovation mediating the assembly of the collagen IV scaffold of basement membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; basement membrane; protein self-assembly; crystal structure; extracellular matrix; kinetics; connective tissue; animal evolution; chloride; collagen IV; ECM; NC1 domain	CRYSTAL-STRUCTURE; ANALYTICAL ULTRACENTRIFUGATION; NETWORK; DOMAINS; FIBRILLOGENESIS; STABILIZATION; RECOGNITION; STABILITY; CELLS	Collagen IV scaffold is a principal component of the basement membrane (BM), a specialized extracellular matrix that is essential for animal multicellularity and tissue evolution. Scaffold assembly begins with the trimerization of -chains into protomers inside the cell, which then are secreted and undergo oligomerization outside the cell. For the ubiquitous scaffold composed of 1- and 2-chains, both intracellular and extracellular stages are mediated by the noncollagenous domain (NC1). The association of protomers is chloride-dependent, whereby chloride ions induce interactions of the protomers' trimeric NC1 domains leading to NC1 hexamer formation. Here, we investigated the mechanisms, kinetics, and functionality of the chloride ion-mediated protomer assembly by using a single-chain technology to produce a stable NC1 trimer comprising 1, 2, and 1 NC1 monomers. We observed that in the presence of chloride, the single-chain NC1-trimer self-assembles into a hexamer, for which the crystal structure was determined. We discovered that a chloride ring, comprising 12 ions, induces the assembly of and stabilizes the NC1 hexamer. Furthermore, we found that the chloride ring is evolutionarily conserved across all animals, first appearing in cnidarians. These findings reveal a fundamental role for the chloride ring in the assembly of collagen IV scaffolds of BMs, a critical event enabling tissue evolution and development. Moreover, the single-chain technology is foundational for generating trimeric NC1 domains of other -chain compositions to investigate the 121, 345, and 565 collagen IV scaffolds and to develop therapies for managing Alport syndrome, Goodpasture's disease, and cancerous tumor growth.	[Pedchenko, Vadim; Bauer, Ryan; Pokidysheva, Elena N.; Fidler, Aaron L.; Hudson, Billy G.; Boudko, Sergei P.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Pedchenko, Vadim; Bauer, Ryan; Pokidysheva, Elena N.; Fidler, Aaron L.; Hudson, Billy G.; Boudko, Sergei P.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Matrix Biol, Nashville, TN 37232 USA; [Al-Shaer, Alaa; Forde, Nancy R.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Forde, Nancy R.] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Fidler, Aaron L.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Aspirnaut Program, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Simon Fraser University; Simon Fraser University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Boudko, SP (corresponding author), Vanderbilt Univ, Dept Med, Div Nephrol, Med Ctr, Nashville, TN 37232 USA.	sergey.budko@vanderbilt.edu	Fidler, Aaron L./C-4031-2014; Forde, Nancy R/D-8865-2015	Fidler, Aaron L./0000-0002-2519-8864; Forde, Nancy R/0000-0002-5479-7073; Boudko, Sergei/0000-0003-3856-4859	Vanderbilt Center for Matrix Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007569, R01DK018381, R25DK096999] Funding Source: NIH RePORTER	Vanderbilt Center for Matrix Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Vanderbilt Center for Structural Biology for use of the Protein Characterization and Biomolecular Crystallography facilities and the Vanderbilt Center for Matrix Biology for support. Technical assistance from Neonila Danylevych and Mohamed Rafi is appreciated.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boudko SP, 2018, METHOD CELL BIOL, V143, P171, DOI 10.1016/bs.mcb.2017.08.010; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Brown KL, 2017, PROTEIN SCI, V26, P2151, DOI 10.1002/pro.3283; Casino P, 2018, IUCRJ, V5, P765, DOI 10.1107/S2052252518012459; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cummings CF, 2016, J CELL BIOL, V213, P479, DOI 10.1083/jcb.201510065; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Delorenzi NJ, 1996, INT J BIOL MACROMOL, V19, P15, DOI 10.1016/0141-8130(96)01094-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fidler AL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.203950; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Harris JR, 2013, MICRON, V49, P60, DOI 10.1016/j.micron.2013.03.004; Hjorleifsson JG, 2017, BIOCHEMISTRY-US, V56, P5075, DOI [10.1021/acs.blochem.7b00690, 10.1021/acs.biochem.7b00690]; Hong P, 2012, J LIQ CHROMATOGR R T, V35, P2923, DOI 10.1080/10826076.2012.743724; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Inman JL, 2015, DEVELOPMENT, V142, P1028, DOI 10.1242/dev.087643; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min XS, 2012, FEBS LETT, V586, P912, DOI 10.1016/j.febslet.2012.02.024; Moreau C, 2016, FRONT IMMUNOL, V7, DOI [10.3389/firmnu.2015.DDD79, 10.3389/fimmu.2016.00079]; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; OZCELIK U, 1994, EUR J PEDIATR, V153, P829; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Pfortmueller CA, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0174-5; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rezaei N, 2018, BIOPHYS J, V115, P1457, DOI 10.1016/j.bpj.2018.09.003; Schrodinger LLC, 2016, PYMOL MOL GRAPH SYST; Sekiguchi R, 2018, CURR TOP DEV BIOL, V130, P143, DOI 10.1016/bs.ctdb.2018.02.005; Sherwood DR, 2015, J CELL BIOL, V210, P369, DOI 10.1083/jcb.201501083; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; VRACKO R, 1974, AM J PATHOL, V77, P314; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	47	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					7968	7981		10.1074/jbc.RA119.007426	http://dx.doi.org/10.1074/jbc.RA119.007426			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30923125	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000470656500001
J	Alfano, M; Perard, J; Carpentier, P; Basset, C; Zambelli, B; Timm, J; Crouzy, S; Ciurli, S; Cavazza, C				Alfano, Marila; Perard, Julien; Carpentier, Philippe; Basset, Christian; Zambelli, Barbara; Timm, Jennifer; Crouzy, Serge; Ciurli, Stefano; Cavazza, Christine			The carbon monoxide dehydrogenase accessory protein CooJ is a histidine-rich multidomain dimer containing an unexpected Ni(II)-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; metal ion-protein interaction; small-angle X-ray scattering (SAXS); X-ray crystallography; molecular modeling; structural biology; carbon monoxide dehydrogenase; enzyme maturation; histidine-rich cluster; nickel-binding protein	RHODOSPIRILLUM-RUBRUM; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; NICKEL INSERTION; IN-VIVO; DYNAMICS; BINDING; REVEALS; MACROMOLECULES	Activation of nickel enzymes requires specific accessory proteins organized in multiprotein complexes controlling metal transfer to the active site. Histidine-rich clusters are generally present in at least one of the metallochaperones involved in nickel delivery. The maturation of carbon monoxide dehydrogenase in the proteobacterium Rhodospirillum rubrum requires three accessory proteins, CooC, CooT, and CooJ, dedicated to nickel insertion into the active site, a distorted [NiFe3S4] cluster coordinated to an iron site. Previously, CooJ from R. rubrum (RrCooJ) has been described as a nickel chaperone with 16 histidines and 2 cysteines at its C terminus. Here, the X-ray structure of a truncated version of RrCooJ, combined with small-angle X-ray scattering data and a modeling study of the full-length protein, revealed a homodimer comprising a coiled coil with two independent and highly flexible His tails. Using isothermal calorimetry, we characterized several metal-binding sites (four per dimer) involving the His-rich motifs and having similar metal affinity (K-D = 1.6 m). Remarkably, biophysical approaches, site-directed mutagenesis, and X-ray crystallography uncovered an additional nickel-binding site at the dimer interface, which binds Ni(II) with an affinity of 380 nm. Although RrCooJ was initially thought to be a unique protein, a proteome database search identified at least 46 bacterial CooJ homologs. These homologs all possess two spatially separated nickel-binding motifs: a variable C-terminal histidine tail and a strictly conserved H(W/F)X2HX3H motif, identified in this study, suggesting a dual function for CooJ both as a nickel chaperone and as a nickel storage protein.	[Alfano, Marila; Perard, Julien; Carpentier, Philippe; Basset, Christian; Timm, Jennifer; Crouzy, Serge; Cavazza, Christine] Univ Grenoble Alpes, Lab Chem & Biol Met, CNRS, CEA, F-38000 Grenoble, France; [Zambelli, Barbara; Ciurli, Stefano] Univ Bologna, Dept Pharm & Biotechnol, Lab Bioinorgan Chem, I-40127 Bologna, Italy; [Timm, Jennifer] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Bologna; University of Massachusetts System; University of Massachusetts Worcester	Cavazza, C (corresponding author), Univ Grenoble Alpes, Lab Chem & Biol Met, CNRS, CEA, F-38000 Grenoble, France.	christine.cavazza@cea.fr	Carpentier, Philippe/AAF-5995-2019; Ciurli, Stefano/K-4355-2014; Cavazza, Christine/AAL-5795-2020	Ciurli, Stefano/0000-0001-9557-926X; Timm, Jennifer/0000-0001-9750-3293	ITERLIS Ph.D. program, CEA Life Sciences Ph.D. fund; FUNBIOCO Project (IDEX-UGA, Initiatives de Recherche Strategiques); COSYNBIO project (Projets Exploratoires, Cellule Energie-CNRS); Department of Pharmacy and Biotechnology of the University of Bologna; Labex ARCANE; CBH-EUR-GS Grant [ANR-17-EURE-0003]; European Community's Seventh Framework Programme H2020 under iNEXT H2020 [653706]; COST Action FeSBioNet [CA15133]	ITERLIS Ph.D. program, CEA Life Sciences Ph.D. fund; FUNBIOCO Project (IDEX-UGA, Initiatives de Recherche Strategiques); COSYNBIO project (Projets Exploratoires, Cellule Energie-CNRS); Department of Pharmacy and Biotechnology of the University of Bologna; Labex ARCANE; CBH-EUR-GS Grant; European Community's Seventh Framework Programme H2020 under iNEXT H2020; COST Action FeSBioNet(European Cooperation in Science and Technology (COST))	This work was supported by the ITERLIS Ph.D. program, CEA Life Sciences Ph.D. funding (to M.A.), the FUNBIOCO Project (IDEX-UGA, Initiatives de Recherche Strategiques), the COSYNBIO project (Projets Exploratoires, Cellule Energie-CNRS), and the Department of Pharmacy and Biotechnology of the University of Bologna. This work has also been supported in part by Labex ARCANE and CBH-EUR-GS Grant ANR-17-EURE-0003. The research leading to these results has received funding from the European Community's Seventh Framework Programme H2020 under iNEXT H2020 Grant 653706 and networking support from COST Action FeSBioNet Contract CA15133. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alfano M, 2018, SUSTAIN ENERG FUELS, V2, P1653, DOI 10.1039/c8se00085a; Banaszak K, 2012, BIOCHEM J, V441, P1017, DOI 10.1042/BJ20111659; BONAM D, 1988, P NATL ACAD SCI USA, V85, P31, DOI 10.1073/pnas.85.1.31; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Colpas GJ, 2000, J BIOL CHEM, V275, P10731, DOI 10.1074/jbc.275.15.10731; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Desguin B, 2016, P NATL ACAD SCI USA, V113, P5598, DOI 10.1073/pnas.1600486113; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fox JD, 1996, J BACTERIOL, V178, P6200, DOI 10.1128/jb.178.21.6200-6208.1996; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hassan SA, 2003, PROTEINS, V51, P109, DOI 10.1002/prot.10330; He YP, 1996, J BIOL CHEM, V271, P120, DOI 10.1074/jbc.271.1.120; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeon WB, 2005, J BIOL INORG CHEM, V10, P903, DOI 10.1007/s00775-005-0043-z; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Jiang W, 2009, J CHEM THEORY COMPUT, V5, P2583, DOI 10.1021/ct900223z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerby RL, 1997, J BACTERIOL, V179, P2259, DOI 10.1128/jb.179.7.2259-2266.1997; Khorasani-Motlagh M, 2017, METALLOMICS, V9, P482, DOI 10.1039/c7mt00037e; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacasse MJ, 2016, BIOCHEMISTRY-US, V55, P6821, DOI 10.1021/acs.biochem.6b00706; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mueller-Dieckmann C, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15070-0; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; Perard J, 2016, BIOCHEMISTRY-US, V55, P1503, DOI 10.1021/acs.biochem.5b01061; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Real-Guerra R, 2012, PLANT MOL BIOL, V78, P461, DOI 10.1007/s11103-012-9878-1; SCHULTZ JE, 1982, J BACTERIOL, V149, P181, DOI 10.1128/JB.149.1.181-190.1982; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sliz P, 1997, STRUCTURE, V5, P775, DOI 10.1016/S0969-2126(97)00232-3; Spangler NJ, 1996, J BIOL CHEM, V271, P7973, DOI 10.1074/jbc.271.14.7973; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Sydor AM, 2014, J BIOL CHEM, V289, P3828, DOI 10.1074/jbc.M113.502781; Timm J, 2017, METALLOMICS, V9, P575, DOI 10.1039/c7mt00063d; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Vinella D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005312; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Watt RK, 1999, J BACTERIOL, V181, P4554, DOI 10.1128/JB.181.15.4554-4560.1999; Watt RK, 1998, J BIOL CHEM, V273, P10019, DOI 10.1074/jbc.273.16.10019; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XW, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4737094; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	52	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7601	7614		10.1074/jbc.RA119.008011	http://dx.doi.org/10.1074/jbc.RA119.008011			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30858174	Green Published, hybrid			2022-12-28	WOS:000470153300008
J	Mehrpouya-Bahrami, P; Miranda, K; Singh, NP; Zumbrun, EE; Nagarkatti, M; Nagarkatti, PS				Mehrpouya-Bahrami, Pegah; Miranda, Kathryn; Singh, Narendra P.; Zumbrun, Elizabeth E.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.			Role of microRNA in CB1 antagonist-mediated regulation of adipose tissue macrophage polarization and chemotaxis during diet-induced obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cannabinoid receptor type 1 (CB1); macrophage; microRNA (miRNA); obesity; adipose tissue; SR141716A; Netrin-1; Unc5b; AGAP-2; inflammation	INSULIN-RESISTANCE; ALTERNATIVE ACTIVATION; DEPENDENT INDUCTION; RISK-FACTORS; FOOD-INTAKE; IN-VIVO; INFLAMMATION; RIMONABANT; EXPRESSION; MONOCYTE	Although cannabinoid receptor 1 (CB1) antagonists have been shown to attenuate diet-induced obesity (DIO) and associated inflammation, the precise molecular mechanisms involved are not clear. In the current study, we investigated the role of microRNA (miR) in the regulation of adipose tissue macrophage (ATM) phenotype following treatment of DIO mice with the CB1 antagonist SR141716A. DIO mice were fed high-fat diet (HFD) for 12 weeks and then treated daily with SR141716A (10 mg/kg) for 4 weeks while continuing HFD. Treated mice experienced weight loss, persistent reduction in fat mass, improvements in metabolic profile, and decreased adipose inflammation. CB1 blockade resulted in down-regulation of several miRs in ATMs, including the miR-466 family and miR-762. Reduced expression of the miR-466 family led to induction of anti-inflammatory M2 transcription factors KLF4 and STAT6, whereas down-regulation of miR-762 promoted induction of AGAP-2, a negative regulator of the neuroimmune retention cues, Netrin-1 and its coreceptor UNC5B. Furthermore, treatment of primary macrophages with SR141716A up-regulated KLF4 and STAT6, reduced secretion of Netrin-1, and increased migration toward the lymph node chemoattractant CCL19. These studies demonstrate for the first time that CB1 receptor blockade attenuates DIO-associated inflammation through alterations in ATM miR expression that promote M2 ATM polarization and macrophage egress from adipose tissue. The current study also identifies additional novel therapeutic targets for diet-induced obesity and metabolic disorder.	[Mehrpouya-Bahrami, Pegah; Miranda, Kathryn; Singh, Narendra P.; Zumbrun, Elizabeth E.; Nagarkatti, Mitzi; Nagarkatti, Prakash S.] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Nagarkatti, PS (corresponding author), Univ South Carolina, 202 Osborne Adm Bldg, Columbia, SC 29208 USA.	prakash@mailbox.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Miranda, Kathryn/0000-0003-0922-7546	National Institutes of Health [P01AT003961, P20GM103641, R01AT006888, R01ES019313, R01MH094755]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01AT003961, P20GM103641, R01AT006888, R01ES019313, and R01MH094755. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00688; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eisenstein A, 2014, J BIOL CHEM, V289, P21071, DOI 10.1074/jbc.M114.566406; Enos RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094897; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esser N, 2013, DIABETOLOGIA, V56, P2487, DOI 10.1007/s00125-013-3023-9; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Gauthier BR, 2006, NAT MED, V12, P36, DOI 10.1038/nm0106-36; Ge Q, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/987285; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; He KY, 2011, MOL BIOL CELL, V22, P1943, DOI 10.1091/mbc.E10-11-0923; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Khan JA, 2011, GENE THER, V18, P437, DOI 10.1038/gt.2010.155; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Li YS, 2013, IMMUNITY, V39, P885, DOI 10.1016/j.immuni.2013.10.011; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Mehrpouya-Bahrami P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15154-6; Miranda K, 2018, INT J OBESITY, V42, P1140, DOI 10.1038/s41366-018-0114-1; O'Rourke RW, 2011, DIABETOLOGIA, V54, P1480, DOI 10.1007/s00125-011-2103-y; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Perkins JM, 2008, CURR DIABETES REP, V8, P12, DOI 10.1007/s11892-008-0004-3; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Sacerdote P, 2005, J NEUROIMMUNOL, V159, P97, DOI 10.1016/j.jneuroim.2004.10.003; Sam AH, 2011, J OBES, V2011, DOI 10.1155/2011/432607; Schafer A, 2008, BRIT J PHARMACOL, V154, P1047, DOI 10.1038/bjp.2008.158; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; SOFIA RD, 1974, PSYCHOPHARMACOLOGIA, V39, P213, DOI 10.1007/BF00421028; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang Q, 2011, OBESITY, V19, P505, DOI 10.1038/oby.2010.213; Wang WW, 2009, AM J PATHOL, V175, P1010, DOI 10.2353/ajpath.2009.090224; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Yang XS, 2014, MOL ENDOCRINOL, V28, P565, DOI 10.1210/me.2013-1293; Zhang YY, 2013, INT J MOL MED, V31, P797, DOI 10.3892/ijmm.2013.1260; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	63	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7669	7681		10.1074/jbc.RA118.005094	http://dx.doi.org/10.1074/jbc.RA118.005094			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30910812	Green Published, hybrid			2022-12-28	WOS:000470153300013
J	Hoffmann, L; Anders, K; Bischof, LF; Ye, X; Reimann, J; Khadouma, S; Pham, TK; van der Does, C; Wright, PC; Essen, LO; Albers, SV				Hoffmann, Lena; Anders, Katrin; Bischof, Lisa F.; Ye, Xing; Reimann, Julia; Khadouma, Sunia; Pham, Trong K.; van der Does, Chris; Wright, Phillip C.; Essen, Lars-Oliver; Albers, Sonja-Verena			Structure and interactions of the archaeal motility repression module ArnA-ArnB that modulates archaellum gene expression in Sulfolobus acidocaldarius	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; cell motility; protein phosphorylation; signal transduction; transcription regulation	FHA DOMAIN; CRYSTAL-STRUCTURE; PROTEIN-KINASES; A-DOMAIN; PHOSPHORYLATION; CLUSTER; SYSTEM	Phosphorylation-dependent interactions play crucial regulatory roles in all domains of life. Forkhead-associated (FHA) and von Willebrand type A (vWA) domains are involved in several phosphorylation-dependent processes of multiprotein complex assemblies. Although well-studied in eukaryotes and bacteria, the structural and functional contexts of these domains are not yet understood in Archaea. Here, we report the structural base for such an interacting pair of FHA and vWA domain-containing proteins, ArnA and ArnB, in the thermoacidophilic archaeon Sulfolobus acidocaldarius, where they act synergistically and negatively modulate motility. The structure of the FHA domain of ArnA at 1.75 resolution revealed that it belongs to the subclass of FHA domains, which recognizes double-pSer/pThr motifs. We also solved the 1.5 resolution crystal structure of the ArnB paralog vWA2, disclosing a complex topology comprising the vWA domain, a -sandwich fold, and a C-terminal helix bundle. We further show that ArnA binds to the C terminus of ArnB, which harbors all the phosphorylation sites identified to date and is important for the function of ArnB in archaellum regulation. We also observed that expression levels of the archaellum components in response to changes in nutrient conditions are independent of changes in ArnA and ArnB levels and that a strong interaction between ArnA and ArnB observed during growth on rich medium sequentially diminishes after nutrient limitation. In summary, our findings unravel the structural features in ArnA and ArnB important for their interaction and functional archaellum expression and reveal how nutrient conditions affect this interaction.	[Hoffmann, Lena; Bischof, Lisa F.; Ye, Xing; Reimann, Julia; Khadouma, Sunia; van der Does, Chris; Albers, Sonja-Verena] Univ Freiburg, Mol Biol Archaea, Inst Biol 2, Schaenzlestr 1, D-79104 Freiburg, Germany; [Bischof, Lisa F.] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Anders, Katrin; Essen, Lars-Oliver] Philipps Univ, Dept Chem, D-35032 Marburg, Germany; [Essen, Lars-Oliver] LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany; [Pham, Trong K.] Univ Sheffield, Dept Chem & Biol Engn, ChELSI Inst, Sheffield S1 3JD, S Yorkshire, England; [Wright, Phillip C.] Newcastle Univ, Fac Sci Agr & Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Freiburg; University of Freiburg; Philipps University Marburg; University of Sheffield; Newcastle University - UK	Albers, SV (corresponding author), Univ Freiburg, Mol Biol Archaea, Inst Biol 2, Schaenzlestr 1, D-79104 Freiburg, Germany.; Essen, LO (corresponding author), Univ Marburg, Dept Chem, Hans Meerwein Str, D-35032 Marburg, Germany.	essen@chemie.uni-marburg.de; sonja.albers@biologie.uni-freiburg.de	Essen, Lars-Oliver/L-3862-2016; Albers, Sonja-Verena/H-8689-2019	Essen, Lars-Oliver/0000-0003-4272-4026; Albers, Sonja-Verena/0000-0003-2459-2226	European Union's Horizon 2020 research and innovation program [686647]; Excellence Initiative of the German Research Foundation (Spemann Graduate School); Germany Research Council [SFB746]; Chinese Scholarship Council; Industrial Biotechnology Catalyst (Innovate UK) [BB/M018172/1, BBSRC BB/M012166/1]; Industrial Biotechnology Catalyst (BBSRC) [BB/M018172/1, BBSRC BB/M012166/1]; Industrial Biotechnology Catalyst (EPSRC) [BB/M018172/1, BBSRC BB/M012166/1];  [SFB987]; BBSRC [BB/M018172/1, BB/M012166/1] Funding Source: UKRI	European Union's Horizon 2020 research and innovation program; Excellence Initiative of the German Research Foundation (Spemann Graduate School); Germany Research Council; Chinese Scholarship Council(China Scholarship Council); Industrial Biotechnology Catalyst (Innovate UK); Industrial Biotechnology Catalyst (BBSRC); Industrial Biotechnology Catalyst (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union's Horizon 2020 research and innovation program under Grant Agreement 686647 (MARA; to S.-V. A. and L.H.); in part by the Excellence Initiative of the German Research Foundation (Spemann Graduate School (to L. F. B.)) and the Germany Research Council in frame of the SFB746 (to S.-V. A. and L. F. B.); by a Chinese Scholarship Council Ph.D. scholarship (to X. Y.); by Industrial Biotechnology Catalyst (Innovate UK, BBSRC, EPSRC) Grants BB/M018172/1 and BBSRC BB/M012166/1 (to T. K. P. and P. C. W.); and by funds from SFB987 (to L.-O. E. and S.-V. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albers SV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00023; Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bewley MA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008193; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BORK P, 1991, BIOCHEM J, V279, P908, DOI 10.1042/bj2790908; Cho KY, 1999, MOL MICROBIOL, V34, P714, DOI 10.1046/j.1365-2958.1999.01633.x; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Duan X, 2011, BIOCHEM BIOPH RES CO, V407, P242, DOI 10.1016/j.bbrc.2011.03.011; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; EDWARDS YJK, 1995, FEBS LETT, V358, P283, DOI 10.1016/0014-5793(94)01447-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esser D, 2012, J PROTEOME RES, V11, P4823, DOI 10.1021/pr300190k; Haurat MF, 2017, MOL MICROBIOL, V103, P181, DOI 10.1111/mmi.13550; Hoffmann L, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.414; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lassak K, 2013, MOL MICROBIOL, V88, P125, DOI 10.1111/mmi.12173; Lassak K, 2012, MOL MICROBIOL, V83, P110, DOI 10.1111/j.1365-2958.2011.07916.x; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Li J, 2000, J CELL SCI, V113, P4143; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Nylander A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063768; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Pham TK, 2010, PROTEOMICS, V10, P3130, DOI 10.1002/pmic.200900448; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Reimann J, 2013, MOL CELL PROTEOMICS, V12, P3908, DOI 10.1074/mcp.M113.027375; Reimann J, 2012, MOL MICROBIOL, V86, P24, DOI 10.1111/j.1365-2958.2012.08186.x; Romes EM, 2016, J BIOL CHEM, V291, P882, DOI 10.1074/jbc.M115.693259; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Spivey VL, 2011, J BIOL CHEM, V286, P26198, DOI 10.1074/jbc.M111.246132; Takizawa M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701497; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Wang B, 2010, J BACTERIOL, V192, P1956, DOI 10.1128/JB.01471-09; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7460	7471		10.1074/jbc.RA119.007709	http://dx.doi.org/10.1074/jbc.RA119.007709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30902813	Green Published, hybrid			2022-12-28	WOS:000468402900030
J	Emrich, SM; Yoast, RE; Xin, P; Zhang, XX; Pathak, T; Nwokonko, R; Gueguinou, MF; Subedi, KP; Zhou, YD; Ambudkar, IS; Hempel, N; Machaca, K; Gill, DL; Trebak, M				Emrich, Scott M.; Yoast, Ryan E.; Xin, Ping; Zhang, Xuexin; Pathak, Trayambak; Nwokonko, Robert; Gueguinou, Maxime F.; Subedi, Krishna P.; Zhou, Yandong; Ambudkar, Indu S.; Hempel, Nadine; Machaca, Khaled; Gill, Donald L.; Trebak, Mohamed			Cross-talk between N-terminal and C-terminal domains in stromal interaction molecule 2 (STIM2) determines enhanced STIM2 sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; calcium release-activated calcium channel protein 1 (ORAI1); calcium imaging; calcium transport; calcium intracellular release; stromal interaction molecule 1 (STIM1); Calcium signaling; cation channel; Ion sensor; SOCE; STIM2	STORE-INDEPENDENT MODES; 2-AMINOETHOXYDIPHENYL BORATE; 2-AMINOETHYLDIPHENYL BORATE; CA2+ CHANNELS; ORAI1; CRAC; ACTIVATION; ENTRY; OLIGOMERIZATION; MECHANISMS	Store-operated Ca2+ entry (SOCE) is a ubiquitous pathway for Ca2+ influx across the plasma membrane (PM). SOCE is mediated by the endoplasmic reticulum (ER)-associated Ca2+-sensing proteins stromal interaction molecule 1 (STIM1) and STIM2, which transition into an active conformation in response to ER Ca2+ store depletion, thereby interacting with and gating PM-associated ORAI1 channels. Although structurally homologous, STIM1 and STIM2 generate distinct Ca2+ signatures in response to varying strengths of agonist stimulation. The physiological functions of these Ca2+ signatures, particularly under native conditions, remain unclear. To investigate the structural properties distinguishing STIM1 and STIM2 activation of ORAI1 channels under native conditions, here we used CRISPR/Cas9 to generate STIM1(-/-), STIM2(-/-), and STIM1/2(-/-) knockouts in HEK293 and colorectal HCT116 cells. We show that depending on cell type, STIM2 can significantly sustain SOCE in response to maximal store depletion. Utilizing the SOCE modifier 2-aminoethoxydiphenyl borate (2-APB), we demonstrate that 2-APB-activated store-independent Ca2+ entry is mediated exclusively by endogenous STIM2. Using variants that either stabilize or disrupt intramolecular interactions of STIM C termini, we show that the increased flexibility of the STIM2 C terminus contributes to its selective store-independent activation by 2-APB. However, STIM1 variants with enhanced flexibility in the C terminus failed to support its store-independent activation. STIM1/STIM2 chimeric constructs indicated that coordination between N-terminal sensitivity and C-terminal flexibility is required for specific store-independent STIM2 activation. Our results clarify the structural determinants underlying activation of specific STIM isoforms, insights that are potentially useful for isoform-selective drug targeting.	[Emrich, Scott M.; Yoast, Ryan E.; Xin, Ping; Zhang, Xuexin; Pathak, Trayambak; Nwokonko, Robert; Gueguinou, Maxime F.; Zhou, Yandong; Gill, Donald L.; Trebak, Mohamed] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA; [Hempel, Nadine] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA 17033 USA; [Subedi, Krishna P.; Ambudkar, Indu S.] NIDCR, Secretory Physiol Sect, NIH, Bethesda, MD 20892 USA; [Machaca, Khaled] Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Qatar Fdn, POB 24144, Doha, Qatar	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Qatar Foundation (QF); Weill Cornell Medical College Qatar	Trebak, M (corresponding author), Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA.	mtrebak@psu.edu	Machaca, Khaled/AAF-3579-2019; zhou, Yandong/AAN-3947-2021; Nwokonko, Robert/ABH-3833-2020; 张学新, XUEXIN ZHANG/AAD-7645-2019	zhou, Yandong/0000-0003-3503-0296; Nwokonko, Robert/0000-0002-0793-7379; 张学新, XUEXIN ZHANG/0000-0001-8276-3885; Hempel, Nadine/0000-0002-5574-8783; Yoast, Ryan/0000-0002-7059-6829; Gueguinou, Maxime/0000-0002-5793-2082	National Institutes of Health [R01HL123364, R01HL097111, R21AG050072, R01GM120783, R01GM109279]; Qatar National Research Fund (QNRF) [NPRP8-110-3-021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL123364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120783, R35GM131916, R01GM109279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG050072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Research Fund (QNRF)(National Research Foundation of KoreaQatar National Research Fund (QNRF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01HL123364, R01HL097111, and R21AG050072 (to M. T.), Grants R01GM120783 and R01GM109279 (to D. L. G.), and Qatar National Research Fund (QNRF) Grant NPRP8-110-3-021 (to M. T. and K. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Bhardwaj R, 2013, BIOSCIENCE REP, V33, P833, DOI 10.1042/BSR20130089; Bittremieux M, 2017, CELL CALCIUM, V62, P60, DOI 10.1016/j.ceca.2017.01.015; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; Desai PN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8323; Fahrner M, 2017, ADV EXP MED BIOL, V993, P59, DOI 10.1007/978-3-319-57732-6_4; Goto J, 2010, CELL CALCIUM, V47, P1, DOI 10.1016/j.ceca.2009.10.004; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Hendron E, 2014, CELL CALCIUM, V56, P482, DOI 10.1016/j.ceca.2014.10.005; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jairaman A, 2013, CHANNELS, V7, P402, DOI 10.4161/chan.25292; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Lunz V, 2019, CELL CALCIUM, V77, P29, DOI 10.1016/j.ceca.2018.11.009; Miederer AM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7899; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Nelson HA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051522; Ong HL, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005748; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Pchitskaya E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17762-8; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Popugaeva E, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0034-7; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rana A, 2015, J CELL BIOL, V209, P653, DOI 10.1083/jcb.201412060; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2013, CHANNELS, V7, P344, DOI 10.4161/chan.26734; Subedi KP, 2018, CELL REP, V23, P522, DOI 10.1016/j.celrep.2018.03.065; Sun SY, 2014, NEURON, V82, P79, DOI 10.1016/j.neuron.2014.02.019; Tian CS, 2016, FUTURE MED CHEM, V8, P817, DOI 10.4155/fmc-2016-0024; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trebak M, 2019, NAT REV IMMUNOL, V19, P154, DOI 10.1038/s41577-018-0110-7; Trebak M, 2017, PHYSIOLOGY, V32, P332, DOI 10.1152/physiol.00011.2017; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wei M, 2016, PFLUG ARCH EUR J PHY, V468, P2061, DOI 10.1007/s00424-016-1880-z; Yamashita M, 2011, J BIOL CHEM, V286, P9429, DOI 10.1074/jbc.M110.189035; Yu F, 2013, J CELL SCI, V126, P2401, DOI 10.1242/jcs.117200; Yu F, 2011, J BIOL CHEM, V286, P8375, DOI 10.1074/jbc.M110.188789; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang XX, 2014, J GEN PHYSIOL, V143, P345, DOI 10.1085/jgp.201311084; Zhang XX, 2013, MOL CELL BIOL, V33, P3715, DOI 10.1128/MCB.00554-13; Zheng L, 2011, P NATL ACAD SCI USA, V108, P1337, DOI 10.1073/pnas.1015125108; Zheng SS, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006898; Zhou YD, 2018, P NATL ACAD SCI USA, V115, pE3398, DOI 10.1073/pnas.1720810115; Zhou YD, 2017, CELL CALCIUM, V63, P8, DOI 10.1016/j.ceca.2017.01.001; Zhou YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9395; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	59	21	21	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6318	6332		10.1074/jbc.RA118.006801	http://dx.doi.org/10.1074/jbc.RA118.006801			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30824535	hybrid, Green Published			2022-12-28	WOS:000468402000010
J	Gao, C; Pallett, MA; Croll, TI; Smith, GL; Graham, SC				Gao, Chen; Pallett, Mitchell A.; Croll, Tristan I.; Smith, Geoffrey L.; Graham, Stephen C.			Molecular basis of cullin-3 (Cul3) ubiquitin ligase subversion by vaccinia virus protein A55	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						poxvirus; innate immunity; viral immunology; E3 ubiquitin ligase; protein structure; structure-function; isothermal titration calorimetry (ITC); X-ray crystallography; immunosuppression; BTB-Kelch	BTB/KELCH PROTEINS; DROSOPHILA KELCH; ADAPTER PROTEIN; BTB PROTEINS; HSV-1 ICP0; ENCODES; FAMILY; DOMAIN; PROTEASOME; SEQUENCE	BTB-Kelch proteins are substrate-specific adaptors for cullin-3 (Cul3) RING-box-based E3 ubiquitin ligases, mediating protein ubiquitylation for subsequent proteasomal degradation. Vaccinia virus encodes three BTB-Kelch proteins: A55, C2, and F3. Viruses lacking A55 or C2 have altered cytopathic effects in cultured cells and altered pathology in vivo. Previous studies have shown that the ectromelia virus orthologue of A55 interacts with Cul3 in cells. We report that the N-terminal BTB-BACK (BB) domain of A55 binds directly to the Cul3 N-terminal domain (Cul3-NTD), forming a 2:2 complex in solution. We solved the structure of an A55BB/Cul3-NTD complex from anisotropic crystals diffracting to 2.3/3.7 angstrom resolution in the best/worst direction, revealing that the overall interaction and binding interface closely resemble the structures of cellular BTB/Cul3-NTD complexes, despite low sequence identity between A55 and cellular BTB domains. Surprisingly, despite this structural similarity, the affinity of Cul3-NTD for A55BB was stronger than for cellular BTB proteins. Glutamate substitution of the A55 residue Ile-48, adjacent to the canonical phi X(D/E) Cul3-binding motif, reduced affinity of A55BB for Cul3-NTD by at least 2 orders of magnitude. Moreover, Ile-48 and the phi X(D/E) motif are conserved in A55 orthologues from other poxviruses, but not in the vaccinia virus proteins C2 or F3. The high-affinity interaction between A55BB and Cul3-NTD suggests that, in addition to directing the Cul3-RING E3 ligase complex to degrade cellular/viral target proteins that are normally unaffected, A55 may also sequester Cul3 from cellular adaptor proteins, thereby protecting substrates of these cellular adaptors from ubiquitylation and degradation.	[Gao, Chen; Pallett, Mitchell A.; Smith, Geoffrey L.; Graham, Stephen C.] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Croll, Tristan I.] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England	University of Cambridge; University of Cambridge	Graham, SC (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	scg34@cam.ac.uk		Graham, Stephen/0000-0003-4547-4034; Smith, Geoffrey L/0000-0002-3730-9955; Gao, Chen/0000-0003-3705-470X; Croll, Tristan/0000-0002-3514-8377; Pallett, Mitchell/0000-0002-4194-3190	Wellcome Trust Principal Research Fellowship - Wellcome Trust [090315]; Sir Henry Dale Fellowship - Wellcome Trust [098406/Z/12/B]; Royal Society	Wellcome Trust Principal Research Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This work was supported by Wellcome Trust Principal Research Fellowship 090315 (to G.L.S.) and Sir Henry Dale Fellowship 098406/Z/12/B, jointly funded by the Wellcome Trust and the Royal Society (to S.C.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Assis FL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02562; Bahar MW, 2011, J STRUCT BIOL, V175, P127, DOI 10.1016/j.jsb.2011.03.010; Balasco N, 2014, BBA-PROTEINS PROTEOM, V1844, P1289, DOI 10.1016/j.bbapap.2014.04.006; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barry M, 2010, VIRUSES-BASEL, V2, P2356, DOI 10.3390/v2102356; Beard PM, 2006, J GEN VIROL, V87, P1521, DOI 10.1099/vir.0.81854-0; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bricogne G, 2017, BUSTER VERSION 2 10; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chen HY, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0017-2; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Clabbers MTB, 2018, ACTA CRYSTALLOGR D, V74, P506, DOI 10.1107/S2059798318007726; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; de Miranda MP, 2003, J GEN VIROL, V84, P2459, DOI 10.1099/vir.0.19292-0; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Froggatt GC, 2007, J GEN VIROL, V88, P1917, DOI 10.1099/vir.0.82815-0; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hudson AM, 2010, J CELL BIOL, V188, P29, DOI 10.1083/jcb.200909017; Jezek Z, 1988, HUMAN MONKEYPOX; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Krek W, 2003, NAT CELL BIOL, V5, P950, DOI 10.1038/ncb1103-950; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lanfranca MP, 2014, CELLS-BASEL, V3, P438, DOI 10.3390/cells3020438; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Mahon C, 2014, BIOMOLECULES, V4, P897, DOI 10.3390/biom4040897; Mathew R, 2012, NATURE, V491, P619, DOI 10.1038/nature11548; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neidel S, 2015, J BIOL CHEM, V290, P5991, DOI 10.1074/jbc.M114.624650; Pinkas DM, 2017, BIOCHEM J, V474, P3747, DOI 10.1042/BCJ20170527; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Rudnicka A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100293; Saini HK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-115; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Seissler T, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110322; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Smaldone G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126808; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Smith MC, 2011, FUTURE VIROL, V6, P421, DOI 10.2217/FVL.11.24; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Suhre K, 2005, J VIROL, V79, P14095, DOI 10.1128/JVI.79.22.14095-14101.2005; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Velazquez-Campoy A, 2005, BIOPHYS CHEM, V115, P115, DOI 10.1016/j.bpc.2004.12.015; Walter TS, 2008, ACTA CRYSTALLOGR F, V64, P14, DOI 10.1107/S1744309107057260; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang Q, 2014, J VIROL, V88, P4853, DOI 10.1128/JVI.02923-13; Wilton BA, 2008, VIROLOGY, V374, P82, DOI 10.1016/j.virol.2007.11.036; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	69	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6416	6429		10.1074/jbc.RA118.006561	http://dx.doi.org/10.1074/jbc.RA118.006561			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30819806	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000468402000019
J	Archer, CR; Enslow, BT; Taylor, AB; De la Rosa, V; Bhattacharya, A; Shapiro, MS				Archer, Crystal R.; Enslow, Benjamin T.; Taylor, Alexander B.; De la Rosa, Victor; Bhattacharya, Akash; Shapiro, Mark S.			A mutually induced conformational fit underlies Ca2+-directed interactions between calmodulin and the proximal C terminus of KCNQ4 K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calmodulin (CaM); potassium channel; nuclear magnetic resonance (NMR); X-ray crystallography; conformational change; calcium-binding protein; isothermal titration calorimetry (ITC); biophysical chemical analysis; calcium signaling; M current; microscale thermophoresis (MST); potassium voltage-gated channel subfamily Q member (KCNQ)	CALCIUM-FREE CALMODULIN; POTASSIUM CHANNEL; STRUCTURAL BASIS; CA2+ CHANNELS; BINDING SITE; ION CHANNELS; N-LOBE; COMPLEX; DOMAIN; CONDUCTANCE	Calmodulin (CaM) conveys intracellular Ca2+ signals to KCNQ (Kv7, M-type) K+ channels and many other ion channels. Whether this calmodulation involves a dramatic structural rearrangement or only slight perturbations of the CaM/KCNQ complex is as yet unclear. A consensus structural model of conformational shifts occurring between low nanomolar and physiologically high intracellular [Ca2+] is still under debate. Here, we used various techniques of biophysical chemical analyses to investigate the interactions between CaM and synthetic peptides corresponding to the A and B domains of the KCNQ4 subtype. We found that in the absence of CaM, the peptides are disordered, whereas Ca2+/CaM imposed helical structure on both KCNQ A and B domains. Isothermal titration calorimetry revealed that Ca2+/CaM has higher affinity for the B domain than for the A domain of KCNQ2-4 and much higher affinity for the B domain when prebound with the A domain. X-ray crystallography confirmed that these discrete peptides spontaneously form a complex with Ca2+/CaM, similar to previous reports of CaM binding KCNQ-AB domains that are linked together. Microscale thermophoresis and heteronuclear single-quantum coherence NMR spectroscopy indicated the C-lobe of Ca2+-free CaM to interact with the KCNQ4 B domain (K-d approximate to 10-20 m), with increasing Ca2+ molar ratios shifting the CaM-B domain interactions via only the CaM C-lobe to also include the N-lobe. Our findings suggest that in response to increased Ca2+, CaM undergoes lobe switching that imposes a dramatic mutually induced conformational fit to both the proximal C terminus of KCNQ4 channels and CaM, likely underlying Ca2+-dependent regulation of KCNQ gating.	[Archer, Crystal R.; De la Rosa, Victor; Shapiro, Mark S.] Univ Texas Hlth San Antonio, Dept Cell & Integrat Physiol, San Antonio, TX 78229 USA; [Archer, Crystal R.; Taylor, Alexander B.; Bhattacharya, Akash] Univ Texas Hlth San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA; [Enslow, Benjamin T.] Univ Texas Hlth San Antonio, Long Sch Med, San Antonio, TX 78229 USA; [De la Rosa, Victor] Univ Autonoma San Luis Potosi, CONACYT, Fac Med, San Luis Potosi 78210, Mexico; [Bhattacharya, Akash] Beckman Coulter Life Sci, 5600 Lindbergh Dr, Loveland, CO 80538 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Universidad Autonoma de San Luis Potosi; Beckman Coulter Inc.	Shapiro, MS (corresponding author), Univ Texas Hlth San Antonio, STRF, Dept Cell & Integrat Physiol, MC 8253,8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu	De la Rosa, Victor/AAM-8583-2021; Bhattacharya, Akash/G-9154-2016	De la Rosa, Victor/0000-0001-5161-3083; Shapiro, Mark/0000-0002-9630-0600; Bhattacharya, Akash/0000-0001-8748-9969; Enslow, Benjamin/0000-0003-4822-0216; Taylor, Alexander/0000-0003-3517-6033	National Institutes of Health [R01 NS 043394, NS 094461]; Faculty Scholar Award; Morrison Trust Foundation; NINDS/National Institutes of Health NRSApredoctoral training fellowship [F31 NS090887]; National Institutes of Health/NHLBI postdoctoral training grant [T32 HL007446]; NIH [R01 AI104476]; IIMS CTSA at UT Health San Antonio (Department of Medicine); NIGMS/NIH [P30 GM124165]; NIH-ORIP HEI [S10-OD021527]; DOE, Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094461, F31NS090887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty Scholar Award; Morrison Trust Foundation; NINDS/National Institutes of Health NRSApredoctoral training fellowship; National Institutes of Health/NHLBI postdoctoral training grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IIMS CTSA at UT Health San Antonio (Department of Medicine); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI; DOE, Argonne National Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 NS 043394 and NS 094461 (to M. S. S.), a Faculty Scholar Award (to M. S. S.), a grant from the Morrison Trust Foundation (to M. S. S.), NINDS/National Institutes of Health NRSApredoctoral training fellowship F31 NS090887 (to C. R. A.), National Institutes of Health/NHLBI postdoctoral training grant T32 HL007446 (to C. R. A.) (directed by James D. Stockand), NIH Grant R01 AI104476 (to Dmitri Ivanov supporting A. B.) and a core usage support grant from the IIMS CTSA at UT Health San Antonio (Department of Medicine). Part of this work was performed at the Northeastern Collaborative Access Team beamlines, which are funded by a program project grant from the NIGMS/NIH (P30 GM124165). The Eiger 16M detector on the 24-ID-E beam line is funded by NIH-ORIP HEI Grant S10-OD021527. This research used resources of the Advanced Photon Source, a user facility operated for the DOE, Argonne National Laboratory under Contract DE-AC02-06CH11357. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alaimo A, 2013, J CELL SCI, V126, P244, DOI 10.1242/jcs.114082; Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Bernardo-Seisdedos G, 2018, P NATL ACAD SCI USA, V115, P2395, DOI 10.1073/pnas.1800235115; Biris N, 2013, J MOL BIOL, V425, P5032, DOI 10.1016/j.jmb.2013.07.025; Black DJ, 2011, BIOCHEMISTRY-US, V50, P10061, DOI 10.1021/bi201300v; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Chang A, 2018, NEURON, V97, P836, DOI 10.1016/j.neuron.2018.01.035; Choveau FS, 2018, J BIOL CHEM, V293, P19411, DOI 10.1074/jbc.RA118.005401; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Cui YF, 2003, ANAL BIOCHEM, V315, P175, DOI 10.1016/S0003-2697(03)00007-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dixon RE, 2012, P NATL ACAD SCI USA, V109, P1749, DOI 10.1073/pnas.1116731109; Dutta Amit K, 2015, Methods Mol Biol, V1229, pE1, DOI 10.1007/978-1-4939-1714-3_48; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Etzioni A, 2011, J NEUROSCI, V31, P14158, DOI 10.1523/JNEUROSCI.2666-11.2011; Evans TIA, 2011, BIOPHYS CHEM, V159, P172, DOI 10.1016/j.bpc.2011.06.007; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Gabelli SB, 2016, CHANNELS, V10, P45, DOI 10.1080/19336950.2015.1075677; Gabelli SB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6126; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Gamper N, 2015, HDB ION CHANNELS; Gamper N, 2006, EMBO J, V25, P4996, DOI 10.1038/sj.emboj.7601374; Gao YH, 2013, J CELL MOL MED, V17, P889, DOI 10.1111/jcmm.12080; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Grabarek Z, 2011, BBA-MOL CELL RES, V1813, P913, DOI 10.1016/j.bbamcr.2011.01.017; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Halling D Brent, 2006, Sci STKE, V2006, per1; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Higashida H, 2005, NEUROSCI RES, V51, P231, DOI 10.1016/j.neures.2004.11.009; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaleka KS, 2012, JOVE-J VIS EXP, DOI 10.3791/3502; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Keowmaneechai E, 2002, J AGR FOOD CHEM, V50, P7145, DOI 10.1021/jf020489a; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Kosenko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082290; Kosenko A, 2012, EMBO J, V31, P3147, DOI 10.1038/emboj.2012.156; Kubota Y, 2007, BIOPHYS J, V93, P3848, DOI 10.1529/biophysj.107.106849; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee CH, 2018, SCIENCE, V360, P508, DOI 10.1126/science.aas9466; Li BX, 2016, SCIENCE, V351, P863, DOI 10.1126/science.aad3647; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Linley JE, 2012, P NATL ACAD SCI USA, V109, pE1578, DOI 10.1073/pnas.1201544109; LINSE S, 1991, J BIOL CHEM, V266, P8050; Liu WJ, 2014, MOL CELL NEUROSCI, V58, P40, DOI 10.1016/j.mcn.2013.12.005; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; Malmendal A, 1999, BIOCHEMISTRY-US, V38, P11844, DOI 10.1021/bi9909288; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Mruk K, 2014, J GEN PHYSIOL, V144, P103, DOI 10.1085/jgp.201311140; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neufeld T, 1998, J MOL RECOGNIT, V11, P20, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<20::AID-JMR383>3.0.CO;2-A; Ooi L, 2013, J NEUROSCI, V33, P6041, DOI 10.1523/JNEUROSCI.4275-12.2013; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rocheleau JM, 2008, J GEN PHYSIOL, V131, P59, DOI 10.1085/jgp.200709816; Sachyani D, 2014, STRUCTURE, V22, P1582, DOI 10.1016/j.str.2014.07.016; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Senguen FT, 2012, BIOCHEMISTRY-US, V51, P6182, DOI 10.1021/bi300698h; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Siloni S, 2015, J CELL SCI, V128, P3489, DOI 10.1242/jcs.173922; Strulovich R, 2016, BIOCHEMISTRY-US, V55, P5353, DOI 10.1021/acs.biochem.6b00477; Suh BC, 2007, J PHYSIOL-LONDON, V582, P911, DOI 10.1113/jphysiol.2007.132647; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Tobelaim WS, 2017, P NATL ACAD SCI USA, V114, pE869, DOI 10.1073/pnas.1612622114; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Vivas O, 2017, ELIFE, V6, DOI 10.7554/eLife.28029; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wang Q, 2013, P NATL ACAD SCI USA, V110, P20545, DOI 10.1073/pnas.1312788110; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Westerlund AM, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006072; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu Q, 2013, J MOL BIOL, V425, P378, DOI 10.1016/j.jmb.2012.11.023; Xu TH, 2007, J BIOL CHEM, V282, P23899, DOI 10.1074/jbc.M702108200; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zaika O, 2011, J BIOL CHEM, V286, P830, DOI 10.1074/jbc.M110.166033; Zamponi GW, 2003, NEURON, V39, P879, DOI 10.1016/S0896-6273(03)00564-6; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang J, 2016, NEURON, V92, P461, DOI 10.1016/j.neuron.2016.09.014; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhang PZ, 2017, BIOPHYS J, V112, P1105, DOI 10.1016/j.bpj.2017.01.020; Zhou QJ, 2015, NATURE, V525, P62, DOI 10.1038/nature14975; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200	108	5	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6094	6112		10.1074/jbc.RA118.006857	http://dx.doi.org/10.1074/jbc.RA118.006857			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30808708	Green Published, hybrid			2022-12-28	WOS:000465077500039
J	Tang, TC; Kienlen-Campard, P; Hu, Y; Perrin, F; Opsomer, R; Octave, JN; Constantinescu, SN; Smith, SO				Tang, Tzu-Chun; Kienlen-Campard, Pascal; Hu, Yi; Perrin, Florian; Opsomer, Remi; Octave, Jean-Noel; Constantinescu, Stefan N.; Smith, Steven O.			Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and -secretase processing of the C99 peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (A); amyloid precursor protein (APP); secretase; nuclear magnetic resonance (NMR); Fourier transform IR (FTIR); fluorescence; neurodegeneration; A42; A40 ratio; membrane interaction	AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; INTRAMEMBRANE PROTEOLYSIS; CEREBRAL-HEMORRHAGE; FLEMISH MUTATION; CLEAVAGE SITE; APP; DOMAIN; GENE; HOMODIMERIZATION	Extracellular deposition of -amyloid (A) peptides in the brain is a hallmark of Alzheimer's disease (AD). Upon -secretase-mediated cleavage of the C-terminal fragment (-CTF) from the A precursor protein, the -secretase complex produces the A peptides associated with AD. The familial T43I mutation within the transmembrane domain of the -CTF (also referred to as C99) increases the ratio between the A42 and A40 peptides largely due to a decrease in A40 formation. A42 is the principal component of amyloid deposits within the brain parenchyma, and an increase in the A42/A40 ratio is correlated with early-onset AD. Using NMR and FTIR spectroscopy, here we addressed how the T43I substitution influences the structure of C55, the minimal sequence containing the entire extracellular and transmembrane (TM) domains of C99 needed for -secretase processing. C-13 NMR chemical shifts indicated that the T43I substitution increases helical structure within the TM domain of C55. These structural changes were associated with a shift of the C55 dimer to the monomer and an increase in the tilt of the TM helix relative to the membrane normal in the T43I mutant compared with that of WT C55. The A21G (Flemish) mutation was previously found to increase secreted A40 levels; here, we combined this mutation in the extracellular domain of C99 with T43I and observed that the T43I/A21G double mutant decreases A40 formation. We discuss how the observed structural changes in the T43I mutant may decrease A40 formation and increase the A42/A40 ratio.	[Tang, Tzu-Chun; Hu, Yi; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Kienlen-Campard, Pascal; Opsomer, Remi; Octave, Jean-Noel] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Perrin, Florian; Constantinescu, Stefan N.] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Perrin, Florian; Constantinescu, Stefan N.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Smith, SO (corresponding author), SUNY Stony Brook, Ctr Struct Biol Z 5215, Stony Brook, NY 11794 USA.	steven.o.smith@stonybrook.edu	Smith, Steven/HDM-9496-2022	Smith, Steven/0000-0003-1861-7159	National Institutes of Health [S10 RR13889, DBI-9977553, AG 27317]; National Science Foundation [S10 RR13889, DBI-9977553]; Foundation for Research on Alzheimer's Disease; Interuniversity Attraction Pole Programme-Belgian State-Belgian Science Policy [IAP-P7/16]; Fondation Medicale Reine Elisabeth (FMRE); Fonds National de la Recherche Scientifique (FNRS) [PDRT. 0177.18]; Action de Recherche Concertee [14/19-059, 16/21-073]; Ludwig Institute for Cancer Research; Fondation contre le Cancer [F/2014/266]; Salus Sanguinis; Fondation "Les Avions de Sebastien"; FNRS-WELBIO [WELBIO-CR-2017A-02]; NATIONAL INSTITUTE ON AGING [RF1AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Foundation for Research on Alzheimer's Disease; Interuniversity Attraction Pole Programme-Belgian State-Belgian Science Policy; Fondation Medicale Reine Elisabeth (FMRE); Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Action de Recherche Concertee; Ludwig Institute for Cancer Research; Fondation contre le Cancer; Salus Sanguinis; Fondation "Les Avions de Sebastien"; FNRS-WELBIO(Fonds de la Recherche Scientifique - FNRSWELBIO); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health and National Science Foundation Instrumentation Grants S10 RR13889 and DBI-9977553 and National Institutes of Health Grant AG 27317 (to S. O. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Foundation for Research on Alzheimer's Disease, the Interuniversity Attraction Pole Programme-Belgian State-Belgian Science Policy (IAP-P7/16), the Fondation Medicale Reine Elisabeth (FMRE), Fonds National de la Recherche Scientifique (FNRS, PDRT. 0177.18), and Action de Recherche Concertee (convention 14/19-059).; Supported by the Ludwig Institute for Cancer Research, Fondation contre le Cancer Grant F/2014/266, Salus Sanguinis, Fondation "Les Avions de Sebastien," Action de Recherche Concertee (convention 16/21-073), and the FNRS-WELBIO (convention WELBIO-CR-2017A-02).	Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bolduc DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17578; BURDICK D, 1992, J BIOL CHEM, V267, P546; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Chen WL, 2014, ACS SYM SER, V1174, P5; Cruts M, 2003, J NEUROL, V250, P1374, DOI 10.1007/s00415-003-0182-5; De Jonghe C, 2001, HUM MOL GENET, V10, P1665, DOI 10.1093/hmg/10.16.1665; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Fukumori A, 2016, EMBO J, V35, P1628, DOI 10.15252/embj.201694151; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hoos MD, 2007, J BIOL CHEM, V282, P9952, DOI 10.1074/jbc.M603494200; Hu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17144-0; Itkin A, 2017, ACS OMEGA, V2, P6525, DOI 10.1021/acsomega.7b00619; KAMINO K, 1992, AM J HUM GENET, V51, P998; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Kumar-Singh S, 2000, HUM MOL GENET, V9, P2589, DOI 10.1093/hmg/9.18.2589; Kwok JBJ, 2000, ANN NEUROL, V47, P249, DOI 10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.3.CO;2-#; Langosch D, 2015, TRENDS BIOCHEM SCI, V40, P318, DOI 10.1016/j.tibs.2015.04.001; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murrell JR, 2000, ARCH NEUROL-CHICAGO, V57, P885, DOI 10.1001/archneur.57.6.885; Nadezhdin KD, 2012, FEBS LETT, V586, P1687, DOI 10.1016/j.febslet.2012.04.062; Pasalar P, 2002, NEUROLOGY, V58, P1574, DOI 10.1212/WNL.58.10.1574; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Smith SO, 2002, BIOPHYS J, V82, P2476, DOI 10.1016/S0006-3495(02)75590-2; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Szaruga M, 2017, CELL, V170, P443, DOI 10.1016/j.cell.2017.07.004; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; Tian Y, 2010, NAT STRUCT MOL BIOL, V17, P151, DOI 10.1038/nsmb.1743; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WANG R, 1991, J BIOL CHEM, V266, P16960; Winkler E, 2015, BIOCHEMISTRY-US, V54, P6149, DOI 10.1021/acs.biochem.5b00986; Xu TH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.26; Yan Y, 2017, J BIOL CHEM, V292, P15826, DOI 10.1074/jbc.M117.789669; Yang GH, 2019, NATURE, V565, P192, DOI 10.1038/s41586-018-0813-8; Zhou R, 2019, SCIENCE, V363, P708, DOI 10.1126/science.aaw0930	46	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5854	5866		10.1074/jbc.RA118.006061	http://dx.doi.org/10.1074/jbc.RA118.006061			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30755484	Green Published, hybrid			2022-12-28	WOS:000465077500017
J	Eriksson, O; Chiu, J; Hogg, PJ; Atkinson, JP; Liszewski, MK; Flaumenhaft, R; Furie, B				Eriksson, Oskar; Chiu, Joyce; Hogg, Philip J.; Atkinson, John P.; Liszewski, M. Kathryn; Flaumenhaft, Robert; Furie, Bruce			Thiol isomerase ERp57 targets and modulates the lectin pathway of complement activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						redox regulation; mass spectrometry (MS); complement system; disulfide; innate immunity; ER protein 57 (ERp57); ficolin; lectin pathway; thiol isomerase	PROTEIN DISULFIDE-ISOMERASE; MANNAN-BINDING LECTIN; VON-WILLEBRAND-FACTOR; THROMBUS FORMATION; GENE ONTOLOGY; PLATELET; MOUSE; REDUCTION; REVEALS; PATTERN	ER protein 57 (ERp57), a thiol isomerase secreted from vascular cells, is essential for complete thrombus formation in vivo, but other extracellular ERp57 functions remain unexplored. Here, we employed a kinetic substrate-trapping approach to identify extracellular protein substrates of ERp57 in platelet-rich plasma. MS-based identification with immunochemical confirmation combined with gene ontology enrichment analysis revealed that ERp57 targets, among other substrates, components of the lectin pathway of complement activation: mannose-binding lectin, ficolin-2, ficolin-3, collectin-10, collectin-11, mannose-binding lectin-associated serine protease-1, and mannose-binding lectin-associated serine protease-2. Ficolin-3, the most abundant lectin pathway initiator in humans, circulates as disulfide-linked multimers of a monomer. ERp57 attenuated ficolin-3 ligand recognition and complement activation by cleaving intermolecular disulfide bonds in large ficolin-3 multimers, thereby reducing multimer size and ligand-binding affinity. We used MS to identify the disulfide-bonding pattern in ficolin-3 multimers and the disulfide bonds targeted by ERp57 and found that Cys(6) and Cys(23) in the N-terminal region of ficolin-3 form the intermolecular disulfide bonds in ficolin-3 multimers that are reduced by ERp57. Our results not only demonstrate that ERp57 can negatively regulate complement activation, but also identify a control mechanism for lectin pathway initiation in the vasculature. We conclude that extensive multimerization in large ficolin-3 multimers leads to a high affinity for ligands and strong complement-activating potential and that ERp57 suppresses complement activation by cleaving disulfide bonds in ficolin-3 and reducing its multimer size.	[Eriksson, Oskar; Flaumenhaft, Robert; Furie, Bruce] Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Ctr Life Sci CLS903,3 Blackfan Circle, Boston, MA 02115 USA; [Eriksson, Oskar; Flaumenhaft, Robert; Furie, Bruce] Harvard Med Sch, Boston, MA 02115 USA; [Chiu, Joyce; Hogg, Philip J.] Univ Sydney, Sydney Med Sch, Natl Hlth & Med Res Council, Centenary Inst,Clin Trials Ctr, Sydney, NSW 2006, Australia; [Atkinson, John P.; Liszewski, M. Kathryn] Washington Univ, Sch Med, Dept Med Rheumatol, St Louis, MO 63110 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Sydney; Centenary Institute; Washington University (WUSTL)	Furie, B (corresponding author), Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Ctr Life Sci CLS903,3 Blackfan Circle, Boston, MA 02115 USA.	bfurie@bidmc.harvard.edu	Chiu, Joyce/H-7772-2017	Chiu, Joyce/0000-0001-8910-8664; Furie, Bruce/0000-0001-7610-1076; Hogg, Philip/0000-0001-6486-2863; Atkinson, John/0000-0002-2514-3441	National Institutes of Health [U54 HL112303, R01 HL136394, R01 GM099111]; National Health and Medical Research Council of Australia; Helen and Robert Ellis Postdoctoral Fellowship from the Sydney Medical School Foundation; Tony Basten Postdoctoral Fellowship from Sydney Medical School Foundation; Swedish Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136394, U54HL112303, U54HL112302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Helen and Robert Ellis Postdoctoral Fellowship from the Sydney Medical School Foundation; Tony Basten Postdoctoral Fellowship from Sydney Medical School Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants U54 HL112303 and R01 HL136394 (to B. F.), National Institutes of Health Grant R01 GM099111 (to J. P. A.), a grant from the National Health and Medical Research Council of Australia (to P. J. H.), and the Helen and Robert Ellis Postdoctoral Fellowship and Tony Basten Postdoctoral Fellowship from the Sydney Medical School Foundation (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an international postdoctoral grant from the Swedish Research Council.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldus IB, 2012, BIOPHYS J, V102, P622, DOI 10.1016/j.bpj.2011.12.039; Bowley SR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14151; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen JM, 2011, J CLIN INVEST, V121, P593, DOI 10.1172/JCI41062; Chiu J, 2014, BIOCHEMISTRY-US, V53, P7, DOI 10.1021/bi401518b; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Ellgaard L, 2016, TRAFFIC, V17, P615, DOI 10.1111/tra.12392; Endo Y, 2004, GENOMICS, V84, P737, DOI 10.1016/j.ygeno.2004.07.006; Feng SJ, 2015, BLOOD, V125, P1034, DOI 10.1182/blood-2014-06-585430; Flaumenhaft R, 2016, BLOOD, V128, P893, DOI 10.1182/blood-2016-04-636456; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Gogia S, 2015, BIORHEOLOGY, V52, P319, DOI 10.3233/BIR-15061; Hamad OA, 2010, J IMMUNOL, V184, P2686, DOI 10.4049/jimmunol.0902810; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hein E, 2013, MOL IMMUNOL, V56, P406, DOI 10.1016/j.molimm.2013.05.233; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Holbrook LM, 2012, J THROMB HAEMOST, V10, P278, DOI 10.1111/j.1538-7836.2011.04593.x; Holbrook LM, 2018, J THROMB HAEMOST, V16, P367, DOI 10.1111/jth.13878; Holbrook LM, 2010, BRIT J HAEMATOL, V148, P627, DOI 10.1111/j.1365-2141.2009.07994.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Java A, 2015, MOL IMMUNOL, V67, P584, DOI 10.1016/j.molimm.2015.07.016; King BC, 2012, J IMMUNOL, V188, P4103, DOI 10.4049/jimmunol.1101295; Kjaer TR, 2016, SCAND J IMMUNOL, V84, P12, DOI 10.1111/sji.12441; Liszewski MK, 2015, J INTERN MED, V277, P294, DOI 10.1111/joim.12338; Liu H, 2001, SCAND J IMMUNOL, V53, P489, DOI 10.1046/j.1365-3083.2001.00908.x; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Noone DG, 2016, KIDNEY INT, V90, P123, DOI 10.1016/j.kint.2016.03.023; Ohashi T, 2004, J BIOL CHEM, V279, P6534, DOI 10.1074/jbc.M310555200; Palarasah Y, 2011, CLIN EXP IMMUNOL, V164, P388, DOI 10.1111/j.1365-2249.2011.04322.x; Passam FH, 2015, BLOOD, V125, P2276, DOI 10.1182/blood-2013-12-547208; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025; Schulman S, 2016, ANTIOXID REDOX SIGN, V24, P1, DOI 10.1089/ars.2015.6530; Schwenk JM, 2017, J PROTEOME RES, V16, P4299, DOI 10.1021/acs.jproteome.7b00467; Teillet F, 2005, J IMMUNOL, V174, P2870, DOI 10.4049/jimmunol.174.5.2870; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wang L, 2013, BLOOD, V122, P3642, DOI 10.1182/blood-2013-06-506691; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Xie LJ, 2001, J EXP MED, V193, P1341, DOI 10.1084/jem.193.12.1341; Yi MC, 2018, J BIOL CHEM, V293, P2640, DOI 10.1074/jbc.RA117.001382; Zacho RM, 2012, J BIOL CHEM, V287, P8071, DOI 10.1074/jbc.M111.301044; Zhou JS, 2017, BLOOD, V130, P817, DOI 10.1182/blood-2016-12-755587; Zhou JS, 2015, J CLIN INVEST, V125, P4391, DOI 10.1172/JCI80319; Zhu S, 2016, J THROMB HAEMOST, V14, P1070, DOI 10.1111/jth.13245	52	9	10	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4878	4888		10.1074/jbc.RA118.006792	http://dx.doi.org/10.1074/jbc.RA118.006792			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30670593	hybrid, Green Published			2022-12-28	WOS:000463985600013
J	Almutairi, SM; Ali, AK; He, W; Yang, DS; Ghorbani, P; Wang, LS; Fullerton, MD; Lee, SH				Almutairi, Saeedah Musaed; Ali, Alaa Kassim; He, William; Yang, Doo-Seok; Ghorbani, Peyman; Wang, Lisheng; Fullerton, Morgan D.; Lee, Seung-Hwan			Interleukin-18 up-regulates amino acid transporters and facilitates amino acid-induced mTORC1 activation in natural killer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						natural killer cells (NK cells); cell proliferation; cell metabolism; amino acid; mammalian target of rapamycin (mTOR); interleukin-18 (IL-18); nutrient uptake; mTORC1	HEAVY-CHAIN GENE; P70 S6 KINASE; CUTTING EDGE; NK CELLS; GAMMA PRODUCTION; T-CELLS; IL-18; PROLIFERATION; EXPRESSION; CYTOKINE	Upon inflammation, natural killer (NK) cells undergo metabolic changes to support their high energy demand for effector function and proliferation. The metabolic changes are usually accompanied by an increase in the expression of nutrient transporters, leading to increased nutrient uptake. Among various cytokines inducing NK cell proliferation, the mechanisms underlying the effect of interleukin (IL)-18 in promoting NK cell proliferation are not completely understood. Here, we demonstrate that IL-18 is a potent cytokine that can enhance the expression of the nutrient transporter CD98/LAT1 for amino acids independently of the mTORC1 pathway and thereby induce a dramatic metabolic change associated with increased proliferation of NK cells. Notably, treatment of IL-18-stimulated NK cells with leucine activates the metabolic sensor mTORC1, indicating that the high expression of amino acid transporters induces amino acid-driven mTORC1 activation. Inhibition of the amino acid transporter CD98/LAT1 abrogated the leucine-driven mTORC1 activation and reduced NK cell effector function. Taken together, our study identified a novel role of IL-18 in up-regulating nutrient transporters on NK cells and thereby inducing metabolic changes, including the mTORC1 activation by amino acids.	[Almutairi, Saeedah Musaed; Ali, Alaa Kassim; He, William; Yang, Doo-Seok; Ghorbani, Peyman; Wang, Lisheng; Fullerton, Morgan D.; Lee, Seung-Hwan] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Almutairi, Saeedah Musaed] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia	University of Ottawa; King Saud University	Lee, SH (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	seunglee@uottawa.ca	Almutairi, Saeedah/ABC-6653-2020	Lee, Seung-Hwan/0000-0001-7703-6421; Yang, Doo/0000-0001-8420-6302; Ghorbani, Peyman/0000-0002-7398-5141; Ali, Alaa/0000-0002-7490-0592	Canadian Institutes of Health Research Grants [MOP-130385, PJT-156106]; Canadian Cancer Society Research Institute [704316]; King Saud University; Saudi Ministry of High Education, Saudi Arabia; Ontario graduate scholarship	Canadian Institutes of Health Research Grants(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); King Saud University(King Saud University); Saudi Ministry of High Education, Saudi Arabia; Ontario graduate scholarship(Ontario Graduate Scholarship)	This work was supported by Canadian Institutes of Health Research Grants MOP-130385 and PJT-156106 and Canadian Cancer Society Research Institute Grant 704316 (to S.-H. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a scholarship from King Saud University and the Saudi Ministry of High Education, Saudi Arabia.; Recipient of an Ontario graduate scholarship.	Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; BIRON CA, 1983, J IMMUNOL, V131, P1539; Broer S, 2011, BIOCHEM J, V436, P193, DOI 10.1042/BJ20101912; Cantor J, 2011, J IMMUNOL, V187, P851, DOI 10.4049/jimmunol.1100002; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Donnelly RP, 2014, J IMMUNOL, V193, P4477, DOI 10.4049/jimmunol.1401558; Edinger AL, 2007, BIOCHEM J, V406, P1, DOI 10.1042/BJ20070490; Esslinger CS, 2005, BIOORGAN MED CHEM, V13, P1111, DOI 10.1016/j.bmc.2004.11.028; French AR, 2006, CYTOKINE, V35, P229, DOI 10.1016/j.cyto.2006.08.006; Goberdhan DCI, 2016, CELL METAB, V23, P580, DOI 10.1016/j.cmet.2016.03.013; Goodier MR, 2000, J IMMUNOL, V165, P139, DOI 10.4049/jimmunol.165.1.139; GOTTESDIENER KM, 1988, MOL CELL BIOL, V8, P3809, DOI 10.1128/MCB.8.9.3809; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Huang KZ, 2014, SEMIN CELL DEV BIOL, V36, P79, DOI 10.1016/j.semcdb.2014.09.011; Hyodo Y, 1999, J IMMUNOL, V162, P1662; Jensen H, 2017, J IMMUNOL, V199, P1967, DOI 10.4049/jimmunol.1700497; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Keppel MP, 2015, J IMMUNOL, V194, P1954, DOI 10.4049/jimmunol.1402099; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lauwerys BR, 1999, CYTOKINE, V11, P822, DOI 10.1006/cyto.1999.0501; Lee SH, 2012, J IMMUNOL, V189, P2712, DOI 10.4049/jimmunol.1201528; Leong JW, 2014, BIOL BLOOD MARROW TR, V20, P463, DOI 10.1016/j.bbmt.2014.01.006; Lian GJ, 2012, J IMMUNOL, V188, P2227, DOI 10.4049/jimmunol.1102586; Lin L, 2015, NAT REV DRUG DISCOV, V14, P543, DOI 10.1038/nrd4626; LINDSTEN T, 1988, MOL CELL BIOL, V8, P3820, DOI 10.1128/MCB.8.9.3820; Loftus RM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04719-2; Loh J, 2005, J VIROL, V79, P661, DOI 10.1128/JVI.79.1.661-667.2005; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; McCracken AN, 2013, TRENDS ENDOCRIN MET, V24, P200, DOI 10.1016/j.tem.2013.01.002; Nandagopal N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00187; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Ni J, 2012, J EXP MED, V209, P2351, DOI 10.1084/jem.20120944; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Romee R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2341; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Son YI, 2001, CANCER RES, V61, P884; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Wawrocki S, 2016, ACTA BIOCHIM POL, V63, P59, DOI 10.18388/abp.2015_1153; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Williams H, 2005, BRIT J HAEMATOL, V129, P266, DOI 10.1111/j.1365-2141.2005.05452.x	55	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4644	4655		10.1074/jbc.RA118.005892	http://dx.doi.org/10.1074/jbc.RA118.005892			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30696773	Green Published, hybrid			2022-12-28	WOS:000462969500030
J	Moorhouse, AJ; Power, JM				Moorhouse, Andrew J.; Power, John M.			Making light work of fine-tuning channelrhodopsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The development of genetically engineered proteins that can control cell excitability with light have revolutionized our understanding of the nervous system. The most widely used of these optogenetic tools is the light-gated ion channel, channelrhodopsin 2 (ChR2). A new study by Cho et al. describes the development of ChR2 variants with improved photocurrents and more selective ion permeability using an automated multifaceted fluorescence-based screening. This methodological framework holds promise not only in refining features of ChR2, but also for other proteins in which fluorescence phenotyping is possible.	[Moorhouse, Andrew J.; Power, John M.] UNSW Sydney, Sch Med Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Moorhouse, AJ (corresponding author), UNSW Sydney, Sch Med Sci, Sydney, NSW 2052, Australia.	a.moorhouse@unsw.edu.au	Power, John M/B-4762-2008; Moorhouse, Andrew J/B-8526-2011	Power, John M/0000-0002-2478-8416; Moorhouse, Andrew J/0000-0001-7957-2498				Beppu K, 2014, NEURON, V81, P314, DOI 10.1016/j.neuron.2013.11.011; Berndt A, 2016, P NATL ACAD SCI USA, V113, P822, DOI 10.1073/pnas.1523341113; Cho YK, 2019, J BIOL CHEM, V294, P3806, DOI 10.1074/jbc.RA118.006996; Deisseroth K, 2017, SCIENCE, V357, DOI 10.1126/science.aan5544; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100	8	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3822	3823		10.1074/jbc.H119.007749	http://dx.doi.org/10.1074/jbc.H119.007749			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30877261	hybrid, Green Published			2022-12-28	WOS:000461854400002
J	Sahu, PK; Tomar, RS				Sahu, Pushpendra Kumar; Tomar, Raghuvir Singh			The natural anticancer agent cantharidin alters GPI-anchored protein sorting by targeting Cdc1-mediated remodeling in endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylphosphatidylinositol (GPI-anchor); yeast genetics; anticancer drug; phospholipid; unfolded protein response (UPR); cell signaling; lipid metabolism; cantharidin; Cdc1; ER homeostasis; ER-Golgi transport; GPI-anchor remodeling; lipid phosphatase	CELL-WALL INTEGRITY; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLSERINE DECARBOXYLASE; CANCER CELLS; YEAST; IDENTIFICATION; PHOSPHATASE; INHIBITION; STRESS	Cantharidin (CTD) is a potent anticancer small molecule produced by several species of blister beetle. It has been a traditional medicine for the management of warts and tumors for many decades. CTD suppresses tumor growth by inducing apoptosis, cell cycle arrest, and DNA damage and inhibits protein phosphatase 2 phosphatase activator (PP2A) and protein phosphatase 1 (PP1). CTD also alters lipid homeostasis, cell wall integrity, endocytosis, adhesion, and invasion in yeast cells. In this study, we identified additional molecular targets of CTD using a Saccharomyces cerevisiae strain that expresses a cantharidin resistance gene (CRG1), encoding a SAM-dependent methyltransferase that methylates and inactivates CTD. We found that CTD specifically affects phosphatidylethanolamine (PE)-associated functions that can be rescued by supplementing the growth media with ethanolamine (ETA). CTD also perturbed endoplasmic reticulum (ER) homeostasis and cell wall integrity by altering the sorting of glycosylphosphatidylinositol (GPI)-anchored proteins. A CTD-dependent genetic interaction profile of CRG1 revealed that the activity of the lipid phosphatase cell division control protein 1 (Cdc1) in GPI-anchor remodeling is the key target of CTD, independently of PP2A and PP1 activities. Moreover, experiments with human cells further suggested that CTD functions through a conserved mechanism in higher eukaryotes. Altogether, we conclude that CTD induces cytotoxicity by targeting Cdc1 activity in GPI-anchor remodeling in the ER.	[Sahu, Pushpendra Kumar; Tomar, Raghuvir Singh] Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal 462066, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Tomar, RS (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Lab Chromatin Biol, Bhopal 462066, Madhya Pradesh, India.	rst@iiserb.ac.in		Tomar, Raghuvir/0000-0002-3574-7839	Indian Institute of Science Education and Research Bhopal; SERB Government of India [EMR/2015/001797]; Department of Biotechnology (DBT)-India	Indian Institute of Science Education and Research Bhopal; SERB Government of India; Department of Biotechnology (DBT)-India(Department of Biotechnology (DBT) India)	This work was supported by funds from the Indian Institute of Science Education and Research Bhopal and partly by SERB Government of India Grant EMR/2015/001797 (to R.S.T.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Junior Research Fellow/Senior Research Fellow (JRF/SRF) fellowship from the Department of Biotechnology (DBT)-India.	Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Chen YL, 2010, MOL MICROBIOL, V75, P1112, DOI 10.1111/j.1365-2958.2009.07018.x; Costa-de-Oliveira S, 2013, CYTOM PART A, V83A, P324, DOI 10.1002/cyto.a.22250; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Delic M, 2012, FREE RADICAL BIO MED, V52, P2000, DOI 10.1016/j.freeradbiomed.2012.02.048; Duffy S, 2016, P NATL ACAD SCI USA, V113, P9967, DOI 10.1073/pnas.1611839113; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; GARABEDIAN MJ, 1992, MOL BIOL CELL, V3, P1245, DOI 10.1091/mbc.3.11.1245; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Huang WW, 2011, INT J ONCOL, V38, P1067, DOI 10.3892/ijo.2011.922; Hughes WE, 2000, J BIOL CHEM, V275, P801, DOI 10.1074/jbc.275.2.801; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kim JA, 2013, J BIOL CHEM, V288, P28713, DOI 10.1074/jbc.M113.488346; Klis FM, 2007, YEAST, V24, P253, DOI 10.1002/yea.1476; Leung AKC, 2017, RECENT PATENTS INFLA, V11, P22, DOI 10.2174/1872213X11666170518114456; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Li HC, 2017, CELL PHYSIOL BIOCHEM, V43, P1829, DOI 10.1159/000484069; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Lissina E, 2013, ACS CHEM BIOL, V8, P2785, DOI 10.1021/cb400607h; Lissina E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002332; Losev E, 2008, MOL CELL BIOL, V28, P3336, DOI 10.1128/MCB.00567-07; LOUKIN S, 1995, J CELL BIOL, V131, P1025, DOI 10.1083/jcb.131.4.1025; Lubeseder-Martellato C, 2016, ONCOTARGET, V7, P49156, DOI 10.18632/oncotarget.9402; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mierke CT, 2011, J BIOL CHEM, V286, P34858, DOI 10.1074/jbc.M111.245183; Muniz M, 2014, J CELL SCI, V127, P2793, DOI 10.1242/jcs.148056; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Paidhungat M, 1998, GENETICS, V148, P1777; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Rodicio R, 2010, YEAST, V27, P531, DOI 10.1002/yea.1785; Rolli E, 2009, MOL BIOL CELL, V20, P4856, DOI 10.1091/mbc.E08-11-1155; Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695; Sakoff JA, 2002, INVEST NEW DRUG, V20, P1, DOI 10.1023/A:1014460818734; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Srivas R, 2016, MOL CELL, V63, P514, DOI 10.1016/j.molcel.2016.06.022; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; STOUGHTON RB, 1959, J INVEST DERMATOL, V33, P287, DOI 10.1038/jid.1959.152; Su CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168095; Sun XY, 2016, MOL CELLS, V39, P869, DOI 10.14348/molcells.2016.0023; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; van Pel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003254; Vazquez HM, 2014, MOL BIOL CELL, V25, P3375, DOI 10.1091/mbc.E14-06-1033; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Wang SX, 2014, P NATL ACAD SCI USA, V111, pE3976, DOI 10.1073/pnas.1411694111; WEAKLEY DR, 1962, J INVEST DERMATOL, V39, P39, DOI 10.1038/jid.1962.78; Wlodarchak N, 2016, CRIT REV BIOCHEM MOL, V51, P162, DOI 10.3109/10409238.2016.1143913; Wu GJ, 2006, CANCER RES, V66, P9829, DOI 10.1158/0008-5472.CAN-06-0506; Yang LH, 2016, J BIOL CHEM, V291, P3905, DOI 10.1074/jbc.M115.705830; YELL JA, 1994, BRIT J DERMATOL, V130, P148, DOI 10.1111/j.1365-2133.1994.tb02893.x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zhang JT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-193; Zhao P, 2012, J BIOL CHEM, V287, P25230, DOI 10.1074/jbc.M112.339465; Zheng LH, 2008, CANCER LETT, V272, P102, DOI 10.1016/j.canlet.2008.06.029; Zimmerman R, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.31	78	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3837	3852		10.1074/jbc.RA118.003890	http://dx.doi.org/10.1074/jbc.RA118.003890			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30659098	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000461854400004
J	Falcone, EL; Bryant, C				Falcone, Emilia Liana; Bryant, Clare			Let's get this pyrin started!	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							INFLAMMASOMES	Inflammasomes enable cells to respond to pathogens or biological damage, but the specific signals being used to convey these messages are not always clear. A new paper identifies two potential microbiota-derived metabolites, the bile acid analogues BAA485 and BAA473, as the first small molecules to activate the pyrin inflammasome. These results suggest that microbiota may be able to modulate this inflammatory process which, in turn, may contribute to the maintenance of intestinal homeostasis.	[Falcone, Emilia Liana] Montreal Clin Res Inst IRCM, Microbiome & Mucosal Def Res Unit, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada; [Falcone, Emilia Liana] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Bryant, Clare] Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; University of Cambridge	Falcone, EL (corresponding author), Montreal Clin Res Inst IRCM, Microbiome & Mucosal Def Res Unit, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.; Bryant, C (corresponding author), Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England.	emilia.falcone@ircm.qc.ca; ceb27@cam.ac.uk		Bryant, Clare Elizabeth/0000-0002-2924-0038	Wellcome Trust [108045/Z/15/Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001216] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Wellcome Trust Investigator Grant 108045/Z/15/Z. To whom correspondence may be addressed: Dept. of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, United Kingdom. Tel.: 44-1223-337600; E-mail: ceb27@cam.ac.uk.	Alimov I, 2019, J BIOL CHEM, V294, P3359, DOI 10.1074/jbc.RA118.005103; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Hoque R, 2014, GASTROENTEROLOGY, V146, P1763, DOI 10.1053/j.gastro.2014.03.014; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Prochnicki T, 2017, CELL METAB, V26, P71, DOI 10.1016/j.cmet.2017.06.018; Sharma D, 2018, GASTROENTEROLOGY, V154, P948, DOI 10.1053/j.gastro.2017.11.276; Van Gorp H, 2016, P NATL ACAD SCI USA, V113, P14384, DOI 10.1073/pnas.1613156113	8	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3367	3368		10.1074/jbc.H119.007830	http://dx.doi.org/10.1074/jbc.H119.007830			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30850508	Green Published, hybrid			2022-12-28	WOS:000461853900005
J	Yang, Y; Mohammed, FS; Zhang, N; Sauve, AA				Yang, Yue; Mohammed, Farheen Sultana; Zhang, Ning; Sauve, Anthony A.			Dihydronicotinamide riboside is a potent NAD(+) concentration enhancer in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NAD biosynthesis; nicotinamide adenine dinucleotide (NAD); nicotinamide adenine dinucleotide (NADH); ADP-ribosylation; biosynthesis; nicotinamide riboside; NRH; dihydronicotinamide riboside; NAD(+) precursor	NICOTINAMIDE-ADENINE-DINUCLEOTIDE; HIGH-FAT DIET; REDOX STATE; METABOLISM; MITOCHONDRIA; MECHANISM; DISEASE; TARGET; SIRT1; NQO2	Interest in pharmacological agents capable of increasing cellular NAD(+) concentrations has stimulated investigations of nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). NR and NMN require large dosages for effect. Herein, we describe synthesis of dihydronicotinamide riboside (NRH) and the discovery that NRH is a potent NAD(+) concentration-enhancing agent, which acts within as little as 1 h after administration to mammalian cells to increase NAD(+) concentrations by 2.5-10-fold over control values. Comparisons with NR and NMN show that in every instance, NRH provides greater NAD(+) increases at equivalent concentrations. NRH also provides substantial NAD(+) increases in tissues when administered by intraperitoneal injection to C57BL/6J mice. NRH substantially increases NAD(+)/NADH ratio in cultured cells and in liver and no induction of apoptotic markers or significant increases in lactate levels in cells. Cells treated with NRH are resistant to cell death caused by NAD(+)-depleting genotoxins such as hydrogen peroxide and methylmethane sulfonate. Studies to identify its biochemical mechanism of action showed that it does not inhibit NAD(+) consumption, suggesting that it acts as a biochemical precursor to NAD(+). Cell lysates possess an ATP-dependent kinase activity that efficiently converts NRH to the compound NMNH, but independent of Nrk1 or Nrk2. These studies identify a putative new metabolic pathway to NAD(+) and a potent pharmacologic agent for NAD(+) concentration enhancement in cells and tissues.	[Yang, Yue; Mohammed, Farheen Sultana; Zhang, Ning; Sauve, Anthony A.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University	Sauve, AA (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA.	aas2004@med.cornell.edu	Zhang, Ning/GVU-7071-2022	Mohammed, Farheen Sultana/0000-0001-9509-3091; Yang, Yue/0000-0002-1481-8175; ZHANG, NING/0000-0003-0909-6099	National Institutes of Health [GM R01-106072]; New York Spinal Cord Research Board Contract [C32098GG]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Spinal Cord Research Board Contract; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by National Institutes of Health Grant GM R01-106072 (to A. A. S.) and New York Spinal Cord Research Board Contract C32098GG (to A. A. S.). The authors A. A. Sauve, Y. Yang, and F. Sultana Mohammed have filed a patent on aspects of this work in conjunction with Cornell University. A. A. Sauve has intellectual property related to NR and derivatives of NR. Chromadex Inc. (Irvine, CA) has a license on intellectual property related to production and uses of NR. A. A. Sauve is a consultant and a co-founder of Metro MidAtlantic Biotech LLC and Metro International Biotech LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Brochier C, 2015, P NATL ACAD SCI USA, V112, P15220, DOI 10.1073/pnas.1509754112; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Dellinger RW, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0016-9; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hayashida S, 2010, MOL CELL BIOCHEM, V339, P285, DOI 10.1007/s11010-010-0391-z; Katsyuba E, 2017, EMBO J, V36, P2670, DOI 10.15252/embj.201797135; Langley B, 2013, NEUROTHERAPEUTICS, V10, P605, DOI 10.1007/s13311-013-0214-5; Li W, 2015, METHODS MOL BIOL, V1241, P39, DOI 10.1007/978-1-4939-1875-1_4; Martens CR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03421-7; Megarity CF, 2014, FEBS LETT, V588, P1666, DOI 10.1016/j.febslet.2014.02.063; Mouchiroud L, 2013, CRIT REV BIOCHEM MOL, V48, P397, DOI 10.3109/10409238.2013.789479; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011; Riches Z, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21921; Ryu D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5504; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002; Zhu XH, 2015, P NATL ACAD SCI USA, V112, P2876, DOI 10.1073/pnas.1417921112	34	45	49	5	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9295	9307		10.1074/jbc.RA118.005772	http://dx.doi.org/10.1074/jbc.RA118.005772			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	30948509	Green Published, hybrid			2022-12-28	WOS:000471751600022
J	Virmani, R; Sajid, A; Singhal, A; Gaur, M; Joshi, J; Bothra, A; Garg, R; Misra, R; Singh, VP; Molle, V; Goel, AK; Singh, A; Kalia, VC; Lee, JK; Hasija, Y; Arora, G; Singh, Y				Virmani, Richa; Sajid, Andaleeb; Singhal, Anshika; Gaur, Mohita; Joshi, Jayadev; Bothra, Ankur; Garg, Richa; Misra, Richa; Singh, Vijay Pal; Molle, Virginie; Goel, Ajay K.; Singh, Archana; Kalia, Vipin C.; Lee, Jung-Kul; Hasija, Yasha; Arora, Gunjan; Singh, Yogendra			The Ser/Thr protein kinase PrkC imprints phenotypic memory in Bacillus anthracis spores by phosphorylating the glycolytic enzyme enolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; signaling; metabolism; glycolysis; phosphorylation; protein phosphorylation; anthrax; phenotypic memory; PrkC; spore germination; virulence	DORMANT SPORES; SUBTILIS; GERMINATION; SPORULATION; RNA; PHOSPHOPROTEOME; METABOLISM; DYNAMICS; BACTERIA	Bacillus anthracis is the causative agent of anthrax in humans, bovine, and other animals. B. anthracis pathogenesis requires differentiation of dormant spores into vegetative cells. The spores inherit cellular components as phenotypic memory from the parent cell, and this memory plays a critical role in facilitating the spores' revival. Because metabolism initiates at the beginning of spore germination, here we metabolically reprogrammed B. anthracis cells to understand the role of glycolytic enzymes in this process. We show that increased expression of enolase (Eno) in the sporulating mother cell decreases germination efficiency. Eno is phosphorylated by the conserved Ser/Thr protein kinase PrkC which decreases the catalytic activity of Eno. We found that phosphorylation also regulates Eno expression and localization, thereby controlling the overall spore germination process. Using MS analysis, we identified the sites of phosphorylation in Eno, and substitution(s) of selected phosphorylation sites helped establish the functional correlation between phosphorylation and Eno activity. We propose that PrkC-mediated regulation of Eno may help sporulating B. anthracis cells in adapting to nutrient deprivation. In summary, to the best of our knowledge, our study provides the first evidence that in sporulating B. anthracis, PrkC imprints phenotypic memory that facilitates the germination process.	[Virmani, Richa; Gaur, Mohita; Misra, Richa; Arora, Gunjan; Singh, Yogendra] Univ Delhi, Dept Zool, Delhi 110007, India; [Virmani, Richa; Sajid, Andaleeb; Singhal, Anshika; Joshi, Jayadev; Bothra, Ankur; Garg, Richa; Singh, Vijay Pal; Singh, Archana; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India; [Virmani, Richa; Hasija, Yasha] Delhi Technol Univ, Delhi 110042, India; [Goel, Ajay K.] Def Res & Dev Estab, Gwalior 474002, India; [Molle, Virginie] Univ Montpellier, DIMNP, CNRS, F-34000 Montpellier, France; [Misra, Richa] Univ Delhi, Sri Venkateswara Coll, Delhi 110021, India; [Kalia, Vipin C.; Lee, Jung-Kul] Konkuk Univ, Dept Chem Engn, 1 Hwayang Dong, Seoul 05029, South Korea; [Arora, Gunjan] NIAID, Immunogenet Lab, NIH, Rockville, MD 20851 USA	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Delhi Technological University; Defence Research & Development Organisation (DRDO); Defence Research & Development Establishment (DRDE); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Delhi; Konkuk University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Arora, G; Singh, Y (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	arorag1983@gmail.com; ysinghdu@gmail.com	Misra, Richa/AAE-6257-2019; Sajid, Andaleeb/AAI-2960-2020; Joshi, Jayadev/AHD-1520-2022; MOLLE, Virginie/D-4050-2019; Bothra, Ankur/AAD-9423-2020; Misra, Richa/B-3860-2018; GAUR, MOHITA/ACJ-7474-2022; Lee, Jungkukl/D-9104-2011; Arora, Gunjan/AAL-3448-2020	Sajid, Andaleeb/0000-0001-6248-4985; MOLLE, Virginie/0000-0002-6573-3411; Bothra, Ankur/0000-0002-9038-740X; Misra, Richa/0000-0003-3630-827X; Arora, Gunjan/0000-0003-0575-6205; Singh, Archana/0000-0003-1388-9489; Singh, Vijay Pal/0000-0003-0547-3336; GAUR, MOHITA/0000-0001-8753-6286	J.C. Bose Fellowship from the Science and Engineering Research Board (SERB), Department of Science and Technology (DST) [SB/S2/JCB-012/2015]; Council of Scientific and Industrial Research (CSIR) senior research fellowship; National Research Foundation of Korea (NRF) Support of Brain Pool Grant [NRF-2018H1D3A2001746]; NRF Basic Science Research Program - Ministry of Science, ICT and Future Planning [2017R1A2B3011676, 2017R1A4A1014806, 2013M3A6A8073184]	J.C. Bose Fellowship from the Science and Engineering Research Board (SERB), Department of Science and Technology (DST)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR) senior research fellowship; National Research Foundation of Korea (NRF) Support of Brain Pool Grant; NRF Basic Science Research Program - Ministry of Science, ICT and Future Planning	This work was supported by J.C. Bose Fellowship SB/S2/JCB-012/2015 from the Science and Engineering Research Board (SERB), Department of Science and Technology (DST); Council of Scientific and Industrial Research (CSIR) senior research fellowship (to R.V.); National Research Foundation of Korea (NRF) Support of Brain Pool Grant NRF-2018H1D3A2001746 (to V.C.K. to work at Konkuk University); and NRF Basic Science Research Program Grants 2017R1A2B3011676, 2017R1A4A1014806, and 2013M3A6A8073184 funded by the Ministry of Science, ICT and Future Planning (to J.-K.L.).	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Arora G, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0015-4; Arora G, 2017, CURR TOP MED CHEM, V17, P2077, DOI 10.2174/1568026617666170130111324; Arora G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003315; Arora G, 2013, BIOMETALS, V26, P715, DOI 10.1007/s10534-013-9646-y; Arora G, 2012, J BIOL CHEM, V287, P26749, DOI 10.1074/jbc.M112.351304; Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; Boel G, 2004, J MOL BIOL, V337, P485, DOI 10.1016/j.jmb.2003.12.082; Bryant-Hudson KM, 2011, J BACTERIOL, V193, P1833, DOI 10.1128/JB.01401-10; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Dale JL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00482; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Gao X., 2011, AM J ANAL CHEM, V2, P250, DOI [DOI 10.4236/ajac.2011.22030, DOI 10.4236/AJAC.2011.22030]; Ghosh S, 2015, J BACTERIOL, V197, P992, DOI 10.1128/JB.02520-14; Granger AC, 2011, APPL ENVIRON MICROB, V77, P32, DOI 10.1128/AEM.01965-10; Korza G, 2016, J BACTERIOL, V198, P3254, DOI 10.1128/JB.00583-16; Kudva IT, 2005, INFECT IMMUN, V73, P5685, DOI 10.1128/IAI.73.9.5685-5696.2005; Kuijper B, 2016, J EVOLUTION BIOL, V29, P265, DOI 10.1111/jeb.12778; LEBIODA L, 1991, BIOCHEMISTRY-US, V30, P2817, DOI 10.1021/bi00225a012; Leggett MJ, 2012, J APPL MICROBIOL, V113, P485, DOI 10.1111/j.1365-2672.2012.05336.x; LEYVAVAZQUEZ MA, 1994, J BACTERIOL, V176, P3903, DOI 10.1128/JB.176.13.3903-3910.1994; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Melo RCN, 2014, NAT PROTOC, V9, P2382, DOI 10.1038/nprot.2014.163; Mutlu A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02477-1; Newman JA, 2012, J MOL BIOL, V416, P121, DOI 10.1016/j.jmb.2011.12.024; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Pereira SFF, 2015, P NATL ACAD SCI USA, V112, pE3274, DOI 10.1073/pnas.1505297112; Pompeo F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00568; Rosenberg A, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0184-7; Sajid A, 2015, ANNU REV MICROBIOL, V69, P527, DOI 10.1146/annurev-micro-020415-111342; Schmidl SR, 2010, MOL CELL PROTEOMICS, V9, P1228, DOI 10.1074/mcp.M900267-MCP200; Schreier B, 2010, BIOCHEMISTRY-US, V49, P7582, DOI 10.1021/bi100954f; Segev E, 2012, CELL, V148, P139, DOI 10.1016/j.cell.2011.11.059; SETLOW P, 1970, J BIOL CHEM, V245, P3637; Setlow P, 2008, CELL, V135, P410, DOI 10.1016/j.cell.2008.10.006; Setlow P, 2014, J BACTERIOL, V196, P1297, DOI 10.1128/JB.01455-13; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Shakir SM, 2010, J BACTERIOL, V192, P400, DOI 10.1128/JB.01221-09; Sinai L, 2015, MOL CELL, V57, P695, DOI 10.1016/j.molcel.2014.12.019; Singh LK, 2015, ENVIRON MICROBIOL, V17, P855, DOI 10.1111/1462-2920.12548; Singhal A, 2015, J BIOL CHEM, V290, P26218, DOI 10.1074/jbc.M115.687269; Singhal A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02264; Sunde EP, 2009, P NATL ACAD SCI USA, V106, P19334, DOI 10.1073/pnas.0908712106; Wang SW, 2015, MBIO, V6, DOI 10.1128/mBio.01859-15; Yang CK, 2014, BIOCHEM BIOPH RES CO, V446, P901, DOI 10.1016/j.bbrc.2014.03.032; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11; Zheng LL, 2016, J PROTEOME RES, V15, P585, DOI 10.1021/acs.jproteome.5b00976	48	16	16	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8930	8941		10.1074/jbc.RA118.005424	http://dx.doi.org/10.1074/jbc.RA118.005424			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30952697	hybrid, Green Published			2022-12-28	WOS:000470971100026
J	Duan, D; Derynck, R				Duan, Dana; Derynck, Rik			Transforming growth factor- (TGF-)-induced up-regulation of TGF- receptors at the cell surface amplifies the TGF- response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription regulation; SMAD transcription factor; Akt PKB; bone morphogenetic protein (BMP); cell-surface receptor; autocrine signaling; Smad activation	FACTOR-BETA RECEPTORS; MESENCHYMAL TRANSITION; SIGNAL-TRANSDUCTION; DIRECT BINDING; IN-VITRO; KINASE; SMAD; INHIBITION; TRANSCRIPTION; INDUCTION	Functional activation of the transforming growth factor- (TGF-) receptors (TGFBRs) is carefully regulated through integration of post-translational modifications, spatial regulation at the cellular level, and TGFBR availability at the cell surface. Although the bulk of TGFBRs resides inside the cells, AKT Ser/Thr kinase (AKT) activation in response to insulin or other growth factors rapidly induces transport of TGFBRs to the cell surface, thereby increasing the cell's responsiveness to TGF-. We now demonstrate that TGF- itself induces a rapid translocation of its own receptors to the cell surface and thus amplifies its own response. This mechanism of response amplification, which hitherto has not been reported for other cell-surface receptors, depended on AKT activation and TGF- type I receptor kinase. In addition to an increase in cell-surface TGFBR levels, TGF- treatment promoted TGFBR internalization, suggesting an overall amplification of TGFBR cycling. The TGF--induced increase in receptor presentation at the cell surface amplified TGF--induced SMAD family member (SMAD) activation and gene expression. Furthermore, bone morphogenetic protein 4 (BMP-4), which also induces AKT activation, increased TGFBR levels at the cell surface, leading to enhanced autocrine activation of TGF--responsive SMADs and gene expression, providing context for the activation of TGF- signaling in response to BMP during development. In summary, our results indicate that TGF-- and BMP-induced activation of low levels of cell surface-associated TGFBRs rapidly mobilizes additional TGFBRs from intracellular stores to the cell surface, increasing the abundance of cell-surface TGFBRs and cells' responsiveness to TGF- signaling.	[Duan, Dana; Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Derynck, Rik] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Duan, Dana; Derynck, Rik] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Derynck, R (corresponding author), Univ Calif San Francisco, Broad Ctr, Dept Cell & Tissue Biol, Rm RMB 1027,35 Med Ctr Way, San Francisco, CA 94143 USA.	rik.derynck@ucsf.edu			National Cancer Institute [RO1-CA63101, RO1-CA136690]; NATIONAL CANCER INSTITUTE [R01CA136690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants RO1-CA63101 and RO1-CA136690 from the National Cancer Institute (to R. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bakin AV, 2002, J CELL SCI, V115, P3193; Budi EH, 2017, TRENDS CELL BIOL, V27, P658, DOI 10.1016/j.tcb.2017.04.005; Budi EH, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa9432; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chen YG, 2012, CELL STEM CELL, V10, P231, DOI 10.1016/j.stem.2012.02.008; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Denissova NG, 2000, P NATL ACAD SCI USA, V97, P6397, DOI 10.1073/pnas.090099297; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gabriel Luke, 2009, J Vis Exp, DOI 10.3791/1669; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Goetschy JF, 1996, EUR J BIOCHEM, V241, P355, DOI 10.1111/j.1432-1033.1996.00355.x; Grafe I, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022202; Hamidi A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4186; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Hill CS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022079; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Holtzhausen A, 2014, FASEB J, V28, P1248, DOI 10.1096/fj.13-239178; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293; Kim YW, 2012, BIOCHEM J, V445, P403, DOI 10.1042/BJ20111923; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Liu SJ, 2016, INT J BIOCHEM CELL B, V76, P135, DOI 10.1016/j.biocel.2016.05.001; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; MANSON JC, 1989, EUR J IMMUNOL, V19, P261, DOI 10.1002/eji.1830190207; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Menke A, 1999, BBA-MOL CELL RES, V1449, P178, DOI 10.1016/S0167-4889(99)00011-7; Meyer C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.204; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mullen AC, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022186; Muthusamy BP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002325; Ramachandran A, 2018, ELIFE, V7, DOI 10.7554/eLife.31756; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Tan SX, 2011, BIOCHEM J, V435, P539, DOI 10.1042/BJ20110040; Teo AKK, 2012, STEM CELLS, V30, P631, DOI 10.1002/stem.1022; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; Wang Y, 2004, J BIOL CHEM, V279, P8038, DOI 10.1074/jbc.M311494200; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wei Y, 2017, J CLIN INVEST, V127, P3675, DOI 10.1172/JCI94624; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Xi Y, 2014, AM J RESP CELL MOL, V50, P51, DOI 10.1165/rcmb.2013-0099OC; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhao ZJ, 2005, BIOORG MED CHEM LETT, V15, P905, DOI 10.1016/j.bmcl.2004.12.062; Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898	70	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8490	8504		10.1074/jbc.RA118.005763	http://dx.doi.org/10.1074/jbc.RA118.005763			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30948511	Green Published, hybrid			2022-12-28	WOS:000471108200018
J	Sawasato, K; Suzuki, S; Nishiyama, K				Sawasato, Katsuhiro; Suzuki, Sonomi; Nishiyama, Ken-ichi			Increased expression of the bacterial glycolipid MPIase is required for efficient protein translocation across membranes in cold conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein export; protein translocation; membrane protein; membrane lipid; glycolipid; lipochaperone; low temperature; membrane fluidity; MPIase (membrane protein integrase); protein integration; low temperature; cold sensitivity; cell stress	CDP-DIGLYCERIDE SYNTHETASE; ESCHERICHIA-COLI; CYTOPLASMIC MEMBRANE; TOPOLOGY INVERSION; SECG; YIDC; RECONSTITUTION; INTEGRATION; INSERTION; CLEAVAGE	Protein integration into and translocation across biological membranes are vital events for organismal survival and are fundamentally conserved among many organisms. Membrane protein integrase (MPIase) is a glycolipid that drives membrane protein integration into the cytoplasmic membrane in Escherichia coli. MPIase also stimulates protein translocation across the membrane, but how its expression is regulated is incompletely understood. In this study, we found that the expression level of MPIase significantly increases in the cold (<25 degrees C), whereas that of the SecYEG translocon does not. Using previously created gene-knockout E. coli strains, we also found that either the cdsA or ynbB gene, both encoding rate-limiting enzymes for MPIase biosynthesis, is responsible for the increase in the MPIase expression. Furthermore, using pulse-chase experiments and protein integration assays, we demonstrated that the increase in MPIase levels is important for efficient protein translocation, but not for protein integration. We conclude that MPIase expression is required to stimulate protein translocation in cold conditions and is controlled by cdsA and ynbB gene expression.	[Sawasato, Katsuhiro; Nishiyama, Ken-ichi] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Suzuki, Sonomi; Nishiyama, Ken-ichi] Iwate Univ, Dept Biol Chem & Food Sci, Fac Agr, Morioka, Iwate 0208550, Japan	Iwate University; Iwate University	Nishiyama, K (corresponding author), Iwate Univ, Dept Biol Chem & Food Sci, Fac Agr, Morioka, Iwate 0208550, Japan.	nishiyam@iwate-u.ac.jp		Nishiyama, Ken-ichi/0000-0003-0478-4482	Japan Society for the Promotion of Science [15KT0073, 16H01374, 16K15083, 17H02209, 18KK0197]; SUNBOR scholarship (Suntory Foundation for Life Sciences)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SUNBOR scholarship (Suntory Foundation for Life Sciences)	This work was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (Grants 15KT0073, 16H01374, 16K15083, 17H02209, and 18KK0197 (to K. N.)). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a SUNBOR scholarship (Suntory Foundation for Life Sciences).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beckwith J, 2013, RES MICROBIOL, V164, P497, DOI 10.1016/j.resmic.2013.03.007; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Chen MY, 2003, J BIOL CHEM, V278, P23295, DOI 10.1074/jbc.M301008200; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Facey SJ, 2004, BBA-MOL CELL RES, V1694, P55, DOI 10.1016/j.bbamcr.2004.03.012; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; ICHO T, 1985, J BIOL CHEM, V260, P2078; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kiefer D, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny106; KUHN A, 1985, J BIOL CHEM, V260, P5914; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARR AG, 1962, J BACTERIOL, V84, P1260, DOI 10.1128/JB.84.6.1260-1267.1962; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; Moser M, 2013, P NATL ACAD SCI USA, V110, P9734, DOI 10.1073/pnas.1303160110; Murakami A, 2004, P NATL ACAD SCI USA, V101, P12330, DOI 10.1073/pnas.0404907101; Nishikawa H, 2017, BIOCHEM BIOPH RES CO, V487, P477, DOI 10.1016/j.bbrc.2017.04.095; NISHIYAMA K, 1992, J BIOL CHEM, V267, P7170; NISHIYAMA K, 1991, BIOCHIM BIOPHYS ACTA, V1065, P89, DOI 10.1016/0005-2736(91)90015-Z; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Nishiyama KI, 2006, J BIOL CHEM, V281, P35667, DOI 10.1074/jbc.M608228200; Nishiyama Ken-ichi, 2014, Biomol Concepts, V5, P429, DOI 10.1515/bmc-2014-0030; Nishiyama K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2267; Nishiyama K, 2010, BIOCHEM BIOPH RES CO, V394, P733, DOI 10.1016/j.bbrc.2010.03.061; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; POGLIANO KJ, 1993, GENETICS, V133, P763; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Sato R, 2019, BIOCHEM BIOPH RES CO, V510, P636, DOI 10.1016/j.bbrc.2019.01.145; Sawasato K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37809-8; Shimizu H, 1997, MOL MICROBIOL, V26, P1013, DOI 10.1046/j.1365-2958.1997.6392003.x; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SPARROW CP, 1985, J BIOL CHEM, V260, P2084; Sugai R, 2007, J BIOL CHEM, V282, P29540, DOI 10.1074/jbc.M704716200; Suzuki H, 1998, MOL MICROBIOL, V29, P331, DOI 10.1046/j.1365-2958.1998.00937.x; Suzuki H, 1999, J BIOL CHEM, V274, P31020, DOI 10.1074/jbc.274.43.31020; Tamura Y, 2013, CELL METAB, V17, P709, DOI 10.1016/j.cmet.2013.03.018; TANI K, 1990, J BIOL CHEM, V265, P17341; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P101, DOI 10.1146/annurev.bi.60.070191.000533; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595	40	8	8	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8403	8411		10.1074/jbc.RA119.008457	http://dx.doi.org/10.1074/jbc.RA119.008457			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30936205	Green Published, hybrid			2022-12-28	WOS:000471108200011
J	Dinman, JD				Dinman, Jonathan D.			Translational recoding signals: Expanding the synthetic biology toolbox	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						translation; RNA; ribosome; synthetic biology; bioengineering; circuitry; frameshift; readthrough; recoding	STRANDED-RNA VIRUS; RIBOSOMAL FRAMESHIFT; MUTATIONAL ANALYSIS; MESSENGER-RNA; GENE; STIMULATION; NMD; EXPRESSION; EFFICIENCY; COMPONENT	Innovation follows discovery. If the 20th century was a golden age of discovery in the biomolecular biosciences, the current century may be remembered by the explosion of beneficial devices and therapies conceived by the bioengineers of the era. Much as the development of solid-state electronic components made possible the information revolution, the rational combining of millions of basic molecular control modules will enable the development of highly sophisticated biomachines that will make today's smartphones appear rudimentary. The molecular toolbox is already well-stocked, particularly in our ability to manipulate DNA, control transcription, generate functionally novel hybrid proteins, and expand the genetic code to include unnatural amino acids. This review focuses on how RNA-based regulatory modules that direct alternative readings of the genetic code can be employed as basic circuit components to expand our ability to control gene expression.	[Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Dinman, JD (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu		Dinman, Jonathan/0000-0002-2402-9698	NIGMS, National Institutes of Health [R01 GM117177, R01 HL119439]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117177] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIGMS, National Institutes of Health, Grants R01 GM117177 and R01 HL119439. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Advani VM, 2016, BIOESSAYS, V38, P21, DOI 10.1002/bies.201500131; Advani VM, 2013, TRANSLATION, V1, DOI 10.4161/trla.24418; Anzalone AV, 2016, NAT METHODS, V13, P453, DOI [10.1038/NMETH.3807, 10.1038/nmeth.3807]; ATKINS JF, 1975, MOL GEN GENET, V139, P19, DOI 10.1007/BF00267992; Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; BELCOURT MF, 1990, CELL, V62, P339, DOI 10.1016/0092-8674(90)90371-K; Belew AT, 2011, NUCLEIC ACIDS RES, V39, P2799, DOI 10.1093/nar/gkq1220; Belew AT, 2014, NATURE, V512, P265, DOI 10.1038/nature13429; BRIERLEY I, 1991, J MOL BIOL, V220, P889, DOI 10.1016/0022-2836(91)90361-9; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; Celik A, 2017, CURR GENET, V63, P1007, DOI 10.1007/s00294-017-0709-4; Chou MY, 2010, RNA, V16, P1236, DOI 10.1261/rna.1922410; CLARE JJ, 1988, P NATL ACAD SCI USA, V85, P6816, DOI 10.1073/pnas.85.18.6816; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Ge ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.11155; GESTELAND RF, 1976, CELL, V7, P381, DOI 10.1016/0092-8674(76)90167-7; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Hu HT, 2016, NUCLEIC ACIDS RES, V44, P256, DOI 10.1093/nar/gkv1307; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; KAWAKAMI K, 1993, GENETICS, V135, P309; Larsen B, 1995, BIOCHEM CELL BIOL, V73, P1123, DOI 10.1139/o95-121; Li YH, 2014, P NATL ACAD SCI USA, V111, pE2172, DOI 10.1073/pnas.1321930111; Lin YH, 2016, NUCLEIC ACIDS RES, V44, P9005, DOI 10.1093/nar/gkw718; Lopinski JD, 2000, MOL CELL BIOL, V20, P1095, DOI 10.1128/MCB.20.4.1095-1103.2000; Marczinke B, 1998, J MOL BIOL, V284, P205, DOI 10.1006/jmbi.1998.2186; May JP, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007459; Napthine S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15582; Napthine S, 2016, NUCLEIC ACIDS RES, V44, P5491, DOI 10.1093/nar/gkw480; Nasif S, 2018, SEMIN CELL DEV BIOL, V75, P78, DOI 10.1016/j.semcdb.2017.08.053; NIRENBERG M, 1966, COLD SPRING HARB SYM, V31, P11, DOI 10.1101/SQB.1966.031.01.008; Olsthoorn RCL, 2004, RNA, V10, P1702, DOI 10.1261/rna.7139704; Plant EP, 2005, NUCLEIC ACIDS RES, V33, P1825, DOI 10.1093/nar/gki329; Rodnina MV, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0182; Su MC, 2005, NUCLEIC ACIDS RES, V33, P4265, DOI 10.1093/nar/gki731; Tang XH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12070; WEIGERT MG, 1965, J MOL BIOL, V12, P448, DOI 10.1016/S0022-2836(65)80267-4; Yu CH, 2013, ACS CHEM BIOL, V8, P733, DOI 10.1021/cb300629b; Yu CH, 2010, NUCLEIC ACIDS RES, V38, P8277, DOI 10.1093/nar/gkq650	43	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7537	7545		10.1074/jbc.REV119.006348	http://dx.doi.org/10.1074/jbc.REV119.006348			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30936208	Green Published, hybrid			2022-12-28	WOS:000470153300001
J	Nakane, T; Angata, K; Sato, T; Kaji, H; Narimatsu, H				Nakane, Takahiro; Angata, Kiyohiko; Sato, Takashi; Kaji, Hiroyuki; Narimatsu, Hisashi			Identification of mammalian glycoproteins with type-I LacdiNAc structures synthesized by the glycosyltransferase B3GALNT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; glycosyltransferase; carbohydrate structure; glycoprotein; endoplasmic reticulum (ER); Golgi; B3GALNT2; LC; MS analysis; type-I LacdiNAc; WFA; Wisteria floribunda agglutinin (WFA); intracellular glycoproteins; endoplasmic reticulum; Golgi	WISTERIA-FLORIBUNDA AGGLUTININ; N-ACETYLGALACTOSAMINE; MASS-SPECTROMETRY; MOLECULAR-CLONING; OLIGOSACCHARIDES; PROTEINS; BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE; N,N'-DIACETYLLACTOSEDIAMINE; BETA-4GALNAC-T3; DYSTROGLYCAN	The type-I LacdiNAc (LDN; GalNAc1-3GlcNAc) has rarely been observed in mammalian cells except in the O-glycan of -dystroglycan, in contrast to type-II LDN structures (GalNAc1-4GlcNAc) in N- and O-glycans that are present in many mammalian glycoproteins, such as pituitary and hypothalamic hormones. Although a 1,3-N-acetylgalactosaminyltransferase 2 (B3GALNT2; type-I LDN synthase) has been cloned, the function of type-I LDN in mammalian cells is still unclear, as its carrier protein(s) has not been identified. In this study, using HeLa cells, we demonstrate that inhibition of Golgi-resident glycosyltransferase increases the abundance of B3GALNT2-synthesized type-I LDN structures, recognized by Wisteria floribunda agglutinin (WFA). Using isotope-coded glycosylation site-specific tagging (IGOT)-LC/MS analysis of Lec8 Chinese hamster cells lacking galactosylation and of cells transfected with the B3GALNT2 gene, we identified the glycoproteins that carry B3GALNT2-generated type-I LDN in their N-glycans. Our results further revealed that LDN presence on low-density lipoprotein receptor-related protein 1 and nicastrin depends on B3GALNT2, indicating the occurrence of type-I LDN in vivo in mammalian cells. Our analysis also uncovered that most of the identified glycoproteins localize to intracellular organelles, particularly to the endoplasmic reticulum. Whereas B4GALNT3 and B4GALNT4 synthesized LDN on extracellular glycoproteins, B3GALNT2 primarily transferred LDN to intracellular glycoproteins, thereby clearly delineating proteins that carry type-I or type-II LDNs. Taken together, our results indicate the presence of mammalian glycoproteins carrying type-I LDN on N-glycans and suggest that type-I and type-II LDNs have different roles in vivo.	[Nakane, Takahiro; Angata, Kiyohiko; Sato, Takashi; Kaji, Hiroyuki; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Glycosci & Glycotechnol Res Grp, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, Tsukuba, Ibaraki 3058568, Japan; [Nakane, Takahiro; Narimatsu, Hisashi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Clin Sci, Tsukuba, Ibaraki 3058575, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Narimatsu, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Glycosci & Glycotechnol Res Grp, Biotechnol Res Inst Drug Discovery, Dept Life Sci & Biotechnol, Tsukuba, Ibaraki 3058568, Japan.; Narimatsu, H (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Clin Sci, Tsukuba, Ibaraki 3058575, Japan.	h.narimatsu@aist.go.jp	Kaji, Hiroyuki/L-7122-2018; Angata, Kiyohiko/M-2749-2018; Narimatsu, Hisashi/M-4757-2018	Kaji, Hiroyuki/0000-0002-0910-9999; Angata, Kiyohiko/0000-0001-5561-1368; Narimatsu, Hisashi/0000-0002-8402-133X	Japan Society for the Promotion of Science, KAKENHI [JP13313213, JP15641201]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science, grants-in-aid for Scientific Research, KAKENHI Grant numbers JP13313213 and JP15641201. The authors declare that they have no conflicts of interest with the contents of this article.	Abo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145834; Anderson DC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182561; Angata K, 2001, J BIOL CHEM, V276, P15369, DOI 10.1074/jbc.M100576200; BERGWERFF AA, 1995, EUR J BIOCHEM, V228, P1009; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; GREEN ED, 1985, J BIOL CHEM, V260, P5623; Haji-Ghassemi O, 2016, J BIOL CHEM, V291, P24085, DOI 10.1074/jbc.M116.750463; Hiruma T, 2004, J BIOL CHEM, V279, P14087, DOI 10.1074/jbc.M310614200; Holliday GL, 2017, METHODS MOL BIOL, V1446, P111, DOI 10.1007/978-1-4939-3743-1_9; Hu D, 2015, MOLECULES, V20, P7637, DOI 10.3390/molecules20057637; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Ito H, 2009, J PROTEOME RES, V8, P1358, DOI 10.1021/pr800735j; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kanagawa Motoi, 2017, J Neuromuscul Dis, V4, P259, DOI 10.3233/JND-170255; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Maroofian R, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0505-2; Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088; Ohkura T, 2002, J BIOCHEM, V132, P891, DOI 10.1093/oxfordjournals.jbchem.a003302; SAMPATH D, 1992, J BIOL CHEM, V267, P4440; Sasaki N, 2011, STEM CELLS, V29, P641, DOI 10.1002/stem.615; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; Sato T, 2017, GLYCOBIOLOGY, V27, P743, DOI 10.1093/glycob/cwx038; Sframeli M, 2017, NEUROMUSCULAR DISORD, V27, P793, DOI 10.1016/j.nmd.2017.06.008; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Sugahara D, 2015, PROTEOMICS, V15, P2921, DOI 10.1002/pmic.201400443; Sugahara D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00680; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; VANLEUVEN F, 1994, GENOMICS, V24, P78, DOI 10.1006/geno.1994.1584; Xue J, 2015, J PROTEOMICS, V112, P224, DOI 10.1016/j.jprot.2014.07.013; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	41	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7433	7444		10.1074/jbc.RA118.006892	http://dx.doi.org/10.1074/jbc.RA118.006892			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30898876	Green Published, hybrid			2022-12-28	WOS:000468402900028
J	Pike, CM; Boyer-Andersen, R; Kinch, LN; Caplan, JL; Neunuebel, MR				Pike, Colleen M.; Boyer-Andersen, Rebecca; Kinch, Lisa N.; Caplan, Jeffrey L.; Neunuebel, M. Ramona			The Legionella effector RavD binds phosphatidylinositol-3-phosphate and helps suppress endolysosomal maturation of the Legionella-containing vacuole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host-pathogen interaction; phosphoinositide; infection; virulence factor; bacterial pathogenesis; bacterial effectors; cellular localization; immune evasion; Legionella pneumophila; Legionnaires' disease	LEGIONNAIRES-DISEASE; ALVEOLAR MACROPHAGES; INTRACELLULAR GROWTH; PNEUMOPHILA; PHAGOSOME; PHOSPHOINOSITIDES	Upon phagocytosis into macrophages, the intracellular bacterial pathogen Legionella pneumophila secretes effector proteins that manipulate host cell components, enabling it to evade lysosomal degradation. However, the bacterial proteins involved in this evasion are incompletely characterized. Here we show that the L. pneumophila effector protein RavD targets host membrane compartments and contributes to the molecular mechanism the pathogen uses to prevent encounters with lysosomes. Protein-lipid binding assays revealed that RavD selectively binds phosphatidylinositol-3-phosphate (PI(3)P) in vitro. We further determined that a C-terminal RavD region mediates the interaction with PI(3)P and that this interaction requires Arg-292. In transiently transfected mammalian cells, mCherry-RavD colocalized with the early endosome marker EGFP-Rab5 as well as the PI(3)P biosensor EGFP-2xFYVE. However, treatment with the phosphoinositide 3-kinase inhibitor wortmannin did not disrupt localization of mCherry-RavD to endosomal compartments, suggesting that RavD's interaction with PI(3)P is not necessary to anchor RavD to endosomal membranes. Using superresolution and immunogold transmission EM, we observed that, upon translocation into macrophages, RavD was retained onto the Legionella-containing vacuole and was also present on small vesicles adjacent to the vacuole. We also report that despite no detectable effects on intracellular growth of L. pneumophila within macrophages or amebae, the lack of RavD significantly increased the number of vacuoles that accumulate the late endosome/lysosome marker LAMP-1 during macrophage infection. Together, our findings suggest that, although not required for intracellular replication of L. pneumophila, RavD is a part of the molecular mechanism that steers the Legionella-containing vacuole away from endolysosomal maturation pathways.	[Pike, Colleen M.; Boyer-Andersen, Rebecca; Caplan, Jeffrey L.; Neunuebel, M. Ramona] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA; [Caplan, Jeffrey L.] Univ Delaware, Dept Biol Sci, 105 Green, Newark, DE 19716 USA; [Caplan, Jeffrey L.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Kinch, Lisa N.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Delaware; University of Delaware; University of Delaware; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Neunuebel, MR (corresponding author), Univ Delaware, Dept Biol Sci, 105 Green, Newark, DE 19716 USA.	neunr@udel.edu		Caplan, Jeffrey/0000-0002-3991-0912; Kinch, Lisa/0000-0003-3041-2615	NIAID, National Institutes of Health [1R21AI142317-01]; Delaware COBRE Program, NIGMS, National Institutes of Health [P20GM104316]; Delaware INBRE Program, NIGMS, National Institutes of Health [P20GM103446]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI142317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446, P20GM104316] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Delaware COBRE Program, NIGMS, National Institutes of Health; Delaware INBRE Program, NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIAID, National Institutes of Health grant 1R21AI142317-01 (to M.R.N.), Delaware COBRE Program, NIGMS, National Institutes of Health Grant P20GM104316 (to M.R.N.), and Delaware INBRE Program, NIGMS, National Institutes of Health Grant P20GM103446 (to J.L.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; CHANDLER FW, 1977, NEW ENGL J MED, V297, P1218, DOI 10.1056/NEJM197712012972206; Chen DQ, 2006, MICROBIOL RES, V161, P246, DOI 10.1016/j.micres.2005.09.001; Clemens DL, 2000, INFECT IMMUN, V68, P2671, DOI 10.1128/IAI.68.5.2671-2684.2000; Copenhaver AM, 2014, INFECT IMMUN, V82, P4325, DOI 10.1128/IAI.01891-14; Del Campo CM, 2014, STRUCTURE, V22, P397, DOI 10.1016/j.str.2013.12.018; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dong N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.236; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Hammond GRV, 2015, BBA-MOL CELL BIOL L, V1851, P746, DOI 10.1016/j.bbalip.2015.02.013; Hilbi H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00091; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Kubori T, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12840; Levin R, 2017, MOL BIOL CELL, V28, P128, DOI 10.1091/mbc.E16-06-0451; Levin R, 2015, BBA-MOL CELL BIOL L, V1851, P805, DOI 10.1016/j.bbalip.2014.09.005; Luo X, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004965; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; NASH TW, 1984, J CLIN INVEST, V74, P771, DOI 10.1172/JCI111493; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Pauwels AM, 2017, TRENDS IMMUNOL, V38, P407, DOI 10.1016/j.it.2017.03.006; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Segal G, 1999, INFECT IMMUN, V67, P2117, DOI 10.1128/IAI.67.5.2117-2124.1999; Segal Gil, 2013, Methods Mol Biol, V954, P595, DOI 10.1007/978-1-62703-161-5_37; Toulabi L, 2013, J BIOL CHEM, V288, P24518, DOI 10.1074/jbc.M113.474239; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; WEBER S, 2014, LEGIONELLA, V5, pe0083, DOI DOI 10.1128/MBIO.00839-13; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Yu XB, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-017-1147-7	40	15	17	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6405	6415		10.1074/jbc.RA118.007086	http://dx.doi.org/10.1074/jbc.RA118.007086			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30733336	Green Published, hybrid			2022-12-28	WOS:000468402000018
J	Rossl, A; Denoncourt, A; Lin, MS; Downey, M				Rossl, Anthony; Denoncourt, Alix; Lin, Mong-Shang; Downey, Michael			A synthetic non-histone substrate to study substrate targeting by the Gcn5 HAT and sirtuin HDACs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; yeast; sirtuin; fusion protein; transcription coactivator; Gcn5; SAGA; synthetic biology; yeast	HISTONE ACETYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; LYSINE ACETYLATION; GENE-EXPRESSION; TERMINAL DOMAIN; PROTEIN SIR2; YEAST SAGA; CELL-CYCLE; TRANSCRIPTION; ADA2	Gcn5 and sirtuins are highly conserved histone acetyltransferase (HAT) and histone deacetylase (HDAC) enzymes that were first characterized as regulators of gene expression. Although histone tails are important substrates of these enzymes, they also target many nonhistone proteins that function in diverse biological processes. However, the mechanisms used by these enzymes to choose their nonhistone substrates are unknown. Previously, we used SILAC-based MS to identify novel nonhistone substrates of Gcn5 and sirtuins in yeast and found a shared target consensus sequence. Here, we use a synthetic biology approach to demonstrate that this consensus sequence can direct acetylation and deacetylation targeting by these enzymes in vivo. Remarkably, fusion of the sequence to a nonsubstrate confers de novo acetylation that is regulated by both Gcn5 and sirtuins. We exploit this synthetic fusion substrate as a tool to define subunits of the Gcn5-containing SAGA and ADA complexes required for nonhistone protein acetylation. In particular, we find a key role for the Ada2 and Ada3 subunits in regulating acetylations on our fusion substrate. In contrast, other subunits tested were largely dispensable, including those required for SAGA stability. In an extended analysis, defects in proteome-wide acetylation observed in ada3 mutants mirror those in ada2 mutants. Altogether, our work argues that nonhistone protein acetylation by Gcn5 is determined in part by specific amino acids surrounding target lysines but that even optimal sequences require both Ada2 and Ada3 for robust acetylation. The synthetic fusion substrate we describe can serve as a tool to further dissect the regulation of both Gcn5 and sirtuin activities in vivo.	[Rossl, Anthony; Denoncourt, Alix; Downey, Michael] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Rossl, Anthony; Denoncourt, Alix; Downey, Michael] Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Lin, Mong-Shang] BioLegend, San Diego, CA 92121 USA	University of Ottawa; University of Ottawa	Downey, M (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.; Downey, M (corresponding author), Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada.	mdowne2@uottawa.ca		Rossl, Anthony/0000-0002-2496-6358	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05015]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant RGPIN-2016-05015 (to M. D.). MongShang Lin is an employee of BioLegend, and the monoclonal antibody generation was carried out in BioLegend's facility in San Diego, CA.	Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; Bentley-DeSousa A, 2018, CELL REP, V22, P3427, DOI 10.1016/j.celrep.2018.02.104; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Cai L, 2013, CELL REP, V4, P1063, DOI 10.1016/j.celrep.2013.08.016; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Candau R, 1996, MOL CELL BIOL, V16, P593; Celic I, 2008, GENETICS, V179, P1769, DOI 10.1534/genetics.108.088914; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Che J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004990; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Choi JK, 2008, MOL CELL BIOL, V28, P6967, DOI 10.1128/MCB.00570-08; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cieniewicz AM, 2014, MOL CELL PROTEOMICS, V13, P2896, DOI 10.1074/mcp.M114.038174; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Downey M, 2016, BRIEF FUNCT GENOMICS, V15, P109, DOI 10.1093/bfgp/elv045; Downey M, 2015, MOL CELL PROTEOMICS, V14, P162, DOI 10.1074/mcp.M114.043141; Downey M, 2013, CURR BIOL, V23, P1638, DOI 10.1016/j.cub.2013.06.050; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Froyd CA, 2011, MOL CELL BIOL, V31, P3351, DOI 10.1128/MCB.05175-11; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Helmlinger D, 2017, TRENDS BIOCHEM SCI, V42, P850, DOI 10.1016/j.tibs.2017.09.001; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; KRUGER W, 1991, MOL CELL BIOL, V11, P4135, DOI 10.1128/MCB.11.8.4135; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Laprade L, 2007, GENETICS, V177, P2007, DOI 10.1534/genetics.107.081976; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Madsen CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8726; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; McCord R, 2003, MOL CELL BIOL, V23, P2009, DOI 10.1128/MCB.23.6.2009-2016.2003; McCormick MA, 2014, CELL REP, V8, P476, DOI 10.1016/j.celrep.2014.06.037; Mead J, 2007, MOL CELL BIOL, V27, P2466, DOI 10.1128/MCB.01641-06; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Peng WM, 2008, GENETICS, V179, P277, DOI 10.1534/genetics.107.085068; Perez-Martin J, 1998, MOL CELL BIOL, V18, P4157, DOI 10.1128/MCB.18.7.4157; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Pracheil T, 2013, J BIOL CHEM, V288, P16986, DOI 10.1074/jbc.M113.451674; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Rossl A, 2016, GENETICS, V204, P569, DOI 10.1534/genetics.116.193524; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Starr AE, 2017, GUT, V66, P1573, DOI 10.1136/gutjnl-2015-310705; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Sterner DE, 2002, J BIOL CHEM, V277, P8178, DOI 10.1074/jbc.M108601200; Sun J, 2018, P NATL ACAD SCI USA, V115, P10010, DOI 10.1073/pnas.1805343115; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wierman MB, 2014, FEMS YEAST RES, V14, P73, DOI 10.1111/1567-1364.12115; Wilson JM, 2006, EMBO REP, V7, P1247, DOI 10.1038/sj.embor.7400829; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Yen YM, 2001, TRAFFIC, V2, P449, DOI 10.1034/j.1600-0854.2001.20703.x; Zhang X, 2018, J PROTEOMICS, V180, P120, DOI 10.1016/j.jprot.2017.07.001	69	6	6	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6227	6239		10.1074/jbc.RA118.006051	http://dx.doi.org/10.1074/jbc.RA118.006051			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30804216	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000468402000003
J	Guo, T; Nan, Z; Miao, C; Jin, XY; Yang, WW; Wang, ZH; Tu, YQ; Bao, HC; Lyu, JL; Zheng, HM; Deng, QN; Guo, PF; Xi, YM; Yang, XH; Ge, WZ				Guo, Ting; Nan, Zi; Miao, Chen; Jin, Xiaoye; Yang, Weiwei; Wang, Zehua; Tu, Yinqi; Bao, Hongcun; Lyu, Jialan; Zheng, Huimei; Deng, Qiannan; Guo, Pengfei; Xi, Yongmei; Yang, Xiaohang; Ge, Wanzhong			The autophagy-related gene Atg101 in Drosophila regulates both neuron and midgut homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; neuron; cell differentiation; homeostasis; aging; neurogenesis; Atg101; insect development; intracellular degradation; midgut	STEM-CELLS; INTERACTS; ULK1; ACTIVATION; LONGEVITY; DISEASE; PROTEIN	Atg101 is an autophagy-related gene identified in worms, flies, mice, and mammals, which encodes a protein that functions in autophagosome formation by associating with the ULK1-Atg13-Fip200 complex. In the last few years, the critical role of Atg101 in autophagy has been well-established through biochemical studies and the determination of its protein structure. However, Atg101's physiological role, both during development and in adulthood, remains less understood. Here, we describe the generation and characterization of an Atg101 loss-of-function mutant in Drosophila and report on the roles of Atg101 in maintaining tissue homeostasis in both adult brains and midguts. We observed that homozygous or hemizygous Atg101 mutants were semi-lethal, with only some of them surviving into adulthood. Both developmental and starvation-induced autophagy processes were defective in the Atg101 mutant animals, and Atg101 mutant adult flies had a significantly shorter lifespan and displayed a mobility defect. Moreover, we observed the accumulation of ubiquitin-positive aggregates in Atg101 mutant brains, indicating a neuronal defect. Interestingly, Atg101 mutant adult midguts were shorter and thicker and exhibited abnormal morphology with enlarged enterocytes. Detailed analysis also revealed that the differentiation from intestinal stem cells to enterocytes was impaired in these midguts. Cell type-specific rescue experiments disclosed that Atg101 had a function in enterocytes and limited their growth. In summary, the results of our study indicate that Drosophila Atg101 is essential for tissue homeostasis in both adult brains and midguts. We propose that Atg101 may have a role in age-related processes.	[Guo, Ting; Nan, Zi; Miao, Chen; Jin, Xiaoye; Yang, Weiwei; Wang, Zehua; Tu, Yinqi; Bao, Hongcun; Lyu, Jialan; Zheng, Huimei; Deng, Qiannan; Guo, Pengfei; Xi, Yongmei; Yang, Xiaohang; Ge, Wanzhong] Zhejiang Univ, Div Human Reprod & Dev Genet, Womens Hosp, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Ting; Nan, Zi; Miao, Chen; Jin, Xiaoye; Yang, Weiwei; Wang, Zehua; Tu, Yinqi; Bao, Hongcun; Lyu, Jialan; Zheng, Huimei; Deng, Qiannan; Guo, Pengfei; Xi, Yongmei; Yang, Xiaohang; Ge, Wanzhong] Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Ting; Nan, Zi; Wang, Zehua; Tu, Yinqi; Bao, Hongcun; Deng, Qiannan; Guo, Pengfei] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Miao, Chen; Jin, Xiaoye; Yang, Weiwei; Lyu, Jialan; Zheng, Huimei; Xi, Yongmei; Yang, Xiaohang; Ge, Wanzhong] Zhejiang Univ, Sch Med, Dept Genet, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Ge, WZ (corresponding author), Zhejiang Univ, Div Human Reprod & Dev Genet, Womens Hosp, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.; Ge, WZ (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.; Ge, WZ (corresponding author), Zhejiang Univ, Sch Med, Dept Genet, Hangzhou 310058, Zhejiang, Peoples R China.	wanzhongge@zju.edu.cn	席, 咏梅/AAE-1909-2022; guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022; Lyu, Jialan/AAO-3620-2021	Ge, Wanzhong/0000-0003-1334-2723; ZHENG, HUIMEI/0000-0001-7129-8412	National Key Research and Development Program of China [2018YFC1003200]; National Natural Science Foundation of China [31371319]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 2018YFC1003200 from the National Key Research and Development Program of China and Grant 31371319 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chang YY, 2010, FEBS LETT, V584, P1342, DOI 10.1016/j.febslet.2010.01.006; Chen HY, 2014, CELL, V159, P829, DOI 10.1016/j.cell.2014.10.028; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Foronda D, 2014, GENE DEV, V28, P2421, DOI 10.1101/gad.241588.114; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Hale AN, 2013, AUTOPHAGY, V9, P951, DOI 10.4161/auto.24273; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hegedus K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470482; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kim M, 2013, AUTOPHAGY, V9, P1201, DOI 10.4161/auto.24811; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang J, 2017, NATURE, V548, P588, DOI 10.1038/nature23678; Liang QQ, 2012, AUTOPHAGY, V8, P1426, DOI 10.4161/auto.21163; Mauvezin C, 2014, METHODS, V68, P134, DOI 10.1016/j.ymeth.2014.03.014; McPhee CK, 2009, BBA-MOL CELL RES, V1793, P1452, DOI 10.1016/j.bbamcr.2009.02.009; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Michel M, 2015, AUTOPHAGY, V11, P2300, DOI 10.1080/15548627.2015.1076605; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mulakkal NC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/273473; Nagy P, 2014, AUTOPHAGY, V10, P453, DOI 10.4161/auto.27442; Noda NN, 2016, CELL STRUCT FUNCT, V41, P13, DOI 10.1247/csf.15013; Noda NN, 2015, ANNU REV BIOPHYS, V44, P101, DOI 10.1146/annurev-biophys-060414-034248; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Popelka H, 2015, AUTOPHAGY, V11, P1953, DOI 10.1080/15548627.2015.1087635; Qi SQ, 2015, STRUCTURE, V23, P1848, DOI 10.1016/j.str.2015.07.011; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Stanley RE, 2014, TRENDS CELL BIOL, V24, P73, DOI 10.1016/j.tcb.2013.07.008; Suzuki H, 2015, AUTOPHAGY, V11, P2123, DOI 10.1080/15548627.2015.1091144; Suzuki H, 2015, NAT STRUCT MOL BIOL, V22, P572, DOI 10.1038/nsmb.3036; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006; Wang LF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005220; Wen JK, 2017, ELIFE, V6, DOI 10.7554/eLife.29338; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhao GL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004984	52	14	15	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5666	5676		10.1074/jbc.RA118.006069	http://dx.doi.org/10.1074/jbc.RA118.006069			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30760524	Green Published, hybrid			2022-12-28	WOS:000464517500034
J	Robinson, LS; Schwebke, J; Lewis, WG; Lewis, AL				Robinson, Lloyd S.; Schwebke, Jane; Lewis, Warren G.; Lewis, Amanda L.			Identification and characterization of NanH2 and NanH3, enzymes responsible for sialidase activity in the vaginal bacterium Gardnerella vaginalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gardnerella vaginalis; sialidase; sialic acid; recombinant protein expression; enzyme catalysis; Bacterial vaginosis; glycoside hydrolase family 33; virulence	SIALATE O-ACETYLESTERASE; LOW-BIRTH-WEIGHT; STREPTOCOCCUS-PNEUMONIAE; BIOFILM FORMATION; PRETERM DELIVERY; SIGNAL PEPTIDES; PREGNANT-WOMEN; VAGINOSIS; NEURAMINIDASE; ACID	Gardnerella vaginalis is abundant in bacterial vaginosis (BV), a condition associated with adverse reproductive health. Sialidase activity is a diagnostic feature of BV and is produced by a subset of G. vaginalis strains. Although its genetic basis has not been formally identified, sialidase activity is presumed to derive from the sialidase A gene, named here nanH1. In this study, BLAST searches predicted two additional G. vaginalis sialidases, NanH2 and NanH3. When expressed in Escherichia coli, NanH2 and NanH3 both displayed broad abilities to cleave sialic acids from 2-3- and 2-6-linked N- and O-linked sialoglycans, including relevant mucosal substrates. In contrast, recombinant NanH1 had limited activity against synthetic and mucosal substrates under the conditions tested. Recombinant NanH2 was much more effective than NanH3 in cleaving sialic acids bearing a 9-O-acetyl ester. Similarly, G. vaginalis strains encoding NanH2 cleaved and foraged significantly more Neu5,9Ac(2) than strains encoding only NanH3. Among a collection of 34 G. vaginalis isolates, nanH2, nanH3, or both were present in all 15 sialidase-positive strains but absent from all 19 sialidase-negative isolates, including 16 strains that were nanH1-positive. We conclude that NanH2 and NanH3 are the primary sources of sialidase activity in G. vaginalis and that these two enzymes can account for the previously described substrate breadth cleaved by sialidases in human vaginal specimens of women with BV. Finally, PCRs of nanH2 or nanH3 from human vaginal specimens had 81% sensitivity and 78% specificity in distinguishing between Lactobacillus dominance and BV, as determined by Nugent scoring.	[Robinson, Lloyd S.; Lewis, Warren G.; Lewis, Amanda L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Lewis, Amanda L.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Robinson, Lloyd S.; Lewis, Warren G.; Lewis, Amanda L.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Schwebke, Jane] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL 35294 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Lewis, AL (corresponding author), Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA.	allewis@wustl.edu	Lewis, Warren G/W-4369-2019	Lewis, Warren G/0000-0003-1210-6403; Lewis, Amanda/0000-0001-6195-3030	NIAID, National Institutes of Health [AI114635, AI127554]; Burroughs Wellcome Fund (BWF) Preterm Birth Initiative; Metrodora Therapeutics (2018 - 2019); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127554, R01AI114635] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund (BWF) Preterm Birth Initiative; Metrodora Therapeutics (2018 - 2019); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grants AI114635 and AI127554 (to W. G. L and A. L. L.) and the Burroughs Wellcome Fund (BWF) Preterm Birth Initiative (to A. L. L.). A. L. L. has had consulting relationships with Talis Biomedical Corporation (2018), Tennor Therapeutics (2016), and Toltec Pharmaceuticals (2017). A. L. L. and W. G. L. have performed contract research for Metis Therapeutics (2017). A. L. L., W. G. L., and L. S. R. have an ongoing research project funded by Metrodora Therapeutics (2018 - 2019). Although all of these relationships pertain to our specific expertise on bacterial vaginosis, none are directly related to the specific topics or assays of interest in this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Amegashie CP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177797; Balashov SV, 2014, J MED MICROBIOL, V63, P162, DOI 10.1099/jmm.0.066407-0; BERARDIGRASSIAS L, 1988, EUR J CLIN MICROBIOL, V7, P406, DOI 10.1007/BF01962348; Berry AM, 1996, J BACTERIOL, V178, P4854, DOI 10.1128/jb.178.16.4854-4860.1996; Blanchette KA, 2016, INFECT IMMUN, V84, P2922, DOI 10.1128/IAI.00277-16; Bradshaw CS, 2005, J CLIN MICROBIOL, V43, P1304, DOI 10.1128/JCM.43.3.1304-1308.2005; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Brittan JL, 2012, MOL ORAL MICROBIOL, V27, P270, DOI 10.1111/j.2041-1014.2012.00658.x; Buschiazzo A, 2008, CURR OPIN CHEM BIOL, V12, P565, DOI 10.1016/j.cbpa.2008.06.017; CAMARA M, 1994, INFECT IMMUN, V62, P3688; Castro J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11640; CAUCI S, 1993, MOL MICROBIOL, V9, P1143, DOI 10.1111/j.1365-2958.1993.tb01244.x; Cauci S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.061; Chang YC, 2012, MBIO, V3, DOI 10.1128/mBio.00220-11; Chen G. W., 2014, XINJIANG RECLAIM SCI, V1, P3, DOI DOI 10.7554/ELIFE.04066; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; CORFIELD AP, 1993, GLYCOCONJUGATE J, V10, P72, DOI 10.1007/BF00731190; Cox C, 2017, INT J STD AIDS, V28, P708, DOI 10.1177/0956462416665060; Cox C, 2015, J MED MICROBIOL, V64, P978, DOI 10.1099/jmm.0.000118; Di Paola M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09842-6; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Gilbert NM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006238; Gilbert NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059539; Hardy L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172522; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hilbert DW, 2016, J CLIN MICROBIOL, V54, P1017, DOI 10.1128/JCM.03104-15; HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Howe L, 1999, INT J STD AIDS, V10, P442, DOI 10.1258/0956462991914438; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; Janulaitiene M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200625; Kim S, 2011, APPL MICROBIOL BIOT, V91, P1, DOI 10.1007/s00253-011-3307-2; Lagace-Wiens PRS, 2008, J CLIN MICROBIOL, V46, P804, DOI 10.1128/JCM.01545-07; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Lewis AL, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00887-16; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Li JH, 2014, APPL ENVIRON MICROB, V80, P1701, DOI 10.1128/AEM.03440-13; Li JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002429; LOCK RA, 1988, MICROB PATHOGENESIS, V4, P33, DOI 10.1016/0882-4010(88)90046-0; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Malki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166757; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marrazzo JM, 2012, J INFECT DIS, V205, P1580, DOI 10.1093/infdis/jis242; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; MCGREGOR JA, 1992, AM J OBSTET GYNECOL, V167, P1588, DOI 10.1016/0002-9378(92)91746-W; Meyn LA, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.011; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; Myhre AK, 2002, ACTA PAEDIATR, V91, P885, DOI 10.1080/080352502760148586; Myziuk L, 2003, J CLIN MICROBIOL, V41, P1925, DOI 10.1128/JCM.41.5.1925-1928.2003; NEUBERGER A, 1972, BIOCHEM J, V129, P683, DOI 10.1042/bj1290683; Olmsted SS, 2003, SEX TRANSM DIS, V30, P257, DOI 10.1097/00007435-200303000-00016; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Plumbridge J, 1999, J BACTERIOL, V181, P47, DOI 10.1128/JB.181.1.47-54.1999; Randis TM, 2013, INFECT IMMUN, V81, P4544, DOI 10.1128/IAI.00627-13; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rezeberga D, 2008, ACTA OBSTET GYN SCAN, V87, P360, DOI 10.1080/00016340801936487; Roberton AM, 2005, J CLIN MICROBIOL, V43, P5504, DOI 10.1128/JCM.43.11.5504-5508.2005; Robinson LS, 2017, J BIOL CHEM, V292, P11861, DOI 10.1074/jbc.M116.769232; Robinson LS, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00879-16; ROGGENTIN P, 1993, MOL MICROBIOL, V9, P915, DOI 10.1111/j.1365-2958.1993.tb01221.x; SADHU K, 1989, J MED MICROBIOL, V29, P229, DOI 10.1099/00222615-29-3-229; Schauer R, 1978, Methods Enzymol, V50, P64; Schellenberg JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146510; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Sharapova Y, 2018, FEBS J, V285, P2428, DOI 10.1111/febs.14486; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; SILVER HM, 1989, AM J OBSTET GYNECOL, V161, P808, DOI 10.1016/0002-9378(89)90406-7; Singh AK, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00774-16; Smayevsky J, 2001, Infect Dis Obstet Gynecol, V9, P17, DOI 10.1155/S1064744901000047; Svare JA, 2006, BJOG-INT J OBSTET GY, V113, P1419, DOI 10.1111/j.1471-0528.2006.01087.x; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; Thompson H, 2009, J BACTERIOL, V191, P3623, DOI 10.1128/JB.01618-08; Varki A., 2009, ESSENTIALS GLYCOBIOL; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; VONNICOLAI H, 1984, ZBL BAKT-INT J MED M, V258, P20, DOI 10.1016/S0176-6724(84)80003-6; Watson JN, 2005, CHEMBIOCHEM, V6, P1999, DOI 10.1002/cbic.200500114; Weiman S, 2009, GLYCOBIOLOGY, V19, P1204, DOI 10.1093/glycob/cwp111; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Wiggins R, 2000, J CLIN MICROBIOL, V38, P3096, DOI 10.1128/JCM.38.8.3096-3097.2000; Wiggins R, 2002, INT J STD AIDS, V13, P755, DOI 10.1258/095646202320753709; Wong A, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00068-18; Xu GG, 2011, J AM CHEM SOC, V133, P1718, DOI 10.1021/ja110733q; Xu GG, 2008, J MOL BIOL, V384, P436, DOI 10.1016/j.jmb.2008.09.032; Zhang Xin, 2002, Zhonghua Fu Chan Ke Za Zhi, V37, P588	92	25	26	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5230	5245		10.1074/jbc.RA118.006221	http://dx.doi.org/10.1074/jbc.RA118.006221			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30723162	hybrid, Green Published			2022-12-28	WOS:000464517500001
J	Konovalov, KA; Pardo-Avila, F; Tse, CKM; Oh, J; Wang, D; Huang, XH				Konovalov, Kirill A.; Pardo-Avila, Fatima; Tse, Carmen Ka Man; Oh, Juntaek; Wang, Dong; Huang, Xuhui			8-Oxo-guanine DNA damage induces transcription errors by escaping two distinct fidelity control checkpoints of RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase II; DNA damage; transcription; mutagenesis mechanism; molecular dynamics; 8-oxo-guanine (8OG); transcriptional bypass; nucleotide misincorporation; transcriptional fidelity	STRUCTURAL BASIS; TRIGGER LOOP; MOLECULAR-DYNAMICS; ELONGATION	RNA polymerase II (Pol II) has an intrinsic fidelity control mechanism to maintain faithful genetic information transfer during transcription. 8-Oxo-guanine (8OG), a commonly occurring damaged guanine base, promotes misincorporation of adenine into the RNA strand. Recent structural work has shown that adenine can pair with the syn conformation of 8OG directly upstream of the Pol II active site. However, it remains unknown how 8OG is accommodated in the active site as a template base for the incoming ATP. Here, we used molecular dynamics (MD) simulations to investigate two consecutive steps that may contribute to the adenine misincorporation by Pol II. First, the mismatch is located in the active site, contributing to initial incorporation of adenine. Second, the mismatch is in the adjacent upstream position, contributing to extension from the mismatched bp. These results are supported by an in vitro transcription assay, confirming that 8OG can induce adenine misincorporation. Our simulations further suggest that 8OG forms a stable bp with the mismatched adenine in both the active site and the adjacent upstream position. This stability predominantly originates from hydrogen bonding between the mismatched adenine and 8OG in a noncanonical syn conformation. Interestingly, we also found that an unstable bp present directly upstream of the active site, such as adenine paired with 8OG in the canonical anti conformation, largely disrupts the stability of the active site. Our findings have uncovered two main factors contributing to how 8OG induces transcriptional errors and escapes Pol II transcriptional fidelity control checkpoints.	[Konovalov, Kirill A.; Huang, Xuhui] HKUST Shenzhen Res Inst, Hitech Pk, Shenzhen 518057, Peoples R China; [Konovalov, Kirill A.; Pardo-Avila, Fatima; Tse, Carmen Ka Man; Huang, Xuhui] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, State Key Lab Mol Neurosci, Dept Chem,Kowloon, Hong Kong, Peoples R China; [Oh, Juntaek; Wang, Dong] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Pardo-Avila, Fatima] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; University of California System; University of California San Diego; Stanford University	Huang, XH (corresponding author), HKUST Shenzhen Res Inst, Hitech Pk, Shenzhen 518057, Peoples R China.; Huang, XH (corresponding author), Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, State Key Lab Mol Neurosci, Dept Chem,Kowloon, Hong Kong, Peoples R China.; Wang, D (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	dongwang@ucsd.edu; xuhuihuang@ust.hk	Oh, Juntaek/AAH-2692-2022; Huang, Xuhui/ABE-3207-2021; Oh, Juntaek/AFM-0371-2022	Huang, Xuhui/0000-0002-7119-9358; Wang, Dong/0000-0002-2829-1546; Oh, Juntaek/0000-0002-7625-2779	Hong Kong Ph.D. Fellowship [PF16-06144]; Hong Kong Research Grant Council [HKUST C6009-15G, 16302214, 16307718, AoE/P-705/16]; Shenzhen Science and Technology Innovation Committee [JCYJ20170413173837121]; Guangzhou Science Technology and Innovation Commission [201704030116]; Innovation and Technology Commission [ITC-CNERC14SC01]; National Institutes of Health [GM102362]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102362] Funding Source: NIH RePORTER	Hong Kong Ph.D. Fellowship; Hong Kong Research Grant Council(Hong Kong Research Grants Council); Shenzhen Science and Technology Innovation Committee; Guangzhou Science Technology and Innovation Commission; Innovation and Technology Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Hong Kong Ph.D. Fellowship Scheme No. PF16-06144 (K. K.). This work was also supported by Hong Kong Research Grant Council HKUST C6009-15G, 16302214, 16307718, and AoE/P-705/16 (to X. H.); Shenzhen Science and Technology Innovation Committee Grant JCYJ20170413173837121 (to X. H.); Guangzhou Science Technology and Innovation Commission Grant 201704030116 (to X. H.); and Innovation and Technology Commission Grant ITC-CNERC14SC01 (to X. H.). This work was also supported by National Institutes of Health Grant GM102362 (to D. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bregeon D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000577; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Da LT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11244; Da LT, 2012, J AM CHEM SOC, V134, P2399, DOI 10.1021/ja210656k; Damsma GE, 2009, J BIOL CHEM, V284, P31658, DOI 10.1074/jbc.M109.022764; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Huang XH, 2010, P NATL ACAD SCI USA, V107, P15745, DOI 10.1073/pnas.1009898107; Kuraoka I, 2003, J BIOL CHEM, V278, P7294, DOI 10.1074/jbc.M208102200; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Scicchitano DA, 2004, DNA REPAIR, V3, P1537, DOI 10.1016/j.dnarep.2004.06.004; Silvia TA, 2004, DNA REPAIR, V3, P483, DOI 10.1016/j.dnarep.2004.01.003; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Unarta IC, 2018, CURR OPIN STRUC BIOL, V49, P54, DOI 10.1016/j.sbi.2018.01.002; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Walmacq C, 2012, MOL CELL, V46, P18, DOI 10.1016/j.molcel.2012.02.006; Wang BB, 2015, NUCLEIC ACIDS RES, V43, P1133, DOI 10.1093/nar/gku1370; Wang BB, 2013, CHEM REV, V113, P8546, DOI 10.1021/cr400046x; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang W, 2018, P NATL ACAD SCI USA, V115, pE2538, DOI 10.1073/pnas.1722050115; Xu J, 2017, NATURE, V551, P653, DOI 10.1038/nature24658; Xu L, 2015, CRIT REV BIOCHEM MOL, V50, P503, DOI 10.3109/10409238.2015.1087960; Zgarbova M, 2015, J CHEM THEORY COMPUT, V11, P5723, DOI 10.1021/acs.jctc.5b00716; Zhang L, 2016, ACCOUNTS CHEM RES, V49, P687, DOI 10.1021/acs.accounts.5b00536	31	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4924	4933		10.1074/jbc.RA118.007333	http://dx.doi.org/10.1074/jbc.RA118.007333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718278	hybrid, Green Published			2022-12-28	WOS:000463985600017
J	Dlouhy, AC; Bailey, DK; Steimle, BL; Parker, HV; Kosman, DJ				Dlouhy, Adrienne C.; Bailey, Danielle K.; Steimle, Brittany L.; Parker, Haley V.; Kosman, Daniel J.			Fluorescence resonance energy transfer links membrane ferroportin, hephaestin but not ferroportin, amyloid precursor protein complex with iron efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron metabolism; metal homeostasis; amyloid precursor protein (APP); membrane transport; fluorescence resonance energy transfer (FRET); ferroportin; hephaestin; iron efflux	FERROXIDASE ACTIVITY; ENDOTHELIAL-CELLS; TRANSPORT; BINDING; APP; MECHANISMS; EXPRESSION; INTERNALIZATION; ACCUMULATION; DIMERIZATION	Iron efflux from mammalian cells is supported by the synergistic actions of the ferrous iron efflux transporter, ferroportin (Fpn) and a multicopper ferroxidase, that is, hephaestin (Heph), ceruloplasmin (Cp) or both. The two proteins stabilize Fpn in the plasma membrane and catalyze extracellular Fe3+ release. The membrane stabilization of Fpn is also stimulated by its interaction with a 22-amino acid synthetic peptide based on a short sequence in the extracellular E2 domain of the amyloid precursor protein (APP). However, whether APP family members interact with Fpn in vivo is unclear. Here, using cyan fluorescent protein (CFP)-tagged Fpn in conjunction with yellow fluorescent protein (YFP) fusions of Heph and APP family members APP, APLP1, and APLP2 in HEK293T cells we used fluorescence and surface biotinylation to quantify Fpn membrane occupancy and also measured Fe-59 efflux. We demonstrate that Fpn and Heph co-localize, and FRET analysis indicated that the two proteins form an iron-efflux complex. In contrast, none of the full-length, cellular APP proteins exhibited Fpn co-localization or FRET. Moreover, iron supplementation increased surface expression of the iron-efflux complex, and copper depletion knocked down Heph activity and decreased Fpn membrane localization. Whereas cellular APP species had no effects on Fpn and Heph localization, addition of soluble E2 elements derived from APP and APLP2, but not APLP1, increased Fpn membrane occupancy. We conclude that a ferroportin-targeting sequence, (K/R)EWEE, present in APP and APLP2, but not APLP1, helps modulate Fpn-dependent iron efflux in the presence of an active multicopper ferroxidase.	[Dlouhy, Adrienne C.; Bailey, Danielle K.; Steimle, Brittany L.; Parker, Haley V.; Kosman, Daniel J.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), Suite 4102,955 Main St, Buffalo, NY 14203 USA.	camkos@buffalo.edu		Kosman, Daniel/0000-0003-3570-7682; , Brittany/0000-0003-3638-8767; Bailey, Danielle/0000-0001-9128-0199	National Institutes of Health NINDS [RO3NS095063, RO1NS102337]; Department of Health and Human Services USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102337, R03NS095063] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Health and Human Services USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NINDS Grants RO3NS095063 and RO1NS102337, from the Department of Health and Human Services USA (to D. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson GJ, 2002, BLOOD CELL MOL DIS, V29, P367, DOI 10.1006/bcmd.2002.0576; Aschemeyer S, 2018, BLOOD, V131, P899, DOI 10.1182/blood-2017-05-786590; Bajar BT, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091488; Bousejra-ElGarah F, 2011, INORG CHEM, V50, P9024, DOI 10.1021/ic201233b; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Chen HJ, 2009, J CELL BIOCHEM, V107, P803, DOI 10.1002/jcb.22178; Cho HH, 2010, J BIOL CHEM, V285, P31217, DOI 10.1074/jbc.M110.149161; Chua K, 2015, BIOORG MED CHEM LETT, V25, P4961, DOI 10.1016/j.bmcl.2015.03.012; Coburger I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081926; Coffey R, 2017, J BIOL CHEM, V292, P12727, DOI 10.1074/jbc.R117.781823; D'Anna MC, 2009, J HISTOCHEM CYTOCHEM, V57, P9, DOI 10.1369/jhc.2008.951616; Dahms SO, 2012, J MOL BIOL, V416, P438, DOI 10.1016/j.jmb.2011.12.057; De Domenico I, 2005, P NATL ACAD SCI USA, V102, P8955, DOI 10.1073/pnas.0503804102; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Deshpande CN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05446-4; Devauges V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044434; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Du F, 2015, MOL NEUROBIOL, V52, P101, DOI 10.1007/s12035-014-8847-x; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Duck KA, 2017, BIOCHEM BIOPH RES CO, V494, P70, DOI 10.1016/j.bbrc.2017.10.083; Duck KA, 2016, BIOMETALS, V29, P573, DOI 10.1007/s10534-016-9952-2; Frazer DM, 2017, AM J CLIN NUTR, V105, P1255, DOI 10.3945/ajcn.117.158188; Fung E, 2013, MOL PHARMACOL, V83, P681, DOI 10.1124/mol.112.083428; Fuqua BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098792; Goncalves AS, 2006, BIOCHEM J, V396, P265, DOI 10.1042/BJ20051682; Han O, 2007, J CELL BIOCHEM, V101, P1000, DOI 10.1002/jcb.21392; Hick M, 2015, ACTA NEUROPATHOL, V129, P21, DOI 10.1007/s00401-014-1368-x; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Hoefgen S, 2014, J STRUCT BIOL, V187, P30, DOI 10.1016/j.jsb.2014.05.006; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Ji CY, 2018, CELL MOL NEUROBIOL, V38, P941, DOI 10.1007/s10571-017-0568-z; Jiang RW, 2015, J NUTR, V145, P1003, DOI 10.3945/jn.114.207316; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Klevanski M, 2014, MOL CELL NEUROSCI, V61, P201, DOI 10.1016/j.mcn.2014.06.004; Kosman DJ, 2010, J BIOL CHEM, V285, P26729, DOI 10.1074/jbc.R110.113217; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Lee SM, 2012, BIOCHEM BIOPH RES CO, V421, P449, DOI 10.1016/j.bbrc.2012.04.008; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Marik SA, 2016, P NATL ACAD SCI USA, V113, P7912, DOI 10.1073/pnas.1604299113; McCarthy RC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00031; McCarthy RC, 2015, CELL MOL LIFE SCI, V72, P709, DOI 10.1007/s00018-014-1771-4; McCarthy RC, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0065-7; McCarthy RC, 2014, EMBO REP, V15, P809, DOI 10.15252/embr.201338064; McCarthy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089003; McCarthy RC, 2013, J BIOL CHEM, V288, P17932, DOI 10.1074/jbc.M113.455428; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Muckenthaler MU, 2017, CELL, V168, P344, DOI 10.1016/j.cell.2016.12.034; Muller UC, 2017, NAT REV NEUROSCI, V18, P281, DOI 10.1038/nrn.2017.29; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nittis T, 2004, J BIOL CHEM, V279, P25696, DOI 10.1074/jbc.M401151200; Philpott CC, 2017, J BIOL CHEM, V292, P12764, DOI 10.1074/jbc.R117.791962; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Rafiee A, 2012, IRAN J PUBLIC HEALTH, V41, P79; Rice AE, 2009, J MOL BIOL, V386, P717, DOI 10.1016/j.jmb.2008.12.063; Rishi G, 2017, AM J PHYSIOL-GASTR L, V313, pG157, DOI 10.1152/ajpgi.00004.2017; Rishi G, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150014; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Singh A, 2006, J BIOL CHEM, V281, P13355, DOI 10.1074/jbc.M512042200; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Terzulli AJ, 2009, J BIOL INORG CHEM, V14, P315, DOI 10.1007/s00775-008-0450-z; Tselepis C, 2010, BIOCHEM J, V427, P289, DOI 10.1042/BJ20091521; Wallace DF, 2017, AM J HEMATOL, V92, P1052, DOI 10.1002/ajh.24844; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Weyer SW, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-36; Yanatori I, 2016, J BIOL CHEM, V291, P17303, DOI 10.1074/jbc.M116.721936; Yeh KY, 2011, GASTROENTEROLOGY, V141, P292, DOI 10.1053/j.gastro.2011.03.059; Yeh KY, 2009, AM J PHYSIOL-GASTR L, V296, pG55, DOI 10.1152/ajpgi.90298.2008; Yu Y, 2006, CLIN CANCER RES, V12, P6876, DOI 10.1158/1078-0432.CCR-06-1954; Ziegler L, 2011, MOL MICROBIOL, V81, P473, DOI 10.1111/j.1365-2958.2011.07704.x	73	24	24	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4202	4214		10.1074/jbc.RA118.005142	http://dx.doi.org/10.1074/jbc.RA118.005142			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30647129	Green Published, hybrid			2022-12-28	WOS:000461854400031
J	Meng, FT; Kassa, T; Strader, MB; Soman, J; Olson, JS; Alayash, AI				Meng, Fantao; Kassa, Tigist; Strader, Michael Brad; Soman, Jayashree; Olson, John S.; Alayash, Abdu I.			Substitutions in the subunits of sickle-cell hemoglobin improve oxidative stability and increase the delay time of sickle-cell fiber formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hemoglobin; gene therapy; mass spectrometry (MS); hypoxia; oxidation-reduction (redox); redox reactions; sickle-cell disease	HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; GENE-THERAPY; HEME; TYROSINE; MUTATION; BINDING; OXYHEMOGLOBIN; DYSFUNCTION	After reacting with hydrogen peroxide (H2O2), sickle-cell hemoglobin (HbS, E6V) remains longer in a highly oxidizing ferryl form (HbFe(4+)=O) and induces irreversible oxidation of hot-spot amino acids, including Cys-93. To control the damaging ferryl heme, here we constructed three HbS variants. The first contained a redox-active Tyr in subunits (F41Y), a substitution present in Hb Mequon; the second contained the Asp (K82D) found in the cleft of Hb Providence; and the third had both of these substitutions. Both the single Tyr-41 and Asp-82 constructs lowered the oxygen affinity of HbS but had little or no effects on autoxidation or heme loss kinetics. In the presence of H2O2, both rHbS F41Y and F41Y/K82D enhanced ferryl Hb reduction by providing a pathway for electrons to reduce the heme via the Tyr-41 side chain. MS analysis of Cys-93 revealed moderate inhibition of thiol oxidation in the HbS single F41Y variant and dramatic 3- to 8-fold inhibition of cysteic acid formation in rHbS K82D and F41Y/K82D, respectively. Under hypoxia, K82D and F41Y/K82D HbS substitutions increased the delay time by approximate to 250 and 600 s before the onset of polymerization compared with the rHbS control and rHbS F41Y, respectively. Moreover, at 60 degrees C, rHbS K82D exhibited superior structural stability. Asp-82 also enhanced the function of Tyr as a redox-active amino acid in the rHbS F41Y/K82D variant. We conclude that the K82D and F41Y substitutions add significant resistance to oxidative stress and anti-sickling properties to HbS and therefore could be potential genome-editing targets.	[Meng, Fantao; Kassa, Tigist; Strader, Michael Brad; Alayash, Abdu I.] US FDA, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, White Oak Campus, Silver Spring, MD 20993 USA; [Soman, Jayashree; Olson, John S.] Rice Univ, BioSci Dept, Houston, TX 77251 USA	US Food & Drug Administration (FDA); Rice University	Alayash, AI (corresponding author), US FDA, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, White Oak Campus, Silver Spring, MD 20993 USA.	abdu.alayash@fda.hhs.gov			National Institutes of Health from NHLBI [HL110900]; Robert A. Welch Foundation [C-0612]; United States Food and Drug Administration (MODSCI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert A. Welch Foundation(The Welch Foundation); United States Food and Drug Administration (MODSCI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL110900 from NHLBI (to J. S. O. and A. I. A.), Robert A. Welch Foundation Grant C-0612 (to J. S. O.), and United States Food and Drug Administration (MODSCI) (to A. I. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham B, 2011, BIOCHEMISTRY-US, V50, P9752, DOI 10.1021/bi200876e; ADACHI K, 1979, J BIOL CHEM, V254, P7765; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alayash AI, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010002; Alayash AI, 1999, J BIOL CHEM, V274, P2029, DOI 10.1074/jbc.274.4.2029; ASAKURA T, 1974, P NATL ACAD SCI USA, V71, P1594, DOI 10.1073/pnas.71.5.1594; Azar S, 2017, MED CLIN N AM, V101, P375, DOI 10.1016/j.mcna.2016.09.009; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; BAUDIN V, 1992, BIOCHIM BIOPHYS ACTA, V1159, P223, DOI 10.1016/0167-4838(92)90029-D; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P3367; BONAVENTURA J, 1976, J BIOL CHEM, V251, P7563; Camus SM, 2015, BLOOD, V125, P3805, DOI 10.1182/blood-2014-07-589283; Cellmer T, 2016, NAT STRUCT MOL BIOL, V23, P459, DOI 10.1038/nsmb.3197; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; Dumoulin A, 1996, PROTEIN SCI, V5, P114; EATON W A, 1987, Blood, V70, P1245; Eaton WA, 2017, BLOOD, V129, P2719, DOI 10.1182/blood-2017-02-765891; GALE RE, 1988, BRIT J HAEMATOL, V70, P251, DOI 10.1111/j.1365-2141.1988.tb02472.x; GARROD ARCHIBALD, 1928, BRIT MED JOUR, V1, P1099; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Ghatge MS, 2016, J STRUCT BIOL, V194, P446, DOI 10.1016/j.jsb.2016.04.003; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; Gizi A, 2011, BLOOD CELL MOL DIS, V46, P220, DOI 10.1016/j.bcmd.2011.01.002; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Harrington DJ, 1997, J MOL BIOL, V272, P398, DOI 10.1006/jmbi.1997.1253; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Hebbel RP, 2014, HEMATOL ONCOL CLIN N, V28, P181, DOI 10.1016/j.hoc.2013.11.005; Jagadeeswaran R, 2017, HEMATOL-AM SOC HEMAT, P440, DOI 10.1182/asheducation-2017.1.440; Jagadeeswaran R, 2017, EXP HEMATOL, V50, P46, DOI 10.1016/j.exphem.2017.02.003; Jana S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120451; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Kassa T, 2015, J BIOL CHEM, V290, P27939, DOI 10.1074/jbc.M115.651257; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; MCCUNE SL, 1994, P NATL ACAD SCI USA, V91, P9852, DOI 10.1073/pnas.91.21.9852; Meng FT, 2017, ANAL BIOCHEM, V521, P11, DOI 10.1016/j.ab.2017.01.002; Mitra A, 2017, HEMOGLOBIN, V41, P300, DOI 10.1080/03630269.2017.1399905; Mollan TL, 2014, FREE RADICAL BIO MED, V69, P265, DOI 10.1016/j.freeradbiomed.2014.01.030; Nagababu E, 2002, BIOCHEMISTRY-US, V41, P7407, DOI 10.1021/bi0121048; NAGEL RL, 1979, P NATL ACAD SCI USA, V76, P670, DOI 10.1073/pnas.76.2.670; Negre O, 2016, HUM GENE THER, V27, P148, DOI 10.1089/hum.2016.007; Niihara Y, 1998, AM J HEMATOL, V58, P117, DOI 10.1002/(SICI)1096-8652(199806)58:2<117::AID-AJH5>3.0.CO;2-V; Pimenova T, 2010, J PROTEOME RES, V9, P4061, DOI 10.1021/pr100252e; Reeder BJ, 2008, FREE RADICAL BIO MED, V44, P274, DOI 10.1016/j.freeradbiomed.2007.06.030; Reeder BJ, 2012, J AM CHEM SOC, V134, P7741, DOI 10.1021/ja211745g; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Silkstone GGA, 2016, BIOCHEM J, V473, P3371, DOI 10.1042/BCJ20160243; Simons M, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180370; Strader MB, 2017, BIOCHEM J, V474, P4171, DOI 10.1042/BCJ20170491; Strader MB, 2017, ANTIOXID REDOX SIGN, V26, P777, DOI 10.1089/ars.2016.6805; Strader MB, 2014, J BIOL CHEM, V289, P22342, DOI 10.1074/jbc.M114.568980; Tam MF, 2015, J BIOL CHEM, V290, P21762, DOI 10.1074/jbc.M115.658054; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; Weickert MJ, 1999, APPL ENVIRON MICROB, V65, P640	60	7	8	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4145	4159		10.1074/jbc.RA118.006452	http://dx.doi.org/10.1074/jbc.RA118.006452			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30630954	Green Published, hybrid			2022-12-28	WOS:000461854400026
J	Wang, MM; Toda, K; Block, A; Maeda, HA				Wang, Minmin; Toda, Kyoko; Block, Anna; Maeda, Hiroshi A.			TAT1 and TAT2 tyrosine aminotransferases have both distinct and shared functions in tyrosine metabolism and degradation in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; plant biochemistry; metabolism; secondary metabolism; plant physiology; tyrosine; amino acid catabolism; aromatic amino acids; dark induced senescence; tocopherols; tyrosine; tyrosine aminotransferase; plant metabolism; 4-hydroxyphenylpyruvate; secondary metabolite	BENZYLISOQUINOLINE ALKALOID BIOSYNTHESIS; AMINO-ACID BIOSYNTHESIS; P-HYDROXYPHENYLPYRUVATE DIOXYGENASE; ELECTRON-TRANSFER FLAVOPROTEIN; FUMARYLACETOACETATE HYDROLASE; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; SUBCELLULAR-LOCALIZATION; AROGENATE DEHYDROGENASE; TOCOPHEROL SYNTHESIS; NITRITE REDUCTASE	Plants produce various l-tyrosine (Tyr)-derived compounds that are critical for plant adaptation and have pharmaceutical or nutritional importance for human health. Tyrosine aminotransferases (TATs) catalyze the reversible reaction between Tyr and 4-hydroxyphenylpyruvate (HPP), representing the entry point in plants for both biosynthesis of various natural products and Tyr degradation in the recycling of energy and nutrients. To better understand the roles of TATs and how Tyr is metabolized in planta, here we characterized single and double loss-of-function mutants of TAT1 (At5g53970) and TAT2 (At5g36160) in the model plant Arabidopsis thaliana. As reported previously, tat1 mutants exhibited elevated and decreased levels of Tyr and tocopherols, respectively. The tat2 mutation alone had no impact on Tyr and tocopherol levels, but a tat1 tat2 double mutant had increased Tyr accumulation and decreased tocopherol levels under high-light stress compared with the tat1 mutant. Relative to WT and the tat2 mutant, the tat1 mutant displayed increased vulnerability to continuous dark treatment, associated with an early drop in respiratory activity and sucrose depletion. During isotope-labeled Tyr feeding in the dark, we observed that the tat1 mutant exhibits much slower C-13 incorporation into tocopherols, fumarate, and other tricarboxylic acid (TCA) cycle intermediates than WT and the tat2 mutant. These results indicate that TAT1 and TAT2 function together in tocopherol biosynthesis, with TAT2 having a lesser role, and that TAT1 plays the major role in Tyr degradation in planta. Our study also highlights the importance of Tyr degradation under carbon starvation conditions during dark-induced senescence in plants.	[Wang, Minmin; Toda, Kyoko; Maeda, Hiroshi A.] Univ Wisconsin, Dept Bot, 430 Lincoln Dr, Madison, WI 53706 USA; [Toda, Kyoko] Natl Agr & Food Res Org NARO, Inst Crop Sci, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058518, Japan; [Block, Anna] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL 32608 USA; [Wang, Minmin] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Wisconsin System; University of Wisconsin Madison; National Agriculture & Food Research Organization - Japan; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Maeda, HA (corresponding author), Univ Wisconsin, Dept Bot, 430 Lincoln Dr, Madison, WI 53706 USA.	maeda2@wisc.edu	Block, Anna/AAF-2556-2020	Block, Anna/0000-0003-1689-4005; Maeda, Hiroshi/0000-0003-0246-694X	National Science Foundation [IOS-1354971]; Agricultural Research Service, United States Department of Agriculture [6036-11210-001-00D]	National Science Foundation(National Science Foundation (NSF)); Agricultural Research Service, United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by National Science Foundation Grant IOS-1354971 (to H. A. M.) and by Agricultural Research Service, United States Department of Agriculture, Project 6036-11210-001-00D (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; [Anonymous], [No title captured]; Aoki Y, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv165; Aprile A, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1473-4; Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; Araujo WL, 2011, PLANT PHYSIOL, V157, P55, DOI 10.1104/pp.111.182188; Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Arnold A, 2014, PLANT PHYSIOL, V165, P1380, DOI 10.1104/pp.114.235358; Aryal UK, 2014, PLANT CELL, V26, P3867, DOI 10.1105/tpc.114.127563; Avila-Ospina L, 2014, J EXP BOT, V65, P3799, DOI 10.1093/jxb/eru039; Beaudoin GAW, 2014, PLANTA, V240, P19, DOI 10.1007/s00425-014-2056-8; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Block A, 2014, PLANT CELL, V26, P1938, DOI 10.1105/tpc.114.125807; Block A, 2013, J BIOL CHEM, V288, P27594, DOI 10.1074/jbc.M113.492769; Brockington SF, 2015, NEW PHYTOL, V207, P1170, DOI 10.1111/nph.13441; Broeckling CD, 2005, J EXP BOT, V56, P323, DOI 10.1093/jxb/eri058; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; Collakova E, 2003, PLANT PHYSIOL, V131, P632, DOI 10.1104/pp.015222; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Dixon DP, 2006, PLANT SCI, V171, P360, DOI 10.1016/j.plantsci.2006.04.008; Dormann P, 2007, PLANTA, V225, P269, DOI 10.1007/s00425-006-0438-2; DURAND R, 1974, FEBS LETT, V39, P218, DOI 10.1016/0014-5793(74)80054-2; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Engqvist MKM, 2011, J BIOL CHEM, V286, P11382, DOI 10.1074/jbc.M110.194175; Falk J, 2002, J PLANT PHYSIOL, V159, P1245, DOI 10.1078/0176-1617-00804; Fernandez-Canon JM, 1998, J BIOL CHEM, V273, P329, DOI 10.1074/jbc.273.1.329; FIEDLER E, 1982, PLANTA, V155, P511, DOI 10.1007/BF01607575; Gandia-Herrero F, 2013, TRENDS PLANT SCI, V18, P334, DOI 10.1016/j.tplants.2013.01.003; Garcia I, 1997, BIOCHEM J, V325, P761, DOI 10.1042/bj3250761; GELFAND DH, 1977, J BACTERIOL, V130, P429, DOI 10.1128/JB.130.1.429-440.1977; Granadino B, 1997, GENOMICS, V43, P115, DOI 10.1006/geno.1997.4805; Gregersen PL, 2013, PLANT MOL BIOL, V82, P603, DOI 10.1007/s11103-013-0013-8; Grierson D, 2013, MOL BIOL BIOCH FRUIT, P43, DOI DOI 10.1002/9781118593714.CH3; Gu LP, 2010, PLANT J, V61, P579, DOI 10.1111/j.1365-313X.2009.04083.x; Han CY, 2013, PLANT PHYSIOL, V162, P1956, DOI 10.1104/pp.113.216804; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Hollander-Czytko H, 2005, J PLANT PHYSIOL, V162, P767, DOI 10.1016/j.jplph.2005.04.019; Huang BB, 2008, MOL BIOL REP, V35, P601, DOI 10.1007/s11033-007-9130-2; Iraqui I, 1998, MOL GEN GENET, V257, P238, DOI 10.1007/s004380050644; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Ishizaki K, 2006, PLANT J, V47, P751, DOI 10.1111/j.1365-313X.2006.02826.x; Jander G, 2004, PLANT J, V39, P465, DOI 10.1111/j.1365-313X.2004.02140.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kobayashi N, 2008, PLANT J, V55, P607, DOI 10.1111/j.1365-313X.2008.03539.x; KRUPINSKA K, 1992, PLANTA, V186, P294, DOI 10.1007/BF00196259; LADU BN, 1955, J BIOL CHEM, V217, P777; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Latimer S, 2018, PLANT J, V95, P358, DOI 10.1111/tpj.13955; Lee EJ, 2011, PLANT PHYSIOL, V157, P1067, DOI 10.1104/pp.111.185512; Lee RH, 2001, J EXP BOT, V52, P1117, DOI 10.1093/jexbot/52.358.1117; Liscombe DK, 2005, PHYTOCHEMISTRY, V66, P1374, DOI 10.1016/j.phytochem.2005.04.029; Liu MC, 2015, PLANT PHYSIOL, V169, P2380, DOI 10.1104/pp.15.01361; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; LOFFELHARDT W, 1979, FEBS LETT, V104, P332, DOI 10.1016/0014-5793(79)80845-5; Maeda H, 2007, CURR OPIN PLANT BIOL, V10, P260, DOI 10.1016/j.pbi.2007.04.006; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Maeda H, 2010, PLANT CELL, V22, P832, DOI 10.1105/tpc.109.073247; Mehere P, 2010, PROTEIN CELL, V1, P1023, DOI 10.1007/s13238-010-0128-5; MEYER CR, 1988, PLANT PHYSIOL, V86, P325, DOI 10.1104/pp.86.2.325; MIFLIN BJ, 1967, NATURE, V214, P1133, DOI 10.1038/2141133a0; MIFLIN BJ, 1974, PLANT PHYSIOL, V54, P550, DOI 10.1104/pp.54.4.550; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Munne-Bosch S, 2002, PLANTA, V214, P608, DOI 10.1007/s004250100646; Nishimura K, 2016, PLANT PHYSIOL, V171, P2280, DOI 10.1104/pp.16.00330; Norris SR, 1998, PLANT PHYSIOL, V117, P1317, DOI 10.1104/pp.117.4.1317; NOVELLI GD, 1967, ANNU REV BIOCHEM, V36, P449, DOI 10.1146/annurev.bi.36.070167.002313; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Peng C, 2015, PLANT PHYSIOL, V169, P1807, DOI 10.1104/pp.15.00461; Petersen M, 2003, PHYTOCHEMISTRY, V62, P121, DOI 10.1016/S0031-9422(02)00513-7; PHANEUF D, 1991, AM J HUM GENET, V48, P525; Phornphutkul C, 2002, NEW ENGL J MED, V347, P2111, DOI 10.1056/NEJMoa021736; Pires MV, 2016, PLANT CELL ENVIRON, V39, P1304, DOI 10.1111/pce.12682; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prabhu PR, 2010, BIOCHEM RES INT, V2010, DOI 10.1155/2010/549572; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Riewe D, 2012, PLANT J, V71, P850, DOI 10.1111/j.1365-313X.2012.05035.x; Rippert P, 2002, PLANT MOL BIOL, V48, P361, DOI 10.1023/A:1014018926676; Rippert P, 2002, EUR J BIOCHEM, V269, P4753, DOI 10.1046/j.1432-1033.2002.03172.x; RISE M, 1989, PLANT PHYSIOL, V89, P1028, DOI 10.1104/pp.89.4.1028; RUBIN JL, 1979, PLANT PHYSIOL, V64, P727, DOI 10.1104/pp.64.5.727; Russo PA, 2001, PEDIATR DEVEL PATHOL, V4, P212, DOI 10.1007/s100240010146; Schenck CA, 2018, PHYTOCHEMISTRY, V149, P82, DOI 10.1016/j.phytochem.2018.02.003; Schenck CA, 2017, NAT CHEM BIOL, V13, P1029, DOI [10.1038/nchembio.2414, 10.1038/NCHEMBIO.2414]; Schenck CA, 2015, NAT CHEM BIOL, V11, P52, DOI 10.1038/nchembio.1693; Siehl DL, 2014, PLANT PHYSIOL, V166, P1162, DOI 10.1104/pp.114.247205; Singh RK, 2011, J EXP BOT, V62, P3375, DOI 10.1093/jxb/err006; Stacey MG, 2016, PLANT PHYSIOL, V172, P1506, DOI 10.1104/pp.16.00941; Starke I, 2001, FRESEN J ANAL CHEM, V371, P380, DOI 10.1007/s002160100941; Torrens-Spence MP, 2018, MOL PLANT, V11, P205, DOI 10.1016/j.molp.2017.12.007; Tsegaye Y, 2002, PLANT PHYSIOL BIOCH, V40, P913, DOI 10.1016/S0981-9428(02)01461-4; Tzin Vered, 2010, Arabidopsis Book, V8, pe0132, DOI 10.1199/tab.0132; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Valentin HE, 2006, PLANT CELL, V18, P212, DOI 10.1105/tpc.105.037077; van Wijk KJ, 2015, ANNU REV PLANT BIOL, V66, P75, DOI 10.1146/annurev-arplant-043014-115547; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; vom Dorp K, 2015, PLANT CELL, V27, P2846, DOI 10.1105/tpc.15.00395; Wang MM, 2018, PHYTOCHEM REV, V17, P131, DOI 10.1007/s11101-017-9520-6; Wang MM, 2016, PHYTOCHEMISTRY, V132, P16, DOI 10.1016/j.phytochem.2016.09.007; WHISTANC.GR, 1970, BIOCHEM J, V117, P593, DOI 10.1042/bj1170593; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Xu JJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01305; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833; Zhi TT, 2016, PLANTA, V244, P557, DOI 10.1007/s00425-016-2530-6	109	22	24	2	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3563	3576		10.1074/jbc.RA118.006539	http://dx.doi.org/10.1074/jbc.RA118.006539			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30630953	Green Published, hybrid			2022-12-28	WOS:000461853900021
J	Chattopadhyay, R; Dyukova, E; Singh, NK; Ohba, M; Mobley, JA; Rao, GN				Chattopadhyay, Rima; Dyukova, Elena; Singh, Nikhlesh K.; Ohba, Motoi; Mobley, James A.; Rao, Gadiparthi N.			Vascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C E-mediated zona occludens-1 phosphorylation at threonine 770/772 (vol 289, pg 3148, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Singh, Nikhlesh/AAA-4253-2020	Singh, Nikhlesh/0000-0002-3665-6023				Chattopadhyay R, 2014, J BIOL CHEM, V289, P3148, DOI 10.1074/jbc.M113.528190	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3311	3311		10.1074/jbc.AAC119.007869	http://dx.doi.org/10.1074/jbc.AAC119.007869			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30824571	Green Published, hybrid			2022-12-28	WOS:000464980100027
J	Smith, WL				Smith, William L.			A seven-step plan for becoming a moderately rich and famous biochemist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						prostaglandin; cyclooxygenase (COX); arachidonic acid (AA) (ARA); eicosanoid; COX-2; lipid mediator; naproxen; NSAID; omega-3 fatty acid; half-sites; aspirin; celecoxib	PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; UNSATURATED FATTY-ACIDS; COLLECTING TUBULE CELLS; VESICULAR GLAND; H SYNTHASE-1; FORMING CYCLOOXYGENASE; ARACHIDONIC-ACID; ENDOCANNABINOID OXYGENATION; CARDIOVASCULAR SAFETY; CATALYTIC SUBUNITS	Omega-6 polyunsaturated fatty acids were identified as essential nutrients in 1930. Their essentiality is largely due to their function as prostaglandin (PG) precursors. I spent most of my career in biochemistry determining how PG biosynthesis is regulated. PGs are lipid mediators formed in response to certain circulating hormones and cytokines. PGs act near their sites of synthesis to signal neighboring cells to coordinate their responses (e.g. when platelets interact with blood vessels). The committed step in PG synthesis is the conversion of a 20-carbon omega-6 fatty acid called arachidonic acid to prostaglandin endoperoxide H-2 (PGH(2)). Depending on the tissue and the hormone or cytokine stimulus, this reaction is catalyzed by either cyclooxygenase-1 or cyclooxygenase-2 (COX-1 or COX-2). Once formed, PGH(2) is converted, again depending on the context, to one of several downstream PG subtypes that act via specific G protein-coupled receptors. Nonsteroidal anti-inflammatory drugs (e.g. aspirin, ibuprofen, and naproxen) block PG synthesis by inhibiting COX-1 and COX-2. COX-2 is also inhibited by COX-2-selective inhibitors. Inhibition of COX-1 by low-dose aspirin prevents thrombosis. COX-2 inhibition reduces inflammation and pain. Investigating the mysteries of COXs anchored my scientific career. I attribute my successes to the great good fortune of having been surrounded by people who helped me make the most of my talents. I have written this reflection in a light-hearted fashion as a self-help essay, while highlighting the people and factors that most impacted me during my upbringing and then during my maturation and evolution as a biochemist.	[Smith, William L.] Univ Michigan, Med Sch, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Smith, WL (corresponding author), Univ Michigan, Med Sch, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	smithww@umich.edu			U.S. Public Health Service through National Institutes of Health [HD10013, DK22042, HL29685, DK20945, GM40713, GM57323, GM68848, CA130810, HL117798]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER	U.S. Public Health Service through National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	My research was generously and continuously supported over the years primarily by the U.S. Public Health Service through National Institutes of Health Grants HD10013, DK22042, HL29685, DK20945, GM40713, GM57323, GM68848, CA130810, and HL117798.	Arakawa T, 1996, J BIOL CHEM, V271, P29569, DOI 10.1074/jbc.271.47.29569; Burde T, 2002, EUR J PHARMACOL, V453, P167, DOI 10.1016/S0014-2999(02)02450-0; DeLong CJ, 2005, BIOCHEM BIOPH RES CO, V338, P53, DOI 10.1016/j.bbrc.2005.07.184; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; DEWITT DL, 1983, J BIOL CHEM, V258, P3285; Dong L, 2016, J LIPID RES, V57, P1043, DOI 10.1194/jlr.M067512; Dong L, 2016, J BIOL CHEM, V291, P4069, DOI 10.1074/jbc.M115.698001; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; FERREIRA SH, 1971, NATURE-NEW BIOL, V231, P237, DOI 10.1038/newbio231237a0; GARCIAPEREZ A, 1984, J CLIN INVEST, V74, P63, DOI 10.1172/JCI111419; GRENIER FC, 1981, AM J PHYSIOL, V241, pF94, DOI 10.1152/ajprenal.1981.241.1.F94; Grosser T, 2017, NEW ENGL J MED, V376, P1389, DOI 10.1056/NEJMc1702534; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HEMLER M, 1976, J BIOL CHEM, V251, P5575; HSI LC, 1994, BIOCHEM BIOPH RES CO, V202, P1592, DOI 10.1006/bbrc.1994.2114; HUSLIG RL, 1979, BIOL REPROD, V21, P589, DOI 10.1095/biolreprod21.3.589; Kang YJ, 2006, J IMMUNOL, V177, P8111, DOI 10.4049/jimmunol.177.11.8111; Kudalkar SN, 2015, J BIOL CHEM, V290, P7897, DOI 10.1074/jbc.M114.634014; KUJUBU DA, 1993, J BIOL CHEM, V268, P5425; Kuklev DV, 2013, J LIPID RES, V54, P1906, DOI 10.1194/jlr.M037192; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lucido MJ, 2016, BIOCHEMISTRY-US, V55, P1226, DOI 10.1021/acs.biochem.5b01378; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; MEADE EA, 1993, J BIOL CHEM, V268, P6610; MERLIE JP, 1988, J BIOL CHEM, V263, P3550; MIYAMOTO T, 1976, J BIOL CHEM, V251, P2629; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; OHKI S, 1979, J BIOL CHEM, V254, P829; OTTO JC, 1994, J BIOL CHEM, V269, P19868; Patrono C, 2017, CLIN PHARMACOL THER, V102, P238, DOI 10.1002/cpt.696; PERCIVAL MD, 1994, ARCH BIOCHEM BIOPHYS, V315, P111, DOI 10.1006/abbi.1994.1478; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; PONTREMOLI S, 1961, J BIOL CHEM, V236, P2975; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Prusakiewicz JJ, 2004, BIOCHEMISTRY-US, V43, P15439, DOI 10.1021/bi048534q; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; Rosenstock M, 2001, EUR J PHARMACOL, V412, P101, DOI 10.1016/S0014-2999(00)00931-6; ROTH GJ, 1983, BIOCHEMISTRY-US, V22, P4672, DOI 10.1021/bi00289a010; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; SHIMOKAWA T, 1991, J BIOL CHEM, V266, P6168; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; SMITH JB, 1971, NATURE-NEW BIOL, V231, P235, DOI 10.1038/newbio231235a0; Smith WL, 2019, J BIOL CHEM, V294, P1697, DOI 10.1074/jbc.TM118.006295; SMITH WL, 1972, BIOCHEMISTRY-US, V11, P3276, DOI 10.1021/bi00767a024; SMITH WL, 1971, J BIOL CHEM, V246, P6700; SMITH WL, 1978, AM J PHYSIOL, V235, pF451, DOI 10.1152/ajprenal.1978.235.5.F451; SMITH WL, 1972, J BIOL CHEM, V247, P1038; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; SUGIMOTO Y, 1992, J BIOL CHEM, V267, P6463; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; TSAI AL, 1994, J BIOL CHEM, V269, P5085; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wada M, 2009, J BIOL CHEM, V284, P30742, DOI 10.1074/jbc.M109.052415; YOKOYAMA C, 1988, FEBS LETT, V231, P347, DOI 10.1016/0014-5793(88)80847-0; YOSHIMOTO A, 1970, J BIOCHEM, V68, P487, DOI 10.1093/oxfordjournals.jbchem.a129379; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2015, J BIOL CHEM, V290, P5606, DOI 10.1074/jbc.M114.632463; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	71	3	3	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					1779	1793		10.1074/jbc.X118.006184	http://dx.doi.org/10.1074/jbc.X118.006184			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30737317	Green Published, hybrid			2022-12-28	WOS:000459711400002
J	Hascall, VC				Hascall, Vincent C.			The journey of hyaluronan research in the Journal of Biological Chemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						hyaluronan; glycosaminoglycan; extracellular matrix; inflammation; fertilization	ALPHA-TRYPSIN INHIBITOR; DIVIDING MESANGIAL CELLS; SMOOTH-MUSCLE-CELLS; MOLECULAR-CLONING; GROWTH-FACTOR; INTRACELLULAR HYALURONAN; ACID SYNTHESIS; HEAVY-CHAINS; IN-VITRO; PROTEIN	Hyaluronan has a very simple structure. It is a linear glycosaminoglycan composed of disaccharide units of GlcNAc and d-glucuronic acid with alternating beta-1,4 and beta-1,3 glycosidic bonds that can be repeated 20,000 or more times, a molecular mass >8 million Da, and a length >20 mu m. However, it has a very complex biology. It is a major, ubiquitous component of extracellular matrices involved in everything from fertilization, development, inflammations, to cancer. This JBC Review highlights some of these processes that were initiated through publications in the Journal of Biological Chemistry.	[Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND20, Cleveland, OH 44195 USA.	hascalv@ccf.org						Abbadi A, 2016, J BIOL CHEM, V291, P1448, DOI 10.1074/jbc.M115.704288; CALVO JC, 1993, ARCH BIOCHEM BIOPHYS, V302, P468, DOI 10.1006/abbi.1993.1241; CHEN L, 1992, J BIOL CHEM, V267, P12380; Coulson-Thomas VJ, 2014, J BIOL CHEM, V289, P23465, DOI 10.1074/jbc.M114.557447; Coulson-Thomas VJ, 2013, STEM CELLS, V31, P2116, DOI 10.1002/stem.1481; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; DEANGELIS PL, 1994, BIOCHEMISTRY-US, V33, P9033, DOI 10.1021/bi00197a001; DEANGELIS PL, 1993, J BIOL CHEM, V268, P19181; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Fulop C, 1997, ARCH BIOCHEM BIOPHYS, V337, P261, DOI 10.1006/abbi.1996.9793; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; HARDINGHAM T E, 1973, Biochemical Society Transactions, V1, P282; HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2; HASCALL VC, 1969, J BIOL CHEM, V244, P2384; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hascall VC, 2000, GLYCOCONJUGATE J, V17, P607, DOI 10.1023/A:1011082728155; Hascall VC, 2014, MATRIX BIOL, V35, P14, DOI 10.1016/j.matbio.2014.01.014; HEINEGARD D, 1974, J BIOL CHEM, V249, P4250; HUANG L, 1993, J BIOL CHEM, V268, P26725; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Lord MS, 2013, J BIOL CHEM, V288, P22930, DOI 10.1074/jbc.M112.404186; McDonald J, 2002, J BIOL CHEM, V277, P4575, DOI 10.1074/jbc.R100064200; Meyer K, 1934, J BIOL CHEM, V107, P629; Midgley AC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aao1822; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Petrey AC, 2016, AM J PATHOL, V186, P2390, DOI 10.1016/j.ajpath.2016.05.004; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; SALUSTRI A, 1990, J BIOL CHEM, V265, P19517; SALUSTRI A, 1990, DEV BIOL, V138, P26, DOI 10.1016/0012-1606(90)90173-G; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395; Sivakumar A, 2018, DEV CELL, V46, P533, DOI 10.1016/j.devcel.2018.08.002; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Teicholz N., 2014, BIG FAT SURPRISE WHY; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Wang AM, 2014, J BIOL CHEM, V289, P11410, DOI 10.1074/jbc.M113.541458; Wang AM, 2014, J BIOL CHEM, V289, P9418, DOI 10.1074/jbc.M113.541441; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang CP, 2015, J BIOL CHEM, V290, P29045, DOI 10.1074/jbc.M115.677401; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Weigel PH, 2017, GLYCOBIOLOGY, V27, P536, DOI 10.1093/glycob/cwx012; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; WEISSMANN B, 1954, J AM CHEM SOC, V76, P1753, DOI 10.1021/ja01636a010; YONEDA M, 1990, J BIOL CHEM, V265, P5247; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	61	10	10	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1690	1696		10.1074/jbc.TM118.005836	http://dx.doi.org/10.1074/jbc.TM118.005836			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710015	Green Published, hybrid			2022-12-28	WOS:000457879200028
J	Bode, DC; Freeley, M; Nield, J; Palma, M; Viles, JH				Bode, David C.; Freeley, Mark; Nield, Jon; Palma, Matteo; Viles, John H.			Amyloid- oligomers have a profound detergent-like effect on lipid membrane bilayers, imaged by atomic force and electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (AB); membrane bilayer; oligomer; atomic force microscopy (AFM); electron microscopy (EM); neurodegeneration; cytotoxicity; large unilamellar vesicles; membrane disruption; mica surface; nanoscale imaging	ALZHEIMERS-DISEASE; BETA-PEPTIDE; DISRUPTION; MECHANISM; MODEL; A-BETA(1-42); AGGREGATION; POLYPEPTIDE; FIBRILS; PLAQUE	The ability of amyloid- peptide (A) to disrupt membrane integrity and cellular homeostasis is believed to be central to Alzheimer's disease pathology. A is reported to have various impacts on the lipid bilayer, but a clearer picture of A influence on membranes is required. Here, we use atomic force and transmission electron microscopies to image the impact of different isolated A assembly types on lipid bilayers. We show that only oligomeric A can profoundly disrupt the bilayer, visualized as widespread lipid extraction and subsequent deposition, which can be likened to an effect expected from the action of a detergent. We further show that A oligomers cause widespread curvature and discontinuities within lipid vesicle membranes. In contrast, this detergent-like effect was not observed for A monomers and fibers, although A fibers did laterally associate and embed into the upper leaflet of the bilayer. The marked impact of A oligomers on membrane integrity identified here reveals a mechanism by which these oligomers may be cytotoxic.	[Bode, David C.; Freeley, Mark; Nield, Jon; Palma, Matteo; Viles, John H.] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England	University of London; Queen Mary University London	Viles, JH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.viles@qmul.ac.uk	Palma, Matteo/E-6392-2011; Nield, Jon/C-5892-2013	Palma, Matteo/0000-0001-8715-4034; Nield, Jon/0000-0001-9983-0239	BBSRC [BB/M023877/1]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC Grant BB/M023877/1. The authors declare that they have no conflicts of interest with the contents of this article.	Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bode DC, 2017, J BIOL CHEM, V292, P1404, DOI 10.1074/jbc.M116.762526; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Canale C, 2018, SEMIN CELL DEV BIOL, V73, P82, DOI 10.1016/j.semcdb.2017.08.046; Canale C, 2013, BIOPHYS CHEM, V182, P23, DOI 10.1016/j.bpc.2013.07.010; Choucair A, 2007, BBA-BIOMEMBRANES, V1768, P146, DOI 10.1016/j.bbamem.2006.09.005; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; El Kirat K, 2010, BBA-BIOMEMBRANES, V1798, P750, DOI 10.1016/j.bbamem.2009.07.026; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Han S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43577; Jang HB, 2008, TRENDS BIOCHEM SCI, V33, P91, DOI 10.1016/j.tibs.2007.10.007; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kiskis J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13489; Koller D, 2014, BBA-BIOMEMBRANES, V1838, P2250, DOI 10.1016/j.bbamem.2014.05.013; Korshavn KJ, 2017, J BIOL CHEM, V292, P4638, DOI 10.1074/jbc.M116.764092; Kuzyk A, 2010, J BIOL CHEM, V285, P31202, DOI 10.1074/jbc.M110.142174; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee J, 2014, BIOCHEMISTRY-US, V53, P4704, DOI 10.1021/bi500587p; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lu T, 2018, PHYS CHEM CHEM PHYS, V20, P8976, DOI [10.1039/c7cp06468c, 10.1039/C7CP06468C]; Matheou CJ, 2015, BIOCHEM J, V466, P233, DOI 10.1042/BJ20141168; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Samori P, 1999, CHEM-EUR J, V5, P2312, DOI 10.1002/(SICI)1521-3765(19990802)5:8<2312::AID-CHEM2312>3.0.CO;2-F; Sasahara K, 2013, PHYS CHEM CHEM PHYS, V15, P8929, DOI 10.1039/c3cp44517h; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Serra-Batiste M, 2016, P NATL ACAD SCI USA, V113, P10866, DOI 10.1073/pnas.1605104113; Sheikh K, 2012, CHEM PHYS LIPIDS, V165, P142, DOI 10.1016/j.chemphyslip.2011.11.011; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Valincius G, 2008, BIOPHYS J, V95, P4845, DOI 10.1529/biophysj.108.130997; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh P, 2014, J BIOL CHEM, V289, P10419, DOI 10.1074/jbc.M113.515866; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Williams TL, 2011, BIOCHEM J, V439, P67, DOI 10.1042/BJ20110750; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309	44	56	56	5	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7566	7572		10.1074/jbc.AC118.007195	http://dx.doi.org/10.1074/jbc.AC118.007195			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30948512	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000470153300005
J	Cao, SF; Chung, S; Kim, S; Li, ZL; Manor, D; Buck, M				Cao, Shufen; Chung, Stacey; Kim, SoonJeung; Li, Zhenlu; Manor, Danny; Buck, Matthias			K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ras protein; protein structure; phosphoinositide; cancer; nuclear magnetic resonance (NMR); molecular dynamics; cell signaling; cell transformation; PIP2; protein-membrane interactions; Ras GTPase	PLASMA-MEMBRANE; H-RAS; MOLECULAR-DYNAMICS; FORCE-FIELD; ANIONIC MEMBRANES; NMR; K-RAS4B; 4,5-BISPHOSPHATE; ORGANIZATION; LOCALIZATION	Ras genes potently drive human cancers, with mutated proto-oncogene GTPase KRAS4B (K-Ras4B) being the most abundant isoform. Targeted inhibition of oncogenic gene products is considered the holy grail of present-day cancer therapy, and recent discoveries of small-molecule KRas4B inhibitors were made thanks to a deeper understanding of the structure and dynamics of this GTPase. Because interactions with biological membranes are key for Ras function, Ras-lipid interactions have become a major focus, especially because such interactions evidently involve both the Ras C terminus for lipid anchoring and its G-protein domain. Here, using NMR spectroscopy and molecular dynamics simulations complemented by biophysical- and cell-biology assays, we investigated the interaction between K-Ras4B with the signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2). We discovered that the 2 and 3 strands as well as helices 4 and 5 of the GTPase G-domain bind to PIP2 and identified the specific residues in these structural elements employed in these interactions, likely occurring in two K-Ras4B orientation states relative to the membrane. Importantly, we found that some of these residues known to be oncogenic when mutated (D47K, D92N, K104M, and D126N) are critical for K-Ras-mediated transformation of fibroblast cells, but do not substantially affect basal and assisted nucleotide hydrolysis and exchange. Moreover, the K104M substitution abolished localization of K-Ras to the plasma membrane. The findings suggest that specific G-domain residues can critically regulate Ras function by mediating interactions with membrane-associated PIP2 lipids; these insights that may inform the future design of therapeutic reagents targeting Ras activity.	[Cao, Shufen; Kim, SoonJeung; Li, Zhenlu; Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Chung, Stacey; Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Manor, Danny; Buck, Matthias] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA.; Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA.; Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.; Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.; Manor, D; Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.; Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA.	Danny.Manor@case.edu; Matthias.Buck@case.edu	LI, ZHENLU/ABA-2654-2020	LI, ZHENLU/0000-0003-2101-8237	National Institutes of Health NIGMS [R01GM112491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116961, R01GM112491] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant R01GM112491 (to the Buck lab). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahmadian MR, 1996, J BIOL CHEM, V271, P16409, DOI 10.1074/jbc.271.27.16409; Ambrogio C, 2018, CELL, V172, P857, DOI 10.1016/j.cell.2017.12.020; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Banerjee A, 2016, CURR OPIN STRUC BIOL, V36, P10, DOI 10.1016/j.sbi.2015.11.010; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Barnard A, 2012, ANGEW CHEM INT EDIT, V51, P6572, DOI 10.1002/anie.201200076; Barrett PJ, 2013, BIOCHEMISTRY-US, V52, P1303, DOI 10.1021/bi4000436; Bouguet-Bonnet S, 2008, J MOL BIOL, V377, P1474, DOI 10.1016/j.jmb.2008.01.081; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Cao SF, 2013, BIOMOL NMR ASSIGN, V7, P121, DOI 10.1007/s12104-012-9391-0; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Ceccon A, 2016, J AM CHEM SOC, V138, P5789, DOI 10.1021/jacs.6b02654; Chadli M, 2017, LANGMUIR, V33, P10385, DOI 10.1021/acs.langmuir.7b01636; Chenette EJ, 2011, ENZYMES, V29, P59, DOI 10.1016/B978-0-12-381339-8.00005-6; Chung JK, 2018, BIOPHYS J, V114, P137, DOI 10.1016/j.bpj.2017.10.042; Clore GM, 2015, METHOD ENZYMOL, V564, P485, DOI 10.1016/bs.mie.2015.06.032; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox Adrienne D, 2010, Small GTPases, V1, P2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Dror RO, 2010, J GEN PHYSIOL, V135, P555, DOI 10.1085/jgp.200910373; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; El-Sibai M, 2007, EUR J IMMUNOL, V37, P261, DOI 10.1002/eji.200635875; Fang ZH, 2018, CELL CHEM BIOL, V25, P1327, DOI 10.1016/j.chembiol.2018.07.009; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gagliardi PA, 2015, BBA-REV CANCER, V1856, P178, DOI 10.1016/j.bbcan.2015.07.003; Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p; Gorfe AA, 2010, CURR MED CHEM, V17, P1, DOI 10.2174/092986710789957832; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Graber ZT, 2017, PHYS CHEM CHEM PHYS, V19, P15285, DOI 10.1039/c7cp00718c; Gregory MC, 2017, BIOCHEM BIOPH RES CO, V487, P351, DOI 10.1016/j.bbrc.2017.04.063; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Gulyas G, 2017, J BIOL CHEM, V292, P18862, DOI 10.1074/jbc.M117.806679; Hedger G, 2015, SCI REP-UK, V5, DOI 10.1038/srep09198; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; Jang H, 2016, BIOCHEM J, V473, P1719, DOI 10.1042/BCJ20160031; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kearney BN, 2014, J MOL BIOL, V426, P611, DOI 10.1016/j.jmb.2013.10.036; Kolay S, 2016, BIOCHEM J, V473, P1681, DOI 10.1042/BCJ20160069; Koldso H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003911; Kucharska I, 2015, J BIOMOL NMR, V61, P261, DOI 10.1007/s10858-015-9905-z; LEONARD DA, 1994, BIOCHEMISTRY-US, V33, P12323, DOI 10.1021/bi00206a040; Li ZL, 2018, ACS CENTRAL SCI, V4, P298, DOI 10.1021/acscentsci.7b00593; Li ZL, 2017, STRUCTURE, V25, P679, DOI 10.1016/j.str.2017.02.007; Li ZL, 2016, BIOPHYS J, V110, P1033, DOI 10.1016/j.bpj.2016.01.020; Lien EC, 2017, CURR OPIN CELL BIOL, V45, P62, DOI 10.1016/j.ceb.2017.02.007; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lobell RB, 2002, MOL CANCER THER, V1, P747; Lobell RB, 2001, CANCER RES, V61, P8758; Lu SM, 2018, CRIT REV BIOCHEM MOL, V53, P192, DOI 10.1080/10409238.2018.1436515; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; Mazhab-Jafari MT, 2013, J AM CHEM SOC, V135, P3367, DOI 10.1021/ja312508w; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Nussinov R, 2013, TRENDS MOL MED, V19, P695, DOI 10.1016/j.molmed.2013.07.009; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prakash Priyanka, 2017, Small GTPases, V8, P129, DOI 10.1080/21541248.2016.1211067; Prakash P, 2016, BIOPHYS J, V110, P1125, DOI 10.1016/j.bpj.2016.01.019; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Prosser RS, 2006, BIOCHEMISTRY-US, V45, P8453, DOI 10.1021/bi060615u; Puthenveetil R, 2017, NANOTECHNOL REV, V6, P111, DOI 10.1515/ntrev-2016-0076; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Solman M, 2015, ELIFE, V4, DOI 10.7554/eLife.08905; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Sosa MS, 2009, BIOCHEMISTRY-US, V48, P8171, DOI 10.1021/bi9010623; Suladze S, 2014, J PHYS CHEM B, V118, P966, DOI 10.1021/jp411466r; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Ubbink M, 2002, ANNU REV BIOPH BIOM, V31, P393, DOI 10.1146/annurev.biophys.31.091701.171000; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van der Hoeven D, 2013, MOL CELL BIOL, V33, P237, DOI 10.1128/MCB.00884-12; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vinogradova O, 2012, TOP CURR CHEM, V326, P35, DOI 10.1007/128_2011_216; Vo U, 2013, BIOMOL NMR ASSIGN, V7, P215, DOI 10.1007/s12104-012-9413-y; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Wang YH, 2012, J AM CHEM SOC, V134, P3387, DOI 10.1021/ja208640t; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamaguchi H, 2010, CANCER SCI, V101, P1632, DOI 10.1111/j.1349-7006.2010.01574.x; Yang MH, 2012, P NATL ACAD SCI USA, V109, P10843, DOI 10.1073/pnas.1201487109; Yang YB, 2018, J BIOL CHEM, V293, P6230, DOI 10.1074/jbc.R117.000582; Ye LB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03314-9; Yin GW, 2017, J BIOL CHEM, V292, P4446, DOI 10.1074/jbc.M116.762435; Zhang XF, 2018, J BIOL CHEM, V293, P7659, DOI 10.1074/jbc.RA118.001779; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008	110	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7068	7084		10.1074/jbc.RA118.004021	http://dx.doi.org/10.1074/jbc.RA118.004021			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30792310	hybrid, Green Published			2022-12-28	WOS:000467394700038
J	Sana, B; Chee, SMQ; Wongsantichon, J; Raghavan, S; Robinson, RC; Ghadessy, FJ				Sana, Barindra; Chee, Sharon M. Q.; Wongsantichon, Jantana; Raghavan, Sarada; Robinson, Robert C.; Ghadessy, Farid J.			Development and structural characterization of an engineered multi-copper oxidase reporter of protein-protein interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; enzyme mutation; enzyme oxidase; X-ray crystallography; structure-function; protein engineering; CueO; MDM2 proto-oncogene; protein-protein interaction; antibody; protein sensor; drug screening tool	GREEN FLUORESCENT PROTEINS; MULTICOPPER OXIDASE; ESCHERICHIA-COLI; BETA-GALACTOSIDASE; ENZYMATIC-ACTIVITY; FUNCTIONAL-ROLE; MDM2; CUEO; P53; BINDING	Protein-protein interactions (PPIs) are ubiquitous in almost all biological processes and are often corrupted in diseased states. A detailed understanding of PPIs is therefore key to understanding cellular physiology and can yield attractive therapeutic targets. Here, we describe the development and structural characterization of novel Escherichia coli CueO multi-copper oxidase variants engineered to recapitulate protein-protein interactions with commensurate modulation of their enzymatic activities. The fully integrated single-protein sensors were developed through modular grafting of ligand-specific peptides into a highly compliant and flexible methionine-rich loop of CueO. Sensitive detection of diverse ligand classes exemplified by antibodies, an E3 ligase, MDM2 proto-oncogene (MDM2), and protease (SplB from Staphylococcus aureus) was achieved in a simple mix and measure homogeneous format with visually observable colorimetric readouts. Therapeutic antagonism of MDM2 by small molecules and peptides in clinical development for treatment of cancer patients was assayed using the MDM2-binding CueO enzyme. Structural characterization of the free and MDM2-bound CueO variant provided functional insight into signal-transducing mechanisms of the engineered enzymes and highlighted the robustness of CueO as a stable and compliant scaffold for multiple applications.	[Sana, Barindra; Chee, Sharon M. Q.; Raghavan, Sarada; Ghadessy, Farid J.] p53 Lab, A STAR, 8A Biomed Grove, Singapore 138648, Singapore; [Wongsantichon, Jantana] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [Wongsantichon, Jantana; Robinson, Robert C.] ASTAR, Inst Mol & Cellular Biol, 61 Biopolis Dr, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Ghadessy, FJ (corresponding author), p53 Lab, A STAR, 8A Biomed Grove, Singapore 138648, Singapore.	fghadessy@p53Lab.a-star.edu.sg		Ghadessy, Farid/0000-0001-8559-903X; Wongsantichon, Jantana/0000-0002-4134-2248	Agency for Science Technology and Research (A*STAR), Singapore	Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science Technology and Research (A*STAR), Singapore. The authors declare that they have no conflicts of interest with the contents of this article.	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BAUM EZ, 1990, P NATL ACAD SCI USA, V87, P10023, DOI 10.1073/pnas.87.24.10023; Beneyton T, 2014, ANALYST, V139, P3314, DOI 10.1039/c4an00228h; Benito A, 1996, J BIOL CHEM, V271, P21251, DOI 10.1074/jbc.271.35.21251; Bottger V, 1996, ONCOGENE, V13, P2141; BRENNAN C, 1994, PROTEIN ENG, V7, P509, DOI 10.1093/protein/7.4.509; BRENNAN CA, 1995, P NATL ACAD SCI USA, V92, P5783, DOI 10.1073/pnas.92.13.5783; Brown CJ, 2013, ACS CHEM BIOL, V8, P506, DOI 10.1021/cb3005148; Brown CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024122; Chee SMQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104914; Choi JH, 2016, PROTEIN SCI, V25, P1605, DOI 10.1002/pro.2962; Djoko KY, 2010, J AM CHEM SOC, V132, P2005, DOI 10.1021/ja9091903; Doi N, 1999, FEBS LETT, V453, P305, DOI 10.1016/S0014-5793(99)00732-2; Dubin G, 2008, J MOL BIOL, V379, P343, DOI 10.1016/j.jmb.2008.03.059; Edwards WR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn363; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferraz RM, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-15; Ferrer-Miralles N, 2000, BIOCHEM BIOPH RES CO, V275, P360, DOI 10.1006/bbrc.2000.3309; Geddie ML, 2005, J BIOL CHEM, V280, P35641, DOI 10.1074/jbc.M508149200; Grass G, 2001, J BACTERIOL, V183, P2145, DOI 10.1128/JB.183.6.2145-2147.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kataoka K, 2007, J MOL BIOL, V373, P141, DOI 10.1016/j.jmb.2007.07.041; Kataoka K, 2013, BIOCHEM BIOPH RES CO, V431, P393, DOI 10.1016/j.bbrc.2013.01.040; Kataoka K, 2011, BIOCHEMISTRY-US, V50, P558, DOI 10.1021/bi101107c; Kim C, 2001, J BACTERIOL, V183, P4866, DOI 10.1128/JB.183.16.4866-4875.2001; Kohn JE, 2005, P NATL ACAD SCI USA, V102, P10841, DOI 10.1073/pnas.0503055102; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lau SY, 2018, PROTEIN ENG DES SEL, V31, P301, DOI 10.1093/protein/gzy018; Legendre D, 1999, NAT BIOTECHNOL, V17, P67, DOI 10.1038/5243; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; MacDonald JT, 2016, BIOCHEM SOC T, V44, P1523, DOI 10.1042/BST20160155; Marvin JS, 2011, PROTEINS, V79, P3025, DOI 10.1002/prot.23118; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadler DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12266; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nirantar SR, 2014, BIOSENS BIOELECTRON, V56, P250, DOI 10.1016/j.bios.2013.12.060; Nirantar SR, 2013, BIOSENS BIOELECTRON, V47, P421, DOI 10.1016/j.bios.2013.03.049; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Plainkum P, 2003, NAT STRUCT BIOL, V10, P115, DOI 10.1038/nsb884; Popowicz GM, 2011, ANGEW CHEM INT EDIT, V50, P2680, DOI 10.1002/anie.201003863; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Roxburgh P, 2012, CARCINOGENESIS, V33, P791, DOI 10.1093/carcin/bgs092; Singh SK, 2011, J BIOL CHEM, V286, P37849, DOI 10.1074/jbc.M111.293589; Stein V, 2017, ACS SYNTH BIOL, V6, P1337, DOI 10.1021/acssynbio.6b00370; Sun DQ, 2014, J MED CHEM, V57, P1454, DOI 10.1021/jm401753e; Vera A, 2005, BIOCHEM BIOPH RES CO, V329, P453, DOI 10.1016/j.bbrc.2005.01.147; Vu B, 2013, ACS MED CHEM LETT, V4, P466, DOI 10.1021/ml4000657; Wongso D, 2017, ANAL CHEM, V89, P6719, DOI 10.1021/acs.analchem.7b00959	54	4	4	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7002	7012		10.1074/jbc.RA118.007141	http://dx.doi.org/10.1074/jbc.RA118.007141			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30770473	hybrid, Green Published			2022-12-28	WOS:000467394700032
J	Coorens, M; Rao, A; Grafe, SK; Unelius, D; Lindforss, U; Agerberth, B; Mjosberg, J; Bergman, P				Coorens, Maarten; Rao, Anna; Grafe, Stefanie Katharina; Unelius, Daniel; Lindforss, Ulrik; Agerberth, Birgitta; Mjosberg, Jenny; Bergman, Peter			Innate lymphoid cell type 3-derived interleukin-22 boosts lipocalin-2 production in intestinal epithelial cells via synergy between STAT3 and NF-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; antimicrobial peptide (AMP); microbiology; mucosal immunology; signal transduction; interleukin-22; STAT3	KAPPA-B; ANTIMICROBIAL DEFENSE; HOST-DEFENSE; EXPRESSION; INFECTION; IL-22; ACTIVATION; TH17; GUT; MACROPHAGES	Escherichia coli and Klebsiella pneumoniae are opportunistic pathogens that are commonly associated with infections at mucosal surfaces, such as the lung or the gut. The host response against these types of infections includes the release of epithelial-derived antimicrobial factors such as lipocalin-2 (LCN-2), a protein that specifically inhibits the iron acquisition of Enterobacteriaceae by binding and neutralizing the bacterial iron-scavenging molecule enterobactin. Regulation of epithelial antimicrobial responses, including the release of LCN-2, has previously been shown to depend on IL-22, a cytokine produced by innate lymphoid cells type 3 (ILC3) during Enterobacteriaceae infections. However, much remains unknown about the extent to which antimicrobial responses are regulated by IL-22 and how IL-22 regulates the expression and production of LCN-2 in intestinal epithelial cells (IECs). Our study demonstrates how IL-22-induced activation of STAT3 synergizes with NF-B-activating cytokines to enhance LCN-2 expression in human IECs and elucidates how ILC3 are involved in LCN-2-mediated host defense against Enterobacteriaceae. Together, these results provide new insight into the role of ILC3 in regulating LCN-2 expression in human IECs and could prove useful in future studies aimed at understanding the host response against Enterobacteriaceae as well as for the development of antimicrobial therapies against Enterobacteriaceae-related infections.	[Coorens, Maarten; Grafe, Stefanie Katharina; Unelius, Daniel; Agerberth, Birgitta; Bergman, Peter] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, S-14186 Stockholm, Sweden; [Rao, Anna; Mjosberg, Jenny] Karolinska Inst, Dept Med, Ctr Infect Med, SE-17177 Stockholm, Sweden; [Lindforss, Ulrik] Linkoping Univ, Dept Clin & Expt Med, S-58183 Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Linkoping University	Bergman, P (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Lab Med, S-14186 Stockholm, Sweden.	peter.bergman@ki.se		Bergman, Peter/0000-0003-3306-3713	Swedish Research Council (Vetenskapsradet); Scandinavian Society for Antimicrobial Chemotherapy (SSAC); Groschinsky Foundation; Karolinska Institutet; German Research Foundation (Deutsche Forschungsgemeinschaft) [RA 2986/1-1]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Scandinavian Society for Antimicrobial Chemotherapy (SSAC); Groschinsky Foundation; Karolinska Institutet(Karolinska Institutet); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the Swedish Research Council (Vetenskapsradet), the Scandinavian Society for Antimicrobial Chemotherapy (SSAC), The Groschinsky Foundation, the Karolinska Institutet (to P. B.), and German Research Foundation (Deutsche Forschungsgemeinschaft) Postdoctoral Fellowship RA 2986/1-1 (to A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2013, MIMS MED MICROBIOLOG; Antoni Lena, 2013, J Crohns Colitis, V7, pe652, DOI 10.1016/j.crohns.2013.05.006; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Backert I, 2014, J IMMUNOL, V193, P3779, DOI 10.4049/jimmunol.1303076; Bambou JC, 2004, J BIOL CHEM, V279, P42984, DOI 10.1074/jbc.M405410200; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Borenshtein D, 2007, INFECT IMMUN, V75, P3271, DOI 10.1128/IAI.01810-06; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Byndloss MX, 2018, MUCOSAL IMMUNOL, V11, P1299, DOI 10.1038/s41385-018-0010-y; Canas MA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00498; Cayatte C, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.2; Cervantes-Barragan L, 2018, CURR OPIN IMMUNOL, V50, P112, DOI 10.1016/j.coi.2018.01.004; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Cramer EP, 2017, BLOOD, V129, P2813, DOI 10.1182/blood-2016-11-753434; Dalli J, 2017, IMMUNITY, V46, P92, DOI 10.1016/j.immuni.2016.12.009; De Simone V, 2015, ONCOGENE, V34, P3493, DOI 10.1038/onc.2014.286; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Fischer N, 2016, P NATL ACAD SCI USA, V113, pE2993, DOI 10.1073/pnas.1605997113; Fletcher SM, 2013, J PUBLIC HEALTH RES, V2, P42, DOI 10.4081/jphr.2013.e9; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Friedrich C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006357; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Geremia A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01296; Giacomin PR, 2015, J EXP MED, V212, P1513, DOI 10.1084/jem.20141831; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Jung M, 2012, MOL CELL BIOL, V32, P3938, DOI 10.1128/MCB.00413-12; Kalanuria AA, 2014, CRIT CARE, V18, DOI 10.1186/cc13775; Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042; Kara EE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003905; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; Kesanakurti D, 2013, ONCOGENE, V32, P5144, DOI 10.1038/onc.2012.546; Konya V, 2018, J ALLERGY CLIN IMMUN, V141, P279, DOI 10.1016/j.jaci.2017.01.045; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Lewis SB, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00068; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Maeshima K, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/6/064116; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Martin JC, 2016, MUCOSAL IMMUNOL, V9, P539, DOI 10.1038/mi.2015.83; Mizuno S, 2014, INFLAMM BOWEL DIS, V20, P1426, DOI 10.1097/MIB.0000000000000105; Mjosberg J, 2016, J ALLERGY CLIN IMMUN, V138, P1265, DOI 10.1016/j.jaci.2016.09.009; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Okumura R, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.20; Pioli PA, 2006, J IMMUNOL, V176, P6647, DOI 10.4049/jimmunol.176.11.6647; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Revu S, 2018, CELL REP, V22, P2642, DOI 10.1016/j.celrep.2018.02.044; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sansone CL, 2015, CELL HOST MICROBE, V18, P571, DOI 10.1016/j.chom.2015.10.010; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Seo SU, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9010; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Singh V, 2016, CELL MOL GASTROENTER, V2, P482, DOI 10.1016/j.jcmgh.2016.03.007; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Steigedal M, 2014, J IMMUNOL, V193, P6081, DOI 10.4049/jimmunol.1401528; Tourret J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153034; Tsai PY, 2017, CELL HOST MICROBE, V21, P671, DOI 10.1016/j.chom.2017.05.009; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020; Weiner J, 2017, TRANSPLANTATION, V101, P2449, DOI 10.1097/TP.0000000000001593; Wozniak KL, 2014, MICROBIOL-SGM, V160, P1440, DOI 10.1099/mic.0.073445-0; Xiong HZ, 2016, CELL, V165, P679, DOI 10.1016/j.cell.2016.03.017; Zheng MQ, 2016, INFECT IMMUN, V84, P782, DOI 10.1128/IAI.01268-15; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110	82	19	19	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6027	6041		10.1074/jbc.RA118.007290	http://dx.doi.org/10.1074/jbc.RA118.007290			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30782844	Green Published, hybrid			2022-12-28	WOS:000465077500033
J	Song, PY; Yang, SP; Hua, H; Zhang, HY; Kong, QB; Wang, J; Luo, T; Jiang, YF				Song, Peiying; Yang, Songpeng; Hua, Hui; Zhang, Hongying; Kong, Qingbin; Wang, Jiao; Luo, Ting; Jiang, Yangfu			The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cancer; drug resistance; oncogene; Trail; GADD34; MCL-1; TRAF	GROWTH ARREST; MCL-1; ACTIVATION; STRESS; DEPHOSPHORYLATION; SUPPRESSION; EXPRESSION; REPRESSION; RESISTANCE; PATHWAY	GADD34 (growth arrest and DNA damage-inducible gene 34) plays a critical role in responses to DNA damage and endoplasmic reticulum stress. GADD34 has opposing effects on different stimuli-induced cell apoptosis events, but the reason for this is unclear. Here, using immunoblotting analyses and various molecular genetic approaches in HepG2 and SMMC-7721 cells, we demonstrate that GADD34 protects hepatocellular carcinoma (HCC) cells from tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by stabilizing a BCL-2 family member, myeloid cell leukemia 1 (MCL-1). We found that GADD34 knockdown decreased MCL-1 levels and that GADD34 overexpression up-regulated MCL-1 expression in HCC cells. GADD34 did not affect MCL-1 transcription but enhanced MCL-1 protein stability. The proteasome inhibitor MG132 abrogated GADD34 depletion-induced MCL-1 down-regulation, suggesting that GADD34 inhibits the proteasomal degradation of MCL-1. Furthermore, GADD34 overexpression promoted extracellular signal-regulated kinase (ERK) phosphorylation through a signaling axis that consists of the E3 ubiquitin ligase tumor necrosis factor receptor-associated factor 6 (TRAF6) and transforming growth factor--activated kinase 1 (MAP3K7)-binding protein 1 (TAB1), which mediated the up-regulation of MCL-1 by GADD34. Of note, TRAIL up-regulated both GADD34 and MCL-1 levels, and knockdown of GADD34 and TRAF6 suppressed the induction of MCL-1 by TRAIL. Correspondingly, GADD34 knockdown potentiated TRAIL-induced apoptosis, and MCL-1 overexpression rescued TRAIL-treated and GADD34-depleted HCC cells from cell death. Taken together, these findings suggest that GADD34 inhibits TRAIL-induced HCC cell apoptosis through TRAF6- and ERK-mediated stabilization of MCL-1.	[Song, Peiying; Yang, Songpeng; Zhang, Hongying; Kong, Qingbin; Jiang, Yangfu] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, State Key Lab Biotherapy,Sect Oncogene, Chengdu 610041, Peoples R China; [Hua, Hui] West China Hosp, Lab Stem Cell Biol, Chengdu 610041, Peoples R China; [Wang, Jiao] Chengdu Univ Tradit Chinese Med, Sch Basic Med, Chengdu 610075, Sichuan, Peoples R China; [Luo, Ting] West China Hosp, Canc Ctr, Chengdu 610041, Peoples R China	Sichuan University; Chengdu University of Traditional Chinese Medicine	Jiang, YF (corresponding author), Sichuan Univ, West China Hosp, Sect Oncogene, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.	jyangfu@scu.edu.cn	Jiang, Yangfu/AAX-2645-2020	Jiang, Yangfu/0000-0002-8696-2651	National Natural Science Foundation of China [81672814, 81872388]; Fundamental Research Fund for the Central Universities [2018SCUH0009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for the Central Universities	This work was supported by Grants 81672814 and 81872388 from the National Natural Science Foundation of China and Grant 2018SCUH0009 from the Fundamental Research Fund for the Central Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Chung JY, 2007, ADV EXP MED BIOL, V597, P93; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Ebinger S, 2016, CANCER CELL, V30, P849, DOI 10.1016/j.ccell.2016.11.002; Emadali A, 2005, J PATHOL, V207, P111, DOI 10.1002/path.1798; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Fransson L, 2014, CELL BIOCHEM FUNCT, V32, P445, DOI 10.1002/cbf.3036; French R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0478-y; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gomez-Bougie P, 2016, CANCER LETT, V383, P204, DOI 10.1016/j.canlet.2016.09.030; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Hsu TS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0165-6; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Ito S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.116; Ito S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08327; Jeong M, 2017, ONCOGENE, V36, P458, DOI 10.1038/onc.2016.215; Kashiwada M, 1998, J EXP MED, V187, P237, DOI 10.1084/jem.187.2.237; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146073; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kuo ML, 2001, ONCOGENE, V20, P677, DOI 10.1038/sj.onc.1204140; Lee JE, 2018, J BIOL CHEM, V293, P5947, DOI 10.1074/jbc.RA118.002124; Lemke J, 2014, CELL DEATH DIFFER, V21, P491, DOI 10.1038/cdd.2013.179; Liu LT, 2016, ANTICANCER RES, V36, P4623, DOI 10.21873/anticanres.11012; Liu LT, 2015, ANTICANCER RES, V35, P5317; Maji S, 2018, ADV CANCER RES, V137, P37, DOI 10.1016/bs.acr.2017.11.001; Merino D, 2016, ONCOGENE, V35, P1877, DOI 10.1038/onc.2015.287; Murphy AC, 2014, APOPTOSIS, V19, P629, DOI 10.1007/s10495-013-0935-2; Ori D, 2013, J IMMUNOL, V190, P4037, DOI 10.4049/jimmunol.1300173; Perini GF, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0608-2; Rojas M, 2015, P NATL ACAD SCI USA, V112, pE3466, DOI 10.1073/pnas.1501557112; Safa A. R., 2012, Experimental Oncology, V34, P176; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Shlyakhtina Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.423; Tanaka Y, 2015, BRIT J CANCER, V113, P669, DOI 10.1038/bjc.2015.263; Teng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.24; Timucin AC, 2019, MED RES REV, V39, P146, DOI 10.1002/med.21516; Van Geelen CMM, 2004, DRUG RESIST UPDATE, V7, P345, DOI 10.1016/j.drup.2004.11.002; von Karstedt S, 2017, NAT REV CANCER, V17, P352, DOI 10.1038/nrc.2017.28; Yuan X, 2018, CANCER METAST REV, V37, P733, DOI 10.1007/s10555-018-9728-y; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	43	16	17	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5945	5955		10.1074/jbc.RA118.006029	http://dx.doi.org/10.1074/jbc.RA118.006029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30782845	Green Published, hybrid			2022-12-28	WOS:000465077500026
J	Su, Y; Ghodke, PP; Egli, M; Li, L; Wang, YS; Guengerich, FP				Su, Yan; Ghodke, Pratibha P.; Egli, Martin; Li, Lin; Wang, Yinsheng; Guengerich, F. Peter			Human DNA polymerase has reverse transcriptase activity in cellular environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; RNA polymerase; reverse transcription; DNA transcription; DNA replication; DNA enzyme; DNA damage; DNA pol eta; translesion synthesis (TLS) enzyme	RIBONUCLEOTIDE INCORPORATION; KINETIC-ANALYSIS; REPLICATION; BYPASS; RNA; TRANSLESION; MECHANISM; REPAIR; ETA; OPPOSITE	Classical DNA and RNA polymerase (pol) enzymes have defined roles with their respective substrates, but several pols have been found to have multiple functions. We reported previously that purified human DNA pol (hpol ) can incorporate both deoxyribonucleoside triphosphates (dNTPs) and ribonucleoside triphosphates (rNTPs) and can use both DNA and RNA as substrates. X-ray crystal structures revealed that two pol residues, Phe-18 and Tyr-92, behave as steric gates to influence sugar selectivity. However, the physiological relevance of these phenomena has not been established. Here, we show that purified hpol adds rNTPs to DNA primers at physiological rNTP concentrations and in the presence of competing dNTPs. When two rATPs were inserted opposite a cyclobutane pyrimidine dimer, the substrate was less efficiently cleaved by human RNase H2. Human XP-V fibroblast extracts, devoid of hpol , could not add rNTPs to a DNA primer, but the expression of transfected hpol in the cells restored this ability. XP-V cell extracts did not add dNTPs to DNA primers hybridized to RNA, but could when hpol was expressed in the cells. HEK293T cell extracts could add dNTPs to DNA primers hybridized to RNA, but lost this ability if hpol was deleted. Interestingly, a similar phenomenon was not observed when other translesion synthesis (TLS) DNA polymeraseshpol , , or were individually deleted. These results suggest that hpol is one of the major reverse transcriptases involved in physiological processes in human cells.	[Su, Yan; Ghodke, Pratibha P.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Li, Lin; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Su, Yan] Encodia, 11125 Flintkote Ave,Suite B, San Diego, CA 92121 USA	Vanderbilt University; University of California System; University of California Riverside	Guengerich, FP (corresponding author), 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Wang, Yin/HCI-9352-2022	Ghodke, Pratibha P./0000-0002-8402-3933	National Institutes of Health [R01 ES026955, R01 ES010546, R01 ES025121]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010546, R01ES026955, R01ES025121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R01 ES026955 and R01 ES010546 (to F. P. G.) and R01 ES025121 (to Y. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.	Bailey LJ, 2017, BIOCHEM SOC T, V45, P513, DOI 10.1042/BST20160162; BALTIMORE D, 1971, P NATL ACAD SCI USA, V68, P1507, DOI 10.1073/pnas.68.7.1507; Belotserkovskii BP, 2018, DNA REPAIR, V71, P69, DOI 10.1016/j.dnarep.2018.08.009; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Caldecott KW, 2014, SCIENCE, V343, P260, DOI 10.1126/science.1248234; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Clausen AR, 2013, P NATL ACAD SCI USA, V110, P16802, DOI 10.1073/pnas.1309119110; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; Conover HN, 2015, GENETICS, V201, P951, DOI 10.1534/genetics.115.181149; Costantino L, 2018, MOL CELL, V71, P487, DOI 10.1016/j.molcel.2018.06.037; Cozens C, 2012, P NATL ACAD SCI USA, V109, P8067, DOI 10.1073/pnas.1120964109; Crespan E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10805; Cronan GE, 2019, P NATL ACAD SCI USA, V116, P1251, DOI 10.1073/pnas.1814512116; de Feraudy S, 2007, ONCOGENE, V26, P5713, DOI 10.1038/sj.onc.1210385; Donigan KA, 2014, J BIOL CHEM, V289, P9136, DOI 10.1074/jbc.M113.545442; Du H, 2018, J BIOL CHEM, V293, P11100, DOI 10.1074/jbc.RA118.003477; Figiel M, 2011, J BIOL CHEM, V286, P10540, DOI 10.1074/jbc.M110.181974; Forslund JME, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007315; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Gosavi RA, 2012, NUCLEIC ACIDS RES, V40, P7518, DOI 10.1093/nar/gks413; Gunther C, 2015, J CLIN INVEST, V125, P413, DOI 10.1172/JCI78001; Hiller B, 2018, CANCER RES, V78, P5917, DOI 10.1158/0008-5472.CAN-18-1099; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kim N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003924; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Kornberg A., 1992, DNA REPLICATION; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Lemor M, 2018, J MOL BIOL, V430, P4908, DOI 10.1016/j.jmb.2018.10.004; Makarova AV, 2014, DNA REPAIR, V18, P63, DOI 10.1016/j.dnarep.2014.02.017; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; O'Flaherty Derek K, 2014, Curr Protoc Nucleic Acid Chem, V59, DOI 10.1002/0471142700.nc0721s59; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Patra A, 2016, J BIOL CHEM, V291, P14134, DOI 10.1074/jbc.M116.732487; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Potenski CJ, 2014, NUCLEIC ACIDS RES, V42, P10226, DOI 10.1093/nar/gku773; Pryor JM, 2018, SCIENCE, V361, P1126, DOI 10.1126/science.aat2477; Samanta B, 2017, ELIFE, V6, DOI 10.7554/eLife.31153; Samara NL, 2018, NAT STRUCT MOL BIOL, V25, P715, DOI 10.1038/s41594-018-0099-4; Schermerhorn KM, 2015, J BIOL CHEM, V290, P21800, DOI 10.1074/jbc.M115.662841; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; SU Y, 2016, CURR PROTOC NUCLEIC, V10, DOI DOI 10.1002/CPNC.2; Su Y, 2017, J BIOL CHEM, V292, P18044, DOI 10.1074/jbc.M117.809723; Su Y, 2016, J BIOL CHEM, V291, P3747, DOI 10.1074/jbc.M115.706226; Su Y, 2015, J BIOL CHEM, V290, P15921, DOI 10.1074/jbc.M115.653691; Thakur M, 2001, GENE CHROMOSOME CANC, V32, P222, DOI 10.1002/gcc.1186; Tian L, 2018, P NATL ACAD SCI USA, V115, P507, DOI 10.1073/pnas.1719746115; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Uehara R, 2018, CELL REP, V25, P1135, DOI 10.1016/j.celrep.2018.10.019; Wanrooij PH, 2017, P NATL ACAD SCI USA, V114, P12466, DOI 10.1073/pnas.1713085114; Watt DL, 2011, DNA REPAIR, V10, P897, DOI 10.1016/j.dnarep.2011.05.009; Williams JS, 2014, DNA REPAIR, V19, P27, DOI 10.1016/j.dnarep.2014.03.029; Williams JS, 2013, MOL CELL, V49, P1010, DOI 10.1016/j.molcel.2012.12.021; Williams JS, 2012, DNA REPAIR, V11, P649, DOI 10.1016/j.dnarep.2012.05.004; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; Yang W, 2018, ANNU REV BIOCHEM, V87, P239, DOI 10.1146/annurev-biochem-062917-012405; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Zhao HC, 2018, EMBO REP, V19, DOI 10.15252/embr.201745335	64	24	24	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6073	6081		10.1074/jbc.RA119.007925	http://dx.doi.org/10.1074/jbc.RA119.007925			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30842261	Green Published, hybrid			2022-12-28	WOS:000465077500037
J	Nguyen, HA; Hoffer, ED; Dunham, CM				Ha An Nguyen; Hoffer, Eric D.; Dunham, Christine M.			Importance of a tRNA anticodon loop modification and a conserved, noncanonical anticodon stem pairing in tRNA(CGG)(Pro) for decoding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						translation; ribosome; transfer RNA (tRNA); RNA modification; mRNA; structural biology; decoding; mRNA frame maintenance	READING FRAME MAINTENANCE; RIBOSOMAL P-SITE; MESSENGER-RNA; EF-P; POSTTRANSCRIPTIONAL MODIFICATIONS; STRUCTURAL INSIGHTS; PEPTIDYL-TRANSFER; WOBBLE BASE; A-SITE; TRANSLATION	Modification of anticodon nucleotides allows tRNAs to decode multiple codons, expanding the genetic code. Additionally, modifications located in the anticodon loop, but outside the anticodon itself, stabilize tRNA-codon interactions, increasing decoding fidelity. Anticodon loop nucleotide 37 is 3 to the anticodon and, in tRNAPro, is methylated at the N1 position in its nucleobase (m(1)G37). The m(1)G37 modification in tRNAPro stabilizes its interaction with the codon and maintains the mRNA frame. However, it is unclear how m(1)G37 affects binding at the decoding center to both cognate and +1 slippery codons. Here, we show that the tRNAPro m(1)G37 modification is important for the association step during binding to a cognate CCG codon. In contrast, m(1)G37 prevented association with a slippery CCC-U or +1 codon. Similar analyses of frameshift suppressor tRNA(SufA6), a tRNAPro derivative containing an extra nucleotide in its anticodon loop that undergoes +1 frameshifting, reveal that m(1)G37 destabilizes interactions with both the cognate CCG and slippery codons. One reason for this destabilization is the disruption of a conserved U32<bold>A</bold>38 nucleotide pairing in the anticodon stem through insertion of G37.5. Restoring the tRNA(SufA6) U32<bold>A</bold>37.5 pairing results in a high-affinity association on the slippery CCC-U codon. Further, an X-ray crystal structure of the 70S ribosome bound to tRNA(SufA6) U32<bold>A</bold>37.5 at 3.6 angstrom resolution shows a reordering of the anticodon loop consistent with the findings from the high-affinity measurements. Our results reveal how the tRNA modification at nucleotide 37 stabilizes interactions with the mRNA codon to preserve the mRNA frame.	[Ha An Nguyen; Hoffer, Eric D.; Dunham, Christine M.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Ha An Nguyen; Dunham, Christine M.] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA	Emory University; Emory University	Dunham, CM (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	christine.m.dunham@emory.edu		Nguyen, Ha An/0000-0003-2620-2893	NIGMS, National Institutes of Health [P30 GM124165]; National Institutes of Health [RR25528, RR028976]; APS, a United States Department of Energy Office of Science User Facility [DE-AC02-06CH11357, W-31-109-Eng-38]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); APS, a United States Department of Energy Office of Science User Facility	We thank Dunham laboratory members for advice and encouragement, Dr. Kurt Fredrick for advice on kinetic binding assays, Stacey Miles for technical assistance, Dr. Tatsuya Maehigashi for crystallization advice, and Dr. Graeme Conn for comments on the manuscript. Crystals were screened and X-ray crystallography data sets were collected at the NE-CAT beamlines (funded by NIGMS, National Institutes of Health, Grant P30 GM124165), using a Pilatus detector (RR029205) and an Eiger detector (OD021527), and at the SER-CAT beamlines (funded by its member institutions and National Institutes of Health Equipment Grants RR25528 and RR028976). This research used resources of the APS, a United States Department of Energy Office of Science User Facility operated by Argonne National Laboratory under Contracts DE-AC02-06CH11357 (NE-CAT) and W-31-109-Eng-38 (SER-CAT).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agris PF, 2018, RNA BIOL, V15, P537, DOI 10.1080/15476286.2017.1356562; Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; AGRIS PF, 1991, BIOCHIMIE, V73, P1345, DOI 10.1016/0300-9084(91)90163-U; Ashraf SS, 1999, RNA, V5, P503, DOI 10.1017/S1355838299981931; Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Cabello-Villegas J, 2002, J MOL BIOL, V319, P1015, DOI 10.1016/S0022-2836(02)00382-0; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Dunham CM, 2007, RNA, V13, P817, DOI 10.1261/rna.367307; Dunkle JA, 2015, BIOCHIMIE, V114, P90, DOI 10.1016/j.biochi.2015.02.007; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagan CE, 2014, RNA, V20, P1944, DOI 10.1261/rna.046953.114; Fagan CE, 2013, P NATL ACAD SCI USA, V110, P9716, DOI 10.1073/pnas.1301585110; Fahlman RP, 2004, BIOCHEMISTRY-US, V43, P7575, DOI 10.1021/bi0495836; Gamper HB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8226; HAGERVALL TG, 1993, J MOL BIOL, V232, P756, DOI 10.1006/jmbi.1993.1429; Hoffer ED, 2019, NUCLEIC ACIDS RES, V47, P1557, DOI 10.1093/nar/gky1178; Hong S, 2018, P NATL ACAD SCI USA, V115, P11226, DOI 10.1073/pnas.1809319115; Hou YM, 2015, RNA, V21, P642, DOI 10.1261/rna.049825.115; Huter P, 2017, MOL CELL, V68, P515, DOI 10.1016/j.molcel.2017.10.014; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Johansson M, 2011, P NATL ACAD SCI USA, V108, P79, DOI 10.1073/pnas.1012612107; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konevega AL, 2004, RNA, V10, P90, DOI 10.1261/rna.5142404; Kothe U, 2007, MOL CELL, V25, P167, DOI 10.1016/j.molcel.2006.11.014; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; KUCHINO Y, 1984, NUCLEIC ACIDS RES, V12, P1559, DOI 10.1093/nar/12.3.1559; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Li JN, 1997, J MOL BIOL, V271, P209, DOI 10.1006/jmbi.1997.1176; Machnicka MA, 2014, RNA BIOL, V11, P1619, DOI 10.4161/15476286.2014.992273; Maehigashi T, 2014, P NATL ACAD SCI USA, V111, P12740, DOI 10.1073/pnas.1409436111; Murakami H, 2009, NAT STRUCT MOL BIOL, V16, P353, DOI 10.1038/nsmb.1580; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P11251, DOI 10.1038/nsmb866; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; O'Connor M, 2002, NUCLEIC ACIDS RES, V30, P759, DOI 10.1093/nar/30.3.759; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Olejniczak M, 2005, NAT STRUCT MOL BIOL, V12, P788, DOI 10.1038/nsmb978; Olejniczak M, 2006, BIOCHIMIE, V88, P943, DOI 10.1016/j.biochi.2006.06.005; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; PERRET V, 1990, BIOCHIMIE, V72, P735, DOI 10.1016/0300-9084(90)90158-D; Phelps SS, 2002, MOL CELL, V10, P799, DOI 10.1016/S1097-2765(02)00686-X; Qian Q, 1998, MOL CELL, V1, P471, DOI 10.1016/S1097-2765(00)80048-9; RIDDLE DL, 1970, J MOL BIOL, V54, P131, DOI 10.1016/0022-2836(70)90451-1; Rozov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10457; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shoji S, 2009, NUCLEIC ACIDS RES, V37, P4033, DOI 10.1093/nar/gkp296; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; SROGA GE, 1992, NUCLEIC ACIDS RES, V20, P3463, DOI 10.1093/nar/20.13.3463; Sundaram M, 2000, BIOCHEMISTRY-US, V39, P12575, DOI 10.1021/bi0014655; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Walker SE, 2006, J MOL BIOL, V360, P599, DOI 10.1016/j.jmb.2006.05.006; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P498, DOI 10.1038/nsmb1242; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Yarian C, 2000, BIOCHEMISTRY-US, V39, P13390, DOI 10.1021/bi001302g; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; YOURNO J, 1970, NATURE, V225, P422, DOI 10.1038/225422a0; YOURNO J, 1972, NATURE-NEW BIOL, V239, P219, DOI 10.1038/newbio239219a0; Zhang Y, 2018, STRUCTURE, V26, P437, DOI 10.1016/j.str.2018.01.013	72	17	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5281	5291		10.1074/jbc.RA119.007410	http://dx.doi.org/10.1074/jbc.RA119.007410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30782843	Green Published, hybrid			2022-12-28	WOS:000464517500004
J	Raj, CJT; Croft, T; Venkatakrishnan, P; Groth, B; Dhugga, G; Cater, T; Lin, SJ				Raj, Christol James Theoga; Croft, Trevor; Venkatakrishnan, Padmaja; Groth, Benjamin; Dhugga, Gagandeep; Cater, Timothy; Lin, Su-Ju			The copper-sensing transcription factor Mac1, the histone deacetylase Hst1, and nicotinic acid regulate de novo NAD(+) biosynthesis in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NAD plus biosynthesis; gene regulation; nicotinamide adenine dinucleotide (NAD); yeast genetics; yeast metabolism; epigenetics; histone deacetylase; metabolic regulation; metal sensing; nicotinic acid; cell metabolism	LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; KYNURENINE PATHWAY; GENE DISRUPTION; QUINOLINIC ACID; METABOLISM; PROTEIN; INHIBITION; DELETION; RIBOSIDE	NADH (NAD(+)) is an essential metabolite involved in various cellular biochemical processes. The regulation of NAD(+) metabolism is incompletely understood. Here, using budding yeast (Saccharomyces cerevisiae), we established an NAD(+) intermediate-specific genetic system to identify factors that regulate the de novo branch of NAD(+) biosynthesis. We found that a mutant strain (mac1) lacking Mac1, a copper-sensing transcription factor that activates copper transport genes during copper deprivation, exhibits increases in quinolinic acid (QA) production and NAD(+) levels. Similar phenotypes were also observed in the hst1 strain, deficient in the NAD(+)-dependent histone deacetylase Hst1, which inhibits de novo NAD(+) synthesis by repressing BNA gene expression when NAD(+) is abundant. Interestingly, the mac1 and hst1 mutants shared a similar NAD(+) metabolism-related gene expression profile, and deleting either MAC1 or HST1 de-repressed the BNA genes. ChIP experiments with the BNA2 promoter indicated that Mac1 works with Hst1-containing repressor complexes to silence BNA expression. The connection of Mac1 and BNA expression suggested that copper stress affects de novo NAD(+) synthesis, and we show that copper stress induces both BNA expression and QA production. Moreover, nicotinic acid inhibited de novo NAD(+) synthesis through Hst1-mediated BNA repression, hindered the reuptake of extracellular QA, and thereby reduced de novo NAD(+) synthesis. In summary, we have identified and characterized novel NAD(+) homeostasis factors. These findings will expand our understanding of the molecular basis and regulation of NAD(+) metabolism.	[Raj, Christol James Theoga; Croft, Trevor; Venkatakrishnan, Padmaja; Groth, Benjamin; Dhugga, Gagandeep; Cater, Timothy; Lin, Su-Ju] Univ Calif Davis, Dept Microbiol & Mol Genet, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu			NIGMS, National Institutes of Health [GM102297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102297] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIGMS, National Institutes of Health, Grant GM102297. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amaral M, 2013, J MOL MED, V91, P705, DOI 10.1007/s00109-013-1046-9; Bedalov A, 2003, MOL CELL BIOL, V23, P7044, DOI 10.1128/MCB.23.19.7044-7054.2003; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brachmann CB, 1998, YEAST, V14, P115; Braidy N, 2017, NEURAL REGEN RES, V12, P39, DOI 10.4103/1673-5374.198971; Breda C, 2016, P NATL ACAD SCI USA, V113, P5435, DOI 10.1073/pnas.1604453113; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Burke D., 2000, METHODS YEAST GENETI, P171; Cankorur-Cetinkaya A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2771-6; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chang KH, 2018, MOL NEUROBIOL, V55, P6319, DOI 10.1007/s12035-017-0845-3; Chini CCS, 2017, MOL CELL ENDOCRINOL, V455, P62, DOI 10.1016/j.mce.2016.11.003; Croft T, 2018, J BIOL CHEM, V293, P2927, DOI 10.1074/jbc.M117.807214; De Freitas JM, 2004, J BIOL CHEM, V279, P4450, DOI 10.1074/jbc.M212308200; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; FOSTER AC, 1985, J NEUROCHEM, V44, P446, DOI 10.1111/j.1471-4159.1985.tb05435.x; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gilmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011544; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Esquivel DG, 2017, NEUROPHARMACOLOGY, V112, P331, DOI 10.1016/j.neuropharm.2016.03.013; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; Gross C, 2000, J BIOL CHEM, V275, P32310, DOI 10.1074/jbc.M005946200; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Iwai K, 1980, Methods Enzymol, V66, P96; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Jensen LT, 1998, J BIOL CHEM, V273, P23805, DOI 10.1074/jbc.273.37.23805; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; KALIKIN L, 1988, BIOCHEM BIOPH RES CO, V152, P559, DOI 10.1016/S0006-291X(88)80074-3; Kato M, 2014, DNA REPAIR, V23, P49, DOI 10.1016/j.dnarep.2014.07.009; Kato M, 2014, J BIOL CHEM, V289, P15577, DOI 10.1074/jbc.M114.558643; Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Li MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r48; Li MG, 2010, MOL CELL BIOL, V30, P3329, DOI 10.1128/MCB.01590-09; Lin JB, 2016, CELL REP, V17, P69, DOI 10.1016/j.celrep.2016.08.073; Liu HW, 2018, P NATL ACAD SCI USA, V115, P10654, DOI 10.1073/pnas.1809392115; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2010, BBA-PROTEINS PROTEOM, V1804, P1567, DOI 10.1016/j.bbapap.2009.09.030; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Mehr AP, 2018, NAT MED, V24, P1351, DOI 10.1038/s41591-018-0138-z; Mole DJ, 2016, NAT MED, V22, P202, DOI 10.1038/nm.4020; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Ohashi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12392-6; Ohashi K, 2013, EUKARYOT CELL, V12, P648, DOI 10.1128/EC.00339-12; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Serpe M, 1999, J BIOL CHEM, V274, P29211, DOI 10.1074/jbc.274.41.29211; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sporty J, 2009, YEAST, V26, P363, DOI 10.1002/yea.1671; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Zhu ZW, 1998, J BIOL CHEM, V273, P1277, DOI 10.1074/jbc.273.3.1277	64	10	10	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5562	5575		10.1074/jbc.RA118.006987	http://dx.doi.org/10.1074/jbc.RA118.006987			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30760525	Green Published, hybrid			2022-12-28	WOS:000464517500026
J	Zhang, Y; Jiang, DS; Li, H; Sun, YF; Jiang, XH; Gong, S; Qian, ZY; Tao, J				Zhang, Yuan; Jiang, Dongsheng; Li, Hua; Sun, Yufang; Jiang, Xinghong; Gong, Shan; Qian, Zhiyuan; Tao, Jin			Melanocortin type 4 receptor-mediated inhibition of A-type K+ current enhances sensory neuronal excitability and mechanical pain sensitivity in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; patch clamp; potassium channel; signal transduction; G-protein-coupled receptor (GPCR); ion channel; pain; cell signaling; A-type K plus current; alpha-melanocyte-stimulating hormone; melanocortin type 4 receptor (MC4R); neuronal excitability; trigeminal ganglion neurons; pain perception; nociception; action potential	MELANOCYTE-STIMULATING HORMONE; KV4.2 POTASSIUM CHANNEL; PROTEIN-KINASE; NEUROPATHIC PAIN; PHOSPHATIDYLINOSITOL 3-KINASE; GANGLION NEURONS; CALCIUM-CHANNELS; P38 MAPK; ACTIVATION; EXPRESSION	alpha-Melanocyte-stimulating hormone (-MSH) has been shown to be involved in nociception, but the underlying molecular mechanisms remain largely unknown. In this study, we report that -MSH suppresses the transient outward A-type K+ current (I-A) in trigeminal ganglion (TG) neurons and thereby modulates neuronal excitability and peripheral pain sensitivity in rats. Exposing small-diameter TG neurons to -MSH concentration-dependently decreased I-A. This -MSH-induced I-A decrease was dependent on the melanocortin type 4 receptor (MC4R) and associated with a hyperpolarizing shift in the voltage dependence of A-type K+ channel inactivation. Chemical inhibition of phosphatidylinositol 3-kinase (PI3K) with wortmannin or of class I PI3Ks with the selective inhibitor CH5132799 prevented the MC4R-mediated I-A response. Blocking G(i/o)-protein signaling with pertussis toxin or by dialysis of TG neurons with the G-blocking synthetic peptide QEHA abolished the -MSH-mediated decrease in I-A. Further, -MSH increased the expression levels of phospho-p38 mitogen-activated protein kinase, and pharmacological or genetic inhibition of p38 abrogated the -MSH-induced I-A response. Additionally, -MSH significantly increased the action potential firing rate of TG neurons and increased the sensitivity of rats to mechanical stimuli applied to the buccal pad area, and both effects were abrogated by I-A blockade. Taken together, our findings suggest that -MSH suppresses I-A by activating MC4R, which is coupled sequentially to the G complex of the G(i/o)-protein and downstream class I PI3K-dependent p38 signaling, thereby increasing TG neuronal excitability and mechanical pain sensitivity in rats.	[Zhang, Yuan; Qian, Zhiyuan] Soochow Univ, Affiliated Hosp 2, Dept Geriatr, 1055 San Xiang Rd, Suzhou 215004, Peoples R China; [Zhang, Yuan; Jiang, Dongsheng; Sun, Yufang; Jiang, Xinghong; Gong, Shan; Tao, Jin] Soochow Univ, Coll Med, Dept Physiol & Neurobiol, 199 Ren Ai Rd, Suzhou 215123, Peoples R China; [Zhang, Yuan; Jiang, Dongsheng; Sun, Yufang; Jiang, Xinghong; Gong, Shan; Tao, Jin] Soochow Univ, Coll Med, Ctr Ion Channelopathy, 199 Ren Ai Rd, Suzhou 215123, Peoples R China; [Li, Hua] Natl Shanghai Ctr New Drug Safety Evaluat & Res, Shanghai 201203, Peoples R China; [Jiang, Dongsheng] Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Tao, Jin] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, Suzhou 215123, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Soochow University - China	Qian, ZY (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Geriatr, 1055 San Xiang Rd, Suzhou 215004, Peoples R China.; Tao, J (corresponding author), Soochow Univ, Coll Med, Dept Physiol & Neurobiol, 199 Ren Ai Rd, Suzhou 215123, Peoples R China.; Tao, J (corresponding author), Soochow Univ, Coll Med, Ctr Ion Channelopathy, 199 Ren Ai Rd, Suzhou 215123, Peoples R China.	zhiyuanqian@suda.edu.cn; taoj@suda.edu.cn	Jiang, Dongsheng/AAG-1284-2020	Jiang, Dongsheng/0000-0003-0961-2671	National Natural Science Foundation of China [81873731, 81771187, 81622014, 81671080, 81571063, 81371229]; Innovation Project of Jiangsu Province Qing-Lan Project; Six Talent Peaks Project of Jiangsu Province [JY-065]; Jiangsu Key Laboratory of Neuropsychiatric Diseases [BM2013003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Jiangsu Province Qing-Lan Project; Six Talent Peaks Project of Jiangsu Province; Jiangsu Key Laboratory of Neuropsychiatric Diseases; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 81873731, 81771187, 81622014, 81671080, 81571063, and 81371229; the Innovation Project of Jiangsu Province Qing-Lan Project (to J. T.); Six Talent Peaks Project of Jiangsu Province Grant JY-065; Jiangsu Key Laboratory of Neuropsychiatric Diseases Grant BM2013003; and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Adan RAH, 2000, EUR J PHARMACOL, V405, P13, DOI 10.1016/S0014-2999(00)00537-9; Adan RAH, 1997, PEPTIDES, V18, P1279, DOI 10.1016/S0196-9781(97)00078-8; Agosti F, 2017, NEUROSCIENCE, V346, P102, DOI 10.1016/j.neuroscience.2017.01.007; Agosti F, 2014, EUR J NEUROSCI, V40, P2755, DOI 10.1111/ejn.12650; Beltramo M, 2003, MOL BRAIN RES, V118, P111, DOI 10.1016/j.molbrainres.2003.08.001; Bertolini A, 2009, PHARMACOL RES, V59, P13, DOI 10.1016/j.phrs.2008.10.005; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Chen Y, 2013, PAIN, V154, P1295, DOI 10.1016/j.pain.2013.04.004; Chien LY, 2007, J NEUROSCI, V27, P9855, DOI 10.1523/JNEUROSCI.0604-07.2007; Chu HC, 2012, INT J NEUROSCI, V122, P74, DOI 10.3109/00207454.2011.630542; Coutts CA, 2009, ACTA PHYSIOL, V195, P259, DOI 10.1111/j.1748-1716.2008.01889.x; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dong YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111594; Duan KZ, 2012, PAIN, V153, P562, DOI 10.1016/j.pain.2011.11.020; Hagenacker T, 2010, BRAIN RES BULL, V83, P292, DOI 10.1016/j.brainresbull.2010.07.010; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hu CL, 2009, J BIOL CHEM, V284, P7465, DOI 10.1074/jbc.M808049200; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1671, DOI 10.1152/jn.00340.2003; Hu HJ, 2006, NEURON, V50, P89, DOI 10.1016/j.neuron.2006.03.010; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Klusa V, 2001, NEUROPEPTIDES, V35, P50, DOI 10.1054/npep.2000.0843; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Li N, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-21; Luo JL, 2011, J PAIN, V12, P600, DOI 10.1016/j.jpain.2010.11.005; Mountjoy KG, 2018, MOL METAB, V9, P207, DOI 10.1016/j.molmet.2017.11.008; Norris CA, 2012, J NEUROSCI, V32, P8865, DOI 10.1523/JNEUROSCI.0937-12.2012; Orestes P, 2013, DIABETES, V62, P3828, DOI 10.2337/db13-0813; Pieri M, 2010, NEUROPHARMACOLOGY, V58, P268, DOI 10.1016/j.neuropharm.2009.06.029; Popiolek-Barczyk K, 2014, PHARMACOL REP, V66, P845, DOI 10.1016/j.pharep.2014.05.001; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; Redman PT, 2009, J PHYSIOL-LONDON, V587, P4393, DOI 10.1113/jphysiol.2009.176321; Rodgers EW, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-143; Roepke TA, 2007, ENDOCRINOLOGY, V148, P4937, DOI 10.1210/en.2007-0605; SANDMAN CA, 1981, PEPTIDES, V2, P231, DOI 10.1016/S0196-9781(81)80040-X; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; Starowicz K, 2009, PHARMACOL REP, V61, P1086, DOI 10.1016/S1734-1140(09)70171-9; Takeda M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-5; Tanabe K, 2007, J NEUROCHEM, V101, P1145, DOI 10.1111/j.1471-4159.2006.04432.x; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; Tao J, 2012, J NEUROPHYSIOL, V107, P1666, DOI 10.1152/jn.00551.2011; Tolhurst DJ, 2009, J NEUROSCI, V29, P2355, DOI 10.1523/JNEUROSCI.3869-08.2009; van der Kraan M, 1999, MOL BRAIN RES, V63, P276, DOI 10.1016/S0169-328X(98)00291-5; Van Hoorick D, 2003, MOL CELL NEUROSCI, V24, P357, DOI 10.1016/S1044-7431(03)00174-X; Vrinten DH, 2001, ANESTH ANALG, V93, P1572, DOI 10.1097/00000539-200112000-00052; Vrinten DH, 2000, J NEUROSCI, V20, P8131; Vydyanathan A, 2005, J NEUROPHYSIOL, V93, P3401, DOI 10.1152/jn.01267.2004; Wang H, 2014, ENDOCRINOLOGY, V155, P168, DOI 10.1210/en.2013-1559; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Winkelman DLB, 2005, J PHARMACOL EXP THER, V314, P1177, DOI 10.1124/jpet.105.087759; Wu RL, 1998, J NEUROSCI, V18, P6261; Xu YF, 2002, J NEUROSCI, V22, P9194; Yang YK, 2017, BBA-MOL BASIS DIS, V1863, P2436, DOI 10.1016/j.bbadis.2017.04.025; Yue JX, 2014, PHARMAZIE, V69, P804, DOI 10.1691/ph.2014.4650; Zhang Q, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0652-1; Zhang Y, 2018, ENDOCRINOLOGY, V159, P2253, DOI 10.1210/en.2018-00108; Zhang Y, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12476; Zhang Y, 2015, J BIOL CHEM, V290, P8644, DOI 10.1074/jbc.M114.615021; Zhang Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005283; Zhao XY, 2016, CELL SIGNAL, V28, P979, DOI 10.1016/j.cellsig.2016.05.004	60	7	8	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5496	5507		10.1074/jbc.RA118.006894	http://dx.doi.org/10.1074/jbc.RA118.006894			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30745360	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000464517500021
J	Lyumkis, D				Lyumkis, Dmitry			Challenges and opportunities in cryo-EM single-particle analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						protein structure; cryo-electron microscopy; single-particle analysis; protein-protein interaction; structural biology; atomic resolution	BEAM-INDUCED MOTION; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; MACROMOLECULAR COMPLEXES; ANGSTROM RESOLUTION; MOLECULAR MICROSCOPY; VITRIFICATION SYSTEM; SPECIMEN PREPARATION; SAMPLE PREPARATION; REVOLUTION WILL	Cryogenic electron microscopy (cryo-EM) enables structure determination of macromolecular objects and their assemblies. Although the techniques have been developing for nearly four decades, they have gained widespread attention in recent years due to technical advances on numerous fronts, enabling traditional microscopists to break into the world of molecular structural biology. Many samples can now be routinely analyzed at near-atomic resolution using standard imaging and image analysis techniques. However, numerous challenges to conventional workflows remain, and continued technical advances open entirely novel opportunities for discovery and exploration. Here, I will review some of the main methods surrounding cryo-EM with an emphasis specifically on single-particle analysis, and I will highlight challenges, open questions, and opportunities for methodology development.	[Lyumkis, Dmitry] Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA; [Lyumkis, Dmitry] Salk Inst Biol Studies, Helmsley Ctr Genom Med, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Lyumkis, D (corresponding author), Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA.; Lyumkis, D (corresponding author), Salk Inst Biol Studies, Helmsley Ctr Genom Med, La Jolla, CA 92037 USA.	dlyumkis@salk.edu			National Institutes of Health [DP5 OD021396, R01 AI136680, U54 GM103368]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI136680, U54AI150472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103368] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants DP5 OD021396, R01 AI136680, and U54 GM103368. The author declares that he has no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeyrathne PD, 2016, ELIFE, V5, DOI 10.7554/eLife.14874; ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Balchin D, 2018, CELL, V174, P1507, DOI 10.1016/j.cell.2018.07.006; Bartesaghi A, 2018, STRUCTURE, V26, P848, DOI 10.1016/j.str.2018.04.004; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Beckers M, 2019, IUCRJ, V6, P18, DOI 10.1107/S2052252518014434; Beckert B, 2018, NAT MICROBIOL, V3, P1115, DOI 10.1038/s41564-018-0237-0; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; Benjamin CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32500; BERRIMAN J, 1994, ULTRAMICROSCOPY, V56, P241, DOI 10.1016/0304-3991(94)90012-4; Biyani N, 2017, J STRUCT BIOL, V198, P124, DOI 10.1016/j.jsb.2017.03.007; Boland A, 2017, NAT STRUCT MOL BIOL, V24, P414, DOI 10.1038/nsmb.3386; Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003; Brink J, 1998, ULTRAMICROSCOPY, V72, P41, DOI 10.1016/S0304-3991(97)00126-5; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Callaway E, 2015, NATURE, V525, P172, DOI 10.1038/525172a; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Chari A, 2015, NAT METHODS, V12, P859, DOI [10.1038/NMETH.3493, 10.1038/nmeth.3493]; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng AC, 2018, J STRUCT BIOL, V204, P270, DOI 10.1016/j.jsb.2018.07.015; Cheng YF, 2006, J MOL BIOL, V355, P1048, DOI 10.1016/j.jmb.2005.11.021; Cheng Y, 2015, CELL, V161, P438, DOI 10.1016/j.cell.2015.03.050; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Choi SS, 2018, CURR OPIN MICROBIOL, V45, P53, DOI 10.1016/j.mib.2018.02.007; D'Imprima E., 2018, DEADLY TOUCH PROTEIN, DOI [10.1101/400432, DOI 10.1101/400432]; Dambacher CM, 2015, J STRUCT BIOL, V192, P151, DOI 10.1016/j.jsb.2015.09.010; Danev R, 2001, ULTRAMICROSCOPY, V88, P243, DOI 10.1016/S0304-3991(01)00088-2; Danev R, 2017, CURR OPIN STRUC BIOL, V46, P87, DOI 10.1016/j.sbi.2017.06.006; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; Dashti A, 2014, P NATL ACAD SCI USA, V111, P17492, DOI 10.1073/pnas.1419276111; Davis JH, 2016, CELL, V167, P1610, DOI 10.1016/j.cell.2016.11.020; de la Cruz MJ, 2017, NAT METHODS, V14, P399, DOI 10.1038/nmeth.4178; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; DeRosier DJ, 2000, ULTRAMICROSCOPY, V81, P83, DOI 10.1016/S0304-3991(99)00120-5; Diebolder CA, 2015, J STRUCT BIOL, V190, P215, DOI 10.1016/j.jsb.2015.03.010; DiMaio F, 2013, PROTEIN SCI, V22, P865, DOI 10.1002/pro.2267; Drulyte I, 2018, ACTA CRYSTALLOGR D, V74, P560, DOI 10.1107/S2059798318006496; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; DUBOCHET J, 1982, J MICROSC-OXFORD, V128, P219, DOI 10.1111/j.1365-2818.1982.tb04625.x; DUBOCHET J, 1981, J MICROSC-OXFORD, V124, pRP3; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Dubochet J, 2018, ANGEW CHEM INT EDIT, V57, P10842, DOI 10.1002/anie.201804280; Dubochet J, 2016, BIOPHYS J, V110, P756, DOI 10.1016/j.bpj.2015.07.049; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Eades A, 2006, ULTRAMICROSCOPY, V106, P432, DOI 10.1016/j.ultramic.2005.12.002; Egerton RF, 2014, ULTRAMICROSCOPY, V145, P85, DOI 10.1016/j.ultramic.2013.10.019; Fan X., 2018, SINGLE PARTICLE CRYO, DOI [10.1101/457861, DOI 10.1101/457861]; Feng XS, 2017, STRUCTURE, V25, P663, DOI 10.1016/j.str.2017.02.005; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; Fernandez-Leiro R, 2016, NATURE, V537, P339, DOI 10.1038/nature19948; Fitzpatrick AWP, 2013, J AM CHEM SOC, V135, P19123, DOI 10.1021/ja4115055; Forsberg BO, 2017, IUCRJ, V4, P723, DOI 10.1107/S205225251701226X; Frank J, 2018, ANGEW CHEM INT EDIT, V57, P10826, DOI 10.1002/anie.201802770; Frank J, 2017, J STRUCT BIOL, V200, P303, DOI 10.1016/j.jsb.2017.06.005; Frank J, 2017, NAT PROTOC, V12, P209, DOI 10.1038/nprot.2017.004; Frenz B, 2017, NAT METHODS, V14, P797, DOI [10.1038/NMETH.4340, 10.1038/nmeth.4340]; Glaeser RM, 2016, METHOD ENZYMOL, V579, P19, DOI 10.1016/bs.mie.2016.04.010; Glaeser RM, 2018, CURR OPIN COLLOID IN, V34, P1, DOI 10.1016/j.cocis.2017.12.009; Glaeser Robert M, 2017, Biophys Rep, V3, P1, DOI 10.1007/s41048-016-0026-3; Glaeser RM, 2011, J STRUCT BIOL, V174, P1, DOI 10.1016/j.jsb.2010.12.005; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; HARAUZ G, 1986, OPTIK, V73, P146; Harris JR, 2014, METHODS MOL BIOL, V1117, P215, DOI 10.1007/978-1-62703-776-1_11; Haselbach D, 2018, CELL, V172, P454, DOI 10.1016/j.cell.2018.01.010; Hattne J, 2018, STRUCTURE, V26, P759, DOI 10.1016/j.str.2018.03.021; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Henderson R, 2018, ANGEW CHEM INT EDIT, V57, P10804, DOI 10.1002/anie.201802731; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Henderson R, 2013, P NATL ACAD SCI USA, V110, P18037, DOI 10.1073/pnas.1314449110; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Herzik M. A., 2018, HIGH RESOLUTION STRU, DOI [10.1101/489898, DOI 10.1101/489898]; Herzik MA, 2017, NAT METHODS, V14, P1075, DOI [10.1038/NMETH.4461, 10.1038/nmeth.4461]; Ho CM, 2018, NATURE, V561, P70, DOI 10.1038/s41586-018-0469-4; Jain T, 2012, J STRUCT BIOL, V179, P68, DOI 10.1016/j.jsb.2012.04.020; Jakobi AJ, 2017, ELIFE, V6, DOI 10.7554/eLife.27131; Jensen GJ, 2000, ULTRAMICROSCOPY, V84, P57, DOI 10.1016/S0304-3991(00)00005-X; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; Jin QY, 2014, STRUCTURE, V22, P496, DOI 10.1016/j.str.2014.01.004; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kelly DF, 2008, J MOL BIOL, V382, P423, DOI 10.1016/j.jmb.2008.07.023; Kelly DF, 2010, METHOD ENZYMOL, V481, P83, DOI 10.1016/S0076-6879(10)81004-3; Kelly DF, 2010, J MOL BIOL, V400, P675, DOI 10.1016/j.jmb.2010.05.045; Kemmerling S, 2013, J STRUCT BIOL, V183, P467, DOI 10.1016/j.jsb.2013.06.012; Khoshouei M, 2017, J STRUCT BIOL, V197, P94, DOI 10.1016/j.jsb.2016.05.009; Kiss G, 2014, MICROSC MICROANAL, V20, P164, DOI 10.1017/S1431927613013937; KRIVANEK OL, 1995, ULTRAMICROSCOPY, V60, P103, DOI 10.1016/0304-3991(95)00050-B; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kujirai T, 2018, SCIENCE, V362, P595, DOI 10.1126/science.aau9904; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lawson CL, 2011, NUCLEIC ACIDS RES, V39, pD456, DOI 10.1093/nar/gkq880; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu YX, 2018, P NATL ACAD SCI USA, V115, P3362, DOI 10.1073/pnas.1718825115; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Lu ZH, 2009, J STRUCT BIOL, V168, P388, DOI 10.1016/j.jsb.2009.08.004; Vilas JL, 2018, STRUCTURE, V26, P337, DOI 10.1016/j.str.2017.12.018; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Lyumkis D, 2010, METHOD ENZYMOL, V483, P291, DOI 10.1016/S0076-6879(10)83015-0; Marsh ja, 2018, PROTEIN COMPLEX ASSE, P45; Martin TG, 2016, P NATL ACAD SCI USA, V113, pE7456, DOI 10.1073/pnas.1612720113; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McMullan G, 2009, ULTRAMICROSCOPY, V109, P1411, DOI 10.1016/j.ultramic.2009.07.004; McMullan G, 2009, ULTRAMICROSCOPY, V109, P1126, DOI 10.1016/j.ultramic.2009.04.002; Merk A, 2016, CELL, V165, P1698, DOI 10.1016/j.cell.2016.05.040; Meyerson JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07084; Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529; Moriya T, 2017, JOVE-J VIS EXP, DOI 10.3791/55448; Muller H, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073011; Mulligan SK, 2015, MICROSC MICROANAL, V21, P1017, DOI 10.1017/S1431927615014324; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Murata K, 2018, BBA-GEN SUBJECTS, V1862, P324, DOI 10.1016/j.bbagen.2017.07.020; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; Naydenova K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00782-3; Nicholls RA, 2018, ACTA CRYSTALLOGR D, V74, P492, DOI 10.1107/S2059798318007313; Noble AJ, 2018, NAT METHODS, V15, P793, DOI 10.1038/s41592-018-0139-3; Noble AJ, 2018, ELIFE, V7, DOI 10.7554/eLife.34257; Nogales E, 2016, NAT METHODS, V13, P24, DOI 10.1038/nmeth.3694; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Palovcak E, 2018, J STRUCT BIOL, V204, P80, DOI 10.1016/j.jsb.2018.07.007; Pantelic RS, 2012, SOLID STATE COMMUN, V152, P1375, DOI 10.1016/j.ssc.2012.04.038; Pantelic RS, 2010, J STRUCT BIOL, V170, P152, DOI 10.1016/j.jsb.2009.12.020; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Patel AB, 2018, SCIENCE, V362, P1376, DOI 10.1126/science.aau8872; Peet MJ, 2019, ULTRAMICROSCOPY, V203, P125, DOI 10.1016/j.ultramic.2019.02.007; Penczek PA, 2002, J STRUCT BIOL, V138, P34, DOI 10.1016/S1047-8477(02)00033-3; Penczek PA, 2010, METHOD ENZYMOL, V482, P73, DOI 10.1016/S0076-6879(10)82003-8; Pfeffer S, 2018, CURR OPIN STRUC BIOL, V52, P111, DOI 10.1016/j.sbi.2018.08.009; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Ramirez-Aportela E, 2018, BIORXIV, DOI [10.1101/433284, DOI 10.1101/433284]; Razinkov I, 2016, J STRUCT BIOL, V195, P190, DOI 10.1016/j.jsb.2016.06.001; Renaud JP, 2018, NAT REV DRUG DISCOV, V17, P471, DOI 10.1038/nrd.2018.77; Richardson JS, 2018, ACTA CRYSTALLOGR D, V74, P132, DOI 10.1107/S2059798317009834; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rosenthal PB, 2015, CURR OPIN STRUC BIOL, V34, P135, DOI 10.1016/j.sbi.2015.07.002; Ruskin RS, 2013, J STRUCT BIOL, V184, P385, DOI 10.1016/j.jsb.2013.10.016; Russo CJ, 2016, CURR OPIN STRUC BIOL, V37, P81, DOI 10.1016/j.sbi.2015.12.007; Sader K, 2013, J STRUCT BIOL, V183, P531, DOI 10.1016/j.jsb.2013.04.014; SAXTON WO, 1995, J MICROSC-OXFORD, V179, P201, DOI 10.1111/j.1365-2818.1995.tb03633.x; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Scapin G, 2018, CELL CHEM BIOL, V25, P1318, DOI 10.1016/j.chembiol.2018.07.006; Scapin G, 2018, NATURE, V556, P122, DOI 10.1038/nature26153; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidli C, 2018, JOVE-J VIS EXP, DOI 10.3791/57310; Schwartz O, 2017, OPT EXPRESS, V25, P14453, DOI 10.1364/OE.25.014453; Shi D, 2013, ELIFE, V2, DOI 10.7554/eLife.01345; Shu F, 2000, P NATL ACAD SCI USA, V97, P3872, DOI 10.1073/pnas.060024697; Snijder J, 2017, J STRUCT BIOL, V198, P38, DOI 10.1016/j.jsb.2017.02.008; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Stella S, 2018, CELL, V175, P1856, DOI 10.1016/j.cell.2018.10.045; Subramaniam S, 2013, P NATL ACAD SCI USA, V110, pE4172, DOI 10.1073/pnas.1313802110; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Takizawa Y, 2017, PROTEIN SCI, V26, P69, DOI 10.1002/pro.3054; Tan YZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06076-6; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Tan YZ, 2016, MICROSCOPY-JPN, V65, P43, DOI 10.1093/jmicro/dfv369; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; Tegunov D, 2018, BIORXIV, DOI [10.1101/338558, DOI 10.1101/338558]; Terwilliger TC, 2018, ACTA CRYSTALLOGR D, V74, P545, DOI 10.1107/S2059798318004655; Thal DM, 2018, NATURE, V559, P45, DOI 10.1038/s41586-018-0259-z; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; van Heel M, 2013, P NATL ACAD SCI USA, V110, pE4175, DOI 10.1073/pnas.1314353110; Verbeke EJ, 2018, CELL REP, V24, P259, DOI 10.1016/j.celrep.2018.06.022; Villa E, 2013, CURR OPIN STRUC BIOL, V23, P771, DOI 10.1016/j.sbi.2013.08.006; Vinothkumar KR, 2016, Q REV BIOPHYS, V49, P1, DOI 10.1017/S0033583516000068; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Voss NR, 2010, METHOD ENZYMOL, V482, P381, DOI 10.1016/S0076-6879(10)82016-6; WAGENKNECHT T, 1989, BIOPHYS J, V55, P455, DOI 10.1016/S0006-3495(89)82839-5; WALKER M, 1995, BIOPHYS J, V68, pS87; Wang JM, 2017, PROTEIN SCI, V26, P1619, DOI 10.1002/pro.3198; Wang JM, 2017, PROTEIN SCI, V26, P396, DOI 10.1002/pro.3093; Wang JM, 2017, PROTEIN SCI, V26, P122, DOI 10.1002/pro.3060; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; White HD, 2003, J STRUCT BIOL, V144, P246, DOI 10.1016/j.jsb.2003.09.027; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Williams CJ, 2013, COMPUT CRYSTALLO NEW, V4, P33; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wlodawer A, 2017, STRUCTURE, V25, P1589, DOI 10.1016/j.str.2017.07.012; Wu SP, 2016, MICROSCOPY-JPN, V65, P35, DOI 10.1093/jmicro/dfv355; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yonekura K, 2015, P NATL ACAD SCI USA, V112, P3368, DOI 10.1073/pnas.1500724112; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang C., 2018, ANAL LOCAL VARIABILI, DOI [10.1101/365940, DOI 10.1101/365940]; Zhang C., 2018, ULTRAMICROSCOPY, V2018; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	213	143	143	19	109	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5181	5197		10.1074/jbc.REV118.005602	http://dx.doi.org/10.1074/jbc.REV118.005602			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30804214	hybrid, Green Published			2022-12-28	WOS:000463985600038
J	Streit, BR; Mattice, JR; Prussia, GA; Peters, JW; DuBois, JL				Streit, Bennett R.; Mattice, Jenna R.; Prussia, Gregory A.; Peters, John W.; DuBois, Jennifer L.			The reactive form of a C-S bond-cleaving, CO2-fixing flavoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin adenine dinucleotide (FAD); microbiology; carbon fixation; oxidase; disulfide; 2-KPCC; C-S bond cleavage; carboxylase; disulfide oxidoreductase; nucleophilic thiolate	GLUTATHIONE-REDUCTASE; ESCHERICHIA-COLI; CATALYTIC DYAD; PK(A) VALUES; MECHANISM; THIOREDOXIN; DISULFIDE; ENZYME; YEAST; CARBOXYLATION	NADPH:2-ketopropyl-coenzyme M oxidoreductase/carboxylase (2-KPCC) is a bacterial disulfide oxidoreductase (DSOR) that, uniquely in this family, catalyzes CO2 fixation. 2-KPCC differs from other DSORs by having a phenylalanine that replaces a conserved histidine, which in typical DSORs is essential for stabilizing the reduced, reactive form of the active site. Here, using site-directed mutagenesis and stopped-flow kinetics, we examined the reactive form of 2-KPCC and its single turnover reactions with a suicide substrate and CO2. The reductive half-reaction of 2-KPCC was kinetically and spectroscopically similar to that of a typical DSOR, GSH reductase, in which the active-site histidine had been replaced with an alanine. However, the reduced, reactive form of 2-KPCC was distinct from those typical DSORs. In the absence of the histidine, the flavin and disulfide moieties were no longer coupled via a covalent or charge transfer interaction as in typical DSORs. Similar to thioredoxins, the pK(a) between 7.5 and 8.1 that controls reactivity appeared to be due to a single proton shared between the cysteines of the dithiol, which effectively stabilizes the attacking cysteine sulfide and renders it capable of breaking the strong C-S bond of the substrate. The lack of a histidine protected 2-KPCC's reactive intermediate from unwanted protonation; however, without its input as a catalytic acid-base, the oxidative half-reaction where carboxylation takes place was remarkably slow, limiting the overall reaction rate. We conclude that stringent regulation of protons in the DSOR active site supports C-S bond cleavage and selectivity for CO2 fixation.	[Streit, Bennett R.; Mattice, Jenna R.; Prussia, Gregory A.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59715 USA; [Prussia, Gregory A.; Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99163 USA	Montana State University System; Montana State University Bozeman; Washington State University	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59715 USA.	jennifer.dubois1@montana.edu		DuBois, Jennifer/0000-0001-5593-3391	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-FG02x04ER15563]; National Science Foundation [MCB1715176]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award DE-FG02x04ER15563 (to J. W. P.). This work was also supported by National Science Foundation Grant MCB1715176 (to J. L. D.). The authors declare that they have no conflicts of interest with the contents of this article.	ARSCOTT LD, 1981, BIOCHEMISTRY-US, V20, P1513, DOI 10.1021/bi00509a016; BASHFORD D, 1993, BIOCHEMISTRY-US, V32, P8045, DOI 10.1021/bi00082a027; BENSON SW, 1978, CHEM REV, V78, P23, DOI 10.1021/cr60311a003; Boyd JM, 2010, J BIOL CHEM, V285, P25232, DOI 10.1074/jbc.M110.144410; Cheng ZY, 2011, CHEM REV, V111, P5768, DOI 10.1021/cr100006x; Clark DD, 2000, BIOCHEMISTRY-US, V39, P1294, DOI 10.1021/bi992282p; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; DEONARAIN MP, 1989, BIOCHEMISTRY-US, V28, P9602, DOI 10.1021/bi00451a008; FOX B, 1982, J BIOL CHEM, V257, P2498; Frey P. A., 2007, ENZYMATIC REACTION M, P387; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; HUBER PW, 1980, BIOCHEMISTRY-US, V19, P4568, DOI 10.1021/bi00561a005; JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001; Jursic BS, 1997, INT J QUANTUM CHEM, V62, P291, DOI 10.1002/(SICI)1097-461X(1997)62:3<291::AID-QUA7>3.0.CO;2-R; Kofoed MA, 2011, J BACTERIOL, V193, P4904, DOI 10.1128/JB.05231-11; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P1, DOI 10.1021/bi00594a001; Maung N, 1999, J MOL STRUC-THEOCHEM, V460, P159, DOI 10.1016/S0166-1280(98)00314-5; MILLER SM, 1990, BIOCHEMISTRY-US, V29, P2831, DOI 10.1021/bi00463a028; ODA Y, 1994, BIOCHEMISTRY-US, V33, P5275, DOI 10.1021/bi00183a034; PEARL L, 1984, FEBS LETT, V174, P96, DOI 10.1016/0014-5793(84)81085-6; Prussia GA, 2016, FEBS LETT, V590, P2991, DOI 10.1002/1873-3468.12325; RIETVELD P, 1994, BIOCHEMISTRY-US, V33, P13888, DOI 10.1021/bi00250a043; Sampogna RV, 1996, BIOPHYS J, V71, P1165, DOI 10.1016/S0006-3495(96)79320-7; THORPE C, 1981, BIOCHEMISTRY-US, V20, P1507, DOI 10.1021/bi00509a015; Veine DM, 1998, BIOCHEMISTRY-US, V37, P15575, DOI 10.1021/bi9811314; VENKATASUBBAN KS, 1984, CRC CR REV BIOCH MOL, V17, P1, DOI 10.3109/10409238409110268; Westphal AH, 1998, EUR J BIOCHEM, V257, P160, DOI 10.1046/j.1432-1327.1998.2570160.x; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x	29	4	4	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5137	5145		10.1074/jbc.RA118.005554	http://dx.doi.org/10.1074/jbc.RA118.005554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30696768	hybrid, Green Published			2022-12-28	WOS:000463985600034
J	Tamarit, B; Bugault, F; Pillet, AH; Lavergne, V; Bochet, P; Garin, N; Schwarz, U; Theze, J; Rose, T				Tamarit, Blanche; Bugault, Florence; Pillet, Anne-Helene; Lavergne, Vincent; Bochet, Pascal; Garin, Nathalie; Schwarz, Ulf; Theze, Jacques; Rose, Thierry			Membrane microdomains and cytoskeleton organization shape and regulate the IL-7 receptor signalosome in human CD4 T-cells (vol 288, pg 8691, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Tamarit B, 2013, J BIOL CHEM, V288, P8691, DOI 10.1074/jbc.M113.449918	1	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5212	5213		10.1074/jbc.AAC119.008288	http://dx.doi.org/10.1074/jbc.AAC119.008288			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30926760	Green Published, hybrid			2022-12-28	WOS:000463985600044
J	Nguyen, KG; Gillam, FB; Hopkins, JJ; Jayanthi, S; Gundampati, RK; Su, GW; Bear, J; Pilkington, GR; Jalah, R; Felber, BK; Liu, J; Thallapuranam, SK; Zaharoff, DA				Nguyen, Khue G.; Gillam, Francis B.; Hopkins, Jared J.; Jayanthi, Srinivas; Gundampati, Ravi Kumar; Su, Guowei; Bear, Jenifer; Pilkington, Guy R.; Jalah, Rashmi; Felber, Barbara K.; Liu, Jian; Thallapuranam, Suresh Kumar; Zaharoff, David A.			Molecular mechanisms of heparin-induced modulation of human interleukin 12 bioactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heparin; interleukin; glycosaminoglycan; cytokine; immunology; heparan sulfate; heparin-binding cytokine; IL-12	FIBROBLAST-GROWTH-FACTOR; CHAIN-LENGTH; BINDING; SULFATE; CELLS; IL-12; CYTOKINE; RECEPTOR; CLUSPRO; CLONING	Human interleukin-12 (hIL-12) is a heparin-binding cytokine whose activity was previously shown to be enhanced by heparin and other sulfated glycosaminoglycans. The current study investigated the mechanisms by which heparin increases hIL-12 activity. Using multiple human cell types, including natural killer cells, an IL-12 indicator cell line, and primary peripheral blood mononuclear and T cells, along with bioactivity, flow cytometry, and isothermal titration calorimetry assays, we found that heparin-dependent modulation of hIL-12 function correlates with several of heparin's biophysical characteristics, including chain length, sulfation level, and concentration. Specifically, only heparin molecules longer than eight saccharide units enhanced hIL-12 activity. Furthermore, heparin molecules with three sulfate groups per disaccharide unit outperformed heparin molecules with one or two sulfate groups per disaccharide unit in terms of enhanced hIL-12 binding and activity. Heparin also significantly reduced the EC50 value of hIL-12 by up to 11.8-fold, depending on the responding cell type. Cytokine-profiling analyses revealed that heparin affected the level, but not the type, of cytokines produced by lymphocytes in response to hIL-12. Interestingly, although murine IL-12 also binds heparin, heparin did not enhance its activity. Using the gathered data, we propose a model of hIL-12 stabilization in which heparin serves as a co-receptor enhancing the interaction between heterodimeric hIL-12 and its receptor subunits. The results of this study provide a foundation for further investigation of heparin's interactions with IL-12 family cytokines and for the use of heparin as an immunomodulatory agent.	[Nguyen, Khue G.; Zaharoff, David A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Nguyen, Khue G.; Gillam, Francis B.; Hopkins, Jared J.; Zaharoff, David A.] Joint Dept Biomed Engn Univ North Carolina Chapel, Raleigh, NC 27695 USA; [Jayanthi, Srinivas; Gundampati, Ravi Kumar; Thallapuranam, Suresh Kumar] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Su, Guowei; Liu, Jian] Univ N Carolina, Div Chem Biol & Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Bear, Jenifer; Pilkington, Guy R.; Jalah, Rashmi; Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, NIH, Frederick, MD 21702 USA; [Pilkington, Guy R.] ImQuest BioSci, Frederick, MD 21704 USA; [Jalah, Rashmi] GlaxoSmithKline GSK Vaccines, Rockville, MD 20850 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Arkansas System; University of Arkansas Fayetteville; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); GlaxoSmithKline	Zaharoff, DA (corresponding author), Joint Dept Biomed Engn Univ North Carolina Chapel, Raleigh, NC 27695 USA.	dazaharo@ncsu.edu	Gundampati, Ravi Kumar/AAL-7624-2020; Jayanthi, Srinivas/AAD-2808-2019; Nguyen, Khue G./T-2348-2019	Nguyen, Khue/0000-0003-4954-1126; Jayanthi, Srinivas/0000-0001-7357-760X	National Institutes of Health Grant from NCI; Arkansas Biosciences Institute; Intramural Research Program of the NCI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER	National Institutes of Health Grant from NCI; Arkansas Biosciences Institute; Intramural Research Program of the NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant from NCI, the Arkansas Biosciences Institute, and by the Intramural Research Program of the NCI, National Institutes of Health (to B. K. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AlvarezSilva M, 1996, J LEUKOCYTE BIOL, V59, P435, DOI 10.1002/jlb.59.3.435; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Choijilsuren G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14573-9; CHUA AO, 1994, J IMMUNOL, V153, P128; CLARKE D, 1995, CYTOKINE, V7, P325, DOI 10.1006/cyto.1995.0041; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; da Costa DS, 2017, ANNU REV BIOMED ENG, V19, P1, DOI [10.1146/annurev-bioeng-071516044610, 10.1146/annurev-bioeng-071516-044610]; Fannon M, 2000, BIOCHEMISTRY-US, V39, P1434, DOI 10.1021/bi991895z; Fieschi C, 2004, BLOOD, V104, P2095, DOI 10.1182/blood-2004-02-0584; Garnier P, 2018, CYTOKINE, V110, P159, DOI 10.1016/j.cyto.2018.04.014; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Hasan M, 1999, J IMMUNOL, V162, P1064; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hochart H, 2008, THROMB HAEMOSTASIS, V99, P570, DOI 10.1160/TH07-06-0424; Jalah R, 2013, J BIOL CHEM, V288, P6763, DOI 10.1074/jbc.M112.436675; Jayanthi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05382-1; Jayanthi S, 2014, PROTEIN EXPRES PURIF, V102, P76, DOI 10.1016/j.pep.2014.07.002; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Leonard JP, 1997, BLOOD, V90, P2541; Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200; MCKEE RF, 1992, GUT, V33, P1549, DOI 10.1136/gut.33.11.1549; Mehrotra PT, 1998, J IMMUNOL, V160, P2637; Najjam S, 1998, GLYCOBIOLOGY, V8, P509, DOI 10.1093/glycob/8.5.509; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Rezaie AR, 2007, THROMB RES, V119, P481, DOI 10.1016/j.thromres.2006.01.009; Salek-Ardakani S, 2000, BLOOD, V96, P1879, DOI 10.1182/blood.V96.5.1879.h8001879_1879_1888; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; SCOTT JE, 1994, VIRCHOWS ARCH, V424, P89; Tam YK, 1999, HUM GENE THER, V10, P1359, DOI 10.1089/10430349950018030; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; WOLF SF, 1991, J IMMUNOL, V146, P3074; Xu XY, 2002, INT J BIOL MACROMOL, V30, P151, DOI 10.1016/S0141-8130(02)00015-6; Xu YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan5954; Xu YM, 2014, NAT CHEM BIOL, V10, P248, DOI [10.1038/NCHEMBIO.1459, 10.1038/nchembio.1459]; Yang JH, 2017, CHEM COMMUN, V53, P1743, DOI 10.1039/c6cc08204a	41	15	15	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4412	4424		10.1074/jbc.RA118.006193	http://dx.doi.org/10.1074/jbc.RA118.006193			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30670588	Green Published, hybrid			2022-12-28	WOS:000462969500011
J	Tammali, R; Saxena, A; Srivastava, SK; Ramana, KV				Tammali, Ravinder; Saxena, Ashish; Srivastava, Satish K.; Ramana, Kota V.			Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells (Expression of Concern of Vol 286, Pg 24089, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Tammali R, 2011, J BIOL CHEM, V286, P24089, DOI 10.1074/jbc.M111.219733	1	2	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1634	1634		10.1074/jbc.EC119.007463	http://dx.doi.org/10.1074/jbc.EC119.007463			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710009	Green Published, hybrid			2022-12-28	WOS:000457879200020
J	Rao, S; Du, GY; Hafner, M; Subramanian, K; Sorger, PK; Gray, NS				Rao, Suman; Du, Guangyan; Hafner, Marc; Subramanian, Kartik; Sorger, Peter K.; Gray, Nathanael S.			A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cancer therapy; chemical biology; drug discovery; small molecule; receptor tyrosine kinase; cell signaling; chemical probe; kinase signaling; multi-targeting; polypharmacology	KINASE INHIBITORS; IMATINIB MESYLATE; MEK INHIBITORS; RAS; PATHWAYS; TYROSINE; TARGETS; KRAS; POLYPHARMACOLOGY; SENSITIVITY	Most cancer cells are dependent on a network of deregulated signaling pathways for survival and are insensitive, or rapidly evolve resistance, to selective inhibitors aimed at a single target. For these reasons, drugs that target more than one protein (polypharmacology) can be clinically advantageous. The discovery of useful polypharmacology remains serendipitous and is challenging to characterize and validate. In this study, we developed a non-genetic strategy for the identification of pathways that drive cancer cell proliferation and represent exploitable signaling vulnerabilities. Our approach is based on using a multitargeted kinase inhibitor, SM1-71, as a tool compound to identify combinations of targets whose simultaneous inhibition elicits a potent cytotoxic effect. As a proof of concept, we applied this approach to a KRAS-dependent non-small cell lung cancer (NSCLC) cell line, H23-KRAS(G12C). Using a combination of phenotypic screens, signaling analyses, and kinase inhibitors, we found that dual inhibition of MEK1/2 and insulin-like growth factor 1 receptor (IGF1R)/insulin receptor (INSR) is critical for blocking proliferation in cells. Our work supports the value of multitargeted tool compounds with well-validated polypharmacology and target space as tools to discover kinase dependences in cancer. We propose that the strategy described here is complementary to existing genetics-based approaches, generalizable to other systems, and enabling for future mechanistic and translational studies of polypharmacology in the context of signaling vulnerabilities in cancers.	[Rao, Suman; Hafner, Marc; Subramanian, Kartik; Sorger, Peter K.] Harvard Med Sch, Lab Syst Pharmacol, Boston, MA 02115 USA; [Rao, Suman; Du, Guangyan; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Rao, Suman; Du, Guangyan; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Hafner, Marc] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Roche Holding; Genentech	Gray, NS (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	Nathanael_Gray@dfci.harvard.edu		Rao, Suman/0000-0002-5046-0852; Sorger, Peter/0000-0002-3364-1838; Hafner, Marc/0000-0003-1337-7598	National Institutes of Health [P50 GM107618, U54-CA225088, U54-HL127365]; Jonathan M. Goldstein and Kaia Miller Goldstein systems pharmacology fellowship; Novartis; Takeda; Astellas; Taiho; Janssen; Kinogen; Voronoi; Her2llc; Deerfield; Sanofi; Merck; NATIONAL CANCER INSTITUTE [U54CA225088] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL127365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonathan M. Goldstein and Kaia Miller Goldstein systems pharmacology fellowship; Novartis(Novartis); Takeda(Takeda Pharmaceutical Company Ltd); Astellas(Astellas Pharmaceuticals); Taiho; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Kinogen; Voronoi; Her2llc; Deerfield; Sanofi; Merck(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P50 GM107618, U54-CA225088, and U54-HL127365 (to S.R., M.H., K.S., and P.K.S.); a Jonathan M. Goldstein and Kaia Miller Goldstein systems pharmacology fellowship (to S.R.); and a Linde Family gift (to G.D.). N.S.G. is a founder, science advisory board member (SAB), and equity holder in Gatekeeper, Syros, Petra, C4, B2S, and Soltego. The Gray lab receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Janssen, Kinogen, Voronoi, Her2llc, Deerfield, and Sanofi. P.K.S. is a founder, SAB member, and equity holder in Merrimack Pharmaceutical and Glencoe Software; he is on the Board of Directors of Applied Biomath and the SAB of RareCyte Inc. In the last five years the Sorger lab has received research funding from Novartis and Merck. M.H. is currently an employee of Genentech, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander PB, 2015, FRONT MED-PRC, V9, P134, DOI 10.1007/s11684-015-0396-9; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Ciceri P, 2014, NAT CHEM BIOL, V10, P305, DOI 10.1038/nchembio.1471; Clark NA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3689-3; Cohen MH, 2009, ONCOLOGIST, V14, P174, DOI 10.1634/theoncologist.2008-0255; Contreras JI, 2018, ACS CHEM BIOL, V13, P1148, DOI 10.1021/acschembio.8b00077; Dagher R, 2002, CLIN CANCER RES, V8, P3034; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Ferguson FM, 2018, NAT REV DRUG DISCOV, V17, P353, DOI 10.1038/nrd.2018.21; Flanigan SA, 2013, CLIN CANCER RES, V19, P6219, DOI 10.1158/1078-0432.CCR-13-0145; Golkowski M, 2014, MEDCHEMCOMM, V5, P363, DOI 10.1039/c3md00315a; Hafner M, 2017, NAT BIOTECHNOL, V35, P500, DOI 10.1038/nbt.3882; Hafner M, 2016, NAT METHODS, V13, P521, DOI [10.1038/NMETH.3853, 10.1038/nmeth.3853]; Jiang ZB, 2016, ONCOL REP, V36, P365, DOI 10.3892/or.2016.4770; Kangaspeska S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2452-5; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; Lake D, 2016, CELL MOL LIFE SCI, V73, P4397, DOI 10.1007/s00018-016-2297-8; Lemeer S, 2013, J PROTEOME RES, V12, P1723, DOI 10.1021/pr301073j; Lovly CM, 2014, CLIN CANCER RES, V20, P2249, DOI 10.1158/1078-0432.CCR-13-1610; Medard G, 2015, J PROTEOME RES, V14, P1574, DOI 10.1021/pr5012608; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Proschak E, 2019, J MED CHEM, V62, P420, DOI 10.1021/acs.jmedchem.8b00760; Rao S, 2019, CELL CHEM BIOL, V26, P818, DOI 10.1016/j.chembiol.2019.02.021; Rix LLR, 2009, LEUKEMIA, V23, P477, DOI 10.1038/leu.2008.334; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Rozengurt E, 2014, MOL CANCER THER, V13, P2477, DOI 10.1158/1535-7163.MCT-14-0330; Russo M, 2014, CANCER DISCOV, V4, P19, DOI 10.1158/2159-8290.CD-13-0906; Sharma S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040933; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Suleymanova N, 2017, ONCOTARGET, V8, P82256, DOI 10.18632/oncotarget.19286; Tan L, 2017, BIOORGAN MED CHEM, V25, P1320, DOI 10.1016/j.bmc.2016.11.034; Tan L, 2017, BIOORGAN MED CHEM, V25, P838, DOI 10.1016/j.bmc.2016.11.035; Tolcher AW, 2015, CLIN CANCER RES, V21, P739, DOI 10.1158/1078-0432.CCR-14-1901; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Wali VB, 2017, CANCER RES, V77, P566, DOI 10.1158/0008-5472.CAN-16-1901; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilky BA, 2015, BRIT J CANCER, V112, P24, DOI 10.1038/bjc.2014.515; Wu P, 2016, DRUG DISCOV TODAY, V21, P5, DOI 10.1016/j.drudis.2015.07.008; Yang G, 2016, BLOOD, V127, P3237, DOI 10.1182/blood-2016-01-695098	45	6	6	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8664	8673		10.1074/jbc.RA118.006805	http://dx.doi.org/10.1074/jbc.RA118.006805			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30858179	Green Published, hybrid			2022-12-28	WOS:000471108200032
J	Ben Ouirane, K; Boulard, Y; Bressanelli, S				Ben Ouirane, Kaouther; Boulard, Yves; Bressanelli, Stephane			The hepatitis C virus RNA-dependent RNA polymerase directs incoming nucleotides to its active site through magnesium-dependent dynamics within its F motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA virus; viral polymerase; molecular dynamics; nucleoside; nucleotide transport; protein motif; RNA-dependent RNA polymerase (RdRp); Single-stranded; positive-sense RNA virus; structural biology	CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CATALYSIS; FIDELITY; COMPLEX; SIMULATIONS; MECHANISM; INSIGHTS	RNA viruses synthesize new genomes in the infected host thanks to dedicated, virally-encoded RNA-dependent RNA polymerases (RdRps). As such, these enzymes are prime targets for antiviral therapy, as has recently been demonstrated for hepatitis C virus (HCV). However, peculiarities in the architecture and dynamics of RdRps raise fundamental questions about access to their active site during RNA polymerization. Here, we used molecular modeling and molecular dynamics simulations, starting from the available crystal structures of HCV NS5B in ternary complex with template-primer duplexes and nucleotides, to address the question of ribonucleotide entry into the active site of viral RdRp. Tracing the possible passage of incoming UTP or GTP through the RdRp-specific entry tunnel, we found two successive checkpoints that regulate nucleotide traffic to the active site. We observed that a magnesium-bound nucleotide first binds next to the tunnel entry, and interactions with the triphosphate moiety orient it such that its base moiety enters first. Dynamics of RdRp motifs F1 + F3 then allow the nucleotide to interrogate the RNA template base prior to nucleotide insertion into the active site. These dynamics are finely regulated by a second magnesium dication, thus coordinating the entry of a magnesium-bound nucleotide with shuttling of the second magnesium necessary for the two-metal ion catalysis. The findings of our work suggest that at least some of these features are general to viral RdRps and provide further details on the original nucleotide selection mechanism operating in RdRps of RNA viruses.	[Ben Ouirane, Kaouther; Boulard, Yves; Bressanelli, Stephane] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, F-91198 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Boulard, Y; Bressanelli, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, F-91198 Gif Sur Yvette, France.	yves.boulard@cea.fr; stephane.bressanelli@i2bc.paris-saclay.fr		Bressanelli, Stephane/0000-0002-0921-6727	Agence Nationale de la Recherche sur le Sida et single-stranded, positive sense RNA ((+)-ssRNA) viruses or in les hepatites virales (France REcherche Nord and sud SIDA-hiv Hepatites) Grant [AAP 2014-2]; Universite 'Paris-Saclay Graduate Student Fellowship	Agence Nationale de la Recherche sur le Sida et single-stranded, positive sense RNA ((+)-ssRNA) viruses or in les hepatites virales (France REcherche Nord and sud SIDA-hiv Hepatites) Grant; Universite 'Paris-Saclay Graduate Student Fellowship	This work was supported by Agence Nationale de la Recherche sur le Sida et single-stranded, positive sense RNA ((+)-ssRNA) viruses or in les hepatites virales (France REcherche Nord and sud SIDA-hiv Hepatites) Grant AAP 2014-2 (to S. B.) and a Universite 'Paris-Saclay Graduate Student Fellowship (to K. B. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdelnabi R, 2017, J VIROL, V91, DOI 10.1128/JVI.00487-17; Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Da LT, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004624; Davis BC, 2013, BIOCHEMISTRY-US, V52, P4541, DOI 10.1021/bi400251g; Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Duan BG, 2014, BIOPHYS J, V107, P2130, DOI 10.1016/j.bpj.2014.09.038; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Freedman H, 2018, J BIOL CHEM, V293, P9696, DOI 10.1074/jbc.RA118.002588; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; GUPTA RK, 1983, BIOCHEM BIOPH RES CO, V117, P210, DOI 10.1016/0006-291X(83)91562-0; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin ZN, 2017, ANTIVIR RES, V143, P151, DOI 10.1016/j.antiviral.2017.04.005; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Mendieta J, 2008, PROTEINS, V71, P565, DOI 10.1002/prot.21711; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Ovchinnikov V, 2012, J PHYS CHEM B, V116, P8584, DOI 10.1021/jp212634z; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Selisko B, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020059; Shu B, 2017, RNA BIOL, V14, P1314, DOI 10.1080/15476286.2017.1300221; Shu B, 2016, P NATL ACAD SCI USA, V113, pE4005, DOI 10.1073/pnas.1602591113; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Tubiana T, 2018, J CHEM INF MODEL, V58, P2178, DOI 10.1021/acs.jcim.8b00512; Wu JQ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010024; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	45	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7573	7587		10.1074/jbc.RA118.005209	http://dx.doi.org/10.1074/jbc.RA118.005209			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30867194	Green Published, hybrid			2022-12-28	WOS:000470153300006
J	Sharma, S; Oot, RA; Khan, MM; Wilkens, S				Sharma, Stuti; Oot, Rebecca A.; Khan, Md Murad; Wilkens, Stephan			Functional reconstitution of vacuolar H+-ATPase from V-o proton channel and mutant V-1-ATPase provides insight into the mechanism of reversible disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; protein-protein interaction; biophysics; membrane protein; molecular motor; biolayer interferometry; lipid nanodisc; reversible disassembly	YEAST VACUOLAR; AFFINITY PURIFICATION; SUBUNIT INTERACTIONS; STRUCTURAL FEATURES; CRYSTAL-STRUCTURE; DISSOCIATION; MEMBRANES; DOMAIN; ISOFORM; COMPLEX	The vacuolar H+-ATPase (V-ATPase; V1Vo-ATPase) is an ATP-dependent proton pump that acidifies subcellular compartments in all eukaryotic organisms. V-ATPase activity is regulated by reversible disassembly into autoinhibited V-1-ATPase and V-o proton channel subcomplexes, a process that is poorly understood on the molecular level. V-ATPase is a rotary motor, and recent structural analyses have revealed different rotary states for disassembled V-1 and V-o, a mismatch that is likely responsible for their inability to reconstitute into holo V-ATPase in vitro. Here, using the model organism Saccharomyces cerevisiae, we show that a key impediment for binding of V-1 to V-o is the conformation of the inhibitory C-terminal domain of subunit H (H-CT). Using biolayer interferometry and biochemical analyses of purified mutant V-1-ATPase and V-o proton channel reconstituted into vacuolar lipid-containing nanodiscs, we further demonstrate that disruption of H-CT's V-1-binding site facilitates assembly of a functionally coupled and stable V1Vo-ATPase. Unlike WT, this mutant enzyme was resistant to MgATP hydrolysis-induced dissociation, further highlighting H-CT's role in the mechanism of V-ATPase regulation. Our findings provide key insight into the molecular events underlying regulation of V-ATPase activity by reversible disassembly.	[Sharma, Stuti; Oot, Rebecca A.; Khan, Md Murad; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Sharma, Stuti] Harvard Med Sch, Dept Cell Biol, 250 Longwood Ave, Boston, MA 02115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu		Khan, Md. Murad/0000-0002-7371-2995	National Institutes of Health [GM058600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM058600 (to S. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bodzeta A, 2017, CELL REP, V20, P1348, DOI 10.1016/j.celrep.2017.07.040; Brown D, 1997, J EXP BIOL, V200, P257; Chan CY, 2014, J BIOL CHEM, V289, P19448, DOI 10.1074/jbc.M114.569855; Couoh-Cardel S, 2015, J BIOL CHEM, V290, P27959, DOI 10.1074/jbc.M115.662494; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; HO MN, 1993, J BIOL CHEM, V268, P18286; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Mazhab-Jafari MT, 2016, NATURE, V539, P118, DOI 10.1038/nature19828; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Oot RA, 2017, PROTEIN SCI, V26, P896, DOI 10.1002/pro.3147; Oot RA, 2016, EMBO J, V35, P1694, DOI 10.15252/embj.201593447; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1996, J BIOL CHEM, V271, P19592, DOI 10.1074/jbc.271.32.19592; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PUOPOLO K, 1990, J BIOL CHEM, V265, P14836; Roh SH, 2018, MOL CELL, V69, P993, DOI 10.1016/j.molcel.2018.02.006; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sharma S, 2018, J BIOL CHEM, V293, P10718, DOI 10.1074/jbc.RA118.002951; Sharma S, 2017, PROTEIN SCI, V26, P1070, DOI 10.1002/pro.3143; Smardon AM, 2015, J BIOL CHEM, V290, P27511, DOI 10.1074/jbc.M115.667634; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; Stam NJ, 2017, J BIOL CHEM, V292, P1749, DOI 10.1074/jbc.M116.766790; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; Thudium CS, 2012, CURR PROTEIN PEPT SC, V13, P141; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Williamson W Ryan, 2010, Commun Integr Biol, V3, P604, DOI 10.4161/cib.3.6.13364; XIE XS, 1994, J BIOL CHEM, V269, P25809; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	51	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6439	6449		10.1074/jbc.RA119.007577	http://dx.doi.org/10.1074/jbc.RA119.007577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30792311	Green Published, hybrid			2022-12-28	WOS:000468402000021
J	Cheng, YL; Tang, QN; Li, YT; Zhang, YS; Zhao, CY; Yan, J; You, HJ				Cheng, Yuanlei; Tang, Qingnan; Li, Yutong; Zhang, Yashuo; Zhao, Chuyuan; Yan, Jie; You, Huijuan			Folding/unfolding kinetics of G-quadruplexes upstream of the P1 promoter of the human BCL-2 oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-quadruplex; B-cell lymphoma 2 (Bcl-2); single-molecule biophysics; promoter; transcription regulation; DNA secondary structure; folding; unfolding kinetics; force spectroscopy; magnetic tweezers; force spectroscopy; oncogene promoter	MAGNETIC TWEEZERS; FORMING REGION; EXPRESSION; PROTEIN; LOOP; POTASSIUM; STABILITY; DYNAMICS; TRACT; GENE	The G-rich Pu39 region of the P1 promoter of the oncogene BCL-2, an apoptosis regulator, can fold into multiple G-quadruplex (G4) structures. Bcl2-2345 and Bcl2-1245 are two major G4 species forming with high thermal stability and distinct topologies in the Pu39 region, but their folding/unfolding kinetics have not yet been investigated. Here, we used magnetic tweezers to measure the mechanical stability and the folding/unfolding kinetics of the Bcl2-2345 and Bcl2-1245 G4 structures. We report that the hybrid-stranded Bcl2-2345 G4 had a lower mechanical stability than the parallel-stranded Bcl2-1245 G4. We observed that the Bcl2-2345 G4 is a kinetically favored structure, whereas the Bcl2-1245 G4, with a slow unfolding rate, may function as a kinetic barrier for transcription. We also determined that in addition to the Bcl2-2345 and Bcl2-1245 G4s, other stable DNA secondary structures, such as a hybrid-stranded Bcl2-1234 G4, can also form in the Pu39 sequence. The characterization of the folding/unfolding kinetics of specific G4s reported here sheds light on the participation of G4s during gene transcription and provides information for designing G4-targeting small molecules that could modulate BCL-2 gene expression.	[Cheng, Yuanlei; Li, Yutong; Zhang, Yashuo; You, Huijuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430030, Hubei, Peoples R China; [Tang, Qingnan; Zhao, Chuyuan; Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore	Huazhong University of Science & Technology; National University of Singapore; National University of Singapore	You, HJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430030, Hubei, Peoples R China.	youhuijuan@hust.edu.cn	cheng, sanshi/GQZ-2396-2022; Yan, Jie/G-2725-2012; You, Huijuan/A-1018-2015	Yan, Jie/0000-0002-8555-7291; You, Huijuan/0000-0001-5371-9666; Cheng, Yuanlei/0000-0002-6081-559X	National Natural Science Foundation of China [21708009]; Fundamental Research Fund for the Central Universities [2017KFYXJJ153]; National Research Foundation, Prime Minister's Office, Singapore; Ministry of Education under the Research Centres of Excellence programme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for the Central Universities; National Research Foundation, Prime Minister's Office, Singapore(National Research Foundation, Singapore); Ministry of Education under the Research Centres of Excellence programme	This work was supported by National Natural Science Foundation of China Grant 21708009 (to H. Y.); Fundamental Research Fund for the Central Universities Grant 2017KFYXJJ153 (to H. Y.); National Research Foundation, Prime Minister's Office, Singapore and the Ministry of Education under the Research Centres of Excellence programme (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal P, 2014, J AM CHEM SOC, V136, P1750, DOI 10.1021/ja4118945; Agrawal P, 2013, NUCLEIC ACIDS RES, V41, P10584, DOI 10.1093/nar/gkt784; Amato J, 2018, CHEMMEDCHEM, V13, P406, DOI 10.1002/cmdc.201700749; Chen H, 2011, BIOPHYS J, V100, P517, DOI 10.1016/j.bpj.2010.12.3700; Chen Y., 2012, CURR PROTOC NUCL ACI, DOI [10.1002/0471142700.nc1705s50, DOI 10.1002/0471142700.NC1705S50]; Cocco S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011910; Cui YX, 2016, BIOCHEMISTRY-US, V55, P2291, DOI 10.1021/acs.biochem.6b00016; Cui YX, 2014, NUCLEIC ACIDS RES, V42, P5755, DOI 10.1093/nar/gku185; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; Falanga AP, 2019, BIOCONJUGATE CHEM, V30, P572, DOI 10.1021/acs.bioconjchem.8b00674; Heckman C, 1997, J BIOL CHEM, V272, P19609, DOI 10.1074/jbc.272.31.19609; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; JOENSUU H, 1994, AM J PATHOL, V145, P1191; LINZELL JL, 1971, J PHYSIOL-LONDON, V216, P683, DOI 10.1113/jphysiol.1971.sp009547; Long X, 2013, NUCLEIC ACIDS RES, V41, P2746, DOI 10.1093/nar/gks1341; Lynch S, 2009, CHEM-EUR J, V15, P8113, DOI 10.1002/chem.200901390; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Onel B, 2016, J AM CHEM SOC, V138, P2563, DOI 10.1021/jacs.5b08596; PEZZELLA F, 1993, NEW ENGL J MED, V329, P690, DOI 10.1056/NEJM199309023291003; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; REED JC, 1994, ANN ONCOL, V5, pS61, DOI 10.1093/annonc/5.suppl_1.S61; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Wang XD, 2010, J MED CHEM, V53, P4390, DOI 10.1021/jm100445e; You HJ, 2017, JOVE-J VIS EXP, DOI 10.3791/56328; You HJ, 2015, J AM CHEM SOC, V137, P2424, DOI 10.1021/ja511680u; You HJ, 2014, NUCLEIC ACIDS RES, V42, P8789, DOI 10.1093/nar/gku581; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686; Yu ZB, 2009, J AM CHEM SOC, V131, P1876, DOI 10.1021/ja806782s; Zhang XH, 2014, J AM CHEM SOC, V136, P16073, DOI 10.1021/ja5090805; Zhao XD, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa837e	32	28	28	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5890	5895		10.1074/jbc.RA119.007516	http://dx.doi.org/10.1074/jbc.RA119.007516			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30787104	Green Published, hybrid			2022-12-28	WOS:000465077500020
J	Mikkelsen, SA; Mogensen, LS; Vilsen, B; Molday, RS; Vestergaard, AL; Andersen, JP				Mikkelsen, Stine A.; Mogensen, Louise S.; Vilsen, Bente; Molday, Robert S.; Vestergaard, Anna L.; Andersen, Jens Peter			Asparagine 905 of the mammalian phospholipid flippase ATP8A2 is essential for lipid substrate-induced activation of ATP8A2 dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; membrane lipid; membrane transport; lipid binding protein; lipid transport; lipid-protein interaction; mutant; molecular modeling; membrane enzyme; transporter; CAMRQ syndrome; enzyme mechanism; mutagenesis; P4-ATPase; phosphatidylserine transport	CRYSTAL-STRUCTURE; TRANSPORT; ATPASE; GENE; CA2+-ATPASE; MECHANISM; RESIDUES; ACIDS; CA2+	The P-type ATPase protein family includes, in addition to ion pumps such as Ca2+-ATPase and Na+,K+-ATPase, also phospholipid flippases that transfer phospholipids between membrane leaflets. P-type ATPase ion pumps translocate their substrates occluded between helices in the center of the transmembrane part of the protein. The large size of the lipid substrate has stimulated speculation that flippases use a different transport mechanism. Information on the functional importance of the most centrally located helices M5 and M6 in the transmembrane domain of flippases has, however, been sparse. Using mutagenesis, we examined the entire M5-M6 region of the mammalian flippase ATP8A2 to elucidate its possible function in the lipid transport mechanism. This mutational screen yielded an informative map assigning important roles in the interaction with the lipid substrate to only a few M5-M6 residues. The M6 asparagine Asn-905 stood out as being essential for the lipid substrate-induced dephosphorylation. The mutants N905A/D/E/H/L/Q/R all displayed very low activities and a dramatic insensitivity to the lipid substrate. Strikingly, Asn-905 aligns with key ion-binding residues of P-type ATPase ion pumps, and N905D was recently identified as one of the mutations causing the neurological disorder cerebellar ataxia, mental retardation, and disequilibrium (CAMRQ) syndrome. Moreover, the effects of substitutions to the adjacent residue Val-906 (i.e. V906A/E/F/L/Q/S) suggest that the lipid substrate approaches Val-906 during the translocation. These results favor a flippase mechanism with strong resemblance to the ion pumps, despite a location of the translocation pathway in the periphery of the transmembrane part of the flippase protein.	[Mikkelsen, Stine A.; Mogensen, Louise S.; Vilsen, Bente; Vestergaard, Anna L.; Andersen, Jens Peter] Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark; [Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 3N9, Canada	Aarhus University; University of British Columbia; University of British Columbia	Andersen, JP (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	jpa@biomed.au.dk		Vilsen, Bente/0000-0002-4727-9382; Molday, Robert/0000-0002-4479-1831; Andersen, Jens Peter/0000-0003-0654-4300	Danish Council for Independent Research Grant [DFF 6110-00271]; Novo Nordisk Foundation [NNF16OC0022510]; Canadian Institutes of Health Research Grant [PJT-148649]; National Institutes of Health [EY002422]; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	Danish Council for Independent Research Grant; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by Danish Council for Independent Research Grant DFF 6110-00271 (to J. P. A.), Novo Nordisk Foundation Grant NNF16OC0022510 (to J. P. A.), Canadian Institutes of Health Research Grant PJT-148649 (to R. S. M.), and National Institutes of Health Grant EY002422 (to R. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 2018, NATURE, V556, P214, DOI 10.1038/s41586-018-0003-8; Alsahli S, 2018, J CENT NERV SYST DIS, V10, DOI 10.1177/1179573518759682; Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Halleck MS, 1998, GENOME RES, V8, P354, DOI 10.1101/gr.8.4.354; Jensen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17742-y; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Martin-Hernandez E, 2016, NEUROGENETICS, V17, P259, DOI 10.1007/s10048-016-0496-y; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Puts CF, 2009, BBA-MOL CELL BIOL L, V1791, P603, DOI 10.1016/j.bbalip.2009.02.005; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Stone Alex, 2012, J Chem Biol, V5, P131, DOI 10.1007/s12154-012-0078-x; Swarts HGP, 2005, J BIOL CHEM, V280, P11488, DOI 10.1074/jbc.M412321200; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111	27	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5970	5979		10.1074/jbc.RA118.007240	http://dx.doi.org/10.1074/jbc.RA118.007240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30760526	Green Published, hybrid			2022-12-28	WOS:000465077500028
J	Chen, CC; Breslin, MB; Guidry, JJ; Lan, MS				Chen, Chiachen; Breslin, Mary Beth; Guidry, Jessie J.; Lan, Michael S.			5-Iodotubercidin represses insulinoma-associated-1 expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenosine receptor; neuroblastoma; adenosine; adenylate kinase (ADK); cyclic AMP (cAMP); cell signaling; 5-iodotubercidin; insulinoma-associated-1 (INSM1); neuroblastoma; proto-oncogene BHLH transcription factor (N-Myc); transcriptional regulation	MYC GENE AMPLIFICATION; N-MYC; ADENOSINE RECEPTOR; HEPATOCELLULAR-CARCINOMA; INHIBITION; ACTIVATION; AGONIST; CF102; AMP; PROLIFERATION	Insulinoma-associated-1 (INSM1) is a key protein functioning as a transcriptional repressor in neuroendocrine differentiation and is activated by N-Myc in human neuroblastoma (NB). INSM1 modulates the phosphoinositide 3-kinase (PI3K)-AKT Ser/Thr kinase (AKT)-glycogen synthase kinase 3 (GSK3) signaling pathway through a positive-feedback loop, resulting in N-Myc stabilization. Accordingly, INSM1 has emerged as a critical player closely associated with N-Myc in facilitating NB cell growth. Here, an INSM1 promoter-driven luciferase-based screen revealed that the compound 5-iodotubercidin suppresses adenosine kinase (ADK), an energy pathway enzyme, and also INSM1 expression and NB tumor growth. Next, we sought to dissect how the ADK pathway contributes to NB tumor cell growth in the context of INSM1 expression. We also found that 5-iodotubercidin inhibits INSM1 expression and induces an intra- and extracellular adenosine imbalance. The adenosine imbalance, which triggers adenosine receptor-3 signaling that decreases cAMP levels and AKT phosphorylation and enhances GSK3 activity. We further observed that GSK3 then phosphorylates -catenin and promotes the cytoplasmic proteasomal degradation pathway. 5-Iodotubercidin treatment and INSM1 inhibition suppressed extracellular signal-regulated kinase 1/2 (ERK1/2) activity and the AKT signaling pathways required for NB cell proliferation. The 5-iodotubercidin treatment also suppressed -catenin, lymphoid enhancer-binding factor 1 (LEF-1), cyclin D1, N-Myc, and INSM1 levels, ultimately leading to apoptosis via caspase-3 and p53 activation. The identification of the signaling pathways that control the proliferation of aggressive NB reported here suggests new options for combination treatments of NB patients.	[Chen, Chiachen; Lan, Michael S.] Louisiana State Univ, Dept Genet, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Breslin, Mary Beth; Lan, Michael S.] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Guidry, Jessie J.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Guidry, Jessie J.] Louisiana State Univ, LSUHSC Prote Core Facil, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Breslin, Mary Beth] Southwest Shadow, SWCTA 7050 W Shelbourne Ave, Las Vegas, NV 89113 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Lan, MS (corresponding author), Louisiana State Univ, Hlth Sci Ctr, 533 Bolivar St,CSRB Box 6-16, New Orleans, LA 70112 USA.	mlan@lsuhsc.edu	Lan, Michael/CAF-1839-2022	Guidry, Jessie/0000-0002-5601-0430; Lan, Michael/0000-0003-4596-5677	National Cancer Institute, National Institutes of Health [CA218764]; Louisiana State University Research Enhancement Program; Departments of Pediatrics/Genetics, Louisiana State University Health Sciences Center; Children's Hospital, New Orleans, LA; NATIONAL CANCER INSTITUTE [R21CA218764] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Louisiana State University Research Enhancement Program; Departments of Pediatrics/Genetics, Louisiana State University Health Sciences Center; Children's Hospital, New Orleans, LA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, National Institutes of Health Grant CA218764, in part by the Louisiana State University Research Enhancement Program, the Departments of Pediatrics/Genetics, Louisiana State University Health Sciences Center, and the Children's Hospital, New Orleans, LA. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annes JP, 2012, P NATL ACAD SCI USA, V109, P3915, DOI 10.1073/pnas.1201149109; Bar-Yehuda S, 2008, INT J ONCOL, V33, P287, DOI 10.3892/ijo_00000008; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chen CC, 2018, CELL SIGNAL, V46, P83, DOI 10.1016/j.cellsig.2018.02.014; Chen CC, 2015, ONCOTARGET, V6, P36700, DOI 10.18632/oncotarget.5485; Cohen S, 2011, J CELL PHYSIOL, V226, P2438, DOI 10.1002/jcp.22593; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; FEOKTISTOV I, 1995, J CLIN INVEST, V96, P1979, DOI 10.1172/JCI118245; Fishman P, 2003, ANTICANCER RES, V23, P2077; Fishman P, 2002, ONCOGENE, V21, P4060, DOI 10.1038/sj.onc.1205531; Fishman P, 2012, DRUG DISCOV TODAY, V17, P359, DOI 10.1016/j.drudis.2011.10.007; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; KOHL NE, 1984, SCIENCE, V226, P1335, DOI 10.1126/science.6505694; Li QDQT, 2016, INT J ONCOL, V48, P2591, DOI 10.3892/ijo.2016.3478; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Maira SM, 2009, BIOCHEM SOC T, V37, P265, DOI 10.1042/BST0370265; Marin RM, 2007, J SEP SCI, V30, P2473, DOI 10.1002/jssc.200700194; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Merighi S, 2005, J BIOL CHEM, V280, P19516, DOI 10.1074/jbc.M413772200; NISEN PD, 1988, J NATL CANCER I, V80, P1633, DOI 10.1093/jnci/80.20.1633; Peyton KJ, 2012, J PHARMACOL EXP THER, V342, P827, DOI 10.1124/jpet.112.194712; Saitoh M, 2004, BIOCHEM PHARMACOL, V67, P2005, DOI 10.1016/j.bcp.2004.01.020; SCHWAB M, 1991, ADV ENZYME REGUL, V31, P329, DOI 10.1016/0065-2571(91)90021-D; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SLAVC I, 1990, CANCER RES, V50, P1459; Stemmer SM, 2013, ONCOLOGIST, V18, P25, DOI 10.1634/theoncologist.2012-0211; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; Wildner H, 2008, DEVELOPMENT, V135, P473, DOI 10.1242/dev.011783; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062527	30	6	7	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5456	5465		10.1074/jbc.RA118.006761	http://dx.doi.org/10.1074/jbc.RA118.006761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30755485	Green Published, hybrid			2022-12-28	WOS:000464517500018
J	Murugan, S; Jakka, P; Namani, S; Mujumdar, V; Radhakrishnan, G				Murugan, Subathra; Jakka, Padmaja; Namani, Swapna; Mujumdar, Varadendra; Radhakrishnan, Girish			The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; Toll-like receptor (TLR); immunosuppression; inflammation; ubiquitylation (ubiquitination)	RECEPTOR; TLR2; CLIP-170; ENZYMES; BRAIN	Pregnenolone is a steroid hormone precursor that is synthesized in various steroidogenic tissues, in the brain, and in lymphocytes. In addition to serving as the precursor for other steroid hormones, pregnenolone exerts its own effect as an anti-inflammatory molecule to maintain immune homeostasis in various inflammatory conditions. Pregnenolone and its metabolic derivatives have been shown to have beneficial effects in the brain, including enhancing memory and learning, reversing depressive disorders, and modulating cognitive functions. A decreased level of pregnenolone has been observed in neuroinflammatory diseases, which emphasizes its role in neuroprotection and neuroregeneration. Although the anti-inflammatory property of pregnenolone was recognized several decades ago, its mechanism of action remains unknown. Here we report that pregnenolone promotes ubiquitination and degradation of the TLR2/4 adaptor protein TIRAP and TLR2 in macrophages and microglial cells. Pregnenolone and its metabolites suppressed the secretion of tumor necrosis factor and interleukin-6 mediated through TLR2 and TLR4 signaling. Pregnenolone has been reported to induce activation of cytoplasmic linker protein 170, and this protein has recently been shown to promote targeted degradation of TIRAP. We observed enhanced degradation of TIRAP and TLR4 suppression by cytoplasmic linker protein 170 in the presence of pregnenolone. Our experimental data reveal novel nongenomic targets of pregnenolone and provide important leads to understand its role in restoring immune homeostasis in various inflammatory conditions.	[Murugan, Subathra; Jakka, Padmaja; Namani, Swapna; Mujumdar, Varadendra; Radhakrishnan, Girish] Natl Inst Anim Biotechnol, Lab Immunol & Microbial Pathogenesis, Hyderabad 500032, Telangana, India; [Jakka, Padmaja; Namani, Swapna] Manipal Acad Higher Educ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Animal Biotechnology (NIAB); Manipal Academy of Higher Education (MAHE)	Radhakrishnan, G (corresponding author), Natl Inst Anim Biotechnol, Lab Immunol & Microbial Pathogenesis, Hyderabad 500032, Telangana, India.	girish@niab.org.in		Radhakrishnan, Girish/0000-0001-9088-0029	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR21564/BRB/10/1561/2016]; University Grant Commission, Government of India; INSPIRE, Department of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); University Grant Commission, Government of India(University Grants Commission, India); INSPIRE, Department of Science and Technology, Government of India	This work was funded by Department of Biotechnology, Ministry of Science and Technology, Government of India Grant BT/PR21564/BRB/10/1561/2016 (to G. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a postdoctoral fellowship from the University Grant Commission, Government of India.; Supported by a research fellowship for doctoral studies from INSPIRE, Department of Science and Technology, Government of India.	Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; DiSanto E, 1996, EUR J PHARMACOL, V299, P179, DOI 10.1016/0014-2999(95)00840-3; Fontaine-Lenoir V, 2006, P NATL ACAD SCI USA, V103, P4711, DOI 10.1073/pnas.0600113103; Gong LL, 2016, EUR J NEUROSCI, V43, P1674, DOI 10.1111/ejn.13257; HENDERSON E, 1950, J CLIN ENDOCRINOL, V10, P455, DOI 10.1210/jcem-10-4-455; Hoagland H, 1944, SCIENCE, V100, P63, DOI 10.1126/science.100.2587.63; Hoffmann O, 2007, J IMMUNOL, V178, P6476, DOI 10.4049/jimmunol.178.10.6476; Hossain MJ, 2017, J NEUROIMMUNOL, V304, P11, DOI 10.1016/j.jneuroim.2016.12.004; Jakka P, 2018, J IMMUNOL, V200, P704, DOI 10.4049/jimmunol.1601559; Jia Y, 2013, P NATL ACAD SCI USA, V110, P8152, DOI 10.1073/pnas.1216671110; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Lansbergen G, 2004, J CELL BIOL, V166, P1003, DOI 10.1083/jcb.200402082; Larti F, 2015, EUR J HUM GENET, V23, P416, DOI 10.1038/ejhg.2014.152; LAZAR G, 1992, FEBS LETT, V308, P137, DOI 10.1016/0014-5793(92)81261-J; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Mahata B, 2014, CELL REP, V7, P1130, DOI 10.1016/j.celrep.2014.04.011; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; MCGAVACK TH, 1951, J CLIN ENDOCRINOL, V11, P559, DOI 10.1210/jcem-11-6-559; Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naylor JC, 2010, BBA-MOL CELL BIOL L, V1801, P951, DOI 10.1016/j.bbalip.2010.05.006; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PINCUS G, 1945, PSYCHOSOM MED, V7, P342, DOI 10.1097/00006842-194511000-00004; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Shih MCM, 2011, MOL CELL ENDOCRINOL, V336, P80, DOI 10.1016/j.mce.2010.12.017; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Vallee M, 2001, BRAIN RES REV, V37, P301, DOI 10.1016/S0165-0173(01)00135-7; Vallee M, 2016, J STEROID BIOCHEM, V160, P78, DOI 10.1016/j.jsbmb.2015.09.030; Vallee M, 2014, SCIENCE, V343, P94, DOI 10.1126/science.1243985; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Weng JH, 2013, NAT CHEM BIOL, V9, P636, DOI [10.1038/NCHEMBIO.1321, 10.1038/nchembio.1321]	40	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4596	4607		10.1074/jbc.RA118.005543	http://dx.doi.org/10.1074/jbc.RA118.005543			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30647133	Green Published, hybrid			2022-12-28	WOS:000462969500026
J	Voelker, DR; Numata, M				Voelker, Dennis R.; Numata, Mari			Phospholipid regulation of innate immunity and respiratory viral infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						antiviral agent; immunology; innate immunity; virology; toll receptor; inflammation; phospholipids; pulmonary surfactant; signaling; viral entry; Toll-like receptors; respiratory system; antivirals	SYNCYTIAL VIRUS-INFECTION; PULMONARY SURFACTANT; RECEPTORS; TLR4; CD14	Toll-like receptors (TLRs) coupled to intracellular signaling cascades function as central elements of innate immunity that control transcription of numerous pro-inflammatory genes. Two minor anionic phospholipids present in the pulmonary surfactant complex, palmitoyl-oleoyl-phosphatidylglycerol (POPG) and phosphatidylinositol (PI), antagonize the cognate ligand activation of TLRs 2 and 4. The lipids block recognition of activating ligands by the TLRs, either directly or via the TLR4 coreceptors CD14 and MD2. Antagonism of TLR activation results in inhibition of the initiating step of the pro-inflammatory signaling pathways. Evidence for this mechanism of action comes from direct binding studies between CD14 and MD2 with POPG and PI. Additional evidence for this mechanism of antagonism also comes from monitoring the reduction of protein phosphorylation events that characterize the intracellular signaling by activated TLRs. The pathogenesis of respiratory syncytial virus (RSV) and influenza A virus (IAV) have been linked to TLR4 activation, and we examined the action of POPG and PI as potential antagonists of the pathology of these viruses. Surprisingly, POPG and PI dramatically curtail infection, in addition to inhibiting inflammatory sequelae associated with RSV and IAV infections. The mechanism of action by the lipids is disruption of virus particle binding to host cell plasma membrane receptors, required for viral uptake. The antagonism of activation of TLRs and virus binding to the alveolar epithelium by resident constituents of the pulmonary surfactant system suggests that POPG and PI function in homeostasis, to prevent inflammatory processes that result in reductions in gas exchange within the alveolar compartment.	[Voelker, Dennis R.; Numata, Mari] Natl Jewish Hlth, Dept Med, Div Pulm, Denver, CO 80206 USA	National Jewish Health	Voelker, DR; Numata, M (corresponding author), 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njhealth.org; nakamuram@njhealth.org			NIGMS, National Institutes of Health [GM 1118819]; Flight Attendant Medical Research Institute [CIA160010]; NHLBI, National Institutes of Health [HL 132821]; NIAID, National Institutes of Health [AI 125357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL132821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI125357] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Flight Attendant Medical Research Institute; NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIGMS, National Institutes of Health Grant GM 1118819 (to D. R. V.); Flight Attendant Medical Research Institute Grant CIA160010 (to M. N.); NHLBI, National Institutes of Health Grant HL 132821 and NIAID, National Institutes of Health Grant AI 125357 (to D. R. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ariki S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/532071; Batenburg JJ, 1998, PROG LIPID RES, V37, P235, DOI 10.1016/S0163-7827(98)00011-3; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Graham BS, 2017, CURR OPIN VIROL, V23, P107, DOI 10.1016/j.coviro.2017.03.012; Griffiths C, 2017, CLIN MICROBIOL REV, V30, P277, DOI 10.1128/CMR.00010-16; Haczku A, 2004, CLIN EXP ALLERGY, V34, P1815, DOI 10.1111/j.1365-2222.2004.02134.x; HALLMAN M, 1994, CLIN PHARMACOKINET, V26, P215, DOI 10.2165/00003088-199426030-00005; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hsia CCW, 2016, COMPR PHYSIOL, V6, P827, DOI 10.1002/cphy.c150028; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kandasamy P, 2016, J LIPID RES, V57, P993, DOI 10.1194/jlr.M065201; Kandasamy P, 2011, J BIOL CHEM, V286, P7841, DOI 10.1074/jbc.M110.170241; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Nkadi PO, 2009, MOL GENET METAB, V97, P95, DOI 10.1016/j.ymgme.2009.01.015; Numata M, 2015, J LIPID RES, V56, P578, DOI 10.1194/jlr.M055723; Numata M, 2013, INT J NANOMED, V8, P1417, DOI 10.2147/IJN.S39888; Numata M, 2012, AM J RESP CELL MOL, V46, P479, DOI 10.1165/rcmb.2011-0194OC; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Veldhuizen EJA, 2000, BBA-BIOMEMBRANES, V1467, P255, DOI 10.1016/S0005-2736(00)00256-X; Wert SE, 2009, PEDIATR DEVEL PATHOL, V12, P253, DOI 10.2350/09-01-0586.1; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	28	37	38	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4282	4289		10.1074/jbc.AW118.003229	http://dx.doi.org/10.1074/jbc.AW118.003229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30733339	Green Published, hybrid			2022-12-28	WOS:000462969500001
J	Farah, E; Li, CH; Cheng, LJ; Kong, YF; Lanman, NA; Pascuzzi, P; Lorenz, GR; Zhang, YQ; Ahmad, N; Li, L; Ratliff, T; Liu, XQ				Farah, Elia; Li, Chaohao; Cheng, Lijun; Kong, Yifan; Lanman, Nadia A.; Pascuzzi, Pete; Lorenz, Gabrielle Renee; Zhang, Yanquan; Ahmad, Nihal; Li, Lang; Ratliff, Tim; Liu, Xiaoqi			NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug resistance; prostate cancer; Notch pathway; androgen receptor; anticancer drug; ADAM; androgen receptor; enzalutamide; Notch1; PF-03084014	STEM-LIKE CELLS; CASTRATION-RESISTANT; PATHWAY; INHIBITION; EXPRESSION; DOCETAXEL; DOMAIN	Prostate cancer is the second leading cause of cancer death among men in the United States. The androgen receptor (AR) antagonist enzalutamide is a Food and Drug Administration-approved drug for treatment of patients with late-stage prostate cancer and is currently under clinical study for early-stage prostate cancer treatment. After a short positive response period, tumors will develop drug resistance. In this study using RNA-Seq and bioinformatics analyses, we observed that NOTCH signaling is a deregulated pathway in enzalutamide-resistant cells. NOTCH2 and c-MYC gene expression positively correlated with AR expression in samples from patient with hormone refractory disease in which AR expression levels correspond to those typically observed in enzalutamide resistance. Cleaved NOTCH1, HES1 (Hes family BHLH transcription factor 1), and c-MYC protein expression levels are elevated in two enzalutamide-resistant cell lines, MR49F and C4-2R, indicating NOTCH signaling activation. Moreover, inhibition of the overexpressed ADAM metallopeptidase domain 10 (ADAM10) in the resistant cells induces an exclusive reduction in cleaved NOTCH1 expression. Furthermore, exposure of enzalutamide-resistant cells to both PF-03084014 and enzalutamide increased cell death, decreased colony formation ability, and resensitized cells to enzalutamide. Knockdown of NOTCH1 in C4-2R increased enzalutamide sensitivity by decreasing cell proliferation and increasing cleaved PARP expression. In a 22RV1 xenograft model, PF-03084014 and enzalutamide decreased tumor growth through reducing cell proliferation and increasing apoptosis. These results indicate that NOTCH1 signaling may contribute to enzalutamide resistance in prostate cancer, and inhibition of NOTCH signaling can resensitize resistant cells to enzalutamide.	[Farah, Elia; Lorenz, Gabrielle Renee; Zhang, Yanquan; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Li, Chaohao; Kong, Yifan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Lanman, Nadia A.; Ratliff, Tim; Liu, Xiaoqi] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Lanman, Nadia A.; Ratliff, Tim] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Pascuzzi, Pete] Purdue Univ, Purdue Univ Lib, W Lafayette, IN 47907 USA; [Cheng, Lijun; Li, Lang] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI 53715 USA; [Liu, Xiaoqi] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison; University of Kentucky	Liu, XQ (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.	Xiaoqi.Liu@uky.edu	Ahmad, Nihal/AAR-4249-2021; Zhang, Yanquan/D-5615-2017	Ahmad, Nihal/0000-0002-4239-9887; Pascuzzi, Pete/0000-0002-9316-4404; Zhang, Yanquan/0000-0003-3527-9972; Atallah, Nadia/0000-0002-1819-7070	National Institutes of Health [R01 CA157429, R01 CA192894, R01 CA196835, R01 CA196634]; Purdue University Center for Cancer Research Grant [P30 CA023168]; NATIONAL CANCER INSTITUTE [R01CA192894, R01CA196835, P30CA023168, R01CA196634, R01CA157429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue University Center for Cancer Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01 CA157429, R01 CA192894, R01 CA196835, and R01 CA196634 (to X. L.). The work was also supported by Purdue University Center for Cancer Research Grant P30 CA023168. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alumkal JJ, 2017, CLIN GENITOURIN CANC, V15, P610, DOI 10.1016/j.clgc.2017.02.007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Atapattu L, 2016, J EXP MED, V213, P1741, DOI 10.1084/jem.20151095; Bahl A, 2014, CANCER TREAT REV, V40, P170, DOI 10.1016/j.ctrv.2013.06.008; Bianchini D, 2014, EUR J CANCER, V50, P78, DOI 10.1016/j.ejca.2013.08.020; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Cui J, 2018, INT J CANCER, V143, P645, DOI 10.1002/ijc.31346; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; Deng G, 2016, J CANCER RES CLIN, V142, P531, DOI 10.1007/s00432-015-1946-x; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Gao LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063563; Guo HJ, 2014, THORAC CANCER, V5, P473, DOI 10.1111/1759-7714.12143; Habets RAJ, 2015, J BIOL CHEM, V290, P14705, DOI 10.1074/jbc.M115.643676; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kita Y, 2018, CANCERS, V10, DOI 10.3390/cancers10100345; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuruma H, 2013, MOL CANCER THER, V12, P567, DOI 10.1158/1535-7163.MCT-12-0798; Li DD, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12480; Liu CF, 2014, CLIN CANCER RES, V20, P3198, DOI 10.1158/1078-0432.CCR-13-3296; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Miller MA, 2017, CLIN CANCER RES, V23, P623, DOI 10.1158/1078-0432.CCR-16-0869; Mohamed AA, 2017, MOL CANCER RES, V15, P1308, DOI 10.1158/1541-7786.MCR-17-0058; Ojo D, 2015, CANCERS, V7, P2290, DOI 10.3390/cancers7040890; Prabakaran DS, 2019, INT J BIOL MACROMOL, V126, P1318, DOI 10.1016/j.ijbiomac.2018.09.114; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tveriakhina L, 2018, ELIFE, V7, DOI 10.7554/eLife.40045; Venkatesh Vandana, 2018, Stem Cell Investig, V5, P5, DOI 10.21037/sci.2018.02.02; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Zhang ZZ, 2018, CANCER RES, V78, P3147, DOI 10.1158/0008-5472.CAN-17-3006; Zhou W, 2018, ONCOL LETT, V16, P2805, DOI 10.3892/ol.2018.9039	36	33	35	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8543	8554		10.1074/jbc.RA118.006983	http://dx.doi.org/10.1074/jbc.RA118.006983			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30940724	hybrid, Green Published			2022-12-28	WOS:000471108200022
J	Yiew, NKH; Greenway, C; Zarzour, A; Ahmadieh, S; Goo, B; Kim, D; Benson, TW; Ogbi, M; Tang, YL; Chen, WQ; Stepp, D; Patel, V; Hilton, R; Lu, XY; Hui, DY; Kim, HW; Weintraub, NL				Yiew, Nicole K. H.; Greenway, Charlotte; Zarzour, Abdalrahman; Ahmadieh, Samah; Goo, Brandee; Kim, David; Benson, Tyler W.; Ogbi, Mourad; Tang, Yao Liang; Chen, Weiqin; Stepp, David; Patel, Vijay; Hilton, Renee; Lu, Xin-Yun; Hui, David Y.; Kim, Ha Won; Weintraub, Neal L.			Enhancer of zeste homolog 2 (EZH2) regulates adipocyte lipid metabolism independent of adipogenic differentiation: Role of apolipoprotein E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid; lipoprotein; adipocyte; obesity; apolipoprotein E (ApoE); EZH2	METHYLTRANSFERASE EZH2; IN-VIVO; HISTONE; H3; PROLIFERATION; ACCUMULATION; INFLAMMATION; METHYLATION; INVOLVEMENT; SUPPRESSION	Enhancer of zeste homolog 2 (EZH2), an epigenetic regulator that plays a key role in cell differentiation and oncogenesis, was reported to promote adipogenic differentiation in vitro by catalyzing trimethylation of histone 3 lysine 27. However, inhibition of EZH2 induced lipid accumulation in certain cancer and hepatocyte cell lines. To address this discrepancy, we investigated the role of EZH2 in adipogenic differentiation and lipid metabolism using primary human and mouse preadipocytes and adipose-specific EZH2 knockout (KO) mice. We found that the EZH2-selective inhibitor GSK126 induced lipid accumulation in human adipocytes, without altering adipocyte differentiation marker gene expression. Moreover, adipocyte-specific EZH2 KO mice, generated by crossing EZH2 floxed mice with adiponectin-Cre mice, displayed significantly increased body weight, adipose tissue mass, and adipocyte cell size and reduced very low-density lipoprotein (VLDL) levels, as compared with littermate controls. These phenotypic alterations could not be explained by differences in feeding behavior, locomotor activity, metabolic energy expenditure, or adipose lipolysis. In addition, human adipocytes treated with either GSK126 or vehicle exhibited comparable rates of glucose-stimulated triglyceride accumulation and fatty acid uptake. Mechanistically, lipid accumulation induced by GSK126 in adipocytes was lipoprotein-dependent, and EZH2 inhibition or gene deletion promoted lipoprotein-dependent lipid uptake in vitro concomitant with up-regulated apolipoprotein E (ApoE) gene expression. Deletion of ApoE blocked the effects of GSK126 to promote lipoprotein-dependent lipid uptake in murine adipocytes. Collectively, these results indicate that EZH2 inhibition promotes lipoprotein-dependent lipid accumulation via inducing ApoE expression in adipocytes, suggesting a novel mechanism of lipid regulation by EZH2.	[Yiew, Nicole K. H.] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Zarzour, Abdalrahman; Ahmadieh, Samah; Goo, Brandee; Tang, Yao Liang; Kim, Ha Won; Weintraub, Neal L.] Augusta Univ, Med Coll Georgia, Dept Med, Div Cardiol, Augusta, GA 30912 USA; [Chen, Weiqin; Stepp, David] Augusta Univ, Med Coll Georgia, Dept Physiol, Augusta, GA 30912 USA; [Lu, Xin-Yun] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Patel, Vijay] Augusta Univ, Med Coll Georgia, Dept Cardiothorac & Vasc Surg, Augusta, GA 30912 USA; [Hilton, Renee] Augusta Univ, Med Coll Georgia, Dept Minimally Invas & Digest Dis Surg, Augusta, GA 30912 USA; [Yiew, Nicole K. H.; Greenway, Charlotte; Zarzour, Abdalrahman; Ahmadieh, Samah; Goo, Brandee; Kim, David; Benson, Tyler W.; Ogbi, Mourad; Tang, Yao Liang; Stepp, David; Kim, Ha Won; Weintraub, Neal L.] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Hui, David Y.] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Yiew, Nicole K. H.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Ohio; University of Cincinnati; Washington University (WUSTL)	Weintraub, NL (corresponding author), Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Dept Med,Div Cardiol, 1460 Laney Walker Blvd, Augusta, GA 30912 USA.	nweintraub@augusta.edu		Tang, Yaoliang/0000-0002-8372-1545; Kim, David/0000-0001-6896-6950; Goo, Brandee/0000-0002-9994-6706; Weintraub, Neal/0000-0002-5138-3705; Kim, Ha Won/0000-0001-6272-4248	National Institutes of Health [HL124097, HL126949, HL134354, AR070029]; American Heart Association Predoctoral Fellowship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL147159, R01HL142097, R01HL134354, R01HL126949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by National Institutes of Health Grants HL124097, HL126949, and HL134354 (to N. L. W.) and AR070029 (to Y. L. T. and N. L. W.) and an American Heart Association Predoctoral Fellowship Award (to N. K. H. Y). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benson TW, 2018, MOL CELL ENDOCRINOL, V473, P79, DOI 10.1016/j.mce.2018.01.006; Chatterjee TK, 2011, J BIOL CHEM, V286, P27836, DOI 10.1074/jbc.M111.262964; Chen YH, 2016, STEM CELLS, V34, P2183, DOI 10.1002/stem.2400; Chen YC, 2005, CANCER RES, V65, P331; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Harris W. S., 2009, CLIN LIPIDOLOGY COMP, P327; Hayden A, 2011, BREAST CANCER RES TR, V127, P109, DOI 10.1007/s10549-010-0982-0; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; HOOD RL, 1982, FED PROC, V41, P2555; Huang ZH, 2015, J LIPID RES, V56, P215, DOI 10.1194/jlr.M050567; Huang ZH, 2009, J BIOL CHEM, V284, P31512, DOI 10.1074/jbc.M109.004754; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Kuhel DG, 2013, DIABETES, V62, P382, DOI 10.2337/db12-0390; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mitrou P, 2010, INT J OBESITY, V34, P770, DOI 10.1038/ijo.2009.293; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Pang B, 2016, ONCOTARGET, V7, P45134, DOI 10.18632/oncotarget.9761; Perri A, 2013, J NEPHROL, V26, P1049, DOI 10.5301/jn.5000269; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Su WP, 2011, LUNG CANCER, V71, P28, DOI 10.1016/j.lungcan.2010.04.009; Ta T, 2017, ONCOL REP, V37, P1430, DOI 10.3892/or.2017.5430; Tan JZ, 2014, ACTA PHARMACOL SIN, V35, P161, DOI 10.1038/aps.2013.161; Ueno K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29264; Vaswani RG, 2016, J MED CHEM, V59, P9928, DOI 10.1021/acs.jmedchem.6b01315; Vella S, 2013, INT J MOL SCI, V14, P24154, DOI 10.3390/ijms141224154; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang JL, 2012, ATHEROSCLEROSIS, V223, P342, DOI 10.1016/j.atherosclerosis.2012.06.003; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wang YY, 2016, ONCOTARGET, V7, P49450, DOI 10.18632/oncotarget.10370; Yi SA, 2016, MOL CELL, V62, P443, DOI 10.1016/j.molcel.2016.03.011; Yiew NKH, 2017, J BIOL CHEM, V292, P6312, DOI 10.1074/jbc.M116.758078; Zhou HY, 2016, MOL CELL BIOL, V36, P2027, DOI 10.1128/MCB.01120-15	36	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8577	8591		10.1074/jbc.RA118.006871	http://dx.doi.org/10.1074/jbc.RA118.006871			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30971429	hybrid, Green Published			2022-12-28	WOS:000471108200025
J	Hsu, MH; Johnson, EF				Hsu, Mei-Hui; Johnson, Eric F.			Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; drug metabolism; protein structure; crystal structure; protein conformation; CYP3A4; CYP3A5; protein plasticity	HUMAN-LIVER; IN-VITRO; STRUCTURAL BASIS; METABOLISM; INHIBITION; EXPRESSION; MICROSOMES; DIVERSITY; MECHANISM; OXIDATION	Cytochrome P450 (CYP) 3A4 is a major contributor to hepatic drug and xenobiotic metabolism in human adults. The related enzyme CYP3A5 is also expressed in adult liver and has broader age and tissue distributions. However, CYP3A5 expression is low in most Caucasians because of the prevalence of an allele that leads to an incorrectly spliced mRNA and premature termination of translation. When expressed, CYP3A5 expands metabolic capabilities and can augment CYP3A4-mediated drug metabolism, thereby reducing drug efficacy and potentially requiring dose adjustments. The extensive role of CYP3A4 in drug metabolism reflects in part the plasticity of the substrate-free enzyme to enlarge its active site and accommodate very large substrates. We have previously shown that the structure of the CYP3A5-ritonavir complex differs substantially from that of the CYP3A4-ritonavir complex. To better understand whether these differences are conserved in other CYP3A5 structures and how they relate to differential plasticity, we determined the X-ray crystallographic structure of the CYP3A5 substrate-free complex to 2.20 resolution. We observed that this structure exhibits a much larger active site than substrate-free CYP3A4 and displays an open substrate access channel. This reflected in part a lower trajectory of the helix F-F connector in CYP3A4 and more extensive -CH interactions between phenylalanine residues forming the roof of the active-site cavity than in CYP3A5. Comparison with the CYP3A5-ritonavir complex confirmed conserved CYP3A5 structural features and indicated differences in plasticity between CYP3A4 and CYP3A5 that favor alternative ritonavir conformations.	[Hsu, Mei-Hui; Johnson, Eric F.] Scripps Res, Dept Mol Med, 10550 North Torrey Pines Dr, La Jolla, CA 92037 USA	Scripps Research Institute	Johnson, EF (corresponding author), Scripps Res, Dept Mol Med, 10550 North Torrey Pines Dr, La Jolla, CA 92037 USA.	johnson@scripps.edu			National Institutes of Health [R01-GM031001]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM031001 (to E. F. J.). The use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AOYAMA T, 1989, J BIOL CHEM, V264, P10388; Branden G, 2014, DRUG DISCOV TODAY, V19, P905, DOI 10.1016/j.drudis.2014.03.012; Dai Y, 2004, BIOCHEM PHARMACOL, V68, P1889, DOI 10.1016/j.bcp.2004.07.012; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hsu MH, 2018, MOL PHARMACOL, V93, P14, DOI 10.1124/mol.117.109744; Ince I, 2013, CLIN PHARMACOKINET, V52, P333, DOI 10.1007/s40262-013-0041-1; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Koudriakova T, 1998, DRUG METAB DISPOS, V26, P552; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Li XH, 2014, DRUG METAB DISPOS, V42, P334, DOI 10.1124/dmd.113.054726; Lu YH, 2012, DRUG METAB DISPOS, V40, P2221, DOI 10.1124/dmd.112.048298; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Niwa T, 2008, CURR DRUG METAB, V9, P20; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; OMURA T, 1964, J BIOL CHEM, V239, P2379; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Sevrioukova IF, 2017, P NATL ACAD SCI USA, V114, P486, DOI 10.1073/pnas.1616198114; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Stevens JC, 2006, DRUG DISCOV TODAY, V11, P440, DOI 10.1016/j.drudis.2006.03.002; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tseng E, 2014, DRUG METAB DISPOS, V42, P1163, DOI 10.1124/dmd.114.057000; Wang HF, 1998, BIOCHEMISTRY-US, V37, P12536, DOI 10.1021/bi980895g; Williams JA, 2002, DRUG METAB DISPOS, V30, P883, DOI 10.1124/dmd.30.8.883; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Wu JJ, 2017, J MED CHEM, V60, P3804, DOI 10.1021/acs.jmedchem.7b00001; Yamazaki H, 2010, BRIT J CLIN PHARMACO, V69, P593, DOI 10.1111/j.1365-2125.2010.03656.x; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yuki H, 2007, J COMPUT CHEM, V28, P1091, DOI 10.1002/jcc.20557; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6	36	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8015	8022		10.1074/jbc.RA119.007928	http://dx.doi.org/10.1074/jbc.RA119.007928			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30926609	Green Published, hybrid			2022-12-28	WOS:000470656500005
J	Sieng, M; Hayes, MP; O'Brien, JB; Fowler, CA; Houtman, JC; Roman, DL; Lyon, AM				Sieng, Monita; Hayes, Michael P.; O'Brien, Joseph B.; Fowler, C. Andrew; Houtman, Jon C.; Roman, David L.; Lyon, Angeline M.			High-resolution structure of RGS17 suggests a role for Ca2+ in promoting the GTPase-activating protein activity by RZ subfamily members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; regulator of G protein signaling (RGS); crystal structure; heterotrimeric G protein; nuclear magnetic resonance (NMR); isothermal titration calorimetry (ITC); cell signaling; GTPase activating protein (GAP); protein crystallization; G protein-coupled receptor (GPCR); RZ subfamily; RGS17	HIGH-THROUGHPUT SCREEN; SIGNALING RGS; PROSTATE-CANCER; REGULATOR; DOMAIN; GAIP; LUNG; DETERMINANTS; CALORIMETRY; RGS17/RGSZ2	Regulator of G protein signaling (RGS) proteins are negative regulators of G protein-coupled receptor (GPCR) signaling through their ability to act as GTPase-activating proteins (GAPs) for activated G subunits. Members of the RZ subfamily of RGS proteins bind to activated G(o), G(z), and G(i1-3) proteins in the nervous system and thereby inhibit downstream pathways, including those involved in Ca2+-dependent signaling. In contrast to other RGS proteins, little is known about RZ subfamily structure and regulation. Herein, we present the 1.5-angstrom crystal structure of RGS17, the most complete and highest-resolution structure of an RZ subfamily member to date. RGS17 cocrystallized with Ca2+ bound to conserved positions on the predicted G-binding surface of the protein. Using NMR chemical shift perturbations, we confirmed that Ca2+ binds in solution to the same site. Furthermore, RGS17 had greater than 55-fold higher affinity for Ca2+ than for Mg2+. Finally, we found that Ca2+ promotes interactions between RGS17 and activated G and decreases the K-m for GTP hydrolysis, potentially by altering the binding mechanism between these proteins. Taken together, these findings suggest that Ca2+ positively regulates RGS17, which may represent a general mechanism by which increased Ca2+ concentration promotes the GAP activity of the RZ subfamily, leading to RZ-mediated inhibition of Ca2+ signaling.	[Sieng, Monita; Lyon, Angeline M.] Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA; [Lyon, Angeline M.] Purdue Univ, Dept Biol Sci, 560 Oval Dr, W Lafayette, IN 47907 USA; [Hayes, Michael P.; O'Brien, Joseph B.; Roman, David L.] Univ Iowa, Coll Pharm, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA; [Fowler, C. Andrew] Univ Iowa, NMR Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Houtman, Jon C.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Fowler, C. Andrew] Bruker BioSpin, 15 Fortune Dr, Billerica, MA 01821 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Iowa; University of Iowa; University of Iowa; Bruker Corporation; Bruker BioSpin GmbH	Lyon, AM (corresponding author), Purdue Univ, Dept Chem, 560 Oval Dr, W Lafayette, IN 47907 USA.; Lyon, AM (corresponding author), Purdue Univ, Dept Biol Sci, 560 Oval Dr, W Lafayette, IN 47907 USA.	lyonam@purdue.edu	; Roman, David/G-2637-2010	Hayes, Michael/0000-0003-2033-6778; Houtman, Jon/0000-0002-5307-9854; Roman, David/0000-0002-8250-0337; O'Brien, Joseph/0000-0003-1113-1279; Lyon, Angeline/0000-0001-7501-0148	United States DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008365] Funding Source: NIH RePORTER	United States DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357. We thank the Life Sciences Collaborative Access Team (LS-CAT) staff members for help with data collection.	Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bodle CR, 2017, J NAT PROD, V80, P1992, DOI 10.1021/acs.jnatprod.7b00112; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faurobert E, 1997, P NATL ACAD SCI USA, V94, P2945, DOI 10.1073/pnas.94.7.2945; Hayes MP, 2016, AAPS J, V18, P550, DOI 10.1208/s12248-016-9894-1; Ishii M, 2005, BIOCHEM J, V385, P65, DOI 10.1042/BJ20040404; Ishii M, 2004, METHOD ENZYMOL, V389, P105; James MA, 2009, CANCER RES, V69, P2108, DOI 10.1158/0008-5472.CAN-08-3495; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Ladbury JE, 2010, BIOCHEM SOC T, V38, P888, DOI 10.1042/BST0380888; Larminie C, 2004, MOL BRAIN RES, V122, P24, DOI 10.1016/j.molbrainres.2003.11.014; Li YH, 2015, J CANCER, V6, P767, DOI 10.7150/jca.11833; Mackie DI, 2011, J BIOMOL SCREEN, V16, P869, DOI 10.1177/1087057111410427; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; Mezzasalma TM, 2007, J BIOMOL SCREEN, V12, P418, DOI 10.1177/1087057106297984; Mondal S, 2015, ASSAY DRUG DEV TECHN, V13, P444, DOI 10.1089/adt.2015.643; Monroy CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062247; Moy FJ, 2000, BIOCHEMISTRY-US, V39, P7063, DOI 10.1021/bi992760w; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nance MR, 2013, STRUCTURE, V21, P438, DOI 10.1016/j.str.2012.12.016; Natochin M, 1998, J BIOL CHEM, V273, P6731, DOI 10.1074/jbc.273.12.6731; Nunn C, 2006, SEMIN CELL DEV BIOL, V17, P390, DOI 10.1016/j.semcdb.2006.04.001; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Posner BA, 1999, BIOCHEMISTRY-US, V38, P7773, DOI 10.1021/bi9906367; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Sokolov E, 2011, CELL SIGNAL, V23, P1603, DOI 10.1016/j.cellsig.2011.05.012; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer JJG, 2009, PROG MOL BIOL TRANSL, V86, P75, DOI 10.1016/S1877-1173(09)86004-3; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang J, 1998, J BIOL CHEM, V273, P26014, DOI 10.1074/jbc.273.40.26014; Ward WHJ, 2001, PROGR MED CHEM, V38, P309, DOI 10.1016/S0079-6468(08)70097-3; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335; Zielinski T, 2009, J BIOMOL SCREEN, V14, P1195, DOI 10.1177/1087057109347473	46	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8148	8160		10.1074/jbc.RA118.006059	http://dx.doi.org/10.1074/jbc.RA118.006059			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30940727	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000470656500014
J	Sonntag, Y; Gena, P; Maggio, A; Singh, T; Artner, I; Oklinski, MK; Johanson, U; Kjellbom, P; Nieland, JD; Nielsen, S; Calamita, G; Rutzler, M				Sonntag, Yonathan; Gena, Patrizia; Maggio, Anna; Singh, Tania; Artner, Isabella; Oklinski, Michal K.; Johanson, Urban; Kjellbom, Per; Nieland, John Dirk; Nielsen, Soren; Calamita, Giuseppe; Ruetzler, Michael			Identification and characterization of potent and selective aquaporin-3 and aquaporin-7 inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aquaporin; molecular docking; glycerol; inhibitor; hydrogen peroxide; aquaporin inhibitor; calcein; CHO cell assay; HyPer; residual pore	HYDROGEN-PEROXIDE TRANSPORT; WATER CHANNEL; COLLECTING DUCT; GLYCEROL TRANSPORT; CELL-MIGRATION; MESSENGER-RNA; CLUSTAL-W; PERMEABILITY; EXPRESSION; PROTEIN	The aquaglyceroporins are a subfamily of aquaporins that conduct both water and glycerol. Aquaporin-3 (AQP3) has an important physiological function in renal water reabsorption, and AQP3-mediated hydrogen peroxide (H2O2) permeability can enhance cytokine signaling in several cell types. The related aquaglyceroporin AQP7 is required for dendritic cell chemokine responses and antigen uptake. Selective small-molecule inhibitors are desirable tools for investigating the biological and pathological roles of these and other AQP isoforms. Here, using a calcein fluorescence quenching assay, we screened a library of 7360 drug-like small molecules for inhibition of mouse AQP3 water permeability. Hit confirmation and expansion with commercially available substances identified the ortho-chloride-containing compound DFP00173, which inhibited mouse and human AQP3 with an IC50 of approximate to 0.1-0.4 m but had low efficacy toward mouse AQP7 and AQP9. Surprisingly, inhibitor specificity testing revealed that the methylurea-linked compound Z433927330, a partial AQP3 inhibitor (IC50, approximate to 0.7-0.9 m), is a potent and efficacious inhibitor of mouse AQP7 water permeability (IC50, approximate to 0.2 m). Stopped-flow light scattering measurements confirmed that DFP00173 and Z433927330 inhibit AQP3 glycerol permeability in human erythrocytes. Moreover, DFP00173, Z433927330, and the previously identified AQP9 inhibitor RF03176 blocked aquaglyceroporin H2O2 permeability. Molecular docking to AQP3, AQP7, and AQP9 homology models suggested interactions between these inhibitors and aquaglyceroporins at similar binding sites. DFP00173 and Z433927330 constitute selective and potent AQP3 and AQP7 inhibitors, respectively, and contribute to a set of isoform-specific aquaglyceroporin inhibitors that will facilitate the evaluation of these AQP isoforms as drug targets.	[Sonntag, Yonathan; Johanson, Urban; Kjellbom, Per] Lund Univ, Dept Chem, Div Biochem & Struct Biol, S-22100 Lund, Sweden; [Gena, Patrizia; Maggio, Anna; Calamita, Giuseppe] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy; [Singh, Tania; Artner, Isabella] Lund Univ, Stem Cell Ctr, S-22184 Lund, Sweden; [Oklinski, Michal K.; Nieland, John Dirk; Nielsen, Soren; Ruetzler, Michael] Aalborg Univ, Dept Hlth Sci & Technol, DK-9220 Aalborg, Denmark	Lund University; Universita degli Studi di Bari Aldo Moro; Lund University; Aalborg University	Rutzler, M (corresponding author), Fredrik Bajers Vej 7E,Room 4-110, DK-9220 Aalborg O, Denmark.	miru@hst.aau.dk	Oklinski, Michal K./AAT-9152-2020; Gena, patrizia/AAC-3396-2022; Johanson, Urban/AHE-8231-2022; Oklinski, Michal Krystian/S-9651-2017; Sonntag, Yonathan/GRF-4277-2022	Oklinski, Michal K./0000-0002-7713-4731; Johanson, Urban/0000-0001-8862-128X; Sonntag, Yonathan/0000-0002-8063-0285; Nieland, John/0000-0001-7423-0122; Artner, Isabella/0000-0002-2895-5664	Aalborg University; Danish Research Council; Stiftelsen Olle Engkvist Byggmastare	Aalborg University; Danish Research Council(Det Frie Forskningsrad (DFF)); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council)	This work was supported by funds from Aalborg University, the Danish Research Council, and Stiftelsen Olle Engkvist Byggmastare. The authors declare that they have no conflicts of interest with the contents of this article.	Bertolotti M, 2016, J LEUKOCYTE BIOL, V100, P1071, DOI 10.1189/jlb.2AB0116-045R; Bertolotti M, 2013, ANTIOXID REDOX SIGN, V19, P1447, DOI 10.1089/ars.2013.5330; Bilan DS, 2013, ACS CHEM BIOL, V8, P535, DOI 10.1021/cb300625g; Calamita G, 2008, AM J PHYSIOL-GASTR L, V295, pG682, DOI 10.1152/ajpgi.90226.2008; Calamita G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00851; de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esteva-Font C, 2016, MOL PHARMACOL, V89, P686, DOI 10.1124/mol.116.103929; Fenton RA, 2010, AM J PHYSIOL-RENAL, V298, pF224, DOI 10.1152/ajprenal.00463.2009; FRIGERI A, 1995, P NATL ACAD SCI USA, V92, P4328, DOI 10.1073/pnas.92.10.4328; FRIGERI A, 1995, J CELL SCI, V108, P2993; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Hara-Chikuma M, 2016, BIOCHEM BIOPH RES CO, V471, P603, DOI 10.1016/j.bbrc.2016.02.010; Hara-Chikuma M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8454; Hara-Chikuma M, 2012, J EXP MED, V209, P1743, DOI 10.1084/jem.20112398; Hara-Chikuma M, 2012, FASEB J, V26, P211, DOI 10.1096/fj.11-186627; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hibuse T, 2005, P NATL ACAD SCI USA, V102, P10993, DOI 10.1073/pnas.0503291102; Hibuse T, 2009, CARDIOVASC RES, V83, P34, DOI 10.1093/cvr/cvp095; Ikezoe K, 2016, SCI REP-UK, V6, DOI 10.1038/srep25781; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Jelen S, 2011, J BIOL CHEM, V286, P44319, DOI 10.1074/jbc.M111.297002; Karreman C, 2002, BIOINFORMATICS, V18, P884, DOI 10.1093/bioinformatics/18.6.884; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Madeira A, 2014, CHEMBIOCHEM, V15, P1487, DOI 10.1002/cbic.201402103; Maeda N, 2004, P NATL ACAD SCI USA, V101, P17801, DOI 10.1073/pnas.0406230101; Martins AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037435; Matsumura K, 2007, MOL CELL BIOL, V27, P6026, DOI 10.1128/MCB.00384-07; Medrano-Fernandez I, 2016, ANTIOXID REDOX SIGN, V24, P1031, DOI 10.1089/ars.2016.6636; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Moniaga CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15319; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Ramirez-Lorca R, 1999, PFLUG ARCH EUR J PHY, V438, P94, DOI 10.1007/s004240050884; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Roudier N, 2002, J BIOL CHEM, V277, P45854, DOI 10.1074/jbc.M208999200; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Satooka H, 2016, MOL CELL BIOL, V36, P1206, DOI 10.1128/MCB.00971-15; Skowronski MT, 2007, AM J PHYSIOL-RENAL, V292, pP956, DOI 10.1152/ajprenal.00314.2006; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sogaard R, 2008, PFLUG ARCH EUR J PHY, V456, P285, DOI 10.1007/s00424-007-0392-2; Sohara E, 2005, AM J PHYSIOL-RENAL, V289, pF1195, DOI 10.1152/ajprenal.00133.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Umenishi F, 1996, DNA CELL BIOL, V15, P475, DOI 10.1089/dna.1996.15.475; Van Huyen JPD, 1998, J MEMBRANE BIOL, V164, P79; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Wacker SJ, 2013, MOL MEMBR BIOL, V30, P246, DOI 10.3109/09687688.2013.773095; Watanabe S, 2016, BIOCHEM BIOPH RES CO, V471, P191, DOI 10.1016/j.bbrc.2016.01.153; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Xia H, 2014, EXP PHYSIOL, V99, P974, DOI 10.1113/expphysiol.2014.078527; Xiong GS, 2017, BIOCHEM BIOPH RES CO, V485, P627, DOI 10.1016/j.bbrc.2017.02.013; Yang BX, 2006, FEBS LETT, V580, P6679, DOI 10.1016/j.febslet.2006.11.025; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zelenina M, 2004, J BIOL CHEM, V279, P51939, DOI 10.1074/jbc.M407645200; Zelenina M, 2003, J BIOL CHEM, V278, P30037, DOI 10.1074/jbc.M302206200; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022	63	23	23	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7377	7387		10.1074/jbc.RA118.006083	http://dx.doi.org/10.1074/jbc.RA118.006083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30862673	Green Published, hybrid			2022-12-28	WOS:000468402900024
J	Naretto, A; Fanuel, M; Ropartz, D; Rogniaux, H; Larocque, R; Czjzek, M; Tellier, C; Michel, G				Naretto, Anais; Fanuel, Mathieu; Ropartz, David; Rogniaux, Helene; Larocque, Robert; Czjzek, Mirjam; Tellier, Charles; Michel, Gurvan			The agar-specific hydrolase ZgAgaC from the marine bacterium Zobellia galactanivorans defines a new GH16 protein subfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; polysaccharide; glycoside hydrolase; algae; crystal structure; agar; GH16; marine bacteria; mass spectrometry; red algae; sulfated polysaccharide; pH microenvironment; evolution	WATER-SOLUBLE POLYSACCHARIDES; CARBOHYDRATE-ACTIVE ENZYMES; ALGA LAURENCIA PINNATIFIDA; RED ALGA; PHOTON-ACTIVATION; STRUCTURAL-CHARACTERIZATION; GLYCOSIDE HYDROLASES; CHEMICAL-STRUCTURE; FAMILY; RESOLUTION	Agars are sulfated galactans from red macroalgae and are composed of a d-galactose (G unit) and l-galactose (L unit) alternatively linked by -1,3 and -1,4 glycosidic bonds. These polysaccharides display high complexity, with numerous modifications of their backbone (e.g. presence of a 3,6-anhydro-bridge (LA unit) and sulfations and methylation). Currently, bacterial polysaccharidases that hydrolyze agars (-agarases and -porphyranases) have been characterized on simple agarose and more rarely on porphyran, a polymer containing both agarobiose (G-LA) and porphyranobiose (GL6S) motifs. How bacteria can degrade complex agars remains therefore an open question. Here, we studied an enzyme from the marine bacterium Zobellia galactanivorans (ZgAgaC) that is distantly related to the glycoside hydrolase 16 (GH16) family -agarases and -porphyranases. Using a large red algae collection, we demonstrate that ZgAgaC hydrolyzes not only agarose but also complex agars from Ceramiales species. Using tandem MS analysis, we elucidated the structure of a purified hexasaccharide product, L6S-G-LA2Me-G(2Pentose)-LA2S-G, released by the activity of ZgAgaC on agar extracted from Osmundea pinnatifida. By resolving the crystal structure of ZgAgaC at high resolution (1.3 ) and comparison with the structures of ZgAgaB and ZgPorA in complex with their respective substrates, we determined that ZgAgaC recognizes agarose via a mechanism different from that of classical -agarases. Moreover, we identified conserved residues involved in the binding of complex oligoagars and demonstrate a probable influence of the acidic polysaccharide's pH microenvironment on hydrolase activity. Finally, a phylogenetic analysis supported the notion that ZgAgaC homologs define a new GH16 subfamily distinct from -porphyranases and classical -agarases.	[Naretto, Anais; Larocque, Robert; Czjzek, Mirjam; Michel, Gurvan] Sorbonne Univ, CNRS, Integrat Biol Marine Models LBI2M, SBR, F-29680 Roscoff, Bretagne, France; [Fanuel, Mathieu; Ropartz, David; Rogniaux, Helene] INRA, Unite Rech Biopolymeres Interact Assemblages BIA, F-44000 Nantes, France; [Tellier, Charles] Univ Nantes, CNRS, UFIP, UMR 6286, 2 Rue Houssiniere, F-44322 Nantes, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Nantes Universite	Tellier, C (corresponding author), Univ Nantes, CNRS, UFIP, UMR 6286, 2 Rue Houssiniere, F-44322 Nantes, France.	Charles.Tellier@univ-nantes.fr; gurvan@sb-roscoff.fr	fanuel, mathieu/GZG-9822-2022	Fanuel, Mathieu/0000-0001-8384-8266; Ropartz, David/0000-0003-4767-6940; MICHEL, Gurvan/0000-0002-3009-6205	Glyco-Ouest interregional network; French National Research Agency (ANR) [ANR-08-BLAN-0065]; ANR investment expenditure program IDEALG Grant [ANR-10-BTBR-04]	Glyco-Ouest interregional network; French National Research Agency (ANR)(French National Research Agency (ANR)); ANR investment expenditure program IDEALG Grant(French National Research Agency (ANR))	Supported by a Ph.D. fellowship granted in the context of the Glyco-Ouest interregional network (Brittany and the "Pays de Loire" region).; Supported by French National Research Agency (ANR) Project ANR-08-BLAN-0065.; Supported by ANR investment expenditure program IDEALG Grant ANR-10-BTBR-04.	Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barbeyron T, 2001, INT J SYST EVOL MICR, V51, P985, DOI 10.1099/00207713-51-3-985; Barbeyron T, 2000, J BIOL CHEM, V275, P35499, DOI 10.1074/jbc.M003404200; Barbeyron T, 2016, ENVIRON MICROBIOL, V18, P4610, DOI 10.1111/1462-2920.13584; BOWKER DM, 1968, J CHEM SOC C, P989, DOI 10.1039/j39680000989; BOWKER DM, 1968, J CHEM SOC C, P983, DOI 10.1039/j39680000983; Brawley SH, 2017, P NATL ACAD SCI USA, V114, pE6361, DOI 10.1073/pnas.1703088114; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; Correc G, 2011, CARBOHYD POLYM, V83, P277, DOI 10.1016/j.carbpol.2010.07.060; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dong WY, 2015, SCI REP-UK, V5, DOI 10.1038/srep15073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira LG, 2012, CARBOHYD RES, V347, P83, DOI 10.1016/j.carres.2011.10.007; Ficko-Blean E., 2015, PERSPECTIVES PHYCOLO, V2, P51, DOI [10.1127/pip/2015/0028, DOI 10.1127/PIP/2015/0028]; Ficko-Blean E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01832-6; Ficko-Blean E, 2015, ACTA CRYSTALLOGR D, V71, P209, DOI 10.1107/S1399004714025024; Genicot-Joncour S, 2009, PLANT PHYSIOL, V151, P1609, DOI 10.1104/pp.109.144329; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Groisillier A, 2015, APPL ENVIRON MICROB, V81, P1790, DOI 10.1128/AEM.02808-14; Groisillier A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-45; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Grunewald N, 2009, BIOMACROMOLECULES, V10, P2998, DOI 10.1021/bm900501g; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Herve C, 2016, NEW PHYTOL, V209, P1428, DOI 10.1111/nph.13786; JACKSON P, 1990, BIOCHEM J, V270, P705, DOI 10.1042/bj2700705; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KEITEL T, 1993, P NATL ACAD SCI USA, V90, P5287, DOI 10.1073/pnas.90.11.5287; KEITEL T, 1994, EUR J BIOCHEM, V222, P203, DOI 10.1111/j.1432-1033.1994.tb18858.x; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; KNUTSEN SH, 1994, BOT MAR, V37, P163, DOI 10.1515/botm.1994.37.2.163; Labourel A, 2015, ACTA CRYSTALLOGR D, V71, P173, DOI 10.1107/S139900471402450X; Labourel A, 2014, J BIOL CHEM, V289, P2027, DOI 10.1074/jbc.M113.538843; LAHAYE M, 1991, HYDROBIOLOGIA, V221, P137, DOI 10.1007/BF00028370; LAWSON CJ, 1970, NATURE, V227, P392, DOI 10.1038/227392a0; Li JA, 2010, CARBOHYD POLYM, V82, P160, DOI 10.1016/j.carbpol.2010.04.045; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mark P, 2009, PROTEINS, V75, P820, DOI 10.1002/prot.22291; Matard-Mann M, 2017, J BIOL CHEM, V292, P19919, DOI 10.1074/jbc.M117.808279; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; McGregor N, 2017, PLANT J, V89, P651, DOI 10.1111/tpj.13421; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; OSTLING S, 1946, ACTA PHYSIOL SCAND, V11, P289, DOI 10.1111/j.1748-1716.1946.tb00349.x; POTIN P, 1992, J APPL PHYCOL, V4, P119, DOI 10.1007/BF02442460; Rebuffet E, 2011, ENVIRON MICROBIOL, V13, P1253, DOI 10.1111/j.1462-2920.2011.02426.x; Rebuffet E, 2010, BIOCHEMISTRY-US, V49, P7590, DOI 10.1021/bi1003475; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ropartz D, 2016, ANAL CHIM ACTA, V933, P1, DOI 10.1016/j.aca.2016.05.036; Ropartz D, 2015, ANAL CHEM, V87, P1042, DOI 10.1021/ac5036007; Ropartz D, 2014, ANAL CHIM ACTA, V807, P84, DOI 10.1016/j.aca.2013.11.018; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; Starr CM, 1996, J CHROMATOGR A, V720, P295, DOI 10.1016/0021-9673(95)00749-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Tempel W, 2005, PROTEINS, V59, P141, DOI 10.1002/prot.20363; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Thomas F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01808; Usov AI, 2011, ADV CARBOHYD CHEM BI, V65, P115, DOI 10.1016/B978-0-12-385520-6.00004-2; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2015, ACTA CRYSTALLOGR A, V71, pS19, DOI 10.1107/S2053273315099672; van de Velde F, 2002, TRENDS FOOD SCI TECH, V13, P73, DOI 10.1016/S0924-2244(02)00066-3; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weiss MS, 2001, ACTA CRYSTALLOGR D, V57, P689, DOI 10.1107/S0907444901003572	72	12	13	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6923	6939		10.1074/jbc.RA118.006609	http://dx.doi.org/10.1074/jbc.RA118.006609			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30846563	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000467394700027
J	Ohishi, Y; Kinoshita, R; Marubashi, S; Ishida, M; Fukuda, M				Ohishi, Yuta; Kinoshita, Riko; Marubashi, Soujiro; Ishida, Morie; Fukuda, Mitsunori			The BLOC-3 subunit HPS4 is required for activation of Rab32/38 GTPases in melanogenesis, but its Rab9 activity is dispensable for melanogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Rab; melanogenesis; membrane trafficking; guanine nucleotide exchange factor (GEF); tyrosinase; BLOC-3; Hermansky-Pudlak syndrome; hypopigmentation; melanosome; Rab9	HERMANSKY-PUDLAK-SYNDROME; HOMOLOGY DOMAIN; PROTEIN; BINDING; TRAFFICKING; MELANOSOMES; SLAC2-A/MELANOPHILIN; DETERMINANT; BIOGENESIS; EFFICIENT	HPS4 biogenesis of lysosome-related organelles complex 3 subunit 2 (HPS4) is one of the genes whose mutations have been associated with Hermansky-Pudlak syndrome (HPS), characterized by ocular albinism and susceptibility to bleeding because of defects in the biogenesis of lysosome-related organelles such as melanosomes. HPS4 protein forms a BLOC-3 complex with HPS1, another HPS gene product, and the complex has been proposed to function as a guanine nucleotide exchange factor (GEF) for RAB32, a member of the Rab small GTPase family (Rab32), and Rab38 (Rab32/38-GEF) and also as a Rab9 effector. Although both Rab32/38 and Rab9 have been shown previously to be involved in melanogenesis in mammalian epidermal melanocytes, the functional relationships of these small GTPases with BLOC-3 remain unknown. In this study, we used site-directed mutagenesis to generate HPS4 mutants that specifically lack either Rab32/38-GEF activity or Rab9-binding activity and investigated their involvement in melanogenesis of melan-le cells (an HPS4-deficient melanocyte cell line derived from light ear mice). Melan-le cells exhibit a clear hypopigmentation phenotype, i.e. reduced expression and abnormal distribution of tyrosinase and reduced melanin content. Although re-expression of WT HPS4 completely rescued this phenotype, the Rab32/38-GEF activity-deficient HPS4 mutant failed to restore melanin content and tyrosinase trafficking in these cells. Unexpectedly, as WT HPS4, the Rab9 binding-deficient HPS4 mutant completely rescued the phenotype. These results indicate that activation of Rab32/38 by HPS4 (or BLOC-3) is essential for melanogenesis of cultured melanocytes and that Rab9 likely regulates melanogenesis independently of HPS4.	[Ohishi, Yuta; Kinoshita, Riko; Marubashi, Soujiro; Ishida, Morie; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Integrat Life Sci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ishida, Morie] NICHD, Cell Biol & Neurobiol Branch, NIH, Bldg 35, Bethesda, MD 20892 USA	Tohoku University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fukuda, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Integrat Life Sci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853; Ohishi, Yuta/0000-0002-0995-9619	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [15H04367]; MEXT [17H05682]; Japan Science and Technology Agency (JST) CREST Grant [JPMJCR17H4]; Hoyu Science Foundation; Kao Melanin Workshop	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST) CREST Grant; Hoyu Science Foundation; Kao Melanin Workshop	This work was supported in part by Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan 15H04367 (to M. F.), Grant-in-Aid for Scientific Research on Innovative Areas from MEXT 17H05682 (to M. F.), Japan Science and Technology Agency (JST) CREST Grant JPMJCR17H4 (to M. F.), a grant from the Hoyu Science Foundation (to M. F.), and a grant from the Kao Melanin Workshop (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aizawa M, 2015, J BIOL CHEM, V290, P22250, DOI 10.1074/jbc.M115.669242; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Bultema JJ, 2014, J BIOL CHEM, V289, P33513, DOI 10.1074/jbc.M114.578948; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; Diaz E, 1997, J CELL BIOL, V138, P283, DOI 10.1083/jcb.138.2.283; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Homma Y, 2016, MOL BIOL CELL, V27, P2107, DOI 10.1091/mbc.E16-02-0091; Huizing M., 2000, GENEREVIEWS; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ishida M, 2016, CELL STRUCT FUNCT, V41, P61, DOI 10.1247/csf.16008; James P, 1996, GENETICS, V144, P1425; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Kiontke S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14034; Kloer DP, 2010, J BIOL CHEM, V285, P7794, DOI 10.1074/jbc.M109.069088; Kobayashi Hotaka, 2015, Methods Mol Biol, V1298, P207, DOI 10.1007/978-1-4939-2569-8_18; Kucera Ana, 2016, Commun Integr Biol, V9, pe1204498, DOI 10.1080/19420889.2016.1204498; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Li F, 2014, P NATL ACAD SCI USA, V111, P2572, DOI 10.1073/pnas.1313655111; Li YY, 2016, IMMUNITY, V44, P422, DOI 10.1016/j.immuni.2016.01.027; Loftus SK, 2002, P NATL ACAD SCI USA, V99, P4471, DOI 10.1073/pnas.072087599; Mahanty S, 2016, PIGM CELL MELANOMA R, V29, P43, DOI 10.1111/pcmr.12434; Marubashi S, 2016, J BIOL CHEM, V291, P1427, DOI 10.1074/jbc.M115.684043; Matsui T, 2013, EMBO REP, V14, P450, DOI 10.1038/embor.2013.32; Matsui T, 2012, J BIOL CHEM, V287, P28619, DOI 10.1074/jbc.M112.370544; Mori Y, 2013, J BIOL CHEM, V288, P9835, DOI 10.1074/jbc.M112.427591; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Ohbayashi N, 2017, J BIOCHEM, V162, P65, DOI 10.1093/jb/mvx027; Ohbayashi N, 2012, J BIOCHEM, V151, P343, DOI 10.1093/jb/mvs009; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Seward SL, 2013, PEDIATRICS, V132, P153, DOI 10.1542/peds.2012-4003; Sitaram A, 2012, PHYSIOLOGY, V27, P85, DOI 10.1152/physiol.00043.2011; Solano-Collado Virtu, 2018, Small GTPases, V9, P216, DOI 10.1080/21541248.2016.1219207; Spano S, 2016, CELL HOST MICROBE, V19, P216, DOI 10.1016/j.chom.2016.01.004; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Tamura K, 2011, J BIOL CHEM, V286, P7507, DOI 10.1074/jbc.M110.191205; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051	54	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6912	6922		10.1074/jbc.RA119.007345	http://dx.doi.org/10.1074/jbc.RA119.007345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30837268	hybrid, Green Published			2022-12-28	WOS:000467394700026
J	Schrader, JM; Irving, CM; Octeau, JC; Christian, JA; Aballo, TJ; Kareemo, DJ; Conti, J; Camberg, JL; Lane, JR; Javitch, JA; Kovoor, A				Schrader, Joseph M.; Irving, Craig M.; Octeau, J. Christopher; Christian, Joseph A.; Aballo, Timothy J.; Kareemo, Dean J.; Conti, Joseph; Camberg, Jodi L.; Lane, J. Robert; Javitch, Jonathan A.; Kovoor, Abraham			The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						D2 dopamine receptor; protein misfolding; G protein-coupled receptor (GPCR); receptor trafficking; schizophrenia; antipsychotic drug; clozapine; pharmacological chaperone; pharmacoperone; receptor up-regulation; receptor supersensitivity	ISOFORMS; BINDING; SUPERSENSITIVITY; GLYCOSYLATION; LOCALIZATION; HALOPERIDOL; TRAFFICKING; EXPRESSION; PSYCHOSIS; PATHWAYS	Most clinically available antipsychotic drugs (APDs) bind dopamine D2 receptors (D2R) at therapeutic concentrations, and it is thought that they suppress psychotic symptoms by serving as competitive antagonists of dopamine at D2R. Here, we present data that demonstrate that APDs act independently of dopamine at an intracellular pool of D2R to enhance transport of D2R to the cell surface and suggest that APDs can act as pharmacological chaperones at D2R. Among the first- and second-generation APDs that we tested, clozapine exhibited the lowest efficacy for translocating D2R to the cell surface. Thus, our observations could provide a cellular explanation for some of the distinct therapeutic characteristics of clozapine in schizophrenia. They also suggest that differential intracellular actions of APDs at their common G protein-coupled receptor (GPCR) target, D2R, could contribute to differences in their clinical profiles.	[Schrader, Joseph M.; Irving, Craig M.; Octeau, J. Christopher; Christian, Joseph A.; Aballo, Timothy J.; Kareemo, Dean J.; Kovoor, Abraham] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA; [Conti, Joseph; Camberg, Jodi L.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA; [Lane, J. Robert] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Div Pharmacol Physiol & Neurosci, Nottingham NG7 2UH, England; [Lane, J. Robert] Univ Birmingham, Ctr Membrane Prot & Receptors, Birmingham, W Midlands, England; [Lane, J. Robert] Univ Nottingham, Nottingham, England; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA; [Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	University of Rhode Island; University of Rhode Island; University of Nottingham; University of Birmingham; University of Nottingham; Columbia University; Columbia University; New York State Psychiatry Institute	Kovoor, A (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.	abekovoor@uri.edu	Camberg, Jodi/AAX-3737-2020	Kareemo, Dean/0000-0002-9575-0407; Lane, J. Robert/0000-0002-7361-7875; Aballo, Timothy/0000-0003-1164-5966; Octeau, Chris/0000-0001-6462-9439	Institutional Development Award (IDeA) Network for Biomedical Research Excellence from the NIGMS, National Institutes of Health [P20GM103430]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) Network for Biomedical Research Excellence from the NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Institutional Development Award (IDeA) Network for Biomedical Research Excellence from the NIGMS, National Institutes of Health, Grant P20GM103430. Abraham Kovoor is a co-founder and owns shares of Cortagenix, LLC, a neuroscience drug-discovery company. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; Beaulieu JM, 2015, BRIT J PHARMACOL, V172, P1, DOI 10.1111/bph.12906; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Boxberger KH, 2014, DRUG METAB DISPOS, V42, P990, DOI 10.1124/dmd.113.055095; Celver J, 2012, J NEUROCHEM, V120, P56, DOI 10.1111/j.1471-4159.2011.07559.x; Celver J, 2010, J NEUROCHEM, V114, P739, DOI 10.1111/j.1471-4159.2010.06805.x; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; deOliveira IR, 1996, J CLIN PHARM THER, V21, P229; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Friedman JH, 2013, BEHAV NEUROL, V27, P469, DOI [10.1155/2013/645429, 10.3233/BEN-129016]; Garzya V, 2007, BIOORG MED CHEM LETT, V17, P400, DOI 10.1016/j.bmcl.2006.10.036; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Herenbrink CK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10842; JUDD AM, 1991, EUR J PHARMACOL, V195, P101, DOI 10.1016/0014-2999(91)90386-5; Kang X, 2010, J CLIN PSYCHIAT, V71, P982, DOI 10.4088/JCP.09com05497yel; Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Kubale V, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071152; Kumagai H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129394; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Lewis S, 2008, BRIT J PSYCHIAT, V192, P161, DOI 10.1192/bjp.bp.107.037218; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Masuho Ikuo, 2015, Methods Mol Biol, V1335, P107, DOI 10.1007/978-1-4939-2914-6_8; Meltzer HY, 2013, ANNU REV MED, V64, P393, DOI 10.1146/annurev-med-050911-161504; Meltzer Herbert Y, 2012, Clin Schizophr Relat Psychoses, V6, P134; Min CC, 2015, BBA-MOL CELL RES, V1853, P41, DOI 10.1016/j.bbamcr.2014.09.024; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Mouillac B., 2017, TOPICS MED CHEM, P1; Octeau JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105791; Peprah K, 2012, BIOORGAN MED CHEM, V20, P1291, DOI 10.1016/j.bmc.2011.12.019; Pereira JND, 2014, AAPS J, V16, P1247, DOI 10.1208/s12248-014-9649-9; Prou D, 2001, J CELL SCI, V114, P3517; Sahlholm K, 2016, EUR NEUROPSYCHOPHARM, V26, P467, DOI 10.1016/j.euroneuro.2016.01.001; Samad TA, 1997, P NATL ACAD SCI USA, V94, P14349, DOI 10.1073/pnas.94.26.14349; Samaha AN, 2007, J NEUROSCI, V27, P2979, DOI 10.1523/JNEUROSCI.5416-06.2007; Scatton B, 2001, EUR PSYCHIAT, V16, p29S; Sedaghat K, 2006, MOL BIOTECHNOL, V34, P1, DOI 10.1385/MB:34:1:1; SEEMAN P, 1988, J CLIN PSYCHOPHARM, V8, pS3, DOI 10.1097/00004714-198808001-00002; SEEMAN P, 1975, P NATL ACAD SCI USA, V72, P4376, DOI 10.1073/pnas.72.11.4376; SEEMAN P, 1976, NATURE, V261, P717, DOI 10.1038/261717a0; Seeman P, 2014, ACS CHEM NEUROSCI, V5, P24, DOI 10.1021/cn400189s; Sharma M, 2013, J BIOL CHEM, V288, P12554, DOI 10.1074/jbc.M112.443945; Silvestri S, 2000, PSYCHOPHARMACOLOGY, V152, P174, DOI 10.1007/s002130000532; Siskind D, 2016, BRIT J PSYCHIAT, V209, P387, DOI 10.1192/bjp.bp.115.177261; Stahl S. M., 2013, STAHLS ESSENTIAL PSY, P180; Suzuki T, 2015, PSYCHIAT RES, V227, P278, DOI 10.1016/j.psychres.2015.02.021; Sykes DA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00716-z; Takeuchi Y, 2003, J NEUROCHEM, V85, P1064, DOI 10.1046/j.1471-4159.2003.01763.x; Tao YX, 2014, ENDOCR REV, V35, P602, DOI 10.1210/er.2013-1121; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; Ulloa-Aguirre A, 2011, RECENT PATENTS ENDOC, V5, P13, DOI 10.2174/187221411794351851; VENTRA C, 1995, J MOL ENDOCRINOL, V14, P375, DOI 10.1677/jme.0.0140375; Wenthur CJ, 2013, ACS CHEM NEUROSCI, V4, P1018, DOI 10.1021/cn400121z; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	63	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5604	5615		10.1074/jbc.RA118.004682	http://dx.doi.org/10.1074/jbc.RA118.004682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	HT4EU	30670597	Green Published, hybrid			2022-12-28	WOS:000464517500029
J	Cohen, I; Coban, M; Shahar, A; Sankaran, B; Hockla, A; Lacham, S; Caulfield, TR; Radisky, ES; Papo, N				Cohen, Itay; Coban, Matt; Shahar, Anat; Sankaran, Banumathi; Hockla, Alexandra; Lacham, Shiran; Caulfield, Thomas R.; Radisky, Evette S.; Papo, Niv			Disulfide engineering of human Kunitz-type serine protease inhibitors enhances proteolytic stability and target affinity toward mesotrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease inhibitor; proteolysis; serine protease; protein engineering; disulfide; protein structure; molecular dynamics; crystal structure	BIOLOGICAL-ACTIVITY; TRYPSIN-INHIBITORS; POTENT INHIBITORS; DYNAMICS; STABILIZATION; DEGRADATION; VALIDATION; REFINEMENT; MECHANISM; EPI-HNE4	Serine protease inhibitors of the Kunitz-bovine pancreatic trypsin inhibitor (BPTI) family are ubiquitous biological regulators of proteolysis. These small proteins are resistant to proteolysis, but can be slowly cleaved within the protease-binding loop by target proteases, thereby compromising their activity. For the human protease mesotrypsin, this cleavage is especially rapid. Here, we aimed to stabilize the Kunitz domain structure against proteolysis through disulfide engineering. Substitution within the Kunitz inhibitor domain of the amyloid precursor protein (APPI) that incorporated a new disulfide bond between residues 17 and 34 reduced proteolysis by mesotrypsin 74-fold. Similar disulfide engineering of tissue factor pathway inhibitor-1 Kunitz domain 1 ((KD1)TFPI1) and bikunin Kunitz domain 2 ((KD2)bikunin) likewise stabilized these inhibitors against mesotrypsin proteolysis 17- and 6.6-fold, respectively. Crystal structures of disulfide-engineered APPI and (KD1)TFPI1 variants in a complex with mesotrypsin at 1.5 and 2.0 angstrom resolution, respectively, confirmed the formation of well-ordered disulfide bonds positioned to stabilize the binding loop. Long all-atom molecular dynamics simulations of disulfide-engineered Kunitz domains and their complexes with mesotrypsin revealed conformational stabilization of the primed side of the inhibitor-binding loop by the engineered disulfide, along with global suppression of conformational dynamics in the Kunitz domain. Our findings suggest that the Cys-17-Cys-34 disulfide slows proteolysis by dampening conformational fluctuations in the binding loop and minimizing motion at the enzyme-inhibitor interface. The generalizable approach developed here for the stabilization against proteolysis of Kunitz domains, which can serve as important scaffolds for therapeutics, may thus find applications in drug development.	[Cohen, Itay; Lacham, Shiran; Papo, Niv] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel; [Cohen, Itay; Lacham, Shiran; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, POB 653, IL-84105 Beer Sheva, Israel; [Coban, Matt; Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA; [Shahar, Anat] NIBN, IL-84105 Beer Sheva, Israel; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Caulfield, Thomas R.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA	Ben Gurion University; Ben Gurion University; Mayo Clinic; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Mayo Clinic	Papo, N (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, POB 653, IL-84105 Beer Sheva, Israel.; Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.; Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, POB 653, IL-84105 Beer Sheva, Israel.	radisky.evette@mayo.edu; papo@bgu.ac.il	Coban, Matt/AAH-7053-2019	Coban, Matt/0000-0001-6396-6759; Caulfield, Thomas/0000-0002-1055-3069; Radisky, Evette/0000-0003-3121-109X	European Research Council [336041]; Prostate Cancer Foundation; Israel Science Foundation (ISF); DKFZ-MOST [GR2495]; National Institutes of Health [R01CA154387]; United States-Israel Binational Science Foundation; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021832] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Prostate Cancer Foundation; Israel Science Foundation (ISF)(Israel Science Foundation); DKFZ-MOST; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the European Research Council "Ideas Program" ERC-2013-StG Grant 336041 (to N. P.), a Prostate Cancer Foundation grant (to N. P.), an Israel Science Foundation (ISF) grant (to N. P.), DKFZ-MOST Grant GR2495 (to N. P.), National Institutes of Health Grant R01CA154387 (to E. S. R.), and a United States-Israel Binational Science Foundation grant (to N. P. and E. S. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alloy AP, 2015, J BIOL CHEM, V290, P21523, DOI 10.1074/jbc.M115.662429; Attucci S, 2006, J PHARMACOL EXP THER, V318, P803, DOI 10.1124/jpet.106.103440; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Caulfield T, 2012, PROTEINS, V80, P2489, DOI 10.1002/prot.24131; Caulfield T, 2011, J STRUCT BIOL, V176, P185, DOI 10.1016/j.jsb.2011.07.015; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Caulfield Thomas R, 2011, J Biophys, V2011, P219515, DOI 10.1155/2011/219515; Caulfield TR, 2011, J MOL GRAPH MODEL, V29, P1006, DOI 10.1016/j.jmgm.2011.04.005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen I, 2018, BIOCHEM J, V475, P1335, DOI 10.1042/BCJ20180070; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Craig DB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-346; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; Devy L, 2007, NEOPLASIA, V9, P927, DOI 10.1593/neo.07544; Dockal M, 2014, J BIOL CHEM, V289, P1732, DOI 10.1074/jbc.M113.533836; Dombkowski AA, 2014, FEBS LETT, V588, P206, DOI 10.1016/j.febslet.2013.11.024; Dubois M, 2007, RAPID COMMUN MASS SP, V21, P352, DOI 10.1002/rcm.2844; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guerin ME, 2018, P NATL ACAD SCI USA, V115, P11525, DOI 10.1073/pnas.1803872115; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; Jiang S, 2007, ORG LETT, V9, P9, DOI 10.1021/ol0621497; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kayode O, 2016, J BIOL CHEM, V291, P26304, DOI 10.1074/jbc.M116.758417; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lehmann A, 2008, EXPERT OPIN BIOL TH, V8, P1187, DOI [10.1517/14712598.8.8.1187, 10.1517/14712598.8.8.1187 ]; Li P, 2007, J MED CHEM, V50, P5976, DOI 10.1021/jm0704898; Liu T, 2016, P NATL ACAD SCI USA, V113, P5910, DOI 10.1073/pnas.1605363113; Longhurst H, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00245; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore EJ, 2017, P NATL ACAD SCI USA, V114, P12472, DOI 10.1073/pnas.1708907114; Pendlebury D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609560; Puschmann A, 2017, BRAIN, V140, P98, DOI 10.1093/brain/aww261; Qin M, 2015, P NATL ACAD SCI USA, V112, P11241, DOI 10.1073/pnas.1503909112; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Read RJ, 2011, STRUCTURE, V19, P1395, DOI 10.1016/j.str.2011.08.006; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh Moh'd A, 2013, Int J Biochem Mol Biol, V4, P129; Salameh MA, 2012, PROTEIN SCI, V21, P1103, DOI 10.1002/pro.2097; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; SCHNEIDER SL, 1973, J BIOL CHEM, V248, P7207; Stein R., 2011, KINETICS ENZYME ACTI, P115; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Torbeev VY, 2011, P NATL ACAD SCI USA, V108, P20982, DOI 10.1073/pnas.1111202108; Trivedi M, 2012, INT J PHARMACEUT, V431, P16, DOI 10.1016/j.ijpharm.2012.03.051; Trivedi MV, 2009, CURR PROTEIN PEPT SC, V10, P614, DOI 10.2174/138920309789630534; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zhang L, 2011, BIOTECHNOL ADV, V29, P923, DOI 10.1016/j.biotechadv.2011.07.013; Zhang YJ, 2013, HUM MOL GENET, V22, P3112, DOI 10.1093/hmg/ddt166	69	16	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5105	5120		10.1074/jbc.RA118.007292	http://dx.doi.org/10.1074/jbc.RA118.007292			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30700553	Green Published, hybrid			2022-12-28	WOS:000463985600032
J	Rhee, SG				Rhee, Sue Goo			A catalytic career: Studies spanning glutamine synthetase, phospholipase C, peroxiredoxin, and the intracellular messenger role of hydrogen peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						glutamine synthase; phospholipase C; peroxiredoxin; peroxidase; hydrogen peroxide; receptor signaling	CYSTEINE-SULFINIC ACID; PROTEIN-TYROSINE PHOSPHATASES; THIOL-SPECIFIC ANTIOXIDANT; REVERSIBLE OXIDATION; CRYSTAL-STRUCTURE; INACTIVATION; ENZYME; CLONING; SEQUENCE; H2O2	I learned biochemistry from P. Boon Chock and Earl Stadtman while working on the regulation of Escherichia coli glutamine synthetase as a postdoctoral fellow at the National Institutes of Health. After becoming a tenured scientist at the same institute, my group discovered, purified, and cloned the first three prototypical members of the phospholipase C family and uncovered the mechanisms by which various cell-surface receptors activate these enzymes to generate diacylglycerol and inositol 1,4,5-trisphosphate. We also discovered the family of peroxiredoxin (Prx) enzymes that catalyze the reduction of H2O2, and we established that mammalian cells express six Prx isoforms that not only protect against oxidative damage but also mediate cell signaling by modulating intracellular H2O2 levels. To validate the signaling role of H2O2, we showed that epidermal growth factor induces a transient increase in intracellular H2O2 levels, and the essential cysteine residue of protein-tyrosine phosphatases is a target for specific and reversible oxidation by the H2O2 produced in such cells. These observations led to a new paradigm in receptor signaling, in which protein tyrosine phosphorylation is achieved not via activation of receptor tyrosine kinases alone but also through concurrent inhibition of protein-tyrosine phosphatases by H2O2. Our studies revealed that Prx isozymes are extensively regulated via phosphorylation as well as by hyperoxidation of the active-site cysteine to cysteine sulfinic acid, with the reverse reaction being catalyzed by sulfiredoxin. This reversible hyperoxidation of Prx was further shown to constitute a universal marker for circadian rhythms in all domains of life.	[Rhee, Sue Goo] Yonsei Univ, Coll Med, Yonsei Biomed Res Inst, Seoul 120752, South Korea; [Rhee, Sue Goo] NHLBI, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA	Yonsei University; Yonsei University Health System; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rhee, SG (corresponding author), Yonsei Univ, Coll Med, Yonsei Biomed Res Inst, Seoul 120752, South Korea.; Rhee, SG (corresponding author), NHLBI, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA.				Korean Science and Engineering Foundation	Korean Science and Engineering Foundation(Korea Science and Engineering Foundation)	I am grateful to the postdoctoral fellows and visiting scientists who graced my laboratory while I was at the NHLBI, National Institutes of Health, and to technicians, graduate students, and postdoctoral fellows who made invaluable contributions to my research programs at Ewha Womans University and Yonsei University School of Medicine in Korea. My research program in Korea had been supported by grants from the Korean Science and Engineering Foundation (National Honor Scientist Program Grant and BioR&D Program Grant). I especially thank the Journal of Biological Chemistry, a journal in which over 80 publications of my work have been published and in which one of our early works on peroxiredoxin (20) was featured as a JBC Classic, for inviting me to write this Reflections.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BENNETT CF, 1988, NATURE, V334, P268, DOI 10.1038/334268a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Cho CS, 2014, P NATL ACAD SCI USA, V111, P12043, DOI 10.1073/pnas.1401100111; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GARCIA E, 1983, J BIOL CHEM, V258, P2246; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Karplus PA, 2015, FREE RADICAL BIO MED, V80, P183, DOI 10.1016/j.freeradbiomed.2014.10.009; Kil IS, 2015, MOL CELL, V59, P651, DOI 10.1016/j.molcel.2015.06.031; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KIM KW, 1988, J BIOL CHEM, V263, P4704; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120; Lim JM, 2015, J CELL BIOL, V210, P23, DOI 10.1083/jcb.201412068; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; RHEE SG, 1978, P NATL ACAD SCI USA, V75, P3138, DOI 10.1073/pnas.75.7.3138; Rhee SG, 2018, ANTIOXID REDOX SIGN, V28, P537, DOI 10.1089/ars.2017.7167; Rhee SG, 2017, ANNU REV BIOCHEM, V86, P749, DOI 10.1146/annurev-biochem-060815-014431; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SHAPIRO BM, 1967, P NATL ACAD SCI USA, V58, P642, DOI 10.1073/pnas.58.2.642; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5419, DOI 10.1073/pnas.85.15.5419; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TAYLOR GD, 1992, BIOCHEM BIOPH RES CO, V188, P1176, DOI 10.1016/0006-291X(92)91355-T; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	54	2	2	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5169	5180		10.1074/jbc.X119.007975	http://dx.doi.org/10.1074/jbc.X119.007975			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30926755	Green Published, hybrid			2022-12-28	WOS:000463985600037
J	Wang, YC; Hirata, T; Maeda, Y; Murakami, Y; Fujita, M; Kinoshita, T				Wang, Yicheng; Hirata, Tetsuya; Maeda, Yusuke; Murakami, Yoshiko; Fujita, Morihisa; Kinoshita, Taroh			Free, unlinked glycosylphosphatidylinositols on mammalian cell surfaces revisited	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylphosphatidylinositol (GPI anchor); glycolipid; galactose; membrane lipid; glycosylation; post-translational modification (PTM); fatty acid remodeling; galactose; glycan biology; GPI transamidase; N-acetylgalactosamine	GPI-ANCHORED PROTEINS; MOLECULAR-WEIGHT ANTIGEN; TOXOPLASMA-GONDII; YEAST; HYPERPHOSPHATASIA; EXPRESSION; MUTATIONS; TRANSPORT; ER; MEMBRANE	Glycosylphosphatidylinositols (GPIs) are linked to many cell-surface proteins, anchor these proteins in the membrane, and are well characterized. However, GPIs that exist in the free form on the mammalian cell surface remain largely unexplored. To investigate free GPIs in cultured cell lines and mouse tissues, here we used the T5-4E10 mAb (T5 mAb), which recognizes unlinked GPIs having an N-acetylgalactosamine (GalNAc) side chain linked to the first mannose at the nonreducing terminus. We detected free GPIs bearing the GalNAc side chain on the surface of Neuro2a and CHO, but not of HEK293, K562, and C2C12 cells. Furthermore, free GPIs were present in mouse pons, medulla oblongata, spinal cord, testis, epididymis, and kidney. Using a panel of Chinese hamster ovary cells defective in both GPI-transamidase and GPI remodeling pathway, we demonstrate that free GPIs follow the same structural remodeling pathway during passage from the endoplasmic reticulum to the plasma membrane as do protein-linked GPI. Specifically, free GPIs underwent post-GPI attachment to protein 1 (PGAP1)-mediated inositol deacylation, PGAP5-mediated removal of the ethanolamine phosphate from the second mannose, and PGAP3- and PGAP2-mediated fatty acid remodeling. Moreover, T5 mAb recognized free GPIs even if the inositol-linked acyl chain or ethanolamine-phosphate side chain linked to the second mannose is not removed. In contrast, addition of a fourth mannose by phosphatidylinositol glycan anchor biosynthesis class Z (PIGZ) inhibited T5 mAb-mediated detection of free GPIs. Our results indicate that free GPIs are normal components of the plasma membrane in some tissues and further characterize free GPIs in mammalian cells.	[Wang, Yicheng; Hirata, Tetsuya; Maeda, Yusuke; Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Wang, Yicheng; Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, World Premier Int WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Fujita, Morihisa] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi 214122, Jiangsu, Peoples R China	Osaka University; Osaka University; Jiangnan University	Kinoshita, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	tkinoshi@biken.osaka-u.ac.jp	Fujita, Morihisa/AAM-4142-2020; Wang, Yicheng/AAJ-3439-2021; Wang, Yicheng/AAM-1923-2020; Kinoshita, Taroh/C-7353-2009	Wang, Yicheng/0000-0001-7789-1938; 	MEXT Japan Society for the Promotion of Science (JSPS) [JP16H04753]	MEXT Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants-in aid Grant Number JP16H04753 from MEXT Japan Society for the Promotion of Science (JSPS) (to T. K). The authors declare that they have no conflicts of interest with the contents of this article.	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Ashida H, 2005, MOL BIOL CELL, V16, P1439, DOI 10.1091/mbc.E04-09-0802; BALDWIN MA, 1990, ANAL BIOCHEM, V191, P174, DOI 10.1016/0003-2697(90)90405-X; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Baumann NA, 2000, J BIOL CHEM, V275, P7378, DOI 10.1074/jbc.275.10.7378; Chiyonobu T, 2014, J MED GENET, V51, P203, DOI 10.1136/jmedgenet-2013-102156; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ferguson M. A. J., 2017, GLYCOSYLPHOSPHATIDYL; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Gas-Pascual E, 2019, J BIOL CHEM, V294, P1104, DOI 10.1074/jbc.RA118.006072; Gotze S, 2014, ANGEW CHEM INT EDIT, V53, P13701, DOI 10.1002/anie.201406706; Hill A, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.28; Hirata T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02799-0; Hirata T, 2015, MOL BIOL CELL, V26, P3071, DOI 10.1091/mbc.E14-11-1568; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Hong YJ, 2003, MOL BIOL CELL, V14, P1780, DOI 10.1091/mbc.E02-12-0794; Kawamoto M, 2018, BMJ CASE REP, V2018; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; Krawitz PM, 2013, BLOOD, V122, P1312, DOI 10.1182/blood-2013-01-481499; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Nakamura N, 1997, J BIOL CHEM, V272, P15834, DOI 10.1074/jbc.272.25.15834; Seong J, 2013, J LIPID RES, V54, P1077, DOI 10.1194/jlr.M034421; SHARMA SD, 1983, J IMMUNOL, V131, P977; Singh N, 1996, J BIOL CHEM, V271, P12879, DOI 10.1074/jbc.271.22.12879; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Taron BW, 2004, J BIOL CHEM, V279, P36083, DOI 10.1074/jbc.M405081200; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; VANTHOF W, 1995, J BIOL CHEM, V270, P24150; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wu CL, 2016, NUCLEIC ACIDS RES, V44, pD313, DOI 10.1093/nar/gkv1104; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	40	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5038	5049		10.1074/jbc.RA119.007472	http://dx.doi.org/10.1074/jbc.RA119.007472			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30728244	Green Published, hybrid			2022-12-28	WOS:000463985600026
J	Mero, B; Radnai, L; Gogl, G; Toke, O; Leveles, I; Koprivanacz, K; Szeder, B; Dulk, M; Kudlik, G; Vas, V; Cserkaszky, A; Sipeki, S; Nyitray, L; Vertessy, BG; Buday, L				Mero, Balazs; Radnai, Laszlo; Gogl, Gergo; Toke, Orsolya; Leveles, Ibolya; Koprivanacz, Kitti; Szeder, Balint; Dulk, Metta; Kudlik, Gyoengyi; Vas, Virag; Cserkaszky, Anna; Sipeki, Szabolcs; Nyitray, Laszlo; Vertessy, Beata G.; Buday, Laszlo			Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphotyrosine signaling; ABL tyrosine kinase; Src homology 3 domain (SH3 domain); X-ray crystallography; nuclear magnetic resonance (NMR); 3BP-2; ABI2; ligand binding; post translational modification (PTM); protein phosphorylation; small-angle X-ray scattering (SAXS)	C-ABL KINASE; RESOLUTION CRYSTAL-STRUCTURES; SRC FAMILY KINASES; CIRCULAR-DICHROISM; HETERONUCLEAR NMR; BACKBONE DYNAMICS; PROTEIN; BINDING; ACTIVATION; GRB2	Src homology 3 (SH3) domains bind proline-rich linear motifs in eukaryotes. By mediating inter- and intramolecular interactions, they regulate the functions of many proteins involved in a wide variety of signal transduction pathways. Phosphorylation at different tyrosine residues in SH3 domains has been reported previously. In several cases, the functional consequences have also been investigated. However, a full understanding of the effects of tyrosine phosphorylation on the ligand interactions and cellular functions of SH3 domains requires detailed structural, atomic-resolution studies along with biochemical and biophysical analyses. Here, we present the first crystal structures of tyrosine-phosphorylated human SH3 domains derived from the Abelson-family kinases ABL1 and ABL2 at 1.6 and 1.4 angstrom resolutions, respectively. The structures revealed that simultaneous phosphorylation of Tyr(89) and Tyr(134) in ABL1 or the homologous residues Tyr(116) and Tyr(161) in ABL2 induces only minor structural perturbations. Instead, the phosphate groups sterically blocked the ligand-binding grooves, thereby strongly inhibiting the interaction with proline-rich peptide ligands. Although some crystal contact surfaces involving phosphotyrosines suggested the possibility of tyrosine phosphorylation-induced dimerization, we excluded this possibility by using small-angle X-ray scattering (SAXS), dynamic light scattering (DLS), and NMR relaxation analyses. Extensive analysis of relevant databases and literature revealed not only that the residues phosphorylated in our model systems are well-conserved in other human SH3 domains, but that the corresponding tyrosines are known phosphorylation sites in vivo in many cases. We conclude that tyrosine phosphorylation might be a mechanism involved in the regulation of the human SH3 interactome.	[Mero, Balazs; Radnai, Laszlo; Leveles, Ibolya; Koprivanacz, Kitti; Szeder, Balint; Dulk, Metta; Kudlik, Gyoengyi; Vas, Virag; Cserkaszky, Anna; Vertessy, Beata G.; Buday, Laszlo] Hungarian Acad Sci, RCNS, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary; [Toke, Orsolya] Hungarian Acad Sci, RCNS, Lab NMR Spect, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary; [Gogl, Gergo; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary; [Leveles, Ibolya; Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, Szt Gellert ter 4, H-1111 Budapest, Hungary; [Sipeki, Szabolcs; Buday, Laszlo] Semmelweis Univ, Sch Med, Dept Med Chem, Tuzolto U 37-47, H-1094 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Hungarian Academy of Sciences; Eotvos Lorand University; Budapest University of Technology & Economics; Semmelweis University	Buday, L (corresponding author), Hungarian Acad Sci, RCNS, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary.; Radnai, L (corresponding author), Scripps Res Inst, Dept Mol Med, 130 Scripps Way, Jupiter, FL 33458 USA.	lradnai@scripps.edu; buday.laszlo@ttk.mta.hu	Vas, Virag/B-8067-2016; Gogl, Gergo/ABH-4309-2020; Nyitray, László/AAE-5910-2020	Vas, Virag/0000-0001-7249-6816; Gogl, Gergo/0000-0002-8597-3711; Nyitray, László/0000-0003-4717-5994; Mero, Balazs/0000-0001-9517-6460; Radnai, Laszlo/0000-0001-6843-3740; Szeder, Balint/0000-0003-3264-3900; Dulk, Metta/0000-0001-9364-2587; Vertessy, Beata G./0000-0002-1288-2982	BioStruct-X	BioStruct-X	We thank Laszlo Drahos and Oliver Ozohanics (Instrumentation Center, MTA TTK) for help in MS measurements. Special thanks are due to Zita Solti for assistance in the expression and purification of recombinant proteins, Protein crystallization and in-house X-ray scattering experiments were performed at the Biostruct Laboratory. We thank BioStruct-X for funding the X-ray crystallography and small-angle X-ray scattering measurements in EMBL Hamburg and ESRF Grenoble.	Adams G, 2016, J BIOL CHEM, V291, P20692, DOI 10.1074/jbc.M116.732719; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Anselmi F, 2012, ANGIOGENESIS, V15, P187, DOI 10.1007/s10456-012-9252-6; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Barreira M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004993; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Broome MA, 1997, ONCOGENE, V14, P17, DOI 10.1038/sj.onc.1200798; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Dionne U, 2018, MOL CELL, V70, P995, DOI 10.1016/j.molcel.2018.05.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan HP, 2013, J BIOL CHEM, V288, P3322, DOI 10.1074/jbc.M112.420497; Fan PD, 2003, CANCER RES, V63, P873; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gmeiner WH, 2001, CELL BIOCHEM BIOPHYS, V35, P127, DOI 10.1385/CBB:35:2:127; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; JOHN BK, 1992, J MAGN RESON, V98, P200, DOI 10.1016/0022-2364(92)90125-Q; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Kurochkina Natalya, 2013, Biophys Rev, V5, P29, DOI 10.1007/s12551-012-0081-z; Levinson NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007683; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; Maru Y, 1996, J BIOL CHEM, V271, P15353, DOI 10.1074/jbc.271.26.15353; Matsumura Y, 2013, BIOPHYS CHEM, V175, P39, DOI 10.1016/j.bpc.2013.02.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Morrogh LM, 1999, EUR J IMMUNOL, V29, P2269; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nisitani S, 1999, P NATL ACAD SCI USA, V96, P2221, DOI 10.1073/pnas.96.5.2221; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Ross B, 2007, BIOCHEM BIOPH RES CO, V353, P463, DOI 10.1016/j.bbrc.2006.12.044; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Sato M, 2011, FEBS LETT, V585, P834, DOI 10.1016/j.febslet.2011.02.012; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith KM, 2001, J BIOL CHEM, V276, P24372, DOI 10.1074/jbc.M100786200; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Steen H, 2003, MOL CELL PROTEOMICS, V2, P138, DOI 10.1074/mcp.M300001-MCP200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tatarova Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036310; Wahl MI, 1997, P NATL ACAD SCI USA, V94, P11526, DOI 10.1073/pnas.94.21.11526; Wilcox HM, 2003, J BIOL CHEM, V278, P37112, DOI 10.1074/jbc.M304811200; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Woessner DW, 2015, LEUKEMIA, V29, P1668, DOI 10.1038/leu.2015.53; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006	61	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4608	4620		10.1074/jbc.RA118.004732	http://dx.doi.org/10.1074/jbc.RA118.004732			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30659095	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000462969500027
J	Wang, PC; Leng, JP; Wang, YS				Wang, Pengcheng; Leng, Jiapeng; Wang, Yinsheng			DNA replication studies of N-nitroso compound-induced O-6-alkyl-2-deoxyguanosine lesions in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA replication; DNA damage; mutagenesis; mass spectrometry (MS); DNA alkylation; N-nitroso compounds; translesion synthesis	TANDEM MASS-SPECTROMETRY; TRANSLESION SYNTHESIS; MUTAGENIC PROPERTIES; IN-VITRO; ADDUCTS; BYPASS; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; REPAIR; RATS; PYRIDYLOXOBUTYL	N-Nitroso compounds (NOCs) are common DNA-alkylating agents, are abundantly present in food and tobacco, and can also be generated endogenously. Metabolic activation of some NOCs can give rise to carboxymethylation and pyridyloxobutylation/pyridylhydroxybutylation of DNA, which are known to be carcinogenic and can lead to gastrointestinal and lung cancer, respectively. Herein, using the competitive replication and adduct bypass (CRAB) assay, along with MS- and NMR-based approaches, we assessed the cytotoxic and mutagenic properties of three O-6-alkyl-2-deoxyguanosine (O-6-alkyl-dG) adducts, i.e. O-6-pyridyloxobutyl-dG (O-6-POB-dG) and O-6-pyridylhydroxybutyl-dG (O-6-PHB-dG), derived from tobacco-specific nitrosamines, and O-6-carboxymethyl-dG (O-6-CM-dG), induced by endogenous N-nitroso compounds. We also investigated two neutral analogs of O-6-CM-dG, i.e. O-6-aminocarbonylmethyl-dG (O-6-ACM-dG) and O-6-hydroxyethyl-dG (O-6-HOEt-dG). We found that, in Escherichia coli cells, these lesions mildly (O-6-POB-dG), moderately (O-6-PHB-dG), or strongly (O-6-CM-dG, O-6-ACM-dG, and O-6-HOEt-dG) impede DNA replication. The strong blockage effects of the last three lesions were attributable to the presence of hydrogen-bonding donor(s) located on the alkyl functionality of these lesions. Except for O-6-POB-dG, which also induced a low frequency of G T transversions, all other lesions exclusively stimulated G A transitions. SOS-induced DNA polymerases played redundant roles in bypassing all the O-6-alkyl-dG lesions investigated. DNA polymerase IV (Pol IV) and Pol V, however, were uniquely required for inducing the G A transition for O-6-CM-dG exposure. Together, our study expands our knowledge about the recognition of important NOC-derived O-6-alkyl-dG lesions by the E. coli DNA replication machinery.	[Wang, Pengcheng; Leng, Jiapeng; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Wang, Pengcheng] Univ Jinan, Inst Surface Anal & Chem Biol, Jinan 250022, Shandong, Peoples R China	University of California System; University of California Riverside; University of Jinan	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022	Wang, Pengcheng/0000-0003-4581-983X	National Institutes of Health [R01 ES025121]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant R01 ES025121. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balbo S, 2014, CARCINOGENESIS, V35, P2798, DOI 10.1093/carcin/bgu204; BOGOVSKI P, 1981, INT J CANCER, V27, P471, DOI 10.1002/ijc.2910270408; BUSBY WF, 1985, CANCER RES, V45, P1367; Carlson ES, 2018, CHEM RES TOXICOL, V31, P358, DOI 10.1021/acs.chemrestox.8b00056; Choi JY, 2008, J BIOL CHEM, V283, P23645, DOI 10.1074/jbc.M801686200; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Cross AJ, 2003, CANCER RES, V63, P2358; de Groot PM, 2018, TRANSL LUNG CANCER R, V7, P220, DOI 10.21037/tlcr.2018.05.06; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Du H, 2018, J BIOL CHEM, V293, P11100, DOI 10.1074/jbc.RA118.003477; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Fuchs RP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012682; Gottschalg E, 2007, CARCINOGENESIS, V28, P356, DOI 10.1093/carcin/bgl150; Harrison KL, 1999, CHEM RES TOXICOL, V12, P106, DOI 10.1021/tx980057n; Harrison KL, 1997, CHEM RES TOXICOL, V10, P652, DOI 10.1021/tx960203u; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; International Agency for Research on Cancer, 2007, IARC MONOGR EVAL CAR, V89; Jakszyn P, 2006, CARCINOGENESIS, V27, P1497, DOI 10.1093/carcin/bgl019; Janion C, 2008, INT J BIOL SCI, V4, P338; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Lao YB, 2007, CHEM RES TOXICOL, V20, P246, DOI 10.1021/tx060208j; Lao YB, 2006, CHEM RES TOXICOL, V19, P674, DOI 10.1021/tx050351x; Leng JP, 2017, ANAL CHEM, V89, P9124, DOI 10.1021/acs.analchem.7b01857; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; LI BFL, 1989, BIOCHEMISTRY-US, V28, P5779, DOI 10.1021/bi00440a012; Li L, 2009, CHEM RES TOXICOL, V22, P1464, DOI 10.1021/tx9001572; Meikrantz W, 1998, CARCINOGENESIS, V19, P369, DOI 10.1093/carcin/19.2.369; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; MIRVISH SS, 1995, CANCER LETT, V93, P17, DOI 10.1016/0304-3835(95)03786-V; Neeley WL, 2007, J BIOL CHEM, V282, P12741, DOI 10.1074/jbc.M700575200; Pauly GT, 2002, CHEM RES TOXICOL, V15, P165, DOI 10.1021/tx0101245; Peterson LA, 2001, CANCER RES, V61, P5757; PETERSON LA, 1991, CANCER RES, V51, P5557; RONAI ZA, 1993, CARCINOGENESIS, V14, P2419, DOI 10.1093/carcin/14.11.2419; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; SMITH CA, 1990, CARCINOGENESIS, V11, P811, DOI 10.1093/carcin/11.5.811; SWANN PF, 1990, MUTAT RES, V233, P81, DOI 10.1016/0027-5107(90)90153-U; Tricker AR, 1997, EUR J CANCER PREV, V6, P226, DOI 10.1097/00008469-199706000-00003; Upadhyaya P, 2008, CHEM RES TOXICOL, V21, P1468, DOI 10.1021/tx8001109; Urban AM, 2012, CHEM RES TOXICOL, V25, P2167, DOI 10.1021/tx300245w; Vaisman Alexandra, 2012, EcoSal Plus, V5, DOI 10.1128/ecosalplus.7.2.2; Wang JS, 2010, NUCLEIC ACIDS RES, V38, P6774, DOI 10.1093/nar/gkq458; Wang JS, 2009, NUCLEIC ACIDS RES, V37, P336, DOI 10.1093/nar/gkn946; Wang LJ, 1999, CHEM RES TOXICOL, V12, P127, DOI 10.1021/tx980251+; Wang PC, 2018, J BIOL CHEM, V293, P15033, DOI 10.1074/jbc.RA118.004676; Wang PC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv941; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Wu J, 2017, NUCLEIC ACIDS RES, V45, P7276, DOI 10.1093/nar/gkx442; Xu YZ, 2000, TETRAHEDRON, V56, P6075, DOI 10.1016/S0040-4020(00)00556-1; Yang J, 2016, CHEM RES TOXICOL, V29, P87, DOI 10.1021/acs.chemrestox.5b00425; Yu Y, 2016, ANAL CHEM, V88, P8036, DOI 10.1021/acs.analchem.6b01349; Yuan BF, 2008, P NATL ACAD SCI USA, V105, P8679, DOI 10.1073/pnas.0711546105; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Zhai QQ, 2014, NUCLEIC ACIDS RES, V42, P10529, DOI 10.1093/nar/gku748; Zhang F, 2013, NUCLEIC ACIDS RES, V41, P5524, DOI 10.1093/nar/gkt198; Zhang SY, 2009, CHEM RES TOXICOL, V22, P926, DOI 10.1021/tx900015d	59	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3899	3908		10.1074/jbc.RA118.007358	http://dx.doi.org/10.1074/jbc.RA118.007358			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655287	Green Published, hybrid			2022-12-28	WOS:000461854400008
J	Hart, GW				Hart, Gerald W.			Nutrient regulation of signaling and transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc); O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); phosphorylation; diabetes; cancer; Alzheimer's disease; neurodegeneration; O-GlcNAcase; kinases	O-GLCNAC-TRANSFERASE; LINKED N-ACETYLGLUCOSAMINE; RNA-POLYMERASE-II; BETA-D-GLUCOSAMINIDASE; NITRIC-OXIDE SYNTHASE; SERUM RESPONSE FACTOR; NUCLEAR-PORE; INSULIN-RESISTANCE; PROTEIN MODIFICATION; ALPHA-SYNUCLEIN	In the early 1980s, while using purified glycosyltransferases to probe glycan structures on surfaces of living cells in the murine immune system, we discovered a novel form of serine/threonine protein glycosylation (O-linked beta-GlcNAc; O-GlcNAc) that occurs on thousands of proteins within the nucleus, cytoplasm, and mitochondria. Prior to this discovery, it was dogma that protein glycosylation was restricted to the luminal compartments of the secretory pathway and on extracellular domains of membrane and secretory proteins. Work in the last 3 decades from several laboratories has shown that O-GlcNAc cycling serves as a nutrient sensor to regulate signaling, transcription, mitochondrial activity, and cytoskeletal functions. O-GlcNAc also has extensive cross-talk with phosphorylation, not only at the same or proximal sites on polypeptides, but also by regulating each other's enzymes that catalyze cycling of the modifications. O-GlcNAc is generally not elongated or modified. It cycles on and off polypeptides in a time scale similar to phosphorylation, and both the enzyme that adds O-GlcNAc, the O-GlcNAc transferase (OGT), and the enzyme that removes O-GlcNAc, O-GlcNAcase (OGA), are highly conserved from C. elegans to humans. Both O-GlcNAc cycling enzymes are essential in mammals and plants. Due to O-GlcNAc's fundamental roles as a nutrient and stress sensor, it plays an important role in the etiologies of chronic diseases of aging, including diabetes, cancer, and neurodegenerative disease. This review will present an overview of our current understanding of O-GlcNAc's regulation, functions, and roles in chronic diseases of aging.	[Hart, Gerald W.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Hart, Gerald W.] Univ Georgia, Biochem & Mol Biol Dept, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hart, GW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.; Hart, GW (corresponding author), Univ Georgia, Biochem & Mol Biol Dept, Athens, GA 30602 USA.	gerald.hart@uga.edu		Hart, Gerald/0000-0001-7812-4351	National Institutes of Health [P01HL107153, R01GM116891, R01DK61671]; Georgia Research Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01HL107153, R01GM116891, and R01DK61671 and the Georgia Research Alliance. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Aguilar H, 2014, AM J PHYSIOL-CELL PH, V306, pC794, DOI 10.1152/ajpcell.00251.2013; Ahmad I, 2006, NUCLEIC ACIDS RES, V34, P175, DOI 10.1093/nar/gkj401; Ahmad I, 2006, J CELL BIOCHEM, V99, P706, DOI 10.1002/jcb.20814; Akimoto Y, 2000, DIABETOLOGIA, V43, P1239, DOI 10.1007/s001250051519; Akimoto Y, 2003, INVEST OPHTH VIS SCI, V44, P3802, DOI 10.1167/iovs.03-0227; Akimoto Y, 2001, ARCH BIOCHEM BIOPHYS, V389, P166, DOI 10.1006/abbi.2001.2331; Akimoto Y, 2007, GLYCOBIOLOGY, V17, P127, DOI 10.1093/glycob/cwl067; Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; Akimoto Yoshihiro, 2011, Clin Proteomics, V8, P15, DOI 10.1186/1559-0275-8-15; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Allison DF, 2012, P NATL ACAD SCI USA, V109, P16888, DOI 10.1073/pnas.1208468109; Alonso J, 2014, J BIOL CHEM, V289, P34433, DOI 10.1074/jbc.R114.609198; Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685; Aquino-Gil M, 2017, BIOCHEM SOC T, V45, P365, DOI 10.1042/BST20160404; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Azuma Y, 2007, BIOL PHARM BULL, V30, P2284, DOI 10.1248/bpb.30.2284; Bachmaier R, 2009, ONCOGENE, V28, P1280, DOI 10.1038/onc.2008.484; Banerjee PS, 2016, MOL ASPECTS MED, V51, P1, DOI 10.1016/j.mam.2016.05.005; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Banerjee S, 2013, J BIOL CHEM, V288, P33927, DOI 10.1074/jbc.M113.500983; BENKO DM, 1988, P NATL ACAD SCI USA, V85, P2573, DOI 10.1073/pnas.85.8.2573; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Bork K, 2008, J NEUROSCI RES, V86, P647, DOI 10.1002/jnr.21526; Brahma MK, 2017, DIABETES METAB J, V41, P1, DOI 10.4093/dmj.2017.41.1.1; BRAIDMAN I, 1974, BIOCHEM J, V143, P295, DOI 10.1042/bj1430295; BRAIDMAN I, 1974, FEBS LETT, V41, P181, DOI 10.1016/0014-5793(74)81206-8; Brimble S, 2010, CURR SIGNAL TRANSD T, V5, P12, DOI 10.2174/157436210790226465; Brister MA, 2014, J AM CHEM SOC, V136, P3803, DOI 10.1021/ja407156m; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chaiyawat P, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00193; Chalkley RJ, 2003, MOL CELL PROTEOMICS, V2, P182, DOI 10.1074/mcp.M300027-MCP200; Chen JY, 2015, FEBS LETT, V589, P2347, DOI 10.1016/j.febslet.2015.07.030; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Chen RR, 2017, CELL MOL NEUROBIOL, V37, P1465, DOI 10.1007/s10571-017-0477-1; Chen XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043724, 10.1371/journal.pone.0036895]; Chen YX, 2006, CHEM BIOL, V13, P937, DOI 10.1016/j.chembiol.2006.06.017; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; CHOU CF, 1992, J BIOL CHEM, V267, P3901; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; Chou TY, 2001, ADV EXP MED BIOL, V491, P413; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Chun YS, 2017, BIOCHEM BIOPH RES CO, V490, P486, DOI 10.1016/j.bbrc.2017.06.067; Chung SS, 2008, BIOCHEM BIOPH RES CO, V372, P713, DOI 10.1016/j.bbrc.2008.05.096; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Considine RV, 2000, J CLIN ENDOCR METAB, V85, P3551, DOI 10.1210/jc.85.10.3551; Constable S, 2017, GLYCOBIOLOGY, V27, P927, DOI 10.1093/glycob/cwx055; DATTA B, 1989, J BIOL CHEM, V264, P20620; Degrell P, 2009, LIFE SCI, V84, P389, DOI 10.1016/j.lfs.2009.01.007; Dehennaut V, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00155; Delporte A, 2014, PLANT PHYSIOL BIOCH, V83, P151, DOI 10.1016/j.plaphy.2014.07.021; Deng YQ, 2008, FASEB J, V22, P138, DOI 10.1096/fj.07-8309com; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Dias WB, 2012, BIOCHEM BIOPH RES CO, V422, P224, DOI 10.1016/j.bbrc.2012.04.124; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Diernfellner ACR, 2012, GENE DEV, V26, P415, DOI 10.1101/gad.188524.112; Din NU, 2010, J CELL BIOCHEM, V109, P585, DOI 10.1002/jcb.22436; Dong DLY, 1996, J BIOL CHEM, V271, P20845, DOI 10.1074/jbc.271.34.20845; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dorfmueller HC, 2006, J AM CHEM SOC, V128, P16484, DOI 10.1021/ja066743n; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Farach AM, 2008, BRAIN CELL BIOL, V36, P191, DOI 10.1007/s11068-008-9036-5; Fardini Y, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00099; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Forma E, 2014, CELL MOL BIOL LETT, V19, P438, DOI 10.2478/s11658-014-0204-6; Fu MN, 2017, BIOCHEM SOC T, V45, P871, DOI 10.1042/BST20160183; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gatta E, 2016, PHARMACOL RES, V105, P186, DOI 10.1016/j.phrs.2016.01.006; Gellai R, 2016, AM J PHYSIOL-RENAL, V311, pF1172, DOI 10.1152/ajprenal.00545.2015; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Ghirardello M, 2018, CHEM-EUR J, V24, P7264, DOI 10.1002/chem.201801083; GIACCARI A, 1995, DIABETOLOGIA, V38, P518, DOI 10.1007/BF00400719; Gloster TM, 2010, CURR SIGNAL TRANSD T, V5, P74, DOI 10.2174/157436210790226537; Goldberg HJ, 2006, ENDOCRINOLOGY, V147, P222, DOI 10.1210/en.2005-0523; Gong CX, 2016, ALZHEIMERS DEMENT, V12, P1078, DOI 10.1016/j.jalz.2016.02.011; GRAEBER MB, 1992, P NATL ACAD SCI USA, V89, P8245, DOI 10.1073/pnas.89.17.8245; GREIS KD, 1994, J VIROL, V68, P8339, DOI 10.1128/JVI.68.12.8339-8349.1994; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; GRIFFITH LS, 1995, J NEUROSCI RES, V41, P270, DOI 10.1002/jnr.490410214; Gu YC, 2014, MOL MED REP, V10, P897, DOI 10.3892/mmr.2014.2269; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Gurel Z, 2018, CLIN SCI, V132, P185, DOI 10.1042/CS20171454; Ha C, 2015, BIOCHEM BIOPH RES CO, V467, P341, DOI 10.1016/j.bbrc.2015.09.155; Ha JR, 2014, EXP CELL RES, V321, P153, DOI 10.1016/j.yexcr.2013.11.021; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Haltiwanger RS, 1997, BIOCHEM BIOPH RES CO, V231, P237, DOI 10.1006/bbrc.1997.6110; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Han I, 2000, BIOCHEM J, V350, P109, DOI 10.1042/0264-6021:3500109; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004596; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hastings NB, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0181-0; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; He YT, 2017, J CEREBR BLOOD F MET, V37, P2938, DOI 10.1177/0271678X16679671; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Hebert LF, 1996, J CLIN INVEST, V98, P930, DOI 10.1172/JCI118876; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Ho SR, 2010, FEBS LETT, V584, P49, DOI 10.1016/j.febslet.2009.11.059; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; HOLT GD, 1987, J BIOL CHEM, V262, P14847; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Huang X, 2013, J BIOL CHEM, V288, P36418, DOI 10.1074/jbc.M113.495713; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Hurtado-Guerrero R, 2008, CURR OPIN STRUC BIOL, V18, P551, DOI 10.1016/j.sbi.2008.09.005; Ido-Kitamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047231; Issad T, 2010, DIABETES METAB, V36, P423, DOI 10.1016/j.diabet.2010.09.001; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jensen RV, 2013, CARDIOVASC RES, V97, P369, DOI 10.1093/cvr/cvs337; Jensen RV, 2013, SCAND CARDIOVASC J, V47, P168, DOI 10.3109/14017431.2012.756984; Jeon BT, 2016, NEUROBIOL AGING, V44, P127, DOI 10.1016/j.neurobiolaging.2016.05.002; Ji S, 2012, BIOCHEM BIOPH RES CO, V417, P1158, DOI 10.1016/j.bbrc.2011.12.086; Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586; Jiang M, 2017, STROKE, V48, P1646, DOI 10.1161/STROKEAHA.117.016579; Jiang MS, 1997, J BIOL CHEM, V272, P2421; Jochmann R, 2009, J VIROL, V83, P3704, DOI 10.1128/JVI.01384-08; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Jozwiak P, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00145; Juang YT, 2002, J IMMUNOL, V168, P2865, DOI 10.4049/jimmunol.168.6.2865; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Kandimalla R, 2017, BBA-MOL BASIS DIS, V1863, P1078, DOI 10.1016/j.bbadis.2016.08.018; Kang J, 2013, FASEB J, V27, P2807, DOI 10.1096/fj.12-220897; Kang MJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.56; Kanwal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069150; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kim EY, 2012, GENE DEV, V26, P490, DOI 10.1101/gad.182378.111; Kim HS, 2009, FEBS LETT, V583, P2474, DOI 10.1016/j.febslet.2009.06.052; Kim SJ, 2016, CURR EYE RES, V41, P249, DOI 10.3109/02713683.2015.1006372; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kroner Z, 2009, ALTERN MED REV, V14, P373; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Krzeslak A, 2010, INT J MOL MED, V25, P643, DOI 10.3892/ijmm_00000387; Kuo M, 2008, BIOCHIMIE, V90, P679, DOI 10.1016/j.biochi.2008.03.005; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Lagerlof O, 2017, P NATL ACAD SCI USA, V114, P1684, DOI 10.1073/pnas.1621367114; Lagerlof Olof, 2014, Adv Neurobiol, V9, P343, DOI 10.1007/978-1-4939-1154-7_16; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lefebvre T, 2004, EUR J BIOCHEM, V271, P3843, DOI 10.1111/j.1432-1033.2004.04316.x; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Leszek J, 2017, CURR TOP MED CHEM, V17, P1331, DOI 10.2174/1568026617666170103163403; Leturcq M, 2017, BIOCHEM SOC T, V45, P323, DOI 10.1042/BST20160388; Levine PM, 2017, BIOORGAN MED CHEM, V25, P4977, DOI 10.1016/j.bmc.2017.04.038; Levine ZG, 2016, ANNU REV BIOCHEM, V85, P631, DOI 10.1146/annurev-biochem-060713-035344; Lewis BA, 2016, J BIOL CHEM, V291, P14056, DOI 10.1074/jbc.M115.684365; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Lewis YE, 2017, ACS CHEM BIOL, V12, P1020, DOI 10.1021/acschembio.7b00113; Li BB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00865-1; Li BB, 2017, NAT STRUCT MOL BIOL, V24, P362, DOI 10.1038/nsmb.3390; Li HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep43601; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Li X, 2006, EUR J NEUROSCI, V23, P2078, DOI 10.1111/j.1460-9568.2006.04735.x; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Lim KH, 2006, FEBS LETT, V580, P4645, DOI 10.1016/j.febslet.2006.07.040; Lim K, 2009, FEBS LETT, V583, P512, DOI 10.1016/j.febslet.2008.12.007; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Liu QQ, 2016, EXP CELL RES, V349, P230, DOI 10.1016/j.yexcr.2016.10.011; LIU SH, 1995, DEV GENET, V16, P229, DOI 10.1002/dvg.1020160303; Liu S, 2016, J CEREBR BLOOD F MET, V36, P393, DOI 10.1177/0271678X15608393; Lozano L, 2014, EXP GERONTOL, V58, P198, DOI 10.1016/j.exger.2014.08.008; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Lynch TP, 2011, CELL CYCLE, V10, P1712, DOI 10.4161/cc.10.11.15561; Ma Junfeng, 2017, Curr Protoc Protein Sci, V87, DOI 10.1002/cpps.24; Ma JF, 2016, J PROTEOME RES, V15, P2254, DOI 10.1021/acs.jproteome.6b00250; Ma JF, 2015, J BIOL CHEM, V290, P29141, DOI 10.1074/jbc.M115.691741; Ma JF, 2013, EXPERT REV PROTEOMIC, V10, P365, DOI 10.1586/14789450.2013.820536; Ma XF, 2017, CELL MOL LIFE SCI, V74, P3667, DOI 10.1007/s00018-017-2542-9; Ma XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063452; Ma YT, 2013, BIOCHEM BIOPH RES CO, V431, P382, DOI 10.1016/j.bbrc.2013.01.043; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Maher PA, 2009, EXPERT REV NEUROTHER, V9, P617, DOI 10.1586/ERN.09.18; Majumdar G, 2003, AM J PHYSIOL-ENDOC M, V285, pE584, DOI 10.1152/ajpendo.00140.2003; Marotta NP, 2015, NAT CHEM, V7, P913, DOI [10.1038/NCHEM.2361, 10.1038/nchem.2361]; Marotta NP, 2012, CHEMBIOCHEM, V13, P2665, DOI 10.1002/cbic.201200478; Marsh SA, 2014, J BIOL CHEM, V289, P34449, DOI 10.1074/jbc.R114.585984; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; McClain DA, 2000, ENDOCRINOLOGY, V141, P1999, DOI 10.1210/en.141.6.1999; McNulty PH, 2007, AM J PHYSIOL-CELL PH, V292, pC1243, DOI 10.1152/ajpcell.00521.2006; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Miller MW, 1999, ARCH BIOCHEM BIOPHYS, V367, P51, DOI 10.1006/abbi.1999.1237; Myers SA, 2016, ELIFE, V5, DOI 10.7554/eLife.10647; Myers SA, 2013, PROTEOMICS, V13, P982, DOI 10.1002/pmic.201200332; Nagel AK, 2015, ADV CANCER RES, V126, P137, DOI 10.1016/bs.acr.2014.12.003; Nagel AK, 2014, MOL CELL PROTEOMICS, V13, P3381, DOI 10.1074/mcp.M114.040691; Nakamura M, 2001, J BIOL CHEM, V276, P43748, DOI 10.1074/jbc.M108594200; Nanashima N, 2005, J BIOL CHEM, V280, P43010, DOI 10.1074/jbc.M509481200; Ning XJ, 2017, CELL MOL NEUROBIOL, V37, P527, DOI 10.1007/s10571-016-0391-y; Noach N, 2007, GLYCOBIOLOGY, V17, P1357, DOI 10.1093/glycob/cwm105; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Olivier-Van Stichelen Stephanie, 2012, Am J Physiol Endocrinol Metab, V302, pE417, DOI 10.1152/ajpendo.00390.2011; Olszewski NE, 2010, BBA-GEN SUBJECTS, V1800, P49, DOI 10.1016/j.bbagen.2009.11.016; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Park K, 2010, DIABETES, V59, P1845, DOI 10.2337/db09-1086; PARK MK, 1987, P NATL ACAD SCI USA, V84, P6462, DOI 10.1073/pnas.84.18.6462; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Pathak S, 2015, NAT STRUCT MOL BIOL, V22, P744, DOI 10.1038/nsmb.3063; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Peterson SB, 2016, CRIT REV BIOCHEM MOL, V51, P150, DOI 10.3109/10409238.2015.1135102; Phoomak C, 2012, ASIAN PAC J CANCER P, V13, P101, DOI 10.7314/APJCP.2012.13.KKSuppl.101; Phueaouan T, 2013, ONCOL REP, V30, P2929, DOI 10.3892/or.2013.2794; Pitcher H, 2006, LANCET NEUROL, V5, P388, DOI 10.1016/S1474-4422(06)70434-3; Qiu HY, 2017, MOL CARCINOGEN, V56, P258, DOI 10.1002/mc.22490; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; REASON AJ, 1992, J BIOL CHEM, V267, P16911; Resto M, 2016, J BIOL CHEM, V291, P22703, DOI 10.1074/jbc.M116.751420; Rex-Mathes M, 2001, BIOCHIMIE, V83, P583, DOI 10.1016/S0300-9084(01)01305-0; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; ROBINSON KA, 1993, DIABETES, V42, P1333, DOI 10.2337/diabetes.42.9.1333; Robles-Flores M, 2008, BBA-MOL CELL RES, V1783, P695, DOI 10.1016/j.bbamcr.2007.07.011; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Roth C, 2017, NAT CHEM BIOL, V13, P610, DOI 10.1038/nchembio.2358; Rozanski W, 2012, CLIN LAB, V58, P579; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sayat R, 2008, EXP CELL RES, V314, P2774, DOI 10.1016/j.yexcr.2008.05.017; Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003; Schultz J, 2002, FEBS LETT, V529, P179, DOI 10.1016/S0014-5793(02)03322-7; Semba RD, 2014, PROTEOM CLIN APPL, V8, P218, DOI 10.1002/prca.201300076; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14500; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Skorobogatko Y, 2014, J BIOL CHEM, V289, P3602, DOI 10.1074/jbc.M113.512814; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Smet-Nocca C, 2011, MOL BIOSYST, V7, P1420, DOI 10.1039/c0mb00337a; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Sohn KC, 2004, BIOCHEM BIOPH RES CO, V322, P1045, DOI 10.1016/j.bbrc.2004.08.023; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; STARR CM, 1990, J BIOL CHEM, V265, P6868; Svejstrup JQ, 2012, EMBO J, V31, P2753, DOI 10.1038/emboj.2012.154; Tallent MK, 2009, J BIOL CHEM, V284, P174, DOI 10.1074/jbc.M807431200; Tarrant MK, 2012, NAT CHEM BIOL, V8, P262, DOI [10.1038/NCHEMBIO.771, 10.1038/nchembio.771]; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trapannone R, 2016, BIOCHEM SOC T, V44, P88, DOI 10.1042/BST20150189; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Tsokos GC, 2003, ANN NY ACAD SCI, V987, P240, DOI 10.1111/j.1749-6632.2003.tb06054.x; Vaidyanathan K, 2017, J BIOL CHEM, V292, P8948, DOI 10.1074/jbc.M116.771030; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Verrijzer CP, 2014, DEV CELL, V31, P521, DOI 10.1016/j.devcel.2014.11.027; Vocadlo DJ, 2012, CURR OPIN CHEM BIOL, V16, P488, DOI 10.1016/j.cbpa.2012.10.021; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wang PF, 2015, J GENET GENOMICS, V42, P467, DOI 10.1016/j.jgg.2015.07.002; Wang S, 2017, J PATHOL, V243, P78, DOI 10.1002/path.4929; Wang Y, 2017, J MED CHEM, V60, P263, DOI 10.1021/acs.jmedchem.6b01237; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Wang Z, 2009, DIABETES, V58, P309, DOI 10.2337/db08-0994; Wani WY, 2017, BRAIN RES BULL, V133, P80, DOI 10.1016/j.brainresbull.2016.08.002; Wani WY, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0311-1; Weigert C, 2003, DIABETES, V52, P650, DOI 10.2337/diabetes.52.3.650; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wells L, 2011, AMINO ACIDS, V40, P877, DOI 10.1007/s00726-010-0709-x; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Willems AP, 2017, J BIOL CHEM, V292, P12621, DOI 10.1074/jbc.M117.790097; Woo CM, 2018, MOL CELL PROTEOMICS, V17, P764, DOI 10.1074/mcp.RA117.000261; Xie ST, 2016, AGING CELL, V15, P455, DOI 10.1111/acel.12449; Xing DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024021; Xing LJ, 2018, EMBO J, V37, DOI 10.15252/embj.201798115; Xu QR, 2014, NUCLEIC ACIDS RES, V42, P5594, DOI 10.1093/nar/gku236; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yehezkel G, 2012, J BIOL CHEM, V287, P28755, DOI 10.1074/jbc.M112.345546; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; YkiJarvinen H, 1996, DIABETES, V45, P302, DOI 10.2337/diabetes.45.3.302; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-42; Yuzwa SA, 2014, CHEM SOC REV, V43, P6839, DOI 10.1039/c4cs00038b; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]; Zachara N. E., 2011, CURR PROTOC MOL BIOL, DOI [DOI 10.1002/0471142727.MB1706S95, 10.1002/0471142727.mb1706s95]; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2012, AM J PHYSIOL-HEART C, V302, pH1905, DOI 10.1152/ajpheart.00445.2011; Zachara NE, 2011, AMINO ACIDS, V40, P793, DOI 10.1007/s00726-010-0695-z; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zentella R, 2016, GENE DEV, V30, P164, DOI 10.1101/gad.270587.115; Zhang JM, 2017, NEUROSCI LETT, V655, P90, DOI 10.1016/j.neulet.2017.06.034; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885; Zhang Y, 2017, BIOCHEM BIOPH RES CO, V484, P79, DOI 10.1016/j.bbrc.2017.01.068; Zhu L, 2015, INT J MOL SCI, V16, P16560, DOI 10.3390/ijms160716560; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008; Zraika S, 2002, ARCH BIOCHEM BIOPHYS, V405, P275, DOI 10.1016/S0003-9861(02)00397-1	341	152	157	15	88	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2211	2231		10.1074/jbc.AW119.003226	http://dx.doi.org/10.1074/jbc.AW119.003226			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30626734	Green Published, hybrid			2022-12-28	WOS:000458895400001
J	Rodriguez-Pascual, F				Rodriguez-Pascual, Fernando			How evolution made the matrix punch at the multicellularity party	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ORIGIN	The basement membrane is a specialized sheet-like form of the extracellular matrix that provides structural support to epithelial cells and tissues, while influencing multiple biological functions, and was essential in the transition to multicellularity. By exploring a variety of genomes, Darris et al. provide evidence that the emergence and divergence of a multifunctional Goodpasture antigen-binding protein (GPBP), a basement membrane constituent, played a role in this transition. These findings help to explain how GPBP contributed to the formation of these extracellular matrices and to more precisely define the transition to multicellular organisms.	[Rodriguez-Pascual, Fernando] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Rodriguez-Pascual, F (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1, E-28049 Madrid, Spain.	frodriguez@cbm.csic.es	Rodríguez-Pascual, Fernando/Q-5100-2019	Rodríguez-Pascual, Fernando/0000-0002-9765-9578				Brown KL, 2017, PROTEIN SCI, V26, P2151, DOI 10.1002/pro.3283; Brunet T, 2017, DEV CELL, V43, P124, DOI 10.1016/j.devcel.2017.09.016; Darris C, 2019, J BIOL CHEM, V294, P759, DOI 10.1074/jbc.RA118.006225; Fahey B, 2012, MOL BIOL EVOL, V29, P1823, DOI 10.1093/molbev/mss060; Fidler AL, 2017, ELIFE, V6, DOI 10.7554/eLife.24176; Germer J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140100; Grau-Bove X, 2017, ELIFE, V6, DOI 10.7554/eLife.26036; Grau-Bove X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10568; Mencarelli C, 2010, J NEUROCHEM, V113, P1369, DOI 10.1111/j.1471-4159.2010.06673.x; Sebe-Pedros A, 2016, CELL, V165, P1224, DOI 10.1016/j.cell.2016.03.034	10	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2019	294	3					770	771		10.1074/jbc.H118.006972	http://dx.doi.org/10.1074/jbc.H118.006972			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL4FC	30659161	Green Published, hybrid			2022-12-28	WOS:000458670200003
J	Crowther, JM; Cross, PJ; Oliver, MR; Leeman, MM; Bartl, AJ; Weatherhead, AW; North, RA; Donovan, KA; Griffin, MDW; Suzuki, H; Hudson, AO; Kasanmascheff, M; Dobson, RCJ				Crowther, Jennifer M.; Cross, Penelope J.; Oliver, Michael R.; Leeman, Mary M.; Bartl, Austin J.; Weatherhead, Anthony W.; North, Rachel A.; Donovan, Katherine A.; Griffin, Michael D. W.; Suzuki, Hironori; Hudson, Andre O.; Kasanmascheff, Muege; Dobson, Renwick C. J.			Structure-function analyses of two plant meso-diaminopimelate decarboxylase isoforms reveal that active-site gating provides stereochemical control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; pyridoxal phosphate; X-ray crystallography; analytical ultracentrifugation; small-angle X-ray scattering (SAXS); DAPDC; lysine biosynthesis; meso-diaminopimelate decarboxylase; stereochemistry	SEDIMENTATION-VELOCITY; CRYSTAL-STRUCTURE; ULTRACENTRIFUGATION; CRYSTALLIZATION; MACROMOLECULES; SCATTERING; ENZYME; LYSINE	meso-Diaminopimelate decarboxylase catalyzes the decarboxylation of meso-diaminopimelate, the final reaction in the diaminopimelate l-lysine biosynthetic pathway. It is the only known pyridoxal-5-phosphate-dependent decarboxylase that catalyzes the removal of a carboxyl group from a d-stereocenter. Currently, only prokaryotic orthologs have been kinetically and structurally characterized. Here, using complementation and kinetic analyses of enzymes recombinantly expressed in Escherichia coli, we have functionally tested two putative eukaryotic meso-diaminopimelate decarboxylase isoforms from the plant species Arabidopsis thaliana. We confirm they are both functional meso-diaminopimelate decarboxylases, although with lower activities than those previously reported for bacterial orthologs. We also report in-depth X-ray crystallographic structural analyses of each isoform at 1.9 and 2.4 resolution. We have captured the enzyme structure of one isoform in an asymmetric configuration, with one ligand-bound monomer and the other in an apo-form. Analytical ultracentrifugation and small-angle X-ray scattering solution studies reveal that A. thaliana meso-diaminopimelate decarboxylase adopts a homodimeric assembly. On the basis of our structural analyses, we suggest a mechanism whereby molecular interactions within the active site transduce conformational changes to the active-site loop. These conformational differences are likely to influence catalytic activity in a way that could allow for d-stereocenter selectivity of the substrate meso-diaminopimelate to facilitate the synthesis of l-lysine. In summary, the A. thaliana gene loci At3g14390 and At5g11880 encode functional. meso-diaminopimelate decarboxylase enzymes whose structures provide clues to the stereochemical control of the decarboxylation reaction catalyzed by these eukaryotic proteins	[Crowther, Jennifer M.; Cross, Penelope J.; Weatherhead, Anthony W.; North, Rachel A.; Suzuki, Hironori; Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Private Bag 4800, Christchurch 8140, New Zealand; [Crowther, Jennifer M.; Cross, Penelope J.; Weatherhead, Anthony W.; North, Rachel A.; Suzuki, Hironori; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8140, New Zealand; [Crowther, Jennifer M.; Oliver, Michael R.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JG, Midlothian, Scotland; [Leeman, Mary M.; Bartl, Austin J.; Hudson, Andre O.] RIT, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA; [Donovan, Katherine A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Donovan, Katherine A.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Griffin, Michael D. W.; Dobson, Renwick C. J.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia; [Kasanmascheff, Muege] Tech Univ Dortmund, Dept Chem & Chem Biol, D-44227 Dortmund, Germany	University of Canterbury; University of Canterbury; University of Edinburgh; Rochester Institute of Technology; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Melbourne; Dortmund University of Technology	Dobson, RCJ (corresponding author), Univ Canterbury, Biomol Interact Ctr, Private Bag 4800, Christchurch 8140, New Zealand.; Dobson, RCJ (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8140, New Zealand.; Hudson, AO (corresponding author), RIT, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA.; Dobson, RCJ (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia.; Kasanmascheff, M (corresponding author), Tech Univ Dortmund, Dept Chem & Chem Biol, D-44227 Dortmund, Germany.	aohsbi@rit.edu; muege.kasanmascheff@tu-dortmund.de; dobson@canterbury.ac.nz	Donovan, Katherine Aleisha/R-7539-2018; Dobson, Renwick/AAZ-7020-2021; North, Rachel/W-3575-2019	Donovan, Katherine Aleisha/0000-0002-8539-5106; Dobson, Renwick/0000-0002-5506-4939; North, Rachel/0000-0001-5011-1567; Kasanmascheff, Muge/0000-0002-8964-8924; Crowther, Jennifer/0000-0002-9670-2204; Suzuki, Hironori/0000-0001-9754-4992; Hudson, Andre/0000-0001-5690-4322; Griffin, Michael/0000-0001-9845-7735	Australian Research Council Future Fellowship [FT140100544]; National Science Foundation [MCB-1120541]; National Institutes of Health [R15GM120653]; College of Science and the Thomas H. Gosnell School of Life Sciences at the Rochester Institute of Technology; New Zealand Royal Society Marsden Fund [UOC1506]; United States Army Research Laboratory; Army Research Office [W911NF-11-1-0481]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM120653] Funding Source: NIH RePORTER	Australian Research Council Future Fellowship(Australian Research Council); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Science and the Thomas H. Gosnell School of Life Sciences at the Rochester Institute of Technology; New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); United States Army Research Laboratory; Army Research Office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Recipient of an Australian Research Council Future Fellowship (Project no. FT140100544.; Supported by National Science Foundation Grant MCB-1120541, National Institutes of Health Grant R15GM120653, and the College of Science and the Thomas H. Gosnell School of Life Sciences at the Rochester Institute of Technology. To whom correspondence may be addressed. Tel.: 585-475-4259; E-mail: aohsbi@rit.edu.; Supported in part by the New Zealand Royal Society Marsden Fund (Contract UOC1506) and the United States Army Research Laboratory and Army Research Office under Contract/Grant W911NF-11-1-0481. To whom correspondence may be addressed. Tel.: 64-3-369-5145; E-mail:renwick.dobson@canterbury.ac.nz.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Ball D. W., 2006, FIELD GUIDE SPECTROS, P65; Bonnett SA, 2013, CHEM BIOL, V20, P772, DOI 10.1016/j.chembiol.2013.04.014; Born TL, 1999, CURR OPIN CHEM BIOL, V3, P607, DOI 10.1016/S1367-5931(99)00016-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B., 2016, ANAL ULTRACENTRIFUGA, P119, DOI [DOI 10.1007/978-4-431-55985-6_8, 10.1007/978-4-431-55985-6_8]; Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481; Dogovski C., 2012, ENZYMOLOGY BACTERIAL, P225; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gokulan K, 2003, J BIOL CHEM, V278, P18588, DOI 10.1074/jbc.M301549200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hu TC, 2008, J BIOL CHEM, V283, P21284, DOI 10.1074/jbc.M801823200; Hudson AO, 2005, BBA-GEN SUBJECTS, V1721, P27, DOI 10.1016/j.bbagen.2004.09.008; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Momany C, 2002, ACTA CRYSTALLOGR D, V58, P549, DOI 10.1107/S0907444902000148; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachar VR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00183; Oliver MR, 2014, ACTA CRYSTALLOGR F, V70, P663, DOI 10.1107/S2053230X14007699; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Peverelli MG, 2016, J BIOL CHEM, V291, P9785, DOI 10.1074/jbc.M115.696591; Peverelli MG, 2015, BIOCHIMIE, V115, P78, DOI 10.1016/j.biochi.2015.05.004; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Son HF, 2018, BIOCHEM BIOPH RES CO, V495, P1815, DOI 10.1016/j.bbrc.2017.11.097; Stavrinides A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12116; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Weyand Simone, 2009, Journal of Structural and Functional Genomics, V10, P209, DOI 10.1007/s10969-009-9065-z	33	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8505	8515		10.1074/jbc.RA118.006825	http://dx.doi.org/10.1074/jbc.RA118.006825			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30962284	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000471108200019
J	Yu, SL; Wang, D; Huang, LM; Zhang, YN; Luo, RH; Adah, D; Tang, YT; Zhao, K; Lu, B				Yu, Songlin; Wang, Dan; Huang, Lingmin; Zhang, Yening; Luo, Ruiheng; Adah, Dickson; Tang, Yiting; Zhao, Kai; Lu, Ben			The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; complement system; IL-1; inflammasome; inflammation	MECHANISMS; INHIBITOR; PKR; WORTMANNIN; ROLES; NALP3; U0126; SHOCK	The NLR family pyrin domain-containing 3 (NLRP3) inflammasome is a multimeric protein complex that mediates maturation of the cytokines IL-1 and IL-18 as well as release of the proinflammatory protein high-mobility group box 1 (HMGB1) and contributes to several inflammatory diseases, including sepsis, gout, and type 2 diabetes. In this context, the well-studied active complement fragment C5a and its receptor C5aR1 or C5aR2 orchestrate the inflammatory responses in many diseases. Although a C5a-C5aR interaction in NLRP3-associated diseases has been suggested, little is known about the details of C5a-C5aR cross-talk with the NLRP3 inflammasome in macrophages. In this study, using mice and murine macrophages and cytokines, immunoblotting, siRNA, and quantitative real-time PCR assays, we demonstrate that C5aR2 deficiency restricts activation of the NLRP3 inflammasome and release of HMGB1 both in vitro and in vivo. Mechanistically, we found that C5aR2 promotes NLRP3 activation by amplifying dsRNA-dependent PKR expression, which is an important NLRP3-activating factor. We also observed that elevation of PKR expression because of the C5a-C5aR2 interaction depends on the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase pathway and type I IFN signaling. In conclusion, these findings reveal that C5aR2 contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages.	[Yu, Songlin; Wang, Dan; Huang, Lingmin; Zhang, Yening; Luo, Ruiheng; Zhao, Kai; Lu, Ben] Cent S Univ, Xiangya Hosp 3, Dept Hematol, Changsha 410000, Hunan, Peoples R China; [Yu, Songlin; Wang, Dan; Huang, Lingmin; Zhang, Yening; Luo, Ruiheng; Zhao, Kai; Lu, Ben] Cent S Univ, Xiangya Hosp 3, Key Lab Nonresolving Inflammat & Canc Hunan Prov, Changsha 410000, Hunan, Peoples R China; [Yu, Songlin] Cent S Univ, Xiangya Hosp 3, Postdoctoral Res Stn Clin Med, Changsha 410000, Hunan, Peoples R China; [Adah, Dickson] Chinese Acad Sci, Guangzhou Inst Biomed, Ctr Infect & Immun, Lab Pathogen Biol,State Key Lab Resp Dis, Guangzhou 510632, Guangdong, Peoples R China; [Adah, Dickson] Chinese Acad Sci, Guangzhou Inst Hlth, Ctr Infect & Immun, Lab Pathogen Biol,State Key Lab Resp Dis, Guangzhou 510632, Guangdong, Peoples R China; [Adah, Dickson] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Tang, Yiting] Cent S Univ, Sch Basic Med Sci, Dept Physiol, Changsha 410000, Hunan, Peoples R China; [Lu, Ben] Cent S Univ, Sch Biol Sci & Technol, Key Lab Med Genet, Changsha 410000, Hunan, Peoples R China; [Lu, Ben] Cent S Univ, Sch Basic Med Sci, Key Lab Sepsis & Translat Med, Changsha 410000, Hunan, Peoples R China; [Lu, Ben] Jinan Univ, Sch Basic Med Sci, Dept Pathophysiol, Guangzhou 510632, Guangdong, Peoples R China	Central South University; Central South University; Central South University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Central South University; Central South University; Central South University; Jinan University	Zhao, K; Lu, B (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Hematol, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.	kaizhao@csu.edu.cn; xybenlu@csu.edu.cn	Lu, Ben/AAN-1068-2021; 张, 叶宁/GRJ-6647-2022	Lu, Ben/0000-0002-8597-0406; Zhao, Kai/0000-0002-3889-2118	National Key Scientific Project [2015CB910700]; National Natural Science Foundation of China [81422027, 81400149, 81470345, 81801967]; Innovation-driven Project of Central South University [2018CX030, 2019CX013]	National Key Scientific Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation-driven Project of Central South University	This work was supported by National Key Scientific Project Grant 2015CB910700; National Natural Science Foundation of China Grants 81422027, 81400149, 81470345, and 81801967; and Innovation-driven Project of Central South University Grant 2018CX030 and 2019CX013. The authors declare that they have no conflicts of interest with the contents of this article.	An LL, 2014, EUR J IMMUNOL, V44, P3669, DOI 10.1002/eji.201444560; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Boriushkin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25013; Bosmann M, 2013, EUR J IMMUNOL, V43, P1907, DOI 10.1002/eji.201243075; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Croker DE, 2014, IMMUNOL CELL BIOL, V92, P631, DOI 10.1038/icb.2014.32; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Fattahi F, 2018, MOL IMMUNOL, V102, P32, DOI 10.1016/j.molimm.2018.06.006; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Haggadone MD, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/1340156; Hajishengallis G, 2017, NAT IMMUNOL, V18, P1288, DOI 10.1038/ni.3858; Hett EC, 2013, NAT CHEM BIOL, V9, P398, DOI [10.1038/nchembio.1236, 10.1038/NCHEMBIO.1236]; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Kalbitz M, 2016, FASEB J, V30, P3997, DOI 10.1096/fj.201600728R; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Khameneh HJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00010; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Li SJ, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0006-9; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Luo BB, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00519; Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; POWIS G, 1994, CANCER RES, V54, P2419; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Riedemann NC, 2003, J LEUKOCYTE BIOL, V74, P966, DOI 10.1189/jlb.0403137; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sarma JV, 2012, CELL HEALTH CYTOSKEL, V4, P73, DOI 10.2147/CHC.S27233; Simon C, 1998, CANCER RES, V58, P1135; Strachan AJ, 2000, J IMMUNOL, V164, P6560, DOI 10.4049/jimmunol.164.12.6560; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Wood AJT, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.13028; Xie M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13280; Xu GL, 2014, HEPATOLOGY, V60, P114, DOI 10.1002/hep.27114; Zhang T, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6073961	51	30	31	6	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8384	8394		10.1074/jbc.RA118.006508	http://dx.doi.org/10.1074/jbc.RA118.006508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30971430	hybrid, Green Published			2022-12-28	WOS:000471108200009
J	Yoo, H; Triandafillou, C; Drummond, DA				Yoo, Haneul; Triandafillou, Catherine; Drummond, D. Allan			Cellular sensing by phase separation: Using the process, not just the products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						biosensor; cell biology; cellular regulation; stress response; biophysics; cyclic GMP-AMP synthase; phase separation; phase transition; poly(A)-binding protein; Sup35	CYCLIC GMP-AMP; HEAT-SHOCK; PROTEIN-SYNTHESIS; OXIDATIVE STRESS; INTRACELLULAR PH; LIQUID-LIKE; YEAST; RNA; PRIONS; PHOSPHORYLATION	Phase separation creates two distinct liquid phases from a single mixed liquid phase, like oil droplets separating from water. Considerable attention has focused on how the products of phase separationthe resulting condensatesmight act as biological compartments, bioreactors, filters, and membraneless organelles in cells. Here, we expand this perspective, reviewing recent results showing how cells instead use the process of phase separation to sense intracellular and extracellular changes. We review case studies in phase separation-based sensing and discuss key features, such as extraordinary sensitivity, which make the process of phase separation ideally suited to meet a range of sensory challenges cells encounter.	[Yoo, Haneul; Drummond, D. Allan] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Triandafillou, Catherine] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA; [Drummond, D. Allan] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Drummond, DA (corresponding author), Univ Chicago, GCIS W234,929 E 57th St, Chicago, IL 60637 USA.	dadrummond@uchicago.edu	; Drummond, D. Allan/A-1250-2015	Yoo, Haneul/0000-0002-5015-2630; Drummond, D. Allan/0000-0001-7018-7059				Al-Husini N, 2018, MOL CELL, V71, P1027, DOI 10.1016/j.molcel.2018.08.003; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Blomberg A, 2000, FEMS MICROBIOL LETT, V182, P1; Bouchard JJ, 2018, MOL CELL, V72, P19, DOI 10.1016/j.molcel.2018.08.027; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; Chantranupong L, 2015, CELL, V161, P67, DOI 10.1016/j.cell.2015.02.041; Cherkasov V, 2015, FEBS LETT, V589, P3654, DOI 10.1016/j.febslet.2015.10.010; Cherkasov V, 2013, CURR BIOL, V23, P2452, DOI 10.1016/j.cub.2013.09.058; CREWS D, 1994, DEV GENET, V15, P297, DOI 10.1002/dvg.1020150310; Delarue M, 2018, CELL, V174, P338, DOI 10.1016/j.cell.2018.05.042; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Du ZQ, 2015, CELL REP, V13, P2865, DOI 10.1016/j.celrep.2015.11.060; Dumetz AC, 2008, BIOPHYS J, V94, P570, DOI 10.1529/biophysj.107.116152; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Garcia DM, 2016, ELIFE, V5, DOI 10.7554/eLife.17978; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Gutierrez J. I., 2017, BIORXIV, DOI [10.1101/165043, DOI 10.1101/165043]; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Holehouse AS, 2018, BIOCHEMISTRY-US, V57, P2415, DOI 10.1021/acs.biochem.7b01136; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Isom DG, 2018, J BIOL CHEM, V293, P2318, DOI 10.1074/jbc.RA117.000422; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; Jin MY, 2017, CELL REP, V20, P895, DOI 10.1016/j.celrep.2017.06.082; Joyner RP, 2016, ELIFE, V5, DOI 10.7554/eLife.09376; Kawai-Noma S, 2010, J CELL BIOL, V190, P223, DOI 10.1083/jcb.201002149; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Kroschwald S, 2018, CELL REP, V23, P3327, DOI 10.1016/j.celrep.2018.05.041; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Lu HS, 2018, NATURE, V558, P318, DOI 10.1038/s41586-018-0174-3; Lynch EM, 2017, NAT STRUCT MOL BIOL, V24, P507, DOI 10.1038/nsmb.3407; Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366; March ZM, 2016, BRAIN RES, V1647, P9, DOI 10.1016/j.brainres.2016.02.037; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Monterroso B, 2019, EMBO REP, V20, DOI 10.15252/embr.201845946; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Munder MC, 2016, ELIFE, V5, DOI 10.7554/eLife.09347; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Nott TJ, 2016, NAT CHEM, V8, P570, DOI [10.1038/NCHEM.2519, 10.1038/nchem.2519]; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Patel A, 2017, SCIENCE, V356, P753, DOI 10.1126/science.aaf6846; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Reyes BA, 2008, J BIOL RHYTHM, V23, P95, DOI 10.1177/0748730407311855; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Rosenzweig ESF, 2017, CELL, V171, P148, DOI 10.1016/j.cell.2017.08.008; Ruff KM, 2018, J MOL BIOL, V430, P4619, DOI 10.1016/j.jmb.2018.06.031; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006; Schmidt HB, 2016, TRENDS BIOCHEM SCI, V41, P46, DOI 10.1016/j.tibs.2015.11.001; Schmidt HB, 2015, ELIFE, V4, DOI 10.7554/eLife.04251; Sengupta P, 2013, CURR BIOL, V23, pR304, DOI 10.1016/j.cub.2013.03.009; Shamir M, 2016, CELL, V164, P1302, DOI 10.1016/j.cell.2016.02.058; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Simpson-Lavy K, 2017, MOL CELL, V68, P1120, DOI 10.1016/j.molcel.2017.11.016; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Weber SC, 2015, CURR BIOL, V25, P641, DOI 10.1016/j.cub.2015.01.012; WEITZEL G, 1987, EXP CELL RES, V170, P64, DOI 10.1016/0014-4827(87)90117-0; WEITZEL G, 1985, EXP CELL RES, V159, P252, DOI 10.1016/S0014-4827(85)80054-9; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	85	91	91	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7151	7159		10.1074/jbc.TM118.001191	http://dx.doi.org/10.1074/jbc.TM118.001191			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877200	hybrid, Green Published			2022-12-28	WOS:000468402900005
J	Zhang, F; Zhang, CX; Xu, XX; Zhang, YX; Gong, X; Yang, ZQ; Zhang, H; Tang, DF; Liang, SP; Liu, ZH				Zhang, Fan; Zhang, Changxin; Xu, Xunxun; Zhang, Yunxiao; Gong, Xue; Yang, Zuqin; Zhang, Heng; Tang, Dongfang; Liang, Songping; Liu, Zhonghua			Naja atra venom peptide reduces pain by selectively blocking the voltage-gated sodium channel Nav1.8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						voltage-dependent anion channel (VDAC); pain; animal model; peptides; electrophysiology; Nav1; 8; snake venom; three-finger peptide; selectivity; neuropathic pain; analgesic	LOW CYTOTOXIC ACTIVITY; AMINO-ACID-SEQUENCE; COBRA CARDIOTOXIN; NEUROPATHIC PAIN; NA(V)1.8; MODEL; INTEGRIN; BINDING; PROTEIN; IDENTIFICATION	The voltage-gated sodium channel Nav1.8 is preferentially expressed in peripheral nociceptive neurons and contributes to inflammatory and neuropathic pain. Therefore, Nav1.8 has emerged as one of the most promising analgesic targets for pain relief. Using large-scale screening of various animal-derived toxins and venoms for Nav1.8 inhibitors, here we identified -EPTX-Na1a, a 62-residue three-finger peptide from the venom of the Chinese cobra (Naja atra), as a potent inhibitor of Nav1.8, exhibiting high selectivity over other voltage-gated sodium channel subtypes. Using whole-cell voltage-clamp recordings, we observed that purified -EPTX-Na1a blocked the Nav1.8 current. This blockade was associated with a depolarizing shift of activation and repolarizing shift of inactivation, a mechanism distinct from that of any other gating modifier toxin identified to date. In rodent models of inflammatory and neuropathic pain, -EPTX-Na1a alleviated nociceptive behaviors more potently than did morphine, indicating that -EPTX-Na1a has a potent analgesic effect. -EPTX-Na1a displayed no evident cytotoxicity and cardiotoxicity and produced no obvious adverse responses in mice even at a dose 30-fold higher than that producing a significant analgesic effect. Our study establishes -EPTX-Na1a as a promising lead for the development of Nav1.8-targeting analgesics to manage pain.	[Zhang, Fan; Zhang, Changxin; Xu, Xunxun; Zhang, Yunxiao; Gong, Xue; Yang, Zuqin; Zhang, Heng; Tang, Dongfang; Liang, Songping; Liu, Zhonghua] Hunan Normal Univ, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Coll Life Sci, Changsha 410081, Hunan, Peoples R China	Hunan Normal University	Liang, SP; Liu, ZH (corresponding author), Hunan Normal Univ, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Coll Life Sci, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; liuzh@hunnu.edu.cn			National Science Foundation [31570782]; Science Fund for Distinguished Young Scholars of Hunan Province [14JJ1018]	National Science Foundation(National Science Foundation (NSF)); Science Fund for Distinguished Young Scholars of Hunan Province(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by National Science Foundation Project 31570782, the Science Fund for Distinguished Young Scholars of Hunan Province under Grant 14JJ1018. The authors declare that they have no conflicts of interest with the contents of this article.	Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Blasius AL, 2011, P NATL ACAD SCI USA, V108, P19413, DOI 10.1073/pnas.1117020108; Bradman MJG, 2015, J NEUROSCI METH, V255, P92, DOI 10.1016/j.jneumeth.2015.08.010; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Doherty KR, 2015, TOXICOL APPL PHARM, V285, P51, DOI 10.1016/j.taap.2015.03.008; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; Erdemli G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00006; Fischer M, 2014, PAIN, V155, P511, DOI 10.1016/j.pain.2013.11.015; Gold MS, 2003, J NEUROSCI, V23, P158; Gong S, 2015, TOXICON, V93, P31, DOI 10.1016/j.toxicon.2014.11.222; Han CY, 2016, NEUROLOGY, V86, P473, DOI 10.1212/WNL.0000000000002333; Han CY, 2015, J NEUROPHYSIOL, V113, P3172, DOI 10.1152/jn.00113.2015; Han ZL, 2015, EUR J PHARMACOL, V754, P58, DOI 10.1016/j.ejphar.2015.02.019; Hoeijmakers JGJ, 2015, NEUROSCI LETT, V596, P51, DOI 10.1016/j.neulet.2014.12.056; Huang C.-F., 2012, INT J ANTENN PROPAG, V2012, P2012, DOI DOI 10.1155/2012/364741; INOUE S, 1987, FEBS LETT, V218, P17, DOI 10.1016/0014-5793(87)81009-8; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Kamiya K, 2008, J PHARMACOL SCI, V108, P301, DOI 10.1254/jphs.08102FP; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Kini RM, 2013, TOXICON, V62, P1, DOI 10.1016/j.toxicon.2012.09.002; Le Bars D, 2001, PHARMACOL REV, V53, P597; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Maingret F, 2008, J GEN PHYSIOL, V131, P211, DOI 10.1085/jgp.200709935; McCleary RJR, 2013, TOXICON, V62, P56, DOI 10.1016/j.toxicon.2012.09.008; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mechaly I, 2005, NEUROSCIENCE, V130, P389, DOI 10.1016/j.neuroscience.2004.09.034; Nogueira-Neto FD, 2008, PHARMACOL BIOCHEM BE, V91, P252, DOI 10.1016/j.pbb.2008.08.016; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Payne CE, 2015, BRIT J PHARMACOL, V172, P2654, DOI 10.1111/bph.13092; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rowe AH, 2013, SCIENCE, V342, P441, DOI 10.1126/science.1236451; Scanio MJC, 2010, BIOORGAN MED CHEM, V18, P7816, DOI 10.1016/j.bmc.2010.09.057; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Seo JA, 2016, CANCER LETT, V371, P30, DOI 10.1016/j.canlet.2015.11.021; Shewell LK, 2014, P NATL ACAD SCI USA, V111, pE5312, DOI 10.1073/pnas.1412703111; TAKECHI M, 1985, BIOCHEM INT, V11, P795; Tang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09241; Thakor DK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-14; Wang CH, 2006, J BIOL CHEM, V281, P656, DOI 10.1074/jbc.M507880200; Wang WJ, 2008, BIOCHEM BIOPH RES CO, V369, P753, DOI 10.1016/j.bbrc.2008.02.091; Wang WJ, 2010, BRIT J PHARMACOL, V160, P1338, DOI 10.1111/j.1476-5381.2010.00781.x; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3	49	11	13	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7324	7334		10.1074/jbc.RA118.007370	http://dx.doi.org/10.1074/jbc.RA118.007370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30804211	hybrid, Green Published			2022-12-28	WOS:000468402900020
J	Wang, AJ; Ren, J; Abbadi, A; Wang, AM; Hascall, VC				Wang, Andrew Jun; Ren, Juan; Abbadi, Amina; Wang, Aimin; Hascall, Vincent C.			Heparin affects cytosolic glucose responses of hyperglycemic dividing mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetic nephropathy; inflammation; hyaluronan; glucose transporter type 4 (GLUT4); extracellular matrix; glomerular lesion; glucose uptake; hyperglycemia; kidney disease; mesangial cells	C-FOS INDUCTION; HYALURONAN MATRIX; PROLIFERATION; MICROANALYSIS; INHIBITION; ACTIVATION; EXPRESSION; ADHESIVE; SULFATE	Mesangial expansion underlies diabetic nephropathy, leading to sclerosis and renal failure. The glycosaminoglycan heparin inhibits mesangial cell growth, but the molecular mechanism is unclear. Here, rat mesangial cells (RMCs) were growth-arrested in the G(0)/G(1) phase of cell division, stimulated to divide in normal glucose (5.6 mm) or high glucose (25.6 mm) with or without heparin, and analyzed for glucose uptake. We observed that RMCs entering the G(1) phase in normal glucose with or without heparin rapidly cease glucose uptake. RMCs entering G(1) in high glucose sustained glucose uptake for the first 3 h, and high-glucose exposure of RMCs only in the first 8 h of G(1) induced the formation of an extracellular monocyte-adhesive hyaluronan matrix after cell division was completed. Moreover, a low heparin concentration under high-glucose conditions blocked glucose uptake by 1 h into G(1). Of note, glucose transporter 4 (glut4) localized on the RMC surface at G(0)/G(1) and was internalized into G(1) cells under normal glucose conditions with or without heparin within 30 min. We also noted that, under high-glucose conditions, glut4 remained on the RMC surface for at least 2 h into G(1) and was internalized by 4 h without heparin and within 1 h with heparin. These results provide evidence that the influx of glucose in hyperglycemic dividing RMCs initiates intermediate glucose metabolism, leading to increased cytosolic UDP sugars, and induces abnormal intracellular hyaluronan synthesis during the S phase of cell division.	[Wang, Andrew Jun; Ren, Juan; Abbadi, Amina; Wang, Aimin; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND20, Cleveland, OH 44195 USA.	wanga@ccf.org			National Institutes of Health [R01 DK62934, P01 HL107147]; Mizutani Foundation [1000057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 DK62934 (to A. W.) and P01 HL107147 (to V. H. and A. W., Project 1) and by Mizutani Foundation Grant 1000057 (to V. H. and A. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Babazono T, 1998, DIABETES, V47, P668, DOI 10.2337/diabetes.47.4.668; Blodgett AB, 2011, DIABETES TECHNOL THE, V13, P743, DOI 10.1089/dia.2011.0041; BROSIUS FC, 1992, KIDNEY INT, V42, P1086, DOI 10.1038/ki.1992.391; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; CASTELLOT JJ, 1986, AM J PATHOL, V125, P493; CASTELLOT JJ, 1985, AM J PATHOL, V120, P427; COFFEY AK, 1985, AM J PATHOL, V120, P248; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DIAMOND JR, 1991, AM J PHYSIOL, V260, pF779, DOI 10.1152/ajprenal.1991.260.6.F779; DIAMOND JR, 1986, RENAL PHYSIOL BIOCH, V9, P366; Dunlop ME, 1996, KIDNEY INT, V50, P40, DOI 10.1038/ki.1996.284; FLOEGE J, 1993, KIDNEY INT, V43, P369, DOI 10.1038/ki.1993.55; FURUTA T, 1993, AM J KIDNEY DIS, V21, P480, DOI 10.1016/S0272-6386(12)80393-3; GAMBARO G, 1992, KIDNEY INT, V42, P285, DOI 10.1038/ki.1992.288; GAMBARO G, 1994, KIDNEY INT, V46, P797, DOI 10.1038/ki.1994.335; HEGELE RG, 1989, CLIN INVEST MED, V12, P181; Kwan J, 2005, KIDNEY INT, V68, P2526, DOI 10.1111/j.1523-1755.2005.00660.x; MAUER SM, 1994, KIDNEY INT, V45, P612, DOI 10.1038/ki.1994.80; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Mene P, 2001, NEPHROL DIAL TRANSPL, V16, P913, DOI 10.1093/ndt/16.5.913; Miralem T, 1996, J BIOL CHEM, V271, P17100, DOI 10.1074/jbc.271.29.17100; NAPARSTEK Y, 1990, ARTHRITIS RHEUM, V33, P1554, DOI 10.1002/art.1780331013; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; SIMONSON MS, 1990, METHOD ENZYMOL, V187, P544; TEMPLETON DM, 1990, J BIOL CHEM, V265, P21764; Wang AM, 2014, J BIOL CHEM, V289, P9418, DOI 10.1074/jbc.M113.541441; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang AM, 1996, KIDNEY INT, V49, P437, DOI 10.1038/ki.1996.63; WANG AM, 1994, J CELL PHYSIOL, V159, P295, DOI 10.1002/jcp.1041590213; Whiteside CI, 2002, AM J PHYSIOL-RENAL, V282, pF975, DOI 10.1152/ajprenal.00014.2002; Wolf G, 1999, KIDNEY INT, V56, P1262, DOI 10.1046/j.1523-1755.1999.00695.x; Xia L, 2006, AM J PHYSIOL-RENAL, V290, pF345, DOI 10.1152/ajprenal.00119.2005; Young B., 1992, Journal of the American Society of Nephrology, V3, P770; YOUNG BA, 1995, KIDNEY INT, V47, P935, DOI 10.1038/ki.1995.139	35	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6591	6597		10.1074/jbc.RA119.007395	http://dx.doi.org/10.1074/jbc.RA119.007395			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30723159	Green Published, hybrid			2022-12-28	WOS:000468402000032
J	Huang, W; Lv, XB; Liu, CY; Zha, ZY; Zhang, H; Jiang, Y; Xiong, Y; Lei, QY; Guan, KL				Huang, Wei; Lv, Xianbo; Liu, Chenying; Zha, Zhengyu; Zhang, Heng; Jiang, Ying; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang			The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCF-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition (vol 287, pg 26245, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Guan, Kun-Liang/ADK-7088-2022					Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036	1	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5809	5809		10.1074/jbc.AAC119.008437	http://dx.doi.org/10.1074/jbc.AAC119.008437			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30979851	Green Published, hybrid			2022-12-28	WOS:000465077500010
J	Levy, M; Elkoshi, N; Barber-Zucker, S; Hoch, E; Zarivach, R; Hershfinkel, M; Sekler, I				Levy, Moshe; Elkoshi, Nadav; Barber-Zucker, Shiran; Hoch, Eitan; Zarivach, Raz; Hershfinkel, Michal; Sekler, Israel			Zinc transporter 10 (ZnT10)-dependent extrusion of cellular Mn2+ is driven by an active Ca2+-coupled exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zinc; anion transport; calcium transport; membrane transport; manganese; hypermanganesemia; manganese extrusion; solute carrier family 30 member 10 (SLC30A10); zinc transport; zinc transporter (ZnT); ion transport; Ca2+ coupled exchange; active transport; cation diffusion facilitator	ALZHEIMERS-DISEASE; INTRACELLULAR TRAFFICKING; MANGANESE; MUTATIONS; SLC30A10; PARKINSONISM; MECHANISM; ALIGNMENT; PROTEINS; CALCIUM	Manganese (Mn2+) is extruded from the cell by the zinc transporter 10 (ZnT10). Loss of ZnT10 expression caused by autosomal mutations in the ZnT10 gene leads to hypermanganesemia in multiple organs. Here, combining fluorescent monitoring of cation influx in HEK293-T cells expressing human ZnT10 with molecular modeling of ZnT10 cation selectivity, we show that ZnT10 is exploiting the transmembrane Ca2+ inward gradient for active cellular exchange of Mn2+. In analyzing ZnT10 activity we used the ability of Fura-2 to spectrally distinguish between Mn2+ and Ca2+ fluxes. We found that (a) application of Mn2+-containing Ca2+-free solution to ZnT10-expressing cells triggers an influx of Mn2+, (b) reintroduction of Ca2+ leads to cellular Mn2+ extrusion against an inward Mn2+ gradient, and (c) the cellular transport of Mn2+ by ZnT10 is coupled to a reciprocal movement of Ca2+. Remarkably, replacing a single asparagine residue in ZnT10 (Asp-43) with threonine (ZnT10 N43T) converted the Mn2+/Ca2+ exchange to an uncoupled channel mode, permeable to both Ca2+ and Mn2+. The findings in our study identify the first ion transporter that uses the Ca2+ gradient for active counter-ion exchange. They highlight a remarkable versatility in metal selectivity and mode of transport controlled by the tetrahedral metal transport site of ZnT proteins.	[Levy, Moshe; Elkoshi, Nadav; Hershfinkel, Michal; Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, IL-8410501 Beer Sheva, Israel; [Hoch, Eitan] Broad Inst & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Hoch, Eitan] Broad Inst & Harvard, Metab Program, Cambridge, MA 02142 USA; [Barber-Zucker, Shiran; Zarivach, Raz] Ben Gurion Univ Negev, Dept Life Sci, IL-8410501 Beer Sheva, Israel; [Barber-Zucker, Shiran; Zarivach, Raz] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-8410501 Beer Sheva, Israel; [Barber-Zucker, Shiran; Zarivach, Raz] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-8410501 Beer Sheva, Israel	Ben Gurion University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Ben Gurion University; Ben Gurion University; Ben Gurion University	Sekler, I (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol & Cell Biol, IL-8410501 Beer Sheva, Israel.	Sekler@bgu.ac.il	ZARIVACH, RAZ/F-1671-2012	ZARIVACH, RAZ/0000-0001-6543-0296; Sekler, Israel/0000-0002-7550-1550; Hershfinkel, Michal/0000-0003-1652-1989	Israel Science Foundation [ISF 1429/17 ISF-China 1210/14, DIP SE2372/1-1, ISF 891/14]; Israel Ministry of Science, Technology and Space, Israel Science Foundation [167/16]; European Molecular Biology Organization; CMST COST Action [CM1306]	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science, Technology and Space, Israel Science Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); CMST COST Action	This work was supported by Israel Science Foundation Grants ISF 1429/17 ISF-China 1210/14 and DIP SE2372/1-1 (to I. S.) and ISF 891/14 (to M. H.) and by the Israel Ministry of Science, Technology and Space, Israel Science Foundation Grant 167/16) (to R. Z. and S. B. -Z.). This work is also supported by the European Molecular Biology Organization and CMST COST Action CM1306. The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Barber-Zucker S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16777-5; Barcena HS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1250-x; Basurto-Islas G, 2013, J BIOL CHEM, V288, P17495, DOI 10.1074/jbc.M112.446070; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Boron WF., 2005, MED PHYSL CELLULAR M, V2nd; Bosomworth HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065475; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; BURCH RE, 1975, CLIN CHEM, V21, P501; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Fernandes J, 2017, TOXICOL SCI, V155, P213, DOI 10.1093/toxsci/kfw196; FONTERIZ RI, 1991, FEBS LETT, V283, P89, DOI 10.1016/0014-5793(91)80560-P; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hare DJ, 2016, METALLOMICS, V8, P628, DOI 10.1039/c6mt00019c; Hoch E, 2012, P NATL ACAD SCI USA, V109, P7202, DOI 10.1073/pnas.1200362109; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kwakye Gunnar F, 2011, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1218s48; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Lyubartseva G, 2010, BRAIN PATHOL, V20, P343, DOI 10.1111/j.1750-3639.2009.00283.x; MARKESBERY WR, 1984, NEUROTOXICOLOGY, V5, P49; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Martinez-Finley EJ, 2013, FREE RADICAL BIO MED, V62, P65, DOI 10.1016/j.freeradbiomed.2013.01.032; Matias Madeleine G, 2010, BMC Res Notes, V3, P158, DOI 10.1186/1756-0500-3-158; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Patrushev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033211; Pirchl M, 2009, NEUROPSYCHIATRIE, V23, P187; Quadri M, 2015, MOVEMENT DISORD, V30, P996, DOI 10.1002/mds.26202; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Roth JA, 2006, BIOL RES, V39, P45, DOI 10.4067/S0716-97602006000100006; Ruffin VA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00043; Rutter GA, 2015, DIABETOLOGIA, V58, P31, DOI 10.1007/s00125-014-3405-7; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sekler I, 2007, MOL MED, V13, P337, DOI 10.2119/2007-00037.Sekler; SIMONS TJB, 1988, NEUROSURG REV, V11, P119, DOI 10.1007/BF01794675; Smith MR, 2017, BIOCHEM BIOPH RES CO, V482, P388, DOI 10.1016/j.bbrc.2016.10.126; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong YW, 2014, J ALZHEIMERS DIS, V42, P865, DOI 10.3233/JAD-140534; Ward ML, 2003, J PHYSIOL-LONDON, V546, P537, DOI 10.1113/jphysiol.2002.029132; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	48	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5879	5889		10.1074/jbc.RA118.006816	http://dx.doi.org/10.1074/jbc.RA118.006816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30755481	hybrid, Green Published			2022-12-28	WOS:000465077500019
J	O'Connor, CM; Hoffa, MT; Taylor, SE; Avelar, RA; Narla, G				O'Connor, Caitlin M.; Hoffa, Matthew T.; Taylor, Sarah E.; Avelar, Rita A.; Narla, Goutham			Protein phosphatase 2A A regulates A protein expression and stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphatase 2 (PP2A); protein phosphatase; cancer biology; cell signaling; tumor suppressor gene; protein expression; PR65A; PR65B; PPP2R1A; PPP2R1B; interactome	11Q DELETIONS; PP2A COMPLEXES; A-ALPHA; SUBUNIT; LUNG; IDENTIFICATION; MUTATIONS	Protein phosphatase 2A (PP2A) represses many oncogenic signaling pathways and is an important tumor suppressor. PP2A comprises three distinct subunits and forms through a highly regulated biogenesis process, with the scaffolding A subunit existing as two highly related isoforms, A and A. PP2A's tumor-suppressive functions have been intensely studied, and PP2A inactivation has been shown to be a prerequisite for tumor formation. Interestingly, although partial loss of the A isoform is growth promoting, complete A loss has no transformative properties. Additionally, in cancer patients, A is found to be inactivated in a haploinsufficient manner. Using both cellular and in vivo systems, colorectal and endometrial cancer cell lines, and biochemical and cellular assays, here we examined why the complete loss of A does not promote tumorigenesis. CRISPR/Cas9-mediated homozygous A deletion resulted in decreased colony formation and tumor growth across multiple cell lines. Protein expression analysis of PP2A family members revealed that the A deletion markedly up-regulates A protein expression by increasing A protein stability. A knockdown in control and A knockout cell lines indicated that A is necessary for cell survival in the A knockout cells. In the setting of A deficiency, co-immunoprecipitation analysis revealed increased binding of specific PP2A regulatory subunits to A, and knockdown of these regulatory subunits restored colony-forming ability. Taken together, our results uncover a mechanism by which PP2A A regulates A protein stability and activity and suggests why homozygous loss of A is rarely seen in cancer patients.	[O'Connor, Caitlin M.; Narla, Goutham] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Hoffa, Matthew T.] Univ Michigan, Div Med Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Taylor, Sarah E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Avelar, Rita A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	Case Western Reserve University; University of Michigan System; University of Michigan; Case Western Reserve University; University of Michigan System; University of Michigan	Narla, G (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	gnarla@med.umich.edu	O'Connor, Caitlin M./AAC-5203-2020; Narla, Goutham/AAZ-5710-2020	O'Connor, Caitlin M./0000-0002-7840-6399; Narla, Goutham/0000-0003-4098-4203; Taylor, Sarah/0000-0003-2743-8099	National Cancer Institute, National Institutes of Health [R01 CA181654, T32 GM008803, F30 CA224979]; NATIONAL CANCER INSTITUTE [F30CA224979, R01CA181654, R01CA240993] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, T32GM008803] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute, National Institutes of Health Grants R01 CA181654 (to G. N.), T32 GM008803 (to C. M. O.), and F30 CA224979 (to S. E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chen HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007019; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Dohner H, 1997, BLOOD, V89, P2516, DOI 10.1182/blood.V89.7.2516; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Haesen D, 2016, CANCER RES, V76, P5719, DOI 10.1158/0008-5472.CAN-15-3342; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; KELDYSH PL, 1993, GENE CHROMOSOME CANC, V6, P45, DOI 10.1002/gcc.2870060109; Lange L, 2017, BIOL OPEN, V6, P752, DOI 10.1242/bio.023200; Little SC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5876; Liu J, 2012, CURR MOL MED, V12, P982, DOI 10.2174/156652412802480916; Oberg EA, 2012, J BIOL CHEM, V287, P43378, DOI 10.1074/jbc.M112.420281; Petzmann S, 2004, VIRCHOWS ARCH, V445, P151, DOI 10.1007/s00428-004-1052-y; Petzmann S, 2001, HUM PATHOL, V32, P333, DOI 10.1053/hupa.2001.22762; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruediger R, 2011, MOL CELL BIOL, V31, P3832, DOI 10.1128/MCB.05744-11; Ruvolo PP, 2016, BBA CLIN, V6, P87, DOI 10.1016/j.bbacli.2016.08.002; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sablina AA, 2007, CELL ADHES MIGR, V1, P140, DOI 10.4161/cam.1.3.4986; Sangodkar J, 2016, FEBS J, V283, P1004, DOI 10.1111/febs.13573; Shih IM, 2011, AM J PATHOL, V178, P1442, DOI 10.1016/j.ajpath.2011.01.009; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Walch AK, 1998, AM J PATHOL, V153, P1089, DOI 10.1016/S0002-9440(10)65653-2; Wiemann S, 2016, NAT METHODS, V13, P191, DOI 10.1038/nmeth.3776; Xiao G, 2018, CELL, V173, P470, DOI 10.1016/j.cell.2018.02.048; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	27	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5923	5934		10.1074/jbc.RA119.007593	http://dx.doi.org/10.1074/jbc.RA119.007593			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30796164	Green Published, hybrid			2022-12-28	WOS:000465077500024
J	Tang, K; Li, YJ; Yu, C; Wei, ZY				Tang, Kun; Li, Yujie; Yu, Cong; Wei, Zhiyi			Structural mechanism for versatile cargo recognition by the yeast class V myosin Myo2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; intracellular trafficking; protein-protein interaction; protein complex; mitochondrial transport; peroxisome; structural biology; X-ray crystallography; cargo binding domain; enzyme evolution; Myo2p; MyoVa; organelle transport	KINESIN-RELATED PROTEIN; GLOBULAR TAIL; MITOCHONDRIAL INHERITANCE; UNCONVENTIONAL MYOSIN; POLARIZED GROWTH; BINDING; DOMAIN; REGIONS; ASSOCIATION; CONTRIBUTE	Class V myosins are actin-dependent motors, which recognize numerous cellular cargos mainly via the C-terminal globular tail domain (GTD). Myo2, a yeast class V myosin, can transport a broad range of organelles. However, little is known about the capacity of Myo2-GTD to recognize such a diverse array of cargos specifically at the molecular level. Here, we solved crystal structures of Myo2-GTD (at 1.9-3.1 resolutions) in complex with three cargo adaptor proteins: Smy1 (for polarization of secretory vesicles), Inp2 (for peroxisome transport), and Mmr1 (for mitochondria transport). The structures of Smy1- and Inp2-bound Myo2-GTD, along with site-directed mutagenesis experiments, revealed a binding site in subdomain-I having a hydrophobic groove with high flexibility enabling Myo2-GTD to accommodate different protein sequences. The Myo2-GTD-Mmr1 complex structure confirmed and complemented a previously identified mitochondrion/vacuole-specific binding region. Moreover, differences between the conformations and locations of cargo-binding sites identified here for Myo2 and those reported for mammalian MyoVA (MyoVA) suggest that class V myosins potentially have co-evolved with their specific cargos. Our structural and biochemical analysis not only uncovers a molecular mechanism that explains the diverse cargo recognition by Myo2-GTD, but also provides structural information useful for future functional studies of class V myosins in cargo transport.	[Tang, Kun; Li, Yujie; Yu, Cong; Wei, Zhiyi] Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China; [Yu, Cong] Shenzhen Key Lab Cell Microenvironm, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China; [Wei, Zhiyi] SUSTech, Neural & Cognit Sci Res Ctr, Shenzhen, Peoples R China	Southern University of Science & Technology; Southern University of Science & Technology	Tang, K; Wei, ZY (corresponding author), Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China.; Wei, ZY (corresponding author), SUSTech, Neural & Cognit Sci Res Ctr, Shenzhen, Peoples R China.	tangk@sustc.edu.cn; weizy@sustc.edu.cn	Li, YuJie/HGT-8657-2022; Wei, Zhiyi/C-4315-2014; Tang, Kun/GSD-3218-2022; Li, yu/HHZ-5236-2022; Wei, Zhiyi/N-9995-2019; , 余聪/AAK-9457-2020	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; 	National Natural Science Foundation of China [31770791, 31570741, 31600612, 31870757]; Natural Science Foundation of Guangdong Province [2016A030312016]; Science and Technology Planning Project of Guangdong Province [2017B030301018]; Shenzhen Science and Technology Innovation Commission [JCYJ20160229153100269, ZDSYS20140509142721429]; Recruitment Program of Global Youth Experts of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Shenzhen Science and Technology Innovation Commission; Recruitment Program of Global Youth Experts of China	This work was supported by the National Natural Science Foundation of China Grants 31770791 and 31570741 (to Z. W.), 31600612 (to K. T.), and 31870757 (to C. Y.), Natural Science Foundation of Guangdong Province Grant 2016A030312016, Science and Technology Planning Project of Guangdong Province Grant 2017B030301018, Shenzhen Science and Technology Innovation Commission Grants JCYJ20160229153100269 and ZDSYS20140509142721429, and the Recruitment Program of Global Youth Experts of China (to Z. W. and C. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beningo KA, 2000, MOL BIOL CELL, V11, P691, DOI 10.1091/mbc.11.2.691; Casavola EC, 2008, MOL MICROBIOL, V67, P1051, DOI 10.1111/j.1365-2958.2008.06106.x; Catlett NL, 2000, J CELL BIOL, V150, P513, DOI 10.1083/jcb.150.3.513; Chen WT, 2018, MOL BIOL CELL, V29, P2346, DOI 10.1091/mbc.E18-02-0122; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Donovan KW, 2015, J CELL BIOL, V209, P359, DOI 10.1083/jcb.201411010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eskin JA, 2016, MOL BIOL CELL, V27, P828, DOI 10.1091/mbc.E15-09-0639; Eves PT, 2012, J CELL BIOL, V198, P69, DOI 10.1083/jcb.201201024; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fagarasanu A, 2009, J CELL BIOL, V186, P541, DOI 10.1083/jcb.200904050; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Heuck A, 2007, P NATL ACAD SCI USA, V104, P19778, DOI 10.1073/pnas.0706780104; Heuck A, 2010, J CELL BIOL, V189, P497, DOI 10.1083/jcb.201002076; Higuchi-Sanabria R, 2016, MOL BIOL CELL, V27, P776, DOI 10.1091/mbc.E15-07-0455; Hodges AR, 2009, CURR BIOL, V19, P2121, DOI 10.1016/j.cub.2009.10.069; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Ishikawa K, 2003, J CELL BIOL, V160, P887, DOI 10.1083/jcb.200210139; Itoh T, 2004, EMBO J, V23, P2520, DOI 10.1038/sj.emboj.7600271; Jin Y, 2011, DEV CELL, V21, P1156, DOI 10.1016/j.devcel.2011.10.009; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207522; LILLIE SH, 1992, NATURE, V356, P358, DOI 10.1038/356358a0; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lwin KM, 2016, MOL BIOL CELL, V27, P2450, DOI 10.1091/mbc.E16-03-0185; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Pashkova N, 2005, J CELL BIOL, V168, P359, DOI 10.1083/jcb.200407146; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pylypenko O, 2016, ELIFE, V5, DOI [10.7554/elife.17523, 10.7554/eLife.17523]; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Swayne TC, 2011, CURR BIOL, V21, P1994, DOI 10.1016/j.cub.2011.10.019; Tang FS, 2003, NATURE, V422, P87, DOI 10.1038/nature01453; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Wei ZY, 2013, P NATL ACAD SCI USA, V110, P11314, DOI 10.1073/pnas.1306768110; Zhang WB, 2016, J BIOL CHEM, V291, P13571, DOI 10.1074/jbc.M116.724328	43	7	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5896	5906		10.1074/jbc.RA119.007550	http://dx.doi.org/10.1074/jbc.RA119.007550			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30804213	hybrid, Green Published			2022-12-28	WOS:000465077500021
J	Francklyn, CS; Mullen, P				Francklyn, Christopher S.; Mullen, Patrick			Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						aminoacyl tRNA synthetase; antibiotic action; malaria; transfer RNA (tRNA); translation; inhibitor; aminoacyl sulfamate; mupirocin; peptidyl transferase; Trojan horse approach	ANGIOGENESIS INHIBITOR BORRELIDIN; PROTEIN-SYNTHESIS INHIBITORS; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; PSEUDOMONIC ACID; PLASMODIUM-FALCIPARUM; STRUCTURAL BASIS; BRUGIA-MALAYI; ANTIBACTERIAL ACTIVITY; EDITING MECHANISMS	Aminoacyl-tRNA synthetases (ARSs) are universal enzymes that catalyze the attachment of amino acids to the 3 ends of their cognate tRNAs. The resulting aminoacylated tRNAs are escorted to the ribosome where they enter protein synthesis. By specifically matching amino acids to defined anticodon sequences in tRNAs, ARSs are essential to the physical interpretation of the genetic code. In addition to their canonical role in protein synthesis, ARSs are also involved in RNA splicing, transcriptional regulation, translation, and other aspects of cellular homeostasis. Likewise, aminoacylated tRNAs serve as amino acid donors for biosynthetic processes distinct from protein synthesis, including lipid modification and antibiotic biosynthesis. Thanks to the wealth of details on ARS structures and functions and the growing appreciation of their additional roles regulating cellular homeostasis, opportunities for the development of clinically useful ARS inhibitors are emerging to manage microbial and parasite infections. Exploitation of these opportunities has been stimulated by the discovery of new inhibitor frameworks, the use of semi-synthetic approaches combining chemistry and genome engineering, and more powerful techniques for identifying leads from the screening of large chemical libraries. Here, we review the inhibition of ARSs by small molecules, including the various families of natural products, as well as inhibitors developed by either rational design or high-throughput screening as antibiotics and anti-parasitic therapeutics.	[Francklyn, Christopher S.; Mullen, Patrick] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont	Francklyn, CS (corresponding author), Univ Vermont, Larner Coll Med, Dept Biochem, Hlth Sci Complex,89 Beaumont Ave, Burlington, VT 05405 USA.	christopher.francklyn@uvm.edu			National Institutes of Health [5RO1 GM-54899]; NIGMS	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 5RO1 GM-54899 from NIGMS (to C. S. F.). This is the sixth article in the "tRNAs and aminoacyl-tRNA synthetases in human disease" JBC Reviews series. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2012, MEDCHEMCOMM, V3, P887, DOI 10.1039/c2md20032e; ANDERTON K, 1965, NATURE, V206, P269, DOI 10.1038/206269a0; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Ataide SF, 2006, ACS CHEM BIOL, V1, P285, DOI 10.1021/cb600200k; Azcarate IG, 2013, BRIT J PHARMACOL, V169, P645, DOI 10.1111/bph.12156; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Banwell MG, 2000, BIOORG MED CHEM LETT, V10, P2263, DOI 10.1016/S0960-894X(00)00456-X; BENZ G, 1982, ANGEW CHEM INT EDIT, V21, P527, DOI 10.1002/anie.198205271; BERGER J, 1949, ARCH BIOCHEM, V22, P476; Bernier S, 2000, BIOORG MED CHEM LETT, V10, P2441, DOI 10.1016/S0960-894X(00)00478-9; Bernier S, 2005, J ENZYM INHIB MED CH, V20, P61, DOI 10.1080/14756360400002007; Bhatt TK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-644; Boczonadi V, 2018, FEBS LETT, V592, P703, DOI 10.1002/1873-3468.12962; Bovee ML, 1999, BIOCHEMISTRY-US, V38, P13725, DOI 10.1021/bi991182g; Broom NJP, 1996, J MED CHEM, V39, P3596, DOI 10.1021/jm950882q; Brown MJB, 2000, BIOCHEMISTRY-US, V39, P6003, DOI 10.1021/bi000148v; Carter Charles W Jr, 2017, Adv Exp Med Biol, V966, P103, DOI 10.1007/5584_2017_93; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; CASSIO D, 1967, BIOCHEMISTRY-US, V6, P827, DOI 10.1021/bi00855a024; Cestari I, 2013, J BIOL CHEM, V288, P14256, DOI [10.1074/jbc.M112.447441, 10.1074/jbc.M1]; Charlton MH, 2018, ACS MED CHEM LETT, V9, P84, DOI 10.1021/acsmedchemlett.7b00374; Chenevert R, 2003, MOL B INT U, P416; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; Chopra S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2421; CLASS YJ, 1995, CHEM REV, V95, P1843, DOI 10.1021/cr00038a005; Cochrane RVK, 2016, ANGEW CHEM INT EDIT, V55, P664, DOI 10.1002/anie.201509345; Crasto CF, 2003, BIOORGAN MED CHEM, V11, P2687, DOI 10.1016/S0968-0896(03)00237-2; Critchley IA, 2005, ANTIMICROB AGENTS CH, V49, P4247, DOI 10.1128/AAC.49.10.4247-4252.2005; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Curnow A W, 1997, Nucleic Acids Symp Ser, P2; Curran SC, 2018, ACS CHEM BIOL, V13, P2261, DOI 10.1021/acschembio.8b00422; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Cusack S, 1996, EMBO J, V15, P2834, DOI 10.1002/j.1460-2075.1996.tb00644.x; Cusack S, 1996, EMBO J, V15, P6321, DOI 10.1002/j.1460-2075.1996.tb01022.x; Decker WK, 2009, BLOOD, V113, P4213, DOI 10.1182/blood-2008-10-185470; Dewan V, 2014, TOP CURR CHEM, V344, P293, DOI 10.1007/128_2013_425; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; Fang PF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7402; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P347; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; Finn J., 2003, AMINOACYL TRNA SYNTH, P405; Forrest AK, 2000, BIOORG MED CHEM LETT, V10, P1871, DOI 10.1016/S0960-894X(00)00360-7; Fukui H, 2009, CIRC RES, V104, P1253, DOI 10.1161/CIRCRESAHA.108.191189; FULLER AT, 1971, NATURE, V234, P416, DOI 10.1038/234416a0; Funahashi Y, 1999, ONCOL RES, V11, P319; Gadakh B, 2015, EUR J MED CHEM, V93, P227, DOI 10.1016/j.ejmech.2015.02.010; Gadakh B, 2014, BIOORGAN MED CHEM, V22, P2875, DOI 10.1016/j.bmc.2014.03.040; Gallay L, 2018, CURR OPIN RHEUMATOL, V30, P664, DOI 10.1097/BOR.0000000000000555; Gao YM, 2012, J AGR FOOD CHEM, V60, P9874, DOI 10.1021/jf302857x; GEARY TG, 1989, AM J TROP MED HYG, V40, P240, DOI 10.4269/ajtmh.1989.40.240; Ghanipour A, 2009, CANCER EPIDEM BIOMAR, V18, P2949, DOI 10.1158/1055-9965.EPI-09-0456; GILBART J, 1993, ANTIMICROB AGENTS CH, V37, P32, DOI 10.1128/AAC.37.1.32; GUIJARRO JI, 1995, J BIOL CHEM, V270, P23520, DOI 10.1074/jbc.270.40.23520; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Gurney R, 2011, APPL MICROBIOL BIOT, V90, P11, DOI 10.1007/s00253-011-3128-3; Guth E, 2005, BIOCHEMISTRY-US, V44, P3785, DOI 10.1021/bi047923h; Habibi D, 2012, INVEST NEW DRUG, V30, P1361, DOI 10.1007/s10637-011-9700-y; HEINSTEIN P, 1982, J PHARM SCI, V71, P197, DOI 10.1002/jps.2600710215; Herman JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3575; Herzog W, 2009, CIRC RES, V104, P1260, DOI 10.1161/CIRCRESAHA.108.191718; Hilander T, 2018, NUCLEIC ACIDS RES, V46, P849, DOI 10.1093/nar/gkx1231; Hill J. M., 1996, U. S. Patent, Patent No. [WO1996US11910, 199611910]; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Houge-Frydrych CSV, 2000, J ANTIBIOT, V53, P364, DOI 10.7164/antibiotics.53.364; Hu YM, 2018, SLAS DISCOV, V23, P65, DOI 10.1177/2472555217722016; Hu YM, 2016, ANTIMICROB AGENTS CH, V60, P4820, DOI 10.1128/AAC.00800-16; Hu Yanmei, 2014, Curr Drug Discov Technol, V11, P279; Hurdle JG, 2005, ANTIMICROB AGENTS CH, V49, P4821, DOI 10.1128/AAC.49.12.4821-4833.2005; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 2001, EMBO REP, V2, P382; Ibba M., 2005, AMINOACYL TRNA SYNTH, P1; Ishiyama A, 2011, J ANTIBIOT, V64, P381, DOI 10.1038/ja.2011.6; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Jackson KE, 2012, INT J PARASITOL, V42, P177, DOI 10.1016/j.ijpara.2011.11.008; Jarvest RL, 2002, J MED CHEM, V45, P1959, DOI 10.1021/jm025502x; Jarvest RL, 1999, BIOORG MED CHEM LETT, V9, P2859, DOI 10.1016/S0960-894X(99)00488-6; Kalidas S, 2014, EUKARYOT CELL, V13, P504, DOI 10.1128/EC.00017-14; Kamberov Yana G, 2011, BMC Res Notes, V4, P381, DOI 10.1186/1756-0500-4-381; Kato N, 2016, NATURE, V538, P344, DOI 10.1038/nature19804; Kawamura T, 2003, J ANTIBIOT, V56, P709, DOI 10.7164/antibiotics.56.709; Kazakov T, 2014, J BACTERIOL, V196, P3377, DOI 10.1128/JB.01584-14; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Khan S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1247-0; Khan Sameena, 2014, Journal of Structural and Functional Genomics, V15, P63, DOI 10.1007/s10969-014-9182-1; Khan S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00188; Kim DG, 2014, NAT CHEM BIOL, V10, P29, DOI [10.1038/nchembio.1381, 10.1038/NCHEMBIO.1381]; Kim DG, 2012, FASEB J, V26, P4142, DOI 10.1096/fj.12-207639; Kim EY, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3452-9; Kim JG, 2006, P NATL ACAD SCI USA, V103, P8846, DOI 10.1073/pnas.0602965103; Kim SY, 2006, BIOORG MED CHEM LETT, V16, P4898, DOI 10.1016/j.bmcl.2006.06.057; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Kim YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040960; KOEPFLI JB, 1949, J AM CHEM SOC, V71, P1048, DOI 10.1021/ja01171a080; KOEPFLI JB, 1947, J AM CHEM SOC, V69, P1837, DOI 10.1021/ja01199a513; KOHNO T, 1990, J BIOL CHEM, V265, P6931; Kong J, 2018, SLAS DISCOV, V23, P174, DOI 10.1177/2472555217734128; KONRAD I, 1977, FEBS LETT, V83, P341, DOI 10.1016/0014-5793(77)81037-5; Kron M, 2003, MOL BIOCHEM PARASIT, V129, P33, DOI 10.1016/S0166-6851(03)00080-X; KRON M, 1995, FEBS LETT, V374, P122, DOI 10.1016/0014-5793(95)01092-S; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Lin JZ, 2018, ANNU REV BIOCHEM, V87, P451, DOI 10.1146/annurev-biochem-062917-011942; Lin ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05821-1; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Liu CX, 2012, J AGR FOOD CHEM, V60, P1251, DOI 10.1021/jf2044982; Liu CX, 2013, INT J SYST EVOL MICR, V63, P1030, DOI 10.1099/ijs.0.041483-0; LUMB M, 1965, NATURE, V206, P263, DOI 10.1038/206263a0; Novoa EM, 2014, P NATL ACAD SCI USA, V111, pE5508, DOI 10.1073/pnas.1405994111; McGaha TL, 2002, J INVEST DERMATOL, V118, P461, DOI 10.1046/j.0022-202x.2001.01690.x; Melnikov SV, 2018, P NATL ACAD SCI USA, V115, pE6245, DOI 10.1073/pnas.1803208115; Mendes RE, 2013, ANTIMICROB AGENTS CH, V57, P2849, DOI 10.1128/AAC.00160-13; Metlitskaya A, 2006, J BIOL CHEM, V281, P18033, DOI 10.1074/jbc.M513174200; Meyer-Schuman R, 2017, HUM MOL GENET, V26, pR114, DOI 10.1093/hmg/ddx231; Milner DA, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a025569; Minajigi A, 2011, BIOCHEMISTRY-US, V50, P1101, DOI 10.1021/bi101360a; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Mirando AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13160; Moss SJ, 2006, CHEM COMMUN, P2341, DOI 10.1039/b602931k; Muguruma H, 2005, CLIN CANCER RES, V11, P8822, DOI 10.1158/1078-0432.CCR-05-1335; Mukai T, 2017, MBIO, V8, DOI 10.1128/mBio.00561-17; Nagamitsu T, 2007, J ORG CHEM, V72, P2744, DOI 10.1021/jo062089i; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Nare B, 2010, ANTIMICROB AGENTS CH, V54, P4379, DOI 10.1128/AAC.00498-10; NASS G, 1976, MOL GEN GENET, V147, P39, DOI 10.1007/BF00337933; Niehues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8520; Nocek B, 2012, J MOL BIOL, V420, P366, DOI 10.1016/j.jmb.2012.04.011; O'Dwyer K, 2015, ANTIMICROB AGENTS CH, V59, P289, DOI 10.1128/AAC.03774-14; O'Reilly R, 2013, DRUG DES DEV THER, V7, P929, DOI 10.2147/DDDT.S30345; Ochsner UA, 2007, EXPERT OPIN INV DRUG, V16, P573, DOI 10.1517/13543784.16.5.573; OKI T, 1989, J ANTIBIOT, V42, P1756, DOI 10.7164/antibiotics.42.1756; Olano C, 2004, CHEM BIOL, V11, P87, DOI 10.1016/j.chembiol.2003.12.018; OSADA H, 1985, ANTIMICROB AGENTS CH, V27, P230, DOI 10.1128/AAC.27.2.230; Otoguro K, 2003, J ANTIBIOT, V56, P727, DOI 10.7164/antibiotics.56.727; Palencia A, 2016, ANTIMICROB AGENTS CH, V60, P6271, DOI 10.1128/AAC.01339-16; Palencia A, 2016, ANTIMICROB AGENTS CH, V60, P5817, DOI 10.1128/AAC.00873-16; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; Petraitiene R, 2005, ANTIMICROB AGENTS CH, V49, P2084, DOI 10.1128/AAC.49.5.2084-2092.2005; Pham JS, 2014, INT J PARASITOL-DRUG, V4, P1, DOI 10.1016/j.ijpddr.2013.10.001; PINION JL, 1995, POULTRY SCI, V74, P391, DOI 10.3382/ps.0740391; Pope AJ, 1998, J BIOL CHEM, V273, P31702, DOI 10.1074/jbc.273.48.31702; Pope AJ, 1998, J BIOL CHEM, V273, P31691, DOI 10.1074/jbc.273.48.31691; Qiu XY, 2001, PROTEIN SCI, V10, P2008, DOI 10.1110/ps.18001; Randall CP, 2016, ANTIMICROB AGENTS CH, V60, P6359, DOI 10.1128/AAC.00674-16; Rath VL, 1998, STRUCT FOLD DES, V6, P439, DOI 10.1016/S0969-2126(98)00046-X; Reader JS, 2005, SCIENCE, V309, P1533, DOI 10.1126/science.1116841; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Robles Sara, 2017, Curr Drug Discov Technol, V14, P156, DOI 10.2174/1570163814666170330100238; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; ROTH A, 1993, FEBS LETT, V326, P87, DOI 10.1016/0014-5793(93)81767-T; Ruan BF, 2005, J BIOL CHEM, V280, P571, DOI 10.1074/jbc.M411039200; Ruan BF, 2004, J BACTERIOL, V186, P8, DOI 10.1128/JB.186.1.8-14.2004; Saint-Leger A, 2016, BIOENGINEERED, V7, P60, DOI 10.1080/21655979.2016.1149270; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; Schulze CJ, 2014, J NAT PROD, V77, P2570, DOI 10.1021/np500727g; SCOTT PM, 1971, J ANTIBIOT, V24, P747, DOI 10.7164/antibiotics.24.747; Shibata A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186587; SHIOZAWA H, 1995, J ANTIBIOT, V48, P907, DOI 10.7164/antibiotics.48.907; SHIOZAWA H, 1993, J ANTIBIOT, V46, P1834, DOI 10.7164/antibiotics.46.1834; Sidhu A, 2015, ACS MED CHEM LETT, V6, P1122, DOI 10.1021/acsmedchemlett.5b00133; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Song Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02201-z; Stefanska AL, 2000, J ANTIBIOT, V53, P357, DOI 10.7164/antibiotics.53.357; Stefanska AL, 2000, J ANTIBIOT, V53, P1346, DOI 10.7164/antibiotics.53.1346; Stoll A., 1958, FESTSCHRIFT A STOLL, P597; Sugawara A, 2013, BIOORG MED CHEM LETT, V23, P2302, DOI 10.1016/j.bmcl.2013.02.075; Sukuru SCK, 2006, J COMPUT AID MOL DES, V20, P159, DOI 10.1007/s10822-006-9043-5; Sun JB, 2018, BIOORGAN MED CHEM, V26, P1488, DOI 10.1016/j.bmc.2018.01.010; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Tahmasebi S, 2018, NAT REV MOL CELL BIO, V19, P791, DOI 10.1038/s41580-018-0034-x; TANAKA K, 1969, BIOCHIM BIOPHYS ACTA, V195, P244, DOI 10.1016/0005-2787(69)90621-2; Targoff IN, 2000, CURR OPIN RHEUMATOL, V12, P475, DOI 10.1097/00002281-200011000-00001; Teng M, 2013, J MED CHEM, V56, P1748, DOI 10.1021/jm301756m; Thomas CM, 2010, NAT REV MICROBIOL, V8, P281, DOI 10.1038/nrmicro2278; Tsai PC, 2017, BRAIN, V140, P1252, DOI 10.1093/brain/awx058; Ubukata M, 1985, Nucleic Acids Symp Ser, P81; Van de Vijver P, 2008, J MED CHEM, V51, P3020, DOI 10.1021/jm8000746; Van de Vijver P, 2009, J BACTERIOL, V191, P6273, DOI 10.1128/JB.00829-09; Vondenhoff GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079234; Vondenhoff GH, 2012, CHEMBIOCHEM, V13, P1959, DOI 10.1002/cbic.201200174; Vondenhoff GHM, 2011, EUR J MED CHEM, V46, P5227, DOI 10.1016/j.ejmech.2011.08.049; Wakabayashi T, 1997, J ANTIBIOT, V50, P671, DOI 10.7164/antibiotics.50.671; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wellman TL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-620; WERNER RG, 1976, EUR J BIOCHEM, V68, P1, DOI 10.1111/j.1432-1033.1976.tb10758.x; Wilkinson B, 2006, BIOORG MED CHEM LETT, V16, P5814, DOI 10.1016/j.bmcl.2006.08.073; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Yu XY, 2001, BIOORG MED CHEM LETT, V11, P541, DOI 10.1016/S0960-894X(00)00697-1; Yu Z, 2011, ORG LETT, V13, P2034, DOI 10.1021/ol200420u; Zeng Y, 2012, ACS CHEM BIOL, V7, P1565, DOI 10.1021/cb300173x; Zhang B, 2018, EUR J MED CHEM, V148, P384, DOI 10.1016/j.ejmech.2018.02.013; Zhang N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006850; Zhao CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114722; Zhao YX, 2012, BIOORGAN MED CHEM, V20, P1240, DOI 10.1016/j.bmc.2011.12.035; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410	202	66	67	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5365	5385		10.1074/jbc.REV118.002956	http://dx.doi.org/10.1074/jbc.REV118.002956			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30670594	Green Published, hybrid			2022-12-28	WOS:000464517500011
J	Luo, J; Yang, BY; Xin, GW; Sun, MJ; Zhang, BY; Guo, X; Jiang, Q; Zhang, CM				Luo, Jia; Yang, Biying; Xin, Guangwei; Sun, Mengjie; Zhang, Boyan; Guo, Xiao; Jiang, Qing; Zhang, Chuanmao			The microtubule-associated protein EML3 regulates mitotic spindle assembly by recruiting the Augmin complex to spindle microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitotic spindle; microtubule; microtubule-associated protein (MAP); checkpoint control; mitosis; cell division; cytoskeleton; Augmin; chromosome congression; EML3; microtubule nucleation; spindle assembly	PROVIDES INSIGHTS; NUCLEATION; ARCHITECTURE; MITOSIS; PHOSPHORYLATION; ORGANIZATION; CHROMOSOMES; GENERATION; ALIGNMENT; CLATHRIN	In all eukaryotes, a functional mitotic spindle is essential for distributing duplicated chromosomes into daughter cells. Mitotic spindle assembly involves highly ordered arrangement of microtubules (MTs). The Augmin protein complex recruits -tubulin ring complex (-TuRC) to MTs and thereby promotes MT-based MT nucleation and mitotic spindle assembly. However, several factors that may promote Augmin recruitment to MTs remain unknown. Here, we show that echinoderm microtubule-associated protein-like 3 (EML3), an MT-associated protein, facilitates binding between MTs and Augmin/-TuRC and recruiting the latter to MTs for proper mitotic spindle assembly and kinetochore-MT connections. Using immunofluorescence microscopy, live-cell imaging, and immunoprecipitation assays, we found that EML3 recruits Augmin/-TuRC to the MTs to enhance MT-based MT nucleation in both spindle and small acentrosomal asters. We also noted that the EML3-mediated recruitment is controlled by cyclin-dependent kinase 1 (CDK1), which phosphorylated EML3 at Thr-881 and promoted its binding to Augmin/-TuRC. RNAi-mediated EML3 knockdown in HeLa cells reduced spindle localization of Augmin/-TuRC, which resulted in abnormal spindle assembly and caused kinetochore-MT misconnection. The introduction of exogenous WT or a Thr-881 phosphorylation mimic EML3 variant into the EML3 knockdown cells restored normal Augmin/-TuRC localization and spindle assembly. The EML3 knockdown also affected the spindle assembly checkpoint, delaying chromosome congression and cell division. Taken together, our results indicate that EML3 regulates mitotic spindle assembly and the kinetochore-MT connection by regulating MT-based MT nucleation and recruiting Augmin/-TuRC to MTs.	[Luo, Jia; Yang, Biying; Xin, Guangwei; Sun, Mengjie; Zhang, Boyan; Guo, Xiao; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Luo, Jia; Yang, Biying; Xin, Guangwei; Sun, Mengjie; Zhang, Boyan; Guo, Xiao; Jiang, Qing; Zhang, Chuanmao] Peking Univ, State Key Lab Membrane Biol, Coll Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University	Zhang, CM (corresponding author), Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.	zhangcm@pku.edu.cn		Guo, Xiao/0000-0002-0533-3547; Zhang, Chuanmao/0000-0003-1359-6475; Zhang, Boyan/0000-0001-7112-9870	National Natural Science Foundation of is China; State Key Basic Research and Development Plan of the Ministry of Science and Technology of China [2016YFA0100501, 31430051, 2016YFA0500201, 31520103906]	National Natural Science Foundation of is China; State Key Basic Research and Development Plan of the Ministry of Science and Technology of China	This work was supported by the National Natural Science Foundation of is China and the State Key Basic Research and Development Plan of the Ministry of Science and Technology of China (Grants 2016YFA0100501, 31430051, 2016YFA0500201, and 31520103906). The authors declare that they have no conflicts of interest with the contents of this article.	Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Fu WX, 2013, P NATL ACAD SCI USA, V110, P15295, DOI 10.1073/pnas.1312382110; Fu WX, 2011, CELL RES, V21, P1655, DOI 10.1038/cr.2011.106; Fu WX, 2010, J CELL SCI, V123, P3645, DOI 10.1242/jcs.075911; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Guo YG, 2012, J CELL BIOL, V198, P205, DOI 10.1083/jcb.201202152; Helmke KJ, 2013, INT REV CEL MOL BIO, V306, P83, DOI 10.1016/B978-0-12-407694-5.00003-1; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hsia KC, 2014, NAT CELL BIOL, V16, P852, DOI 10.1038/ncb3030; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Kamasaki T, 2013, J CELL BIOL, V202, P25, DOI 10.1083/jcb.201304031; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Liu T, 2014, CURR BIOL, V24, P2708, DOI 10.1016/j.cub.2014.09.053; Lu Shan, 2018, Biophys Rep, V4, P68, DOI 10.1007/s41048-018-0050-6; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Masoud K, 2013, PLANT J, V75, P245, DOI 10.1111/tpj.12179; Meunier S, 2012, J CELL SCI, V125, P2805, DOI 10.1242/jcs.092429; Meunier S, 2011, NAT CELL BIOL, V13, P1406, DOI 10.1038/ncb2372; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Petry S, 2011, P NATL ACAD SCI USA, V108, P14473, DOI 10.1073/pnas.1110412108; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Song JG, 2018, J CELL BIOL, V217, P2417, DOI 10.1083/jcb.201711090; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Tegha-Dunghu J, 2008, J CELL SCI, V121, P1718, DOI 10.1242/jcs.019174; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Uehara R, 2009, P NATL ACAD SCI USA, V106, P6998, DOI 10.1073/pnas.0901587106; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wang G, 2014, J CELL SCI, V127, P4111, DOI 10.1242/jcs.151753; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Xu X. W., 2016, ELS WILEY ONLINE LIB, DOI [10.1002/9780470015902.a0022518, DOI 10.1002/9780470015902.A0022518]; Zhang XY, 2009, J CELL SCI, V122, P2240, DOI 10.1242/jcs.042747; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	42	4	4	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5643	5656		10.1074/jbc.RA118.007164	http://dx.doi.org/10.1074/jbc.RA118.007164			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30723163	Green Published, hybrid			2022-12-28	WOS:000464517500032
J	Serio, RN; Laursen, KB; Urvalek, AM; Gross, SS; Gudas, LJ				Serio, Ryan N.; Laursen, Kristian B.; Urvalek, Alison M.; Gross, Steven S.; Gudas, Lorraine J.			Ethanol promotes differentiation of embryonic stem cells through retinoic acid receptor-gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stem cells; differentiation; alcohol; retinol; retinoic acid; alcohol-associated birth defects; RAR; Rdh10; Stra6; teratogen; ethanol	VITAMIN-A; POTENTIAL MECHANISM; NUCLEAR RECEPTORS; GENE-EXPRESSION; RAR-GAMMA; F9 CELLS; METABOLISM; 4-OXORETINOL; DISRUPTION; ACTIVATION	Ethanol (EtOH) is a teratogen, but its teratogenic mechanisms are not fully understood. The alcohol form of vitamin A (retinol/ROL) can be oxidized to all-trans-retinoic acid (RA), which plays a critical role in stem cell differentiation and development. Using an embryonic stem cell (ESC) model to analyze EtOH's effects on differentiation, we show here that EtOH and acetaldehyde, but not acetate, increase differentiation-associated mRNA levels, and that EtOH decreases pluripotency-related mRNAs. Using reporter assays, ChIP assays, and retinoic acid receptor- (RAR) knockout ESC lines generated by CRISPR/Cas9 and homologous recombination, we demonstrate that EtOH signals via RAR binding to RA response elements (RAREs) in differentiation-associated gene promoters or enhancers. We also report that EtOH-mediated increases in homeobox A1 (Hoxa1) and cytochrome P450 family 26 subfamily A member 1 (Cyp26a1) transcripts, direct RA target genes, require the expression of the RA-synthesizing enzyme, aldehyde dehydrogenase 1 family member A2 (Aldh1a2), suggesting that EtOH-mediated induction of Hoxa1 and Cyp26a1 requires ROL from the serum. As shown with CRISPR/Cas9 knockout lines, the retinol dehydrogenase gene Rdh10 and a functional RARE in the ROL transporter stimulated by retinoic acid 6 (Stra6) gene are required for EtOH induction of Hoxa1 and Cyp26a1. We conclude that EtOH stimulates stem cell differentiation by increasing the influx and metabolism of ROL for downstream RAR-dependent transcription. In stem cells, EtOH may shift cell fate decisions to alter developmental outcomes by increasing endogenous ROL/RA signaling via increased Stra6 expression and ROL oxidation.	[Serio, Ryan N.; Gross, Steven S.; Gudas, Lorraine J.] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Laursen, Kristian B.; Urvalek, Alison M.; Gross, Steven S.; Gudas, Lorraine J.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University	Gudas, LJ (corresponding author), 1300 York Ave, New York, NY 10065 USA.	ljgudas@med.cornell.edu			National Institutes of Health [F31-AA024024, T32-CA062948, R01-AA018332, R21-AA021484]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA024024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Institutes of Health Grants F31-AA024024 (to R. N. S.) and T32-CA062948, R01-AA018332, and R21-AA021484 (to L. J. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achkar CC, 1996, P NATL ACAD SCI USA, V93, P4879, DOI 10.1073/pnas.93.10.4879; Al Tanoury Z, 2014, J CELL SCI, V127, P2095, DOI 10.1242/jcs.145979; Arzumanyan A, 2009, ALCOHOL CLIN EXP RES, V33, P2172, DOI 10.1111/j.1530-0277.2009.01057.x; Belyaeva OV, 2017, J BIOL CHEM, V292, P5884, DOI 10.1074/jbc.M117.776914; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; BOYLAN JF, 1993, P NATL ACAD SCI USA, V90, P9601, DOI 10.1073/pnas.90.20.9601; Chen AC, 1996, J BIOL CHEM, V271, P14971, DOI 10.1074/jbc.271.25.14971; Chen Y, 2016, SCIENCE, V353, DOI 10.1126/science.aad8266; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deltour L, 1996, FASEB J, V10, P1050, DOI 10.1096/fasebj.10.9.8801166; Delva L, 1999, MOL CELL BIOL, V19, P7158; Diani-Moore S, 2014, DRUG METAB DISPOS, V42, P294, DOI 10.1124/dmd.113.055368; Fernandez CC, 2009, J CELL BIOCHEM, V106, P427, DOI 10.1002/jcb.22023; Feuerborn A, 2015, TRENDS GENET, V31, P483, DOI 10.1016/j.tig.2015.07.001; Gao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112698; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Gudas L J, 1986, Prog Clin Biol Res, V226, P181; Gudas LJ, 2013, SEMIN CELL DEV BIOL, V24, P701, DOI 10.1016/j.semcdb.2013.08.002; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Kane MA, 2010, FASEB J, V24, P823, DOI 10.1096/fj.09-141572; Kashyap V, 2013, J CELL SCI, V126, P999, DOI 10.1242/jcs.119701; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kim YK, 2015, HEPATOL SURG NUTR, V4, P268, DOI 10.3978/j.issn.2304-3881.2015.01.06; Lane MA, 1999, P NATL ACAD SCI USA, V96, P13524, DOI 10.1073/pnas.96.23.13524; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; Langton S, 2008, DEV BIOL, V315, P331, DOI 10.1016/j.ydbio.2007.12.021; LAROSA GJ, 1988, P NATL ACAD SCI USA, V85, P329, DOI 10.1073/pnas.85.2.329; Laursen KB, 2018, J BIOL CHEM, V293, P11891, DOI 10.1074/jbc.RA118.001951; Laursen KB, 2015, J BIOL CHEM, V290, P4356, DOI 10.1074/jbc.M114.613968; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Lopez-Lazaro M, 2016, ORAL ONCOL, V62, P149, DOI 10.1016/j.oraloncology.2016.10.001; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Marrs JA, 2010, ALCOHOL, V44, P707, DOI 10.1016/j.alcohol.2009.03.004; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Molotkov A, 2002, J BIOL CHEM, V277, P22553, DOI 10.1074/jbc.M201603200; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; Sanchez-Alvarez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063794; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Shabtai Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18719-7; Simandi Z, 2016, MOL CELL, V63, P647, DOI 10.1016/j.molcel.2016.06.039; Smith SM, 2014, BIRTH DEFECTS RES C, V102, P210, DOI 10.1002/bdrc.21078; Stowell AR, 1998, J FORENSIC SCI, V43, P14, DOI 10.1520/JFS16083J; Suh MJ, 2006, ANAL CHEM, V78, P5719, DOI 10.1021/ac060492j; SULIK KK, 1988, DEVELOPMENT, V103, P213; TALBOT NC, 1993, MOL REPROD DEV, V36, P139, DOI 10.1002/mrd.1080360204; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; Taneja R, 1996, P NATL ACAD SCI USA, V93, P6197, DOI 10.1073/pnas.93.12.6197; Urvalek AM, 2014, J BIOL CHEM, V289, P19519, DOI 10.1074/jbc.M114.556555; Veazey KJ, 2013, ALCOHOL CLIN EXP RES, V37, P1111, DOI 10.1111/acer.12080; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; Wongsiriroj N, 2014, J LIPID RES, V55, P104, DOI 10.1194/jlr.M043844; Yelin R, 2005, DEV BIOL, V279, P193, DOI 10.1016/j.ydbio.2004.12.014; Yelin R, 2007, DIFFERENTIATION, V75, P393, DOI 10.1111/j.1432-0436.2006.00147.x; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zachman RD, 1998, ALCOHOL CLIN EXP RES, V22, P1544, DOI 10.1097/00000374-199810000-00026; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	60	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5536	5548		10.1074/jbc.RA118.007153	http://dx.doi.org/10.1074/jbc.RA118.007153			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30737277	Green Published, hybrid			2022-12-28	WOS:000464517500024
J	van den Bijgaart, RJE; Kroesen, M; Wassink, M; Brok, IC; Kers-Rebel, ED; Boon, L; Heise, T; van Scherpenzeel, M; Lefeber, DJ; Boltje, TJ; den Brok, MH; Hoogerbrugge, PM; Bull, C; Adema, GJ				van den Bijgaart, Renske J. E.; Kroesen, Michiel; Wassink, Melissa; Brok, Ingrid C.; Kers-Rebel, Esther D.; Boon, Louis; Heise, Torben; van Scherpenzeel, Monique; Lefeber, Dirk J.; Boltje, Thomas J.; den Brok, Martijn H.; Hoogerbrugge, Peter M.; Buell, Christian; Adema, Gosse J.			Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuroblastoma; sialic acid; histone deacetylase inhibitor (HDAC inhibitor) (HDI); sialyltransferase; cancer; glycosyltransferase; disialoganglioside; GD2	N-GLYCOLYLNEURAMINIC ACID; COLONY-STIMULATING FACTOR; HIGH-RISK NEUROBLASTOMA; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; T-CELLS; ANTI-GD2 ANTIBODY; CANCER; GANGLIOSIDES; SUPPRESSION	Neuroblastoma cells highly express the disialoganglioside GD2, a tumor-associated carbohydrate antigen, which is only sparsely expressed on healthy tissue. GD2 is a primary target for the development of immunotherapy for neuroblastoma. Immunotherapy with monoclonal anti-GD2 antibodies has proven safety and efficacy in clinical trials and is included in the standard treatment for children with high-risk neuroblastoma. Strategies to modulate GD2 expression in neuroblastoma could further improve anti-GD2-targeted immunotherapy. Here, we report that the cellular sialylation pathway, as well as epigenetic reprogramming, strongly modulates GD2 expression in human and mouse neuroblastoma cell lines. Recognition of GD2 by the 14G2a antibody is sialic acid-dependent and was blocked with the fluorinated sialic acid mimetic Ac(5)3F(ax)Neu5Ac. Interestingly, sialic acid supplementation using a cell-permeable sialic acid analogue (Ac(5)Neu5Ac) boosted GD2 expression without or with minor alterations in overall cell surface sialylation. Furthermore, sialic acid supplementation with Ac(5)Neu5Ac combined with various histone deacetylase (HDAC) inhibitors, including vorinostat, enhanced GD2 expression in neuroblastoma cells beyond their individual effects. Mechanistic studies revealed that Ac(5)Neu5Ac supplementation increased intracellular CMP-Neu5Ac concentrations, thereby providing higher substrate levels for sialyltransferases. Furthermore, HDAC inhibitor treatment increased mRNA expression of the sialyltransferases GM3 synthase (ST3GAL5) and GD3 synthase (ST8SIA1), both of which are involved in GD2 biosynthesis. Our findings reveal that sialic acid analogues and HDAC inhibitors enhance GD2 expression and could potentially be employed to boost anti-GD2 targeted immunotherapy in neuroblastoma patients.	[van den Bijgaart, Renske J. E.; Wassink, Melissa; Brok, Ingrid C.; Kers-Rebel, Esther D.; den Brok, Martijn H.; Buell, Christian; Adema, Gosse J.] Radboud Univ Nijmegen, Med Ctr, Radiotherapy & OncoImmunol Lab, Dept Radiat Oncol, NL-6525 GA Nijmegen, Netherlands; [Kroesen, Michiel] Erasmus MC, Dept Radiotherapy, NL-3000 CA Rotterdam, Netherlands; [Boon, Louis] Bioceros, NL-3584 CM Utrecht, Netherlands; [Heise, Torben; Boltje, Thomas J.] Radboud Univ Nijmegen, Cluster Mol Chem, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [van Scherpenzeel, Monique; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Translat Metab Lab, Dept Lab Med, NL-6525 DA Nijmegen, Netherlands; [Hoogerbrugge, Peter M.] Princess Maxima Ctr Pediat Oncol, NL-3584 CS Utrecht, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Radboud University Nijmegen	Adema, GJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radiotherapy & OncoImmunol Lab, Dept Radiat Oncol, NL-6525 GA Nijmegen, Netherlands.	gosse.adema@radboudumc.nl	Büll, Christian/L-9417-2013; Boltje, Thomas/F-9695-2015; Brok, Martijn H den/O-1054-2013; van den Bijgaart, Renske/I-8030-2016; Büll, Christian/AAN-1946-2021; Lefeber, Dirk DJ/A-2146-2014; Wassink, Melissa/J-1855-2018; Boon, Laurence/HCI-3629-2022; Adema, G.J./H-8007-2014	Büll, Christian/0000-0001-7785-2920; Büll, Christian/0000-0001-7785-2920; van den Bijgaart, Renske/0000-0003-0941-267X; Kroesen, Michiel/0000-0002-1346-2277; Boon, Louis/0000-0002-0937-9171; den Brok, Martijn/0000-0002-2368-0411	KWF Kankerbestrijding (Dutch Cancer Society) [KUN2015-7604]; Villa Joep Foundation; Stichting Vrienden KOC Nijmegen	KWF Kankerbestrijding (Dutch Cancer Society); Villa Joep Foundation; Stichting Vrienden KOC Nijmegen	This work was supported by Grant KUN2015-7604 (to G. J. A., T. J. B., and C. B.) from the KWF Kankerbestrijding (Dutch Cancer Society) and by continuous financial support from the Villa Joep Foundation (to P. M. H. and G. J. A.) and Stichting Vrienden KOC Nijmegen (to P. M. H. and G. J. A.). The authors declare no potential conflicts of interest.	Ahmed M, 2014, FEBS LETT, V588, P288, DOI 10.1016/j.febslet.2013.11.030; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025220; Battula VL, 2012, J CLIN INVEST, V122, P2066, DOI 10.1172/JCI59735; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8633, DOI 10.1074/jbc.275.12.8633; Bull C, 2018, CANCER RES, V78, P3574, DOI 10.1158/0008-5472.CAN-17-3376; Bull C, 2017, IMMUNOL CELL BIOL, V95, P408, DOI 10.1038/icb.2016.105; Bull C, 2015, ACS CHEM BIOL, V10, P2353, DOI 10.1021/acschembio.5b00501; Bull C, 2014, BBA-REV CANCER, V1846, P238, DOI 10.1016/j.bbcan.2014.07.005; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Bull C, 2013, MOL CANCER THER, V12, P1935, DOI 10.1158/1535-7163.MCT-13-0279; Burkart MD, 1999, CHEM COMMUN, P1525, DOI 10.1039/a903362i; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Cheng B, 2016, CHEMBIOCHEM, V17, P11, DOI 10.1002/cbic.201500344; Cheung NKV, 2014, INT J CANCER, V135, P2199, DOI 10.1002/ijc.28851; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; CHEUNG NKV, 1985, CANCER RES, V45, P2642; Davies LRL, 2015, TOP CURR CHEM, V366, P31, DOI 10.1007/128_2013_419; Dobrenkov K, 2014, SEMIN ONCOL, V41, P589, DOI 10.1053/j.seminoncol.2014.07.003; Fest S, 2006, CANCER RES, V66, P10567, DOI 10.1158/0008-5472.CAN-06-1158; Fukuda M, 1998, INT J MOL MED, V2, P471; Gargett T, 2016, MOL THER, V24, P1135, DOI 10.1038/mt.2016.63; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Kroesen M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1164919; Kroesen M, 2014, INT J CANCER, V134, P1335, DOI 10.1002/ijc.28463; Kroesen M, 2012, IMMUNOTHERAPY-UK, V4, P163, DOI [10.2217/imt.11.169, 10.2217/IMT.11.169]; Kushner BH, 2014, CLIN CANCER RES, V20, P1375, DOI 10.1158/1078-0432.CCR-13-1012; Louis CU, 2015, ANNU REV MED, V66, P49, DOI 10.1146/annurev-med-011514-023121; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Mackall CL, 2014, NAT REV CLIN ONCOL, V11, P693, DOI 10.1038/nrclinonc.2014.177; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Mora J, 2016, EXPERT REV CLIN PHAR, V9, P647, DOI 10.1586/17512433.2016.1160775; MUJOO K, 1989, CANCER RES, V49, P2857; MUJOO K, 1987, CANCER RES, V47, P1098; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Schnaar R.L., 2015, ESSENTIALS GLYCOBIOL, P125; SJOBERG ER, 1993, J BIOL CHEM, V268, P10185; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; Sphyris N, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975068; Suzuki Y, 2011, J NEUROCHEM, V116, P874, DOI 10.1111/j.1471-4159.2010.07042.x; SVENNERHOLM L, 1994, BBA-LIPID LIPID MET, V1214, P115, DOI 10.1016/0005-2760(94)90034-5; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Varki A., 2017, ESSENTIALS GLYCOBIOL, V3, P179; Wang ZY, 2009, CURR OPIN CHEM BIOL, V13, P565, DOI 10.1016/j.cbpa.2009.08.001; YAMAGUCHI H, 1990, P NATL ACAD SCI USA, V87, P3333, DOI 10.1073/pnas.87.9.3333; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	52	16	16	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4437	4449		10.1074/jbc.RA118.002763	http://dx.doi.org/10.1074/jbc.RA118.002763			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30670592	Green Published, hybrid			2022-12-28	WOS:000462969500013
J	Kam, A; Loo, S; Dutta, B; Sze, SK; Tam, JP				Kam, Antony; Loo, Shining; Dutta, Bamaprasad; Sze, Siu Kwan; Tam, James P.			Plant-derived mitochondria-targeting cysteine-rich peptide modulates cellular bioenergetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; cell-penetrating peptide (CPP); peptides; peptide chemical synthesis; peptide interaction; mitochondria	LIVER ALDEHYDE DEHYDROGENASE; ALPHA-AMYLASE INHIBITORS; PENETRATING PEPTIDES; NEUTROPHIL ELASTASE; PROTEIN IMPORT; TRANSLOCATION; ANTIOXIDANTS; PRESEQUENCE; CYCLOTIDES; MECHANISM	Mitochondria are attractive therapeutic targets for developing agents to delay age-related frailty and diseases. However, few promising leads have been identified from natural products. Previously, we identified roseltide rT1, a hyperstable 27-residue cysteine-rich peptide from Hibiscus sabdariffa, as a knottin-type neutrophil elastase inhibitor. Here, we show that roseltide rT1 is also a cell-penetrating, mitochondria-targeting peptide that increases ATP production. Results from flow cytometry, live-cell imaging, pulldown assays, and genetically-modified cell lines supported that roseltide rT1 enters cells via glycosaminoglycan-dependent endocytosis, and enters the mitochondria through TOM20, a mitochondrial protein import receptor. We further showed that roseltide rT1 increases cellular ATP production via mitochondrial membrane hyperpolarization. Using biotinylated roseltide rT1 for target identification and proteomic analysis, we showed that human mitochondrial membrane ATP synthase subunit O is an intramitochondrial target. Collectively, these data support our discovery that roseltide rT1 is a first-in-class mitochondria-targeting, cysteine-rich peptide with potentials to be developed into tools to further our understanding of mitochrondria-related diseases.	[Kam, Antony; Loo, Shining; Dutta, Bamaprasad; Sze, Siu Kwan; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	JPTam@ntu.edu.sg	Tam, James P/A-2176-2011; LOO, Shining/AAT-2864-2021; Dutta, Bamaprasad/AAH-4006-2020; Sze, Siu Kwan/AAO-3342-2020; Kam, Antony/P-5978-2019	Tam, James P/0000-0003-4433-198X; LOO, Shining/0000-0002-2220-8297; Dutta, Bamaprasad/0000-0002-2309-8771; Sze, Siu Kwan/0000-0002-5652-1687; Kam, Antony/0000-0003-2155-6887	Competitive Research Grant from the National Research Foundation in Singapore [NRF-CRP8-2011-05]; Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC); AcRF Tier 3 Grant [MOE2016-T3-1-003]	Competitive Research Grant from the National Research Foundation in Singapore(National Research Foundation, Singapore); Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC)(Nanyang Technological University); AcRF Tier 3 Grant	This work was supported in part by Competitive Research Grant NRF-CRP8-2011-05 from the National Research Foundation in Singapore, Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC), and AcRF Tier 3 Grant MOE2016-T3-1-003. The authors declare that they have no conflicts of interest with the contents of this article.	Armstrong JA, 2018, J BIOL CHEM, V293, P8032, DOI 10.1074/jbc.RA118.003200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; CHEN HM, 1995, GENOMICS, V28, P470, DOI 10.1006/geno.1995.1176; Cheng ZY, 2013, ANTIOXID REDOX SIGN, V19, P240, DOI 10.1089/ars.2013.5255; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; de Cavanagh EMV, 2011, CARDIOVASC RES, V89, P31, DOI 10.1093/cvr/cvq285; Dumont M, 2011, FREE RADICAL BIO MED, V51, P1014, DOI 10.1016/j.freeradbiomed.2010.11.026; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Ferrari R, 1996, J CARDIOVASC PHARM, V28, pS1; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Garcia Angie E, 2010, Curr Mol Pharmacol, V3, P153; Hammen PK, 1996, J BIOL CHEM, V271, P21041, DOI 10.1074/jbc.271.35.21041; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Hoshino A, 2004, MICROBIOL IMMUNOL, V48, P985, DOI 10.1111/j.1348-0421.2004.tb03621.x; Huang JG, 2011, NANO TODAY, V6, P478, DOI 10.1016/j.nantod.2011.08.002; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; Kloss A, 2009, EUR J PHARM BIOPHARM, V72, P219, DOI 10.1016/j.ejpb.2008.10.016; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; Loo SN, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02162; Loo SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep39401; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nguyen KNT, 2016, FEBS J, V283, P2067, DOI 10.1111/febs.13720; Nguyen PQT, 2015, J NAT PROD, V78, P695, DOI 10.1021/np500866c; Nguyen PQT, 2014, FEBS J, V281, P4351, DOI 10.1111/febs.12939; Otvos Laszlo Jr., 2008, V494, P263, DOI 10.1007/978-1-59745-419-3_15; Pae J, 2016, BBA-BIOMEMBRANES, V1858, P1860, DOI 10.1016/j.bbamem.2016.04.010; Parker GC, 2009, STEM CELLS DEV, V18, P803, DOI 10.1089/scd.2009.1806.edi; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Salvioli S, 2001, FEBS LETT, V492, P9, DOI 10.1016/S0014-5793(01)02199-8; Sheu SS, 2006, BBA-MOL BASIS DIS, V1762, P256, DOI 10.1016/j.bbadis.2005.10.007; SNOW AD, 1987, LAB INVEST, V57, P687; Suomalainen A, 2011, SEMIN FETAL NEONAT M, V16, P236, DOI 10.1016/j.siny.2011.05.003; Szeto H. H., 2008, DRUG ADDICTION, P535; Szeto HH, 2006, AAPS J, V8, pE521, DOI 10.1208/aapsj080362; THORNTON K, 1993, J BIOL CHEM, V268, P19906; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WANG Y, 1993, J BIOL CHEM, V268, P4759; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; WEISS MJ, 1987, P NATL ACAD SCI USA, V84, P5444, DOI 10.1073/pnas.84.15.5444; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Yamamoto H, 2011, P NATL ACAD SCI USA, V108, P91, DOI 10.1073/pnas.1014918108; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Yousif LF, 2009, CHEMBIOCHEM, V10, P2081, DOI 10.1002/cbic.200900017; Yousif LF, 2009, CHEMBIOCHEM, V10, P1939, DOI 10.1002/cbic.200900185; Zhang XY, 2016, ONCOL LETT, V12, P4887, DOI 10.3892/ol.2016.5302; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	58	15	15	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4000	4011		10.1074/jbc.RA118.006693	http://dx.doi.org/10.1074/jbc.RA118.006693			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30674551	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000461854400016
J	Shanbhogue, P; Hoffmann, RM; Airola, MV; Maini, R; Hamelin, DJ; Garcia-Diaz, M; Burke, JE; Hannun, YA				Shanbhogue, Prajna; Hoffmann, Reece M.; Airola, Michael V.; Maini, Rohan; Hamelin, David J.; Garcia-Diaz, Miguel; Burke, John E.; Hannun, Yusuf A.			The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; enzyme mechanism; lipid; sphingolipid; sphingomyelinase	NECROSIS-FACTOR-ALPHA; AMYLOID-BETA; CERAMIDE; MECHANISM; NSMASE2; PROTEIN; IDENTIFICATION; STRESS; PREDICTION; SECRETION	Neutral sphingomyelinase 2 (nSMase2) produces the bioactive lipid ceramide and has important roles in neurodegeneration, cancer, and exosome formation. Although nSMase2 has low basal activity, it is fully activated by phosphatidylserine (PS). Previous work showed that interdomain interactions within nSMase2 are needed for PS activation. Here, we use multiple approaches, including small angle X-ray scattering, hydrogen-deuterium exchange-MS, circular dichroism and thermal shift assays, and membrane yeast two-hybrid assays, to define the mechanism mediating this interdomain interactions within nSMase2. In contrast to what we previously assumed, we demonstrate that PS binding at the N-terminal and juxtamembrane regions of nSMase2 rather acts as a conformational switch leading to interdomain interactions that are critical to enzyme activation. Our work assigns a unique function for a class of linkers of lipid-activated, membrane-associated proteins. It indicates that the linker actively participates in the activation mechanism via intramolecular interactions, unlike the canonical linkers that typically aid protein dimerization or localization.	[Shanbhogue, Prajna; Airola, Michael V.; Maini, Rohan; Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Garcia-Diaz, Miguel; Hannun, Yusuf A.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Shanbhogue, Prajna; Hannun, Yusuf A.] SUNY Stony Brook, Canc Ctr, Stony Brook, NY 11794 USA; [Hoffmann, Reece M.; Hamelin, David J.; Burke, John E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8N 1A1, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Victoria	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Canc Ctr, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Burke, John/H-3922-2019; Shanbhogue, Prajna/ABB-6599-2021	Burke, John/0000-0001-7904-9859; Hamelin, David/0000-0001-8201-0664; Airola, Michael/0000-0003-4981-1253	NIGMS, National Institutes of Health [P41 GM111244]; Department of Energy Office of Biological and Environmental Research [KP1605010]; National Institutes of Health [S10 OD012331]; Department of Energy Office of Science [DE-SC0012704]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100021, P41GM111244, R35GM118128, R35GM128666] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We also thank Dr. Lin Yang and Dr. Shirish Chodankar at Brookhaven National Lab National Synchrotron Light Source II for their help with SAXS data collection and data processing. The LiX Beamline is part of the Life Science Biomedical Technology Research resource, jointly supported by the NIGMS, National Institutes of Health under Grant P41 GM111244 and by the Department of Energy Office of Biological and Environmental Research under Grant KP1605010, with additional support from National Institutes of Health Grant S10 OD012331. National Synchrotron Light Source II is a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Brookhaven National Laboratory under Contract DE-SC0012704. We would also like to thank Dr. Erwin London for help with circular dichroism data collection and analysis. We thank Dr. Lina Marie Obeid and Dr. Chiara Luberto for helpful discussions and feedback.	Airola MV, 2017, P NATL ACAD SCI USA, V114, pE5549, DOI 10.1073/pnas.1705134114; Chaube R, 2012, BBA-MOL CELL BIOL L, V1821, P313, DOI 10.1016/j.bbalip.2011.10.015; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Cogolludo A, 2009, CARDIOVASC RES, V82, P296, DOI 10.1093/cvr/cvn349; de Andrade SA, 2005, BIOCHEM BIOPH RES CO, V327, P117, DOI 10.1016/j.bbrc.2004.11.146; Dornan GL, 2018, J MOL BIOL, V430, P3129, DOI 10.1016/j.jmb.2018.07.020; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Filosto S, 2010, J BIOL CHEM, V285, P10213, DOI 10.1074/jbc.M109.069963; Gorelik A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12196; Guo BB, 2016, J BIOL CHEM, V291, P5128, DOI 10.1074/jbc.M115.684258; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Horres CR, 2012, NEUROCHEM RES, V37, P1137, DOI 10.1007/s11064-011-0692-y; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIM MY, 1991, J BIOL CHEM, V266, P484; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kolmakova A, 2004, ARTERIOSCL THROM VAS, V24, P264, DOI 10.1161/01.ATV.0000112036.72200.ac; Kong JN, 2015, INT J CANCER, V137, P1610, DOI 10.1002/ijc.29542; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lu B, 2014, J BIOL CHEM, V289, P22161, DOI 10.1074/jbc.M114.569327; Lucic I, 2018, P NATL ACAD SCI USA, V115, pE3940, DOI 10.1073/pnas.1716109115; Matsuda I, 2000, BIOCHEM BIOPH RES CO, V275, P565, DOI 10.1006/bbrc.2000.3351; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; Revill K, 2013, GASTROENTEROLOGY, V145, P1424, DOI 10.1053/j.gastro.2013.08.055; Sagy-Bross C, 2013, NEUROCHEM INT, V63, P541, DOI 10.1016/j.neuint.2013.09.007; Shamseddine AA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.268; Shamseddine Achraf A, 2015, Adv Biol Regul, V57, P24, DOI 10.1016/j.jbior.2014.10.002; Shanbhogue P, 2020, HANDB EXP PHARMACOL, V259, P19, DOI 10.1007/164_2018_179; Singh R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-256; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tani M, 2007, FEBS LETT, V581, P1323, DOI 10.1016/j.febslet.2007.02.046; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Wu BX, 2011, J BIOL CHEM, V286, P22362, DOI 10.1074/jbc.M110.156471; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	43	11	11	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7488	7502		10.1074/jbc.RA118.007288	http://dx.doi.org/10.1074/jbc.RA118.007288			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30890560	Green Published, hybrid			2022-12-28	WOS:000468402900032
J	Abd Rahim, MS; Cherniayskyi, YK; Tieleman, DP; Dames, SA				Abd Rahim, Munirah S.; Cherniayskyi, Yevhen K.; Tieleman, D. Peter; Dames, Sonja A.			NMR- and MD simulation-based structural characterization of the membrane-associating FATC domain of ataxia telangiectasia mutated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase; membrane; nuclear magnetic resonance (NMR); molecular dynamics (MD) simulation; signal transduction; ataxia telangiectasia mutated; phosphatidylinositol 3-kinase-related kinase; protein membrane interactions; signaling at membranes; structural dynamics; FATC domain; solution structure	PHOSPHATIDYLINOSITOL 3-KINASE-RELATED KINASES; PARTICLE MESH EWALD; ATM PROTEIN-KINASE; CELLULAR-RESPONSE; GENE-PRODUCT; DNA-PKCS; RAPAMYCIN; TARGET; PEPTIDES; ACTIVATION	The Ser/Thr protein kinase ataxia telangiectasia mutated (ATM) plays an important role in the DNA damage response, signaling in response to redox signals, the control of metabolic processes, and mitochondrial homeostasis. ATM localizes to the nucleus and at the plasma membrane, mitochondria, peroxisomes, and other cytoplasmic vesicular structures. It has been shown that the C-terminal FATC domain of human ATM (hATMfatc) can interact with a range of membrane mimetics and may thereby act as a membrane-anchoring unit. Here, NMR structural and N-15 relaxation data, NMR data using spin-labeled micelles, and MD simulations of micelle-associated hATMfatc revealed that it binds the micelle by a dynamic assembly of three helices with many residues of hATMfatc located in the headgroup region. We observed that none of the three helices penetrates the micelle deeply or makes significant tertiary contacts to the other helices. NMR-monitored interaction experiments with hATMfatc variants in which two conserved aromatic residues (Phe(3049) and Trp(3052)) were either individually or both replaced by alanine disclosed that the double substitution does not abrogate the interaction with micelles and bicelles at the high concentrations at which these aggregates are typically used, but impairs interactions with small unilamellar vesicles, usually used at much lower lipid concentrations and considered a better mimetic for natural membranes. We conclude that the observed dynamic structure of micelle-associated hATMfatc may enable it to interact with differently composed membranes or membrane-associated interaction partners and thereby regulate ATM's kinase activity. Moreover, the FATC domain of ATM may function as a membrane-anchoring unit for other biomolecules.	[Abd Rahim, Munirah S.; Dames, Sonja A.] Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany; [Cherniayskyi, Yevhen K.; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Cherniayskyi, Yevhen K.; Tieleman, D. Peter] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Dames, Sonja A.] Helmholtz Zentrum Munchen, Inst Struct Biol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany	Technical University of Munich; University of Calgary; University of Calgary; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.	sonja.dames@tum.de	Abd Rahim, Munirah Sufiyah/GZL-3432-2022	Abd Rahim, Munirah Sufiyah/0000-0003-4027-0817; Dames, Sonja/0000-0001-7495-6943	German Research Foundation [DA 1195/3-2]; Canada Research Chairs program; German Academic Exchange Service (DAAD); Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation; Natural Sciences and Engineering Research Council of Canada; Technische Universitat Munchen (TUM) diversity and talent management office Laura-Bassi award; Helmholtz portfolio theme "metabolic dysfunction and common disease" of the Helmholtz Zentrum Munchen	German Research Foundation(German Research Foundation (DFG)); Canada Research Chairs program(Canada Research Chairs); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Technische Universitat Munchen (TUM) diversity and talent management office Laura-Bassi award; Helmholtz portfolio theme "metabolic dysfunction and common disease" of the Helmholtz Zentrum Munchen	This work was supported by German Research Foundation Grant DA 1195/3-2 (to S. A. D.). This work was undertaken, in part, with the support of funding from the Canada Research Chairs program. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a German Academic Exchange Service (DAAD) Ph.D. stipend.; The Alberta Innovates Technology Futures Strategic Chair in (Bio) Molecular Simulation. Work in this author's group was supported by the Natural Sciences and Engineering Research Council of Canada.; Supported by the Technische Universitat Munchen (TUM) diversity and talent management office Laura-Bassi award and the Helmholtz portfolio theme "metabolic dysfunction and common disease" of the Helmholtz Zentrum Munchen.	Abd Rahim MS, 2018, BIOMOL NMR ASSIGN, V12, P149, DOI 10.1007/s12104-018-9798-3; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baretic D, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700933; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Camargo DCR, 2012, BIOCHEMISTRY-US, V51, P4909, DOI 10.1021/bi3002133; Chen BPC, 2012, CANCER LETT, V327, P103, DOI 10.1016/j.canlet.2011.12.004; Cremona CA, 2014, ONCOGENE, V33, P3351, DOI 10.1038/onc.2013.275; Czarny P, 2015, INT J MOL SCI, V16, P2641, DOI 10.3390/ijms16022641; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Dames SA, 2010, J BIOL CHEM, V285, P7766, DOI 10.1074/jbc.M109.058404; Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Cicco M, 2018, PROTEIN SCI, V27, P546, DOI 10.1002/pro.3321; De Cicco M, 2015, MEMBRANES, V5, P553, DOI 10.3390/membranes5040553; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoke SMT, 2010, CURR GENET, V56, P447, DOI 10.1007/s00294-010-0313-3; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huth JR, 1997, PROTEIN SCI, V6, P2359; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Knutson BA, 2010, J STRUCT BIOL, V170, P354, DOI 10.1016/j.jsb.2010.01.002; Koehler J, 2011, PROG NUCL MAG RES SP, V59, P360, DOI 10.1016/j.pnmrs.2011.05.001; Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruger A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001959; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lau WCY, 2016, CELL CYCLE, V15, P1117, DOI 10.1080/15384101.2016.1158362; Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Lin CM, 2012, LANGMUIR, V28, P689, DOI 10.1021/la203755v; Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414; Llorca O, 2003, ONCOGENE, V22, P3867, DOI 10.1038/sj.onc.1206649; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Luchette PA, 2001, BBA-BIOMEMBRANES, V1513, P83, DOI 10.1016/S0005-2736(01)00358-3; Ma YX, 2018, BBA-MOL CELL RES, V1865, P1293, DOI 10.1016/j.bbamcr.2018.06.011; Marinoglou Konstantina, 2012, Yale Journal of Biology and Medicine, V85, P469; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Morita T, 2007, J BIOL CHEM, V282, P7799, DOI 10.1074/jbc.M610159200; Mugler A, 2013, P NATL ACAD SCI USA, V110, P5927, DOI 10.1073/pnas.1218301110; Myers GA, 2012, J AM CHEM SOC, V134, P19652, DOI 10.1021/ja306074k; Pancholi NJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0269; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Quek H, 2018, IMMUNOL CELL BIOL, V96, P8, DOI 10.1111/imcb.1001; Sawicka M, 2016, J BIOL CHEM, V291, P13436, DOI 10.1074/jbc.M115.708263; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen CX, 2013, P NATL ACAD SCI USA, V110, P11869, DOI 10.1073/pnas.1220898110; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Sommer LAM, 2014, J PHYS CHEM B, V118, P4817, DOI 10.1021/jp501533d; Sommer LAM, 2014, FEBS LETT, V588, P1755, DOI 10.1016/j.febslet.2014.03.031; Sommer LAM, 2013, J BIOL CHEM, V288, P20046, DOI 10.1074/jbc.M113.467233; Sommer LAM, 2012, PROTEIN SCI, V21, P1566, DOI 10.1002/pro.2127; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; TAUSK RJM, 1974, BIOPHYS CHEM, V2, P175, DOI 10.1016/0301-4622(74)80004-9; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11655; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Weschayanwiwat P, 2005, J SURFACTANTS DETERG, V8, P65, DOI 10.1007/s11743-005-0332-8; Whiles JA, 2002, BIOORG CHEM, V30, P431, DOI 10.1016/S0045-2068(02)00527-8; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yagi H, 2010, J BIOMOL NMR, V47, P143, DOI 10.1007/s10858-010-9416-x; Yan J, 2000, INT J RADIAT BIOL, V76, P1025, DOI 10.1080/09553000050111497; Zhang JW, 2015, NAT CELL BIOL, V17, P1259, DOI 10.1038/ncb3230; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017	86	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7098	7112		10.1074/jbc.RA119.007653	http://dx.doi.org/10.1074/jbc.RA119.007653			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30867195	Green Published, hybrid			2022-12-28	WOS:000467394700040
J	Kim, SP; Da, H; Li, Z; Kushwaha, P; Beil, C; Mei, L; Xiong, WC; Wolfgang, MJ; Clemens, TL; Riddle, RC				Kim, Soohyun P.; Da, Hao; Li, Zhu; Kushwaha, Priyanka; Beil, Conor; Mei, Lin; Xiong, Wen-Cheng; Wolfgang, Michael J.; Clemens, Thomas L.; Riddle, Ryan C.			Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; osteoblast; Wnt signaling; adipose tissue metabolism; glucose metabolism; sclerostin	BONE-FORMATION; NEGATIVE REGULATOR; ENERGY-METABOLISM; BETA-CATENIN; DELETION; GENE; DENSITY; WHITE; MASS; TRANSCRIPTION	Sclerostin exerts profound local control over bone acquisition and also mediates endocrine communication between fat and bone. In bone, sclerostin's anti-osteoanabolic activity is enhanced by low-density lipoprotein receptor-related protein 4 (Lrp4), which facilitates its interaction with the Lrp5 and Lrp6 Wnt co-receptors. To determine whether Lrp4 similarly affects sclerostin's endocrine function, we examined body composition as well as glucose and fatty acid metabolism in mice rendered deficient of Lrp4 in the adipocyte (AdLrp4) or the osteoblast (ObLrp4). AdLrp4 mice exhibit a reduction in adipocyte hypertrophy and improved glucose and lipid homeostasis, marked by increased glucose and insulin tolerance and reduced serum fatty acids, and mirror the effect of sclerostin deficiency on whole-body metabolism. Indeed, epistasis studies place adipocyte-expressed Lrp4 and sclerostin in the same genetic cascade that regulates adipocyte function. Intriguingly, ObLrp4 mice, which exhibit dramatic increases in serum sclerostin, accumulate body fat and develop impairments in glucose tolerance and insulin sensitivity despite development of a high bone mass phenotype. These data indicate that expression of Lrp4 by both the adipocyte and osteoblast is required for normal sclerostin endocrine function and that the impact of sclerostin deficiency on adipocyte physiology is distinct from the effect on osteoblast function.	[Kim, Soohyun P.; Da, Hao; Li, Zhu; Kushwaha, Priyanka; Beil, Conor; Clemens, Thomas L.; Riddle, Ryan C.] Johns Hopkins Univ, Sch Med, Dept Orthoped Surg, Baltimore, MD 21205 USA; [Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Mei, Lin; Xiong, Wen-Cheng] Case Western Reserve Univ, Dept Neurosci, Med Sch, Cleveland, OH 44106 USA; [Clemens, Thomas L.; Riddle, Ryan C.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Riddle, RC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthoped Surg, Baltimore, MD 21205 USA.; Riddle, RC (corresponding author), Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA.	rriddle1@jhmi.edu		Da, Hao/0000-0002-8894-5978	Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [BX003724, BX001234]; NIDDK, National Institutes of Health [DK099134, DK116746]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK116746, R01DK099134] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001234, I01BX003724] Funding Source: NIH RePORTER	Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review Awards BX003724 (to R. C. R.) and BX001234 (to T. L. C.) from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development and NIDDK, National Institutes of Health Grants DK099134 (to R. C. R.) and DK116746 (to M. J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amrein K, 2012, J CLIN ENDOCR METAB, V97, P148, DOI 10.1210/jc.2011-2152; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brun J, 2017, DIABETES, V66, P2541, DOI 10.2337/db17-0116; Chang MK, 2014, P NATL ACAD SCI USA, V111, pE5187, DOI 10.1073/pnas.1413828111; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Christodoulides C, 2006, J CELL SCI, V119, P2613, DOI 10.1242/jcs.02975; Daniele G, 2015, DIABETES CARE, V38, P1509, DOI 10.2337/dc14-2989; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Frey JL, 2018, ENDOCRINOLOGY, V159, P272, DOI 10.1210/en.2017-00850; Frey JL, 2015, MOL CELL BIOL, V35, P1979, DOI 10.1128/MCB.01343-14; Garcia-Martin A, 2012, J CLIN ENDOCR METAB, V97, P234, DOI 10.1210/jc.2011-2186; Gaudio A, 2012, J CLIN ENDOCR METAB, V97, P3744, DOI 10.1210/jc.2012-1901; Ge CX, 2016, J CELL PHYSIOL, V231, P587, DOI 10.1002/jcp.25102; Gennari L, 2012, J CLIN ENDOCR METAB, V97, P1737, DOI 10.1210/jc.2011-2958; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Holdsworth G, 2012, J BIOL CHEM, V287, P26464, DOI 10.1074/jbc.M112.350108; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kajimura D, 2013, CELL METAB, V17, P901, DOI 10.1016/j.cmet.2013.04.009; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Karner CM, 2015, J CLIN INVEST, V125, P551, DOI 10.1172/JCI78470; Kim SP, 2017, P NATL ACAD SCI USA, V114, pE11238, DOI 10.1073/pnas.1707876115; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leupin O, 2011, J BIOL CHEM, V286, P19489, DOI 10.1074/jbc.M110.190330; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Modica S, 2016, CELL REP, V16, P2243, DOI 10.1016/j.celrep.2016.07.048; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Urano T, 2012, J CLIN ENDOCR METAB, V97, pE1473, DOI 10.1210/jc.2012-1218; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Wedrychowicz A, 2019, BONE, V120, P232, DOI 10.1016/j.bone.2018.07.021; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033; Xiong L, 2015, P NATL ACAD SCI USA, V112, P3487, DOI 10.1073/pnas.1419714112; Yang T, 2017, PHYSIOL REV, V97, P1211, DOI 10.1152/physrev.00013.2016; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	50	17	17	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6899	6911		10.1074/jbc.RA118.006769	http://dx.doi.org/10.1074/jbc.RA118.006769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30842262	Green Published, hybrid			2022-12-28	WOS:000467394700025
J	Kim, SSY; Sze, L; Lam, KP				Kim, Susana Soo-Yeon; Sze, Lynette; Lam, Kong-Peng			The stress granule protein G3BP1 binds viral dsRNA and RIG-I to enhance interferon- response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; viral immunology; RIG-I-like receptor (RLR); interferon; double-stranded RNA (dsRNA)	ENDORIBONUCLEASE G3BP; RNA; PHOSPHORYLATION; INDUCTION; COMPLEXES; MEDIATE	RIG-I senses viral RNA in the cytosol and initiates host innate immune response by triggering the production of type 1 interferon. A recent RNAi knockdown screen yielded close to hundred host genes whose products affected viral RNA-induced IFN- production and highlighted the complexity of the antiviral response. The stress granule protein G3BP1, known to arrest mRNA translation, was identified as a regulator of RIG-I-induced IFN- production. How G3BP1 functions in RIG-I signaling is not known, however. Here, we overexpress G3BP1 with RIG-I in HEK293T cells and found that G3BP1 significantly enhances RIG-I-induced ifn-b mRNA synthesis. More importantly, we demonstrate that G3BP1 binds RIG-I and that this interaction involves the C-terminal RGG domain of G3BP1. Confocal microscopy studies also show G3BP1 co-localization with RIG-I and with infecting vesicular stomatitis virus in Cos-7 cells. Interestingly, immunoprecipitation studies using biotin-labeled viral dsRNA or poly(I<bold>C</bold>) and cell lysate-derived or in vitro translated G3BP1 indicated that G3BP1 could directly bind these substrates and again via its RGG domain. Computational modeling further revealed a juxtaposed interaction between G3BP1 RGG and RIG-I RNA-binding domains. Together, our data reveal G3BP1 as a critical component of RIG-I signaling and possibly acting as a co-sensor to promote RIG-I recognition of pathogenic RNA.	[Kim, Susana Soo-Yeon; Sze, Lynette; Lam, Kong-Peng] ASTAR, Immunol Grp, Bioproc Technol Inst, Singapore, Singapore; [Lam, Kong-Peng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Lam, Kong-Peng] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kim, SSY; Lam, KP (corresponding author), Bioproc Technol Inst, 20 Biopolis Way, Singapore 138668, Singapore.	Susana_kim@bti.a-star.edu.sg; lam_kong_peng@bti.a-star.edu.sg			Agency for Science, Technology and Research	Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; Cobos Jimenez V., 2015, RNA VIROLOGY, V486, P94, DOI [10.1016/j.virol.2015.09.007 26432022, DOI 10.1016/J.VIROL.2015.09.007]; Dinh PX, 2013, J VIROL, V87, P372, DOI 10.1128/JVI.02305-12; Dougherty JD, 2015, VIRUSES-BASEL, V7, P6127, DOI 10.3390/v7122922; Gadaleta P, 2002, VIRUS RES, V86, P87, DOI 10.1016/S0168-1702(02)00049-7; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kim SSY, 2014, J IMMUNOL, V193, P840, DOI 10.4049/jimmunol.1301601; Lee KG, 2015, CELL REP, V10, P1055, DOI 10.1016/j.celrep.2015.01.039; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu ZS, 2019, NAT IMMUNOL, V20, P18, DOI 10.1038/s41590-018-0262-4; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; Nikolic J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005942; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Oshiumi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014258; Ozdilek BA, 2017, NUCLEIC ACIDS RES, V45, P7984, DOI 10.1093/nar/gkx460; Parker F, 1996, MOL CELL BIOL, V16, P2561; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Ramachandran B, 2018, J BIOL CHEM, V293, P7942, DOI 10.1074/jbc.RA118.002046; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; van der Lee R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004553; Yagi R, 2018, NUCLEIC ACIDS RES, V46, P5894, DOI 10.1093/nar/gky391; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	34	48	52	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6430	6438		10.1074/jbc.RA118.005868	http://dx.doi.org/10.1074/jbc.RA118.005868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30804210	Green Published, hybrid			2022-12-28	WOS:000468402000020
J	Lessard, DV; Zinder, OJ; Hotta, T; Verhey, KJ; Ohi, R; Berger, CL				Lessard, Dominique V.; Zinder, Oraya J.; Hotta, Takashi; Verhey, Kristen J.; Ohi, Ryoma; Berger, Christopher L.			Polyglutamylation of tubulin's C-terminal tail controls pausing and motility of kinesin-3 family member KIF1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular motor; single-molecule biophysics; kinesin; post-translational modification (PTM); microtubule; cytoskeleton; K-loop; KIF1A; neuron; polyglutamylation	AXONAL-TRANSPORT; BETA-TUBULIN; CARGO TRANSPORT; ALPHA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; FRONTOTEMPORAL DEMENTIA; PROTEIN KIF1A; MOTOR KIF1A; K-LOOP; TAU	The kinesin-3 family member KIF1A plays a critical role in site-specific neuronal cargo delivery during axonal transport. KIF1A cargo is mislocalized in many neurodegenerative diseases, indicating that KIF1A's highly efficient, superprocessive motility along axonal microtubules needs to be tightly regulated. One potential regulatory mechanism may be through posttranslational modifications (PTMs) of axonal microtubules. These PTMs often occur on the C-terminal tails of the microtubule tracks, act as molecular traffic signals helping to direct kinesin motor cargo delivery, and include C-terminal tail polyglutamylation important for KIF1A cargo transport. KIF1A initially interacts with microtubule C-terminal tails through its K-loop, a positively charged surface loop of the KIF1A motor domain. However, the role of the K-loop in KIF1A motility and response to perturbations in C-terminal tail polyglutamylation is underexplored. Using single-molecule imaging, we present evidence that KIF1A pauses on different microtubule lattice structures, linking multiple processive segments together and contributing to KIF1A's characteristic superprocessive run length. Furthermore, modifications of the KIF1A K-loop or tubulin C-terminal tail polyglutamylation reduced KIF1A pausing and overall run length. These results suggest a new mechanism to regulate KIF1A motility via pauses mediated by K-loop/polyglutamylated C-terminal tail interactions, providing further insight into KIF1A's role in axonal transport.	[Lessard, Dominique V.; Zinder, Oraya J.; Berger, Christopher L.] Univ Vermont, Dept Mol Physiol & Biophys, 122 HSRF,149 Beaumont Ave, Burlington, VT 05405 USA; [Hotta, Takashi; Verhey, Kristen J.; Ohi, Ryoma] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Vermont; University of Michigan System; University of Michigan	Berger, CL (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, 122 HSRF,149 Beaumont Ave, Burlington, VT 05405 USA.	cberger@uvm.edu		Berger, Christopher/0000-0001-8481-3479	NIGMS, National Institutes of Health [GM101066, GM070862, GM086610]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101066, R01GM070862, R01GM086610] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants GM101066 (to C.L.B.), GM070862 (to K.J.V), and GM086610 (to R.O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; AUDEBERT S, 1994, J CELL SCI, V107, P2313; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; Carabalona A, 2016, NAT NEUROSCI, V19, P253, DOI 10.1038/nn.4213; Castle MJ, 2014, MOL THER, V22, P554, DOI 10.1038/mt.2013.237; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Dantas TJ, 2016, CYTOSKELETON, V73, P566, DOI 10.1002/cm.21293; Ghosh-Roy A, 2012, DEV CELL, V23, P716, DOI 10.1016/j.devcel.2012.08.010; Ginsburg A, 2017, J PHYS CHEM B, V121, P8427, DOI 10.1021/acs.jpcb.7b01057; Goedert M, 2000, ANN NY ACAD SCI, V920, P74; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Gramlich MW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44290; Gumy LF, 2017, NEURON, V94, P347, DOI 10.1016/j.neuron.2017.03.046; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hoeprich GJ, 2017, TRAFFIC, V18, P304, DOI 10.1111/tra.12478; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Hotta T, 2016, PLANT PHYSIOL, V170, P1189, DOI 10.1104/pp.15.01173; Hung COY, 2016, TRAFFIC, V17, P1155, DOI 10.1111/tra.12428; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Karasmanis EP, 2018, DEV CELL, V46, P204, DOI 10.1016/j.devcel.2018.06.013; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Kopeikina KJ, 2012, TRANSL NEUROSCI, V3, P223, DOI 10.2478/s13380-012-0032-y; Lacroix B, 2011, METHODS MOL BIOL, V777, P57, DOI 10.1007/978-1-61779-252-6_4; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; Lee JR, 2015, HUM MUTAT, V36, P69, DOI 10.1002/humu.22709; Lee JR, 2003, J BIOL CHEM, V278, P2624, DOI 10.1074/jbc.M211152200; Lipka J, 2016, EMBO J, V35, P302, DOI 10.15252/embj.201592929; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Magiera MM, 2018, CELL, V173, P1323, DOI 10.1016/j.cell.2018.05.018; McVicker DP, 2014, CYTOSKELETON, V71, P184, DOI 10.1002/cm.21163; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Monroy BY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03909-2; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Niwa S, 2016, CELL REP, V16, P2129, DOI 10.1016/j.celrep.2016.07.043; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Padzik A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00057; Regnard C, 1999, J CELL SCI, V112, P4281; Rodriguez-Martin T, 2016, NEUROBIOL DIS, V85, P1, DOI 10.1016/j.nbd.2015.10.007; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Schoch KM, 2016, NEURON, V90, P941, DOI 10.1016/j.neuron.2016.04.042; Siddiqui N, 2017, BIOCHEMISTRY-MOSCOW+, V82, P803, DOI 10.1134/S0006297917070057; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Soppina V, 2014, MOL BIOL CELL, V25, P2161, DOI 10.1091/mbc.E14-01-0696; Soppina V, 2014, P NATL ACAD SCI USA, V111, P5562, DOI 10.1073/pnas.1400759111; Stavoe AKH, 2016, DEV CELL, V38, P171, DOI 10.1016/j.devcel.2016.06.012; Stern JL, 2017, MOL BIOL CELL, V28, P1079, DOI 10.1091/mbc.E16-10-0728; Tanaka Y, 2016, NEURON, V90, P1215, DOI 10.1016/j.neuron.2016.05.002; Thompson AR, 2013, BIOPHYS J, V104, P2651, DOI 10.1016/j.bpj.2013.05.022; Trybus KM, 2013, CURR BIOL, V23, pR623, DOI 10.1016/j.cub.2013.06.005; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Widlund PO, 2012, MOL BIOL CELL, V23, P4393, DOI 10.1091/mbc.E12-06-0444; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhang R, 2018, P NATL ACAD SCI USA, V115, pE6191, DOI 10.1073/pnas.1802637115	71	24	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6353	6363		10.1074/jbc.RA118.005765	http://dx.doi.org/10.1074/jbc.RA118.005765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30770469	Green Published, hybrid			2022-12-28	WOS:000468402000013
J	McCoy, JC; Walker, RG; Murray, NH; Thompson, TB				McCoy, Jason C.; Walker, Ryan G.; Murray, Nathan H.; Thompson, Thomas B.			Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transforming growth factor beta (TGF-); protein structure; X-ray crystallography; inhibitor; myostatin; structural biology; muscle development; tissue homeostasis; GDF8; GDF11; WFIKKN; follistatin; antagonism	MUSCLE MASS; DAN-FAMILY; ACTIVIN-A; PROTEINASE-INHIBITOR; EXTRACELLULAR DOMAIN; SKELETAL-MUSCLE; MYOSTATIN; COMPLEX; BINDING; CANCER	Growth differentiation factor 8 (GDF8; also known as myostatin) and GDF11 are closely related members of the transforming growth factor (TGF-) family. GDF8 strongly and negatively regulates skeletal muscle growth, and GDF11 has been implicated in various age-related pathologies such as cardiac hypertrophy. GDF8 and GDF11 signaling activities are controlled by the extracellular protein antagonists follistatin; follistatin-like 3 (FSTL3); and WAP, follistatin/kazal, immunoglobulin, Kunitz, and netrin domain-containing (WFIKKN). All of these proteins contain a follistatin domain (FSD) important for ligand binding and antagonism. Here, we investigated the structure and function of the FSD from murine WFIKKN2 and compared it with the FSDs of follistatin and FSTL3. Using native gel shift and surface plasmon resonance analyses, we determined that the WFIKKN2 FSD can interact with both GDF8 and GDF11 and block their interactions with the type II receptor activin A receptor type 2B (ActRIIB). Further, we solved the crystal structure of the WFIKKN2 FSD to 1.39 resolution and identified surface-exposed residues that, when substituted with alanine, reduce antagonism of GDF8 in full-length WFIKKN2. Comparison of the WFIKKN2 FSD with those of follistatin and FSTL3 revealed differences in both the FSD structure and position of residues within the domain that are important for ligand antagonism. Taken together, our results indicate that both WFIKKN and follistatin utilize their FSDs to block the type II receptor but do so via different binding interactions.	[McCoy, Jason C.; Walker, Ryan G.; Murray, Nathan H.; Thompson, Thomas B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Walker, Ryan G.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Murray, Nathan H.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University System of Ohio; University of Cincinnati; Harvard University; University of Wisconsin System; University of Wisconsin Madison	Thompson, TB (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	Tom.Thompson@uc.edu		Murray, Nathan/0000-0001-7185-2591; Thompson, Thomas/0000-0002-7041-5047	NIGMS, National Institutes of Health [R01 GM114640]; American Heart Association [12PRE11790027, 18PRE33990312]; Elevian; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM127726, R01GM114640] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); Elevian; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant R01 GM114640 and American Heart Association Grants 12PRE11790027 (to R.G.W.) and 18PRE33990312 (to J.C.M.). Thomas B. Thompson is a consultant for Acceleron Pharma. Ryan G. Walker is a co-founder, scientific advisor, and holder of private equity in Elevian, a company that aims to develop medicines to restore regenerative capacity. Elevian provides sponsored research support for R.G.W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; [Anonymous], 2018, PYMOL MOL GRAPHICS S; Brun C, 2014, CELL PHYSIOL BIOCHEM, V34, P1241, DOI 10.1159/000366335; Cash JN, 2012, MOL ENDOCRINOL, V26, P1167, DOI 10.1210/me.2012-1061; Cash JN, 2012, J BIOL CHEM, V287, P1043, DOI 10.1074/jbc.M111.270801; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Hinck AP, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022103; Ibrahim BS, 2004, BIOCHEM BIOPH RES CO, V313, P8, DOI 10.1016/j.bbrc.2003.11.082; JOHANSSON MW, 1994, EUR J BIOCHEM, V223, P389, DOI 10.1111/j.1432-1033.1994.tb19005.x; Kattamuri C, 2012, J MOL BIOL, V424, P313, DOI 10.1016/j.jmb.2012.10.003; Keutmann HT, 2004, MOL ENDOCRINOL, V18, P228, DOI 10.1210/me.2003-0112; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee YS, 2013, P NATL ACAD SCI USA, V110, pE3713, DOI 10.1073/pnas.1309907110; Loumaye A, 2015, J CLIN ENDOCR METAB, V100, P2030, DOI 10.1210/jc.2014-4318; Lu L, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00205; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mendell JR, 2015, MOL THER, V23, P192, DOI 10.1038/mt.2014.200; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; Monestier O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-541; Monestier O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043710; Nolan K, 2016, CELL REP, V16, P2077, DOI 10.1016/j.celrep.2016.07.046; Nolan K, 2014, PROTEIN SCI, V23, P999, DOI 10.1002/pro.2485; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Ozek C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35716-6; Pariani S, 2016, BIOCHIMIE, V123, P85, DOI 10.1016/j.biochi.2016.02.002; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Rinaldi F, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0092-8; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Singh P, 2016, CTS-CLIN TRANSL SCI, V9, P302, DOI 10.1111/cts.12420; Smith RC, 2013, CURR OPIN SUPPORT PA, V7, P352, DOI 10.1097/SPC.0000000000000013; Szlama G, 2010, FEBS J, V277, P5040, DOI 10.1111/j.1742-4658.2010.07909.x; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Tsuchida K, 2008, CURR OPIN DRUG DISC, V11, P487; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Walker RG, 2018, P NATL ACAD SCI USA, V115, pE866, DOI 10.1073/pnas.1714622115; Walker RG, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0350-1; Walker RG, 2016, CIRC RES, V118, P1125, DOI 10.1161/CIRCRESAHA.116.308391; Walker RG, 2015, J BIOL CHEM, V290, P7506, DOI 10.1074/jbc.M114.624130; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525; Zimmers TA, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0639-9	63	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6333	6343		10.1074/jbc.RA118.005831	http://dx.doi.org/10.1074/jbc.RA118.005831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30814254	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000468402000011
J	van Winden, VJC; Damen, MPM; Ummels, R; Bitter, W; Houben, ENG				van Winden, Vincent J. C.; Damen, Merel P. M.; Ummels, Roy; Bitter, Wilbert; Houben, Edith N. G.			Protease domain and transmembrane domain of the type VII secretion mycosin protease determine system-specific functioning in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; protein secretion; serine protease; protein stability; protein complex; Mycobacterium marinum; T7SS; type VII secretion system	TUBERCULOSIS; SUGGESTS; CYTOSOL; MYCP1; BCG	Mycobacteria use type VII secretion systems to secrete proteins across their highly hydrophobic diderm cell envelope. Pathogenic mycobacteria, such as Mycobacterium tuberculosis and Mycobacterium marinum, have up to five of these systems, named ESX-1 to ESX-5. Most of these systems contain a set of five conserved membrane components, of which the four Ecc proteins form the core membrane-embedded secretion complex. The fifth conserved membrane protein, mycosin protease (MycP), is not part of the core complex but is essential for secretion, as it stabilizes this membrane complex. Here we investigated which MycP domains are required for this stabilization by producing hybrid constructs between MycP(1) and MycP(5) in M. marinum and analyzed their effect on ESX-1 and ESX-5 secretion. We found that both the protease and transmembrane domain are required for the ESX system-specific function of mycosins. In addition, we observed that the transmembrane domain strongly affects MycP protein levels. We also show that the extended loops 1 and 2 in the protease domain are probably primarily involved in MycP stability, whereas loop 3 and the MycP(5)-specific loop 5 are dispensable. The atypical propeptide, or N-terminal extension, is required only for MycP stability. Finally, we show that the protease domain of MycP(P1), encoded by the esx-P1 locus on the pRAW plasmid, is functionally redundant to the protease domain of MycP(5). These results provide the first insight into the regions of mycosins involved in interaction with and stabilization of their respective ESX complexes.	[van Winden, Vincent J. C.; Ummels, Roy; Bitter, Wilbert] Vrije Univ Amsterdam, Amsterdam UMC, Dept Med Microbiol & Infect Control, NL-1081 HZ Amsterdam, Netherlands; [Damen, Merel P. M.; Bitter, Wilbert; Houben, Edith N. G.] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, Sect Mol Microbiol, NL-1081 HZ Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Houben, ENG (corresponding author), Vrije Univ Amsterdam, Sect Mol Microbiol, Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands.	e.n.g.houben@vu.nl	Bitter, Wilbert/ABG-3726-2020; Bitter, Wilbert/AAA-6872-2019; Bitter, W/CAJ-5778-2022; Houben, Edith N.G./B-2110-2015	Bitter, Wilbert/0000-0001-8347-6511; Houben, Edith N.G./0000-0002-8805-2002; Damen, Merel PM/0000-0003-4233-2671	VIDI from the Netherlands Organization of Scientific Research (NWO) [864.12.006]; ALW Open Grant from the Netherlands Organization of Scientific Research (NWO) [ALWOP.319]; CCA from Amsterdam University Medical Center	VIDI from the Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ALW Open Grant from the Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CCA from Amsterdam University Medical Center	This work was funded by VIDI Grant 864.12.006 (to E. N. G. H.) and ALW Open Grant ALWOP.319 (to M. P. M. D.), both from the Netherlands Organization of Scientific Research (NWO), and by the CCA from Amsterdam University Medical Center (to V. J. C. v. W. and W. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Ates LS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005190; Beckham KSH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.47; Brown GD, 2000, GENE, V254, P147, DOI 10.1016/S0378-1119(00)00277-8; Dumas E, 2016, GENOME BIOL EVOL, V8, P387, DOI 10.1093/gbe/evw001; Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Rosenberg OS, 2015, CELL, V161, P501, DOI 10.1016/j.cell.2015.03.040; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Solomonson M, 2013, J BIOL CHEM, V288, P17782, DOI 10.1074/jbc.M113.462036; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sun DM, 2013, PROTEIN CELL, V4, P921, DOI 10.1007/s13238-013-3089-7; Ummels R, 2014, MBIO, V5, DOI 10.1128/mBio.01744-14; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Winden VJC, 2016, MBIO, V7, DOI 10.1128/mBio.01471-16; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH004; Wagner' JM, 2016, BMC STRUCT BIOL, V16, DOI [10.1186/s12900-016-0056-6, 10.1186/S12900-016-0056-6]; Wagner JM, 2013, J STRUCT BIOL, V184, P115, DOI 10.1016/j.jsb.2013.09.022	28	9	9	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4806	4814		10.1074/jbc.RA118.007090	http://dx.doi.org/10.1074/jbc.RA118.007090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30692196	Green Published, hybrid			2022-12-28	WOS:000463985600007
J	Lara, P; Tellgren-Roth, A; Behesti, H; Horn, Z; Schiller, N; Enquist, K; Cammenberg, M; Liljenstrom, A; Hatten, ME; von Heijne, G; Nilsson, I				Lara, Patricia; Tellgren-Roth, Asa; Behesti, Hourinaz; Horn, Zachi; Schiller, Nina; Enquist, Karl; Cammenberg, Malin; Liljenstrom, Amanda; Hatten, Mary E.; von Heijne, Gunnar; Nilsson, IngMarie			Murine astrotactins 1 and 2 have a similar membrane topology and mature via endoproteolytic cleavage catalyzed by a signal peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal peptidase; glycosylation; glycosylation inhibitor; cell migration; neuron; Astrotactin; central nervous system; neuronal migration; signal peptidase; topology	AMINO-ACID; IMPORTANT DETERMINANT; PROTEIN; TRANSLOCATION; INSERTION; SEQUON	Astrotactin 1 (Astn1) and Astn2 are membrane proteins that function in glial-guided migration, receptor trafficking, and synaptic plasticity in the brain as well as in planar polarity pathways in the skin. Here we used glycosylation mapping and protease protection approaches to map the topologies of mouse Astn1 and Astn2 in rough microsomal membranes and found that Astn2 has a cleaved N-terminal signal peptide, an N-terminal domain located in the lumen of the rough microsomal membranes (topologically equivalent to the extracellular surface in cells), two transmembrane helices, and a large C-terminal lumenal domain. We also found that Astn1 has the same topology as Astn2, but we did not observe any evidence of signal peptide cleavage in Astn1. Both Astn1 and Astn2 mature through endoproteolytic cleavage in the second transmembrane helix; importantly, we identified the endoprotease responsible for the maturation of Astn1 and Astn2 as the endoplasmic reticulum signal peptidase. Differences in the degree of Astn1 and Astn2 maturation possibly contribute to the higher levels of the C-terminal domain of Astn1 detected on neuronal membranes of the central nervous system. These differences may also explain the distinct cellular functions of Astn1 and Astn2, such as in membrane adhesion, receptor trafficking, and planar polarity signaling.	[Lara, Patricia; Tellgren-Roth, Asa; Schiller, Nina; Enquist, Karl; Cammenberg, Malin; Liljenstrom, Amanda; von Heijne, Gunnar; Nilsson, IngMarie] Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16C, S-10691 Stockholm, Sweden; [Behesti, Hourinaz; Horn, Zachi; Hatten, Mary E.] Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10065 USA	Stockholm University; Rockefeller University	von Heijne, G; Nilsson, I (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16C, S-10691 Stockholm, Sweden.	gunnar@dbb.su.se; ingmarie@dbb.su.se	von Heijne, Gunnar/AAH-9389-2019; von heijne, gunnar/F-5576-2011	Behesti, Hourinaz/0000-0001-9383-9929; von heijne, gunnar/0000-0002-4490-8569	Knut and Alice Wallenberg Foundation [2012.0282]; Swedish Research Council [621-2014-3713]; Swedish Cancer Foundation [15 0888]; Swedish Foundation for International Cooperation in Research and Higher Education [210/083(12), KU 2003-4674]; Swedish Foundation for Strategic Research [A305:200]; SSF-Infection Biology Grant 2012 [SB12-0026]; Eugene W. Chinery Trust; Renate, Hans, and Maria Hofmann Trust	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Swedish Foundation for International Cooperation in Research and Higher Education; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); SSF-Infection Biology Grant 2012; Eugene W. Chinery Trust; Renate, Hans, and Maria Hofmann Trust	This work was supported by Knut and Alice Wallenberg Foundation Grant 2012.0282 and the Swedish Research Council Grant 621-2014-3713 (to G. v. H.), Swedish Cancer Foundation Grant 15 0888 (to G. v. H. and I. N.), Swedish Foundation for International Cooperation in Research and Higher Education Grant 210/083(12); KU 2003-4674 (to I. N.), Swedish Foundation for Strategic Research Grant A305:200 and SSF-Infection Biology Grant 2012(SB12-0026 (to I. N.), the Eugene W. Chinery Trust (to M. E. H.), and the Renate, Hans, and Maria Hofmann Trust (to M. E. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams NC, 2002, DEVELOPMENT, V129, P965; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; Behesti H, 2018, P NATL ACAD SCI USA, V115, pE9717, DOI 10.1073/pnas.1809382115; Chang H, 2017, IUBMB LIFE, V69, P572, DOI 10.1002/iub.1641; Chang H, 2017, J BIOL CHEM, V292, P3506, DOI 10.1074/jbc.M116.768077; Chang H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005532; Cuviello F, 2015, FEBS LETT, V589, P3921, DOI 10.1016/j.febslet.2015.10.030; EDMONDSON JC, 1988, J CELL BIOL, V106, P505, DOI 10.1083/jcb.106.2.505; Green N., 2002, ENZYMES, P57; Horn Z, 2018, P NATL ACAD SCI USA, V115, P10556, DOI 10.1073/pnas.1811100115; Igura M, 2011, GLYCOBIOLOGY, V21, P575, DOI 10.1093/glycob/cwq196; JOHANSSON M, 1993, MOL GEN GENET, V239, P251, DOI 10.1007/BF00281625; Kapp K., 2009, PROTEIN TRANSPORT EN, P1; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Lara P, 2017, J BIOL CHEM, V292, P11349, DOI 10.1074/jbc.M117.779421; LILJESTROM P, 1991, J VIROL, V65, P147; Lundin C, 2006, FEBS LETT, V580, P2281, DOI 10.1016/j.febslet.2006.03.040; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Ni T, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160053; Nilsson I, 2003, J BIOL CHEM, V278, P29389, DOI 10.1074/jbc.M212310200; Nilsson I, 2002, FEBS LETT, V516, P106, DOI 10.1016/S0014-5793(02)02511-5; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Pene V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175810; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	33	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4538	4545		10.1074/jbc.RA118.007093	http://dx.doi.org/10.1074/jbc.RA118.007093			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30696770	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000462969500022
J	Kerruth, S; Coates, C; Durst, CD; Oertner, TG; Torok, K				Kerruth, Silke; Coates, Catherine; Duerst, Celine D.; Oertner, Thomas G.; Torok, Katalin			The kinetic mechanisms of fast-decay red-fluorescent genetically encoded calcium indicators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calcium imaging; fluorescence; kinetics; biosensor	NEURAL ACTIVITY; CALMODULIN; PROTEINS; INHIBITION; PEPTIDES	Genetically encoded calcium indicators (GECIs) are useful reporters of cell-signaling, neuronal, and network activities. We have generated novel fast variants and investigated the kinetic mechanisms of two recently developed red-fluorescent GECIs (RGECIs), mApple-based jRGECO1a and mRuby-based jRCaMP1a. In the formation of fluorescent jRGECO1a and jRCaMP1a complexes, calcium binding is followed by rate-limiting isomerization. However, fluorescence decay of calcium-bound jRGECO1a follows a different pathway from its formation: dissociation of calcium occurs first, followed by the peptide, similarly to GCaMP-s. In contrast, fluorescence decay of calcium-bound jRCaMP1a occurs by the reversal of the on-pathway: peptide dissociation is followed by calcium. The mechanistic differences explain the generally slower off-kinetics of jRCaMP1a-type indicators compared with GCaMP-s and jRGECO1a-type GECI: the fluorescence decay rate of f-RCaMP1 was 21 s(-1), compared with 109 s(-1) for f-RGECO1 and f-RGECO2 (37 degrees C). Thus, the CaM-peptide interface is an important determinant of the kinetic responses of GECIs; however, the topology of the structural link to the fluorescent protein demonstrably affects the internal dynamics of the CaM-peptide complex. In the dendrites of hippocampal CA3 neurons, f-RGECO1 indicates calcium elevation in response to a 100 action potential train in a linear fashion, making the probe particularly useful for monitoring large-amplitude, fast signals, e.g. those in dendrites, muscle cells, and immune cells.	[Kerruth, Silke; Coates, Catherine; Torok, Katalin] St Georges Univ London, Mol & Clin Sci Res Inst, Cranmer Terrace, London SW17 0RE, England; [Duerst, Celine D.; Oertner, Thomas G.] Ctr Mol Neurobiol Hamburg, Inst Synapt Physiol, D-20251 Hamburg, Germany	St Georges University London	Torok, K (corresponding author), St Georges Univ London, Mol & Clin Sci Res Inst, Cranmer Terrace, London SW17 0RE, England.	k.torok@sgul.ac.uk	Oertner, Thomas/F-2214-2010	Oertner, Thomas/0000-0002-2312-7528; Coates, Catherine/0000-0002-8538-5901; Torok, Katalin/0000-0002-3107-4534; Durst, Celine/0000-0003-3821-2888	Biotechnology and Biological Sciences Research Council [BB/M02556X/1]; BBSRC [BB/M02556X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Biotechnology and Biological Sciences Research Council Grant BB/M02556X/1 (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Badura A, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.2.025008; Barnett LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170934; Broussard GJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00097; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dana H., 2018, HIGH PERFORMANCE GFP, DOI [10.1101/434589, DOI 10.1101/434589]; Dana H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205444; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Ding JJ, 2014, SCI CHINA LIFE SCI, V57, P269, DOI 10.1007/s11427-013-4599-5; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Gee Christine E, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.prot094888; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Gutfreund H., 1995, KINETICS LIFE SCI, P216; Helassa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep38276; Helassa N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15978; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/NMETH.3185, 10.1038/nmeth.3185]; Jama AM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.157057; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Montagni E, 2019, J PHYS D APPL PHYS, V52, DOI 10.1088/1361-6463/aaf26c; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039933; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Shen Y, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0480-0; Sun XNR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3170; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; Wabnig S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135584; Wiegert J Simon, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.prot094904; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zhao YJ, 2017, NEURON, V96, P355, DOI 10.1016/j.neuron.2017.09.041; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	39	12	12	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3934	3946		10.1074/jbc.RA118.004543	http://dx.doi.org/10.1074/jbc.RA118.004543			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30651353	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000461854400011
J	Snead, D; Eliezer, D				Snead, David; Eliezer, David			Intrinsically disordered proteins in synaptic vesicle trafficking and release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						intrinsically disordered protein; neurotransmitter release; lipid vesicle; protein folding; membrane trafficking; -synuclein; complexin; membraneless organelles; phase transitions; synaptic vesicles	BOUND ALPHA-SYNUCLEIN; N-TERMINAL ACETYLATION; SPONTANEOUS NEUROTRANSMITTER RELEASE; LIPID-BINDING DOMAIN; PARKINSONS-DISEASE; SNARE-COMPLEX; MEMBRANE CURVATURE; WILD-TYPE; MOLECULAR RECOGNITION; PHOSPHOLIPID-BINDING	The past few years have resulted in an increased awareness and recognition of the prevalence and roles of intrinsically disordered proteins and protein regions (IDPs and IDRs, respectively) in synaptic vesicle trafficking and exocytosis and in overall synaptic organization. IDPs and IDRs constitute a class of proteins and protein regions that lack stable tertiary structure, but nevertheless retain biological function. Their significance in processes such as cell signaling is now well accepted, but their pervasiveness and importance in other areas of biology are not as widely appreciated. Here, we review the prevalence and functional roles of IDPs and IDRs associated with the release and recycling of synaptic vesicles at nerve terminals, as well as with the architecture of these terminals. We hope to promote awareness, especially among neuroscientists, of the importance of this class of proteins in these critical pathways and structures. The examples discussed illustrate some of the ways in which the structural flexibility conferred by intrinsic protein disorder can be functionally advantageous in the context of cellular trafficking and synaptic function.	[Snead, David; Eliezer, David] Weill Cornell Med, Dept Biochem, New York, NY 10021 USA	Cornell University	Eliezer, D (corresponding author), Weill Cornell Med, Dept Biochem, New York, NY 10021 USA.	dae2005@med.cornell.edu		Eliezer, David/0000-0002-1311-7537	National Institutes of Health [R37AG019391, R01GM117518, F30MH101982, MSTPGM07739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R37AG019391 (to D. E.), R01GM117518 (to D. E.), F30MH101982 (to D. S.), and MSTPGM07739 (to D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahn BH, 2002, J BIOL CHEM, V277, P12334, DOI 10.1074/jbc.M110414200; Ambroggio E, 2010, EMBO J, V29, P292, DOI 10.1038/emboj.2009.341; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Arai M, 2015, P NATL ACAD SCI USA, V112, P9614, DOI 10.1073/pnas.1512799112; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Baker RW, 2015, SCIENCE, V349, P1111, DOI 10.1126/science.aac7906; Balazs A, 2009, FEBS J, V276, P3744, DOI 10.1111/j.1742-4658.2009.07090.x; Banerjee R, 2016, J BIOL CHEM, V291, P6679, DOI 10.1074/jbc.R116.719930; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Barcelo-Coblijn G, 2007, J NEUROCHEM, V101, P132, DOI 10.1111/j.1471-4159.2006.04348.x; Bielopolski N, 2014, J BIOL CHEM, V289, P17087, DOI 10.1074/jbc.M113.515296; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Borbat P, 2006, J AM CHEM SOC, V128, P10004, DOI 10.1021/ja063122l; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brewer KD, 2015, NAT STRUCT MOL BIOL, V22, P555, DOI 10.1038/nsmb.3035; Broersen K, 2006, BIOCHEMISTRY-US, V45, P15610, DOI 10.1021/bi061743l; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Brose N, 2008, MOL CELLS, V25, P7; Buhl LK, 2013, MOL CELL NEUROSCI, V52, P161, DOI 10.1016/j.mcn.2012.11.009; Burger VM, 2016, J BIOL CHEM, V291, P6706, DOI 10.1074/jbc.R115.692590; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; Capraro BR, 2010, J AM CHEM SOC, V132, P1200, DOI 10.1021/ja907936c; Castagnet PI, 2005, J NEUROCHEM, V94, P839, DOI 10.1111/j.1471-4159.2005.03247.x; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Cho RW, 2015, NEURON, V88, P749, DOI 10.1016/j.neuron.2015.10.011; Cho RW, 2014, P NATL ACAD SCI USA, V111, P10317, DOI 10.1073/pnas.1409311111; Cho RW, 2010, MOL CELL NEUROSCI, V45, P389, DOI 10.1016/j.mcn.2010.07.012; Choi BK, 2013, P NATL ACAD SCI USA, V110, P4087, DOI 10.1073/pnas.1218424110; Choi UB, 2016, ELIFE, V5, DOI 10.7554/eLife.16886; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Colbert KN, 2013, P NATL ACAD SCI USA, V110, P12637, DOI 10.1073/pnas.1303753110; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Franceschi G, 2009, J MOL BIOL, V394, P94, DOI 10.1016/j.jmb.2009.09.008; DeWitt DC, 2013, BIOCHEMISTRY-US, V52, P2385, DOI 10.1021/bi4002369; Diao JJ, 2013, J AM CHEM SOC, V135, P15274, DOI 10.1021/ja407392n; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Dikiy I, 2016, ACS CHEM BIOL, V11, P2428, DOI 10.1021/acschembio.6b00539; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Dikiy I, 2012, BBA-BIOMEMBRANES, V1818, P1013, DOI 10.1016/j.bbamem.2011.09.008; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Drew CJG, 2007, HUM MOL GENET, V16, P2288, DOI 10.1093/hmg/ddm181; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Drouet V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/289728; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Eliezer D, 2008, PARKINSON'S DISEASE: MOLECULAR AND THERAPEUTIC INSIGHTS FROM MODEL SYSTEMS, P575, DOI 10.1016/B978-0-12-374028-1.00042-7; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Fasshauer D, 2003, BBA-MOL CELL RES, V1641, P87, DOI 10.1016/S0167-4889(03)00090-9; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fealey ME, 2016, BIOCHEMISTRY-US, V55, P2914, DOI 10.1021/acs.biochem.6b00085; Ferreon ACM, 2007, BIOCHEMISTRY-US, V46, P4499, DOI 10.1021/bi602461y; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Fusco G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12563; Gauer JW, 2012, BIOPHYS J, V103, P238, DOI 10.1016/j.bpj.2012.05.051; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; George JM, 2002, GENOME BIOL, V3; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Glynn D, 2005, HUM MOL GENET, V14, P2369, DOI 10.1093/hmg/ddi239; Glynn D, 2007, BRAIN RES BULL, V72, P108, DOI 10.1016/j.brainresbull.2006.10.017; Golovko MY, 2007, J NEUROCHEM, V101, P201, DOI 10.1111/j.1471-4159.2006.04357.x; Golovko MY, 2006, BIOCHEMISTRY-US, V45, P6956, DOI 10.1021/bi0600289; Golovko MY, 2005, BIOCHEMISTRY-US, V44, P8251, DOI 10.1021/bi0502137; Gong JH, 2016, P NATL ACAD SCI USA, V113, pE7590, DOI 10.1073/pnas.1609917113; Guharoy M, 2016, J BIOL CHEM, V291, P6723, DOI 10.1074/jbc.R115.692665; Gundelfinger Eckart D, 2015, Front Synaptic Neurosci, V7, P19, DOI 10.3389/fnsyn.2015.00019; Han GA, 2013, J CELL SCI, V126, P2361, DOI 10.1242/jcs.126862; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Hunt T, 1990, TRENDS BIOCHEM SCI, V15, P305; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Ishizuka T, 1997, NEUROSCI LETT, V232, P107, DOI 10.1016/S0304-3940(97)00586-7; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iyer J, 2013, MOL CELL NEUROSCI, V56, P244, DOI 10.1016/j.mcn.2013.06.002; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kaeser-Woo YJ, 2012, J NEUROSCI, V32, P2877, DOI 10.1523/JNEUROSCI.3360-11.2012; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lai Y, 2016, P NATL ACAD SCI USA, V113, pE4698, DOI 10.1073/pnas.1604348113; Lai Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03756; Lai Y, 2014, BIOCHEMISTRY-US, V53, P3889, DOI 10.1021/bi5002536; Lai Y, 2013, BIOCHEM J, V456, P25, DOI 10.1042/BJ20130949; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lautenschlager J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03111-4; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee SH, 2012, CURR PROTEIN PEPT SC, V13, P34, DOI 10.2174/138920312799277974; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liu F, 2008, FREE RADICAL BIO MED, V45, P242, DOI 10.1016/j.freeradbiomed.2008.03.022; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Mahul-Mellier AL, 2014, HUM MOL GENET, V23, P2858, DOI 10.1093/hmg/ddt674; Makke M, 2018, ELIFE, V7, DOI 10.7554/eLife.38981; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; Maltsev AS, 2013, J AM CHEM SOC, V135, P2943, DOI 10.1021/ja312415q; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martin JA, 2011, CURR BIOL, V21, P97, DOI 10.1016/j.cub.2010.12.014; Martin S, 2013, J CELL SCI, V126, P2353, DOI 10.1242/jcs.126813; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Milovanovic D, 2018, SCIENCE, V361, P604, DOI 10.1126/science.aat5671; Milovanovic D, 2017, NEURON, V93, P995, DOI 10.1016/j.neuron.2017.02.013; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Montesinos ML, 2005, BRAIN RES REV, V49, P416, DOI 10.1016/j.brainresrev.2005.06.002; Morton LA, 2014, BBA-BIOMEMBRANES, V1838, P3137, DOI 10.1016/j.bbamem.2014.08.027; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakamura T, 2001, BIOCHEM BIOPH RES CO, V280, P1085, DOI 10.1006/bbrc.2000.4253; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nielsen MS, 2001, J BIOL CHEM, V276, P22680, DOI 10.1074/jbc.M101181200; Oaks AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060378; Oaks AW, 2011, FEBS LETT, V585, P1001, DOI 10.1016/j.febslet.2011.03.009; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Papoian GA, 2008, P NATL ACAD SCI USA, V105, P14237, DOI 10.1073/pnas.0807977105; Parisotto D, 2014, J BIOL CHEM, V289, P9639, DOI 10.1074/jbc.M113.514273; Payton JE, 2004, J MOL BIOL, V337, P1001, DOI 10.1016/j.jmb.2004.02.014; Pechstein Arndt, 2010, Front Synaptic Neurosci, V2, P143, DOI 10.3389/fnsyn.2010.00143; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Pietrosemoli N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003144; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Quilty MC, 2006, EXP NEUROL, V199, P249, DOI 10.1016/j.expneurol.2005.10.018; Ramezani M., 2018, 492066 BIORXIV; Rappley I, 2009, BIOCHEMISTRY-US, V48, P1077, DOI 10.1021/bi801871h; Redler S, 2017, EUR J HUM GENET, V25, P889, DOI 10.1038/ejhg.2017.52; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Ruiperez V, 2010, PROG LIPID RES, V49, P420, DOI 10.1016/j.plipres.2010.05.004; Sakon JJ, 2010, NAT METHODS, V7, P203, DOI [10.1038/nmeth.1421, 10.1038/NMETH.1421]; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Seiler F, 2009, FEBS LETT, V583, P2343, DOI 10.1016/j.febslet.2009.06.025; Sen Arpita, 2012, Biomol Concepts, V3, P117; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snead D, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00154; Snead David, 2014, Exp Neurobiol, V23, P292, DOI 10.5607/en.2014.23.4.292; Snead D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5955; Soper JH, 2008, MOL BIOL CELL, V19, P1093, DOI 10.1091/mbc.E07-08-0827; Spillantini MG, 1999, PARKINSONISM RELAT D, V5, P157, DOI 10.1016/S1353-8020(99)00031-0; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; Tamamizu-Kato S, 2006, BIOCHEMISTRY-US, V45, P10947, DOI 10.1021/bi060939i; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Uversky VN, 2016, J BIOL CHEM, V291, P6681, DOI 10.1074/jbc.R115.685859; Vanni S, 2013, BIOPHYS J, V104, P575, DOI 10.1016/j.bpj.2012.11.3837; Vargas KJ, 2014, J NEUROSCI, V34, P9364, DOI 10.1523/JNEUROSCI.4787-13.2014; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wentzel C, 2013, NEURON, V78, P1012, DOI 10.1016/j.neuron.2013.05.010; Wersinger C, 2003, MOL CELL NEUROSCI, V24, P91, DOI 10.1016/S1044-7431(03)00124-6; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wragg RT, 2013, NEURON, V77, P323, DOI 10.1016/j.neuron.2012.11.005; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Xue MS, 2010, NAT STRUCT MOL BIOL, V17, P568, DOI 10.1038/nsmb.1791; Xue MS, 2009, NEURON, V64, P367, DOI 10.1016/j.neuron.2009.09.043; Yang XF, 2013, P NATL ACAD SCI USA, V110, P20777, DOI 10.1073/pnas.1321367110; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zeng ML, 2016, CELL, V166, P1163, DOI 10.1016/j.cell.2016.07.008; Zhao L, 2007, DEV BIOL, V309, P236, DOI 10.1016/j.ydbio.2007.07.009; Zhou QJ, 2017, NATURE, V548, P420, DOI 10.1038/nature23484; Zhou QJ, 2015, NATURE, V525, P62, DOI 10.1038/nature14975; Zhu M, 2006, BIOCHEMISTRY-US, V45, P8135, DOI 10.1021/bi052584t	226	36	36	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3325	3342		10.1074/jbc.REV118.006493	http://dx.doi.org/10.1074/jbc.REV118.006493			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30700558	Green Published, hybrid			2022-12-28	WOS:000461853900001
J	Warren, NJH; Eastman, A				Warren, Nicholas J. H.; Eastman, Alan			Reply to Koh: Signaling dynamics of DNA damage response invoked by combination therapy are dose-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Letter									[Warren, Nicholas J. H.; Eastman, Alan] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Lebanon, NH 03756 USA	Dartmouth College; Norris Cotton Cancer Center	Eastman, A (corresponding author), Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Lebanon, NH 03756 USA.	Alan.R.Eastman@Dartmouth.edu			NATIONAL CANCER INSTITUTE [R01CA117874] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA117874] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Koh SB, 2019, J BIOL CHEM, V294, P2191, DOI 10.1074/jbc.L119.007381; Koh SB, 2018, CANCER RES, V78, P3054, DOI 10.1158/0008-5472.CAN-17-3932; Montano R, 2017, ONCOTARGET, V8, P67754, DOI 10.18632/oncotarget.18834; Montano R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-604; Warren NJH, 2019, J BIOL CHEM, V294, P1763, DOI 10.1074/jbc.RA118.005231	5	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2192	2192		10.1074/jbc.RL119.007419	http://dx.doi.org/10.1074/jbc.RL119.007419			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30737319	hybrid, Green Published			2022-12-28	WOS:000459711400037
J	Yang, JH; Li, Y; Yan, W; Li, WM; Qiu, Q; Ye, HY; Chen, LJ				Yang, Jianhong; Li, Yong; Yan, Wei; Li, Weimin; Qiu, Qiang; Ye, Haoyu; Chen, Lijuan			Covalent modification of Cys-239 in -tubulin by small molecules as a strategy to promote tubulin heterodimer degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tubulin; microtubule; anticancer drug; cytoskeleton; small molecule; covalent modification; protein degradation; T0070907; tubulin degradation; tubulin inhibitor	BETA-TUBULIN; CANCER-CELLS; GROWTH ARREST; BINDING; AGENT; ALPHA; ISOTHIOCYANATES; POLYMERIZATION; MICROTUBULES; INHIBITORS	Clinical microtubule-targeting drugs are functionally divided into microtubule-destabilizing and microtubule-stabilizing agents. Drugs from both classes achieve microtubule inhibition by binding different sites on tubulin and inhibiting or promoting polymerization with no concomitant effects on the protein levels of tubulin heterodimers. Here, we have identified a series of small molecules with diverse structures potentially representing a third class of novel tubulin inhibitors that promote degradation by covalent binding to Cys-239 of -tubulin. The small molecules highlighted in this study include T0070907 (a peroxisome proliferator-activated receptor inhibitor), T007-1 (a T0070907 derivative), T138067, N,N-ethylene-bis(iodoacetamide) (EBI), and allyl isothiocyanate (AITC). Label-free quantitative proteomic analysis revealed that T007-1 promotes tubulin degradation with high selectivity. Mass spectrometry findings showed covalent binding of both T0070907 and T007-01 to Cys-239 of -tubulin. Furthermore, T007-1 exerted a degradative effect on tubulin isoforms possessing Cys-239 (2, 4, and 5()) but not those containing Ser-239 (3, 6) or mutant -tubulin with a C239S substitution. Three small molecules (T138067, EBI, and AITC) also reported to bind covalently to Cys-239 of -tubulin similarly induced tubulin degradation. Our results strongly suggest that covalent modification of Cys-239 of -tubulin by small molecules could serve as a novel strategy to promote tubulin heterodimer degradation. We propose that these small molecules represent a third novel class of tubulin inhibitor agents that exert their effects through degradation activity.	[Yang, Jianhong; Li, Yong; Yan, Wei; Qiu, Qiang; Ye, Haoyu; Chen, Lijuan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Yang, Jianhong; Li, Yong; Yan, Wei; Qiu, Qiang; Ye, Haoyu; Chen, Lijuan] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China; [Li, Weimin] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Ye, HY; Chen, LJ (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.; Ye, HY; Chen, LJ (corresponding author), Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China.	yhy1984_hb@163.com; chenlijuan125@163.com			National Natural Science Foundation of China [81803021, 81872900, 81874297]; drug Innovation Major Project [2018ZX09721002-001-004]; 1.3.5 project for disciplines of excellence, the West China Hospital, Sichuan University; Post-doctoral Research Project, West China Hospital, Sichuan University [2018HXBH027]; Sichuan Science and Technology Program [2019YJ0088]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); drug Innovation Major Project; 1.3.5 project for disciplines of excellence, the West China Hospital, Sichuan University; Post-doctoral Research Project, West China Hospital, Sichuan University; Sichuan Science and Technology Program	This work was supported by National Natural Science Foundation of China Grants 81803021, 81872900, and 81874297, the drug Innovation Major Project (2018ZX09721002-001-004), the 1.3.5 project for disciplines of excellence, the West China Hospital, Sichuan University, Post-doctoral Research Project, West China Hospital, Sichuan University Grant 2018HXBH027, and Sichuan Science and Technology Program Grant 2019YJ0088. The authors declare that they have no conflicts of interest with the contents of this article.	Alhosin M, 2012, INVEST NEW DRUG, V30, P1813, DOI 10.1007/s10637-011-9734-1; Antony ML, 2014, J BIOL CHEM, V289, P1852, DOI 10.1074/jbc.M113.496844; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Bruce F., 2008, MED SCI SPORTS EXERC, V30, P100; Clegg A, 2002, THORAX, V57, P20, DOI 10.1136/thorax.57.1.20; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Doodhi H, 2016, CURR BIOL, V26, P1713, DOI 10.1016/j.cub.2016.04.053; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Ernest H., 2008, ROLE MICROTUBULES CE; Fortin S, 2011, J PHARMACOL EXP THER, V336, P460, DOI 10.1124/jpet.110.171082; Geng F, 2011, J BIOL CHEM, V286, P32259, DOI 10.1074/jbc.M111.278127; Gil G, 2017, ACS CHEM BIOL, V12, P389, DOI 10.1021/acschembio.6b01018; Harris G, 2009, BIOCHEM BIOPH RES CO, V388, P345, DOI 10.1016/j.bbrc.2009.08.009; Hayashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122217; Kaur R, 2014, EUR J MED CHEM, V87, P89, DOI 10.1016/j.ejmech.2014.09.051; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Marinelli P, 2018, REDOX BIOL, V14, P566, DOI 10.1016/j.redox.2017.10.022; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Michaud LB, 2009, ANN PHARMACOTHER, V43, P1294, DOI 10.1345/aph.1M005; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Prota AE, 2014, ANGEW CHEM INT EDIT, V53, P1621, DOI 10.1002/anie.201307749; Schaefer KL, 2007, INT J CANCER, V120, P702, DOI 10.1002/ijc.22361; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Shan B, 1999, P NATL ACAD SCI USA, V96, P5686, DOI 10.1073/pnas.96.10.5686; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Wieczorek M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1093; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Yang JH, 2018, J BIOL CHEM, V293, P9461, DOI 10.1074/jbc.RA117.001658; Yang JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12103; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807	35	18	18	5	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8161	8170		10.1074/jbc.RA118.006325	http://dx.doi.org/10.1074/jbc.RA118.006325			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30940730	Green Published, hybrid			2022-12-28	WOS:000470656500015
J	Kant, S; Davuluri, G; Alchirazi, KA; Welch, N; Heit, C; Kumar, A; Gangadhariah, M; Kim, A; McMullen, MR; Willard, B; Luse, DS; Nagy, LE; Vasiliou, V; Marini, AM; Weiner, ID; Dasarathy, S				Kant, Sashi; Davuluri, Gangarao; Alchirazi, Khaled A.; Welch, Nicole; Heit, Claire; Kumar, Avinash; Gangadhariah, Mahesha; Kim, Adam; McMullen, Megan R.; Willard, Belinda; Luse, Donal S.; Nagy, Laura E.; Vasiliou, Vasilis; Marini, Anna Maria; Weiner, I. David; Dasarathy, Srinivasan			Ethanol sensitizes skeletal muscle to ammonia-induced molecular perturbations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteostasis; signaling; autophagy; ammonia; skeletal muscle; RhBG; sarcopenia	ALCOHOLIC LIVER-DISEASE; UREA-CYCLE ENZYMES; PROTEIN-SYNTHESIS; TRANSPORTER PROTEINS; GENE-EXPRESSION; HYPERAMMONEMIA; SARCOPENIA; PHOSPHORYLATION; ACETALDEHYDE; CIRRHOSIS	Ethanol causes dysregulated muscle protein homeostasis while simultaneously causing hepatocyte injury. Because hepatocytes are the primary site for physiological disposal of ammonia, a cytotoxic cellular metabolite generated during a number of metabolic processes, we determined whether hyperammonemia aggravates ethanol-induced muscle loss. Differentiated murine C2C12 myotubes, skeletal muscle from pair-fed or ethanol-treated mice, and human patients with alcoholic cirrhosis and healthy controls were used to quantify protein synthesis, mammalian target of rapamycin complex 1 (mTORC1) signaling, and autophagy markers. Alcohol-metabolizing enzyme expression and activity in mouse muscle and myotubes and ureagenesis in hepatocytes were quantified. Expression and regulation of the ammonia transporters, RhBG and RhCG, were quantified by real-time PCR, immunoblots, reporter assays, biotin-tagged promoter pulldown with proteomics, and loss-of-function studies. Alcohol and aldehyde dehydrogenases were expressed and active in myotubes. Ethanol exposure impaired hepatocyte ureagenesis, induced muscle RhBG expression, and elevated muscle ammonia concentrations. Simultaneous ethanol and ammonia treatment impaired protein synthesis and mTORC1 signaling and increased autophagy with a consequent decreased myotube diameter to a greater extent than either treatment alone. Ethanol treatment and withdrawal followed by ammonia exposure resulted in greater impairment in muscle signaling and protein synthesis than ammonia treatment in ethanol-naive myotubes. Of the three transcription factors that were bound to the RhBG promoter in response to ethanol and ammonia, DR1/NC2 indirectly regulated transcription of RhBG during ethanol and ammonia treatment. Direct effects of ethanol were synergistic with increased ammonia uptake in causing dysregulated skeletal muscle proteostasis and signaling perturbations with a more severe sarcopenic phenotype.	[Kant, Sashi; Davuluri, Gangarao; Alchirazi, Khaled A.; Welch, Nicole; Kumar, Avinash; Gangadhariah, Mahesha; Kim, Adam; McMullen, Megan R.; Nagy, Laura E.; Dasarathy, Srinivasan] Cleveland Clin, Dept Inflammat & Immun, Cleveland, OH 44195 USA; [Luse, Donal S.] Cleveland Clin, Dept Cardiovasc & Metab Sci, Cleveland, OH 44195 USA; [Dasarathy, Srinivasan] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Metab & Prote Core, Cleveland, OH 44195 USA; [Heit, Claire] Univ Colorado Anschutz Med Campus, Dept Pharmaceut Sci, Sch Pharm, Aurora, CO 80045 USA; [Vasiliou, Vasilis] Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06510 USA; [Marini, Anna Maria] Univ Libre Bruxelles, Biol Membrane Transport Lab, Dept Mol Biol, IBMM, CP300, B-6041 Gosselies, Belgium; [Weiner, I. David] Univ Florida, Dept Med, Div Nephrol Hypertens & Renal Transplantat, Sch Med, Gainesville, FL 32610 USA; [Weiner, I. David] North Florida South Georgia Vet Hlth Syst, Nephrol & Hypertens Sect, Gainesville, FL 32608 USA; [Davuluri, Gangarao] Pennington Biomed Res Ctr, Integrated Physiol & Mol Metab, Baton Rouge, LA 70808 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; Universite Libre de Bruxelles; State University System of Florida; University of Florida; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dasarathy, S (corresponding author), Lerner Res Inst, NE4 208,9500 Euclid Ave, Cleveland, OH 44195 USA.	dasaras@ccf.org	Weiner, David/N-3908-2019; Kant, Sashi/V-3864-2019	Weiner, David/0000-0002-0046-0600; Kant, Sashi/0000-0002-9015-8383; Kim, Adam/0000-0002-3186-3912; Gangadhariah, Mahesha/0000-0003-4355-4364; Welch, Nicole/0000-0002-4655-5146	National Institutes of Health [R21 AA022742, R21 AR071046, UO1 AA026976, RO1 GM119174, RO1 DK113196, P50 AA024333, UO1 AA021890, RO1 DK045788, RO1 DK107798, UO1 AA021724, R24 AA022057]; Mikati Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR071046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK113196, T32DK083251, R01DK107798, R01DK045788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024333, U01AA026976, U01AA021890, U01AA021724, R24AA022057] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mikati Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R21 AA022742 (to S. D.), R21 AR071046 (to S. D. and G. D.), UO1 AA026976 (to S. D.), RO1 GM119174, RO1 DK113196 (to S. D.), P50 AA024333 (to L. E. N. and S. D.), UO1 AA021890 (to L. E. N. and S. D.), RO1 DK045788 (to I. D. W.), RO1 DK107798 (to I. D. W.), UO1 AA021724 (to V. V.), and R24 AA022057 (to V. V.) and a Mikati Foundation grant (to S. D. and G. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aagaard NK, 2004, ALCOHOL CLIN EXP RES, V28, P697, DOI 10.1097/01.ALC.0000125355.31808.DC; Bakhautdin B, 2014, J HEPATOL, V61, P1029, DOI 10.1016/j.jhep.2014.06.007; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Damink SWMO, 2009, METAB BRAIN DIS, V24, P169, DOI 10.1007/s11011-008-9122-5; Dasarathy J, 2017, ALCOHOL CLIN EXP RES, V41, P1419, DOI 10.1111/acer.13425; Dasarathy S, 2018, CURR OPIN CLIN NUTR, V21, P30, DOI 10.1097/MCO.0000000000000426; Dasarathy S, 2017, METAB BRAIN DIS, V32, P529, DOI 10.1007/s11011-016-9938-3; Dasarathy S, 2016, J HEPATOL, V65, P1232, DOI 10.1016/j.jhep.2016.07.040; Dasarathy S, 2016, CLIN LIVER DIS, V20, P535, DOI 10.1016/j.cld.2016.02.010; Davuluri G, 2016, J PHYSIOL-LONDON, V594, P7341, DOI 10.1113/JP272796; Davuluri G, 2016, J HEPATOL, V65, P929, DOI 10.1016/j.jhep.2016.06.004; Dreos R, 2013, NUCLEIC ACIDS RES, V41, pD157, DOI 10.1093/nar/gks1233; Fernandez-Sola J, 2007, ALCOHOL CLIN EXP RES, V31, P1953, DOI 10.1111/j.1530-0277.2007.00530.x; Glavind E, 2018, SCAND J GASTROENTERO, V53, P592, DOI 10.1080/00365521.2017.1399163; Guirguis J, 2015, ALCOHOL CLIN EXP RES, V39, P2085, DOI 10.1111/acer.12887; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Holmuhamedov EL, 2012, J BIOL CHEM, V287, P7692, DOI 10.1074/jbc.M111.293399; Hong-Brown LQ, 2001, ALCOHOL CLIN EXP RES, V25, P1373; Hong-Brown LQ, 2007, J BIOL CHEM, V282, P3702, DOI 10.1074/jbc.M606593200; INOSTROZA JA, 1992, CELL, V70, P477; Kumar A, 2017, HEPATOLOGY, V65, P2045, DOI 10.1002/hep.29107; Lang CH, 1999, AM J PHYSIOL-ENDOC M, V277, pE268, DOI 10.1152/ajpendo.1999.277.2.E268; Lang CH, 2000, ALCOHOL CLIN EXP RES, V24, P322, DOI 10.1097/00000374-200003000-00010; Lang CH, 2005, INT J BIOCHEM CELL B, V37, P2180, DOI 10.1016/j.biocel.2005.04.013; Lang CH, 2004, ALCOHOL CLIN EXP RES, V28, P1758, DOI 10.1097/01.ALC.0000145787.66405.59; Lang CH, 2001, INT J BIOCHEM CELL B, V33, P457, DOI 10.1016/S1357-2725(00)00081-9; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; LOCKWOOD AH, 1979, J CLIN INVEST, V63, P449, DOI 10.1172/JCI109322; MAIER KP, 1974, EUR J CLIN INVEST, V4, P193, DOI 10.1111/j.1365-2362.1974.tb00391.x; MAIER KP, 1978, KLIN WOCHENSCHR, V56, P291, DOI 10.1007/BF01489175; Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005; MARWAY JS, 1995, ALCOHOL ALCOHOLISM, V30, P211; McDaniel J, 2016, AM J PHYSIOL-GASTR L, V310, pG163, DOI 10.1152/ajpgi.00322.2015; Merhi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128683; Molina PE, 2008, ALCOHOL CLIN EXP RES, V32, P138, DOI 10.1111/j.1530-0277.2007.00549.x; Nakahara T, 2006, METABOLISM, V55, P843, DOI 10.1016/j.metabol.2006.02.009; PACY PJ, 1991, ALCOHOL ALCOHOLISM, V26, P505, DOI 10.1093/oxfordjournals.alcalc.a045152; PREEDY VR, 1992, ALCOHOL ALCOHOLISM, V27, P241; PREEDY VR, 1991, BIOCHEM SOC T, V19, pS167, DOI 10.1042/bst019167s; Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110; Qiu J, 2012, AM J PHYSIOL-ENDOC M, V303, pE983, DOI 10.1152/ajpendo.00183.2012; REILLY ME, 1995, ADVERSE DRUG REACT T, V14, P117; RUDMAN D, 1973, J CLIN INVEST, V52, P2241, DOI 10.1172/JCI107410; RYPINS EB, 1980, GASTROENTEROLOGY, V78, P1419; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schricker T, 1997, DEUT MED WOCHENSCHR, V122, P75, DOI 10.1055/s-2008-1047579; Steiner JL, 2016, ALCOHOL ALCOHOLISM, V51, P242, DOI 10.1093/alcalc/agv105; Steiner JL, 2015, AM J PHYSIOL-ENDOC M, V308, pE699, DOI 10.1152/ajpendo.00006.2015; Steiner JL, 2014, J APPL PHYSIOL, V117, P1170, DOI 10.1152/japplphysiol.00180.2014; Stern RA, 2015, ANIMAL, V9, P992, DOI 10.1017/S1751731115000117; Takeda K, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12596; Thapaliya S, 2014, AUTOPHAGY, V10, P677, DOI 10.4161/auto.27918; Tsien C, 2015, HEPATOLOGY, V61, P2018, DOI 10.1002/hep.27717; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Weiner ID, 2003, ACTA PHYSIOL SCAND, V179, P331, DOI 10.1046/j.0001-6772.2003.01210.x; Xue Y, 2017, MOL CELL, V67, P594, DOI 10.1016/j.molcel.2017.06.029; YEUNG KC, 1994, GENE DEV, V8, P2097, DOI 10.1101/gad.8.17.2097; Zawada RJX, 2009, BIOCHEM CELL BIOL, V87, P541, DOI [10.1139/O09-011, 10.1139/o09-011]	61	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7231	7244		10.1074/jbc.RA118.005411	http://dx.doi.org/10.1074/jbc.RA118.005411			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30872403	Green Published, hybrid			2022-12-28	WOS:000468402900013
J	Cong, XJ; Zheng, Q; Ren, WW; Cheron, JB; Fiorucci, S; Wen, TQ; Zhang, CB; Yu, HM; Golebiowski, J; Yu, YQ				Cong, Xiaojing; Zheng, Qian; Ren, Wenwen; Cheron, Jean-Baptiste; Fiorucci, Sebastien; Wen, Tieqiao; Zhang, Chunbo; Yu, Hongmeng; Golebiowski, Jerome; Yu, Yiqun			Zebrafish olfactory receptors ORAs differentially detect bile acids and bile salts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						site-directed mutagenesis; receptor structure-function; molecular docking; molecular dynamics; homology modeling; behavioral assay; fish ORA; olfactory receptor	MOLECULAR-DYNAMICS; ODORANT RECEPTORS; ACTIVATION; GENES; ORGANIZATION; EXPRESSION; NEURONS; SINGLE; SERVER	The fish olfactory receptor ORA family is orthologous to the mammalian vomeronasal receptors type 1. It consists of six highly conserved chemosensory receptors expected to be essential for survival and communication. We deorphanized the zebrafish ORA family in a heterologous cell system. The six receptors responded specifically to lithocholic acid (LCA) and closely related C-24 5-bile acids/salts. LCA attracted zebrafish as strongly as food in behavioral tests, whereas the less potent cholanic acid elicited weaker attraction, consistent with the in vitro results. The ORA-ligand recognition patterns were probed with site-directed mutagenesis guided by in silico modeling. We revealed the receptors' structure-function relationship underlying their specificity and selectivity for these compounds. Bile acids/salts are putative fish semiochemicals or pheromones sensed by the olfactory system with high specificity. This work identified their receptors and provided the basis for probing the roles of ORAs and bile acids/salts in fish chemosensation.	[Zheng, Qian; Wen, Tieqiao; Yu, Yiqun] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China; [Cong, Xiaojing; Cheron, Jean-Baptiste; Fiorucci, Sebastien; Golebiowski, Jerome] Univ Cote Dazur, CNRS, Inst Chim Nice, UMR7272, F-06108 Nice, France; [Yu, Hongmeng; Yu, Yiqun] Fudan Univ, Dept Otolaryngol, Eye Ear Nose & Throat Hosp, Shanghai Key Clin Disciplines Otorhinolaryngol, Shanghai 200031, Peoples R China; [Golebiowski, Jerome] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu 711873, South Korea; [Ren, Wenwen] Fudan Univ, Inst Biomed Sci, Shanghai 200031, Peoples R China; [Zhang, Chunbo] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA	Shanghai University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Cote d'Azur; Fudan University; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Fudan University; Illinois Institute of Technology	Yu, YQ (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China.; Golebiowski, J (corresponding author), Univ Cote Dazur, CNRS, Inst Chim Nice, UMR7272, F-06108 Nice, France.; Yu, HM; Yu, YQ (corresponding author), Fudan Univ, Dept Otolaryngol, Eye Ear Nose & Throat Hosp, Shanghai Key Clin Disciplines Otorhinolaryngol, Shanghai 200031, Peoples R China.; Golebiowski, J (corresponding author), Daegu Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu 711873, South Korea.	hongmengyush@fudan.edu.cn; jerome.golebiowski@unice.fr; yiqun_yu@shu.edu.cn	Fiorucci, Sebastien/A-2060-2010	Fiorucci, Sebastien/0000-0003-2245-0478	National Natural Science Foundation of China [81700894, 31771155]; Shanghai Municipal Education Commission, the Shanghai Eastern Scholar Program; Shanghai Municipal Human Resources and Social Security Bureau, Shanghai Talent Development Fund; EENT Hospital of Fudan University, the Startup Fund; Shanghai University, the Startup Fund; French National Research Agency (Agence Nationale de la Recherche, ANR), Project NEUROLF, ANR-NSF-NIH Collaborative Research in Computational Neuroscience; French government, through the UCAJEDI Investments in the Future project [ANR-15-IDEX-01]; German Research Foundation (Deutsche Forschungsgemeinschaft Grant) [CO 1715/1-1]; Shanghai Municipal Commission of Heath and Family Planning Grant [201740187]; Shanghai Natural Science Foundation Grant [16ZR1405100]; National Institutes of Health Grant [DC011650]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission, the Shanghai Eastern Scholar Program; Shanghai Municipal Human Resources and Social Security Bureau, Shanghai Talent Development Fund; EENT Hospital of Fudan University, the Startup Fund; Shanghai University, the Startup Fund; French National Research Agency (Agence Nationale de la Recherche, ANR), Project NEUROLF, ANR-NSF-NIH Collaborative Research in Computational Neuroscience(French National Research Agency (ANR)); French government, through the UCAJEDI Investments in the Future project; German Research Foundation (Deutsche Forschungsgemeinschaft Grant)(German Research Foundation (DFG)); Shanghai Municipal Commission of Heath and Family Planning Grant; Shanghai Natural Science Foundation Grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Natural Science Foundation of China Grants 81700894 and 31771155 (to Y. Y.); Shanghai Municipal Education Commission, the Shanghai Eastern Scholar Program (to Y. Y.); Shanghai Municipal Human Resources and Social Security Bureau, Shanghai Talent Development Fund (to Y. Y.); the EENT Hospital of Fudan University, the Startup Fund (to Y. Y.); Shanghai University, the Startup Fund (to Y. Y.); the French National Research Agency (Agence Nationale de la Recherche, ANR), Project NEUROLF (to J. G.) as part of the ANR-NSF-NIH Collaborative Research in Computational Neuroscience; the French government, through the UCAJEDI Investments in the Future project managed by the ANR Grant ANR-15-IDEX-01 (to X. C. and J. G.); the German Research Foundation (Deutsche Forschungsgemeinschaft Grant CO 1715/1-1) (to X. C.); the Shanghai Municipal Commission of Heath and Family Planning Grant 201740187 (to H. Y.); the Shanghai Natural Science Foundation Grant 16ZR1405100 (to H. Y.). This work was also supported by National Institutes of Health Grant DC011650 (to C. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Behrens M, 2014, J BIOL CHEM, V289, P19778, DOI 10.1074/jbc.M114.573162; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Buchinger TJ, 2014, CHEM SENSES, V39, P647, DOI 10.1093/chemse/bju039; Charlier L, 2012, CELL MOL LIFE SCI, V69, P4205, DOI 10.1007/s00018-012-1116-0; Cong X, 2017, CURR PHARM DESIGN, V23, P4390, DOI 10.2174/1381612823666170710151255; Cvicek V, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004805; de March CA, 2018, ANGEW CHEM INT EDIT, V57, P4554, DOI 10.1002/anie.201713065; de March CA, 2015, J AM CHEM SOC, V137, P8611, DOI 10.1021/jacs.5b04659; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Doyle WI, 2018, J NEUROSCI, V38, P3377, DOI 10.1523/JNEUROSCI.2488-17.2018; Fuss SH, 2001, J NEUROSCI, V21, P8396, DOI 10.1523/JNEUROSCI.21-21-08396.2001; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Hagey LR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P308, DOI 10.1086/649966; Hofmann AF, 2010, J LIPID RES, V51, P226, DOI 10.1194/jlr.R000042; Hussain A, 2013, P NATL ACAD SCI USA, V110, P19579, DOI 10.1073/pnas.1318596110; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Johnstone KA, 2008, MAR GENOM, V1, P23, DOI 10.1016/j.margen.2008.04.003; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Meredith TL, 2012, J EXP BIOL, V215, P2660, DOI 10.1242/jeb.066241; Oka Y, 2012, CHEM SENSES, V37, P219, DOI 10.1093/chemse/bjr095; Ota T, 2012, GENE, V499, P273, DOI 10.1016/j.gene.2012.03.002; Pfister P, 2005, P NATL ACAD SCI USA, V102, P5489, DOI 10.1073/pnas.0402581102; Pfister P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000379; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saraiva LR, 2007, GENOME RES, V17, P1448, DOI 10.1101/gr.6553207; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; TATTRIE NH, 1968, CAN J BIOCHEM CELL B, V46, P819, DOI 10.1139/o68-124; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weng PL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38199; Yu YQ, 2015, P NATL ACAD SCI USA, V112, P14966, DOI 10.1073/pnas.1517510112; Zhang CB, 2001, J COMP PHYSIOL B, V171, P161, DOI 10.1007/s003600000170; Zhang HT, 2015, J BIOL CHEM, V290, P29127, DOI 10.1074/jbc.M115.689000; Zhu GL, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2896-9; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	44	14	14	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6762	6771		10.1074/jbc.RA118.006483	http://dx.doi.org/10.1074/jbc.RA118.006483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30833327	Green Published, hybrid			2022-12-28	WOS:000467394700014
J	Jarosz-Griffiths, HH; Corbett, NJ; Rowland, HA; Fisher, K; Jones, AC; Baron, J; Howell, GJ; Cowleyl, SA; Chintawar, S; Cader, MZ; Kellett, KAB; Hooper, NM				Jarosz-Griffiths, Heledd H.; Corbett, Nicola J.; Rowland, Helen A.; Fisher, Kate; Jones, Alys C.; Baron, Jennifer; Howell, Gareth J.; Cowleyl, Sally A.; Chintawar, Satyan; Cader, M. Zameel; Kellett, Katherine A. B.; Hooper, Nigel M.			Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid- oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (AB); induced pluripotent stem cell (iPS cell) (iPSC); prion; neurodegenerative disease; Alzheimer disease; oxidative stress; cell surface protein; metallopeptidase ADAM10; proteolytic shedding	ANGIOTENSIN-CONVERTING ENZYME; ALZHEIMERS-DISEASE BRAIN; GLUTAMATE-RECEPTOR 5; PRECURSOR PROTEIN; ALPHA-SECRETASE; BETA OLIGOMERS; A-BETA; MEMORY IMPAIRMENT; APPS-ALPHA; INHIBITION	The cellular prion protein (PrPC) is a key neuronal receptor for -amyloid oligomers (AO), mediating their neurotoxicity, which contributes to the neurodegeneration in Alzheimer's disease (AD). Similarly to the amyloid precursor protein (APP), PrPC is proteolytically cleaved from the cell surface by a disintegrin and metalloprotease, ADAM10. We hypothesized that ADAM10-modulated PrPC shedding would alter the cellular binding and cytotoxicity of AO. Here, we found that in human neuroblastoma cells, activation of ADAM10 with the muscarinic agonist carbachol promotes PrPC shedding and reduces the binding of AO to the cell surface, which could be blocked with an ADAM10 inhibitor. Conversely, siRNA-mediated ADAM10 knockdown reduced PrPC shedding and increased AO binding, which was blocked by the PrPC-specific antibody 6D11. The retinoic acid receptor analog acitretin, which up-regulates ADAM10, also promoted PrPC shedding and decreased AO binding in the neuroblastoma cells and in human induced pluripotent stem cell (iPSC)-derived cortical neurons. Pretreatment with acitretin abolished activation of Fyn kinase and prevented an increase in reactive oxygen species caused by AO binding to PrPC. Besides blocking AO binding and toxicity, acitretin also increased the nonamyloidogenic processing of APP. However, in the iPSC-derived neurons, A and other amyloidogenic processing products did not exhibit a reciprocal decrease upon acitretin treatment. These results indicate that by promoting the shedding of PrPC in human neurons, ADAM10 activation prevents the binding and cytotoxicity of AO, revealing a potential therapeutic benefit of ADAM10 activation in AD.	[Jarosz-Griffiths, Heledd H.; Corbett, Nicola J.; Rowland, Helen A.; Fisher, Kate; Jones, Alys C.; Kellett, Katherine A. B.; Hooper, Nigel M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci,Div Neurosci & Expt Psychol, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Baron, Jennifer; Howell, Gareth J.] Univ Manchester, Flow Cytometry Facil Lab, Fac Biol Med & Hlth, CTF Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Cowleyl, Sally A.] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England; [Cowleyl, Sally A.] Univ Oxford, Oxford Parkinsons Dis Ctr, South Parks Rd, Oxford OX1 3QX, England; [Chintawar, Satyan; Cader, M. Zameel] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Chintawar, Satyan; Cader, M. Zameel] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX1 3QX, England; [Jarosz-Griffiths, Heledd H.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Clin & Translat Rheumatol, Leeds LS9 7TF, W Yorkshire, England	University of Manchester; University of Manchester; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Leeds	Hooper, NM (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci,Div Neurosci & Expt Psychol, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	nigel.hooper@manchester.ac.uk		Corbett, Nicola/0000-0002-7531-7462; Jarosz-Griffiths, Heledd/0000-0001-5154-4815; Cader, Zameel/0000-0002-6952-406X; Kellett, Katherine/0000-0002-2802-0615; Chintawar, Satyan/0000-0003-3663-2328; Hooper, Nigel/0000-0002-5811-3484	Alzheimer's Research UK [PG2013-12]; Medical Research Council [MC_PC_16033, MR/N013255/1, MR/M024997/1, MCEX MR/N50192X/1]; Dr Donald Dean Fund in Dementia Research; University of Manchester; MRC [MR/N013255/1, MC_EX_MR/N50192X/1, MC_PC_16033, MC_PC_16034, MR/M024997/1, MR/M024962/1, MR/L023784/1, MR/L023784/2, 1826685] Funding Source: UKRI	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dr Donald Dean Fund in Dementia Research; University of Manchester; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Alzheimer's Research UK Grant PG2013-12; Medical Research Council Grants MC_PC_16033, MR/N013255/1, MR/M024997/1, and MCEX MR/N50192X/1; the Dr Donald Dean Fund in Dementia Research; and the University of Manchester. None of the funding bodies had any role in the design of the study; in the collection, analysis, or interpretation of the data; or in the writing of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article.	Altmeppen HC, 2015, ELIFE, V4, DOI 10.7554/eLife.04260; Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Baud A, 2017, ANAL CHEM, V89, P2440, DOI 10.1021/acs.analchem.6b04368; Ben Halima S, 2016, CELL REP, V14, P2127, DOI 10.1016/j.celrep.2016.01.076; Beraldo FH, 2016, J BIOL CHEM, V291, P21945, DOI 10.1074/jbc.M116.738286; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Canet-Aviles RM, 2002, MOL BRAIN RES, V102, P62, DOI 10.1016/S0169-328X(02)00184-5; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Chabrier MA, 2012, J NEUROSCI, V32, P17345, DOI 10.1523/JNEUROSCI.0172-12.2012; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Colombo A, 2013, NEUROBIOL DIS, V49, P137, DOI 10.1016/j.nbd.2012.08.011; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Cui LL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0796-x; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Endres K, 2014, NEUROLOGY, V83, P1930, DOI 10.1212/WNL.0000000000001017; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Haas LT, 2017, CELL REP, V20, P76, DOI 10.1016/j.celrep.2017.06.023; Haas LT, 2016, BRAIN, V139, P526, DOI 10.1093/brain/awv356; Hamilton A, 2016, CELL REP, V15, P1859, DOI 10.1016/j.celrep.2016.04.077; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hussain I, 2003, J BIOL CHEM, V278, P36264, DOI 10.1074/jbc.M304186200; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Kim M, 2009, HUM MOL GENET, V18, P3987, DOI 10.1093/hmg/ddp323; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Moss ML, 2011, J BIOL CHEM, V286, P40443, DOI 10.1074/jbc.M111.280495; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Parkin ET, 2002, BIOCHEMISTRY-US, V41, P4972, DOI 10.1021/bi015936e; Parvathy S, 1998, BIOCHEMISTRY-US, V37, P1680, DOI 10.1021/bi972034y; Perera WSS, 1999, FEBS LETT, V463, P273, DOI 10.1016/S0014-5793(99)01648-8; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Risse E, 2015, J BIOL CHEM, V290, P17020, DOI 10.1074/jbc.M115.637124; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Suh J, 2013, NEURON, V80, P385, DOI 10.1016/j.neuron.2013.08.035; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; van Wilgenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071098; Vaughan PFT, 1998, MOL NEUROBIOL, V18, P125, DOI 10.1007/BF02914269; Vincent B, 2001, J BIOL CHEM, V276, P37743; Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135	66	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7085	7097		10.1074/jbc.RA118.005364	http://dx.doi.org/10.1074/jbc.RA118.005364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30872401	Green Published, hybrid			2022-12-28	WOS:000467394700039
J	Yamazaki, T; Inui, M; Hiemori, K; Tomono, S; Itoh, M; Ichimonji, I; Nakashima, A; Takagi, H; Biswas, M; Izawa, K; Kitaura, J; Imai, T; Sugiura, N; Tateno, H; Akashi-Takamura, S				Yamazaki, Tatsuya; Inui, Masanori; Hiemori, Keiko; Tomono, Susumu; Itoh, Makoto; Ichimonji, Isao; Nakashima, Akina; Takagi, Hidekazu; Biswas, Mrityunjoy; Izawa, Kumi; Kitaura, Jiro; Imai, Teruko; Sugiura, Nobuo; Tateno, Hiroaki; Akashi-Takamura, Sachiko			Receptor-destroying enzyme (RDE) from Vibrio cholerae modulates IgE activity and reduces the initiation of anaphylaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunoglobulin E (IgE); allergy; Vibrio cholerae; mast cell; inflammation; anaphylaxis; autoimmune disorder; glycans; immune response; oligomannose	INFLUENZA-VIRUS INFECTION; ANTIBODIES; EXPRESSION; GLYCOSYLATION; ACTIVATION; MEMBRANE; IDENTIFICATION; DEGRANULATION; PROTEIN; TOXIN	IgE plays a key role in allergies by binding to allergens and then sensitizing mast cells through the Fc receptor, resulting in the secretion of proinflammatory mediators. Therefore, IgE is a major target for managing allergies. Previous studies have reported that oligomannose on IgE can be a potential target to inhibit allergic responses. However, enzymes that can modulate IgE activity are not yet known. Here, we found that the commercial receptor-destroying enzyme (RDE) (II) from Vibrio cholerae culture fluid specifically modulates IgE, but not IgG, and prevents the initiation of anaphylaxis. RDE (II)-treated IgE cannot access its binding site on bone marrow-derived mast cells, resulting in reduced release of histamine and cytokines. We also noted that RDE (II)-treated IgE could not induce passive cutaneous anaphylaxis in mouse ears. Taken together, we concluded that RDE (II) modulates the IgE structure and renders it unable to mediate allergic responses. To reveal the mechanism by which RDE (II) interferes with IgE activity, we performed lectin microarray analysis to unravel the relationship between IgE modulation and glycosylation. We observed that RDE (II) treatment significantly reduced the binding of IgE to Lycopersicon esculentum lectin, which recognizes poly-N-acetylglucosamine and poly-N-acetyllactosamine. These results suggest that RDE (II) specifically modulates branched glycans on IgE, thereby interfering with its ability to induce allergic responses. Our findings may provide a basis for the development of drugs to inhibit IgE activity in allergies.	[Yamazaki, Tatsuya; Inui, Masanori; Tomono, Susumu; Itoh, Makoto; Ichimonji, Isao; Nakashima, Akina; Takagi, Hidekazu; Biswas, Mrityunjoy; Akashi-Takamura, Sachiko] Aichi Med Univ, Dept Microbiol & Immunol, Sch Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan; [Hiemori, Keiko; Tateno, Hiroaki] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan; [Izawa, Kumi; Kitaura, Jiro] Juntendo Univ, Atopy Res Ctr, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Izawa, Kumi; Kitaura, Jiro] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Div Stem Cell Signaling,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Imai, Teruko] Kumamoto Univ, Grad Sch Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan; [Sugiura, Nobuo] Aichi Med Univ, Inst Mol Sci Med, Sch Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan	Aichi Medical University; National Institute of Advanced Industrial Science & Technology (AIST); Juntendo University; University of Tokyo; Kumamoto University; Aichi Medical University	Akashi-Takamura, S (corresponding author), Aichi Med Univ, Dept Microbiol & Immunol, Sch Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	sachiko@aichi-med-u.ac.jp	Yamazaki, Tatsuya/AAE-2042-2021	Yamazaki, Tatsuya/0000-0002-2645-6490	JSPS KAKENHI [15K09491, 16H05898]; Joint Research Project of the Institute of Medical Science grants; University of Tokyo [2016-3008]; Aichi Medical University [3094117003]; TOYOAKI Scholarship Foundation; Aikeikai Foundation; Nitto Foundation; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Joint Research Project of the Institute of Medical Science grants; University of Tokyo; Aichi Medical University; TOYOAKI Scholarship Foundation(Toyoaki Scholarship Foundation); Aikeikai Foundation; Nitto Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by JSPS KAKENHI Grant Numbers 15K09491 (to S.A.-T.) and 16H05898 (to S.T.), Joint Research Project of the Institute of Medical Science grants, University of Tokyo Grant 2016-3008, Aichi Medical University for Unit Support Grant 3094117003, the TOYOAKI Scholarship Foundation, the Aikeikai Foundation, the Nitto Foundation, and Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	ADA GL, 1961, J GEN MICROBIOL, V24, P409, DOI 10.1099/00221287-24-3-409; Ainai Akira, 2006, Human Antibodies, V15, P139; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Asanuma H, 2008, BIOCHEM BIOPH RES CO, V366, P445, DOI 10.1016/j.bbrc.2007.11.135; Balbino B, 2018, PHARMACOL THERAPEUT, V191, P50, DOI 10.1016/j.pharmthera.2018.05.015; Bjorklund JEM, 1999, MOL IMMUNOL, V36, P213, DOI 10.1016/S0161-5890(99)00036-X; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Ferreira-Medeiros Mildred, 2004, Int. J. Morphol., V22, P285, DOI 10.4067/S0717-95022004000400008; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hattori M, 2005, J BIOSCI BIOENG, V100, P631, DOI 10.1263/jbb.100.631; Immel F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154264; Inamura M, 2006, NEUROSCI RES, V55, P45, DOI 10.1016/j.neures.2006.01.004; ISHIZAKA K, 1967, J IMMUNOL, V99, P1187; Ishizaka K, 2016, J ALLERGY CLIN IMMUN, V137, P1646, DOI 10.1016/j.jaci.2015.12.1343; Joo HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136394; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Kobayashi N, 2004, J GENE MED, V6, P584, DOI 10.1002/jgm.541; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; LIU FT, 1980, J IMMUNOL, V124, P2728; Maeda-Yamamoto M, 2004, J IMMUNOL, V172, P4486, DOI 10.4049/jimmunol.172.7.4486; Maruzuru Y, 2018, CELL HOST MICROBE, V23, P254, DOI 10.1016/j.chom.2017.12.014; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Moll A, 2014, J BACTERIOL, V196, P3937, DOI 10.1128/JB.02094-14; Mondal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103119; Naidu RA, 2004, VIROLOGY, V319, P107, DOI 10.1016/j.virol.2003.10.012; Nakayama M, 1986, Nihon Ika Daigaku Zasshi, V53, P534; Natsume A, 2008, DRUG DES DEV THER, V3, P7; Oettgen HC, 2016, J ALLERGY CLIN IMMUN, V137, P1631, DOI 10.1016/j.jaci.2016.04.009; Ohura K, 2010, DRUG METAB DISPOS, V38, P323, DOI 10.1124/dmd.109.029413; Park JK, 2002, J BIOL CHEM, V277, P29555, DOI 10.1074/jbc.M202978200; Shade KTC, 2015, J EXP MED, V212, P457, DOI 10.1084/jem.20142182; Shade KTC, 2013, ANTIBODIES, V2, P392, DOI 10.3390/antib2030392; Sharma R, 1996, HISTOCHEM CELL BIOL, V105, P459, DOI 10.1007/BF01457659; TAMURA SI, 1992, J IMMUNOL, V149, P981; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Tateno H, 2010, METHOD ENZYMOL, V478, P181, DOI 10.1016/S0076-6879(10)78008-3; TYRRELL DAJ, 1952, J IMMUNOL, V69, P563; Wu G, 2016, GLYCOCONJUGATE J, V33, P447, DOI 10.1007/s10719-015-9638-y; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yamazaki T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00047; Yamazaki T, 2011, JPN J INFECT DIS, V64, P40; Yoshida K, 2017, INT IMMUNOPHARMACOL, V43, P99, DOI 10.1016/j.intimp.2016.12.014; Zhao R, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9155-z	46	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6659	6669		10.1074/jbc.RA118.006375	http://dx.doi.org/10.1074/jbc.RA118.006375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30833330	hybrid, Green Published			2022-12-28	WOS:000467394700001
J	Zuo, XF; Lobo, G; Fulmer, D; Guo, LL; Dang, YJ; Su, YH; Ilatovskaya, DV; Nihalani, D; Rohrer, B; Body, SC; Norris, RA; Lipschutz, JH				Zuo, Xiaofeng; Lobo, Glenn; Fulmer, Diana; Guo, Lilong; Dang, Yujing; Su, Yanhui; Ilatovskaya, Dada, V; Nihalani, Deepak; Rohrer, Barbel; Body, Simon C.; Norris, Russell A.; Lipschutz, Joshua H.			The exocyst acting through the primary cilium is necessary for renal ciliogenesis, cystogenesis, and tubulogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cilia; trafficking; development; exocytosis; cell biology; ciliary targeting sequence; exocyst; primary cilia; protein trafficking; vesicle	COMPLEX; SEC10; CDC42; INTERACTS; ACTIVATION; MEMBRANE; EFFECTOR; DELIVERY; SUBUNIT; RAIA	The exocyst is a highly conserved protein complex found in most eukaryotic cells and is associated with many functions, including protein translocation in the endoplasmic reticulum, vesicular basolateral targeting, and ciliogenesis in the kidney. To investigate the exocyst functions, here we exchanged proline for alanine in the highly conserved VXPX ciliary targeting motif of EXOC5 (exocyst complex component 5), a central exocyst gene/protein, and generated stable EXOC5 ciliary targeting sequence-mutated (EXOC5CTS-m) Madin-Darby canine kidney (MDCK) cells. The EXOC5CTS-m protein was stable and could bind other members of the exocyst complex. Culturing stable control, EXOC5-overexpressing (OE), Exoc5-knockdown (KD), and EXOC5CTS-m MDCK cells on Transwell filters, we found that primary ciliogenesis is increased in EXOC5 OE cells and inhibited in Exoc5-KD and EXOC5CTS-m cells. Growing cells in collagen gels until the cyst stage, we noted that EXOC5-OE cells form mature cysts with single lumens more rapidly than control cysts, whereas Exoc5-KD and EXOC5CTS-m MDCK cells failed to form mature cysts. Adding hepatocyte growth factor to induce tubulogenesis, we observed that EXOC5-OE cell cysts form tubules more efficiently than control MDCK cell cysts, EXOC5CTS-m MDCK cell cysts form significantly fewer tubules than control cell cysts, and Exoc5-KD cysts did not undergo tubulogenesis. Finally, we show that EXOC5 mRNA almost completely rescues the ciliary phenotypes in exoc5-mutant zebrafish, unlike the EXOC5CTS-m mRNA, which could not efficiently rescue the phenotypes. Taken together, these results indicate that the exocyst, acting through the primary cilium, is necessary for renal ciliogenesis, cystogenesis, and tubulogenesis.	[Zuo, Xiaofeng; Lobo, Glenn; Fulmer, Diana; Guo, Lilong; Dang, Yujing; Su, Yanhui; Ilatovskaya, Dada, V; Nihalani, Deepak; Norris, Russell A.; Lipschutz, Joshua H.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Lobo, Glenn; Rohrer, Barbel] Med Univ South Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Fulmer, Diana; Guo, Lilong; Norris, Russell A.] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Rohrer, Barbel] Ralph H Johnson Vet Affairs Med Ctr, Div Res, Charleston, SC 29401 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29401 USA; [Body, Simon C.] Harvard Med Sch, Dept Anesthesiol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lipschutz, JH (corresponding author), Med Univ South Carolina, 96 Jonathan Lucas St,CSB 829, Charleston, SC 29425 USA.	Lipschut@musc.edu	Body, Simon/AAQ-7572-2020; Guo, Lilong/AAJ-8492-2021; GUO, LILONG/AAH-7104-2019; Lobo, Glenn P./AAI-9736-2020; nihalani, deepak/AAK-9453-2020	Body, Simon/0000-0001-6721-7050; Guo, Lilong/0000-0001-9376-3274; Ilatovskaya, Daria/0000-0003-4832-4170; Fulmer, Diana/0000-0001-7675-9951	Veterans Affairs Merit Award [I01 BX000820, RX000444, BX003050]; National Institutes of Health Grants [P30DK074038, R21EY025034, R01HL131546, P20GM103444, R01HL127692, R01DK087956, R01EY019320, R00DK105160, T32HL007260, F31HL142159]; Polycystic Kidney Disease Foundation [221G18a]; SC SmartState Centers of Excellence Endowment; American Heart Association AWRP Winter 2017 Collaborative Sciences Award;  [18PRE34080172]; NATIONAL EYE INSTITUTE [R21EY025034] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127692, R01HL131546, F31HL142159, T32HL007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038, R01DK087956, R00DK105160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103444] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003050, I01RX000444, I01BX000820] Funding Source: NIH RePORTER	Veterans Affairs Merit Award(US Department of Veterans Affairs); National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polycystic Kidney Disease Foundation; SC SmartState Centers of Excellence Endowment; American Heart Association AWRP Winter 2017 Collaborative Sciences Award(American Heart Association); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by Veterans Affairs Merit Award I01 BX000820 (to J.H.L.) and Grants RX000444 and BX003050 (to B.R.); National Institutes of Health Grants P30DK074038 (to J.H.L.), R21EY025034 (to G.P.L.), R01HL131546 to (R.A.N.), P20GM103444 (to R.A.N.), R01HL127692 (to R.A.N.), R01DK087956 (to D.N.), R01EY019320 (to B.R.), R00DK105160 (to D.V.I.), and T32HL007260 and F31HL142159 (to D.B.F.); Polycystic Kidney Disease Foundation Grant 221G18a (to D.V.I.); a grant from the SC SmartState Centers of Excellence Endowment (to B.R., and D.N.); and American Heart Association AWRP Winter 2017 Collaborative Sciences Award (to R.A.N., J.H.L., and S.B.) and Grant 18PRE34080172 (to L.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Baek JI, 2016, J BIOL CHEM, V291, P8632, DOI 10.1074/jbc.M115.688663; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Chen JX, 2017, SCI REP-UK, V7, DOI 10.1038/srep40909; Choi SY, 2015, INVEST OPHTH VIS SCI, V56, P3361, DOI 10.1167/iovs.14-15692; Choi SY, 2013, J AM SOC NEPHROL, V24, P1435, DOI 10.1681/ASN.2012121236; Fogelgren B, 2014, AM J PHYSIOL-RENAL, V307, pF1334, DOI 10.1152/ajprenal.00032.2014; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Happe H, 2011, J PATHOL, V224, P133, DOI 10.1002/path.2856; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Lipschutz Joshua H, 2001, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1505s12; Lobo GP, 2017, J BIOL CHEM, V292, P14814, DOI 10.1074/jbc.M117.795674; Mei KR, 2018, NAT STRUCT MOL BIOL, V25, P139, DOI 10.1038/s41594-017-0016-2; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; Park KM, 2010, AM J PHYSIOL-RENAL, V298, pF818, DOI 10.1152/ajprenal.00596.2009; Picco A, 2017, CELL, V168, P400, DOI 10.1016/j.cell.2017.01.004; Polzin A, 2002, MOL CELL BIOL, V22, P1714, DOI 10.1128/MCB.22.6.1714-1722.2002; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; Rogers KK, 2003, KIDNEY INT, V63, P1632, DOI 10.1046/j.1523-1755.2003.00902.x; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Shi Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16498-9; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Toikkanen JH, 2003, J BIOL CHEM, V278, P20946, DOI 10.1074/jbc.M213111200; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	36	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6710	6718		10.1074/jbc.RA118.006527	http://dx.doi.org/10.1074/jbc.RA118.006527			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30824539	Green Published, hybrid			2022-12-28	WOS:000467394700010
J	Banba, A; Tsuji, A; Kimura, H; Murai, M; Miyoshi, H				Banba, Atsushi; Tsuji, Atsuhito; Kimura, Hironori; Murai, Masatoshi; Miyoshi, Hideto			Defining the mechanism of action of S1QELs, specific suppressors of superoxide production in the quinone-reaction site in mitochondrial complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; mitochondria; Complex I; ubiquinone; enzyme inhibitor; chemical biology; photoaffinity labeling; oxidative stress; electron transfer chain	NADH-UBIQUINONE OXIDOREDUCTASE; HYDROGEN-PEROXIDE PRODUCTION; DIRECTED TOSYL CHEMISTRY; 49 KDA; HEART-MITOCHONDRIA; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; BINDING-SITE; ANTIOXIDANT; INHIBITORS	Site-specific suppressors of superoxide production (named S1QELs) in the quinone-reaction site in mitochondrial respiratory complex I during reverse electron transfer have been previously reported; however, their mechanism of action remains elusive. Using bovine heart submitochondrial particles, we herein investigated the effects of S1QELs on complex I functions. We found that the inhibitory effects of S1QELs on complex I are distinctly different from those of other known quinone-site inhibitors. For example, the inhibitory potencies of S1QELs significantly varied depending on the direction of electron transfer (forward or reverse). S1QELs marginally suppressed the specific chemical modification of Asp(160) in the 49-kDa subunit, located deep in the quinone-binding pocket, by the tosyl chemistry reagent AL1. S1QELs also failed to suppress the binding of a photoreactive quinazoline-type inhibitor ([I-125]AzQ) to the 49-kDa subunit. Moreover, a photoaffinity labeling experiment with photoreactive S1QEL derivatives indicated that they bind to a segment in the ND1 subunit that is not considered to make up the binding pocket for quinone or inhibitors. These results indicate that unlike known quinone-site inhibitors, S1QELs do not occupy the quinone- or inhibitor-binding pocket; rather, they may indirectly modulate the quinone-redox reactions by inducing structural changes of the pocket through binding to ND1. We conclude that this indirect effect may be a prerequisite for S1QELs' direction-dependent modulation of electron transfer. This, in turn, may be responsible for the suppression of superoxide production during reverse electron transfer without significantly interfering with forward electron transfer.	[Banba, Atsushi; Tsuji, Atsuhito; Kimura, Hironori; Murai, Masatoshi; Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Miyoshi, H (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	miyoshi@kais.kyoto-u.ac.jp		Murai, Masatoshi/0000-0001-6601-2854; Miyoshi, Hideto/0000-0002-1792-554X	Japan Society for the Promotion of Science KAKENHI [JP26292060, JP18H02147, JP18K05458]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants JP26292060 and JP18H02147 (to H. M.) and JP18K05458 (to M. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Brand MD, 2016, CELL METAB, V24, P582, DOI 10.1016/j.cmet.2016.08.012; Brash DE, 2002, P NATL ACAD SCI USA, V99, P13969, DOI 10.1073/pnas.232574399; Ernster L, 1967, METHODS ENZYMOL, V10, P729, DOI DOI 10.1016/0076-6879(67)10120-1; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Krumova K, 2013, J AM CHEM SOC, V135, P17135, DOI 10.1021/ja408227f; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert AJ, 2007, AGING CELL, V6, P607, DOI 10.1111/j.1474-9726.2007.00312.x; Lambert AJ, 2010, AGING CELL, V9, P78, DOI 10.1111/j.1474-9726.2009.00538.x; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Le Bras M, 2005, HISTOL HISTOPATHOL, V20, P205, DOI 10.14670/HH-20.205; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Masuya T, 2014, BIOCHEMISTRY-US, V53, P7816, DOI 10.1021/bi501342w; Masuya T, 2014, BIOCHEMISTRY-US, V53, P2307, DOI 10.1021/bi500205x; MATSUNOYAGI A, 1985, J BIOL CHEM, V260, P4424; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Murai M, 2006, BIOCHEMISTRY-US, V45, P9778, DOI 10.1021/bi060713f; Murai M, 2011, BIOCHEMISTRY-US, V50, P6901, DOI 10.1021/bi200883c; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakanishi S, 2011, BBA-BIOENERGETICS, V1807, P1170, DOI 10.1016/j.bbabio.2011.05.012; Nazarewicz RR, 2013, ANTIOXID REDOX SIGN, V19, P344, DOI 10.1089/ars.2013.5185; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Orr AL, 2013, FREE RADICAL BIO MED, V65, P1047, DOI 10.1016/j.freeradbiomed.2013.08.170; Pravda L, 2018, NUCLEIC ACIDS RES, V46, pW368, DOI 10.1093/nar/gky309; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829; Robb EL, 2018, J BIOL CHEM, V293, P9869, DOI 10.1074/jbc.RA118.003647; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Takaoka Y, 2013, ANGEW CHEM INT EDIT, V52, P4088, DOI 10.1002/anie.201207089; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Tsukiji S, 2009, NAT CHEM BIOL, V5, P341, DOI 10.1038/nchembio.157; Uno SP, 2019, J BIOL CHEM, V294, P679, DOI 10.1074/jbc.RA118.006056; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	46	14	14	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6550	6561		10.1074/jbc.RA119.007687	http://dx.doi.org/10.1074/jbc.RA119.007687			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30824536	hybrid, Green Published			2022-12-28	WOS:000468402000029
J	Jimenez-Vicente, E; Yang, ZY; del Campo, JSM; Cash, VL; Seefeldt, LC; Dean, DR				Jimenez-Vicente, Emilio; Yang, Zhi-Yong; del Campo, Julia S. Martin; Cash, Valerie L.; Seefeldt, Lance C.; Dean, Dennis R.			The NifZ accessory protein has an equivalent function in maturation of both nitrogenase MoFe protein P-clusters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitrogenase; nitrogen fixation; metalloenzyme; nitrogen metabolism; iron-sulfur protein; Azotobacter vinelandii; FeMo-cofactor; NifW; NifZ; P-cluster; maturation	IRON-MOLYBDENUM COFACTOR; CRYSTALLOGRAPHIC STRUCTURE; GENE-PRODUCT; BIOSYNTHESIS; PURIFICATION; APODINITROGENASE; STRAINS; SYSTEM; MUTANT; CARBON	The Mo-dependent nitrogenase comprises two interacting components called the Fe protein and the MoFe protein. The MoFe protein is an (22) heterotetramer that harbors two types of complex metalloclusters, both of which are necessary for N-2 reduction. One type is a 7Fe-9S-Mo-C-homocitrate species designated FeMo-cofactor, which provides the N-2-binding catalytic site, and the other is an 8Fe-7S species designated the P-cluster, involved in mediating intercomponent electron transfer to FeMo-cofactor. The MoFe protein's catalytic partner, Fe protein, is also required for both FeMo-cofactor formation and the conversion of an immature form of P-clusters to the mature species. This latter process involves several assembly factors, NafH, NifW, and NifZ, and precedes FeMo-cofactor insertion. Here, using various protein affinity-based purification methods as well as in vivo, EPR spectroscopy, and MALDI measurements, we show that several MoFe protein species accumulate in a NifZ-deficient background of the nitrogen-fixing microbe Azotobacter vinelandii. These included fully active MoFe protein replete with FeMo-cofactor and mature P-cluster, inactive MoFe protein having no FeMo-cofactor and only immature P-cluster, and partially active MoFe protein having one -unit with a FeMo-cofactor and mature P-cluster and the other -unit with no FeMo-cofactor and immature P-cluster. Also, NifW could associate with MoFe protein having immature P-clusters and became dissociated upon P-cluster maturation. Furthermore, both P-clusters could mature in vitro without NifZ. These findings indicate that NifZ has an equivalent, although not essential, function in the maturation of both P-clusters contained within the MoFe protein.	[Jimenez-Vicente, Emilio; del Campo, Julia S. Martin; Cash, Valerie L.; Dean, Dennis R.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Yang, Zhi-Yong; Seefeldt, Lance C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Virginia Polytechnic Institute & State University; Utah System of Higher Education; Utah State University	Dean, DR (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.	deandr@vt.edu	Yang, Zhiyong/E-7834-2013	Yang, Zhiyong/0000-0001-8186-9450; S. Martin del Campo, Julia/0000-0001-8914-2504; Seefeldt, Lance/0000-0002-6457-9504; Dean, Dennis/0000-0001-8960-6196	Fralin Life Science Institute; Agricultural Experiment Station Hatch Program; McIntire-Stennis Program at Virginia Tech	Fralin Life Science Institute; Agricultural Experiment Station Hatch Program; McIntire-Stennis Program at Virginia Tech	Mass spectrometry resources used in this work are maintained in part through funding by the Fralin Life Science Institute, the Agricultural Experiment Station Hatch Program, and the McIntire-Stennis Program at Virginia Tech and are managed by Richard F. Helm.	ALLEN RM, 1993, J BIOL CHEM, V268, P23670; BURGESS BK, 1980, BIOCHIM BIOPHYS ACTA, V614, P196, DOI 10.1016/0005-2744(80)90180-1; Chatterjee R, 1997, J BIOL CHEM, V272, P21604, DOI 10.1074/jbc.272.34.21604; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; Cotton MS, 2009, J AM CHEM SOC, V131, P4558, DOI 10.1021/ja807525m; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Dos Santos PC, 2011, METHODS MOL BIOL, V766, P81, DOI 10.1007/978-1-61779-194-9_6; FILLER WA, 1986, EUR J BIOCHEM, V160, P371, DOI 10.1111/j.1432-1033.1986.tb09981.x; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; Hu Y, 2007, P NATL ACAD SCI USA, V104, P10424, DOI 10.1073/pnas.0704297104; Hu YL, 2004, J BIOL CHEM, V279, P54963, DOI 10.1074/jbc.M408983200; IMPERIAL J, 1987, J BACTERIOL, V169, P1784, DOI 10.1128/jb.169.4.1784-1786.1987; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Jimenez-Vicente E, 2018, METHOD ENZYMOL, V613, P231, DOI 10.1016/bs.mie.2018.10.007; Jimenez-Vicente E, 2018, J BIOL CHEM, V293, P9812, DOI 10.1074/jbc.RA118.002994; Jimenez-Vicente E, 2015, BIOLOGICAL NITROGEN FIXATION, VOLS 1 AND 2, P75; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; KIM S, 1994, J BIOL CHEM, V269, P4215; Kim S, 1996, J BIOL CHEM, V271, P9764, DOI 10.1074/jbc.271.16.9764; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Lee CC, 2012, P NATL ACAD SCI USA, V109, P6922, DOI 10.1073/pnas.1202429109; Lee CC, 2009, P NATL ACAD SCI USA, V106, P18474, DOI 10.1073/pnas.0909149106; NAGATANI HH, 1974, J BACTERIOL, V120, P697, DOI 10.1128/JB.120.2.697-701.1974; PAUL W, 1989, EUR J BIOCHEM, V178, P675, DOI 10.1111/j.1432-1033.1989.tb14497.x; Poza-Carrion C, 2014, J BACTERIOL, V196, P595, DOI 10.1128/JB.00942-13; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Ribbe MW, 2002, J BIOL CHEM, V277, P23469, DOI 10.1074/jbc.M202061200; ROBINSON AC, 1986, J BACTERIOL, V166, P180, DOI 10.1128/jb.166.1.180-186.1986; ROBINSON AC, 1987, J BIOL CHEM, V262, P14327; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Rupnik K, 2018, INORG CHEM, V57, P4719, DOI 10.1021/acs.inorgchem.8b00428; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; STRANDBERG GW, 1968, CAN J MICROBIOL, V14, P25, DOI 10.1139/m68-005; UGALDE RA, 1984, J BACTERIOL, V159, P888, DOI 10.1128/JB.159.3.888-893.1984; Yoshizawa JM, 2009, J AM CHEM SOC, V131, P9321, DOI 10.1021/ja9035225	38	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6204	6213		10.1074/jbc.RA119.007905	http://dx.doi.org/10.1074/jbc.RA119.007905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30846561	hybrid, Green Published			2022-12-28	WOS:000468402000001
J	Kuhaudomlarp, S; Pergolizzi, G; Patron, NJ; Henrissat, B; Field, RA				Kuhaudomlarp, Sakonwan; Pergolizzi, Giulia; Patron, Nicola J.; Henrissat, Bernard; Field, Robert A.			Unraveling the subtleties of -(13)-glucan phosphorylase specificity in the GH94, GH149, and GH161 glycoside hydrolase families	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gram-positive bacteria; carbohydrate metabolism; glycoside hydrolase; glycobiology; phosphorylase-1; 3-glucan; carbohydrate utilization loci; enzyme evolution; heterokont; orthologs	LAMINARIBIOSE PHOSPHORYLASE; EUGLENA-GRACILIS; STRUCTURAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; PURIFICATION; BETA-1,3-GLUCAN; EVOLUTION; SEQUENCE; GLUCAN; CHRYSOLAMINARIN	Glycoside phosphorylases (GPs) catalyze the phosphorolysis of glycans into the corresponding sugar 1-phosphates and shortened glycan chains. Given the diversity of natural -(13)-glucans and their wide range of biotechnological applications, the identification of enzymatic tools that can act on -(13)-glucooligosaccharides is an attractive area of research. GP activities acting on -(13)-glucooligosaccharides have been described in bacteria, the photosynthetic excavate Euglena gracilis, and the heterokont Ochromonas spp. Previously, we characterized -(13)-glucan GPs from bacteria and E. gracilis, leading to their classification in glycoside hydrolase family GH149. Here, we characterized GPs from Gram-positive bacteria and heterokont algae acting on -(13)-glucooligosaccharides. We identified a phosphorylase sequence from Ochromonas spp. (OcP1) together with its orthologs from other species, leading us to propose the establishment of a new GH family, designated GH161. To establish the activity of GH161 members, we recombinantly expressed a bacterial GH161 gene sequence (PapP) from the Gram-positive bacterium Paenibacillus polymyxa ATCC 842 in Escherichia coli. We found that PapP acts on -(13)-glucooligosaccharide acceptors with a degree of polymerization (DP) 2. This activity was distinct from that of characterized GH149 -(13)-glucan phosphorylases, which operate on acceptors with DP 1. We also found that bacterial GH161 genes co-localize with genes encoding -glucosidases and ATP-binding cassette transporters, highlighting a probable involvement of GH161 enzymes in carbohydrate degradation. Importantly, in some species, GH161 and GH94 genes were present in tandem, providing evidence that GPs from different CAZy families may work sequentially to degrade oligosaccharides.	[Kuhaudomlarp, Sakonwan; Pergolizzi, Giulia; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Patron, Nicola J.] Earlham Inst, Norwich Res Pk, Norwich NR4 7UZ, Norfolk, England; [Henrissat, Bernard] Aix Marseille Univ, Architecture & Fonct Macromol Biol, 163 Ave Luminy, F-13288 Marseille, France; [Henrissat, Bernard] CNRS, UMR 7257, 163 Ave Luminy, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 23218, Saudi Arabia; [Kuhaudomlarp, Sakonwan] Univ Grenoble Alpes, CNRS, CERMAV, F-38000 Grenoble, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Field, RA (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	rob.field@jic.ac.uk	Henrissat, Bernard/J-2475-2012; Kuhaudomlarp, Sakonwan/AAO-1251-2021	Henrissat, Bernard/0000-0002-3434-8588; Kuhaudomlarp, Sakonwan/0000-0003-4415-3781	UK BBSRC Institute Strategic Program Molecules from Nature (MfN) [BB/PO12523/1]; Open Plant Synthetic Biology Centre [BB/LO1413/1]; John Innes Foundation; Royal Thai Government Scholarship program; BBSRC [BB/L014130/1, BBS/E/T/000PR9819, BBS/E/J/000C0618] Funding Source: UKRI	UK BBSRC Institute Strategic Program Molecules from Nature (MfN); Open Plant Synthetic Biology Centre; John Innes Foundation; Royal Thai Government Scholarship program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by UK BBSRC Institute Strategic Program Molecules from Nature (MfN) Grant BB/PO12523/1, Open Plant Synthetic Biology Centre Grant BB/LO1413/1, the John Innes Foundation, and the Royal Thai Government Scholarship program. The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 2018, J BIOL CHEM, V293, P8812, DOI 10.1074/jbc.RA117.001536; Aimanianda V, 2009, J BIOL CHEM, V284, P13401, DOI 10.1074/jbc.M807667200; ALBRECHT GJ, 1971, PHYTOCHEMISTRY, V10, P1293, DOI 10.1016/S0031-9422(00)84330-7; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Barsanti L, 2001, J APPL PHYCOL, V13, P59, DOI 10.1023/A:1008105416065; Barsanti L, 2011, NAT PROD REP, V28, P457, DOI 10.1039/c0np00018c; BEATTIE A, 1961, BIOCHEM J, V79, P531, DOI 10.1042/bj0790531; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Caballero MA, 2016, ALGAL RES, V20, P180, DOI 10.1016/j.algal.2016.10.008; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cheng YM, 2009, APPL MICROBIOL BIOT, V81, P1051, DOI 10.1007/s00253-008-1617-9; Chiku K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114882; Chow V, 2016, APPL ENVIRON MICROB, V82, P1789, DOI 10.1128/AEM.03526-15; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; De Groeve MRM, 2010, ANAL BIOCHEM, V401, P162, DOI 10.1016/j.ab.2010.02.028; Fabris M, 2012, PLANT J, V70, P1004, DOI 10.1111/j.1365-313X.2012.04941.x; Granum E, 2002, HYDROBIOLOGIA, V477, P155, DOI 10.1023/A:1021077407766; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Huang WC, 2018, P NATL ACAD SCI USA, V115, P4791, DOI 10.1073/pnas.1719274115; KITAOKA M, 1993, ARCH BIOCHEM BIOPHYS, V304, P508, DOI 10.1006/abbi.1993.1383; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Kuhaudomlarp S, 2019, CHEMBIOCHEM, V20, P181, DOI 10.1002/cbic.201800260; Kuhaudomlarp S, 2018, J BIOL CHEM, V293, P2865, DOI 10.1074/jbc.RA117.000936; Laroche Celine, 2007, Recent Pat Biotechnol, V1, P59, DOI 10.2174/187220807779813938; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Maqbool A, 2015, BIOCHEM SOC T, V43, P1011, DOI 10.1042/BST20150135; MARECHAL LR, 1967, BIOCHIM BIOPHYS ACTA, V146, P417, DOI 10.1016/0005-2744(67)90226-4; MARECHAL LR, 1963, BIOCHEM BIOPH RES CO, V13, P106, DOI 10.1016/0006-291X(63)90172-4; Nam YW, 2015, J BIOL CHEM, V290, P18281, DOI 10.1074/jbc.M115.664664; Neyrinck AM, 2007, INT IMMUNOPHARMACOL, V7, P1497, DOI 10.1016/j.intimp.2007.06.011; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; O'Neill EC, 2017, CARBOHYD RES, V451, P118, DOI 10.1016/j.carres.2017.07.005; O'Neill EC, 2015, CARBOHYD RES, V403, P23, DOI 10.1016/j.carres.2014.06.010; Olson EJ, 1996, INFECT IMMUN, V64, P3548, DOI 10.1128/IAI.64.9.3548-3554.1996; PAULSEN BS, 1978, CARBOHYD RES, V62, P386, DOI 10.1016/S0008-6215(00)80888-5; Pergolizzi G, 2017, PROTEIN PEPTIDE LETT, V24, P696, DOI 10.2174/0929866524666170811125109; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; Scheible WR, 2004, CURR OPIN PLANT BIOL, V7, P285, DOI 10.1016/j.pbi.2004.03.006; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stasinopoulos SJ, 1999, GLYCOBIOLOGY, V9, P31, DOI 10.1093/glycob/9.1.31; Storseth TR, 2005, CARBOHYD RES, V340, P1159, DOI 10.1016/j.carres.2004.12.036; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Trindade MI, 2003, APPL ENVIRON MICROB, V69, P24, DOI 10.1128/AEM.69.1.24-32.2003; Unfried F, 2018, ISME J, V12, P2894, DOI 10.1038/s41396-018-0243-5; Volman JJ, 2008, PHYSIOL BEHAV, V94, P276, DOI 10.1016/j.physbeh.2007.11.045; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05289-x; Yamamoto Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1949, DOI 10.1271/bbb.130411; Yang PL, 2007, J MICROBIOL BIOTECHN, V17, P58; Zhu YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38248	57	11	12	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6483	6493		10.1074/jbc.RA119.007712	http://dx.doi.org/10.1074/jbc.RA119.007712			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30819804	hybrid, Green Published			2022-12-28	WOS:000468402000024
J	Zhang, ZP; Zhang, TP; Ge, YL; Tang, MF; Ma, WB; Zhang, QF; Gong, SZ; Wright, WE; Shay, J; Liu, HY; Zhao, Y				Zhang, Zepeng; Zhang, Tianpeng; Ge, Yuanlong; Tang, Mengfan; Ma, Wenbin; Zhang, Qinfen; Gong, Shengzhao; Wright, Woodring E.; Shay, Jerry; Liu, Haiying; Zhao, Yong			2D gel electrophoresis reveals dynamics of t-loop formation during the cell cycle and t-loop in maintenance regulated by heterochromatin state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						telomere; heterochromatin; homologous recombination; gel electrophoresis; histone acetylation; 2D gel electrophoresis; homologous recombination; t-loops; telomere	RICH TELOMERIC OVERHANGS; EXTRACHROMOSOMAL CIRCULAR DNA; ROLLING CIRCLE REPLICATION; MAMMALIAN TELOMERES; END; MECHANISMS; GENERATION; PROTECTION; SHELTERIN; COMPLEX	Linear chromosome ends are capped by telomeres that have been previously reported to adopt a t-loop structure. The lack of simple methods for detecting t-loops has hindered progress in understanding the dynamics of t-loop formation and its function in protecting chromosome ends. Here, we employed a classical two-dimensional agarose gel method (2D gel method) to innovatively apply to t-loop detection. Briefly, restriction fragments of genomic DNA were separated in a 2D gel, and the telomere sequence was detected by in-gel hybridization with telomeric probe. Using this method, we found that t-loops are present throughout the cell cycle, and t-loop formation tightly couples to telomere replication. We also observed that t-loop abundance positively correlates with chromatin condensation, i.e. cells with less compact telomeric chromatin (ALT cells and trichostatin A (TSA)-treated HeLa cells) exhibited fewer t-loops. Moreover, we observed that telomere dysfunction-induced foci, ALT-associated promyelocytic leukemia bodies, and telomere sister chromatid exchanges are activated upon TSA-induced loss of t-loops. These findings confirm the importance of the t-loop in protecting linear chromosomes from damage or illegitimate recombination.	[Zhang, Zepeng; Zhang, Tianpeng; Ge, Yuanlong; Tang, Mengfan; Ma, Wenbin; Zhang, Qinfen; Liu, Haiying; Zhao, Yong] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Gene Funct & Regulat, Guangzhou 510006, Guangdong, Peoples R China; [Wright, Woodring E.; Shay, Jerry] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Gong, Shengzhao] Guangdong Ind Tech Coll, Dept Chem Engn, Guangzhou 510006, Guangdong, Peoples R China; [Liu, Haiying] 135 Xingang Xi Rd, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Guangdong Industry Polytechnic	Liu, HY; Zhao, Y (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510006, Guangdong, Peoples R China.	liuhy5@mail.sysu.edu.cn; zhaoy82@mail.sysu.edu.cn		Zhao, Yong/0000-0001-5068-2212; Zhang, Tianpeng/0000-0002-1297-3374	National Natural Science Foundation of China [81771506, 31571410, 31701196]; National Key R&D Program of China [2018YFA0107000]; Guangzhou Municipal People's Livelihood Science and Technology Plan [201803010108, 201604016111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Guangzhou Municipal People's Livelihood Science and Technology Plan	This work was supported by the National Natural Science Foundation of China Grants 81771506, 31571410, and 31701196, National Key R&D Program of China Grant 2018YFA0107000, and Guangzhou Municipal People's Livelihood Science and Technology Plan Grants 201803010108 and 201604016111. The authors declare that they have no conflicts of interest with the contents of this article.	Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Belanger KG, 1996, NUCLEIC ACIDS RES, V24, P2166, DOI 10.1093/nar/24.11.2166; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Boivin A, 1998, GENETICS, V150, P1539; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Cohen S, 2005, NUCLEIC ACIDS RES, V33, P4519, DOI 10.1093/nar/gki764; Cohen S, 2003, GENOME RES, V13, P1133, DOI 10.1101/gr.907603; Cohen S, 2009, CYTOGENET GENOME RES, V124, P327, DOI 10.1159/000218136; Dai XY, 2010, EMBO J, V29, P2788, DOI 10.1038/emboj.2010.156; de Bruin D, 2001, NATURE, V409, P109, DOI 10.1038/35051119; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DIJKWEL PA, 1995, MOL CELL BIOL, V15, P3023; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Episkopou H, 2014, NUCLEIC ACIDS RES, V42, P4391, DOI 10.1093/nar/gku114; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Kalejta RF, 1996, MOL CELL BIOL, V16, P4915; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; KRYSAN PJ, 1991, MOL CELL BIOL, V11, P1464, DOI 10.1128/MCB.11.3.1464; Luke-Glaser S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00180; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; Oganesian L, 2013, DNA REPAIR, V12, P238, DOI 10.1016/j.dnarep.2012.12.008; Oganesian L, 2011, MOL CELL, V42, P224, DOI 10.1016/j.molcel.2011.03.015; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pickett HA, 2015, NAT STRUCT MOL BIOL, V22, P875, DOI 10.1038/nsmb.3106; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Raices M, 2005, PLOS GENET, V1, P748, DOI 10.1371/journal.pgen.0010081; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Stansel RM, 2001, EMBO J, V20, P5532; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wei C, 2003, CELL MOL LIFE SCI, V60, P2283, DOI 10.1007/s00018-003-3244-z; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Wu S, 2014, CELL CYCLE, V13, P2869, DOI 10.4161/15384101.2014.946834; Zhang TP, 2017, EMBO REP, V18, P1412, DOI 10.15252/embr.201643866; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026	49	3	3	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6645	6656		10.1074/jbc.RA119.007677	http://dx.doi.org/10.1074/jbc.RA119.007677			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30819801	hybrid, Green Published			2022-12-28	WOS:000468402000037
J	Liu, L; Zhou, Y; Qu, MB; Qiu, Y; Guo, XM; Zhang, YB; Liu, T; Yang, J; Yang, Q				Liu, Lin; Zhou, Yong; Qu, Mingbo; Qiu, Yu; Guo, Xingming; Zhang, Yuebin; Liu, Tian; Yang, Jun; Yang, Qing			Structural and biochemical insights into the catalytic mechanisms of two insect chitin deacetylases of the carbohydrate esterase 4 family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chitin; carbohydrate; carbohydrate-binding protein; protein structure; Bombyx mori; structural biology; carbohydrate esterase; chitin deacetylase; chitosan; deacetylation activity; SeMet single-wavelength anomalous diffraction	DE-N-ACETYLATION; OLIGOSACCHARIDE DEACETYLASE; PHYLOGENETIC ANALYSIS; DOMAIN ORGANIZATION; PROTEIN; CHITOSAN; BINDING; WALL; IDENTIFICATION; POLY-BETA-1,6-N-ACETYL-D-GLUCOSAMINE	Insect chitin deacetylases (CDAs) catalyze the removal of acetyl groups from chitin and modify this polymer during its synthesis and reorganization. CDAs are essential for insect survival and therefore represent promising targets for insecticide development. However, the structural and biochemical characteristics of insect CDAs have remained elusive. Here, we report the crystal structures of two insect CDAs from the silk moth Bombyx mori: BmCDA1, which may function in cuticle modification, and BmCDA8, which may act in modifying peritrophic membranes in the midgut. Both enzymes belong to the carbohydrate esterase 4 (CE4) family. Comparing their overall structures at 1.98-2.4 resolution with those from well-studied microbial CDAs, we found that two unique loop regions in BmCDA1 and BmCDA8 contribute to the distinct architecture of their substrate-binding clefts. These comparisons revealed that both BmCDA1 and BmCDA8 possess a much longer and wider substrate-binding cleft with a very open active site in the center than the microbial CDAs, including VcCDA from Vibrio cholerae and ArCE4A from Arthrobacter species AW19M34-1. Biochemical analyses indicated that BmCDA8 is an active enzyme that requires its substrates to occupy subsites 0, +1, and +2 for catalysis. In contrast, BmCDA1 also required accessory proteins for catalysis. To the best of our knowledge, our work is the first to unveil the structural and biochemical features of insect proteins belonging to the CE4 family.	[Liu, Lin; Zhou, Yong; Qu, Mingbo; Guo, Xingming; Liu, Tian; Yang, Jun; Yang, Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, Dalian 116024, Peoples R China; [Liu, Lin; Zhou, Yong; Qu, Mingbo; Guo, Xingming; Liu, Tian; Yang, Jun; Yang, Qing] Dalian Univ Technol, Sch Software, Dalian 116024, Peoples R China; [Qiu, Yu] Sanofi, Biol Res, Dept Prot Engn, Bridgewater, NJ 08807 USA; [Zhang, Yuebin] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Mol Modeling & Design, State Key Lab Mol React Dynam, Dalian 116024, Peoples R China; [Yang, Qing] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Dalian University of Technology; Dalian University of Technology; Sanofi-Aventis; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, Q (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, State Key Lab Fine Chem Engn, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Dalian Univ Technol, Sch Software, Dalian 116024, Peoples R China.; Yang, Q (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	qingyang@dlut.edu.cn	Liu, Tian/E-2481-2012; Yang, Qing/GZK-2526-2022; Qu, Mingbo/L-6231-2016	Liu, Tian/0000-0001-9768-5496; Yang, Qing/0000-0001-8623-7532; Qu, Mingbo/0000-0003-0397-1630; liu, lin/0000-0002-4248-7377	National Key RAMP;D Program of China [2017YFD0200501]; Program for National Natural Science Funds for Distinguished Young Scholar [31425021]; National Natural Science Foundation of China [31772193]	National Key RAMP;D Program of China; Program for National Natural Science Funds for Distinguished Young Scholar; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the National Key R&D Program of China (2017YFD0200501), the Program for National Natural Science Funds for Distinguished Young Scholar (31425021), and the National Natural Science Foundation of China (31772193). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres E, 2014, ANGEW CHEM INT EDIT, V53, P6882, DOI 10.1002/anie.201400220; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; Arnaouteli S, 2015, J BIOL CHEM, V290, P13465, DOI 10.1074/jbc.M115.640029; Aruchami M., 1986, P263; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Blair DE, 2006, BIOCHEMISTRY-US, V45, P9416, DOI 10.1021/bi0606694; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Brosson D, 2005, FEMS MICROBIOL LETT, V247, P81, DOI 10.1016/j.femsle.2005.04.031; Chatterjee S, 2005, PROCESS BIOCHEM, V40, P395, DOI 10.1016/j.procbio.2004.01.025; Das S, 2006, MOL BIOCHEM PARASIT, V148, P86, DOI 10.1016/j.molbiopara.2006.03.002; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giastas P, 2018, BIOCHEMISTRY-US, V57, P753, DOI 10.1021/acs.biochem.7b00919; Guo W, 2005, INSECT BIOCHEM MOLEC, V35, P1224, DOI 10.1016/j.ibmb.2005.06.003; Hekmat O, 2003, BIOCHEM J, V374, P369, DOI 10.1042/BJ20030204; Heustis RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040426; Hirano T, 2015, FEBS LETT, V589, P145, DOI 10.1016/j.febslet.2014.11.039; Jakubowska AK, 2010, J VIROL, V84, P2547, DOI 10.1128/JVI.01860-09; Kadokura K, 2007, BIOTECHNOL LETT, V29, P1209, DOI 10.1007/s10529-007-9386-6; KAFETZOPOULOS D, 1993, P NATL ACAD SCI USA, V90, P2564, DOI 10.1073/pnas.90.7.2564; Little DJ, 2015, J BIOL CHEM, V290, P22827, DOI 10.1074/jbc.M115.672469; Little DJ, 2014, J BIOL CHEM, V289, P35907, DOI 10.1074/jbc.M114.611400; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Liu T, 2011, BIOCHEM J, V438, P467, DOI 10.1042/BJ20110390; Liu ZL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02043-1; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Muthukrishnan S., 2016, EXTRACELLULAR COMPOS, P31, DOI DOI 10.1007/978-3-319-40740-1; Oberbarnscheidt L, 2007, PROTEINS, V66, P250, DOI 10.1002/prot.21217; Petkau G, 2012, J BIOL CHEM, V287, P21396, DOI 10.1074/jbc.M112.359984; Qi-Sheng Wang, 2018, Nuclear Science and Techniques, V29, DOI 10.1007/s41365-018-0398-9; Qu M, 2017, INSECT MOL BIOL, V26, P432, DOI 10.1111/imb.12308; Qu MB, 2014, J PROTEOME RES, V13, P2931, DOI 10.1021/pr5000957; Shaik MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019207; Shao ZR, 2019, NEW PHYTOL, V221, P1890, DOI 10.1111/nph.15510; Stivala A, 2011, BIOINFORMATICS, V27, P3315, DOI 10.1093/bioinformatics/btr575; Taylor EJ, 2006, J BIOL CHEM, V281, P10968, DOI 10.1074/jbc.M513066200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tetreau G, 2015, INSECT BIOCHEM MOLEC, V62, P114, DOI 10.1016/j.ibmb.2015.01.006; Tokuyasu K, 2000, BIOCHEMISTRY-US, V39, P8837, DOI 10.1021/bi0005355; TSIGOS I, 1995, J BIOL CHEM, V270, P26286, DOI 10.1074/jbc.270.44.26286; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Tuveng TR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187544; Urch JE, 2009, PROTEIN SCI, V18, P1197, DOI 10.1002/pro.128; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Xi Y, 2014, INSECT MOL BIOL, V23, P695, DOI 10.1111/imb.12113; Yu RR, 2019, INSECT MOL BIOL, V28, P301, DOI 10.1111/imb.12554; Yu RR, 2016, J BIOL CHEM, V291, P24352, DOI 10.1074/jbc.M116.720581; Zhao Y, 2010, MAR DRUGS, V8, P24, DOI 10.3390/md8010024; Zhong XW, 2014, INT J MOL SCI, V15, P1946, DOI 10.3390/ijms15021946; Zhou GY, 2010, AFR J MICROBIOL RES, V4, P2597	58	13	18	4	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5774	5783		10.1074/jbc.RA119.007597	http://dx.doi.org/10.1074/jbc.RA119.007597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30755482	Green Published, hybrid			2022-12-28	WOS:000465077500004
J	Wang, XH; Wang, XX; Zhang, SY; Sun, HW; Li, SJ; Ding, HW; You, Y; Zhang, XW; Ye, SD				Wang, Xiaohu; Wang, Xiaoxiao; Zhang, Shuyuan; Sun, Hongwei; Li, Sijia; Ding, Huiwen; You, Yu; Zhang, Xuewu; Ye, Shou-Dong			The transcription factor TFCP2L1 induces expression of distinct target genes and promotes self-renewal of mouse and human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; STAT3; pluripotency; Wnt pathway; differentiation; naive; Tfcp2l1	GROUND-STATE; SIGNALING PATHWAYS; PLURIPOTENCY; DIFFERENTIATION; NETWORK; ESRRB; KLF4; FIBROBLASTS; CIRCUITRY; LINES	TFCP2L1 (transcription factor CP2-like 1) is a transcriptional regulator critical for maintaining mouse and human embryonic stem cell (ESC) pluripotency. However, the direct TFCP2L1 target genes are uncharacterized. Here, using gene overexpression, immunoblotting, quantitative real-time PCR, ChIP, and reporter gene assays, we show that TFCP2L1 primarily induces estrogen-related receptor (Esrrb) expression that supports mouse ESC identity and also selectively enhances Kruppel-like factor 4 (Klf4) expression and thereby promotes human ESC self-renewal. Specifically, we found that in mouse ESCs, TFCP2L1 binds directly to the Esrrb gene promoter and regulates its transcription. Esrrb knockdown impaired Tfcp2l1's ability to induce interleukin 6 family cytokine (leukemia inhibitory factor)-independent ESC self-renewal and to reprogram epiblast stem cells to naive pluripotency. Conversely, Esrrb overexpression blocked differentiation induced by Tfcp2l1 down-regulation. Moreover, we identified Klf4 as a direct TFCP2L1 target in human ESCs, bypassing the requirement for activin A and basic fibroblast growth factor in short-term human ESC self-renewal. Enforced Klf4 expression recapitulated the self-renewal-promoting effect of Tfcp2l1, whereas Klf4 knockdown eliminated these effects and caused loss of colony-forming capability. These findings indicate that TFCP2L1 functions differently in naive and primed pluripotency, insights that may help elucidate the different states of pluripotency.	[Wang, Xiaohu; Zhang, Shuyuan; Sun, Hongwei; Li, Sijia; Ding, Huiwen; You, Yu; Ye, Shou-Dong] Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei 230601, Anhui, Peoples R China; [You, Yu; Ye, Shou-Dong] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230601, Anhui, Peoples R China; [Wang, Xiaoxiao] Univ Sci & Technol China, Affiliated Hosp 1, Anhui Prov Hosp, Dept Anesthesiol, Hefei 230001, Anhui, Peoples R China; [Zhang, Xuewu] Zhejiang Univ, Dept Hematol, Inst Hematol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China	Anhui University; Anhui University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Zhejiang University	Ye, SD (corresponding author), Anhui Univ, Sch Life Sci, 111 Jiu Long Rd, Hefei 230601, Anhui, Peoples R China.	shdye@126.com			Natural Science Foundation of China [31671535]; Scientific Research Startup Fund of Anhui University [J01006068]; Open Fund for Discipline Construction, Institute of Physical Science and Information Technology, Anhui University [S01003106]; Undergraduate Research Training Program of Anhui University [KYXL2017034]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Startup Fund of Anhui University; Open Fund for Discipline Construction, Institute of Physical Science and Information Technology, Anhui University; Undergraduate Research Training Program of Anhui University(Anhui University)	This work was supported by Grant 31671535 from the Natural Science Foundation of China; Grant J01006068 from the Scientific Research Startup Fund of Anhui University; Grant S01003106 from the Open Fund for Discipline Construction, Institute of Physical Science and Information Technology, Anhui University; and Grant KYXL2017034 from the Undergraduate Research Training Program of Anhui University. The authors declare that they have no conflicts of interest with the contents of this article.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Guo G, 2017, DEVELOPMENT, V144, P2748, DOI 10.1242/dev.146811; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hasegawa K, 2006, STEM CELLS, V24, P2649, DOI 10.1634/stemcells.2005-0657; Huang DL, 2018, BIOL OPEN, V7, DOI 10.1242/bio.029264; Huang GY, 2015, CELL MOL LIFE SCI, V72, P1741, DOI 10.1007/s00018-015-1833-2; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kim H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3403; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liu KS, 2017, J CELL SCI, V130, P3809, DOI 10.1242/jcs.206532; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135; Qiu DB, 2015, STEM CELL REP, V5, P314, DOI 10.1016/j.stemcr.2015.07.014; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sun HW, 2018, J CELL PHYSIOL, V233, P6944, DOI 10.1002/jcp.26483; Sun HW, 2017, DEV BIOL, V431, P272, DOI 10.1016/j.ydbio.2017.09.004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamane M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162404; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Yeo JC, 2014, CELL STEM CELL, V14, P864, DOI 10.1016/j.stem.2014.04.015; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	48	16	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6007	6016		10.1074/jbc.RA118.006341	http://dx.doi.org/10.1074/jbc.RA118.006341			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30782842	hybrid, Green Published			2022-12-28	WOS:000465077500031
J	Wu, CX; Liao, JL; Park, Y; Reed, X; Engel, VA; Hoang, NC; Takagi, Y; Johnson, SM; Wang, M; Federici, M; Nichols, RJ; Sanishvili, R; Cookson, MR; Hoang, QQ				Wu, Chun-Xiang; Liao, Jingling; Park, Yangshin; Reed, Xylena; Engel, Victoria A.; Hoang, Neo C.; Takagi, Yuichiro; Johnson, Steven M.; Wang, Mu; Federici, Mark; Nichols, R. Jeremy; Sanishvili, Ruslan; Cookson, Mark R.; Hoang, Quyen Q.			Parkinson's disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						leucine-rich repeat kinase 2 (LRRK2); Parkinson disease; GTPase; conformational change; molecular dynamics; conformational dynamics; disease mutation; enzyme activation; kinase; Ras of complex proteins (ROC)	KINASE-ACTIVITY; PROTEIN; BINDING; GENE	Mutation in leucine-rich repeat kinase 2 (LRRK2) is a common cause of familial Parkinson's disease (PD). Recently, we showed that a disease-associated mutation R1441H rendered the GTPase domain of LRRK2 catalytically less active and thereby trapping it in a more persistently on conformation. However, the mechanism involved and characteristics of this on conformation remained unknown. Here, we report that the Ras of complex protein (ROC) domain of LRRK2 exists in a dynamic dimer-monomer equilibrium that is oppositely driven by GDP and GTP binding. We also observed that the PD-associated mutations at residue 1441 impair this dynamic and shift the conformation of ROC to a GTP-bound-like monomeric conformation. Moreover, we show that residue Arg-1441 is critical for regulating the conformational dynamics of ROC. In summary, our results reveal that the PD-associated substitutions at Arg-1441 of LRRK2 alter monomer-dimer dynamics and thereby trap its GTPase domain in an activated state.	[Wu, Chun-Xiang; Liao, Jingling; Park, Yangshin; Engel, Victoria A.; Hoang, Neo C.; Takagi, Yuichiro; Johnson, Steven M.; Wang, Mu; Hoang, Quyen Q.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hoang, Quyen Q.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Wu, Chun-Xiang; Liao, Jingling; Park, Yangshin; Engel, Victoria A.; Hoang, Neo C.; Hoang, Quyen Q.] Indiana Univ Sch Med, Stark Neurosci Inst, Indianapolis, IN 46202 USA; [Liao, Jingling] Wuhan Univ Sci & Technol, Sch Med, Dept Publ Hlth, Wuhan 430081, Hubei, Peoples R China; [Reed, Xylena; Cookson, Mark R.] NIH, Neurogenet Lab, Bldg 10, Bethesda, MD 20892 USA; [Wang, Mu] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou 215123, Jiangsu, Peoples R China; [Federici, Mark] ThermoFisher Sci, Carlsbad, CA 92087 USA; [Nichols, R. Jeremy] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Xray Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Wuhan University of Science & Technology; National Institutes of Health (NIH) - USA; Xi'an Jiaotong-Liverpool University; Stanford University; United States Department of Energy (DOE); Argonne National Laboratory	Hoang, QQ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	qqhoang@iu.edu	Cookson, Mark/AAW-2516-2021	Cookson, Mark/0000-0002-1058-3831; Nichols, R Jeremy/0000-0002-5228-7571	National Institutes of Health [R01GM111639, R01GM115844, R01GM120350]; Michael J. Fox Foundation [R01GM111695]; U.S. National Science Foundation [MCB-1157688]; Intramural Research Program of the National Institutes of Health, National Institute on Aging; Travel and Learn program of the Indiana Association of Chinese-Americans (IACA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111695, T32GM077229, R01GM111639, R01GM120350, R01GM115844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; U.S. National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Travel and Learn program of the Indiana Association of Chinese-Americans (IACA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01GM111639 and R01GM115844 and the Michael J. Fox Foundation(to Q. Q. H.), Grant R01GM111695 and U.S. National Science Foundation Grant MCB-1157688 (to Y. T.), the Intramural Research Program of the National Institutes of Health, National Institute on Aging (to M. R. C.), National Institutes of Health Grant R01GM120350 (to S. M. J.), and funding from the Travel and Learn program of the Indiana Association of Chinese-Americans (IACA) (to N. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Deyaert E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01103-4; Giasson BI, 2008, NEUROSIGNALS, V16, P99, DOI 10.1159/000109764; Gotthardt K, 2008, EMBO J, V27, P2352, DOI 10.1038/emboj.2008.167; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Huang X., 2018, FASEB J, DOI [10.1096/fj201802031R, DOI 10.1096/FJ201802031R]; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li YC, 2009, BBA-MOL BASIS DIS, V1792, P1194, DOI 10.1016/j.bbadis.2009.09.010; Liao JL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124074; Liao JL, 2014, P NATL ACAD SCI USA, V111, P4055, DOI 10.1073/pnas.1323285111; Liu ZY, 2015, FASEB J, V29, DOI 10.1096/fj.15-277095; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Petsko GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-108; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	22	14	15	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5907	5913		10.1074/jbc.RA119.007631	http://dx.doi.org/10.1074/jbc.RA119.007631			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30796162	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000465077500022
J	Speciale, I; Duncan, GA; Unione, L; Agarkova, IV; Garozzo, D; Jimenez-Barbero, J; Lin, S; Lowary, TL; Molinaro, A; Noel, E; Laugieri, ME; Tonetti, MG; Van Etten, JL; De Castro, C				Speciale, Immacolata; Duncan, Garry A.; Unione, Luca; Agarkova, Irina V.; Garozzo, Domenico; Jimenez-Barbero, Jesus; Lin, Sicheng; Lowary, Todd L.; Molinaro, Antonio; Noel, Eric; Laugieri, Maria Elena; Tonetti, Michela G.; Van Etten, James L.; De Castro, Cristina			The N-glycan structures of the antigenic variants of chlorovirus PBCV-1 major capsid protein help to identify the virus-encoded glycosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA viruses; glycosyltransferase; bioinformatics; nuclear magnetic resonance (NMR); N-linked glycosylation; post-translational modification (PTM); capsid protein; molecular modeling; Paramecium bursaria chlorella virus 1 (PBCV-1)	CHLORELLA; GLYCOSYLATION; PATHWAY; BIOSYNTHESIS; FEATURES; REVEALS; GLUCOSE	The chlorovirus Paramecium bursaria chlorella virus 1 (PBCV-1) is a large dsDNA virus that infects the microalga Chlorella variabilis NC64A. Unlike most other viruses, PBCV-1 encodes most, if not all, of the machinery required to glycosylate its major capsid protein (MCP). The structures of the four N-linked glycans from the PBCV-1 MCP consist of nonasaccharides, and similar glycans are not found elsewhere in the three domains of life. Here, we identified the roles of three virus-encoded glycosyltransferases (GTs) that have four distinct GT activities in glycan synthesis. Two of the three GTs were previously annotated as GTs, but the third GT was identified in this study. We determined the GT functions by comparing the WT glycan structures from PBCV-1 with those from a set of PBCV-1 spontaneous GT gene mutants resulting in antigenic variants having truncated glycan structures. According to our working model, the virus gene a064r encodes a GT with three domains: domain 1 has a -l-rhamnosyltransferase activity, domain 2 has an -l-rhamnosyltransferase activity, and domain 3 is a methyltransferase that decorates two positions in the terminal -l-rhamnose (Rha) unit. The a075l gene encodes a -xylosyltransferase that attaches the distal d-xylose (Xyl) unit to the l-fucose (Fuc) that is part of the conserved N-glycan core region. Last, gene a071r encodes a GT that is involved in the attachment of a semiconserved element, -d-Rha, to the same l-Fuc in the core region. Our results uncover GT activities that assemble four of the nine residues of the PBCV-1 MCP N-glycans.	[Speciale, Immacolata; De Castro, Cristina] Univ Napoli Federico II, Dept Agr Sci, Via Univ 100, I-80055 Portici, NA, Italy; [Duncan, Garry A.] Nebraska Wesleyan Univ, Dept Biol, Lincoln, NE 68504 USA; [Unione, Luca; Jimenez-Barbero, Jesus] CIC BioGUNE, Chem Glycobiol Lab, Bizkaia Technol Pk,Bld 800, Derio 48170, Spain; [Agarkova, Irina V.; Noel, Eric; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Agarkova, Irina V.; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Garozzo, Domenico] CNR, Inst Polymers Composites & Biomat, Via P Gaifami 18, I-95126 Catania, Italy; [Jimenez-Barbero, Jesus] Basque Fdn Sci IKERBASQUE, Bilbao 48940, Spain; [Jimenez-Barbero, Jesus] Univ Basque Country, Dept Organ Chem 2, Fac Sci & Technol, UPV EHU, Leioa 48940, Spain; [Lin, Sicheng; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Gunning Lemieux Chem Ctr, Edmonton, AB T6G 2G2, Canada; [Lin, Sicheng; Lowary, Todd L.] Univ Alberta, Dept Chem, Gunning Lemieux Chem Ctr, Edmonton, AB T6G 2G2, Canada; [Molinaro, Antonio] Univ Napoli Federico II, Dept Chem Sci, I-80126 Naples, Italy; [Noel, Eric] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Laugieri, Maria Elena; Tonetti, Michela G.] Univ Genoa, Dept Expt Med, Viale Benedetto 15-1, I-16132 Genoa, Italy; [Laugieri, Maria Elena; Tonetti, Michela G.] Univ Genoa, Ctr Excellence Biomed Res, Viale Benedetto 15-1, I-16132 Genoa, Italy	University of Naples Federico II; CIC bioGUNE; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR); Basque Foundation for Science; University of Basque Country; University of Alberta; University of Alberta; University of Naples Federico II; University of Nebraska System; University of Nebraska Lincoln; University of Genoa; University of Genoa	De Castro, C (corresponding author), Univ Napoli Federico II, Dept Agr Sci, Via Univ 100, I-80055 Portici, NA, Italy.; Van Etten, JL (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA.	jvanetten1@unl.edu; decastro@unina.it	De Castro, Cristina/I-5899-2012; Tonetti, Michela/F-3039-2018; TONETTI, MICHELA/AAF-3404-2021; Garozzo, Domenico/I-8839-2014; Lowary, Todd L/F-9608-2019; JIMENEZ-BARBERO, JESUS/D-4431-2014; Unione, Luca/O-6483-2017	De Castro, Cristina/0000-0002-5147-1756; TONETTI, MICHELA/0000-0002-8829-7173; Garozzo, Domenico/0000-0002-9087-9818; Lowary, Todd L/0000-0002-8331-8211; Noel, Eric/0000-0003-0839-5476; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Unione, Luca/0000-0002-8724-8783; Speciale, Immacolata/0000-0003-4363-7450	Mizutani Foundation Grant [180047]; National Institutes of Health IDeA Networks of Biomedical Research Excellence program; National Science Foundation [1736030]; MINECO, CSIC [CTQ2015-64597-C2-1P]; MINECO, Severo Ochoa Excellence Accreditation [SEV-2016-0644]	Mizutani Foundation Grant; National Institutes of Health IDeA Networks of Biomedical Research Excellence program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); MINECO, CSIC; MINECO, Severo Ochoa Excellence Accreditation	This work was supported by Mizutani Foundation Grant 180047 (to C. D. C.), the National Institutes of Health IDeA Networks of Biomedical Research Excellence program (to G. A. D.), and National Science Foundation Grant 1736030 (to J. V. E.). This work was also supported by MINECO, CSIC, Grant CTQ2015-64597-C2-1P and Severo Ochoa Excellence Accreditation SEV-2016-0644 (to CIC bioGUNE). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagdonaite I, 2018, GLYCOBIOLOGY, V28, P443, DOI 10.1093/glycob/cwy021; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; Chothi MP, 2010, J VIROL, V84, P8829, DOI 10.1128/JVI.00770-10; Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6; De Castro C, 2018, P NATL ACAD SCI USA, V115, pE44, DOI 10.1073/pnas.1613432115; De Castro C, 2016, ANGEW CHEM INT EDIT, V55, P654, DOI 10.1002/anie.201509150; De Castro C, 2013, P NATL ACAD SCI USA, V110, P13956, DOI 10.1073/pnas.1313005110; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; DeAngelis PL, 1997, SCIENCE, V278, P1800, DOI 10.1126/science.278.5344.1800; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; Dunigan DD, 2012, J VIROL, V86, P8821, DOI 10.1128/JVI.00907-12; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645; Graves MV, 2001, VIROLOGY, V285, P332, DOI 10.1006/viro.2001.0937; Hunter E., 2007, FIELDS VIROLOGY, P141; Jeanniard A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-158; Jeevarajah D, 2004, J BACTERIOL, V186, P6792, DOI 10.1128/JB.186.20.6792-6799.2004; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Landstein D, 1995, VIROLOGY, V214, P413, DOI 10.1006/viro.1995.0051; Markine-Goriaynoff N, 2004, J GEN VIROL, V85, P2741, DOI 10.1099/vir.0.80320-0; Mulakala C, 2013, J MOL GRAPH MODEL, V46, P41, DOI 10.1016/j.jmgm.2013.09.005; Neves RPP, 2013, J CHEM THEORY COMPUT, V9, P2718, DOI 10.1021/ct400055v; Oka T, 2007, J BIOL CHEM, V282, P5389, DOI 10.1074/jbc.M610196200; Olofsson S, 1998, SCAND J INFECT DIS, V30, P435, DOI 10.1080/00365549850161386; Piacente F, 2017, J BIOL CHEM, V292, P7385, DOI 10.1074/jbc.M117.783217; Piacente F, 2014, GLYCOBIOLOGY, V24, P51, DOI 10.1093/glycob/cwt089; Piacente F, 2012, J BIOL CHEM, V287, P3009, DOI 10.1074/jbc.M111.314559; Quispe CF, 2017, VIROLOGY, V500, P103, DOI 10.1016/j.virol.2016.10.013; Rommel AJ, 2016, BIOCHEM J, V473, P3451, DOI 10.1042/BCJ20160280; Speciale I, 2017, ANTON LEEUW INT J G, V110, P1391, DOI 10.1007/s10482-017-0861-3; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Van Etten JL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040088; Van Etten JL, 2010, BBA-GEN SUBJECTS, V1800, P152, DOI 10.1016/j.bbagen.2009.07.024; VANETTEN JL, 1983, SCIENCE, V219, P994, DOI 10.1126/science.219.4587.994; VANETTEN JL, 1983, VIROLOGY, V126, P117, DOI 10.1016/0042-6822(83)90466-X; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; WANG IN, 1993, P NATL ACAD SCI USA, V90, P3840, DOI 10.1073/pnas.90.9.3840; Zhang Y, 2007, STRUCTURE, V15, P1031, DOI 10.1016/j.str.2007.07.006	39	12	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5688	5699		10.1074/jbc.RA118.007182	http://dx.doi.org/10.1074/jbc.RA118.007182			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30737276	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000464517500036
J	Ikeno, S; Nakano, N; Sano, K; Minowa, T; Sato, W; Akatsu, R; Sakata, N; Hanagata, N; Fujii, M; Itoh, F; Itoh, S				Ikeno, Souichi; Nakano, Naoko; Sano, Keigo; Minowa, Takashi; Sato, Wataru; Akatsu, Ryosuke; Sakata, Nobuo; Hanagata, Nobutaka; Fujii, Makiko; Itoh, Fumiko; Itoh, Susumu			PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-beta (TGF-beta) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); receptor protein serine; threonine kinase; signal transduction; SMAD transcription factor; transforming growth factor (TGF-); tumor; transcription; cell signaling; PDZK1-interacting protein 1 (PDZK1IP1); Smad4	FUNCTIONAL-CHARACTERIZATION; FAMILY-MEMBERS; MAP17; IDENTIFICATION; ACTIVATOR; APOPTOSIS; PROMOTER; ELEMENTS; PATHWAY; COMPLEX	Transforming growth factor (TGF)-beta signaling in humans is stringently regulated to prevent excessive TGF-beta signaling. In tumors, TGF-beta signaling can both negatively and positively regulate tumorigenesis dependent on tumor type, but the reason for these opposite effects is unclear. TGF-beta signaling is mainly mediated via the Smad-dependent pathway, and herein we found that PDZK1-interacting protein 1 (PDZK1IP1) interacts with Smad4. PDZK1IP1 inhibited both the TGF-beta and the bone morphogenetic protein (BMP) pathways without affecting receptor-regulated Smad (R-Smad) phosphorylation. Rather than targeting R-Smad phosphorylation, PDZK1IP1 could interfere with TGF-beta- and BMP-induced R-Smad/Smad4 complex formation. Of note, PDZK1IP1 retained Smad4 in the cytoplasm of TGF-beta-stimulated cells. To pinpoint PDZK1IP1's functional domain, we created several PDZK1IP1 variants and found that its middle region, from Phe(40) to Ala(49), plays a key role in its Smad4-regulating activity. PDZK1IP1 knockdown enhanced the expression of the TGF-beta target genes Smad7 and prostate transmembrane protein androgen-induced (TMEPAI) upon TGF-beta stimulation. In contrast, PDZK1IP1 overexpression suppressed TGF-beta-induced reporter activities, cell migration, and cell growth inhibition. In a xenograft tumor model in which TGF-beta was previously shown to elicit tumor-promoting effects, PDZK1IP1 gain of function decreased tumor size and increased survival rates. Taken together, these findings indicate that PDZK1IP1 interacts with Smad4 and thereby suppresses the TGF-beta signaling pathway.	[Ikeno, Souichi; Nakano, Naoko; Sano, Keigo; Sato, Wataru; Akatsu, Ryosuke; Sakata, Nobuo; Itoh, Susumu] Showa Pharmaceut Univ, Lab Biochem, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan; [Minowa, Takashi; Hanagata, Nobutaka] Natl Inst Mat Sci, Nanotechnol Innovat Stn, Tsukuba, Ibaraki 3050047, Japan; [Fujii, Makiko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Hiroshima, Hiroshima 7348553, Japan; [Itoh, Fumiko] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Hachioji, Tokyo 1920392, Japan	Showa Pharmaceutical University; National Institute for Materials Science; Hiroshima University; Tokyo University of Pharmacy & Life Sciences	Itoh, S (corresponding author), Showa Pharmaceut Univ, Lab Biochem, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	sitoh@ac.shoyaku.ac.jp	Sakata, Nobuo/L-9753-2015	Sakata, Nobuo/0000-0001-9967-8409; Hanagata, Nobutaka/0000-0001-6079-3426; Itoh, Fumiko/0000-0002-6134-5331	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [15K18866]; Takeda Science Foundation; Daiichi-Sankyo Foundation of Life Science; Naito Foundation; Vehicle Racing Commemorative Foundation; Mitsubishi Foundation; Science Research Promotion Fund; Research Foundation for Pharmaceutical Sciences; MEXT [S1311012]; Showa Pharmaceutical University; Medical Research Institute, Tokyo Medical and Dental University; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Daiichi-Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation); Vehicle Racing Commemorative Foundation; Mitsubishi Foundation; Science Research Promotion Fund; Research Foundation for Pharmaceutical Sciences; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Showa Pharmaceutical University; Medical Research Institute, Tokyo Medical and Dental University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Young Scientists (B) 15K18866 (to N. N.) and the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) (to S. Itoh) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); the Takeda Science Foundation (to S. Itoh); the Daiichi-Sankyo Foundation of Life Science (to S. Itoh); the Naito Foundation (to S. Itoh); the Vehicle Racing Commemorative Foundation (to S. Itoh); the Mitsubishi Foundation (to S. Itoh); the Science Research Promotion Fund (S. Itoh); the Research Foundation for Pharmaceutical Sciences (to N. N.); the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Grant S1311012) (to N. N. and S. Itoh); and a grant-in-aid for young scientists of Showa Pharmaceutical University (to S. Ikeno and N. N.). This work was also supported by the Joint Usage/Research Program of the Medical Research Institute, Tokyo Medical and Dental University and by the Core-to-Core program "Cooperative International Framework in TGF-beta Family Signaling" of the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blasco T, 2003, AM J PHYSIOL-RENAL, V285, pF799, DOI 10.1152/ajprenal.00149.2003; Carnero A, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00112; Coady MJ, 2017, AM J PHYSIOL-RENAL, V313, pF467, DOI 10.1152/ajprenal.00628.2016; Coady MJ, 2017, J AM SOC NEPHROL, V28, P85, DOI 10.1681/ASN.2015111282; de Miguel-Luken MJ, 2015, ONCOTARGET, V6, P12625, DOI 10.18632/oncotarget.3470; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ferrer I, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0871-7; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Guijarro MV, 2007, J CELL BIOCHEM, V101, P112, DOI 10.1002/jcb.21163; Guijarro MV, 2007, CARCINOGENESIS, V28, P2443, DOI 10.1093/carcin/bgm154; Guijarro MV, 2007, CARCINOGENESIS, V28, P2096, DOI 10.1093/carcin/bgm124; Guijarro MV, 2007, CARCINOGENESIS, V28, P1646, DOI 10.1093/carcin/bgm083; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Hill CS, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022079; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Itoh S, 2018, J BIOCHEM, V164, P195, DOI 10.1093/jb/mvy059; Itoh S, 2011, GROWTH FACTORS, V29, P163, DOI 10.3109/08977194.2011.614236; Jaeger C, 2000, J INVEST DERMATOL, V115, P375, DOI 10.1046/j.1523-1747.2000.00071.x; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Kocher O, 1996, AM J PATHOL, V149, P493; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lanaspa MA, 2007, AM J PHYSIOL-RENAL, V292, pF230, DOI 10.1152/ajprenal.00075.2006; Garcia-Heredia JM, 2017, CLIN CANCER RES, V23, P3871, DOI 10.1158/1078-0432.CCR-16-2358; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Moses HL, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021865; Nakano N, 2017, J BIOL CHEM, V292, P4099, DOI 10.1074/jbc.M116.769109; Nakano N, 2014, J BIOL CHEM, V289, P12680, DOI 10.1074/jbc.M114.558981; Nakano N, 2010, J BIOL CHEM, V285, P38023, DOI 10.1074/jbc.M110.132209; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pribanic S, 2003, AM J PHYSIOL-RENAL, V285, pF784, DOI 10.1152/ajprenal.00109.2003; Seoane J, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022277; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Zhao M, 2018, INT J BIOL SCI, V14, P111, DOI 10.7150/ijbs.23230; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483	46	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4966	4980		10.1074/jbc.RA118.004153	http://dx.doi.org/10.1074/jbc.RA118.004153			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718277	Green Published, hybrid			2022-12-28	WOS:000463985600021
J	Pontejo, SM; Sanchez, C; Ruiz-Arguello, B; Alcami, A				Pontejo, Sergio M.; Sanchez, Carolina; Ruiz-Arguello, Begona; Alcami, Antonio			Insights into ligand binding by a viral tumor necrosis factor (TNF) decoy receptor yield a selective soluble human type 2 TNF receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); receptor; viral immunology; inflammation; autoimmune disease; decoy receptor	PRELIGAND ASSEMBLY DOMAIN; LYMPHOTOXIN-BETA-RECEPTOR; CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; FACTOR AGENTS; FACTOR-ALPHA; LT-ALPHA; DISTINCT; APOPTOSIS; HOMOLOG	Etanercept is a soluble form of the tumor necrosis factor receptor 2 (TNFR2) that inhibits pathological tumor necrosis factor (TNF) responses in rheumatoid arthritis and other inflammatory diseases. However, besides TNF, etanercept also blocks lymphotoxin-alpha (LT alpha), which has no clear therapeutic value and might aggravate some of the adverse effects associated with etanercept. Poxviruses encode soluble TNFR2 homologs, termed viral TNF decoy receptors (vTNFRs), that display unique specificity properties. For instance, cytokine response modifier D (CrmD) inhibits mouse and human TNF and mouse LT alpha, but it is inactive against human LT alpha. Here, we analyzed the molecular basis of these immunomodulatory activities in the ectromelia virus-encoded CrmD. We found that the overall molecular mechanism to bind TNF and LT alpha from mouse and human origin is fairly conserved in CrmD and dominated by a groove under its 50s loop. However, other ligand-specific binding determinants optimize CrmD for the inhibition of mouse ligands, especially mouse TNF. Moreover, we show that the inability of CrmD to inhibit human LT alpha is caused by a Glu-Phe-Glu motif in its 90s loop. Importantly, transfer of this motif to etanercept diminished its anti-LT alpha activity in >60-fold while weakening its TNF-inhibitory capacity in 3-fold. This new etanercept variant could potentially be used in the clinic as a safer alternative to conventional etanercept. This work is the most detailed study of the vTNFR-ligand interactions to date and illustrates that a better knowledge of vTNFRs can provide valuable information to improve current anti-TNF therapies.	[Pontejo, Sergio M.; Sanchez, Carolina; Ruiz-Arguello, Begona; Alcami, Antonio] CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Pontejo, Sergio M.; Sanchez, Carolina; Ruiz-Arguello, Begona; Alcami, Antonio] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Ruiz-Arguello, Begona] Progenika Biopharma, Derio 48160, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Alcami, A (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Nicolas Cabrera 1,Campus Cantoblanco, E-28049 Madrid, Spain.	aalcami@cbm.csic.es	Pontejo, Sergio M./AAN-6403-2020; Alcami, Antonio/F-8512-2015	Pontejo, Sergio M./0000-0002-7756-9831; Alcami, Antonio/0000-0002-3333-6016; Sanchez Fernandez, Carolina/0000-0002-5183-8167	Spanish Ministry of Economy and Competitiveness [SAF2012-38957, SAF2015-67485-R]; European Union (European Regional Development Fund); Consejo Superior de Investigaciones Cientificas	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union (European Regional Development Fund)(European Commission); Consejo Superior de Investigaciones Cientificas	This work was supported by Spanish Ministry of Economy and Competitiveness Grants SAF2012-38957 and SAF2015-67485-R and the European Union (European Regional Development Fund). S. M. Pontejo, C. Sanchez, and A. Alcami are inventors of a patent application on the potential use of the variant form of etanercept, but there is no company involved or development of this reagent as a drug so far.r Recipient of a Junta para la Ampliacion de Estudios Ph.D. studentship from Consejo Superior de Investigaciones Cientificas.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Alejo A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04098-8; Alejo A, 2011, ADV EXP MED BIOL, V691, P203, DOI 10.1007/978-1-4419-6612-4_21; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bopst M, 2001, EUR J IMMUNOL, V31, P1935, DOI 10.1002/1521-4141(200106)31:6&lt;1935::AID-IMMU1935&gt;3.0.CO;2-N; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Branschadel M, 2010, CELL SIGNAL, V22, P404, DOI 10.1016/j.cellsig.2009.10.011; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chan FKM, 2000, ANN RHEUM DIS, V59, P50, DOI 10.1136/ard.59.suppl_1.i50; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; Cunnion KM, 1999, MOL GENET METAB, V67, P278, DOI 10.1006/mgme.1999.2878; Ehlers S, 2003, J IMMUNOL, V170, P5210, DOI 10.4049/jimmunol.170.10.5210; Fellermann K, 2013, DIGEST DIS, V31, P374, DOI 10.1159/000354703; Garces S, 2013, ANN RHEUM DIS, V72, P1947, DOI 10.1136/annrheumdis-2012-202220; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; GOH CR, 1991, PROTEIN ENG, V4, P785; Graham SC, 2007, J MOL BIOL, V372, P660, DOI 10.1016/j.jmb.2007.06.082; HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539; Hymowitz SG, 2000, BIOCHEMISTRY-US, V39, P633, DOI 10.1021/bi992242l; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Jacobs M, 2000, CLIN IMMUNOL, V94, P192, DOI 10.1006/clim.2000.4835; Kennedy WP, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0467-3; Liu CZ, 2010, J IMMUNOL, V184, P6910, DOI 10.4049/jimmunol.0904033; Loparev VN, 1998, P NATL ACAD SCI USA, V95, P3786, DOI 10.1073/pnas.95.7.3786; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Magis C, 2012, TRENDS BIOCHEM SCI, V37, P353, DOI 10.1016/j.tibs.2012.06.002; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; Mitoma H, 2018, CYTOKINE, V101, P56, DOI 10.1016/j.cyto.2016.08.014; Montanuy I, 2011, FASEB J, V25, P1960, DOI 10.1096/fj.10-177188; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Murray KM, 1997, ANN PHARMACOTHER, V31, P1335, DOI 10.1177/106002809703101111; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Neregard P, 2014, SCAND J RHEUMATOL, V43, P85, DOI 10.3109/03009742.2013.834964; Olleros ML, 2002, J IMMUNOL, V168, P3394, DOI 10.4049/jimmunol.168.7.3394; Orlinick JR, 1997, J BIOL CHEM, V272, P28889, DOI 10.1074/jbc.272.46.28889; Pontejo SM, 2015, J BIOL CHEM, V290, P15973, DOI 10.1074/jbc.M115.650119; Reading PC, 2002, VIROLOGY, V292, P285, DOI 10.1006/viro.2001.1236; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Rooney IA, 2000, J BIOL CHEM, V275, P14307, DOI 10.1074/jbc.275.19.14307; Saraiva M, 2001, J VIROL, V75, P226, DOI 10.1128/JVI.75.1.226-233.2001; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Schreiber M, 1997, J VIROL, V71, P2171, DOI 10.1128/JVI.71.3.2171-2181.1997; Schreiber M, 1996, J IMMUNOL, V157, P4486; Sedger LM, 2006, J VIROL, V80, P9300, DOI 10.1128/JVI.02449-05; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Smith CA, 1996, VIROLOGY, V223, P132, DOI 10.1006/viro.1996.0462; Smulski CR, 2013, J BIOL CHEM, V288, P10914, DOI 10.1074/jbc.M112.427583; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Willrich MAV, 2015, TRANSL RES, V165, P270, DOI 10.1016/j.trsl.2014.09.006; Xue XG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002162; YAMAGISHI J, 1990, PROTEIN ENG, V3, P713, DOI 10.1093/protein/3.8.713; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004; Zhan CY, 2009, BIOCHEMISTRY-US, V48, P7636, DOI 10.1021/bi900031w; Zhang GY, 2004, CURR OPIN STRUC BIOL, V14, P154, DOI 10.1016/j.sbi.2004.03.003	62	9	11	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5214	5227		10.1074/jbc.RA118.005828	http://dx.doi.org/10.1074/jbc.RA118.005828			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30723161	hybrid, Green Published			2022-12-28	WOS:000463985600045
J	Mohammad-Beigi, H; Aliakbari, F; Sahin, C; Lomax, C; Tawfike, A; Schafer, NP; Amiri-Nowdijeh, A; Eskandari, H; Moller, IM; Hosseini-Mazinani, M; Christiansen, G; Ward, JL; Morshedi, D; Otzen, DE				Mohammad-Beigi, Hossein; Aliakbari, Farhang; Sahin, Cagla; Lomax, Charlotte; Tawfike, Ahmed; Schafer, Nicholas P.; Amiri-Nowdijeh, Alireza; Eskandari, Hoda; Moller, Ian Max; Hosseini-Mazinani, Mehdi; Christiansen, Gunna; Ward, Jane L.; Morshedi, Dina; Otzen, Daniel E.			Oleuropein derivatives from olive fruit extracts reduce -synuclein fibrillation and oligomer toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Parkinson disease; protein aggregation; amyloid; -synuclein (-synuclein); neurodegeneration; cell toxicity; Mediterranean diet; membrane permeabilization; oligomerization; olive polyphenols	ALPHA-SYNUCLEIN; MEDITERRANEAN DIET; PHENOLIC-COMPOUNDS; AGGREGATION; OIL; CONFORMATION; ASSOCIATION; POLYPHENOLS; ADHERENCE	Aggregation of -synuclein (SN) is implicated in neuronal degeneration in Parkinson's disease and has prompted searches for natural compounds inhibiting SN aggregation and reducing its tendency to form toxic oligomers. Oil from the olive tree (Olea europaea L.) represents the main source of fat in the Mediterranean diet and contains variable levels of phenolic compounds, many structurally related to the compound oleuropein. Here, using SN aggregation, fibrillation, size-exclusion chromatography-multiangle light scattering (SEC-MALS)-based assays, and toxicity assays, we systematically screened the fruit extracts of 15 different olive varieties to identify compounds that can inhibit SN aggregation and oligomer toxicity and also have antioxidant activity. Polyphenol composition differed markedly among varieties. The variety with the most effective antioxidant and aggregation activities, Koroneiki, combined strong inhibition of SN fibril nucleation and elongation with strong disaggregation activity on preformed fibrils and prevented the formation of toxic SN oligomers. Fractionation of the Koroneiki extract identified oleuropein aglycone, hydroxyl oleuropein aglycone, and oleuropein as key compounds responsible for the differences in inhibition across the extracts. These phenolic compounds inhibited SN amyloidogenesis by directing SN monomers into small SN oligomers with lower toxicity, thereby suppressing the subsequent fibril growth phase. Our results highlight the molecular consequences of differences in the level of effective phenolic compounds in different olive varieties, insights that have implications for long-term human health.	[Mohammad-Beigi, Hossein; Aliakbari, Farhang; Sahin, Cagla; Schafer, Nicholas P.; Eskandari, Hoda; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark; [Aliakbari, Farhang; Morshedi, Dina] Natl Inst Genet Engn & Biotechnol, Dept Ind & Environm Biotechnol, POB 1417863171, Tehran, Iran; [Amiri-Nowdijeh, Alireza; Hosseini-Mazinani, Mehdi] Natl Inst Genet Engn & Biotechnol, Dept Agr Biotechnol, POB 1417863171, Tehran, Iran; [Sahin, Cagla; Moller, Ian Max] Aarhus Univ, Dept Mol Biol & Genet, Forsogsvej 1, DK-4200 Slagelse, Denmark; [Lomax, Charlotte; Tawfike, Ahmed; Ward, Jane L.] Rothamsted Res, Computat & Analyt Sci Dept, Harpenden AL5 2JQ, Herts, England; [Christiansen, Gunna] Aarhus Univ, Dept Biomed Med Microbiol & Immunol, DK-8000 Aarhus C, Denmark; [Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark; [Schafer, Nicholas P.] Rice Univ, Dept Chem, Ctr Theoret Biol Phys, Houston, TX 77005 USA	Aarhus University; Aarhus University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Aarhus University; Aarhus University; Rice University	Mohammad-Beigi, H; Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.; Morshedi, D (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Ind & Environm Biotechnol, POB 1417863171, Tehran, Iran.; Otzen, DE (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	beigi@inano.au.dk; morshedi@nigeb.ac.ir; dao@inano.au.dk	Mohammad-Beigi, Hossein/AAP-8565-2020; Aliakbari, Farhang/GZM-7193-2022; Tawfike, Ahmed Fares/O-4310-2017	Mohammad-Beigi, Hossein/0000-0003-2303-795X; Tawfike, Ahmed Fares/0000-0003-2061-3093; Christiansen, Gunna/0000-0003-0540-1367; Lomax, Charlotte/0000-0002-6303-4000; Sahin, Cagla/0000-0002-2889-5200; Aliakbari, Farhang/0000-0002-0928-3743	Center for International Scientific Studies and Collaboration (CISSC) [982]; Independent Research Fund of Denmark, Technology and Production [4005-00082]; Biotechnology and Biological Sciences Research Council (BBSRC) of theUK; Tailoring Plant Metabolism Institute Strategic Programme - BBSRC [BB/E/C/000I0410]; BBSRC [BBS/E/C/000I0410] Funding Source: UKRI	Center for International Scientific Studies and Collaboration (CISSC); Independent Research Fund of Denmark, Technology and Production; Biotechnology and Biological Sciences Research Council (BBSRC) of theUK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tailoring Plant Metabolism Institute Strategic Programme - BBSRC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant 982 from the Center for International Scientific Studies and Collaboration (CISSC) (to H. M. B., F. A., and D. M.), Grant 4005-00082 from the Independent Research Fund of Denmark, Technology and Production (to H. E., N. P. S., C. S., I. M. M., G. C., and D. E. O.), a grant to Rothamsted Research from the Biotechnology and Biological Sciences Research Council (BBSRC) of theUK(to C. L., A. T., and J. L. W.), and Tailoring Plant Metabolism Institute Strategic Programme Grant BB/E/C/000I0410 funded by the BBSRC (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Ahmad E, 2011, BIOCHIMIE, V93, P793, DOI 10.1016/j.biochi.2010.12.012; Aliakbari F, 2017, SCI IRAN, V24, P3542, DOI 10.24200/sci.2017.4419; Amiri-Nowdijeh A, 2018, J AGR SCI TECH-IRAN, V20, P347; Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Casamenti F, 2017, EXPERT REV NEUROTHER, V17, P345, DOI 10.1080/14737175.2017.1245617; Chen L, 2007, BIOCHEM BIOPH RES CO, V356, P548, DOI 10.1016/j.bbrc.2007.02.163; Daccache A, 2011, NEUROCHEM INT, V58, P700, DOI 10.1016/j.neuint.2011.02.010; Dai J, 2008, AM J CLIN NUTR, V88, P1364, DOI 10.3945/ajcn.2008.26528; Diomede L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058893; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fink Anthony L., 2006, P265; Gaskins AJ, 2010, AM J CLIN NUTR, V92, P1461, DOI 10.3945/ajcn.110.000026; Giehm L, 2010, ANAL BIOCHEM, V400, P270, DOI 10.1016/j.ab.2010.02.001; Hardy J, 2003, LANCET NEUROL, V2, P221, DOI 10.1016/S1474-4422(03)00350-8; Hosseini-Mazinani M., 2013, IRANIAN OLIVE CATALO, DOI [10.1007/s10727-013-0071-4, DOI 10.1007/S10727-013-0071-4]; Ingelsson M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00408; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Mandel S, 2004, FREE RADICAL BIO MED, V37, P304, DOI 10.1016/j.freeradbiomed.2004.04.012; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Mohammad-Beigi H, 2016, RSC ADV, V6, P85312, DOI 10.1039/c6ra08502d; Mohammad-Beigi H, 2015, NANOSCALE, V7, P19627, DOI 10.1039/c5nr05663b; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Nakamura K, 2013, NEUROTHERAPEUTICS, V10, P391, DOI 10.1007/s13311-013-0182-9; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nesgaard L, 2009, BBA-PROTEINS PROTEOM, V1794, P84, DOI 10.1016/j.bbapap.2008.09.021; Omar SH, 2018, FITOTERAPIA, V128, P118, DOI 10.1016/j.fitote.2018.05.011; Palazzi L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26645-5; Paslawski W, 2014, BIOCHEMISTRY-US, V53, P6252, DOI 10.1021/bi5007833; Paslawski W, 2014, ANGEW CHEM INT EDIT, V53, P7560, DOI 10.1002/anie.201400491; Perni M, 2017, P NATL ACAD SCI USA, V114, pE1009, DOI 10.1073/pnas.1610586114; Petridis A, 2012, HORTSCIENCE, V47, P339, DOI 10.21273/HORTSCI.47.3.339; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Rigacci S, 2011, CURR ALZHEIMER RES, V8, P841, DOI 10.2174/156720511798192682; Rigacci S, 2010, J NUTR BIOCHEM, V21, P726, DOI 10.1016/j.jnutbio.2009.04.010; Romero C, 2017, J SCI FOOD AGR, V97, P1725, DOI 10.1002/jsfa.7920; Sahin C, 2017, BIOPHYS CHEM, V220, P34, DOI 10.1016/j.bpc.2016.11.002; Servili M, 2002, EUR J LIPID SCI TECH, V104, P602, DOI 10.1002/1438-9312(200210)104:9/10<602::AID-EJLT602>3.0.CO;2-X; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tripoli E, 2005, NUTR RES REV, V18, P98, DOI 10.1079/NRR200495; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; Vossen P.M., 2007, ORGANIC OLIVE PRODUC; Wu C, 2006, BIOPHYS J, V91, P3664, DOI 10.1529/biophysj.106.081877; Zhao J, 2017, RSC ADV, V7, P32508, DOI 10.1039/c7ra03752j	51	30	31	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4215	4232		10.1074/jbc.RA118.005723	http://dx.doi.org/10.1074/jbc.RA118.005723			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655291	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000461854400032
J	Quesada, V; Sanchez, LM; Alvarez, J; Lopez-Otin, C				Quesada, Victor; Sanchez, Luis M.; Alvarez, Jesus; Lopez-Otin, Carlos			RETRACTION: Withdrawal: Identification and characterization of human and mouse ovastacin: A novel metalloproteinase similar to hatching enzymes from arthropods, birds, amphibians, and fish. (Retraction of Vol 279, Pg 26627, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Lopez-Otin, Carlos/AAB-2106-2020	Lopez-Otin, Carlos/0000-0001-6964-1904				Quesada C, 2004, J BIOL CHEM, V279, P26627, DOI 10.1074/jbc.M401588200	1	0	0	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1432	1432		10.1074/jbc.W118.007326	http://dx.doi.org/10.1074/jbc.W118.007326			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30808003	Green Published, hybrid			2022-12-28	WOS:000457879500035
J	Maupin-Furlow, JA				Maupin-Furlow, Julie A.			Putting phage to work in deubiquitinase ligand discovery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							11 USP11; SENSITIVITY	Inhibiting deubiquitinase (DUB) function is a promising strategy for the treatment of cancers and other human diseases. Of the hundreds of human DUBs, USP11 has emerged as an ideal therapeutic target, as it regulates DNA double-strand break repair by homologous recombination (HR) and other functions central to eukaryotic cell survival. A new study by Spiliotopoulos et al. cleverly uses next-generation phage display (NGPD) to identify peptide ligands that bind USP11 in a unique pocket that impacts HR. The study provides an important step toward novel DUB inhibitors that may reduce the resistance of some cancers to current treatment options.	[Maupin-Furlow, Julie A.] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Maupin-Furlow, Julie A.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Maupin-Furlow, JA (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.; Maupin-Furlow, JA (corresponding author), Univ Florida, Genet Inst, Gainesville, FL 32611 USA.	jmaupin@ufl.edu	Maupin-Furlow, Julie/AAW-4035-2020	Maupin-Furlow, Julie/0000-0001-6105-0923	National Science Foundation Bilateral BBSRC-NSF/BIO program [1642283]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Bio-sciences, Physical Biosciences Program [DE-FG02-05ER15650]; NIGMS, National Institutes of Health [R01 GM57498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057498] Funding Source: NIH RePORTER	National Science Foundation Bilateral BBSRC-NSF/BIO program; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Bio-sciences, Physical Biosciences Program(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Bilateral BBSRC-NSF/BIO program Grant 1642283, U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Bio-sciences, Physical Biosciences Program Grant DE-FG02-05ER15650, and NIGMS, National Institutes of Health Grant R01 GM57498. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Deng TG, 2018, P NATL ACAD SCI USA, V115, P4678, DOI 10.1073/pnas.1714938115; Harper S, 2014, BIOCHEMISTRY-US, V53, P2966, DOI 10.1021/bi500116x; Kapadia B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03028-y; Lee EW, 2015, CELL DEATH DIFFER, V22, P1463, DOI 10.1038/cdd.2014.234; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Spiliotopoulos A, 2019, J BIOL CHEM, V294, P424, DOI 10.1074/jbc.RA118.004469; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Wu HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4214; Zhang EC, 2016, AM J CANCER RES, V6, P2901	10	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					437	438		10.1074/jbc.H118.006803	http://dx.doi.org/10.1074/jbc.H118.006803			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30635442	Green Published, hybrid			2022-12-28	WOS:000456263600005
J	Gupta, S; Sutter, M; Remesh, SG; Dominguez-Martin, MA; Bao, H; Feng, XYA; Chan, LJG; Petzold, CJ; Kerfeld, CA; Ralston, CY				Gupta, Sayan; Sutter, Markus; Remesh, Soumya G.; Dominguez-Martin, Maria Agustina; Bao, Han; Feng, Xinyu A.; Chan, Leanne-Jade G.; Petzold, Christopher J.; Kerfeld, Cheryl A.; Ralston, Corie Y.			X-ray radiolytic labeling reveals the molecular basis of orange carotenoid protein photoprotection and its interactions with fluorescence recovery protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein conformation; photosynthetic pigment; protein complex; carotenoid; mass spectrometry (MS); carotenoid chromophore; fluorescence recovery protein; orange carotenoid protein; time-resolved X-ray footprinting	CRYSTAL-STRUCTURE; HYDROGEN-BOND; WATER; IDENTIFICATION; STABILITY; STATE; FRP	In cyanobacterial photoprotection, the orange carotenoid protein (OCP) is photoactivated under excess light conditions and binds to the light-harvesting antenna, triggering the dissipation of captured light energy. In low light, the OCP relaxes to the native state, a process that is accelerated in the presence of fluorescence recovery protein (FRP). Despite the importance of the OCP in photoprotection, the precise mechanism of photoactivation by this protein is not well-understood. Using time-resolved X-ray-mediated in situ hydroxyl radical labeling, we probed real-time solvent accessibility (SA) changes at key OCP residues during photoactivation and relaxation. We observed a biphasic photoactivation process in which carotenoid migration preceded domain dissociation. We also observed a multiphasic relaxation process, with collapsed domain association preceding the final conformational rearrangement of the carotenoid. Using steady-state hydroxyl radical labeling, we identified sites of interaction between the FRP and OCP. In combination, the findings in this study provide molecular-level insights into the factors driving structural changes during OCP-mediated photoprotection in cyanobacteria, and furnish a basis for understanding the physiological relevance of the FRP-mediated relaxation process.	[Gupta, Sayan; Sutter, Markus; Remesh, Soumya G.; Feng, Xinyu A.; Kerfeld, Cheryl A.; Ralston, Corie Y.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Sutter, Markus; Kerfeld, Cheryl A.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA; [Chan, Leanne-Jade G.; Petzold, Christopher J.] Lawrence Berkeley Natl Lab, Biol Syst Div, Berkeley, CA 94720 USA; [Chan, Leanne-Jade G.; Petzold, Christopher J.] Lawrence Berkeley Natl Lab, Div Engn, Berkeley, CA 94720 USA; [Sutter, Markus; Dominguez-Martin, Maria Agustina; Bao, Han; Kerfeld, Cheryl A.] Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA; [Sutter, Markus; Dominguez-Martin, Maria Agustina; Bao, Han; Kerfeld, Cheryl A.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Michigan State University; United States Department of Energy (DOE); Michigan State University	Ralston, CY (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.; Kerfeld, CA (corresponding author), Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA.	ckerfeld@lbl.gov; cyralston@lbl.gov	; Dominguez Martin, Maria Agustina/F-3929-2016	Petzold, Christopher/0000-0002-8270-5228; Dominguez Martin, Maria Agustina/0000-0002-3500-2052; Sutter, Markus/0000-0001-6290-4820	National Institutes of Health [1R01GM126218]; Office of Science, Office of Biological and Environmental Research, of the United States DOE [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM126218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research, of the United States DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The XFMS was supported in part by National Institutes of Health Grant 1R01GM126218, and conducted at the Advanced Light Source and Joint BioEnergy Institute, supported by the Office of Science, Office of Biological and Environmental Research, of the United States DOE under contract DE-AC02-05CH11231. We acknowledge Jun Feng for experimental help at beamline 5.3.1, and Emily G. Pawlowski for assistance in purifying the OCP.	Bandara S, 2017, P NATL ACAD SCI USA, V114, P6286, DOI 10.1073/pnas.1700956114; Bao H, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.89; Berera R, 2012, J PHYS CHEM B, V116, P2568, DOI 10.1021/jp2108329; Biswal HS, 2012, J PHYS CHEM LETT, V3, P755, DOI 10.1021/jz300207k; Boulay C, 2010, P NATL ACAD SCI USA, V107, P11620, DOI 10.1073/pnas.1002912107; Breiten B, 2013, J AM CHEM SOC, V135, P15579, DOI 10.1021/ja4075776; Chakraborty D, 2015, J PHYS CHEM B, V119, P12760, DOI 10.1021/acs.jpcb.5b05791; Gupta S, 2016, J SYNCHROTRON RADIAT, V23, P1056, DOI 10.1107/S1600577516009024; Gupta S, 2015, P NATL ACAD SCI USA, V112, pE5567, DOI 10.1073/pnas.1512240112; Gupta S, 2014, NATURE, V512, P101, DOI 10.1038/nature13382; Gupta S, 2010, STRUCTURE, V18, P839, DOI 10.1016/j.str.2010.04.012; Harris D, 2016, P NATL ACAD SCI USA, V113, pE1655, DOI 10.1073/pnas.1523680113; Kerfeld CA, 2003, STRUCTURE, V11, P55, DOI 10.1016/S0969-2126(02)00936-X; Kirilovsky D, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.180, 10.1038/nplants.2016.180]; Konold PE, 2019, J AM CHEM SOC, V141, P520, DOI 10.1021/jacs.8b11373; Leonelli L, 2017, P NATL ACAD SCI USA, V114, pE7002, DOI 10.1073/pnas.1704373114; Leverenz RL, 2015, SCIENCE, V348, P1463, DOI 10.1126/science.aaa7234; Leverenz RL, 2014, PLANT CELL, V26, P426, DOI 10.1105/tpc.113.118588; Maksimov EG, 2015, BIOPHYS J, V109, P595, DOI 10.1016/j.bpj.2015.06.052; Melchionna S, 2006, BIOPHYS J, V90, P4204, DOI 10.1529/biophysj.105.078972; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niedzwiedzki DM, 2014, J PHYS CHEM B, V118, P6141, DOI 10.1021/jp5041794; Pal D, 2001, J BIOMOL STRUCT DYN, V19, P115, DOI 10.1080/07391102.2001.10506725; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reddi R, 2016, MOL BIOSYST, V12, P2408, DOI 10.1039/c6mb00259e; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shcherbakova DM, 2015, ANNU REV BIOCHEM, V84, P519, DOI 10.1146/annurev-biochem-060614-034411; Slonimskiy YB, 2018, BBA-BIOENERGETICS, V1859, P382, DOI 10.1016/j.bbabio.2018.03.001; Sluchanko NN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06195-0; Sluchanko NN, 2017, BBA-BIOENERGETICS, V1858, P1, DOI 10.1016/j.bbabio.2016.10.005; Sterpone F, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/28/284113; Sutter M, 2013, P NATL ACAD SCI USA, V110, P10022, DOI 10.1073/pnas.1303673110; Thurotte A, 2017, BBA-BIOENERGETICS, V1858, P308, DOI 10.1016/j.bbabio.2017.02.003; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Wilson A, 2010, J BIOL CHEM, V285, P18364, DOI 10.1074/jbc.M110.115709; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047	38	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8848	8860		10.1074/jbc.RA119.007592	http://dx.doi.org/10.1074/jbc.RA119.007592			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30979724	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000470971100019
J	Toledo, PL; Torkko, JM; Muller, A; Wegbrod, C; Sonmez, A; Solimena, M; Ermacora, MR				Toledo, Pamela L.; Torkko, Juha M.; Mueller, Andreas; Wegbrod, Carolin; Soenmez, Anke; Solimena, Michele; Ermacora, Mario R.			ICA512 RESP18 homology domain is a protein-condensing factor and insulin fibrillation inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; amyloid; insulin secretion; secretion; diabetes; trafficking; IA-2; ICA512; protein targeting; PTPRN; secretory granule	SECRETORY GRANULES; TARGETED DISRUPTION; MATURE ECTODOMAIN; MEMBRANE-PROTEIN; PHASE-SEPARATION; ISLET CELLS; BETA-CELLS; GLUCOSE; EXPRESSION; IA-2	Type 1 diabetes islet cell autoantigen 512 (ICA512/IA-2) is a tyrosine phosphatase-like intrinsic membrane protein involved in the biogenesis and turnover of insulin secretory granules (SGs) in pancreatic islet -cells. Whereas its membrane-proximal and cytoplasmic domains have been functionally and structurally characterized, the role of the ICA512 N-terminal segment named regulated endocrine-specific protein 18 homology domain (RESP18HD), which encompasses residues 35-131, remains largely unknown. Here, we show that ICA512 RESP18HD residues 91-131 encode for an intrinsically disordered region (IDR), which in vitro acts as a condensing factor for the reversible aggregation of insulin and other -cell proteins in a pH and Zn2+-regulated fashion. At variance with what has been shown for other granule cargoes with aggregating properties, the condensing activity of ICA512 RESP18HD is displayed at a pH close to neutral, i.e. in the pH range found in the early secretory pathway, whereas it is resolved at acidic pH and Zn2+ concentrations resembling those present in mature SGs. Moreover, we show that ICA512 RESP18HD residues 35-90, preceding the IDR, inhibit insulin fibrillation in vitro. Finally, we found that glucose-stimulated secretion of RESP18HD upon exocytosis of SGs from insulinoma INS-1 cells is associated with cleavage of its IDR, conceivably to prevent its aggregation upon exposure to neutral pH in the extracellular milieu. Taken together, these findings point to ICA512 RESP18HD being a condensing factor for protein sorting and granulogenesis early in the secretory pathway and for prevention of amyloidogenesis.	[Toledo, Pamela L.; Torkko, Juha M.; Ermacora, Mario R.] Univ Nacl Quilmes, Grp Biol Estruct & Biotecnol, RA-1876 Bernal, Buenos Aires, Argentina; [Toledo, Pamela L.; Torkko, Juha M.; Ermacora, Mario R.] Univ Nacl La Plata, CIC, CONICET, IMBICE, B1906APO, La Plata, Buenos Aires, Argentina; [Torkko, Juha M.; Mueller, Andreas; Wegbrod, Carolin; Soenmez, Anke; Solimena, Michele] Tech Univ Dresden, Univ Hosp, Dept Mol Diabetol, D-01307 Dresden, Germany; [Torkko, Juha M.; Mueller, Andreas; Wegbrod, Carolin; Soenmez, Anke; Solimena, Michele] Tech Univ Dresden, Fac Med, D-01307 Dresden, Germany; [Torkko, Juha M.; Mueller, Andreas; Wegbrod, Carolin; Soenmez, Anke; Solimena, Michele] Tech Univ Dresden, Univ Hosp, Helmholtz Ctr Munich, Paul Langerhans Inst Dresden, D-01307 Dresden, Germany; [Torkko, Juha M.; Mueller, Andreas; Wegbrod, Carolin; Soenmez, Anke; Solimena, Michele] German Ctr Diabet Res DZD eV, D-85764 Neuherberg, Germany; [Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society	Solimena, M (corresponding author), Univ Hosp & Fac Med, Dept Mol Diabetol, Fetscherstr 74, D-01326 Dresden, Germany.; Ermacora, MR (corresponding author), Univ Nacl Quilmes, Roque Saenz Pena 352, RA-1876 Bernal, Buenos Aires, Argentina.	michele.solimena@tu-dresden.de; ermacora@unq.edu.ar	Solimena, Michele/GVS-5990-2022; Müller, Andreas/GPW-6233-2022	Müller, Andreas/0000-0002-3560-5769; Ermacora, Mario/0000-0002-1754-4202	German Ministry for Education and Research (BMBF); European Union's Horizon 2020 research and innovation programme; EFPIA	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union's Horizon 2020 research and innovation programme; EFPIA	The German Center for Diabetes Research (DZD) is supported by the German Ministry for Education and Research (BMBF). The Innovative Medicines Initiative 2 Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. We thank Daniela Richter for the immunostaining of human pancreatic tissue sections; Jurgen Weitz, Marius Distler, and Nicole Radisch for the provision of surgical pancreatic specimens; Patrick Keller for antibody production at MPI-CBG; Marc Gentzel (Biotec, Dresden) for MS analysis, and Katja Pfriem for outstanding administrative assistance.	Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Arvan P, 2004, TRAFFIC, V5, P53, DOI 10.1111/j.1600-0854.2004.00152.x; Beuret N, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0347-9; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; Bystrenova E, 2018, COLLOID SURFACE B, V161, P177, DOI 10.1016/j.colsurfb.2017.10.054; Cui W, 2009, FEBS J, V276, P3365, DOI 10.1111/j.1742-4658.2009.07061.x; Dannies PS, 2012, ENDOCR REV, V33, P254, DOI 10.1210/er.2011-1002; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Dubey K, 2014, BIOCHEMISTRY-US, V53, P8001, DOI 10.1021/bi501333q; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Gilead S., 2006, ANGEW CHEM INT EDIT, V118, P6626, DOI DOI 10.1002/ANGE.200602034; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Horvath I, 2016, P NATL ACAD SCI USA, V113, P12473, DOI 10.1073/pnas.1610371113; HUTTON JC, 1984, EXPERIENTIA, V40, P1091, DOI 10.1007/BF01971456; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kanuru M, 2017, BIOCHEMISTRY-US, V56, P149, DOI 10.1021/acs.biochem.6b00660; Khmelinskii A, 2016, MOL BIOL CELL, V27, P360, DOI 10.1091/mbc.E15-07-0525; Kubosaki A, 2005, DIABETES, V54, pS46, DOI 10.2337/diabetes.54.suppl_2.S46; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Liu YM, 2009, DIABETES OBES METAB, V11, P54, DOI 10.1111/j.1463-1326.2009.01107.x; Ludwig DB, 2011, BIOTECHNOL BIOENG, V108, P2359, DOI 10.1002/bit.23188; Mawhinney MT, 2017, PROTEINS, V85, P2096, DOI 10.1002/prot.25365; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; Mziaut H, 2008, P NATL ACAD SCI USA, V105, P674, DOI 10.1073/pnas.0710931105; Mziaut H, 2016, MOL METAB, V5, P656, DOI 10.1016/j.molmet.2016.05.015; Neukam M., 2017, FLIM BASED PH MEASUR, DOI [10.1101/174391, DOI 10.1101/174391]; Nilsson MR, 2016, AMYLOID, V23, P139, DOI 10.1080/13506129.2016.1179183; Noguera Martin E., 2015, Journal of Structural and Functional Genomics, V16, P1, DOI 10.1007/s10969-014-9191-0; Noguera ME, 2013, PROTEIN PEPTIDE LETT, V20, P1009; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Primo ME, 2008, J BIOL CHEM, V283, P4674, DOI 10.1074/jbc.M708144200; Primo ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024191; Primo ME, 2006, BBA-PROTEINS PROTEOM, V1764, P174, DOI 10.1016/j.bbapap.2005.11.014; Ratha BN, 2016, J BIOL CHEM, V291, P23545, DOI 10.1074/jbc.M116.742460; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rindler MJ, 1998, J BIOL CHEM, V273, P31180, DOI 10.1074/jbc.273.47.31180; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Santos J, 2004, BIOCHEMISTRY-US, V43, P1715, DOI 10.1021/bi0358162; Schubert S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012929; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Solimena M, 2018, DIABETOLOGIA, V61, P641, DOI 10.1007/s00125-017-4500-3; Sosa L, 2016, BBA-PROTEINS PROTEOM, V1864, P511, DOI 10.1016/j.bbapap.2016.01.013; Susa AC, 2014, J AM CHEM SOC, V136, P12912, DOI 10.1021/ja504031d; Tantipolphan R, 2010, J PHARMACEUT BIOMED, V52, P195, DOI 10.1016/j.jpba.2010.01.014; Torii S, 2009, ENDOCR J, V56, P639, DOI 10.1507/endocrj.K09E-157; Torkko JM, 2015, MOL CELL BIOL, V35, P914, DOI 10.1128/MCB.00994-14; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Trajkovski M, 2008, J BIOL CHEM, V283, P33719, DOI 10.1074/jbc.M804928200; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Wang Y, 2011, P NATL ACAD SCI USA, V108, P16606, DOI 10.1073/pnas.1112241108; Wasmeier C, 1996, J BIOL CHEM, V271, P18161, DOI 10.1074/jbc.271.30.18161; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wheeler RJ, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0193; Zhang G, 2007, J ENDOCRINOL, V195, P313, DOI 10.1677/JOE-07-0252	58	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8564	8576		10.1074/jbc.RA119.007607	http://dx.doi.org/10.1074/jbc.RA119.007607			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30979722	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000471108200024
J	Johnson, T; Payne, S; Grove, R; McCarthy, S; Oeltjen, E; Mach, C; Adamec, J; Wilson, MA; Van Cott, K; Blum, P				Johnson, Tyler; Payne, Sophie; Grove, Ryan; McCarthy, Samuel; Oeltjen, Erin; Mach, Collin; Adamec, Jiri; Wilson, Mark A.; Van Cott, Kevin; Blum, Paul			Methylation deficiency of chromatin proteins is a non-mutational and epigenetic-like trait in evolved lines of the archaeon Sulfolobus solfataricus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; epigenetics; chromatin modification; protein methylation; evolution; mass spectrometry (MS)	DNA-BINDING PROTEIN; LYSINE METHYLATION; SSO7D; ACETYLATION; SAC7D; CREN7; IDENTIFICATION; FLEXIBILITY; STABILITY; MECHANISM	Archaea are a distinct and deeply rooted lineage that harbor eukaryotic-like mechanisms, including several that manage chromosome function. In previous work, the thermoacidophilic crenarchaeon, Sulfolobus solfataricus, was subjected to adaptive laboratory evolution to produce three strains, called SARC, with a new heritable trait of super acid resistance. These strains acquired heritable conserved transcriptomes, yet one strain contained no mutations. Homologous recombination without allele replacement at SARC acid resistance genes caused changes in both phenotype and expression of the targeted gene. As recombination displaces chromatin proteins, their involvement was predicted in the SARC trait. Native chromatin proteins are basic and highly abundant and undergo post-translational modification through lysine monomethylation. In this work, their modification states were investigated. In all SARC lines, two chromatin proteins, Cren7 and Sso7d, were consistently undermethylated, whereas other chromatin proteins were unaltered. This pattern was heritable in the absence of selection and independent of transient exposure to acid stress. The bulk of Sso7d was undermethylated at three contiguous N-terminal lysine residues but not at central or C-terminal regions. The N-terminal region formed a solvent-exposed patch located on the opposite side of the binding domain associated with the DNA minor groove. By analogy to eukaryotic histones, this patch could interact with other chromosomal proteins and be modulated by differential post-translational modification. Previous work established an epigenetic-like mechanism of adaptation and inheritance in S. solfataricus. The identification of heritable epigenetic marks in this work further supports the occurrence of an epigenetic process in archaea.	[Johnson, Tyler; Payne, Sophie; McCarthy, Samuel; Oeltjen, Erin; Mach, Collin; Blum, Paul] Univ Nebraska, Sch Biol Sci, Beadle Ctr Genet, Lincoln, NE 68588 USA; [Grove, Ryan; Adamec, Jiri; Wilson, Mark A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Grove, Ryan; Adamec, Jiri; Wilson, Mark A.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Van Cott, Kevin] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA; [Blum, Paul] Univ Calif Santa Cruz, Dept Microbiol & Toxicol, Santa Cruz, CA 95064 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of California System; University of California Santa Cruz	Blum, P (corresponding author), Univ Nebraska, Sch Biol Sci, Beadle Ctr Genet E234, 1901 Vine St, Lincoln, NE 68588 USA.	pblum1@unl.edu			National Science Foundation [MCB-1517408]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-1517408 (to P. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; BAUMANN H, 1994, NAT STRUCT BIOL, V1, P808, DOI 10.1038/nsb1194-808; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Biyani K, 2005, BIOCHEMISTRY-US, V44, P14217, DOI 10.1021/bi051266r; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; CHOLI T, 1988, BIOCHIM BIOPHYS ACTA, V950, P193, DOI 10.1016/0167-4781(88)90011-5; Chu YD, 2012, J BACTERIOL, V194, P6917, DOI 10.1128/JB.01535-12; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cleynen I, 2008, INT J ONCOL, V32, P289; Couturier M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00137; Cubonova L, 2005, J BACTERIOL, V187, P5482, DOI 10.1128/JB.187.15.5482-5485.2005; Dijk J., 1986, BACTERIAL CHROMATIN, P184; EDMONDSON SP, 1995, BIOCHEMISTRY-US, V34, P13289, DOI 10.1021/bi00041a004; Edmondson SP, 2001, METHOD ENZYMOL, V334, P129; Feng YG, 2010, PROTEIN SCI, V19, P1253, DOI 10.1002/pro.385; Forbes AJ, 2004, P NATL ACAD SCI USA, V101, P2678, DOI 10.1073/pnas.0306575101; Frasca F, 2006, CANCER RES, V66, P2980, DOI 10.1158/0008-5472.CAN-05-2637; Guagliardi A, 2000, J BIOL CHEM, V275, P31813, DOI 10.1074/jbc.M002122200; Guo L, 2008, NUCLEIC ACIDS RES, V36, P1129, DOI 10.1093/nar/gkm1128; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Kahsai MA, 2005, BIOCHEMISTRY-US, V44, P2822, DOI 10.1021/bi047669t; KUBINYI H, 1991, ANAL CHIM ACTA, V247, P107, DOI 10.1016/S0003-2670(00)83059-7; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Lundback T, 1998, J MOL BIOL, V276, P775, DOI 10.1006/jmbi.1997.1558; Marino-Ramirez L, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar048; McCarthy S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00549-15; McCarthy S, 2016, APPL ENVIRON MICROB, V82, P857, DOI 10.1128/AEM.03225-15; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Najima Y, 2005, J BIOL CHEM, V280, P27523, DOI 10.1074/jbc.M414549200; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Payne S, 2018, P NATL ACAD SCI USA, V115, P12271, DOI 10.1073/pnas.1808221115; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; ROLFSMEIER M, 1995, J BACTERIOL, V177, P482, DOI 10.1128/jb.177.2.482-485.1995; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; STERNER R, 1979, J BIOL CHEM, V254, P1577; Sun F, 2013, NUCLEIC ACIDS RES, V41, P8182, DOI 10.1093/nar/gkt588; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Teale MJ, 2003, ACTA CRYSTALLOGR D, V59, P1320, DOI 10.1107/S090744490301062X; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; White MF, 2002, TRENDS GENET, V18, P621, DOI 10.1016/S0168-9525(02)02808-1; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Zhang JY, 2009, NUCLEIC ACIDS RES, V37, P1107, DOI 10.1093/nar/gkn1011; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang QC, 2010, BBA-GENE REGUL MECH, V1799, P28, DOI 10.1016/j.bbagrm.2009.11.009; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhang ZF, 2010, MOL MICROBIOL, V76, P749, DOI 10.1111/j.1365-2958.2010.07136.x; ZINDER SH, 1978, NATURE, V273, P226, DOI 10.1038/273226a0	56	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7821	7832		10.1074/jbc.RA118.006469	http://dx.doi.org/10.1074/jbc.RA118.006469			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30918025	Green Published, hybrid			2022-12-28	WOS:000470153300024
J	Lyon, YA; Collier, MP; Riggs, DL; Degiacomi, MT; Benesch, JLP; Julian, RR				Lyon, Yana A.; Collier, Miranda P.; Riggs, Dylan L.; Degiacomi, Matteo T.; Benesch, Justin L. P.; Julian, Ryan R.			Structural and functional consequences of age-related isomerization in alpha-crystallins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; mass spectrometry (MS); radical; chaperone; protein structure; protein self-assembly; protein phosphorylation; protein chemical modification; molecular dynamics; epimer	HEAT-SHOCK-PROTEIN; B-CRYSTALLIN; QUATERNARY STRUCTURE; CHAPERONE ACTIVITY; ASPARTYL RESIDUES; MASS-SPECTROMETRY; SUBUNIT EXCHANGE; BETA-CRYSTALLIN; CRYAB MUTATION; PHOSPHORYLATION	Long-lived proteins are subject to spontaneous degradation and may accumulate a range of modifications over time, including subtle alterations such as side-chain isomerization. Recently, tandem MS has enabled identification and characterization of such peptide isomers, including those differing only in chirality. However, the structural and functional consequences of these perturbations remain largely unexplored. Here, we examined the impact of isomerization of aspartic acid or epimerization of serine at four sites mapping to crucial oligomeric interfaces in human A- and B-crystallin, the most abundant chaperone proteins in the eye lens. To characterize the effect of isomerization on quaternary assembly, we utilized synthetic peptide mimics, enzyme assays, molecular dynamics calculations, and native MS experiments. The oligomerization of recombinant forms of A- and B-crystallin that mimic isomerized residues deviated from native behavior in all cases. Isomerization also perturbs recognition of peptide substrates, either enhancing or inhibiting kinase activity. Specifically, epimerization of serine (ASer-162) dramatically weakened inter-subunit binding. Furthermore, phosphorylation of BSer-59, known to play an important regulatory role in oligomerization, was severely inhibited by serine epimerization and altered by isomerization of nearby BAsp-62. Similarly, isomerization of BAsp-109 disrupted a vital salt bridge with BArg-120, a contact that when broken has previously been shown to yield aberrant oligomerization and aggregation in several disease-associated variants. Our results illustrate how isomerization of amino acid residues, which may seem to be only a minor structural perturbation, can disrupt native structural interactions with profound consequences for protein assembly and activity.	[Lyon, Yana A.; Riggs, Dylan L.; Julian, Ryan R.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Collier, Miranda P.; Benesch, Justin L. P.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, South Parks Rd, Oxford OX1 3QZ, England; [Degiacomi, Matteo T.] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England	University of California System; University of California Riverside; University of Oxford; Durham University	Julian, RR (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.; Benesch, JLP (corresponding author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, South Parks Rd, Oxford OX1 3QZ, England.	justin.benesch@chem.ox.ac.uk; ryan.julian@ucr.edu	Julian, Ryan/AAE-9781-2020; Degiacomi, Matteo/M-4342-2017	Degiacomi, Matteo/0000-0003-4672-471X; Julian, Ryan/0000-0003-1580-8355	National Institutes of Health from NIGMS [R01GM107099]; Oxford University Press Clarendon Award; Engineering and Physical Sciences Research Council [EP/P016499/1, EP/J01835X/1]; BBSRC [BB/J018082/1] Funding Source: UKRI; EPSRC [EP/J01835X/1, EP/P016499/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107099] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oxford University Press Clarendon Award; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM107099 from NIGMS (to R.R.J.), Oxford University Press Clarendon Award (to M.P.C.), and Engineering and Physical Sciences Research Council Grants EP/P016499/1 (to M.T.D.) and EP/J01835X/1 (to J.L.P.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad MF, 2008, J MOL BIOL, V375, P1040, DOI 10.1016/j.jmb.2007.11.019; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Bakthisaran R, 2016, BBA-GEN SUBJECTS, V1860, P167, DOI 10.1016/j.bbagen.2015.09.017; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Boelens WC, 2014, PROG BIOPHYS MOL BIO, V115, P3, DOI 10.1016/j.pbiomolbio.2014.02.005; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Brodehl A, 2017, HUM MUTAT, V38, P947, DOI 10.1002/humu.23248; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Catterall JB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2675; Chandler SA, 2018, CURR OPIN CHEM BIOL, V42, P130, DOI 10.1016/j.cbpa.2017.11.019; Ciano M, 2016, BIOCHEM BIOPH RES CO, V479, P325, DOI 10.1016/j.bbrc.2016.09.071; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Clark AR, 2012, INT J BIOCHEM CELL B, V44, P1687, DOI 10.1016/j.biocel.2012.02.015; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; El-Hawiet A, 2010, J AM SOC MASS SPECTR, V21, P1893, DOI 10.1016/j.jasms.2010.07.008; Fichna JP, 2017, BBA CLIN, V7, P1, DOI 10.1016/j.bbacli.2016.11.004; Fujii N, 2016, BBA-GEN SUBJECTS, V1860, P183, DOI 10.1016/j.bbagen.2015.08.001; GEIGER T, 1987, J BIOL CHEM, V262, P785; Grey AC, 2008, MOL VIS, V14, P171; Haslbeck M, 2016, BBA-GEN SUBJECTS, V1860, P149, DOI 10.1016/j.bbagen.2015.06.008; Hilton GR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0405; Hochberg GKA, 2014, PROG BIOPHYS MOL BIO, V115, P11, DOI 10.1016/j.pbiomolbio.2014.03.003; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Hooi MYS, 2013, PROTEIN SCI, V22, P93, DOI 10.1002/pro.2191; Hooi MYS, 2011, AGE, V33, P131, DOI 10.1007/s11357-010-9171-7; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1999, EYE, V13, P403, DOI 10.1038/eye.1999.114; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; IWAKI T, 1992, AM J PATHOL, V140, P345; Jansson ET, 2018, J SEP SCI, V41, P385, DOI 10.1002/jssc.201700852; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Kato K, 1998, J BIOL CHEM, V273, P28346, DOI 10.1074/jbc.273.43.28346; Kato K, 2001, J NEUROCHEM, V76, P730, DOI 10.1046/j.1471-4159.2001.00038.x; Kondrat Frances D L, 2015, Methods Mol Biol, V1261, P349, DOI 10.1007/978-1-4939-2230-7_18; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Li HL, 2017, ANAL CHEM, V89, P2731, DOI 10.1021/acs.analchem.6b02377; Li RY, 2011, J NEUROCHEM, V118, P354, DOI 10.1111/j.1471-4159.2011.07317.x; Lyon YA, 2018, EXP EYE RES, V171, P131, DOI 10.1016/j.exer.2018.03.018; Lyon YA, 2017, J PROTEOME RES, V16, P1797, DOI 10.1021/acs.jproteome.7b00073; Maddala R, 2005, EXP CELL RES, V306, P203, DOI 10.1016/j.yexcr.2005.01.026; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mainz A, 2012, J BIOL CHEM, V287, P1128, DOI 10.1074/jbc.M111.309047; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; MASTERS PM, 1978, P NATL ACAD SCI USA, V75, P1204, DOI 10.1073/pnas.75.3.1204; MCFADDEN PN, 1987, ARCH BIOCHEM BIOPHYS, V259, P227, DOI 10.1016/0003-9861(87)90490-5; Michiel M, 2009, BIOCHEMISTRY-US, V48, P442, DOI 10.1021/bi8014967; Ni WQ, 2010, ANAL CHEM, V82, P7485, DOI 10.1021/ac101806e; Noguchi S, 1998, J MOL BIOL, V278, P231, DOI 10.1006/jmbi.1998.1674; Noguchi S, 2010, BIOPOLYMERS, V93, P1003, DOI 10.1002/bip.21514; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qin ZX, 2015, NEUROBIOL AGING, V36, P1029, DOI 10.1016/j.neurobiolaging.2014.10.036; Rehder DS, 2008, BIOCHEMISTRY-US, V47, P2518, DOI 10.1021/bi7018223; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Riggs DL, 2017, ACS CHEM BIOL, V12, P2875, DOI 10.1021/acschembio.7b00686; Rose RJ, 2012, NAT METHODS, V9, P1084, DOI [10.1038/NMETH.2208, 10.1038/nmeth.2208]; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Takata T, 2016, FEBS J, V283, P850, DOI 10.1111/febs.13635; Tao YQ, 2014, ANAL CHEM, V86, P9733, DOI 10.1021/ac502296c; Tardieu A, 1998, INT J BIOL MACROMOL, V22, P211, DOI 10.1016/S0141-8130(98)00018-X; Truscott RJW, 2016, TRENDS BIOCHEM SCI, V41, P654, DOI 10.1016/j.tibs.2016.06.004; Truscott RJW, 2016, BBA-GEN SUBJECTS, V1860, P192, DOI 10.1016/j.bbagen.2015.08.016; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Yamamoto A, 1998, J NEUROSCI, V18, P2063; ZIGLER JS, 1981, TRENDS BIOCHEM SCI, V6, P133	72	20	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7546	7555		10.1074/jbc.RA118.007052	http://dx.doi.org/10.1074/jbc.RA118.007052			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30804217	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-28	WOS:000470153300002
J	Segawa, K; Tamura, N; Mima, J				Segawa, Kazuya; Tamura, Naoki; Mima, Joji			Homotypic and heterotypic trans-assembly of human Rab-family small GTPases in reconstituted membrane tethering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane reconstitution; membrane trafficking; Rab; small GTPase; liposome; endomembrane system; membrane tethering; RAB member RAS oncogene family; Ras superfamily; transport vesicle	FUSION; SPECIFICITY; PROTEINS; DOCKING; SNARES; ARF	Membrane tethering is a highly regulated event occurring during the initial physical contact between membrane-bounded transport carriers and their target subcellular membrane compartments, thereby ensuring the spatiotemporal specificity of intracellular membrane trafficking. Although Rab-family small GTPases and specific Rab-interacting effectors, such as coiled-coil tethering proteins and multisubunit tethering complexes, are known to be involved in membrane tethering, how these protein components directly act upon the tethering event remains enigmatic. Here, using a chemically defined reconstitution system, we investigated the molecular basis of membrane tethering by comprehensively and quantitatively evaluating the intrinsic capacities of 10 representative human Rab-family proteins (Rab1a, -3a, -4a, -5a, -6a, -7a, -9a, -11a, -27a, and -33b) to physically tether two distinct membranes via homotypic and heterotypic Rab-Rab assembly. All of the Rabs tested, except Rab27a, specifically caused homotypic membrane tethering at physiologically relevant Rab densities on membrane surfaces (e.g. Rab/lipid molar ratios of 1:100-1:3,000). Notably, endosomal Rab5a retained its intrinsic potency to drive efficient homotypic tethering even at concentrations below the Rab/lipid ratio of 1:3,000. Comprehensive reconstitution experiments further uncovered that heterotypic combinations of human Rab-family isoforms, including Rab1a/6a, Rab1a/9a, and Rab1a/33b, can directly and selectively mediate membrane tethering. Rab1a and Rab9a in particular synergistically triggered very rapid and efficient membrane tethering reactions through their heterotypic trans-assembly on two opposing membranes. In conclusion, our findings establish that, in the physiological context, homotypic and heterotypic trans-assemblies of Rab-family small GTPases can provide the essential molecular machinery necessary to drive membrane tethering in eukaryotic endomembrane systems.	[Segawa, Kazuya; Tamura, Naoki; Mima, Joji] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Mima, J (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	joji.mima@protein.osaka-u.ac.jp		Mima, Joji/0000-0002-0454-8669	Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT); MEXT	Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT) and Grants-in-Aid for Scientific Research from MEXT (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunet S, 2014, TRAFFIC, V15, P1282, DOI 10.1111/tra.12200; Chia Pei Zhi Cheryl, 2014, F1000Prime Rep, V6, P74, DOI 10.12703/P6-74; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Furukawa N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04277; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hernandez JM, 2014, P NATL ACAD SCI USA, V111, P12037, DOI 10.1073/pnas.1407435111; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Ho RY, 2016, TRAFFIC, V17, P1078, DOI 10.1111/tra.12421; Ho RY, 2015, MOL BIOL CELL, V26, P2655, DOI 10.1091/mbc.E14-04-0922; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Inoshita M, 2017, J BIOL CHEM, V292, P18500, DOI 10.1074/jbc.M117.811356; Izawa R, 2012, J BIOL CHEM, V287, P3445, DOI 10.1074/jbc.M111.307439; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Ji H, 2010, BIOPHYS J, V99, P553, DOI 10.1016/j.bpj.2010.04.060; Khan AR, 2013, STRUCTURE, V21, P1284, DOI 10.1016/j.str.2013.06.016; Kuhlee A, 2015, FEBS LETT, V589, P2487, DOI 10.1016/j.febslet.2015.06.001; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mima Joji, 2018, Biophys Rev, V10, P543, DOI 10.1007/s12551-017-0358-3; MOORE I, 1995, TRENDS BIOCHEM SCI, V20, P10, DOI 10.1016/S0968-0004(00)88939-2; Murray DH, 2016, NATURE, V537, P107, DOI 10.1038/nature19326; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Pylypenko Olena, 2018, Small GTPases, V9, P22, DOI 10.1080/21541248.2017.1336191; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tamura N, 2014, BIOL OPEN, V3, P1108, DOI 10.1242/bio.20149340; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Waters MG, 2000, TRAFFIC, V1, P588, DOI 10.1034/j.1600-0854.2000.010802.x; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.01879	44	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7722	7739		10.1074/jbc.RA119.007947	http://dx.doi.org/10.1074/jbc.RA119.007947			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30910814	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000470153300017
J	Kermani, AA; Roy, R; Gopalasingam, C; Kocurek, KI; Patel, TR; Alderwick, LJ; Besra, GS; Futterer, K				Kermani, Ali A.; Roy, Rana; Gopalasingam, Chai; Kocurek, Klaudia I.; Patel, Trushar R.; Alderwick, Luke J.; Besra, Gurdyal S.; Fuetterer, Klaus			Crystal structure of the TreS:Pep2 complex, initiating -glucan synthesis in the GlgE pathway of mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; analytical ultracentrifugation; X-ray crystallography; trehalose; enzyme catalysis; protein complex; pathogenesis; -glucan; capsule; immune evasion; maltose kinase; trehalose synthase	ALPHA-GLUCAN; PROTEIN INTERACTIONS; TREHALOSE; TUBERCULOSIS; GLYCOGEN; BIOSYNTHESIS; SPECIFICITY; REFINEMENT	A growing body of evidence implicates the mycobacterial capsule, the outermost layer of the mycobacterial cell envelope, in modulation of the host immune response and virulence of mycobacteria. Mycobacteria synthesize the dominant capsule component, (14)-linked glucan, via three interconnected and potentially redundant metabolic pathways. Here, we report the crystal structure of the Mycobacterium smegmatis TreS:Pep2 complex, containing trehalose synthase (TreS) and maltokinase (Pep2), which converts trehalose to maltose 1-phosphate as part of the TreS:Pep2-GlgE pathway. The structure, at 3.6 angstrom resolution, revealed that a diamond-shaped TreS tetramer forms the core of the complex and that pairs of Pep2 monomers bind to opposite apices of the tetramer in a 4 + 4 configuration. However, for the M. smegmatis orthologues, results from isothermal titration calorimetry and analytical ultracentrifugation experiments indicated that the prevalent stoichiometry in solution is 4 TreS + 2 Pep2 protomers. The observed discrepancy between the crystallized complex and the behavior in the solution state may be explained by the relatively weak affinity of Pep2 for TreS (K-d 3.5 m at mildly acidic pH) and crystal packing favoring the 4 + 4 complex. Proximity of the ATP-binding site in Pep2 to the complex interface provides a rational basis for rate enhancement of Pep2 upon binding to TreS, but the complex structure appears to rule out substrate channeling between the active sites of TreS and Pep2. Our findings provide a structural model for the trehalose synthase:maltokinase complex in M. smegmatis that offers critical insights into capsule assembly.	[Kermani, Ali A.; Roy, Rana; Gopalasingam, Chai; Kocurek, Klaudia I.; Patel, Trushar R.; Alderwick, Luke J.; Besra, Gurdyal S.; Fuetterer, Klaus] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Kermani, Ali A.] Univ Michigan, Dept Mol Cellular & Dev Biol, 930 N Univ Ave, Ann Arbor, MI 48109 USA; [Patel, Trushar R.] Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, 4401 Univ Dr West, Lethbridge, AB T1K 3M4, Canada	University of Birmingham; University of Michigan System; University of Michigan; University of Lethbridge	Besra, GS; Futterer, K (corresponding author), Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.	G.Besra@bham.ac.uk; k.futterer@bham.ac.uk	Patel, Trushar/F-2776-2011	Patel, Trushar/0000-0003-0627-2923; Kermani, Ali Asghar/0000-0002-4994-9730; Futterer, Klaus/0000-0001-7445-5372; Besra, Gurdyal/0000-0002-5605-0395; Kocurek, Klaudia Izabela/0000-0003-2911-5971; Alderwick, Luke/0000-0002-1257-6053	Medical Research Council [MR/K012118/1, MR/S000542/1]; Wellcome Trust [084923/B/08/Z]; MRC [MR/S000542/1, MR/K012118/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Medical Research Council Grants MR/K012118/1 and MR/S000542/1 and by Wellcome Trust Grant 084923/B/08/Z. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bianchetti CM, 2013, J MOL BIOL, V425, P4267, DOI 10.1016/j.jmb.2013.05.030; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; Caner S, 2013, GLYCOBIOLOGY, V23, P1075, DOI 10.1093/glycob/cwt044; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; De Smet KAL, 2000, MICROBIOL-UK, V146, P199, DOI 10.1099/00221287-146-1-199; Dinadayala P, 2008, GLYCOBIOLOGY, V18, P502, DOI 10.1093/glycob/cwn031; Ehrt S, 2014, CURR TOP MICROBIOL, V374, P163, DOI 10.1007/82_2012_299; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fraga J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08026; Garg SK, 2007, PROTEIN EXPRES PURIF, V51, P198, DOI 10.1016/j.pep.2006.08.005; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalscheuer R, 2010, DRUG NEWS PERSPECT, V23, P619, DOI 10.1358/dnp.2010.23.10.1534855; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Koliwer-Brandl H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005768; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ku SY, 2007, J BIOL CHEM, V282, P22195, DOI 10.1074/jbc.M611045200; Li J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06418; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendes V, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-21; Romero MM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-262; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Roy R, 2013, ACS CHEM BIOL, V8, P2245, DOI 10.1021/cb400508k; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sambrook J., 1987, MOL CLONING LAB MANU; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Smith CA, 2012, J BIOL CHEM, V287, P12893, DOI 10.1074/jbc.M112.341206; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stadthagen G, 2007, J BIOL CHEM, V282, P27270, DOI 10.1074/jbc.M702676200; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]	39	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7348	7359		10.1074/jbc.RA118.004297	http://dx.doi.org/10.1074/jbc.RA118.004297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877199	Green Published, hybrid			2022-12-28	WOS:000468402900022
J	Das, A; Narayanam, MK; Paul, S; Mukhnerjee, P; Ghosh, S; Dastidar, DG; Chakrabarty, S; Ganguli, A; Basu, B; Pal, M; Chatterji, U; Banerjee, SK; Karmakar, P; Kumar, D; Chakrabarti, G				Das, Amlan; Narayanam, Maruthi Kumar; Paul, Santanu; Mukhnerjee, Pritha; Ghosh, Suvranil; Dastidar, Debabrata Ghosh; Chakrabarty, Subhendu; Ganguli, Arnab; Basu, Biswarup; Pal, Mahadeb; Chatterji, Urmi; Banerjee, Sushanta K.; Karmakar, Parimal; Kumar, Dalip; Chakrabarti, Gopal			A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting -secretase-mediated activation of Notch signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; -secretase; autophagy; apoptosis; drug design; triazole	IN-VITRO PROPAGATION; THERAPEUTIC TARGET; STEM-CELLS; APOPTOSIS; PATHWAY; EXPRESSION; IDENTIFICATION; ANTICANCER; RESISTANCE; POPULATION	Notch signaling is reported to be deregulated in several malignancies, including breast, and the enzyme -secretase plays an important role in the activation and nuclear translocation of Notch intracellular domain (NICD). Hence, pharmacological inhibition of -secretase might lead to the subsequent inhibition of Notch signaling in cancer cells. In search of novel -secretase inhibitors (GSIs), we screened a series of triazole-based compounds for their potential to bind -secretase and observed that 3-(34,5-trimethoxyphenyl)-5-(N-methyl-3-indolyl)-1,2,4-triazole compound (also known as NMK-T-057) can bind to -secretase complex. Very interestingly, NMK-T-057 was found to inhibit proliferation, colony-forming ability, and motility in various breast cancer (BC) cells such as MDA-MB-231, MDA-MB-468, 4T1 (triple-negative cells), and MCF-7 (estrogen receptor (ER)/progesterone receptor (PR)-positive cell line) with negligible cytotoxicity against noncancerous cells (MCF-10A and peripheral blood mononuclear cells). Furthermore, significant induction of apoptosis and inhibition of epithelial-to-mesenchymal transition (EMT) and stemness were also observed in NMK-T-057-treated BC cells. The in silico study revealing the affinity of NMK-T-057 toward -secretase was further validated by a fluorescence-based -secretase activity assay, which confirmed inhibition of -secretase activity in NMK-T-057-treated BC cells. Interestingly, it was observed that NMK-T-057 induced significant autophagic responses in BC cells, which led to apoptosis. Moreover, NMK-T-057 was found to inhibit tumor progression in a 4T1-BALB/c mouse model. Hence, it may be concluded that NMK-T-057 could be a potential drug candidate against BC that can trigger autophagy-mediated cell death by inhibiting -secretase-mediated activation of Notch signaling.	[Das, Amlan; Paul, Santanu; Dastidar, Debabrata Ghosh; Chakrabarty, Subhendu; Ganguli, Arnab; Chakrabarti, Gopal] Univ Calcutta, Dept Biotechnol, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India; [Das, Amlan; Paul, Santanu; Dastidar, Debabrata Ghosh; Chakrabarty, Subhendu; Ganguli, Arnab; Chakrabarti, Gopal] Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India; [Mukhnerjee, Pritha; Chatterji, Urmi] Univ Calcutta, Dept Zool, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India; [Das, Amlan] Natl Inst Technol, Dept Chem, Ravangla 737139, South Sikkim, India; [Narayanam, Maruthi Kumar; Kumar, Dalip] Birla Inst Technol & Sci, Dept Chem, Pilani 333031, Rajasthan, India; [Ghosh, Suvranil; Pal, Mahadeb] Bose Inst, Div Mol Med, P-1-12,CIT Rd,Scheme VIIM, Kolkata 700054, W Bengal, India; [Dastidar, Debabrata Ghosh] Guru Nanak Inst Pharmaceut Sci & Technol, Div Pharmaceut, 157-F Nilgunj Rd, Kolkata 700114, W Bengal, India; [Basu, Biswarup] Chittaranjan Natl Canc Inst, Dept Expt Hematol & Neuroendocrinol, 37 Shyama Prasad Mukherjee Rd, Kolkata 700026, W Bengal, India; [Banerjee, Sushanta K.] Vet Affairs Med Ctr, Canc Res Unit, Kansas City, MO 64128 USA; [Banerjee, Sushanta K.] Univ Kansas, Dept Anat, Med Ctr, Kansas City, KS 66160 USA; [Banerjee, Sushanta K.] Univ Kansas, Dept Cell Biol & Pathol, Med Ctr, Kansas City, KS 66160 USA; [Narayanam, Maruthi Kumar] UCLA, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Narayanam, Maruthi Kumar] UCLA, David Geffen Sch Med, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; [Karmakar, Parimal] Jadavpur Univ, Dept Life Sci & Biotechnol, 188 Raja SC Mullick Rd, Kolkata 700032, Western Bengal, India	University of Calcutta; University of Calcutta; University of Calcutta; Birla Institute of Technology & Science Pilani (BITS Pilani); Department of Science & Technology (India); Bose Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Jadavpur University	Das, A; Chakrabarti, G (corresponding author), Univ Calcutta, Dept Biotechnol, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India.; Das, A; Chakrabarti, G (corresponding author), Univ Calcutta, Dr BC Guha Ctr Genet Engn & Biotechnol, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India.; Das, A (corresponding author), Natl Inst Technol, Dept Chem, Ravangla 737139, South Sikkim, India.; Kumar, D (corresponding author), Birla Inst Technol & Sci, Dept Chem, Pilani 333031, Rajasthan, India.	adas1980@nitsikkim.ac.in; dalipk@pilani.bits-pilani.ac.in; gcbcg@caluniv.ac.in	Narayanam, Maruthi Kumar/F-8726-2011; Ganguli, Arnab/AAO-8635-2020; Dastidar, D.G/AAF-2784-2020; Banerjee, Sushanta/AAG-6534-2021; Basu, Biswarup/ABD-3331-2020; Das, Amlan/HHC-0898-2022	Narayanam, Maruthi Kumar/0000-0001-8612-5602; Ganguli, Arnab/0000-0001-9939-027X; Dastidar, D.G/0000-0002-4762-7295; Basu, Biswarup/0000-0002-5417-2735; Das, Amlan/0000-0002-9295-3743; Banerjee, Sushanta/0000-0002-7698-0717; GHOSH, SUVRANIL/0000-0002-0003-349X	University with Potential for Excellence (UPE)-II grant from the Government of India; Dr. D. S. Kothari Postdoctoral Fellowship (DSKPDF) [BL/15-16/0193]; University Grants Commission, Government of India [F.42/2006 (BSR)/BL/1617/0351]	University with Potential for Excellence (UPE)-II grant from the Government of India; Dr. D. S. Kothari Postdoctoral Fellowship (DSKPDF); University Grants Commission, Government of India(University Grants Commission, India)	This work was partially supported by a University with Potential for Excellence (UPE)-II grant from the Government of India (to G.C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Dr. D. S. Kothari Postdoctoral Fellowship (DSKPDF) BL/15-16/0193 and Fellowship F.42/2006 (BSR)/BL/1617/0351 from the University Grants Commission, Government of India.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hussaini H, 2011, MOL CANCER THER, V10, P9, DOI 10.1158/1535-7163.MCT-10-0677; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Azzam DJ, 2013, EMBO MOL MED, V5, P1502, DOI 10.1002/emmm.201302558; Balko JM, 2012, NAT MED, V18, P1052, DOI 10.1038/nm.2795; Bhoopathi P, 2010, CELL DEATH DIFFER, V17, P1529, DOI 10.1038/cdd.2010.28; Bolos V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3447; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Boyle ST, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0592-0; Chaabane W, 2013, ARCH IMMUNOL THER EX, V61, P43, DOI 10.1007/s00005-012-0205-y; Chatterjee A, 2017, J CELL BIOCHEM, V118, P3796, DOI 10.1002/jcb.26029; Chen Q, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0018-5; Cho S, 2011, P NATL ACAD SCI USA, V108, P20778, DOI 10.1073/pnas.1019452108; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Cui J, 2018, INT J CANCER, V143, P645, DOI 10.1002/ijc.31346; Dai G, 2019, MOL CARCINOGEN, V58, P3, DOI 10.1002/mc.22873; Alves FRD, 2009, MINI-REV MED CHEM, V9, P782, DOI 10.2174/138955709788452649; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Efferson CL, 2010, CANCER RES, V70, P2476, DOI 10.1158/0008-5472.CAN-09-3114; Espinoza I, 2013, CANCER LETT, V341, P41, DOI 10.1016/j.canlet.2013.08.027; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ganguli A, 2016, FOOD CHEM TOXICOL, V90, P160, DOI 10.1016/j.fct.2016.02.011; Genc M, 2016, ACTA CHIM SLOV, V63, P726, DOI 10.17344/acsi.2016.2428; Ghoncheh Mahshid, 2016, Asian Pac J Cancer Prev, V17, P47; Ghosh A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198143; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gupta S, 2015, J BIOL CHEM, V290, P31051, DOI 10.1074/jbc.M115.670182; Gupta S, 2016, SOUTH ASIAN J CANCER, V5, P85, DOI 10.4103/2278-330X.187552; Hage S, 2014, NEURODEGENER DIS, V14, P39, DOI 10.1159/000355557; Haque I, 2012, J BIOL CHEM, V287, P38569, DOI 10.1074/jbc.M112.389064; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Jin JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep27871; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Kumar D, 2011, CHEM BIOL DRUG DES, V77, P182, DOI 10.1111/j.1747-0285.2010.01051.x; Liu WF, 2017, ONCOTARGETS THER, V10, DOI 10.2147/OTT.S117250; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Lohberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043664; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mao L, 2018, INT J CANCER, V142, P999, DOI 10.1002/ijc.31115; McGowan PM, 2011, MOL CANCER RES, V9, P834, DOI 10.1158/1541-7786.MCR-10-0457; Meurette O, 2009, CANCER RES, V69, P5015, DOI 10.1158/0008-5472.CAN-08-3478; Mioc M, 2017, INT J ONCOL, V50, P1175, DOI 10.3892/ijo.2017.3912; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mukherjee P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08971-2; Pal D, 2017, MOL CARCINOGEN, V56, P1127, DOI 10.1002/mc.22579; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rakha EA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1827; Ranjan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26165; Ray A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137614; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Schott AF, 2013, CLIN CANCER RES, V19, P1512, DOI 10.1158/1078-0432.CCR-11-3326; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sriuranpong V, 2001, CANCER RES, V61, P3200; Strickley RG, 2004, PHARM RES-DORDR, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Su F, 2016, ONCOTARGET, V7, P4142, DOI 10.18632/oncotarget.6769; Suman S, 2013, BRIT J CANCER, V109, P2587, DOI 10.1038/bjc.2013.642; Sztanke K, 2008, EUR J MED CHEM, V43, P1085, DOI 10.1016/j.ejmech.2007.07.009; Sztanke K, 2008, EUR J MED CHEM, V43, P404, DOI 10.1016/j.ejmech.2007.03.033; Tamagnone L, 2018, MOLECULES, V23, DOI 10.3390/molecules23020431; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Wang Y, 2018, J CELL BIOCHEM, V119, P5893, DOI 10.1002/jcb.26781; Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001; Wang ZW, 2008, ANTICANCER RES, V28, P3621; Wu XT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10533; Yuan X, 2015, CANCER LETT, V369, P20, DOI 10.1016/j.canlet.2015.07.048; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200; Zhong Y, 2016, ONCOTARGETS THER, V9, P6885, DOI 10.2147/OTT.S109606	77	17	17	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6733	6750		10.1074/jbc.RA119.007671	http://dx.doi.org/10.1074/jbc.RA119.007671			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30824542	Green Published, hybrid			2022-12-28	WOS:000467394700012
J	Absalom, NL; Ahring, PK; Liao, VW; Balle, T; Jiang, T; Anderson, LL; Arnold, JC; McGregor, IS; Bowen, MT; Chebib, M				Absalom, Nathan L.; Ahring, Philip K.; Liao, Vivian W.; Balle, Thomas; Jiang, Tian; Anderson, Lyndsey L.; Arnold, Jonathon C.; McGregor, Iain S.; Bowen, Michael T.; Chebib, Mary			Functional genomics of epilepsy-associated mutations in the GABA(A) receptor subunits reveal that one mutation impairs function and two are catastrophic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GABA receptor; epilepsy; channel activation; neurotransmitter; cryo-electron microscopy; brain disorder; concatemer; heterozygous; missense; synaptic transmission; neurotransmission	GABRA1; GAMMA-2-SUBUNIT; ACTIVATION; ALPHA-1	A number of epilepsy-causing mutations have recently been identified in the genes of the 1, 3, and 2 subunits comprising the -aminobutyric acid type A (GABA(A)) receptor. These mutations are typically dominant, and in certain cases, such as the 1 and 3 subunits, they may lead to a mix of receptors at the cell surface that contain no mutant subunits, a single mutated subunit, or two mutated subunits. To determine the effects of mutations in a single subunit or in two subunits on receptor activation, we created a concatenated protein assembly that links all five subunits of the 132 receptor and expresses them in the correct orientation. We created nine separate receptor variants with a single-mutant subunit and four receptors containing two subunits of the 2(R323Q), 3(D120N), 3(T157M), 3(Y302C), and 3(S254F) epilepsy-causing mutations. We found that the singly mutated 2(R323Q) subunit impairs GABA activation of the receptor by reducing GABA potency. A single 3(D120N), 3(T157M), or 3(Y302C) mutation also substantially impaired receptor activation, and two copies of these mutants within a receptor were catastrophic. Of note, an effect of the 3(S254F) mutation on GABA potency depended on the location of this mutant subunit within the receptor, possibly because of the membrane environment surrounding the transmembrane region of the receptor. Our results highlight that precise functional genomic analyses of GABA(A) receptor mutations using concatenated constructs can identify receptors with an intermediate phenotype that contribute to epileptic phenotypes and that are potential drug targets for precision medicine approaches.	[Absalom, Nathan L.; Ahring, Philip K.; Liao, Vivian W.; Balle, Thomas; Jiang, Tian; Anderson, Lyndsey L.; Arnold, Jonathon C.; McGregor, Iain S.; Bowen, Michael T.; Chebib, Mary] Univ Sydney, Brain & Mind Ctr, 94 Mallett St, Camperdown, NSW 2050, Australia; [Anderson, Lyndsey L.; Arnold, Jonathon C.; McGregor, Iain S.; Bowen, Michael T.] Univ Sydney, Lambert Initiat Cannabinoid Therapeut, 94 Mallett St, Camperdown, NSW 2050, Australia; [Absalom, Nathan L.; Ahring, Philip K.; Liao, Vivian W.; Balle, Thomas; Jiang, Tian; Chebib, Mary] Univ Sydney, Sch Pharm, Fac Med & Hlth, Camperdown, NSW 2006, Australia; [Anderson, Lyndsey L.; Arnold, Jonathon C.] Univ Sydney, Discipline Pharmacol, Fac Med & Hlth, Camperdown, NSW 2006, Australia; [McGregor, Iain S.; Bowen, Michael T.] Univ Sydney, Sch Psychol, Fac Sci, Camperdown, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Chebib, M (corresponding author), Univ Sydney, Brain & Mind Ctr, 94 Mallett St, Camperdown, NSW 2050, Australia.	mary.collins@sydney.edu.au	Arnold, Jonathon C/ACF-5231-2022; Liao, Vivian/AAD-9818-2022	Liao, Vivian/0000-0001-8608-0563; mcgregor, iain/0000-0002-9307-7159; Jiang, Tian/0000-0002-0379-6345; Arnold, Jonathon/0000-0002-0159-9997; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350	Lambert Initiative; National Health and Medical Research Council [APP1124567, APP1081733]	Lambert Initiative; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Lambert Initiative and by National Health and Medical Research Council Grants APP1124567 and APP1081733. The authors declare that they have no conflicts of interest with the contents of this article.	Absalom NL, 2004, EXP PHYSIOL, V89, P145, DOI 10.1113/expphysiol.2003.026815; Ahring PK, 2016, PHARMACOL RES, V111, P563, DOI 10.1016/j.phrs.2016.05.014; Ahring PK, 2018, J GEN PHYSIOL, V150, P453, DOI 10.1085/jgp.201711846; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Boillot M, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000035; Bouzat C, 2012, J PHYSIOL-PARIS, V106, P23, DOI 10.1016/j.jphysparis.2011.09.012; Chua HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141359; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Gallagher MJ, 2004, J NEUROSCI, V24, P5570, DOI 10.1523/JNEUROSCI.1301-04.2004; Gontika Maria P, 2017, Child Neurol Open, V4, p2329048X17706794, DOI 10.1177/2329048X17706794; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Hammer H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120239; Has ATC, 2016, SCI REP-UK, V6, DOI 10.1038/srep28674; Hernandez CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162883; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Howard MA, 2017, ANNU REV NEUROSCI, V40, P149, DOI 10.1146/annurev-neuro-072116-031250; Janve VS, 2016, ANN NEUROL, V79, P806, DOI 10.1002/ana.24631; Johannesen K, 2016, NEUROLOGY, V87, P1140, DOI 10.1212/WNL.0000000000003087; Kang JQ, 2015, NAT NEUROSCI, V18, P988, DOI 10.1038/nn.4024; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Khazipov R, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022764; Kodera H, 2016, EPILEPSIA, V57, P566, DOI 10.1111/epi.13344; Lachance-Touchette P, 2011, EUR J NEUROSCI, V34, P237, DOI 10.1111/j.1460-9568.2011.07767.x; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Liu J, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0392-5; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Moller RS, 2016, MOL SYNDROMOL, V7, P210, DOI 10.1159/000448369; Olsen RW, 2018, NEUROPHARMACOLOGY, V136, P10, DOI 10.1016/j.neuropharm.2018.01.036; Papandreou A, 2016, DEV MED CHILD NEUROL, V58, P416, DOI 10.1111/dmcn.12976; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Shen DD, 2017, BRAIN, V140, P49, DOI 10.1093/brain/aww272; Shin DJ, 2018, MOL PHARMACOL, V93, P178, DOI 10.1124/mol.117.110403; Sigel E, 2006, BIOCHEM SOC T, V34, P868, DOI 10.1042/BST0340868; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sigel E, 2009, BIOCHEM SOC T, V37, P1338, DOI 10.1042/BST0371338; Stosser MB, 2018, GENET MED, V20, P403, DOI 10.1038/gim.2017.114; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; WOOD J D, 1975, Progress in Neurobiology (Oxford), V5, P77, DOI 10.1016/0301-0082(75)90008-8	47	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6157	6171		10.1074/jbc.RA118.005697	http://dx.doi.org/10.1074/jbc.RA118.005697			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30728247	Green Published, hybrid			2022-12-28	WOS:000465077500043
J	Li, WT; Liu, WJ; Kakoki, A; Wang, RJ; Adebali, O; Jiang, YC; Sancar, A				Li, Wentao; Liu, Wenjie; Kakoki, Ayano; Wang, Rujin; Adebali, Ogun; Jiang, Yuchao; Sancar, Aziz			Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleotide excision repair; cancer stem cells; differentiation; neuron; vascular smooth muscle cells; muscle cell; neuron; nucleotide excision repair; stem cell; cell differentiation; genome stability; transcriptomics; NT2 cell; retinoic acid (RA); bone morphogenetic protein-2 (BMP-2)	TRANSCRIPTION-COUPLED REPAIR; XPC DNA-REPAIR; STEM-CELLS; UV DAMAGE; ESCHERICHIA-COLI; THYMINE DIMER; NUCLEASE; COMPLEX; GENOME; COACTIVATOR	Embryonic stem cells can self-renew and differentiate, holding great promise for regenerative medicine. They also employ multiple mechanisms to preserve the integrity of their genomes. Nucleotide excision repair, a versatile repair mechanism, removes bulky DNA adducts from the genome. However, the dynamics of the capacity of nucleotide excision repair during stem cell differentiation remain unclear. Here, using immunoslot blot assay, we measured repair rates of UV-induced DNA damage during differentiation of human embryonic carcinoma (NTERA-2) cells into neurons and muscle cells. Our results revealed that the capacity of nucleotide excision repair increases as cell differentiation progresses. We also found that inhibition of the apoptotic signaling pathway has no effect on nucleotide excision repair capacity. Furthermore, RNA-Seq-based transcriptomic analysis indicated that expression levels of four core repair factors, xeroderma pigmentosum (XP) complementation group A (XPA), XPC, XPG, and XPF-ERCC1, are progressively up-regulated during differentiation, but not those of replication protein A (RPA) and transcription factor IIH (TFIIH). Together, our findings reveal that increase of nucleotide excision repair capacity accompanies cell differentiation, supported by the up-regulated transcription of genes encoding DNA repair enzymes during differentiation of two distinct cell lineages.	[Li, Wentao; Liu, Wenjie; Kakoki, Ayano; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Liu, Wenjie] Xiamen Univ, Sch Pharmaceut Sci, Fujian Prov Key Lab Innovat Drug Target Res, Xiamen 361102, Fujian, Peoples R China; [Wang, Rujin] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27599 USA; [Jiang, Yuchao] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Jiang, Yuchao] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Adebali, Ogun] Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, TR-34956 Istanbul, Turkey	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Xiamen University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Sabanci University	Sancar, A (corresponding author), Genet Med Bldg 3073 CB 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Li, Wentao/AAU-1637-2020; Adebali, Ogun/N-4159-2016	Li, Wentao/0000-0003-2313-6384; Adebali, Ogun/0000-0001-9213-4070; Jiang, Yuchao/0000-0001-6905-6377	National Institutes of Health [GM118102, ES027255, CA142538]; UNC Lineberger Comprehensive Cancer Center developmental award [2017T109]; China Scholarship Council [201506315077]; Fundamental Research Funds of Xiamen University; EMBO - Scientific and Technological Research Council of Turkey (TUBITAK); NATIONAL CANCER INSTITUTE [P01CA142538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027255, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Lineberger Comprehensive Cancer Center developmental award; China Scholarship Council(China Scholarship Council); Fundamental Research Funds of Xiamen University; EMBO - Scientific and Technological Research Council of Turkey (TUBITAK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118102 and ES027255 (to A. S.) and CA142538 (to Y. J.) and UNC Lineberger Comprehensive Cancer Center developmental award 2017T109 (to Y. J.). This work was also supported by the Financial Funds of China Scholarship Council (201506315077) and the Fundamental Research Funds of Xiamen University (to W. Liu) and by EMBO Installation Grant Award funded by the Scientific and Technological Research Council of Turkey (TUBITAK) (to O. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adebali O, 2017, J BIOL CHEM, V292, P18386, DOI 10.1074/jbc.C117.818807; Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Cattoglio C, 2015, P NATL ACAD SCI USA, V112, pE2317, DOI 10.1073/pnas.1505569112; Chadalavada Rajendrakumar S. V., 2005, Functional & Integrative Genomics, V5, P59, DOI 10.1007/s10142-005-0132-7; de Waard H, 2008, DNA REPAIR, V7, P1659, DOI 10.1016/j.dnarep.2008.06.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fong YW, 2011, CELL, V147, P120, DOI 10.1016/j.cell.2011.08.038; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Heyer BS, 2000, GENE DEV, V14, P2072; Hsu PH, 2007, MUTAT RES-FUND MOL M, V614, P3, DOI 10.1016/j.mrfmmm.2006.06.008; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Ito S, 2014, FEBS LETT, V588, P1128, DOI 10.1016/j.febslet.2014.02.033; Kemp MG, 2016, J BIOL CHEM, V291, P9330, DOI 10.1074/jbc.M116.719740; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; LEE VMY, 1986, J NEUROSCI, V6, P514; Li WT, 2018, P NATL ACAD SCI USA, V115, pE3408, DOI 10.1073/pnas.1801687115; Li WT, 2017, P NATL ACAD SCI USA, V114, P6752, DOI 10.1073/pnas.1706021114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mao P, 2016, P NATL ACAD SCI USA, V113, P9057, DOI 10.1073/pnas.1606667113; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Nouspikel T, 2013, FUTURE ONCOL, V9, P867, DOI [10.2217/FON.13.22, 10.2217/fon.13.22]; PEDERSEN RA, 1975, EXP CELL RES, V95, P247, DOI 10.1016/0014-4827(75)90548-0; Potten CS, 1997, STEM CELLS, V15, P82, DOI 10.1002/stem.150082; RASKO I, 1993, SOMAT CELL MOLEC GEN, V19, P245, DOI 10.1007/BF01233072; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Rocha CRR, 2013, MUTAT RES-REV MUTAT, V752, P25, DOI 10.1016/j.mrrev.2012.09.001; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tichy ED, 2008, EXP CELL RES, V314, P1929, DOI 10.1016/j.yexcr.2008.02.007; Van Sloun PPH, 1999, NUCLEIC ACIDS RES, V27, P3276, DOI 10.1093/nar/27.16.3276; Vreeswijk MPG, 1998, CANCER RES, V58, P1978; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yimit A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08290-2; Zhang ET, 2015, P NATL ACAD SCI USA, V112, P14817, DOI 10.1073/pnas.1520104112	54	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5914	5922		10.1074/jbc.RA119.007861	http://dx.doi.org/10.1074/jbc.RA119.007861			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30808711	Green Published, hybrid			2022-12-28	WOS:000465077500023
J	Smith, LM; Kostylev, MA; Lee, S; Strittmatter, SM				Smith, Levi M.; Kostylev, Mikhail A.; Lee, Suho; Strittmatter, Stephen M.			Systematic and standardized comparison of reported amyloid- receptors for sufficiency, affinity, and Alzheimer's disease relevance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid- (A); A receptor; prion; receptor; oligomer; prion protein (PrPC); neurodegeneration; leukocyte immunoglobulin-like receptor subfamily B member 2 (LilrB2); Nogo receptor 1 (NgR1); EphA1; FcRIIb; SorLA; sortilin; p75(NTR); PGRMC1; NLGN1; RAGE; EphB2; FZD5; mGluR5; EphA4; nAchRa7; NR2B; NR1	PRECURSOR PROTEIN; PRION-PROTEIN; SYNAPTIC PLASTICITY; NATURAL OLIGOMERS; MEMORY IMPAIRMENT; BETA OLIGOMERS; A-BETA(1-42); PEPTIDE; NEUROTOXICITY; SORLA/LR11	Oligomeric assemblies of amyloid- (A) peptide (Ao) in the brains of individuals with Alzheimer's disease (AD) are toxic to neuronal synapses. More than a dozen A receptor candidates have been suggested to be responsible for various aspects of the molecular pathology and memory impairment in mouse models of AD. A lack of consistent experimental design among previous studies of different receptor candidates limits evaluation of the relative roles of these candidates, producing some controversy within the field. Here, using cell-based assays with several A species, including Ao from AD brains obtained by autopsy, we directly compared the A-binding capacity of multiple receptor candidates while accounting for variation in expression and confirming cell surface expression. In a survey of 15 reported A receptors, only cellular prion protein (PrPC), Nogo receptor 1 (NgR1), and leukocyte immunoglobulin-like receptor subfamily B member 2 (LilrB2) exhibited direct binding to synaptotoxic assemblies of synthetic A. Both PrPC and NgR1 preferentially bound synaptotoxic oligomers rather than nontoxic monomers, and the method of oligomer preparation did not significantly alter our binding results. Hippocampal neurons lacking both NgR1 and LilrB2 exhibited a partial reduction of Ao binding, but this reduction was lower than in neurons lacking PrPC under the same conditions. Finally, binding studies with soluble Ao from human AD brains revealed a strong affinity for PrPC, weak affinity for NgR1, and no detectable affinity for LilrB2. These findings clarify the relative contributions of previously reported A receptors under controlled conditions and highlight the prominence of PrPC as an A-binding site.	[Smith, Levi M.; Kostylev, Mikhail A.; Lee, Suho; Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, Dept Neurol, 333 Cedar St, New Haven, CT 06536 USA; [Smith, Levi M.; Kostylev, Mikhail A.; Lee, Suho; Strittmatter, Stephen M.] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, Dept Neurosci, 333 Cedar St, New Haven, CT 06536 USA; [Smith, Levi M.] Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06536 USA	Yale University; Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, BCMM 436, CNNR Program, 295 Congress Ave, New Haven, CT 06536 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092	National Institutes of Health [R01AG034924, P50AG047270, RF1AG05300, R35NS097283]; Falk Medical Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034924, P50AG047270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Falk Medical Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01AG034924, P50AG047270, RF1AG05300, and R35NS097283 and the Falk Medical Research Trust (to S. M. S.). S. M. S. is the founder of ReNetX Bio, which seeks to develop therapeutics targeting NgR1, and is an inventor on a patent regarding PrPC antagonism for Alzheimer therapy. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alzheimer A, 1906, NEUROLOGISCHES CENTR, V23, P1129; Amar F, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2021; Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166; Burstein AH, 2018, JPAD-J PREV ALZHEIM, V5, P149, DOI 10.14283/jpad.2018.18; Cao Q, 2018, NAT CHEM, V10, P1213, DOI 10.1038/s41557-018-0147-z; Carlo AS, 2013, J NEUROSCI, V33, P358, DOI 10.1523/JNEUROSCI.2425-12.2013; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Dinamarca MC, 2011, BIOCHEMISTRY-US, V50, P8127, DOI 10.1021/bi201246t; Fu AKY, 2014, P NATL ACAD SCI USA, V111, P9959, DOI 10.1073/pnas.1405803111; Galasko D, 2014, NEUROLOGY, V82, P1536, DOI 10.1212/WNL.0000000000000364; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111898; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111899; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kostylev MA, 2018, MOL CELL, V72, P426, DOI 10.1016/j.molcel.2018.10.009; Kostylev MA, 2015, J BIOL CHEM, V290, P17415, DOI 10.1074/jbc.M115.643577; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Martin P., 2015, WORLD ALZHEIMER REPO; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Purro SA, 2018, BIOL PSYCHIAT, V83, P358, DOI 10.1016/j.biopsych.2017.11.020; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith LM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024075; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Wang XX, 2014, J NEUROTRAUM, V31, P1955, DOI 10.1089/neu.2014.3355; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003604	48	37	38	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6042	6053		10.1074/jbc.RA118.006252	http://dx.doi.org/10.1074/jbc.RA118.006252			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30787106	Green Published, hybrid			2022-12-28	WOS:000465077500034
J	Zhang, X; Zhang, SN; Zhang, L; Lu, JX; Zhao, CY; Luo, F; Li, D; Li, XM; Liu, C				Zhang, Xiang; Zhang, Shengnan; Zhang, Li; Lu, Jinxia; Zhao, Chunyu; Luo, Feng; Li, Dan; Li, Xueming; Liu, Cong			Heat shock protein 104 (HSP104) chaperones soluble Tau via a mechanism distinct from its disaggregase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; heat shock protein (HSP); amyloid; protein aggregation; Tau protein (Tau); holdase; HSP104; protein fibrils	N-TERMINAL DOMAIN; PLASTICITY; REVEALS; PROPAGATION; PRIONS; SYSTEM; MODEL; MOTIF	Heat shock protein 104 (HSP104) is a conserved AAA+ protein disaggregase, can disassemble the toxic aggregates formed by different amyloid proteins, and is protective in various animal models associated with amyloid-related diseases. Extensive studies have attempted to elucidate how HSP104 disassembles the aggregated form of clients. Here, we found that HSP104 exhibits a potent holdase activity that does not require energy, prevents the soluble form of amyloid clients from aggregating, and differs from HSP104's disaggregase activity. Using cryo-EM, NMR, and additional biophysical approaches, we found that HSP104 utilizes its small subdomain of nucleotide-binding domain 2 (ssNBD2) to capture the soluble amyloid client (K19 of Tau) independent of its ATP hydrolysis activity. Our results indicate that HSP104 utilizes two fundamental distinct mechanisms to chaperone different forms of amyloid client and highlight the important yet previously unappreciated function of ssNBD2 in chaperoning amyloid client and thereby preventing pathological aggregation.	[Zhang, Xiang; Zhang, Shengnan; Zhao, Chunyu; Luo, Feng; Liu, Cong] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 26 Qiuyue Rd, Shanghai 201210, Peoples R China; [Zhang, Li; Li, Xueming] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Lu, Jinxia; Li, Dan] Shanghai Jiao Tong Univ, Bio X Inst, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Zhang, Xiang; Zhao, Chunyu; Luo, Feng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Tsinghua University; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, C (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 26 Qiuyue Rd, Shanghai 201210, Peoples R China.; Li, XM (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.	lixueming@tsinghua.edu.cn; liulab@sioc.ac.cn		liu, cong/0000-0003-3425-6672	National Natural Science Foundation of China [31470748]; Major State Basic Research Development Program [2016YFA0501902]; Chinese Academy of Sciences; "1000 Talents Plan" of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); "1000 Talents Plan" of China	This work was supported by National Natural Science Foundation of China Grant 31470748), Major State Basic Research Development Program Grant 2016YFA0501902, and funds from the Chinese Academy of Sciences, and the "1000 Talents Plan" of China. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Carroni M, 2014, ELIFE, V3, DOI 10.7554/eLife.02481; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cushman-Nick M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003781; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Eisenberg DS, 2017, ANNU REV BIOCHEM, V86, P69, DOI 10.1146/annurev-biochem-061516-045104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Heuck A, 2016, ELIFE, V5, DOI 10.7554/eLife.21516; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Koldewey P, 2017, J BIOL CHEM, V292, P12010, DOI 10.1074/jbc.R117.796862; Koldewey P, 2016, CELL, V166, P369, DOI 10.1016/j.cell.2016.05.054; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Landau M, 2017, J BIOL CHEM, V292, P16380, DOI 10.1074/jbc.H117.780528; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li XM, 2015, J STRUCT BIOL, V192, P174, DOI 10.1016/j.jsb.2015.09.003; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li YW, 2018, CELL RES, V28, P897, DOI 10.1038/s41422-018-0075-x; Liu ZY, 2017, PROTEIN PEPTIDE LETT, V24, P315, DOI 10.2174/0929866524666170206122616; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Luo F, 2018, NAT STRUCT MOL BIOL, V25, P341, DOI 10.1038/s41594-018-0050-8; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Sweeny EA, 2016, J MOL BIOL, V428, P1870, DOI 10.1016/j.jmb.2015.11.016; Sweeny EA, 2011, JOVE-J VIS EXP, DOI 10.3791/3190; Sweeny EA, 2015, MOL CELL, V57, P836, DOI 10.1016/j.molcel.2014.12.021; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Xu LA, 2018, CELL MOL LIFE SCI, V75, P1445, DOI 10.1007/s00018-017-2698-3; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Zhao ML, 2016, J MOL BIOL, V428, P1912, DOI 10.1016/j.jmb.2015.10.026; Zheng J, 2011, J AM CHEM SOC, V133, P3144, DOI 10.1021/ja110545h	61	12	13	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4956	4965		10.1074/jbc.RA118.005980	http://dx.doi.org/10.1074/jbc.RA118.005980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718279	Green Published, hybrid			2022-12-28	WOS:000463985600020
J	Zheng, YF; Ming, PP; Zhu, CL; Si, Y; Xu, SL; Chen, AD; Wang, J; Zhang, BH				Zheng, Yongfa; Ming, Pingpo; Zhu, Chengliang; Si, Yu; Xu, Shilei; Chen, Aidong; Wang, Jun; Zhang, Binghong			Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis B virus (HBV; Hep B); cancer biology; cell migration; interleukin 6 (IL-6); inflammation; HBV X protein; HBV-associated HCC; IL-6-STAT3 signaling; SH2D5; transketolase	NF-KAPPA-B; CANCER; STAT3; LIVER; TRANSCRIPTION; ACTIVATION; INDUCTION; CARCINOMA; IL-6; RNA	Hepatitis B virus X protein (HBx) critically contributes to the development of hepatocellular carcinoma (HCC). However, the mechanisms by which HBx promotes HCC remain unclear. In the present study, using a combination of gene expression profiling and immunohistochemistry, we found higher levels of SH2 domain-containing 5 (SH2D5) in liver tissue from HBV-associated HCC (HBV-HCC) patients than in adjacent nontumor tissues. Moreover, HBV infection elevated SH2D5 levels, and we observed that HBx plays an important role in SH2D5 induction. We also found that HBx triggers SH2D5 expression through the NF-kappa B and c-Jun kinase pathways. Employing SH2D5 overexpression or knockdown, we further demonstrate that SH2D5 promotes HCC cell proliferation both in vitro and in vivo. While investigating the mechanism of SH2D5-mediated stimulation of HCC cell proliferation, we noted that HBV induces SH2D5 binding to transketolase (TKT), a pentose phosphate pathway enzyme, thereby promoting an interaction between and signal transducer and activator of transcription 3 (STAT3). Furthermore, HBx stimulated STAT3 phosphorylation at Tyr-705 and promoted the activity and downstream signaling pathway of STAT3 via the SH2D5-TKT interaction. Taken together, our results suggest that SH2D5 is an HBV-induced protein capable of binding to TKT, leading to induction of HCC cell proliferation.	[Zheng, Yongfa; Ming, Pingpo] Wuhan Univ, Renmin Hosp, Dept Oncol, Wuhan 430060, Hubei, Peoples R China; [Zhu, Chengliang] Wuhan Univ, Renmin Hosp, Dept Clin Lab, Wuhan 430060, Hubei, Peoples R China; [Zhang, Binghong] Wuhan Univ, Renmin Hosp, Dept Neonatol, Hubei Zhang Rd,Wuchang Dist 99,Jiefang Rd 238, Wuhan 430060, Hubei, Peoples R China; [Si, Yu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Otolaryngol Head & Neck Surg, Guangzhou 510120, Guangdong, Peoples R China; [Xu, Shilei] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gen Surg, Guangzhou 510530, Guangdong, Peoples R China; [Chen, Aidong] Nanjing Med Univ, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China; [Wang, Jun] Jiangnan Univ, Peoples Hosp Wuxi 5, Ctr Clin Lab, Wuxi 214005, Jiangsu, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Sun Yat Sen University; Sun Yat Sen University; Nanjing Medical University; Jiangnan University	Zhang, BH (corresponding author), Wuhan Univ, Renmin Hosp, Dept Neonatol, Hubei Zhang Rd,Wuchang Dist 99,Jiefang Rd 238, Wuhan 430060, Hubei, Peoples R China.	binghongzhangrm@126.com			Quality Test and Operation with the Anesthesia Center of Experimental Animal of Hubei Province Research Grant [2060403]; National Natural Science Foundation of China [81703035, 81600794, 31571168]; National Key R&D Program of China [2016YFC1303800]	Quality Test and Operation with the Anesthesia Center of Experimental Animal of Hubei Province Research Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	This work was supported by Quality Test and Operation with the Anesthesia Center of Experimental Animal of Hubei Province Research Grant 2060403, Key Program of National Natural Science Foundation of China Research Grant 81703035, the National Natural Science Foundation of China Research Grants 81600794 and 31571168, and National Key R&D Program of China Research Grant 2016YFC1303800. The authors declare that they have no conflicts of interest with the contents of this article.	Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chen SZ, 2017, CANCER LETT, V394, P22, DOI 10.1016/j.canlet.2017.02.011; Chen XY, 2017, J BIOL CHEM, V292, P21291, DOI 10.1074/jbc.M117.805937; Diaz-Moralli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025323; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Gray EJ, 2014, J BIOL CHEM, V289, P35397, DOI 10.1074/jbc.M114.615112; Gui SL, 2015, FEBS LETT, V589, P4112, DOI 10.1016/j.febslet.2015.11.011; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hsieh A, 2011, CANCER LETT, V300, P162, DOI 10.1016/j.canlet.2010.09.018; Jing MZ, 2016, VACCINE, V34, P516, DOI 10.1016/j.vaccine.2015.11.069; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Kitamura H, 2017, CANCER SCI, V108, P1947, DOI 10.1111/cas.13332; Krockenberger M, 2010, ANTICANCER RES, V30, P1653; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu BA, 2012, PHILOS T R SOC B, V367, P2556, DOI 10.1098/rstb.2012.0107; Liu D, 2016, HEPATOLOGY, V64, P390, DOI 10.1002/hep.28594; Liu S, 2015, J HEPATOL, V62, P1015, DOI 10.1016/j.jhep.2014.11.035; Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642; Liu Y, 2010, J BIOL CHEM, V285, P27429, DOI 10.1074/jbc.M110.142752; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Peng NF, 2016, J IMMUNOL, V196, P2753, DOI 10.4049/jimmunol.1501481; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P1297, DOI 10.1016/S1357-2725(98)00095-8; Schultz H, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-35; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Svinka J, 2014, HEPAT ONCOL, V1, P106, DOI [10.2217/HEP.13.7, 10.2217/hep.13.7]; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xia LM, 2012, J HEPATOL, V57, P600, DOI 10.1016/j.jhep.2012.04.020; Xu IMJ, 2016, P NATL ACAD SCI USA, V113, pE725, DOI 10.1073/pnas.1508779113; Xu XJ, 2009, INT J CANCER, V124, P1330, DOI 10.1002/ijc.24078; Yang H, 2016, AM J CANCER RES, V6, P2690; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Zhang JW, 2018, HEPATOLOGY, V67, P171, DOI 10.1002/hep.29405	37	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4815	4827		10.1074/jbc.RA118.005739	http://dx.doi.org/10.1074/jbc.RA118.005739			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30659097	Green Published, hybrid			2022-12-28	WOS:000463985600008
J	Nguyen, KT; Kim, JM; Park, SE; Hwang, CS				Kha The Nguyen; Kim, Jeong-Mok; Park, Sang-Eun; Hwang, Cheol-Sang			N-terminal methionine excision of proteins creates tertiary destabilizing N-degrons of the Arg/N-end rule pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin ligase; protein degradation; proteasome; acetylation; N-end rule; N-terminal acetylation; N-terminal amidase; N-terminal arginylation; N-terminal methionine excision	IN-VIVO; CELLULAR-PROTEINS; UBIQUITIN LIGASES; DEGRADATION; ACETYLATION; TFG; SPECIFICITY; INTERACTS; ACETYLTRANSFERASES; COMPLEXES	All organisms begin protein synthesis with methionine (Met). The resulting initiator Met of nascent proteins is irreversibly processed by Met aminopeptidases (MetAPs). N-terminal (Nt) Met excision (NME) is an evolutionarily conserved and essential process operating on up to two-thirds of proteins. However, the universal function of NME remains largely unknown. MetAPs have a well-known processing preference for Nt-Met with Ala, Ser, Gly, Thr, Cys, Pro, or Val at position 2, but using CHX-chase assays to assess protein degradation in yeast cells, as well as protein-binding and RT-qPCR assays, we demonstrate here that NME also occurs on nascent proteins bearing Met-Asn or Met-Gln at their N termini. We found that the NME at these termini exposes the tertiary destabilizing Nt residues (Asn or Gln) of the Arg/N-end rule pathway, which degrades proteins according to the composition of their Nt residues. We also identified a yeast DNA repair protein, MQ-Rad16, bearing a Met-Gln N terminus, as well as a human tropomyosin-receptor kinase-fused gene (TFG) protein, MN-TFG, bearing a Met-Asn N terminus as physiological, MetAP-processed Arg/N-end rule substrates. Furthermore, we show that the loss of the components of the Arg/N-end rule pathway substantially suppresses the growth defects of naa20 yeast cells lacking the catalytic subunit of NatB Nt acetylase at 37 degrees C. Collectively, the results of our study reveal that NME is a key upstream step for the creation of the Arg/N-end rule substrates bearing tertiary destabilizing residues in vivo.	[Kha The Nguyen; Kim, Jeong-Mok; Park, Sang-Eun; Hwang, Cheol-Sang] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH)	Hwang, CS (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea.	cshwang@postech.ac.kr	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957; Kim, Jeong-Mok/0000-0002-7223-248X	Samsung Science and Technology Foundation [SSTF-BA1401-17]; National Research Foundation of Korea (NRF) - Korean Government (MSIP) [NRF-2017R1A5A1015366]; BK21 Plus Program; POSCO Green Science and Innovation Grant	Samsung Science and Technology Foundation(Samsung); National Research Foundation of Korea (NRF) - Korean Government (MSIP); BK21 Plus Program; POSCO Green Science and Innovation Grant	This work was supported by the Samsung Science and Technology Foundation Grant SSTF-BA1401-17, National Research Foundation of Korea (NRF) Grant NRF-2017R1A5A1015366 funded by the Korean Government (MSIP), the BK21 Plus Program, and the POSCO Green Science and Innovation Grant. The authors declare that they have no conflicts of interest with the contents of this article.	ARFIN SM, 1988, BIOCHEMISTRY-US, V27, P7979, DOI 10.1021/bi00421a001; Avci D, 2014, MOL CELL, V56, P630, DOI 10.1016/j.molcel.2014.10.012; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bonissone S, 2013, MOL CELL PROTEOMICS, V12, P14, DOI 10.1074/mcp.M112.019075; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Chen SP, 2002, ARCH BIOCHEM BIOPHYS, V398, P87, DOI 10.1006/abbi.2001.2675; Dissmeyer N, 2018, NEW PHYTOL, V218, P929, DOI 10.1111/nph.14619; Dong C, 2018, NAT CHEM BIOL, V14, P466, DOI 10.1038/s41589-018-0036-1; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Eldeeb M, 2016, PROTEIN PEPTIDE LETT, V23, P343, DOI 10.2174/0929866523666160108115809; Frottin F, 2016, ONCOTARGET, V7, P63306, DOI 10.18632/oncotarget.11216; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Gietz RD, 2014, METHODS MOL BIOL, V1163, P33, DOI 10.1007/978-1-4939-0799-1_4; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Giglione C, 2015, BIOCHIMIE, V114, P134, DOI 10.1016/j.biochi.2014.11.008; Goder V, 2008, FEBS LETT, V582, P1575, DOI 10.1016/j.febslet.2008.03.056; Hanna MG, 2017, P NATL ACAD SCI USA, V114, pE7707, DOI 10.1073/pnas.1709120114; Hernandez L, 1999, BLOOD, V94, P3265; Hisaoka M, 2004, GENE CHROMOSOME CANC, V40, P325, DOI 10.1002/gcc.20044; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kats I, 2018, MOL CELL, V70, P488, DOI 10.1016/j.molcel.2018.03.033; Nguyen KT, 2019, J BIOL CHEM, V294, P379, DOI 10.1074/jbc.RA118.005556; Nguyen KT, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0097-y; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim I, 2013, MOL CELL PROTEOMICS, V12, P3370, DOI 10.1074/mcp.O113.031708; Kim JM, 2018, SCIENCE, V362, P1019, DOI 10.1126/science.aat0174; Kim JM, 2014, CELL CYCLE, V13, P1366, DOI 10.4161/cc.28751; Lee JH, 2015, TRENDS PHARMACOL SCI, V36, P782, DOI 10.1016/j.tips.2015.07.004; Lee KE, 2016, MOL CELLS, V39, P169, DOI 10.14348/molcells.2016.2329; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Lim B, 2012, CARCINOGENESIS, V33, P1450, DOI 10.1093/carcin/bgs164; Meinnel T, 2008, PROTEOMICS, V8, P626, DOI 10.1002/pmic.200700592; Miranda C, 2006, J CELL PHYSIOL, V208, P154, DOI 10.1002/jcp.20644; Neal S, 2018, MOL CELL, V69, P915, DOI 10.1016/j.molcel.2018.02.014; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Piatkov KI, 2015, MICROB CELL, V2, P376, DOI 10.15698/mic2015.10.231; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Ree R, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0116-z; SADIS S, 1995, MOL CELL BIOL, V15, P4086; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; SCHILD D, 1992, YEAST, V8, P385, DOI 10.1002/yea.320080506; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Stolz A, 2010, TRAFFIC, V11, P1363, DOI 10.1111/j.1600-0854.2010.01093.x; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Van Damme P, 2015, PROTEOMICS, V15, P2436, DOI 10.1002/pmic.201400575; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wadas B, 2016, J BIOL CHEM, V291, P17178, DOI 10.1074/jbc.M116.734640; Walker KW, 1999, J BIOL CHEM, V274, P13403, DOI 10.1074/jbc.274.19.13403; Xu F, 2015, PLANT CELL, V27, P1547, DOI 10.1105/tpc.15.00173; Zattas D, 2013, MOL BIOL CELL, V24, P890, DOI 10.1091/mbc.E12-11-0838	61	19	19	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4464	4476		10.1074/jbc.RA118.006913	http://dx.doi.org/10.1074/jbc.RA118.006913			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30674553	hybrid, Green Published			2022-12-28	WOS:000462969500015
J	Kubota-Kawai, H; Burton-Smith, RN; Tokutsu, R; Song, CH; Akimoto, S; Yokono, M; Ueno, Y; Kim, E; Watanabe, A; Murata, K; Minagawa, J				Kubota-Kawai, Hisako; Burton-Smith, Raymond N.; Tokutsu, Ryutaro; Song, Chihong; Akimoto, Seiji; Yokono, Makio; Ueno, Yoshifumi; Kim, Eunchul; Watanabe, Akimasa; Murata, Kazuyoshi; Minagawa, Jun			Ten antenna proteins are associated with the core in the supramolecular organization of the photosystem I supercomplex in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosynthesis; Chlamydomonas; light-harvesting complex (antenna complex); cryo-electron microscopy; single-particle analysis; green algae; LHCI; photosystem I; Chlamydomonas reinhardtii; cryo-electron microscopy (cryo-EM); photosynthesis; outer antenna; photosynthetic efficiency	LIGHT-HARVESTING-COMPLEX; PSI-LHCI; PROTEOMICS; EVOLUTION; INSIGHTS; SITE	Photosystem I (PSI) is a large pigment-protein complex mediating light-driven charge separation and generating a highly negative redox potential, which is eventually utilized to produce organic matter. In plants and algae, PSI possesses outer antennae, termed light-harvesting complex I (LHCI), which increase the energy flux to the reaction center. The number of outer antennae for PSI in the green alga Chlamydomonas reinhardtii is known to be larger than that of land plants. However, their exact number and location remain to be elucidated. Here, applying a newly established sample purification procedure, we isolated a highly pure PSI-LHCI supercomplex containing all nine LHCA gene products under state 1 conditions. Single-particle cryo-EM revealed the 3D structure of this supercomplex at 6.9 resolution, in which the densities near the PsaF and PsaJ subunits were assigned to two layers of LHCI belts containing eight LHCIs, whereas the densities between the PsaG and PsaH subunits on the opposite side of the LHCI belt were assigned to two extra LHCIs. Using single-particle cryo-EM, we also determined the 2D projection map of the lhca2 mutant, which confirmed the assignment of LHCA2 and LHCA9 to the densities between PsaG and PsaH. Spectroscopic measurements of the PSI-LHCI supercomplex suggested that the bound LHCA2 and LHCA9 proteins have the ability to increase the light-harvesting energy for PSI. We conclude that the PSI in C. reinhardtii has a larger and more distinct outer-antenna organization and higher light-harvesting capability than that in land plants.	[Kubota-Kawai, Hisako; Burton-Smith, Raymond N.; Tokutsu, Ryutaro; Kim, Eunchul; Watanabe, Akimasa; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan; [Kubota-Kawai, Hisako; Burton-Smith, Raymond N.; Tokutsu, Ryutaro; Watanabe, Akimasa; Minagawa, Jun] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan; [Tokutsu, Ryutaro; Watanabe, Akimasa; Minagawa, Jun] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi 4448585, Japan; [Murata, Kazuyoshi] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Sch Life Sci, Okazaki, Aichi 4448585, Japan; [Song, Chihong; Murata, Kazuyoshi] Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan; [Akimoto, Seiji; Ueno, Yoshifumi] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Yokono, Makio] Nippon Flour Mills Co Ltd, Innovat Ctr, Atsugi, Kanagawa 2430041, Japan; [Kubota-Kawai, Hisako] Yamagata Univ, Fac Sci, Yamagata 9908560, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kobe University; Yamagata University	Minagawa, J (corresponding author), Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan.	minagawa@nibb.ac.jp	Tokutsu, Ryutaro/V-7596-2019; Tokutsu, Ryutaro/GRF-0208-2022; Kim, Eunchul/E-9565-2013; Yokono, Makio/N-8425-2015	Tokutsu, Ryutaro/0000-0003-2037-255X; Kim, Eunchul/0000-0003-3380-3953; Watanabe, Akimasa/0000-0001-6068-1328; Kubota-Kawai, Hisako/0000-0001-7804-102X; Yokono, Makio/0000-0002-4813-2120; Murata, Kazuyoshi/0000-0001-9446-3652; Minagawa, Jun/0000-0002-3028-3203	Japan Society for the Promotion of Science (JSPS) KAKENHI [16H06553, 17J40032, 16H06280]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid 16H06553 (to R. T., S. A., and J. M.) and 17J40032 (to H. K.-K.) and by Advanced Bioimaging Support (ABiS) from Grant-in-Aid for Scientific Research on Innovative Areas 16H06280 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto S, 2012, BBA-BIOENERGETICS, V1817, P1483, DOI 10.1016/j.bbabio.2012.01.006; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker DR, 2014, J PHYS CHEM B, V118, P2703, DOI 10.1021/jp407948p; BASSI R, 1992, J BIOL CHEM, V267, P25714; Bazzacco P, 2012, BIOCHEMISTRY-US, V51, P1416, DOI 10.1021/bi201862v; Drop B, 2014, PLANT J, V78, P181, DOI 10.1111/tpj.12459; Drop B, 2011, J BIOL CHEM, V286, P44878, DOI 10.1074/jbc.M111.301101; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Hippler M, 2001, PLANT J, V28, P595, DOI 10.1046/j.1365-313X.2001.01175.x; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kubota-Kawai H, 2018, NAT PLANTS, V4, P218, DOI 10.1038/s41477-018-0130-0; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Le Quiniou C, 2015, BBA-BIOENERGETICS, V1847, P458, DOI 10.1016/j.bbabio.2015.02.001; Marco P, 2018, BBA-BIOENERGETICS, V1859, P234, DOI 10.1016/j.bbabio.2018.01.001; Mazor Y, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.14; Mazor Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07433; Mozzo M, 2010, BBA-BIOENERGETICS, V1797, P212, DOI 10.1016/j.bbabio.2009.10.005; Mutoh R, 2015, BIOCHEMISTRY-US, V54, P6052, DOI 10.1021/acs.biochem.5b00601; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; O'Connor D. V., 1984, TIME CORRELATED SING; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ozawa SI, 2018, PLANT PHYSIOL, V178, P583, DOI 10.1104/pp.18.00749; Pi X, 2018, P NATL ACAD SCI USA, V115, P4423, DOI 10.1073/pnas.1722482115; Qin XC, 2015, SCIENCE, V348, P989, DOI 10.1126/science.aab0214; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sharma KS, 2012, LANGMUIR, V28, P4625, DOI 10.1021/la205026r; Stauber EJ, 2009, PROTEOMICS, V9, P398, DOI 10.1002/pmic.200700620; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Steinbeck J, 2018, P NATL ACAD SCI USA, V115, P10517, DOI 10.1073/pnas.1809973115; Subramanyam R, 2006, FEBS LETT, V580, P233, DOI 10.1016/j.febslet.2005.12.003; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Takahashi Y, 2004, BIOCHEMISTRY-US, V43, P7816, DOI 10.1021/bi035988z; Tokutsu R, 2004, PLANT CELL PHYSIOL, V45, P138, DOI 10.1093/pcp/pch013; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Watanabe M, 2011, PLANT CELL PHYSIOL, V52, P162, DOI 10.1093/pcp/pcq183	45	20	21	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4304	4314		10.1074/jbc.RA118.006536	http://dx.doi.org/10.1074/jbc.RA118.006536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30670590	Green Published, hybrid			2022-12-28	WOS:000462969500003
J	Nakazawa, N; Arakawa, O; Ebe, M; Yanagida, M				Nakazawa, Norihiko; Arakawa, Orie; Ebe, Masahiro; Yanagida, Mitsuhiro			Casein kinase II-dependent phosphorylation of DNA topoisomerase II suppresses the effect of a catalytic topo II inhibitor, ICRF-193, in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA topoisomerase; protein phosphorylation; chromosomes; yeast genetics; mitosis; cell cycle; anticancer drug; casein kinase II; chromosome segregation; DNA topoisomerase II; fission yeast; ICRF-193	QUANTITATIVE PHOSPHOPROTEOMICS REVEALS; C-TERMINAL DOMAIN; PROTEIN-KINASE; CELL-CYCLE; IN-VIVO; CK2; DYNAMICS; ALPHA; CHROMOSOMES; MUTANTS	DNA topoisomerase II (topo II) regulates the topological state of DNA and is necessary for DNA replication, transcription, and chromosome segregation. Topo II has essential functions in cell proliferation and therefore is a critical target of anticancer drugs. In this study, using Phos-tag SDS-PAGE analysis in fission yeast (Schizosaccharomyces pombe), we identified casein kinase II (Cka1/CKII)-dependent phosphorylation at the C-terminal residues Ser(1363) and Ser(1364) in topo II. We found that this phosphorylation decreases the inhibitory effect of an anticancer catalytic inhibitor of topo II, ICRF-193, on mitosis. Consistent with the constitutive activity of Cka1/CKII, Ser(1363) and Ser(1364) phosphorylation of topo II was stably maintained throughout the cell cycle. We demonstrate that ICRF-193-induced chromosomal mis-segregation is further exacerbated in two temperature-sensitive mutants, cka1-372 and cka1/orb5-19, of the catalytic subunit of CKII or in the topo II nonphosphorylatable alanine double mutant top2-S1363A,S1364A but not in cells of the phosphomimetic glutamate double mutant top2-S1363E,S1364E. Our results suggest that Ser(1363) and Ser(1364) in topo II are targeted by Cka1/CKII kinase and that their phosphorylation facilitates topo II ATPase activity in the N-terminal region, which regulates protein turnover on chromosome DNA. Because CKII-mediated phosphorylation of the topo II C-terminal domain appears to be evolutionarily conserved, including in humans, we propose that attenuation of CKII-controlled topo II phosphorylation along with catalytic topo II inhibition may promote anticancer effects.	[Nakazawa, Norihiko; Arakawa, Orie; Ebe, Masahiro; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol Grad Univ, Cell Unit G0, Onna Son, Okinawa 9040495, Japan	Okinawa Institute of Science & Technology Graduate University	Nakazawa, N; Yanagida, M (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Cell Unit G0, Onna Son, Okinawa 9040495, Japan.	nakazawa@oist.jp; myanagid@gmail.com			OIST Graduate University	OIST Graduate University	We thank Drs. Yukinobu Nakaseko and Mitsuko Hatanaka for identification of the cka1-372 mutation in the early stage of this work and Dr. Steven D. Aird for editing the manuscript. We are also grateful for the generous support of OIST Graduate University.	ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; ACKERMAN P, 1988, J BIOL CHEM, V263, P12653; Adachi N, 1997, NUCLEIC ACIDS RES, V25, P3135, DOI 10.1093/nar/25.15.3135; ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Andoh T, 1998, BBA-GENE STRUCT EXPR, V1400, P155, DOI 10.1016/S0167-4781(98)00133-X; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; CARDENAS ME, 1993, J CELL SCI, V104, P533; Carpy A, 2014, MOL CELL PROTEOMICS, V13, P1925, DOI 10.1074/mcp.M113.035824; Clarke DJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112438; CORBETT AH, 1992, J BIOL CHEM, V267, P20513; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; DEVORE RF, 1992, CANCER RES, V52, P2156; Dickey JS, 2005, BIOCHEMISTRY-US, V44, P11546, DOI 10.1021/bi050811l; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Ganapathi RN, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00089; Gandin V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11127; Hanif IM, 2010, INT J BIOCHEM CELL B, V42, P1602, DOI 10.1016/j.biocel.2010.06.010; Haraguchi T, 1997, GENES CELLS, V2, P369, DOI 10.1046/j.1365-2443.1997.1280326.x; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; Isabelle C., 2017, TOR1 CK2 KINASES CON, DOI [10.1371/journal.pbio.2000245, DOI 10.1371/JOURNAL.PBIO.2000245]; ISHIDA R, 1994, J CELL BIOL, V126, P1341, DOI 10.1083/jcb.126.6.1341; Ishida R, 2001, CELL STRUCT FUNCT, V26, P215, DOI 10.1247/csf.26.215; ISHIDA R, 1991, CANCER RES, V51, P4909; Kettenbach AN, 2015, MOL CELL PROTEOMICS, V14, P1275, DOI 10.1074/mcp.M114.045245; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Morris SK, 2000, J BIOL CHEM, V275, P2613, DOI 10.1074/jbc.275.4.2613; Nakazawa N, 2016, GENES CELLS, V21, P978, DOI 10.1111/gtc.12397; Nakazawa N, 2015, GENES CELLS, V20, P481, DOI 10.1111/gtc.12239; Nakazawa N, 2011, J CELL SCI, V124, P1795, DOI 10.1242/jcs.078733; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pierre F, 2011, J MED CHEM, V54, P635, DOI 10.1021/jm101251q; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Rusin SF, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00097; SAIJO M, 1990, BIOCHEMISTRY-US, V29, P583, DOI 10.1021/bi00454a036; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; SHIOZAKI K, 1992, J CELL BIOL, V119, P1023, DOI 10.1083/jcb.119.5.1023; SHIOZAKI K, 1991, MOL CELL BIOL, V11, P6093, DOI 10.1128/MCB.11.12.6093; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; STONE EM, 1993, CURR BIOL, V3, P13, DOI 10.1016/0960-9822(93)90140-J; Su SSY, 1996, J CELL SCI, V109, P1347; Swaffer MP, 2018, CELL REP, V24, P503, DOI 10.1016/j.celrep.2018.06.036; TAAGEPERA S, 1993, P NATL ACAD SCI USA, V90, P8407, DOI 10.1073/pnas.90.18.8407; TAKANO H, 1991, CANCER RES, V51, P3951; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; UEMURA T, 1986, EMBO J, V5, P1003, DOI 10.1002/j.1460-2075.1986.tb04315.x; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WELLS NJ, 1994, J BIOL CHEM, V269, P29746	71	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3772	3782		10.1074/jbc.RA118.004955	http://dx.doi.org/10.1074/jbc.RA118.004955			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30635402	Green Published, hybrid			2022-12-28	WOS:000461853900037
J	Garg, RR; Jackson, CB; Rahman, MM; Khan, AR; Lewin, AS; McFadden, G				Garg, Rekha R.; Jackson, Cody B.; Rahman, Masmudur M.; Khan, Amir R.; Lewin, Alfred S.; McFadden, Grant			Myxoma virus M013 protein antagonizes NF-B and inflammasome pathways via distinct structural motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						poxvirus; inflammasome; innate immunity; NF-kappa B (NF-KB); host-pathogen interaction; ASC-1; immune evasion; myxoma virus; PYRIN domain	KAPPA-B; PYRIN DOMAIN; HOMEOSTASIS	Among the repertoire of immunoregulatory proteins encoded by myxoma virus, M013 is a viral homologue of the viral pyrin domain-only protein (vPOP) family. In myeloid cells, M013 protein has been shown to inhibit both the inflammasome and NF-B signaling pathways by direct binding to ASC1 and NF-B1, respectively. In this study, a three-dimensional homology model of the M013 pyrin domain (PYD) was built based on similarities to known PYD structures. A distinctive feature of the deduced surface electrostatic map of the M013 PYD is the presence of a negatively region consisting of numerous aspartate and glutamate residues in close proximity. Single-site mutations of aspartate and glutamate residues reveal their role in interactions with ASC-1. The biological significance of charge complementarity in the M013-ASC-1 interaction was further confirmed by functional assays of caspase-1 activation and subsequent secretion of cytokines. M013 also has a unique 33-residue C-terminal tail that follows the N-terminal PYD, and it is enriched in positively charged residues. Deletion of the tail of M013 significantly inhibited the interactions between M013 and NF-B1, thus compromising the ability of the viral protein to suppress the secretion of pro-inflammatory cytokines. These results demonstrate that vPOP M013 exploits distinct structural motifs to regulate both the inflammasome and NF-B pathways.	[Garg, Rekha R.; Jackson, Cody B.; Rahman, Masmudur M.; Lewin, Alfred S.; McFadden, Grant] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Rahman, Masmudur M.; McFadden, Grant] Arizona State Univ, Ctr Immunotherapy Vaccines & Virotherapy, Biodesign Inst, Tempe, AZ 85281 USA; [Khan, Amir R.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland	State University System of Florida; University of Florida; Arizona State University; Arizona State University-Tempe; Trinity College Dublin	Lewin, AS; McFadden, G (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.; McFadden, G (corresponding author), Arizona State Univ, Ctr Immunotherapy Vaccines & Virotherapy, Biodesign Inst, Tempe, AZ 85281 USA.; Khan, AR (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	Amir.Khan@tcd.ie; lewin@ufl.edu; grantmcf@asu.edu		Khan, Amir/0000-0003-1176-6952; McFadden, Grant/0000-0002-2556-3526; Jackson, Cody/0000-0002-0686-9423; Lewin, Alfred/0000-0002-4192-9727	Science Foundation Ireland [SFI-12/IA/1239]; National Institutes of Health [R01 AI100987]; Arizona State University; Shaler Richardson Professorship Endowment; NATIONAL EYE INSTITUTE [R01EY026268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100987] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona State University; Shaler Richardson Professorship Endowment; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Science Foundation Ireland Grant SFI-12/IA/1239 (to A. R. K.), National Institutes of Health Grant R01 AI100987 (to G. M. and M. M. R.), start-up funding from Arizona State University (to G. M.), and the Shaler Richardson Professorship Endowment (to A. S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Awad F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175336; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Cameron C, 1999, VIROLOGY, V264, P298, DOI 10.1006/viro.1999.0001; Chemical Computing Group, 2018, MOL OP ENV; CORDLE SR, 1993, J BIOL CHEM, V268, P11803; Dorfleutner A, 2007, VIRUS GENES, V35, P685, DOI 10.1007/s11262-007-0141-9; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ildefonso CJ, 2015, HUM GENE THER, V26, P59, DOI 10.1089/hum.2014.089; Indramohan M, 2018, J MOL BIOL, V430, P153, DOI 10.1016/j.jmb.2017.10.004; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; Kerr PJ, 2015, VIRUSES-BASEL, V7, P1020, DOI 10.3390/v7031020; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Rahman MM, 2011, J VIROL, V85, P12505, DOI 10.1128/JVI.00410-11; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Rahman MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000635; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; ROSS J, 1977, J HYG-CAMBRIDGE, V79, P411, DOI 10.1017/S0022172400053262; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175	34	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8480	8489		10.1074/jbc.RA118.006040	http://dx.doi.org/10.1074/jbc.RA118.006040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30940649	hybrid, Green Published			2022-12-28	WOS:000471108200017
J	Ortega, JT; Parmar, T; Jastrzebska, B				Ortega, Joseph T.; Parmar, Tanu; Jastrzebska, Beata			Flavonoids enhance rod opsin stability, folding, and self-association by directly binding to ligand-free opsin and modulating its conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); flavonoid; regeneration; receptor; oligomerization; eye disease; opsin; photoreception; rhodopsin; stability	PH-DEPENDENT INTERACTION; TRANSDUCIN ACTIVATION; BIOLOGICAL EVALUATION; VISUAL CYCLE; IN-VIVO; RHODOPSIN; PHYTOCHEMICALS; DERIVATIVES; DYNAMICS; DISEASE	Rhodopsin (Rho) is a visual G protein-coupled receptor expressed in the rod photoreceptors of the eye, where it mediates transmission of a light signal into a cell and converts this signal into a nerve impulse. More than 100 mutations in Rho are linked to various ocular impairments, including retinitis pigmentosa (RP). Accordingly, much effort has been directed toward developing ligands that target Rho and improve its folding and stability. Natural compounds may provide another viable approach to such drug discovery efforts. The dietary polyphenol compounds, ubiquitously present in fruits and vegetables, have beneficial effects in several eye diseases. However, the underlying mechanism of their activity is not fully understood. In this study, we used a combination of computational methods, biochemical and biophysical approaches, including bioluminescence resonance energy transfer, and mammalian cell expression systems to clarify the effects of four common bioactive flavonoids (quercetin, myricetin, and their mono-glycosylated forms quercetin-3-rhamnoside and myricetrin) on rod opsin stability, function, and membrane organization. We observed that by directly interacting with ligand-free opsin, flavonoids modulate its conformation, thereby causing faster entry of the retinal chromophore into its binding pocket. Moreover, flavonoids significantly increased opsin stability, most likely by introducing structural rigidity and promoting receptor self-association within the biological membranes. Of note, the binding of flavonoids to an RP-linked P23H opsin variant partially restored its normal cellular trafficking. Together, our results suggest that flavonoids could be utilized as lead compounds in the development of effective nonretinoid therapeutics for managing RP-related retinopathies.	[Ortega, Joseph T.; Parmar, Tanu; Jastrzebska, Beata] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	bxj27@case.edu	Ortega, Joseph/AFN-8883-2022	Jastrzebska, Beata/0000-0001-5209-8685	National Institutes of Health [P30EY11373, P30CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY011373, R01EY025214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Drs. Ronald E. Stenkamp and Marcin Golczak for helpful comments on this manuscript. We thank Dr. Yinghua Chen for the assistance with Tecan microplate reader measurement from PEPCMBC at the department of Physiology and Biophysics, Case Western Reserve University. The NEI Visual Sciences Research Center (VSRC) CORE Grant P30EY11373 (Case Western Reserve University) was supported by the National Institutes of Health, and the Small Molecule Drug Development Shared Resource (Case Western Reserve University) was supported by Grant P30CA043703 from the National Institutes of Health.	Anand David Alexander Victor, 2016, Pharmacogn Rev, V10, P84, DOI 10.4103/0973-7847.194044; Athanasiou D, 2018, PROG RETIN EYE RES, V62, P1, DOI 10.1016/j.preteyeres.2017.10.002; Behnen P, 2018, ISCIENCE, V4, P1, DOI 10.1016/j.isci.2018.05.001; Belaunzaran-Zamudio Pablo F, 2017, Pathog Immun, V2, P151, DOI 10.20411/pai.v2i2.181; Bergler-Czop B, 2016, ACTA PHARMACEUT, V66, P471, DOI 10.1515/acph-2016-0039; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chen YY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04261-1; Chen Yuanyuan, 2015, Methods Mol Biol, V1271, P369, DOI 10.1007/978-1-4939-2330-4_24; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Comar WD, 2014, J AM CHEM SOC, V136, P8342, DOI 10.1021/ja501948w; Erlandson SC, 2018, ANNU REV BIOPHYS, V47, P1, DOI 10.1146/annurev-biophys-070317-032931; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Fan J, 2005, J PHYSIOL-LONDON, V568, P83, DOI 10.1113/jphysiol.2005.091942; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gao SQ, 2018, MOL PHARMACOL, V94, P1132, DOI 10.1124/mol.118.112581; Gao SQ, 2018, MOL PHARMACOL, V93, P438, DOI 10.1124/mol.117.111294; GENTRY AH, 1984, J ETHNOPHARMACOL, V11, P337, DOI 10.1016/0378-8741(84)90079-5; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Gragg M, 2018, BBA-MOL BASIS DIS, V1864, P2938, DOI 10.1016/j.bbadis.2018.06.004; Herrera-Hernandez MG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11391-x; Hashemzadeh M, 2015, REV CARDIOVASC MED, V16, P68, DOI 10.3909/ricm0754; Hassan NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15571-7; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hofmann L, 2016, ANAL BIOCHEM, V499, P63, DOI 10.1016/j.ab.2016.01.016; Hussain RM, 2018, EXPERT OPIN PHARMACO, V19, P471, DOI 10.1080/14656566.2018.1448060; Huvaere K, 2015, J SCI FOOD AGR, V95, P20, DOI 10.1002/jsfa.6796; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Jastrzebska Beata, 2015, Methods Mol Biol, V1271, P221, DOI 10.1007/978-1-4939-2330-4_15; Jastrzebska B, 2013, AMINO ACIDS, V45, P1303, DOI 10.1007/s00726-013-1593-y; Jastrzebska B, 2009, BIOCHEMISTRY-US, V48, P5159, DOI 10.1021/bi900284x; Jeong S, 2016, DRUG DES DEV THER, V10, P2211, DOI 10.2147/DDDT.S103370; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Li Y, 2017, FASEB J, V31, P2603, DOI 10.1096/fj.201601339R; Pinheiro GKLD, 2018, ARQ BRAS OFTALMOL, V81, P443, DOI 10.5935/0004-2749.20180086; Majumdar S, 2010, J PHARM PHARMACOL, V62, P951, DOI 10.1211/jpp.62.08.0001; Mallory DP, 2018, BIOCHEMISTRY-US, V57, P5188, DOI 10.1021/acs.biochem.8b00403; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; Milea D, 2015, GRAEF ARCH CLIN EXP, V253, P1839, DOI 10.1007/s00417-015-3167-z; Miyake S, 2012, LAB INVEST, V92, P102, DOI 10.1038/labinvest.2011.132; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mozaffarieh M, 2007, EXPERT OPIN EMERG DR, V12, P195, DOI 10.1517/14728214.12.2.195; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Noorwez SM, 2008, INVEST OPHTH VIS SCI, V49, P3224, DOI 10.1167/iovs.07-1539; Ohgane K, 2010, BIOORGAN MED CHEM, V18, P7022, DOI 10.1016/j.bmc.2010.08.014; Palczewski K, 2006, VISION RES, V46, P4425, DOI 10.1016/j.visres.2006.10.009; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parveen A, 2018, MOLECULES, V23, DOI 10.3390/molecules23071519; Parveen A, 2018, PHYTOMEDICINE, V39, P146, DOI 10.1016/j.phymed.2017.12.018; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Perusek L, 2013, NUTRIENTS, V5, P2646, DOI 10.3390/nu5072646; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Rhone M, 2008, NUTR REV, V66, P465, DOI 10.1111/j.1753-4887.2008.00078.x; Salom D, 2006, J STRUCT BIOL, V156, P497, DOI 10.1016/j.jsb.2006.05.003; Sassano MF, 2013, J MED CHEM, V56, P2406, DOI 10.1021/jm301749y; Semwal DK, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020090; SURYA A, 1995, J BIOL CHEM, V270, P5024, DOI 10.1074/jbc.270.10.5024; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Tirupula KC, 2009, PHOTOCHEM PHOTOBIOL, V85, P463, DOI 10.1111/j.1751-1097.2008.00533.x; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Tzekov R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007492; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Wen G, 2017, CHEM BIOL DRUG DES, V90, P580, DOI 10.1111/cbdd.12981; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Xin J, 2018, J ENZYM INHIB MED CH, V33, P1545, DOI 10.1080/14756366.2018.1509212; Yanamala N, 2009, PHOTOCHEM PHOTOBIOL, V85, P454, DOI 10.1111/j.1751-1097.2008.00517.x	76	18	18	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8101	8122		10.1074/jbc.RA119.007808	http://dx.doi.org/10.1074/jbc.RA119.007808			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30944172	Green Published, hybrid			2022-12-28	WOS:000470656500011
J	Tuladhar, R; Yarravarapu, N; Ma, YY; Zhang, CW; Herbert, J; Kim, J; Chen, C; Lum, L				Tuladhar, Rubina; Yarravarapu, Nageswari; Ma, Yuyong; Zhang, Chengwei; Herbert, Jeremiah; Kim, James; Chen, Chuo; Lum, Lawrence			Stereoselective fatty acylation is essential for the release of lipidated WNT proteins from the acyltransferase Porcupine (PORCN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt pathway; signal transduction; fatty acid; Wnt signaling; acyltransferase; posttranslational modification (PTM); fatty acylation; membrane-bound O-acyltransferase (MBOAT); palmitoleation; Porcupine (PORCN); Wntless (WLS)	BOUND O-ACYLTRANSFERASES; SECRETION; INHIBITION; PALMITOYLATION; IDENTIFICATION; RECOGNITION; WNTLESS; CANCER; TISSUE	The maintenance of adult animal tissues depends upon highly conserved intercellular signaling molecules that include the secreted WNT proteins. Although it is generally accepted that lipidation of WNTs by the acyltransferase Porcupine (PORCN) and their subsequent recognition by the Wntless (WLS) protein is essential for their cellular secretion, the molecular understanding of this process remains limited. Using structurally diverse fatty acyl donor analogs and mouse embryonic fibroblasts expressing PORCN protein from different metazoan phyla, we demonstrate here that PORCN active-site features, which are conserved across the animal kingdom, enforce cis-9 fatty acylation of WNTs. Aberrant acylation of a WNT with an exogenously supplied trans-9 fatty acid induced the accumulation of WNT-PORCN complexes, suggesting that the fatty acyl species is critical for the extrication of lipidated WNTs from PORCN. Our findings reveal a previously unrecognized fatty acyl-selective checkpoint in the manufacturing of a lipoprotein that forms a basis for WNT signaling sensitivity to trans fats and to PORCN inhibitors in clinical development.	[Tuladhar, Rubina; Yarravarapu, Nageswari; Herbert, Jeremiah; Lum, Lawrence] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Ma, Yuyong; Zhang, Chengwei; Chen, Chuo] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kim, James] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kim, James] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lum, L (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.; Chen, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Kim, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.; Kim, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	james.kim@utsouthwestern.edu; chuo.chen@utsouthwestern.edu; lawrence.lum@utsouthwestern.edu	Yarravarapu, Nageswari/AAY-7197-2021	Chen, Chuo/0000-0002-3118-4901; Yarravarapu, Nageswari/0000-0002-1975-0077	Welch Foundation [I-1665]; Cancer Prevention and Research Institute of Texas Grant [RP130212]; NCI, National Institutes of Health [1R01 CA168761]; American Cancer Society [RSG-16-090-01-TBG]; NATIONAL CANCER INSTITUTE [R01CA168761] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas Grant; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Welch Foundation Grant I-1665 (to L. L.); Cancer Prevention and Research Institute of Texas Grant RP130212 (to L. L. and C. C.); NCI, National Institutes of Health Grant 1R01 CA168761 (to J. K.); and American Cancer Society Grant RSG-16-090-01-TBG (to J. K). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Asciolla JJ, 2017, J BIOL CHEM, V292, P13507, DOI 10.1074/jbc.C117.800136; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep19665; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Dodge ME, 2012, J BIOL CHEM, V287, P23246, DOI 10.1074/jbc.M112.372029; Duraiswamy AJ, 2015, J MED CHEM, V58, P5889, DOI 10.1021/acs.jmedchem.5b00507; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Glaeser K, 2018, EMBO J, V37, DOI 10.15252/embj.201797311; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Janda CY, 2015, BIOCHEM SOC T, V43, P211, DOI 10.1042/BST20140249; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kulak O, 2013, JOVE-J VIS EXP, DOI 10.3791/50369; Lee CJ, 2019, J BIOL CHEM, V294, P231, DOI 10.1074/jbc.RA118.005746; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma D, 2018, NATURE, V562, P286, DOI 10.1038/s41586-018-0568-2; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; Miranda M, 2014, FEBS LETT, V588, P4815, DOI 10.1016/j.febslet.2014.11.016; Nile AH, 2017, P NATL ACAD SCI USA, V114, P4147, DOI 10.1073/pnas.1618293114; Nile AH, 2016, NAT CHEM BIOL, V12, P60, DOI [10.1038/NCHEMBIO.2005, 10.1038/nchembio.2005]; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tuladhar R, 2015, BIOCHEM SOC T, V43, P235, DOI 10.1042/BST20140282; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	40	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6273	6282		10.1074/jbc.RA118.007268	http://dx.doi.org/10.1074/jbc.RA118.007268			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30737280	Green Published, hybrid			2022-12-28	WOS:000468402000006
J	Wang, JC; Kinch, LN; Denard, B; Lee, CE; Gharehdaghi, EE; Grishin, N; Ye, J				Wang, Jingcheng; Kinch, Lisa N.; Denard, Bray; Lee, Ching-En; Gharehdaghi, Elina Esmaeilzadeh; Grishin, Nick; Ye, Jin			Identification of residues critical for topology inversion of the transmembrane protein TM4SF20 through regulated alternative translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; protein translocation; protein chimera; transmembrane domain; ceramide; TM4SF20; Topology	MEMBRANE-PROTEIN; ORGANIZATION; TRAM	Adopting a proper topology is crucial for transmembrane proteins to perform their functions. We previously reported that ceramide regulates a transmembrane protein called TM4SF20 (transmembrane 4 L six family member 20) through topological inversion by altering the direction through which the protein is translocated across membranes during translation. This regulatory mechanism, denoted regulated alternative translocation (RAT), depends on a GXXXN motif present in the first transmembrane helix of TM4SF20. Here, using site-directed mutagenesis, we show that Asn-26 in the motif is crucial for RAT of TM4SF20, as it cannot be replaced even by Gln. In contrast, Gly-22 in the motif could be substituted by other small residues such as Ala and Ser without affecting RAT of TM4SF20. We further demonstrate that the GXXXN motif alone is insufficient to induce RAT of a transmembrane protein because TM4SF4, a relative of TM4SF20 that also contains the motif in the first transmembrane helix, did not undergo RAT. Using TM4SF40-TM4SF20 chimeras, we identified Pro-29 of TM4SF20 as another important element required for RAT of the protein. Substituting Pro-29 alone did not affect RAT of TM4SF20, whereas replacing Pro-29 together with either Leu-25 or Val-17 of TM4SF20 with the corresponding residues of TM4SF4 abolished RAT of TM4SF20. Because Val-17, Gly-22, Leu-25, Asn-26, and Pro-29 are predicted to reside along the same surface of the transmembrane helix, our results suggest that interactions with other proteins mediated by this surface during translocation may be critical for RAT of TM4SF20.	[Wang, Jingcheng; Denard, Bray; Lee, Ching-En; Gharehdaghi, Elina Esmaeilzadeh; Ye, Jin] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys & Biochem, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ye, J (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Jin.Ye@UTSouthwestern.edu		Kinch, Lisa/0000-0003-3041-2615; Wang, Jingcheng/0000-0001-7109-3222	National Institutes of Health [GM-116106, HL-20948]; Welch Foundation [I-1832]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM-116106 and HL-20948 and Welch Foundation Grant I-1832 (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altenhoff AM, 2018, NUCLEIC ACIDS RES, V46, pD477, DOI 10.1093/nar/gkx1019; Bogdanov M, 2014, BBA-MOL CELL RES, V1843, P1475, DOI 10.1016/j.bbamcr.2013.12.007; Bogdanov M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404103; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Chen QY, 2016, MOL CELL, V63, P567, DOI 10.1016/j.molcel.2016.06.032; Chen QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108528; DeCaprio J., 2017, COLD SPRING HARB PRO, V2017; Denard B, 2012, ELIFE, V1, DOI 10.7554/eLife.00090; Denard B, 2011, CELL HOST MICROBE, V10, P65, DOI 10.1016/j.chom.2011.06.006; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; Huang YH, 2012, J COMPUT AID MOL DES, V26, P1171, DOI 10.1007/s10822-012-9607-5; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kearse MG, 2017, GENE DEV, V31, P1717, DOI 10.1101/gad.305250.117; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Langelaan DN, 2010, J CHEM INF MODEL, V50, P2213, DOI 10.1021/ci100324n; Lear JD, 2003, BIOCHEMISTRY-US, V42, P6400, DOI 10.1021/bi020573j; Mol A. R., 2018, 416347 BIORXIV; Rapoport TA, 2017, ANNU REV CELL DEV BI, V33, P369, DOI 10.1146/annurev-cellbio-100616-060439; Van Rhee A M, 1995, Drug Des Discov, V13, P133; Vitrac H, 2017, J BIOL CHEM, V292, P1613, DOI 10.1074/jbc.M116.765719; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Zhang J, 2014, NATURE, V509, P119, DOI 10.1038/nature13288; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	29	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6054	6061		10.1074/jbc.RA119.007681	http://dx.doi.org/10.1074/jbc.RA119.007681			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30808712	hybrid, Green Published			2022-12-28	WOS:000465077500035
J	Jeeva, S; Mir, S; Velasquez, A; Ragan, J; Leka, A; Wu, S; Sevarany, AT; Royster, AD; Almeida, NA; Chan, F; O'Brien, L; Mir, MA				Jeeva, Subbiah; Mir, Sheema; Velasquez, Adrain; Ragan, Jacquelyn; Leka, Aljona; Wu, Sharon; Sevarany, Ariga Tahmasian; Royster, Austin D.; Almeida, Nicholas A.; Chan, Fion; O'Brien, Lea; Mir, Mohammad Ayoub			Crimean-Congo hemorrhagic fever virus nucleocapsid protein harbors distinct RNA-binding sites in the stalk and head domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral replication; virology; viral protein; RNA-protein interaction; viral polymerase; C-C chemokine receptor type 5 (CCR5); CCHF; nucleocapsid	NUCLEOPROTEIN REVEALS; ENCAPSIDATION; INSIGHTS	Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne Nairovirus that causes severe hemorrhagic fever with a mortality rate of up to 30% in certain outbreaks worldwide. The virus has wide endemic distribution. There is no effective antiviral therapeutic or FDA approved vaccine for this zoonotic viral illness. The multifunctional CCHFV nucleocapsid protein (N protein) plays a crucial role in the establishment of viral infection and is an important structural component of the virion. Here we show that CCHFV N protein has a distant RNA-binding site in the stalk domain that specifically recognizes the vRNA panhandle, formed by the base pairing of complementary nucleotides at the 5' and 3' termini of the vRNA genome. Using multiple approaches, including filter-bonding analysis, GFP reporter assay, and biolayer interferometry we observed an N protein-panhandle interaction both in vitro and in vivo. The purified WT CCHFV N protein and the stalk domain also recognize the vRNA panhandle of hazara virus, another Nairovirus in the family Bunyaviridae, demonstrating the genus-specific nature of N protein-panhandle interaction. Another RNA-binding site was identified at the head domain of CCHFV N protein that nonspecifically recognizes the single strand RNA (ssRNA) of viral or nonviral origin. Expression of CCHFV N protein stalk domain active in panhandle binding, dramatically inhibited the hazara virus replication in cell culture, illustrating the role of N protein-panhandle interaction in Nairovirus replication. Our findings reveal the stalk domain of N protein as a potential target in therapeutic interventions to manage CCHFV disease.	[Jeeva, Subbiah; Ragan, Jacquelyn; Mir, Mohammad Ayoub] Western Univ Hlth Sci, Pomona, CA 91766 USA; [Mir, Sheema] Appl BioCode, Santa Fe Springs, CA 90670 USA; [Velasquez, Adrain; Leka, Aljona; Wu, Sharon; Sevarany, Ariga Tahmasian; Royster, Austin D.; Almeida, Nicholas A.; Chan, Fion; O'Brien, Lea] Calif State Polytech Univ Pomona, Coll Sci, Pomona, CA 91766 USA	Western University of Health Sciences; California State University System; California State Polytechnic University Pomona	Mir, MA (corresponding author), Western Univ Hlth Sci, Pomona, CA 91766 USA.	mmir@westernu.edu		Mir, Sheema/0000-0001-7279-8734	National Institutes of Health [1R15AI126395-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI126395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 1R15AI126395-01A1 (to M. A. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksoy D, 2018, AGRI, V30, P12, DOI 10.5505/agri.2017.76259; Bergeron E, 2010, J VIROL, V84, P216, DOI 10.1128/JVI.01859-09; Carter SD, 2012, J VIROL, V86, P10914, DOI 10.1128/JVI.01555-12; Elliot R.M., 2000, VIRUS TAXONOMY, P599; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Ergonul O, 2008, ANTIVIR RES, V78, P125, DOI 10.1016/j.antiviral.2007.11.002; Flick R, 2005, CURR MOL MED, V5, P753, DOI 10.2174/156652405774962335; Flick R, 2002, J VIROL, V76, P10849, DOI 10.1128/JVI.76.21.10849-10860.2002; Ganaie SS, 2014, BIOCHEM J, V464, P109, DOI 10.1042/BJ20140449; Ghaemi Z, 2017, J PHYS CHEM B, V121, P8437, DOI 10.1021/acs.jpcb.7b04318; Gunes Turabi, 2006, Mikrobiyoloji Bulteni, V40, P279; Guo Y, 2012, P NATL ACAD SCI USA, V109, P5046, DOI 10.1073/pnas.1200808109; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Hussein ITM, 2012, J VIROL, V86, P7520, DOI 10.1128/JVI.07204-11; Jeeva S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184935; Jeeva S, 2017, J VIROL, V91, DOI [10.1128/JVI.00636-17, 10.1128/jvi.00636-17]; JIN H, 1993, J GEN VIROL, V74, P2293, DOI 10.1099/0022-1317-74-10-2293; Koksal I, 2014, EPIDEMIOL INFECT, V142, P239, DOI 10.1017/S0950268813001155; Labuda M, 2004, PARASITOLOGY, V129, pS221, DOI 10.1017/S0031182004005220; Macleod JML, 2015, J GEN VIROL, V96, P524, DOI 10.1099/vir.0.071332-0; Mir MA, 2010, J BIOL CHEM, V285, P11357, DOI 10.1074/jbc.M110.102459; Mourya DT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001653; Olal D, 2014, NUCLEIC ACIDS RES, V42, P6025, DOI 10.1093/nar/gku229; Oncu Serkan, 2013, Virologica Sinica, V28, P193, DOI 10.1007/s12250-013-3327-4; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Reguera J, 2013, P NATL ACAD SCI USA, V110, P7246, DOI 10.1073/pnas.1302298110; Salim NN, 2016, J BIOL CHEM, V291, P24702, DOI 10.1074/jbc.M116.750729; Sargianou M, 2013, EXPERT REV ANTI-INFE, V11, P897, DOI 10.1586/14787210.2013.827890; Schmaljohn C, 2001, FIELDS VIROLOGY, P1581; SWANEPOEL R, 1987, AM J TROP MED HYG, V36, P120, DOI 10.4269/ajtmh.1987.36.120; Swanepoel R., 1994, INFECT DIS LIVESTOCK, P723; Uyar Y, 2010, MIKROBIYOL BUL, V44, P57; Wang Y, 2012, J VIROL, V86, P12294, DOI 10.1128/JVI.01627-12; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001	37	8	8	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5023	5037		10.1074/jbc.RA118.004976	http://dx.doi.org/10.1074/jbc.RA118.004976			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30723154	Green Published, hybrid			2022-12-28	WOS:000463985600025
J	Ozaslan, D; Wang, S; Ahmed, BA; Kocabas, AM; McCastlain, JC; Kilic, F				Ozaslan, Deniz; Wang, Sophie; Ahmed, Billow A.; Kocabas, Arif M.; McCastlain, John C.; Kilic, Fusun			Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter: A specific role for sialic acid residues (Expression of Concern of Vol 278, Pg 43991, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Ozaslan D, 2003, J BIOL CHEM, V278, P43991, DOI 10.1074/jbc.M306360200	1	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5210	5210		10.1074/jbc.EC119.008297	http://dx.doi.org/10.1074/jbc.EC119.008297			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30926758	hybrid, Green Published			2022-12-28	WOS:000463985600042
J	Emmott, E; de Rougemont, A; Hosmillo, M; Lu, J; Fitzmaurice, T; Haas, J; Goodfellow, I				Emmott, Edward; de Rougemont, Alexis; Hosmillo, Myra; Lu, Jia; Fitzmaurice, Timothy; Haas, Juergen; Goodfellow, Ian			Polyprotein processing and intermolecular interactions within the viral replication complex spatially and temporally control norovirus protease activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease; fluorescence resonance energy transfer (FRET); viral replication; plus-stranded RNA virus; RNA virus; Calicivirus; Norovirus; Precursor	MURINE NOROVIRUS; RNA-SYNTHESIS; PROTEINASE-POLYMERASE; VIRUS; CLEAVAGE; INITIATION; VPG; DISCOVERY; PRECURSOR; RECEPTOR	Norovirus infections are a major cause of acute viral gastroenteritis and a significant burden on global human health. A vital process for norovirus replication is the processing of the nonstructural polyprotein by a viral protease into the viral components required to form the viral replication complex. This cleavage occurs at different rates, resulting in the accumulation of stable precursor forms. Here, we characterized how precursor forms of the norovirus protease accumulate during infection. Using stable forms of the protease precursors, we demonstrated that all of them are proteolytically active in vitro, but that when expressed in cells, their activities are determined by both substrate and protease localization. Although all precursors could cleave a replication complex-associated substrate, only a subset of precursors lacking the NS4 protein were capable of efficiently cleaving a cytoplasmic substrate. By mapping the full range of protein-protein interactions among murine and human norovirus proteins with the LUMIER assay, we uncovered conserved interactions between replication complex members that modify the localization of a protease precursor subset. Finally, we demonstrate that fusion to the membrane-bound replication complex components permits efficient cleavage of a fused substrate when active polyprotein-derived protease is provided in trans. These findings offer a model for how norovirus can regulate the timing of substrate cleavage throughout the replication cycle. Because the norovirus protease represents a key target in antiviral therapies, an improved understanding of its function and regulation, as well as identification of interactions among the other nonstructural proteins, offers new avenues for antiviral drug design.	[Emmott, Edward; Hosmillo, Myra; Lu, Jia; Fitzmaurice, Timothy; Goodfellow, Ian] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Hills Rd, Cambridge CB2 0QQ, England; [de Rougemont, Alexis] Univ Hosp Dijon Bourgogne, Natl Reference Ctr Gastroenteritis Viruses Labol, F-21700 Dijon, France; [de Rougemont, Alexis] Bourgogne Franche Comte Univ, AgroSup Dijon, PAM, UMR A 02 102, F-21000 Dijon, France; [Haas, Juergen] Univ Edinburgh, Med Sch, Div Infect & Pathway Med, Edinburgh EH16 4SB, Midlothian, Scotland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Edinburgh	Goodfellow, I (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Hills Rd, Cambridge CB2 0QQ, England.; Emmott, E (corresponding author), Northeastern Univ, Dept Bioengn, 360 Huntington Ave, Boston, MA 02115 USA.	e.emmott@northeastern.edu; ig299@cam.ac.uk	de ROUGEMONT, Alexis/M-1090-2016	de ROUGEMONT, Alexis/0000-0002-3084-9414; Fitzmaurice, Tim/0000-0003-1403-2495; Lu, Jia/0000-0003-3995-324X; Goodfellow, Ian/0000-0002-9483-510X; Emmott, Edward/0000-0002-3239-8178; Hosmillo, Myra/0000-0002-3514-7681	Cambridge National Institute for Health Research Cambridge Biomedical Research Centre Cell Phenotyping Hub; BBSRC [BB/I012303/1, BB/N001176/1] Funding Source: UKRI	Cambridge National Institute for Health Research Cambridge Biomedical Research Centre Cell Phenotyping Hub; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Cambridge National Institute for Health Research Cambridge Biomedical Research Centre Cell Phenotyping Hub. The authors declare that they have no conflicts of interest with the contents of this article.	Arias A, 2012, JOVE-J VIS EXP, DOI 10.3791/4145; Arias A, 2013, FUTURE MICROBIOL, V8, P1475, DOI 10.2217/fmb.13.109; Bailey D, 2010, J GEN VIROL, V91, P739, DOI 10.1099/vir.0.016279-0; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Barrios-Rodiles M, 2017, METHODS MOL BIOL, V1550, P137, DOI 10.1007/978-1-4939-6747-6_11; Belliot G, 2005, J VIROL, V79, P2393, DOI 10.1128/JVI.79.4.2393-2403.2005; Cameron CE, 2010, FUTURE MICROBIOL, V5, P867, DOI 10.2217/FMB.10.40; Chaudhry Y, 2007, J GEN VIROL, V88, P2091, DOI 10.1099/vir.0.82940-0; Chung L, 2014, J BIOL CHEM, V289, P21738, DOI 10.1074/jbc.M114.550657; Cotton BT, 2017, J VIROL, V91, DOI 10.1128/JVI.02138-16; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Emmott E, 2017, MOL CELL PROTEOMICS, V16, pS215, DOI 10.1074/mcp.M116.062448; Emmott E, 2015, J BIOL CHEM, V290, P27841, DOI 10.1074/jbc.M115.688234; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Haga K, 2016, P NATL ACAD SCI USA, V113, pE6248, DOI 10.1073/pnas.1605575113; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Hwang S., 2014, CURR PROTOC MICROBIO, V33, p15K21, DOI DOI 10.1002/9780471729259.MC15K02S33; Hyde JL, 2010, VIROLOGY, V406, P138, DOI 10.1016/j.virol.2010.06.047; Hyde JL, 2009, J VIROL, V83, P9709, DOI 10.1128/JVI.00600-09; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kaiser WJ, 2006, J GEN VIROL, V87, P363, DOI 10.1099/vir.0.81456-0; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Karst SM, 2016, J MED VIROL, V88, P1837, DOI 10.1002/jmv.24559; Karst SM, 2015, ANNU REV VIROL, V2, P525, DOI 10.1146/annurev-virology-100114-055204; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; May J, 2013, VIROLOGY, V444, P218, DOI 10.1016/j.virol.2013.06.013; Medvedev A, 2017, VIROLOGY, V503, P37, DOI 10.1016/j.virol.2017.01.003; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Oh HS, 2009, J VIROL, V83, P9370, DOI 10.1128/JVI.02076-08; Olspert A, 2016, PEERJ, V4, DOI 10.7717/peerj.2134; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Pathak Harsh B, 2008, J Biol Chem, V283, P30677, DOI 10.1074/jbc.M806101200; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; Reid CR, 2015, VIRUSES-BASEL, V7, P4385, DOI 10.3390/v7082825; Rocha-Pereira J, 2016, CURR OPIN VIROL, V20, P92, DOI 10.1016/j.coviro.2016.09.009; Rohayem J, 2006, J VIROL, V80, P7060, DOI 10.1128/JVI.02195-05; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scheffler U, 2007, J GEN VIROL, V88, P2013, DOI 10.1099/vir.0.82797-0; SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Subba-Reddy CV, 2011, J VIROL, V85, P13027, DOI 10.1128/JVI.06191-11; Thorne L, 2012, J VIROL, V86, P11441, DOI 10.1128/JVI.00439-12; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Vashist S, 2012, J VIROL, V86, P11977, DOI 10.1128/JVI.00432-12; Vashist S, 2012, J VIROL METHODS, V184, P69, DOI 10.1016/j.jviromet.2012.05.012; Viswanathan P, 2013, VIROLOGY, V438, P20, DOI 10.1016/j.virol.2013.01.006; Wei L, 2001, J VIROL, V75, P1211, DOI 10.1128/JVI.75.3.1211-1219.2001	48	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4259	4271		10.1074/jbc.RA118.006780	http://dx.doi.org/10.1074/jbc.RA118.006780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30647130	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000461854400035
J	Nakamichi, Y; Fouquet, T; Ito, S; Watanabe, M; Matsushika, A; Inoue, H				Nakamichi, Yusuke; Fouquet, Thierry; Ito, Shotaro; Watanabe, Masahiro; Matsushika, Akinori; Inoue, Hiroyuki			Structural and functional characterization of a bifunctional GH30-7 xylanase B from the filamentous fungus Talaromyces cellulolyticus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; X-ray crystallography; enzyme structure; polysaccharide; mass spectrometry (MS); glucuronoxylanase; glycoside hydrolase family 30; Talaromyces cellulolyticus; xylobiohydrolase; xylooligosaccharide	HYDROLASE FAMILY 30; GLUCURONOXYLAN-SPECIFIC XYLANASE; ACREMONIUM-CELLULOLYTICUS; THERMOTOGA-MARITIMA; EXO-MODE; STRAIN; SYSTEM; IMPROVEMENT; RECOGNITION; ENZYMES	Glucuronoxylanases are endo-xylanases and members of the glycoside hydrolase family 30 subfamilies 7 (GH30-7) and 8 (GH30-8). Unlike for the well-studied GH30-8 enzymes, the structural and functional characteristics of GH30-7 enzymes remain poorly understood. Here, we report the catalytic properties and three-dimensional structure of GH30-7 xylanase B (Xyn30B) identified from the cellulolytic fungus Talaromyces cellulolyticus. Xyn30B efficiently degraded glucuronoxylan to acidic xylooligosaccharides (XOSs), including an -1,2-linked 4-O-methyl-d-glucuronosyl substituent (MeGlcA). Rapid analysis with negative-mode electrospray-ionization multistage MS (ESI(-)-MSn) revealed that the structures of the acidic XOS products are the same as those of the hydrolysates (MeGlcA(2)Xyl(n), n > 2) obtained with typical glucuronoxylanases. Acidic XOS products were further degraded by Xyn30B, releasing first xylobiose and then xylotetraose and xylohexaose as transglycosylation products. This hydrolase reaction was unique to Xyn30B, and the substrate was cleaved at the xylobiose unit from its nonreducing end, indicating that Xyn30B is a bifunctional enzyme possessing both endo-glucuronoxylanase and exo-xylobiohydrolase activities. The crystal structure of Xyn30B was determined as the first structure of a GH30-7 xylanase at 2.25 resolution, revealing that Xyn30B is composed of a pseudo-(/)(8)-catalytic domain, lacking an 6 helix, and a small -rich domain. This structure and site-directed mutagenesis clarified that Arg(46), conserved in GH30-7 glucuronoxylanases, is a critical residue for MeGlcA appendage-dependent xylan degradation. The structural comparison between Xyn30B and the GH30-8 enzymes suggests that Asn(93) in the 2-2 loop is involved in xylobiohydrolase activity. In summary, our findings indicate that Xyn30B is a bifunctional endo- and exo-xylanase.	[Nakamichi, Yusuke; Watanabe, Masahiro; Matsushika, Akinori; Inoue, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Bioconvers Grp, 3-11-32 Kagamiyama, Hiroshima 7390046, Japan; [Ito, Shotaro] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Biobased Mat Chem, 3-11-32 Kagamiyama, Hiroshima 7390046, Japan; [Fouquet, Thierry] AIST, Res Inst Sustainable Chem, Polymer Chem Grp, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan; [Matsushika, Akinori] Hiroshima Univ, Grad Sch Adv Sci Matter, 1-3-1 Kagamiyama, Hiroshima 7398530, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Hiroshima University	Inoue, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Sustainable Chem, Hiroshima 7390046, Japan.	inoue-h@aist.go.jp	Nakamichi, Yusuke/Y-2830-2019; Nakamichi, Yusuke/H-1221-2018; Ito, Shotaro/L-5701-2016; Inoue, Hiroyuki/AAQ-3226-2020; Fouquet, Thierry/O-1679-2013; Inoue, Hiroyuki/L-9990-2016; Matsushika, Akinori/B-8721-2018	Nakamichi, Yusuke/0000-0001-7089-663X; Nakamichi, Yusuke/0000-0001-7089-663X; Ito, Shotaro/0000-0001-5212-7466; Inoue, Hiroyuki/0000-0003-0190-2893; Fouquet, Thierry/0000-0002-9473-9425; Inoue, Hiroyuki/0000-0003-0190-2893; Matsushika, Akinori/0000-0002-5283-2875; Watanabe, Masahiro/0000-0001-5211-1333				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adav SS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012419; [Anonymous], 2018, PYMOL MOL GRAPHICS S; Biely P, 2014, FEBS J, V281, P3894, DOI 10.1111/febs.12925; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Cataldi TRI, 2000, FRESEN J ANAL CHEM, V368, P739, DOI 10.1007/s002160000588; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang X, 2009, J BIOSCI BIOENG, V107, P256, DOI 10.1016/j.jbiosc.2008.11.022; Fouquet T, 2019, J MASS SPECTROM, V54, P213, DOI 10.1002/jms.4321; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fujii T, 2018, FUNGAL CELLULOLYTIC, P58; Fujii T, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00014-15; Fujii T, 2012, BIOSCI BIOTECH BIOCH, V76, P245, DOI 10.1271/bbb.110498; Fushinobu S, 2005, J BIOL CHEM, V280, P17180, DOI 10.1074/jbc.M413693200; Gatard S, 2017, CARBOHYD RES, V451, P72, DOI 10.1016/j.carres.2017.09.012; Hurlbert JC, 2001, J BACTERIOL, V183, P2093, DOI 10.1128/JB.183.6.2093-2100.2001; Inoue H, 2013, J IND MICROBIOL BIOT, V40, P823, DOI 10.1007/s10295-013-1286-2; Jiang ZQ, 2004, J BIOTECHNOL, V114, P125, DOI 10.1016/j.jbiotec.2004.05.007; Jiang ZQ, 2001, J BIOSCI BIOENG, V92, P423, DOI [10.1263/jbb.92.423, 10.1016/S1389-1723(01)80290-5]; John FJS, 2006, J BACTERIOL, V188, P8617, DOI 10.1128/JB.01283-06; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karnaouri A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00281; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kolbusz MA, 2014, FUNGAL GENET BIOL, V72, P10, DOI 10.1016/j.fgb.2014.05.006; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larson SB, 2003, BIOCHEMISTRY-US, V42, P8411, DOI 10.1021/bi034144c; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo HY, 2010, APPL MICROBIOL BIOT, V86, P1829, DOI 10.1007/s00253-009-2410-0; Maehara T, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01850-17; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Padilha IQM, 2014, INT MICROBIOL, V17, P175, DOI 10.2436/20.1501.01.220; Peterson R, 2012, MICROBIOL-SGM, V158, P58, DOI 10.1099/mic.0.054031-0; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Reis A, 2003, CARBOHYD RES, V338, P1497, DOI 10.1016/S0008-6215(03)00196-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos CR, 2014, J BIOL CHEM, V289, P7362, DOI 10.1074/jbc.M113.537167; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; St John F.J., 2016, J MOL CATAL B-ENZYM, V133, pS445, DOI [10.1016/j.molcatb.2017.03.008, DOI 10.1016/J.MOLCATB.2017.03.008]; St John FJ, 2018, BIOCHEM J, V475, P1533, DOI 10.1042/BCJ20180050; St John FJ, 2014, ACTA CRYSTALLOGR D, V70, P2950, DOI 10.1107/S1399004714019531; St John FJ, 2011, J MOL BIOL, V407, P92, DOI 10.1016/j.jmb.2011.01.010; St John FJ, 2010, FEBS LETT, V584, P4435, DOI 10.1016/j.febslet.2010.09.051; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Suchova K, 2018, ARCH BIOCHEM BIOPHYS, V643, P42, DOI 10.1016/j.abb.2018.02.014; Tenkanen M, 2013, FEBS J, V280, P285, DOI 10.1111/febs.12069; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Urbanikova L, 2011, FEBS J, V278, P2105, DOI 10.1111/j.1742-4658.2011.08127.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valenzuela SV, 2012, APPL ENVIRON MICROB, V78, P3923, DOI 10.1128/AEM.07932-11; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao YY, 2008, PROTEIN ENG DES SEL, V21, P561, DOI 10.1093/protein/gzn033; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	59	30	30	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4065	4078		10.1074/jbc.RA118.007207	http://dx.doi.org/10.1074/jbc.RA118.007207			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655295	Green Published, hybrid			2022-12-28	WOS:000461854400020
J	Stewart, M				Stewart, Murray			Polyadenylation and nuclear export of mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						nuclear transport; polyadenylation; RNA splicing; nuclear pore; RNA helicase; RNA binding protein; gene expression pathway; nuclear posttranscriptional modification; ribonuclear protein (RNP); spliceosome	BOX PROTEIN DBP5; POLY(A) BINDING-PROTEIN; STRUCTURAL BASIS; POLYADENOSINE-RNA; PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; FACTOR YRA1; NAB2; YEAST; END	In eukaryotes, the separation of translation from transcription by the nuclear envelope enables mRNA modifications such as capping, splicing, and polyadenylation. These modifications are mediated by a spectrum of ribonuclear proteins that associate with preRNA transcripts, coordinating the different steps and coupling them to nuclear export, ensuring that only mature transcripts reach the cytoplasmic translation machinery. Although the components of this machinery have been identified and considerable functional insight has been achieved, a number of questions remain outstanding about mRNA nuclear export and how it is integrated into the nuclear phase of the gene expression pathway. Nuclear export factors mediate mRNA transit through nuclear pores to the cytoplasm, after which these factors are removed from the mRNA, preventing transcripts from returning to the nucleus. However, as outlined in this review, several aspects of the mechanism by which transport factor binding and release are mediated remain unclear, as are the roles of accessory nuclear components in these processes. Moreover, the mechanisms by which completion of mRNA splicing and polyadenylation are recognized, together with how they are coordinated with nuclear export, also remain only partially characterized. One attractive hypothesis is that dissociating poly(A) polymerase from the cleavage and polyadenylation machinery could signal completion of mRNA maturation and thereby provide a mechanism for initiating nuclear export. The impressive array of genetic, molecular, cellular, and structural data that has been generated about these systems now provides many of the tools needed to define the precise mechanisms involved in these processes and how they are integrated.	[Stewart, Murray] MRC, Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	ms@mrc-lmb.cam.ac.uk			Medical Research Council (MRC) [MC_U105178939, MC-A025-5PL41, MC_UP_1201/6]; Leverhulme Emeritus Fellowship [EM-2016-062]; MRC [MC_U105178939, MC_UP_1201/6] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Emeritus Fellowship(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Medical Research Council (MRC) Grants MC_U105178939, MC-A025-5PL41, and MC_UP_1201/6 and Leverhulme Emeritus Fellowship EM-2016-062 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aibara S, 2017, NUCLEIC ACIDS RES, V45, P1529, DOI 10.1093/nar/gkw1224; Aibara S, 2015, NUCLEIC ACIDS RES, V43, P1883, DOI 10.1093/nar/gkv032; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Batisse J, 2009, J BIOL CHEM, V284, P34911, DOI 10.1074/jbc.M109.062034; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Bonnet A, 2015, NUCLEIC ACIDS RES, V43, P4249, DOI 10.1093/nar/gkv280; Brockmann C, 2012, STRUCTURE, V20, P1007, DOI 10.1016/j.str.2012.03.011; Casanal A, 2017, SCIENCE, V358, P1056, DOI 10.1126/science.aao6535; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Eckmann CR, 2011, WIRES RNA, V2, P348, DOI 10.1002/wrna.56; Estruch F, 2003, MOL BIOL CELL, V14, P1664, DOI 10.1091/mbc.E02-09-0602; Ezeokonkwo C, 2012, FEBS LETT, V586, P1173, DOI 10.1016/j.febslet.2012.03.036; Ezeokonkwo C, 2011, RNA, V17, P652, DOI 10.1261/rna.2273111; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; Fica SM, 2017, NAT STRUCT MOL BIOL, V24, P791, DOI 10.1038/nsmb.3463; Gonzalez-Aguilera C, 2011, MOL BIOL CELL, V22, P2729, DOI 10.1091/mbc.E11-01-0055; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Hautbergue GM, 2008, P NATL ACAD SCI USA, V105, P5154, DOI 10.1073/pnas.0709167105; Helming S, 2001, MOL CELL BIOL, V21, P2026, DOI 10.1128/MCB.21.6.2026-2037.2001; Hocine S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000752; Hodge CA, 2011, GENE DEV, V25, P1052, DOI 10.1101/gad.2041611; Hurt E, 2000, J BIOL CHEM, V275, P8361, DOI 10.1074/jbc.275.12.8361; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Iglesias N, 2010, GENE DEV, V24, P1927, DOI 10.1101/gad.583310; Jani D, 2012, NUCLEIC ACIDS RES, V40, P4562, DOI 10.1093/nar/gks059; Johnson SA, 2011, NAT STRUCT MOL BIOL, V18, P1164, DOI 10.1038/nsmb.2126; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Katahira J, 2015, GENES-BASEL, V6, P163, DOI 10.3390/genes6020163; Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; Kelly SM, 2014, RNA, V20, P681, DOI 10.1261/rna.043984.113; Kelly SM, 2010, J BIOL CHEM, V285, P26022, DOI 10.1074/jbc.M110.141127; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kim SJ, 2018, NATURE, V555, P475, DOI 10.1038/nature26003; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kushn U, 2017, RNA, V23, P473, DOI 10.1261/rna.057026.116; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Leija-Martinez N, 2014, NUCLEIC ACIDS RES, V42, P13963, DOI 10.1093/nar/gku1249; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Lin DH, 2019, ANN REV BIOCH; Liu SM, 2005, J MOL BIOL, V349, P515, DOI 10.1016/j.jmb.2005.04.003; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Ma WK, 2013, J MOL BIOL, V425, P3824, DOI 10.1016/j.jmb.2013.05.016; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Martin G, 2008, BBA-GENE REGUL MECH, V1779, P206, DOI 10.1016/j.bbagrm.2007.12.003; Misra A, 2016, RNA BIOL, V13, P259, DOI 10.1080/15476286.2015.1112490; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Muller-McNicoll M, 2016, GENE DEV, V30, P553, DOI 10.1101/gad.276477.115; Natalizio BJ, 2013, TRENDS CELL BIOL, V23, P365, DOI 10.1016/j.tcb.2013.03.006; Nino CA, 2013, CHEM REV, V113, P8523, DOI 10.1021/cr400002g; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; Qu XP, 2009, MOL CELL BIOL, V29, P5327, DOI 10.1128/MCB.00468-09; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Schmidt HB, 2016, TRENDS BIOCHEM SCI, V41, P46, DOI 10.1016/j.tibs.2015.11.001; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; Shi M, 2017, NUCLEIC ACIDS RES, V45, P9640, DOI 10.1093/nar/gkx597; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; Singh G, 2015, ANNU REV BIOCHEM, V84, P325, DOI 10.1146/annurev-biochem-080111-092106; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Soucek S, 2016, MOL CELL BIOL, V36, P2697, DOI 10.1128/MCB.00402-16; Soucek S, 2012, BBA-GENE REGUL MECH, V1819, P546, DOI 10.1016/j.bbagrm.2012.03.006; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stewart M, 2010, TRENDS BIOCHEM SCI, V35, P609, DOI 10.1016/j.tibs.2010.07.001; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Teplova M, 2011, NAT STRUCT MOL BIOL, V18, P990, DOI 10.1038/nsmb.2094; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tran EJ, 2014, BBA-MOL CELL RES, V1843, P2784, DOI 10.1016/j.bbamcr.2014.08.003; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; Valkov E, 2012, BBA-GENE REGUL MECH, V1819, P578, DOI 10.1016/j.bbagrm.2012.02.017; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wickramasinghe VO, 2014, NUCLEIC ACIDS RES, V42, P5059, DOI 10.1093/nar/gku095; Wickramasinghe VO, 2010, NUCLEUS-AUSTIN, V1, P393, DOI 10.4161/nucl.1.5.12351; Zahn R, 2016, ELIFE, V5, DOI 10.7554/eLife.14119; Zheng C, 2010, J BIOL CHEM, V285, P20704, DOI 10.1074/jbc.M110.107276; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	88	45	46	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					2977	2987		10.1074/jbc.REV118.005594	http://dx.doi.org/10.1074/jbc.REV118.005594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30683695	Green Published, hybrid			2022-12-28	WOS:000464980100001
J	Hu, TJ; Schreiter, FC; Bagchi, RA; Tatman, PD; Hannink, M; McKinsey, TA				Hu, Tianjing; Schreiter, Friederike C.; Bagchi, Rushita A.; Tatman, Philip D.; Hannink, Mark; McKinsey, Timothy A.			HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone deacetylase (HDAC); cardiac hypertrophy; oxidative stress; mitochondria; nuclear factor 2 (erythroid-derived 2-like factor; NFE2L2; Nrf2); cardiomyocyte; histone deacetylase; mitochondria; NRF2; oxidative stress	HISTONE DEACETYLASES; DISEASE; HEART; UBIQUITINATION; HYPERTROPHY; REPRESSION; INHIBITORS; ROLES; MEF2A	Histone deacetylase 5 (HDAC5) and HDAC9 are class IIa HDACs that function as signal-responsive repressors of the epigenetic program for pathological cardiomyocyte hypertrophy. The conserved deacetylase domains of HDAC5 and HDAC9 are not required for inhibition of cardiac hypertrophy. Thus, the biological function of class IIa HDAC catalytic activity in the heart remains unknown. Here we demonstrate that catalytic activity of HDAC5, but not HDAC9, suppresses mitochondrial reactive oxygen species generation and subsequent induction of NF-E2-related factor 2 (NRF2)-dependent antioxidant gene expression in cardiomyocytes. Treatment of cardiomyocytes with TMP195 or TMP269, which are selective class IIa HDAC inhibitors, or shRNA-mediated knockdown of HDAC5 but not HDAC9 leads to stimulation of NRF2-mediated transcription in a reactive oxygen species-dependent manner. Conversely, ectopic expression of catalytically active HDAC5 decreases cardiomyocyte oxidative stress and represses NRF2 activation. These findings establish a role of the catalytic domain of HDAC5 in the control of cardiomyocyte redox homeostasis and define TMP195 and TMP269 as a novel class of NRF2 activators that function by suppressing the enzymatic activity of an epigenetic regulator.	[Hu, Tianjing; Bagchi, Rushita A.; McKinsey, Timothy A.] Univ Colorado, Dept Med, Div Cardiol, Anschutz Med Campus, Aurora, CO 80045 USA; [Hu, Tianjing; Bagchi, Rushita A.; McKinsey, Timothy A.] Univ Colorado, Consortium Fibrosis Res & Translat, Anschutz Med Campus, Aurora, CO 80045 USA; [Tatman, Philip D.] Univ Colorado, Med Scientist Training Program, Anschutz Med Campus, Aurora, CO 80045 USA; [Schreiter, Friederike C.] Heidelberg Univ, Dept Mol Cardiol & Epigenet, Heidelberg, Germany; [Hannink, Mark] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Hannink, Mark] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Schreiter, Friederike C.] German Ctr Cardiovasc Res, Heidelberg, Germany	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Ruprecht Karls University Heidelberg; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; German Centre for Cardiovascular Research	McKinsey, TA (corresponding author), Univ Colorado, Dept Med, Div Cardiol, Anschutz Med Campus, Aurora, CO 80045 USA.; McKinsey, TA (corresponding author), Univ Colorado, Consortium Fibrosis Res & Translat, Anschutz Med Campus, Aurora, CO 80045 USA.	timothy.mckinsey@ucdenver.edu	Bagchi, Rushita/U-5038-2017	Bagchi, Rushita/0000-0002-9075-0766; Hu, Tianjing/0000-0002-5798-5395	National Institutes of Health [HL116848, HL127240]; American Heart Association [16SFRN31400013]; German Centre for Cardiovascular Research (Deutsches Zentrum fur Herz-Kreislauf-Forschung); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116848, R01HL127240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); German Centre for Cardiovascular Research (Deutsches Zentrum fur Herz-Kreislauf-Forschung); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL116848 and HL127240 and American Heart Association Grant 16SFRN31400013 (to T. A. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the German Centre for Cardiovascular Research (Deutsches Zentrum fur Herz-Kreislauf-Forschung).	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bai Y, 2013, J MOL CELL CARDIOL, V57, P82, DOI 10.1016/j.yjmcc.2013.01.008; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; Eba S, 2013, AM J RESP CELL MOL, V49, P324, DOI 10.1165/rcmb.2011-0396OC; Ferguson BS, 2013, P NATL ACAD SCI USA, V110, P9806, DOI 10.1073/pnas.1301509110; Gardin JM, 2004, JAMA-J AM MED ASSOC, V292, P2396, DOI 10.1001/jama.292.19.2396; Gheorghiade M, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002727; Gonzalez-Hernandez MB, 2012, JOVE-J VIS EXP, DOI 10.3791/4297; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Heltweg B, 2004, J MED CHEM, V47, P5235, DOI 10.1021/jm0497592; Hendrick E, 2017, ONCOGENE, V36, P4859, DOI 10.1038/onc.2017.103; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Hur W, 2010, CHEM BIOL, V17, P537, DOI 10.1016/j.chembiol.2010.03.013; Ichikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008391; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Kern JT, 2007, CURR TOP MED CHEM, V7, P972, DOI 10.2174/156802607780906825; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lemon DD, 2015, FEBS LETT, V589, P1080, DOI 10.1016/j.febslet.2015.03.017; Lemon DD, 2011, J MOL CELL CARDIOL, V51, P41, DOI 10.1016/j.yjmcc.2011.04.005; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Lobera M, 2013, NAT CHEM BIOL, V9, P319, DOI [10.1038/nchembio.1223, 10.1038/NCHEMBIO.1223]; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Oka SI, 2009, J MOL MED, V87, P785, DOI 10.1007/s00109-009-0471-2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; von Hardenberg A, 2017, HANDB EXP PHARMACOL, V243, P491, DOI 10.1007/164_2016_123; Xing YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044899; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	41	21	22	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8640	8652		10.1074/jbc.RA118.007006	http://dx.doi.org/10.1074/jbc.RA118.007006			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30962285	hybrid, Green Published			2022-12-28	WOS:000471108200030
J	Yang, D; Yan, Y; Yang, X; Liu, J; Zheng, GL; Xie, LP; Zhang, RQ				Yang, Dong; Yan, Yi; Yang, Xue; Liu, Jun; Zheng, Guilan; Xie, Liping; Zhang, Rongqing			A basic protein, N25, from a mollusk modifies calcium carbonate morphology and shell biomineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomineralization; protein secretion; vesicles; extracellular matrix protein; protein folding; attachment energy; calcite binding protein; morphological simulation; N25	ACIDIC MATRIX PROTEIN; PEARL OYSTER; KEY MACROMOLECULE; PRISMATIC LAYER; SIGNAL PEPTIDES; NACREOUS LAYER; FAMILY; CRYSTALLIZATION; IDENTIFICATION; POLYMORPHISM	Biomineralization is a widespread biological process in the formation of shells, teeth, or bones. Matrix proteins in biominerals have been widely investigated for their roles in directing biomineralization processes such as crystal morphologies, polymorphs, and orientations. Here, we characterized a basic matrix protein, named mantle protein N25 (N25), identified previously in the Akoya pearl oyster (Pinctada fucata). Unlike some known acidic matrix proteins containing Asp or Glu as possible Ca2+-binding residues, we found that N25 is rich in Pro (12.4%), Ser (12.8%), and Lys (8.8%), suggesting it may perform a different function. We used the recombinant protein purified by refolding from inclusion bodies in a Ca(HCO3)(2) supersaturation system and found that it specifically affects calcite morphologies. An X-ray powder diffraction (XRD) assay revealed that N25 could help delay the transformation of vaterites (a metastable calcium carbonate polymorph) to calcite. We also used fluorescence super-resolution imaging to map the distribution of N25 in CaCO3 crystals and transfected a recombinant N25-EGFP vector into HEK-293T cells to mimic the native process in which N25 is secreted by mantle epithelial cells and integrated into mineral structures. Our observations suggest N25 specifically affects crystal morphologies and provide evidence that basic proteins lacking acidic groups can also direct biomineralization. We propose that the attachment of N25 to specific sites on CaCO3 crystals may inhibit some crystal polymorphs or morphological transformation.	[Yang, Dong; Yan, Yi; Yang, Xue; Liu, Jun; Zheng, Guilan; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Inst Marine Biotechnol, Sch Life Sci, Collaborat Innovat Ctr Deep Sea Biol, Beijing 100084, Peoples R China; [Zhang, Rongqing] Tsinghua Univ, Yangtze Delta Reg Inst, Dept Biotechnol & Biomed, Jiaxing 314006, Zhejiang, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP; Zhang, RQ (corresponding author), Tsinghua Univ, Inst Marine Biotechnol, Sch Life Sci, Collaborat Innovat Ctr Deep Sea Biol, Beijing 100084, Peoples R China.; Zhang, RQ (corresponding author), Tsinghua Univ, Yangtze Delta Reg Inst, Dept Biotechnol & Biomed, Jiaxing 314006, Zhejiang, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Science Foundation of China [31872543, 31372502, 31502139, 31572594]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science Foundation of China Projects 31872543, 31372502, 31502139, and 31572594. The authors declare that they have no conflicts of interest with the contents of this article.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Aizenberg J, 1999, J AM CHEM SOC, V121, P4500, DOI 10.1021/ja984254k; Arias J.L., 2007, BIOMINERALIZATION PA; Baeuerlein E., 2007, HDB BIOMINERALIZATIO, V2, P89; Bahn SY, 2015, CRYST GROWTH DES, V15, P3666, DOI 10.1021/acs.cgd.5b00275; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Burgess R. R., 2009, GUIDE PROTEIN PURIFI, P201; Cantaert B, 2012, ADV FUNCT MATER, V22, P907, DOI 10.1002/adfm.201102385; CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050; DOCHERTY R, 1991, J PHYS D APPL PHYS, V24, P89, DOI 10.1088/0022-3727/24/2/001; Dujardin E, 2002, ADV ENG MATER, V4, P461, DOI 10.1002/1527-2648(20020717)4:7<461::AID-ADEM461>3.0.CO;2-K; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Fu MF, 2016, ANGEW CHEM INT EDIT, V55, P908, DOI 10.1002/anie.201508010; Fujimura Takuya, 1995, Venus the Japanese Journal of Malacology, V54, P25; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Gries K, 2011, CRYST GROWTH DES, V11, P729, DOI 10.1021/cg101240e; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Liu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17269; Liu J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1524-2; Lowenstam H. A., 1989, BIOMINERALISATION, P6; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Malini RI, 2017, CRYST GROWTH DES, V17, P5811, DOI 10.1021/acs.cgd.7b00874; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; McGinty EL, 2012, MAR GENOM, V5, P27, DOI 10.1016/j.margen.2011.08.006; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Metzler RA, 2010, J AM CHEM SOC, V132, P6329, DOI 10.1021/ja909735y; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Pan C, 2014, J BIOL CHEM, V289, P2776, DOI 10.1074/jbc.M113.504027; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rinkevich B, 2011, MAR BIOTECHNOL, V13, P345, DOI 10.1007/s10126-010-9354-3; Rohl AL, 2003, CURR OPIN SOLID ST M, V7, P21, DOI 10.1016/S1359-0286(03)00019-6; ROSE RA, 1994, AQUACULTURE, V126, P35, DOI 10.1016/0044-8486(94)90246-1; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Su JT, 2013, BIOCHEM J, V453, P179, DOI 10.1042/BJ20130285; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2013, CAN J ZOOL, V91, P349, DOI 10.1139/cjz-2012-0333; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; Wilt FH, 2003, DIFFERENTIATION, V71, P237, DOI 10.1046/j.1432-0436.2003.7104501.x; Yan Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06375-w; Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179	57	13	14	3	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8371	8383		10.1074/jbc.RA118.007338	http://dx.doi.org/10.1074/jbc.RA118.007338			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30967473	Green Published, hybrid			2022-12-28	WOS:000471108200008
J	Kuan, II; Lee, CC; Chen, CH; Lu, J; Kuo, YS; Wu, HC				Kuan, I-I; Lee, Chi-Chiu; Chen, Chien-Hsu; Lu, Jean; Kuo, Yuan-Sung; Wu, Han-Chung			The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR-LIN28-LET7 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mesenchymal stem cells (MSCs); epithelial cell adhesion molecule (EpCAM); epidermal growth factor receptor (EGFR); pluripotency; proliferation; HMGA2; Lin28; multipotency	DNA ARCHITECTURAL FACTOR; GROUP PROTEIN HMGA2; TRANSCRIPTION FACTOR; EXPRESSION PATTERNS; SELF-RENEWAL; BONE; OCT4; DIFFERENTIATION; SOX2; PLURIPOTENCY	Mesenchymal stem cells (MSCs) are widely considered to be an attractive cell source for regenerative therapies, but maintaining multipotency and self-renewal in cultured MSCs is especially challenging. Hence, the development and mechanistic description of strategies that help promote multipotency in MSCs will be vital to future clinical use. Here, using an array of techniques and approaches, including cell biology, RT-quantitative PCR, immunoblotting, immunofluorescence, flow cytometry, and ChIP assays, we show that the extracellular domain of epithelial cell adhesion molecule (EpCAM) (EpEX) significantly increases the levels of pluripotency factors through a signaling cascade that includes epidermal growth factor receptor (EGFR), signal transducer and activator of transcription 3 (STAT3), and Lin-28 homolog A (LIN28) and enhances the proliferation of human bone marrow MSCs. Moreover, we found that EpEX-induced LIN28 expression reduces the expression of the microRNA LET7 and up-regulates that of the transcription factor high-mobility group AT-hook 2 (HMGA2), which activates the transcription of pluripotency factors. Surprisingly, we found that EpEX treatment also enhances osteogenesis of MSCs under differentiation conditions, as evidenced by increases in osteogenic markers, including Runt-related transcription factor 2 (RUNX2). Taken together, our results indicate that EpEX stimulates EGFR signaling and thereby context-dependently controls MSC states and activities, promoting cell proliferation and multipotency under maintenance conditions and osteogenesis under differentiation conditions.	[Kuan, I-I; Lee, Chi-Chiu; Chen, Chien-Hsu; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Lu, Jean; Wu, Han-Chung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Kuo, Yuan-Sung] Natl Taiwan Univ, Dept Surg, Coll Med, Taipei 100, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Wu, HC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169	Ministry of Science and Technology [106-0210-01-15-02, 107-0210-01-19-01]; Academia Sinica	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Academia Sinica and Ministry of Science and Technology Grants 106-0210-01-15-02 and 107-0210-01-19-01. The authors declare that they have no conflicts of interest with the contents of this article.	Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bittle GJ, 2018, CIRC RES, V123, P288, DOI 10.1161/CIRCRESAHA.117.311206; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brighton CT, 1997, J ORTHOP TRAUMA, V11, P244, DOI 10.1097/00005131-199705000-00002; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Cheng L, 2007, J PATHOL, V211, P1, DOI 10.1002/path.2105; Chien CS, 2015, CANCER RES, V75, P2553, DOI 10.1158/0008-5472.CAN-14-2215; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Cleynen I, 2008, INT J ONCOL, V32, P289; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Duque G, 2008, CURR OPIN RHEUMATOL, V20, P429, DOI 10.1097/BOR.0b013e3283025e9c; Fang XF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-11; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Ge W, 2009, AM J TRANSPLANT, V9, P1760, DOI 10.1111/j.1600-6143.2009.02721.x; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617; Kim JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007166; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Kuan II, 2017, SCI REP-UK, V7, DOI 10.1038/srep41852; Le Blanc K, 2018, CYTOTHERAPY, V20, P273, DOI 10.1016/j.jcyt.2018.01.009; Lee H, 2016, PROTEIN CELL, V7, P100, DOI 10.1007/s13238-015-0212-y; Lengler J, 2005, OPHTHALMIC RES, V37, P301, DOI 10.1159/000087774; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Li O, 2007, FEBS LETT, V581, P3533, DOI 10.1016/j.febslet.2007.06.072; Li O, 2006, GENESIS, V44, P523, DOI 10.1002/dvg.20242; Li ZZ, 2012, DEV CELL, V23, P1176, DOI 10.1016/j.devcel.2012.10.019; Liang KH, 2018, CANCER LETT, V433, P165, DOI 10.1016/j.canlet.2018.06.040; Liao TT, 2016, CELL REP, V14, P520, DOI 10.1016/j.celrep.2015.12.064; Lin CW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386235; Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Liu LF, 2010, J CELL PHYSIOL, V225, P837, DOI 10.1002/jcp.22291; Liu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083083; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mahajan A, 2010, MODERN PATHOL, V23, P673, DOI 10.1038/modpathol.2010.49; Markovic A, 2012, EXPERT REV ANTICANC, V12, P1149, DOI [10.1586/ERA.12.91, 10.1586/era.12.91]; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matic Igor, 2016, Open Access Maced J Med Sci, V4, P9, DOI 10.3889/oamjms.2016.008; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Monzen K, 2008, NAT CELL BIOL, V10, P567, DOI 10.1038/ncb1719; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oryan A, 2017, CELLS TISSUES ORGANS, V204, P59, DOI 10.1159/000469704; Oshima K, 2005, BIOCHEM BIOPH RES CO, V331, P520, DOI 10.1016/j.bbrc.2005.03.210; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pan M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006624; Peng Guang-Hua, 2013, Methods Mol Biol, V935, P311, DOI 10.1007/978-1-62703-080-9_22; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pfannkuche K, 2009, STEM CELL REV REP, V5, P224, DOI 10.1007/s12015-009-9078-9; Pierantozzi E, 2011, STEM CELLS DEV, V20, P915, DOI 10.1089/scd.2010.0353; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854; Rawlinson NJ, 2008, CANCER GENET CYTOGEN, V181, P119, DOI 10.1016/j.cancergencyto.2007.11.008; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Reim G, 2002, DEVELOPMENT, V129, P917; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stefani G, 2015, RNA, V21, P985, DOI 10.1261/rna.045542.114; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taniguchi N, 2011, J BIOL CHEM, V286, P41489, DOI 10.1074/jbc.M111.236984; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Triboulet R, 2015, CELL REP, V13, P260, DOI 10.1016/j.celrep.2015.08.086; Valero MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029760; Wang TZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0402-5; Wei JJ, 2010, AM J SURG PATHOL, V34, P18, DOI 10.1097/PAS.0b013e3181be5d72; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yeom SY, 2014, MOL CANCER THER, V13, P3049, DOI 10.1158/1535-7163.MCT-14-0244; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x	87	9	10	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7769	7786		10.1074/jbc.RA119.007386	http://dx.doi.org/10.1074/jbc.RA119.007386			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30926604	Green Published, hybrid			2022-12-28	WOS:000470153300020
J	Pergu, R; Dagar, S; Kumar, H; Kumar, R; Bhattacharya, J; Mylavarapu, SVS				Pergu, Rajaiah; Dagar, Sunayana; Kumar, Harsh; Kumar, Rajesh; Bhattacharya, Jayanta; Mylavarapu, Sivaram V. S.			The chaperone ERp29 is required for tunneling nanotube formation by stabilizing MSec	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-cell interaction; endoplasmic reticulum (ER); chaperone; plasma membrane; protein stability; protein-disulfide isomerase; post-translational modification (PTM); chaperone; endoplasmic reticulum; intercellular communication; MSec; tunneling nanotubes; endoplasmic reticulum protein 29 (ERP29); TNF-induced protein 2 (TNAIP2); interactome	ENDOPLASMIC-RETICULUM PROTEIN; SQUAMOUS-CELL CARCINOMA; MEMBRANE NANOTUBES; IN-VIVO; INTERCELLULAR CONNECTIONS; MITOCHONDRIAL TRANSFER; STROMAL CELLS; BINDING-SITE; CA2+ SIGNALS; TNFAIP2	Tunneling nanotubes (TNTs) are membrane conduits that mediate long-distance intercellular cross-talk in several organisms and play vital roles during development, pathogenic transmission, and cancer metastasis. However, the molecular mechanisms of TNT formation and function remain poorly understood. The protein MSec (also known as TNF-induced protein 2 (TNFAIP2) and B94) is essential for TNT formation in multiple cell types. Here, using affinity protein purification, mass spectrometric identification, and confocal immunofluorescence microscopy assays, we found that MSec interacts with the endoplasmic reticulum (ER) chaperone ERp29. siRNA-mediated ERp29 depletion in mammalian cells significantly reduces TNT formation, whereas its overexpression induces TNT formation, but in a strictly MSec-dependent manner. ERp29 stabilized MSec protein levels, but not its mRNA levels, and the chaperone activity of ERp29 was required for maintaining MSec protein stability. Subcellular ER fractionation and subsequent limited proteolytic treatment suggested that MSec is associated with the outer surface of the ER. The ERp29-MSec interaction appeared to require the presence of other bridging protein(s), perhaps triggered by post-translational modification of ERp29. Our study implicates MSec as a target of ERp29 and reveals an indispensable role for the ER in TNT formation, suggesting new modalities for regulating TNT numbers in cells and tissues.	[Pergu, Rajaiah; Dagar, Sunayana; Kumar, Harsh; Mylavarapu, Sivaram V. S.] NCR Biotech Sci Cluster, Reg Ctr Biotechnol, Lab Cellular Dynam, Faridabad 121001, Haryana, India; [Kumar, Rajesh; Bhattacharya, Jayanta] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, HIV Vaccine Translat Res Lab, Faridabad 121001, Haryana, India; [Pergu, Rajaiah; Kumar, Harsh; Mylavarapu, Sivaram V. S.] Manipal Acad Higher Educ, Manipal 576104, Karnataka, India; [Dagar, Sunayana; Mylavarapu, Sivaram V. S.] Kalinga Inst Ind Technol, Bhubaneswar 751024, Odisha, India	Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Manipal Academy of Higher Education (MAHE); Kalinga Institute of Industrial Technology (KIIT)	Mylavarapu, SVS (corresponding author), NCR Biotech Sci Cluster, Reg Ctr Biotechnol, Lab Cellular Dynam, Faridabad 121001, Haryana, India.	sivaram@rcb.res.in	Kumar, Harsh/AAE-6792-2019; Dagar, Sunayana/AAX-5387-2020; Pergu, Rajaiah/AAO-1014-2020	Kumar, Harsh/0000-0003-2384-2115; Dagar, Sunayana/0000-0002-5070-9232	Regional Centre for Biotechnology (RCB); DBT National Bioscience Grant [BT/HRD/NBA/34/01/2012]	Regional Centre for Biotechnology (RCB); DBT National Bioscience Grant	This work was supported by institutional funding from the Regional Centre for Biotechnology (RCB) (to S. V. S. M.). The HIV experiments were supported by research funding from DBT National Bioscience Grant Award BT/HRD/NBA/34/01/2012 (to J. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Abounit Saida, 2015, Curr Protoc Cell Biol, V67, DOI 10.1002/0471143030.cb1210s67; Ariazi J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00333; Arkwright PD, 2010, CELL RES, V20, P72, DOI 10.1038/cr.2009.112; Armijo-Weingart L, 2017, MOL CELL NEUROSCI, V84, P36, DOI 10.1016/j.mcn.2017.03.007; Austefjord Magnus Wiger, 2014, Commun Integr Biol, V7, pe27934, DOI 10.4161/cib.27934; Bambang IF, 2013, ONCOGENE, V32, P1240, DOI 10.1038/onc.2012.149; Barak NN, 2009, J MOL BIOL, V385, P1630, DOI 10.1016/j.jmb.2008.11.052; Barnewitz K, 2004, J BIOL CHEM, V279, P39829, DOI 10.1074/jbc.M406839200; Baryshev M, 2006, BIOCHEM BIOPH RES CO, V340, P617, DOI 10.1016/j.bbrc.2005.12.052; Barzilai S, 2016, J LEUKOCYTE BIOL, V99, P1045, DOI 10.1189/jlb.3VMA0915-427R; Brunkard JO, 2017, CURR OPIN PLANT BIOL, V35, P76, DOI 10.1016/j.pbi.2016.11.007; Caneparo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020230; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Chen CC, 2014, ONCOGENE, V33, P3648, DOI 10.1038/onc.2013.345; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; Cheng Z, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0142-9; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Connor Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9671; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Das S, 2009, MOL BIOL CELL, V20, P2593, DOI 10.1091/mbc.E08-07-0790; Einstein MH, 2002, CLIN CANCER RES, V8, P549; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; Gonzalez-Mendez L, 2017, ELIFE, V6, DOI 10.7554/eLife.24045; Gousset K, 2013, J CELL SCI, V126, P4424, DOI 10.1242/jcs.129239; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Grumbach Y, 2014, AM J PHYSIOL-CELL PH, V307, pC701, DOI 10.1152/ajpcell.00134.2014; Guescini M, 2012, EXP CELL RES, V318, P603, DOI 10.1016/j.yexcr.2012.01.005; Guo W, 2007, REPRODUCTION, V133, P575, DOI 10.1530/REP-06-0301; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Hashimoto M, 2016, J IMMUNOL, V196, P1832, DOI 10.4049/jimmunol.1500845; Hubbard MJ, 2000, EUR J BIOCHEM, V267, P1945, DOI 10.1046/j.1432-1327.2000.01193.x; Huettner JE, 2006, STEM CELLS, V24, P1654, DOI 10.1634/stemcells.2005-0003; Hurtig J, 2010, WIRES NANOMED NANOBI, V2, P260, DOI 10.1002/wnan.80; Jackson MV, 2016, STEM CELLS, V34, P2210, DOI 10.1002/stem.2372; Jia L, 2016, ONCOGENE, V35, P2040, DOI 10.1038/onc.2015.263; Kimura S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33548; Kimura S, 2012, EXP CELL RES, V318, P1699, DOI 10.1016/j.yexcr.2012.05.013; Kobayashi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003822; Kondratiev S, 2011, AM J SURG PATHOL, V35, P1531, DOI 10.1097/PAS.0b013e31822bd476; Kornberg TB, 2014, DEVELOPMENT, V141, P729, DOI 10.1242/dev.086223; LaCava J, 2015, BIOTECHNIQUES, V58, P103, DOI 10.2144/000114262; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Lock JT, 2016, CELL CALCIUM, V60, P266, DOI 10.1016/j.ceca.2016.06.004; Lou Emil, 2012, Commun Integr Biol, V5, P399, DOI 10.4161/cib.20569; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Ma HH, 2012, MOL CELL PROTEOMICS, V11, P501, DOI 10.1074/mcp.O111.016246; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; MacLeod JC, 2004, J COMP NEUROL, V477, P29, DOI 10.1002/cne.20222; Marlein CR, 2017, BLOOD, V130, P1649, DOI 10.1182/blood-2017-03-772939; Martinez MG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006061; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McKinney MC, 2011, DEV DYNAM, V240, P1391, DOI 10.1002/dvdy.22612; Mkrtchian S, 2006, ANTIOXID REDOX SIGN, V8, P325, DOI 10.1089/ars.2006.8.325; Mukerji J, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-33; Niedenberger BA, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.161323; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Olinares PDB, 2016, ANAL CHEM, V88, P2799, DOI 10.1021/acs.analchem.5b04477; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Patil S, 2016, J VIROL, V90, P3446, DOI 10.1128/JVI.03090-15; Pawar A, 2016, CELL SIGNAL, V28, P1225, DOI 10.1016/j.cellsig.2016.05.023; Peralta B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001667; Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009; Polak R, 2015, BLOOD, V126, P2404, DOI 10.1182/blood-2015-03-634238; Potriquet J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175967; Pyrgaki C, 2010, DEV BIOL, V344, P941, DOI 10.1016/j.ydbio.2010.06.010; Rainey-Barger EK, 2007, MOL BIOL CELL, V18, P1253, DOI 10.1091/mbc.E06-11-1004; Rainey-Barger EK, 2009, J VIROL, V83, P1483, DOI 10.1128/JVI.02057-08; Roberts KL, 2015, J VIROL, V89, P1537, DOI 10.1128/JVI.03306-14; Rusiniak ME, 2000, CANCER RES, V60, P1824; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Rustom A, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160057; Rytlewski JA, 2015, MICROVASC RES, V99, P26, DOI 10.1016/j.mvr.2015.02.005; Sainath R, 2015, CELL TISSUE RES, V359, P267, DOI 10.1007/s00441-014-1955-0; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Sargsyan E, 2002, J BIOL CHEM, V277, P17009, DOI 10.1074/jbc.M200539200; Schiller C, 2013, J CELL SCI, V126, P767, DOI 10.1242/jcs.114033; Seyed-Razavi Y, 2013, IMMUNOL CELL BIOL, V91, P89, DOI 10.1038/icb.2012.52; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Shnyder SD, 2002, J HISTOCHEM CYTOCHEM, V50, P557, DOI 10.1177/002215540205000413; Sisakhtnezhad S, 2015, EUR J CELL BIOL, V94, P429, DOI 10.1016/j.ejcb.2015.06.010; Smith IF, 2011, BIOPHYS J, V100, pL37, DOI 10.1016/j.bpj.2011.03.007; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Suaud L, 2011, J BIOL CHEM, V286, P21239, DOI 10.1074/jbc.M111.240267; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Takahashi A, 2013, J CELL BIOCHEM, V114, P1238, DOI 10.1002/jcb.24433; Teddy JM, 2004, DEVELOPMENT, V131, P6141, DOI 10.1242/dev.01534; Thayanithy V, 2014, TRANSL RES, V164, P359, DOI 10.1016/j.trsl.2014.05.011; Thayanithy V, 2014, EXP CELL RES, V323, P178, DOI 10.1016/j.yexcr.2014.01.014; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; VIDUGIRIENE J, 1994, J CELL BIOL, V127, P333, DOI 10.1083/jcb.127.2.333; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang TZ, 2006, INT J CARDIOL, V109, P74, DOI 10.1016/j.ijcard.2005.05.072; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wang Y, 2011, CELL DEATH DIFFER, V18, P732, DOI 10.1038/cdd.2010.147; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xie YB, 2017, ONCOL REP, V37, P2920, DOI 10.3892/or.2017.5557; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064973; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109318; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507	105	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7177	7193		10.1074/jbc.RA118.005659	http://dx.doi.org/10.1074/jbc.RA118.005659			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877198	Green Published, hybrid			2022-12-28	WOS:000468402900008
J	Chatterjee, KS; Tripathi, V; Das, R				Chatterjee, Kiran Sankar; Tripathi, Vasvi; Das, Ranabir			A conserved and buried edge-to-face aromatic interaction in small ubiquitin-like modifier (SUMO) has a role in SUMO stability and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); nuclear magnetic resonance (NMR); SUMO-interacting motif (SIM); sumoylation; protein structure; protein misfolding; aromatic interactions; aromatic ring; aromatic triad; protein dynamics	MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; HYDROPHOBIC CORE; PI-INTERACTIONS; HUMAN CYTOMEGALOVIRUS; PROTEIN STABILITY; SUMOYLATION; BINDING; PHOSPHORYLATION; MACROMOLECULES	Aromatic amino acids buried at a protein's core are often involved in mutual paired interactions. Ab initio energy calculations have highlighted that the conformational orientations and the effects of substitutions are important for stable aromatic interactions among aromatic rings, but studies in the context of a protein's fold and function are elusive. Small ubiquitin-like modifier (SUMO) is a common post-translational modifier that affects diverse cellular processes. Here, we report that a highly conserved aromatic triad of three amino acids, Phe(36)-Tyr(51)-Phe(64), is a unique SUMO signature that is absent in other ubiquitin-like homologous folds. We found that a specific edge-to-face conformation between the Tyr(51)-Phe(64) pair of interacting aromatics is vital to the fold and stability of SUMO. Moreover, the noncovalent binding of SUMO-interacting motif (SIM) at the SUMO surface was critically dependent on the paired aromatic interactions buried at the core. NMR structural studies revealed that perturbation of the Tyr(51)-Phe(64) conformation disrupts several long-range tertiary contacts in SUMO, leading to a heterogeneous and dynamic protein with attenuated SUMOylation both in vitro and in cells. A subtle perturbation of the edge-to-face conformation by a Tyr to Phe substitution significantly decreased stability, SUMO/SIM affinity, and the rate of SUMOylation. Our results highlight that absolute co-conservation of specific aromatic pairs inside the SUMO protein core has a role in its stability and function.	[Chatterjee, Kiran Sankar; Tripathi, Vasvi; Das, Ranabir] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Das, R (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, Karnataka, India.	rana@ncbs.res.in		Tripathi, Vasvi/0000-0002-9438-5049	Tata Institute of Fundamental Research; DBT-Ramalingaswamy Fellowship [BT/HRD/23/02/2006]	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); DBT-Ramalingaswamy Fellowship	This work was supported by the Tata Institute of Fundamental Research and DBT-Ramalingaswamy Fellowship BT/HRD/23/02/2006 (to R. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Berndt A, 2009, J VIROL, V83, P12881, DOI 10.1128/JVI.01525-09; Bhattacharya S, 2018, J PHYS CHEM B, V122, P9128, DOI 10.1021/acs.jpcb.8b06844; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Burroughs AM, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-4; Cappadocia L, 2015, STRUCTURE, V23, P126, DOI 10.1016/j.str.2014.10.015; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Cockroft SL, 2007, ORG BIOMOL CHEM, V5, P1062, DOI 10.1039/b617576g; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feligioni M, 2015, AIMS MOL SCI, V2, P382, DOI 10.3934/molsci.2015.4.382; Fischer FR, 2008, CHEM COMMUN, P4031, DOI 10.1039/b809058k; Frank BS, 2002, PROTEIN SCI, V11, P680, DOI 10.1110/ps.22202; Gardarsson H, 2014, CHEM-EUR J, V20, P4608, DOI 10.1002/chem.201304810; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hill RB, 1998, J AM CHEM SOC, V120, P1138, DOI 10.1021/ja9733649; Hillier BJ, 1998, FOLD DES, V3, P87, DOI 10.1016/S1359-0278(98)00014-5; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; HUNTER CA, 1991, J MOL BIOL, V218, P837, DOI 10.1016/0022-2836(91)90271-7; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11259, DOI 10.1021/bi00093a001; Jiang X, 2012, BIOCHEMISTRY-US, V51, P9480, DOI 10.1021/bi301329w; KELLIS JT, 1989, BIOCHEMISTRY-US, V28, P4914, DOI 10.1021/bi00437a058; Kim E, 1998, J AM CHEM SOC, V120, P11192, DOI 10.1021/ja982620u; Kim ET, 2010, J VIROL, V84, P8111, DOI 10.1128/JVI.00459-10; Kim ET, 2009, BIOCHEM BIOPH RES CO, V388, P41, DOI 10.1016/j.bbrc.2009.07.103; KNELLER DG, 1993, J CELL BIOCHEM, P254; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lee EC, 2005, J AM CHEM SOC, V127, P4530, DOI 10.1021/ja037454r; Lee SY, 2014, J MOL BIOL, V426, P1377, DOI 10.1016/j.jmb.2013.10.042; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; PALIWAL S, 1994, J AM CHEM SOC, V116, P4497, DOI 10.1021/ja00089a057; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodriguez HM, 2000, PROTEIN SCI, V9, P1993, DOI 10.1110/ps.9.10.1993; Rott R, 2017, P NATL ACAD SCI USA, V114, P13176, DOI 10.1073/pnas.1704351114; Sabate R, 2012, BIOMACROMOLECULES, V13, P1916, DOI 10.1021/bm3004385; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Surana P, 2016, PROTEIN SCI, V25, P1438, DOI 10.1002/pro.2940; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wheeler SE, 2011, J AM CHEM SOC, V133, P10262, DOI 10.1021/ja202932e; Wheeler SE, 2009, MOL PHYS, V107, P749, DOI 10.1080/00268970802537614	54	11	11	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6772	6784		10.1074/jbc.RA118.006642	http://dx.doi.org/10.1074/jbc.RA118.006642			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30824543	hybrid, Green Published			2022-12-28	WOS:000467394700015
J	Peng, B; Ortega, J; Gu, LY; Chang, ZJ; Li, GM				Peng, Bo; Ortega, Janice; Gu, Liya; Chang, Zhijie; Li, Guo-Min			Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3/Snail signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage response; DNA mismatch repair; phosphorylation; epithelial-mesenchymal transition (EMT); cancer biology; cell migration; G(2); M arrest; PCNA; proliferating cell nuclear antigen; ATM signaling; Snail; cancer; kinase cascade; posttranslational regulation; metastasis	EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR; MISMATCH REPAIR; BREAST-CANCER; PCNA; EXPRESSION; PROTEIN; CARCINOMA; MARKERS; ALPHA	Proliferating cell nuclear antigen (PCNA) and its posttranslational modifications regulate DNA metabolic reactions, including DNA replication and repair, at replication forks. PCNA phosphorylation at Tyr-211 (PCNA-Y211p) inhibits DNA mismatch repair and induces misincorporation during DNA synthesis. Here, we describe an unexpected role of PCNA-Y211p in cancer promotion and development. Cells expressing phosphorylation-mimicking PCNA, PCNA-Y211D, show elevated hallmarks specific to the epithelial-mesenchymal transition (EMT), including the up-regulation of the EMT-promoting factor Snail and the down-regulation of EMT-inhibitory factors E-cadherin and GSK3. The PCNA-Y211D-expressing cells also exhibited active cell migration and underwent G(2)/M arrest. Interestingly, all of these EMT-associated activities required the activation of ATM and Akt kinases, as inactivating these protein kinases by gene knockdown or inhibitors blocked EMT-associated signaling and cell migration. We concluded that PCNA phosphorylation promotes cancer progression via the ATM/Akt/GSK3/Snail signaling pathway. In conclusion, this study identifies a novel PCNA function and reveals the molecular basis of phosphorylated PCNA-mediated cancer development and progression.	[Peng, Bo; Chang, Zhijie] Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R China; [Ortega, Janice; Gu, Liya; Li, Guo-Min] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Tsinghua University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Li, GM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	guo-min.li@utsouthwestern.edu	Chang, Zhijie/AAH-8109-2019	Chang, Zhijie/0000-0003-1567-3227; Ortega, Janice/0000-0002-1193-0532; Li, Guo-Min/0000-0002-9842-4578	NCI, National Institutes of Health [A167181]; Cancer Prevention and Research Institute of Texas [RR160101]; Tsinghua-Peking Joint Center for Life Sciences	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas; Tsinghua-Peking Joint Center for Life Sciences	This work was supported by NCI, National Institutes of Health Grant A167181 and the Cancer Prevention and Research Institute of Texas Grant RR160101 (to G.-M. L). This work was also supported by Tsinghua-Peking Joint Center for Life Sciences. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe T, 2014, DNA REPAIR, V22, P153, DOI 10.1016/j.dnarep.2014.08.003; [Anonymous], 2009, PCNA CROSSROAD CANC; Ben-Izhak O, 2002, HISTOPATHOLOGY, V41, P519, DOI 10.1046/j.1365-2559.2002.01444.x; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; GRANDIS JR, 1993, CANCER RES, V53, P3579; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Grille SJ, 2003, CANCER RES, V63, P2172; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; GULLICK WJ, 1991, BRIT MED BULL, V47, P87, DOI 10.1093/oxfordjournals.bmb.a072464; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoffmann I, 2000, PROTOPLASMA, V211, P8, DOI 10.1007/BF01279894; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Jurikova M, 2016, ACTA HISTOCHEM, V118, P544, DOI 10.1016/j.acthis.2016.05.002; Kabeche L, 2018, SCIENCE, V359, P108, DOI 10.1126/science.aan6490; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Korpanty GJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00204; Lee YJ, 2010, AM J PHYSIOL-RENAL, V298, pF1263, DOI 10.1152/ajprenal.00475.2009; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Liu LL, 2014, HEPATOLOGY, V59, P531, DOI 10.1002/hep.26677; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Malkas LH, 2006, P NATL ACAD SCI USA, V103, P19472, DOI 10.1073/pnas.0604614103; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ortega J, 2015, P NATL ACAD SCI USA, V112, P5667, DOI 10.1073/pnas.1417711112; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sarkaria JN, 1998, CANCER RES, V58, P4375; Shaw Leslie M, 2005, Methods Mol Biol, V294, P97; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun MN, 2012, J MOL CELL BIOL, V4, P304, DOI 10.1093/jmcb/mjs048; TILLOTSON JK, 1991, CANCER LETT, V60, P109, DOI 10.1016/0304-3835(91)90216-5; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Weber AM, 2015, PHARMACOL THERAPEUT, V149, P124, DOI 10.1016/j.pharmthera.2014.12.001; Weinberg RA, 2014, BIOLOGY OF CANCER, SECOND EDITION, P1; Yazinski SA, 2016, ANNU REV GENET, V50, P155, DOI 10.1146/annurev-genet-121415-121658; Ying TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29385; Zhao D, 2017, NATURE, V542, P484, DOI 10.1038/nature21357; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	56	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7037	7045		10.1074/jbc.RA119.007897	http://dx.doi.org/10.1074/jbc.RA119.007897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30858175	hybrid, Green Published			2022-12-28	WOS:000467394700035
J	Tauber, D; Parker, R				Tauber, Devin; Parker, Roy			15-Deoxy-(12,14)-prostaglandin J2 promotes phosphorylation of eukaryotic initiation factor 2 and activates the integrated stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prostaglandin; eukaryotic initiation factor 2 (eIF2); stress granule; stress response; neuroinflammation; proteasome	UNFOLDED PROTEIN RESPONSE; TRANSGENIC MOUSE MODEL; GRANULES; INHIBITION; SUPPRESSION; TRIAL; TRANSLATION; NEURONS; MEMORY; RNA	Stress granules (SGs) are cytoplasmic RNA-protein aggregates formed in response to inhibition of translation initiation. SGs contribute to the stress response and are implicated in a variety of diseases, including cancer and some forms of neurodegeneration. Neurodegenerative diseases often involve chronic phosphorylation of eukaryotic initiation factor 2 (eIF2), with deletions of eIF2 kinases or treatment with eIF2 kinase inhibitors being protective in some animal models of disease. However, how and why the integrated stress response (ISR) is activated in different forms of neurodegeneration remains unclear. Because neuroinflammation is common to many neurodegenerative diseases, we hypothesized that inflammatory factors contribute to ISR activation in a cell-nonautonomous manner. Using fluorescence microscopy and immunoblotting, we show here that the endogenously produced product of inflammation, 15-deoxy-(12,14)-prostaglandin J2 (15-d-PGJ2), triggers eIF2 phosphorylation, thereby activating the ISR, repressing bulk translation, and triggering SG formation. Our findings define a mechanism by which inflammation activates the ISR in a cell-nonautonomous manner and suggest that inhibition of 15-d-PGJ2 production might be a useful therapeutic strategy in some neuroinflammatory contexts.	[Tauber, Devin; Parker, Roy] Univ Colorado, Dept Biochem, 596 UCB, Boulder, CO 80309 USA; [Parker, Roy] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute	Parker, R (corresponding author), Univ Colorado, Dept Biochem, 596 UCB, Boulder, CO 80309 USA.	roy.parker@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019	Tauber, Devin/0000-0002-8521-1573	National Institutes of Health [R01GM45443, T32GM008758]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045443, T32GM008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM45443 (to R.P.) and T32GM008758 (to D.T.) and the Howard Hughes Medical Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Ansari MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep27611; Aulas A, 2017, J CELL SCI, V130, P927, DOI 10.1242/jcs.199240; Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Campo PA, 2002, CELL GROWTH DIFFER, V13, P409; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Chung HC, 2018, CELL, V172, P811, DOI 10.1016/j.cell.2017.12.038; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Lima IVD, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/946813; DeGracia DJ, 2007, NEUROSCIENCE, V146, P562, DOI 10.1016/j.neuroscience.2007.01.050; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Figueiredo-Pereira ME, 2016, ANN NY ACAD SCI, V1363, P125, DOI 10.1111/nyas.12987; Figueiredo-Pereira ME, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00104; Grabocka E, 2016, CELL, V167, P1803, DOI 10.1016/j.cell.2016.11.035; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Liu H, 2013, NEUROTOX RES, V24, P191, DOI 10.1007/s12640-013-9377-4; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Marcone S, 2013, PROTEOMICS, V13, P2135, DOI 10.1002/pmic.201200289; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; Moon SL, 2018, TRENDS MOL MED, V24, P575, DOI 10.1016/j.molmed.2018.04.001; Myeku N, 2018, TRENDS MOL MED, V24, P18, DOI 10.1016/j.molmed.2017.11.006; Nijholt DAT, 2012, J PATHOL, V226, P693, DOI 10.1002/path.3969; Pompl PN, 2003, FASEB J, V17, P725, DOI 10.1096/fj.02-0876fje; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Stutzbach LD, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-31; Tsai JC, 2018, SCIENCE, V359, P1483, DOI 10.1126/science.aaq0939; Wu CT, 2011, FREE RADICAL BIO MED, V51, P671, DOI 10.1016/j.freeradbiomed.2011.04.038; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	42	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6344	6352		10.1074/jbc.RA118.007138	http://dx.doi.org/10.1074/jbc.RA118.007138			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30723157	Green Published, hybrid			2022-12-28	WOS:000468402000012
J	Jiang, GS; Huang, C; Liao, X; Li, JX; Wu, XR; Zeng, FQ; Huang, CS				Jiang, Guosong; Huang, Chao; Liao, Xin; Li, Jingxia; Wu, Xue-Ru; Zeng, Fuqing; Huang, Chuanshu			The RING domain in the anti-apoptotic protein XIAP stabilizes c-Myc protein and preserves anchorage-independent growth of bladder cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-linked inhibitor of apoptosis protein (XIAP); MYC proto-oncogene BHLH transcription factor (c-Myc); cell biology; cell growth; invasion; anchorage-independent growth; bladder cancer; kinase signaling; oncoprotein; RING domain	X-LINKED INHIBITOR; GLYCOGEN-SYNTHASE KINASE-3-BETA; DEGRADATION; PHOSPHORYLATION; INACTIVATION; TRANSFORMATION; PROTEOLYSIS; STATISTICS; EXPRESSION; MIGRATION	X-linked inhibitor of apoptosis protein (XIAP) suppresses apoptosis and plays key roles in the development, growth, migration, and invasion of cancer cells. Therefore, XIAP has recently attracted much attention as a potential antineoplastic therapeutic target, requiring elucidation of the molecular mechanisms underlying its biological activities. Here, using shRNA-mediated gene silencing, immunoblotting, quantitative RT-PCR, anchorage-independent growth assay, and invasive assay, we found that XIAP's RING domain, but not its BIR domain, is crucial for XIAP-mediated up-regulation of c-Myc protein expression in human bladder cancer (BC) cells. Mechanistically, we observed that the RING domain stabilizes c-Myc by inhibiting its phosphorylation at Thr-58 and that this inhibition is due to activated ERK1/2-mediated phosphorylation of glycogen synthase kinase-3 (GSK-3) at Ser-9. Functional studies further revealed that c-Myc protein promotes anchorage-independent growth and invasion stimulated by the XIAP RING domain in human BC cells. Collectively, the findings in our study uncover that the RING domain of XIAP supports c-Myc protein stability, providing insight into the molecular mechanism and role of c-Myc overexpression in cancer progression. Our observations support the notion of targeting XIAP's RING domain and c-Myc in cancer therapy.	[Jiang, Guosong; Huang, Chao; Liao, Xin; Li, Jingxia; Huang, Chuanshu] New York Univ, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA; [Jiang, Guosong; Huang, Chao; Zeng, Fuqing] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, 1277 JieFang Ave, Wuhan 430022, Hubei, Peoples R China; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA	New York University; Huazhong University of Science & Technology; New York University	Huang, CS (corresponding author), New York Univ, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.; Zeng, FQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, 1277 JieFang Ave, Wuhan 430022, Hubei, Peoples R China.	zengfuqingpro@163.com; chuanshu.huang@nyumc.org		Wu, Xue-Ru/0000-0001-6058-6291; Huang, Chuanshu/0000-0003-4133-5096	NCI, National Institutes of Health [CA165980, CA177665, CA217923, CA229234]; NIEHS, National Institutes of Health [ES000260]; NATIONAL CANCER INSTITUTE [P01CA165980, R01CA217923, R01CA229234, R01CA177665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	H This work was supported by NCI, National Institutes of Health, Grants CA165980, CA177665, CA217923, and CA229234 and NIEHS, National Institutes of Health, Grant ES000260. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Cao ZP, 2013, J BIOL CHEM, V288, P20238, DOI 10.1074/jbc.M112.448365; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Coma S, 2010, CANCER RES, V70, P3823, DOI 10.1158/0008-5472.CAN-09-3048; Dubrez L, 2013, ONCOTARGETS THER, V6, P1285, DOI 10.2147/OTT.S33375; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Flanagan L, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0437-1; Gearhart J, 2007, NEW ENGL J MED, V357, P1469, DOI 10.1056/NEJMp078126; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Guo W, 2014, BIOCHEM BIOPH RES CO, V447, P563, DOI 10.1016/j.bbrc.2014.04.055; Hu WB, 2017, ELIFE, V6, DOI 10.7554/eLife.28021; Huang C, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0376-9; Huang X, 2013, EMBO J, V32, P2204, DOI 10.1038/emboj.2013.133; Jiao Lin, 2018, Autophagy, V14, P671, DOI 10.1080/15548627.2017.1381804; Jin HL, 2016, ONCOTARGET, V7, P56540, DOI 10.18632/oncotarget.10645; Jin HL, 2015, ONCOTARGET, V6, P522, DOI 10.18632/oncotarget.2680; Kraehn GM, 2001, BRIT J CANCER, V84, P72, DOI 10.1054/bjoc.2000.1535; Liao X, 2017, FREE RADICAL BIO MED, V113, P478, DOI 10.1016/j.freeradbiomed.2017.10.387; Liu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035682; Luo J, 2007, J BIOL CHEM, V282, P28274, DOI 10.1074/jbc.M702373200; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Murali A, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.305; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rice KL, 2009, BLOOD, V114, P5499, DOI 10.1182/blood-2009-03-206524; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tang QL, 2012, JNCI-J NATL CANCER I, V104, P749, DOI 10.1093/jnci/djs210; Tsujio I, 2000, FEBS LETT, V469, P111, DOI 10.1016/S0014-5793(00)01234-5; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Wu B, 2018, FEBS LETT, V592, P299, DOI 10.1002/1873-3468.12949; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yu YH, 2018, INT J CANCER, V142, P2040, DOI 10.1002/ijc.31223; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2014, J CELL SCI, V127, P2920, DOI 10.1242/jcs.148130; Zhu JL, 2014, CANCER PREV RES, V7, P1270, DOI 10.1158/1940-6207.CAPR-14-0233	42	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5935	5944		10.1074/jbc.RA118.005621	http://dx.doi.org/10.1074/jbc.RA118.005621			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30819803	Green Published, hybrid			2022-12-28	WOS:000465077500025
J	Kitab, B; Satoh, M; Ohmori, Y; Munakata, T; Sudoh, M; Kohara, M; Tsukiyama-Kohara, K				Kitab, Bouchra; Satoh, Masaaki; Ohmori, Yusuke; Munakata, Tsubasa; Sudoh, Masayuki; Kohara, Michinori; Tsukiyama-Kohara, Kyoko			Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis C virus (HCV); RNA polymerase; RNA virus; RNA synthesis; ribonucleotide reductase; host factor; hPLIC1; M2 subunit of ribonucleotide reductase; NS5B; viral replication; plus-stranded RNA virus; viral polymerase; liver cancer	CELL-CYCLE; DNA-DAMAGE; EXPRESSION; RRM2; QUANTIFICATION; UBIQUITINATION; PATHWAY; TARGET	Hepatitis C virus (HCV) establishes a chronic infection that can lead to cirrhosis and hepatocellular carcinoma. The HCV life cycle is closely associated with host factors that promote or restrict viral replication, the characterization of which could help to identify potential therapeutic targets. To this end, here we performed a genome-wide microarray analysis and identified ribonucleotide reductase M2 (RRM2) as a cellular factor essential for HCV replication. We found that RRM2 is up-regulated in response to HCV infection in quiescent hepatocytes from humanized chimeric mouse livers. To elucidate the molecular basis of RRM2 expression in HCV-infected cells, we used HCV-infected hepatocytes from chimeric mice and hepatoma cells infected with the HCV strain JFH1. Both models exhibited increased RRM2 mRNA and protein expression levels. Moreover, siRNA-mediated silencing of RRM2 suppressed HCV replication and infection. Of note, RRM2 and RNA polymerase nonstructural protein 5B (NS5B) partially co-localized in cells and co-immunoprecipitated, suggesting that they might interact. RRM2 knockdown reduced NS5B expression, which depended on the protein degradation pathway, as NS5B RNA levels did not decrease and NS5B protein stability correlated with RRM2 protein levels. We also found that RRM2 silencing decreased levels of hPLIC1 (human homolog 1 of protein linking integrin-associated protein and cytoskeleton), a ubiquitin-like protein that interacts with NS5B and promotes its degradation. This finding suggests that there is a dynamic interplay between RRM2 and the NS5B-hPLIC1 complex that has an important function in HCV replication. Together, these results identify a role of host RRM2 in viral RNA replication.	[Kitab, Bouchra; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Transboundary Anim Dis Ctr, Kagoshima 8908580, Japan; [Kitab, Bouchra; Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima 8908580, Japan; [Satoh, Masaaki] Natl Inst Infect Dis, Virol 1, Shinjuku Ku, Tokyo 1628640, Japan; [Ohmori, Yusuke; Sudoh, Masayuki] Chugai Pharmaceut Co Ltd, Res Div, Kamakura, Kanagawa 2478530, Japan; [Munakata, Tsubasa; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 1568506, Japan	Kagoshima University; Kagoshima University; National Institute of Infectious Diseases (NIID); Chugai Pharmaceutical Co., Ltd.; Roche Holding; Tokyo Metropolitan Institute of Medical Science	Tsukiyama-Kohara, K (corresponding author), Kagoshima Univ, Transboundary Anim Dis Ctr, Kagoshima 8908580, Japan.; Tsukiyama-Kohara, K (corresponding author), Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima 8908580, Japan.; Kohara, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 1568506, Japan.	kohara-mc@igakuken.or.jp; kkohara@vet.kagoshima-u.ac.jp			Japan Agency for Medical Research and Development [16fk0210108s0201]; Japan Science and Technology Agency; Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Agency for Medical Research and Development Grants 16fk0210108s0201 and 16fk0210108s0201 (to M. K. and K. T.-K.) and by grants from the Japan Science and Technology Agency; the Ministry of Health, Labour, and Welfare of Japan; and the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation. The authors declare that they have no conflicts of interest with the contents of this article.	Anacker DC, 2016, VIROLOGY, V499, P383, DOI 10.1016/j.virol.2016.09.028; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chung RT, 2014, NEW ENGL J MED, V370, P1576, DOI 10.1056/NEJMp1400986; Dai L, 2015, BLOOD, V126, P2821, DOI 10.1182/blood-2015-07-658823; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gao L, 2003, J VIROL, V77, P4149, DOI 10.1128/JVI.77.7.4149-4159.2003; Grolmusz VK, 2016, AM J CANCER RES, V6, P2041; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kyono K, 2002, BIOCHEM BIOPH RES CO, V292, P659, DOI 10.1006/bbrc.2002.6702; Lee B, 2014, GUT LIVER, V8, P662, DOI 10.5009/gnl13392; Liu X, 2016, BIOCHEM PHARMACOL, V103, P118, DOI 10.1016/j.bcp.2016.01.003; Liu XY, 2013, CLIN SCI, V124, P567, DOI 10.1042/CS20120240; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 2013, CURR TOP MICROBIOL, V369, P167, DOI 10.1007/978-3-642-27340-7_7; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Ricardo-Lax I, 2015, J HEPATOL, V63, P789, DOI 10.1016/j.jhep.2015.05.017; Saito M, 2012, J MED VIROL, V84, P733, DOI 10.1002/jmv.23250; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Salem NE, 2013, MICROBIOL IMMUNOL, V57, P179, DOI 10.1111/1348-0421.12025; Satoh M, 2011, J INFECT DIS, V204, P1172, DOI 10.1093/infdis/jir501; Scholle F, 2004, J VIROL, V78, P1513, DOI 10.1128/JVI.78.3.1513-1524.2004; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tsukiyama-Kohara K, 2004, J BIOL CHEM, V279, P14531, DOI 10.1074/jbc.M312822200; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang N, 2014, BRIT J CANCER, V110, P1034, DOI 10.1038/bjc.2013.817; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Wilson PM, 2011, NUCLEIC ACIDS RES, V39, pE112, DOI 10.1093/nar/gkr350	33	12	12	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5759	5773		10.1074/jbc.RA118.004397	http://dx.doi.org/10.1074/jbc.RA118.004397			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30755480	Green Published, hybrid			2022-12-28	WOS:000465077500003
J	Maeda, TK; Sugiura, D; Okazaki, IM; Maruhashi, T; Okazaki, T				Maeda, Takeo K.; Sugiura, Daisuke; Okazaki, Il-mi; Maruhashi, Takumi; Okazaki, Taku			Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; T cell; T cell receptor (TCR); inhibition mechanism; immunotherapy; monoclonal antibody; cytokine induction; co-receptor; immune checkpoint; LAG-3	CUTTING EDGE; PROTEIN; CD223; MECHANISM; BLOCKADE; KINASE; LIGAND; PD-1; CD4	T cell activation is tightly regulated by both stimulatory and inhibitory co-receptors and has been a focus in the development of interventions for managing cancer or autoimmune diseases. Targeting the inhibitory co-receptors programmed cell death 1 (PD-1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4) has successfully eradicated tumors but induced immune-related adverse events in humans and mice. The beneficial and adverse effects of targeting these co-receptors highlight their importance in cancer immunity and also autoimmunity. Although the therapeutic potencies of other inhibitory co-receptors are under extensive investigation, their inhibitory mechanisms and their functional differences are not well understood. Here we analyzed the inhibitory mechanisms of lymphocyte activation gene-3 (LAG-3), another inhibitory co-receptor, by using an in vitro T cell activation system and a high-affinity anti-LAG-3 antibody that strongly interferes with the binding of LAG-3 to its ligand. We found that the expression level of LAG-3 strongly correlates with the inhibitory function of LAG-3, suggesting that LAG-3 functions as a rheostat rather than as a breaker of T cell activation. By evaluating the inhibitory capacities of various LAG-3 variants relative to their expression levels, we found that LAG-3 transduces two independent inhibitory signals through an FXXL motif in the membrane-proximal region and the C-terminal EX repeat. These motifs have not been reported previously for inhibitory co-receptors, suggesting that LAG-3 inhibits T cell activation through a nonredundant inhibitory mechanisms along with the other inhibitory co-receptors. Our findings provide a rationale for combinatorial targeting of LAG-3 and the other inhibitory co-receptors to improve cancer immunotherapy.	[Maeda, Takeo K.; Sugiura, Daisuke; Okazaki, Il-mi; Maruhashi, Takumi; Okazaki, Taku] Tokushima Univ, Div Immune Regulat, Inst Adv Med Sci, 3-18-15 Kuramoto, Tokushima 7708503, Japan	Tokushima University	Okazaki, T (corresponding author), Tokushima Univ, Div Immune Regulat, Inst Adv Med Sci, 3-18-15 Kuramoto, Tokushima 7708503, Japan.	tokazaki@genome.tokushima-u.ac.jp		Okazaki, Il-mi/0000-0001-8644-0100; Sugiura, Daisuke/0000-0002-3865-3889; Maruhashi, Takumi/0000-0003-2944-1611; Okazaki, Taku/0000-0003-4790-1925	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency; Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development [JP18am0301007]; Japan Society for the Promotion of Science [JP18H05417]	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development JP18am0301007 (to T. O.), and Grant-in-Aid by the Japan Society for the Promotion of Science JP18H05417 (to T. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; Bae J, 2014, J IMMUNOL, V193, P3101, DOI 10.4049/jimmunol.1401025; BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Chiara F, 2004, J BIOL CHEM, V279, P19732, DOI 10.1074/jbc.M314070200; Esensten JH, 2016, IMMUNITY, V44, P973, DOI 10.1016/j.immuni.2016.04.020; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1995, EUR J IMMUNOL, V25, P2718, DOI 10.1002/eji.1830250949; Iouzalen N, 2001, EUR J IMMUNOL, V31, P2885, DOI 10.1002/1521-4141(2001010)31:10<2885::AID-IMMU2885>3.0.CO;2-2; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Marion S, 2007, J BIOL CHEM, V282, P18937, DOI 10.1074/jbc.M700090200; Maruhashi T, 2018, NAT IMMUNOL, V19, P1415, DOI 10.1038/s41590-018-0217-9; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Schildberg FA, 2016, IMMUNITY, V44, P955, DOI 10.1016/j.immuni.2016.05.002; Terskikh AV, 1997, P NATL ACAD SCI USA, V94, P1663, DOI 10.1073/pnas.94.5.1663; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Wang J, 2019, CELL, V176, P334, DOI 10.1016/j.cell.2018.11.010; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392	31	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6017	6026		10.1074/jbc.RA119.007455	http://dx.doi.org/10.1074/jbc.RA119.007455			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30760527	hybrid, Green Published			2022-12-28	WOS:000465077500032
J	Yamamoto, M; Du, QL; Song, JP; Wang, HY; Watanabe, A; Tanaka, Y; Kawaguchi, Y; Inoue, J; Matsuda, Z				Yamamoto, Mizuki; Du, Qingling; Song, Jiping; Wang, Hongyun; Watanabe, Aya; Tanaka, Yuetsu; Kawaguchi, Yasushi; Inoue, Jun-ichiro; Matsuda, Zene			Cell-cell and virus-cell fusion assay-based analyses of alanine insertion mutants in the distal 9 portion of the JRFL gp41 subunit from HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); membrane fusion; viral protein; virology; virus entry; envelope protein; gp41; NanoLuc; syncytia formation; Vpr	MEMBRANE-FUSION; SCANNING MUTAGENESIS; HEPTAD REPEAT; COILED COILS; PROTEIN; GLYCOPROTEIN; AGGREGATION; REPORTER; REGIONS; EPITOPE	Membrane fusion is the first essential step in HIV-1 replication. The gp41 subunit of HIV-1 envelope protein (Env), a class I fusion protein, achieves membrane fusion by forming a structure called a six-helix bundle composed of N- and C-terminal heptad repeats. We have recently shown that the distal portion of the 9 helix in the C-terminal heptad repeat of X4-tropic HXB2 Env plays a critical role in the late-stage membrane fusion and viral infection. Here, we used R5-tropic JRFL Env and constructed six alanine insertion mutants, 641+A to 646+A, in the further distal portion of 9 where several glutamine residues are conserved (the number corresponds to the position of the inserted alanine in JRFL Env). 644+A showed the most severe defect in syncytia formation. Decreased fusion pore formation activity, revealed by a dual split protein assay, was observed in all mutants except 641+A. Sequence analysis and substitution of inserted 644A with Gln revealed that the glutamine residue at position 644 that forms complex hydrogen-bond networks with other polar residues on the surface of the six-helix bundle is critical for cell-cell fusion. We also developed a split NanoLuc (R) (Nluc) reporter-based assay specific to the virus-cell membrane fusion step to analyze several of the mutants. Interestingly syncytia-competent mutants failed to display Nluc activities. In addition to defective fusion activity, a reduction of Env incorporation into virions may further contribute to differences in cell-cell and virus-cell fusions.	[Yamamoto, Mizuki; Watanabe, Aya; Kawaguchi, Yasushi; Inoue, Jun-ichiro; Matsuda, Zene] Univ Tokyo, Res Ctr Asian Infect Dis, Inst Med Sci, 4-6-1 Minato Ku, Tokyo 1088639, Japan; [Yamamoto, Mizuki; Watanabe, Aya; Inoue, Jun-ichiro] Univ Tokyo, Div Cellular & Mol Biol, Inst Med Sci, 4-6-1 Minato Ku, Tokyo 1088639, Japan; [Kawaguchi, Yasushi] Univ Tokyo, Div Mol Virol, Inst Med Sci, Dept Microbiol & Immunol, Tokyo 1088639, Japan; [Du, Qingling; Song, Jiping; Wang, Hongyun; Matsuda, Zene] Chinese Acad Sci, Lab Struct Virol & Immunol, Inst Biophys, Beijing 100864, Peoples R China; [Tanaka, Yuetsu] Univ Ryukyus, Dept Immunol, Grad Sch Med, Nishihara, Okinawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of the Ryukyus	Matsuda, Z (corresponding author), Univ Tokyo, Res Ctr Asian Infect Dis, Inst Med Sci, 4-6-1 Minato Ku, Tokyo 1088639, Japan.; Inoue, J (corresponding author), Univ Tokyo, Div Cellular & Mol Biol, Inst Med Sci, 4-6-1 Minato Ku, Tokyo 1088639, Japan.	jun-i@ims.u-tokyo.ac.jp; zmatsuda@ims.u-tokyo.ac.jp	Yamamoto, Mizuki/AAW-1688-2020	Yamamoto, Mizuki/0000-0003-3731-1702; Kawaguchi, Yasushi/0000-0001-8232-6925	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development [JP18fm0108006]; Program of Japan Initiative for Global Research Network on Infectious Diseases from the Japan Agency for Medical Research and Development [JP18fm0108006]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [16H06575]; Japan Society for the Promotion of Science [18K15235]	Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Program of Japan Initiative for Global Research Network on Infectious Diseases from the Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Research Program on Emerging and Re-emerging Infectious Diseases and the Program of Japan Initiative for Global Research Network on Infectious Diseases from the Japan Agency for Medical Research and Development under Grant JP18fm0108006; Grantin-Aid 16H06575 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to J. I.); and Grant-in-Aid 18K15235 from Japan Society for the Promotion of Science (to M. Y.). This work was also supported by funds from the Japan Society for the Promotion of Science Coreto-Core Program, A: Advanced Research Networks (to J. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Brown JH, 1996, PROTEINS, V26, P134; BUTINI L, 1994, EUR J IMMUNOL, V24, P2191, DOI 10.1002/eji.1830240939; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; COHEN EA, 1990, J VIROL, V64, P3097, DOI 10.1128/JVI.64.6.3097-3099.1990; Diaz-Aguilar B, 2013, BIOCHEMISTRY-US, V52, P3552, DOI 10.1021/bi400201h; Dixon A. S. V., 2017, U. S. patent, Patent No. [9,797,889 B2, 9797889]; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; GRUBER MF, 1991, AIDS RES HUM RETROV, V7, P45, DOI 10.1089/aid.1991.7.45; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; HEINZ DW, 1993, NATURE, V361, P561, DOI 10.1038/361561a0; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Johnson LM, 2011, J AM CHEM SOC, V133, P10038, DOI 10.1021/ja203358t; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kondo N, 2015, J BIOL CHEM, V290, P6558, DOI 10.1074/jbc.M114.623181; Liu DH, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0410-9; Markosyan RM, 2003, MOL BIOL CELL, V14, P926, DOI 10.1091/mbc.E02-09-0573; Matsuda Z., 2011, CURR PROTOC CELL BIO, V50, DOI [10.1002/0471143030.cb2609s50, DOI 10.1002/0471143030.CB2609S50]; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Nakane S, 2015, METHODS MOL BIOL, P229, DOI 10.1007/978-1-4939-2703-6_17; Nakane S, 2015, J BIOL CHEM, V290, P15279, DOI 10.1074/jbc.M114.628610; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Schwinn MK, 2018, ACS CHEM BIOL, V13, P467, DOI 10.1021/acschembio.7b00549; Sen J, 2010, BIOCHEMISTRY-US, V49, P5057, DOI 10.1021/bi1005267; Suntoke TR, 2005, J BIOL CHEM, V280, P19852, DOI 10.1074/jbc.M502196200; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vetter IR, 1996, PROTEIN SCI, V5, P2399, DOI 10.1002/pro.5560051203; Wang HB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113880, 10.1371/journal.pone.0089155, 10.1371/journal.pone.0091730]; Wang JQ, 2009, J VIROL METHODS, V161, P216, DOI 10.1016/j.jviromet.2009.06.017; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Yi HA, 2015, BIOCHEMISTRY-US, V54, P1681, DOI 10.1021/bi501171r; YUAN X, 1990, AIDS RES HUM RETROV, V6, P1265, DOI 10.1089/aid.1990.6.1265	42	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5677	5687		10.1074/jbc.RA118.004579	http://dx.doi.org/10.1074/jbc.RA118.004579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30737278	Green Published, hybrid			2022-12-28	WOS:000464517500035
J	Davis, DL; Gable, K; Suemitsu, J; Dunn, TM; Wattenberg, BW				Davis, Deanna L.; Gable, Kenneth; Suemitsu, John; Dunn, Teresa M.; Wattenberg, Binks W.			The ORMDL/Orm-serine palmitoyltransferase (SPT) complex is directly regulated by ceramide: Reconstitution of SPT regulation in isolated membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sphingolipid; homeostasis; endoplasmic reticulum (ER); lipid metabolism; lipid signaling; cell signaling; phytoceramide; sphingomyelin; sphingosine	SPHINGOLIPID BIOSYNTHESIS; PROTEINS MEDIATE; ORM; SPHINGOSINE; DIHYDROCERAMIDE; CHOLESTEROL; HOMEOSTASIS; BIOPHYSICS; EXPRESSION; SUBUNITS	Sphingolipids compose a lipid family critical for membrane structure as well as intra- and intercellular signaling. De novo sphingolipid biosynthesis is initiated by the enzyme serine palmitoyltransferase (SPT), which resides in the endoplasmic reticulum (ER) membrane. In both yeast and mammalian species, SPT activity is homeostatically regulated through small ER membrane proteins, the Orms in yeast and the ORMDLs in mammalian cells. These proteins form stable complexes with SPT. In yeast, the homeostatic regulation of SPT relies, at least in part, on phosphorylation of the Orms. However, this does not appear to be the case for the mammalian ORMDLs. Here, we accomplished a cell-free reconstitution of the sphingolipid regulation of the ORMDL-SPT complex to probe the underlying regulatory mechanism. Sphingolipid and ORMDL-dependent regulation of SPT was demonstrated in isolated membranes, essentially free of cytosol. This suggests that this regulation does not require soluble cytosolic proteins or small molecules such as ATP. We found that this system is particularly responsive to the pro-apoptotic sphingolipid ceramide and that this response is strictly stereospecific, indicating that ceramide regulates the ORMDL-SPT complex via a specific binding interaction. Yeast membranes harboring the Orm-SPT system also directly responded to sphingolipid, suggesting that yeast cells have, in addition to Orm phosphorylation, an additional Orm-dependent SPT regulatory mechanism. Our results indicate that ORMDL/Orm-mediated regulation of SPT involves a direct interaction of sphingolipid with the membrane-bound components of the SPT-regulatory apparatus.	[Davis, Deanna L.; Suemitsu, John; Wattenberg, Binks W.] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Gable, Kenneth; Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20814 USA; [Wattenberg, Binks W.] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40202 USA	Virginia Commonwealth University; Uniformed Services University of the Health Sciences - USA; University of Louisville	Wattenberg, BW (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.	brian.wattenberg@vcuhealth.org			Bridge Grant from the University of Louisville School of Medicine; James Graham Brown Cancer Center; National Institutes of Health [R01HL131340]; National Institutes of Health, Department of Defense Grant [HL14-007.001/BIO-71-8822]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131340] Funding Source: NIH RePORTER	Bridge Grant from the University of Louisville School of Medicine; James Graham Brown Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, Department of Defense Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Bridge Grant from the University of Louisville School of Medicine (to B. W.), the James Graham Brown Cancer Center (to B. W.), National Institutes of Health Grant R01HL131340 (to B. W.), and National Institutes of Health, Department of Defense Grant HL14-007.001/BIO-71-8822 (to T. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barenholz Y, 2004, SUB CELL BIOCHEM, V37, P167; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cai L, 2016, J LIPID RES, V57, P1412, DOI 10.1194/jlr.M065920; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Davis Deanna, 2018, Advances in Biological Regulation, V70, P3, DOI 10.1016/j.jbior.2018.08.002; Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Gupta SD, 2015, J BIOL CHEM, V290, P90, DOI 10.1074/jbc.M114.588236; Gururaj C, 2013, J BIOL CHEM, V288, P20453, DOI 10.1074/jbc.M113.472860; Ha SG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3479; Han GS, 2019, BBA-MOL CELL BIOL L, V1864, P245, DOI 10.1016/j.bbalip.2018.11.007; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Harmon JM, 2013, J BIOL CHEM, V288, P10144, DOI 10.1074/jbc.M113.451526; Harrison PJ, 2018, NAT PROD REP, V35, P921, DOI 10.1039/c8np00019k; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Liu LK, 2017, J CELL BIOL, V216, P131, DOI 10.1083/jcb.201606059; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; MANDON EC, 1991, EUR J BIOCHEM, V198, P667, DOI 10.1111/j.1432-1033.1991.tb16065.x; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Oyeniran C, 2015, J ALLERGY CLIN IMMUN, V136, P1035, DOI 10.1016/j.jaci.2015.02.031; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Siow D, 2015, J LIPID RES, V56, P898, DOI 10.1194/jlr.M057539; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Wang S, 2015, P NATL ACAD SCI USA, V112, P3728, DOI 10.1073/pnas.1422455112; Wang XH, 2017, INT J BIOCHEM CELL B, V87, P8, DOI 10.1016/j.biocel.2017.03.007	39	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5146	5156		10.1074/jbc.RA118.007291	http://dx.doi.org/10.1074/jbc.RA118.007291			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30700557	Green Published, hybrid			2022-12-28	WOS:000463985600035
J	Hei, ZF; Wu, SQ; Liu, ZZ; Wang, J; Fang, PF				Hei, Zhoufei; Wu, Siqi; Liu, Zaizhou; Wang, Jing; Fang, Pengfei			Retractile lysyl-tRNA synthetase-AIMP2 assembly in the human multi-aminoacyl-tRNA synthetase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; protein complex; crystal structure; molecular biology; translation; aminoacyl-tRNA syntheses complex-interacting multifunctional protein 2 (AIMP2); cardiomyopathy; lysyl-tRNA synthetase (LysRS); multi-aminoacyl-tRNA syntheses complex (MSC)	ACTIVATING POLYPEPTIDE-II; P43 COMPONENT; TRANSLATION; PHOSPHORYLATION; CYTOKINE; TRIGGER	Multi-aminoacyl-tRNA synthetase complex (MSC) is the second largest machinery for protein synthesis in human cells and also regulates multiple nontranslational functions through its components. Previous studies have shown that the MSC can respond to external signals by releasing its components to function outside it. The internal assembly is fundamental to MSC regulation. Here, using crystal structural analyses (at 1.88 resolution) along with molecular modeling, gel-filtration chromatography, and co-immunoprecipitation, we report that human lysyl-tRNA synthetase (LysRS) forms a tighter assembly with the scaffold protein aminoacyl-tRNA synthetase complex-interacting multifunctional protein 2 (AIMP2) than previously observed. We found that two AIMP2 N-terminal peptides form an antiparallel scaffold and hold two LysRS dimers through four binding motifs and additional interactions. Of note, the four catalytic subunits of LysRS in the tightly assembled complex were all accessible for tRNA recognition. We further noted that two recently reported human disease-associated mutations conflict with this tighter assembly, cause LysRS release from the MSC, and inactivate the enzyme. These findings reveal a previously unknown dimension of MSC subcomplex assembly and suggest that the retractility of this complex may be critical for its physiological functions.	[Hei, Zhoufei; Wu, Siqi; Liu, Zaizhou; Wang, Jing; Fang, Pengfei] Univ Chinese Acad Sci, Chinese Acad Sci, State Key Lab Bioorgan & Nat Prod Chem, Ctr Excellence Mol Synth,Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of Chinese Academy of Sciences, CAS	Fang, PF (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	fangpengfei@sioc.ac.cn	Fang, Pengfei/O-3696-2015	Fang, Pengfei/0000-0002-3448-5494; Wang, Jing/0000-0002-7566-1212; Hei, Zhoufei/0000-0002-1350-3729	National Natural Science Foundation of China [21778064, 21778067]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB20000000]; 1000-Talent Young Investigator Award; 100-Talent Program of the Chinese Academy of Sciences; State Key Laboratory of Bioorganic and Natural Products Chemistry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); 1000-Talent Young Investigator Award; 100-Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Bioorganic and Natural Products Chemistry(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grant 21778064, Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB20000000, and a 1000-Talent Young Investigator Award (to P.F.); and by the 100-Talent Program of the Chinese Academy of Sciences, National Natural Science Foundation of China Grant 21778067, and funds from the State Key Laboratory of Bioorganic and Natural Products Chemistry (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arif A, 2012, MOL CELL BIOL, V32, P5046, DOI 10.1128/MCB.01168-12; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; CIRAKOGLU B, 1985, FEBS LETT, V183, P185; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Duchon AA, 2017, J VIROL, V91, DOI 10.1128/JVI.01240-17; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Havrylenko S, 2015, INT J MOL SCI, V16, P6571, DOI 10.3390/ijms16036571; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; KAO J, 1992, J BIOL CHEM, V267, P20239; Kim DG, 2016, CANCER RES, V76, P3422, DOI 10.1158/0008-5472.CAN-15-3255; Kim DG, 2014, NAT CHEM BIOL, V10, P29, DOI [10.1038/nchembio.1381, 10.1038/NCHEMBIO.1381]; Kim DG, 2012, FASEB J, V26, P4142, DOI 10.1096/fj.12-207639; Kleiman L, 2010, FEBS LETT, V584, P359, DOI 10.1016/j.febslet.2009.11.038; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; Lee EY, 2016, NAT IMMUNOL, V17, P1252, DOI 10.1038/ni.3542; Lee MS, 2016, J MICROBIOL BIOTECHN, V26, P432, DOI 10.4014/jmb.1511.11056; Liu S, 2016, RNA, V22, P1828, DOI 10.1261/rna.058081.116; Motzik A, 2013, TRENDS MOL MED, V19, P726, DOI 10.1016/j.molmed.2013.07.011; Murray JC, 2004, J LEUKOCYTE BIOL, V75, P772, DOI 10.1189/jlb.1003487; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Remion A, 2016, FEBS OPEN BIO, V6, P696, DOI 10.1002/2211-5463.12074; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Schwarz MA, 1999, J EXP MED, V190, P341, DOI 10.1084/jem.190.3.341; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verrigni D, 2017, CLIN GENET, V91, P918, DOI 10.1111/cge.12931; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019	40	12	12	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4775	4783		10.1074/jbc.RA118.006356	http://dx.doi.org/10.1074/jbc.RA118.006356			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30733335	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000463985600004
J	Chakravorty, S; Shipelskiy, Y; Kumar, A; Majumdar, A; Yang, TH; Nairn, BL; Newton, SM; Klebba, PE				Chakravorty, Somnath; Shipelskiy, Yan; Kumar, Ashish; Majumdar, Aritri; Yang, Taihao; Nairn, Brittany L.; Newton, Salete M.; Klebba, Phillip E.			Universal fluorescent sensors of high-affinity iron transport, applied to ESKAPE pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; fluorescence; ligand-binding protein; siderophore; pathogenesis; iron; spectroscopy; heme; ESKAPE pathogen	FERRIC ENTEROBACTIN; SALMONELLA-ENTERICA; ESCHERICHIA-COLI; TONB; PROTEINS; BINDING; SORTASE; CLONING; TYPHIMURIUM; HEMOGLOBIN	Sensitive assays of biochemical specificity, affinity, and capacity are valuable both for basic research and drug discovery. We created fluorescent sensors that monitor high-affinity binding reactions and used them to study iron acquisition by ESKAPE bacteria, which are frequently responsible for antibiotic-resistant infections. By introducing site-directed Cys residues in bacterial iron transporters and modifying them with maleimide fluorophores, we generated living cells or purified proteins that bind but do not transport target compounds. These constructs sensitively detected ligand concentrations in solution, enabling accurate, real-time spectroscopic analysis of membrane transport by other cells. We assessed the efficacy of these fluorescent decoy (FD) sensors by characterizing active iron transport in the ESKAPE bacteria. The FD sensors monitored uptake of both ferric siderophores and hemin by the pathogens. An FD sensor for a particular ligand was universally effective in observing the uptake of that compound by all organisms we tested. We adapted the FD sensors to microtiter format, where they allow high-throughput screens for chemicals that block iron uptake, without genetic manipulations of the virulent target organisms. Hence, screening assays with FD sensors facilitate studies of mechanistic biochemistry, as well as discovery of chemicals that inhibit prokaryotic membrane transport. With appropriate design, FD sensors are potentially applicable to any pro- or eukaryotic high-affinity ligand transport process.	[Chakravorty, Somnath; Shipelskiy, Yan; Kumar, Ashish; Majumdar, Aritri; Yang, Taihao; Newton, Salete M.; Klebba, Phillip E.] Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA; [Nairn, Brittany L.] Bethel Univ, Dept Biol Sci, St Paul, MN 55112 USA; [Chakravorty, Somnath] Jacobs Sch Med & Biomed Sci, Buffalo, NY 14203 USA; [Shipelskiy, Yan] Pueblo Chem Depot PCAPP, Battelle Mem Inst, Pueblo, CO 81006 USA	Kansas State University	Klebba, PE (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA.	peklebba@ksu.edu			NIAID, National Institutes of Health [R21AI115187]; Kansas IDeA Network of Biomedical Research Excellence (K-INBRE; National Institute of General Medical Sciences of the National Institutes of Health) [P20GM103418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Kansas IDeA Network of Biomedical Research Excellence (K-INBRE; National Institute of General Medical Sciences of the National Institutes of Health); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIAID, National Institutes of Health Award R21AI115187 (to P. E. K. and S. M. N.) and a Kansas IDeA Network of Biomedical Research Excellence (K-INBRE; National Institute of General Medical Sciences of the National Institutes of Health Grant P20GM103418) postdoctoral research award (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachman MA, 2012, MBIO, V3, DOI 10.1128/mBio.00224-11; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Elemam A, 2009, CLIN INFECT DIS, V49, P271, DOI 10.1086/600042; Fisher JF, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025221; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hanson M, 2016, J BIOMOL SCREEN, V21, P316, DOI 10.1177/1087057115613788; HASHIMOTOGOTOH T, 1986, GENE, V41, P125; HENDERSON DP, 1993, MOL MICROBIOL, V7, P461, DOI 10.1111/j.1365-2958.1993.tb01137.x; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Jordan LD, 2013, P NATL ACAD SCI USA, V110, P11553, DOI 10.1073/pnas.1304243110; Khan SN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00174; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Klebba PE, 2016, J BACTERIOL, V198, P1013, DOI 10.1128/JB.00823-15; KONOPKA K, 1982, BIOCHEMISTRY-US, V21, P6503, DOI 10.1021/bi00268a028; Lery LMS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-41; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; Malmirchegini GR, 2014, J BIOL CHEM, V289, P34886, DOI 10.1074/jbc.M114.583013; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Nagy TA, 2013, INFECT IMMUN, V81, P4063, DOI 10.1128/IAI.00412-13; Nairn BL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00889-16; NEILANDS JB, 1952, J AM CHEM SOC, V74, P4846, DOI 10.1021/ja01139a033; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Ostberg KL, 2013, INFECT IMMUN, V81, P3442, DOI 10.1128/IAI.00280-13; Parrow NL, 2013, INFECT IMMUN, V81, P3503, DOI 10.1128/IAI.00602-13; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Pi HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050020; Rouault TA, 2017, J BIOL CHEM, V292, P12744, DOI 10.1074/jbc.R117.789537; Russo TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026734; RUTZ JM, 1991, J BACTERIOL, V173, P5964, DOI 10.1128/jb.173.19.5964-5974.1991; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; Smallwood CR, 2014, J GEN PHYSIOL, V144, P201, DOI 10.1085/jgp.20131115907012014c; Smith KD, 2007, INT J BIOCHEM CELL B, V39, P1776, DOI 10.1016/j.biocel.2007.07.003; Stokes-Rees I, 2010, P NATL ACAD SCI USA, V107, P21476, DOI 10.1073/pnas.1012095107; Tacconelli E, 2017, GLOBAL PRIORITY LIST; Thulasiraman P, 1998, J BACTERIOL, V180, P6689, DOI 10.1128/JB.180.24.6689-6696.1998; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; Tsolis RM, 1996, INFECT IMMUN, V64, P4549, DOI 10.1128/IAI.64.11.4549-4556.1996; Valdebenito M, 2007, FEMS MICROBIOL LETT, V277, P182, DOI 10.1111/j.1574-6968.2007.00956.x; Williams PH, 2006, VACCINE, V24, P3840, DOI 10.1016/j.vaccine.2005.07.020; WILLIAMS PH, 1979, INFECT IMMUN, V26, P925, DOI 10.1128/IAI.26.3.925-932.1979; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x	49	4	4	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4682	4692		10.1074/jbc.RA118.006921	http://dx.doi.org/10.1074/jbc.RA118.006921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30679312	Green Published, hybrid			2022-12-28	WOS:000462969500033
J	Ling, TY; Yi, F; Lu, T; Wang, XL; Sun, XJ; Willis, MS; Wu, LQ; Shen, WK; Adelman, JP; Lee, HC				Ling, Tian-You; Yi, Fu; Lu, Tong; Wang, Xiao-Li; Sun, Xiaojing; Willis, Monte S.; Wu, Li-Qun; Shen, Win-Kuang; Adelman, John P.; Lee, Hon-Chi			F-box protein-32 down-regulates small-conductance calcium-activated potassium channel 2 in diabetic mouse atria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; diabetes; cardiomyocyte; cardiovascular disease; ubiquitin ligase; protein degradation; atrial fibrillation; atrogin-1; diabetes mellitus; HL-1 cells; SK channels	CA2+-ACTIVATED K+ CHANNELS; UBIQUITIN-PROTEASOME SYSTEM; SK CHANNELS; FIBRILLATION; DEGRADATION; ROLES; CELLS	Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation, but the underlying ionic mechanism for this association remains unclear. We recently reported that expression of the small-conductance calcium-activated potassium channel 2 (SK2, encoded by KCCN2) in atria from diabetic mice is significantly down-regulated, resulting in reduced SK currents in atrial myocytes from these mice. We also reported that the level of SK2 mRNA expression is not reduced in DM atria but that the ubiquitin-proteasome system (UPS), a major mechanism of intracellular protein degradation, is activated in vascular smooth muscle cells in DM. This suggests a possible role of the UPS in reduced SK currents. To test this possibility, we examined the role of the UPS in atrial SK2 down-regulation in DM. We found that a muscle-specific E3 ligase, F-box protein 32 (FBXO-32, also called atrogin-1), was significantly up-regulated in diabetic mouse atria. Enhanced FBXO-32 expression in atrial cells significantly reduced SK2 protein expression, and siRNA-mediated FBXO-32 knockdown increased SK2 protein expression. Furthermore, co-transfection of SK2 with FBXO-32 complementary DNA in HEK293 cells significantly reduced SK2 expression, whereas co-transfection with atrogin-1F complementary DNA (a nonfunctional FBXO-32 variant in which the F-box domain is deleted) did not have any effects on SK2. These results indicate that FBXO-32 contributes to SK2 down-regulation and that the F-box domain is essential for FBXO-32 function. In conclusion, DM-induced SK2 channel down-regulation appears to be due to an FBXO-32-dependent increase in UPS-mediated SK2 protein degradation.	[Ling, Tian-You; Wu, Li-Qun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200025, Peoples R China; [Ling, Tian-You; Yi, Fu; Lu, Tong; Wang, Xiao-Li; Sun, Xiaojing; Lee, Hon-Chi] Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55905 USA; [Yi, Fu] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Dis, Xian 710032, Shaanxi, Peoples R China; [Willis, Monte S.] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Shen, Win-Kuang] Mayo Clin, Dept Cardiovasc Dis, Phoenix, AZ 85259 USA; [Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Shanghai Jiao Tong University; Mayo Clinic; Air Force Military Medical University; Indiana University System; Indiana University Bloomington; Mayo Clinic; Mayo Clinic Phoenix; Oregon Health & Science University	Yi, F; Lee, HC (corresponding author), Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55905 USA.	xjcardio@fmmu.edu.cn	yi, fu/HGE-6093-2022; Lu, Tong/A-7745-2009	Lu, Tong/0000-0002-2393-7643; /0000-0002-0769-5816	National Natural Science Foundation of China [81400248, 81470479]; Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China [DLY201604]; Xijing Hospital, Fourth Military Medical University, Xi'an, China; Mayo Clinic Foundation; American Diabetes Association [ADA 1-12-BS-119, ADA 1-16-IBS-195, ADA 1-18-IBS-210]; NHLBI, National Institute of Health [HL74180, HL080118]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074180] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China; Xijing Hospital, Fourth Military Medical University, Xi'an, China; Mayo Clinic Foundation; American Diabetes Association(American Diabetes Association); NHLBI, National Institute of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by funding from the National Natural Science Foundation of China (81400248 and 81470479); Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China (DLY201604); Xijing Hospital, Fourth Military Medical University, Xi'an, China; the Mayo Clinic Foundation; the American Diabetes Association (ADA 1-12-BS-119, ADA 1-16-IBS-195, and ADA 1-18-IBS-210), and the NHLBI, National Institute of Health (HL74180 and HL080118). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Black SA, 2002, AM J PUBLIC HEALTH, V92, P543, DOI 10.2105/AJPH.92.4.543; Chang PC, 2015, TRENDS CARDIOVAS MED, V25, P508, DOI 10.1016/j.tcm.2015.01.010; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Ciechanover Aaron, 2006, Proc Am Thorac Soc, V3, P21, DOI 10.1513/pats.200510-106JH; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Haugaard MM, 2015, HEART RHYTHM, V12, P825, DOI 10.1016/j.hrthm.2014.12.028; Hershko A, 2005, ANGEW CHEM INT EDIT, V44, P5932, DOI 10.1002/anie.200501724; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Kannel WB, 2008, MED CLIN N AM, V92, P17, DOI 10.1016/j.mcna.2007.09.002; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Ling TY, 2013, HEART RHYTHM, V10, P1001, DOI 10.1016/j.hrthm.2013.03.005; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lu T, 2012, DIABETES, V61, P1860, DOI 10.2337/db11-1658; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Mahida S, 2014, HEART RHYTHM, V11, P1233, DOI 10.1016/j.hrthm.2014.03.045; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Movahed MR, 2005, INT J CARDIOL, V105, P315, DOI 10.1016/j.ijcard.2005.02.050; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; Qi XY, 2014, CIRCULATION, V129, P430, DOI 10.1161/CIRCULATIONAHA.113.003019; Resnick HE, 2002, ANNU REV MED, V53, P245, DOI 10.1146/annurev.med.53.082901.103904; Shmukler BE, 2001, BBA-GENE STRUCT EXPR, V1518, P36, DOI 10.1016/S0167-4781(01)00166-X; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Stokes A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170219; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; WHO, 2016, GLOB REP PSOR; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Yi F, 2015, J BIOL CHEM, V290, P7016, DOI 10.1074/jbc.M114.607952; Yi F, 2014, J BIOL CHEM, V289, P10853, DOI 10.1074/jbc.M113.520940; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361; Zhang XD, 2015, HEART RHYTHM, V12, P1845, DOI 10.1016/j.hrthm.2015.04.046; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	36	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4160	4168		10.1074/jbc.RA118.003837	http://dx.doi.org/10.1074/jbc.RA118.003837			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30635400	Green Published, hybrid			2022-12-28	WOS:000461854400027
J	Ying, GX; Frederick, JM; Baehr, W				Ying, Guoxin; Frederick, Jeanne M.; Baehr, Wolfgang			Deletion of both centrin 2 (CETN2) and CETN3 destabilizes the distal connecting cilium of mouse photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retina; retina degeneration; phototransduction; photoreceptor; cilia; gene knockout; calcium-binding protein; centrin; centriole; connecting cilium; electroretinography; transition zone	MEMBRANE-PROTEIN; GENE; MICE; LOCALIZATION; CELLS; CILIARY; IDENTIFICATION; DEGENERATION; MICROTUBULES; DUPLICATION	Centrins (CETN1-4) are ubiquitous and conserved EF-hand-family Ca2+-binding proteins associated with the centrosome, basal body, and transition zone. Deletion of CETN1 or CETN2 in mice causes male infertility or dysosmia, respectively, without affecting photoreceptor function. However, it remains unclear to what extent centrins are redundant with each other in photoreceptors. Here, to explore centrin redundancy, we generated Cetn3(GT/GT) single-knockout and Cetn2(-/-);Cetn3(GT/GT) double-knockout mice. Whereas the Cetn3 deletion alone did not affect photoreceptor function, simultaneous ablation of Cetn2 and Cetn3 resulted in attenuated scotopic and photopic electroretinography (ERG) responses in mice at 3 months of age, with nearly complete retina degeneration at 1 year. Removal of CETN2 and CETN3 activity from the lumen of the connecting cilium (CC) destabilized the photoreceptor axoneme and reduced the CC length as early as postnatal day 22 (P22). In Cetn2(-/-);Cetn3(GT/GT) double-knockout mice, spermatogenesis-associated 7 (SPATA7), a key organizer of the photoreceptor-specific distal CC, was depleted gradually, and CETN1 was condensed to the mid-segment of the CC. Ultrastructural analysis revealed that in this double knockout, the axoneme of the CC expanded radially at the distal end, with vertically misaligned outer segment discs and membrane whorls. These observations suggest that CETN2 and CETN3 cooperate in stabilizing the CC/axoneme structure.	[Ying, Guoxin; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ying, GX; Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.	g.ying@utah.edu; wbaehr@hsc.utah.edu			National Institutes of Health [1R01 EY08123, 1R01 EY019298]; NEI [1P30 EY014800-039003]; University of Utah Dept. of Ophthalmology from Research to Prevent Blindness (RPB, New York); RPB Senior Investigator award; RPB Nelson Trust award; NATIONAL EYE INSTITUTE [R01EY019298, P30EY014800, R01EY008123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); University of Utah Dept. of Ophthalmology from Research to Prevent Blindness (RPB, New York); RPB Senior Investigator award; RPB Nelson Trust award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants 1R01 EY08123 and 1R01 EY019298 (to W. B.) and 1P30 EY014800-039003 from the NEI (NEI core grant). This work also was supported by unrestricted grants to the University of Utah Dept. of Ophthalmology from Research to Prevent Blindness (RPB, New York). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of an RPB Senior Investigator award and an RPB Nelson Trust award.	Avasthi P, 2013, J CELL SCI, V126, P3204, DOI 10.1242/jcs.128587; BARON AT, 1992, BIOL CELL, V76, P383, DOI 10.1016/0248-4900(92)90442-4; BARON AT, 1988, J CELL BIOL, V107, P2669, DOI 10.1083/jcb.107.6.2669; BAUM P, 1986, P NATL ACAD SCI USA, V83, P5512, DOI 10.1073/pnas.83.15.5512; Bicek AD, 2009, MOL BIOL CELL, V20, P2943, DOI 10.1091/mbc.E08-09-0909; Bornens M, 2007, ADV EXP MED BIOL, V607, P119; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Coleman JA, 2014, J CELL SCI, V127, P1138, DOI 10.1242/jcs.145052; Dantas TJ, 2012, CELL MOL LIFE SCI, V69, P2979, DOI 10.1007/s00018-012-0961-1; Dantas TJ, 2011, J CELL BIOL, V193, P307, DOI 10.1083/jcb.201012093; Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Delaval B, 2011, CELL CYCLE, V10, P3964, DOI 10.4161/cc.10.22.18150; Dharmat R, 2018, J CELL BIOL, V217, P2851, DOI 10.1083/jcb.201712117; Eblimit A, 2015, HUM MOL GENET, V24, P1584, DOI 10.1093/hmg/ddu573; Friedberg F, 2006, MOL BIOL REP, V33, P243, DOI 10.1007/s11033-006-9004-z; Gao JG, 2002, P NATL ACAD SCI USA, V99, P5698, DOI 10.1073/pnas.042122399; Gavet O, 2003, MOL BIOL CELL, V14, P1818, DOI 10.1091/mbc.E02-11-0709; Giessl A, 2004, J BIOL CHEM, V279, P51472, DOI 10.1074/jbc.M406770200; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Hart PE, 1999, GENOMICS, V60, P111, DOI 10.1006/geno.1999.5880; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Karlstetter M, 2014, HUM MOL GENET, V23, P5197, DOI 10.1093/hmg/ddu242; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Koblenz B, 2003, J CELL SCI, V116, P2635, DOI 10.1242/jcs.00497; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2003, INVEST OPHTH VIS SCI, V44, P4171, DOI 10.1167/iovs.03-0410; Liu Q, 2002, INVEST OPHTH VIS SCI, V43, P22; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; Paoletti A, 1996, J CELL SCI, V109, P3089; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Portran D, 2017, NAT CELL BIOL, V19, P391, DOI 10.1038/ncb3481; Prosser SL, 2015, J CELL BIOL, V208, P693, DOI 10.1083/jcb.201411070; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Pulvermuller A, 2002, MOL CELL BIOL, V22, P2194, DOI 10.1128/MCB.22.7.2194-2203.2002; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Robison P, 2016, SCIENCE, V352, DOI 10.1126/science.aaf0659; Salisbury JL, 2007, J CELL PHYSIOL, V213, P420, DOI 10.1002/jcp.21226; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; SCHIEBEL E, 1995, TRENDS CELL BIOL, V5, P197, DOI 10.1016/S0962-8924(00)88999-0; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Sharif AS, 2018, J NEUROSCI, V38, P3160, DOI 10.1523/JNEUROSCI.2964-17.2018; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Stuck MW, 2016, PROG RETIN EYE RES, V52, P47, DOI 10.1016/j.preteyeres.2015.12.002; Thompson JR, 2006, J BIOL CHEM, V281, P18746, DOI 10.1074/jbc.M513667200; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; Xu ZJ, 2017, SCIENCE, V356, P328, DOI 10.1126/science.aai8764; Yang CH, 2010, MOL BIOL CELL, V21, P4361, DOI 10.1091/mbc.E10-04-0298; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Ying GX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161236; Ying GX, 2014, J NEUROSCI, V34, P6377, DOI 10.1523/JNEUROSCI.0067-14.2014; Zhu XM, 2002, MOL VIS, V8, P462	64	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3957	3973		10.1074/jbc.RA118.006371	http://dx.doi.org/10.1074/jbc.RA118.006371			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30647131	Green Published, hybrid			2022-12-28	WOS:000461854400013
J	Silverman, JM; Christy, D; Shyu, CC; Moon, KM; Fernando, S; Gidden, Z; Cowan, CM; Ban, YX; Stacey, RG; Grad, LI; McAlary, L; Mackenzie, IR; Foster, LJ; Cashman, NR				Silverman, Judith M.; Christy, Darren; Shyu, Chih Cheih; Moon, Kyung-Mee; Fernando, Sarah; Gidden, Zoe; Cowan, Catherine M.; Ban, Yuxin; Stacey, R. Greg; Grad, Leslie I.; McAlary, Luke; Mackenzie, Ian R.; Foster, Leonard J.; Cashman, Neil R.			CNS-derived extracellular vesicles from superoxide dismutase 1 (SOD1)(G93A) ALS mice originate from astrocytes and neurons and carry misfolded SOD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						exosome (vesicle); amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); neurodegeneration; proteomics; astrocyte; extracellular vesicles; central nervous system (CNS); secretion; protein homeostasis	NANOPARTICLE TRACKING ANALYSIS; PROTEIN DISULFIDE-ISOMERASE; TRANSGENIC-MOUSE MODEL; PROTEOMIC ANALYSIS; SECRETION PATHWAY; GENE-EXPRESSION; FLOW-CYTOMETRY; MOTOR-NEURONS; DATA SETS; EXOSOMES	Extracellular vesicles (EVs) are secreted by myriad cells in culture and also by unicellular organisms, and their identification in mammalian fluids suggests that EV release also occurs at the organism level. However, although it is clearly important to better understand EVs' roles in organismal biology, EVs in solid tissues have received little attention. Here, we modified a protocol for EV isolation from primary neural cell culture to collect EVs from frozen whole murine and human neural tissues by serial centrifugation and purification on a sucrose gradient. Quantitative proteomics comparing brain-derived EVs from nontransgenic (NTg) and a transgenic amyotrophic lateral sclerosis (ALS) mouse model, superoxide dismutase 1 (SOD1)(G93A), revealed that these EVs contain canonical exosomal markers and are enriched in synaptic and RNA-binding proteins. The compiled brain EV proteome contained numerous proteins implicated in ALS, and EVs from SOD1(G93A) mice were significantly depleted in myelin-oligodendrocyte glycoprotein compared with those from NTg animals. We observed that brain- and spinal cord-derived EVs, from NTg and SOD1(G93A) mice, are positive for the astrocyte marker GLAST and the synaptic marker SNAP25, whereas CD11b, a microglial marker, was largely absent. EVs from brains and spinal cords of the SOD1(G93A) ALS mouse model, as well as from human SOD1 familial ALS patient spinal cord, contained abundant misfolded and nonnative disulfide-cross-linked aggregated SOD1. Our results indicate that CNS-derived EVs from an ALS animal model contain pathogenic disease-causing proteins and suggest that brain astrocytes and neurons, but not microglia, are the main EV source.	[Silverman, Judith M.; Christy, Darren; Shyu, Chih Cheih; Fernando, Sarah; Gidden, Zoe; Cowan, Catherine M.; Ban, Yuxin; Grad, Leslie I.; McAlary, Luke; Cashman, Neil R.] Univ British Columbia, Dept Med, Ctr Brain Hlth, Vancouver, BC V6T 1B5, Canada; [Moon, Kyung-Mee; Stacey, R. Greg; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1B5, Canada; [McAlary, Luke] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Mackenzie, Ian R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1B5, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Cashman, NR (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC V6T 1B5, Canada.	neil.cashman@vch.ca		Gidden, Zoe/0000-0002-6704-3035; McAlary, Luke/0000-0002-1764-3809; Fernando, Sarah/0000-0001-8862-6830	Bernice Ramsay ALS Canada; Paul Heller Memorial Fund	Bernice Ramsay ALS Canada; Paul Heller Memorial Fund	This work was supported by a Bernice Ramsay ALS Canada grant, along with funding from the Paul Heller Memorial Fund (to J. M. S.). N. R. C. is the Chief Scientific Officer of ProMIS Neurosciences, which has licensed the 3H1 misfolded SOD1-specific antibody technology.	An K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-47; Antonucci Flavia, 2016, Front Synaptic Neurosci, V8, P7, DOI 10.3389/fnsyn.2016.00007; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Ayers JI, 2014, ACTA NEUROPATHOL, V128, P791, DOI 10.1007/s00401-014-1342-7; Bakkar N, 2018, ACTA NEUROPATHOL, V135, P227, DOI 10.1007/s00401-017-1785-8; Basso M, 2013, J BIOL CHEM, V288, P15699, DOI 10.1074/jbc.M112.425066; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Bowyer JF, 1999, ANN NY ACAD SCI, V890, P314, DOI 10.1111/j.1749-6632.1999.tb08009.x; Brett SI, 2017, PROSTATE, V77, P1335, DOI 10.1002/pros.23393; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Cestra G, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00085; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Ciryam P, 2017, P NATL ACAD SCI USA, V114, pE3935, DOI 10.1073/pnas.1613854114; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Da Cruz S, 2017, ACTA NEUROPATHOL, V134, P97, DOI 10.1007/s00401-017-1688-8; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Deng JT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01115-6; Ding XB, 2015, ONCOTARGET, V6, P24178, DOI 10.18632/oncotarget.4680; Ditsworth D, 2017, ACTA NEUROPATHOL, V133, P907, DOI 10.1007/s00401-017-1698-6; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gibbs MR, 2017, P NATL ACAD SCI USA, V114, P980, DOI 10.1073/pnas.1613665114; Gillis J, 2010, NAT PROTOC, V5, P1148, DOI 10.1038/nprot.2010.78; Grad LI, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024117; Grad LI, 2015, NEUROBIOL DIS, V77, P257, DOI 10.1016/j.nbd.2015.02.009; Grad LI, 2014, PRION, V8, P331, DOI 10.4161/19336896.2014.983398; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Inglis H, 2015, JOVE-J VIS EXP, DOI 10.3791/52484; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Ito D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5436; Jaronen M, 2013, HUM MOL GENET, V22, P646, DOI 10.1093/hmg/dds472; Jeppesen DK, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25011; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kapur M, 2017, NEURON, V96, P616, DOI 10.1016/j.neuron.2017.09.057; Keerthikumar S, 2015, ONCOTARGET, V6, P15375, DOI 10.18632/oncotarget.3801; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Lachenal G, 2011, MOL CELL NEUROSCI, V46, P409, DOI 10.1016/j.mcn.2010.11.004; Lederer CW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-26; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Li CCY, 2013, RNA BIOL, V10, P1333, DOI 10.4161/rna.25281; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McAlary L, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00499; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ngolab J, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0445-5; Nolte-'t Hoen ENM, 2012, NANOMED-NANOTECHNOL, V8, P712, DOI 10.1016/j.nano.2011.09.006; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Noor A, 2017, INT J NEUROSCI, V127, P805, DOI 10.1080/00207454.2016.1248240; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Parker R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r81; Paschon V, 2016, MOL NEUROBIOL, V53, P2016, DOI 10.1007/s12035-015-9142-1; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Peschl P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00529; Pospichalova V, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.25530; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ravits J, 2014, EXP NEUROL, V262, P121, DOI 10.1016/j.expneurol.2014.07.021; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00253; Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Song F, 2014, AMYOTROPH LAT SCL FR, V15, P77, DOI 10.3109/21678421.2013.853802; Sproviero D, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00487; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tokuda E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-016-0145-9; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Vestad B, 2017, J EXTRACELL VESICLES, V6, P1, DOI 10.1080/20013078.2017.1344087; Woehlbier U, 2016, EMBO J, V35, P845, DOI 10.15252/embj.201592224; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	94	63	63	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3744	3759		10.1074/jbc.RA118.004825	http://dx.doi.org/10.1074/jbc.RA118.004825			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30635404	Green Published, hybrid			2022-12-28	WOS:000461853900035
J	Frixione, E; Ruiz-Zamarripa, L				Frixione, Eugenio; Ruiz-Zamarripa, Lourdes			The "scientific catastrophe" in nucleic acids research that boosted molecular biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							THYMUS; DNA		[Frixione, Eugenio; Ruiz-Zamarripa, Lourdes] IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 07000, DF, Mexico; [Frixione, Eugenio] IPN, CINVESTAV, Ctr Res & Adv Studies, Program Sci & Technol Soc, Mexico City 07000, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Frixione, E (corresponding author), IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 07000, DF, Mexico.; Frixione, E (corresponding author), IPN, CINVESTAV, Ctr Res & Adv Studies, Program Sci & Technol Soc, Mexico City 07000, DF, Mexico.	frixione@cinvestav.mx						Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Booth H, 1996, J CHEM EDUC, V73, P928, DOI 10.1021/ed073p928; BROWN DM, 1954, J CHEM SOC, P40, DOI 10.1039/jr9540000040; cAltmann R., 1889, ARCH ANAT PHYSL, P524; Chargaff E, 1968, Prog Nucleic Acid Res Mol Biol, V8, P297; CHARGAFF E, 1949, J BIOL CHEM, V177, P405; CHARGAFF E, 1951, J CELL COMPAR PHYSL, V38, P41, DOI 10.1002/jcp.1030380406; Chargaff E., 1955, NUCLEIC ACIDS CHEM B, P368; Cobb M., 2015, LIFES GREATEST SECRE; Dahm R, 2008, HUM GENET, V122, P565, DOI 10.1007/s00439-007-0433-0; Fischer E., 1891, BER, V24, P4214; FRUTON JS, 1979, TRENDS BIOCHEM SCI, V4, P49, DOI 10.1016/0968-0004(79)90351-7; GLASS B, 1965, P AM PHILOS SOC, V109, P227; GULLAND JM, 1945, ANNU REV BIOCHEM, V14, P175, DOI 10.1146/annurev.bi.14.070145.001135; GULLAND JM, 1947, SYM SOC EXP BIOL, V1, P1; Hammarsten O., 1894, Z PHYSL CHEM, V19, P19; Hargittai I, 2009, STRUCT CHEM, V20, P753, DOI 10.1007/s11224-009-9497-x; Hausmann R., 2002, GRASP ESSENCE LIFE H, P42; Hunter G. K., 1999, AMBIX, V46, P73, DOI DOI 10.1179/amb.1999.46.2.73; Jacobs W. A., 1909, J BIOL CHEM, V6, pxxxvi; JONES ME, 1953, YALE J BIOL MED, V26, P80; Jones W., 1914, NUCLEIC ACIDS THEIR, P77; Kohler R. E., 1982, MED CHEM BIOCH MAKIN, P269; Kossel A., 1911, HARVEY LECT CHEM COM, V7, P33; Kossel A., 1893, BER DTSCH CHEM GES, V26, P2753; Levene P. A., 1931, NUCL ACIDS; Levene P. A., 1909, BER DEUT CHEM GES, V43, P2703; Levene P. A., 1929, J BIOL CHEM, V81, P711; Levene P. A., 1929, SCIENCE, V69, P556; Levene PA, 1909, BER DTSCH CHEM GES, V42, P2474, DOI 10.1002/cber.190904202148; Levene PA, 1935, J BIOL CHEM, V109, P623; Levene PA, 1929, J BIOL CHEM, V83, P803; Levene PA, 1912, J BIOL CHEM, V12, P411; Levene PA, 1917, J AM CHEM SOC, V39, P828, DOI 10.1021/ja02249a037; Levene PA, 1900, J AM CHEM SOC, V22, P329, DOI 10.1021/ja02044a003; Levene PA, 1904, AM J PHYSIOL, V12, P213, DOI 10.1152/ajplegacy.1904.12.2.213; Levene PA, 1910, J AM CHEM SOC, V32, P231, DOI 10.1021/ja01920a010; Levene PA, 1908, BER DTSCH CHEM GES, V41, P1905, DOI 10.1002/cber.19080410266; Levene PA, 1909, BIOCHEM Z, V17, P120; Levene PA, 1930, J BIOL CHEM, V85, P785; Levene PA, 1909, BER DTSCH CHEM GES, V42, P3247, DOI 10.1002/cber.19090420351; Levene PA, 1929, J BIOL CHEM, V83, P793; Morange Michel, 1998, HIST MOL BIOL; Olby R., 1973, PATH DOUBLE HELIX; Osborne TB, 1902, H-S Z PHYSIOL CHEM, V36, P85, DOI 10.1515/bchm2.1902.36.2-3.85; Portugal F. H., 1977, CENTURY DNA HIST DIS; Schmidt G, 1938, SCIENCE, V88, P172, DOI 10.1126/science.88.2277.172; Schmidt G, 1939, J BIOL CHEM, V127, P251; Schmidt G, 1938, J BIOL CHEM, V126, P423; Signer R, 1938, NATURE, V141, P122, DOI 10.1038/141122a0; Staudinger H, 1920, BER DTSCH CHEM GES, V53, P1073, DOI 10.1002/cber.19200530627; Steudel H, 1906, H-S Z PHYSIOL CHEM, V49, P406, DOI 10.1515/bchm2.1906.49.4-6.406; TIPSON R S, 1957, Adv Carbohydr Chem, V12, P1; Todd A. R., 1953, HARVEY LECT 1951 195, V1951-1952, P1; van Slyke D. D., 1944, BIOGRAPH MEM NATL AC, V24, P73; WHITFELD PR, 1953, NATURE, V171, P1151, DOI 10.1038/1711151a0	56	5	6	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2249	2255		10.1074/jbc.CL119.007397	http://dx.doi.org/10.1074/jbc.CL119.007397			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30765511	Green Published, hybrid			2022-12-28	WOS:000458895400004
J	Smith, WL; Malkowski, MG				Smith, William L.; Malkowski, Michael G.			Interactions of fatty acids, nonsteroidal anti-inflammatory drugs, and coxibs with the catalytic and allosteric subunits of cyclooxygenases-1 and-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						prostaglandin; arachidonic acid (AA) (ARA); eicosanoid; cyclooxygenase (COX); allosteric regulation; eicosapentaenoic acid; naproxen; NSAID; oleic acid; palmitic acid	PROSTAGLANDIN-H SYNTHASE; ENDOCANNABINOID OXYGENATION; ARACHIDONIC-ACID; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CROSS-TALK; SUBCELLULAR-LOCALIZATION; ENDOPEROXIDE SYNTHETASE; ARGININE 120; INHIBITION	Prostaglandin endoperoxide H synthases-1 and -2, commonly called cyclooxygenases-1 and -2 (COX-1 and -2), catalyze the committed step in prostaglandin biosynthesis-the conversion of arachidonic acid to prostaglandin endoperoxide H-2. Both COX isoforms are sequence homodimers that function as conformational heterodimers having allosteric (Eallo) and catalytic (Ecat) subunits. At least in the case of COX-2, the enzyme becomes folded into a stable Eallo/Ecat pair. Some COX inhibitors (i.e. nonsteroidal anti-inflammatory drugs and coxibs) and common fatty acids (FAs) modulate Ecat activity by binding Eallo. However, the interactions and outcomes often differ between isoforms. For example, naproxen directly and completely inhibits COX-1 by binding Ecat but indirectly and incompletely inhibits COX-2 by binding Eallo. Additionally, COX-1 is allosterically inhibited up to 50% by common FAs like palmitic acid, whereas COX-2 is allosterically activated 2-fold by palmitic acid. FA binding to Eallo also affects responses to COX inhibitors. Thus, COXs are physiologically and pharmacologically regulated by the FA tone of the milieu in which each operates-COX-1 in the endoplasmic reticulum and COX-2 in the Golgi apparatus. Cross-talk between Eallo and Ecat involves a loop in Eallo immediately downstream of Arg-120. Mutational studies suggest that allosteric modulation requires a direct interaction between the carboxyl group of allosteric effectors and Arg-120 of Eallo; however, structural studies show some allosterically active FAs positioned in COX-2 in a conformation lacking an interaction with Arg-120. Thus, many details about the biological consequences of COX allosterism and how ligand binding to Eallo modulates Ecat remain to be resolved.	[Smith, William L.] Univ Michigan, Med Sch, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA; [Malkowski, Michael G.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Struct Biol, Rm 5154,955 Main St, Buffalo, NY 14203 USA	University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Smith, WL (corresponding author), Univ Michigan, Med Sch, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.; Malkowski, MG (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Struct Biol, Rm 5154,955 Main St, Buffalo, NY 14203 USA.	smithww@umich.edu; mgm22@buffalo.edu		Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health [GM68848, CA 130810, HL 117798, GM 077176, GM 115386]; NATIONAL CANCER INSTITUTE [P50CA130810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM68848 (to W. L. S.), CA 130810 (to W. L. S.), HL 117798 (to W. L. S.), GM 077176 (to M. G. M.), and GM 115386 (to M. G. M.). This JBC Review is part of a collection honoring Herbert Tabor on the occasion of his 100th birthday. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accioly MT, 2008, CANCER RES, V68, P1732, DOI 10.1158/0008-5472.CAN-07-1999; Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Blobaum AL, 2015, J BIOL CHEM, V290, P12793, DOI 10.1074/jbc.M114.635987; Burde T, 2002, EUR J PHARMACOL, V453, P167, DOI 10.1016/S0014-2999(02)02450-0; CULP BR, 1979, PROSTAG LEUKOTR ESS, V3, P269, DOI 10.1016/0161-4630(79)90068-5; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; Dong L, 2016, J BIOL CHEM, V291, P25641, DOI 10.1074/jbc.M116.757310; Dong L, 2016, J LIPID RES, V57, P1043, DOI 10.1194/jlr.M067512; Dong L, 2016, J BIOL CHEM, V291, P4069, DOI 10.1074/jbc.M115.698001; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kudalkar SN, 2015, J BIOL CHEM, V290, P7897, DOI 10.1074/jbc.M114.634014; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Leslie CC, 2010, BIOCHIMIE, V92, P620, DOI 10.1016/j.biochi.2010.03.001; Li XZ, 2018, J LIPID RES, V59, P2035, DOI 10.1194/jlr.M079996ERR; Li XZ, 2018, FASEB J, V32, P5326, DOI 10.1096/fj.201800252R; Liu W, 2006, FASEB J, V20, P1097, DOI 10.1096/fj.05-5273com; Liu Y, 2016, J BIOL CHEM, V291, P948, DOI 10.1074/jbc.M115.668038; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; Lucido MJ, 2016, BIOCHEMISTRY-US, V55, P1226, DOI 10.1021/acs.biochem.5b01378; Malkowski M.G., 2017, ENCY INORGANIC BIOIN, P1; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Murakami M, 2016, ADV IMMUNOL, V132, P91, DOI 10.1016/bs.ai.2016.05.001; OTTO JC, 1994, J BIOL CHEM, V269, P19868; Otto JC, 1996, J BIOL CHEM, V271, P9906, DOI 10.1074/jbc.271.17.9906; PERCIVAL MD, 1994, ARCH BIOCHEM BIOPHYS, V315, P111, DOI 10.1006/abbi.1994.1478; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; Rosenstock M, 2001, EUR J PHARMACOL, V412, P101, DOI 10.1016/S0014-2999(00)00931-6; ROTH GJ, 1981, J BIOL CHEM, V256, P18; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; SMITH WL, 1971, J BIOL CHEM, V246, P6700; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Swinney DC, 1997, J BIOL CHEM, V272, P12393, DOI 10.1074/jbc.272.19.12393; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; VANDEROUDERAA FJ, 1980, EUR J BIOCHEM, V109, P1; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2015, J BIOL CHEM, V290, P5606, DOI 10.1074/jbc.M114.632463; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	65	26	27	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1697	1705		10.1074/jbc.TM118.006295	http://dx.doi.org/10.1074/jbc.TM118.006295			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710016	hybrid, Green Published			2022-12-28	WOS:000457879200029
J	Das, D; Patra, S; Bridwell-Rabb, J; Barondeau, DP				Das, Deepika; Patra, Shachin; Bridwell-Rabb, Jennifer; Barondeau, David P.			Mechanism of frataxin "bypass" in human iron-sulfur cluster biosynthesis with implications for Friedreich's ataxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial disease; iron-sulfur protein; enzyme kinetics; analytical ultracentrifugation; circular dichroism (CD); fluorescence anisotropy; neurodegeneration; cysteine labeling; iron-sulfur assembly; ISCU2 M140I	MITOCHONDRIAL CYSTEINE DESULFURASE; YEAST FRATAXIN; SCAFFOLD PROTEIN; ISD11; BIOGENESIS; BINDING; ISCU; ACTS; NFS1; ACTIVATION	In humans, mitochondrial iron-sulfur cluster biosynthesis is an essential biochemical process mediated by the assembly complex consisting of cysteine desulfurase (NFS1), LYR protein (ISD11), acyl-carrier protein (ACP), and the iron-sulfur cluster assembly scaffold protein (ISCU2). The protein frataxin (FXN) is an allosteric activator that binds the assembly complex and stimulates the cysteine desulfurase and iron-sulfur cluster assembly activities. FXN depletion causes loss of activity of iron-sulfur-dependent enzymes and the development of the neurodegenerative disease Friedreich's ataxia. Recently, a mutation that suppressed the loss of the FXN homolog in Saccharomyces cerevisiae was identified that encodes an amino acid substitution equivalent to the human variant ISCU2 M140I. Here, we developed iron-sulfur cluster synthesis and transfer functional assays and determined that the human ISCU2 M140I variant can substitute for FXN in accelerating the rate of iron-sulfur cluster formation on the monothiol glutaredoxin (GRX5) acceptor protein. Incorporation of both FXN and the M140I substitution had an additive effect, suggesting an acceleration of distinct steps in iron-sulfur cluster biogenesis. In contrast to the canonical role of FXN in stimulating the formation of [2Fe-2S]-ISCU2 intermediates, we found here that the M140I substitution in ISCU2 promotes the transfer of iron-sulfur clusters to GRX5. Together, these results reveal an unexpected mechanism that replaces FXN-based stimulation of the iron-sulfur cluster biosynthetic pathway and suggest new strategies to overcome the loss of cellular FXN that may be relevant to the development of therapeutics for Friedreich's ataxia.	[Das, Deepika; Patra, Shachin; Bridwell-Rabb, Jennifer; Barondeau, David P.] Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA; [Das, Deepika] Emory Univ, Oxford Coll, 801 Emory St,Pierce Hall, Oxford, GA 30054 USA; [Bridwell-Rabb, Jennifer] Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA	Texas A&M University System; Texas A&M University College Station; Emory University; University of Michigan System; University of Michigan	Barondeau, DP (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA.	barondeau@tamu.edu	Barondeau, David/D-6736-2015; Patra, Shachin/W-5682-2019	Barondeau, David/0000-0002-6422-9053; Patra, Shachin/0000-0003-4223-1731; Bridwell-Rabb, Jennifer/0000-0002-7437-6217; Das, Deepika/0000-0001-8145-2671	National Institutes of Health [R01GM096100]; National Science Foundation [CHE1508269]; Robert A. Welch Foundation [A-1647]; National Science Foundation Extreme Science and Engineering Discovery Environment Grant [MCB070038]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); National Science Foundation Extreme Science and Engineering Discovery Environment Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM096100, National Science Foundation Grant CHE1508269, and Robert A. Welch Foundation Grant A-1647. The LIMS cluster at the Bioinformatics Core Facility at the University of Texas Health Science Center at San Antonio and multiple High-Performance Computing clusters were supported by National Science Foundation Extreme Science and Engineering Discovery Environment Grant MCB070038. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Bridwell-Rabb J, 2011, BIOCHEMISTRY-US, V50, P7265, DOI 10.1021/bi200895k; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cai K, 2018, BIOCHEMISTRY-US, V57, P1491, DOI 10.1021/acs.biochem.7b01234; Cai K, 2017, ACS CHEM BIOL, V12, P918, DOI 10.1021/acschembio.6b01005; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cory SA, 2017, P NATL ACAD SCI USA, V114, pE5325, DOI 10.1073/pnas.1702849114; Demeler B., 2016, ANAL ULTRACENTRIFUGA, P119, DOI [DOI 10.1007/978-4-431-55985-6_8, 10.1007/978-4-431-55985-6_8]; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fox NG, 2018, BIOCHIMIE, V152, P211, DOI 10.1016/j.biochi.2018.07.012; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3871, DOI 10.1021/bi5014485; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3880, DOI 10.1021/bi5014497; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Parent A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6686; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312; Terali K, 2013, BIOCHEM BIOPH RES CO, V440, P235, DOI 10.1016/j.bbrc.2013.09.039; Tsai CL, 2011, BIOCHEMISTRY-US, V50, P6478, DOI 10.1021/bi200666h; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Vranish JN, 2015, J AM CHEM SOC, V137, P390, DOI 10.1021/ja510998s; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yoon H, 2014, BIOCHEM J, V459, P71, DOI 10.1042/BJ20131273; Yoon H, 2012, BIOCHEM J, V441, P473, DOI 10.1042/BJ20111637; Zaidi A, 2015, BIOCHIMIE, V115, P120, DOI 10.1016/j.biochi.2015.05.016; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	42	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9276	9284		10.1074/jbc.RA119.007716	http://dx.doi.org/10.1074/jbc.RA119.007716			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	30975898	Green Published, hybrid			2022-12-28	WOS:000471751600020
J	Luhr, M; Torgersen, ML; Szalai, P; Hashim, A; Brech, A; Staerk, J; Engedal, N				Luhr, Morten; Torgersen, Maria Lyngaas; Szalai, Paula; Hashim, Adnan; Brech, Andreas; Staerk, Judith; Engedal, Nikolai			The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; endoplasmic reticulum stress (ER stress); unfolded protein response (UPR); protein degradation; signal transduction; activating transcription factor 4 (ATF4); autophagic sequestration; GABA type A receptor-associated protein (GABARAP); microtubule-associated protein 1 light chain 3 (LC3); pancreatic EIF2-kinase (PERK); tunicamycin (TM); inositol-requiring enzyme 1 (IRE1); autophagic degradation	ENDOPLASMIC-RETICULUM TURNOVER; UNFOLDED PROTEIN RESPONSE; INDUCED GENE-EXPRESSION; AMINO-ACID DEPRIVATION; ACTIVATES AUTOPHAGY; PROSTATE-CANCER; CELL-DEATH; NONSELECTIVE AUTOPHAGY; MONITORING AUTOPHAGY; DEGRADATION	Endoplasmic reticulum (ER) stress is thought to activate autophagy via unfolded protein response (UPR)-mediated transcriptional up-regulation of autophagy machinery components and modulation of microtubule-associated protein 1 light chain 3 (LC3). The upstream UPR constituents pancreatic EIF2- kinase (PERK) and inositol-requiring enzyme 1 (IRE1) have been reported to mediate these effects, suggesting that UPR may stimulate autophagy via PERK and IRE1. However, how the UPR and its components affect autophagic activity has not been thoroughly examined. By analyzing the flux of LC3 through the autophagic pathway, as well as the sequestration and degradation of autophagic cargo, we here conclusively show that the classical ER stressor tunicamycin (TM) enhances autophagic activity in mammalian cells. PERK and its downstream factor, activating transcription factor 4 (ATF4), were crucial for this induction, but surprisingly, IRE1 constitutively suppressed autophagic activity. TM-induced autophagy required autophagy-related 13 (ATG13), Unc-51-like autophagy-activating kinases 1/2 (ULK1/ULK2), and GABA type A receptor-associated proteins (GABARAPs), but interestingly, LC3 proteins appeared to be redundant. Strikingly, ATF4 was activated independently of PERK in both LNCaP and HeLa cells, and our further examination revealed that ATF4 and PERK regulated autophagy through separate mechanisms. Specifically, whereas ATF4 controlled transcription and was essential for autophagosome formation, PERK acted in a transcription-independent manner and was required at a post-sequestration step in the autophagic pathway. In conclusion, our results indicate that TM-induced UPR activates functional autophagy, and whereas IRE1 is a negative regulator, PERK and ATF4 are required at distinct steps in the autophagic pathway.	[Luhr, Morten; Szalai, Paula; Hashim, Adnan; Staerk, Judith; Engedal, Nikolai] Univ Oslo, Ctr Mol Med Norway NCMM, Nord EMBL Partnership Mol Med, POB 1137 Blindern, N-0318 Oslo, Norway; [Torgersen, Maria Lyngaas; Brech, Andreas] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, N-0379 Oslo, Norway; [Brech, Andreas] Univ Oslo, CanCell, N-0310 Oslo, Norway; [Brech, Andreas] Univ Oslo, Dept Biosci, N-0310 Oslo, Norway; [Engedal, Nikolai] Oslo Univ Hosp, Dept Haematol, N-0372 Oslo, Norway; [Engedal, Nikolai] Oslo Univ Hosp, Norwegian Ctr Stem Cell Res, Dept Immunol, N-0372 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Engedal, N (corresponding author), Univ Oslo, Ctr Mol Med Norway NCMM, Nord EMBL Partnership Mol Med, POB 1137 Blindern, N-0318 Oslo, Norway.	nikolai.engedal@ncmm.uio.no	Torgersen, Maria Lyngaas L/F-3492-2017; Engedal, Nikolai/AAJ-8951-2020; Hashim, Adnan/Y-8924-2019; Lindner, Paula/S-6929-2019	Torgersen, Maria Lyngaas L/0000-0003-2616-7194; Engedal, Nikolai/0000-0003-3718-3464; Lindner, Paula/0000-0003-0734-6429; Staerk, Judith/0000-0001-8698-6998; Brech, Andreas/0000-0002-9803-1774	Research Council of Norway [230686]; University of Oslo; Nansen Foundation; Anders Jahre Foundation; Legacy in memory of Henrik Homan	Research Council of Norway(Research Council of Norway); University of Oslo; Nansen Foundation; Anders Jahre Foundation; Legacy in memory of Henrik Homan	This work was supported by grants from the Research Council of Norway (Project 230686) and the University of Oslo, the Nansen Foundation, the Anders Jahre Foundation, and the Legacy in memory of Henrik Homan (to N. E.). The authors declare that they have no conflicts of interest with the contents of this article.	An H, 2018, NAT CELL BIOL, V20, P135, DOI 10.1038/s41556-017-0007-x; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Axten JM, 2017, EXPERT OPIN THER PAT, V27, P37, DOI 10.1080/13543776.2017.1238072; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bestebroer J, 2013, TRAFFIC, V14, P1029, DOI 10.1111/tra.12091; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Cadwell K, 2018, J CELL BIOL, V217, P813, DOI 10.1083/jcb.201706157; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carson JP, 1999, CANCER RES, V59, P1449; Castillo K, 2011, EMBO J, V30, P4465, DOI 10.1038/emboj.2011.318; Chen SL, 2018, P NATL ACAD SCI USA, V115, pE6237, DOI 10.1073/pnas.1805032115; DATEMA R, 1978, EUR J BIOCHEM, V90, P505, DOI 10.1111/j.1432-1033.1978.tb12630.x; Donoso G, 2005, BIOCHEM J, V387, P897, DOI 10.1042/BJ20041312; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Engedal N, 2016, AUTOPHAGY, V12, P439, DOI 10.1080/15548627.2015.1076606; Engedal N, 2013, AUTOPHAGY, V9, P1475, DOI 10.4161/auto.25900; Moruno-Manchon JF, 2013, BIOCHEM J, V449, P497, DOI 10.1042/BJ20121122; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Fumagalli F, 2016, NAT CELL BIOL, V18, P1173, DOI 10.1038/ncb3423; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Garcia-Navas R, 2012, AUTOPHAGY, V8, P1557, DOI 10.4161/auto.21315; Grumati P, 2017, ELIFE, V6, DOI 10.7554/eLife.25555; Hanson HH, 2010, J BIOL CHEM, V285, P20982, DOI 10.1074/jbc.M109.092031; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Itkonen HM, 2015, ONCOGENE, V34, P3744, DOI 10.1038/onc.2014.307; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Jin HO, 2009, FREE RADICAL BIO MED, V46, P1158, DOI 10.1016/j.freeradbiomed.2009.01.015; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaufman DR, 2017, MOL BIOL CELL, V28, P1636, DOI 10.1091/mbc.E16-12-0828; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Kjos I, 2017, EMBO REP, V18, P1727, DOI 10.15252/embr.201744069; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lee H, 2012, HUM MOL GENET, V21, P101, DOI 10.1093/hmg/ddr445; Li WM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01609-x; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lipatova Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005390; Lipatova Z, 2013, MOL BIOL CELL, V24, P3133, DOI 10.1091/mbc.E13-05-0269; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luhr M, 2017, METHOD ENZYMOL, V587, P351, DOI 10.1016/bs.mie.2016.09.064; Luhr M, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2836; Luhr M, 2018, JOVE-J VIS EXP, DOI 10.3791/57971; Mancini R, 2003, J BIOL CHEM, V278, P46895, DOI 10.1074/jbc.M302979200; Margariti A, 2013, J BIOL CHEM, V288, P859, DOI 10.1074/jbc.M112.412783; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Doan NTQ, 2015, STEROIDS, V97, P2, DOI 10.1016/j.steroids.2014.07.009; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Munoz JP, 2013, EMBO J, V32, P2348, DOI 10.1038/emboj.2013.168; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; PFEIFER U, 1978, J CELL BIOL, V78, P152, DOI 10.1083/jcb.78.1.152; Pike LRG, 2013, BIOCHEM J, V449, P389, DOI 10.1042/BJ20120972; PLOMP PJAM, 1987, EUR J BIOCHEM, V164, P197, DOI 10.1111/j.1432-1033.1987.tb11011.x; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Qiu W, 2011, HEPATOLOGY, V53, P1515, DOI 10.1002/hep.24269; Ramkumar A, 2017, AUTOPHAGY, V13, P1331, DOI 10.1080/15548627.2017.1327509; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Saetre F, 2015, FEBS J, V282, P2202, DOI 10.1111/febs.13268; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; SCHWORER CM, 1981, J BIOL CHEM, V256, P7652; Seglen PO, 2015, METHODS, V75, P25, DOI 10.1016/j.ymeth.2014.12.021; Sehgal P, 2017, J BIOL CHEM, V292, P19656, DOI 10.1074/jbc.M117.796920; Sharma M, 2017, J GEN VIROL, V98, P1027, DOI 10.1099/jgv.0.000792; Shenkman M, 2007, CELL STRESS CHAPERON, V12, P373, DOI 10.1379/CSC-281.1; Shimodaira Y, 2014, BIOCHEM BIOPH RES CO, V445, P524, DOI 10.1016/j.bbrc.2014.02.054; Smith MD, 2018, DEV CELL, V44, P217, DOI 10.1016/j.devcel.2017.11.024; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Szalai P, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2835; Szalai P, 2015, EXP CELL RES, V333, P21, DOI 10.1016/j.yexcr.2015.02.003; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; Vaites LP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00392-17; van Vliet AR, 2017, MOL CELL, V65, P885, DOI 10.1016/j.molcel.2017.01.020; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wang J, 2014, AUTOPHAGY, V10, P766, DOI 10.4161/auto.27954; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xi HB, 2014, IUBMB LIFE, V66, P110, DOI 10.1002/iub.1251; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	106	69	71	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8197	8217		10.1074/jbc.RA118.002829	http://dx.doi.org/10.1074/jbc.RA118.002829			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30926605	Green Published, hybrid			2022-12-28	WOS:000470656500018
J	Vydyam, P; Dutta, D; Sutram, N; Bhattacharyya, S; Bhattacharyya, MK				Vydyam, Pratap; Dutta, Dibyendu; Sutram, Niranjan; Bhattacharyya, Sunanda; Bhattacharyya, Mrinal Kanti			A small-molecule inhibitor of the DNA recombinase Rad51 from Plasmodium falciparum synergizes with the antimalarial drugs artemisinin and chloroquine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plasmodium; DNA repair; homologous recombination; drug screening; malaria; artemisinin; B02; comet assay; PfRad51; small-molecule inhibitor	DISRUPTS HOMOLOGOUS RECOMBINATION; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; MAMMALIAN RAD51; PROTEIN; IDENTIFICATION; DAMAGE; REPLICATION; MECHANISM; ACCURACY	Malaria parasites repair DNA double-strand breaks (DSBs) primarily through homologous recombination (HR). Here, because the unrepaired DSBs lead to the death of the unicellular parasite Plasmodium falciparum, we investigated its recombinase, PfRad51, as a potential drug target. Undertaking an in silico screening approach, we identified a compound, B02, that docks to the predicted tertiary structure of PfRad51 with high affinity. B02 inhibited a drug-sensitive P. falciparum strain (3D7) and multidrug-resistant parasite (Dd2) in culture, with IC50 values of 8 and 3 m, respectively. We found that B02 is more potent against these P. falciparum strains than against mammalian cell lines. Our findings also revealed that the antimalarial activity of B02 synergizes with those of two first-line malaria drugs, artemisinin (ART) and chloroquine (CQ), lowering the IC50 values of ART and CQ by 15- and 8-fold, respectively. Our results also provide mechanistic insights into the anti-parasitic activity of B02, indicating that it blocks the ATPase and strand-exchange activities of PfRad51 and abrogates the formation of PfRad51 foci on damaged DNA at chromosomal sites, probably by blocking homomeric interactions of PfRad51 proteins. The B02-mediated PfRad51 disruption led to the accumulation of unrepaired parasitic DNA and rendered parasites more sensitive to DNA-damaging agents, including ART. Our findings provide a rationale for targeting the Plasmodium DSB repair pathway in combination with ART. We propose that identification of a specific inhibitor of HR in Plasmodium may enable investigations of HR's role in Plasmodium biology, including generation of antigenic diversity.	[Vydyam, Pratap; Dutta, Dibyendu; Sutram, Niranjan; Bhattacharyya, Mrinal Kanti] Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500046, TS, India; [Bhattacharyya, Sunanda] Univ Hyderabad, Dept Biotechnol & Bioinformat, Sch Life Sci, Hyderabad 500046, TS, India	University of Hyderabad; University of Hyderabad	Bhattacharyya, MK (corresponding author), Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500046, TS, India.	mkbsl@uohyd.ernet.in	Dutta, Dibyendu/O-6016-2019	Dutta, Dibyendu/0000-0003-1715-173X; Vydyam, Pratap/0000-0003-4944-6006	Department of Science and Technology-FIST; University Grant Commission-SAP	Department of Science and Technology-FIST(Department of Science & Technology (India)); University Grant Commission-SAP	Support from Department of Science and Technology-FIST and University Grant Commission-SAP to the Department of Biochemistry is acknowledged. Computational work incorporated in the paper was carried out at the Department of Biotechnology and funded the Bioinformatics Infrastructure Facility, University of Hyderabad. We thank Mrinnanda Bhattacharya for line editing of the manuscript.	Achanta SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041925; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Badugu SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125358; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya MK, 2005, MOL BIOCHEM PARASIT, V139, P33, DOI 10.1016/j.molbiopara.2004.09.007; Bhattacharyya MK, 2003, INT J PARASITOL, V33, P1385, DOI 10.1016/S0020-7519(03)00212-1; Bhattacharyya MK, 2004, INFECT GENET EVOL, V4, P91, DOI 10.1016/j.meegid.2004.01.008; Breitinger H-G., 2012, DRUG SYNERGY MECH ME, DOI [10.5772/30922, DOI 10.5772/30922]; Budke B, 2013, J MED CHEM, V56, P254, DOI 10.1021/jm301565b; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Chalapareddy S, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00025-15; Chalapareddy S, 2014, ANTIMICROB AGENTS CH, V58, P4341, DOI 10.1128/AAC.02519-13; Chang YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004890; Chen J, 2010, NUCLEIC ACIDS RES, V38, P4889, DOI 10.1093/nar/gkq209; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; FRANKENBERGSCHWAGER M, 1990, INT J RADIAT BIOL, V58, P569, DOI 10.1080/09553009014551931; Gopalakrishnan AM, 2015, ANTIMICROB AGENTS CH, V59, P317, DOI 10.1128/AAC.03663-14; Gopalakrishnan AM, 2013, MBIO, V4, DOI 10.1128/mBio.00252-13; Graves AP, 2008, J MOL BIOL, V377, P914, DOI 10.1016/j.jmb.2008.01.049; Gupta DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23603; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Huang F, 2011, ACS CHEM BIOL, V6, P628, DOI 10.1021/cb100428c; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Klonis N, 2013, CURR OPIN MICROBIOL, V16, P722, DOI 10.1016/j.mib.2013.07.005; Kokabu Y, 2013, BIOPHYS J, V104, P1556, DOI 10.1016/j.bpj.2013.02.014; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Mitra P, 2015, BIOCHEM J, V470, P115, DOI 10.1042/BJ20150452; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Normand A, 2014, BIOCHEM PHARMACOL, V91, P293, DOI 10.1016/j.bcp.2014.07.033; Roy N, 2014, MOL MICROBIOL, V94, P353, DOI 10.1111/mmi.12762; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; WHO, 2015, WORLD MAL REP 2015; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	47	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8171	8183		10.1074/jbc.RA118.005009	http://dx.doi.org/10.1074/jbc.RA118.005009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30936202	Green Published, hybrid			2022-12-28	WOS:000470656500016
J	Huang, X; Swanson, R; Kroh, HK; Bock, PE				Huang, Xin; Swanson, Richard; Kroh, Heather K.; Bock, Paul E.			Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coagulation factor; serpin; prothrombin; protease inhibitor; protease; factor Va; factor Xa; protein Z; protein Z-dependent protease inhibitor; prothrombinase	FACTOR PATHWAY INHIBITOR; C-MEDIATED CLEAVAGES; FACTOR-XA; FACTOR-V; KINETIC CHARACTERIZATION; EXTRINSIC PATHWAY; ACTIVE-SITE; BLOOD; ANTITHROMBIN; ACTIVATION	Current thought holds that factor Xa (FXa) bound in the prothrombinase complex is resistant to regulation by protein protease inhibitors during prothrombin activation. Here we provide evidence that, contrary to this view, the FXa-specific serpin inhibitor, protein Z-dependent protease inhibitor (ZPI), complexed with its cofactor, protein Z (PZ), functions as a physiologically significant inhibitor of prothrombinase-bound FXa during prothrombin activation. Kinetics studies showed that the rapid rate of inhibition of FXa by the ZPI-PZ complex on procoagulant membrane vesicles (k(a(app)) approximate to 10(7) m(-1) s(-1)) was decreased approximate to 10-fold when FXa was bound to FVa in prothrombinase and a further approximate to 3-4-fold when plasma levels of S195A prothrombin were present (k(a(app)) 2 x 10(5) m(-1) s(-1)). Nevertheless, the ZPI-PZ complex produced a major inhibition of thrombin generation during prothrombinase-catalyzed activation of prothrombin under physiologically relevant conditions. The importance of ZPI-PZ complex anticoagulant regulation of FXa both before and after incorporation into prothrombinase was supported by thrombin generation assays in plasma. These showed enhanced thrombin generation when the inhibitor was neutralized with a PZ-specific antibody and decreased thrombin generation when exogenous ZPI-PZ complex was added whether prothrombin was activated directly by FXa or through extrinsic or intrinsic pathway activators. Moreover, the PZ antibody enhanced thrombin generation both in the absence and presence of activated protein C (APC) anticoagulant activity. Taken together, these results suggest an important anticoagulant role for the ZPI-PZ complex in regulating both free FXa generated in the initiation phase of coagulation as well as prothrombinase-bound FXa in the propagation phase that complement prothrombinase regulation by APC.	[Huang, Xin; Swanson, Richard] Univ Illinois, Dept Periodont, Chicago, IL 60612 USA; [Kroh, Heather K.; Bock, Paul E.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University	Huang, X (corresponding author), 801 S Paulina St, Chicago, IL 60612 USA.	xinhuang@uic.edu		Huang, Xin/0000-0002-4730-9318	American Heart Association Scientist Development [SDG 48880022]; National Institutes of Health [R37 HL39888, R01 HL38779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	American Heart Association Scientist Development(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Scientist Development Grant SDG 48880022 (to X. H.) and National Institutes of Health Grants R37 HL39888 (to Drs. Steven Olson and X. H.) and R01 HL38779 (to P. E. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Bafunno V, 2011, THROMB RES, V128, P508, DOI 10.1016/j.thromres.2011.08.007; Bolkun L, 2013, THROMB RES, V131, pE110, DOI 10.1016/j.thromres.2012.11.031; BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; Brufatto N, 2001, J BIOL CHEM, V276, P17663, DOI 10.1074/jbc.M011586200; Clark SR, 2013, P NATL ACAD SCI USA, V110, P5875, DOI 10.1073/pnas.1222419110; CONARD J, 1983, HAEMOSTASIS, V13, P363; Cui JS, 2000, BLOOD, V96, P4222, DOI 10.1182/blood.V96.13.4222.h8004222_4222_4226; Dentali F, 2008, BRIT J HAEMATOL, V143, P284, DOI 10.1111/j.1365-2141.2008.07331.x; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Girard TJ, 2019, J THROMB HAEMOST, V17, P149, DOI 10.1111/jth.14337; GRUBER A, 1992, BLOOD, V79, P2340; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Hille ETM, 1997, BLOOD, V89, P1963, DOI 10.1182/blood.V89.6.1963; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huang X, 2017, J BIOL CHEM, V292, P14625, DOI 10.1074/jbc.M117.793901; Huang X, 2015, J BIOL CHEM, V290, P9906, DOI 10.1074/jbc.M114.633479; Huang X, 2010, J BIOL CHEM, V285, P20399, DOI 10.1074/jbc.M110.112748; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Kemkes-Matthes B, 2002, THROMB RES, V106, P183, DOI 10.1016/S0049-3848(02)00181-0; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kroh HK, 2011, J BIOL CHEM, V286, P23345, DOI 10.1074/jbc.M111.230292; LAWSON JH, 1991, J BIOL CHEM, V266, P11317; Lechtenberg BC, 2013, BLOOD, V122, P2777, DOI 10.1182/blood-2013-06-511733; LINDHOUT T, 1986, BIOCHEMISTRY-US, V25, P5962, DOI 10.1021/bi00368a019; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; MANN KG, 1992, SEMIN HEMATOL, V29, P213; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; Mast AE, 1996, BLOOD, V87, P1845; MILETICH JP, 1987, BLOOD, V69, P1580; Newell-Caito JL, 2011, J BIOL CHEM, V286, P38286, DOI 10.1074/jbc.M111.247122; Norstrom EA, 2006, J BIOL CHEM, V281, P31486, DOI 10.1074/jbc.M606441200; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; Sengupta T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161896; SILVERBERG SA, 1977, J BIOL CHEM, V252, P8481; Smirnov MD, 1999, BLOOD, V94, P3839, DOI 10.1182/blood.V94.11.3839.423k07_3839_3846; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; Tran S, 2008, J BIOL CHEM, V283, P6648, DOI 10.1074/jbc.M708036200; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391	49	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7644	7657		10.1074/jbc.RA118.006787	http://dx.doi.org/10.1074/jbc.RA118.006787			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30918026	Green Published, hybrid			2022-12-28	WOS:000470153300011
J	Shorter, J				Shorter, James			Phase separation of RNA-binding proteins in physiology and disease: An introduction to the JBC Reviews thematic series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						TAR DNA-binding protein 43 (TDP-43) (TARDBP); fused in sarcoma (FUS); amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); RNA-binding protein; heterogeneous nuclear ribonucleoprotein (hnRNP); biomolecular condensates; frontotemporal dementia; Liquid-liquid phase separation; membraneless organelles		In recent years, there has been a jarring awakening that liquid-liquid phase separation (LLPS) of key protein and nucleic acid scaffolds underpins the biogenesis of diverse membraneless organelles, including P granules and stress granules in the cytoplasm and nucleoli and paraspeckles in the nucleus. These biomolecular condensates are proposed to be critical organizers of subcellular biochemistry and to control the flow of information from genotype to phenotype. Despite clear biological utility, LLPS can also have deleterious outcomes. Phase-separated compartments can concentrate specific RNA-binding proteins (RBPs), such as TDP-43 and fused in sarcoma (FUS), that through low-complexity, prion-like domains have an intrinsic tendency to form self-templating fibrils that are closely tied to fatal neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. This series of reviews illuminates the molecular language underlying membraneless organelle biogenesis, how prion-like domains and post-translational modifications regulate phase behavior, how cells exploit the phase-separation process for adaptive modalities, and how phase separation is corrupted in neurodegenerative diseases. Collectively, these pieces provide a cutting-edge view of our functional and mechanistic understanding of phase separation in physiology and disease.	[Shorter, James] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Shorter, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	jshorter@pennmedicine.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533	NIGMS NIH HHS [R01 GM099836] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099836] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Elbaum-Garfinkle S, 2019, J BIOL CHEM, V294, P7160, DOI 10.1074/jbc.REV118.001188; Franzmann TM, 2019, J BIOL CHEM, V294, P7128, DOI 10.1074/jbc.TM118.001190; Gomes E, 2019, J BIOL CHEM, V294, P7115, DOI 10.1074/jbc.TM118.001192; Hofweber M, 2019, J BIOL CHEM, V294, P7137, DOI 10.1074/jbc.TM118.001189; Yoo H, 2019, J BIOL CHEM, V294, P7151, DOI 10.1074/jbc.TM118.001191	5	26	26	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7113	7114		10.1074/jbc.REV119.007944	http://dx.doi.org/10.1074/jbc.REV119.007944			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30948513	Green Published, hybrid			2022-12-28	WOS:000468402900001
J	Zhang, CG; Wang, RC; Liu, ZY; Bunker, E; Lee, S; Giuntini, M; Chapnick, D; Liu, XD				Zhang, Conggang; Wang, Rongchun; Liu, Zeyu; Bunker, Eric; Lee, Schuyler; Giuntini, Michelle; Chapnick, Douglas; Liu, Xuedong			The plant triterpenoid celastrol blocks PINK1-dependent mitophagy by disrupting PINK1's association with the mitochondrial protein TOM20	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						parkin; PTEN-induced putative kinase 1 (PINK1); mitophagy; mitochondria; chemical biology; celastrol; gamitrinib; plant terpenoid; TOM20; TOM70	NF-KAPPA-B; HEAT-SHOCK; DAMAGED MITOCHONDRIA; QUALITY-CONTROL; PARKIN; ACTIVATION; IMPORT; MECHANISMS; INDUCERS; IDENTIFICATION	A critical function of the PTEN-induced kinase 1 (PINK1)-Parkin pathway is to mediate the clearing of unhealthy or damaged mitochondria via mitophagy. Loss of either PINK1 or Parkin protein expression is associated with Parkinson's disease. Here, using a high-throughput screening approach along with recombinant protein expression and kinase, immunoblotting, and immunofluorescence live-cell imaging assays, we report that celastrol, a pentacyclic triterpenoid isolated from extracts of the medicinal plant Tripterygium wilfordii, blocks recruitment pof Parkin to mitochondria, preventing mitophagy in response to mitochondrial depolarization induced by carbonyl cyanide m-chlorophenylhydrazone or to gamitrinib-induced inhibition of mitochondrial heat shock protein 90 (HSP90). Celastrol's effect on mitophagy was independent of its known role in microtubule disruption. Instead, we show that celastrol suppresses Parkin recruitment by inactivating PINK1 and preventing it from phosphorylating Parkin and also ubiquitin. We also observed that PINK1 directly and strongly associates with TOM20, a component of the translocase of outer mitochondrial membrane (TOM) machinery and relatively weak binding to another TOM subunit, TOM70. Moreover, celastrol disrupted binding between PINK1 and TOM20 both in vitro and in vivo but did not affect binding between TOM20 and TOM70. Using native gel analysis, we also show that celastrol disrupts PINK1 complex formation upon mitochondrial depolarization and sequesters PINK1 to high-molecular-weight protein aggregates. These results reveal that celastrol regulates the mitochondrial quality control pathway by interfering with PINK1-TOM20 binding.	[Zhang, Conggang; Wang, Rongchun; Liu, Zeyu; Bunker, Eric; Lee, Schuyler; Giuntini, Michelle; Chapnick, Douglas; Liu, Xuedong] Univ Colorado, JSCBB, Dept Biochem, Boulder, CO 80303 USA; [Wang, Rongchun] Shandong Acad Sci, Qilu Univ Technol, Inst Biol, 28789 East Jinshi St, Jinan 250103, Shandong, Peoples R China	University of Colorado System; University of Colorado Boulder; Qilu University of Technology	Liu, XD (corresponding author), JSCBB, Dept Biochem, 3415 Colorado Ave, Boulder, CO 80303 USA.; Liu, XD (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	Xuedong.Liu@colorado.edu		LIU, XUEDONG/0000-0001-7209-4964	NIGMS, National Institutes of Health [R01GM113141, T32GM08759]; NCI, National Institutes of Health [R01CA107098]; National Institutes of Health [S10 RR026680, S10OD021601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, R01GM113141] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021601] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIGMS, National Institutes of Health Grant R01GM113141 and NCI, National Institutes of Health Grant R01CA107098 (to X.L.) The ImageXpress MicroXL was supported by National Institutes of Health Grant S10 RR026680, and the BDAria cell sorter was supported by National Institutes of Health Grant S10OD021601. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by NIGMS, National Institutes of Health Predoctoral Training Grant T32GM08759.	Akabane S, 2016, MOL CELL, V62, P371, DOI 10.1016/j.molcel.2016.03.037; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Chadli A, 2010, J BIOL CHEM, V285, P4224, DOI 10.1074/jbc.M109.081018; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; Fan ACY, 2011, J BIOL CHEM, V286, P32208, DOI 10.1074/jbc.M111.280446; Fiesel FC, 2017, ONCOTARGET, V8, P106233, DOI 10.18632/oncotarget.22287; Figueiredo JN, 1998, J NAT PROD, V61, P718, DOI 10.1021/np9704157; Gehrke S, 2015, CELL METAB, V21, P95, DOI 10.1016/j.cmet.2014.12.007; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Grenier K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00100; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hollville E, 2014, MOL CELL, V55, P451, DOI 10.1016/j.molcel.2014.06.001; Jin HZ, 2002, J NAT PROD, V65, P89, DOI 10.1021/np010428r; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kim JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062068; Klaic L, 2012, ACS CHEM BIOL, V7, P928, DOI 10.1021/cb200539u; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lee S, 2015, J BIOL CHEM, V290, P904, DOI 10.1074/jbc.M114.606798; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Muller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036; Munch C, 2016, NATURE, V534, P710, DOI 10.1038/nature18302; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Setty AR, 2005, SEMIN ARTHRITIS RHEU, V34, P773, DOI 10.1016/j.semarthrit.2005.01.011; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012; Yang CZ, 2014, P NATL ACAD SCI USA, V111, P249, DOI 10.1073/pnas.1321341111; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang CG, 2017, J BIOL CHEM, V292, P15105, DOI 10.1074/jbc.M117.783175; Zhang CG, 2015, CELL RES, V25, P394, DOI 10.1038/cr.2014.159; Zhang CG, 2014, CURR BIOL, V24, P1854, DOI 10.1016/j.cub.2014.07.014; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhang Y, 2011, CHEM BIOL, V18, P1355, DOI 10.1016/j.chembiol.2011.09.008; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	55	14	15	6	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7472	7487		10.1074/jbc.RA118.006506	http://dx.doi.org/10.1074/jbc.RA118.006506			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30885942	Green Published, hybrid			2022-12-28	WOS:000468402900031
J	Banerjee, R				Banerjee, Ruma			Balancing on the road less traveled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						adenosylcobalamin (AdoCbl); enzyme; sulfur; enzyme mechanism; cell metabolism; cobalamin	METHIONINE SYNTHASE; CATALYSIS	Sitting down to the task of writing, I found my pen drifting inexorably to a personal recollection of the metaphorical transcontinental road that I had traveled to become a scientist, instead of reviewing a facet of our scientific contributions. Factors that prepared me for my improbable journey in an era when international calls were operator-assisted and unaffordable and the internet was the stuff of science fiction were my family's love and the sheltered environment of my all-girls school and college experiences, which nurtured my self-confidence. The path of scientific inquiry is heady, and it is hard. The paucity of diversity, of women and minorities, particularly as the road steepens, helps perpetuate stereotypes and inadvertently encourages disparities. It is my hope that by sharing snippets of my journey, enriched as it has been by a diversity of mentors, mentees, colleagues, and friends, and the opportunity to express my curiosity and creativity, that a young person contemplating the scientific road will find encouragement.	[Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [HL058984, DK45776, GM130183]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM130183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL058984, DK45776, and GM130183. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Banerjee R, 2017, CURR OPIN CHEM BIOL, V37, P115, DOI 10.1016/j.cbpa.2017.02.021; BANERJEE RV, 1989, J BIOL CHEM, V264, P13888; BANERJEE RV, 1988, BIOCHEMISTRY-US, V27, P9062, DOI 10.1021/bi00425a027; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Landry AP, 2018, ACS CHEM BIOL, V13, P1651, DOI 10.1021/acschembio.8b00258; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834	11	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6685	6688		10.1074/jbc.AW119.008136	http://dx.doi.org/10.1074/jbc.AW119.008136			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30923127	Green Published, hybrid			2022-12-28	WOS:000467394700003
J	Cheung-Lee, WL; Parry, ME; Cartagena, AJ; Darst, SA; Link, AJ				Cheung-Lee, Wai Ling; Parry, Madison E.; Cartagena, Alexis Jaramillo; Darst, Seth A.; Link, A. James			Discovery and structure of the antimicrobial lasso peptide citrocin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); natural product; antibiotic resistance; peptide transport; nuclear magnetic resonance (NMR); RNA polymerase; membrane transport; citrocin; lasso peptide; microcin; RiPPs	MICROCIN J25; ANTIBACTERIAL PEPTIDE; PROTEIN STRUCTURES; ESCHERICHIA-COLI; RNA-POLYMERASE; MODEL	We report the identification of citrocin, a 19-amino acid-long antimicrobial lasso peptide from the bacteria Citrobacter pasteurii and Citrobacter braakii. We refactored the citrocin gene cluster and heterologously expressed it in Escherichia coli. We determined citrocin's NMR structure in water and found that is reminiscent of that of microcin J25 (MccJ25), an RNA polymerase-inhibiting lasso peptide that hijacks the TonB-dependent transporter FhuA to gain entry into cells. Citrocin has moderate antimicrobial activity against E. coli and Citrobacter strains. We then performed an in vitro RNA polymerase (RNAP) inhibition assay using citrocin and microcin J25 against E. coli RNAP. Citrocin has a higher minimal inhibition concentration than microcin J25 does against E. coli but surprisingly is approximate to 100-fold more potent as an RNAP inhibitor. This suggests that citrocin uptake by E. coli is limited. We found that unlike MccJ25, citrocin's activity against E. coli relied on neither of the two proton motive force-linked systems, Ton and Tol-Pal, for transport across the outer membrane. The structure of citrocin contains a patch of positive charge consisting of Lys-5 and Arg-17. We performed mutagenesis on these residues and found that the R17Y construct was matured into a lasso peptide but no longer had activity, showing the importance of this side chain for antimicrobial activity. In summary, we heterologously expressed and structurally and biochemically characterized an antimicrobial lasso peptide, citrocin. Despite being similar to MccJ25 in sequence, citrocin has an altered activity profile and does not use the same outer-membrane transporter to enter susceptible cells.	[Cheung-Lee, Wai Ling; Parry, Madison E.; Link, A. James] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Link, A. James] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Link, A. James] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Cartagena, Alexis Jaramillo; Darst, Seth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10065 USA; [Cartagena, Alexis Jaramillo; Darst, Seth A.] Rockefeller Univ, Triinst Training Program Chem Biol, New York, NY 10065 USA	Princeton University; Princeton University; Princeton University; Rockefeller University; Rockefeller University	Link, AJ (corresponding author), 207 Hoyt Lab, Princeton, NJ 08544 USA.	ajlink@princeton.edu		Cheung, Wai/0000-0001-7938-9001; Link, A. James/0000-0001-5066-9691; Jaramillo Cartagena, Alexis/0000-0001-7285-1419	National Institutes of Health [GM107036, GM118130]; Princeton University SEAS Innovation Funds; Helen Shipley Hunt Fund; Focused Research Team for Precision Antibiotics; Princeton University; American Society of Microbiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118130, R01GM107036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Princeton University SEAS Innovation Funds; Helen Shipley Hunt Fund; Focused Research Team for Precision Antibiotics; Princeton University(Princeton University); American Society of Microbiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM107036 (to A. J. L.) and GM118130 (to S. A. D.). This work was also supported in part by Princeton University SEAS Innovation Funds, the Helen Shipley Hunt Fund, and the Focused Research Team for Precision Antibiotics. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a Dodds Fellowship from Princeton University.; Supported by a Robert D. Watkins Graduate Research Fellowship from the American Society of Microbiology.	Allen CD, 2016, ACS CHEM BIOL, V11, P3043, DOI 10.1021/acschembio.6b00588; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Baba Tomoya, 2006, Mol Syst Biol, V2; Bayro MJ, 2003, J AM CHEM SOC, V125, P12382, DOI 10.1021/ja036677e; Blond A, 1999, EUR J BIOCHEM, V259, P747, DOI 10.1046/j.1432-1327.1999.00085.x; Blond A, 2002, EUR J BIOCHEM, V269, P6212, DOI 10.1046/j.1432-1033.2002.03340.x; Braffman NR, 2019, P NATL ACAD SCI USA, V116, P1273, DOI 10.1073/pnas.1817352116; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; BRENNER DJ, 1993, INT J SYST BACTERIOL, V43, P777, DOI 10.1099/00207713-43-4-777; Clermont D, 2015, INT J SYST EVOL MICR, V65, P1486, DOI 10.1099/ijs.0.000122; Corbalan N, 2013, J BACTERIOL, V195, P5352, DOI 10.1128/JB.00824-13; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delgado MA, 2001, J BACTERIOL, V183, P4543, DOI 10.1128/JB.183.15.4543-4550.2001; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hegemann JD, 2015, ACCOUNTS CHEM RES, V48, P1909, DOI 10.1021/acs.accounts.5b00156; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Kim YC, 2014, BBA-MOL CELL RES, V1843, P1717, DOI 10.1016/j.bbamcr.2014.04.010; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lazzaroni JC, 1999, FEMS MICROBIOL LETT, V177, P191, DOI 10.1016/S0378-1097(99)00293-1; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Maksimov MO, 2012, P NATL ACAD SCI USA, V109, P15223, DOI 10.1073/pnas.1208978109; Maksimov MO, 2012, NAT PROD REP, V29, P996, DOI 10.1039/c2np20070h; Mathavan I, 2014, NAT CHEM BIOL, V10, P340, DOI [10.1038/nchembio.1499, 10.1038/NCHEMBIO.1499]; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Pan SJ, 2010, PROTEIN EXPRES PURIF, V71, P200, DOI 10.1016/j.pep.2009.12.010; Piscotta FJ, 2015, CHEM COMMUN, V51, P409, DOI 10.1039/c4cc07778d; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rebuffat S, 2012, BIOCHEM SOC T, V40, P1456, DOI 10.1042/BST20120183; Rosengren KJ, 2004, BIOCHEMISTRY-US, V43, P4696, DOI 10.1021/bi0361261; Rosengren KJ, 2003, J AM CHEM SOC, V125, P12464, DOI 10.1021/JA0367703; SALOMON RA, 1992, J BACTERIOL, V174, P7428, DOI 10.1128/jb.174.22.7428-7435.1992; SALOMON RA, 1995, J BACTERIOL, V177, P3323, DOI 10.1128/jb.177.11.3323-3325.1995; Spronk CAEM, 2004, PROG NUCL MAG RES SP, V45, P315, DOI 10.1016/j.pnmrs.2004.08.003; Spronk CAEM, 2003, J BIOMOL NMR, V25, P225, DOI 10.1023/A:1022819716110; Spronk CAEM, 2002, J BIOMOL NMR, V22, P281, DOI 10.1023/A:1014971029663; Thomas X, 2004, J BIOL CHEM, V279, P28233, DOI 10.1074/jbc.M400228200; Unterholzner Simon J, 2013, Mob Genet Elements, V3, pe26219; Wilson KA, 2003, J AM CHEM SOC, V125, P12475, DOI 10.1021/JA036756q; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Zong CH, 2017, J AM CHEM SOC, V139, P10403, DOI 10.1021/jacs.7b04830	44	27	28	0	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6822	6830		10.1074/jbc.RA118.006494	http://dx.doi.org/10.1074/jbc.RA118.006494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30846564	hybrid, Green Published			2022-12-28	WOS:000467394700019
J	Zhao, ZD; Lan, MY; Li, JJ; Dong, Q; Li, X; Liu, BD; Li, G; Wang, HL; Zhang, ZQ; Zhu, B				Zhao, Zuodong; Lan, Mengying; Li, Jingjing; Dong, Qiang; Li, Xiang; Liu, Baodong; Li, Gang; Wang, Hailin; Zhang, Zhuqiang; Zhu, Bing			The proinflammatory cytokine TNF induces DNA demethylation-dependent and -independent activation of interleukin-32 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA methylation; DNA demethylation; tumor necrosis factor (TNF); gene regulation; NF-B; inflammation; epigenetics; transcription; gene activation; IL-32; TNF	NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; BASE-RESOLUTION ANALYSIS; FACTOR-BINDING; TET PROTEINS; GENE-EXPRESSION; ALPHA BLOCKADE; HUMAN-DISEASES; IL-32; HYDROXYMETHYLATION	IL-32 is a cytokine involved in proinflammatory immune responses to bacterial and viral infections. However, the role of epigenetic events in the regulation of IL-32 gene expression is understudied. Here we show that IL-32 is repressed by DNA methylation in HEK293 cells. Using ChIP sequencing, locus-specific methylation analysis, CRISPR/Cas9-mediated genome editing, and RT-qPCR (quantitative RT-PCR) and immunoblot assays, we found that short-term treatment (a few hours) with the proinflammatory cytokine tumor necrosis factor (TNF) activates IL-32 in a DNA demethylation-independent manner. In contrast, prolonged TNF treatment (several days) induced DNA demethylation at the promoter and a CpG island in the IL-32 gene in a TET (ten-eleven translocation) family enzyme- and NF-B-dependent manner. Notably, the hypomethylation status of transcriptional regulatory elements in IL-32 was maintained for a long time (several weeks), causing elevated IL-32 expression even in the absence of TNF. Considering that IL-32 can, in turn, induce TNF expression, we speculate that such feedforward events may contribute to the transition from an acute inflammatory response to chronic inflammation.	[Zhao, Zuodong] Tsinghua Univ, Sch Life Sci, Tsinghua Univ Peking Univ Natl Inst Biol Sci Join, Beijing 100084, Peoples R China; [Zhao, Zuodong; Lan, Mengying; Li, Jingjing; Dong, Qiang; Li, Xiang; Zhang, Zhuqiang; Zhu, Bing] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Zhao, Zuodong] Nat Inst Biol Sci, Beijing 102206, Peoples R China; [Liu, Baodong; Wang, Hailin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China; [Lan, Mengying; Li, Jingjing; Zhu, Bing] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Li, Gang] Univ Macau, Fac Hlth Sci, Macau 999078, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Macau	Zhang, ZQ; Zhu, B (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Zhu, B (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.	zhangzhuqiang@ibp.ac.cn; zhubing@ibp.ac.cn		Zhao, Zuodong/0000-0002-5858-4155	NSFC-FDCT [31761163001, 033/2017/AFJ]; Ministry of Science and Technology of the People's Republic of China [2016YFA0100400, 2015CB856200, 2017YFA0504200]; National Natural Science Foundation of China [31521002, 31425013, 31730047, 31571344]; Chinese Academy of Sciences [XDB08010103, XDBP10, QYZDY-SSW-SMC031]	NSFC-FDCT; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the NSFC-FDCT Joint Grants 31761163001 (to B. Z.) and 033/2017/AFJ (to G. L.). This work was also supported by Ministry of Science and Technology of the People's Republic of China Grants 2016YFA0100400, 2015CB856200, and 2017YFA0504200; National Natural Science Foundation of China Grants 31521002, 31425013, 31730047, and 31571344; and Chinese Academy of Sciences Grants XDB08010103, XDBP10, and QYZDY-SSW-SMC031). The authors declare that they have no conflicts of interest with the contents of this article.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Bai XY, 2015, P NATL ACAD SCI USA, V112, P5111, DOI 10.1073/pnas.1424302112; Bai XY, 2010, J IMMUNOL, V184, P3830, DOI 10.4049/jimmunol.0901913; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bosshart H, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.53; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; D'Urso A, 2014, TRENDS GENET, V30, P230, DOI 10.1016/j.tig.2014.04.004; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1732; Dong Q, 2018, P NATL ACAD SCI USA, V115, pE4013, DOI 10.1073/pnas.1800505115; Dubois-Chevalier J, 2014, NUCLEIC ACIDS RES, V42, P10943, DOI 10.1093/nar/gku780; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Fujiki K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3262; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heinhuis B, 2011, ANN RHEUM DIS, V70, P660, DOI 10.1136/ard.2010.139196; Hong JT, 2017, PHARMACOL THERAPEUT, V174, P127, DOI 10.1016/j.pharmthera.2017.02.025; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Johnson DG, 2013, CELL, V152, P685, DOI 10.1016/j.cell.2013.01.017; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Joosten LAB, 2013, CELL MOL LIFE SCI, V70, P3883, DOI 10.1007/s00018-013-1301-9; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kim Soohyun, 2014, Immune Netw, V14, P123, DOI 10.4110/in.2014.14.3.123; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Li W, 2010, J IMMUNOL, V185, P5056, DOI 10.4049/jimmunol.0902667; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Li X, 2018, J BIOL CHEM, V293, P7423, DOI 10.1074/jbc.RA117.000757; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; LOWENTHAL JW, 1989, P NATL ACAD SCI USA, V86, P2331, DOI 10.1073/pnas.86.7.2331; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Montoya D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009546; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Perera A, 2015, CELL REP, V11, P283, DOI 10.1016/j.celrep.2015.03.020; Rampal R, 2014, CELL REP, V9, P1841, DOI 10.1016/j.celrep.2014.11.004; Rasool ST, 2008, IMMUNOL LETT, V117, P161, DOI 10.1016/j.imlet.2008.01.007; Ribeiro-Dias F, 2017, J LEUKOCYTE BIOL, V101, P39, DOI [10.1189/jlb.4ru0416-175rr, 10.1189/jlb.4RU0416-175RR]; Rodriguez-Gill A, 2018, JOVE-J VIS EXP, DOI 10.3791/57272; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shioya M, 2007, CLIN EXP IMMUNOL, V149, P480, DOI 10.1111/j.1365-2249.2007.03439.x; SILKE J, 1995, FEBS LETT, V370, P170, DOI 10.1016/0014-5793(95)00830-3; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Suganuma T, 2013, CURR OPIN CELL BIOL, V25, P322, DOI 10.1016/j.ceb.2013.02.016; Sun ZY, 2015, MOL CELL, V57, P750, DOI 10.1016/j.molcel.2014.12.035; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Tsai YP, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0513-0; Wang CZ, 2018, SCI CHINA LIFE SCI, V61, P515, DOI 10.1007/s11427-018-9276-7; Wang YP, 2015, MOL CELL, V57, P662, DOI 10.1016/j.molcel.2014.12.023; Wong M, 2008, CLIN IMMUNOL, V126, P121, DOI 10.1016/j.clim.2007.08.013; Wu D, 2018, NATURE, V559, P637, DOI 10.1038/s41586-018-0350-5; Wu H, 2014, NAT BIOTECHNOL, V32, P1231, DOI 10.1038/nbt.3073; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Xia B, 2015, NAT METHODS, V12, P1047, DOI [10.1038/NMETH.3569, 10.1038/nmeth.3569]; Xiong J, 2016, MOL CELL, V64, P913, DOI 10.1016/j.molcel.2016.10.013; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012	71	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6785	6795		10.1074/jbc.RA118.006255	http://dx.doi.org/10.1074/jbc.RA118.006255			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30824537	hybrid, Green Published			2022-12-28	WOS:000467394700016
J	Liang, MF; Xie, XQ; Pan, J; Jin, GW; Yu, C; Wei, ZY				Liang, Mingfu; Xie, Xingqiao; Pan, Jian; Jin, Gaowei; Yu, Cong; Wei, Zhiyi			Structural basis of the target-binding mode of the G protein-coupled receptor kinase-interacting protein in the regulation of focal adhesion dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						focal adhesion; crystal structure; structure-function; protein-protein interaction; protein complex; structural biology; cell migration; GTPase activating protein (GAP); complex structure; paxillin (PXN); PTPRF-interacting protein alpha 2 (PPFIA2); single alpha-helix	PAXILLIN LD MOTIFS; GTPASE-ACTIVATING PROTEINS; EXTRACELLULAR-MATRIX; GIT1; FAMILY; DOMAIN; RECOGNITION; PIX; VINCULIN; COMPLEX	Focal adhesions (FAs) are specialized sites where intracellular cytoskeleton elements connect to the extracellular matrix and thereby control cell motility. FA assembly depends on various scaffold proteins, including the G protein-coupled receptor kinase-interacting protein 1 (GIT1), paxillin, and liprin-. Although liprin- and paxillin are known to competitively interact with GIT1, the molecular basis governing these interactions remains elusive. To uncover the underlying mechanisms of how GIT1 is involved in FA assembly by alternatively binding to liprin- and paxillin, here we solved the crystal structures of GIT1 in complex with liprin- and paxillin at 1.8 and 2.6 resolutions, respectively. These structures revealed that the paxillin-binding domain (PBD) of GIT1 employs distinct binding modes to recognize a single -helix of liprin- and the LD4 motif of paxillin. Structure-based design of protein variants produced two binding-deficient GIT1 variants; specifically, these variants lost the ability to interact with liprin- only or with both liprin- and paxillin. Expressing the GIT1 variants in COS7 cells, we discovered that the two PBD-meditated interactions play different roles in either recruiting GIT1 to FA or facilitating FA assembly. Additionally, we demonstrate that, unlike for the known binding mode of the FAT domain to LD motifs, the PBD of GIT1 uses different surface patches to achieve high selectivity in LD motif recognition. In summary, our results have uncovered the mechanisms by which GIT1's PBD recognizes cognate paxillin and liprin- structures, information we anticipate will be useful for future investigations of GIT1-protein interactions in cells.	[Liang, Mingfu; Xie, Xingqiao; Pan, Jian; Jin, Gaowei; Yu, Cong; Wei, Zhiyi] Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China; [Xie, Xingqiao] Southern Univ Sci & Technol, Acad Adv Interdisciplinary Studies, Shenzhen 518055, Peoples R China; [Yu, Cong] Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China; [Yu, Cong] Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China; [Wei, Zhiyi] SUSTech, Neural & Cognit Sci Res Ctr, Shenzhen, Peoples R China	Southern University of Science & Technology; Southern University of Science & Technology; Southern University of Science & Technology	Yu, C; Wei, ZY (corresponding author), Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China.; Yu, C (corresponding author), Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China.; Yu, C (corresponding author), Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China.; Wei, ZY (corresponding author), SUSTech, Neural & Cognit Sci Res Ctr, Shenzhen, Peoples R China.	yuc@sustc.edu.cn; weizy@sustc.edu.cn	Wei, Zhiyi/N-9995-2019; Wei, Zhiyi/C-4315-2014; , 余聪/AAK-9457-2020	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; 	National Natural Science Foundation of China [31770791, 31570741, 31870757]; Natural Science Foundation of Guangdong Province [2016A030312016]; Science and Technology Planning Project of Guangdong Province [2017B030301018]; Shenzhen Science and Technology Innovation Commission [JCYJ20160229153100269, JCYJ20160301112450474, ZDSYS20140509142721429]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Shenzhen Science and Technology Innovation Commission	This work was supported by National Natural Science Foundation of China Grants 31770791 and 31570741 (to Z. W.) and 31870757 (to C. Y.); Natural Science Foundation of Guangdong Province Grant 2016A030312016; Science and Technology Planning Project of Guangdong Province Grant 2017B030301018; and Shenzhen Science and Technology Innovation Commission Grants JCYJ20160229153100269 (to Z. W.), JCYJ20160301112450474 (to X. X.), and ZDSYS20140509142721429 (to C. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam T, 2014, BIOCHEM J, V460, P317, DOI 10.1042/BJ20140298; Asperti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020757; Asperti C, 2010, EXP CELL RES, V316, P915, DOI 10.1016/j.yexcr.2010.01.017; Asperti C, 2009, J CELL SCI, V122, P3225, DOI 10.1242/jcs.054155; Astro V, 2016, SCI REP-UK, V6, DOI 10.1038/srep33653; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Burridge K, 2017, FEBS J, V284, P3355, DOI 10.1111/febs.14195; Cernohorska M, 2016, BBA-MOL CELL RES, V1863, P1282, DOI 10.1016/j.bbamcr.2016.03.016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eva R, 2014, CURR OPIN NEUROBIOL, V27, P179, DOI 10.1016/j.conb.2014.03.018; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Garron ML, 2008, J MOL BIOL, V375, P1320, DOI 10.1016/j.jmb.2007.11.040; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Haase K, 2014, PROG MOL BIOL TRANSL, V126, P103, DOI 10.1016/B978-0-12-394624-9.00005-1; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Hong ST, 2015, EXP NEUROBIOL, V24, P8, DOI 10.5607/en.2015.24.1.8; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kanteti R, 2016, ONCOTARGET, V7, P31586, DOI 10.18632/oncotarget.8040; Ko J, 2003, J NEUROSCI, V23, P1667; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Lulo J, 2009, BIOCHEM BIOPH RES CO, V383, P347, DOI 10.1016/j.bbrc.2009.04.011; Manabe R, 2002, J CELL SCI, V115, P1497; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nishiya N, 2002, J BIOCHEM, V132, P279, DOI 10.1093/oxfordjournals.jbchem.a003222; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Stiegler AL, 2012, J BIOL CHEM, V287, P32566, DOI 10.1074/jbc.M112.367342; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Totaro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093199; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Vanarotti MS, 2016, BIOCHEMISTRY-US, V55, P1332, DOI 10.1021/acs.biochem.5b01274; Vanarotti MS, 2014, J MOL BIOL, V426, P3985, DOI 10.1016/j.jmb.2014.08.014; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Vitali Teresa, 2019, Small GTPases, V10, P280, DOI 10.1080/21541248.2017.1299271; Webb DJ, 2007, J BIOL CHEM, V282, P6929, DOI 10.1074/jbc.M610981200; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Wong MY, 2018, P NATL ACAD SCI USA, V115, P2234, DOI 10.1073/pnas.1719012115; Yoo Sungsoo M, 2020, Small GTPases, V11, P77, DOI 10.1080/21541248.2017.1362496; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zhou W, 2016, J CELL SCI, V129, P1963, DOI 10.1242/jcs.179465; Zurner M, 2009, GENOMICS, V93, P243, DOI 10.1016/j.ygeno.2008.10.007	54	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5827	5839		10.1074/jbc.RA118.006915	http://dx.doi.org/10.1074/jbc.RA118.006915			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30737283	Green Published, hybrid			2022-12-28	WOS:000465077500015
J	Steinbusch, MMF; Caron, MMJ; Surtel, DAM; van den Akker, GGH; van Dijk, PJ; Friedrich, F; Zabel, B; van Rhijn, LW; Peffers, MJ; Welting, TJM				Steinbusch, Mandy M. F.; Caron, Marjolein M. J.; Surtel, Don A. M.; van den Akker, Guus G. H.; van Dijk, Paul J.; Friedrich, Franziska; Zabel, Bernhard; van Rhijn, Lodewijk W.; Peffers, Mandy J.; Welting, Tim J. M.			The antiviral protein viperin regulates chondrogenic differentiation via CXCL10 protein secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cartilage biology; chondrogenesis; small nucleolar RNA (snoRNA); transforming growth factor beta (TGF-B); chemokine; secretion; C-X-C motif chemokine ligand 10; cartilage-hair hypoplasia; chondrogenic differentiation; RMRP snoRNA; viperin	INTERFERON-INDUCIBLE PROTEIN; MESENCHYMAL STEM-CELLS; RNASE MRP; GENE-EXPRESSION; MESSENGER-RNA; GROWTH-FACTOR; INHIBITION; GAMMA; ACTIVATION; MUTATIONS	Viperin (also known as radical SAM domain-containing 2 (RSAD2)) is an interferon-inducible and evolutionary conserved protein that participates in the cell's innate immune response against a number of viruses. Viperin mRNA is a substrate for endoribonucleolytic cleavage by RNase mitochondrial RNA processing (MRP) and mutations in the RNase MRP small nucleolar RNA (snoRNA) subunit of the RNase MRP complex cause cartilage-hair hypoplasia (CHH), a human developmental condition characterized by metaphyseal chondrodysplasia and severe dwarfism. It is unknown how CHH-pathogenic mutations in RNase MRP snoRNA interfere with skeletal development, and aberrant processing of RNase MRP substrate RNAs is thought to be involved. We hypothesized that viperin plays a role in chondrogenic differentiation. Using immunohistochemistry, real-time quantitative PCR, immunoblotting, ELISA, siRNA-mediated gene silencing, plasmid-mediated gene overexpression, label-free MS proteomics, and promoter reporter bioluminescence assays, we discovered here that viperin is expressed in differentiating chondrocytic cells and regulates their protein secretion and the outcome of chondrogenic differentiation by influencing transforming growth factor beta (TGF-beta)/SMAD family 2/3 (SMAD2/3) activity via C-X-C motif chemokine ligand 10 (CXCL10). Of note, we observed disturbances in this viperin-CXCL10-TGF-beta/SMAD2/3 axis in CHH chondrocytic cells. Our results indicate that the antiviral protein viperin controls chondrogenic differentiation by influencing secretion of soluble proteins and identify a molecular route that may explain impaired chondrogenic differentiation of cells from individuals with CHH.	[Steinbusch, Mandy M. F.; Caron, Marjolein M. J.; Surtel, Don A. M.; van den Akker, Guus G. H.; van Rhijn, Lodewijk W.; Welting, Tim J. M.] Maastricht Univ, Dept Orthoped Surg, Lab Expt Orthoped, NL-6202 AZ Maastricht, Netherlands; [van Dijk, Paul J.] Maastricht Univ, Dept Anat & Embryol, NL-6202 AZ Maastricht, Netherlands; [Friedrich, Franziska] Univ Freiburg, Univ Heart Ctr Freiburg, Fac Med, Inst Expt Cardiovasc Med, D-79110 Freiburg, Germany; [Zabel, Bernhard] Otto van Guericke Univ Magdeburg, Med Fac, D-39106 Magdeburg, Germany; [Peffers, Mandy J.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England	Maastricht University; Maastricht University; Universitats Herzzentrum Freiburg; University of Freiburg; Otto von Guericke University; University of Liverpool	Welting, TJM (corresponding author), Maastricht Univ, Med Ctr, Dept Orthopaed Surg, POB 5800, NL-6202 AZ Maastricht, Netherlands.	t.welting@maastrichtuniversity.nl	van den Akker, Guus/AAD-9536-2019; Peffers, Mandy Jayne/AAV-9411-2020	Peffers, Mandy Jayne/0000-0001-6979-0440	Netherlands Organisation for Scientific Research [DN 82-304]; Deutsche Forschungsgemeinschaft; Dutch Arthritis Association [LLP14]; Wellcome Trust Clinical Intermediate Fellowship Grant [107471]; MRC [MR/P020941/1] Funding Source: UKRI	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dutch Arthritis Association; Wellcome Trust Clinical Intermediate Fellowship Grant(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Bilateral Cooperation Grant DN 82-304 from The Netherlands Organisation for Scientific Research and the Deutsche Forschungsgemeinschaft and by Dutch Arthritis Association Grant LLP14. This work is also supported in part by a Wellcome Trust Clinical Intermediate Fellowship Grant 107471 (to M. J. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Amanatullah DF, 2014, J TISSUE ENG REGEN M, V8, P505, DOI 10.1002/term.1543; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Baron J, 2015, NAT REV ENDOCRINOL, V11, P735, DOI 10.1038/nrendo.2015.165; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; Cristino S, 2008, TISSUE ENG PT A, V14, P97, DOI 10.1089/ten.a.2007.0121; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dhillon NK, 2007, J IMMUNOL, V179, P2722, DOI 10.4049/jimmunol.179.5.2722; French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Goldfarbi KC, 2017, GENE DEV, V31, P59, DOI 10.1101/gad.286963.116; GOLDRING MB, 1994, J CELL BIOCHEM, V54, P85, DOI 10.1002/jcb.240540110; Grewal TS, 2000, FASEB J, V14, P523, DOI 10.1096/fasebj.14.3.523; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Groot AJ, 2014, MOL CELL BIOL, V34, P2822, DOI 10.1128/MCB.00206-14; Hermanns P, 2005, HUM MOL GENET, V14, P3723, DOI 10.1093/hmg/ddi403; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Kong L, 2008, CELL MOL LIFE SCI, V65, P3494, DOI 10.1007/s00018-008-8342-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep27105; Makitie O, 1998, EUR J PEDIATR, V157, P816, DOI 10.1007/s004310050943; Makitie O, 1993, GENEREVIEWS; Mattijssen S, 2010, WIRES RNA, V1, P102, DOI 10.1002/wrna.9; Mattijssen S, 2011, CELL MOL LIFE SCI, V68, P2469, DOI 10.1007/s00018-010-0568-3; Morimoto H, 2013, CELL TISSUE RES, V351, P41, DOI 10.1007/s00441-012-1521-6; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Osaki M, 2003, BIOCHEM J, V369, P103, DOI 10.1042/BJ20020928; Osawa A, 2006, GENOMICS, V88, P52, DOI 10.1016/j.ygeno.2006.02.013; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Peffers MJ, 2014, J BIOL CHEM, V289, P25867, DOI 10.1074/jbc.M114.566554; Peffers MJ, 2013, INT J MOL SCI, V14, P20658, DOI 10.3390/ijms141020658; Qiu LQ, 2009, BLOOD, V113, P3520, DOI 10.1182/blood-2008-07-171942; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Satish L, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0119-8; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Shahabuddin S, 2006, AM J PHYSIOL-CELL PH, V291, pC34, DOI 10.1152/ajpcell.00441.2005; Steinbusch MMF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06809-5; Thorpe CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20455; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; van Beuningen HM, 2014, TISSUE ENG PT A, V20, P2243, DOI [10.1089/ten.tea.2013.0553, 10.1089/ten.TEA.2013.0553]; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Yu JSL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8212; Zhang Y, 2008, CELL DEATH DIFFER, V15, P1760, DOI 10.1038/cdd.2008.112	47	9	10	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5121	5136		10.1074/jbc.RA119.007356	http://dx.doi.org/10.1074/jbc.RA119.007356			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30718282	Green Published, hybrid			2022-12-28	WOS:000463985600033
J	Wang, J; Zheng, X; Qin, ZL; Wei, LY; Lu, YJ; Peng, Q; Gao, YX; Zhang, XM; Zhang, XY; Li, ZS; Fu, YX; Liu, PS; Liu, C; Yan, Q; Xiong, W; Li, GY; Lu, JH; Ma, J				Wang, Jia; Zheng, Xiang; Qin, Zailong; Wei, Lingyu; Lu, Yuanjun; Peng, Qiu; Gao, Yingxue; Zhang, Xuemei; Zhang, Xiaoyue; Li, Zhengshuo; Fu, Yuxin; Liu, Peishan; Liu, Can; Yan, Qun; Xiong, Wei; Li, Guiyuan; Lu, Jianhong; Ma, Jian			Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA viruses; microRNA (miRNA); cellular senescence; gastric cancer; p53; Epstein-Barr virus; miR-BART3-3p	TUMOR-SUPPRESSOR; CELLULAR SENESCENCE; ENCODED MICRORNAS; IN-VIVO; CARCINOMA; P53; PROTEIN; CELLS; LMP1; SURVEILLANCE	Epstein-Barr virus-associated gastric cancer (EBVaGC) accounts for about 10% of all gastric cancer cases and has unique pathological and molecular characteristics. EBV encodes a large number of microRNAs, which actively participate in the development of EBV-related tumors. Here, we report that EBV-miR-BART3-3p (BART3-3p) promotes gastric cancer cell growth in vitro and in vivo. Moreover, BART3-3p inhibits the senescence of gastric cancer cells induced by an oncogene (RAS(G12V)) or chemotherapy (irinotecan). LMP1 and EBNA3C encoded by EBV have also been reported to have antisenescence effects; however, in EBVaGC specimens, LMP1 expression is very low, and EBNA3C is not expressed. BART3-3p inhibits senescence of gastric cancer cells in a nude mouse model and inhibits the infiltration of natural killer cells and macrophages in tumor by altering the senescence-associated secretory phenotype (SASP). Mechanistically, BART3-3p directly targeted the tumor suppressor gene TP53 and caused down-regulation of p53's downstream target, p21. Analysis from clinical EBVaGC samples also showed a negative correlation between BART3-3p and TP53 expression. It is well known that mutant oncogene RAS(G12V) or chemotherapeutic drugs can induce senescence, and here we show that both RAS(G12V) and a chemotherapy drug also can induce BART3-3p expression in EBV-positive gastric cancer cells, forming a feedback loop that keeps the EBVaGC senescence at a low level. Our results suggest that, although TP53 is seldom mutated in EBVaGC, its expression is finely regulated such that EBV-encoded BART3-3p may play an important role by inhibiting the senescence of gastric cancer cells.	[Wang, Jia; Ma, Jian] Cent S Univ, Hunan Canc Hosp, Changsha 410013, Hunan, Peoples R China; [Wang, Jia; Ma, Jian] Cent S Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China; [Wang, Jia; Zheng, Xiang; Qin, Zailong; Wei, Lingyu; Lu, Yuanjun; Peng, Qiu; Gao, Yingxue; Zhang, Xuemei; Zhang, Xiaoyue; Li, Zhengshuo; Fu, Yuxin; Liu, Peishan; Liu, Can; Xiong, Wei; Li, Guiyuan; Lu, Jianhong; Ma, Jian] Cent S Univ, Sch Basic Med Sci, Dept Microbiol, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Wang, Jia] Changzhi Med Coll, Dept Immunol, Changzhi 046000, Shanxi, Peoples R China; [Zheng, Xiang] Hunan Key Lab Translat Radiat Oncol, Changsha 410013, Hunan, Peoples R China; [Qin, Zailong; Ma, Jian] Third Xiangya Hosp, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha 410013, Hunan, Peoples R China; [Wei, Lingyu; Xiong, Wei; Li, Guiyuan; Ma, Jian] Cent S Univ, Natl Hlth Commiss, Key Lab Carcinogenesis, Changsha 410078, Hunan, Peoples R China; [Lu, Yuanjun; Xiong, Wei; Li, Guiyuan; Ma, Jian] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha 410078, Hunan, Peoples R China; [Yan, Qun] Cent S Univ, Xiangya Hosp, Dept Clin Lab, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University; Central South University; Changzhi Medical College; Central South University; Central South University; Central South University	Ma, J (corresponding author), Cent S Univ, Hunan Canc Hosp, Changsha 410013, Hunan, Peoples R China.; Ma, J (corresponding author), Cent S Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China.; Lu, JH; Ma, J (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Microbiol, Canc Res Inst, Changsha 410078, Hunan, Peoples R China.; Ma, J (corresponding author), Third Xiangya Hosp, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha 410013, Hunan, Peoples R China.; Ma, J (corresponding author), Cent S Univ, Natl Hlth Commiss, Key Lab Carcinogenesis, Changsha 410078, Hunan, Peoples R China.; Ma, J (corresponding author), Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha 410078, Hunan, Peoples R China.	jianhlu@csu.edu.cn; majian@csu.edu.cn	Lu, Jianhong/AAM-8841-2020	Lu, Jianhong/0000-0002-4436-1217; Wang, Jia/0000-0002-9107-9433; Ma, Jian/0000-0001-9395-0416	National Natural Science Foundation of China [81472694, 81672889, 81672993, 31670171]; China 111 Project [111-2-12]; Hunan Province Science and Technology Project [2016JC2035]; Key Laboratory of Translational Radiation Oncology Hunan Province Open Research Fund Program [2015TP1009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China 111 Project(Ministry of Education, China - 111 Project); Hunan Province Science and Technology Project; Key Laboratory of Translational Radiation Oncology Hunan Province Open Research Fund Program	This work was supported by National Natural Science Foundation of China Grants 81472694, 81672889, 81672993, and 31670171; China 111 Project Grant 111-2-12; Hunan Province Science and Technology Project Grant 2016JC2035; and Key Laboratory of Translational Radiation Oncology Hunan Province Open Research Fund Program Grant 2015TP1009. The authors declare that they have no conflicts of interest with the contents of this article.	Albanese M, 2016, P NATL ACAD SCI USA, V113, pE6467, DOI 10.1073/pnas.1605884113; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Cai LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8353; Chan JM, 2010, CARCINOGENESIS, V31, P812, DOI 10.1093/carcin/bgq034; Chen JN, 2012, J CLIN GASTROENTEROL, V46, P262, DOI 10.1097/MCG.0b013e318249c4b8; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003; Fan CM, 2018, J CANCER, V9, P2852, DOI 10.7150/jca.25460; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; He BY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.253; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; Ito Y, 2017, TRENDS CELL BIOL, V27, P830, DOI 10.1016/j.tcb.2017.07.004; Jiang C, 2018, INT J CANCER, V143, P3209, DOI 10.1002/ijc.31642; Jung YJ, 2014, J VIROL, V88, P9027, DOI 10.1128/JVI.00721-14; Kang D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004979; Lee E, 2018, ONCOGENE, V37, P5858, DOI 10.1038/s41388-018-0367-0; Lee JH, 2009, J GASTROEN HEPATOL, V24, P354, DOI 10.1111/j.1440-1746.2009.05775.x; Lei T, 2013, INT J CANCER, V133, P79, DOI 10.1002/ijc.28007; LEVINE PH, 1995, INT J CANCER, V60, P642, DOI 10.1002/ijc.2910600513; Lu YJ, 2017, J INNATE IMMUN, V9, P574, DOI 10.1159/000479749; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; Marquitz AR, 2012, P NATL ACAD SCI USA, V109, P9593, DOI 10.1073/pnas.1202910109; Menendez JA, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00049; Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167; Murphy G, 2009, GASTROENTEROLOGY, V137, P824, DOI 10.1053/j.gastro.2009.05.001; Neault M, 2016, CELL REP, V14, P1966, DOI 10.1016/j.celrep.2016.01.068; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; Nishikawa J, 1999, J VIROL, V73, P1286, DOI 10.1128/JVI.73.2.1286-1292.1999; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Qiu J, 2014, P NATL ACAD SCI USA, V111, P11157, DOI 10.1073/pnas.1406136111; Saab R, 2011, SEMIN CANCER BIOL, V21, P385, DOI 10.1016/j.semcancer.2011.09.013; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Shinozaki-Ushiku A, 2015, J VIROL, V89, P5581, DOI 10.1128/JVI.03639-14; Speck O, 2015, APPL IMMUNOHISTO M M, V23, P633, DOI 10.1097/PAI.0000000000000122; Verhoeven RJA, 2016, J VIROL, V90, P6475, DOI 10.1128/JVI.00613-16; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Xin BZ, 2001, J VIROL, V75, P3010, DOI 10.1128/JVI.75.6.3010-3015.2001; Yang XH, 2000, ONCOGENE, V19, P2002, DOI 10.1038/sj.onc.1203515; Ye ZM, 2016, CANCER LETT, V370, P216, DOI 10.1016/j.canlet.2015.10.023; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Zhang XM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01774; Zheng X, 2018, J VIROL, V92, DOI 10.1128/JVI.01022-18	49	25	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4854	4866		10.1074/jbc.RA118.006853	http://dx.doi.org/10.1074/jbc.RA118.006853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30674552	Green Published, hybrid			2022-12-28	WOS:000463985600011
J	Wang, ZG; Khor, S; Cai, DS				Wang, Zhouguang; Khor, Sinan; Cai, Dongsheng			Age-dependent decline of hypothalamic HIF2 alpha in response to insulin and its contribution to advanced age-associated metabolic disorders in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia-inducible factor (HIF); insulin resistance; obesity; aging; hypothalamus; cell signaling; diabetes	HYPOXIA-INDUCIBLE FACTOR-1; BETA/NF-KAPPA-B; FOOD-INTAKE; STEM-CELLS; PROOPIOMELANOCORTIN DEFICIENCY; BODY-WEIGHT; OBESITY; GLUCOSE; ENERGY; BINDING	Hypoxia-inducible factor-2 alpha (HIF2 alpha) is a nuclear transcription factor that plays a critical role in cell survival including metabolic adaptation under hypoxia as well as normoxia, but whether HIF2 alpha contributes to the control of whole-body metabolic balance is unclear. In this study, we found that the hypothalamic HIF2 alpha protein level rapidly increases in young mice that are centrally stimulated with insulin. However, this insulin-induced HIF2 alpha up-regulation is substantially attenuated in mice of advanced age. This attenuation is comparable with the effect of high-calorie feeding in young mice. Of note, unlike high-calorie feeding conditions, age-dependent HIF2 alpha attenuation occurs without impaired activation of the hypothalamic IR/IRS-2/AKT/FOXO1 pathway in response to insulin. Molecular and physiological analyses revealed that hypothalamic HIF2 alpha contributes to the action of central insulin in regulation of proopiomelanocortin (Pomc) gene expression and food intake. HIF2 alpha knockout in POMC neurons led to age-dependent excess weight gain and fat increase, a phenotype that was associated with a mild degree of glucose intolerance and insulin resistance. In conclusion, hypothalamic HIF2 alpha responds to insulin, and the up-regulation is involved in adaptive metabolic regulation as age increases, whereas impairment of HIF2 alpha in the hypothalamus contributes to weight gain and glucose disorders in age-dependent manners.	[Wang, Zhouguang; Khor, Sinan; Cai, Dongsheng] Albert Einstein Coll Med, Inst Aging Res, Diabet Res Ctr, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Cai, DS (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu	Wang, Zhouguang/F-7918-2017	Wang, Zhouguang/0000-0001-9903-0362	National Institutes of Health [RO1 DK 099136, AG 031774]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK099136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants RO1 DK 099136 and AG 031774. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bento CF, 2011, DIABETOLOGIA, V54, P1946, DOI 10.1007/s00125-011-2191-8; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Clegg DJ, 2011, PHYSIOL BEHAV, V103, P10, DOI 10.1016/j.physbeh.2011.01.010; Coll AP, 2013, CURR OPIN PHARMACOL, V13, P970, DOI 10.1016/j.coph.2013.09.010; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005; Garcia-San Frutos M, 2007, ENDOCRINOLOGY, V148, P5238, DOI 10.1210/en.2007-0543; Grillo CA, 2007, PHYSIOL BEHAV, V92, P691, DOI 10.1016/j.physbeh.2007.05.043; He X, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011152; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Isoe T, 2010, KIDNEY INT, V78, P48, DOI 10.1038/ki.2010.99; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lai TW, 2012, J MOL CELL BIOL, V4, P184, DOI 10.1093/jmcb/mjs009; Mercer AJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00019; Millington GWM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-18; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Ropelle ER, 2009, J PHYSIOL-LONDON, V587, P2341, DOI 10.1113/jphysiol.2009.170050; Sartorius T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126804; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 2000, ANNU REV PSYCHOL, V51, P255, DOI 10.1146/annurev.psych.51.1.255; Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhang H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001112; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282; Zhang YL, 2017, CELL METAB, V25, P1091, DOI 10.1016/j.cmet.2017.04.002	36	10	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4946	4955		10.1074/jbc.RA118.005429	http://dx.doi.org/10.1074/jbc.RA118.005429			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30709906	Green Published, hybrid			2022-12-28	WOS:000463985600019
J	Cai, CX; Teng, L; Vu, D; He, JQ; Guo, YR; Li, QH; Tang, XL; Rokosh, G; Bhatnagar, A; Bolli, R				Cai, Chuanxi; Teng, Lei; Duc Vu; He, Jia-Qiang; Guo, Yiru; Li, Qianghong; Tang, Xian-Liang; Rokosh, Gregg; Bhatnagar, Aruni; Bolli, Roberto			The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-related kinase (ERK)/NRF2 signaling pathway and cytokine release (vol 287, pg 33720, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Cai, Chuanxi/AAW-1488-2020; Guo, Yiru/L-2618-2015	Guo, Yiru/0000-0002-0614-9899; Rokosh, Gregg/0000-0002-9214-2254				Cai CX, 2012, J BIOL CHEM, V287, P33720, DOI 10.1074/jbc.M112.385542	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4725	4727		10.1074/jbc.AAC119.008182	http://dx.doi.org/10.1074/jbc.AAC119.008182			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30902920	hybrid, Green Published			2022-12-28	WOS:000462969500037
J	Kronfel, CM; Hernandez, CV; Frick, JP; Hernandez, LS; Gutu, A; Karty, JA; Boutaghou, MN; Kehoe, DM; Cole, RB; Schluchter, WM				Kronfel, Christina M.; Hernandez, Carla V.; Frick, Jacob P.; Hernandez, Leanora S.; Gutu, Andrian; Karty, Jonathan A.; Boutaghou, M. Nazim; Kehoe, David M.; Cole, Richard B.; Schluchter, Wendy M.			CpeF is the bilin lyase that ligates the doubly linked phycoerythrobilin on -phycoerythrin in the cyanobacterium Fremyella diplosiphon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; post-translational modification (PTM); light-harvesting complex (antenna complex); mass spectrometry (MS); fluorescence; photosynthesis; photosynthetic pigment; bilin lyase; phycobiliprotein; phycobilisome	CHROMATICALLY ADAPTING CYANOBACTERIUM; SYNECHOCOCCUS SP PCC-7002; CHROMOPHORE ATTACHMENT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BETA-PHYCOCYANIN; ENERGY-TRANSFER; CPCF GENES; SUBUNIT; BIOSYNTHESIS	Phycoerythrin (PE) is a green light-absorbing protein present in the light-harvesting complex of cyanobacteria and red algae. The spectral characteristics of PE are due to its prosthetic groups, or phycoerythrobilins (PEBs), that are covalently attached to the protein chain by specific bilin lyases. Only two PE lyases have been identified and characterized so far, and the other bilin lyases are unknown. Here, using in silico analyses, markerless deletion, biochemical assays with purified and recombinant proteins, and site-directed mutagenesis, we examined the role of a putative lyase-encoding gene, cpeF, in the cyanobacterium Fremyella diplosiphon. Analyzing the phenotype of the cpeF deletion, we found that cpeF is required for proper PE biogenesis, specifically for ligation of the doubly linked PEB to Cys-48/Cys-59 residues of the CpeB subunit of PE. We also show that in a heterologous host, CpeF can attach PEB to Cys-48/Cys-59 of CpeB, but only in the presence of the chaperone-like protein CpeZ. Additionally, we report that CpeF likely ligates the A ring of PEB to Cys-48 prior to the attachment of the D ring to Cys-59. We conclude that CpeF is the bilin lyase responsible for attachment of the doubly ligated PEB to Cys-48/Cys-59 of CpeB and together with other specific bilin lyases contributes to the post-translational modification and assembly of PE into mature light-harvesting complexes.	[Kronfel, Christina M.; Hernandez, Carla V.; Frick, Jacob P.; Hernandez, Leanora S.; Schluchter, Wendy M.] Univ New Orleans, Dept Biol Sci, 2000 Lakeshore Dr, New Orleans, LA 70148 USA; [Boutaghou, M. Nazim; Cole, Richard B.] Univ New Orleans, Dept Chem, New Orleans, LA 70148 USA; [Gutu, Andrian; Kehoe, David M.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Karty, Jonathan A.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Cole, Richard B.] Sorbonne Univ Paris 06, F-75252 Paris, France; [Kronfel, Christina M.] USDA, Southern Reg Res Ctr, 1100 Robert E Lee Blvd, New Orleans, LA 70124 USA; [Gutu, Andrian] Janelia Res Campus Med, Howard Hughes Med Inst, 19700 Helix Dr, Ashburn, VA 20147 USA; [Boutaghou, M. Nazim] Shimadzu Sci Instruments, 7102 Riverwood Dr, Columbia, MD 21046 USA	University of Louisiana System; University of New Orleans; University of Louisiana System; University of New Orleans; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Sorbonne Universite; United States Department of Agriculture (USDA); Howard Hughes Medical Institute	Schluchter, WM (corresponding author), Univ New Orleans, Dept Biol Sci, 2000 Lakeshore Dr, New Orleans, LA 70148 USA.	wschluch@uno.edu		Karty, Jonathan/0000-0003-1022-9100	National Science Foundation [MCB-1029414, MCB-1818187, MCB-1244339, MCB-0843664]; University of New Orleans Graduate School performance and accountability fellowship; Div Of Molecular and Cellular Bioscience [1244339] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of New Orleans Graduate School performance and accountability fellowship; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-1029414 and MCB-1818187 (to D. M. K.) and MCB-1244339 and MCB-0843664 (to W. M. S.) and by a University of New Orleans Graduate School performance and accountability fellowship (to C. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvey RM, 2003, PLANT CELL, V15, P2448, DOI 10.1105/tpc.015016; Anderson LK, 1998, MOL MICROBIOL, V30, P467, DOI 10.1046/j.1365-2958.1998.01081.x; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; [Anonymous], [No title captured]; Bezy RP, 2011, P NATL ACAD SCI USA, V108, P18542, DOI 10.1073/pnas.1107427108; BHALERAO RP, 1994, PLANT MOL BIOL, V26, P313, DOI 10.1007/BF00039542; Biswas A, 2011, J BIOL CHEM, V286, P35509, DOI 10.1074/jbc.M111.284281; Biswas A, 2010, APPL ENVIRON MICROB, V76, P2729, DOI 10.1128/AEM.03100-09; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; Bolte K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-56; Bretaudeau A, 2013, NUCLEIC ACIDS RES, V41, pD396, DOI 10.1093/nar/gks1091; Chang WR, 1996, J MOL BIOL, V262, P721, DOI 10.1006/jmbi.1996.0547; COBLEY JG, 1993, PLASMID, V30, P90, DOI 10.1006/plas.1993.1037; Cobley JG, 2002, MOL MICROBIOL, V44, P1517, DOI 10.1046/j.1365-2958.2002.02966.x; COBLEY JG, 1983, J BACTERIOL, V153, P1486, DOI 10.1128/JB.153.3.1486-1492.1983; Dammeyer T, 2008, J BIOL CHEM, V283, P27547, DOI 10.1074/jbc.M803765200; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; DELORIMIER R, 1993, PLANT MOL BIOL, V21, P225, DOI 10.1007/BF00019939; DEMARSAC NT, 1977, J BACTERIOL, V130, P82, DOI 10.1128/JB.130.1.82-91.1977; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P28988; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; Gasper R, 2017, J BIOL CHEM, V292, P3089, DOI 10.1074/jbc.M116.769703; GINDT YM, 1994, BBA-BIOENERGETICS, V1186, P153, DOI 10.1016/0005-2728(94)90174-0; GLAZER AN, 1994, J APPL PHYCOL, V6, P105, DOI 10.1007/BF02186064; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Gutu A, 2013, P NATL ACAD SCI USA, V110, P16253, DOI 10.1073/pnas.1306332110; Gutu A, 2012, MOL PLANT, V5, P1, DOI 10.1093/mp/ssr054; JUNG LJ, 1995, J BIOL CHEM, V270, P12877, DOI 10.1074/jbc.270.21.12877; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kronfel CM, 2013, BIOCHEMISTRY-US, V52, P8663, DOI 10.1021/bi401192z; Martinez-Oyanedel J, 2004, BIOL RES, V37, P733, DOI 10.4067/S0716-97602004000500003; Noubir S, 2002, MOL MICROBIOL, V43, P749, DOI 10.1046/j.1365-2958.2002.02783.x; ONG LJ, 1991, J BIOL CHEM, V266, P9515; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; Seib LO, 2002, J BACTERIOL, V184, P962, DOI 10.1128/jb.184.4.962-970.2002; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Shukla A, 2012, P NATL ACAD SCI USA, V109, P20136, DOI 10.1073/pnas.1211777109; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; Toole CM, 1998, MOL MICROBIOL, V30, P475, DOI 10.1046/j.1365-2958.1998.01082.x; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; Yerrapragada S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00355-15; Zhao C, 2017, P NATL ACAD SCI USA, V114, P13170, DOI 10.1073/pnas.1715495114; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhou J., 1992, THESIS; ZHOU JH, 1992, J BIOL CHEM, V267, P16138; Zhou W, 2014, J BIOL CHEM, V289, P26677, DOI 10.1074/jbc.M114.586743	61	10	10	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3987	3999		10.1074/jbc.RA118.007221	http://dx.doi.org/10.1074/jbc.RA118.007221			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30670589	Green Published, hybrid			2022-12-28	WOS:000461854400015
J	Menezes, SV; Kovacevic, Z; Richardson, DR				Menezes, Sharleen V.; Kovacevic, Zaklina; Richardson, Des R.			The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anti-cancer drug; molecular pharmacology; cancer; epidermal growth factor receptor (EGFR); cancer biology; metastasis suppressor; mitogen-inducible gene 6 (MIG6); NDRG1; oncogenic signaling	EFFECTIVE ANTIPROLIFERATIVE AGENTS; EPITHELIAL-MESENCHYMAL TRANSITION; ISONICOTINOYL HYDRAZONE CLASS; SELECTIVE ANTITUMOR-ACTIVITY; IRON CHELATORS; EGF RECEPTOR; PANCREATIC-CANCER; MOLECULAR TARGETS; TUMOR-METASTASIS; KINASE DOMAIN	The metastasis suppressor, N-Myc downstream-regulated gene-1 (NDRG1) inhibits a plethora of oncogenic signaling pathways by down-regulating the epidermal growth factor receptor (EGFR). Herein, we examined the mechanism involved in NDRG1-mediated EGFR down-regulation. NDRG1 overexpression potently increased the levels of mitogen-inducible gene 6 (MIG6), which inhibits EGFR and facilitates its lysosomal processing and degradation. Conversely, silencing NDRG1 in multiple human cancer cell types decreased MIG6 expression, demonstrating the regulatory role of NDRG1. Further, NDRG1 overexpression facilitated MIG6-EGFR association in the cytoplasm, possibly explaining the significantly (p <0.001) increased half-life of MIG6 from 1.6 +/- 0.2 h under control conditions to 7.9 +/- 0.4 h after NDRG1 overexpression. The increased MIG6 levels enhanced EGFR co-localization with the late endosome/lysosomal marker, lysosomal-associated membrane protein 2 (LAMP2). An increase in EGFR levels after MIG6 silencing was particularly apparent when NDRG1 was overexpressed, suggesting a role for MIG6 in NDRG1-mediated down-regulation of EGFR. Silencing phosphatase and tensin homolog (PTEN), which facilitates early to late endosome maturation, decreased MIG6, and also increased EGFR levels in both the presence and absence of NDRG1 overexpression. These results suggest a role for PTEN in regulating MIG6 expression. Anti-tumor drugs of the di-2-pyridylketone thiosemicarbazone class that activate NDRG1 expression also potently increased MIG6 and induced its cytosolic co-localization with NDRG1. This was accompanied by a decrease in activated and total EGFR levels and its redistribution to late endosomes/lysosomes. In conclusion, NDRG1 promotes EGFR down-regulation through the EGFR inhibitor MIG6, which leads to late endosomal/lysosomal processing of EGFR.	[Menezes, Sharleen V.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Mol Pharmacol & Pathol Program, Dept Pathol, Med Fdn Bldg K25, Sydney, NSW 2006, Australia; [Menezes, Sharleen V.; Kovacevic, Zaklina; Richardson, Des R.] Univ Sydney, Bosch Inst, Med Fdn Bldg K25, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Kovacevic, Z; Richardson, DR (corresponding author), Univ Sydney, Mol Pharmacol & Pathol Program, Dept Pathol, Med Fdn Bldg K25, Sydney, NSW 2006, Australia.	zaklina.kovacevic@sydney.edu.au; d.richardson@med.usyd.edu.au	Kovacevic, Zaklina/ABD-9581-2021	Kovacevic, Zaklina/0000-0002-4742-4690; Richardson, Des/0000-0002-5506-3274	National Health and Medical Research Council of Australia (NHMRC) [1060482]; Cure Cancer Australia Foundation; Cancer Australia; Australian Postgraduate Award from the University of Sydney; NHMRC Senior Principal Research Fellowship [1062607]; NHMRC Peter Doherty Early Career Fellowship [1037323]; Cancer Institute New South Wales Early Career Fellowship [12-ECF2-17]; NHMRC RD Wright Fellowship [APP1140447]; Cancer Institute New South Wales Career Development Fellowship [CDF171126]; Priority-driven Collaborative Cancer Research Scheme Grant [1086449]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cure Cancer Australia Foundation; Cancer Australia; Australian Postgraduate Award from the University of Sydney; NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Early Career Fellowship; NHMRC RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Career Development Fellowship; Priority-driven Collaborative Cancer Research Scheme Grant	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grant 1060482 (to D. R. R. and Z. K.), Priority-driven Collaborative Cancer Research Scheme Grant 1086449, Cure Cancer Australia Foundation, and Cancer Australia (to Z. K.). This work was also supported by an Australian Postgraduate Award from the University of Sydney (to S. V. M), an NHMRC Senior Principal Research Fellowship (1062607) (to D. R. R.), an NHMRC Peter Doherty Early Career Fellowship (1037323) (to Z. K), a Cancer Institute New South Wales Early Career Fellowship (12-ECF2-17), an NHMRC RD Wright Fellowship (APP1140447), and a Cancer Institute New South Wales Career Development Fellowship (CDF171126). The authors declare that they have no conflicts of interest with the contents of this article.	Accornero P, 2010, J MOL ENDOCRINOL, V44, P115, DOI 10.1677/JME-09-0035; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Anastasi S, 2005, ONCOGENE, V24, P4540, DOI 10.1038/sj.onc.1208658; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Chu FY, 2017, P NATL ACAD SCI USA, V114, P10338, DOI 10.1073/pnas.1702226114; Darnell G., 1999, Blood, V94, P781; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Fiorini M, 2002, ONCOGENE, V21, P6530, DOI 10.1038/sj.onc.1205823; Frosi Y, 2010, J CELL BIOL, V189, P557, DOI 10.1083/jcb.201002032; Fry WHD, 2009, EXP CELL RES, V315, P697, DOI 10.1016/j.yexcr.2008.07.022; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Ghalayini MK, 2013, BIOSCIENCE REP, V33, P451, DOI 10.1042/BSR20130042; Gosney JA, 2018, J BIOL CHEM, V293, P5895, DOI 10.1074/jbc.RA117.000632; Guang RJ, 2000, CANCER RES, V60, P749; Guo ZL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0330-x; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jansson PJ, 2015, PHARMACOL RES, V100, P255, DOI 10.1016/j.phrs.2015.08.013; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kim-Fuchs C, 2014, DIGEST SURG, V31, P135, DOI 10.1159/000363065; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lane DJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057273; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lee JC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091435; Lee KH, 2006, BIOCHIMIE, V88, P163, DOI 10.1016/j.biochi.2005.07.011; Li PC, 2016, AM J TRANSL RES, V8, P5370; Liang SX, 2003, CARCINOGENESIS, V24, P1601, DOI 10.1093/carcin/bgg116; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Liu WS, 2015, ONCOTARGET, V6, P35522, DOI 10.18632/oncotarget.5849; Liu WS, 2015, ONCOTARGET, V6, P8851, DOI 10.18632/oncotarget.3316; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lui GYL, 2015, MOL PHARMACOL, V87, P543, DOI 10.1124/mol.114.096529; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Menezes SV, 2019, CARCINOGENESIS, V40, P805, DOI 10.1093/carcin/bgy178; Menezes SV, 2017, J BIOL CHEM, V292, P12772, DOI 10.1074/jbc.R117.776393; MORGAN EH, 1981, BIOCHIM BIOPHYS ACTA, V642, P119, DOI 10.1016/0005-2736(81)90143-7; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Park E, 2015, NAT STRUCT MOL BIOL, V22, P703, DOI 10.1038/nsmb.3074; Park KC, 2018, BBA-MOL BASIS DIS, V1864, P2644, DOI 10.1016/j.bbadis.2018.04.011; PATERSON S, 1984, J CELL PHYSIOL, V120, P225, DOI 10.1002/jcp.1041200217; Pietiainen V, 2013, J CELL SCI, V126, P3961, DOI 10.1242/jcs.128132; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; RICHARDSON DR, 1994, J CELL PHYSIOL, V161, P160, DOI 10.1002/jcp.1041610119; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Seebacher NA, 2016, J BIOL CHEM, V291, P3796, DOI 10.1074/jbc.M115.682450; Shinde SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10689; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stacy AE, 2016, J MED CHEM, V59, P8601, DOI 10.1021/acs.jmedchem.6b01050; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; vanBelzen N, 1997, LAB INVEST, V77, P85; Wang YQ, 2010, CELL ADHES MIGR, V4, P7, DOI 10.4161/cam.4.1.10497; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Xi RX, 2017, MOL PHARMACOL, V91, P499, DOI 10.1124/mol.116.107870; Xu DZ, 2005, J BIOL CHEM, V280, P2924, DOI 10.1074/jbc.M408907200; Xu YX, 2018, ONCOL LETT, V15, P7999, DOI 10.3892/ol.2018.8279; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	78	26	25	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4045	4064		10.1074/jbc.RA118.006279	http://dx.doi.org/10.1074/jbc.RA118.006279			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30679310	hybrid, Green Published			2022-12-28	WOS:000461854400019
J	Esneau, C; Raynal, B; Roblin, P; Brule, S; Richard, CA; Fix, J; Eleouet, JF; Galloux, M				Esneau, Camille; Raynal, Bertrand; Roblin, Pierre; Brule, Sebastien; Richard, Charles-Adrien; Fix, Jenna; Eleouet, Jean-Francois; Galloux, Marie			Biochemical characterization of the respiratory syncytial virus N-0-P complex in solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; structural model; small-angle X-ray scattering (SAXS); mutagenesis; analytical ultracentrifugation; N-0-P complex; nucleoprotein N; respiratory syncytial virus; structure-function; viral replication	NUCLEOPROTEIN-RNA COMPLEX; CRYSTAL-STRUCTURE; BINDING-SITE; PHOSPHOPROTEIN; IDENTIFICATION; PROTEINS; INSIGHTS; REGION; FORMS	As all the viruses belonging to the Mononegavirales order, the nonsegmented negative-strand RNA genome of respiratory syncytial virus (RSV) is encapsidated by the viral nucleoprotein N. N protein polymerizes along the genomic and anti-genomic RNAs during replication. This requires the maintenance of the neosynthesized N protein in a monomeric and RNA-free form by the viral phosphoprotein P that plays the role of a chaperone protein, forming a soluble N-0-P complex. We have previously demonstrated that residues 1-30 of P specifically bind to N-0. Here, to isolate a stable N-0-P complex suitable for structural studies, we used the N-terminal peptide of P (P40) to purify truncated forms of the N protein. We show that to purify a stable N-0-P-like complex, a deletion of the first 30 N-terminal residues of N (N-30) is required to impair N oligomerization, whereas the presence of a full-length C-arm of N is required to inhibit RNA binding. We generated structural models of the RSV N-0-P with biophysical approaches, including hydrodynamic measurements and small-angle X-ray scattering (SAXS), coupled with biochemical and functional analyses of human RSV (hRSV) N-30 mutants. These models suggest a strong structural homology between the hRSV and the human metapneumovirus (hMPV) N-0-P complexes. In both complexes, the P40-binding sites on N-0 appear to be similar, and the C-arm of N provides a high flexibility and a propensity to interact with the N RNA groove. These findings reveal two potential sites to target on N-0-P for the development of RSV antivirals.	[Esneau, Camille; Richard, Charles-Adrien; Fix, Jenna; Eleouet, Jean-Francois; Galloux, Marie] Univ Paris Saclay, Untie Virol & Immunol Mol, INRA, F-78350 Jouy En Josas, France; [Raynal, Bertrand; Brule, Sebastien] Inst Pasteur, Plate Forme Biophys Mol, C2RT, 25 Rue Docteur Roux, F-75015 Paris, France; [Roblin, Pierre] Synchrotron SOLEIL, F-91410 Lorme Des Merisiers, Saint Aubin, France; [Roblin, Pierre] Univ Paul Sabatier, Lab Genie Chim, UMR 5503, Toulouse, France; [Esneau, Camille] Hunter Med Res Inst, New Lambton Hts, NSW 2305, Australia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; SOLEIL Synchrotron; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Hunter Medical Research Institute; University of Newcastle	Eleouet, JF; Galloux, M (corresponding author), Univ Paris Saclay, Untie Virol & Immunol Mol, INRA, F-78350 Jouy En Josas, France.	jean-francois.eleouet@inra.fr; marie.galloux@inra.fr	Esneau, Camille/AAD-3239-2022; Eléouët, Jean-François/AAD-1994-2019	RICHARD, Charles-Adrien/0000-0001-5306-2297; Brule, Sebastien/0000-0002-8797-6748; raynal, Bertrand/0000-0001-5634-0408; Esneau, Camille/0000-0002-5479-1851; ELeouet, Jean-Francois/0000-0002-7361-4885	French Agence Nationale de la Recherche, specific program ANR Blanc [ANR-13-IVS3-0007]	French Agence Nationale de la Recherche, specific program ANR Blanc(French National Research Agency (ANR))	This work was supported by the French Agence Nationale de la Recherche, specific program ANR Blanc 2013 "Respisyncycell" ANR-13-IVS3-0007. The authors declare that they have no conflicts of interest with the contents of this article.	Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; Aggarwal M, 2018, J VIROL, V92, DOI 10.1128/JVI.01304-17; Bakker SE, 2013, J GEN VIROL, V94, P1734, DOI 10.1099/vir.0.053025-0; Bird GH, 2014, J CLIN INVEST, V124, P2113, DOI 10.1172/JCI71856; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Castel G, 2009, J VIROL, V83, P10808, DOI 10.1128/JVI.00977-09; Chenal A, 2002, PROTEIN ENG, V15, P383, DOI 10.1093/protein/15.5.383; Chenavas S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003275; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Cowton VM, 2006, J GEN VIROL, V87, P1805, DOI 10.1099/vir.0.81786-0; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; El Omari K, 2008, ACTA CRYSTALLOGR F, V64, P1019, DOI 10.1107/S1744309108031059; Fix Jenna, 2011, Open Virol J, V5, P103, DOI 10.2174/1874357901105010103; Gaillard V, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02241-16, 10.1128/aac.02241-16]; Galloux M, 2015, J VIROL, V89, P3484, DOI 10.1128/JVI.03666-14; Galloux M, 2012, J VIROL, V86, P8375, DOI 10.1128/JVI.00058-12; GARCIA J, 1993, VIROLOGY, V195, P243, DOI 10.1006/viro.1993.1366; GarciaBarreno B, 1996, J VIROL, V70, P801; Guryanov SG, 2016, J VIROL, V90, P2849, DOI 10.1128/JVI.02865-15; Hardy RW, 1998, J VIROL, V72, P520, DOI 10.1128/JVI.72.1.520-526.1998; Jamin M, 2017, ADV VIRUS RES, V97, P143, DOI 10.1016/bs.aivir.2016.09.001; Karlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031719; Kirchdoerfer RN, 2015, CELL REP, V12, P140, DOI 10.1016/j.celrep.2015.06.003; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Leyrat C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002248; Liljeroos L, 2013, P NATL ACAD SCI USA, V110, P11133, DOI 10.1073/pnas.1309070110; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pereira N, 2017, J BIOL CHEM, V292, P2120, DOI [10.1074/jbc.M116.765958, 10.1074/jbc.m116.765958]; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Renner M, 2016, ELIFE, V5, DOI 10.7554/eLife.12627; Rincheval V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00655-9; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; Shapiro AB, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0191-2; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tran TL, 2009, J VIROL, V83, P6363, DOI 10.1128/JVI.00335-09; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Yabukarsi F, 2014, NAT STRUCT MOL BIOL, V21, P754, DOI 10.1038/nsmb.2868; Zarzycka B, 2016, DRUG DISCOV TODAY, V21, P48, DOI 10.1016/j.drudis.2015.09.011; Zhu TF, 2017, J VIROL, V91, DOI [10.1128/JVI.00996-17, 10.1128/jvi.00996-17]	42	14	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3647	3660		10.1074/jbc.RA118.006453	http://dx.doi.org/10.1074/jbc.RA118.006453			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30626736	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000461853900027
J	Zhang, YZ; Tada, T; Ozono, S; Yao, WT; Tanaka, M; Yamaoka, S; Kishigami, S; Fujita, H; Tokunaga, K				Zhang, Yanzhao; Tada, Takuya; Ozono, Seiya; Yao, Weitong; Tanaka, Michiko; Yamaoka, Shoji; Kishigami, Satoshi; Fujita, Hideaki; Tokunaga, Kenzo			Membrane-associated RING-CH (MARCH) 1 and 2 are MARCH family members that inhibit HIV-1 infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV; membrane protein; glycoprotein; host-pathogen interaction; macrophage; antiviral factor; HIV-1; macrophage; MARCH family; membrane-associated RING-CH	E3 UBIQUITIN LIGASE; COMPLEX CLASS-I; DOWN-REGULATION; ANTIGEN PRESENTATION; MESSENGER-RNA; PROTEIN; STABILIZATION; EXPRESSION; SURFACE; RECOGNITION	Membrane-associated RING-CH 8 (MARCH8) is one of 11 members of the MARCH family of RING finger E3 ubiquitin ligases and down-regulates several membrane proteins (e.g. major histocompatibility complex II [MHC-II], CD86, and transferrin receptor). We recently reported that MARCH8 also targets HIV-1 envelope glycoproteins and acts as an antiviral factor. However, it remains unclear whether other family members might have antiviral functions similar to those of MARCH8. Here we show that MARCH1 and MARCH2 are MARCH family members that reduce virion incorporation of envelope glycoproteins. Infectivity assays revealed that MARCH1 and MARCH2 dose-dependently suppress viral infection. Treatment with type I interferon enhanced endogenous expression levels of MARCH1 and MARCH2 in monocyte-derived macrophages. Expression of these proteins in virus-producing cells decreased the efficiency of viral entry and down-regulated HIV-1 envelope glycoproteins from the cell surface, resulting in reduced incorporation of envelope glycoproteins into virions, as observed in MARCH8 expression. With the demonstration that MARCH1 and MARCH2 are antiviral MARCH family members as presented here, these two proteins join a growing list of host factors that inhibit HIV-1 infection.	[Zhang, Yanzhao; Tada, Takuya; Ozono, Seiya; Yao, Weitong; Tanaka, Michiko; Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Tokyo 1628640, Japan; [Ozono, Seiya; Kishigami, Satoshi] Univ Yamanashi, Fac Life & Environm Sci, Yamanashi 4008510, Japan; [Yao, Weitong; Yamaoka, Shoji] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo 1138519, Japan; [Fujita, Hideaki] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki 8593298, Japan; [Tada, Takuya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	National Institute of Infectious Diseases (NIID); University of Yamanashi; Tokyo Medical & Dental University (TMDU); Nagasaki International University; New York University	Tokunaga, K (corresponding author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan.	tokunaga@nih.go.jp	Yanzhao, Zhang/AAI-4175-2021; Tada, Takuya/GOP-1100-2022; Tokunaga, Kenzo/Q-9914-2018	Yanzhao, Zhang/0000-0002-1937-4438; Tada, Takuya/0000-0003-0779-9954; Tokunaga, Kenzo/0000-0002-2625-5322; Fujita, Hideaki/0000-0002-4105-4430	Japan Agency for Medical Research and Development (AMED, Research Program on HIV/AIDS) [17fk0410308j0503]; Japan Society for the Promotion of Science (KAKENHI) [18K07156]	Japan Agency for Medical Research and Development (AMED, Research Program on HIV/AIDS)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Agency for Medical Research and Development (AMED, Research Program on HIV/AIDS, 17fk0410308j0503) and the Japan Society for the Promotion of Science (KAKENHI, 18K07156) to K. T. The authors declare that they have no conflicts of interest with the contents of this article.	Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bartee E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015132; Chen R, 2012, P NATL ACAD SCI USA, V109, P14128, DOI 10.1073/pnas.1205246109; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Hoer S, 2007, FEBS LETT, V581, P45, DOI 10.1016/j.febslet.2006.11.075; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Iyengar PV, 2011, J BIOL CHEM, V286, P39082, DOI 10.1074/jbc.M111.256875; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; Korfali N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018762; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; Mahmoud L, 2014, RNA BIOL, V11, P124, DOI 10.4161/rna.27863; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Morokuma Y, 2007, J BIOL CHEM, V282, P24806, DOI 10.1074/jbc.M700414200; Nice TJ, 2010, J IMMUNOL, V185, P5369, DOI 10.4049/jimmunol.1000247; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Tada T, 2015, NAT MED, V21, P1502, DOI 10.1038/nm.3956; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; van de Kooij B, 2013, J BIOL CHEM, V288, P6617, DOI 10.1074/jbc.M112.448209; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhang Y, 2018, VIROLOGY, V518, P293, DOI 10.1016/j.virol.2018.02.003	32	22	22	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2019	294	10					3397	3405		10.1074/jbc.AC118.005907	http://dx.doi.org/10.1074/jbc.AC118.005907			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FU	30630952	Green Published, hybrid			2022-12-28	WOS:000461853900008
J	Pfeffer, SR				Pfeffer, Suzanne R.			NPC intracellular cholesterol transporter 1 (NPC1)-mediated cholesterol export from lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						cholesterol; cholesterol-binding protein; lysosome; transporter; low-density lipoprotein (LDL); Hedgehog; Niemann-Pick C disease; NPC1; NPC2; Patched; cholesterol transport; lysosomes; sterol metabolism; NPC intracellular cholesterol transporter	PICK C1 PROTEIN; STEROL-BINDING; C2 PROTEIN; DOMAIN; DEFICIENT; REVEALS; MECHANISM; RESIDUES; INSIGHTS; REQUIRES	Low-density lipoprotein particles are taken up by cells and delivered to the lysosome where their cholesterol esters are cleaved off by acid lipase. The released, free cholesterol is then exported from lysosomes for cellular needs or storage. This article summarizes recent advances in our understanding of the molecular basis of cholesterol export from lysosomes. Cholesterol export requires NPC intracellular cholesterol transporter 1 (NPC1) and NPC2, genetic mutations of which can cause Niemann-Pick type C disease, a disorder characterized by massive lysosomal accumulation of cholesterol and glycosphingolipids. Analysis of the NPC1 and NPC2 structures and biochemical properties, together with new structures of the related Patched (PTCH) protein, provides new clues to the mechanisms by which NPC proteins may function.	[Pfeffer, Suzanne R.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	pfeffer@stanford.edu		Pfeffer, Suzanne/0000-0002-6462-984X	NHLBI [HL134991]; Notre Dame University Ara Parseghian Medical Research Foundation; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134991] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Notre Dame University Ara Parseghian Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant HL134991 from the NHLBI, National Institutes of Health, and the Notre Dame University Ara Parseghian Medical Research Foundation. This JBC Review is part of a collection honoring Herbert Tabor on the occasion of his 100th birthday. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Gong X, 2018, SCIENCE, V361, DOI 10.1126/science.aas8935; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Li J, 2015, P NATL ACAD SCI USA, V112, P14876, DOI 10.1073/pnas.1520490112; Li XC, 2017, P NATL ACAD SCI USA, V114, P9116, DOI 10.1073/pnas.1711716114; Li XC, 2016, P NATL ACAD SCI USA, V113, P10079, DOI 10.1073/pnas.1611956113; Li XC, 2016, P NATL ACAD SCI USA, V113, P8212, DOI 10.1073/pnas.1607795113; Liu RH, 2009, J BIOL CHEM, V284, P1840, DOI 10.1074/jbc.M803741200; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; McCauliff LA, 2015, J BIOL CHEM, V290, P27321, DOI 10.1074/jbc.M115.667469; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Ohgane K, 2013, CHEM BIOL, V20, P391, DOI 10.1016/j.chembiol.2013.02.009; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Qi XF, 2018, SCIENCE, V362, P52, DOI 10.1126/science.aas8843; Qi XF, 2018, NATURE, V560, P128, DOI 10.1038/s41586-018-0308-7; Trinh MN, 2017, P NATL ACAD SCI USA, V114, P89, DOI 10.1073/pnas.1619571114; Trinh MN, 2018, ELIFE, V7, DOI 10.7554/eLife.38564; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wilke S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-62; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Zhang YX, 2018, CELL, V175, P1352, DOI 10.1016/j.cell.2018.10.026; Zhao YG, 2016, FEBS LETT, V590, P605, DOI 10.1002/1873-3468.12089	32	88	89	5	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1706	1709		10.1074/jbc.TM118.004165	http://dx.doi.org/10.1074/jbc.TM118.004165			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710017	Green Published, hybrid			2022-12-28	WOS:000457879200030
J	Samuel, CE				Samuel, Charles E.			Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						innate immunity; RNA editing; interferon; double-stranded RNA (dsRNA); RIG-I-like receptor (RLR); 2'-5'-oligoadenylate synthetase; ADAR; adenosine deaminase acting on RNA; protein kinase PKR; RNA deamination	PROTEIN-KINASE PKR; EDITING ENZYME ADAR1; SPLICE-SITE VARIANTS; PRE-MESSENGER-RNA; I-LIKE RECEPTORS; Z-ALPHA DOMAIN; INTERFERON ACTION; MEASLES-VIRUS; BINDING DOMAINS; HUMAN-CELLS	Herbert "Herb" Tabor, who celebrated his 100(th) birthday this past year, served the Journal of Biological Chemistry as a member of the Editorial Board beginning in 1961, as an Associate Editor, and as Editor-in-Chief for 40 years, from 1971 until 2010. Among the many discoveries in biological chemistry during this period was the identification of RNA modification by C6 deamination of adenosine (A) to produce inosine (I) in double-stranded (ds) RNA. This posttranscriptional RNA modification by adenosine deamination, known as A-to-I RNA editing, diversifies the transcriptome and modulates the innate immune interferon response. A-to-I editing is catalyzed by a family of enzymes, adenosine deaminases acting on dsRNA (ADARs). The roles of A-to-I editing are varied and include effects on mRNA translation, pre-mRNA splicing, and micro-RNA silencing. Suppression of dsRNA-triggered induction and action of interferon, the cornerstone of innate immunity, has emerged as a key function of ADAR1 editing of self (cellular) and nonself (viral) dsRNAs. A-to-I modification of RNA is essential for the normal regulation of cellular processes. Dysregulation of A-to-I editing by ADAR1 can have profound consequences, ranging from effects on cell growth and development to autoimmune disorders.	[Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			National Institutes of Health Research from the NIAID [AI-12520, AI-20611]	National Institutes of Health Research from the NIAID	This work was supported in part by National Institutes of Health Research Grants AI-12520 and AI-20611 from the NIAID. This JBC Review is part of a collection honoring Herbert Tabor on the occasion of his 100th birthday. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; Bass BL, 1997, RNA, V3, P947; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; BERRY MJ, 1985, J BIOL CHEM, V260, P1240; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Casey JL, 2006, CURR TOP MICROBIOL, V307, P67; CATTANEO R, 1992, CURR TOP MICROBIOL, V176, P63; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Chen YT, 2018, J BIOL CHEM, V293, P10158, DOI 10.1074/jbc.RA117.001197; Chilibeck KA, 2006, J BIOL CHEM, V281, P16530, DOI 10.1074/jbc.M511831200; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Chung HC, 2018, CELL, V172, P811, DOI 10.1016/j.cell.2017.12.038; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; Dawson TR, 2004, J BIOL CHEM, V279, P4941, DOI 10.1074/jbc.M310068200; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; Eisenberg E, 2018, NAT REV GENET, V19, P473, DOI 10.1038/s41576-018-0006-1; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; Fritzell K, 2018, SEMIN CELL DEV BIOL, V79, P123, DOI 10.1016/j.semcdb.2017.11.018; Fumagalli D, 2015, CELL REP, V13, P277, DOI 10.1016/j.celrep.2015.09.032; Gallo A, 2017, HUM GENET, V136, P1265, DOI 10.1007/s00439-017-1837-0; Gan ZJ, 2006, J BIOL CHEM, V281, P33386, DOI 10.1074/jbc.M604484200; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; George CX, 2008, VIROLOGY, V380, P338, DOI 10.1016/j.virol.2008.07.029; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; George CX, 2015, VIROLOGY, V485, P363, DOI 10.1016/j.virol.2015.08.001; George CX, 2011, J INTERF CYTOK RES, V31, P99, DOI 10.1089/jir.2010.0097; Guengerich FP, 2019, J BIOL CHEM, V294, P1671, DOI 10.1074/jbc.TM118.004144; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Heale BSE, 2009, EMBO J, V28, P3145, DOI 10.1038/emboj.2009.244; Heraud-Farlow JE, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1301-4; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hood JL, 2012, CURR TOP MICROBIOL, V353, P61, DOI 10.1007/82_2011_157; Horsch M, 2011, J BIOL CHEM, V286, P18614, DOI 10.1074/jbc.M110.200881; HOVANESSIAN AG, 1977, NATURE, V268, P537, DOI 10.1038/268537a0; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Jha BK, 2011, J BIOL CHEM, V286, P26319, DOI 10.1074/jbc.M111.253443; Jiang QF, 2017, NAT REV CANCER, V17, P381, DOI 10.1038/nrc.2017.23; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawakubo K, 2000, GENE, V258, P165, DOI 10.1016/S0378-1119(00)00368-1; KIM U, 1994, J BIOL CHEM, V269, P13480; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kuttan A, 2012, P NATL ACAD SCI USA, V109, pE3295, DOI 10.1073/pnas.1212548109; Lassig C, 2017, J BIOL CHEM, V292, P9000, DOI 10.1074/jbc.R117.788398; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098; Lazzari E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01890-w; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li YZ, 2017, ELIFE, V6, DOI 10.7554/eLife.25687; Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113; Li ZQ, 2012, J VIROL, V86, P3787, DOI 10.1128/JVI.06307-11; Li ZQ, 2010, VIROLOGY, V396, P316, DOI 10.1016/j.virol.2009.10.026; Liddicoat BJ, 2016, EXP HEMATOL, V44, P947, DOI 10.1016/j.exphem.2016.06.250; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu Y, 1996, J VIROL, V70, P1961, DOI 10.1128/JVI.70.3.1961-1968.1996; Liu Y, 2000, P NATL ACAD SCI USA, V97, P12541, DOI 10.1073/pnas.97.23.12541; Liu Y, 1999, J BIOL CHEM, V274, P5070, DOI 10.1074/jbc.274.8.5070; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; McAllister CS, 2012, J BIOL CHEM, V287, P36384, DOI 10.1074/jbc.M112.390039; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; McAllister CS, 2009, J BIOL CHEM, V284, P1644, DOI 10.1074/jbc.M807888200; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; MCMILLAN NAJ, 1995, J BIOL CHEM, V270, P2601, DOI 10.1074/jbc.270.6.2601; Mladenova D, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00243; Montiel-Gonzalez MF, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw738; Nakano M, 2016, J BIOL CHEM, V291, P894, DOI 10.1074/jbc.M115.699363; Neeman Y, 2006, RNA, V12, P1802, DOI 10.1261/rna.165106; Nemlich Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04600-2; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Oakes E, 2017, J BIOL CHEM, V292, P4326, DOI 10.1074/jbc.M117.779868; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; OConnell MA, 1997, J BIOL CHEM, V272, P473; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Parada GE, 2014, NUCLEIC ACIDS RES, V42, P10564, DOI 10.1093/nar/gku744; PATTERSON JB, 1995, VIROLOGY, V210, P508, DOI 10.1006/viro.1995.1370; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Peng XX, 2018, CANCER CELL, V33, P817, DOI 10.1016/j.ccell.2018.03.026; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pfaller CK, 2015, J VIROL, V89, P7735, DOI 10.1128/JVI.01017-15; Pfaller CK, 2014, J VIROL, V88, P456, DOI 10.1128/JVI.02572-13; Pinto Y, 2018, NUCLEIC ACIDS RES, V46, P71, DOI 10.1093/nar/gkx1176; Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5; Placido D, 2007, STRUCTURE, V15, P395, DOI 10.1016/j.str.2007.03.001; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; Ramaswami G, 2016, METHODS, V107, P42, DOI 10.1016/j.ymeth.2016.05.011; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; Samuel CE, 2003, J BIOL CHEM, V278, P1389, DOI 10.1074/jbc.R200032200; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; SAMUEL CE, 1984, J BIOL CHEM, V259, P3451; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stephens OM, 2004, CHEM BIOL, V11, P1239, DOI 10.1016/j.chembiol.2004.06.009; Strehblow A, 2002, MOL BIOL CELL, V13, P3822, DOI 10.1091/mbc.E02-03-0161; STROBEL SA, 1994, BIOCHEMISTRY-US, V33, P13824, DOI 10.1021/bi00250a037; Tan MH, 2017, NATURE, V550, P249, DOI 10.1038/nature24041; Toth AM, 2009, J BIOL CHEM, V284, P29350, DOI 10.1074/jbc.M109.045146; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Walkley CR, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1347-3; Wang C, 2017, CANCER LETT, V411, P27, DOI 10.1016/j.canlet.2017.09.036; Wang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20248; Wang Q., 2017, GENES, V8, pE41; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; WANG Y, 1995, J MOL BIOL, V254, P184, DOI 10.1006/jmbi.1995.0610; Wang Y, 2009, J MOL BIOL, V393, P777, DOI 10.1016/j.jmb.2009.08.070; Wang YM, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700188; Wang YM, 2017, GENOME RES, V27, P1112, DOI 10.1101/gr.219741.116; Wang YR, 2018, BIOCHEMISTRY-US, V57, P1640, DOI 10.1021/acs.biochem.7b01100; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Weier HUG, 2000, CYTOGENET CELL GENET, V89, P214, DOI 10.1159/000015615; WEIER HUG, 1995, GENOMICS, V30, P372, DOI 10.1006/geno.1995.0034; Wu B, 2015, CURR OPIN VIROL, V12, P91, DOI 10.1016/j.coviro.2015.04.004; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Yang SY, 2014, J IMMUNOL, V193, P3436, DOI 10.4049/jimmunol.1401136; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yang WD, 2005, J BIOL CHEM, V280, P3946, DOI 10.1074/jbc.M407876200; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zahn RC, 2007, J VIROL, V81, P457, DOI 10.1128/JVI.00067-06	146	72	74	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1710	1720		10.1074/jbc.TM118.004166	http://dx.doi.org/10.1074/jbc.TM118.004166			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710018	hybrid, Green Published			2022-12-28	WOS:000457879200031
J	Sengupta, S; Naz, S; Das, I; Ahad, A; Padhi, A; Naik, SK; Ganguli, G; Pattanaik, KP; Raghav, SK; Nandicoori, VK; Sonawane, A				Sengupta, Srabasti; Naz, Saba; Das, Ishani; Ahad, Abdul; Padhi, Avinash; Naik, Sumanta Kumar; Ganguli, Geetanjali; Pattanaik, Kali Prasad; Raghav, Sunil Kumar; Nandicoori, Vinay Kumar; Sonawane, Avinash			RETRACTION: Withdrawal: Mycobacterium tuberculosis EsxL inhibits MHC-II expression by promoting hypermethylation in class-II transactivator loci in macrophages. (Retraction of Vol 292, Pg 6855, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Raghav, Sunil/AAL-1121-2021					Sengupta S, 2017, J BIOL CHEM, V292, P6855, DOI 10.1074/jbc.M117.775205	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1632	1632		10.1074/jbc.W119.007461	http://dx.doi.org/10.1074/jbc.W119.007461			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710007	hybrid, Green Published			2022-12-28	WOS:000457879200018
J	Worby, CA; Dixon, JE				Worby, Carolyn A.; Dixon, Jack E.			Reversible phosphorylation: a birthday tribute to Herb Tabor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						phosphorylation; phospholipid; cancer biology; phosphatase; phosphatase and tensin homolog (PTEN); secretion; protein kinase A (PKA)	TUMOR-SUPPRESSOR; PROTEIN-KINASE; CRYSTAL-STRUCTURE; PHOSPHOPROTEOME; FAM20C; ACID; GENE	Herb Tabor was the Editor-in-Chief of the Journal of Biological Chemistry (JBC) spanning the years 1971-2010. This year, Herb turns 100. What do you give a person turning 100? Our answer to this question was to dedicate two of our favorite JBC papers to Herb. Both of these papers focus on reversible phosphorylation, which we briefly review. In addition, we delve into a new finding that centers around a novel family of secreted kinases, suggesting that there are many new and exciting discoveries yet to explore.	[Worby, Carolyn A.; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Dixon, JE (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Dixon, JE (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	jedixon@ucsd.edu			National Institutes of Health [DK18024, DK18849]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024, R01DK018849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health Grants DK18024 and DK18849 (to J. E. D. and C. A. W.). This JBC Review is part of a collection honoring Herbert Tabor on the occasion of his 100th birthday. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bahl JMC, 2008, ANAL CHEM, V80, P6308, DOI 10.1021/ac800835y; BERTHET J, 1957, J Biol Chem, V224, P463; Carrascal M, 2010, J PROTEOME RES, V9, P876, DOI 10.1021/pr900780s; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cori GT, 1943, J BIOL CHEM, V151, P31; CORI GT, 1945, J BIOL CHEM, V158, P321; FISCHER EH, 1955, J BIOL CHEM, V216, P121; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; GUAN KL, 1991, J BIOL CHEM, V266, P17026; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lasa M, 1997, EUR J BIOCHEM, V243, P719, DOI 10.1111/j.1432-1033.1997.00719.x; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lipman FA, 1932, J BIOL CHEM, V98, P0109; Lipmann F, 1933, BIOCHEM Z, V262, P9; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Simpson MA, 2007, AM J HUM GENET, V81, P906, DOI 10.1086/522240; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111; Tagliabracci VS, 2013, TRENDS BIOCHEM SCI, V38, P121, DOI 10.1016/j.tibs.2012.11.008; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Xiao JY, 2013, P NATL ACAD SCI USA, V110, P10574, DOI 10.1073/pnas.1309211110; Zhou WD, 2009, J PROTEOME RES, V8, P5523, DOI 10.1021/pr900603n	31	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1638	1642		10.1074/jbc.TME118.004161	http://dx.doi.org/10.1074/jbc.TME118.004161			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710011	Green Published, hybrid			2022-12-28	WOS:000457879200022
J	Marino, G; Uria, JA; Puente, XS; Quesada, V; Bordallo, J; Lopez-Otin, C				Marino, Guillermo; Uria, Jose A.; Puente, Xose S.; Quesada, Victor; Bordallo, Javier; Lopez-Otin, Carlos			RETRACTION: Withdrawal: Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. (Retraction of Vol 278, Pg 3671, 2003)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													marino, guillermo/HGB-8664-2022; bordallo, javier/X-5360-2019; Puente, Xosé S./ADB-0672-2022; Lopez-Otin, Carlos/AAB-2106-2020	bordallo, javier/0000-0002-5786-3929; Puente, Xosé S./0000-0001-9525-1483; Lopez-Otin, Carlos/0000-0001-6964-1904				Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1431	1431		10.1074/jbc.W118.007325	http://dx.doi.org/10.1074/jbc.W118.007325			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30808002	Green Published, hybrid			2022-12-28	WOS:000457879500034
J	Arenas, J; Pupo, E; de Jonge, E; Perez-Ortega, J; Schaarschmidt, J; van der Ley, P; Tommassen, J				Arenas, Jesus; Pupo, Elder; de Jonge, Eline; Perez-Ortega, Jesus; Schaarschmidt, Joerg; van der Ley, Peter; Tommassen, Jan			Substrate specificity of the pyrophosphohydrolase LpxH determines the asymmetry of Bordetella pertussis lipid A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bordetella pertussis; lipopolysaccharide (LPS); endotoxin; lipid A; Toll-like receptor 4 (TLR4); innate immunity; acyl chain length; LpxA; LpxH; Neisseria meningitidis	STRUCTURAL-CHARACTERIZATION; EXPRESSION; EPIDEMIOLOGY	Lipopolysaccharides are anchored to the outer membrane of Gram-negative bacteria by a hydrophobic moiety known as lipid A, which potently activates the host innate immune response. Lipid A of Bordetella pertussis, the causative agent of whooping cough, displays unusual structural asymmetry with respect to the length of the acyl chains at the 3 and 3 positions, which are 3OH-C10 and 3OH-C14 chains, respectively. Both chains are attached by the acyltransferase LpxA, the first enzyme in the lipid A biosynthesis pathway, which, in B. pertussis, has limited chain length specificity. However, this only partially explains the strict asymmetry of lipid A. In attempts to modulate the endotoxicity of B. pertussis lipid A, here we expressed the gene encoding LpxA from Neisseria meningitidis, which specifically attaches 3OH-C12 chains, in B. pertussis. This expression was lethal, suggesting that one of the downstream enzymes in the lipid A biosynthesis pathway in B. pertussis cannot handle precursors with a 3OH-C12 chain. We considered that the UDP-diacylglucosamine pyrophosphohydrolase LpxH could be responsible for this defect as well as for the asymmetry of B. pertussis lipid A. Expression of meningococcal LpxH in B. pertussis indeed resulted in new symmetric lipid A species with 3OH-C10 or 3OH-C14 chains at both the 3 and 3 positions, as revealed by MS analysis. Furthermore, co-expression of meningococcal lpxH and lpxA resulted in viable cells that incorporated 3OH-C12 chains in B. pertussis lipid A. We conclude that the asymmetry of B. pertussis lipid A is determined by the acyl chain length specificity of LpxH.	[Arenas, Jesus; de Jonge, Eline; Perez-Ortega, Jesus; Tommassen, Jan] Univ Utrecht, Dept Mol Microbiol, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Arenas, Jesus; de Jonge, Eline; Perez-Ortega, Jesus; Tommassen, Jan] Univ Utrecht, Inst Biomembranes, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Pupo, Elder; van der Ley, Peter] Inst Translat Vaccinol Intravacc, Antonie van Leeuwenhoeklaan 9, NL-3721 MA Bilthoven, Netherlands; [Schaarschmidt, Joerg] Univ Utrecht, Computat Struct Biol Grp, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University	Arenas, J (corresponding author), Univ Utrecht, Dept Mol Microbiol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.; Arenas, J (corresponding author), Univ Utrecht, Inst Biomembranes, Padualaan 8, NL-3584 CH Utrecht, Netherlands.; Arenas, J (corresponding author), Univ Zaragoza, Unit Microbiol & Immunol, Ave Miguel Servet 177, E-50013 Zaragoza, Spain.	jaarenas@unizar.es	Arenas, Jesús/A-5420-2017	Arenas, Jesús/0000-0002-8134-0693; Perez-Ortega, Jesus/0000-0002-8022-499X; de Jonge, Eline/0000-0003-3089-5899	IntraVacc	IntraVacc	This work was partially funded by IntraVacc. Part of this work is included in a European Patent Application with reference number 17160604.9.	Arenas J, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00162; Arenas J, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0493-6; Brummelman J, 2015, INFECT IMMUN, V83, P227, DOI 10.1128/IAI.02197-14; CAROFF M, 1994, J BACTERIOL, V176, P5156, DOI 10.1128/jb.176.16.5156-5159.1994; Caroff M, 2000, FEBS LETT, V477, P8, DOI 10.1016/S0014-5793(00)01720-8; Cho J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.154, 10.1038/nmicrobiol.2016.154]; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Geurtsen J, 2006, INFECT IMMUN, V74, P5574, DOI 10.1128/IAI.00834-06; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-25; Li YY, 2012, P NATL ACAD SCI USA, V109, P8716, DOI 10.1073/pnas.1202908109; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Okada C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32822; Piet JR, 2011, J BACTERIOL, V193, P2371, DOI 10.1128/JB.01331-10; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Richie DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160918; Sealey KL, 2016, INFECT GENET EVOL, V40, P136, DOI 10.1016/j.meegid.2016.02.032; Shah NR, 2014, ANTIMICROB AGENTS CH, V58, P4931, DOI 10.1128/AAC.02590-14; Shah NR, 2013, J BIOL CHEM, V288, P11751, DOI 10.1074/jbc.M112.434365; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith EW, 2015, BIOCHEMISTRY-US, V54, P5937, DOI 10.1021/acs.biochem.5b00720; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Steeghs L, 2002, CELL MICROBIOL, V4, P599, DOI 10.1046/j.1462-5822.2002.00214.x; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; Sweet CR, 2002, J BIOL CHEM, V277, P18281, DOI 10.1074/jbc.M201057200; Vadovic P, 2007, ACTA VIROL, V51, P249; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; VERWEY WF, 1949, J BACTERIOL, V58, P127, DOI 10.1128/JB.58.2.127-134.1949; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Wyckoff TJO, 1998, J BIOL CHEM, V273, P32369, DOI 10.1074/jbc.273.49.32369	34	4	4	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					7982	7989		10.1074/jbc.RA118.004680	http://dx.doi.org/10.1074/jbc.RA118.004680			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30926608	Green Published, hybrid			2022-12-28	WOS:000470656500002
J	Bhanu, NV; Sidoli, S; Yuan, ZF; Molden, RC; Garcia, BA				Bhanu, Natarajan V.; Sidoli, Simone; Yuan, Zuo-Fei; Molden, Rosalynn C.; Garcia, Benjamin A.			Regulation of proline-directed kinases and the trans-histone code H3K9me3/H4K20me3 during human myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; histone; acetyltransferase; acetylation; myogenesis; Kinase; mass spectrometry; myotube	TRANSCRIPTION FACTOR; PROTEIN; MUSCLE; PHOSPHORYLATION; IDENTIFICATION; METHYLATION; INHIBITORS; NETWORKS; TARGETS; GENES	We present a system-level analysis of proteome, phosphoproteome, and chromatin state of precursors of muscle cells (myoblasts) differentiating into specialized myotubes. Using stable isotope labeling of amino acids in cell culture and nano-liqud chromatography-mass spectrometry/mass spectrometry, we found that phosphorylation motifs targeted by the kinases protein kinase C, cyclin-dependent kinase, and mitogen-activated protein kinase showed increased phosphorylation during myodifferentiation of LHCN-M2 human skeletal myoblast cell line. Drugs known to inhibit these kinases either promoted (PD0325901 and GW8510) or stalled (CHIR99021 and roscovitine) differentiation, resulting in myotube and myoblast phenotypes, respectively. The proteomes, especially the myogenic and chromatin-related proteins including histone methyltransferases, correlated with their phenotypes, leading us to quantify histone post-translational modifications and identify two gene-silencing marks, H3K9me3 and H4K20me3, with relative abundances changing in correlation with these phenotypes. ChIP-quantitative PCR demonstrated that H3K9me3 is erased from the gene loci of myogenic regulatory factors namely MYOD1, MYOG, and MYF5 in differentiating myotubes. Together, our work integrating histone post-translational modification, phosphoproteomics, and full proteome analysis gives a comprehensive understanding of the close connection between signaling pathways and epigenetics during myodifferentiation in vitro.	[Bhanu, Natarajan V.; Sidoli, Simone; Yuan, Zuo-Fei; Molden, Rosalynn C.; Garcia, Benjamin A.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Epigenet Inst, Rm 9-124,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA; [Molden, Rosalynn C.] Regeneron Pharmaceut, Tarrytown, NY 10591 USA	University of Pennsylvania; Pennsylvania Medicine; Regeneron	Garcia, BA (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Epigenet Inst, Rm 9-124,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	bgarci@pennmedicine.upenn.edu	Sidoli, Simone/AAC-2196-2019	Sidoli, Simone/0000-0001-9073-6641	National Institutes of Health [R01GM110174, R01AI118891]; Department of Defense [W81XWH-113-1-0426]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM110174 and R01AI118891 and Department of Defense Grant W81XWH-113-1-0426. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; An W. F., 2014, DISCOVERY POTENT HIG; Ansseau E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146893; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baraibar MA, 2011, FREE RADICAL BIO MED, V51, P1522, DOI 10.1016/j.freeradbiomed.2011.06.032; Bhanu NV, 2016, PROTEOMICS, V16, P448, DOI 10.1002/pmic.201500231; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boonsanay V, 2016, CELL STEM CELL, V18, P229, DOI 10.1016/j.stem.2015.11.002; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1315s35, 10.1002/0471250953.bi1316s36]; Consalvi S, 2011, MOL MED, V17, P457, DOI 10.2119/molmed.2011.00049; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eom GH, 2011, J BIOL CHEM, V286, P34733, DOI 10.1074/jbc.M110.203307; Fomina-Yadlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028808; Gonnet F, 2008, PROTEOMICS, V8, P264, DOI 10.1002/pmic.200700261; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Greenberg SA, 2007, MUSCLE NERVE, V36, P447, DOI 10.1002/mus.20823; Guo K, 1997, J BIOL CHEM, V272, P791, DOI 10.1074/jbc.272.2.791; Hamed M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02390; Hammamieh R, 2007, OMICS, V11, P143, DOI 10.1089/omi.2007.4322; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; Jin W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121908; Kidder BL, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0115-7; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Knight JDR, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-29; Kuninger D, 2004, GENOMICS, V84, P876, DOI 10.1016/j.ygeno.2004.07.013; Li QR, 2009, J PROTEOME RES, V8, P5375, DOI 10.1021/pr900659n; Lindskog C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1686-y; Ling BMT, 2012, P NATL ACAD SCI USA, V109, P841, DOI 10.1073/pnas.1111628109; Liu J, 2015, J NEUROSCI, V35, P352, DOI 10.1523/JNEUROSCI.2606-14.2015; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Reeves EKM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-26; Ripple MO, 2013, J BIOL CHEM, V288, P2933, DOI 10.1074/jbc.M112.430082; Ruan JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035376; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin J, 2007, MOL CELL BIOL, V27, P8113, DOI 10.1128/MCB.00794-07; Sidoli S, 2016, JOVE-J VIS EXP, DOI 10.3791/54112; Song CX, 2012, MOL CELL PROTEOMICS, V11, P1070, DOI 10.1074/mcp.M111.012625; Stadler G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-12; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tao YZ, 2011, J CELL BIOL, V194, P551, DOI 10.1083/jcb.201010090; Taverna D, 2015, BONE, V74, P83, DOI 10.1016/j.bone.2015.01.004; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wauson EM, 2013, BIOCHEMISTRY-US, V52, P5164, DOI 10.1021/bi4007644; Windelinckx A, 2011, PHYSIOL GENOMICS, V43, P981, DOI 10.1152/physiolgenomics.00200.2010; WUNSCH AM, 1991, MECH AGEING DEV, V59, P299, DOI 10.1016/0047-6374(91)90140-U; Xu J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4886-4; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang YP, 2009, CYTOKINE, V46, P137, DOI 10.1016/j.cyto.2008.12.015; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011; Zhang Y, 2000, J MOL ENDOCRINOL, V25, P221, DOI 10.1677/jme.0.0250221; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	65	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8296	8308		10.1074/jbc.RA118.004977	http://dx.doi.org/10.1074/jbc.RA118.004977			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30872405	Green Published, hybrid			2022-12-28	WOS:000470656500025
J	Tejero, J; Hunt, AP; Santolini, J; Lehnert, N; Stuehr, DJ				Tejero, Jesus; Hunt, Andrew P.; Santolini, Jerome; Lehnert, Nicolai; Stuehr, Dennis J.			Mechanism and regulation of ferrous heme-nitric oxide (NO) oxidation in NO synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitric oxide; nitric-oxide synthase; heme; enzyme mechanism; computational biology; thermodynamics; enzyme kinetics; dioxygenation; heme protein; heme-thiolate; reaction mechanism; redox reaction	LIGAND-PROTEIN INTERACTIONS; GAUSSIAN-BASIS SETS; SUBUNIT DIMERIZATION; KINETIC-PARAMETERS; ELECTRON-TRANSFER; OXYGENASE DOMAIN; L-ARGININE; ATOMS LI; TETRAHYDROBIOPTERIN; CATALYSIS	Nitric oxide (NO) synthases (NOSs) catalyze the formation of NO from l-arginine. We have shown previously that the NOS enzyme catalytic cycle involves a large number of reactions but can be characterized by a global model with three main rate-limiting steps. These are the rate of heme reduction by the flavin domain (k(r)), of dissociation of NO from the ferric heme-NO complex (k(d)), and of oxidation of the ferrous heme-NO complex (k(ox)). The reaction of oxygen with the ferrous heme-NO species is part of a futile cycle that does not directly contribute to NO synthesis but allows a population of inactive enzyme molecules to return to the catalytic cycle, and thus, enables a steady-state NO synthesis rate. Previously, we have reported that this reaction does involve the reaction of oxygen with the NO-bound ferrous heme complex, but the mechanistic details of the reaction, that could proceed via either an inner-sphere or an outer-sphere mechanism, remained unclear. Here, we present additional experiments with neuronal NOS (nNOS) and inducible NOS (iNOS) variants (nNOS W409F and iNOS K82A and V346I) and computational methods to study how changes in heme access and electronics affect the reaction. Our results support an inner-sphere mechanism and indicate that the particular heme-thiolate environment of the NOS enzymes can stabilize an N-bound Fe-III-N(O)OO- intermediate species and thereby catalyze this reaction, which otherwise is not observed or favorable in proteins like globins that contain a histidine-coordinated heme.	[Tejero, Jesus; Santolini, Jerome; Stuehr, Dennis J.] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Hunt, Andrew P.; Lehnert, Nicolai] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Hunt, Andrew P.; Lehnert, Nicolai] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Tejero, Jesus] Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15213 USA; [Santolini, Jerome] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC,UMR 9891, F-91191 Gif Sur Yvette, France	Cleveland Clinic Foundation; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Stuehr, DJ (corresponding author), Cleveland Clin Fdn, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; Hunt, Andrew/0000-0003-0565-9050; Santolini, Jerome/0000-0001-8919-112X	National Institutes of Health [GM51491]; National Science Foundation [CHE-1464696]; American Heart Association [0625632B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM51491 (to D. J. S.) and by National Science Foundation Grant CHE-1464696 (to N. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by American Heart Association Postdoctoral Fellowship 0625632B. Present address: Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA 15213.	AbuSoud HM, 1997, J BIOL CHEM, V272, P17349, DOI 10.1074/jbc.272.28.17349; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andersen JF, 2000, BIOCHEMISTRY-US, V39, P10118, DOI 10.1021/bi000766b; Arnold EV, 1996, METHOD ENZYMOL, V269, P41; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Blomberg LM, 2004, J BIOL INORG CHEM, V9, P923, DOI 10.1007/s00775-004-0585-5; Brunel A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.195446; Carabet LA, 2017, J PHYS CHEM B, V121, P8706, DOI 10.1021/acs.jpcb.7b06494; CHEUNG E, 1995, CAN J CHEM, V73, P1181, DOI 10.1139/v95-145; Copeland DM, 2003, PROTEINS, V53, P182, DOI 10.1002/prot.10495; Couture M, 2001, J BIOL CHEM, V276, P38280; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Crane BR, 2008, BIOCHEM SOC T, V36, P1149, DOI 10.1042/BST0361149; Fernandez ML, 2005, J BIOL INORG CHEM, V10, P595, DOI 10.1007/s00775-005-0004-6; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gao YT, 2004, J BIOL CHEM, V279, P18759, DOI 10.1074/jbc.M308936200; Ghosh DK, 1999, EMBO J, V18, P6260, DOI 10.1093/emboj/18.22.6260; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Hannibal L, 2011, J BIOL CHEM, V286, P39224, DOI 10.1074/jbc.M111.286351; Haque MM, 2013, FEBS J, V280, P4439, DOI 10.1111/febs.12404; Herold S, 2005, BIOCHEMISTRY-US, V44, P6223, DOI 10.1021/bi0475929; Herold S, 1999, ARCH BIOCHEM BIOPHYS, V372, P393, DOI 10.1006/abbi.1999.1534; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Lang J, 2011, BIOCHEMISTRY-US, V50, P10069, DOI 10.1021/bi200965e; Lang J, 2009, J INORG BIOCHEM, V103, P1102, DOI 10.1016/j.jinorgbio.2009.05.011; Li D, 2004, J BIOL CHEM, V279, P26489, DOI 10.1074/jbc.M400968200; Li HY, 2006, J BIOL INORG CHEM, V11, P753, DOI 10.1007/s00775-006-0123-8; LIND J, 1989, J AM CHEM SOC, V111, P7654, DOI 10.1021/ja00201a078; Marchal S, 2004, J BIOL CHEM, V279, P19824, DOI 10.1074/jbc.M313587200; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Moller JKS, 2004, CHEM-EUR J, V10, P2291, DOI 10.1002/chem.200305368; Ost TWB, 2005, J BIOL CHEM, V280, P965, DOI 10.1074/jbc.M411191200; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Pant K, 2005, J MOL BIOL, V352, P932, DOI 10.1016/j.jmb.2005.07.070; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; Salerno JC, 2009, FEBS J, V276, P6677, DOI 10.1111/j.1742-4658.2009.07382.x; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Santolini J, 2019, FRONT BIOSCI-LANDMRK, V24, P133, DOI 10.2741/4711; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Simonneaux G, 2005, CHEM REV, V105, P2627, DOI 10.1021/cr030731s; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Tejero J, 2009, FEBS J, V276, P4505, DOI 10.1111/j.1742-4658.2009.07157.x; TSAI JHM, 1994, J AM CHEM SOC, V116, P4115, DOI 10.1021/ja00088a072; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; Whited CA, 2012, J AM CHEM SOC, V134, P27, DOI 10.1021/ja2069533	63	12	12	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7904	7916		10.1074/jbc.RA119.007810	http://dx.doi.org/10.1074/jbc.RA119.007810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30926606	Green Published, hybrid			2022-12-28	WOS:000470153300030
J	Aluri, S; Zhao, RB; Lin, K; Shin, DS; Fiser, A; Goldman, ID				Aluri, Srinivas; Zhao, Rongbao; Lin, Kai; Shin, Daniel Sanghoon; Fiser, Andras; Goldman, I. David			Substitutions that lock and unlock the proton-coupled folate transporter (PCFT-SLC46A1) in an inward-open conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transporter; membrane transport; structural model; protein motif; folate; folate malabsorption disease; GXXXDXXGR(R; K); proton-coupled folate transporter (PCFT); solute carrier family 46 member 1 (SLC46A1)	METAL-TETRACYCLINE/H+ ANTIPORTER; CYSTEINE ACCESSIBILITY; TRANSMEMBRANE DOMAIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; LACTOSE PERMEASE; FUNCTIONAL ROLES; CONSERVED MOTIF; MUTATION; IDENTIFICATION	The proton-coupled folate transporter (PCFT) mediates intestinal absorption of folates and their transport from blood to cerebrospinal fluid across the choroid plexus. Substitutions at Asp-109 in the first intracellular loop between the first and second transmembrane domains (TMDs) abolish PCFT function, but protein expression and trafficking to the cell membrane are retained. Here, we used site-directed mutagenesis, the substituted-cysteine accessibility method, functional analyses, and homology modeling to determine whether the D109A substitution locks PCFT in one of its conformational states. Cys-substituted residues lining the PCFT aqueous translocation pathway and accessible in WT PCFT to the membrane-impermeable cysteine-biotinylation reagent, MTSEA-biotin, lost accessibility when introduced into the D109A scaffold. Substitutions at Gly-305 located exofacially within the eighth TMD, particularly with bulky residues, when introduced into the D109A scaffold largely restored function and MTSEA-biotin accessibility to Cys-substituted residues within the pathway. Likewise, Ser-196 substitution in the fifth TMD, predicted by homology modeling to be in proximity to Gly-305, also partially restored function found in solute transporters, is critical to oscillation of the carrier among its conformational states. Substitutions at Asp-109 and Gly-112 lock PCFT in an inward-open conformation, resulting in the loss of function. However, the integrity of the locked protein is preserved, indicated by the restoration of function after insertion of a second unlocking mutation. and accessibility. Similarly, the inactivating G112K substitution within the first intracellular loop was partially reactivated by introducing the G305L substitution. These data indicate that the first intracellular loop, with a sequence identical to motif A (GXXXDXXGR(R/K))	[Aluri, Srinivas; Zhao, Rongbao; Lin, Kai; Shin, Daniel Sanghoon; Goldman, I. David] Albert Einstein Coll Med, Dept Pharmacol, Bronx, NY 10461 USA; [Zhao, Rongbao; Shin, Daniel Sanghoon; Goldman, I. David] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Fiser, Andras] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Lin, Kai] PLA, Air Force Med Ctr, Beijing 100142, Peoples R China; [Shin, Daniel Sanghoon] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Los Angeles	Goldman, ID (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	i.david.goldman@einstein.yu.edu	Aluri, Srinivas/AAK-5129-2020	Aluri, Srinivas/0000-0003-4084-1747; Shin, Daniel/0000-0002-3784-5336	NCI, National Institutes of Health [CA082621]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA082621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI141816] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NCI, National Institutes of Health, Grant CA082621. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akyuz N, 2015, NATURE, V518, P68, DOI 10.1038/nature14158; Aluri S, 2018, AM J PHYSIOL-CELL PH, V314, pC289, DOI 10.1152/ajpcell.00215.2017; Aluri S, 2018, BLOOD ADV, V2, P61, DOI 10.1182/bloodadvances.2017012690; Aluri S, 2017, BBA-BIOMEMBRANES, V1859, P2193, DOI 10.1016/j.bbamem.2017.08.006; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Bozzi AT, 2016, STRUCTURE, V24, P2102, DOI 10.1016/j.str.2016.09.017; Cain SM, 2000, J MEMBRANE BIOL, V176, P159, DOI 10.1007/s002320001085; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Date SS, 2016, FEBS OPEN BIO, V6, P216, DOI 10.1002/2211-5463.12041; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Diop-Bove NK, 2009, MOL CANCER THER, V8, P2424, DOI 10.1158/1535-7163.MCT-08-0938; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Giovannetti E, 2017, ANN ONCOL, V28, P2725, DOI 10.1093/annonc/mdx499; GRIFFITH J K, 1992, Current Opinion in Cell Biology, V4, P684, DOI 10.1016/0955-0674(92)90090-Y; JESSENMARSHALL AE, 1995, J BIOL CHEM, V270, P16251, DOI 10.1074/jbc.270.27.16251; JessenMarshall AE, 1997, J BACTERIOL, V179, P2616, DOI 10.1128/jb.179.8.2616-2622.1997; Jiang DH, 2013, P NATL ACAD SCI USA, V110, P14664, DOI 10.1073/pnas.1308127110; Lasry I, 2008, BLOOD, V112, P2055, DOI 10.1182/blood-2008-04-150276; Liu ZY, 2010, J MOL BIOL, V396, P617, DOI 10.1016/j.jmb.2009.12.044; Magnani F, 2016, NAT PROTOC, V11, P1554, DOI 10.1038/nprot.2016.088; Mahadeo K, 2010, AM J PHYSIOL-CELL PH, V299, pC1153, DOI 10.1152/ajpcell.00113.2010; Matherly LH, 2018, CANCER CHEMOTH PHARM, V81, P1, DOI 10.1007/s00280-017-3473-8; Matherly LH, 2014, DRUG METAB DISPOS, V42, P632, DOI 10.1124/dmd.113.055723; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Rai BK, 2006, BIOINFORMATICS, V22, P2691, DOI 10.1093/bioinformatics/btl449; Ryan RM, 2010, J NEUROCHEM, V114, P565, DOI 10.1111/j.1471-4159.2010.06796.x; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shin DS, 2013, AM J PHYSIOL-CELL PH, V304, pC1159, DOI 10.1152/ajpcell.00353.2012; Shin DS, 2012, AM J PHYSIOL-CELL PH, V302, pC1405, DOI 10.1152/ajpcell.00435.2011; Shin DS, 2010, BLOOD, V116, P5162, DOI 10.1182/blood-2010-06-291237; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Unal ES, 2009, AM J PHYSIOL-CELL PH, V297, pC66, DOI 10.1152/ajpcell.00096.2009; Unal ES, 2009, J BIOL CHEM, V284, P17846, DOI 10.1074/jbc.M109.008060; Visentin M, 2015, AM J PHYSIOL-CELL PH, V308, pC631, DOI 10.1152/ajpcell.00238.2014; Visentin M, 2014, ANNU REV PHYSIOL, V76, P251, DOI 10.1146/annurev-physiol-020911-153251; Wilson MR, 2014, J BIOL CHEM, V289, P25287, DOI 10.1074/jbc.M114.578252; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P15525; YAMAGUCHI A, 1995, BIOCHEMISTRY-US, V34, P11800, DOI 10.1021/bi00037a018; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhao RB, 2017, AM J PHYSIOL-CELL PH, V312, pC517, DOI 10.1152/ajpcell.00350.2016; Zhao RB, 2017, MOL ASPECTS MED, V53, P57, DOI 10.1016/j.mam.2016.09.002; Zhao RB, 2016, J BIOL CHEM, V291, P8162, DOI 10.1074/jbc.M115.693929; Zhao RB, 2012, AM J PHYSIOL-CELL PH, V303, pC673, DOI 10.1152/ajpcell.00123.2012; Zhao RB, 2010, BIOCHEMISTRY-US, V49, P2925, DOI 10.1021/bi9021439	50	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7245	7258		10.1074/jbc.RA118.005533	http://dx.doi.org/10.1074/jbc.RA118.005533			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30858177	Green Published, hybrid			2022-12-28	WOS:000468402900014
J	Corsa, CAS; Pearson, GL; Renberg, A; Askar, MM; Vozheiko, T; MacDougald, OA; Soleimanpour, SA				Corsa, Callie A. S.; Pearson, Gemma L.; Renberg, Aaron; Askar, Matthew M.; Vozheiko, Tracy; MacDougald, Ormond A.; Soleimanpour, Scott A.			The E3 ubiquitin ligase parkin is dispensable for metabolic homeostasis in murine pancreatic cells and adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; mitophagy; autophagy; mitochondria; adipose tissue; cell; metabolism; adipocyte; islet; E3 ubiquitin ligase	MEDIATED MITOPHAGY; BETA-CELLS; INSULIN; GENE; MITOCHONDRIA; CLEC16A; MAINTENANCE; POPULATION; LOCUS; RISK	The E3 ubiquitin ligase parkin is a critical regulator of mitophagy and has been identified as a susceptibility gene for type 2 diabetes (T2D). However, its role in metabolically active tissues that precipitate T2D development is unknown. Specifically, pancreatic cells and adipocytes both rely heavily on mitochondrial function in the regulation of optimal glycemic control to prevent T2D, but parkin's role in preserving quality control of cell or adipocyte mitochondria is unclear. Although parkin has been reported previously to control mitophagy, here we show that, surprisingly, parkin is dispensable for glucose homeostasis in both cells and adipocytes during diet-induced insulin resistance in mice. We observed that insulin secretion, cell formation, and islet architecture were preserved in parkin-deficient cells and islets, suggesting that parkin is not necessary for control of cell function and islet compensation for diet-induced obesity. Although transient parkin deficiency mildly impaired mitochondrial turnover in cell lines, parkin deletion in primary cells yielded no deficits in mitochondrial clearance. In adipocyte-specific deletion models, lipid uptake and -oxidation were increased in cultured cells, whereas adipose tissue morphology, glucose homeostasis, and beige-to-white adipocyte transition were unaffected in vivo. In key metabolic tissues where mitochondrial dysfunction has been implicated in T2D development, our experiments unexpectedly revealed that parkin is not an essential regulator of glucose tolerance, whole-body energy metabolism, or mitochondrial quality control. These findings highlight that parkin-independent processes maintain cell and adipocyte mitochondrial quality control in diet-induced obesity.	[Corsa, Callie A. S.; Askar, Matthew M.; MacDougald, Ormond A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA; [Pearson, Gemma L.; Renberg, Aaron; Vozheiko, Tracy; MacDougald, Ormond A.; Soleimanpour, Scott A.] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Soleimanpour, Scott A.] Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	MacDougald, OA (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA.; MacDougald, OA; Soleimanpour, SA (corresponding author), Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA.; Soleimanpour, SA (corresponding author), Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI 48105 USA.	macdouga@med.umich.edu; ssol@med.umich.edu		Soleimanpour, Scott/0000-0001-6777-4498; Askar, Matthew/0000-0003-2252-8554; Pearson, Gemma/0000-0003-4253-1830; MacDougald, Ormond/0000-0001-6907-7960	NIDDK, National Institutes of Health [R24 DK092759, RO1 DK62876, R01 DK108921, T32 DK101357]; American Diabetes Association [1-18-PDF-064]; JDRF [CDA-2016-189, SRA-2018-539]; Danish Diabetes Academy - Novo Nordisk Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK110768, P30DK020572, R24DK092759, P30DK089503, T32DK101357, R01DK108921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); JDRF(Juvenile Diabetes Research Foundation); Danish Diabetes Academy - Novo Nordisk Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIDDK, National Institutes of Health Grants R24 DK092759 and RO1 DK62876 (to O. A. M.), R01 DK108921 (to S. A. S.), and T32 DK101357 (to C. A. S. C.); American Diabetes Association Grant 1-18-PDF-064 (to C. A. S. C.); and JDRF Grants CDA-2016-189 and SRA-2018-539 (to S. A. S.). The JDRF career development award to S. A. S. is partly supported by the Danish Diabetes Academy, which is supported by the Novo Nordisk Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altshuler-Keylin S, 2016, CELL METAB, V24, P402, DOI 10.1016/j.cmet.2016.08.002; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Cummins TD, 2014, AM J PHYSIOL-ENDOC M, V307, pE262, DOI 10.1152/ajpendo.00271.2013; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hofmeister-Brix A, 2013, J BIOL CHEM, V288, P35824, DOI 10.1074/jbc.M113.526632; Hoshino A, 2014, P NATL ACAD SCI USA, V111, P3116, DOI 10.1073/pnas.1318951111; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jin HS, 2014, MOL CELL ENDOCRINOL, V382, P178, DOI 10.1016/j.mce.2013.09.031; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Kaufman BA, 2015, MOL ASPECTS MED, V42, P91, DOI 10.1016/j.mam.2015.01.004; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Kusminski CM, 2016, DIABETES, V65, P1534, DOI 10.2337/db15-1323; Leak TS, 2008, HUM GENET, V124, P63, DOI 10.1007/s00439-008-0523-7; Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044; Lindsay RS, 2001, DIABETES, V50, P2850, DOI 10.2337/diabetes.50.12.2850; Lopez-Lluch G, 2017, MECH AGEING DEV, V162, P108, DOI 10.1016/j.mad.2016.12.005; Lu XD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aap8526; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; Mulder H, 2009, MOL CELL ENDOCRINOL, V297, P34, DOI 10.1016/j.mce.2008.05.015; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pearson G, 2018, DIABETES, V67, P265, DOI 10.2337/db17-0321; Pearson GL, 2014, DIABETOLOGIA, V57, P129, DOI 10.1007/s00125-013-3083-x; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rim JS, 2005, FASEB J, V19, P1205, DOI 10.1096/fj.04-3204fje; RODBELL M, 1964, J BIOL CHEM, V239, P375; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shires SE, 2017, CIRC RES, V120, P1234, DOI 10.1161/CIRCRESAHA.116.310179; Soleimanpour SA, 2015, DIABETES, V64, P3475, DOI 10.2337/db15-0376; Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016; Taylor D, 2017, OBESITY, V25, P704, DOI 10.1002/oby.21786; Thorens B, 2015, DIABETOLOGIA, V58, P558, DOI 10.1007/s00125-014-3468-5; Villa E, 2018, TRENDS CELL BIOL, V28, P882, DOI 10.1016/j.tcb.2018.07.004; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Wongseree W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-294	46	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7296	7307		10.1074/jbc.RA118.006763	http://dx.doi.org/10.1074/jbc.RA118.006763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877201	Green Published, hybrid			2022-12-28	WOS:000468402900018
J	Graab, P; Bock, C; Weiss, K; Hirth, A; Koller, N; Braner, M; Jung, J; Loehr, F; Tampe, R; Behrends, C; Abele, R				Graab, Philipp; Bock, Christoph; Weiss, Konstantin; Hirth, Alexander; Koller, Nicole; Braner, Markus; Jung, Jennifer; Loehr, Frank; Tampe, Robert; Behrends, Christian; Abele, Rupert			Lysosomal targeting of the ABC transporter TAPL is determined by membrane-localized charged residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; intracellular trafficking; lysosome; protein targeting; transmembrane domain; ATP-binding cassette subfamily B member 9 (ABCB9); polypeptide transporter; protein-protein interaction; TMD0; Yip1-interacting factor homolog B membrane-trafficking protein (YIF1B)	CELL ANTIGEN RECEPTOR; INVARIANT CHAIN; CLASS-II; MEDIATED ENDOCYTOSIS; TRANSMEMBRANE DOMAIN; RISK-FACTOR; TRAFFICKING; COMPLEX; LAMP-1; TRANSLOCATION	The human lysosomal polypeptide ABC transporter TAPL (ABC subfamily B member 9, ABCB9) transports 6-59-amino-acid-long polypeptides from the cytosol into lysosomes. The subcellular localization of TAPL depends solely on its N-terminal transmembrane domain, TMD0, which lacks conventional targeting sequences. However, the intracellular route and the molecular mechanisms that control TAPL localization remain unclear. Here, we delineated the route of TAPL to lysosomes and investigated the determinants of single trafficking steps. By synchronizing trafficking events by a retention using selective hooks (RUSH) assay and visualizing individual intermediate steps through immunostaining and confocal microscopy, we demonstrate that TAPL takes the direct route to lysosomes. We further identified conserved charged residues within TMD0 transmembrane helices that are essential for individual steps of lysosomal targeting. Substitutions of these residues retained TAPL in the endoplasmic reticulum (ER) or Golgi. We also observed that for release from the ER, a salt bridge between Asp-17 and Arg-57 is essential. An interactome analysis revealed that Yip1-interacting factor homolog B membrane-trafficking protein (YIF1B) interacts with TAPL. We also found that YIF1B is involved in ER-to-Golgi trafficking and interacts with TMD0 of TAPL via its transmembrane domain and that this interaction strongly depends on the newly identified salt bridge within TMD0. These results expand our knowledge about lysosomal trafficking of TAPL and the general function of extra transmembrane domains of ABC transporters.	[Graab, Philipp; Bock, Christoph; Weiss, Konstantin; Hirth, Alexander; Koller, Nicole; Braner, Markus; Tampe, Robert; Abele, Rupert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Loehr, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Loehr, Frank] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Jung, Jennifer; Behrends, Christian] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Behrends, Christian] Ludwig Maximilians Univ Munchen, Munich Cluster Syst Neurol, Feodor Lynen Str 17, D-81377 Munich, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; University of Munich	Abele, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Bioctr, Max von Laue Str 9, D-60438 Frankfurt, Germany.	abele@em.uni-frankfurt.de	Behrends, Christian/AAX-4201-2021; Tampe, Robert/H-2953-2015	Behrends, Christian/0000-0002-9184-7607; Weiss, Konstantin Julian/0000-0003-4895-9459; Lohr, Frank/0000-0001-6399-9497; Tampe, Robert/0000-0002-0403-2160	German Research Foundation [SFB 807, SFB 1177, SPP 1623, EXC1010, AB149/1-2]; Boehringer Ingelheim Foundation; Center for Biomolecular Magnetic Resonance	German Research Foundation(German Research Foundation (DFG)); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Center for Biomolecular Magnetic Resonance	This work was supported by German Research Foundation Grants SFB 807 (to P. G., C. Bock, N. K., R. A., and R. T.), SFB 1177 (to C. Behrends), SPP 1623 (to R. T. and M. B.), EXC1010 SyNergy (to C. Behrends), and AB149/1-2 (to R. A.); the Boehringer Ingelheim Foundation (to C. Behrends); and the Center for Biomolecular Magnetic Resonance (to F. L.). The authors declare that they have no conflicts of interest with the contents of this article.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; Alterio J, 2015, TRAFFIC, V16, P978, DOI 10.1111/tra.12306; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Blees A, 2017, NATURE, V551, P525, DOI 10.1038/nature24627; Blees A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17341; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; Bock C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33841-w; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Busch JI, 2016, HUM MOL GENET, V25, P2681, DOI 10.1093/hmg/ddw127; Carrel D, 2008, J NEUROSCI, V28, P8063, DOI 10.1523/JNEUROSCI.4487-07.2008; CASTELLINO F, 1995, IMMUNITY, V2, P73, DOI 10.1016/1074-7613(95)90080-2; Chen Y, 2017, J CELL BIOL, V216, P4141, DOI 10.1083/jcb.201707172; Cosson P, 2013, TRENDS CELL BIOL, V23, P511, DOI 10.1016/j.tcb.2013.05.005; Demirel O, 2007, J BIOL CHEM, V282, P37836, DOI 10.1074/jbc.M708139200; Demirel O, 2012, J CELL SCI, V125, P4230, DOI 10.1242/jcs.087346; Demirel O, 2010, TRAFFIC, V11, P383, DOI 10.1111/j.1600-0854.2009.01021.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jung J, 2017, ELIFE, V6, DOI [10.7554/eLife.23063, 10.75554/eLife.23063]; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kamakura A, 2008, BIOCHEM BIOPH RES CO, V377, P847, DOI 10.1016/j.bbrc.2008.10.078; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Kawaguchi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30183; Kawai H, 2009, MOL BIOL CELL, V20, P2979, DOI 10.1091/mbc.E08-09-0912; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; Kirshner H, 2013, J MICROSC-OXFORD, V249, P13, DOI 10.1111/j.1365-2818.2012.03675.x; Kiss K, 2015, BIOCHEM J, V467, P127, DOI 10.1042/BJ20141085; Kobayashi A, 2000, J BIOCHEM, V128, P711, DOI 10.1093/oxfordjournals.jbchem.a022805; Kuijpers M, 2013, EMBO J, V32, P2056, DOI 10.1038/emboj.2013.131; Lang CM, 2012, J BIOL CHEM, V287, P19355, DOI 10.1074/jbc.M112.365098; Lawand M, 2019, MOL IMMUNOL, V113, P75, DOI 10.1016/j.molimm.2018.06.268; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nie C, 2018, P NATL ACAD SCI USA, V115, pE3155, DOI 10.1073/pnas.1704639115; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robertson MJ, 2014, NAT PROTOC, V9, P851, DOI 10.1038/nprot.2014.046; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Sage D, 2017, METHODS, V115, P28, DOI 10.1016/j.ymeth.2016.12.015; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Staudt C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010047; Stevenson NL, 2017, J CELL SCI, V130, P4132, DOI 10.1242/jcs.212308; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Thomas C, 2018, CURR OPIN STRUC BIOL, V51, P116, DOI 10.1016/j.sbi.2018.03.016; Tumulka F, 2013, J BIOMOL NMR, V57, P141, DOI 10.1007/s10858-013-9774-2; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wolters JC, 2005, J BIOL CHEM, V280, P23631, DOI 10.1074/jbc.M503231200; Zhang F, 2000, J BIOL CHEM, V275, P23287, DOI 10.1074/jbc.M001819200; Zollmann T, 2015, P NATL ACAD SCI USA, V112, P2046, DOI 10.1073/pnas.1418100112	67	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7308	7323		10.1074/jbc.RA118.007071	http://dx.doi.org/10.1074/jbc.RA118.007071			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30877195	hybrid, Green Published			2022-12-28	WOS:000468402900019
J	Leth, JM; Mertens, HDT; Leth-Espensen, KZ; Jorgensen, TJD; Ploug, M				Leth, Julie M.; Mertens, Haydyn D. T.; Leth-Espensen, Katrine Zinck; Jorgensen, Thomas J. D.; Ploug, Michael			Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor structure-function; surface plasmon resonance (SPR); protein evolution; urokinase receptor; disulfide; fibrinolysis; hydrogen exchange mass spectrometry; small-angle X-ray scattering (SAXS); plasminogen regulation; LU domain	PLASMINOGEN-ACTIVATOR UPA; CRYSTAL-STRUCTURE; ACETYLCHOLINE-RECEPTOR; CELLULAR RECEPTOR; VITRONECTIN; PROTEIN; ANTIBODY; DOMAIN; LOCALIZATION; ADHESION	The urokinase receptor (uPAR) is a founding member of a small protein family with multiple Ly6/uPAR (LU) domains. The motif defining these LU domains contains five plesiotypic disulfide bonds stabilizing its prototypical three-fingered fold having three protruding loops. Notwithstanding the detailed knowledge on structure-function relationships in uPAR, one puzzling enigma remains unexplored. Why does the first LU domain in uPAR (DI) lack one of its consensus disulfide bonds, when the absence of this particular disulfide bond impairs the correct folding of other single LU domain-containing proteins? Here, using a variety of contemporary biophysical methods, we found that reintroducing the two missing half-cystines in uPAR DI caused the spontaneous formation of the corresponding consensus 7-8 LU domain disulfide bond. Importantly, constraints due to this cross-link impaired (i) the binding of uPAR to its primary ligand urokinase and (ii) the flexible interdomain assembly of the three LU domains in uPAR. We conclude that the evolutionary deletion of this particular disulfide bond in uPAR DI may have enabled the assembly of a high-affinity urokinase-binding cavity involving all three LU domains in uPAR. Of note, an analogous neofunctionalization occurred in snake venom -neurotoxins upon loss of another pair of the plesiotypic LU domain half-cystines. In summary, elimination of the 7-8 consensus disulfide bond in the first LU domain of uPAR did have significant functional and structural consequences.	[Leth, Julie M.; Leth-Espensen, Katrine Zinck; Ploug, Michael] Rigshosp, Finsen Lab, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark; [Leth, Julie M.; Leth-Espensen, Katrine Zinck; Ploug, Michael] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark; [Mertens, Haydyn D. T.] European Mol Biol Lab Hamburg, Notkestr 85, D-22607 Hamburg, Germany; [Leth-Espensen, Katrine Zinck; Jorgensen, Thomas J. D.] Univ Southern Denmark, Dept Biochem & Mol Biol, DK-5320 Odense M, Denmark	Rigshospitalet; University of Copenhagen; European Molecular Biology Laboratory (EMBL); University of Southern Denmark	Ploug, M (corresponding author), Rigshosp, Finsen Lab, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	m-ploug@finsenlab.dk		Leth-Espensen, Katrine Zinck/0000-0002-3845-3676; Mertens, Haydyn/0000-0002-5664-744X; Ploug, Michael/0000-0003-2215-4265; Jorgensen, Thomas J.D./0000-0002-7149-316X				Adeyo O, 2015, BRIT J DERMATOL, V173, P1066, DOI 10.1111/bjd.13868; Almholt K, 2018, J IMMUNOL, V200, P957, DOI 10.4049/jimmunol.1701317; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Beigneux AP, 2015, CIRC RES, V116, P624, DOI 10.1161/CIRCRESAHA.116.305085; Boonstra MC, 2017, ORAL ONCOL, V66, P1, DOI 10.1016/j.oraloncology.2016.12.026; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Chana-Munoz A, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1353-z; Christensen A, 2017, ONCOTARGET, V8, P15407, DOI 10.18632/oncotarget.14282; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; De Lorenzi V, 2016, EMBO REP, V17, P982, DOI 10.15252/embr.201541681; Diaz A, 2017, J NEUROSCI, V37, P10310, DOI 10.1523/JNEUROSCI.1630-17.2017; Ducancel F, 1996, J BIOL CHEM, V271, P31345, DOI 10.1074/jbc.271.49.31345; Ferraris GMS, 2014, EMBO J, V33, P2458, DOI 10.15252/embj.201387611; Fong LG, 2016, TRENDS ENDOCRIN MET, V27, P455, DOI 10.1016/j.tem.2016.04.013; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gardsvoll H, 2004, PROTEIN EXPRES PURIF, V34, P284, DOI 10.1016/j.pep.2003.12.002; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2013, J HISTOCHEM CYTOCHEM, V61, P802, DOI 10.1369/0022155413501879; Gardsvoll H, 2011, J BIOL CHEM, V286, P43515, DOI 10.1074/jbc.M111.300020; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Gyetko MR, 2004, J LEUKOCYTE BIOL, V76, P648, DOI 10.1189/jlb.0104023; Hansen LV, 2004, BIOCHEM J, V380, P845, DOI 10.1042/BJ20031478; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; HUBER K, 1984, J LAB CLIN MED, V103, P684; Jendroszek A, 2017, THROMB HAEMOSTASIS, V117, P1688, DOI 10.1160/TH17-02-0102; Jing YQ, 2017, MOL CANCER RES, V15, P1410, DOI 10.1158/1541-7786.MCR-17-0016; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; Kriegbaum MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25833; Kurbegovic S, 2018, BIOCONJUGATE CHEM, V29, P3833, DOI 10.1021/acs.bioconjchem.8b00669; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; Liu DG, 2017, BIOCHEMISTRY-US, V56, P1768, DOI 10.1021/acs.biochem.6b01039; Liu SH, 2017, ONCOTARGET, V8, P65123, DOI 10.18632/oncotarget.17729; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lund IK, 2011, CURR DRUG TARGETS, V12, P1744; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Merino P, 2017, J BIOL CHEM, V292, P2741, DOI 10.1074/jbc.M116.761650; Mertens HDT, 2012, J BIOL CHEM, V287, P34304, DOI 10.1074/jbc.M112.398404; Mevorach D, 2015, MOL IMMUNOL, V67, P51, DOI 10.1016/j.molimm.2015.03.005; Pawlak J, 2006, J BIOL CHEM, V281, P29030, DOI 10.1074/jbc.M605850200; Persson M, 2015, THERANOSTICS, V5, P1303, DOI 10.7150/thno.12956; Persson M, 2013, THERANOSTICS, V3, P618, DOI 10.7150/thno.6810; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petranka J, 1996, BLOOD CELL MOL DIS, V22, P281, DOI 10.1006/bcmd.1996.0111; Pilbeam Kristy, 2018, Oncotarget, V9, P11938, DOI 10.18632/oncotarget.21187; Plengpanich W, 2014, J BIOL CHEM, V289, P19491, DOI 10.1074/jbc.M114.558528; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; PLOUG M, 1993, J BIOL CHEM, V268, P17539; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Ploug M, 2013, THERANOSTICS, V3, P467, DOI 10.7150/thno.3791; Rubinstein R, 2008, BIOINFORMATICS, V24, P498, DOI 10.1093/bioinformatics/btm637; Rullo AF, 2016, ANGEW CHEM INT EDIT, V55, P3642, DOI 10.1002/anie.201510866; Seeds N, 2011, CELL MOL NEUROBIOL, V31, P961, DOI 10.1007/s10571-011-9701-6; Sunagar K, 2013, TOXINS, V5, P2172, DOI 10.3390/toxins5112172; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thornton S, 2017, BLOOD ADV, V1, P545, DOI 10.1182/bloodadvances.2016004002; Trelle MB, 2017, ANAL CHEM, V89, P616, DOI 10.1021/acs.analchem.6b02518; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wada T, 2015, CLIN KIDNEY J, V8, P708, DOI 10.1093/ckj/sfv090; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Wiersinga WJ, 2010, J IMMUNOL, V184, P3079, DOI 10.4049/jimmunol.0901008; Wong JWH, 2011, MOL BIOL EVOL, V28, P327, DOI 10.1093/molbev/msq194; Xu D, 2017, CHEMMEDCHEM, V12, P1794, DOI 10.1002/cmdc.201700572; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058; Zhao BY, 2015, J MOL BIOL, V427, P1389, DOI 10.1016/j.jmb.2015.01.022	72	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7403	7418		10.1074/jbc.RA119.007847	http://dx.doi.org/10.1074/jbc.RA119.007847			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30894413	Green Published, hybrid			2022-12-28	WOS:000468402900026
J	Gupta, A; Marzinek, JK; Jefferies, D; Bond, PJ; Harryson, P; Wohland, T				Gupta, Anjali; Marzinek, Jan K.; Jefferies, Damien; Bond, Peter J.; Harryson, Pia; Wohland, Thorsten			The disordered plant dehydrin Lti30 protects the membrane during water-related stress by cross-linking lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane lipid; intrinsically disordered protein; histidine; lipid bilayer; fluorescence correlation spectroscopy (FCS); molecular dynamics; Diffusion; disorder; K-segments; Lti30; supported lipid bilayers	FLUORESCENCE CORRELATION SPECTROSCOPY; CATION-PI INTERACTIONS; PLASMA-MEMBRANE; DESICCATION TOLERANCE; ARABIDOPSIS-THALIANA; COLD-ACCLIMATION; MAIZE DHN1; METAL-ION; BINDING; CELL	Dehydrins are intrinsically disordered proteins, generally expressed in plants as a response to embryogenesis and water-related stress. Their suggested functions are in membrane stabilization and cell protection. All dehydrins contain at least one copy of the highly conserved K-segment, proposed to be a membrane-binding motif. The dehydrin Lti30 (Arabidopsis thaliana) is up-regulated during cold and drought stress conditions and comprises six K-segments, each with two adjacent histidines. Lti30 interacts with the membrane electrostatically via pH-dependent protonation of the histidines. In this work, we seek a molecular understanding of the membrane interaction mechanism of Lti30 by determining the diffusion and molecular organization of Lti30 on model membrane systems by imaging total internal reflection- fluorescence correlation spectroscopy (ITIR-FCS) and molecular dynamics (MD) simulations. The dependence of the diffusion coefficient explored by ITIR-FCS together with MD simulations yields insights into Lti30 binding, domain partitioning, and aggregation. The effect of Lti30 on membrane lipid diffusion was studied on fluorescently labeled supported lipid bilayers of different lipid compositions at mechanistically important pH conditions. In parallel, we compared the mode of diffusion for short individual K-segment peptides. The results indicate that Lti30 binds the lipid bilayer via electrostatics, which restricts the mobility of lipids and bound protein molecules. At low pH, Lti30 binding induced lipid microdomain formation as well as protein aggregation, which could be correlated with one another. Moreover, at physiological pH, Lti30 forms nanoscale aggregates when proximal to the membrane suggesting that Lti30 may protect the cell by cross-linking the membrane lipids.	[Gupta, Anjali; Wohland, Thorsten] Natl Univ Singapore, Ctr BioImaging Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Gupta, Anjali; Bond, Peter J.; Wohland, Thorsten] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Marzinek, Jan K.; Jefferies, Damien; Bond, Peter J.] ASTAR, Bioinformat Inst, 30 Biopolis St,07-01 Matrix, Singapore 138671, Singapore; [Jefferies, Damien] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England; [Harryson, Pia] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Wohland, Thorsten] Natl Univ Singapore, Dept Chem, 3 Sci Dr 3, Singapore 117543, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); University of Southampton; Stockholm University; National University of Singapore	Wohland, T (corresponding author), Natl Univ Singapore, Ctr BioImaging Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Wohland, T (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Harryson, P (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.; Wohland, T (corresponding author), Natl Univ Singapore, Dept Chem, 3 Sci Dr 3, Singapore 117543, Singapore.	pia.harryson@dbb.su.se; twohland@nus.edu.sg	Gupta, Anjali/HCH-5986-2022	Gupta, Anjali/0000-0002-9860-6312; Marzinek, Jan/0000-0002-5493-8753; Bond, Peter/0000-0003-2900-098X	National University of Singapore [MOE2016-T2-2-121]; Ministry of Education of Singapore	National University of Singapore(National University of Singapore); Ministry of Education of Singapore(Ministry of Education, Singapore)	Recipient of a research scholarship from the National University of Singapore.; Recipient of Grant MOE2016-T2-2-121 from the Ministry of Education of Singapore.	Abusharkh SE, 2014, LANGMUIR, V30, P12897, DOI 10.1021/la502654j; Bag N, 2014, BBA-BIOMEMBRANES, V1838, P802, DOI 10.1016/j.bbamem.2013.10.009; Bag N, 2012, CHEMPHYSCHEM, V13, P2784, DOI 10.1002/cphc.201200032; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Castillo N, 2013, CHEM PHYS LIPIDS, V169, P95, DOI 10.1016/j.chemphyslip.2013.02.001; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Chibowski E, 2016, ADSORPTION, V22, P755, DOI 10.1007/s10450-016-9767-z; Clarke MW, 2015, J BIOL CHEM, V290, P26900, DOI 10.1074/jbc.M115.678219; CROWE LM, 1992, ADV SPACE RES-SERIES, V12, P239, DOI 10.1016/0273-1177(92)90178-Z; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; Disalvo EA, 2008, BBA-BIOMEMBRANES, V1778, P2655, DOI 10.1016/j.bbamem.2008.08.025; Du QS, 2008, J MOL GRAPH MODEL, V27, P140, DOI 10.1016/j.jmgm.2008.03.008; Engerer LK, 2011, J ORG CHEM, V76, P42, DOI 10.1021/jo101307z; Eriksson S, 2016, PLANT PHYSIOL, V171, P932, DOI 10.1104/pp.15.01531; Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Goers J, 2003, PROTEIN SCI, V12, P702, DOI 10.1110/ps.0230903; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Hara M, 2001, J PLANT PHYSIOL, V158, P1333, DOI 10.1078/0176-1617-00600; Hara M, 2009, PLANT CELL ENVIRON, V32, P532, DOI 10.1111/j.1365-3040.2009.01947.x; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou QC, 2016, PLANT CELL ENVIRON, V39, P1029, DOI 10.1111/pce.12666; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Koldso H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003911; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Lucero A, 2008, J PHYS CHEM B, V112, P7651, DOI 10.1021/jp8013157; MAKINO K, 1991, BIOPHYS CHEM, V41, P175, DOI 10.1016/0301-4622(91)80017-L; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Mouillon JM, 2008, PLANT PHYSIOL, V148, P1925, DOI 10.1104/pp.108.124099; Nachbar M, 2017, J PLANT PHYSIOL, V216, P219, DOI 10.1016/j.jplph.2017.06.006; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; O'Leary EI, 2018, J BIOL CHEM, V293, P11195, DOI 10.1074/jbc.RA118.002780; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Priyakumar UD, 2004, TETRAHEDRON, V60, P3037, DOI 10.1016/j.tet.2004.01.086; Puhakainen T, 2004, PLANT MOL BIOL, V54, P743, DOI 10.1023/B:PLAN.0000040903.66496.a4; Remko M, 2006, J PHYS CHEM A, V110, P1960, DOI 10.1021/jp054119b; Sankaran J, 2013, ANAL CHEM, V85, P3948, DOI 10.1021/ac303485t; Sankaran J, 2010, OPT EXPRESS, V18, P25468, DOI 10.1364/OE.18.025468; Sharma KK, 2019, PROG BIOPHYS MOL BIO, V143, P38, DOI 10.1016/j.pbiomolbio.2018.09.001; Sierra MB, 2016, COLLOID SURFACE B, V142, P199, DOI 10.1016/j.colsurfb.2016.02.061; SIMON EW, 1974, NEW PHYTOL, V73, P377, DOI 10.1111/j.1469-8137.1974.tb02118.x; Sirois S, 2003, J COMPUT CHEM, V24, P1110, DOI 10.1002/jcc.10176; STEPONKUS PL, 1989, J BIOENERG BIOMEMBR, V21, P21, DOI 10.1007/BF00762210; SUGAWARA Y, 1990, Cryobiology, V27, P667; Svensson J, 2000, PROTEIN EXPRES PURIF, V20, P169, DOI 10.1006/prep.2000.1297; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; Wawrezinieck L, 2005, BIOPHYS J, V89, P4029, DOI 10.1529/biophysj.105.067959	56	17	17	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6468	6482		10.1074/jbc.RA118.007163	http://dx.doi.org/10.1074/jbc.RA118.007163			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30819802	Green Published, hybrid			2022-12-28	WOS:000468402000023
J	Jean, L; Brimijoin, S; Vaux, DJ				Jean, Letitia; Brimijoin, Stephen; Vaux, David J.			In vivo localization of human acetylcholinesterase-derived species in a -sheet conformation at the core of senile plaques in Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; acetylcholinesterase (AChE); proteolysis; brain; amyloid-beta (AB); beta-sheet conformation; oligomerization domain; seeding; senile plaques; transgenic mice	BETA-AMYLOID PEPTIDES; BRAIN ACETYLCHOLINESTERASE; OLFACTORY DYSFUNCTION; PERIPHERAL SITE; MOLECULAR-FORMS; MOUSE MODEL; PROTEIN; PRECURSOR; BUTYRYLCHOLINESTERASE; AGGREGATION	Many neurodegenerative diseases are characterized by amyloid deposition. In Alzheimer's disease (AD), -amyloid (A) peptides accumulate extracellularly in senile plaques. The AD amyloid cascade hypothesis proposes that A production or reduced clearance leads to toxicity. In contrast, the cholinergic hypothesis argues for a specific pathology of brain cholinergic pathways. However, neither hypothesis in isolation explains the pattern of AD pathogenesis. Evidence suggests that a connection exists between these two scenarios: the synaptic form of human acetylcholinesterase (hAChE-S) associates with plaques in AD brains; among hAChE variants, only hAChE-S enhances A fibrillization in vitro and A deposition and toxicity in vivo. Only hAChE-S contains an amphiphilic C-terminal domain (T40, AChE(575-614)), with AChE(586-599) homologous to A and forming amyloid fibrils, which implicates T40 in AD pathology. We previously showed that the amyloid scavenger, insulin-degrading enzyme (IDE), generates T40-derived amyloidogenic species that, as a peptide mixture, seed A fibrillization. Here, we characterized 11 peptides from a T40-IDE digest for -sheet conformation, surfactant activity, fibrillization, and seeding capability. We identified residues important for amyloidogenicity and raised polyclonal antibodies against the most amyloidogenic peptide. These new antisera, alongside other specific antibodies, labeled sections from control, hAChE-S, hAPPswe, and hAChE-S/hAPPswe transgenic mice. We observed that hAChE-S -sheet species co-localized with A in mature plaque cores, surrounded by hAChE-S -helical species. This observation provides the first in vivo evidence of the conformation of hAChE-S species within plaques. Our results may explain the role of hAChE-S in A deposition and aggregation, as amyloidogenic hAChE-S -sheet species might seed A aggregation.	[Jean, Letitia; Vaux, David J.] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England; [Brimijoin, Stephen] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA	University of Oxford; Mayo Clinic	Vaux, DJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England.	david.vaux@path.ox.ac.uk		Jean, Letitia/0000-0002-6450-7148; Vaux, David/0000-0002-4901-9795	Synaptica Ltd.	Synaptica Ltd.	Supported by a research grant from Synaptica Ltd.	Alvarez A, 1998, J NEUROSCI, V18, P3213; Alvarez A, 1997, J MOL BIOL, V272, P348, DOI 10.1006/jmbi.1997.1245; Apelt J, 2002, BRAIN RES, V953, P17, DOI 10.1016/S0006-8993(02)03262-6; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; ATACK JR, 1983, NEUROSCI LETT, V40, P199, DOI 10.1016/0304-3940(83)90302-6; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; BAKER HF, 1993, INT J EXP PATHOL, V74, P441; Beeri R, 1997, J NEUROCHEM, V69, P2441; BEERI R, 1995, CURR BIOL, V5, P1063, DOI 10.1016/S0960-9822(95)00211-9; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Berson A, 2010, RAMBAM MAIMONIDES ME, V1, DOI 10.5041/RMMJ.10014; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Bronfman FC, 2000, NEUROBIOL DIS, V7, P152, DOI 10.1006/nbdi.2000.0283; CARSON KA, 1991, BRAIN RES, V540, P204, DOI 10.1016/0006-8993(91)90508-S; Chi EY, 2010, BIOPHYS J, V98, P2299, DOI 10.1016/j.bpj.2010.01.056; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Christen-Zaech S, 2003, CAN J NEUROL SCI, V30, P20, DOI 10.1017/S0317167100002389; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Cottingham MG, 2004, LAB INVEST, V84, P523, DOI 10.1038/labinvest.3700054; Cottingham MG, 2003, BIOCHEMISTRY-US, V42, P10863, DOI 10.1021/bi034768i; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Darvesh S, 2012, J NEUROPATH EXP NEUR, V71, P2, DOI 10.1097/NEN.0b013e31823cc7a6; Diamant S, 2006, P NATL ACAD SCI USA, V103, P8628, DOI 10.1073/pnas.0602922103; Dubois B, 2015, ALZHEIMERS DEMENT, V11, P1041, DOI 10.1016/j.jalz.2014.10.003; Dumont M, 2006, J NEURAL TRANSM, V113, P1225, DOI 10.1007/s00702-005-0373-6; Esparza TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38187; Farchi N, 2007, NEURODEGENER DIS, V4, P171, DOI 10.1159/000101842; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FISHMAN EB, 1986, ANN NEUROL, V19, P246, DOI 10.1002/ana.410190305; Fodero LR, 2002, J NEUROCHEM, V81, P441, DOI 10.1046/j.1471-4159.2002.00902.x; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Franks KH, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00234; GEULA C, 1989, BRAIN RES, V498, P185, DOI 10.1016/0006-8993(89)90419-8; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu W, 2003, J NEUROCHEM, V86, P470, DOI 10.1046/j.1471-4159.2003.01855.x; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Jean L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000652; Jean L, 2012, BIOPHYS J, V102, P1154, DOI 10.1016/j.bpj.2012.01.041; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; Jiang DL, 2009, J PHYS CHEM B, V113, P3160, DOI 10.1021/jp8085792; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; Kolisnyk B, 2017, CEREB CORTEX, V27, P3553, DOI 10.1093/cercor/bhw177; Kovacs T, 2004, AGEING RES REV, V3, P215, DOI 10.1016/j.arr.2003.10.003; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; LIAO J, 1994, J NEUROCHEM, V63, P1446; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; Madhusudan A, 2009, EUR J NEUROSCI, V30, P1064, DOI 10.1111/j.1460-9568.2009.06884.x; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; MORAN MA, 1993, ACTA NEUROPATHOL, V85, P362, DOI 10.1007/BF00334445; Morinaga A, 2010, BBA-PROTEINS PROTEOM, V1804, P986, DOI 10.1016/j.bbapap.2010.01.012; Morris VK, 2011, J BIOL CHEM, V286, P15955, DOI 10.1074/jbc.M110.214197; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; Rees Tina M., 2005, Current Alzheimer Research, V2, P291, DOI 10.2174/1567205054367847; Saez-Valero J, 1999, J NEUROCHEM, V72, P1600, DOI 10.1046/j.1471-4159.1999.721600.x; Saez-Valero J, 2003, BRAIN RES, V965, P283, DOI 10.1016/S0006-8993(02)04159-8; Saxena A, 2003, BIOCHEMISTRY-US, V42, P15292, DOI 10.1021/bi030150x; Sberna G, 1998, J NEUROCHEM, V71, P723; SCHEGG KM, 1992, NEUROBIOL AGING, V13, P697, DOI 10.1016/0197-4580(92)90092-C; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; SMITH CK, 1995, SCIENCE, V270, P980, DOI 10.1126/science.270.5238.980; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sternfeld M, 2000, P NATL ACAD SCI USA, V97, P8647, DOI 10.1073/pnas.140004597; ULRICH J, 1990, ACTA NEUROPATHOL, V80, P624, DOI 10.1007/BF00307630; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; WRIGHT CI, 1993, ANN NEUROL, V34, P373, DOI 10.1002/ana.410340312; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Zanuy D, 2004, PHYS BIOL, V1, P89, DOI 10.1088/1478-3967/1/2/005	85	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6253	6272		10.1074/jbc.RA118.006230	http://dx.doi.org/10.1074/jbc.RA118.006230			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30787102	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000468402000005
J	Sun, M; Kotler, JLM; Liu, SS; Street, TO				Sun, Ming; Kotler, Judy L. M.; Liu, Shanshan; Street, Timothy O.			The endoplasmic reticulum (ER) chaperones BiP and Grp94 selectively associate when BiP is in the ADP conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heat shock protein 90 (Hsp90); chaperone; nucleotide; fluorescence resonance energy transfer (FRET); fluorescence anisotropy; nuclear magnetic resonance (NMR); allostery; BiP; Grp94; structural dynamics	SUBSTRATE TRANSFER; COOPERATIVE ACTION; HSP90; PROTEIN; HSP70; P53; COMPLEXES; REVEALS; PARALOG; DOMAIN	Hsp70 and Hsp90 chaperones are critical for protein quality control in the cytosol, whereas organelle-specific Hsp70/Hsp90 paralogs provide similar protection for mitochondria and the endoplasmic reticulum (ER). Cytosolic Hsp70/Hsp90 can operate sequentially with Hsp90 selectively associating with Hsp70 after Hsp70 is bound to a client protein. This observation has long suggested that Hsp90 could have a preference for interacting with clients at their later stages of folding. However, recent work has shown that cytosolic Hsp70/Hsp90 can directly interact even in the absence of a client, which opens up an alternative possibility that the ordered interactions of Hsp70/Hsp90 with clients could be a consequence of regulated changes in the direct interactions between Hsp70 and Hsp90. However, it is unknown how such regulation could occur mechanistically. Here, we find that the ER Hsp70/Hsp90 (BiP/Grp94) can form a direct complex in the absence of a client. Importantly, the direct interaction between BiP and Grp94 is nucleotide-specific, with BiP and Grp94 having higher affinity under ADP conditions and lower affinity under ATP conditions. We show that this nucleotide-specific association between BiP and Grp94 is largely due to the conformation of BiP. When BiP is in the ATP conformation its substrate-binding domain blocks Grp94; in contrast, Grp94 can readily associate with the ADP conformation of BiP, which represents the client-bound state of BiP. Our observations provide a mechanism for the sequential involvement of BiP and Grp94 in client folding where the conformation of BiP provides the signal for the subsequent recruitment of Grp94.	[Sun, Ming; Kotler, Judy L. M.; Liu, Shanshan; Street, Timothy O.] Brandeis Univ, Dept Biochem, Waltham, MA 02453 USA; [Liu, Shanshan] Wuhan Univ, Inst Adv Studies, Wuhan 430072, Hubei, Peoples R China	Brandeis University; Wuhan University	Street, TO (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02453 USA.	tstreet@brandeis.edu			NIGMS, National Institutes of Health [R01 GM115356]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115356] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM115356. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvira S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6484; CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Fersht A., 1999, STRUCTURE MECH PROTE, P127; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Genest O, 2015, J MOL BIOL, V427, P3877, DOI 10.1016/j.jmb.2015.10.010; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; Halpin JC, 2016, J BIOL CHEM, V291, P6447, DOI 10.1074/jbc.M115.702928; Huck JD, 2017, CELL REP, V20, P2800, DOI 10.1016/j.celrep.2017.08.079; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kravats AN, 2018, P NATL ACAD SCI USA, V115, pE2210, DOI 10.1073/pnas.1719969115; Kravats AN, 2017, J MOL BIOL, V429, P858, DOI 10.1016/j.jmb.2016.12.014; Liu SS, 2016, PROTEIN SCI, V25, P2209, DOI 10.1002/pro.3049; Luengo TM, 2018, MOL CELL, V70, P545, DOI 10.1016/j.molcel.2018.03.028; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; MELNICK J, 1992, J BIOL CHEM, V267, P21303; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nakamoto H, 2014, J BIOL CHEM, V289, P6110, DOI 10.1074/jbc.M113.524801; Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.08961; Radli M, 2018, J MOL BIOL, V430, P3029, DOI 10.1016/j.jmb.2018.05.026; Rohl A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7655; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Schumacher RJ, 1996, BIOCHEMISTRY-US, V35, P14889, DOI 10.1021/bi961825h; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Sung N, 2016, ACTA CRYSTALLOGR D, V72, P904, DOI 10.1107/S2059798316009906; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Yang J, 2015, STRUCTURE, V23, P2191, DOI 10.1016/j.str.2015.10.012	39	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6387	6396		10.1074/jbc.RA118.007050	http://dx.doi.org/10.1074/jbc.RA118.007050			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30787103	Green Published, hybrid			2022-12-28	WOS:000468402000016
J	Zhang, SH; Liu, DX; Wang, L; Li, YH; Wang, YH; Zhang, H; Su, ZK; Fang, WG; Qin, XX; Shang, DS; Li, B; Han, XN; Zhao, WD; Chen, YH				Zhang, Shu-Hong; Liu, Dong-Xin; Wang, Li; Li, Yu-Hua; Wang, Yan-Hua; Zhang, Hu; Su, Zheng-Kang; Fang, Wen-Gang; Qin, Xiao-Xue; Shang, De-Shu; Li, Bo; Han, Xiao-Ning; Zhao, Wei-Dong; Chen, Yu-Hua			A CASPR1-ATP1B3 protein interaction modulates plasma membrane localization of Na+/K+-ATPase in brain microvascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Na; K plus -ATPase; brain; endothelial cell; endoplasmic reticulum (ER); glutamate; ATP1B3; blood-brain barrier; contactin-associated protein 1 (CASPR1); CNS homeostasis; CNTNAP1	NA-K-ATPASE; ENDOPLASMIC-RETICULUM; PARANODAL JUNCTIONS; NA,K-ATPASE; GLUTAMATE; BARRIER; EXPRESSION; RECEPTOR; CASPR; IDENTIFICATION	Contactin-associated protein 1 (CASPR1 or CNTNAP1) was recently reported to be expressed in brain microvascular endothelial cells (BMECs), the major component of the blood-brain barrier. To investigate CASPR1's physiological role in BMECs, here we used CASPR1 as a bait in a yeast two-hybrid screen to identify CASPR1-interacting proteins and identified the 3 subunit of Na+/K+-ATPase (ATP1B3) as a CASPR1-binding protein. Using recombinant and purified CASPR1, RNAi, GST-pulldown, immunofluorescence, immunoprecipitation, and Na+/K+-ATPase activity assays, we found that ATP1B3's core proteins, but not its glycosylated forms, interact with CASPR1, which was primarily located in the endoplasmic reticulum of BMECs. CASPR1 knockdown reduced ATP1B3 glycosylation and prevented its plasma membrane localization, phenotypes that were reversed by expression of full-length CASPR1. We also found that the CASPR1 knockdown reduces the plasma membrane distribution of the 1 subunit of Na+/K+-ATPase, which is the major component assembled with ATP1B3 in the complete Na+/K+-ATPase complex. The binding of CASPR1 with ATP1B3, but not the 1 subunit, indicated that CASPR1 binds with ATP1B3 to facilitate the assembly of Na+/K+-ATPase. Furthermore, the activity of Na+/K+-ATPase was reduced in CASPR1-silenced BMECs. Interestingly, shRNA-mediated CASPR1 silencing reduced glutamate efflux through the BMECs. These results demonstrate that CASPR1 binds with ATP1B3 and thereby contributes to the regulation of Na+/K+-ATPase maturation and trafficking to the plasma membrane in BMECs. We conclude that CASPR1-mediated regulation of Na+/K+-ATPase activity is important for glutamate transport across the blood-brain barrier.	[Zhang, Shu-Hong; Liu, Dong-Xin; Wang, Li; Li, Yu-Hua; Wang, Yan-Hua; Zhang, Hu; Su, Zheng-Kang; Fang, Wen-Gang; Qin, Xiao-Xue; Shang, De-Shu; Li, Bo; Han, Xiao-Ning; Zhao, Wei-Dong; Chen, Yu-Hua] China Med Univ, Minist Publ Hlth, Dept Dev Cell Biol, Key Lab Cell Biol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Zhang, Shu-Hong; Liu, Dong-Xin; Wang, Li; Li, Yu-Hua; Wang, Yan-Hua; Zhang, Hu; Su, Zheng-Kang; Fang, Wen-Gang; Qin, Xiao-Xue; Shang, De-Shu; Li, Bo; Han, Xiao-Ning; Zhao, Wei-Dong; Chen, Yu-Hua] China Med Univ, Minist Educ, Key Lab Med Cell Biol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Zhang, Shu-Hong] Jiamusi Univ, Sch Basic Med, Dept Cell Biol, 258 Xuefu St, Jiamusi 154007, Heilongjiang, Peoples R China	China Medical University; China Medical University; Jiamusi University	Zhao, WD; Chen, YH (corresponding author), China Med Univ, Minist Publ Hlth, Dept Dev Cell Biol, Key Lab Cell Biol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.; Zhao, WD; Chen, YH (corresponding author), China Med Univ, Minist Educ, Key Lab Med Cell Biol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	wdzhao@cmu.edu.cn; yhchen@cmu.edu.cn	wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yuan/HHC-1520-2022; wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; Wang, Yin/HCI-9352-2022; Wang, Yanbo/HFZ-8018-2022	li, Yuhua/0000-0002-9036-1920; Liu, Dongxin/0000-0002-0956-5142	National Natural Science Foundation of China [31771258, 31171291, 31571057, 81171537, 81201255, 31670845, 81671168]; National 1000 Plan Program; Innovation Team Program Foundation of the Ministry of Education of China [IRT13101, IRT_ 17R107]; Foundation of Liaoning Province [LT2011011, LR2012025, LS201609, LQNK201731]; Intramural Program of China Medical University [JQ20160002]; Program of Distinguished Professor of Liaoning Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 1000 Plan Program; Innovation Team Program Foundation of the Ministry of Education of China(Ministry of Education, China); Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); Intramural Program of China Medical University; Program of Distinguished Professor of Liaoning Province	This work was supported by National Natural Science Foundation of China Grants 31771258, 31171291, 31571057, 81171537, 81201255, 31670845, and 81671168; the National 1000 Plan Program; Innovation Team Program Foundation of the Ministry of Education of China Grants IRT13101 and IRT_ 17R107; the Program of Distinguished Professor of Liaoning Province; Foundation of Liaoning Province Grants LT2011011, LR2012025, LS201609, and LQNK201731; and Intramural Program of China Medical University Grant JQ20160002. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Beggah AT, 1997, J BIOL CHEM, V272, P10318; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; BLANCO G, 1994, J BIOL CHEM, V269, P23420; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Gillessen T, 2002, ADV EXP MED BIOL, V513, P3; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hunsberger HC, 2015, J NEUROCHEM, V132, P169, DOI 10.1111/jnc.12967; HUTCHISON HT, 1985, EXP NEUROL, V87, P260, DOI 10.1016/0014-4886(85)90216-X; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Keaney J, 2015, FEBS J, V282, P4067, DOI 10.1111/febs.13412; Lian WN, 2006, J CELL SCI, V119, P11, DOI 10.1242/jcs.02706; Malik N, 1996, J BIOL CHEM, V271, P22754, DOI 10.1074/jbc.271.37.22754; MARKS MJ, 1978, LIFE SCI, V23, P2735, DOI 10.1016/0024-3205(78)90654-9; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; Murakami S, 2016, J PHYSIOL SCI, V66, P127, DOI 10.1007/s12576-015-0404-5; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Nishitsuji H, 2016, J BIOL CHEM, V291, P4754, DOI 10.1074/jbc.M115.679357; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Riordan M, 2005, AM J PHYSIOL-RENAL, V288, pF1236, DOI 10.1152/ajprenal.00438.2004; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Tokbtaeva E, 2010, BIOCHEMISTRY-US, V49, P3116, DOI 10.1021/bi100115a; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; VORBRODT AW, 1988, PROG HISTOCHEM CYTOC, V18, P1; Wolswijk G, 2003, BRAIN, V126, P1638, DOI 10.1093/brain/awg151; Zhang LN, 2013, FUND CLIN PHARMACOL, V27, P96, DOI 10.1111/fcp.12000; Zhao WD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04637-3; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	44	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6375	6386		10.1074/jbc.RA118.006263	http://dx.doi.org/10.1074/jbc.RA118.006263			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30792309	hybrid, Green Published			2022-12-28	WOS:000468402000015
J	Deng, WT; Fernandez, A; McLaughlin, SL; Klinke, DJ				Deng, Wentao; Fernandez, Audry; McLaughlin, Sarah L.; Klinke, David J.			WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						melanoma; metastasis; invasion; epithelial-mesenchymal transition (EMT); tumor microenvironment; cancer; Wnt signaling; AKT signaling; secreted protein; WNT1-inducible signaling pathway protein 1 (WISP1; CCN4)	INDUCED SECRETED PROTEIN-1; SQUAMOUS-CELL CARCINOMA; TISSUE GROWTH-FACTOR; CCN FAMILY; STROMAL FIBROBLASTS; EXPRESSION; CANCER; WISP-1; ACTIVATION; REGULATOR	Besides intrinsic changes, malignant cells also release soluble signals that reshape their microenvironment. Among these signals is WNT1-inducible signaling pathway protein 1 (WISP1), a secreted matricellular protein whose expression is elevated in several cancers, including melanoma, and is associated with reduced survival of patients diagnosed with primary melanoma. Here, we found that WISP1 knockout increases cell proliferation and represses wound healing, migration, and invasion of mouse and human melanoma cells in multiple in vitro assays. Metastasis assays revealed that WISP1 knockout represses tumor metastasis of B16F10 and YUMM1.7 melanoma cells in both C57BL/6Ncrl and NOD-scid IL2R(null) (NSG) mice. WT B16F10 cells having an invasion phenotype in a transwell assay possessed a gene expression signature similar to that observed in the epithelial-mesenchymal transition (EMT), including E-cadherin repression and fibronectin and N-cadherin induction. Upon WISP1 knockout, expression of these EMT signature genes went in the opposite direction in both mouse and human cell lines, and EMT-associated gene expression was restored upon exposure to media containing WISP1 or to recombinant WISP1 protein. In vivo, Wisp1 knockout-associated metastasis repression was reversed by the reintroduction of either WISP1 or snail family transcriptional repressor 1 (SNAI1). Experiments testing EMT gene activation and inhibition with recombinant WISP1 or kinase inhibitors in B16F10 and YUMM1.7 cells suggested that WISP1 activates AKT Ser/Thr kinase and that MEK/ERK signaling pathways shift melanoma cells from proliferation to invasion. Our results indicate that WISP1 present within the tumor microenvironment stimulates melanoma invasion and metastasis by promoting an EMT-like process.	[Deng, Wentao; Fernandez, Audry; Klinke, David J.] West Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26505 USA; [Deng, Wentao; Fernandez, Audry; McLaughlin, Sarah L.; Klinke, David J.] West Virginia Univ, Canc Inst, Morgantown, WV 26505 USA; [McLaughlin, Sarah L.] West Virginia Univ, Anim Models & Imaging Facil, Morgantown, WV 26505 USA; [Klinke, David J.] West Virginia Univ, Dept Chem & Biomed Engn, Morgantown, WV 26505 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University	Klinke, DJ (corresponding author), West Virginia Univ, Dept Chem & Biomed Engn, POB 6102, Morgantown, WV 26506 USA.	david.klinke@mail.wvu.edu		Klinke, David/0000-0003-3299-4938; Fernandez Gomez, Audry/0000-0002-3436-625X; McLaughlin, Sarah/0000-0002-8413-3585	National Science Foundation [CBET-1644932]; NCI, National Institutes of Health [R01CA193473]; NATIONAL CANCER INSTITUTE [R01CA193473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488, U54GM104942] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant CBET-1644932 (to D. J. K.) and NCI, National Institutes of Health, Grant R01CA193473 (to D. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aladowicz E, 2013, FUTURE ONCOL, V9, P713, DOI [10.2217/fon.13.9, 10.2217/FON.13.9]; Bedogni B, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12194; Berschneider B, 2011, INT J BIOCHEM CELL B, V43, P306, DOI 10.1016/j.biocel.2010.11.013; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; Chiang KC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08686; Chuang JY, 2015, ONCOTARGET, V6, P4239, DOI 10.18632/oncotarget.2978; Chuang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078022; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Damsky WE, 2014, ONCOGENE, V33, P2413, DOI 10.1038/onc.2013.194; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Denecker G, 2014, CELL DEATH DIFFER, V21, P1250, DOI 10.1038/cdd.2014.44; Deng WT, 2017, ANALYST, V142, P2945, DOI 10.1039/c7an00623c; Deng WT, 2015, J CELL SCI, V128, P1123, DOI 10.1242/jcs.162164; French DM, 2004, AM J PATHOL, V165, P855, DOI 10.1016/S0002-9440(10)63348-2; Golan T, 2015, MOL CELL, V59, P664, DOI 10.1016/j.molcel.2015.06.028; Gurbuz I, 2015, INT J BIOCHEM CELL B, V62, P142, DOI 10.1016/j.biocel.2015.03.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto Y, 1998, J EXP MED, V187, P289, DOI 10.1084/jem.187.3.289; Heise RL, 2011, J BIOL CHEM, V286, P17435, DOI 10.1074/jbc.M110.137273; Herlyn M, 2010, J INVEST DERMATOL, V130, P911, DOI 10.1038/jid.2009.441; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hou CH, 2011, BIOCHEM PHARMACOL, V81, P1286, DOI 10.1016/j.bcp.2011.03.016; Howard JD, 2013, PIGM CELL MELANOMA R, V26, P697, DOI 10.1111/pcmr.12131; Inkson CA, 2008, J CELL BIOCHEM, V104, P1865, DOI 10.1002/jcb.21754; Jia SQ, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317699755; Jing D, 2017, INT J ONCOL, V51, P1261, DOI 10.3892/ijo.2017.4119; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kaur A, 2016, NATURE, V532, P250, DOI 10.1038/nature17392; Klinke DJ, 2015, MOL BIOL CELL, V26, P4135, DOI 10.1091/mbc.E15-02-0083; Klinke DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003409; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Kulkarni YM, 2012, INTEGR BIOL-UK, V4, P925, DOI 10.1039/c2ib20053h; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lau LF, 2016, J CELL COMMUN SIGNAL, V10, P121, DOI 10.1007/s12079-016-0324-z; Lee JT, 2007, J CELL BIOCHEM, V101, P862, DOI 10.1002/jcb.21204; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Liu YD, 2018, INT IMMUNOPHARMACOL, V59, P375, DOI 10.1016/j.intimp.2018.04.033; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Lu S, 2016, EUR J PHARMACOL, V788, P90, DOI 10.1016/j.ejphar.2016.06.027; Maeda A, 2015, J BIOL CHEM, V290, P14004, DOI 10.1074/jbc.M114.628818; Meeth K, 2016, PIGM CELL MELANOMA R, V29, P590, DOI 10.1111/pcmr.12498; Nagai Y, 2011, ANTICANCER RES, V31, P991; Ono M, 2018, MATRIX BIOL, V68-69, P533, DOI 10.1016/j.matbio.2018.01.004; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perbal B, 2018, J CELL COMMUN SIGNAL, V12, P625, DOI 10.1007/s12079-018-0491-1; Rosano L, 2013, NAT REV CANCER, V13, P637, DOI 10.1038/nrc3546; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schlegelmilch K, 2014, GENE, V551, P243, DOI 10.1016/j.gene.2014.09.002; Shao H, 2011, ONCOGENE, V30, P4316, DOI 10.1038/onc.2011.142; Shao HW, 2016, ONCOTARGET, V7, P79248, DOI 10.18632/oncotarget.13021; Soon LL, 2003, J BIOL CHEM, V278, P11465, DOI 10.1074/jbc.M210945200; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spranger S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1086862; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stephens S, 2015, J CELL COMMUN SIGNAL, V9, P63, DOI 10.1007/s12079-015-0267-9; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tanaka S, 2003, HEPATOLOGY, V37, P1122, DOI 10.1053/jhep.2003.50187; Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vandamme N, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00352; Venkatesan B, 2010, CELL SIGNAL, V22, P809, DOI 10.1016/j.cellsig.2010.01.005; Wang SH, 2012, CURR NEUROVASC RES, V9, P20, DOI 10.2174/156720212799297137; Webster MR, 2015, BBA-REV CANCER, V1856, P244, DOI 10.1016/j.bbcan.2015.10.002; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Wu CL, 2013, CELL SIGNAL, V25, P2812, DOI 10.1016/j.cellsig.2013.09.005; Xu LF, 2000, GENE DEV, V14, P585; Xue GD, 2016, CANCER TREAT REV, V49, P1, DOI 10.1016/j.ctrv.2016.06.009; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoshioka Y, 2016, BONE, V83, P162, DOI 10.1016/j.bone.2015.11.007; Zhang HF, 2015, ONCOTARGET, V6, P6218, DOI 10.18632/oncotarget.3358; Zhang XQ, 2015, AM J CANCER RES, V5, P2344; Zhou LL, 2015, J CANCER, V6, P717, DOI 10.7150/jca.10865	77	26	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5261	5280		10.1074/jbc.RA118.006122	http://dx.doi.org/10.1074/jbc.RA118.006122			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30723155	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000464517500003
J	Ponzini, E; De Palma, A; Cerboni, L; Natalello, A; Rossi, R; Moons, R; Konijnenberg, A; Narkiewicz, J; Legname, G; Sobott, F; Mauri, P; Santambrogio, C; Grandori, R				Ponzini, Erika; De Palma, Antonella; Cerboni, Lucilla; Natalello, Antonino; Rossi, Rossana; Moons, Rani; Konijnenberg, Albert; Narkiewicz, Joanna; Legname, Giuseppe; Sobott, Frank; Mauri, PierLuigi; Santambrogio, Carlo; Grandori, Rita			Methionine oxidation in -synuclein inhibits its propensity for ordered secondary structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (-synuclein); dopamine; amyloid; mass spectrometry (MS); circular dichroism (CD); Fourier transform IR (FTIR); neurodegenerative disease; epigallocatechin-3-gallate; ion mobility (IM); methionine oxidation	ALPHA-SYNUCLEIN; INFRARED-SPECTROSCOPY; DOPAMINE; INSIGHTS; AGGREGATION; MECHANISMS; SULFOXIDE; REGULATOR; OLIGOMERS; TOXICITY	alpha-Synuclein (AS) is an intrinsically disordered protein highly expressed in dopaminergic neurons. Its amyloid aggregates are the major component of Lewy bodies, a hallmark of Parkinson's disease (PD). AS is particularly exposed to oxidation of its methionine residues, both in vivo and in vitro. Oxidative stress has been implicated in PD and oxidized -synuclein has been shown to assemble into soluble, toxic oligomers, rather than amyloid fibrils. However, the structural effects of methionine oxidation are still poorly understood. In this work, oxidized AS was obtained by prolonged incubations with dopamine (DA) or epigallocatechin-3-gallate (EGCG), two inhibitors of AS aggregation, indicating that EGCG promotes the same final oxidation product as DA. The conformational transitions of the oxidized and non-oxidized protein were monitored by complementary biophysical techniques, including MS, ion mobility (IM), CD, and FTIR spectroscopy assays. Although the two variants displayed very similar structures under conditions that stabilize highly disordered or highly ordered states, differences emerged in the intermediate points of transitions induced by organic solvents, such as trifluoroethanol (TFE) and methanol (MeOH), indicating a lower propensity of the oxidized protein for forming either - or -type secondary structures. Furthermore, oxidized AS displayed restricted secondary-structure transitions in response to dehydration and slightly amplified tertiary-structure transitions induced by ligand binding. This difference in susceptibility to induced folding could explain the loss of fibrillation potential observed for oxidized AS. Finally, site-specific oxidation kinetics point out a minor delay in Met-127 modification, likely due to the effects of AS intrinsic structure.	[Ponzini, Erika; Cerboni, Lucilla; Natalello, Antonino; Santambrogio, Carlo; Grandori, Rita] Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy; [De Palma, Antonella; Rossi, Rossana; Mauri, PierLuigi] Natl Res Council Italy, Inst Biomed Technol, I-20090 Milan, Italy; [Moons, Rani; Konijnenberg, Albert; Sobott, Frank] Univ Antwerp, Biomol & Analyt Mass Spectrometry, Groenenborgerlaan 171, B-2020 Antwerp, Belgium; [Narkiewicz, Joanna; Legname, Giuseppe] SISSA, Dept Neurosci, I-34136 Trieste, Italy; [Narkiewicz, Joanna; Legname, Giuseppe] ELETTRA Sincrotrone Trieste SCpA, I-34136 Trieste, Italy; [Sobott, Frank] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Sobott, Frank] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Antwerp; International School for Advanced Studies (SISSA); Elettra Sincrotrone Trieste; University of Leeds; University of Leeds	Santambrogio, C; Grandori, R (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.	carlo.santambrogio@unimib.it; rita.grandori@unimib.it	Ponzini, Erika/X-9593-2019; Rossi, Rossana/H-9229-2018; De Palma, Antonella/K-8451-2016; Mauri, Pietro Luigi/AAC-3095-2019; Legname, Giuseppe/C-1723-2012; Santambrogio, Carlo/W-6070-2019; Natalello, Antonino/B-9659-2012	Ponzini, Erika/0000-0002-3103-740X; Rossi, Rossana/0000-0002-0313-7083; De Palma, Antonella/0000-0001-5937-8604; Mauri, Pietro Luigi/0000-0003-4364-0393; Legname, Giuseppe/0000-0003-0716-4393; Santambrogio, Carlo/0000-0003-3986-6971; Natalello, Antonino/0000-0002-1489-272X	Fondazione Regionale per la Ricerca Biomedica (FRRB-Regione Lombardia); University of MilanoBicocca (FAR -Fondo di Ateneo per la Ricerca); EU COST Action [BM1403]	Fondazione Regionale per la Ricerca Biomedica (FRRB-Regione Lombardia); University of MilanoBicocca (FAR -Fondo di Ateneo per la Ricerca); EU COST Action(European Cooperation in Science and Technology (COST))	This work was supported by the Fondazione Regionale per la Ricerca Biomedica (FRRB-Regione Lombardia), a grant from the University of MilanoBicocca (FAR -Fondo di Ateneo per la Ricerca), and the EU COST Action BM1403. The authors declare that they have no conflicts of interest with the contents of this article.	Ami Diletta, 2012, Methods Mol Biol, V895, P85, DOI 10.1007/978-1-61779-927-3_7; Ami D, 2012, BIOPHYS J, V102, P1676, DOI 10.1016/j.bpj.2012.02.045; Arakawa H, 2004, BIOL PHARM BULL, V27, P277, DOI 10.1248/bpb.27.277; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bengoa-Vergniory N, 2017, ACTA NEUROPATHOL, V134, P819, DOI 10.1007/s00401-017-1755-1; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Binolfi A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10251; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Carmo-Goncalves P, 2014, AMYLOID, V21, P163, DOI 10.3109/13506129.2014.912208; Coskuner O, 2013, ACS CHEM NEUROSCI, V4, P1549, DOI 10.1021/cn4001389; De Franceschi G, 2017, J BIOL CHEM, V292, P6927, DOI 10.1074/jbc.M116.765149; Devika PT, 2008, PHARMACOL RES, V57, P351, DOI 10.1016/j.phrs.2008.03.008; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hansel A, 2005, BBA-PROTEINS PROTEOM, V1703, P239, DOI 10.1016/j.bbapap.2004.09.010; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Kjaergaard M, 2010, PROTEIN SCI, V19, P1555, DOI 10.1002/pro.435; Konijnenberg A, 2016, ANAL CHEM, V88, P8468, DOI 10.1021/acs.analchem.6b00731; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latawiec D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009234; Lautenschlager J, 2017, TRENDS CELL BIOL, V27, P468, DOI 10.1016/j.tcb.2017.02.002; Legge FS, 2009, J PHYS CHEM B, V113, P14006, DOI 10.1021/jp903842u; Leong SL, 2009, NEUROCHEM RES, V34, P1838, DOI 10.1007/s11064-009-9986-8; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Maltsev AS, 2013, J AM CHEM SOC, V135, P2943, DOI 10.1021/ja312415q; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Nakaso K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055068; Natalello A, 2015, METHODS MOL BIOL, V1258, P347, DOI 10.1007/978-1-4939-2205-5_20; Natalello A, 2011, PROTEINS, V79, P611, DOI 10.1002/prot.22909; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Pivato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050027; Rekas A, 2010, EUR BIOPHYS J BIOPHY, V39, P1407, DOI 10.1007/s00249-010-0595-x; Rodriguez AR, 2013, BIOMACROMOLECULES, V14, P3610, DOI 10.1021/bm400971p; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Celej MS, 2012, BIOCHEM J, V443, P719, DOI 10.1042/BJ20111924; Spillantini MG, 2018, CELL TISSUE RES, V373, P137, DOI 10.1007/s00441-017-2706-9; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Vitali M, 2018, BBA-GEN SUBJECTS, V1862, P1556, DOI 10.1016/j.bbagen.2018.03.026; Zhou WB, 2010, BBA-MOL BASIS DIS, V1802, P322, DOI 10.1016/j.bbadis.2009.12.004	43	19	20	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5657	5665		10.1074/jbc.RA118.001907	http://dx.doi.org/10.1074/jbc.RA118.001907			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30755483	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000464517500033
J	Zhang, QM; Xiao, KH; Paredes, JM; Mamonova, T; Sneddon, WB; Liu, HD; Wang, DW; Li, S; McGarvey, JC; Uehling, D; Al-awar, R; Joseph, B; Jean-Alphonse, F; Orte, A; Friedman, PA				Zhang, Qiangmin; Xiao, Kunhong; Paredes, Jose M.; Mamonova, Tatyana; Sneddon, W. Bruce; Liu, Hongda; Wang, Dawei; Li, Sheng; McGarvey, Jennifer C.; Uehling, David; Al-awar, Rima; Joseph, Babu; Jean-Alphonse, Frederic; Orte, Angel; Friedman, Peter A.			Parathyroid hormone initiates dynamic NHERF1 phosphorylation cycling and conformational changes that regulate NPT2A-dependent phosphate transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PDZ domain; protein-protein interaction; protein phosphorylation; phosphoprotein phosphatase 1 (PP1); hydrogen-deuterium exchange; structural biology; NHERF1; NPT2A; phosphate transport	RENAL PROXIMAL TUBULES; POSTTRANSLATIONAL MODIFICATIONS; FACTOR-I; PROTEIN PHOSPHATASE-1; INTRINSIC DISORDER; STRUCTURAL BASIS; RECEPTOR; BINDING; EBP50; IIA	Na+-H+ exchanger regulatory factor-1 (NHERF1) is a PDZ protein that scaffolds membrane proteins, including sodium-phosphate co-transport protein 2A (NPT2A) at the plasma membrane. NHERF1 is a phosphoprotein with 40 Ser and Thr residues. Here, using tandem MS analysis, we characterized the sites of parathyroid hormone (PTH)-induced NHERF1 phosphorylation and identified 10 high-confidence phosphorylation sites. Ala replacement at Ser(46), Ser(162), Ser(181), Ser(269), Ser(280), Ser(291), Thr(293), Ser(299), and Ser(302) did not affect phosphate uptake, but S290A substitution abolished PTH-dependent phosphate transport. Unexpectedly, Ser(290) was rapidly dephosphorylated and rephosphorylated after PTH stimulation, and we found that protein phosphatase 1 (PP1), which binds NHERF1 through a conserved VxF/W PP1 motif, dephosphorylates Ser(290). Mutating (VPF259)-V-257 eliminated PP1 binding and blunted dephosphorylation. Tautomycetin blocked PP1 activity and abrogated PTH-sensitive phosphate transport. Using fluorescence lifetime imaging (FLIM), we observed that PTH paradoxically and transiently elevates intracellular phosphate. Added phosphate blocked PP1-mediated Ser(290) dephosphorylation of recombinant NHERF1. Hydrogen-deuterium exchange MS revealed that -sheets in NHERF1's PDZ2 domain display lower deuterium uptake than those in the structurally similar PDZ1, implying that PDZ1 is more cloistered. Dephosphorylated NHERF1 exhibited faster exchange at C-terminal residues suggesting that NHERF1 dephosphorylation precedes Ser(290) rephosphorylation. Our results show that PP1 and NHERF1 form a holoenzyme and that a multiprotein kinase cascade involving G protein-coupled receptor kinase 6A controls the Ser(290) phosphorylation status of NHERF1 and regulates PTH-sensitive, NPT2A-mediated phosphate uptake. These findings reveal how reversible phosphorylation modifies protein conformation and function and the biochemical mechanisms underlying PTH control of phosphate transport.	[Zhang, Qiangmin; Xiao, Kunhong; Mamonova, Tatyana; Sneddon, W. Bruce; Liu, Hongda; Wang, Dawei; McGarvey, Jennifer C.; Jean-Alphonse, Frederic; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Xiao, Kunhong] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Xiao, Kunhong] Univ Pittsburgh, Sch Med, Biomed Mass Spectrometry Ctr, Pittsburgh, PA 15261 USA; [Paredes, Jose M.; Orte, Angel] Univ Granada, Fac Pharm, Dept Phys Chem, E-18071 Granada, Spain; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Uehling, David; Al-awar, Rima; Joseph, Babu] Ontario Inst Canc Res, Dept Drug Discovery, Toronto, ON M5G 0A3, Canada; [McGarvey, Jennifer C.] Sosei Heptares, Steinmetz Bldg,Granta Pk, Great Abington CB21 6GP, Cambs, England; [Jean-Alphonse, Frederic] INRA, Unite Physiol Reprod & Comportements PRC, UMR85, Biol & Bioinformat Syst Signalisat BIOS Grp, Nouzilly, France; [Jean-Alphonse, Frederic] CNRS, UMR7247, Nouzilly, France; [Jean-Alphonse, Frederic] Univ Tours, Tours, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Granada; University of California System; University of California San Diego; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Heptares Therapeutics Ltd.; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, E1356 Thomas E Starzl Biomed Sci Tower, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	M.Paredes, Jose/M-3494-2014; Orte, Angel/J-4810-2012; Xiao, Kunhong/AAG-4275-2020	M.Paredes, Jose/0000-0002-3252-9174; Orte, Angel/0000-0003-1905-4183; Xiao, Kunhong/0000-0002-1069-1226; JEAN-ALPHONSE, Frederic/0000-0002-7380-5825; Liu, Hongda/0000-0002-5977-9130	National Institutes of Health [DK105811, DK111427]; Spanish Ministry of Economy and Competitiveness [CTQ2014-56370-R]; Agencia Estatal de Investigacion (AEI); European Regional Development Fund (ERDF); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111427, R01DK105811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy and Competitiveness(Spanish Government); Agencia Estatal de Investigacion (AEI); European Regional Development Fund (ERDF)(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Awards DK105811 and DK111427 (to P. A. F.), Spanish Ministry of Economy and Competitiveness Grant CTQ2014-56370-R, the Agencia Estatal de Investigacion (AEI), and the European Regional Development Fund (ERDF) (to A. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrews LD, 2014, BIOCHEMISTRY-US, V53, P6811, DOI 10.1021/bi500765p; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Ba JM, 2003, AM J PHYSIOL-RENAL, V285, pF1233, DOI 10.1152/ajprenal.00249.2003; Bacic D, 2004, KIDNEY INT, V66, pS5, DOI 10.1111/j.1523-1755.2004.09102.x; Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Bertolotti A, 2018, BIOCHEM J, V475, P3707, DOI 10.1042/BCJ20170726; Bhattacharya S, 2010, J BIOL CHEM, V285, P9981, DOI 10.1074/jbc.M109.074005; BIBER J, 1990, METHOD ENZYMOL, V191, P494; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Broadbent D, 2017, ADV IMMUNOL, V136, P353, DOI 10.1016/bs.ai.2017.05.008; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Centonze M, 2018, TRANSL ONCOL, V11, P374, DOI 10.1016/j.tranon.2018.01.006; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Cheng H, 2009, STRUCTURE, V17, P660, DOI 10.1016/j.str.2009.03.009; Choy MS, 2017, J AM CHEM SOC, V139, P17703, DOI 10.1021/jacs.7b09368; Clinkenbeard EL, 2017, BONE, V102, P31, DOI 10.1016/j.bone.2017.01.034; Courbebaisse M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034764; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Darling AL, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00158; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Eisinger ML, 2017, P NATL ACAD SCI USA, V114, P11691, DOI 10.1073/pnas.1703422114; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Fouassier L, 2005, EXP CELL RES, V306, P264, DOI 10.1016/j.yexcr.2005.02.011; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; GESEK FA, 1992, J CLIN INVEST, V90, P749, DOI 10.1172/JCI115947; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; He JQ, 2001, J BIOL CHEM, V276, P41559, DOI 10.1074/jbc.M106859200; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Herrero-Foncubierta P, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18010161; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jiang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081904; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Khajeh JA, 2014, J MOL BIOL, V426, P2755, DOI 10.1016/j.jmb.2014.05.011; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kremer KN, 2015, J BIOL CHEM, V290, P29478, DOI 10.1074/jbc.M115.668160; Kumar GS, 2016, ELIFE, V5, DOI 10.7554/eLife.16539; Lederer E, 2019, PFLUG ARCH EUR J PHY, V471, P137, DOI 10.1007/s00424-018-2246-5; Li JQ, 2007, J BIOL CHEM, V282, P27086, DOI 10.1074/jbc.M702019200; Li JQ, 2009, J MOL BIOL, V392, P166, DOI 10.1016/j.jmb.2009.07.005; Li JQ, 2005, J BIOL CHEM, V280, P37634, DOI 10.1074/jbc.M502305200; Lim H, 2016, ONCOTARGET, V7, P10283, DOI 10.18632/oncotarget.7184; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mamonova T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129554; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Maus M, 2001, ANAL CHEM, V73, P2078, DOI 10.1021/ac000877g; McWhirter C, 2008, J AM CHEM SOC, V130, P13673, DOI 10.1021/ja803612z; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Naderi ASA, 2010, NAT REV NEPHROL, V6, P657, DOI 10.1038/nrneph.2010.121; Nagai S, 2011, J BIOL CHEM, V286, P1618, DOI 10.1074/jbc.M110.198416; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Normanno D, 2017, ELIFE, V6, DOI 10.7554/eLife.22900; Paredes JM, 2013, J PHYS CHEM B, V117, P8143, DOI 10.1021/jp405041c; Park JY, 2015, BIOCHEM CELL BIOL, V93, P290, DOI 10.1139/bcb-2014-0145; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pfister MF, 1997, J BIOL CHEM, V272, P20125, DOI 10.1074/jbc.272.32.20125; Pfister MF, 1998, P NATL ACAD SCI USA, V95, P1909, DOI 10.1073/pnas.95.4.1909; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Roy SJ, 2013, MOL ENDOCRINOL, V27, P1245, DOI 10.1210/me.2013-1091; Rubino R, 2014, PFLUG ARCH EUR J PHY, V466, P2269, DOI 10.1007/s00424-014-1474-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sim ATR, 1999, CELL CALCIUM, V26, P209, DOI 10.1054/ceca.1999.0072; Sneddon WB, 2016, J BIOL CHEM, V291, P18632, DOI 10.1074/jbc.M116.744052; Song GJ, 2015, J BIOL CHEM, V290, P2879, DOI 10.1074/jbc.M114.609768; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sun CY, 2013, MOL CELLS, V36, P47, DOI 10.1007/s10059-013-0014-0; Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Vaquero J, 2017, ONCOGENE, V36, P3067, DOI 10.1038/onc.2016.462; Voltz JW, 2007, J BIOL CHEM, V282, P33879, DOI 10.1074/jbc.M703481200; Wang B, 2013, BONE, V52, P268, DOI 10.1016/j.bone.2012.10.001; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang B, 2010, J BIOL CHEM, V285, P26976, DOI 10.1074/jbc.M110.147785; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2011, J BIOL CHEM, V286, P37216, DOI 10.1074/jbc.M111.288357; Weinman EJ, 2011, AM J PHYSIOL-RENAL, V300, pF231, DOI 10.1152/ajprenal.00532.2010; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Weinman EJ, 2009, AM J PHYSIOL-RENAL, V297, pF1560, DOI 10.1152/ajprenal.90657.2008; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Xiao KH, 2018, NAT PROTOC, V13, P1403, DOI 10.1038/nprot.2018.037; Xin FX, 2012, BIOINFORMATICS, V28, P2905, DOI 10.1093/bioinformatics/bts541; Zhang Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep01247; Zhang QM, 2018, J BIOL CHEM, V293, P5556, DOI 10.1074/jbc.RA118.001737; Zhao SM, 1997, J BIOL CHEM, V272, P28368, DOI 10.1074/jbc.272.45.28368; Zhou JY, 2017, P NATL ACAD SCI USA, V114, P9355, DOI 10.1073/pnas.1619981114	105	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4546	4571		10.1074/jbc.RA119.007421	http://dx.doi.org/10.1074/jbc.RA119.007421			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30696771	Green Published, hybrid			2022-12-28	WOS:000462969500023
J	Goodman, CM				Goodman, Catherine M.			How a fortuitous collaboration helped catalyze new insights into helper proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HEAT-SHOCK-PROTEIN; PROTECTIVE ACTIVITY; ALPHA-CRYSTALLIN; HSP27; TOLERANCE					cgoodman@asbmb.org	Goodman, Catherine/AAO-6148-2020	Goodman, Catherine/0000-0003-3415-8554				Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; CIOCCA DR, 1993, JNCI-J NATL CANCER I, V85, P1558, DOI 10.1093/jnci/85.19.1558; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Ehrnsperger M, 1999, J BIOL CHEM, V274, P14867, DOI 10.1074/jbc.274.21.14867; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kresge N, 2006, J BIOL CHEM, V281; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Osakabe Y, 2010, J BIOL CHEM, V285, P9190, DOI 10.1074/jbc.M109.051938; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947	21	0	0	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2019	294	6					2208	2210		10.1074/jbc.CL119.007667	http://dx.doi.org/10.1074/jbc.CL119.007667			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM8EO	30737320	Green Published, hybrid			2022-12-28	WOS:000459711400039
J	Marino, G; Salvador-Montoliu, N; Fueyo, A; Knecht, E; Mizushima, N; Lopez-Otin, C				Marino, Guillermo; Salvador-Montoliu, Natalia; Fueyo, Antonio; Knecht, Erwin; Mizushima, Noboru; Lopez-Otin, Carlos			RETRACTION: Withdrawal: Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. (Retraction of Vol 282, Pg 18573, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													marino, guillermo/HGB-8664-2022; Lopez-Otin, Carlos/AAB-2106-2020	Lopez-Otin, Carlos/0000-0001-6964-1904				Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1435	1435		10.1074/jbc.W118.007329	http://dx.doi.org/10.1074/jbc.W118.007329			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30808006	Green Published, hybrid			2022-12-28	WOS:000457879500038
J	Velasco, G; Cal, S; Quesada, V; Sanchez, LM; Lopez-Otin, C				Velasco, Gloria; Cal, Santiago; Quesada, Victor; Sanchez, Luis M.; Lopez-Otin, Carlos			RETRACTION: Withdrawal: Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins. (Retraction of Vol 277, Pg 37637, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Velasco, Gloria/AAS-5842-2021; Lopez-Otin, Carlos/AAB-2106-2020	Velasco, Gloria/0000-0001-8032-5056; Lopez-Otin, Carlos/0000-0001-6964-1904				VEIASCO G, 2002, J BIOL CHEM, V277, P37637	1	1	1	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1430	1430		10.1074/jbc.W118.007324	http://dx.doi.org/10.1074/jbc.W118.007324			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30808001	hybrid, Green Published			2022-12-28	WOS:000457879500033
J	Mascaro, C; Ortega, A; Carceller, E; Rodriguez, RR; Ciceri, F; Lunardi, S; Yu, L; Hilbert, M; Maes, T				Mascaro, Cristina; Ortega, Alberto; Carceller, Elena; Ruiz Rodriguez, Raquel; Ciceri, Filippo; Lunardi, Serena; Yu, Li; Hilbert, Manuel; Maes, Tamara			Chemoprobe-based assays of histone lysine demethylase 1A target occupation enable in vivo pharmacokinetics and pharmacodynamics studies of KDM1A inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; enzyme inactivation; pharmacokinetics; protein-drug interaction; drug development; chemoprobe; chemoproteomics; lysine demethylase; histone demethylase; FAD; translational studies; target engagement; chromatin modification; histone lysine demethylase (KDM)	ACTIVITY-BASED PROBES; FAMILY; POTENT	Screening of cellular activity for inhibitors of histone lysine modifiers is most frequently performed indirectly by analyzing changes in the total levels of histone marks targeted by lysine methylases/demethylases. However, inhibition of histone lysine modifiers often leads to local rather than total changes in histone marks. Also, because histone modifications can be modulated by more than one cellular enzyme, it is not always clear whether changes in histone marks are a direct or indirect consequence of the inhibitor treatment applied. Direct assessment of target occupation can provide a useful tool to quantify the fraction of an epigenetic modifier that is bound to a pharmacological inhibitor (target engagement). Here, we developed and used a novel chemoprobe-based immunoassay to quantify target engagement in cells. Quantification of the fraction of free KDM1A was made possible, in an immune-based assay, by coupling a biotinylated chemoprobe to a warhead capable of selectively and irreversibly binding to the free active form of KDM1A. The results obtained confirmed that this approach is able to determine the degree of target engagement in a dose-dependent manner. Furthermore, the assay can be also used on tissue extracts to analyze the in vivo pharmacokinetics and pharmacodynamics relationship of KDM1A inhibitors, as has been exemplified with ORY-1001 (iadademstat), a potent and irreversible inhibitor of KDM1A. The principle of this assay may be applied to other targets, and the KDM1A probe may be employed in chemoproteomic analyses.	[Mascaro, Cristina; Ortega, Alberto; Carceller, Elena; Ruiz Rodriguez, Raquel; Ciceri, Filippo; Lunardi, Serena; Maes, Tamara] Oryzon Genom SA, Carrer St Ferran 74, Barcelona 08940, Spain; [Yu, Li] Roche Innovat Ctr New York, New York, NY 10016 USA; [Hilbert, Manuel] Roche Innovat Ctr Basel, Grenzacherstr 124, CH-4070 Basel, Switzerland	Oryzon Genomics, SA; Roche Holding	Maes, T (corresponding author), Oryzon Genom SA, Carrer St Ferran 74, Barcelona 08940, Spain.	tmaes@oryzon.com		Maes, Tamara/0000-0001-5104-6867				Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Becher I, 2014, ACS CHEM BIOL, V9, P1736, DOI 10.1021/cb500235n; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cervelli M, 2003, J BIOL CHEM, V278, P5271, DOI 10.1074/jbc.M207888200; Fiskus W, 2014, LEUKEMIA, V28, P2155, DOI 10.1038/leu.2014.119; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Gonzales E.C., 2017, Patent, Patent No. [WO2017158136, 2017158136]; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hitchin JR, 2013, MEDCHEMCOMM, V4, P1513, DOI 10.1039/c3md00226h; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Maes T, 2017, ALZHEIMERS DEMENT, V13; Maes T, 2018, CANCER CELL, V33, P495, DOI 10.1016/j.ccell.2018.02.002; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Ortega Munoz A, 2013, (Hetero)Aryl Cyclopropylamine Compounds as LSD1 Inhibitors, Patent No. [WO2013/057320, 2013057320]; Ourailidou ME, 2017, BIOORGAN MED CHEM, V25, P847, DOI 10.1016/j.bmc.2016.11.043; Pollock JA, 2012, ACS CHEM BIOL, V7, P1221, DOI 10.1021/cb300108c; Rasmussen PB, 2014, EPIGENOMICS-UK, V6, P277, DOI [10.2217/epi.14.14, 10.2217/EPI.14.14]; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sorna V, 2013, J MED CHEM, V56, P9496, DOI 10.1021/jm400870h; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Yang MJ, 2007, BIOCHEMISTRY-US, V46, P8058, DOI 10.1021/bi700664y; Zhou XF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-294	26	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8311	8322		10.1074/jbc.RA118.006980	http://dx.doi.org/10.1074/jbc.RA118.006980			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30804215	hybrid, Green Published			2022-12-28	WOS:000470656500028
J	Mansueto, MS; Reens, A; Rakhilina, L; Chi, A; Pan, BS; Miller, JR				Mansueto, My S.; Reens, Abigail; Rakhilina, Larissa; Chi, An; Pan, Bo-Sheng; Miller, J. Richard			A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						spleen tyrosine kinase (SYK); enzyme kinetics; autophosphorylation; phosphorylation; non-receptor tyrosine kinase (nRTK); cell signaling; conformational change; enzyme activation; immunity; ITAM (immune-receptor tyrosine activation motif); tonic signalling	MOLECULAR-MECHANISM; ANTIGEN-RECEPTOR; STRUCTURAL BASIS; LOOP TYROSINES; IN-VIVO; PHOSPHORYLATION; SITES	Spleen tyrosine kinase (SYK) is a signaling node in many immune pathways and comprises two tandem Src homology (SH) 2 domains, an SH2-kinase linker, and a C-terminal tyrosine kinase domain. Two prevalent models of SYK activation exist. The OR-gate model contends that SYK can be fully activated by phosphorylation or binding of its SH2 domains to a dual-phosphorylated immune-receptor tyrosine-based activation motif (ppITAM). An alternative model proposes that SYK activation requires ppITAM binding and phosphorylation of the SH2-kinase linker by a SRC family kinase such as LYN proto-oncogene, SRC family tyrosine kinase (LYN). To evaluate these two models, we generated directly comparable unphosphorylated (upSYK) and phosphorylated (pSYK) proteins with or without an N-terminal glutathione S-transferase (GST) tag, resulting in monomeric or obligatory dimeric SYK, respectively. We assessed the ability of a ppITAM peptide and LYN to activate these SYK proteins. The ppITAM peptide strongly activated GST-SYK but was less effective in activating upSYK untagged with GST. LYN alone activated untagged upSYK to a greater extent than did ppITAM, and inclusion of both proteins rapidly and fully activated upSYK. Using immunoblot and phosphoproteomic approaches, we correlated the kinetics and order of site-specific SYK phosphorylation. Our results are consistent with the alternative model, indicating that ppITAM binding primes SYK for rapid LYN-mediated phosphorylation of Tyr-352 and then Tyr-348 of the SH2-kinase linker, which facilitates activation loop phosphorylation and full SYK activation. This gradual activation mechanism may also explain how SYK maintains ligand-independent tonic signaling, important for B-cell development and survival.	[Mansueto, My S.; Reens, Abigail; Rakhilina, Larissa; Pan, Bo-Sheng; Miller, J. Richard] Merck & Co Inc, Dept Pharmacol, Boston, MA 02115 USA; [Chi, An] Merck & Co Inc, Dept Chem Biol, Boston, MA 02115 USA; [Reens, Abigail] Univ Colorado, Boulder, CO 80309 USA	Merck & Company; Merck & Company; University of Colorado System; University of Colorado Boulder	Miller, JR (corresponding author), 33 Ave Louis Pasteur, Boston, MA 02115 USA.	james.miller2@merck.com						Antenucci L, 2018, J BIOL CHEM, V293, P4591, DOI 10.1074/jbc.RA117.000660; Arias-Palomo E, 2009, BBA-PROTEINS PROTEOM, V1794, P1211, DOI 10.1016/j.bbapap.2009.04.010; Bohnenberger H, 2011, EUR J IMMUNOL, V41, P1550, DOI 10.1002/eji.201041326; Bond PJ, 2011, J BIOL CHEM, V286, P25872, DOI 10.1074/jbc.M111.223321; Cha HS, 2006, J PHARMACOL EXP THER, V317, P571, DOI 10.1124/jpet.105.097436; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Couture C, 1997, EUR J BIOCHEM, V246, P447, DOI 10.1111/j.1432-1033.1997.00447.x; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Geahlen RL, 2014, TRENDS PHARMACOL SCI, V35, P414, DOI 10.1016/j.tips.2014.05.007; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Gradler U, 2013, J MOL BIOL, V425, P309, DOI 10.1016/j.jmb.2012.11.007; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Meng FY, 2007, J AM SOC MASS SPECTR, V18, P226, DOI 10.1016/j.jasms.2006.09.014; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; NARULA SS, 1995, STRUCTURE, V3, P1061, DOI 10.1016/S0969-2126(01)00242-8; Norman P, 2014, EXPERT OPIN THER PAT, V24, P573, DOI 10.1517/13543776.2014.890184; Papp E, 2007, BIOCHEMISTRY-US, V46, P15103, DOI 10.1021/bi701596u; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Sanderson MP, 2010, MOL IMMUNOL, V48, P171, DOI 10.1016/j.molimm.2010.08.012; Shults MD, 2005, NAT METHODS, V2, P277, DOI 10.1038/NMETH747; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Yan QR, 2013, MOL CELL BIOL, V33, P2188, DOI 10.1128/MCB.01637-12; Yates JR, 1998, ANAL CHEM, V70, P3557, DOI 10.1021/ac980122y; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 1998, J IMMUNOL, V161, P4366; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105	32	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7658	7668		10.1074/jbc.RA119.008045	http://dx.doi.org/10.1074/jbc.RA119.008045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30923129	Green Published, hybrid			2022-12-28	WOS:000470153300012
J	Nahar, A; Fu, XY; Polovin, G; Orth, JD; Park, S				Nahar, Asrafun; Fu, Xinyi; Polovin, George; Orth, James D.; Park, Soyeon			Two alternative mechanisms regulate the onset of chaperone-mediated assembly of the proteasomal ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases associated with diverse cellular activities (AAA); chaperone; proteasome; protein assembly; protein complex	26S PROTEASOME; TRANSCRIPTIONAL REGULATOR; 20S PROTEASOME; S PROTEASOME; PARTICLE; PATHWAY; PROTEIN; YEAST; SUBUNITS; CORE	The proteasome holoenzyme is a molecular machine that degrades most proteins in eukaryotes. In the holoenzyme, its heterohexameric ATPase injects protein substrates into the proteolytic core particle, where degradation occurs. The heterohexameric ATPase, referred to as 'Rpt ring', assembles through six ATPase subunits (Rpt1-Rpt6) individually binding to specific chaperones (Rpn14, Nas6, Nas2, and Hsm3). Here, our findings suggest that the onset of Rpt ring assembly can be regulated by two alternative mechanisms. Excess Rpt subunits relative to their chaperones are sequestered into multiple puncta specifically during early-stage Rpt ring assembly. Sequestration occurs during stressed conditions, for example heat, which transcriptionally induce Rpt subunits. When the free Rpt pool is limited experimentally, Rpt subunits are competent for proteasome assembly even without their cognate chaperones. These data suggest that sequestration may regulate amounts of individual Rpt subunits relative to their chaperones, allowing for proper onset of Rpt ring assembly. Indeed, Rpt subunits in the puncta can later resume their assembly into the proteasome. Intriguingly, when proteasome assembly resumes in stressed cells or is ongoing in unstressed cells, excess Rpt subunits are recognized by an alternative mechanismdegradation by the proteasome holoenzyme itself. Rpt subunits undergo proteasome assembly until the holoenzyme complex is generated at a sufficient level. The fully-formed holoenzyme can then degrade any remaining excess Rpt subunits, thereby regulating its own Rpt ring assembly. These two alternative mechanisms, degradation and sequestration of Rpt subunits, may help control the onset of chaperone-mediated Rpt ring assembly, thereby promoting proper proteasome holoenzyme formation.	[Nahar, Asrafun; Fu, Xinyi; Polovin, George; Orth, James D.; Park, Soyeon] Univ Colorado Boulder, Dept Mol Cellular & Dev Biol, 1945 Colorado Ave, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Park, S (corresponding author), Univ Colorado Boulder, Dept Mol Cellular & Dev Biol, 1945 Colorado Ave, Boulder, CO 80309 USA.	soyeon.park-1@colorado.edu		Fu, Xinyi/0000-0002-7928-8697	Boettcher Webb-Waring Biomedical Research Award; University of Colorado Start-up fund; National Institutes of Health [1R01GM127688-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM127688] Funding Source: NIH RePORTER	Boettcher Webb-Waring Biomedical Research Award; University of Colorado Start-up fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Boettcher Webb-Waring Biomedical Research Award, a University of Colorado Start-up fund, and National Institutes of Health Grant 1R01GM127688-01A1 (to S. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BALZI E, 1994, J BIOL CHEM, V269, P2206; Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; ECKER DJ, 1987, J BIOL CHEM, V262, P3524; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster F, 2009, BIOCHEM BIOPH RES CO, V388, P228, DOI 10.1016/j.bbrc.2009.07.145; Fukunaga K, 2010, BIOCHEM BIOPH RES CO, V396, P1048, DOI 10.1016/j.bbrc.2010.05.061; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gerlinger UM, 1997, MOL BIOL CELL, V8, P2487, DOI 10.1091/mbc.8.12.2487; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanssum A, 2014, MOL CELL, V55, P566, DOI 10.1016/j.molcel.2014.06.017; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Li F, 2017, P NATL ACAD SCI USA, V114, P1548, DOI 10.1073/pnas.1612922114; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Marshall RS, 2016, CELL REP, V16, P1717, DOI 10.1016/j.celrep.2016.07.015; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Park S, 2013, NATURE, V497, P512, DOI 10.1038/nature12123; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Preissler S, 2015, EMBO J, V34, P1905, DOI 10.15252/embj.201490194; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rousseau A, 2016, NATURE, V536, P184, DOI 10.1038/nature18943; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Satoh T, 2014, STRUCTURE, V22, P731, DOI 10.1016/j.str.2014.02.014; Shim SM, 2012, CELL REP, V2, P603, DOI 10.1016/j.celrep.2012.07.013; Shirozu R, 2015, FEBS LETT, V589, P933, DOI 10.1016/j.febslet.2015.02.025; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sokolova V, 2015, SCI REP-UK, V5, DOI 10.1038/srep14909; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; TANAKA K, 1989, BIOCHEM BIOPH RES CO, V159, P1309, DOI 10.1016/0006-291X(89)92253-5; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tomko RJ, 2011, MOL CELL, V44, P907, DOI 10.1016/j.molcel.2011.11.020; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Tsvetkov P, 2017, P NATL ACAD SCI USA, V114, P382, DOI 10.1073/pnas.1619067114; Waite KA, 2016, J BIOL CHEM, V291, P3239, DOI 10.1074/jbc.M115.699124; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026	61	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6562	6577		10.1074/jbc.RA118.006298	http://dx.doi.org/10.1074/jbc.RA118.006298			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30814255	Green Published, hybrid			2022-12-28	WOS:000468402000030
J	Steingruber, M; Keller, L; Socher, E; Ferre, S; Hesse, AM; Coute, Y; Hahn, F; Buscher, N; Plachter, B; Sticht, H; Marschall, M				Steingruber, Mirjam; Keller, Lena; Socher, Eileen; Ferre, Sabrina; Hesse, Anne-Marie; Coute, Yohann; Hahn, Friedrich; Buescher, Nicole; Plachter, Bodo; Sticht, Heinrich; Marschall, Manfred			Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral replication; cyclin; protein kinase; protein assembly; phosphorylation; reprogramming; cyclins B1; T1; and H; human cytomegalovirus; protein phosphorylation; regulatory interaction; viral kinase pUL97-cyclin complexes	NUCLEAR EGRESS COMPLEX; INTRANUCLEAR LOCALIZATION; RETINOBLASTOMA PROTEIN; UL97 PHOSPHORYLATES; DEPENDENT KINASES; VIRAL PROTEIN; IN-VITRO; INFECTION; PUL69; REPLICATION	Human cytomegalovirus (HCMV) is a common -herpesvirus causing life-long latent infections. HCMV replication interferes with cell cycle regulation in host cells because the HCMV-encoded cyclin-dependent kinase (CDK) ortholog pUL97 extensively phosphorylates the checkpoint regulator retinoblastoma protein. pUL97 also interacts with cyclins B1, T1, and H, and recent findings have strongly suggested that these interactions influence pUL97 substrate recognition. Interestingly, here we detected profound mechanistic differences among these pUL97-cyclin interactions. Our study revealed the following. (i) pUL97 interacts with cyclins B1 and H in a manner dependent on pUL97 activity and HCMV-specific cyclin modulation, respectively. (ii) The phosphorylated state of both proteins is an important determinant of the pUL97-cyclin B1 interaction. (iii) Activated phospho-Thr-315 cyclin H is up-regulated during HCMV replication. (iv) Thr-315 phosphorylation is independent of intracellular pUL97 or CDK7 activity. (v) pUL97-mediated in vitro phosphorylation is detectable for cyclin B1 but not H. (vi) Mutual transphosphorylation between pUL97 and CDK7 is not detectable, and an MS-based phosphosite analysis indicated that pUL97 might unexpectedly not be phosphorylated in its T-loop. (vii) The binary complexes pUL97-cyclin H and CDK7-cyclin H as well as the ternary complex pUL97-cyclin-H-CDK7 are detectable in an assembly-based CoIP approach. (viii) pUL97 self-interaction can be bridged by the transcriptional cyclins T1 or H but not by the classical cell cycle-regulating B1 cyclin. Combined, our findings unravel a number of cyclin type-specific differences in pUL97 interactions and suggest a multifaceted regulatory impact of cyclins on HCMV replication.	[Steingruber, Mirjam; Keller, Lena; Hahn, Friedrich; Marschall, Manfred] Friedrich Alexander Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Socher, Eileen; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Div Bioinformat, D-91054 Erlangen, Germany; [Ferre, Sabrina; Hesse, Anne-Marie; Coute, Yohann] Univ Grenoble Alpes, CEA, INSERM, BIG BGE, F-38000 Grenoble, France; [Buescher, Nicole; Plachter, Bodo] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Virol, D-55131 Mainz, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Johannes Gutenberg University of Mainz	Steingruber, M; Marschall, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany.; Sticht, H (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Div Bioinformat, D-91054 Erlangen, Germany.	mirjam.steingruber@uk-erlangen.de; heinrich.sticht@fau.de; manfred.marschall@fau.de	Couté, Yohann/G-2695-2015	Couté, Yohann/0000-0003-3896-6196; Hesse, Anne-Marie/0000-0001-6110-0636; Socher, Eileen/0000-0002-6239-3749; Ferre, Sabrina/0000-0002-1379-3025; Hahn, Friedrich/0000-0003-3011-8416	Deutsche Forschungsgemeinschaft [MA1289/8-1, STI155/5-1, PL236/7-1, ANR-10-INBS-08-01]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants MA1289/8-1, STI155/5-1, and PL236/7-1) and the proteomic experiments were supported in part by the ProFl Grant ANR-10-INBS-08-01. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], [No title captured]; Baek MC, 2004, VIROLOGY, V324, P184, DOI 10.1016/j.virol.2004.03.015; Baek MC, 2002, J VIROL, V76, P11943, DOI 10.1128/JVI.76.23.11943-11952.2002; Becke S, 2010, J GEN VIROL, V91, P2531, DOI 10.1099/vir.0.022293-0; Bigley TM, 2015, J VIROL, V89, P10230, DOI 10.1128/JVI.00986-15; Buxmann H, 2017, DTSCH ARZTEBL INT, V114, P45, DOI 10.3238/arztebl.2017.0045; Chou SW, 2008, REV MED VIROL, V18, P233, DOI 10.1002/rmv.574; Dell'Oste V, 2014, J VIROL, V88, P6970, DOI 10.1128/JVI.00384-14; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Graf L, 2016, J GEN VIROL, V97, P144, DOI 10.1099/jgv.0.000337; Graf L, 2013, VIRUSES-BASEL, V5, P3213, DOI 10.3390/v5123213; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; Hume AJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-1; Hutterer C, 2015, ANTIMICROB AGENTS CH, V59, P2062, DOI 10.1128/AAC.04534-14; Iwahori S, 2017, J BIOL CHEM, V292, P6583, DOI 10.1074/jbc.M116.773150; Iwahori S, 2015, J BIOL CHEM, V290, P19666, DOI 10.1074/jbc.M115.660043; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kaldis P, 1999, CELL MOL LIFE SCI, V55, P284, DOI 10.1007/s000180050290; Kawaguchi Y, 1999, J VIROL, V73, P4456, DOI 10.1128/JVI.73.5.4456-4460.1999; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; Kochin V, 2014, J CELL SCI, V127, P2683, DOI 10.1242/jcs.141820; Konig P, 2017, J GEN VIROL, V98, P2850, DOI 10.1099/jgv.0.000939; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Marschall M, 2000, ANTIMICROB AGENTS CH, V44, P1588, DOI 10.1128/AAC.44.6.1588-1597.2000; Marschall M, 2003, VIROLOGY, V311, P60, DOI 10.1016/S0042-6822(03)00147-8; Marschall M, 2002, J GEN VIROL, V83, P1013, DOI 10.1099/0022-1317-83-5-1013; Marschall M, 2001, J GEN VIROL, V82, P1439, DOI 10.1099/0022-1317-82-6-1439; Marschall M, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1934; Marschall M, 2011, ADV VIRUS RES, V80, P69, DOI 10.1016/B978-0-12-385987-7.00004-X; Milbradt J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005825; Milbradt J, 2014, MOL CELL PROTEOMICS, V13, P2132, DOI 10.1074/mcp.M113.035782; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Mocarski Jr E, 2013, FIELDS VIROLOGY, V2, P1960; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Oberstein A, 2015, PROTEOMICS, V15, P2006, DOI 10.1002/pmic.201400607; Rechter S, 2009, J BIOL CHEM, V284, P8942, DOI 10.1074/jbc.M805693200; Reyda S, 2014, VIRUSES-BASEL, V6, P172, DOI 10.3390/v6010172; Romaker D, 2006, J MED CHEM, V49, P7044, DOI 10.1021/jm060696s; ROWE WP, 1956, P SOC EXP BIOL MED, V92, P418, DOI 10.3181/00379727-92-22497; Ruiz-Carrascoso G, 2013, J MED VIROL, V85, P1250, DOI 10.1002/jmv.23570; Schregel V, 2007, J GEN VIROL, V88, P395, DOI 10.1099/vir.0.82393-0; Sharma M, 2015, J VIROL, V89, P523, DOI 10.1128/JVI.02426-14; Sonntag E, 2017, J GEN VIROL, V98, P2569, DOI 10.1099/jgv.0.000931; Sonntag E, 2016, J GEN VIROL, V97, P1676, DOI 10.1099/jgv.0.000495; Steingruber M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080219; Steingruber M, 2015, VIRUSES-BASEL, V7, P4582, DOI 10.3390/v7082834; Thomas M, 2009, J GEN VIROL, V90, P567, DOI 10.1099/vir.0.005827-0; Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x; Webel R, 2014, J VIROL, V88, P4776, DOI 10.1128/JVI.00192-14; Webel R, 2012, J GEN VIROL, V93, P1756, DOI 10.1099/vir.0.040592-0; Webel R, 2011, J GEN VIROL, V92, P638, DOI 10.1099/vir.0.026799-0	56	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6188	6203		10.1074/jbc.RA118.007049	http://dx.doi.org/10.1074/jbc.RA118.007049			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30782840	hybrid, Green Published			2022-12-28	WOS:000465077500045
J	Zhang, H; Liu, CY; Zha, ZY; Zhao, B; Yao, J; Zhao, SM; Xiong, Y; Lei, QY; Guan, KL				Zhang, Heng; Liu, Chen-Ying; Zha, Zheng-Yu; Zhao, Bin; Yao, Jun; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang			TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition (vol 284, pg 13355, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Guan, Kun-Liang/ADK-7088-2022					Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200	1	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5808	5808		10.1074/jbc.AAC119.008436	http://dx.doi.org/10.1074/jbc.AAC119.008436			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30979850	hybrid, Green Published			2022-12-28	WOS:000465077500009
J	Amado, E; Muth, G; Arechaga, I; Cabezon, E				Amado, Eric; Muth, Guenther; Arechaga, Ignacio; Cabezon, Elena			The FtsK-like motor TraB is a DNA-dependent ATPase that forms higher-order assemblies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA binding protein; bacterial conjugation; ATPase; G-quadruplex; antibiotics; DNA segregation; DNA translocation; DNA-dependent ATPase; FtsK-like ATPase; Streptomyces; DNA translocase; conjugal plasmid transfer; motor protein; TRS sequence	DIRECTIONAL TRANSLOCATION; CHROMOSOME SEGREGATION; BACTERIAL CONJUGATION; SINGLE-MOLECULE; CELL-DIVISION; PROTEIN; MECHANISM; TRWB; STREPTOMYCES; SPOIIIE	TraB is an FtsK-like DNA translocase responsible for conjugative plasmid transfer in mycelial Streptomyces. Unlike other conjugative systems, which depend on a type IV secretion system, Streptomyces requires only TraB protein to transfer the plasmid as dsDNA. The gamma-domain of this protein specifically binds to repeated 8-bp motifs on the plasmid sequence, following a mechanism that is reminiscent of the FtsK/SpoIIIE chromosome segregation system. In this work, we purified and characterized the enzymatic activity of TraB, revealing that it is a DNA-dependent ATPase that is highly stimulated by dsDNA substrates. Interestingly, we found that unlike the SpoIIIE protein, the gamma-domain of TraB does not confer sequence-specific ATPase stimulation. We also found that TraB binds G-quadruplex DNA structures with higher affinity than TraB-recognition sequences (TRSs). An EM-based structural analysis revealed that TraB tends to assemble as large complexes comprising four TraB hexamers, which might be a prerequisite for DNA translocation across cell membranes. In summary, our findings shed light on the molecular mechanism used by the DNA-translocating motor TraB, which may be shared by other membrane-associated machineries involved in DNA binding and translocation.	[Amado, Eric; Arechaga, Ignacio; Cabezon, Elena] Univ Cantabria, CSIC, Dept Biol Mol, Santander, Spain; [Amado, Eric; Arechaga, Ignacio; Cabezon, Elena] Univ Cantabria, CSIC, Inst Biomed Biotecnol Cantabria IBBTEC, Santander, Spain; [Muth, Guenther] Eberhard Karls Univ Tuebingen, Interfakultaeres Inst Mikrobiol & Infekt Med Tueb, Mikrobiol Biotechnol, D-72074 Tubingen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Arechaga, I; Cabezon, E (corresponding author), Univ Cantabria, CSIC, Dept Biol Mol, Santander, Spain.; Arechaga, I; Cabezon, E (corresponding author), Univ Cantabria, CSIC, Inst Biomed Biotecnol Cantabria IBBTEC, Santander, Spain.	arechagai@unican.es; cabezone@unican.es	Cabezon, Elena/K-5874-2014	Cabezon, Elena/0000-0002-6177-5016	Spanish Ministerio de Economia y Competitividad (MINECO) [BFU2016-78521-R]; Deutsche Forschungsgemeinschaft [SFB766]	Spanish Ministerio de Economia y Competitividad (MINECO); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Spanish Ministerio de Economia y Competitividad (MINECO) Grants BFU2016-78521-R (to E. C. and I. A.) and Deutsche Forschungsgemeinschaft SFB766 (to G. M). The authors declare that they have no conflicts of interest with the contents of this article.	Barre FX, 2000, GENE DEV, V14, P2976, DOI 10.1101/gad.188700; Berezuk AM, 2014, J BIOL CHEM, V289, P23287, DOI 10.1074/jbc.M114.569624; Besprozvannaya M, 2013, J BIOL CHEM, V288, P28962, DOI 10.1074/jbc.M113.484055; Bigot S, 2006, NAT STRUCT MOL BIOL, V13, P1026, DOI 10.1038/nsmb1159; Cabezon E, 2006, RES MICROBIOL, V157, P299, DOI 10.1016/j.resmic.2005.12.002; Cabezon E, 2015, FEMS MICROBIOL REV, V39, P81, DOI 10.1111/1574-6976.12085; Cabezon E, 2012, CURR OPIN BIOTECH, V23, P537, DOI 10.1016/j.copbio.2011.11.031; Cattoni DI, 2014, NUCLEIC ACIDS RES, V42, P2624, DOI 10.1093/nar/gkt1231; Cattoni DI, 2013, EMBO REP, V14, P473, DOI 10.1038/embor.2013.39; Chara O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23400-8; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Demarre G, 2013, ADV EXP MED BIOL, V973, P245, DOI 10.1007/978-1-4614-5037-5_12; Diagne CT, 2014, NUCLEIC ACIDS RES, V42, P1721, DOI 10.1093/nar/gkt1024; Fiche JB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001557; Franco B, 2003, PLASMID, V50, P242, DOI 10.1016/S0147-619X(03)00063-5; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Graham JE, 2010, P NATL ACAD SCI USA, V107, P20263, DOI 10.1073/pnas.1007518107; Grainge I, 2008, CURR BIOL, V18, pR871, DOI 10.1016/j.cub.2008.07.047; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kosono S, 1996, MOL MICROBIOL, V19, P397, DOI 10.1046/j.1365-2958.1996.379909.x; Lee JY, 2012, P NATL ACAD SCI USA, V109, P6531, DOI 10.1073/pnas.1201613109; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lowe J, 2008, MOL CELL, V31, P498, DOI 10.1016/j.molcel.2008.05.027; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Matilla I, 2010, J BIOL CHEM, V285, P17537, DOI 10.1074/jbc.M109.084137; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Oganesian L, 2006, EMBO J, V25, P1148, DOI 10.1038/sj.emboj.7601006; Pena A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413849; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Possoz C, 2001, MOL MICROBIOL, V42, P159, DOI 10.1046/j.1365-2958.2001.02618.x; Ptacin JL, 2008, NAT STRUCT MOL BIOL, V15, P485, DOI 10.1038/nsmb.1412; Reuther J, 2006, MOL MICROBIOL, V61, P436, DOI 10.1111/j.1365-2958.2006.05258.x; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Sivanathan V, 2006, NAT STRUCT MOL BIOL, V13, P965, DOI 10.1038/nsmb1158; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Tato I, 2007, J BIOL CHEM, V282, P25569, DOI 10.1074/jbc.M703464200; Vogelmann J, 2011, EMBO J, V30, P2246, DOI 10.1038/emboj.2011.121; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Zawadzki P, 2013, P NATL ACAD SCI USA, V110, P17302, DOI 10.1073/pnas.1311065110; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207	45	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5050	5059		10.1074/jbc.RA119.007459	http://dx.doi.org/10.1074/jbc.RA119.007459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30723158	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000463985600027
J	Bai, Y; Lang, EJM; Nazmi, AR; Parker, EJ				Bai, Yu; Lang, Eric J. M.; Nazmi, Ali Reza; Parker, Emily J.			Domain cross-talk within a bifunctional enzyme provides catalytic and allosteric functionality in the biosynthesis of aromatic amino acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; protein domain; enzyme catalysis; enzyme structure; multifunctional enzyme; 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase; Bifunctional enzyme; chorismate mutase; conformational change; DAHPS	3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; 3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE SYNTHASE; CHORISMATE MUTASE; PREVOTELLA-NIGRESCENS; SUBSTRATE AMBIGUITY; CRYSTAL-STRUCTURE; DAHP SYNTHASE; PROTEIN; PURIFICATION; COMPLEX	Because of their special organization, multifunctional enzymes play crucial roles in improving the performance of metabolic pathways. For example, the bacterium Prevotella nigrescens contains a distinctive bifunctional protein comprising a 3-deoxy-D-arabino heptulosonate-7-phosphate synthase (DAH7PS), catalyzing the first reaction of the biosynthetic pathway of aromatic amino acids, and a chorismate mutase (CM), functioning at a branch of this pathway leading to the synthesis of tyrosine and phenylalanine. In this study, we characterized this P. nigrescens enzyme and found that its two catalytic activities exhibit substantial hetero-interdependence and that the separation of its two distinct catalytic domains results in a dramatic loss of both DAH7PS and CM activities. The protein displayed a unique dimeric assembly, with dimerization solely via the CM domain. Small angle X-ray scattering (SAXS)-based structural analysis of this protein indicated a DAH7PS-CM hetero-interaction between the DAH7PS and CM domains, unlike the homo-association between DAH7PS domains normally observed for other DAH7PS proteins. This hetero-interaction provides a structural basis for the functional interdependence between the two domains observed here. Moreover, we observed that DAH7PS is allosterically inhibited by prephenate, the product of the CM-catalyzed reaction. This allostery was accompanied by a striking conformational change as observed by SAXS, implying that altering the hetero-domain interaction underpins the allosteric inhibition. We conclude that for this C-terminal CM-linked DAH7PS, catalytic function and allosteric regulation appear to be delivered by a common mechanism, revealing a distinct and efficient evolutionary strategy to utilize the functional advantages of a bifunctional enzyme.	[Bai, Yu; Parker, Emily J.] Victoria Univ Wellington, Ferrier Res Inst, Maurice Wilkins Ctr, Wellington 6012, New Zealand; [Lang, Eric J. M.; Nazmi, Ali Reza; Parker, Emily J.] Univ Canterbury, Maurice Wilkins Ctr, Biomol Interact Ctr, Christchurch 8041, New Zealand; [Lang, Eric J. M.; Nazmi, Ali Reza; Parker, Emily J.] Univ Canterbury, Dept Chem, Christchurch 8041, New Zealand; [Lang, Eric J. M.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Nazmi, Ali Reza] Scion, Biotransformat, Rotorua 3020, New Zealand	Victoria University Wellington; University of Canterbury; University of Canterbury; University of Bristol; Scion	Parker, EJ (corresponding author), Private Bag 600, Wellington, New Zealand.	emily.parker@vuw.ac.nz		Nazmi, Ali Reza/0000-0003-1262-5078; Parker, Emily/0000-0002-9571-9987; Bai, Yu/0000-0002-5698-0023; Lang, Eric/0000-0002-3808-054X	Marsden Fund (Royal Society of New Zealand Marsden Fund) [UOC1105]; University of Canterbury; Maurice Wilkins Centre	Marsden Fund (Royal Society of New Zealand Marsden Fund); University of Canterbury; Maurice Wilkins Centre	This work was supported by Marsden Fund (Royal Society of New Zealand Marsden Fund) Grant UOC1105, the University of Canterbury, and the Maurice Wilkins Centre. The authors declare that they have no conflicts of interest with the contents of this article.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; BLACKMORE PF, 1976, FEBS LETT, V64, P222, DOI 10.1016/0014-5793(76)80288-8; Burschowsky D, 2018, BIOCHEMISTRY-US, V57, P557, DOI 10.1021/acs.biochem.7b01018; Cross PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145187; Cross PJ, 2013, FEBS LETT, V587, P3063, DOI 10.1016/j.febslet.2013.07.044; Cross PJ, 2013, PROTEIN SCI, V22, P1087, DOI 10.1002/pro.2293; Cross PJ, 2013, P NATL ACAD SCI USA, V110, P2111, DOI 10.1073/pnas.1217923110; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Curien G, 2008, PLANT PHYSIOL BIOCH, V46, P325, DOI 10.1016/j.plaphy.2007.12.006; Fan YF, 2018, P NATL ACAD SCI USA, V115, P3006, DOI 10.1073/pnas.1717621115; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Fukui K, 1999, J CLIN MICROBIOL, V37, P3141, DOI 10.1128/JCM.37.10.3141-3145.1999; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; GRAY JV, 1990, BIOCHEMISTRY-US, V29, P376, DOI 10.1021/bi00454a011; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Jensen RA, 2002, J MOL EVOL, V54, P416, DOI 10.1007/s00239-001-0031-z; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee D., 2005, PDB ID 1YBZ CONSERVE, DOI [10.2210/odb1YBZ/odb, DOI 10.2210/ODB1YBZ/ODB]; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Light SH, 2012, PROTEIN SCI, V21, P887, DOI 10.1002/pro.2075; Liu YJ, 2008, APPL ENVIRON MICROB, V74, P5497, DOI 10.1128/AEM.00262-08; Nazmi AR, 2016, J BIOL CHEM, V291, P21836, DOI 10.1074/jbc.M116.741637; Nazmi AR, 2014, J MOL BIOL, V426, P656, DOI 10.1016/j.jmb.2013.11.008; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palmer T., 2007, ENZYMES BIOCH BIOTEC; PARAVICINI G, 1989, EUR J BIOCHEM, V186, P361, DOI 10.1111/j.1432-1033.1989.tb15217.x; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pratap S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06578-1; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Schofield LR, 2004, PROTEIN EXPRES PURIF, V34, P17, DOI 10.1016/j.pep.2003.11.008; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; STEPHENS CM, 1991, J BIOL CHEM, V266, P20810; Stingu CS, 2013, J INVESTIG CLIN DENT, V4, P20, DOI 10.1111/j.2041-1626.2012.00129.x; Subramaniam PS, 1998, J BACTERIOL, V180, P119, DOI 10.1128/JB.180.1.119-127.1998; Walker GE, 1996, MICROBIOL-SGM, V142, P1973, DOI 10.1099/13500872-142-8-1973; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200; Wu J, 2003, J BIOL CHEM, V278, P27525, DOI 10.1074/jbc.M304631200; Yakob M, 2011, J PERIODONTAL RES, V46, P749, DOI 10.1111/j.1600-0765.2011.01398.x; Zhou L, 2012, BIOORG CHEM, V40, P79, DOI 10.1016/j.bioorg.2011.09.002	60	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4828	4842		10.1074/jbc.RA118.005220	http://dx.doi.org/10.1074/jbc.RA118.005220			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30670586	Green Published, hybrid			2022-12-28	WOS:000463985600009
J	Hawse, WF; Cattley, RT				Hawse, William F.; Cattley, Richard T.			T cells transduce T-cell receptor signal strength by generating different phosphatidylinositols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T-cell receptor (TCR); phosphatase and tensin homolog (PTEN); phosphatidylinositol signaling; signal transduction; T-cell; T helper cells; cell differentiation; AKT; T regulatory cell	FOCAL ADHESION KINASE; PROTEIN-KINASE; ACTIVATION; TCR; AKT; PHOSPHORYLATION; COMPLEX; BINDING; 4,5-BISPHOSPHATE; RICTOR	T-cell receptor (TCR) signaling strength is a dominant factor regulating T-cell differentiation, thymic development, and cytokine signaling. The molecular mechanisms by which TCR signal strength is transduced to downstream signaling networks remains ill-defined. Using computational modeling, biochemical assays, and imaging flow cytometry, we found here that TCR signal strength differentially generates phosphatidylinositol species. Weak TCR signals generated elevated phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and reduced phosphatidylinositol (3,4,5)-trisphosphate (PIP3) levels, whereas strong TCR signals reduced PI(4,5)P2 and elevated PIP3 levels. A proteomics screen revealed that focal adhesion kinase bound PI(4,5)P2, biochemical assays disclosed that focal adhesion kinase is preferentially activated by weak TCR signals and is required for optimal Treg induction, and further biochemical experiments revealed how TCR signaling strength regulates AKT activation. Low PIP3 levels generated by weak TCR signals were sufficient to activate phosphoinositide-dependent kinase-1 to phosphorylate AKT on Thr-308 but insufficient to activate mTOR complex 2 (mTORC2), whereas elevated PIP3 levels generated by a strong TCR signal were required to activate mTORC2 to phosphorylate Ser-473 on AKT. Our results provide support for a model that links TCR signaling to mTORC2 activation via phosphoinositide 3-kinase signaling. Together, the findings in this work establish that T cells measure TCR signal strength by generating different levels of phosphatidylinositol species that engage alternate signaling networks to control cell fate decisions.	[Hawse, William F.; Cattley, Richard T.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hawse, WF (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA.	whawse@pitt.edu			Competitive Medical Research Fund grant from the University of Pittsburgh Medical Center; University of Pittsburgh Department of Immunology	Competitive Medical Research Fund grant from the University of Pittsburgh Medical Center; University of Pittsburgh Department of Immunology	This work was supported by a Competitive Medical Research Fund grant from the University of Pittsburgh Medical Center (to W. F. H.) and startup funds generously provided by the University of Pittsburgh Department of Immunology (to W. F. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed F, 2009, J IMMUNOL METHODS, V347, P79, DOI 10.1016/j.jim.2009.05.014; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Burton TJ, 2012, J CLIN ENDOCR METAB, V97, P100, DOI 10.1210/jc.2011-1537; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Choi S, 2016, NAT CELL BIOL, V18, P1324, DOI 10.1038/ncb3441; Chouaki-Benmansour N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23109-8; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Gawden-Bone CM, 2018, IMMUNITY, V49, P427, DOI 10.1016/j.immuni.2018.08.017; Gokhale NA, 2013, BIOCHEM J, V453, P413, DOI 10.1042/BJ20121528; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Gross C, 2015, CELL REP, V11, P727, DOI 10.1016/j.celrep.2015.03.060; Hashimoto-Tane A, 2016, J EXP MED, V213, P1609, DOI 10.1084/jem.20151088; Hawse WF, 2017, J IMMUNOL, V199, P589, DOI 10.4049/jimmunol.1700369; Hawse WF, 2015, J IMMUNOL, V194, P4615, DOI 10.4049/jimmunol.1402554; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; Iwata A, 2017, NAT IMMUNOL, V18, P563, DOI 10.1038/ni.3714; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Jungmichel S, 2014, CELL REP, V6, P578, DOI 10.1016/j.celrep.2013.12.038; Kim EH, 2012, J IMMUNOL, V188, P4305, DOI 10.4049/jimmunol.1103568; Le Floc'h A, 2013, J EXP MED, V210, P2721, DOI 10.1084/jem.20131324; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Love PE, 2000, J IMMUNOL, V165, P3080, DOI 10.4049/jimmunol.165.6.3080; Malek M, 2017, MOL CELL, V68, P566, DOI 10.1016/j.molcel.2017.09.024; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Osborne SL, 2001, J CELL SCI, V114, P2501; Raab M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16001; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Sobol M, 2013, NUCLEUS-PHILA, V4, P478, DOI 10.4161/nucl.27154; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Turner MS, 2014, DIABETOLOGIA, V57, P1428, DOI 10.1007/s00125-014-3233-9; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; WARD SG, 1992, EUR J IMMUNOL, V22, P45, DOI 10.1002/eji.1830220108; Ward SG, 2001, CURR OPIN IMMUNOL, V13, P332, DOI 10.1016/S0952-7915(00)00223-5; Waugh Mark G., 2009, V462, P279, DOI 10.1007/978-1-60327-115-8_19; Yildirim S, 2013, J CELL SCI, V126, P2730, DOI 10.1242/jcs.123661; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zhou J, 2015, BIOPHYS J, V108, P698, DOI 10.1016/j.bpj.2014.11.3454	58	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4793	4805		10.1074/jbc.RA118.006524	http://dx.doi.org/10.1074/jbc.RA118.006524			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30692200	hybrid, Green Published			2022-12-28	WOS:000463985600006
J	Tedja, R; Roberts, CM; Alvero, AB; Cardenas, C; Yang-Hartwich, Y; Spadinger, S; Pitruzzello, M; Yin, G; Glackin, CA; Mor, G				Tedja, Roslyn; Roberts, Cai M.; Alvero, Ayesha B.; Cardenas, Carlos; Yang-Hartwich, Yang; Spadinger, Sydney; Pitruzzello, Mary; Yin, Gang; Glackin, Carlotta A.; Mor, Gil			Protein kinase C alpha-mediated phosphorylation of Twist1 at Ser-144 prevents Twist1 ubiquitination and stabilizes it	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; ovarian cancer; ubiquitylation (ubiquitination); epithelial-mesenchymal transition (EMT); post-transcriptional regulation; embryonic development; NetphosK3; 1; PKCalpha; Twist1	NF-KAPPA-B; TRANSCRIPTION FACTOR; PKC-ALPHA; BREAST; EXPRESSION; DEGRADATION; ACTIVATION; MUTATIONS; BETA; DIFFERENTIATION	Twist1 is a basic helix-loop-helix transcription factor that plays a key role in embryonic development, and its expression is down-regulated in adult cells. However, Twist1 is highly expressed during cancer development, conferring a proliferative, migratory, and invasive phenotype to malignant cells. Twist1 expression can be regulated post-translationally by phosphorylation or ubiquitination events. We report in this study a previously unknown and relevant Twist1 phosphorylation site that controls its stability. To identify candidate phosphorylation sites in Twist1, we first conducted an in silico analysis of the Twist1 protein, which yielded several potential sites. Because most of these sites were predicted to be phosphorylated by protein kinase C (PKC), we overexpressed PKC alpha in several cell lines and found that it phosphorylates Twist1 on Ser-144. Using a combination of immunoblotting, immunoprecipitation, protein overexpression, and CRISPR/Cas9-mediated PKC alpha knockout experiments, we observed that PKC alpha-mediated Twist1 phosphorylation at Ser-144 inhibits Twist1 ubiquitination and consequently stabilizes it. These results provide evidence for a direct association between PKC alpha and Twist1 and yield critical insights into the PKC alpha/Twist1 signaling axis that governs cancer aggressiveness.	[Tedja, Roslyn; Roberts, Cai M.; Alvero, Ayesha B.; Cardenas, Carlos; Yang-Hartwich, Yang; Spadinger, Sydney; Pitruzzello, Mary; Mor, Gil] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06511 USA; [Yin, Gang] Cent S Univ, Xiangya Hosp, Sch Basic Med Sci, Dept Pathol, Changsha 410083, Hunan, Peoples R China; [Glackin, Carlotta A.] City Hope Natl Med Ctr, Dept Stem Cell & Dev Biol, Duarte, CA 91010 USA	Yale University; Central South University; City of Hope	Mor, G (corresponding author), Yale Univ, 333 Cedar St,LSOG312, New Haven, CT 06511 USA.	gil.mor@yale.edu		Alvero, Ayesha/0000-0002-6593-3595	NCI, National Institutes of Health [RO1CA199004]; Sands Family Foundation; Discovery to Cure Program; Debra Levine Endowment; NATIONAL CANCER INSTITUTE [R01CA199004] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sands Family Foundation; Discovery to Cure Program; Debra Levine Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health Grant RO1CA199004 (to G. M., A. B. A., and R. T.) and funds from the Sands Family Foundation (to G. M. and A. B. A.), the Discovery to Cure Program (to G. M.), and the Debra Levine Endowment (to G. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abera MB, 2015, MOL PHARMACOL, V87, P832, DOI 10.1124/mol.115.097725; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Asanoma K, 2015, MOL CELL BIOL, V35, P4096, DOI 10.1128/MCB.00678-15; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chen Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-104; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; Craveiro V, 2013, CANCER MED-US, V2, P751, DOI 10.1002/cam4.115; Croset M, 2014, J BONE MINER RES, V29, P1886, DOI 10.1002/jbmr.2215; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; El Ghouzzi V, 2000, HUM MOL GENET, V9, P813, DOI 10.1093/hmg/9.5.813; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Gajula RP, 2015, NEOPLASIA, V17, P16, DOI 10.1016/j.neo.2014.10.009; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Gitelman I, 1997, DEV BIOL, V189, P205, DOI 10.1006/dbio.1997.8614; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Howe LR, 2003, CANCER RES, V63, P1906; Johnson D, 1998, AM J HUM GENET, V63, P1282, DOI 10.1086/302122; Kamsteeg M, 2003, ONCOGENE, V22, P2611, DOI 10.1038/sj.onc.1206422; Kasinathan NK, 2018, J FUNCT FOODS, V41, P240, DOI 10.1016/j.jff.2017.12.048; Lahn M, 2004, ONCOLOGY-BASEL, V67, P1, DOI 10.1159/000080279; Lee MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029758; Lin YW, 2017, ONCOTARGET, V8, P75127, DOI 10.18632/oncotarget.20561; Maia AM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-184; Mandil R, 2001, CANCER RES, V61, P4612; Matsuo N, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-240; Nuti SV, 2014, ONCOTARGET, V5, P7260, DOI 10.18632/oncotarget.2428; O'Rourke MP, 2002, INT J DEV BIOL, V46, P401; Rose CSP, 1997, TRENDS GENET, V13, P384, DOI 10.1016/S0168-9525(97)01296-1; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shiota M, 2017, ENDOCR-RELAT CANCER, V24, P171, DOI 10.1530/ERC-16-0384; Shiota M, 2014, CLIN CANCER RES, V20, P951, DOI 10.1158/1078-0432.CCR-13-1809; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Sun XG, 1999, CELL GROWTH DIFFER, V10, P343; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wang N, 2015, ONCOTARGET, V6, P20977, DOI 10.18632/oncotarget.4007; WAYS DK, 1995, J CLIN INVEST, V95, P1906, DOI 10.1172/JCI117872; Xu Y, 2017, ONCOGENE, V36, P1157, DOI 10.1038/onc.2016.286; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yin G, 2013, ONCOGENE, V32, P39, DOI 10.1038/onc.2012.33; Zhong JT, 2013, DISCOV MED, V15, P7	47	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5082	5093		10.1074/jbc.RA118.005921	http://dx.doi.org/10.1074/jbc.RA118.005921			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30733340	Green Published, hybrid			2022-12-28	WOS:000463985600030
J	Andrew, RJ; De Rossi, P; Nguyen, P; Kowalski, HR; Recupero, AJ; Guerbette, T; Krause, SV; Rice, RC; Laury-Kleintop, L; Wagner, SL; Thinakaran, G				Andrew, Robert J.; De Rossi, Pierre; Nguyen, Phuong; Kowalski, Haley R.; Recupero, Aleksandra J.; Guerbette, Thomas; Krause, Sofia V.; Rice, Richard C.; Laury-Kleintop, Lisa; Wagner, Steven L.; Thinakaran, Gopal			Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); beta-amyloid (AB); beta-secretase 1 (BACE1); pathogenesis; 5XFAD; APP; BACE1; BIN1; GWAS; amphiphysin; neurodegeneration; endocytosis; secretase; amyloid	PRECURSOR PROTEIN; AMPHIPHYSIN FAMILY; BETA; ENDOCYTOSIS; BACE1; MICE; TRAFFICKING; APP; RECEPTOR; ASSOCIATION	Alzheimer's disease (AD) is pathologically characterized by the deposition of the -amyloid (A) peptide in senile plaques in the brain, leading to neuronal dysfunction and eventual decline in cognitive function. Genome-wide association studies have identified the bridging integrator 1 (BIN1) gene within the second most significant susceptibility locus for late-onset AD. BIN1 is a member of the amphiphysin family of proteins and has reported roles in the generation of membrane curvature and endocytosis. Endocytic dysfunction is a pathological feature of AD, and endocytosis of the amyloid precursor protein is an important step in its subsequent cleavage by -secretase (BACE1). In vitro evidence implicates BIN1 in endosomal sorting of BACE1 and A generation in neurons, but a role for BIN1 in this process in vivo is yet to be described. Here, using biochemical and immunohistochemistry analyses we report that a 50% global reduction of BIN1 protein levels resulting from a single Bin1 allele deletion in mice does not change BACE1 levels or localization in vivo, nor does this reduction alter the production of endogenous murine A in nontransgenic mice. Furthermore, we found that reduction of BIN1 levels in the 5XFAD mouse model of amyloidosis does not alter A deposition nor behavioral deficits associated with cerebral amyloid burden. Finally, a conditional BIN1 knockout in excitatory neurons did not alter BACE1, APP, C-terminal fragments derived from BACE1 cleavage of APP, or endogenous A levels. These results indicate that BIN1 function does not regulate A generation in vivo.	[Andrew, Robert J.; De Rossi, Pierre; Kowalski, Haley R.; Recupero, Aleksandra J.; Guerbette, Thomas; Krause, Sofia V.; Rice, Richard C.; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Nguyen, Phuong; Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Laury-Kleintop, Lisa] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Wagner, Steven L.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92161 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago; University of California System; University of California San Diego; Lankenau Medical Center; Lankenau Institute for Medical Research; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Chicago; University of Chicago	Thinakaran, G (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.; Thinakaran, G (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Thinakaran, G (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	gopal@uchicago.edu	Guerbette, Thomas/AGR-6964-2022; GUERBETTE, Thomas/AAL-6542-2020	De Rossi, Pierre/0000-0002-2356-4269; Recupero, Aleksandra/0000-0002-3321-4385; Kowalski, Haley/0000-0003-3530-5579	 [S10OD010649]; NATIONAL INSTITUTE ON AGING [RF1AG056061, RF1AG054223] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the University of Chicago Grossman Institute for Neuroscience for shared equipment support. Confocal imaging was performed at the Integrated Microscopy Core Facility at the University of Chicago (supported by grant S10OD010649).	Adams SL, 2016, J NEUROPATH EXP NEUR, V75, P779, DOI 10.1093/jnen/nlw056; Andersen OM, 2016, ACTA NEUROPATHOL, V132, P653, DOI 10.1007/s00401-016-1615-4; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Andrew RJ, 2017, P NATL ACAD SCI USA, V114, pE9665, DOI 10.1073/pnas.1708568114; Buggia-Prevot V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-1; Buggia-Prevot V, 2013, CELL REP, V5, P1552, DOI 10.1016/j.celrep.2013.12.006; Calafate S, 2016, CELL REP, V17, P931, DOI 10.1016/j.celrep.2016.09.063; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CAN-07-1100; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; De Rossi P, 2016, MOL PSYCHIATR, V21, P1768, DOI 10.1038/mp.2015.195; De Rossi P, 2019, BRAIN PATHOL, V29, P485, DOI 10.1111/bpa.12687; De Rossi Pierre, 2017, Matters (Zur), V2017, DOI 10.19185/matters.201611000018; De Rossi P, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0124-1; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Giannoni P, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00096; Glennon EBC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078806; Gong P, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-87; Gu LH, 2018, BRAIN RES BULL, V137, P285, DOI 10.1016/j.brainresbull.2017.12.013; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Holler CJ, 2014, J ALZHEIMERS DIS, V42, P1221, DOI 10.3233/JAD-132450; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lee S, 2016, ANN NEUROL, V79, P929, DOI 10.1002/ana.24647; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Malki I, 2017, FEBS J, V284, P3218, DOI 10.1111/febs.14185; Miyagawa T, 2016, HUM MOL GENET, V25, P2948, DOI 10.1093/hmg/ddw146; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nasrabady SE, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0515-3; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ou-Yang MH, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-134; Prokic I, 2014, J MOL MED, V92, P453, DOI 10.1007/s00109-014-1138-1; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Sadleir KR, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-1; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shi Y, 2018, NAT REV IMMUNOL, V18, P759, DOI 10.1038/s41577-018-0051-1; Tampellini D, 2009, J NEUROSCI, V29, P9704, DOI 10.1523/JNEUROSCI.2292-09.2009; Tan MS, 2013, TRENDS MOL MED, V19, P594, DOI 10.1016/j.molmed.2013.06.004; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Ubelmann F, 2017, EMBO REP, V18, P102, DOI 10.15252/embr.201642738; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Veeraraghavalu K, 2014, J NEUROSCI, V34, P3668, DOI 10.1523/JNEUROSCI.5079-13.2014; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884	59	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4477	4487		10.1074/jbc.RA118.006379	http://dx.doi.org/10.1074/jbc.RA118.006379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30692199	Green Published, hybrid			2022-12-28	WOS:000462969500016
J	Vlieg, HC; Huizinga, EG; Janssen, BJC				Vlieg, Hedwich C.; Huizinga, Eric G.; Janssen, Bert J. C.			Structure and flexibility of the extracellular region of the PirB receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor; crystal structure; neurobiology; cell signaling; synaptic plasticity; surface plasmon resonance (SPR); immunoglobulin-like domain	IMMUNOGLOBULIN-LIKE RECEPTOR; MYELIN-ASSOCIATED GLYCOPROTEIN; MHC CLASS-I; CRYSTAL-STRUCTURE; INHIBITORY-RECEPTOR; ACTIVATING RECEPTOR; NOGO RECEPTOR; BINDING; PROTEIN; IDENTIFICATION	Murine paired immunoglobulin receptor B (PirB) and its human ortholog leukocyte immunoglobulin-like receptor B2 (LILRB2) are widely expressed inhibitory receptors that interact with a diverse set of extracellular ligands and exert functions ranging from down-regulation of immune responses to inhibition of neuronal growth. However, structural information that could shed light on how PirB interacts with its ligands is lacking. Here, we report crystal structures of the PirB ectodomain; the first full ectodomain structure for a LILR family member, at 3.3-4.5 resolution. The structures reveal that PirB's six Ig-like domains are arranged at acute angles, similar to the structures of leukocyte immunoglobulin-like receptor (LILR) and killer-cell immunoglobulin-like receptor (KIR). We observe that this regular arrangement is followed throughout the ectodomain, resulting in an extended zigzag conformation. In two out of the five structures reported here, the repeating zigzag is broken by the first domain that can adopt two alternative orientations. Quantitative binding experiments revealed a 9 m dissociation constant for PirB-myelin-associated glycoprotein (MAG) ectodomain interactions. Taken together, these structural findings and the observed PirBMAG interactions are compatible with a model for intercellular signaling in which the PirB extracellular domains, which point away from the cell surface, enable interaction with ligands in trans.	[Vlieg, Hedwich C.; Huizinga, Eric G.; Janssen, Bert J. C.] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Crystal & Struct Chem,Dept Chem, NL-3584 CH Utrecht, Netherlands	Utrecht University	Janssen, BJC (corresponding author), Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Crystal & Struct Chem,Dept Chem, NL-3584 CH Utrecht, Netherlands.	b.j.c.janssen@uu.nl	Janssen, Bert/I-3338-2016	Janssen, Bert/0000-0002-8101-8370	Netherland Organization for Scientific Research (NWO) VIDI Grant [723.012.002]; NWO [01.80.104.00]	Netherland Organization for Scientific Research (NWO) VIDI Grant; NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherland Organization for Scientific Research (NWO) VIDI Grant 723.012.002 and NWO Grant 01.80.104.00. The authors declare that they have no conflicts of interest with the contents of this article.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Baldwin KT, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00023; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berg KL, 1998, ONCOGENE, V17, P2535, DOI 10.1038/sj.onc.1202203; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Bochner DN, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010157; Boghdadi AG, 2018, MOL NEUROBIOL, V55, P1831, DOI 10.1007/s12035-017-0433-6; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Cheng H, 2011, J BIOL CHEM, V286, P18013, DOI 10.1074/jbc.M111.221028; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Fan XM, 2014, BLOOD, V124, P2421, DOI 10.1182/blood-2014-03-557645; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; Hudson LE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00281; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel Evgeny, 2012, J Mol Biochem, V1, P76; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Matsushita H, 2011, J BIOL CHEM, V286, P25739, DOI 10.1074/jbc.M110.157859; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Moradi S, 2015, J BIOL CHEM, V290, P10460, DOI 10.1074/jbc.M114.612291; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nam G, 2013, PROTEIN CELL, V4, P761, DOI 10.1007/s13238-013-3908-x; Pronker MF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13584; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ryu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019245; Saulquin X, 2003, J EXP MED, V197, P933, DOI 10.1084/jem.20021624; Schimmele B, 2005, J MOL BIOL, V352, P229, DOI 10.1016/j.jmb.2005.06.073; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Shiroishi M, 2006, J BIOL CHEM, V281, P19536, DOI 10.1074/jbc.M603076200; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Yang ZR, 2008, P NATL ACAD SCI USA, V105, P10095, DOI 10.1073/pnas.0804551105; Zander H, 2007, J MOL RECOGNIT, V20, P185, DOI 10.1002/jmr.823; Zhang H, 2005, IMMUNITY, V22, P235, DOI 10.1016/j.immuni.2005.01.004; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095	52	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4634	4643		10.1074/jbc.RA118.004396	http://dx.doi.org/10.1074/jbc.RA118.004396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30674550	hybrid, Green Published			2022-12-28	WOS:000462969500029
J	Holz, GG; Chepurny, OG; Leech, CA				Holz, George G.; Chepurny, Oleg G.; Leech, Colin A.			"A-kinase" regulator runs amok to provide a paradigm shift in cAMP signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The activity of the archetypal protein kinase A (PKA) is typically thought of in regards to the catalytic subunit, which is inhibited by the regulatory subunits in the absence of cAMP. However, it is now reported that one of the regulatory subunit isoforms (PKA-RI alpha) takes on a function of its own upon binding to cAMP, acting independently of this canonical cAMP signaling mechanism. PKA-RI alpha instead binds to and stimulates the catalytic activity of a guanine nucleotide exchange factor (P-REX1) that itself promotes Rac1 GTPase activation. This newly discovered function of PKA-RI alpha adds an additional layer of complexity to our understanding of cAMP signal transduction.	[Holz, George G.; Chepurny, Oleg G.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Holz, George G.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Leech, Colin A.] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Holz, GG (corresponding author), SUNY Upstate Med Univ, IHP 4310 505 Irving Ave, Syracuse, NY 13210 USA.	holzg@upstate.edu	Holz, George G/A-3386-2012	Holz, George/0000-0002-1781-3580	National Institutes of Health [R01-DK069575]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01-DK069575 (to G. G. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chavez-Vargas L, 2016, J BIOL CHEM, V291, P6182, DOI 10.1074/jbc.M115.712216; Adame-Garcia SR, 2019, J BIOL CHEM, V294, P2232, DOI 10.1074/jbc.RA118.006691; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770	3	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2019	294	7					2247	2248		10.1074/jbc.H119.007622	http://dx.doi.org/10.1074/jbc.H119.007622			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HL7CN	30765510	Green Published, hybrid			2022-12-28	WOS:000458895400003
J	Bond, JS				Bond, Judith S.			Proteases: History, discovery, and roles in health and disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						proteinase; metalloprotease; protein degradation; protein complex; protein domain; astacins; meprins; metalloproteinase	METALLOPROTEASES MEPRIN-ALPHA; MOLECULAR-WEIGHT PROTEASES; MOUSE KIDNEY; BETA-GENE; DIFFERENTIAL EXPRESSION; DIABETIC-NEPHROPATHY; PARTIAL-PURIFICATION; TARGETED DISRUPTION; PROTEOLYTIC-ENZYMES; ASTACIN FAMILY	The Journal of Biological Chemistry (JBC) has been a major vehicle for disseminating and recording the discovery and characterization of proteolytic enzymes. The pace of discovery in the protease field accelerated during the 1971-2010 period that Dr. Herb Tabor served as the JBC's editor-in-chief. When he began his tenure, the fine structure and kinetics of only a few proteases were known; now thousands of proteases have been characterized, and over 600 genes for proteases have been identified in the human genome. In this review, besides reflecting on Dr. Tabor's invaluable contributions to the JBC and the American Society for Biochemistry and Molecular Biology (ASBMB), I endeavor to provide an overview of the extensive history of protease research, highlighting a few discoveries and roles of proteases in vivo. In addition, metalloproteinases, particularly meprins of the astacin family, will be discussed with regard to structural characteristics, regulation, mechanisms of action, and roles in health and disease. Proteases and protein degradation play crucial roles in living systems, and I briefly address future directions in this highly diverse and thriving research area.	[Bond, Judith S.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Bond, JS (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	jsb13@psu.edu						Anson ML, 1937, J GEN PHYSIOL, V20, P663, DOI 10.1085/jgp.20.5.663; Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; AULD DS, 1970, BIOCHEMISTRY-US, V9, P602, DOI 10.1021/bi00805a022; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Banerjee S, 2011, AM J PHYSIOL-GASTR L, V300, pG273, DOI 10.1152/ajpgi.00504.2009; Bao JL, 2013, AM J PHYSIOL-RENAL, V305, pF714, DOI 10.1152/ajprenal.00179.2012; Barrett A. J., 1980, MAMMALIAN PROTEASES, V1, P359; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bergmann M, 1937, J BIOL CHEM, V118, P405; BERLIN CM, 1965, MOL PHARMACOL, V1, P149; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BEYNON RJ, 1983, SCIENCE, V219, P1351, DOI 10.1126/science.6338590; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; BOND JS, 1984, P NATL ACAD SCI-BIOL, V81, P5542, DOI 10.1073/pnas.81.17.5542; BOND JS, 1980, DIABETES, V29, P648, DOI 10.2337/diabetes.29.8.648; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; BUTLER PE, 1988, J BIOL CHEM, V263, P13419; Bylander J, 2008, AM J PHYSIOL-RENAL, V294, pF480, DOI 10.1152/ajprenal.00214.2007; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; COFFEY JW, 1968, J BIOL CHEM, V243, P3255; CRAIG SS, 1987, AM J PHYSIOL, V253, pC535, DOI 10.1152/ajpcell.1987.253.4.C535; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; DeMartino GN, 2018, J BIOL CHEM, V293, P5384, DOI 10.1074/jbc.TM118.002429; DEMARTINO GN, 1979, J BIOL CHEM, V254, P3712; Dietrich JM, 1996, J BIOL CHEM, V271, P2271, DOI 10.1074/jbc.271.4.2271; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; Eagle ARR, 2005, HUM GENET, V118, P12, DOI 10.1007/s00439-005-0019-7; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; FOLK JE, 1960, J BIOL CHEM, V235, P2272; GALLOP PM, 1957, J BIOL CHEM, V227, P891; Garcia-Caballero A, 2011, CHANNELS, V5, P14, DOI 10.4161/chan.5.1.13759; GORBEA CM, 1993, J BIOL CHEM, V268, P21035; Hengst JA, 2004, J BIOL CHEM, V279, P34856, DOI 10.1074/jbc.M405774200; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HOUGH R, 1987, J BIOL CHEM, V262, P8303; Ishmael FT, 2005, J BIOL CHEM, V280, P13895, DOI 10.1074/jbc.M414218200; Ishmael SS, 2006, J BIOL CHEM, V281, P37404, DOI 10.1074/jbc.M602769200; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; JIANG WP, 1992, J BIOL CHEM, V267, P9185; Johnson GD, 1997, J BIOL CHEM, V272, P28126, DOI 10.1074/jbc.272.44.28126; Kadowaki T, 2000, J BIOL CHEM, V275, P25577, DOI 10.1074/jbc.M003521200; Keiffer TR, 2014, J BIOL CHEM, V289, P7580, DOI 10.1074/jbc.M113.546309; KIMMEL JR, 1954, J BIOL CHEM, V207, P515; KOUNNAS MZ, 1991, J BIOL CHEM, V266, P17350; Kumar JM, 2001, BBA-GENE STRUCT EXPR, V1518, P106, DOI 10.1016/S0167-4781(01)00188-9; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; MARCHAND P, 1995, J BIOL CHEM, V270, P5449, DOI 10.1074/jbc.270.10.5449; Mathew R, 2005, AM J PHYSIOL-RENAL, V289, pF911, DOI 10.1152/ajprenal.00037.2005; Matters GL, 1999, MOL CARCINOGEN, V25, P169, DOI 10.1002/(SICI)1098-2744(199907)25:3<169::AID-MC3>3.0.CO;2-Y; Matters GL, 2005, CLIN EXP METASTAS, V22, P331, DOI 10.1007/s10585-005-0660-5; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P37, DOI 10.1038/newbio238037a0; MILSTEIN C, 1972, NATURE-NEW BIOL, V239, P117, DOI 10.1038/newbio239117a0; Mohrlen F, 2006, EVOL DEV, V8, P223, DOI 10.1111/j.1525-142X.2006.00092.x; Niyitegeka JMV, 2015, AM J PHYSIOL-RENAL, V308, pF56, DOI 10.1152/ajprenal.00167.2014; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Northrop JH, 1931, SCIENCE, V73, P262, DOI 10.1126/science.73.1888.262; Northrop JH, 1930, J GEN PHYSIOL, V13, P739, DOI 10.1085/jgp.13.6.739; Ongeri EM, 2011, AM J PHYSIOL-RENAL, V301, pF871, DOI 10.1152/ajprenal.00703.2010; Orth K, 1996, J BIOL CHEM, V271, P20977, DOI 10.1074/jbc.271.35.20977; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; RECKELHOFF JF, 1985, IMMUNOGENETICS, V22, P617, DOI 10.1007/BF00430310; Robertson TB, 1907, J BIOL CHEM, V2, P317; Robertson TB, 1907, J BIOL CHEM, V3, P95; ROSE IA, 1979, J BIOL CHEM, V254, P8135; Schimke R. T., 1975, INTRACELLULAR PROTEI; SCHIMKE RT, 1965, J BIOL CHEM, V240, P4609; Schoenheimer R., 1942, DYNAMIC STATE BODY C; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Sun Q, 2009, EXP HEMATOL, V37, P346, DOI 10.1016/j.exphem.2008.10.016; Tang J, 1998, ARCH BIOCHEM BIOPHYS, V349, P192, DOI 10.1006/abbi.1997.0453; TITANI K, 1987, BIOCHEMISTRY-US, V26, P222, DOI 10.1021/bi00375a029; TRACHTMAN H, 1995, BIOCHEM BIOPH RES CO, V208, P498, DOI 10.1006/bbrc.1995.1366; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Tsukuba T, 2002, ARCH BIOCHEM BIOPHYS, V397, P191, DOI 10.1006/abbi.2001.2672; Tsukuba T, 1998, J BIOL CHEM, V273, P35260, DOI 10.1074/jbc.273.52.35260; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Villa JP, 2003, J BIOL CHEM, V278, P42545, DOI 10.1074/jbc.M303718200; WAXMAN L, 1987, J BIOL CHEM, V262, P2451; WILK S, 1980, J NEUROCHEM, V35, P1172, DOI 10.1111/j.1471-4159.1980.tb07873.x; WOLFE PB, 1982, J BIOL CHEM, V257, P7898; Yan L, 2000, DEV BIOL, V219, P115, DOI 10.1006/dbio.1999.9568; Yura RE, 2009, AM J PHYSIOL-RENAL, V296, pF135, DOI 10.1152/ajprenal.90524.2008	98	67	67	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1643	1651		10.1074/jbc.TM118.004156	http://dx.doi.org/10.1074/jbc.TM118.004156			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710012	hybrid, Green Published			2022-12-28	WOS:000457879200023
J	Jakob, U				Jakob, Ursula			Capturing A beta 42 aggregation in the cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ALZHEIMERS-DISEASE; MUTATION	Novel imaging techniques with ever-increasing resolution are invaluable tools for the study of protein deposition, as they allow the self-assembly of proteins to be directly investigated in living cells. For the first time, the acceleration in A beta 42 aggregation induced by the Arctic mutation was monitored in cells, revealing a number of distinct morphologies that form sequentially. This approach will help discriminate the impacts of mutations on amyloid protein processing, A beta aggregation propensity, and other mechanistic outcomes.						Cecchi, Cristina/0000-0001-8387-7737; Bemporad, Francesco/0000-0002-0643-6249				Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Golde TE, 2018, SCIENCE, V362, P1250, DOI 10.1126/science.aau0437; Lu M, 2019, J BIOL CHEM, V294, P1478, DOI 10.1074/jbc.RA118.004511; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Willig KI, 2014, CURR OPIN CHEM BIOL, V20, P16, DOI 10.1016/j.cbpa.2014.03.021	10	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1488	1489		10.1074/jbc.H119.007392	http://dx.doi.org/10.1074/jbc.H119.007392			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710006	Green Published, hybrid			2022-12-28	WOS:000457879200005
J	Kumar, S; Sharma, C; Kaushik, SR; Kulshreshtha, A; Chaturvedi, S; Nanda, RK; Bhaskar, A; Chattopadhyay, D; Das, G; Dwivedi, VP				Kumar, Santosh; Sharma, Chetan; Kaushik, Sandeep Rai; Kulshreshtha, Ankur; Chaturvedi, Shivam; Nanda, Ranjan Kumar; Bhaskar, Ashima; Chattopadhyay, Debprasad; Das, Gobardhan; Dwivedi, Ved Prakash			The phytochemical bergenin as an adjunct immunotherapy for tuberculosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; immunotherapy; drug resistance; cytokine; T helper cells; infectious disease; adjunct therapy; bergenin; isoniazid; multidrug resistance; natural product; T cells; memory cells; immunity	CALMETTE-GUERIN VACCINE; CELL-DIFFERENTIATION; TGF-BETA; T-CELLS; BCG; INTERLEUKIN-12; T-HELPER-2; ACTIVATION; RESISTANCE; MOLECULES	The widespread availability and use of modern synthetic therapeutic agents have led to a massive decline in ethnomedical therapies. However, these synthetic agents often possess toxicity leading to various adverse effects. For instance, anti-tubercular treatment (ATT) is toxic, lengthy, and severely impairs host immunity, resulting in posttreatment vulnerability to reinfection and reactivation of tuberculosis (TB). Incomplete ATT enhances the risk for the generation of multidrug- or extensively drug-resistant (MDR or XDR, respectively) variants of Mycobacterium tuberculosis (M. tb), the TB-causing microbe. Therefore, a new therapeutic approach that minimizes these risks is urgently needed to combat this deadly disease and prevent future TB epidemics. Previously, we have shown that the phytochemical bergenin induces T helper 1 (Th1)- and Th17 cell-based protective immune responses and potently inhibits mycobacterial growth in a murine model of M. tb infection, suggesting bergenin as a potential adjunct agent to TB therapy. Here, we combined ATT therapy with bergenin and found that this combination reduces immune impairment and the length of treatment in mice. We observed that co-treatment with the anti-TB drug isoniazid and bergenin produces additive effects and significantly reduces bacterial loads compared with isoniazid treatment alone. The bergenin co-treatment also reduced isoniazid-induced immune impairment; promoted long-lasting, antigen-specific central memory T cell responses; and acted as a self-propelled vaccine. Of note, bergenin treatment significantly reduced the bacterial burden of a multidrug-resistant TB strain. These observations suggest that bergenin is a potent immunomodulatory agent that could be further explored as a potential adjunct to TB therapy.	[Kumar, Santosh; Sharma, Chetan; Kaushik, Sandeep Rai; Chaturvedi, Shivam; Nanda, Ranjan Kumar; Dwivedi, Ved Prakash] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Kulshreshtha, Ankur] Inst Genom & Integrat Biol, New Delhi 110007, India; [Bhaskar, Ashima] Natl Inst Immunol, Signal Transduct Lab 1, New Delhi 110067, India; [Chattopadhyay, Debprasad] ID & BG Hosp, ICMR Virus Unit, Kolkata 700010, W Bengal, India; [Das, Gobardhan] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; Jawaharlal Nehru University, New Delhi	Das, G (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.; Dwivedi, VP (corresponding author), Aruna Asaf Ali Marg, New Delhi 110067, India.	das07@gmail.com; vedprakashbt@gmail.com	Nanda, Ranjan/ABD-3967-2021; KULSHRESHTHA, ANKUR/AFP-2527-2022	KULSHRESHTHA, ANKUR/0000-0001-5139-6744; Dwivedi, Ved Prakash/0000-0003-4321-2567; Sharma, Chetan/0000-0002-6446-8951; Kaushik, Sandeep Rai/0000-0002-3463-3522; BHASKAR, ASHIMA/0000-0002-7367-874X	International Centre for Genetic Engineering and Biotechnology (ICGEB, New Delhi, India)	International Centre for Genetic Engineering and Biotechnology (ICGEB, New Delhi, India)	We acknowledge the support of the DBT-supported Tuberculosis Aerosol Challenge Facility and Bio-experimentation Facility (Animal House) at the International Centre for Genetic Engineering and Biotechnology (ICGEB, New Delhi, India) and their staff in accomplishing this work.	Bhattacharya D, 2014, J BIOL CHEM, V289, P33404, DOI 10.1074/jbc.M114.600452; Bhattacharya D, 2014, J BIOL CHEM, V289, P16508, DOI 10.1074/jbc.M114.558098; Byrd TF, 2007, CURR NEUROL NEUROSCI, V7, P470, DOI 10.1007/s11910-007-0073-8; Cadena AM, 2016, MBIO, V7, DOI 10.1128/mBio.00342-16; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; Das J, 2009, J EXP MED, V206, P3157, DOI 10.1084/jem.20082286120409c; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Duhen T, 2014, J IMMUNOL, V193, P120, DOI 10.4049/jimmunol.1302734; Dwivedi VP, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00149; Dwivedi VP, 2012, J BIOL CHEM, V287, P33656, DOI 10.1074/jbc.M112.375154; FINE PEM, 1989, REV INFECT DIS, V11, pS353; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gomez-Cansino R, 2017, AN ACAD BRAS CIENC, V89, P31, DOI 10.1590/0001-3765201720160298; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Jnawali HN, 2016, J NAT PROD, V79, P961, DOI 10.1021/acs.jnatprod.5b01033; Kernodle DS, 2010, CLIN INFECT DIS, V51, P177, DOI 10.1086/653533; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lee H, 2016, J IND MICROBIOL BIOT, V43, P205, DOI 10.1007/s10295-015-1709-3; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Mukherjee H, 2013, J ETHNOPHARMACOL, V149, P335, DOI 10.1016/j.jep.2013.06.045; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS165; Rahman MA, 2015, J BIOL CHEM, V290, P14407, DOI 10.1074/jbc.M115.653600; Rook GAW, 2007, CURR MOL MED, V7, P327; Santarlasci V, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00182; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Singh DK, 2016, J INFECT DIS, V214, P1456, DOI 10.1093/infdis/jiw395; Stanford J L, 1990, Bull Int Union Tuberc Lung Dis, V65, P27; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Tousif S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00739; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2018, GLOB TUB REP 2018; World Health Organization, 2015, TUB VACC DEV; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	44	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8555	8563		10.1074/jbc.RA119.008005	http://dx.doi.org/10.1074/jbc.RA119.008005			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30975902	Green Published, hybrid			2022-12-28	WOS:000471108200023
J	Colige, A; Monseur, C; Crawley, JTB; Santamaria, S; de Groot, R				Colige, Alain; Monseur, Christine; Crawley, James T. B.; Santamaria, Salvatore; de Groot, Rens			Proteomic discovery of substrates of the cardiovascular protease ADAMTS7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS; substrate specificity; proteolysis; tissue inhibitor of metalloproteinase (TIMP); proteolytic enzyme; ADAMTS7; autolysis; cleavage sites; LTBP4; TIMP-4	MUSCLE-CELL MIGRATION; TISSUE INHIBITORS; SPACER DOMAIN; LONG FORM; BINDING; CLEAVAGE; GENE; DISEASE; TIMP4; AGGRECANASE-1	The protease ADAMTS7 functions in the extracellular matrix (ECM) of the cardiovascular system. However, its physiological substrate specificity and mechanism of regulation remain to be explored. To address this, we conducted an unbiased substrate analysis using terminal amine isotopic labeling of substrates (TAILS). The analysis identified candidate substrates of ADAMTS7 in the human fibroblast secretome, including proteins with a wide range of functions, such as collagenous and noncollagenous extracellular matrix proteins, growth factors, proteases, and cell-surface receptors. It also suggested that autolysis occurs at Glu-729-Val-730 and Glu-732-Ala-733 in the ADAMTS7 Spacer domain, which was corroborated by N-terminal sequencing and Western blotting. Importantly, TAILS also identified proteolysis of the latent TGF--binding proteins 3 and 4 (LTBP3/4) at a Glu-Val and Glu-Ala site, respectively. Using purified enzyme and substrate, we confirmed ADAMTS7-catalyzed proteolysis of recombinant LTBP4. Moreover, we identified multiple additional scissile bonds in an N-terminal linker region of LTBP4 that connects fibulin-5/tropoelastin and fibrillin-1-binding regions, which have an important role in elastogenesis. ADAMTS7-mediated cleavage of LTBP4 was efficiently inhibited by the metalloprotease inhibitor TIMP-4, but not by TIMP-1 and less efficiently by TIMP-2 and TIMP-3. As TIMP-4 expression is prevalent in cardiovascular tissues, we propose that TIMP-4 represents the primary endogenous ADAMTS7 inhibitor. In summary, our findings reveal LTBP4 as an ADAMTS7 substrate, whose cleavage may potentially impact elastogenesis in the cardiovascular system. We also identify TIMP-4 as a likely physiological ADAMTS7 inhibitor.	[Colige, Alain; Monseur, Christine] Univ Liege, GIGA, Lab Connect Tissue Biol, B-4000 Liege, Belgium; [Crawley, James T. B.; Santamaria, Salvatore; de Groot, Rens] Imperial Coll London, Ctr Haematol, London W12 0NN, England	University of Liege; Imperial College London	de Groot, R (corresponding author), 5th Fl,Commonwealth Bldg,Hammersmith Hosp Campus, London W12 0NN, England.	R.deGroot@imperial.ac.uk	Crawley, James TB/A-9290-2008	Crawley, James TB/0000-0002-6723-7841; Santamaria, Salvatore/0000-0001-8670-7776; de Groot, Rens/0000-0002-1044-9499	British Heart Foundation [PG/18/19/33584]; Imperial College London; Fonds De La Recherche Scientifique-FNRS Grant [7.6536.18]; Fonds Leon Fredericq; ULiege	British Heart Foundation(British Heart Foundation); Imperial College London(General Electric); Fonds De La Recherche Scientifique-FNRS Grant(Fonds de la Recherche Scientifique - FNRS); Fonds Leon Fredericq; ULiege	This work was supported by British Heart Foundation Grant PG/18/19/33584 (to R. d. G. and J. T. B. C.), Imperial College London (to S. S. and R. d. G.), Fonds De La Recherche Scientifique-FNRS Grant 7.6536.18 (to A. C. and C. M.), Fonds Leon Fredericq and ULiege (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Arroyo AG, 2015, CIRCULATION, V131, P1156, DOI 10.1161/CIRCULATIONAHA.115.015711; Bauer RC, 2015, CIRCULATION, V131, P1202, DOI 10.1161/CIRCULATIONAHA.114.012669; Bekhouche M, 2016, FASEB J, V30, P1741, DOI 10.1096/fj.15-279869; Bengtsson E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03573-4; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Cain SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35956; de Groot R., 2019, METHODS MOL BIOL; de Groot R, 2015, BLOOD, V125, P1968, DOI 10.1182/blood-2014-08-594556; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Doll S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01747-2; Fabre B, 2014, J MED CHEM, V57, P10205, DOI 10.1021/jm500505f; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Georgiadis K., 2002, T ORTHOP RES SOC, V48, P167; Guo CQ, 2016, BIOMED REP, V4, P73, DOI 10.3892/br.2015.535; Guo DC, 2018, AM J HUM GENET, V102, P706, DOI 10.1016/j.ajhg.2018.03.002; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Hubmacher D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41871; Hubmacher D, 2015, MATRIX BIOL, V47, P34, DOI 10.1016/j.matbio.2015.05.004; Huckert M, 2015, HUM MOL GENET, V24, P3038, DOI 10.1093/hmg/ddv053; Jin SY, 2010, BLOOD, V115, P2300, DOI 10.1182/blood-2009-07-235101; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kessler T, 2015, CIRCULATION, V131, P1191, DOI 10.1161/CIRCULATIONAHA.114.014072; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P85; Koski C, 1999, J BIOL CHEM, V274, P32619, DOI 10.1074/jbc.274.46.32619; Koskivirta I, 2006, HISTOCHEM CELL BIOL, V126, P335, DOI 10.1007/s00418-006-0163-8; Koskivirta I, 2010, J BIOL CHEM, V285, P24487, DOI 10.1074/jbc.M110.136820; Liu CJ, 2006, FASEB J, V20, P988, DOI 10.1096/fj.05-3877fje; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Mead TJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.92941; Muller M, 2016, BIOCHEM BIOPH RES CO, V471, P380, DOI 10.1016/j.bbrc.2016.02.025; Mularczyk EJ, 2018, HUM MOL GENET, V27, P3675, DOI 10.1093/hmg/ddy276; Nicholson AC, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-11; Noda K, 2013, P NATL ACAD SCI USA, V110, P2852, DOI 10.1073/pnas.1215779110; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Pu XY, 2013, AM J HUM GENET, V92, P366, DOI 10.1016/j.ajhg.2013.01.012; Rahkonen OP, 2002, BBA-GENE STRUCT EXPR, V1577, P45, DOI 10.1016/S0167-4781(02)00404-9; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Rifkin DB, 2018, MATRIX BIOL, V71-72, P90, DOI 10.1016/j.matbio.2017.11.014; Robertson IB, 2015, MATRIX BIOL, V47, P44, DOI 10.1016/j.matbio.2015.05.005; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; Santamaria S, 2017, INT J EXP PATHOL, V98, pA3; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; Todorovic V, 2011, DEV DYNAM, V240, P176, DOI 10.1002/dvdy.22521; Wang LW, 2019, MATRIX BIOL, V77, P117, DOI 10.1016/j.matbio.2018.09.004; Wang L, 2009, CIRC RES, V104, P688, DOI 10.1161/CIRCRESAHA.108.188425; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	55	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8037	8045		10.1074/jbc.RA119.007492	http://dx.doi.org/10.1074/jbc.RA119.007492			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30926607	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000470656500007
J	Yu, A; Fox, SG; Cavallini, A; Kerridge, C; O'Neill, MJ; Wolak, J; Bose, S; Morimoto, RI				Yu, Anan; Fox, Susan G.; Cavallini, Annalisa; Kerridge, Caroline; O'Neill, Michael J.; Wolak, Joanna; Bose, Suchira; Morimoto, Richard I.			Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Tau protein (Tau); chaperone; heat-shock protein (HSP); protein aggregation; heat-shock protein 90 (Hsp90); chaperone competition; Clathrin-mediated endocytosis; HSC70; HSP27; HSP70	CLATHRIN-MEDIATED ENDOCYTOSIS; UBIQUITIN-PROTEASOME SYSTEM; AMPA RECEPTOR ENDOCYTOSIS; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; PATHOLOGY; PROPAGATION; CHAPERONES	Tauopathies are a diverse class of neurodegenerative diseases characterized by the formation of insoluble tau aggregates and the loss of cellular function and neuronal death. Tau inclusions have been shown to contain a number of proteins, including molecular chaperones, but the consequences of these entrapments are not well established. Here, using a human cell system for seeding-dependent tau aggregation, we demonstrate that the molecular chaperones heat-shock cognate 71-kDa protein (HSC70)/heat-shock protein 70 (HSP70), HSP90, and J-domain co-chaperones are sequestered by tau aggregates. By employing single-cell analysis of protein-folding and clathrin-mediated endocytosis, we show that both chaperone-dependent cellular activities are significantly impaired by tau aggregation and can be reversed by treatment with small-molecule regulators of heat-shock transcription factor 1 (HSF1) proteostasis that induce the expression of cytosolic chaperones. These results reveal that the sequestration of cytoplasmic molecular chaperones by tau aggregates interferes with two arms of the proteostasis network, likely having profound negative consequences for cellular function.	[Yu, Anan; Fox, Susan G.; Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA; [Cavallini, Annalisa; Kerridge, Caroline; O'Neill, Michael J.; Wolak, Joanna; Bose, Suchira] Eli Lilly & Co Ltd, Lilly Res Ctr, Sunninghill Rd, Windlesham GU20 6PH, Surrey, England	Northwestern University; Eli Lilly	Morimoto, RI (corresponding author), Northwestern Univ, Rice Inst Biomed Res, Dept Mol Biosci, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu		Morimoto, Richard/0000-0002-3431-445X; Wolak, Joanna/0000-0003-1068-1770	National Institutes of Health from NIA [R37-AG026647, P01-AG054409]; Daniel F. and Ada L. Rice Foundation; Eli Lilly & Co. Ltd., Lilly Research Centre; NATIONAL INSTITUTE ON AGING [RF1AG054409, R37AG026647, P01AG054407] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Daniel F. and Ada L. Rice Foundation; Eli Lilly & Co. Ltd., Lilly Research Centre; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R37-AG026647 and P01-AG054409 from NIA, the Daniel F. and Ada L. Rice Foundation (to R. I. M.), and a research grant from Eli Lilly & Co. Ltd., Lilly Research Centre. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Baughman HER, 2018, J BIOL CHEM, V293, P2687, DOI 10.1074/jbc.M117.803411; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; BRORSON JR, 1995, J NEUROSCI, V15, P4515; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciryam P, 2015, TRENDS PHARMACOL SCI, V36, P72, DOI 10.1016/j.tips.2014.12.004; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cosker KE, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020669; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DeVos SL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00267; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jinwal UK, 2010, J BIOL CHEM, V285, P16798, DOI 10.1074/jbc.M110.113753; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Klaips CL, 2018, J CELL BIOL, V217, P51, DOI 10.1083/jcb.201709072; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Kundra R, 2017, P NATL ACAD SCI USA, V114, pE5703, DOI 10.1073/pnas.1618417114; Labbadia J, 2015, MOL CELL, V59, P639, DOI 10.1016/j.molcel.2015.06.027; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mead E, 2016, J ALZHEIMERS DIS, V54, P1521, DOI 10.3233/JAD-150960; Minjarez B, 2013, J ALZHEIMERS DIS, V34, P239, DOI 10.3233/JAD-121480; Mok SA, 2018, NAT STRUCT MOL BIOL, V25, P384, DOI 10.1038/s41594-018-0057-1; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Schmidt T, 2002, ANN NEUROL, V51, P302, DOI 10.1002/ana.10101; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; Vitale F, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0585-2; Voss K, 2012, BIOCHEMISTRY-US, V51, P888, DOI 10.1021/bi2018078; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Watanabe S, 2014, NATURE, V515, P228, DOI 10.1038/nature13846; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; WITMAN GB, 1976, P NATL ACAD SCI USA, V73, P4070, DOI 10.1073/pnas.73.11.4070; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	89	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7917	7930		10.1074/jbc.RA119.007527	http://dx.doi.org/10.1074/jbc.RA119.007527			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30936201	hybrid, Green Published			2022-12-28	WOS:000470153300031
J	Albertolle, ME; Glass, SM; Trefts, E; Guengerich, FP				Albertolle, Matthew E.; Glass, Sarah M.; Trefts, Elijah; Guengerich, F. Peter			Isotopic tagging of oxidized and reduced cysteines (iTORC) for detecting and quantifying sulfenic acids, disulfides, and free thiols in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thiol; disulfide; mass spectrometry (MS); proteomics; oxidative stress; oxidation-reduction (redox); cysteine; isotopic tagging of oxidized and reduced cysteines (iTORC); oxidative damage; sulfenic acid	REACTIVITY; INACTIVATION; CHEMISTRY; PROTEINS; PATHWAY	Oxidative modifications of cysteine residues are an important component in signaling pathways, enzymatic regulation, and redox homeostasis. Current direct and indirect methods detect specific modifications and a general binary population of free or oxidized cysteines, respectively. In an effort to combine both direct and indirect detection strategies, here we developed a method that we designate isotopic tagging of oxidized and reduced cysteines (iTORC). This method uses synthetic molecules for rapid isotopic coding of sulfenic acids, reduced cysteines, and disulfides in cells. Our approach utilizes isotopically distinct benzothiazine and halogenated benzothiazine probes to sequentially alkylate sulfenic acids and then free thiols and, finally, after a reduction step, cysteines oxidized to disulfides or other phosphine-reducible states. We ascertained that the iodinated benzothiazine probe has reduced cross-reactivity toward primary amines and is highly reactive with the cysteine of GSH, with a calculated rate constant of 2 x 10(5) m(-1) s(-1) (pH 8.0, 23 degrees C) (i.e. 10-20 times faster than N-ethylmaleimide). We applied iTORC to a mouse hepatocyte lysate to identify known sulfenylated and disulfide-bonded proteins, including elongation factor 1-1 and mouse serum albumin, and found that iTORC reliably detected their expected oxidation status. This method can be easily employed to study the effects of oxidants on recombinant proteins and cell and tissue extracts, and the efficiencies of the alkylating agents enable completion of all three labeling steps within 2 h. In summary, we demonstrate here that halogenated benzothiazine-based alkylating agents can be utilized to rapidly measure the cellular thiol status in cells.	[Albertolle, Matthew E.; Glass, Sarah M.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Trefts, Elijah] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Glass, Sarah/0000-0003-1942-7293	National Institutes of Health [R01 GM118122, F31 HL136133, T32 ES007028, F31 DK112553, R37 DK050277, R01 DK054902]; American Heart Association Pre-doctoral Fellowship [PRE33410007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL136133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054902, F31DK112553, R37DK050277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Pre-doctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM118122 (to F. P. G.), F31 HL136133 (to M. E. A.), T32 ES007028 (to F. P. G. and S. M. G.), F31 DK112553 (to E. T.), R37 DK050277 (to E. T.), and R01 DK054902 (to E. T.) and American Heart Association Pre-doctoral Fellowship PRE33410007 (to M. E. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albertolle ME, 2018, J INORG BIOCHEM, V186, P228, DOI 10.1016/j.jinorgbio.2018.05.014; Albertolle ME, 2018, MOL CELL PROTEOMICS, V17, P889, DOI 10.1074/mcp.RA117.000382; Albertolle ME, 2017, J BIOL CHEM, V292, P11230, DOI 10.1074/jbc.M117.792200; Alcock LJ, 2018, CHEM SOC REV, V47, P231, DOI 10.1039/c7cs00607a; Alvarez B, 2010, METHOD ENZYMOL, V473, P117, DOI 10.1016/S0076-6879(10)73005-6; BEDNAR RA, 1990, BIOCHEMISTRY-US, V29, P3684, DOI 10.1021/bi00467a014; BENITEZ LV, 1974, J BIOL CHEM, V249, P6234; Carroll K. S., 2018, United States Patent, Patent No. [9,977,024, 9977024]; Chen XF, 2017, ACS CHEM BIOL, V12, P2201, DOI 10.1021/acschembio.7b00444; Devarie-Baez NO, 2016, FREE RADICAL RES, V50, P172, DOI 10.3109/10715762.2015.1090571; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fu Ling, 2019, Curr Protoc Protein Sci, V95, pe76, DOI 10.1002/cpps.76; Guo J, 2014, NAT PROTOC, V9, P64, DOI 10.1038/nprot.2013.161; Gupta V, 2017, J AM CHEM SOC, V139, P5588, DOI 10.1021/jacs.7b01791; Gupta V, 2016, CHEM SCI, V7, P400, DOI 10.1039/c5sc02569a; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051; Holman Jerry D, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1317s37; Liu T, 2015, ACTA BIOCH BIOPH SIN, V47, P1011, DOI 10.1093/abbs/gmv113; Parvez S, 2018, CHEM REV, V118, P8798, DOI 10.1021/acs.chemrev.7b00698; Portillo-Ledesma S, 2018, BIOCHEMISTRY-US, V57, P3416, DOI 10.1021/acs.biochem.8b00188; Prakash AS, 2018, ANAL CHEM, V90, P14173, DOI 10.1021/acs.analchem.8b02517; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Seo YH, 2011, ANGEW CHEM INT EDIT, V50, P1342, DOI 10.1002/anie.201007175; SHAKED Z, 1980, BIOCHEMISTRY-US, V19, P4156, DOI 10.1021/bi00559a004; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sigrist CJA, 2005, BIOINFORMATICS, V21, P4060, DOI 10.1093/bioinformatics/bti614; Sreedhar B, 2007, SYNTHETIC COMMUN, V37, P4149, DOI 10.1080/00397910701574908; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Truong TH, 2016, CELL CHEM BIOL, V23, P837, DOI 10.1016/j.chembiol.2016.05.017; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Volovenko Y, 2007, J HETEROCYCLIC CHEM, V44, P1413, DOI 10.1002/jhet.5570440627; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5776; Zhou HY, 2011, J AM CHEM SOC, V133, P15803, DOI 10.1021/ja2077137	35	4	4	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6522	6530		10.1074/jbc.AC118.007225	http://dx.doi.org/10.1074/jbc.AC118.007225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30850396	hybrid, Green Published			2022-12-28	WOS:000468402000027
J	Li, MN; Liu, YK; Wei, YM; Wu, CC; Meng, HB; Niu, WH; Zhou, Y; Wang, HR; Wen, QY; Fan, SQ; Li, Z; Li, XY; Zhou, JD; Cao, K; Xiong, W; Zeng, ZY; Li, XL; Qiu, YZ; Li, GY; Zhou, M				Li, Mengna; Liu, Yukun; Wei, Yanmei; Wu, Chunchun; Meng, Hanbing; Niu, Weihong; Zhou, Yao; Wang, Heran; Wen, Qiuyuan; Fan, Songqing; Li, Zheng; Li, Xiayu; Zhou, Jianda; Cao, Ke; Xiong, Wei; Zeng, Zhaoyang; Li, Xiaoling; Qiu, Yuanzheng; Li, Guiyuan; Zhou, Ming			Zinc-finger protein YY1 suppresses tumor growth of human nasopharyngeal carcinoma by inactivating c-Myc-mediated microRNA-141 transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor; transcription regulation; proliferation; cell cycle; apoptosis; tumor suppressor gene; c-Myc; microRNA 141; nasopharyngeal carcinoma (NPC); Yin Yang 1 (YY1)	YIN YANG 1; CANCER; EXPRESSION; MECHANISM; PROVIDES; DOMAIN; GENE; BRD7; MAX	Yin Yang 1 (YY1) is a zinc-finger protein that plays critical roles in various biological processes by interacting with DNA and numerous protein partners. YY1 has been reported to play dual biological functions as either an oncogene or tumor suppressor in the development and progression of multiple cancers, but its role in human nasopharyngeal carcinoma (NPC) has not yet been revealed. In this study, we found that YY1 overexpression significantly inhibits cell proliferation and cell-cycle progression from G(1) to S and promotes apoptosis in NPC cells. Moreover, we identified YY1 as a component of the c-Myc complex and observed that ectopic expression of YY1 inhibits c-Myc transcriptional activity, as well as the promoter activity and expression of the c-Myc target gene microRNA-141 (miR-141). Furthermore, restoring miR-141 expression could at least partially reverse the inhibitory effect of YY1 on cell proliferation and tumor growth and on the expression of some critical c-Myc targets, such as PTEN/AKT pathway components both in vitro and in vivo. We also found that YY1 expression is reduced in NPC tissues, negatively correlates with miR-141 expression and clinical stages in NPC patients, and positively correlates with survival prognosis. Our results reveal a previously unappreciated mechanism in which the YY1/c-Myc/miR-141 axis plays a critical role in NPC progression and may provide some potential and valuable targets for the diagnosis and treatment of NPC.	[Li, Mengna; Liu, Yukun; Wei, Yanmei; Wu, Chunchun; Meng, Hanbing; Niu, Weihong; Zhou, Yao; Wang, Heran; Li, Guiyuan; Zhou, Ming] Cent S Univ, Hunan Canc Hosp, Changsha 410013, Hunan, Peoples R China; [Li, Mengna; Liu, Yukun; Wei, Yanmei; Wu, Chunchun; Meng, Hanbing; Niu, Weihong; Zhou, Yao; Wang, Heran; Li, Guiyuan; Zhou, Ming] Cent S Univ, Affiliated Tumor Hosp, Xiangya Med Sch, Changsha 410013, Hunan, Peoples R China; [Li, Mengna; Liu, Yukun; Wei, Yanmei; Wu, Chunchun; Meng, Hanbing; Niu, Weihong; Zhou, Yao; Li, Zheng; Xiong, Wei; Zeng, Zhaoyang; Li, Xiaoling; Li, Guiyuan; Zhou, Ming] Cent S Univ, Key Lab Carcinogenesis, Chinese Minist Hlth, Key Lab Carcinogenesis & Canc Invas, Changsha 410078, Hunan, Peoples R China; [Li, Mengna; Liu, Yukun; Wei, Yanmei; Wu, Chunchun; Meng, Hanbing; Niu, Weihong; Zhou, Yao; Li, Zheng; Xiong, Wei; Zeng, Zhaoyang; Li, Xiaoling; Li, Guiyuan; Zhou, Ming] Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Wen, Qiuyuan; Fan, Songqing] Cent S Univ, XiangYa Hosp 2, Changsha 410011, Hunan, Peoples R China; [Qiu, Yuanzheng] Cent S Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha 410008, Hunan, Peoples R China; [Li, Zheng] Cent S Univ, High Resolut Mass Spectrometry Lab, Adv Res Ctr, Changsha 410013, Hunan, Peoples R China; [Li, Xiayu; Zhou, Jianda; Cao, Ke] Cent S Univ, XiangYa Hosp 3, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Zhou, M (corresponding author), Cent S Univ, Affiliated Tumor Hosp, Xiangya Med Sch, Changsha 410013, Hunan, Peoples R China.	zhouming2001@163.com	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022; wu, Xianrui/AAM-6540-2021	wu, Xianrui/0000-0003-4803-5934	National Natural Science Foundation of China [81772990, 81572748]; "111" Project [111-2-12]; Central South University Graduate Research and Innovation Project [2018zzts823, 2018zzts233]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111" Project(Ministry of Education, China - 111 Project); Central South University Graduate Research and Innovation Project	This work was supported by National Natural Science Foundation of China Grants 81772990 and 81572748, the "111" Project Grant 111-2-12, and the Central South University Graduate Research and Innovation Project Grants 2018zzts823 and 2018zzts233. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Austen M, 1998, ONCOGENE, V17, P511, DOI 10.1038/sj.onc.1201968; Beaulieu ME, 2013, METHODS MOL BIOL, V1012, P7, DOI 10.1007/978-1-62703-429-6_2; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Chua MLK, 2016, LANCET, V387, P1012, DOI 10.1016/S0140-6736(15)00055-0; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Khachigian LM, 2018, INT J CANCER, V143, P460, DOI 10.1002/ijc.31255; Lee AWM, 2015, J CLIN ONCOL, V33, P3356, DOI 10.1200/JCO.2015.60.9347; Lee MH, 2012, ONCOGENE, V31, P116, DOI 10.1038/onc.2011.217; Liu HY, 2006, DNA CELL BIOL, V25, P346, DOI 10.1089/dna.2006.25.346; Liu HY, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-111; Liu Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.64; Liu YK, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0734-2; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Masmoudi A, 2007, CANCER TREAT REV, V33, P499, DOI 10.1016/j.ctrv.2007.04.007; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nair SK, 2006, CURR TOP MICROBIOL, V302, P123; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Niu ZX, 2015, ACTA BIOCH BIOPH SIN, V47, P183, DOI 10.1093/abbs/gmu129; Pan JJ, 2016, CANCER-AM CANCER SOC, V122, P546, DOI 10.1002/cncr.29795; Rahl PB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a020990; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Shen Y, 2017, EXP HEMATOL, V53, P16, DOI 10.1016/j.exphem.2017.04.009; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Shrivastava A, 1996, P NATL ACAD SCI USA, V93, P10638, DOI 10.1073/pnas.93.20.10638; Trop-Steinberg S, 2018, AM J MED SCI, V355, P67, DOI 10.1016/j.amjms.2017.06.007; Wen QY, 2015, INT J CLIN EXP PATHO, V8, P8236; Wu SR, 2013, CANCER RES, V73, P1787, DOI 10.1158/0008-5472.CAN-12-0366; Xu J, 2015, CANCER CELL, V27, P177, DOI 10.1016/j.ccell.2014.11.025; Yu X, 2016, AM J TRANSL RES, V8, P742; Yue M, 2017, CELL REP, V21, P3819, DOI 10.1016/j.celrep.2017.12.002; Zhang JJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-130; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhang Qiang, 2011, Critical Reviews in Oncogenesis, V16, P163; Zhao R, 2017, CELL MOL IMMUNOL, V14, P830, DOI 10.1038/cmi.2016.31	38	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6172	6187		10.1074/jbc.RA118.006281	http://dx.doi.org/10.1074/jbc.RA118.006281			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30718276	Green Published, hybrid			2022-12-28	WOS:000465077500044
J	Zhang, M; Hu, C; Moses, N; Haakenson, J; Xiang, SY; Quan, D; Fang, B; Yang, Z; Bai, WL; Bepler, G; Li, GM; Zhang, XM				Zhang, Mu; Hu, Chen; Moses, Niko; Haakenson, Joshua; Xiang, Shengyan; Quan, Daniel; Fang, Bin; Yang, Zhe; Bai, Wenlong; Bepler, Gerold; Li, Guo-Min; Zhang, Xiaohong Mary			HDAC6 regulates DNA damage response via deacetylating MLH1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone deacetylase 6 (HDAC6); DNA damage response; DNA mismatch repair; drug resistance; acetylation; acetylation; DNA damage response; DNA repair; HDAC6; MLH1	MISMATCH-REPAIR; HISTONE DEACETYLASES; HYPERMETHYLATION; EXPRESSION; MUTATIONS; CELLS	MutL homolog 1 (MLH1) is a key DNA mismatch repair protein, which plays an important role in maintenance of genomic stability and the DNA damage response. Here, we report that MLH1 is a novel substrate of histone deacetylase 6 (HDAC6). HDAC6 interacts with and deacetylates MLH1 both in vitro and in vivo. Interestingly, deacetylation of MLH1 blocks the assembly of the MutS-MutL complex. Moreover, we have identified four novel acetylation sites in MLH1 by MS analysis. The deacetylation mimetic mutant, but not the WT and the acetylation mimetic mutant, of MLH1 confers resistance to 6-thioguanine. Overall, our findings suggest that the MutS-MutL complex serves as a sensor for DNA damage response and that HDAC6 disrupts the MutS-MutL complex by deacetylation of MLH1, leading to the tolerance of DNA damage.	[Zhang, Mu; Hu, Chen; Bepler, Gerold; Zhang, Xiaohong Mary] Wayne State Univ, Sch Med, Dept Oncol, Karmanos Canc Inst,Mol Therapeut Program, Detroit, MI 48201 USA; [Moses, Niko] Wayne State Univ, Sch Med, Dept Oncol, Karmanos Canc Inst,Canc Biol Grad Program, Detroit, MI 48201 USA; [Haakenson, Joshua; Xiang, Shengyan; Bai, Wenlong] Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Quan, Daniel] Wayne State Univ, Sch Med, Detroit, MI 48201 USA; [Fang, Bin] H Lee Moffitt Canc Ctr & Res Inst, Prote Core, Tampa, FL 33612 USA; [Yang, Zhe] Wayne State Univ, Sch Med, Dept Microbiol Immunol & Biochem, Detroit, MI 48201 USA; [Li, Guo-Min] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; State University System of Florida; University of South Florida; Wayne State University; H Lee Moffitt Cancer Center & Research Institute; Wayne State University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, XM (corresponding author), Karmanos Canc Inst, 4100 John R St, Detroit, MI 48201 USA.	zhangx@karmanos.org	Bai, Wenlong/A-8977-2013; XIANG, SHENGYAN/C-3176-2013	Bai, Wenlong/0000-0002-9536-0556; XIANG, SHENGYAN/0000-0002-6940-3559; Quan, Daniel/0000-0003-1752-0080	National Institutes of Health [R01CA164147]; Karmanos Cancer Institute startup funds; Wayne State University; NATIONAL CANCER INSTITUTE [T32CA009531, R01CA164147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karmanos Cancer Institute startup funds; Wayne State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant R01CA164147 and by Karmanos Cancer Institute startup funds (to X. M. Z.) and Graduate Research Assistantship from Wayne State University (to X. M. Z. and N. M). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aebi S, 1996, CANCER RES, V56, P3087; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Fink D, 1998, CLIN CANCER RES, V4, P1; Gong JG, 1999, NATURE, V399, P806; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Han Y, 2016, ONCOTARGETS THER, V9, P5081, DOI 10.2147/OTT.S106345; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Larrea AA, 2010, CELL, V141, DOI 10.1016/j.cell.2010.05.002; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Papadopoulos N, 1997, HUM MUTAT, V10, P89, DOI 10.1002/(SICI)1098-1004(1997)10:2<89::AID-HUMU1>3.3.CO;2-K; Plotz G, 2003, NUCLEIC ACIDS RES, V31, P3217, DOI 10.1093/nar/gkg420; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033160; Yanamadala S, 2003, MOL CANCER RES, V1, P747; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028	25	17	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5813	5826		10.1074/jbc.RA118.006374	http://dx.doi.org/10.1074/jbc.RA118.006374			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30770470	hybrid, Green Published			2022-12-28	WOS:000465077500014
J	de Taeye, SW; Go, EP; Sliepen, K; de la Pena, AT; Badal, K; Medina-Ramirez, M; Lee, WH; Desaire, H; Wilson, IA; Moore, JP; Ward, AB; Sanders, RW				de Taeye, Steven W.; Go, Eden P.; Sliepen, Kwinten; de la Pena, Alba Torrents; Badal, Kimberly; Medina-Ramirez, Max; Lee, Wen-Hsin; Desaire, Heather; Wilson, Ian A.; Moore, John P.; Ward, Andrew B.; Sanders, Rogier W.			Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); glycoprotein structure; structure-function; protein design; antibody; vaccine development; HIV-1 envelope glycoprotein trimer	CRYO-EM STRUCTURE; GLYCOSYLATION SITES; DISULFIDE BONDS; GLYCOPROTEIN COMPLEX; CYSTEINE RESIDUES; CRYSTAL-STRUCTURE; V1/V2 DOMAIN; GP120; POTENT; APEX	A successful HIV-1 vaccine will likely need to elicit broadly neutralizing antibodies (bNAbs) that target the envelope glycoprotein (Env) spike on the virus. Native-like recombinant Env trimers of the SOSIP design now serve as a platform for achieving this challenging goal. However, SOSIP trimers usually do not bind efficiently to the inferred germline precursors of bNAbs (gl-bNAbs). We hypothesized that the inherent flexibilities of the V1 and V2 variable loops in the Env trimer contribute to the poor recognition of gl-bNAb epitopes at the trimer apex that extensively involve V2 residues. To reduce local V2 flexibility and improve the binding of V2-dependent bNAbs and gl-bNAbs, we designed BG505 SOSIP.664 trimer variants containing newly created disulfide bonds intended to stabilize the V2 loop in an optimally antigenic configuration. The first variant, I184C/E190C, contained a new disulfide bond within the V2 loop, whereas the second variant, E153C/R178C, had a new disulfide bond that cross-linked V2 and V1. The resulting engineered native-like trimer variants were both more reactive with and were neutralized by V2 bNAbs and gl-bNAbs, a finding that may be valuable in the design of germline targeting and boosting trimer immunogens to create an antigenic conformation optimal for HIV vaccine development.	[de Taeye, Steven W.; Sliepen, Kwinten; de la Pena, Alba Torrents; Badal, Kimberly; Medina-Ramirez, Max; Sanders, Rogier W.] Univ Amsterdam, Amsterdam UMC, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Go, Eden P.; Desaire, Heather] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Lee, Wen-Hsin; Wilson, Ian A.; Ward, Andrew B.] IAVI Neutralizing Antibody Ctr, Scripps CHAVI ID, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Lee, Wen-Hsin; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Amsterdam; University of Kansas; International AIDS Vaccine Initiative; Scripps Research Institute; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Dept Med Microbiol, Amsterdam UMC, Ctr Infect & Immun Amsterdam, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl	Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Lee, Wen-Hsin/0000-0001-9445-6671	National Institutes of Health HIVRAD Grant [P01 AI110657]; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery [OPP1132237]; AIDSfonds Netherlands [2016019]; Netherlands Organization for Scientific Research [91818627]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, P01AI110657] Funding Source: NIH RePORTER	National Institutes of Health HIVRAD Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; AIDSfonds Netherlands; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health HIVRAD Grant P01 AI110657, by Grant OPP1132237 from the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery, and by AIDSfonds Netherlands Grant 2016019. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of Vici Grant 91818627 from the Netherlands Organization for Scientific Research.	Andrabi R, 2015, IMMUNITY, V43, P959, DOI 10.1016/j.immuni.2015.10.014; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bohl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069406; Bonsignori M, 2017, IMMUNOL REV, V275, P145, DOI [10., 10.1111/imr.12509]; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Bontjer I, 2010, J BIOL CHEM, V285, P36456, DOI 10.1074/jbc.M110.156588; Bontjer I, 2009, J VIROL, V83, P368, DOI 10.1128/JVI.01404-08; Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; de la Pena AT, 2017, CELL REP, V20, P1805, DOI 10.1016/j.celrep.2017.07.077; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Derdeyn CA, 2014, CURR OPIN HIV AIDS, V9, P210, DOI 10.1097/COH.0000000000000057; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Go EP, 2016, J VIROL, V90, P2884, DOI 10.1128/JVI.01953-15; Go EP, 2014, J PROTEOME RES, V13, P4012, DOI 10.1021/pr5003643; Go EP, 2011, J PROTEOME RES, V10, P578, DOI 10.1021/pr100764a; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Jobes DV, 2006, AIDS RES HUM RETROV, V22, P1014, DOI 10.1089/aid.2006.22.1014; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Landais E, 2017, IMMUNITY, V47, P990, DOI 10.1016/j.immuni.2017.11.002; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mason RD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005537; Mathys L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101181; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Medina-Ramirez M, 2017, J EXP MED, V214, P2573, DOI 10.1084/jem.20161160; MOORE JP, 1994, J VIROL, V68, P6836, DOI 10.1128/JVI.68.11.6836-6847.1994; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Plotkin S, 2014, P NATL ACAD SCI USA, V111, P12283, DOI 10.1073/pnas.1400472111; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rantalainen K, 2018, CELL REP, V23, P3249, DOI 10.1016/j.celrep.2018.05.046; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Saha P, 2012, BIOCHEMISTRY-US, V51, P1836, DOI 10.1021/bi300003v; Sanders RW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-10; Sanders RW, 2008, MOL BIOL CELL, V19, P4707, DOI 10.1091/mbc.E08-07-0670; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Scharf L, 2015, CELL, V162, P1379, DOI 10.1016/j.cell.2015.08.035; Shen GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141233; Sliepen K, 2015, VIROLOGY, V486, P116, DOI 10.1016/j.virol.2015.08.002; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Thenin S, 2012, J GEN VIROL, V93, P1495, DOI 10.1099/vir.0.042614-0; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; van Anken E, 2008, MOL BIOL CELL, V19, P4298, DOI 10.1091/mbc.E07-12-1282; van den Kerkhof TLGM, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0279-4; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; Voss JE, 2017, CELL REP, V21, P222, DOI 10.1016/j.celrep.2017.09.024; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang WK, 1996, AIDS RES HUM RETROV, V12, P1195, DOI 10.1089/aid.1996.12.1195; WANG WK, 1995, AIDS RES HUM RETROV, V11, P185, DOI 10.1089/aid.1995.11.185; Watkins JD, 2011, J VIROL, V85, P12811, DOI 10.1128/JVI.05994-11; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738; WILLEY RL, 1993, J VIROL, V67, P3639, DOI 10.1128/JVI.67.6.3639-3643.1993; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	86	13	14	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5616	5631		10.1074/jbc.RA118.005396	http://dx.doi.org/10.1074/jbc.RA118.005396			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30728245	Green Published, hybrid			2022-12-28	WOS:000464517500030
J	Gonzalez-Serrano, LE; Chihade, JW; Sissler, M				Gonzalez-Serrano, Ligia Elena; Chihade, Joseph W.; Sissler, Marie			When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						aminoacyl tRNA synthetase; mitochondria; genetic disease; central nervous system (CNS); mutant	SPINAL-CORD INVOLVEMENT; BRAIN-STEM INVOLVEMENT; PONTOCEREBELLAR HYPOPLASIA; HIGH LACTATE; PATHOGENIC MUTATIONS; SIDEROBLASTIC ANEMIA; CRYSTAL-STRUCTURE; PERRAULT SYNDROME; LACTIC-ACIDOSIS; HEARING-LOSS	Mitochondrial aminoacyl-tRNA synthetases (mt-aaRSs) are essential components of the mitochondrial translation machinery. The correlation of mitochondrial disorders with mutations in these enzymes has raised the interest of the scientific community over the past several years. Most surprising has been the wide-ranging presentation of clinical manifestations in patients with mt-aaRS mutations, despite the enzymes' common biochemical role. Even among cases where a common physiological system is affected, phenotypes, severity, and age of onset varies depending on which mt-aaRS is mutated. Here, we review work done thus far and propose a categorization of diseases based on tissue specificity that highlights emerging patterns. We further discuss multiple in vitro and in cellulo efforts to characterize the behavior of WT and mutant mt-aaRSs that have shaped hypotheses about the molecular causes of these pathologies. Much remains to do in order to complete our understanding of these proteins. We expect that futher work is likely to result in the discovery of new roles for the mt-aaRSs in addition to their fundamental function in mitochondrial translation, informing the development of treatment strategies and diagnoses.	[Gonzalez-Serrano, Ligia Elena; Sissler, Marie] Univ Strasbourg, CNRS, Architecture & React ARN, UPR9002, F-67000 Strasbourg, France; [Chihade, Joseph W.] Carleton Coll, Dept Chem, Northfield, MN 55057 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Carleton College	Sissler, M (corresponding author), IBMC, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	m.sissler@ibmc-cnrs.unistra.fr		SISSLER, Marie/0000-0001-8594-5238	CNRS; Universite de Strasbourg (UNISTRA); French National Program "Investissement d'Avenir" (Labex MitoCross) [ANR-11-LABX-0057_MITOCROSS]; Carleton College; Towsley Foundation; LabEx MitoCross	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg (UNISTRA); French National Program "Investissement d'Avenir" (Labex MitoCross)(French National Research Agency (ANR)); Carleton College; Towsley Foundation; LabEx MitoCross	This work was supported in part by CNRS, Universite de Strasbourg (UNISTRA), and the French National Program "Investissement d'Avenir" (Labex MitoCross), administered by the "Agence National de la Recherche," and referenced as ANR-11-LABX-0057_MITOCROSS, by Carleton College, and by the Towsley Foundation (to J. W. C.). This is the second article in the "tRNAs and aminoacyl-tRNA synthetases in human disease" JBC Reviews series. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by LabEx MitoCross.	Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809; Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Ardissone A, 2015, JIMD REP, V20, P95, DOI 10.1007/8904_2014_397; Baertling F, 2017, METAB BRAIN DIS, V32, P267, DOI 10.1007/s11011-016-9890-2; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Belostotsky R, 2011, AM J HUM GENET, V88, P193, DOI 10.1016/j.ajhg.2010.12.010; Blocquel D, 2017, NUCLEIC ACIDS RES, V45, P8091, DOI 10.1093/nar/gkx455; Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011; Bonnefond L, 2005, RNA, V11, P558, DOI 10.1261/rna.7246805; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Bonnefond L, 2007, STRUCTURE, V15, P1505, DOI 10.1016/j.str.2007.09.018; Bruni F, 2018, HUM MUTAT, V39, P563, DOI 10.1002/humu.23398; Bullard JM, 2000, BBA-GENE STRUCT EXPR, V1490, P245, DOI 10.1016/S0167-4781(99)00240-7; Bullard JN, 1999, J MOL BIOL, V288, P567, DOI 10.1006/jmbi.1999.2708; Burke EA, 2018, CLIN GENET, V93, P712, DOI 10.1111/cge.13172; Carapito C, 2017, METHODS, V113, P111, DOI 10.1016/j.ymeth.2016.10.012; Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9; Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811; Chimnaronk S, 2004, ACTA CRYSTALLOGR D, V60, P1319, DOI 10.1107/S0907444904011217; Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079; Cho JS, 2017, EPILEPSY RES, V129, P118, DOI 10.1016/j.eplepsyres.2016.11.022; Coughlin CR, 2015, J MED GENET, V52, P532, DOI 10.1136/jmedgenet-2015-103049; Dallabona C, 2014, NEUROLOGY, V82, P2063, DOI 10.1212/WNL.0000000000000497; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956; Diodato D, 2014, HUM MUTAT, V35, P983, DOI 10.1002/humu.22590; Echevarria L, 2014, BIOCHEM J, V460, P91, DOI 10.1042/BJ20131107; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Elo JM, 2012, HUM MOL GENET, V21, P4521, DOI 10.1093/hmg/dds294; Euro L, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00021; Fender A, 2006, J BIOL CHEM, V281, P15980, DOI 10.1074/jbc.M511633200; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Gaudry A, 2012, PROTEIN ENG DES SEL, V25, P473, DOI 10.1093/protein/gzs046; Gonzalez-Serrano LE, 2018, J BIOL CHEM, V293, P13604, DOI 10.1074/jbc.RA118.003400; Gotz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006; Gray MW, 2001, GENOME BIOL, V2; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Hallberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001; Hallmann K, 2014, NEUROLOGY, V83, P2183, DOI 10.1212/WNL.0000000000001055; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Hilander T, 2018, NUCLEIC ACIDS RES, V46, P849, DOI 10.1093/nar/gkx1231; Hosseini M, 2018, NUCLEIC ACIDS RES, V46, P10946, DOI 10.1093/nar/gky762; Joseph JT, 2014, J NEUROPATH EXP NEUR, V73, P1009, DOI 10.1097/NEN.0000000000000123; Kartvelishvili E, 2017, PROTEIN SCI, V26, P1505, DOI 10.1002/pro.3176; Kastrissianakis K, 2013, ARCH DIS CHILD, V98, P1004, DOI 10.1136/archdischild-2013-304308; Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020; Klipcan L, 2012, J MOL BIOL, V415, P527, DOI 10.1016/j.jmb.2011.11.029; Klipcan L, 2009, P NATL ACAD SCI USA, V106, P11045, DOI 10.1073/pnas.0905212106; Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010; Lakshmanan R, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000135; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Lee EY, 2018, BIOCHEM PHARMACOL, V154, P424, DOI 10.1016/j.bcp.2018.06.009; Lerat J, 2016, HUM MUTAT, V37, P1354, DOI 10.1002/humu.23120; Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884; Lieber DS, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-30; Linnankivi T, 2016, HUM MUTAT, V37, P884, DOI 10.1002/humu.23021; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Luhl S, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0525-9; Mazurova S, 2017, CARDIOL YOUNG, V27, P936, DOI 10.1017/S1047951116001876; Messmer M, 2009, BIOCHIMIE, V91, P596, DOI 10.1016/j.biochi.2009.02.005; Mizuguchi T, 2017, J HUM GENET, V62, P525, DOI 10.1038/jhg.2016.163; Moosa S, 2017, AM J MED GENET A, V173, P1102, DOI 10.1002/ajmg.a.38116; Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277; Mudge SJ, 1998, GENE, V209, P45, DOI 10.1016/S0378-1119(98)00007-9; Musante L, 2017, HUM MUTAT, V38, P621, DOI 10.1002/humu.23205; Namavar Y, 2011, BRAIN, V134, P143, DOI 10.1093/brain/awq287; Neuenfeldt A, 2013, NUCLEIC ACIDS RES, V41, P2698, DOI 10.1093/nar/gks1322; Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3; Ognjenovic J, 2018, RNA BIOL, V15, P623, DOI 10.1080/15476286.2017.1330245; Oliveira R, 2017, JIMD REP, V33, P61, DOI 10.1007/8904_2016_581; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Riley LG, 2016, JIMD REP, V28, P49, DOI 10.1007/8904_2015_515; Riley LG, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-193; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; Rotig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010; Sahin S, 2016, J NEUROL SCI, V365, P54, DOI 10.1016/j.jns.2016.04.008; Sauter C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17332; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Schwartzentruber J, 2014, HUM MUTAT, V35, P1285, DOI 10.1002/humu.22629; Schwenzer H, 2014, TOP CURR CHEM, V344, P247, DOI 10.1007/128_2013_457; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Simon M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005097; Sissler M, 2004, RNA, V10, P841, DOI 10.1261/rna.5267604; Sissler M, 2008, METHODS, V44, P176, DOI 10.1016/j.ymeth.2007.11.002; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Sofou K, 2015, MOL GENET GENOM MED, V3, P59, DOI 10.1002/mgg3.115; Sohm N, 2004, J MOL BIOL, V339, P17, DOI 10.1016/j.jmb.2004.03.066; Solda G, 2016, J HUM GENET, V61, P295, DOI 10.1038/jhg.2015.149; Sommerville EW, 2017, JAMA NEUROL, V74, P686, DOI 10.1001/jamaneurol.2016.4357; Son S. H., 2013, AMINOACYL TRNA SYNTH, P145; Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070; Suzuki H, 2007, J BIOL CHEM, V282, P4076, DOI 10.1074/jbc.M608187200; Talim B, 2013, BRAIN, V136, DOI 10.1093/brain/aws197; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; Theisen BE, 2017, AM J MED GENET A, V173, P2505, DOI 10.1002/ajmg.a.38339; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Uluc K, 2008, J NEUROL SCI, V273, P118, DOI 10.1016/j.jns.2008.06.002; van Berge L, 2014, BRAIN, V137, P1019, DOI 10.1093/brain/awu026; van Berge L, 2013, BIOCHEM J, V450, P345, DOI 10.1042/BJ20121564; van Berge L, 2012, BIOCHEM J, V441, P955, DOI 10.1042/BJ20110795; Verrigni D, 2017, CLIN GENET, V91, P918, DOI 10.1111/cge.12931; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Walker MA, 2016, J CHILD NEUROL, V31, P1127, DOI 10.1177/0883073816643402; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang Y, 2016, J BIOL CHEM, V291, P6507, DOI 10.1074/jbc.M115.700849; Webb BD, 2015, HUM MUTAT, V36, P587, DOI 10.1002/humu.22781; Yang Y, 2016, HUM MUTAT, V37, P165, DOI 10.1002/humu.22930; Zhang J, 2018, EXP THER MED, V15, P1099, DOI 10.3892/etm.2017.5491	119	32	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5309	5320		10.1074/jbc.REV118.002953	http://dx.doi.org/10.1074/jbc.REV118.002953			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30647134	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000464517500007
J	Huseby, CJ; Bundschuh, R; Kuret, J				Huseby, Carol J.; Bundschuh, Ralf; Kuret, Jeff			The role of annealing and fragmentation in human tau aggregation dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer's disease; tau protein (tau); aggregation; kinetics; mathematical modeling; neurodegeneration; amyloid; tauopathy; protein misfolding	PAIRED HELICAL FILAMENTS; TO-TAIL POLYMERIZATION; SECONDARY NUCLEATION; SENSITIVITY-ANALYSIS; ALZHEIMERS-DISEASE; PROTEIN-TAU; ACTIN; LENGTH; MECHANISM; ASSOCIATION	Alzheimer's disease pathogenesis is associated with the conversion of monomeric tau protein into filamentous aggregates. Because both toxicity and prion-like spread of pathogenic tau depend in part on aggregate size, the processes that underlie filament formation and size distribution are of special importance. Here, using a combination of biophysical and computational approaches, we investigated the fibrillation dynamics of the human tau isoform 2N4R. We found that tau filaments engage in a previously uncharacterized secondary process involving end-to-end annealing and that rationalization of empirical aggregation data composed of total protomer concentrations and fibril length distributions requires inclusion of this process along with filament fragmentation. We noted that annealing of 2N4R tau filaments is robust, with an intrinsic association rate constant of a magnitude similar to that mediating monomer addition and consistent with diffusion-mediated protein-protein interactions in the absence of long-range attractive forces. In contrast, secondary nucleation on the surface of tau filaments did not detectably contribute to tau aggregation dynamics. These results indicate that tau filament ends engage in a range of homotypic interactions involving monomers, oligomers, and filaments. They further indicate that, in the case of tau protein, fibril annealing and fragmentation along with primary nucleation and elongation are the major processes controlling filament size distribution.	[Huseby, Carol J.; Bundschuh, Ralf; Kuret, Jeff] Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Kuret, Jeff] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kuret, J (corresponding author), Ohio State Univ, Coll Med, 1060 Carmack Rd, Columbus, OH 43210 USA.	kuret.3@osu.edu	; Bundschuh, Ralf/B-9623-2008	Huseby, Carol/0000-0002-9558-5560; Bundschuh, Ralf/0000-0002-6699-8614	National Institutes of Health [AG054018]; NATIONAL INSTITUTE ON AGING [T32AG044402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant AG054018 (to J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrianantoandro E, 2001, J MOL BIOL, V312, P721, DOI 10.1006/jmbi.2001.5005; Ball D. W., 2014, PHYS CHEM, P696; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chin AF, 2016, BIOPHYS J, V110, P362, DOI 10.1016/j.bpj.2015.12.013; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608918; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Crystal AS, 2003, J NEUROCHEM, V86, P1359, DOI 10.1046/j.1471-4159.2003.01949.x; Doi M., 1986, THEORY POLYM DYNAMIC, P24; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GomezIsla T, 1996, J NEUROSCI, V16, P4491; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; HAGESTEDT T, 1989, J CELL BIOL, V109, P1643, DOI 10.1083/jcb.109.4.1643; HILL TL, 1981, BIOPHYS J, V33, P353, DOI 10.1016/S0006-3495(81)84900-4; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P4803, DOI 10.1073/pnas.77.8.4803; HILL TL, 1983, BIOPHYS J, V44, P285, DOI 10.1016/S0006-3495(83)84301-X; Huseby CJ, 2016, METHODS MOL BIOL, V1345, P101, DOI 10.1007/978-1-4939-2978-8_7; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Kundel F, 2018, ACS CHEM NEUROSCI, V9, P1276, DOI 10.1021/acschemneuro.8b00094; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Meyer V, 2016, J BIOL CHEM, V291, P12271, DOI 10.1074/jbc.M116.715557; Mirbaha H, 2015, J BIOL CHEM, V290, P14893, DOI 10.1074/jbc.M115.652693; MURPHY DB, 1988, J CELL BIOL, V106, P1947, DOI 10.1083/jcb.106.6.1947; Nanavaty N, 2017, METHODS MOL BIOL, V1523, P101, DOI 10.1007/978-1-4939-6598-4_6; Pastor MT, 2008, J MOL BIOL, V375, P695, DOI 10.1016/j.jmb.2007.08.012; Pavlova A, 2016, P NATL ACAD SCI USA, V113, pE127, DOI 10.1073/pnas.1504415113; Ramachandran G, 2012, J MOL BIOL, V421, P296, DOI 10.1016/j.jmb.2012.01.007; Ramachandran G, 2011, J BIOL CHEM, V286, P38948, DOI 10.1074/jbc.M111.271874; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; ROTHWELL SW, 1986, J CELL BIOL, V102, P619, DOI 10.1083/jcb.102.2.619; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 2012, CHEM REV, V112, pPR1, DOI 10.1021/cr200301u; Schafer KN, 2013, J BIOL CHEM, V288, P32599, DOI 10.1074/jbc.M113.503474; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; SEGEL LA, 1989, SIAM REV, V31, P446, DOI 10.1137/1031091; Sept D, 1999, BIOPHYS J, V77, P2911, DOI 10.1016/S0006-3495(99)77124-9; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tornquist M, 2018, CHEM COMMUN, V54, P8667, DOI 10.1039/c8cc02204f; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; WEGNER A, 1982, BIOCHEMISTRY-US, V21, P1909, DOI 10.1021/bi00537a032; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xue WF, 2013, BIOPHYS J, V105, P2811, DOI 10.1016/j.bpj.2013.10.034; Yin HS, 2006, FEBS LETT, V580, P211, DOI 10.1016/j.febslet.2005.11.077; Zampieri M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000420; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c; Zhong Q, 2012, J BIOL CHEM, V287, P20711, DOI 10.1074/jbc.M112.364067	71	8	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4728	4737		10.1074/jbc.RA118.006943	http://dx.doi.org/10.1074/jbc.RA118.006943			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30745358	Green Published, hybrid			2022-12-28	WOS:000463985600001
J	Park, J; Selvam, B; Sanematsu, K; Shigemura, N; Shukla, D; Procko, E				Park, Jihye; Selvam, Balaji; Sanematsu, Keisuke; Shigemura, Noriatsu; Shukla, Diwakar; Procko, Erik			Structural architecture of a dimeric class C GPCR based on co-trafficking of sweet taste receptor subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); membrane trafficking; dimerization; directed evolution; molecular modeling; structural model; mutagenesis; deep mutational scan	EVOLUTIONARY CONSERVATION; HEPTAHELICAL DOMAIN; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; N-GLYCOSYLATION; HUMAN T1R3; GLUTAMATE; ACTIVATION; EXPRESSION; IDENTIFICATION	Class C G protein-coupled receptors (GPCRs) are obligatory dimers that are particularly important for neuronal responses to endogenous and environmental stimuli. Ligand recognition through large extracellular domains leads to the reorganization of transmembrane regions to activate G protein signaling. Although structures of individual domains are known, the complete architecture of a class C GPCR and the mechanism of interdomain coupling during receptor activation are unclear. By screening a mutagenesis library of the human class C sweet taste receptor subunit T1R2, we enhanced surface expression and identified a dibasic intracellular retention motif that modulates surface expression and co-trafficking with its heterodimeric partner T1R3. Using a highly expressed T1R2 variant, dimerization sites along the entire subunit within all the structural domains were identified by a comprehensive mutational scan for co-trafficking with T1R3 in human cells. The data further reveal that the C terminus of the extracellular cysteine-rich domain needs to be properly folded for T1R3 dimerization and co-trafficking, but not for surface expression of T1R2 alone. These results guided the modeling of the T1R2-T1R3 dimer in living cells, which predicts a twisted arrangement of domains around the central axis, and a continuous folded structure between transmembrane domain loops and the cysteine-rich domains. These insights have implications for how conformational changes between domains are coupled within class C GPCRs.	[Park, Jihye; Procko, Erik] Univ Illinois, Dept Biochem, 315 Roger Adams Lab,600 South Mathews Ave, Urbana, IL 61801 USA; [Selvam, Balaji; Shukla, Diwakar] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Sanematsu, Keisuke; Shigemura, Noriatsu] Kyushu Univ, Res & Dev Ctr 5 Sense Devices, Sect Oral Neurosci, Grad Sch Dent Sci,Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan; [Sanematsu, Keisuke; Shigemura, Noriatsu] Kyushu Univ, Res & Dev Ctr 5 Sense Devices, Div Sensory Physiol Med Applicat Sensing, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Kyushu University; Kyushu University	Procko, E (corresponding author), Univ Illinois, Dept Biochem, 315 Roger Adams Lab,600 South Mathews Ave, Urbana, IL 61801 USA.	procko@illinois.edu	Shukla, Diwakar/GRY-2518-2022	Shukla, Diwakar/0000-0003-4079-5381; Selvam, Balaji/0000-0002-7677-290X; Procko, Erik/0000-0002-0028-490X; Shigemura, Noriatsu/0000-0002-3061-6362	National Institutes of Health NIMH [R21MH113155]; JSPS KAKENHI [JP18K09523]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH113155] Funding Source: NIH RePORTER	National Institutes of Health NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health NIMH Award R21MH113155 (to E.P.) for development of deep mutational scanning in human cells and in part by JSPS KAKENHI Grant JP18K09523 (to K.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; Ashikawa Y, 2011, PROTEIN SCI, V20, P1720, DOI 10.1002/pro.707; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Case DA, 2014, AMBER 14; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Cheron JB, 2017, PROTEINS, V85, P332, DOI 10.1002/prot.25228; Christopher JA, 2015, J MED CHEM, V58, P6653, DOI 10.1021/acs.jmedchem.5b00892; Chun L, 2012, ACTA PHARMACOL SIN, V33, P312, DOI 10.1038/aps.2011.186; Cvicek V, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004805; Dore AS, 2014, NATURE, V511, P557, DOI 10.1038/nature13396; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Gacasan SB, 2017, AIMS BIOPHYS, V4, P491, DOI 10.3934/biophy.2017.3.491; Geng Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13662; Geng Y, 2013, NATURE, V504, P254, DOI 10.1038/nature12725; Heredia JD, 2018, J IMMUNOL, V200, P3825, DOI 10.4049/jimmunol.1800343; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kleffner R, 2017, BIOINFORMATICS, V33, P2765, DOI 10.1093/bioinformatics/btx283; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Koehl A, 2019, NATURE, V566, P79, DOI 10.1038/s41586-019-0881-4; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Koizumi T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12947; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Leach K, 2017, PHARMACOL RES, V116, P105, DOI 10.1016/j.phrs.2016.12.006; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Levitz J, 2016, NEURON, V92, P143, DOI 10.1016/j.neuron.2016.08.036; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Maillet EL, 2015, CHEM SENSES, V40, P577, DOI 10.1093/chemse/bjv045; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Morini G, 2005, J MED CHEM, V48, P5520, DOI 10.1021/jm0503345; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nango E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25745; Nasrallah C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22729-4; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Norskov-Lauritsen L, 2015, FEBS LETT, V589, P588, DOI 10.1016/j.febslet.2015.01.019; Nuemket N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15530; Nufer O, 2003, CURR BIOL, V13, pR391, DOI 10.1016/S0960-9822(03)00318-X; Olofsson L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6206; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Ray K, 2007, J BIOL CHEM, V282, P5310, DOI 10.1074/jbc.M609610200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanematsu K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22807; Sanematsu K, 2014, J BIOL CHEM, V289, P25711, DOI 10.1074/jbc.M114.560409; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Shimizu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100425; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Temussi PA, 2002, FEBS LETT, V526, P1, DOI 10.1016/S0014-5793(02)03155-1; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Vafabakhsh R, 2015, NATURE, V524, P497, DOI 10.1038/nature14679; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Walters DE, 2006, J AGR FOOD CHEM, V54, P10129, DOI 10.1021/jf062359y; Winnig M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-66; Woo CH, 2015, MOL BIOL CELL, V26, P4280, DOI 10.1091/mbc.E15-06-0361; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Xue L, 2015, NAT CHEM BIOL, V11, P134, DOI [10.1038/nchembio.1711, 10.1038/NCHEMBIO.1711]; Yamniuk AP, 2016, J MOL BIOL, V428, P2860, DOI 10.1016/j.jmb.2016.05.014; Zhang C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600241; Zhang XJC, 2014, PROTEIN CELL, V5, P492, DOI 10.1007/s13238-014-0062-z	77	23	23	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4759	4774		10.1074/jbc.RA118.006173	http://dx.doi.org/10.1074/jbc.RA118.006173			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30723160	hybrid, Green Published			2022-12-28	WOS:000463985600003
J	Heitz, SD; Hamelin, DJ; Hoffmann, RM; Greenberg, N; Salloum, G; Erami, Z; Khalil, BD; Shymanets, A; Steidle, EA; Gong, GQ; Nurnberg, B; Burke, JE; Flanagan, JU; Bresnick, AR; Backer, JM				Heitz, Samantha D.; Hamelin, David J.; Hoffmann, Reece M.; Greenberg, Nili; Salloum, Gilbert; Erami, Zahra; Khalil, Bassem D.; Shymanets, Aliaksei; Steidle, Elizabeth A.; Gong, Grace Q.; Nuernberg, Bernd; Burke, John E.; Flanagan, Jack U.; Bresnick, Anne R.; Backer, Jonathan M.			A single discrete Rab5-binding site in phosphoinositide 3-kinase is required for tumor cell invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoinositide 3-kinase (PI 3-kinase); Rab; G protein-coupled receptor (GPCR); receptor tyrosine kinase; GTPase; breast cancer; chemotaxis; invasion; matrix degradation; p85; PIK3CB; PIK3R1	SUBUNIT; PI3K-ALPHA; MUTATIONS; GTPASE; GROWTH; BETA; P85	Phosphoinositide 3-kinase (PI3K) is regulated by receptor tyrosine kinases (RTKs), G protein-coupled receptors (GPCRs), and small GTPases such as Rac1 and Rab5. Our lab previously identified two residues (Gln(596) and Ile(597)) in the helical domain of the catalytic subunit (p110) of PI3K whose mutation disrupts binding to Rab5. To better define the Rab5-p110 interface, we performed alanine-scanning mutagenesis and analyzed Rab5 binding with an in vitro pulldown assay with GST-Rab5(GTP). Of the 35 p110 helical domain mutants assayed, 11 disrupted binding to Rab5 without affecting Rac1 binding, basal lipid kinase activity, or G-stimulated kinase activity. These mutants defined the Rab5-binding interface within p110 as consisting of two perpendicular -helices in the helical domain that are adjacent to the initially identified Gln(596) and Ile(597) residues. Analysis of the Rab5-PI3K interaction by hydrogen-deuterium exchange MS identified p110 peptides that overlap with these helices; no interactions were detected between Rab5 and other regions of p110 or p85. Similarly, the binding of Rab5 to isolated p85 could not be detected, and mutations in the Ras-binding domain (RBD) of p110 had no effect on Rab5 binding. Whereas soluble Rab5 did not affect PI3K activity in vitro, the interaction of these two proteins was critical for chemotaxis, invasion, and gelatin degradation by breast cancer cells. Our results define a single, discrete Rab5-binding site in the p110 helical domain, which may be useful for generating inhibitors to better define the physiological role of Rab5-PI3K coupling in vivo.	[Heitz, Samantha D.; Greenberg, Nili; Salloum, Gilbert; Erami, Zahra; Khalil, Bassem D.; Steidle, Elizabeth A.; Backer, Jonathan M.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Bresnick, Anne R.; Backer, Jonathan M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Hamelin, David J.; Hoffmann, Reece M.; Burke, John E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 3E6, Canada; [Shymanets, Aliaksei; Nuernberg, Bernd] Eberhard Karls Univ Tubingen, Inst Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany; [Shymanets, Aliaksei; Nuernberg, Bernd] Eberhard Karls Univ Tubingen, Interfac Ctr Pharmacogen & Pharma Res, D-72074 Tubingen, Germany; [Gong, Grace Q.; Flanagan, Jack U.] Univ Auckland, Maurice Wilkins Ctr Biodiscovery, Mol Med & Pathol, Auckland Private Bag 92019, New Zealand; [Khalil, Bassem D.] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10065 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Victoria; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Auckland; Memorial Sloan Kettering Cancer Center	Backer, JM (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.; Bresnick, AR; Backer, JM (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	anne.bresnick@einstein.yu.edu; jonathan.backer@einstein.yu.edu	Burke, John/H-3922-2019	Burke, John/0000-0001-7904-9859; Salloum, Gilbert/0000-0002-7137-6772; Hamelin, David/0000-0001-8201-0664; Gong, Grace/0000-0002-7609-0466; Nurnberg, Bernd/0000-0002-5995-6555; Steidle, Elizabeth/0000-0002-8225-7197	National Institutes of Health [T32AG023475, K12-GM102779, R01 GM119279, T32GM007491]; Macromolecular Therapeutics Core of the Albert Einstein Cancer Center through NCI, National Institutes of Health [CA013330]; Deutsche Forschungsgemeinschaft [GRK 1302, NU 53/13-1]; Maurice Wilkins Centre for Biodiscovery; Cancer Research Society Operating Grant [CRS-22641]; Health Research Council of New Zealand [13-763]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM102779, R01GM119279, T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macromolecular Therapeutics Core of the Albert Einstein Cancer Center through NCI, National Institutes of Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Maurice Wilkins Centre for Biodiscovery; Cancer Research Society Operating Grant; Health Research Council of New Zealand(Health Research Council of New Zealand); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants T32AG023475 (to S. D. H., Z. E., and E. A. S.), K12-GM102779 (to E. A. S.), R01 GM119279 (to J. M. B and A. R. B), and T32GM007491 (to N. G.) and the Macromolecular Therapeutics Core of the Albert Einstein Cancer Center through NCI, National Institutes of Health Grant CA013330. J. M. B. is on the scientific advisory board of Karus Therapeutics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Deutsche Forschungsgemeinschaft Grants GRK 1302 and NU 53/13-1.; Supported by the Maurice Wilkins Centre for Biodiscovery.; Supported by Cancer Research Society Operating Grant CRS-22641.; Supported by Health Research Council of New Zealand Grant 13-763.	Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; Chen PI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090384; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Dbouk HA, 2010, P NATL ACAD SCI USA, V107, P19897, DOI 10.1073/pnas.1008739107; Dornan GL, 2017, P NATL ACAD SCI USA, V114, P1982, DOI 10.1073/pnas.1617244114; Dou ZX, 2013, MOL CELL, V50, P29, DOI 10.1016/j.molcel.2013.01.022; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Khalil BD, 2016, CANCER RES, V76, P2944, DOI 10.1158/0008-5472.CAN-15-1675; Knight ZA, 2007, NAT PROTOC, V2, P2459, DOI 10.1038/nprot.2007.361; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Langemeyer L, 2014, ELIFE, V3, DOI 10.7554/eLife.01623; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Salamon Rachel S, 2015, Methods Mol Biol, V1298, P271, DOI 10.1007/978-1-4939-2569-8_23; Shymanets A, 2015, BIOCHEM J, V469, P59, DOI 10.1042/BJ20150099; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Whitecross DE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16029-6; Wu HY, 2009, P NATL ACAD SCI USA, V106, P20258, DOI 10.1073/pnas.0902369106; Yuzugullu H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9501; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	34	7	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4621	4633		10.1074/jbc.RA118.006032	http://dx.doi.org/10.1074/jbc.RA118.006032			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30659094	Green Published, hybrid			2022-12-28	WOS:000462969500028
J	Tong, HC; Wang, XH; Dong, YZ; Hu, QQ; Zhao, ZY; Zhu, Y; Dong, LX; Bai, F; Dong, XZ				Tong, Huichun; Wang, Xinhui; Dong, Yuzhu; Hu, Qingqing; Zhao, Ziyi; Zhu, Yun; Dong, Linxuan; Bai, Fan; Dong, Xiuzhu			A Streptococcus aquaporin acts as peroxiporin for efflux of cellular hydrogen peroxide and alleviation of oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aquaporin; hydrogen peroxide; oxidative stress; transcription regulation; bacteria; Streptococcus; H2O2 detoxification; H2O2-facilitator; H2O2-induced expression	PLASMA-MEMBRANE AQUAPORINS; WATER CHANNELS; LACTIC-ACID; OLIGOFERMENTANS; TRANSPORT; H2O2; RECONSTITUTION; PERMEABILITY; FACILITATE; GLYCEROL	Aquaporins (AQPs) are transmembrane proteins widely distributed in various organisms, and they facilitate bidirectional diffusion of water and uncharged solutes. The catalase-negative bacterium Streptococcus oligofermentans produces the highest H2O2 levels reported to date, which has to be exported to avoid oxidative stress. Here, we report that a S. oligofermentans aquaporin functions as a peroxiporin facilitating bidirectional transmembrane H2O2 transport. Knockout of this aquaporin homolog, So-AqpA, reduced H2O2 export by approximate to 50% and increased endogenous H2O2 retention, as indicated by the cellular H2O2 reporter HyPer. Heterologous expression of So-aqpA accelerated exogenous H2O2 influx into Saccharomyces cerevisiae and Escherichia coli cells, indicating that So-AqpA acts as an H2O2-transferring aquaporin. Alanine substitution revealed Phe-40 as a key residue for So-AqpA-mediated H2O2 transport. Northern blotting, qPCR, and luciferase reporter assays disclosed that H2O2 induces a >10-fold expression of So-aqpA. Super-resolution imaging showed that H2O2 treatment increases So-AqpA protein molecules per cell by 1.6- to 3-fold. Inactivation of two redox-regulatory transcriptional repressors, PerR and MntR, reduced H2O2-induced So-aqpA expression to 1.8- and 4-fold, respectively. Electrophoretic mobility shift assays determined that MntR, but not PerR, binds to the So-aqpA promoter, indicating that MntR directly regulates H2O2-induced So-aqpA expression. Importantly, So-aqpA deletion decreased oxic growth and intraspecies competition and diminished the competitive advantages of S. oligofermentans over the caries pathogen Streptococcus mutans. Of note, So-aqpA orthologs with the functionally important Phe-40 are present in all streptococci. Our work has uncovered an intrinsic, H2O2-inducible bacterial peroxiporin that has a key physiological role in H2O2 detoxification in S. oligofermentans.	[Tong, Huichun; Wang, Xinhui; Dong, Yuzhu; Hu, Qingqing; Dong, Linxuan; Dong, Xiuzhu] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Tong, Huichun; Wang, Xinhui; Dong, Yuzhu; Hu, Qingqing; Dong, Xiuzhu] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Zhao, Ziyi; Zhu, Yun; Bai, Fan] Peking Univ, Sch Life Sci, Biomed Pioneering Innovat Ctr BIOPIC, 5 Yiheyuan Rd, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University	Tong, HC; Dong, XZ (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, 1 Beichen West Rd, Beijing 100101, Peoples R China.; Tong, HC; Dong, XZ (corresponding author), Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China.	tonghuichun@im.ac.cn; dongxz@im.ac.cn	ZHAO, ZIYI/AAG-5359-2022; Dong, Xiuzhu/EBF-2196-2022; ZHAO, ZIYI/AFK-7002-2022	ZHAO, ZIYI/0000-0002-0811-2782; Dong, Xiuzhu/0000-0002-6926-5459; ZHAO, ZIYI/0000-0002-0811-2782	National Natural Science Foundation of China [31370098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China Grant No. 31370098. The authors declare that they have no conflicts of interest with the contents of this article.	Agre P, 1998, J BIOL CHEM, V273, P14659, DOI 10.1074/jbc.273.24.14659; Al Ghouleh I, 2013, CARDIOVASC RES, V97, P134, DOI 10.1093/cvr/cvs295; Almasalmeh A, 2014, FEBS J, V281, P647, DOI 10.1111/febs.12653; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bi CS, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00412; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2014, BBA-GEN SUBJECTS, V1840, P1596, DOI 10.1016/j.bbagen.2013.09.017; Bienert GP, 2013, BIOCHEM J, V454, P559, DOI 10.1042/BJ20130388; Bienert GP, 2011, PLANT J, V66, P306, DOI 10.1111/j.1365-313X.2011.04496.x; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Calamita G, 2000, MOL MICROBIOL, V37, P254, DOI 10.1046/j.1365-2958.2000.02016.x; Calamita G, 1998, P NATL ACAD SCI USA, V95, P3627, DOI 10.1073/pnas.95.7.3627; Calamita G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00851; Chen ZY, 2017, J BIOL CHEM, V292, P5519, DOI 10.1074/jbc.M116.764126; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LEBLANC DJ, 1992, PLASMID, V28, P130, DOI 10.1016/0147-619X(92)90044-B; Lim JB, 2014, J MICROBIOL METH, V106, P33, DOI 10.1016/j.mimet.2014.07.038; Liu L, 2012, APPL ENVIRON MICROB, V78, P2120, DOI 10.1128/AEM.07539-11; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Medrano-Fernandez I, 2016, ANTIOXID REDOX SIGN, V24, P1031, DOI 10.1089/ars.2016.6636; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Mosca AF, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110207; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rodrigues C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122090; Rodrigues O, 2017, P NATL ACAD SCI USA, V114, P9200, DOI 10.1073/pnas.1704754114; Savage DF, 2007, J MOL BIOL, V368, P607, DOI 10.1016/j.jmb.2007.02.070; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Tong HC, 2003, INT J SYST EVOL MICR, V53, P1101, DOI 10.1099/ijs.0.02493-0; Tong HC, 2007, MOL MICROBIOL, V63, P872, DOI 10.1111/j.1365-2958.2006.05546.x; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; Verdoucq L, 2008, BIOCHEM J, V415, P409, DOI 10.1042/BJ20080275; Wang SY, 2014, P NATL ACAD SCI USA, V111, P8452, DOI 10.1073/pnas.1406593111; Wang XH, 2014, APPL ENVIRON MICROB, V80, P2351, DOI 10.1128/AEM.00064-14; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; Zhang YB, 2012, BIOPHYS CHEM, V160, P69, DOI 10.1016/j.bpc.2011.07.006	49	12	12	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4583	4595		10.1074/jbc.RA118.006877	http://dx.doi.org/10.1074/jbc.RA118.006877			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30705089	hybrid, Green Published			2022-12-28	WOS:000462969500025
J	Rosario-Cruz, Z; Eletsky, A; Daigham, NS; Al-Tameemi, H; Swapna, GVT; Kahn, PC; Szyperski, T; Montelione, GT; Boyd, JM				Rosario-Cruz, Zuelay; Eletsky, Alexander; Daigham, Nourhan S.; Al-Tameemi, Hassan; Swapna, G. V. T.; Kahn, Peter C.; Szyperski, Thomas; Montelione, Gaetano T.; Boyd, Jeffrey M.			The copBL operon protects Staphylococcus aureus from copper toxicity: CopL is an extracellular membrane-associated copper-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; lipoprotein; metal homeostasis; methicillin-resistant Staphylococcus aureus (MRSA); structural biology; virulence factor; metal; arginine-catabolic mobile element (ACME); redox homeostasis	CIS PEPTIDE-BONDS; P-TYPE ATPASES; ESCHERICHIA-COLI; NMR STRUCTURE; IRON; CLUSTER; HOMEOSTASIS; VIRULENCE; EFFLUX; IDENTIFICATION	As complications associated with antibiotic resistance have intensified, copper (Cu) is attracting attention as an antimicrobial agent. Recent studies have shown that copper surfaces decrease microbial burden, and host macrophages use Cu to increase bacterial killing. Not surprisingly, microbes have evolved mechanisms to tightly control intracellular Cu pools and protect against Cu toxicity. Here, we identified two genes (copB and copL) encoded within the Staphylococcus aureus arginine-catabolic mobile element (ACME) that we hypothesized function in Cu homeostasis. Supporting this hypothesis, mutational inactivation of copB or copL increased copper sensitivity. We found that copBL are co-transcribed and that their transcription is increased during copper stress and in a strain in which csoR, encoding a Cu-responsive transcriptional repressor, was mutated. Moreover, copB displayed genetic synergy with copA, suggesting that CopB functions in Cu export. We further observed that CopL functions independently of CopB or CopA in Cu toxicity protection and that CopL from the S. aureus clone USA300 is a membrane-bound and surface-exposed lipoprotein that binds up to four Cu+ ions. Solution NMR structures of the homologous Bacillus subtilis CopL, together with phylogenetic analysis and chemical-shift perturbation experiments, identified conserved residues potentially involved in Cu+ coordination. The solution NMR structure also revealed a novel Cu-binding architecture. Of note, a CopL variant with defective Cu+ binding did not protect against Cu toxicity in vivo. Taken together, these findings indicate that the ACME-encoded CopB and CopL proteins are additional factors utilized by the highly successful S. aureus USA300 clone to suppress copper toxicity.	[Rosario-Cruz, Zuelay; Al-Tameemi, Hassan; Kahn, Peter C.; Montelione, Gaetano T.; Boyd, Jeffrey M.] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA; [Daigham, Nourhan S.; Swapna, G. V. T.; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Daigham, Nourhan S.; Swapna, G. V. T.; Montelione, Gaetano T.] Rutgers State Univ, Northeast Struct Genom Consortium, Piscataway, NJ 08854 USA; [Eletsky, Alexander; Szyperski, Thomas] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Eletsky, Alexander; Szyperski, Thomas] Northeast Struct Genom Consortium, Buffalo, NY 14260 USA; [Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Eletsky, Alexander] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Georgia; University of Georgia	Montelione, GT (corresponding author), Dept Mol Biol & Biochem, 679 Hoes Lane, Piscataway, NJ 08854 USA.; Boyd, JM (corresponding author), Dept Biochem & Microbiol, 76 Lipman Dr, New Brunswick, NJ 08901 USA.	gtm@rutgers.edu; jeffboyd@SEBS.rutgers.edu	Al-Tameemi, Hassan/X-8418-2019	Al-Tameemi, Hassan/0000-0002-1947-798X; Boyd, Jeffrey/0000-0001-7721-3926; Montelione, Gaetano/0000-0002-9440-3059	Rutgers University; Charles and Johanna Busch Foundation; United States Department of Agriculture MRF Project [NE-1028]; National Institute of Allergy and Infectious Diseases (NIAID) [1R01AI139100-01]; Community Outreach Project of the National Institutes of Health NIGMS Protein Structure Initiative Grant [U54 GM094597]; NIGMS [R01 GM120574, S10 OD018207]; James Macmillan Endowed Fellowship; Jerome and Lorraine Aresty Chair Endowment and National Institutes of Health Grant [R01 GM120574]; National Science Foundation [MCB-1615570]; National Institutes of Health Award from NIAID [1R01AI139100-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI139100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120574] Funding Source: NIH RePORTER	Rutgers University; Charles and Johanna Busch Foundation; United States Department of Agriculture MRF Project; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Community Outreach Project of the National Institutes of Health NIGMS Protein Structure Initiative Grant; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); James Macmillan Endowed Fellowship; Jerome and Lorraine Aresty Chair Endowment and National Institutes of Health Grant; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Award from NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Rutgers University, the Charles and Johanna Busch Foundation, the United States Department of Agriculture MRF Project NE-1028 (to J. M. B.), National Institute of Allergy and Infectious Diseases (NIAID) grant 1R01AI139100-01 (to J. M. B.) and as a Community Outreach Project of the National Institutes of Health NIGMS Protein Structure Initiative Grant U54 GM094597 (to G. T. M. and T. S.). Support was also provide by NIGMS Grants R01 GM120574 (to G. T. M.) and S10 OD018207 (to G. T. M.). G. T. M. is a founder of Nexomics Biosciences, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the James Macmillan Endowed Fellowship and Rutgers University.; Supported by the Jerome and Lorraine Aresty Chair Endowment and National Institutes of Health Grant R01 GM120574.; Supported by National Science Foundation Grant MCB-1615570.; Supported by National Institutes of Health Award 1R01AI139100-01 from NIAID.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arguello JM, 2016, METALLOMICS, V8, P906, DOI 10.1039/c6mt00089d; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Badarau A, 2011, J AM CHEM SOC, V133, P2983, DOI 10.1021/ja1091547; Bagchi P, 2013, J AM CHEM SOC, V135, P18549, DOI 10.1021/ja408827d; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bertini I, 2010, COORDIN CHEM REV, V254, P506, DOI 10.1016/j.ccr.2009.07.024; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chillappagari S, 2010, J BACTERIOL, V192, P2512, DOI 10.1128/JB.00058-10; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delmar JA, 2013, BIOMETALS, V26, P593, DOI 10.1007/s10534-013-9628-0; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Fung DKC, 2013, J BACTERIOL, V195, P4556, DOI 10.1128/JB.00543-13; Goddard D., 2008, SPARKY 3; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; GUNTHER MR, 1995, ARCH BIOCHEM BIOPHYS, V316, P515, DOI 10.1006/abbi.1995.1068; Hao XL, 2015, APPL MICROBIOL BIOT, V99, P5817, DOI 10.1007/s00253-015-6749-0; Harris RK, 2008, PURE APPL CHEM, V80, P59, DOI 10.1351/pac200880010059; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang YJ, 2006, PROTEINS, V62, P587, DOI 10.1002/prot.20820; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Jansson M, 1996, J BIOMOL NMR, V7, P131; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Joska TM, 2014, J MICROBIOL METH, V100, P46, DOI 10.1016/j.mimet.2013.11.013; Kay KL, 2016, METALLOMICS, V8, P709, DOI 10.1039/c6mt00036c; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller RLJ, 2004, COMPUTER AIDED RESON, P1; Kiedrowski MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095574; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mashruwala AA, 2017, ELIFE, V6, DOI 10.7554/eLife.23845; Mashruwala AA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006233; Mashruwala AA, 2016, METHODS MOL BIOL, V1373, P33, DOI 10.1007/7651_2015_275; Mashruwala AA, 2015, MOL MICROBIOL, V95, P383, DOI 10.1111/mmi.12860; Mikolay A, 2010, APPL MICROBIOL BIOT, V87, P1875, DOI 10.1007/s00253-010-2640-1; Montelione G.T., 2012, BIOL REP, V4, P7, DOI DOI 10.3410/B4-7; Navarre WW, 1996, J BACTERIOL, V178, P441, DOI 10.1128/jb.178.2.441-446.1996; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; Olson Bradley J S C, 2007, Curr Protoc Protein Sci, VChapter 3, DOI 10.1002/0471140864.ps0304s48; Osman D, 2013, MOL MICROBIOL, V87, P466, DOI 10.1111/mmi.12107; OSTERBERG R, 1979, J INORG BIOCHEM, V10, P341, DOI 10.1016/S0162-0134(00)80200-7; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Pang YY, 2014, J INNATE IMMUN, V6, P353, DOI 10.1159/000355915; PELTON JG, 1993, PROTEIN SCI, V2, P543; Planet PJ, 2015, J INFECT DIS, V212, P1874, DOI 10.1093/infdis/jiv320; Planet PJ, 2013, MBIO, V4, DOI 10.1128/mBio.00889-13; Purves J, 2018, ENVIRON MICROBIOL, V20, P1576, DOI 10.1111/1462-2920.14088; Radford DS, 2003, FEMS MICROBIOL LETT, V220, P105, DOI 10.1016/S0378-1097(03)00095-8; Rahman O, 2008, WORLD J MICROB BIOT, V24, P2377, DOI 10.1007/s11274-008-9795-2; Rajkarnikar A, 2013, BIOCHEM BIOPH RES CO, V436, P128, DOI 10.1016/j.bbrc.2013.04.027; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Resch G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058187; Roberts CA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00100-17; Rosario-Cruz Z, 2015, MOL MICROBIOL, V98, P218, DOI 10.1111/mmi.13115; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Schmidt MG, 2012, J CLIN MICROBIOL, V50, P2217, DOI 10.1128/JCM.01032-12; Scholz C, 1998, BIOL CHEM, V379, P361; Schrodinger L., 2015, PYMOL MOL GRAPHICS S; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Singleton C, 2007, BIOMETALS, V20, P275, DOI 10.1007/s10534-006-9068-1; Singleton C, 2009, BIOCHEM J, V424, P347, DOI 10.1042/BJ20091079; Singleton C, 2009, DALTON T, P688, DOI 10.1039/b810412c; Sitthisak S, 2005, APPL ENVIRON MICROB, V71, P5650, DOI 10.1128/AEM.71.9.5650-5653.2005; Sitthisak S, 2007, MICROBIOL-SGM, V153, P4274, DOI 10.1099/mic.0.2007/009860-0; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Sousa FL, 2012, BBA-BIOENERGETICS, V1817, P629, DOI 10.1016/j.bbabio.2011.09.020; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Tan GQ, 2014, MOL MICROBIOL, V93, P629, DOI 10.1111/mmi.12676; Tavares P, 2006, J INORG BIOCHEM, V100, P2087, DOI 10.1016/j.jinorgbio.2006.09.003; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Thurlow LR, 2013, CELL HOST MICROBE, V13, P100, DOI 10.1016/j.chom.2012.11.012; Tjandra N, 1996, J AM CHEM SOC, V118, P6264, DOI 10.1021/ja960106n; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Xiao ZG, 2013, METALLOMICS, V5, P501, DOI 10.1039/c3mt00032j; Zapotoczna M, 2018, MBIO, V9, DOI 10.1128/mBio.00550-18; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	113	22	22	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4027	4044		10.1074/jbc.RA118.004723	http://dx.doi.org/10.1074/jbc.RA118.004723			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655293	Green Published, hybrid			2022-12-28	WOS:000461854400018
J	Cejka, P				Cejka, Petr			Seeing is believing: DNA zipping promotes DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BINDING; CTP1	DNA double-strand break repair by homologous recombination is initiated by the Ctp1 protein together with the Mre11-Rad50-Nbs1 nuclease complex in Schizosaccharomyces pombe, but the mechanism by which Ctp1 promotes this process has remained unknown. Andres et al. now use atomic force microscopy to image Ctp1-DNA complexes, demonstrating a striking capacity of Ctp1 filaments to bridge DNA molecules. This unanticipated role of Ctp1 might help explain how the processing of DNA ends is coordinated to facilitate DNA break repair.	[Cejka, Petr] USI, Fac Biomed Sci, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Cejka, Petr] ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland	Universita della Svizzera Italiana; ETH Zurich	Cejka, P (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	petr.cejka@irb.usi.ch		Cejka, Petr/0000-0002-9087-032X	Swiss National Science Foundation (SNCF) [31003A_175444]; European Research Council (ERC) [681630]	Swiss National Science Foundation (SNCF); European Research Council (ERC)(European Research Council (ERC))	This work was supported by Swiss National Science Foundation (SNCF) Grant 31003A_175444) and European Research Council (ERC) Grant 681630. The author declares that he has no conflicts of interest with the contents of this article.	Andres SN, 2019, J BIOL CHEM, V294, P3312, DOI 10.1074/jbc.RA118.006759; Andres SN, 2015, NAT STRUCT MOL BIOL, V22, P158, DOI 10.1038/nsmb.2945; Cannavo E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06417-5; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Davies OR, 2015, NAT STRUCT MOL BIOL, V22, P150, DOI 10.1038/nsmb.2937; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Oh J, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120589; Qvist P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002310; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033	10	0	0	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3321	3322		10.1074/jbc.H119.007814	http://dx.doi.org/10.1074/jbc.H119.007814			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30824572	hybrid, Green Published			2022-12-28	WOS:000464980100029
J	Aziz, M; Wang, XQ; Tripathi, A; Bankaitis, VA; Chapman, KD				Aziz, Mina; Wang, Xiaoqiang; Tripathi, Ashutosh; Bankaitis, Vytas A.; Chapman, Kent D.			Structural analysis of a plant fatty acid amide hydrolase provides insights into the evolutionary diversity of bioactive acylethanolamides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; endocannabinoid; lipid signaling; Arabidopsis; hydrolase; fatty acid amide hydrolase (FAAH); N-acylethanolamines; oxylipins; quorum sensing; squeeze and lock mechanism; seed germination	N-ACYLETHANOLAMINES; CRYSTAL-STRUCTURE; ENDOCANNABINOIDS; IDENTIFICATION; METABOLISM; GROWTH; ENZYME; SITE	N-Acylethanolamines (NAEs) are fatty acid derivatives that in animal systems include the well-known bioactive metabolites of the endocannabinoid signaling pathway. Plants use NAE signaling as well, and these bioactive molecules often have oxygenated acyl moieties. Here, we report the three-dimensional crystal structures of the signal-terminating enzyme fatty acid amide hydrolase (FAAH) from Arabidopsis in its apo and ligand-bound forms at 2.1- and 3.2- resolutions, respectively. This plant FAAH structure revealed features distinct from those of the only other available FAAH structure (rat). The structures disclosed that although catalytic residues are conserved with the mammalian enzyme, AtFAAH has a more open substrate-binding pocket that is partially lined with polar residues. Fundamental differences in the organization of the membrane-binding cap and the membrane access channel also were evident. In accordance with the observed structural features of the substrate-binding pocket, kinetic analysis showed that AtFAAH efficiently uses both unsubstituted and oxygenated acylethanolamides as substrates. Moreover, comparison of the apo and ligand-bound AtFAAH structures identified three discrete sets of conformational changes that accompany ligand binding, suggesting a unique squeeze and lock substrate-binding mechanism. Using molecular dynamics simulations, we evaluated these conformational changes further and noted a partial unfolding of a random-coil helix within the region 531-537 in the apo structure but not in the ligand-bound form, indicating that this region likely confers plasticity to the substrate-binding pocket. We conclude that the structural divergence in bioactive acylethanolamides in plants is reflected in part in the structural and functional properties of plant FAAHs.	[Aziz, Mina; Wang, Xiaoqiang; Chapman, Kent D.] Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA; [Aziz, Mina; Wang, Xiaoqiang; Chapman, Kent D.] Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA; [Tripathi, Ashutosh; Bankaitis, Vytas A.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wang, XQ; Chapman, KD (corresponding author), Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA.; Wang, XQ; Chapman, KD (corresponding author), Univ North Texas, BioDiscovery Inst, Denton, TX 76203 USA.	xiaoqiang.wang@unt.edu; chapman@unt.edu		Chapman, Kent/0000-0003-0489-3072	United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; Laboratory for Molecular Simulation and High Performance Research Computing at Texas AM University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R35GM131804] Funding Source: NIH RePORTER	United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Laboratory for Molecular Simulation and High Performance Research Computing at Texas AM University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank staff scientists at the Stanford Synchrotron Radiation Laboratory (SSRL) for assistance with data collection. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393). We also thank The Laboratory for Molecular Simulation and High Performance Research Computing at Texas A&M University for software, support, and computer time.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blaise M, 2010, EMBO J, V29, P3118, DOI 10.1038/emboj.2010.192; Blancaflor EB, 2014, PLANT J, V79, P568, DOI 10.1111/tpj.12427; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; CUDNEY B, 1994, ACTA CRYSTALLOGR D, V50, P414, DOI 10.1107/S0907444994002660; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan C, 2013, J BIOL CHEM, V288, P21422, DOI 10.1074/jbc.M113.453837; Gachet MS, 2017, SCI REP-UK, V7, DOI 10.1038/srep41177; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iannotti FA, 2016, PROG LIPID RES, V62, P107, DOI 10.1016/j.plipres.2016.02.002; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Keereetaweep J, 2015, PLANT J, V82, P315, DOI 10.1111/tpj.12821; Keereetaweep J, 2013, PLANT CELL, V25, P3824, DOI 10.1105/tpc.113.119024; Kilaru A, 2011, J BIOL CHEM, V286, P15205, DOI 10.1074/jbc.M110.217588; Kim Sang-Chul, 2013, Methods Mol Biol, V1009, P115, DOI 10.1007/978-1-62703-401-2_12; Kim SC, 2009, J BIOL CHEM, V284, P34065, DOI 10.1074/jbc.M109.059022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee S, 2015, BIOCHEM BIOPH RES CO, V467, P268, DOI 10.1016/j.bbrc.2015.09.177; Liebeschuetz JW, 2012, J COMPUT AID MOL DES, V26, P737, DOI 10.1007/s10822-012-9551-4; Lucanic M, 2011, NATURE, V473, P226, DOI 10.1038/nature10007; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Mileni M, 2008, P NATL ACAD SCI USA, V105, P12820, DOI 10.1073/pnas.0806121105; Min XS, 2011, P NATL ACAD SCI USA, V108, P7379, DOI 10.1073/pnas.1016167108; Molecular Operating Environment (MOE), 2018, MOL OP ENV MOE VERS; Moriarty NW, 2017, ACTA CRYSTALLOGR D, V73, P123, DOI 10.1107/S2059798316016570; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palermo G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004231; Palmer AG, 2014, ACS CHEM BIOL, V9, P1834, DOI 10.1021/cb500191a; Patricelli MP, 1998, BIOCHEMISTRY-US, V37, P15177, DOI 10.1021/bi981733n; Schrodinger Maestro, 2018, MAESTR REL 2018 1; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Shrestha R, 2003, J BIOL CHEM, V278, P34990, DOI 10.1074/jbc.M305613200; Teplitski M, 2011, CHEM REV, V111, P100, DOI 10.1021/cr100045m; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103	41	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7419	7432		10.1074/jbc.RA118.006672	http://dx.doi.org/10.1074/jbc.RA118.006672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30894416	Green Published, hybrid			2022-12-28	WOS:000468402900027
J	Choquet, K; Forget, D; Meloche, E; Dicaire, MJ; Bernard, G; Vanderver, A; Schiffmann, R; Fabian, MR; Teichmann, M; Coulombe, B; Brais, B; Kleinman, CL				Choquet, Karine; Forget, Diane; Meloche, Elisabeth; Dicaire, Marie-Josee; Bernard, Genevieve; Vanderver, Adeline; Schiffmann, Raphael; Fabian, Marc R.; Teichmann, Martin; Coulombe, Benoit; Brais, Bernard; Kleinman, Claudia L.			Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase III; transfer RNA (tRNA); myelin; CRISPR; Cas; proteomics; brain cytoplasmic 200 RNA (BCYRN1); leukodystrophy; oligodendrocyte; RNA-seq; transcription	BC1 RNA; BRF1 MUTATIONS; RARS CAUSE; HYPOMYELINATION; TRANSLATION; SYNTHETASE; GENES; METHYLATION; EXPRESSION; EFFICIENT	RNA polymerase III (Pol III) is an essential enzyme responsible for the synthesis of several small noncoding RNAs, a number of which are involved in mRNA translation. Recessive mutations in POLR3A, encoding the largest subunit of Pol III, cause POLR3-related hypomyelinating leukodystrophy (POLR3-HLD), characterized by deficient central nervous system myelination. Identification of the downstream effectors of pathogenic POLR3A mutations has so far been elusive. Here, we used CRISPR-Cas9 to introduce the POLR3A mutation c.2554AG (p.M852V) into human cell lines and assessed its impact on Pol III biogenesis, nuclear import, DNA occupancy, transcription, and protein levels. Transcriptomic profiling uncovered a subset of transcripts vulnerable to Pol III hypofunction, including a global reduction in tRNA levels. The brain cytoplasmic BC200 RNA (BCYRN1), involved in translation regulation, was consistently affected in all our cellular models, including patient-derived fibroblasts. Genomic BC200 deletion in an oligodendroglial cell line led to major transcriptomic and proteomic changes, having a larger impact than those of POLR3A mutations. Upon differentiation, mRNA levels of the MBP gene, encoding myelin basic protein, were significantly decreased in POLR3A-mutant cells. Our findings provide the first evidence for impaired Pol III transcription in cellular models of POLR3-HLD and identify several candidate effectors, including BC200 RNA, having a potential role in oligodendrocyte biology and involvement in the disease.	[Choquet, Karine; Bernard, Genevieve; Brais, Bernard; Kleinman, Claudia L.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 0C7, Canada; [Choquet, Karine; Fabian, Marc R.; Kleinman, Claudia L.] Jewish Gen Hosp, Lady Davis Inst Med Res, 3999 Cote Ste Catherine Rd,Rm E-542, Montreal, PQ H3T 1E2, Canada; [Choquet, Karine; Meloche, Elisabeth; Dicaire, Marie-Josee; Brais, Bernard] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Forget, Diane; Coulombe, Benoit] IRCM, Translat Prote Lab, Montreal, PQ H2W 1R7, Canada; [Bernard, Genevieve; Brais, Bernard] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 0G4, Canada; [Bernard, Genevieve] McGill Univ, Dept Pediat, Montreal, PQ H3A 0G4, Canada; [Bernard, Genevieve] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Dept Internal Med,Div Med Genet, Montreal, PQ H4A 3J1, Canada; [Bernard, Genevieve] McGill Univ, Hlth Ctr, Res Inst, Child Hlth & Human Dev Program, Montreal, PQ H4A 3J1, Canada; [Bernard, Genevieve] McGill Univ, Hlth Ctr, Res Inst, MyeliNeuroGene Lab, Montreal, PQ H4A 3J1, Canada; [Vanderver, Adeline] CHOP, Div Neurol, Philadelphia, PA 19104 USA; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX 75204 USA; [Teichmann, Martin] Univ Bordeaux, CNRS UMR5320, INSERM U1212, Bordeaux, France; [Coulombe, Benoit] Univ Montreal, Dept Biochim & Med Mol, Montreal, PQ H3T 1J4, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University; McGill University; McGill University; McGill University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor Scott & White Health; Baylor University Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite de Montreal	Kleinman, CL (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, 3999 Cote Ste Catherine Rd,Rm E-542, Montreal, PQ H3T 1E2, Canada.	claudia.kleinman@mcgill.ca	Brais, Bernard/Y-3910-2019; Vanderver, Adeline/CAG-5072-2022; Bernard, Geneviève/AAU-7569-2020; Teichmann, Martin/M-7407-2014	Bernard, Geneviève/0000-0002-9634-2966; Teichmann, Martin/0000-0002-5257-0510	Canadian Institutes of Health Research [MOP-126141, MOP-G2-341146-159133-BRIDG, 201610PJT-377869]; Fondation Leuco Dystrophie; European Leukodystrophy Association [2015-004C2C]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation Leuco Dystrophie; European Leukodystrophy Association	This work was supported in part by Canadian Institutes of Health Research Grants MOP-126141, MOP-G2-341146-159133-BRIDG, and 201610PJT-377869, Fondation Leuco Dystrophie, and European Leukodystrophy Association Grant 2015-004C2C. The authors declare that they have no conflicts of interest with the contents of this article.	Alla RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085648; Antonicka H, 2017, EMBO REP, V18, P28, DOI 10.15252/embr.201643391; Arimbasseri AG, 2016, TRENDS BIOCHEM SCI, V41, P546, DOI 10.1016/j.tibs.2016.03.003; Arimbasseri AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005671; Azmanov DN, 2016, HUM MOL GENET, V25, P4302, DOI 10.1093/hmg/ddw263; Bernard G, 2011, AM J HUM GENET, V89, P415, DOI 10.1016/j.ajhg.2011.07.014; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Bonhoure N, 2015, GENE DEV, V29, P934, DOI 10.1101/gad.258350.115; Booy EP, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0679-7; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Canella D, 2012, GENOME RES, V22, P666, DOI 10.1101/gr.130286.111; Choquet K, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0294-y; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/NMETH.3508, 10.1038/nmeth.3508]; De Vries GH, 2010, NEUROCHEM RES, V35, P1978, DOI 10.1007/s11064-010-0318-9; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorboz I, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000289; Dumay-Odelot H, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.27526; Duning K, 2008, J NEUROCHEM, V105, P351, DOI 10.1111/j.1471-4159.2007.05138.x; Eccles J. C., 1967, CEREBELLUM NEURONAL, P7; Eom T, 2014, J CELL BIOL, V207, P237, DOI 10.1083/jcb.201401005; Eom T, 2011, MOL CELL BIOL, V31, P4538, DOI 10.1128/MCB.05885-11; Faresse NJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003028; Feinstein M, 2010, AM J HUM GENET, V87, P820, DOI 10.1016/j.ajhg.2010.10.016; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Gogakos T, 2017, CELL REP, V20, P1463, DOI 10.1016/j.celrep.2017.07.029; Hein PP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-141; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; Jee YH, 2017, CLIN GENET, V91, P739, DOI 10.1111/cge.12887; Kapur M, 2017, NEURON, V96, P616, DOI 10.1016/j.neuron.2017.09.057; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kevelam SH, 2016, NEUROPEDIATRICS, V47, P349, DOI 10.1055/s-0036-1588020; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Kim Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05097-3; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Kutter C, 2011, NAT GENET, V43, P948, DOI 10.1038/ng.906; La Piana R, 2016, NEUROLOGY, V86, P1622, DOI 10.1212/WNL.0000000000002612; Lalonde S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178700; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MCLAURIN J, 1995, J NEUROBIOL, V26, P283, DOI 10.1002/neu.480260212; Mendes MI, 2018, AM J HUM GENET, V102, P676, DOI 10.1016/j.ajhg.2018.02.011; Minnerop M, 2017, BRAIN, V140, P1561, DOI 10.1093/brain/awx095; Nafisinia M, 2017, EUR J HUM GENET, V25, P1134, DOI 10.1038/ejhg.2017.119; Nakayama T, 2017, HUM MUTAT, V38, P1348, DOI 10.1002/humu.23250; Orioli A, 2016, GENOME RES, V26, P624, DOI 10.1101/gr.201400.115; Orioli A, 2012, GENE, V493, P185, DOI 10.1016/j.gene.2011.06.015; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramsay EP, 2018, BBA-GENE REGUL MECH, V1861, P285, DOI 10.1016/j.bbagrm.2017.11.005; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Shin H, 2017, RNA BIOL, V14, P1418, DOI 10.1080/15476286.2017.1297913; Shin H, 2017, BMB REP, V50, P318, DOI 10.5483/BMBRep.2017.50.6.217; Simons C, 2015, AM J HUM GENET, V96, P675, DOI 10.1016/j.ajhg.2015.02.012; Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479; Singh R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.168; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006; Tetreault M, 2011, AM J HUM GENET, V89, P652, DOI 10.1016/j.ajhg.2011.10.006; Thiffault I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8623; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; Turowski TW, 2016, GENOME RES, V26, P933, DOI 10.1101/gr.205492.116; Vanderver A, 2013, J NEUROPATH EXP NEUR, V72, P67, DOI 10.1097/NEN.0b013e31827c99d2; Voccoli V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.483; Wolf NI, 2014, NEUROLOGY, V83, P1898, DOI 10.1212/WNL.0000000000001002; Wolf NI, 2014, ANN NEUROL, V76, P134, DOI 10.1002/ana.24167; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]	71	23	26	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7445	7459		10.1074/jbc.RA118.006271	http://dx.doi.org/10.1074/jbc.RA118.006271			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30898877	Green Published, hybrid			2022-12-28	WOS:000468402900029
J	Xie, JL; Van Damme, P; Fang, D; Proud, CG				Xie, Jianling; Van Damme, Petra; Fang, Danielle; Proud, Christopher G.			Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						translation elongation factor; heat shock protein (HSP); proteasome; protein synthesis; apoptosis; cancer; elongation; eukaryotic elongation factor 2 kinase (eEF2K); molecular chaperone; mRNA translation	INHIBITION; DEGRADATION; MECHANISM	Eukaryotic elongation factor 2 kinase (eEF2K) negatively regulates the elongation stage of mRNA translation and is activated under different stress conditions to slow down protein synthesis. One effect of eEF2K is to alter the repertoire of expressed proteins, perhaps to aid survival of stressed cells. Here, we applied pulsed stable isotope labeling with amino acids in cell culture (SILAC) to study changes in the synthesis of specific proteins in human lung adenocarcinoma (A549) cells in which eEF2K had been depleted by an inducible shRNA. We discovered that levels of heat-shock protein 90 (HSP90) are increased in eEF2K-depleted human cells as well as in eEF2K-knockout (eEF2K(-/-)) mouse embryonic fibroblasts (MEFs). This rise in HSP90 coincided with an increase in the fraction of HSP90 mRNAs associated with translationally active polysomes, irrespective of unchanged total HSP90 levels. These results indicate that blocking eEF2K function can enhance expression of HSP90 chaperones. In eEF2K(-/-) mouse embryonic fibroblasts (MEFs), inhibition of HSP90 by its specific inhibitor AUY922 promoted the accumulation of ubiquitinated proteins. Notably, HSP90 inhibition promoted apoptosis of eEF2K(-/-) MEFs under proteostatic stress induced by the proteasome inhibitor MG132. Up-regulation of HSP90 likely protects cells from protein folding stress, arising, for example, from faster rates of polypeptide synthesis due to the lack of eEF2K. Our findings indicate that eEF2K and HSPs closely cooperate to maintain proper proteostasis and suggest that concomitant inhibition of HSP90 and eEF2K could be a strategy to decrease cancer cell survival.	[Xie, Jianling; Fang, Danielle; Proud, Christopher G.] South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, North Terrace, Adelaide, SA 5000, Australia; [Van Damme, Petra] Univ Ghent, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Van Damme, Petra] VIB Ctr Med Biotechnol, Ghent, Belgium; [Fang, Danielle; Proud, Christopher G.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia	South Australian Health & Medical Research Institute (SAHMRI); Ghent University; Flanders Institute for Biotechnology (VIB); University of Adelaide	Proud, CG (corresponding author), South Australian Hlth & Med Res Inst, Lifelong Hlth Theme, North Terrace, Adelaide, SA 5000, Australia.; Proud, CG (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia.	christopher.proud@sahmri.com	Xie, Jianling/N-1877-2014; Van Damme, Petra/C-7269-2008	Xie, Jianling/0000-0002-0588-8016; Van Damme, Petra/0000-0001-9090-027X				Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Centenera MM, 2012, CLIN CANCER RES, V18, P3562, DOI 10.1158/1078-0432.CCR-12-0782; Conn CS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003520; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Gismondi A, 2014, NUCLEIC ACIDS RES, V42, P12668, DOI 10.1093/nar/gku996; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; Jonckheere V, 2018, MOL CELL PROTEOMICS, V17, P694, DOI 10.1074/mcp.RA117.000360; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Moore CEJ, 2015, MOL CELL BIOL, V35, P1788, DOI 10.1128/MCB.01457-14; Proud CG, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033050; Scheckel C, 2018, NAT REV GENET, V19, P405, DOI 10.1038/s41576-018-0011-4; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Varland S, 2018, MOL CELL PROTEOMICS, V17, P2309, DOI 10.1074/mcp.RA118.000982; Wang XM, 2015, BIOCHEM J, V467, P321, DOI 10.1042/BJ20150089; Xie JL, 2019, CURR BIOL, V29, P737, DOI 10.1016/j.cub.2019.01.029; Xie JL, 2018, INT J CANCER, V142, P1865, DOI 10.1002/ijc.31210; Xie JL, 2015, MOL CELL BIOL, V35, P1805, DOI 10.1128/MCB.00012-15; Yang J, 2001, CANCER RES, V61, P4010; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112	26	13	12	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7169	7176		10.1074/jbc.AC119.008036	http://dx.doi.org/10.1074/jbc.AC119.008036			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30890561	Green Published, hybrid			2022-12-28	WOS:000468402900007
J	Komatsubara, AT; Goto, Y; Kondo, Y; Matsuda, M; Aoki, K				Komatsubara, Akira T.; Goto, Yuhei; Kondo, Yohei; Matsuda, Michiyuki; Aoki, Kazuhiro			Single-cell quantification of the concentrations and dissociation constants of endogenous proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence correlation spectroscopy (FCS); protein-protein interaction; extracellular signal-regulated kinase (ERK); RSK; nuclear translocation; dissociation constant; fluorescence cross-correlation spectroscopy (FCCS); live-cell analysis; single-cell analysis	MAP KINASE CASCADE; ERK; DYNAMICS; REPAIR; GENE; PHOSPHORYLATION; HETEROGENEITY; INHIBITION; EFFICIENCY; PATHWAYS	Kinetic simulation is a useful approach for elucidating complex cell-signaling systems. The numerical simulations required for kinetic modeling in live cells critically require parameters such as protein concentrations and dissociation constants (K-d). However, only a limited number of parameters have been measured experimentally in living cells. Here we describe an approach for quantifying the concentration and K-d of endogenous proteins at the single-cell level with CRISPR/Cas9-mediated knock-in and fluorescence cross-correlation spectroscopy. First, the mEGFP gene was knocked in at the end of the mitogen-activated protein kinase 1 (MAPK1) gene, encoding extracellular signal-regulated kinase 2 (ERK2), through homology-directed repair or microhomology-mediated end joining. Next, the HaloTag gene was knocked in at the end of the ribosomal S6 kinase 2 (RSK2) gene. We then used fluorescence correlation spectroscopy to measure the protein concentrations of endogenous ERK2-mEGFP and RSK2-HaloTag fusion constructs in living cells, revealing substantial heterogeneities. Moreover, fluorescence cross-correlation spectroscopy analyses revealed temporal changes in the apparent K-d values of the binding between ERK2-mEGFP and RSK2-HaloTag in response to epidermal growth factor stimulation. Our approach presented here provides a robust and efficient method for quantifying endogenous protein concentrations and dissociation constants in living cells.	[Komatsubara, Akira T.; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto 6068501, Japan; [Komatsubara, Akira T.; Goto, Yuhei; Kondo, Yohei; Aoki, Kazuhiro] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Quantitat Biol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Goto, Yuhei; Kondo, Yohei; Aoki, Kazuhiro] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst, Quantitat Biol Res Grp, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan; [Kondo, Yohei; Aoki, Kazuhiro] Kyoto Univ, Grad Sch Med, Imaging Platform Spatiotemporal Informat, Sakyo Ku, Kyoto 6068501, Japan; [Kondo, Yohei; Aoki, Kazuhiro] Grad Univ Adv Studies, SOKENDAI, Fac Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Komatsubara, Akira T.] RIKEN, Quantitat Biol Ctr, Lab Cell Polar Regulat, Suita, Osaka 5650874, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS); Kyoto University; Kyoto University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); RIKEN	Aoki, K (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Exploratory Res Ctr Life & Living Syst, Higashiyama 5-1, Okazaki, Aichi 4448787, Japan.	k-aoki@nibb.ac.jp	Goto, Yuhei/AAX-5076-2021; Aoki, Kazuhiro/I-5483-2019	Goto, Yuhei/0000-0002-5597-158X; Aoki, Kazuhiro/0000-0001-7263-1555; Kondo, Yohei/0000-0002-2801-4522; Matsuda, Michiyuki/0000-0002-5876-9969	Spectrography and Bioimaging Facility; Functional Genomics Facility; NIBB Core Research Facilities; Platform for Dynamic Approaches to Living Systems from the Ministry of Education, Culture, Sports, and Science, Japan; JST, CREST Grant [JPMJCR1654]; MEXT/JSPS KAKENHI Grant [15H05949]; JSPS KAKENHI [16H01425, 16H01447, 16KT0069, 18H04754, 18H02444]; Hori Sciences and Arts Foundation; Nakajima Foundation	Spectrography and Bioimaging Facility; Functional Genomics Facility; NIBB Core Research Facilities; Platform for Dynamic Approaches to Living Systems from the Ministry of Education, Culture, Sports, and Science, Japan; JST, CREST Grant; MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hori Sciences and Arts Foundation; Nakajima Foundation	This work was supported by the Spectrography and Bioimaging Facility and Functional Genomics Facility, NIBB Core Research Facilities. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Platform for Dynamic Approaches to Living Systems from the Ministry of Education, Culture, Sports, and Science, Japan; by JST, CREST Grant JPMJCR1654; and by MEXT/JSPS KAKENHI Grant 15H05949 "Resonance Bio."; Supported by the Platform for Dynamic Approaches to Living Systems from the Ministry of Education, Culture, Sports, and Science, Japan; by JST, CREST Grant JPMJCR1654; by JSPS KAKENHI Grants 16H01425 "Resonance Bio," 16H01447, 16KT0069, 18H04754 "Resonance Bio," and 18H02444; and by funds from the Hori Sciences and Arts Foundation and the Nakajima Foundation.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Aoki K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01541; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Burkhard KA, 2011, J BIOL CHEM, V286, P2477, DOI 10.1074/jbc.M110.177899; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Gaudet S, 2016, TRENDS BIOTECHNOL, V34, P458, DOI 10.1016/j.tibtech.2016.02.009; Kholodenko B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002961; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kinjo Masataka, 2011, Cold Spring Harb Protoc, V2011, P1262, DOI 10.1101/pdb.prot065938; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Ling QH, 2012, SCIENCE, V338, P655, DOI 10.1126/science.1225053; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Macville M, 1999, CANCER RES, V59, P141; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Miura H, 2018, CELL REP, V24, P2658, DOI 10.1016/j.celrep.2018.08.020; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Nakatake Y, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-64; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Ries J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113009; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sadaie W, 2014, MOL CELL BIOL, V34, P3272, DOI 10.1128/MCB.00087-14; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SCHWARTZ F, 1991, P NATL ACAD SCI USA, V88, P10416, DOI 10.1073/pnas.88.23.10416; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Shi XK, 2009, BIOPHYS J, V97, P678, DOI 10.1016/j.bpj.2009.05.006; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Stewart-Ornstein J, 2016, CELL REP, V14, P1800, DOI 10.1016/j.celrep.2016.01.045; Sudhaharan T, 2009, J BIOL CHEM, V284, P13602, DOI 10.1074/jbc.M900894200; Vaidyanathan H, 2007, P NATL ACAD SCI USA, V104, P19837, DOI 10.1073/pnas.0704514104; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	44	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6062	6072		10.1074/jbc.RA119.007685	http://dx.doi.org/10.1074/jbc.RA119.007685			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30739083	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000465077500036
J	Leonard, EK; Leff, MI; Spangler, JB				Leonard, Elissa K.; Leff, Michael I.; Spangler, Jamie B.			Weaponizing T-cell receptors through molecular engineering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CYTOMEGALOVIRUS; SELECTION	T-cell receptors (TCRs) recognize pathogens to ignite immune responses, making them attractive scaffolds for development as immunotherapeutics. However, manipulation of TCRs has been impeded by difficulties in their engineering and expression. Wagner and colleagues now establish new platforms to generate high-affinity TCR variants that potently activate T cells, and they also create soluble TCR fusion proteins that specifically recognize cognate peptides. This work provides specific tools to combat cytomegalovirus (CMV) infection and helps illuminate a general path to actuation of engineered TCR-based therapeutics.	[Leonard, Elissa K.; Spangler, Jamie B.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Leff, Michael I.] Johns Hopkins Univ, Dept Mol & Cell Biol, Baltimore, MD 21218 USA; [Spangler, Jamie B.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Spangler, JB (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.; Spangler, JB (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	jamie.spangler@jhu.edu			Department of Defense [RT170165]; V Foundation Scholars award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM123914] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); V Foundation Scholars award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Department of Defense Grant RT170165 and a V Foundation Scholars award (to J. B. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chervin AS, 2008, J IMMUNOL METHODS, V339, P175, DOI 10.1016/j.jim.2008.09.016; Grilo AL, 2019, TRENDS BIOTECHNOL, V37, P9, DOI 10.1016/j.tibtech.2018.05.014; Malecek K, 2013, J IMMUNOL METHODS, V392, P1, DOI 10.1016/j.jim.2013.02.018; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Wagner EK, 2019, J BIOL CHEM, V294, P5790, DOI 10.1074/jbc.RA118.007187; Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996	10	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5805	5806		10.1074/jbc.H119.008479	http://dx.doi.org/10.1074/jbc.H119.008479			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30979848	Green Published, hybrid			2022-12-28	WOS:000465077500007
J	Saelices, L; Nguyen, BA; Chung, K; Wang, YF; Ortega, A; Lee, JH; Coelho, T; Bijzet, J; Benson, MD; Eisenberg, DS				Saelices, Lorena; Nguyen, Binh A.; Chung, Kevin; Wang, Yifei; Ortega, Alfredo; Lee, Ji H.; Coelho, Teresa; Bijzet, Johan; Benson, Merrill D.; Eisenberg, David S.			A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; protein aggregation; inhibition mechanism; aging; drug discovery; peptides; amyloidosis; inhibition; peptide; seeding; transthyretin	TAFAMIDIS; POLYNEUROPATHY; PROTEIN; AGGREGATION; DIFLUNISAL; DEPOSITS; SAFETY; POTENT	The tetrameric protein transthyretin is a transporter of retinol and thyroxine in blood, cerebrospinal fluid, and the eye, and is secreted by the liver, choroid plexus, and retinal epithelium, respectively. Systemic amyloid deposition of aggregated transthyretin causes hereditary and sporadic amyloidoses. A common treatment of patients with hereditary transthyretin amyloidosis is liver transplantation. However, this procedure, which replaces the patient's variant transthyretin with the WT protein, can fail to stop subsequent cardiac deposition, ultimately requiring heart transplantation. We recently showed that preformed amyloid fibrils present in the heart at the time of surgery can template or seed further amyloid aggregation of native transthyretin. Here we assess possible interventions to halt this seeding, using biochemical and EM assays. We found that chemical or mutational stabilization of the transthyretin tetramer does not hinder amyloid seeding. In contrast, binding of the peptide inhibitor TabFH2 to ex vivo fibrils efficiently inhibits amyloid seeding by impeding self-association of the amyloid-driving strands F and H in a tissue-independent manner. Our findings point to inhibition of amyloid seeding by peptide inhibitors as a potential therapeutic approach.	[Saelices, Lorena; Nguyen, Binh A.; Chung, Kevin; Wang, Yifei; Ortega, Alfredo; Lee, Ji H.; Eisenberg, David S.] Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Howard Hughes Med Inst,UCLA DOE Inst, Box 951570, Los Angeles, CA 90095 USA; [Saelices, Lorena; Nguyen, Binh A.; Chung, Kevin; Wang, Yifei; Ortega, Alfredo; Lee, Ji H.; Eisenberg, David S.] Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Howard Hughes Med Inst,UCLA DOE Inst, Box 951570, Los Angeles, CA 90095 USA; [Coelho, Teresa] Ctr Hosp Porto, Hosp Santo Antonio, Dept Neurophysiol, P-4099001 Porto, Portugal; [Coelho, Teresa] Ctr Hosp Porto, Hosp Santo Antonio, Corino de Andrade Unit, P-4099001 Porto, Portugal; [Bijzet, Johan] Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9713 GZ Groningen, Netherlands; [Benson, Merrill D.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of Groningen; Indiana University System; Indiana University Bloomington	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Biol Chem, Howard Hughes Med Inst,UCLA DOE Inst, Box 951570, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Howard Hughes Med Inst,UCLA DOE Inst, Box 951570, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Eisenberg, David/0000-0003-2432-5419; Saelices Gomez, Lorena/0000-0002-1904-2150	Amyloidosis Foundation [20160759, 20170827]; National Institutes of Health [R01-AG048120]; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [R01AG048120] Funding Source: NIH RePORTER	Amyloidosis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Amyloidosis Foundation Grant 20160759 and 20170827, National Institutes of Health Grant R01-AG048120, and The Howard Hughes Medical Institute. The authors and UCLA have filed an international patent application for the TTR inhibitors (number PCT/US17/40103). D. S. E. is an advisor and equity holder of ADRx, Inc. L. S. is a consultant of ADRx, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Benson MD, 2013, MUSCLE NERVE, V47, P157, DOI 10.1002/mus.23521; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Castano Adam, 2012, Congest Heart Fail, V18, P315, DOI 10.1111/j.1751-7133.2012.00303.x; Coelho T., 1996, NEUROMUSCUL DISORD, V6, pS20, DOI 10.1016/0960-8966(96)88826-2; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Cruz MW, 2016, AMYLOID, V23, P178, DOI 10.1080/13506129.2016.1207163; Cruz MW, 2015, NEUROL THER, V4, P61, DOI 10.1007/s40120-015-0031-3; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Fujita T, 2017, CARDIOLOGY, V137, P74, DOI 10.1159/000455089; Galant NJ, 2017, CLIN SCI, V131, P395, DOI 10.1042/CS20160413; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hazenberg BPC, 1999, ANN RHEUM DIS, V58, P96, DOI 10.1136/ard.58.2.96; Higaki JN, 2016, AMYLOID, V23, P86, DOI 10.3109/13506129.2016.1148025; Hosoi A, 2016, J BIOL CHEM, V291, P25096, DOI 10.1074/jbc.M116.738138; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Lozeron P, 2013, EUR J NEUROL, V20, P1539, DOI 10.1111/ene.12225; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Obici L, 2014, EXPERT OPIN INV DRUG, V23, P1239, DOI 10.1517/13543784.2014.922541; Pinney JH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000098; Plante-Bordeneuve V, 2017, J NEUROL, V264, P268, DOI 10.1007/s00415-016-8337-3; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Saelices L, 2018, NEUROBIOL DIS, V120, P118, DOI 10.1016/j.nbd.2018.09.007; Saelices L, 2018, P NATL ACAD SCI USA, V115, pE6741, DOI 10.1073/pnas.1805131115; Saelices L, 2015, J BIOL CHEM, V290, P28932, DOI 10.1074/jbc.M115.659912; Seidler PM, 2018, NAT CHEM, V10, P170, DOI [10.1038/NCHEM.2889, 10.1038/nchem.2889]; Sekijima Y, 2015, AMYLOID, V22, P79, DOI 10.3109/13506129.2014.997872; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Yazaki M, 2000, BIOCHEM BIOPH RES CO, V274, P702, DOI 10.1006/bbrc.2000.3203	34	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6130	6141		10.1074/jbc.RA118.005257	http://dx.doi.org/10.1074/jbc.RA118.005257			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30733338	Green Published, hybrid			2022-12-28	WOS:000465077500041
J	Close, AF; Dadheech, N; Villela, BS; Rouillard, C; Buteau, J				Close, Anne-Francoise; Dadheech, Nidheesh; Villela, Barbara Scoralick; Rouillard, Claude; Buteau, Jean			The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of beta-cell mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-cell; diabetes; apoptosis; nuclear receptor; cytokine; pancreas; insulin; Nr4a	SKELETAL-MUSCLE; NGFI-B; NUR77; EXPRESSION; NOR-1; METABOLISM; KINASE; PATHOGENESIS; ACTIVATION; PATHWAYS	The Nr4a subfamily of nuclear receptor comprises three members in mammalian cells: Nur77/Nr4a1, Nurr1/Nr4a2, and Nor1/Nr4a3. Nr4a proteins play key roles in the regulation of glucose homeostasis in peripheral metabolic tissues. However, their biological functions in -cells remain relatively uncharacterized. Here we sought to investigate the potential role of Nor1 in the regulation of -cell mass and, in particular, beta-cell survival/apoptosis. We used histological analysis to examine the consequences of genetic deletion of either Nur77 and Nor1 on beta-cell mass, investigated the expression patterns of Nr4as in human islets and INS cells and performed gain- and loss-of-function experiments to further characterize the role of Nor1 in beta-cell apoptosis. Surprisingly, Nor1 knockout mice displayed increased beta-cell mass, whereas mice with genetic deletion of Nur77 did not exhibit any significant differences compared with their WT littermates. The increase in beta-cell mass in Nor1 knockout mice was accompanied by improved glucose tolerance. A gene expression study performed in both human islets and INS cells revealed that Nor1 expression is significantly increased by pro-inflammatory cytokines and, to a lesser extent, by elevated concentrations of glucose. Nor1 overexpression in both INS and human islet cells caused apoptosis, whereas siRNA-mediated Nor1 knockdown prevented cytokine-induced beta-cell death. Finally, Nor1 expression was up-regulated in islets of individuals with type 2 diabetes. Altogether, our results uncover that Nor1 negatively regulates beta-cell mass. Nor1 represents a promising molecular target in diabetes treatment to prevent beta-cell destruction.	[Close, Anne-Francoise; Dadheech, Nidheesh; Villela, Barbara Scoralick; Buteau, Jean] Univ Alberta, Dept AFNS, Edmonton, AB T6G 2E1, Canada; [Close, Anne-Francoise; Dadheech, Nidheesh; Villela, Barbara Scoralick; Buteau, Jean] Alberta Diabet Inst, Edmonton, AB T6G 2E1, Canada; [Rouillard, Claude] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ G1V 4G2, Canada; [Rouillard, Claude] CHU Quebec, Ctr Rech, Quebec City, PQ G1V 4G2, Canada	University of Alberta; Laval University; Laval University	Buteau, J (corresponding author), Univ Alberta, 5-126 Li Ka Shing Ctr, Edmonton, AB T6G 2E1, Canada.	jbuteau@ualberta.ca	Close, Anne-Françoise/GWZ-2344-2022; Rouillard, Claude/G-9127-2017; Dadheech, Nidheesh/E-3142-2017	Rouillard, Claude/0000-0003-4210-9330; Dadheech, Nidheesh/0000-0002-7155-0486	Alberta Diabetes Foundation; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Wallonie-Bruxelles International; Alberta Innovates Health Solutions; Canadian Institutes of Health Research New Investigator Award	Alberta Diabetes Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wallonie-Bruxelles International; Alberta Innovates Health Solutions; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported by the Alberta Diabetes Foundation, the Canadian Institutes of Health Research, and the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a scholarship from Wallonie-Bruxelles International and Alberta Innovates Health Solutions.; Supported by a Canadian Institutes of Health Research New Investigator Award.	Arredondo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055035; Auwerx J, 1999, CELL, V97, P161; Briand O, 2012, MOL ENDOCRINOL, V26, P399, DOI 10.1210/me.2011-1317; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chao LC, 2012, J LIPID RES, V53, P2610, DOI 10.1194/jlr.M029355; Close AF, 2013, DIABETES METAB, V39, P478, DOI 10.1016/j.diabet.2013.07.005; Diaz MB, 2006, CELL METAB, V4, P339, DOI 10.1016/j.cmet.2006.10.005; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Gao WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091462; Gissendanner CR, 2008, DEV BIOL, V313, P767, DOI 10.1016/j.ydbio.2007.11.014; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kanzleiter T, 2009, BBA-MOL BASIS DIS, V1792, P777, DOI 10.1016/j.bbadis.2009.05.002; Kawasaki E, 2009, J APPL PHYSIOL, V106, P1826, DOI 10.1152/japplphysiol.90923.2008; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kurakula K, 2014, BBA-MOL CELL RES, V1843, P2543, DOI 10.1016/j.bbamcr.2014.06.010; Lammi J, 2008, MOL CELL ENDOCRINOL, V295, P87, DOI 10.1016/j.mce.2008.08.023; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Levesque D., 2009, HDB NEUROPSYCHIATRIC, P195; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Maira M, 1999, MOL CELL BIOL, V19, P7549; Meier JJ, 2012, DIABETOLOGIA, V55, P1346, DOI 10.1007/s00125-012-2466-8; Meier JJ, 2013, DIABETES CARE, V36, pS113, DOI 10.2337/dcS13-2008; Nonogaki K, 2009, BIOCHEM BIOPH RES CO, V386, P311, DOI 10.1016/j.bbrc.2009.06.023; Ordelheide AM, 2013, MOL METAB, V2, P243, DOI 10.1016/j.molmet.2013.06.003; Pearen MA, 2013, MOL ENDOCRINOL, V27, P1897, DOI 10.1210/me.2013-1205; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Tessem JS, 2014, P NATL ACAD SCI USA, V111, P5242, DOI 10.1073/pnas.1320953111; Thompson J, 2010, EUR J IMMUNOL, V40, P2041, DOI 10.1002/eji.200940231; Veum VL, 2012, INT J OBESITY, V36, P1195, DOI 10.1038/ijo.2011.240; Volakakis N, 2006, J MOL ENDOCRINOL, V37, P317, DOI 10.1677/jme.1.02106; Weyrich P, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-77; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; Wingate AD, 2006, BIOCHEM J, V393, P715, DOI 10.1042/BJ20050967	43	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4889	4897		10.1074/jbc.RA118.005135	http://dx.doi.org/10.1074/jbc.RA118.005135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30696767	hybrid, Green Published			2022-12-28	WOS:000463985600014
J	Frossi, B; Antoniali, G; Yu, KF; Akhtar, N; Kaplan, MH; Kelley, MR; Tell, G; Pucillo, CEM				Frossi, Barbara; Antoniali, Giulia; Yu, Kefei; Akhtar, Nahid; Kaplan, Mark H.; Kelley, Mark R.; Tell, Gianluca; Pucillo, Carlo E. M.			Endonuclease and redox activities of human apurinic/apyrimidinic endonuclease 1 have distinctive and essential functions in IgA class switch recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						base excision repair (BER); DNA endonuclease; DNA transcription; immunoglobulin A (IgA); immunology; apurinic; apyrimidinic endonuclease 1 (APE1); base excision repair (BER); class switch recombination; immunoglobulin A (IgA); redox-inhibitor	BASE EXCISION-REPAIR; DNA-REPAIR; ENDOTHELIAL-CELLS; AP ENDONUCLEASE; ENZYME HAP1; IMMUNOGLOBULIN; APE1/REF-1; CANCER; IDENTIFICATION; EXPRESSION	The base excision repair (BER) pathway is an important DNA repair pathway and is essential for immune responses. In fact, it regulates both the antigen-stimulated somatic hypermutation (SHM) process and plays a central function in the process of class switch recombination (CSR). For both processes, a central role for apurinic/apyrimidinic endonuclease 1 (APE1) has been demonstrated. APE1 acts also as a master regulator of gene expression through its redox activity. APE1's redox activity stimulates the DNA-binding activity of several transcription factors, including NF-kappa B and a few others involved in inflammation and in immune responses. Therefore, it is possible that APE1 has a role in regulating the CSR through its function as a redox coactivator. The present study was undertaken to address this question. Using the CSR-competent mouse B-cell line CH12F3 and a combination of specific inhibitors of APE1's redox (APX3330) and repair (compound 3) activities, APE1-deficient or -reconstituted cell lines expressing redox-deficient or endonuclease-deficient proteins, and APX3330-treated mice, we determined the contributions of both endonuclease and redox functions of APE1 in CSR. We found that APE1's endonuclease activity is essential for IgA-class switch recombination. We provide evidence that the redox function of APE1 appears to play a role in regulating CSR through the interleukin-6 signaling pathway and in proper IgA expression. Our results shed light on APE1's redox function in the control of cancer growth through modulation of the IgA CSR process.	[Frossi, Barbara; Pucillo, Carlo E. M.] Univ Udine, Dept Med, Lab Immunol, Piazzale M Kolbe 4, I-33100 Udine, Italy; [Antoniali, Giulia; Tell, Gianluca] Univ Udine, Dept Med, Lab Mol Biol & DNA Repair, Piazzale M Kolbe 4, I-33100 Udine, Italy; [Yu, Kefei] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Akhtar, Nahid; Kaplan, Mark H.; Kelley, Mark R.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA	University of Udine; University of Udine; Michigan State University; Indiana University System; Indiana University Bloomington	Pucillo, CEM (corresponding author), Univ Udine, Dept Med, Lab Immunol, Piazzale M Kolbe 4, I-33100 Udine, Italy.; Tell, G (corresponding author), Univ Udine, Dept Med, Lab Mol Biol & DNA Repair, Piazzale M Kolbe 4, I-33100 Udine, Italy.	gianluca.tell@uniud.it; carlo.pucillo@uniud.it	Frossi, Barbara/AFL-0800-2022; Antoniali, Giulia/AAA-1637-2021; Pucillo, Carlo/A-5515-2008	Frossi, Barbara/0000-0001-9855-2396; Antoniali, Giulia/0000-0002-2639-1893; Pucillo, Carlo/0000-0002-4872-6156; Yu, Kefei/0000-0002-3870-2812; Tell, Gianluca/0000-0001-8845-6448; Kaplan, Mark/0000-0002-2923-8245	Associazione Italiana per la Ricerca sul Cancro [IG19862]; National Institutes of Health [R01CA205166, R01CA167291]; NATIONAL CANCER INSTITUTE [R01CA167291, R01CA205166] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Associazione Italiana per la Ricerca sul Cancro Grant IG19862 (to G. T.), by National Institutes of Health Grants R01CA205166 and R01CA167291 (to M. R. K.), and by funds granted the Earl and Betty Herr Professor in Pediatric Oncology Research and the Riley Children's Foundation (to M. R. K.). Mark R. Kelley is Chief Scientific Officer of Apexian Pharmaceuticals, the biotech company that has licensed APX3330 used in these studies. Apexian Pharmaceuticals had neither control nor oversight of the studies, interpretation, or presentation of the data in this manuscript. They did not have to approve the manuscript in any way prior to its submission. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Antoniali G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00842-8; Antoniali G, 2014, MOL BIOL CELL, V25, P532, DOI 10.1091/mbc.E13-05-0286; BARZILAY G, 1995, NUCLEIC ACIDS RES, V23, P1544, DOI 10.1093/nar/23.9.1544; Biswas A, 2015, AM J PHYSIOL-CELL PH, V309, pC296, DOI 10.1152/ajpcell.00022.2015; Cesaratto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070909; Georgiadis M., 2012, BIOORG MED CHEM; Georgiadis MM, 2008, MUTAT RES-FUND MOL M, V643, P54, DOI 10.1016/j.mrfmmm.2008.04.008; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Guan ZJ, 2005, ARTERIOSCL THROM VAS, V25, P96, DOI 10.1161/01.ATV.0000150418.14698.75; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Jiang SJ, 2015, INT J ONCOL, V47, P610, DOI 10.3892/ijo.2015.3048; Kelley MR, 2016, J PHARMACOL EXP THER, V359, P300, DOI 10.1124/jpet.116.235283; Kelley MR, 2011, ANTIOXID REDOX SIGN, V14, P1387, DOI 10.1089/ars.2010.3410; LEE YTN, 1977, J SURG ONCOL, V9, P179, DOI 10.1002/jso.2930090212; Logsdon DP, 2016, MOL CANCER THER, V15, P2722, DOI 10.1158/1535-7163.MCT-16-0253; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Luo MH, 2012, BIOCHEMISTRY-US, V51, P695, DOI 10.1021/bi201034z; Mantha AK, 2014, MITOCHONDRION, V16, P38, DOI 10.1016/j.mito.2013.10.007; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; Montaldi AP, 2015, MUTAT RES-GEN TOX EN, V793, P19, DOI 10.1016/j.mrgentox.2015.06.001; Nath S, 2017, CELL SIGNAL, V39, P18, DOI 10.1016/j.cellsig.2017.07.019; Nyland RL, 2010, J MED CHEM, V53, P1200, DOI 10.1021/jm9014857; Poletto M, 2016, MOL CARCINOGEN, V55, P688, DOI 10.1002/mc.22313; Rai G, 2012, J MED CHEM, V55, P3101, DOI 10.1021/jm201537d; ROBERTS MM, 1975, CANCER, V36, P221, DOI 10.1002/1097-0142(197507)36:1<221::AID-CNCR2820360124>3.0.CO;2-P; Schrader CE, 2009, PHILOS T R SOC B, V364, P645, DOI 10.1098/rstb.2008.0200; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Tell G, 2015, ONCOTARGET, V6, P584, DOI 10.18632/oncotarget.2705; Tell G, 2010, CELL MOL LIFE SCI, V67, P3589, DOI 10.1007/s00018-010-0486-4; Vuong BQ, 2013, NAT IMMUNOL, V14, P1183, DOI 10.1038/ni.2732; Vuong BQ, 2012, SEMIN IMMUNOL, V24, P264, DOI 10.1016/j.smim.2012.05.006; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Welinder C, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00143; Wilson DM, 2010, CELL MOL LIFE SCI, V67, P3621, DOI 10.1007/s00018-010-0488-2; Xie JY, 2010, CL LYMPH MYELOM LEUK, V10, P385, DOI 10.3816/CLML.2010.n.072; Xu JL, 2014, P NATL ACAD SCI USA, V111, P17242, DOI 10.1073/pnas.1420221111; Zaky A, 2018, EXP NEUROL, V307, P1, DOI 10.1016/j.expneurol.2018.05.014; Zhang J, 2013, BIOCHEMISTRY-US, V52, P2955, DOI 10.1021/bi400179m	42	13	13	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5198	5207		10.1074/jbc.RA118.006601	http://dx.doi.org/10.1074/jbc.RA118.006601			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30705092	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000463985600039
J	Rivero-Rios, P; Romo-Lozano, M; Madero-Perez, J; Thomas, AP; Biosa, A; Greggio, E; Hilfiker, S				Rivero-Rios, Pilar; Romo-Lozano, Maria; Madero-Perez, Jesus; Thomas, Andrew P.; Biosa, Alice; Greggio, Elisa; Hilfiker, Sabine			The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						leucine-rich repeat kinase 2 (LRRK2); Rab; receptor endocytosis; lysosome; receptor recycling; GTPase; neurodegeneration; Parkinson disease; early recycling compartment; endolysosome; protein homeostasis; RAB7A; RAB8A	PARKINSONS-DISEASE; ACTIVATING PROTEIN; REGULATES AUTOPHAGY; PATHOGENIC LRRK2; ALPHA-SYNUCLEIN; RECEPTOR; MUTATIONS; BINDING; ENDOSOMES; HOMOLOG	Mutations in the gene encoding for leucine-rich repeat kinase 2 (LRRK2) are a common cause of hereditary Parkinson's disease. LRRK2 regulates various intracellular vesicular trafficking pathways, including endolysosomal degradative events such as epidermal growth factor receptor (EGFR) degradation. Recent studies have revealed that a subset of RAB proteins involved in secretory and endocytic recycling are LRRK2 kinase substrates in vivo. However, the effects of LRRK2-mediated phosphorylation of these substrates on membrane trafficking remain unknown. Here, using an array of immunofluorescence and pulldown assays, we report that expression of active or phosphodeficient RAB8A variants rescues the G2019S LRRK2-mediated effects on endolysosomal membrane trafficking. Similarly, up-regulation of the RAB11-Rabin8-RAB8A cascade, which activates RAB8A, also reverted these trafficking deficits. Loss of RAB8A mimicked the effects of G2019S LRRK2 on endolysosomal trafficking and decreased RAB7A activity. Expression of pathogenic G2019S LRRK2 or loss of RAB8A interfered with EGFR degradation by causing its accumulation in a RAB4-positive endocytic compartment, which was accompanied by a deficit in EGFR recycling and was rescued upon expression of active RAB7A. Dominant-negative RAB7A expression resulted in similar deficits in EGF degradation, accumulation in a RAB4 compartment, and deficits in EGFR recycling, which were all rescued upon expression of active RAB8A. Taken together, these findings suggest that, by impairing RAB8A function, pathogenic G2019S LRRK2 deregulates endolysosomal transport and endocytic recycling events.	[Rivero-Rios, Pilar; Romo-Lozano, Maria; Madero-Perez, Jesus; Hilfiker, Sabine] CSIC, Inst Parasitol & Biomed Lopez Neyra, Avda Conocimiento S-N, Granada 18016, Spain; [Thomas, Andrew P.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Biosa, Alice; Greggio, Elisa] Univ Padua, Dept Biol, I-35121 Padua, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Padua	Hilfiker, S (corresponding author), CSIC, Inst Parasitol & Biomed Lopez Neyra, Avda Conocimiento S-N, Granada 18016, Spain.	sabine.hilfiker@ipb.csic.es	Biosa, Alice/AAC-2574-2022; Perez, Jesus Madero/AAB-2430-2021; Hilfiker, Sabine/L-6369-2014	Perez, Jesus Madero/0000-0002-3473-6011; Hilfiker, Sabine/0000-0002-5167-7682; Rivero-Rios, Pilar/0000-0001-9398-2995; Romo-Lozano, Maria/0000-0002-1508-7634	Michael J. Fox Foundation tk; Fonds Europeen de Developpement Economique et Regional (FEDER); Spanish Ministry of Economy and Competitiveness (MINECO) Grant [SAF2017-89402-R]; Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (Spain); 4for Parkinson's Research	Michael J. Fox Foundation tk; Fonds Europeen de Developpement Economique et Regional (FEDER); Spanish Ministry of Economy and Competitiveness (MINECO) Grant; Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (Spain)(BBVA Foundation); 4for Parkinson's Research(Parkinson's UK)	This work was supported by funding from the Michael J. Fox Foundation tk; 4for Parkinson's Research, Fonds Europeen de Developpement Economique et Regional (FEDER), Spanish Ministry of Economy and Competitiveness (MINECO) Grant SAF2017-89402-R, and the Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (Spain). The authors declare that they have no conflicts of interest with the contents of this article.	Abeliovich A, 2016, NATURE, V539, P207, DOI 10.1038/nature20414; Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Biskup S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-102; Braun AC, 2015, J CELL SCI, V128, P1386, DOI 10.1242/jcs.163857; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; BURTON JL, 1994, EMBO J, V13, P5547, DOI 10.1002/j.1460-2075.1994.tb06892.x; Chamberland JP, 2016, J CELL SCI, V129, P2625, DOI 10.1242/jcs.173708; Chi SS, 2011, J BIOL CHEM, V286, P35196, DOI 10.1074/jbc.M111.247577; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Civiero L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043472; Cookson MR, 2016, BIOCHEM SOC T, V44, P1603, DOI 10.1042/BST20160228; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808; Devergne O, 2017, CELL REP, V18, P1831, DOI 10.1016/j.celrep.2017.02.002; Dhekne HS, 2018, ELIFE, V7, DOI 10.7554/eLife.40202; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gomez-Suaga P, 2014, HUM MOL GENET, V23, P6779, DOI 10.1093/hmg/ddu395; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Goueli BS, 2012, P NATL ACAD SCI USA, V109, P15787, DOI 10.1073/pnas.1204540109; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Henry AG, 2015, HUM MOL GENET, V24, P6013, DOI 10.1093/hmg/ddv314; Hockey LN, 2015, J CELL SCI, V128, P232, DOI 10.1242/jcs.164152; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Jimenez-Orgaz A, 2018, EMBO J, V37, P235, DOI 10.15252/embj.201797128; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim MJ, 2017, HUM MOL GENET, V26, P729, DOI 10.1093/hmg/ddw413; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lai YC, 2015, EMBO J, V34, P2840, DOI 10.15252/embj.201591593; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Madero-Perez J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0235-y; Madero-Perez J, 2017, BIOCHEM SOC T, V45, P147, DOI 10.1042/BST20160392; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Ritter B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001670; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Schapansky J, 2018, NEUROBIOL DIS, V111, P26, DOI 10.1016/j.nbd.2017.12.005; Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015; Shinde SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10689; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Soukup SF, 2016, NEURON, V92, P829, DOI 10.1016/j.neuron.2016.09.037; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Steger M, 2017, ELIFE, V6, DOI 10.7554/eLife.31012; Toyofuku T, 2015, MOL CELL BIOL, V35, P3044, DOI 10.1128/MCB.00085-15; Vetter M, 2015, NAT STRUCT MOL BIOL, V22, P695, DOI 10.1038/nsmb.3065; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Yasuda S, 2016, J CELL SCI, V129, P329, DOI 10.1242/jcs.178095; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zhang XM, 2005, BIOCHEM BIOPH RES CO, V335, P154, DOI 10.1016/j.bbrc.2005.07.070; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	72	39	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4738	4758		10.1074/jbc.RA118.005008	http://dx.doi.org/10.1074/jbc.RA118.005008			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30709905	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000463985600002
J	Sandoval, JE; Huang, YH; Muise, A; Goodell, MA; Reich, NO				Sandoval, Jonathan E.; Huang, Yung-Hsin; Muise, Abigail; Goodell, Margaret A.; Reich, Norbert O.			Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mutation; enzyme kinetics; epigenetics; DNA methyltransferase; DNA methylation; DNA binding protein	CPG ISLAND HYPERMETHYLATION; EMBRYONIC STEM-CELLS; METHYLATION PATTERNS; TUMOR-SUPPRESSOR; BINDING PROTEIN; SITE; HYPOMETHYLATION; MAINTENANCE; MECHANISM; SUGGESTS	Eukaryotic DNA methylation prevents genomic instability by regulating the expression of oncogenes and tumor-suppressor genes. The negative effects of dysregulated DNA methylation are highlighted by a strong correlation between mutations in the de novo DNA methyltransferase gene DNA methyltransferase 3 (DNMT3A) and poor prognoses among acute myeloid leukemia (AML) patients. We show here that clinically observed DNMT3A mutations dramatically alter enzymatic activity, including mutations that lead to 6-fold hypermethylation and 3-fold hypomethylation of the human cyclin-dependent kinase inhibitor 2B (CDKN2B or p15) gene promoter. Our results provide insights into the clinically observed heterogeneity of p15 methylation in AML. Cytogenetically normal AML (CN-AML) constitutes 40-50% of all AML cases and is the most epigenetically diverse AML subtype with pronounced changes in non-CpG DNA methylation. We identified a subset of DNMT3A mutations that enhance the enzyme's ability to perform non-CpG methylation by 2-8-fold. Many of these mutations mapped to DNMT3A regions known to interact with proteins that themselves contribute to AML, such as thymine DNA glycosylase (TDG). Using functional mapping of TDG-DNMT3A interactions, we provide evidence that TDG and DNMT3-like (DNMT3L) bind distinct regions of DNMT3A. Furthermore, DNMT3A mutations caused diverse changes in the ability of TDG and DNMT3L to affect DNMT3A function. Cell-based studies of one of these DNMT3A mutations (S714C) replicated the enzymatic studies and revealed that it causes dramatic losses of genome-wide methylation. In summary, mutations in DNMT3A lead to diverse levels of activity, interactions with epigenetic machinery components and cellular changes.	[Sandoval, Jonathan E.; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Sandoval, Jonathan E.; Muise, Abigail] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Huang, Yung-Hsin; Goodell, Margaret A.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Huang, Yung-Hsin; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Huang, Yung-Hsin; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu		Huang, Yung-Hsin/0000-0002-5180-934X; sandoval, jonathan/0000-0003-1986-0804	National Science Foundation [1808775]; National Institutes of Health [CA183252, DK092883-01, CA222736]; NATIONAL CANCER INSTITUTE [F99CA222736, K00CA222736, R01CA183252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092883] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Science Foundation Grant 1808775 (to N. R.) and National Institutes of Health Grants CA183252, DK092883-01, and CA222736 (to M. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggerholm A, 1999, CANCER RES, V59, P436; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cameron EE, 1999, BLOOD, V94, P2445, DOI 10.1182/blood.V94.7.2445.419k19_2445_2451; Chen D, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0072-9; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen WJ, 2007, J BIOL CHEM, V282, P11365, DOI 10.1074/jbc.M700186200; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Du JM, 2015, NAT REV MOL CELL BIO, V16, P519, DOI 10.1038/nrm4043; Esposito MT, 2014, CHROMOSOMA, V123, P545, DOI 10.1007/s00412-014-0482-9; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Galonska C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02708-5; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; Gu TP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1464-7; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Hata K, 2002, DEVELOPMENT, V129, P1983; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Holz-Schietinger C, 2012, J BIOL CHEM, V287, P30941, DOI 10.1074/jbc.M112.366625; Holz-Schietinger C, 2011, J BIOL CHEM, V286, P41479, DOI 10.1074/jbc.M111.284687; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Hou HA, 2016, EXPERT REV HEMATOL, V9, P447, DOI 10.1586/17474086.2016.1144469; Huang YH, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1306-z; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lei Y, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1566-2; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Matzke MA, 2014, NAT REV GENET, V15, P394, DOI 10.1038/nrg3683; Melnick AM, 2010, BEST PRACT RES CL HA, V23, P463, DOI 10.1016/j.beha.2010.09.017; Shiba N, 2012, BRIT J HAEMATOL, V156, P413, DOI 10.1111/j.1365-2141.2011.08879.x; PEDRALINOY G, 1986, J BIOL CHEM, V261, P7600; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Qu Y, 2014, EPIGENETICS-US, V9, P1108, DOI 10.4161/epi.29315; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rau RE, 2016, BLOOD, V128, P971, DOI 10.1182/blood-2015-11-684225; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Santini V, 2001, ANN INTERN MED, V134, P573, DOI 10.7326/0003-4819-134-7-200104030-00011; Schuermann D, 2016, NUCLEIC ACIDS RES, V44, P2187, DOI 10.1093/nar/gkv1520; Spencer DH, 2017, CELL, V168, P801, DOI 10.1016/j.cell.2017.01.021; Stegelmann F, 2011, LEUKEMIA, V25, P1217, DOI 10.1038/leu.2011.77; Stirzaker C, 2017, ONCOGENE, V36, P1328, DOI 10.1038/onc.2016.297; Su JZ, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1492-3; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262	54	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4898	4910		10.1074/jbc.RA118.006795	http://dx.doi.org/10.1074/jbc.RA118.006795			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30705090	Green Published, hybrid			2022-12-28	WOS:000463985600015
J	Ma, XY; Das, NK; Castillo, C; Gourani, A; Perekatt, AO; Verzi, MP; Shah, YM				Ma, Xiaoya; Das, Nupur K.; Castillo, Cristina; Gourani, Ayla; Perekatt, Ansu O.; Verzi, Michael P.; Shah, Yatrik M.			SMAD family member 3 (SMAD3) and SMAD4 repress HIF2-dependent iron-regulatory genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; iron; iron metabolism; gene expression; SMAD transcription factor; DMT1; HIF; Iron; SMAD	HYPOXIA-INDUCIBLE FACTOR; DNA-BINDING ACTIVITY; GROWTH-FACTOR-BETA; FACTOR-I; CANCER PROGRESSION; STRUCTURAL BASIS; TGF-BETA; METABOLISM; DOMAIN; PHOSPHORYLATION	Hypoxia-inducible factor 2 (HIF2) directly regulates a battery of genes essential for intestinal iron absorption. Interestingly, iron deficiency and overload disorders do not result in increased intestinal expression of glycolytic or angiogenic HIF2 target genes. Similarly, inflammatory and tumor foci can induce a distinct subset of HIF2 target genes in vivo. These observations indicate that different stimuli activate distinct subsets of HIF2 target genes via mechanisms that remain unclear. Here, we conducted a high-throughput siRNA-based screen to identify genes that regulate HIF2's transcriptional activity on the promoter of the iron transporter gene divalent metal transporter-1 (DMT1). SMAD family member 3 (SMAD3) and SMAD4 were identified as potential transcriptional repressors. Further analysis revealed that SMAD4 signaling selectively represses iron-absorptive gene promoters but not the inflammatory or glycolytic HIF2 or HIF1 target genes. Moreover, the highly homologous SMAD2 did not alter HIF2 transcriptional activity. During iron deficiency, SMAD3 and SMAD4 expression was significantly decreased via proteasomal degradation, allowing for derepression of iron target genes. Several iron-regulatory genes contain a SMAD-binding element (SBE) in their proximal promoters; however, mutation of the putative SBE on the DMT1 promoter did not alter the repressive function of SMAD3 or SMAD4. Importantly, the transcription factor forkhead box protein A1 (FOXA1) was critical in SMAD4-induced DMT1 repression, and DNA binding of SMAD4 was essential for the repression of HIF2 activity, suggesting an indirect repressive mechanism through DNA binding. These results provide mechanistic clues to how HIF signaling can be regulated by different cellular cues.	[Ma, Xiaoya; Das, Nupur K.; Castillo, Cristina; Gourani, Ayla; Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Perekatt, Ansu O.; Verzi, Michael P.] Rutgers State Univ, Inst Human Genet, Dept Genet, Piscataway, NJ 08854 USA; [Perekatt, Ansu O.; Verzi, Michael P.] Rutgers State Univ, Rutgers Canc Inst, Piscataway, NJ 08854 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Shah, YM (corresponding author), Dept Mol & Integrat Physiol, 1137 Catherine St,MSII R7712B, Ann Arbor, MI 48109 USA.	shahy@umich.edu	Das, Nupur/AAK-7877-2020	Das, Nupur/0000-0002-5652-1134; Castillo Apaza, Cristina/0000-0001-6125-1813	National Institutes of Health [CA148828, DK095201, CA190558]; NATIONAL CANCER INSTITUTE [R01CA148828, R01CA190558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants CA148828 and DK095201 (to Y. M. S.) and CA190558 (to M. P. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson ER, 2012, MOL CELL BIOL, V32, P4068, DOI 10.1128/MCB.00723-12; Barsoum IB, 2014, CANCER RES, V74, P665, DOI 10.1158/0008-5472.CAN-13-0992; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Brahimi-Horn MC, 2007, BIOCHEM PHARMACOL, V73, P450, DOI 10.1016/j.bcp.2006.10.013; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Chen YG, 2012, CELL STEM CELL, V10, P231, DOI 10.1016/j.stem.2012.02.008; Endo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098858; Friedl W, 1999, GENE CHROMOSOME CANC, V25, P403, DOI 10.1002/(SICI)1098-2264(199908)25:4<403::AID-GCC15>3.3.CO;2-G; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Jones JB, 2000, NUCLEIC ACIDS RES, V28, P2363, DOI 10.1093/nar/28.12.2363; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kuang CZ, 2004, ONCOGENE, V23, P1021, DOI 10.1038/sj.onc.1207219; Ma XY, 2017, J BIOL CHEM, V292, P17046, DOI 10.1074/jbc.M117.805655; Ma XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179889; Ma XY, 2013, INT J SPORT NUTR EXE, V23, P513, DOI 10.1123/ijsnem.23.5.513; Maesawa C, 1997, JPN J CANCER RES, V88, P340, DOI 10.1111/j.1349-7006.1997.tb00386.x; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mimeault M, 2013, J CELL MOL MED, V17, P30, DOI 10.1111/jcmm.12004; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Qiu GZ, 2017, TRENDS PHARMACOL SCI, V38, P669, DOI 10.1016/j.tips.2017.05.002; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shah YM, 2014, GASTROENTEROLOGY, V146, P630, DOI 10.1053/j.gastro.2013.12.031; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Shuttleworth VG, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207761; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Taube JH, 2010, J BIOL CHEM, V285, P16135, DOI 10.1074/jbc.M109.088096; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Triner D, 2016, J CLIN INVEST, V126, P3689, DOI 10.1172/JCI84430; Uchida K, 1996, CANCER RES, V56, P5583; Wan M, 2004, J BIOL CHEM, V279, P14484, DOI 10.1074/jbc.C400005200; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Xie LW, 2014, MOL CELL BIOL, V34, P3013, DOI 10.1128/MCB.00324-14; Xue X, 2016, CELL METAB, V24, P447, DOI 10.1016/j.cmet.2016.07.015; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Xue X, 2013, CARCINOGENESIS, V34, P163, DOI 10.1093/carcin/bgs313; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Yang Y, 2015, CURR MED CHEM, V22, P4189, DOI 10.2174/0929867322666150825163318	49	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3974	3986		10.1074/jbc.RA118.005549	http://dx.doi.org/10.1074/jbc.RA118.005549			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30659096	hybrid, Green Published			2022-12-28	WOS:000461854400014
J	Andres, SN; Li, ZMM; Erie, DA; Williams, RS				Andres, Sara N.; Li, Zimeng M.; Erie, Dorothy A.; Williams, R. Scott			Ctp1 protein-DNA filaments promote DNA bridging and DNA double-strand break repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; homologous recombination; atomic force microscopy (AFM); Schizosaccharomyces pombe; structural biology; chromosome damage; CtIP; Ctp1; DNA bridging; Sae2; DNA-binding protein	MRE11 COMPLEX; END RESECTION; CTIP; ENDONUCLEASE; NUCLEASE; SAE2; MRE11-RAD50-NBS1; BINDING	The Ctp1 protein in Schizosaccharomyces pombe is essential for DNA double-strand break (DSB) repair by homologous recombination. Fission yeast Ctp1 and its budding yeast (Sae2) and human (CtIP) homologs control Mre11-Rad50-Nbs1 nuclease complex activity and harbor DNA-binding and -bridging activities. However, the molecular basis for Ctp1-DNA transactions remains undefined. Here, we report atomic force microscopy (AFM) imaging of S. pombe Ctp1-DNA complexes revealing that Ctp1 polymerizes on dsDNA molecules and forms synaptic filaments that bridge two dsDNA strands. We observed that Ctp1 DNA filaments are typified by an average filament length of approximate to 180 bp of dsDNA and a Ctp1 tetramer footprint of approximate to 15 bp. Biochemical results characterizing Ctp1 variants with impaired DNA-binding or -bridging properties were consistent with Ctp1-mediated DNA bridging requiring the intact and correctly folded Ctp1 tetramer. Furthermore, mutations altering Ctp1 oligomerization and DNA bridging in vitro conferred cell sensitivity to DSB-producing agents. Together, these results support an important role for Ctp1-regulated DNA strand coordination required for DNA DSB repair in S. pombe.	[Andres, Sara N.; Williams, R. Scott] NIEHS, Genome Integr & Struct Biol Lab, Dept Hlth & Human Serv, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Li, Zimeng M.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27695 USA; [Erie, Dorothy A.] Univ N Carolina, Dept Chem, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Andres, Sara N.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 3T7, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; McMaster University	Williams, RS (corresponding author), NIEHS, Genome Integr & Struct Biol Lab, Dept Hlth & Human Serv, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.; Erie, DA (corresponding author), Univ N Carolina, Dept Chem, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	derie@unc.edu; williamsrs@niehs.nih.gov	Williams, R Scott/A-6059-2015	Williams, R Scott/0000-0002-4610-8397; Andres, Sara/0000-0002-4795-2856	intramural research program of the National Institutes of Health; NIEHS, National Institutes of Health [1Z01ES102765]; NIGMS, National Institutes of Health [GM080294, GM109832]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079480, R01GM109832, R35GM127151] Funding Source: NIH RePORTER	intramural research program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the intramural research program of the National Institutes of Health; NIEHS, National Institutes of Health, Grant 1Z01ES102765 (to R. S. W.); and NIGMS, National Institutes of Health, Grants GM080294 and GM109832 (to D. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand R, 2016, MOL CELL, V64, P940, DOI 10.1016/j.molcel.2016.10.017; Andres SN, 2017, DNA REPAIR, V56, P109, DOI 10.1016/j.dnarep.2017.06.013; Andres SN, 2015, NAT STRUCT MOL BIOL, V22, P158, DOI 10.1038/nsmb.2945; Andres SN, 2015, ENVIRON MOL MUTAGEN, V56, P1, DOI 10.1002/em.21892; Brouwer I, 2016, NATURE, V535, P566, DOI 10.1038/nature18643; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Davies OR, 2015, NAT STRUCT MOL BIOL, V22, P150, DOI 10.1038/nsmb.2937; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Qvist P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002310; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Rothenberg M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000722; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Tournier S, 1997, YEAST, V13, P727, DOI 10.1002/(SICI)1097-0061(19970630)13:8<727::AID-YEA134>3.0.CO;2-W; Wang H., 2006, PROTEIN INTERACTIONS, P39; Wang WB, 2017, GENE DEV, V31, P2331, DOI 10.1101/gad.307900.117; Westmoreland JW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003420; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Zhou Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1309; Zhu M, 2018, P NATL ACAD SCI USA, V115, P8793, DOI 10.1073/pnas.1808189115	40	15	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3312	3320		10.1074/jbc.RA118.006759	http://dx.doi.org/10.1074/jbc.RA118.006759			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30626735	hybrid, Green Published			2022-12-28	WOS:000464980100028
J	Llano, E; Pendas, AM; Aza-Blanc, P; Kornberg, TB; Lopez-Otin, C				Llano, Elena; Pendas, Alberto M.; Aza-Blanc, Pedro; Kornberg, Thomas B.; Lopez-Otin, Carlos			RETRACTION: Withdrawal: Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development. (Retraction of Vol 275, Pg 35978, 2000)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Llano E, 2000, J BIOL CHEM, V275, P35978, DOI 10.1074/jbc.M006045200	1	1	1	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1428	1428		10.1074/jbc.W118.007322	http://dx.doi.org/10.1074/jbc.W118.007322			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30807999	Green Published, hybrid			2022-12-28	WOS:000457879500031
J	Chakraborty, P; Chatterjee, S; Kesarwani, P; Thyagarajan, K; Iamsawat, S; Dalheim, A; Nguyen, H; Selvam, SP; Nasarre, P; Scurti, G; Hardiman, G; Maulik, N; Ball, L; Gangaraju, V; Rubinstein, MP; Klauber-DeMore, N; Hill, EG; Ogretmen, B; Yu, XZ; Nishimura, MI; Mehrotra, S				Chakraborty, Paramita; Chatterjee, Shilpak; Kesarwani, Pravin; Thyagarajan, Krishnamurthy; Iamsawat, Supinya; Dalheim, Annika; Hung Nguyen; Selvam, Shanmugam P.; Nasarre, Patrick; Scurti, Gina; Hardiman, Gary; Maulik, Nilanjana; Ball, Lauren; Gangaraju, Vamsi; Rubinstein, Mark P.; Klauber-DeMore, Nancy; Hill, Elizabeth G.; Ogretmen, Besim; Yu, Xue-Zhong; Nishimura, Michael I.; Mehrotra, Shikhar			Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T-cell; melanoma; cell metabolism; antioxidant; immunotherapy; adoptive cell therapy; cell-surface thiol; redox protein; thioredoxin	ALPHA-KETOGLUTARATE; OXIDATIVE STRESS; MEMORY; GLUTATHIONE; ACTIVATION; AMPK; INVOLVEMENT; LYMPHOCYTES; ROS	Adoptive transfer of tumor epitope-reactive T cells has emerged as a promising strategy to control tumor growth. However, chronically-stimulated T cells expanded for adoptive cell transfer are susceptible to cell death in an oxidative tumor microenvironment. Because oxidation of cell-surface thiols also alters protein functionality, we hypothesized that increasing the levels of thioredoxin (Trx), an antioxidant molecule facilitating reduction of proteins through cysteine thiol-disulfide exchange, in T cells will promote their sustained antitumor function. Using pre-melanosome protein (Pmel)-Trx1 transgenic mouse-derived splenic T cells, flow cytometry, and gene expression analysis, we observed here that higher Trx expression inversely correlated with reactive oxygen species and susceptibility to T-cell receptor restimulation or oxidation-mediated cell death. These Trx1-overexpressing T cells exhibited a cluster of differentiation 62L(hi) (CD62L(hi)) central memory-like phenotype with reduced glucose uptake (2-NBDG(lo)) and decreased effector function (interferon (lo)). Furthermore, culturing tumor-reactive T cells in the presence of recombinant Trx increased the dependence of T cells on mitochondrial metabolism and improved tumor control. We conclude that strategies for increasing the antioxidant capacity of antitumor T cells modulate their immunometabolic phenotype leading to improved immunotherapeutic control of established tumors.	[Chakraborty, Paramita; Chatterjee, Shilpak; Kesarwani, Pravin; Thyagarajan, Krishnamurthy; Nasarre, Patrick; Rubinstein, Mark P.; Klauber-DeMore, Nancy; Mehrotra, Shikhar] Med Univ South Carolina, Dept Surg, Hollings Canc Ctr, Charleston, SC 29425 USA; [Iamsawat, Supinya; Hung Nguyen; Yu, Xue-Zhong] Med Univ South Carolina, Dept Microbiol & Immunol, Hollings Canc Ctr, Charleston, SC 29425 USA; [Selvam, Shanmugam P.; Gangaraju, Vamsi; Ogretmen, Besim] Med Univ South Carolina, Dept Biochem & Mol Biol, Hollings Canc Ctr, Charleston, SC 29425 USA; [Hardiman, Gary] Med Univ South Carolina, Dept Nephrol, Hollings Canc Ctr, Charleston, SC 29425 USA; [Ball, Lauren] Med Univ South Carolina, Dept Pharmaceut & Biomed Sci, Hollings Canc Ctr, Charleston, SC 29425 USA; [Hill, Elizabeth G.] Med Univ South Carolina, Dept Publ Hlth, Hollings Canc Ctr, Charleston, SC 29425 USA; [Dalheim, Annika; Scurti, Gina; Nishimura, Michael I.] Loyola Univ, Dept Surg, Maywood, IL 60153 USA; [Maulik, Nilanjana] Univ Connecticut, Dept Surg, Hlth Ctr, Farmington, CT 06030 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Loyola University Chicago; University of Connecticut	Mehrotra, S (corresponding author), Med Univ South Carolina, Dept Surg, Hollings Canc Ctr HO 512H, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	mehrotr@musc.edu	Nguyen, Hung D/AAN-5364-2021; Chakraborty, Paramita/AAL-9606-2020	Nguyen, Hung D/0000-0001-9416-5137; Chakraborty, Paramita/0000-0002-0320-8697; Yu, Xue-Zhong/0000-0002-1751-2884; Nasarre, Patrick/0000-0001-6910-9264; Ball, Lauren/0000-0001-6780-1679; Kesarwani, Pravin/0000-0002-9095-1568; Hardiman, Gary/0000-0003-4558-0400	National Institutes of Health [P30 CA138313, 5P20GM103542]; South Carolina Clinical & Translational Research (SCTR) Institute [UL1TR001450]; SC Center of Biomedical Research Excellence (COBRE) in Oxidants, Redox Balance, and Stress Signaling; NATIONAL CANCER INSTITUTE [P30CA138313, P01CA203628, R21CA198646] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Clinical & Translational Research (SCTR) Institute; SC Center of Biomedical Research Excellence (COBRE) in Oxidants, Redox Balance, and Stress Signaling; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Hollings Cancer Center Shared Resources was supported in part by National Institutes of Health Grant P30 CA138313. The Medical University of South Carolina was recipient of the South Carolina Clinical & Translational Research (SCTR) Institute Grant UL1TR001450, SC Center of Biomedical Research Excellence (COBRE) in Oxidants, Redox Balance, and Stress Signaling, and National Institutes of Health Grant 5P20GM103542.	Adluri RS, 2011, J MOL CELL CARDIOL, V50, P239, DOI 10.1016/j.yjmcc.2010.11.002; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Cha YJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030907; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chang WK, 2002, CLIN IMMUNOL, V104, P151, DOI 10.1006/clim.2002.5257; Chatterjee S, 2018, CELL METAB, V27, P85, DOI 10.1016/j.cmet.2017.10.006; Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Edwards C, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0167-2; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Go YM, 2013, MOL CELL PROTEOMICS, V12, P3285, DOI 10.1074/mcp.M113.030437; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Haugaard N, 2000, ANN NY ACAD SCI, V899, P148; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; ISHII T, 1987, J CELL PHYSIOL, V133, P330, DOI 10.1002/jcp.1041330217; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kesarwani P, 2016, ONCOTARGET, V7, P69371, DOI 10.18632/oncotarget.12674; Kesarwani P, 2014, CANCER RES, V74, P6036, DOI 10.1158/0008-5472.CAN-14-1084; Kishton RJ, 2017, CELL METAB, V26, P94, DOI 10.1016/j.cmet.2017.06.016; Klysz D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab2610; Lai ZW, 2012, ARTHRITIS RHEUM-US, V64, P2937, DOI 10.1002/art.34502; Lemire J, 2010, FEMS MICROBIOL LETT, V309, P170, DOI 10.1111/j.1574-6968.2010.02034.x; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Mak TW, 2017, IMMUNITY, V46, P1089, DOI 10.1016/j.immuni.2017.06.009; Mehrotra S, 2009, ADV CANCER RES, V102, P197, DOI 10.1016/S0065-230X(09)02006-5; Metallo CM, 2010, GENE DEV, V24, P2717, DOI 10.1101/gad.2010510; Mougiakakos D, 2011, BLOOD, V117, P857, DOI 10.1182/blood-2010-09-307041; Muri J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04274-w; Norell H, 2009, CANCER RES, V69, P6282, DOI 10.1158/0008-5472.CAN-09-1176; Osipovich AB, 2016, DEVELOPMENT, V143, P4595, DOI 10.1242/dev.141465; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shao D, 2014, CELL METAB, V19, P232, DOI 10.1016/j.cmet.2013.12.013; SMYTH MJ, 1991, J IMMUNOL, V146, P1921; Spanaki C, 2012, NEUROTOX RES, V21, P117, DOI 10.1007/s12640-011-9285-4; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Tripathi P, 2010, J IMMUNOL, V185, P2116, DOI 10.4049/jimmunol.1000842; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282; Wang K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.50; Woods DM, 2017, BLOOD, V130, P146, DOI 10.1182/blood-2016-08-731505; Xu J, 2012, CRIT REV FOOD SCI, V52, P373, DOI 10.1080/10408398.2010.500245; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yoshida T, 2003, ANTIOXID REDOX SIGN, V5, P563, DOI 10.1089/152308603770310211	53	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2019	294	23					9198	9212		10.1074/jbc.RA118.006753	http://dx.doi.org/10.1074/jbc.RA118.006753			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ID5XV	30971427	hybrid, Green Published			2022-12-28	WOS:000471751600015
J	Svoboda, P; Krizova, E; Sestakova, S; Vapenkova, K; Knejzlik, Z; Rimpelova, S; Rayova, D; Volfova, N; Krizova, I; Rumlova, M; Sykora, D; Kizek, R; Haluzik, M; Zidek, V; Zidkova, J; Skop, V				Svoboda, Petr; Krizova, Edita; Sestakova, Sarka; Vapenkova, Kamila; Knejzlik, Zdenek; Rimpelova, Silvie; Rayova, Diana; Volfova, Nikol; Krizova, Ivana; Rumlova, Michaela; Sykora, David; Kizek, Rene; Haluzik, Martin; Zidek, Vaclav; Zidkova, Jarmila; Skop, Vojtech			Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells, and its inhibition slows cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NAMPT; nicotinamide adenine dinucleotide (NAD); cancer; epigenetics; sirtuin; GFP fusion; nuclear localization; pre-B cell colony enhancing factor (PBEF); visfatin	SUBCELLULAR-LOCALIZATION; DNA-REPLICATION; CANCER-CELLS; IN-VITRO; VISFATIN; METABOLISM; POLY(ADP-RIBOSE); BIOSYNTHESIS; EXPRESSION; MECHANISM	Nicotinamide phosphoribosyltransferase (NAMPT) is located in both the nucleus and cytoplasm and has multiple biological functions including catalyzing the rate-limiting step in NAD synthesis. Moreover, up-regulated NAMPT expression has been observed in many cancers. However, the determinants and regulation of NAMPT's nuclear transport are not known. Here, we constructed a GFP-NAMPT fusion protein to study NAMPT's subcellular trafficking. We observed that in unsynchronized 3T3-L1 preadipocytes, 25% of cells had higher GFP-NAMPT fluorescence in the cytoplasm, and 62% had higher GFP-NAMPT fluorescence in the nucleus. In HepG2 hepatocytes, 6% of cells had higher GFP-NAMPT fluorescence in the cytoplasm, and 84% had higher GFP-NAMPT fluorescence in the nucleus. In both 3T3-L1 and HepG2 cells, GFP-NAMPT was excluded from the nucleus immediately after mitosis and migrated back into it as the cell cycle progressed. In HepG2 cells, endogenous, untagged NAMPT displayed similar changes with the cell cycle, and in nonmitotic cells, GFP-NAMPT accumulated in the nucleus. Similarly, genotoxic, oxidative, or dicarbonyl stress also caused nuclear NAMPT localization. These interventions also increased poly(ADP-ribosyl) polymerase and sirtuin activity, suggesting an increased cellular demand for NAD. We identified a nuclear localization signal in NAMPT and amino acid substitution in this sequence ((RSKK)-R-424 to ASGA), which did not affect its enzymatic activity, blocked nuclear NAMPT transport, slowed cell growth, and increased histone H-3 acetylation. These results suggest that NAMPT is transported into the nucleus where it presumably increases NAD synthesis required for cell proliferation. We conclude that specific inhibition of NAMPT transport into the nucleus might be a potential avenue for managing cancer.	[Svoboda, Petr; Krizova, Edita; Sestakova, Sarka; Vapenkova, Kamila; Knejzlik, Zdenek; Rimpelova, Silvie; Rayova, Diana; Volfova, Nikol; Zidkova, Jarmila; Skop, Vojtech] Univ Chem & Technol Prague, Dept Biochem & Microbiol, Prague 16628 6, Czech Republic; [Krizova, Ivana; Rumlova, Michaela] Univ Chem & Technol Prague, Dept Biotechnol, Prague 16628 6, Czech Republic; [Sykora, David] Univ Chem & Technol Prague, Dept Analyt Chem, Prague 16628 6, Czech Republic; [Svoboda, Petr; Zidek, Vaclav] Czech Acad Sci, Inst Physiol, Prague 14220 4, Czech Republic; [Kizek, Rene] Univ Vet & Pharmaceut Sci Brno, Dept Human Pharmacol & Toxicol, Brno 61242, Czech Republic; [Haluzik, Martin; Skop, Vojtech] Inst Clin & Expt Med, Ctr Expt Med, Prague 14021 4, Czech Republic; [Haluzik, Martin] Inst Clin & Expt Med, Diabet Ctr, Prague 14021 4, Czech Republic; [Haluzik, Martin] Charles Univ Prague, Inst Med Biochem & Lab Diagnost, Prague 12808 2, Czech Republic; [Haluzik, Martin] Gen Univ Hosp Prague, Prague 12808 2, Czech Republic; [Skop, Vojtech] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	University of Chemistry & Technology, Prague; University of Chemistry & Technology, Prague; University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of Veterinary Sciences Brno; Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; General University Hospital Prague; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Skop, V (corresponding author), Univ Chem & Technol Prague, Dept Biochem & Microbiol, Prague 16628 6, Czech Republic.; Skop, V (corresponding author), NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA.	skopv@vscht.cz	Rimpelová, Silvie/AAH-8796-2020; Sykora, David/D-2657-2009; Svoboda, Petr/B-7865-2014; Rumlova, Michaela/G-9142-2018; Rimpelova, Silvie/D-3077-2015	Rimpelová, Silvie/0000-0002-3008-1396; Sykora, David/0000-0001-8098-3171; Svoboda, Petr/0000-0001-7297-4208; Rumlova, Michaela/0000-0002-5645-8227; Rimpelova, Silvie/0000-0002-3008-1396; Rayova, Diana/0000-0002-6420-6724; Skop, Vojtech/0000-0002-4685-4429; Volfova, Nikol/0000-0002-8040-2610	Technological Agency of the Czech Republic [TA02010013]; Czech Science Foundation, MH CZ-DRO (Institute for Clinical and Experimental Medicine) [14-36804G, IN 00023001]; specific university research Ministry of Education, Youth and Sports Grant [20-SVV/2017];  [OPPC CZ.2.16/3.1.00/24503];  [NPU I LO1601]	Technological Agency of the Czech Republic; Czech Science Foundation, MH CZ-DRO (Institute for Clinical and Experimental Medicine); specific university research Ministry of Education, Youth and Sports Grant; ; 	This work was supported by Grant TA02010013 from the Technological Agency of the Czech Republic, Grant 14-36804G from the Czech Science Foundation, MH CZ-DRO (Institute for Clinical and Experimental Medicine, IN 00023001), and by financial support from specific university research Ministry of Education, Youth and Sports Grant 20-SVV/2017. Acquisition of the SpectraMax (R) i3 Multi-Mode Detection Platform (Molecular Devices) used within the publication was financed by the projects OPPC CZ.2.16/3.1.00/24503 and NPU I LO1601. The authors declare that they have no conflicts of interest with the contents of this article.	Alaee M, 2017, J BREAST CANCER, V20, P20, DOI 10.4048/jbc.2017.20.1.20; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Baranovskiy AG, 2014, NUCLEIC ACIDS RES, V42, P14013, DOI 10.1093/nar/gku1209; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Buldak RJ, 2014, EUR J HISTOCHEM, V58, P239, DOI 10.4081/ejh.2014.2408; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Cao Z, 2017, CELL PROLIFERAT, V50, P1; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Del Nagro C, 2014, J BIOL CHEM, V289, P35182, DOI 10.1074/jbc.M114.580159; Di Stefano M, 2013, FEBS J, V280, P4711, DOI 10.1111/febs.12433; Hasmann M, 2003, CANCER RES, V63, P7436; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; KAUFMAN ER, 1985, MOL CELL BIOL, V5, P3092, DOI 10.1128/MCB.5.11.3092; Ke HL, 2015, AM J CANCER RES, V5, P2447; Khaidizar FD, 2017, GENES CELLS, V22, P982, DOI 10.1111/gtc.12542; Khan JA, 2007, EXPERT OPIN THER TAR, V11, P695, DOI 10.1517/14728222.11.5.695; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P13142, DOI 10.1073/pnas.0907506106; Kozako T, 2014, MOLECULES, V19, P20295, DOI 10.3390/molecules191220295; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Liederer BM, 2019, XENOBIOTICA, V49, P1063, DOI 10.1080/00498254.2018.1528407; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Messner S, 2011, TRENDS CELL BIOL, V21, P534, DOI 10.1016/j.tcb.2011.06.001; Mohammadi M, 2019, J CELL PHYSIOL, V234, P5011, DOI 10.1002/jcp.27302; Moschen AR, 2010, MUTAT RES-FUND MOL M, V690, P95, DOI 10.1016/j.mrfmmm.2009.06.012; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neumann CS, 2018, MOL CANCER THER, V17, P2633, DOI 10.1158/1535-7163.MCT-18-0643; Ocon-Grove OM, 2010, REPRODUCTION, V139, P217, DOI 10.1530/REP-08-0377; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; Opitz CA, 2015, BIOCHEM SOC T, V43, P1127, DOI 10.1042/BST20150133; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Pan JH, 2019, J CELL PHYSIOL, V234, P4385, DOI 10.1002/jcp.27228; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Reddy PS, 2008, CANCER BIOL THER, V7, P663, DOI 10.4161/cbt.7.5.5663; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Romacho T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078283; Rongvaux A, 2008, J IMMUNOL, V181, P4685, DOI 10.4049/jimmunol.181.7.4685; Roulston A, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1052180; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Shackelford R, 2013, ANTICANCER RES, V33, P3047; Skop V, 2010, PHYSIOL RES, V59, P615, DOI 10.33549/physiolres.931845; Skop V, 2014, DIFFERENTIATION, V87, P220, DOI 10.1016/j.diff.2014.06.002; Svoboda P, 2017, PHYSIOL RES, V66, P709, DOI 10.33549/physiolres.933370; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tarrant JM, 2015, TOXICOL MECH METHOD, V25, P201, DOI 10.3109/15376516.2015.1014080; Thakur BK, 2013, INT J CANCER, V132, P766, DOI 10.1002/ijc.27726; Timney BL, 2016, J CELL BIOL, V215, P57, DOI 10.1083/jcb.201601004; Vaquero A, 2009, INT J DEV BIOL, V53, P303, DOI 10.1387/ijdb.082675av; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vodenicharov MD, 2005, J CELL SCI, V118, P589, DOI 10.1242/jcs.01636; von Heideman A, 2010, CANCER CHEMOTH PHARM, V65, P1165, DOI 10.1007/s00280-009-1125-3; Wang RH, 2014, INT J BIOL SCI, V10, P1193, DOI 10.7150/ijbs.11066; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Williamson WD, 2012, FRONT BIOSCI-LANDMRK, V17, P984, DOI 10.2741/3969; Wood M, 2018, ARCH BIOCHEM BIOPHYS, V638, P8, DOI 10.1016/j.abb.2017.12.009; Yan XF, 2017, CANCER CHEMOTH PHARM, V80, P395, DOI 10.1007/s00280-017-3365-y; Zabka TS, 2015, TOXICOL SCI, V144, P163, DOI 10.1093/toxsci/kfu268; Zecchin A, 2015, CURR OPIN BIOTECH, V34, P73, DOI 10.1016/j.copbio.2014.11.022	67	18	18	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2019	294	22					8676	8689		10.1074/jbc.RA118.003505	http://dx.doi.org/10.1074/jbc.RA118.003505			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC4XL	30975903	Green Published, hybrid			2022-12-28	WOS:000470971100001
J	Peng, Y; Wu, S; Tang, QY; Li, SH; Peng, C				Peng, Yi; Wu, Song; Tang, Qiyu; Li, Shuaihua; Peng, Cheng			KGF-1 accelerates wound contraction through the TGF-1/Smad signaling pathway in a double-paracrine manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						wound healing; transforming growth factor (TGF-); cell migration; cell proliferation; cell-cell interaction; diabetic wound; epithelial-mesenchymal interaction; wound contraction	GROWTH-FACTOR-BETA; COLLAGEN GEL CONTRACTION; KERATINOCYTE GROWTH; TGF-BETA; FIBROBLAST COCULTURES; FACTOR EXPRESSION; MYOFIBROBLAST; DIFFERENTIATION; PROLIFERATION; INDUCTION	KGF-1 plays an important role in the wound healing process. Loss of the KGF-1 gene in diabetic mice attenuated the process of wound contraction, suggesting that KGF-1 contributes to wound contraction. However, the mechanism remains unclear. To investigate the role of KGF-1 in diabetic wound contraction, we established a keratinocyte-fibroblast co-culture system. Concentrations of transforming growth factor 1 (TGF-1) in conditioned supernatant treated with KGF-1 (KGF-1 group), tk;4KGF-1-neutralizing antibody (anti-KGF-1 group), TGF-1 (TGF-1tk;1 group), KGF-1 and TGF-1-neutralizing antibody (KGF-1 + anti-TGF-1 group) were tested by ELISA. Conditioned medium was added to fibroblast-populated collagen lattice (FPCL) to investigate the effect of KGF-1 on fibroblastqj contraction. TGF-1, Col-I, p-Smad2, p-Smad3, and -smooth muscle actin (-SMA) were examined by Western blotting. A diabetic rat wound model was utilized to evaluate wound morphology, histology, immunohistochemistry, and protein expression in wound tissue after treatment with KGF-1. ELISA assays revealed that the concentration of TGF-1 in the conditioned supernatant in the KGF-1 group was significantly higher. The contractile capacity of FPCL stimulated by conditioned medium derived from the KGF-1 group was significantly elevated; however, the contractile activity of FPCL induced by KGF-1 was attenuated by TGF-1-neutralizing antibody. The Western blot results suggest that KGF-1 is able to stimulate TGF-1 activation with increased Col-I, p-Smad2, p-Smad3, and -SMA expression. Diabetic wounds treated with KGF-1 had a higher degree of contraction with significantly higher expression of TGF-1, Col-I, p-Smad2, p-Smad3, and -SMA. Our findings demonstrate that KGF-1 promotes fibroblast contraction and accelerates wound contraction via the TGF-1/Smad signaling pathway in a double-paracrine manner.	[Peng, Yi; Tang, Qiyu; Peng, Cheng] Cent S Univ, Xiangya Hosp 3, Dept Plast Surg, Changsha 410013, Hunan, Peoples R China; [Peng, Yi; Wu, Song] Cent S Univ, Xiangya Hosp 3, Dept Orthoped Surg, Changsha 410013, Hunan, Peoples R China; [Li, Shuaihua] Peoples Hosp Chenzhou 1, Dept Cosmet & Plast Surg, Chenzhou 423000, Hunan, Peoples R China	Central South University; Central South University	Peng, C (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Plast Surg, Changsha 410013, Hunan, Peoples R China.	pcheng83@csu.edu.cn			National Natural Science Foundation of China [81301636]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81301636. The authors declare that they have no conflicts of interest with the contents of this article.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chin GS, 2001, PLAST RECONSTR SURG, V108, P423, DOI 10.1097/00006534-200108000-00022; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P; Fang QH, 2013, J INFLAMM RES, V6, P25, DOI 10.2147/JIR.S35136; Finch PW, 2004, ADV CANCER RES, V91, P69, DOI 10.1016/S0065-230X(04)91003-2; Florin L, 2005, J CELL SCI, V118, P1981, DOI 10.1242/jcs.02303; Ghahary A, 2007, WOUND REPAIR REGEN, V15, pS46, DOI 10.1111/j.1524-475X.2007.00225.x; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hsieh SC, 2016, LIFE SCI, V161, P19, DOI 10.1016/j.lfs.2016.07.011; Kossi J, 2001, ANN CHIR GYNAECOL, V90, P15; Lichtman MK, 2016, WOUND REPAIR REGEN, V24, P215, DOI 10.1111/wrr.12398; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Maas-Szabowski N, 2001, J INVEST DERMATOL, V116, P816, DOI 10.1046/j.1523-1747.2001.01349.x; Maas-Szabowski N, 2000, J INVEST DERMATOL, V114, P1075, DOI 10.1046/j.1523-1747.2000.00987.x; Marti G, 2004, GENE THER, V11, P1780, DOI 10.1038/sj.gt.3302383; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Meckmongkol TT, 2007, BIOCHEM BIOPH RES CO, V360, P709, DOI 10.1016/j.bbrc.2007.06.121; Mukhopadhyay A, 2005, BRIT J DERMATOL, V152, P639, DOI 10.1111/j.1365-2133.2005.06545.x; Peng C, 2011, J INT MED RES, V39, P416, DOI 10.1177/147323001103900209; Peng C, 2011, PLAST RECONSTR SURG, V128, p673E, DOI 10.1097/PRS.0b013e318230c521; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Shannon DB, 2006, WOUND REPAIR REGEN, V14, P172, DOI 10.1111/j.1743-6109.2006.00107.x; Shephard P, 2004, AM J PATHOL, V164, P2055, DOI 10.1016/S0002-9440(10)63764-9; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tan AM, 2015, MOL MED, V21, P544, DOI 10.2119/molmed.2015.00063; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Verrecchia Franck, 2002, Curr Rheumatol Rep, V4, P143, DOI 10.1007/s11926-002-0010-4; Weber CE, 2012, J BURN CARE RES, V33, P311, DOI 10.1097/BCR.0b013e318240541e; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896	39	24	25	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8361	8370		10.1074/jbc.RA118.006189	http://dx.doi.org/10.1074/jbc.RA118.006189			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30894415	Green Published, hybrid			2022-12-28	WOS:000471108200007
J	Vogel, D; Rosenthal, M; Gogrefe, N; Reindl, S; Gunther, S				Vogel, Dominik; Rosenthal, Maria; Gogrefe, Nadja; Reindl, Sophia; Guenther, Stephan			Biochemical characterization of the Lassa virus L protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral polymerase; recombinant protein expression; viral replication; RNA polymerase; viral transcription; arenavirus; genome replication initiation; hemorrhagic fever; LASV; prime-and-realign mechanism	DE-NOVO INITIATION; DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; IN-VITRO; 5 ENDS; REPLICATION; TRANSCRIPTION; BUNYAVIRIDAE; SYSTEM; MECHANISM	The L protein of arena- and bunyaviruses is structurally and functionally related to the orthomyxovirus polymerase complex. It plays a central role in the viral life cycle, as it replicates the virus genome and generates viral mRNA via a cap-snatching mechanism. Here, we aimed to biochemically characterize the L protein of Lassa virus, a human-pathogenic arenavirus endemic in West Africa. Full-length 250-kDa L protein was expressed using a baculovirus expression system. A low-resolution structure calculated from small-angle X-ray scattering data revealed a conformation similar to that in the crystal structure of the orthomyxovirus polymerase complex. Although the L protein did not exhibit cap-snatching endonuclease activity, it synthesized RNA in vitro. RNA polymerization required manganese rather than magnesium ions, was independent of nucleotide primers, and was inhibited by viral Z protein. Maximum activity was mediated by double-stranded promoter sequences with a minimum length of 17 nucleotides, containing a nontemplated 5-G overhang, as in the natural genome context, as well as the naturally occurring base mismatches between the complementary promoter strands. Experiments with various short primers revealed the presence of two replication initiation sites at the template strand and evidence for primer translocation as proposed by the prime-and-realign hypothesis. Overall, our findings provide the foundation for a detailed understanding of the mechanistic differences and communalities in the polymerase proteins of segmented negative-strand RNA viruses and for the search for antiviral compounds targeting the RNA polymerase of Lassa virus.	[Vogel, Dominik; Rosenthal, Maria; Gogrefe, Nadja; Reindl, Sophia; Guenther, Stephan] Bernhard Nocht Inst Trop Med, Dept Virol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany; [Guenther, Stephan] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, D-20359 Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research	Reindl, S; Gunther, S (corresponding author), Bernhard Nocht Inst Trop Med, Dept Virol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.; Gunther, S (corresponding author), German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, D-20359 Hamburg, Germany.	reindl@bnitm.de; guenther@bni.uni-hamburg.de	Rosenthal, Maria/M-1857-2019	Rosenthal, Maria/0000-0003-2986-936X; Gunther, Stephan/0000-0002-6562-0230; Vogel, Dominik/0000-0001-6797-9696	German Research Foundation (Deutsche Forschungsgemeinschaft) [GU 883/4-1]; Dr. Ing. Wilhelm und Maria Kirmser-Stiftung	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Dr. Ing. Wilhelm und Maria Kirmser-Stiftung	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) Grant GU 883/4-1 (to S. G.) and the Dr. Ing. Wilhelm und Maria Kirmser-Stiftung. The authors declare that they have no conflicts of interest with the contents of this article.	Amroun A, 2017, CRIT REV MICROBIOL, V43, P753, DOI [10.1080/1040841X.2017.1307805, 10.1080/1040841x.2017.1307805]; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; AUPERIN DD, 1984, J VIROL, V52, P897, DOI 10.1128/JVI.52.3.897-904.1984; AUPERIN DD, 1986, VIROLOGY, V154, P155, DOI 10.1016/0042-6822(86)90438-1; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Brunotte L, 2011, J VIROL, V85, P324, DOI 10.1128/JVI.00721-10; Cornu TI, 2001, J VIROL, V75, P9415, DOI 10.1128/JVI.75.19.9415-9426.2001; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Dulin D, 2015, CELL REP, V10, P983, DOI 10.1016/j.celrep.2015.01.031; Loureiro ME, 2011, J VIROL, V85, P12304, DOI 10.1128/JVI.05691-11; Fernandez-Garcia Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005635; Ferron F, 2017, VIRUS RES, V234, P118, DOI 10.1016/j.virusres.2017.01.018; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GARCIN D, 1995, J VIROL, V69, P5754, DOI 10.1128/JVI.69.9.5754-5762.1995; GARCIN D, 1992, J VIROL, V66, P1370, DOI 10.1128/JVI.66.3.1370-1376.1992; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; Hass M, 2004, J VIROL, V78, P13793, DOI 10.1128/JVI.78.24.13793-13803.2004; Hass M, 2008, J VIROL, V82, P10207, DOI 10.1128/JVI.00220-08; Hass M, 2006, J VIROL, V80, P12414, DOI 10.1128/JVI.01374-06; Hastie KM, 2016, J VIROL, V90, P4556, DOI 10.1128/JVI.02896-15; Hays H, 2002, BIOCHEMISTRY-US, V41, P4771, DOI 10.1021/bi0120648; Hengrung N, 2015, NATURE, V527, P114, DOI 10.1038/nature15525; Jacamo R, 2003, J VIROL, V77, P10383, DOI 10.1128/JVI.77.19.10383-10393.2003; JIN H, 1993, J GEN VIROL, V74, P2293, DOI 10.1099/0022-1317-74-10-2293; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kranzusch PJ, 2011, P NATL ACAD SCI USA, V108, P19743, DOI 10.1073/pnas.1112742108; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Lehmann M, 2014, J VIROL, V88, P8713, DOI 10.1128/JVI.00652-14; Lelke M, 2010, J VIROL, V84, P1934, DOI 10.1128/JVI.01657-09; Liu XJ, 2018, J VIROL, V92, DOI [10.1128/JVI.01414-17, 10.1128/jvi.01414-17]; Marq JB, 2010, J BIOL CHEM, V285, P18208, DOI 10.1074/jbc.M109.089425; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Ortin J, 2015, VIROLOGY, V479, P532, DOI 10.1016/j.virol.2015.03.018; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; POLYAK SJ, 1995, J VIROL, V69, P3211, DOI 10.1128/JVI.69.5.3211-3215.1995; RAJU R, 1990, VIROLOGY, V174, P53, DOI 10.1016/0042-6822(90)90053-T; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Ranjith-Kumar CT, 2001, J VIROL, V75, P8615, DOI 10.1128/JVI.75.18.8615-8623.2001; Reguera J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005636; Reguera J, 2016, CURR OPIN STRUC BIOL, V36, P75, DOI 10.1016/j.sbi.2016.01.002; Reich S, 2017, NUCLEIC ACIDS RES, V45, P3353, DOI 10.1093/nar/gkx043; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Rosenthal M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006400; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tambo E, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0421-8; te Velthuis AJW, 2018, J VIROL, V92, DOI 10.1128/JVI.01775-17; Thierry E, 2016, MOL CELL, V61, P125, DOI 10.1016/j.molcel.2015.11.016; Vieth S, 2004, VIROLOGY, V318, P153, DOI 10.1016/j.virol.2003.09.009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wallat GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087577; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000	61	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8088	8100		10.1074/jbc.RA118.006973	http://dx.doi.org/10.1074/jbc.RA118.006973			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30926610	hybrid, Green Published			2022-12-28	WOS:000470656500010
J	Ryu, I; Kim, YK				Ryu, Incheol; Kim, Yoon Ki			AU-rich element-mediated mRNA decay via the butyrate response factor 1 controls cellular levels of polyadenylated replication-dependent histone mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA; RNA degradation; RNA metabolism; RNA turnover; RNA-protein interaction; ARE-mediated mRNA decay; mRNA stability; posttranscriptional regulation; polyadenylation; butyrate response factor 1 (BRF1); ZFP36 ring finger protein like 1 (ZFP36L1); histone mRNA biogenesis; Hu antigen R (HuR); ELAV like RNA binding protein 1 (ELAVL1); replication-dependent histone mRNA	DEGRADATION; PROTEIN; PHOSPHORYLATION; TURNOVER; CLEAVAGE; GENE	Replication-dependent histone (RDH) mRNAs have a nonpolyadenylated 3-UTR that ends in a highly conserved stem-loop structure. Nonetheless, a subset of RDH mRNAs has a poly(A) tail under physiological conditions. The biological meaning of poly(A)-containing (+) RDH mRNAs and details of their biosynthesis remain elusive. Here, using HeLa cells and Western blotting, qRT-PCR, and biotinylated RNA pulldown assays, we show that poly(A)(+) RDH mRNAs are post-transcriptionally regulated via adenylate- and uridylate-rich element-mediated mRNA decay (AMD). We observed that the rapid degradation of poly(A)(+) RDH mRNA is driven by butyrate response factor 1 (BRF1; also known as ZFP36 ring finger protein-like 1) under normal conditions. Conversely, cellular stresses such as UV C irradiation promoted BRF1 degradation, increased the association of Hu antigen R (HuR; also known as ELAV-like RNA-binding protein 1) with the 3-UTR of poly(A)(+) RDH mRNAs, and eventually stabilized the poly(A)(+) RDH mRNAs. Collectively, our results provide evidence that AMD surveils poly(A)(+) RDH mRNAs via BRF1-mediated degradation under physiological conditions.	[Ryu, Incheol; Kim, Yoon Ki] Korea Univ, Ctr Mol Biol Translat, Creat Res Initiat, Seoul 02841, South Korea; [Ryu, Incheol; Kim, Yoon Ki] Korea Univ, Div Life Sci, Seoul 02841, South Korea	Korea University; Korea University	Kim, YK (corresponding author), Korea Univ, Ctr Mol Biol Translat, Creat Res Initiat, Seoul 02841, South Korea.	ryu.incheol@gmail.com; yk-kim@korea.ac.kr		Kim, Yoon Ki/0000-0003-1303-072X	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning) [NRF-2015R1A3A2033665]; Korea University grant; NRF [2013R1A1A2063273, 2016R-1D1A1B03933894]	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning); Korea University grant; NRF	This work was supported by National Research Foundation of Korea (NRF) Grant NRF-2015R1A3A2033665 funded by the Korea government (Ministry of Science, ICT and Future Planning) and by a Korea University grant. The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by NRF Grants 2013R1A1A2063273 and 2016R-1D1A1B03933894.	BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Brocato J, 2015, BIOL TRACE ELEM RES, V166, P72, DOI 10.1007/s12011-015-0296-5; Choe J, 2013, NUCLEIC ACIDS RES, V41, P1307, DOI 10.1093/nar/gks1196; COLLART D, 1991, BIOCHEMISTRY-US, V30, P1610, DOI 10.1021/bi00220a024; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Grammatikakis I, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1372; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Gruber JJ, 2012, MOL CELL, V45, P87, DOI 10.1016/j.molcel.2011.12.020; Hoefig KP, 2014, WIRES RNA, V5, P577, DOI 10.1002/wrna.1232; Kari V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063745; Khabar KSA, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1368; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; KIRSH AL, 1989, GENE DEV, V3, P2172, DOI 10.1101/gad.3.12b.2172; Ngoc LV, 2014, MOL CELL BIOL, V34, P4315, DOI 10.1128/MCB.00643-14; Lyons SM, 2016, NUCLEIC ACIDS RES, V44, P9190, DOI 10.1093/nar/gkw620; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mayr C, 2017, ANNU REV GENET, V51, P171, DOI 10.1146/annurev-genet-120116-024704; Mayr C, 2016, TRENDS CELL BIOL, V26, P227, DOI 10.1016/j.tcb.2015.10.012; Murigneux V, 2013, METHODS, V63, P32, DOI 10.1016/j.ymeth.2013.03.022; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Park OH, 2019, MOL CELL, V74, P494, DOI 10.1016/j.molcel.2019.02.034; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Romeo V, 2016, CURR OPIN CELL BIOL, V40, P23, DOI 10.1016/j.ceb.2016.01.015; Romeo V, 2014, MOL CELL BIOL, V34, P4272, DOI 10.1128/MCB.00791-14; Ryu I, 2019, CELL REP, V26, P2126, DOI 10.1016/j.celrep.2019.01.101; Ryu I, 2019, FASEB J, V33, P2680, DOI 10.1096/fj.201800431R; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; von Roretz C, 2011, WIRES RNA, V2, P336, DOI 10.1002/wrna.55; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016	31	1	1	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7558	7565		10.1074/jbc.AC118.006766	http://dx.doi.org/10.1074/jbc.AC118.006766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30962286	Green Published, hybrid			2022-12-28	WOS:000470153300004
J	Banerjee, A; Phillips, BL; Deng, QD; Seyfried, NT; Pavlath, GK; Vest, KE; Corbett, AH				Banerjee, Ayan; Phillips, Brittany L.; Deng, Quidong; Seyfried, Nicholas T.; Pavlath, Grace K.; Vest, Katherine E.; Corbett, Anita H.			Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; skeletal muscle; TAR DNA-binding protein 43 (TDP-43) (TARDBP); muscular dystrophy; RNA-binding protein; proteomics; protein-protein interaction; gene regulation; oculopharyngeal muscular dystrophy (OPMD); PABPN1; poly(A) polyalanine tract	OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; IN-VIVO; PATHOGENIC MECHANISMS; TDP-43 ACCUMULATION; POLY(A) TAIL; MATRIN 3; PABPN1; INCLUSIONS; SORTILIN; GENE	Oculopharyngeal muscular dystrophy (OPMD) is a late-onset, primarily autosomal dominant disease caused by a short GCN expansion in the PABPN1 (polyadenylate-binding protein nuclear 1) gene that results in an alanine expansion at the N terminus of the PABPN1 protein. Expression of alanine-expanded PABPN1 is linked to the formation of nuclear aggregates in tissues from individuals with OPMD. However, as with other nuclear aggregate-associated diseases, controversy exists over whether these aggregates are the direct cause of pathology. An emerging hypothesis is that a loss of PABPN1 function and/or aberrant protein interactions contribute to pathology in OPMD. Here, we present the first global proteomic analysis of the protein interactions of WT and alanine-expanded PABPN1 in skeletal muscle tissue. These data provide both insight into the function of PABPN1 in muscle and evidence that the alanine expansion alters the protein-protein interactions of PABPN1. We extended this analysis to demonstrate altered complex formation with and loss of function of TDP-43 (TAR DNA-binding protein 43), which we show interacts with alanine-expanded but not WT PABPN1. The results from our study support a model where altered protein interactions with alanine-expanded PABPN1 that lead to loss or gain of function could contribute to pathology in OPMD.	[Banerjee, Ayan; Phillips, Brittany L.; Corbett, Anita H.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Phillips, Brittany L.] Emory Univ, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA; [Deng, Quidong; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Biochem, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Pavlath, Grace K.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Vest, Katherine E.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Banerjee, Ayan] Mitobridge, 1030 Massachusetts Ave,Suite 200, Cambridge, MA 02138 USA	Emory University; Emory University; Emory University; Emory University; University System of Ohio; University of Cincinnati	Corbett, AH (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.; Vest, KE (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	katherine.vest@uc.edu; acorbe2@emory.edu	Corbett, Anita/AAH-6106-2021	Corbett, Anita/0000-0002-0461-6895; Vest, Katherine/0000-0002-3391-8649	National Institutes of Health [5RO1AR061987, 5F32AR068207]; Muscular Dystrophy Association [255856, 422006]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061987, F32AR068207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants 5RO1AR061987 (to A. H. C. and G. K. P.) and 5F32AR068207 (to K.E.V.) and Muscular Dystrophy Association Grants 255856 (to A. B.) and 422006 (to A. H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Baker A, 2007, BBA-MOL BASIS DIS, V1772, P173, DOI 10.1016/j.bbadis.2006.10.003; Afroz T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00062-0; Aktas T, 2017, NATURE, V544, P115, DOI 10.1038/nature21715; Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Amiel J, 2004, HUM MOL GENET, V13, pR235, DOI 10.1093/hmg/ddh251; Apponi LH, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-23; Apponi LH, 2010, HUM MOL GENET, V19, P1058, DOI 10.1093/hmg/ddp569; Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Banerjee A, 2017, NUCLEIC ACIDS RES, V45, P10706, DOI 10.1093/nar/gkx786; Banerjee A, 2013, FEBS J, V280, P4230, DOI 10.1111/febs.12294; Berciano MT, 2004, HUM MOL GENET, V13, P829, DOI 10.1093/hmg/ddh101; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Calado A, 2000, RNA, V6, P245, DOI 10.1017/S1355838200991908; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Chartier A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005092; Chi BK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27136-3; Chou CC, 2015, HUM MOL GENET, V24, P5154, DOI 10.1093/hmg/ddv238; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Corbeil-Girard LP, 2005, NEUROBIOL DIS, V18, P551, DOI 10.1016/j.nbd.2004.10.019; Cortese A, 2014, NEUROBIOL AGING, V35, P1491, DOI 10.1016/j.neurobiolaging.2013.12.029; Cutler AA, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2654; Cykowski MD, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0528-y; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Davies JE, 2005, NAT MED, V11, P672, DOI 10.1038/nm1242; Davis SA, 2018, NEUROSCI LETT, V678, P8, DOI 10.1016/j.neulet.2018.04.053; de Klerk E, 2012, NUCLEIC ACIDS RES, V40, P9089, DOI 10.1093/nar/gks655; Dion P, 2005, NEUROBIOL DIS, V18, P528, DOI 10.1016/j.nbd.2004.09.021; Donovan LE, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt186; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fan XP, 2003, CAN J NEUROL SCI, V30, P244, DOI 10.1017/S0317167100002675; Figueroa JD, 2004, EXP CELL RES, V296, P163, DOI 10.1016/j.yexer.2004.01.025; Franco-Iborra S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00342; Fronz K, 2011, J BIOL CHEM, V286, P32986, DOI 10.1074/jbc.M111.273912; Gerstberger S, 2014, ADV EXP MED BIOL, V825, P1, DOI 10.1007/978-1-4939-1221-6_1; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; Holler CJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0100-17.2017; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Jouan L, 2014, CAN J NEUROL SCI, V41, P508, DOI 10.1017/S0317167100018588; Kamelgarn M, 2016, BBA-MOL BASIS DIS, V1862, P2004, DOI 10.1016/j.bbadis.2016.07.015; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Koh HR, 2014, NUCLEIC ACIDS RES, V42, P8556, DOI 10.1093/nar/gku523; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Kusters B, 2009, ACTA NEUROPATHOL, V117, P209, DOI 10.1007/s00401-008-0471-2; Lei L, 1999, MOL CELL BIOL, V19, P8372; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lopez-Gonzalez R, 2016, NEURON, V92, P383, DOI 10.1016/j.neuron.2016.09.015; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; Mankodi A, 2012, NEUROBIOL DIS, V45, P539, DOI 10.1016/j.nbd.2011.09.010; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Messaed C, 2009, NEUROBIOL DIS, V34, P397, DOI 10.1016/j.nbd.2009.02.013; Messaed C, 2007, NEUROBIOL DIS, V26, P546, DOI 10.1016/j.nbd.2007.02.004; Mohagheghi F, 2016, HUM MOL GENET, V25, P534, DOI 10.1093/hmg/ddv491; Moore KS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20518-7; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; PAUZNER R, 1991, MUSCLE NERVE, V14, P947, DOI 10.1002/mus.880141004; Phillips BL, 2018, NUCLEIC ACIDS RES, V46, P7643, DOI 10.1093/nar/gky535; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Randolph ME, 2014, J PHYSIOL-LONDON, V592, P5301, DOI 10.1113/jphysiol.2014.280420; Raz V, 2011, NUCLEUS-PHILA, V2, P208, DOI 10.4161/nucl.2.3.15736; Renz A, 1996, NUCLEIC ACIDS RES, V24, P843, DOI 10.1093/nar/24.5.843; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Ricketts T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085962; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Tada M, 2018, AM J PATHOL, V188, P507, DOI 10.1016/j.ajpath.2017.10.007; Tavanez JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006418; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Toriumi K, 2008, J NEUROSCI RES, V86, P1529, DOI 10.1002/jnr.21619; Toriumi K, 2009, GENES CELLS, V14, P751, DOI 10.1111/j.1365-2443.2009.01307.x; Uyama E, 2000, MUSCLE NERVE, V23, P1549, DOI 10.1002/1097-4598(200010)23:10<1549::AID-MUS11>3.0.CO;2-0; Vest KE, 2017, HUM MOL GENET, V26, P3235, DOI 10.1093/hmg/ddx206; Vest Katherine E, 2015, J Neuromuscul Dis, V2, P439; Villagra NT, 2008, MOL CELL NEUROSCI, V37, P622, DOI 10.1016/j.mcn.2007.12.012; Vogler TO, 2018, NATURE, V563, P508, DOI 10.1038/s41586-018-0665-2; Wang WZ, 2016, NAT MED, V22, P869, DOI 10.1038/nm.4130; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; Wobst HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177181; Yamaguchi A, 2016, SCI REP, V6, P1, DOI DOI 10.1038/srep35195; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zheng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021023	90	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7360	7376		10.1074/jbc.RA118.007287	http://dx.doi.org/10.1074/jbc.RA118.007287			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30837270	Green Published, hybrid			2022-12-28	WOS:000468402900023
J	Braganza, A; Quesnelle, K; Bickta, J; Reyes, C; Wang, YN; Jessup, M; St Croix, C; Arlotti, J; Singh, SV; Shiva, S				Braganza, Andrea; Quesnelle, Kelly; Bickta, Janelle; Reyes, Christopher; Wang, Yinna; Jessup, Morgan; St Croix, Claudette; Arlotti, Julie; Singh, Shivendra V.; Shiva, Sruti			Myoglobin induces mitochondrial fusion, thereby inhibiting breast cancer cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myoglobin; breast cancer; reactive oxygen species (ROS); parkin; oxidative stress; cell cycle; heme protein; mitochondrial fusion; proliferation; tumor growth	NITRIC-OXIDE; ENDOGENOUS MYOGLOBIN; OXYGEN DELIVERY; FATTY-ACID; EXPRESSION; MFN2; IDENTIFICATION; MITOFUSIN-2; TOLERANCE	Myoglobin is a monomeric heme protein expressed ubiquitously in skeletal and cardiac muscle and is traditionally considered to function as an oxygen reservoir for mitochondria during hypoxia. It is now well established that low concentrations of myoglobin are aberrantly expressed in a significant proportion of breast cancer tumors. Despite being expressed only at low levels in these tumors, myoglobin is associated with attenuated tumor growth and a better prognosis in breast cancer patients, but the mechanism of this myoglobin-mediated protection against further cancer growth remains unclear. Herein, we report a signaling pathway by which myoglobin regulates mitochondrial dynamics and thereby decreases cell proliferation. We demonstrate in vitro that expression of human myoglobin in MDA-MB-231, MDA-MB-468, and MCF7 breast cancer cells induces mitochondrial hyperfusion by up-regulating mitofusins 1 and 2, the predominant catalysts of mitochondrial fusion. This hyperfusion causes cell cycle arrest and subsequent inhibition of cell proliferation. Mechanistically, increased mitofusin expression was due to myoglobin-dependent free-radical production, leading to the oxidation and degradation of the E3 ubiquitin ligase parkin. We recapitulated this pathway in a murine model in which myoglobin-expressing xenografts exhibited decreased tumor volume with increased mitofusin, markers of cell cycle arrest, and decreased parkin expression. Furthermore, in human triple-negative breast tumor tissues, mitofusin and myoglobin levels were positively correlated. Collectively, these results elucidate a new function for myoglobin as a modulator of mitochondrial dynamics and reveal a novel pathway by which myoglobin decreases breast cancer cell proliferation and tumor growth by up-regulating mitofusin levels.	[Braganza, Andrea; Quesnelle, Kelly; Wang, Yinna; Shiva, Sruti] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Shiva, Sruti] Univ Pittsburgh, Sch Med, Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15261 USA; [Bickta, Janelle; Reyes, Christopher] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15261 USA; [Jessup, Morgan] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15261 USA; [St Croix, Claudette] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Arlotti, Julie; Singh, Shivendra V.; Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Arlotti, Julie; Singh, Shivendra V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA; [Quesnelle, Kelly] Western Michigan Univ, Dept Biomed Sci, Homer Stryker Sch Med, Kalamazoo, MI 49008 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Michigan University	Shiva, S (corresponding author), Univ Pittsburgh, BST1240E,200 Lothrop St, Pittsburgh, PA 15216 USA.	sss43@pitt.edu	St Croix, Claudette/AAA-3338-2022; Quesnelle, Kelly/AAJ-2580-2021	Reyes, Christopher/0000-0002-6735-7624; Braganza Jardini, Andrea/0000-0002-7391-3658	National Institutes of Health [R01 HL133003-01A1, 1R01GM113816-01, T32 HL110849]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110849, T32HL076124, T32HL129964, R01HL133003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL133003-01A1 and 1R01GM113816-01 (to S. S.) and T32 HL110849 Training in Translational Research and Entrepreneurship in Pulmonary Vascular Biology (to A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boutant M, 2017, EMBO J, V36, P1543, DOI 10.15252/embj.201694914; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; COLE RP, 1982, J APPL PHYSIOL, V53, P1116, DOI 10.1152/jappl.1982.53.5.1116; Fang D, 2016, SCI REP-UK, V6, DOI 10.1038/srep31462; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105; Hendgen-Cotta UB, 2017, SCI REP-UK, V7, DOI 10.1038/srep43219; Higdon AN, 2012, AM J PHYSIOL-HEART C, V302, pH1394, DOI 10.1152/ajpheart.00584.2011; Jourd'heuil D, 1998, NITRIC OXIDE-BIOL CH, V2, P37, DOI 10.1006/niox.1998.0167; Jue T, 2016, J PHYSIOL BIOCHEM, V73, P359, DOI 10.1007/s13105-017-0559-z; Kamga C, 2012, NITRIC OXIDE-BIOL CH, V26, P251, DOI 10.1016/j.niox.2012.03.005; Khoo NKH, 2010, FREE RADICAL BIO MED, V48, P230, DOI 10.1016/j.freeradbiomed.2009.10.046; Kim JK, 2018, BIOCHEM BIOPH RES CO, V496, P1013, DOI 10.1016/j.bbrc.2017.02.076; Kristiansen G, 2010, BRIT J CANCER, V102, P1736, DOI 10.1038/sj.bjc.6605702; Kristiansen G, 2011, J BIOL CHEM, V286, P43417, DOI 10.1074/jbc.M111.227553; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Li D, 2015, ACTA BIOCH BIOPH SIN, V47, P441, DOI 10.1093/abbs/gmv035; Lim KL, 2012, ANTIOXID REDOX SIGN, V16, P935, DOI 10.1089/ars.2011.4105; Lou YQ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0515-0; Ma L, 2015, ONCOL LETT, V10, P3816, DOI 10.3892/ol.2015.3748; Meller S, 2014, VIRCHOWS ARCH, V465, P419, DOI 10.1007/s00428-014-1646-y; Meng FJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-34; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; NEWMAN ESR, 1991, BIOCHEM BIOPH RES CO, V179, P1414, DOI 10.1016/0006-291X(91)91730-Z; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Pride CK, 2014, CARDIOVASC RES, V101, P57, DOI 10.1093/cvr/cvt224; Qiu Y, 1998, J BIOL CHEM, V273, P23426, DOI 10.1074/jbc.273.36.23426; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; RAO SI, 1994, J BIOL CHEM, V269, P7210; Rayner BS, 2009, BIOCHEM J, V423, P169, DOI 10.1042/BJ20090716; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Richards MP, 2013, ANTIOXID REDOX SIGN, V18, P2342, DOI 10.1089/ars.2012.4887; Rizi BS, 2015, CANCER RES, V75, P456, DOI 10.1158/0008-5472.CAN-14-1337; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Sriram R, 2008, FEBS LETT, V582, P3643, DOI 10.1016/j.febslet.2008.09.047; Stolz DB, 1999, AM J PATHOL, V155, P1487, DOI 10.1016/S0002-9440(10)65464-8; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Touvier M, 2005, JNCI-J NATL CANCER I, V97, P1338, DOI 10.1093/jnci/dji276; Westrate LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091911; WITTENBERG BA, 1975, J BIOL CHEM, V250, P9038; WITTENBERG BA, 1987, P NATL ACAD SCI USA, V84, P7503, DOI 10.1073/pnas.84.21.7503; Wittenberg JB, 2007, J EXP BIOL, V210, P2082, DOI 10.1242/jeb.003947; Xia Y, 2008, J HUAZHONG U SCI-MED, V28, P185, DOI 10.1007/s11596-008-0218-2; Xu K, 2017, SCI REP-UK, V7, DOI 10.1038/srep41718; Yamada T, 2016, J PHYSIOL-LONDON, V594, P483, DOI 10.1113/JP270824; Yamada T, 2013, J APPL PHYSIOL, V114, P490, DOI 10.1152/japplphysiol.00789.2012; Zhang GE, 2013, INT J MOL SCI, V14, P13005, DOI 10.3390/ijms140713005	53	19	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7269	7282		10.1074/jbc.RA118.006673	http://dx.doi.org/10.1074/jbc.RA118.006673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30872402	Green Published, hybrid			2022-12-28	WOS:000468402900016
J	Dumbrepatil, AB; Ghosh, S; Zegalia, KA; Malec, PA; Hoff, JD; Kennedy, RT; Marsh, ENG				Dumbrepatil, Arti B.; Ghosh, Soumi; Zegalia, Kelcie A.; Malec, Paige A.; Hoff, J. Damon; Kennedy, Robert T.; Marsh, E. Neil G.			Viperin interacts with the kinase IRAK1 and the E3 ubiquitin ligase TRAF6, coupling innate immune signaling to antiviral ribonucleotide synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; ubiquitin ligase; protein kinase; Toll-like receptor (TLR); signal transduction; antiviral protein; interleukin 1 receptor associated kinase 1 (IRAK1); radical SAM enzymes; S-adenosylmethionine domain containing 2 (RSAD2); TNF receptor-associated factor 6 (TRAF6)	INTERFERON-INDUCIBLE PROTEIN; C VIRUS-REPLICATION; S-ADENOSYLMETHIONINE; POLYUBIQUITINATION; INHIBITOR; STABILITY; MECHANISM	Virus-inhibitory protein, endoplasmic reticulum-associated, interferon-inducible (viperin) is a radical SAM enzyme that plays a multifaceted role in the cellular antiviral response. Viperin has recently been shown to catalyze the SAM-dependent formation of 3-deoxy-3,4-didehydro-CTP (ddhCTP), which inhibits some viral RNA polymerases. Viperin is also implicated in regulating Lys-63-linked polyubiquitination of interleukin-1 receptor-associated kinase-1 (IRAK1) by the E3 ubiquitin ligase tumor necrosis factor receptor-associated factor 6 (TRAF6) as part of the Toll-like receptor-7 and -9 (TLR7/9) innate immune signaling pathways. In these pathways, the poly-ubiquitination of IRAK1 by TRAF6 is necessary to activate IRAK1, which then phosphorylates downstream targets and ultimately leads to the production of type I interferons. That viperin is a component of these pathways suggested that its enzymatic activity might be regulated by interactions with partner proteins. To test this idea, we have reconstituted the interactions between viperin, IRAK1, and TRAF6 by transiently expressing these enzymes in HEK 293T cells. We show that IRAK1 and TRAF6 increase viperin activity approximate to 10-fold to efficiently catalyze the radical-mediated dehydration of CTP to ddhCTP. Furthermore, we found that TRAF6-mediated ubiquitination of IRAK1 requires the association of viperin with both IRAK1 and TRAF6. Ubiquitination appears to depend on structural changes in viperin induced by SAM binding, but, significantly, does not require catalytically active viperin. We conclude that the synergistic activation of viperin and IRAK1 provides a mechanism that couples innate immune signaling with the production of the antiviral nucleotide ddhCTP.	[Dumbrepatil, Arti B.; Ghosh, Soumi; Zegalia, Kelcie A.; Malec, Paige A.; Kennedy, Robert T.; Marsh, E. Neil G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Hoff, J. Damon] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Marsh, E. Neil G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Marsh, ENG (corresponding author), Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	nmarsh@umich.edu	; Marsh, Neil/G-7553-2016	Ghosh, Soumi/0000-0001-6101-0147; Dumbrepatil, Arti/0000-0002-0105-9667; Marsh, Neil/0000-0003-1713-1683; Zegalia, Kelcie/0000-0003-0389-134X; Hoff, Jeremy/0000-0002-4054-848X	National Institutes of Health [GM 093088, DK 046960]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM 093088 (to E. N. G. M.) and DK 046960 (to R. T. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; BORCHARDT RT, 1979, BIOCHEM BIOPH RES CO, V89, P919, DOI 10.1016/0006-291X(79)91866-7; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; CABOCHE M, 1978, J CELL PHYSIOL, V97, P361, DOI 10.1002/jcp.1040970311; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; Fenwick MK, 2017, P NATL ACAD SCI USA, V114, P6806, DOI 10.1073/pnas.1705402114; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Fu TM, 2018, P NATL ACAD SCI USA, V115, P1783, DOI 10.1073/pnas.1721788115; Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4; Haldar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031797; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Jiang X, 2011, IMMUNITY, V34, P285, DOI 10.1016/j.immuni.2011.03.012; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Makins C, 2016, J BIOL CHEM, V291, P26806, DOI 10.1074/jbc.M116.751040; Marsh ENG, 2004, BIOORG CHEM, V32, P326, DOI 10.1016/j.bioorg.2004.06.001; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Panayiotou C, 2018, J VIROL, V92, DOI 10.1128/JVI.00501-18; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Carcamo JRP, 2018, VIROLOGY, V514, P216, DOI 10.1016/j.virol.2017.10.012; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Vonderstein K, 2018, J VIROL, V92, DOI 10.1128/JVI.01751-17; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Wang L, 2017, P NATL ACAD SCI USA, V114, P13507, DOI 10.1073/pnas.1714386114; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	48	28	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6888	6898		10.1074/jbc.RA119.007719	http://dx.doi.org/10.1074/jbc.RA119.007719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30872404	Green Published, hybrid			2022-12-28	WOS:000467394700024
J	Michno, W; Nystrom, S; Wehrli, P; Lashley, T; Brinkmalm, G; Guerard, L; Syvanen, S; Sehlin, D; Kaya, I; Brinet, D; Nilsson, KPR; Hammarstrom, P; Blennow, K; Zetterberg, H; Hanrieder, J				Michno, Wojciech; Nystrom, Sofie; Wehrli, Patrick; Lashley, Tammaryn; Brinkmalm, Gunnar; Guerard, Laurent; Syvanen, Stina; Sehlin, Dag; Kaya, Ibrahim; Brinet, Dimitri; Nilsson, K. Peter R.; Hammarstrom, Per; Blennow, Kaj; Zetterberg, Henrik; Hanrieder, Jorg			Pyroglutamation of amyloid-x-42 (Ax-42) followed by A1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (A); Alzheimer disease; mass spectrometry (MS); imaging; protein aggregation; neurodegeneration; pyroglutamation; plaque polymorphism; hyperspectral imaging; transgenic mice; pyroglutamic acid	HEREDITARY CEREBRAL-HEMORRHAGE; A-BETA-DEPOSITION; PRECURSOR PROTEIN; CEREBROSPINAL-FLUID; TRANSGENIC MOUSE; MASS-SPECTROMETRY; AGGREGATION PATHWAYS; SENILE PLAQUES; IN-VITRO; PEPTIDE	Amyloid- (A) pathology in Alzheimer's disease (AD) is characterized by the formation of polymorphic deposits comprising diffuse and cored plaques. Because diffuse plaques are predominantly observed in cognitively unaffected, amyloid-positive (CU-AP) individuals, pathogenic conversion into cored plaques appears to be critical to AD pathogenesis. Herein, we identified the distinct A species associated with amyloid polymorphism in brain tissue from individuals with sporadic AD (s-AD) and CU-AP. To this end, we interrogated A polymorphism with amyloid conformation-sensitive dyes and a novel in situ MS paradigm for chemical characterization of hyperspectrally delineated plaque morphotypes. We found that maturation of diffuse into cored plaques correlated with increased A1-40 deposition. Using spatial in situ delineation with imaging MS (IMS), we show that A1-40 aggregates at the core structure of mature plaques, whereas A1-42 localizes to diffuse amyloid aggregates. Moreover, we observed that diffuse plaques have increased pyroglutamated Ax-42 levels in s-AD but not CU-AP, suggesting an AD pathology-related, hydrophobic functionalization of diffuse plaques facilitating A1-40 deposition. Experiments in tgAPP(Swe) mice verified that, similar to what has been observed in human brain pathology, diffuse deposits display higher levels of A1-42 and that A plaque maturation over time is associated with increases in A1-40. Finally, we found that A1-40 deposition is characteristic for cerebral amyloid angiopathy deposition and maturation in both humans and mice. These results indicate that N-terminal Ax-42 pyroglutamation and A1-40 deposition are critical events in priming and maturation of pathogenic A from diffuse into cored plaques, underlying neurotoxic plaque development in AD.	[Michno, Wojciech; Wehrli, Patrick; Brinkmalm, Gunnar; Kaya, Ibrahim; Brinet, Dimitri; Blennow, Kaj; Zetterberg, Henrik; Hanrieder, Jorg] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, S-43180 Molndal, Sweden; [Nystrom, Sofie; Nilsson, K. Peter R.; Hammarstrom, Per] Linkoping Univ, Dept Phys Chem & Biol, S-58183 Linkoping, Sweden; [Lashley, Tammaryn; Zetterberg, Henrik; Hanrieder, Jorg] UCL, Dept Neurodegenerat Dis, UCL Queen Sq Inst Neurol, London WC1N 3BG, England; [Syvanen, Stina; Sehlin, Dag] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75236 Uppsala, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, S-43180 Molndal, Sweden; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London WC1E 6BT, England; [Guerard, Laurent] Univ Gothenburg, Sahlgrenska Acad, Ctr Cellular Imaging, S-41390 Gothenburg, Sweden	University of Gothenburg; Linkoping University; University of London; University College London; Uppsala University; Sahlgrenska University Hospital; University of London; University College London; University of Gothenburg	Hanrieder, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Molndal Hosp, House V, S-43180 Molndal, Sweden.	jh@gu.se	Brinkmalm, Gunnar/AAH-3914-2021; Michno, Wojciech/C-2599-2019	Michno, Wojciech/0000-0002-3096-3604; Sehlin, Dag/0000-0002-9430-3859; Kaya, Ibrahim/0000-0003-3345-5602; Hammarstrom, Per/0000-0001-5827-3587; Lashley, Tammaryn/0000-0001-7389-0348; Syvanen, Stina/0000-0002-8196-4041; Guerard, Laurent/0000-0002-5166-8524; Nystrom, Sofie/0000-0002-4303-4783; Hanrieder, Jorg/0000-0001-6059-198X	Leonard Wolfson Centre for Experimental Neurology; Reta Lila Weston Institute for Neurological Studies; Medical Research Council	Leonard Wolfson Centre for Experimental Neurology; Reta Lila Weston Institute for Neurological Studies; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff at the Centre for Cellular Imaging (CCI), Core Facilities, Sahlgrenska Academy at the University of Gothenburg and the National Microscopy Infrastructure, NMI (VR-RFI 2016-00968), for help with development of hyperspectral imaging paradigm and microscopy expertise. TL acknowledges the Leonard Wolfson Centre for Experimental Neurology for financial support. The Queen Square Brain Bank is supported by the Reta Lila Weston Institute for Neurological Studies and the Medical Research Council.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brinkmalm G, 2012, J MASS SPECTROM, V47, P591, DOI 10.1002/jms.2987; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Condello C, 2018, P NATL ACAD SCI USA, V115, pE782, DOI 10.1073/pnas.1714966115; Cummings DM, 2015, BRAIN, V138, P1992, DOI 10.1093/brain/awv127; D'Arrigo C, 2009, BIOPOLYMERS, V91, P861, DOI 10.1002/bip.21271; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; Dickson TC, 2001, NEUROSCIENCE, V105, P99, DOI 10.1016/S0306-4522(01)00169-5; Dong MY, 2016, CHEMPHYSCHEM, V17, P2558, DOI 10.1002/cphc.201600256; Ellingsen PG, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101313; Esbjorner EK, 2014, CHEM BIOL, V21, P732, DOI 10.1016/j.chembiol.2014.03.014; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fukumoto H, 1996, NEURODEGENERATION, V5, P13, DOI 10.1006/neur.1996.0002; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Gu L, 2013, J NEUROCHEM, V126, P305, DOI 10.1111/jnc.12202; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Hanrieder J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009308; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang THJ, 2000, J BIOL CHEM, V275, P36436, DOI 10.1074/jbc.M005698200; IKEDA S, 1989, LAB INVEST, V60, P113; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jiang DL, 2012, LANGMUIR, V28, P12711, DOI 10.1021/la3021436; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kaya I, 2017, ACS CHEM NEUROSCI, V8, P2778, DOI 10.1021/acschemneuro.7b00314; Klingstedt T, 2013, CHEMBIOCHEM, V14, P607, DOI 10.1002/cbic.201200731; Kumar-Singh S, 2008, GENES BRAIN BEHAV, V7, P67, DOI 10.1111/j.1601-183X.2007.00380.x; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lord A, 2011, AM J PATHOL, V178, P2286, DOI 10.1016/j.ajpath.2011.01.052; Mann DMA, 1996, AM J PATHOL, V148, P1257; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MORI H, 1992, J BIOL CHEM, V267, P17082; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nilsson KPR, 2007, ACS CHEM BIOL, V2, P553, DOI 10.1021/cb700116u; Nystrom S, 2013, ACS CHEM BIOL, V8, P1128, DOI 10.1021/cb4000376; Pannee J, 2016, J NEUROCHEM, V139, P651, DOI 10.1111/jnc.13838; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Portelius E, 2007, J PROTEOME RES, V6, P4433, DOI 10.1021/pr0703627; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Psonka-Antonczyk KM, 2016, FRONT CHEM, V4, DOI 10.33839/fchem.2016.00044; Rasmussen J, 2017, P NATL ACAD SCI USA, V114, P13018, DOI 10.1073/pnas.1713215114; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Shin RW, 1997, J NEUROSCI, V17, P8187; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; TAGLIAVINI F, 1988, NEUROSCI LETT, V93, P191, DOI 10.1016/0304-3940(88)90080-8; Terai K, 2001, BRAIN RES, V900, P48, DOI 10.1016/S0006-8993(01)02202-8; Thal Dietmar R, 2006, Sci Aging Knowledge Environ, V2006, pre1, DOI 10.1126/sageke.2006.6.re1; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Verbeek MM, 2009, ANN NEUROL, V66, P245, DOI 10.1002/ana.21694; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V76, P541, DOI 10.1007/BF00689591; Yang JH, 2011, ANAL CHEM, V83, P5728, DOI 10.1021/ac200998a	76	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6719	6732		10.1074/jbc.RA118.006604	http://dx.doi.org/10.1074/jbc.RA118.006604			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30814252	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000467394700011
J	Malak, OA; Gluhov, GS; Grizel, AV; Kudryashova, KS; Sokolova, OS; Loussouarn, G				Malak, Olfat A.; Gluhov, Grigory S.; Grizel, Anastasia V.; Kudryashova, Kseniya S.; Sokolova, Olga S.; Loussouarn, Gildas			Voltage-dependent activation in EAG channels follows a ligand-receptor rather than a mechanical-lever mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; electrophysiology; peptides; physiology; biophysics; allosteric regulation; EAG channel; Kv 10; 2 channel; S4-S5 linker; S6 C-terminus; voltage dependence	AMINO-TERMINAL DOMAIN; CRYO-EM STRUCTURE; S4-S5 LINKER; POTASSIUM CHANNELS; GATING MECHANISM; N-TERMINUS; HERG; SENSOR; REVEALS; DEACTIVATION	Ether-a-go-go family (EAG) channels play a major role in many physiological processes in humans, including cardiac repolarization and cell proliferation. Cryo-EM structures of two of them, K(V)10.1 and human ether-a-go-go-related gene (hERG or K(V)11.1), have revealed an original nondomain-swapped structure, suggesting that the mechanism of voltage-dependent gating of these two channels is quite different from the classical mechanical-lever model. Molecular aspects of hERG voltage-gating have been extensively studied, indicating that the S4-S5 linker (S4-S5(L)) acts as a ligand binding to the S6 gate (S6 C-terminal part, S6(T)) and stabilizes it in a closed state. Moreover, the N-terminal extremity of the channel, called N-Cap, has been suggested to interact with S4-S5(L) to modulate channel voltage-dependent gating, as N-Cap deletion drastically accelerates hERG channel deactivation. In this study, using COS-7 cells, site-directed mutagenesis, electrophysiological measurements, and immunofluorescence confocal microscopy, we addressed whether these two major mechanisms of voltage-dependent gating are conserved in K(V)10.2 channels. Using cysteine bridges and S4-S5(L)-mimicking peptides, we show that the ligand/receptor model is conserved in K(V)10.2, suggesting that this model is a hallmark of EAG channels. Truncation of the N-Cap domain, Per-Arnt-Sim (PAS) domain, or both in K(V)10.2 abolished the current and altered channel trafficking to the membrane, unlike for the hERG channel in which N-Cap and PAS domain truncations mainly affected channel deactivation. Our results suggest that EAG channels function via a conserved ligand/receptor model of voltage gating, but that the N-Cap and PAS domains have different roles in these channels.	[Malak, Olfat A.; Loussouarn, Gildas] Univ Nantes, Inst Thorax, CNRS, INSERM, F-44007 Nantes, France; [Gluhov, Grigory S.; Kudryashova, Kseniya S.; Sokolova, Olga S.] Moscow MV Lomonosov State Univ, Moscow 119234, Russia; [Grizel, Anastasia V.] St Petersburg State Univ, St Petersburg 199034, Russia; [Kudryashova, Kseniya S.] Russian Acad Sci, Inst Bioorgan Chem, Shemyakin Ovchinnikov Inst, Moscow 117997, Russia	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Lomonosov Moscow State University; Saint Petersburg State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Loussouarn, G (corresponding author), UN, IRS, Inst Thorax, INSERM,UMR 1087,CNRS,UMR 6291, 8 Quai Moncousu BP 70721, F-44007 Nantes 1, France.	gildas.loussouarn@inserm.fr	Sokolova, Olga/AAM-8289-2020; Sokolova, Olga S/G-7794-2016; Loussouarn, Gildas/D-3590-2015; Loussouarn, Gildas/ABH-6043-2020; Glukhov, Grigoriy/E-7262-2018; Kudryashova, Ksenia S/A-9510-2014; Grizel, Anastasia V/A-4415-2015	Sokolova, Olga/0000-0003-4678-232X; Loussouarn, Gildas/0000-0001-8007-5931; Loussouarn, Gildas/0000-0001-8007-5931; Grizel, Anastasia V/0000-0003-4875-8171; Kudryashova, Ksenia/0000-0002-6937-3193	Moscow Lomonosov State University Program of Development	Moscow Lomonosov State University Program of Development	We thank Isabelle Baro for careful reading of the manuscript. We thank the MicroPiCell facility of SFR Sante F. Bonamy for confocal microscopy experiments (Nantes). O. A. M. personally thanks Line Pomaret for her generous support. The LSM710-Confocor3 microscope was supported by the Moscow Lomonosov State University Program of Development.	Barros F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020248; Beekwilder JP, 2003, J PHARMACOL EXP THER, V304, P531, DOI 10.1124/jpet.102.042135; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Charpentier F, 2010, J MOL CELL CARDIOL, V48, P37, DOI 10.1016/j.yjmcc.2009.08.005; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; de la Pea P, 2018, PFLUG ARCH EUR J PHY, V470, P517, DOI 10.1007/s00424-017-2093-9; de la Pena P, 2013, BIOCHEM J, V451, P463, DOI 10.1042/BJ20121717; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Fernandez-Trillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024674; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Gilchrist Annette, 2002, Sci STKE, V2002, ppl1, DOI 10.1126/stke.2002.118.pl1; Goodchild SJ, 2014, CHANNELS, V8, P84, DOI 10.4161/chan.26775; Horton RM, 2013, BIOTECHNIQUES, V54, P129; Jimenez-Perez L, 2016, J BIOL CHEM, V291, P3569, DOI 10.1074/jbc.M115.678995; Jouni M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002159; Ju M, 2002, FEBS LETT, V524, P204, DOI 10.1016/S0014-5793(02)03055-7; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Ke Y, 2014, J BIOL CHEM, V289, P13782, DOI 10.1074/jbc.M113.531277; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ma LJ, 2011, BIOPHYS J, V100, P885, DOI 10.1016/j.bpj.2010.12.3726; Malak OA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00155-2; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Osteen JD, 2012, P NATL ACAD SCI USA, V109, P7103, DOI 10.1073/pnas.1201582109; Pal S, 2003, J NEUROSCI, V23, P4798; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Piron J, 2010, J PHYSIOL-LONDON, V588, P3471, DOI 10.1113/jphysiol.2010.195313; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Silva J, 2005, CIRCULATION, V112, P1384, DOI 10.1161/CIRCULATIONAHA.105.543306; Sokolova O S, 2012, Bioorg Khim, V38, P177; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Thouta S, 2014, BIOPHYS J, V106, P1057, DOI 10.1016/j.bpj.2014.01.035; Tomczak AP, 2017, J GEN PHYSIOL, V149, P577, DOI 10.1085/jgp.201611742; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Vardanyan V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00145; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; Yang Y, 2013, J NEUROSCI, V33, P16586, DOI 10.1523/JNEUROSCI.2307-13.2013; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	44	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6506	6521		10.1074/jbc.RA119.007626	http://dx.doi.org/10.1074/jbc.RA119.007626			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30808709	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000468402000026
J	Malfacini, D; Patt, J; Annala, S; Harpsoe, K; Eryilmaz, F; Reher, R; Crusemann, M; Hanke, W; Zhang, H; Tietze, D; Gloriam, DE; Brauner-Osborne, H; Stromgaard, K; Konig, GM; Inoue, A; Gomeza, J; Kostenis, E				Malfacini, Davide; Patt, Julian; Annala, Suvi; Harpsoe, Kasper; Eryilmaz, Funda; Reher, Raphael; Cruesemann, Max; Hanke, Wiebke; Zhang, Hang; Tietze, Daniel; Gloriam, David E.; Brauner-Osborne, Hans; Stromgaard, Kristian; Koenig, Gabriele M.; Inoue, Asuka; Gomeza, Jesus; Kostenis, Evi			Rational design of a heterotrimeric G protein subunit with artificial inhibitor sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); signal transduction; pharmacology; CRISPR; Cas; DMR; FR900359; label-free; YM-254890	CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVATION; RECEPTOR; G-ALPHA(Q); YM-254890; CYCLASE; TRANSDUCERS; MECHANISM; INSIGHTS	Transmembrane signals initiated by a range of extracellular stimuli converge on members of the Gq family of heterotrimeric G proteins, which relay these signals in target cells. Gq family G proteins comprise Gq, G11, G14, and G16, which upon activation mediate their cellular effects via inositol lipid-dependent and -independent signaling to control fundamental processes in mammalian physiology. To date, highly specific inhibition of Gq/11/14 signaling can be achieved only with FR900359 (FR) and YM-254890 (YM), two naturally occurring cyclic depsipeptides. To further development of FR or YM mimics for other G subunits, we here set out to rationally design G16 proteins with artificial FR/YM sensitivity by introducing an engineered depsipeptide-binding site. Thereby we permit control of G16 function through ligands that are inactive on the WT protein. Using CRISPR/Cas9-generated Gq/G11-null cells and loss- and gain-of-function mutagenesis along with label-free whole-cell biosensing, we determined the molecular coordinates for FR/YM inhibition of Gq and transplanted these to FR/YM-insensitive G16. Intriguingly, despite having close structural similarity, FR and YM yielded biologically distinct activities: it was more difficult to perturb Gq inhibition by FR and easier to install FR inhibition onto G16 than perturb or install inhibition with YM. A unique hydrophobic network utilized by FR accounted for these unexpected discrepancies. Our results suggest that non-Gq/11/14 proteins should be amenable to inhibition by FR scaffold-based inhibitors, provided that these inhibitors mimic the interaction of FR with G proteins harboring engineered FR-binding sites.	[Malfacini, Davide; Patt, Julian; Annala, Suvi; Eryilmaz, Funda; Gomeza, Jesus; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Nussallee 6, D-53115 Bonn, Germany; [Reher, Raphael; Cruesemann, Max; Hanke, Wiebke; Koenig, Gabriele M.] Univ Bonn, Inst Pharmaceut Biol, Nussallee 6, D-53115 Bonn, Germany; [Harpsoe, Kasper; Zhang, Hang; Gloriam, David E.; Brauner-Osborne, Hans; Stromgaard, Kristian] Univ Copenhagen, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Tietze, Daniel] Tech Univ Darmstadt, Eduard Zintl Inst Inorgan & Phys Chem, D-64287 Darmstadt, Germany; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Reher, Raphael] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biol & Biomed, La Jolla, CA 92093 USA; [Zhang, Hang] Zhengzhou Univ, Coinnovat Ctr Henan Prov New Drug R&D & Preclin S, Minist Educ, Key Lab Adv Drug Preparat Technol, 100 Kexue Ave, Zhengzhou 450001, Henan, Peoples R China; [Zhang, Hang] Zhengzhou Univ, Sch Pharmaceut Sci, 100 Kexue Ave, Zhengzhou 450001, Henan, Peoples R China	University of Bonn; University of Bonn; University of Copenhagen; Technical University of Darmstadt; Tohoku University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Zhengzhou University; Zhengzhou University	Kostenis, E (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, Nussallee 6, D-53115 Bonn, Germany.	kostenis@uni-bonn.de	Bräuner-Osborne, Hans/S-3298-2019; Harpsøe, Kasper/V-6870-2018; Gloriam, David E./A-1904-2011; Tietze, Daniel/D-4332-2012	Bräuner-Osborne, Hans/0000-0001-9495-7388; Harpsøe, Kasper/0000-0002-9326-9644; Gloriam, David E./0000-0002-4299-7561; Tietze, Daniel/0000-0002-9251-1902; Reher, Raphael/0000-0002-5858-1173; Crusemann, Max/0000-0001-6660-2715; Malfacini, Davide/0000-0003-4562-9550; Stromgaard, Kristian/0000-0003-2206-4737; Zhang, Hang/0000-0002-5479-3435	German Research Foundation (Deutsche Forschungsgemeinschaft) [FOR2372]; Lundbeck Foundation [1079971001]; Novo Nordisk Foundation [NNF17OC0031226]; Japan Agency for Medical Research and Development [PRIME JP17gm5910013, LEAP JP17gm0010004]; Deutsche Bund Umwelt (DBU)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Deutsche Bund Umwelt (DBU)	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grant FOR2372 (to E.K. and G. M. K.) and Lundbeck Foundation Grant 1079971001) and Novo Nordisk Foundation Grant NNF17OC0031226(to D.G.). Japan Agency for Medical Research and Development Grants PRIME JP17gm5910013 and LEAP JP17gm0010004 (to A. I.) partially supported this work. W.H. is greatful for a scholarship from the Deutsche Bund Umwelt (DBU) to support her doctoral studies. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a scholarship from the Deutsche Bund Umwelt (DBU).	Bolognini D, 2016, J BIOL CHEM, V291, P18915, DOI 10.1074/jbc.M116.736157; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bynagari YS, 2009, J BIOL CHEM, V284, P13413, DOI 10.1074/jbc.M808970200; Campbell AP, 2018, NAT REV DRUG DISCOV, V17, P789, DOI 10.1038/nrd.2018.135; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Crusemann M, 2018, ANGEW CHEM INT EDIT, V57, P836, DOI 10.1002/anie.201707996; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Gao Jianjiong, SCI SIGNAL, V6, DOI [10.1126/scisignal.2004088, DOI 10.1126/SCISIGNAL.2004088]; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goh FG, 2009, BRIT J PHARMACOL, V158, P1695, DOI 10.1111/j.1476-5381.2009.00415.x; Goricanec D, 2016, P NATL ACAD SCI USA, V113, pE3629, DOI 10.1073/pnas.1604125113; Gulati S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04432-0; Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Higa-Nakamine S, 2015, J BIOL CHEM, V290, P25974, DOI 10.1074/jbc.M115.681700; Hisaoka-Nakashima K, 2015, J BIOL CHEM, V290, P13678, DOI 10.1074/jbc.M114.622415; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Inamdar V, 2015, PLATELETS, V26, P771, DOI 10.3109/09537104.2014.998993; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Kaur H, 2015, ORG LETT, V17, P492, DOI 10.1021/ol503507g; KELLIS JT, 1988, NATURE, V333, P784, DOI 10.1038/333784a0; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Klepac K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10895; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li B, 2018, J BIOL CHEM, V293, P4752, DOI 10.1074/jbc.RA117.000163; Liao Y, 2016, J BIOL CHEM, V291, P7505, DOI 10.1074/jbc.M115.704122; Lokits AD, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1147-8; Lutz S, 2002, N-S ARCH PHARMACOL, V365, P50, DOI 10.1007/s00210-001-0500-3; Mahoney JP, 2016, CURR OPIN STRUC BIOL, V41, P247, DOI 10.1016/j.sbi.2016.11.005; Matthey M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2288; Maziarz M, 2018, J BIOL CHEM, V293, P19586, DOI 10.1074/jbc.RA118.005291; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852; Orth JHC, 2005, J BIOL CHEM, V280, P36701, DOI 10.1074/jbc.M507203200; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Preininger Anita M, 2004, Sci STKE, V2004, pre3, DOI 10.1126/stke.2182004re3; Reher R, 2018, CHEMMEDCHEM, V13, P1634, DOI 10.1002/cmdc.201800304; Reher R, 2018, J NAT PROD, V81, P1628, DOI 10.1021/acs.jnatprod.8b00222; Rensing DT, 2015, ORG LETT, V17, P2270, DOI 10.1021/acs.orglett.5b00944; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Schroder R, 2011, NAT PROTOC, V6, P1748, DOI 10.1038/nprot.2011.386; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Skinner JJ, 2017, P NATL ACAD SCI USA, V114, P13453, DOI 10.1073/pnas.1711543114; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Taniguchi M, 2004, BIOORGAN MED CHEM, V12, P3125, DOI 10.1016/j.bmc.2004.04.006; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Walther TH, 2014, CURR OPIN STRUC BIOL, V27, P63, DOI 10.1016/j.sbi.2014.05.003; Xiong XF, 2016, NAT CHEM, V8, P1035, DOI [10.1038/NCHEM.2577, 10.1038/nchem.2577]; Yasui F, 2008, BRIT J PHARMACOL, V154, P890, DOI 10.1038/bjp.2008.140; Zaima K, 2013, J NAT MED-TOKYO, V67, P196, DOI 10.1007/s11418-012-0644-0; Zhang H, 2018, EUR J MED CHEM, V156, P847, DOI 10.1016/j.ejmech.2018.07.023; Zhang H, 2017, CHEMMEDCHEM, V12, P830, DOI 10.1002/cmdc.201700155	67	19	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5747	5758		10.1074/jbc.RA118.007250	http://dx.doi.org/10.1074/jbc.RA118.007250			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30745359	Green Published, hybrid			2022-12-28	WOS:000465077500002
J	Zuo, YN; Wang, PF; Sun, JF; Guo, SC; Wang, GQ; Zuo, T; Fan, SL; Zhou, P; Liang, MF; Shi, XL; Wang, XQ; Zhang, LQ				Zuo, Yanan; Wang, Pengfei; Sun, Jianfeng; Guo, Shichun; Wang, Guiqin; Zuo, Teng; Fan, Shilong; Zhou, Paul; Liang, Mifang; Shi, Xuanling; Wang, Xinquan; Zhang, Linqi			Complementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodies (vol 293, pg 16503, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													ZHANG, LIN/GYD-9123-2022	Fan, Shilong/0000-0001-9272-2438				Zuo YA, 2018, J BIOL CHEM, V293, P16503, DOI 10.1074/jbc.RA118.004604	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5735	5735		10.1074/jbc.AAC119.008421	http://dx.doi.org/10.1074/jbc.AAC119.008421			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30952830	Green Published, hybrid			2022-12-28	WOS:000464517500039
J	Bourkas, MEC; Arshad, H; Al-Azzawi, ZAM; Halgas, O; Shikiya, RA; Mehrabian, M; Schmitt-Ulms, G; Bartz, JC; Watts, JC				Bourkas, Matthew E. C.; Arshad, Hamza; Al-Azzawi, Zaid A. M.; Halgas, Ondrej; Shikiya, Ronald A.; Mehrabian, Mohadeseh; Schmitt-Ulms, Gerold; Bartz, Jason C.; Watts, Joel C.			Engineering a murine cell line for the stable propagation of hamster prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; cell culture; neurodegeneration; protein aggregation; CRISPR; Cas; neuron; bovine spongiform encephalopathy; Creutzfeldt-Jakob disease; heterologous system	TRANSMISSIBLE MINK ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; CHRONIC WASTING DISEASE; SPONGIFORM ENCEPHALOPATHY; SCRAPIE INFECTION; MOUSE SCRAPIE; PROTEIN; STRAINS; PRP; CONVERSION	Prions are infectious protein aggregates that cause several fatal neurodegenerative diseases. Prion research has been hindered by a lack of cellular paradigms for studying the replication of prions from different species. Although hamster prions have been widely used to study prion replication in animals and within in vitro amplification systems, they have proved challenging to propagate in cultured cells. Because the murine catecholaminergic cell line CAD5 is susceptible to a diverse range of mouse prion strains, we hypothesized that it might also be capable of propagating nonmouse prions. Here, using CRISPR/Cas9-mediated genome engineering, we demonstrate that CAD5 cells lacking endogenous mouse PrP expression (CAD5-PrP-/- cells) can be chronically infected with hamster prions following stable expression of hamster PrP. When exposed to the 263K, HY, or 139H hamster prion strains, these cells stably propagated high levels of protease-resistant PrP. Hamster prion replication required absence of mouse PrP, and hamster PrP inhibited the propagation of mouse prions. Cellular homogenates from 263K-infected cells exhibited prion seeding activity in the RT-QuIC assay and were infectious to naive cells expressing hamster PrP. Interestingly, murine N2a neuroblastoma cells ablated for endogenous PrP expression were susceptible to mouse prions, but not hamster prions upon expression of cognate PrP, suggesting that CAD5 cells either possess cellular factors that enhance or lack factors that restrict the diversity of prion strains that can be propagated. We conclude that transfected CAD5-PrP-/- cells may be a useful tool for assessing the biology of prion strains and dissecting the mechanism of prion replication.	[Bourkas, Matthew E. C.; Arshad, Hamza; Al-Azzawi, Zaid A. M.; Mehrabian, Mohadeseh; Schmitt-Ulms, Gerold; Watts, Joel C.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 0S8, Canada; [Bourkas, Matthew E. C.; Arshad, Hamza; Al-Azzawi, Zaid A. M.; Halgas, Ondrej; Watts, Joel C.] Univ Toronto, Dept Biochem, Toronto, ON M5T 0S8, Canada; [Mehrabian, Mohadeseh; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5T 0S8, Canada; [Shikiya, Ronald A.; Bartz, Jason C.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Toronto; University of Toronto; University of Toronto; Creighton University	Watts, JC (corresponding author), Krembil Discovery Tower,Rm 4KD481,60 Leonard Ave, Toronto, ON M5T 0S8, Canada.	joel.watts@utoronto.ca		Halgas, Ondrej/0000-0002-2858-9123; Watts, Joel/0000-0002-2604-2925; Bartz, Jason/0000-0003-4081-7886	Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-05112]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2015-05112 (to J. C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Altmeppen Hermann C, 2012, Am J Neurodegener Dis, V1, P15; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bardelli M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007335; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; Blochberger TC, 1997, PROTEIN ENG, V10, P1465, DOI 10.1093/protein/10.12.1465; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Ghodrati F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26685-x; Giles K, 2016, J PHARMACOL EXP THER, V358, P537, DOI 10.1124/jpet.116.235556; Giles K, 2015, J PHARMACOL EXP THER, V355, P2, DOI 10.1124/jpet.115.224659; Grassmann A, 2013, VIRUSES-BASEL, V5, P374, DOI 10.3390/v5010374; Herbst A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003755; Herva ME, 2012, PRION, V6, P371, DOI 10.4161/pri.20198; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Krejciova Z, 2017, J EXP MED, V214, P3481, DOI 10.1084/jem.20161547; KRISTENSSON K, 1993, NEUROLOGY, V43, P2335, DOI 10.1212/WNL.43.11.2335; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lu D, 2013, J PHARMACOL EXP THER, V347, P325, DOI 10.1124/jpet.113.205799; Maas E, 2007, J BIOL CHEM, V282, P18702, DOI 10.1074/jbc.M701309200; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Marbiah MM, 2014, EMBO J, V33, P1527, DOI 10.15252/embj.201387150; Mays CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018047; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; Moudjou M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29116; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Oelschlegel AM, 2012, J VIROL, V86, P5297, DOI 10.1128/JVI.00181-12; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Orru CD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050140; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Qi YP, 1997, J NEUROSCI, V17, P1217; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Schatzl HM, 1997, J VIROL, V71, P8821; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Shikiya RA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006298; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; SURI C, 1993, J NEUROSCI, V13, P1280; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Watts JC, 2018, ACTA NEUROPATHOL, V135, P159, DOI 10.1007/s00401-017-1790-y; Watts JC, 2014, J BIOL CHEM, V289, P19841, DOI 10.1074/jbc.R114.550707; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998	74	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4911	4923		10.1074/jbc.RA118.007135	http://dx.doi.org/10.1074/jbc.RA118.007135			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30705093	Green Published, hybrid			2022-12-28	WOS:000463985600016
J	Gourinchas, G; Vide, U; Winkler, A				Gourinchas, Geoffrey; Vide, Ursula; Winkler, Andreas			Influence of the N-terminal segment and the PHY-tongue element on light-regulation in bacteriophytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photoreceptor; signal transduction; photobiology; cyclic di-GMP (c-di-GMP); ultraviolet-visible spectroscopy (UV-visible spectroscopy); protein engineering; bilin; diguanylate cyclase; GGDEF; phytochrome	CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BACTERIAL PHYTOCHROMES; PR STATES; PLANT; CHROMOPHORE; REVEALS; DOMAIN; PFR; PHOTOCONVERSION	Photoreceptors enable the integration of ambient light stimuli to trigger lifestyle adaptations via modulation of central metabolite levels involved in diverse regulatory processes. Red light-sensing bacteriophytochromes are attractive targets for the development of innovative optogenetic tools because of their natural modularity of coupling with diverse functionalities and the natural availability of the light-absorbing biliverdin chromophore in animal tissues. However, a rational design of such tools is complicated by the poor understanding of molecular mechanisms of light signal transduction over long distancesfrom the site of photon absorption to the active site of downstream enzymatic effectors. Here we show how swapping structural elements between two bacteriophytochrome homologs provides additional insight into light signal integration and effector regulation, involving a fine-tuned interplay of important structural elements of the sensor, as well as the sensor-effector linker. Facilitated by the availability of structural information of inhibited and activated full-length structures of one of the two homologs (Idiomarina species A28L phytochrome-activated diguanylyl cyclase (IsPadC)) and characteristic differences in photoresponses of the two homologs, we identify an important cross-talk between the N-terminal segment, containing the covalent attachment site of the chromophore, and the PHY-tongue region. Moreover, we highlight how these elements influence the dynamic range of photoactivation and how activation can be improved to light/dark ratios of approximate to 800-fold by reducing basal dark-state activities at the same time as increasing conversion in the light state. This will enable future optimization of optogenetic tools aiming at a direct allosteric regulation of enzymatic effectors.	[Gourinchas, Geoffrey; Vide, Ursula; Winkler, Andreas] Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria; [Winkler, Andreas] BioTechMed Graz, A-8010 Graz, Austria	Graz University of Technology	Winkler, A (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	andreas.winkler@TUGraz.at	Gourinchas, Geoffrey/AAF-7377-2021; Gourinchas, Geoffrey/D-1277-2017	Winkler, Andreas/0000-0001-6221-9671; Gourinchas, Geoffrey/0000-0003-2543-3518	NAWI Graz; Austrian Science Fund through the Ph.D. program "DK Molecular Enzymology"; Austrian Science Fund (FWF) [P27124]	NAWI Graz; Austrian Science Fund through the Ph.D. program "DK Molecular Enzymology"; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by NAWI Graz, by the Austrian Science Fund through the Ph.D. program "DK Molecular Enzymology" (to G. G.), and by the Austrian Science Fund (FWF): P27124 (to A. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Anders K, 2015, CURR OPIN STRUC BIOL, V35, P7, DOI 10.1016/j.sbi.2015.07.005; Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; Antoniani D, 2010, APPL MICROBIOL BIOT, V85, P1095, DOI 10.1007/s00253-009-2199-x; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; Bellini D, 2012, STRUCTURE, V20, P1436, DOI 10.1016/j.str.2012.06.002; Bjorling A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600920; Borucki B, 2009, BIOCHEMISTRY-US, V48, P6305, DOI 10.1021/bi900436v; Buhrke D, 2018, CHEMPHYSCHEM, V19, P566, DOI 10.1002/cphc.201701311; Burgie ES, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14037-0; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chernov KG, 2017, CHEM REV, V117, P6423, DOI 10.1021/acs.chemrev.6b00700; CHERRY JR, 1992, P NATL ACAD SCI USA, V89, P5039, DOI 10.1073/pnas.89.11.5039; Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Duanmu DQ, 2014, P NATL ACAD SCI USA, V111, P15827, DOI 10.1073/pnas.1416751111; Engelhard C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01497-7; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Etzl S, 2018, J BIOL CHEM, V293, P9078, DOI 10.1074/jbc.RA118.003069; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Gourinchas G, 2018, ELIFE, V7, DOI 10.7554/eLife.34815; Gourinchas G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602498; Heintzen C., 2012, WILEY INTERDISCIP RE, V1, P411, DOI DOI 10.1002/WMTS.36; Hennig L, 2001, J BIOL CHEM, V276, P7913, DOI 10.1074/jbc.M009793200; Otero LH, 2016, J MOL BIOL, V428, P3702, DOI 10.1016/j.jmb.2016.04.012; Ihalainen JA, 2018, J AM CHEM SOC, V140, P12396, DOI 10.1021/jacs.8b04659; Jordan ET, 1997, PLANT PHYSIOL, V115, P693, DOI 10.1104/pp.115.2.693; Kikis EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000352; Klose C, 2015, NAT PLANTS, V1, P1, DOI [10.1038/nplants.2015.90, 10.1038/NPLANTS.2015.90]; Lamparter T, 2004, BIOCHEMISTRY-US, V43, P3659, DOI 10.1021/bi035693l; Losi A, 2017, PHOTOCHEM PHOTOBIOL, V93, P141, DOI 10.1111/php.12674; Mroginski MA, 2007, ACCOUNTS CHEM RES, V40, P258, DOI 10.1021/ar6000523; Murgida DH, 2007, BIOPHYS J, V93, P2410, DOI 10.1529/biophysj.107.108092; Nagano S, 2016, J PLANT RES, V129, P123, DOI 10.1007/s10265-016-0789-0; Piatkevich KD, 2013, CHEM SOC REV, V42, P3441, DOI 10.1039/c3cs35458j; Reichhart E, 2016, ANGEW CHEM INT EDIT, V55, P6339, DOI 10.1002/anie.201601736; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Ryu MH, 2014, P NATL ACAD SCI USA, V111, P10167, DOI 10.1073/pnas.1324301111; Salewski J, 2013, J BIOL CHEM, V288, P16800, DOI 10.1074/jbc.M113.457531; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07392-7; Schmidt P, 1998, PHOTOCHEM PHOTOBIOL, V68, P754, DOI 10.1111/j.1751-1097.1998.tb02541.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00498; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Toh KC, 2010, P NATL ACAD SCI USA, V107, P9170, DOI 10.1073/pnas.0911535107; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van Thor JJ, 2001, BIOCHEMISTRY-US, V40, P11460, DOI 10.1021/bi002651d; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Zienicke Benjamin, 2013, J Biol Chem, V288, P31738, DOI 10.1074/jbc.M113.479535	58	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4498	4510		10.1074/jbc.RA118.007260	http://dx.doi.org/10.1074/jbc.RA118.007260			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30683693	Green Published, hybrid			2022-12-28	WOS:000462969500018
J	Isaji, T; Im, S; Kameyama, A; Wang, YQ; Fukuda, T; Gu, JG				Isaji, Tomoya; Im, Sanghun; Kameyama, Akihiko; Wang, Yuqin; Fukuda, Tomohiko; Gu, Jianguo			A complex between phosphatidylinositol 4-kinase II alpha and integrin alpha 3 beta 1 is required for N-glycan sialylation in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; integrin; phosphatidylinositol kinase (PI kinase); sialic acid; glycosylation; epithelial-mesenchymal transition (EMT); integrin 31; phosphatidylinositol 4-kinase II; posttranslational modification; sialylation	BETA-PROPELLER DOMAIN; BREAST-CANCER; GOLGI LOCALIZATION; ADHESION; GLYCOSYLATION; EXPRESSION; GROWTH; PROTEIN; GOLPH3; GLYCOSYLTRANSFERASES	Aberrant N-glycan sialylation of glycoproteins is closely associated with malignant phenotypes of cancer cells and metastatic potential, which includes cell adhesion, migration, and growth. Recently, phosphatidylinositol 4-kinase II (PI4KII), which is localized to the trans-Golgi network, was identified as a regulator of Golgi phosphoprotein 3 (GOLPH3) and of vesicle transport in the Golgi apparatus. GOLPH3 is a target of PI4KII and helps anchor sialyltransferases and thereby regulates sialylation of cell surface receptors. However, how PI4KII-mediated sialyation of cell surface proteins is regulated remains unclear. In this study, using several cell lines, CRISPR/Cas9-based gene knockout and short hairpin RNA-mediated silencing, RT-PCR, lentivirus-mediated overexpression, and immunoblotting methods, we confirmed that PI4KII knockdown suppresses the sialylation of N-glycans on the cell surface, in Akt phosphorylation and activation, and integrin 3-mediated cell migration of MDA-MB-231 breast cancer cells. Interestingly, both integrin 31 and PI4KII co-localized to the trans-Golgi network, where they physically interacted with each other, and PI4KII specifically associated with integrin 3 but not 5. Furthermore, overexpression of both integrin 31 and PI4KII induced hypersialylation. Conversely, integrin 3 knockout significantly inhibited the sialylation of membrane proteins, such as the epidermal growth factor receptor, as well as in total cell lysates. These findings suggest that the malignant phenotype of cancer cells is affected by a sialylation mechanism that is regulated by a complex between PI4KII and integrin 31.	[Isaji, Tomoya; Im, Sanghun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan; [Kameyama, Akihiko] Natl Inst Adv Ind Sci & Technol, Dept Life Sci & Biotechnol, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan; [Wang, Yuqin] Nantong Univ, Dept Pharmacol, Coll Pharm, Nantong 226001, Jiangsu, Peoples R China	Tohoku Medical & Pharmaceutical University; National Institute of Advanced Industrial Science & Technology (AIST); Nantong University	Gu, JG (corresponding author), Tohoku Med & Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-mpu.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021		Japan Society for the Promotion of Science, National Natural Science Foundation of China [15H04354, JP17H03808]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [31670807, 18H04868]	Japan Society for the Promotion of Science, National Natural Science Foundation of China; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research 15H04354 (to J. G.) and JP17H03808 (to A. K.) from the Japan Society for the Promotion of Science, National Natural Science Foundation of China Grant 31670807, and Grant-in-Aid for Scientific Research on Innovative Areas 18H04868 (to J. G.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Baumlova A, 2014, EMBO REP, V15, P1085, DOI 10.15252/embr.201438841; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Boura E, 2015, EXP CELL RES, V337, P136, DOI 10.1016/j.yexcr.2015.03.028; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Cagnet S, 2014, ONCOGENE, V33, P4286, DOI 10.1038/onc.2013.391; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Chu KME, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.84; Clayton EL, 2013, PROG LIPID RES, V52, P294, DOI 10.1016/j.plipres.2013.04.002; Coleman DT, 2016, ONCOTARGET, V7, P32664, DOI 10.18632/oncotarget.8706; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dogic D, 1998, J CELL SCI, V111, P793; Eckert ESP, 2014, J BIOL CHEM, V289, P31319, DOI 10.1074/jbc.M114.608182; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Grabenhorst E, 1999, J BIOL CHEM, V274, P36107, DOI 10.1074/jbc.274.51.36107; Grottke A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146370; Guo HB, 2002, CANCER RES, V62, P6837; Hang QL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33507; Hasehira K, 2017, GLYCOCONJUGATE J, V34, P797, DOI 10.1007/s10719-016-9699-6; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hou S, 2016, FASEB J, V30, P4120, DOI 10.1096/fj.201600665R; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Itakura Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061160; JONJIC N, 1993, PATHOL RES PRACT, V189, P979; Kameyama A, 2019, BBA-PROTEINS PROTEOM, V1867, P76, DOI 10.1016/j.bbapap.2018.05.006; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Li J, 2010, ONCOGENE, V29, P2550, DOI 10.1038/onc.2010.14; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Lu DM, 2012, J BIOL CHEM, V287, P21856, DOI 10.1074/jbc.M112.348094; Lu JS, 2016, J BIOL CHEM, V291, P5708, DOI 10.1074/jbc.M115.712836; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Matoba K, 2017, CELL REP, V18, P32, DOI 10.1016/j.celrep.2016.12.017; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Mitchell K, 2010, CANCER RES, V70, P6359, DOI 10.1158/0008-5472.CAN-09-4283; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Morrow AA, 2014, MOL CANCER RES, V12, P1492, DOI 10.1158/1541-7786.MCR-13-0604; Ng MM, 2013, MOL BIOL CELL, V24, P796, DOI 10.1091/mbc.E12-07-0525; Nishikaze T, 2017, ANAL CHEM, V89, P2353, DOI 10.1021/acs.analchem.6b04150; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Pereira NA, 2014, J BIOL CHEM, V289, P14762, DOI 10.1074/jbc.M114.548305; Qin YB, 2009, J BIOL CHEM, V284, P22544, DOI 10.1074/jbc.M109.014399; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tanabe K, 2006, ANAL BIOCHEM, V348, P324, DOI 10.1016/j.ab.2005.10.035; Tokuda E, 2014, CANCER RES, V74, P3054, DOI 10.1158/0008-5472.CAN-13-2441; Toyoda M, 2016, GLYCOCONJUGATE J, V33, P917, DOI 10.1007/s10719-016-9700-4; Varki A, 2015, ESSENTIALS GLYCOBIOL, DOI DOI 10.1101/GLYCOBIOLOGY.3E.047; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wang YC, 2015, 2015 14TH IAPR INTERNATIONAL CONFERENCE ON MACHINE VISION APPLICATIONS (MVA), P1, DOI 10.1109/MVA.2015.7153119; Weixel KM, 2005, J BIOL CHEM, V280, P10501, DOI 10.1074/jbc.M414304200; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200; Yanagida K, 1999, ANAL BIOCHEM, V274, P229, DOI 10.1006/abio.1999.4263; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Yauch RL, 2000, BIOCHEM J, V351, P629, DOI 10.1042/0264-6021:3510629; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zhou QJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4552; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	88	14	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4425	4436		10.1074/jbc.RA118.005208	http://dx.doi.org/10.1074/jbc.RA118.005208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30659093	Green Published, hybrid			2022-12-28	WOS:000462969500012
J	Bass, MV; Nikitina, T; Norouzi, D; Zhurkin, VB; Grigoryev, SA				Bass, Mikhail V.; Nikitina, Tatiana; Norouzi, Davood; Zhurkin, Victor B.; Grigoryev, Sergei A.			Nucleosome spacing periodically modulates nucleosome chain folding and DNA topology in circular nucleosome arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin structure; DNA topology; nucleosome; histone; computer modeling; electron microscopy (EM); gene regulation; epigenetics; chromatin higher order structure; linker DNA; conformational simulation; epigenetic regulation	CHROMATIN FIBER; REPEAT LENGTH; ORGANIZATION; YEAST; VARIABILITY; DEPENDENCE; CHICKEN; EM	The length of linker DNA that separates nucleosomes is highly variable, but its mechanistic role in modulating chromatin structure and functions remains unknown. Here, we established an experimental system using circular arrays of positioned nucleosomes to investigate whether variations in nucleosome linker length could affect nucleosome folding, self-association, and interactions. We conducted EM, DNA topology, native electrophoretic assays, and Mg2+-dependent self-association assays to study intrinsic folding of linear and circular nucleosome arrays with linker DNA length of 36 bp and 41 bp (3.5 turns and 4 turns of DNA double helix, respectively). These experiments revealed that potential artifacts arising from open DNA ends and full DNA relaxation in the linear arrays do not significantly affect overall chromatin compaction and self-association. We observed that the 0.5 DNA helical turn difference between the two DNA linker lengths significantly affects DNA topology and nucleosome interactions. In particular, the 41-bp linkers promoted interactions between any two nucleosome beads separated by one bead as expected for a zigzag fiber, whereas the 36-bp linkers promoted interactions between two nucleosome beads separated by two other beads and also reduced negative superhelicity. Monte Carlo simulations accurately reproduce periodic modulations of chromatin compaction, DNA topology, and internucleosomal interactions with a 10-bp periodicity. We propose that the nucleosome spacing and associated chromatin structure modulations may play an important role in formation of different chromatin epigenetic states, thus suggesting implications for how chromatin accessibility to DNA-binding factors and the RNA transcription machinery is regulated.	[Bass, Mikhail V.; Grigoryev, Sergei A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Bass, Mikhail V.] Lomonosov Moscow State Univ, Biol Fac, Dept Mol Biol, Moscow 119192, Russia; [Nikitina, Tatiana; Norouzi, Davood; Zhurkin, Victor B.] NCI, Lab Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Lomonosov Moscow State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grigoryev, SA (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.; Zhurkin, VB (corresponding author), NCI, Lab Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	zhurkin@nih.gov; sag17@psu.edu			National Science Foundation [1516999]; Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010844] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Science Foundation Grant 1516999 (to S. A. G.) and Intramural Research Program of the National Cancer Institute, National Institutes of Health (to V. B. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baldi S, 2018, NAT STRUCT MOL BIOL, V25, P894, DOI 10.1038/s41594-018-0110-0; BAUER WR, 1980, SCI AM, V243, P118; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Buckwalter JM, 2017, NUCLEIC ACIDS RES, V45, P9372, DOI 10.1093/nar/gkx562; Cai SJ, 2018, MOL BIOL CELL, V29, P2450, DOI 10.1091/mbc.E18-05-0331; Carruthers LM, 2000, METHOD ENZYMOL, V321, P66; Chereji RV, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1398-0; Collepardo-Guevara R, 2014, P NATL ACAD SCI USA, V111, P8061, DOI 10.1073/pnas.1315872111; COMPTON JL, 1976, P NATL ACAD SCI USA, V73, P4382, DOI 10.1073/pnas.73.12.4382; Correll SJ, 2012, EMBO J, V31, P2416, DOI 10.1038/emboj.2012.80; Ekundayo B, 2017, J MOL BIOL, V429, P3031, DOI 10.1016/j.jmb.2017.09.002; Funke JJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600974; Grigoryev SA, 2018, BIOPHYS J, V114, P2290, DOI 10.1016/j.bpj.2018.03.009; Grigoryev SA, 2016, P NATL ACAD SCI USA, V113, P1238, DOI 10.1073/pnas.1518280113; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Joti Y, 2012, NUCLEUS-PHILA, V3, P404, DOI 10.4161/nucl.21222; Kulaeva OI, 2012, MOL CELL BIOL, V32, P4892, DOI 10.1128/MCB.01127-12; LEUBA SH, 1994, P NATL ACAD SCI USA, V91, P11621, DOI 10.1073/pnas.91.24.11621; LOHR D, 1986, J BIOL CHEM, V261, P9904; LOHR D, 1977, P NATL ACAD SCI USA, V74, P79, DOI 10.1073/pnas.74.1.79; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Nikitina T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700957; Nizovtseva EV, 2017, NUCLEIC ACIDS RES, V45, P3059, DOI 10.1093/nar/gkw1240; Norouzi D, 2018, BIOPHYS J, V115, P1644, DOI 10.1016/j.bpj.2018.06.032; Norouzi D, 2015, BIOPHYS J, V108, P2591, DOI 10.1016/j.bpj.2015.04.015; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Ou HD, 2017, SCIENCE, V357, DOI 10.1126/science.aag0025; Perisic O, 2010, J MOL BIOL, V403, P777, DOI 10.1016/j.jmb.2010.07.057; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Risca VI, 2017, NATURE, V541, P237, DOI 10.1038/nature20781; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schlick T, 2012, J BIOL CHEM, V287, P5183, DOI 10.1074/jbc.R111.305763; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SHURE M, 1977, NUCLEIC ACIDS RES, V4, P1183, DOI 10.1093/nar/4.5.1183; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vaughan RM, 2018, P NATL ACAD SCI USA, V115, P8775, DOI 10.1073/pnas.1806373115; Vian L, 2018, CELL, V173, P1165, DOI 10.1016/j.cell.2018.03.072; Voong LN, 2016, CELL, V167, P1555, DOI 10.1016/j.cell.2016.10.049; Wang JP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000175; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Wong H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000877; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; Yan Y, 2018, NUCLEIC ACIDS RES, V46, P4417, DOI 10.1093/nar/gky153	54	15	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4233	4246		10.1074/jbc.RA118.006412	http://dx.doi.org/10.1074/jbc.RA118.006412			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30630950	Green Published, hybrid			2022-12-28	WOS:000461854400033
J	Burke, JE				Burke, John E.			Dynamic structural biology at the protein membrane interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						phosphoinositide; hydrogen-deuterium exchange mass spectrometry; HDX-MS; phosphatidylinositide 3-kinase (PI3K); phosphatidylinositol kinase; Akt PKB; protein dynamics; PI3K; PI4K; PI3K; Akt; Akt; lipid signaling	HYDROGEN-DEUTERIUM EXCHANGE; PHOSPHOLIPASE A(2); IMMUNODEFICIENCY MUTATIONS; MASS-SPECTROMETRY; 3A PROTEIN; III-BETA; ACTIVATION; ACBD3; BINDING; INHIBITORS	Since I started doing scientific research, I've been fascinated by the interplay of protein structure and dynamics and how they together mediate protein function. A particular area of interest has been in understanding the mechanistic basis of how lipid-signaling enzymes function on membrane surfaces. In this award lecture article, I will describe my laboratory's studies on the structure and dynamics of lipid-signaling enzymes on membrane surfaces. This is important, as many lipid-signaling enzymes are regulated through dynamic regulatory mechanisms that control their enzymatic activity. This article will discuss my continued enthusiasm in using a synergistic application of hydrogen-deuterium exchange MS (HDX-MS) with other structural biology techniques to probe the mechanistic basis for how membrane-localized signaling enzymes are regulated and how these approaches can be used to understand how they are misregulated in disease. I will discuss specific examples of how we have used HDX-MS to study phosphoinositide kinases and the protein kinase Akt. An important focus will be on a description of how HDX-MS can be used as a powerful tool to optimize the design of constructs for X-ray crystallography and EM. The use of a diverse toolbox of biophysical methods has revealed novel insight into the complex and varied regulatory networks that control the function of lipid-signaling enzymes and enabled unique insight into the mechanics of membrane recruitment.	[Burke, John E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 2Y2, Canada	University of Victoria	Burke, JE (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 2Y2, Canada.	jeburke@uvic.ca	Burke, John/H-3922-2019	Burke, John/0000-0001-7904-9859	Canadian Institutes of Health Research [CRN-142393]; Cancer Research Society Operating Grant [CRS-22641]; Natural Sciences and Engineering Research Council of Canada Discovery Grant [NSERC-05218]; Michael Smith Foundation for Health Research Scholar Award [17686]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society Operating Grant; Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research Scholar Award(Michael Smith Foundation for Health Research)	This work was supported by a Canadian Institutes of Health Research New Investigator award and Open Operating Grant CRN-142393, Cancer Research Society Operating Grant CRS-22641, Natural Sciences and Engineering Research Council of Canada Discovery Grant NSERC-05218, and Michael Smith Foundation for Health Research Scholar Award 17686. The author declares that he has no conflicts of interest with the contents of this article.	Altan-Bonnet N, 2012, TRENDS BIOCHEM SCI, V37, P293, DOI 10.1016/j.tibs.2012.03.004; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Brunschwig C, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00012-18, 10.1128/aac.00012-18]; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Burke JE, 2018, MOL CELL, V71, P653, DOI 10.1016/j.molcel.2018.08.005; Burke JE, 2015, TRENDS BIOCHEM SCI, V40, P88, DOI 10.1016/j.tibs.2014.12.003; Burke JE, 2014, SCIENCE, V344, P1035, DOI 10.1126/science.1253397; Burke John E., 2013, Advances in Biological Regulation, V53, P97, DOI 10.1016/j.jbior.2012.09.005; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Burke JE, 2011, STRUCTURE, V19, P1127, DOI 10.1016/j.str.2011.06.003; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cao J, 2013, J BIOL CHEM, V288, P1806, DOI 10.1074/jbc.R112.421909; Castro-Falcon G, 2018, J MED CHEM, V61, P10463, DOI 10.1021/acs.jmedchem.8b00975; Clarke JH, 2015, BIOCHEM J, V466, P359, DOI 10.1042/BJ20141333; D'Angelo G, 2013, NATURE, V501, DOI 10.1038/nature12423; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Dornan GL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00575; Dornan GL, 2017, P NATL ACAD SCI USA, V114, P1982, DOI 10.1073/pnas.1617244114; Dornan GL, 2016, BIOCHEM SOC T, V44, P260, DOI 10.1042/BST20150219; Dyment DA, 2013, AM J HUM GENET, V93, P158, DOI 10.1016/j.ajhg.2013.06.005; Ebner M, 2017, MOL CELL, V65, P416, DOI 10.1016/j.molcel.2016.12.028; Efremov RG, 2017, METHOD ENZYMOL, V594, P1, DOI 10.1016/bs.mie.2017.05.007; Engen JR, 2015, ANNU REV ANAL CHEM, V8, P127, DOI 10.1146/annurev-anchem-062011-143113; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Fowler ML, 2016, PROTEIN SCI, V25, P826, DOI 10.1002/pro.2879; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gentile DR, 2017, CELL CHEM BIOL, V24, P1455, DOI 10.1016/j.chembiol.2017.08.025; Greninger AL, 2012, J VIROL, V86, P3605, DOI 10.1128/JVI.06778-11; Guttman M, 2016, METHOD ENZYMOL, V566, P405, DOI 10.1016/bs.mie.2015.05.021; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Ishikawa-Sasaki K, 2014, J VIROL, V88, P6586, DOI 10.1128/JVI.00208-14; Jenkins ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06196-z; Kato N, 2016, NATURE, V538, P344, DOI 10.1038/nature19804; Klima M, 2017, STRUCTURE, V25, P219, DOI 10.1016/j.str.2016.11.021; Klima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep23641; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Lucic I, 2018, P NATL ACAD SCI USA, V115, pE3940, DOI 10.1073/pnas.1716109115; Manjunatha UH, 2017, NATURE, V546, P376, DOI 10.1038/nature22337; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Masson GR, 2017, EXPERT OPIN DRUG DIS, V12, P981, DOI 10.1080/17460441.2017.1363734; Masson GR, 2016, BIOCHEM J, V473, P135, DOI 10.1042/BJ20150931; McGregor LM, 2017, BIOCHEMISTRY-US, V56, P3178, DOI 10.1021/acs.biochem.7b00271; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; McPhail JA, 2017, STRUCTURE, V25, P121, DOI 10.1016/j.str.2016.11.016; Nnadi CI, 2018, J CHEM INF MODEL, V58, P464, DOI 10.1021/acs.jcim.7b00399; Ohashi Y, 2016, AUTOPHAGY, V12, P2129, DOI 10.1080/15548627.2016.1226736; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Paquet T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad9735; Polevoy G, 2009, J CELL BIOL, V187, P847, DOI 10.1083/jcb.200908107; Powell CJ, 2018, P NATL ACAD SCI USA, V115, pE10548, DOI 10.1073/pnas.1811167115; Powell CJ, 2017, J BIOL CHEM, V292, P19469, DOI 10.1074/jbc.M117.809632; Prevost N, 2009, BLOOD, V113, P447, DOI 10.1182/blood-2008-06-162032; Pulkoski-Gross MJ, 2018, J LIPID RES, V59, P462, DOI 10.1194/jlr.M081307; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rostislavleva K, 2015, SCIENCE, V350, P140, DOI 10.1126/science.aac7365; Rutaganira FU, 2016, J MED CHEM, V59, P1830, DOI 10.1021/acs.jmedchem.5b01311; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sasaki J, 2012, EMBO J, V31, P754, DOI 10.1038/emboj.2011.429; Sharma S, 2009, PROTEINS, V76, P882, DOI 10.1002/prot.22394; Siempelkamp BD, 2017, J BIOL CHEM, V292, P12256, DOI 10.1074/jbc.M117.789263; Takeda AJ, 2017, J ALLERGY CLIN IMMUN, V140, P1152, DOI 10.1016/j.jaci.2017.03.026; Teoule F, 2013, J VIROL, V87, P11031, DOI 10.1128/JVI.00304-13; Vadas O, 2017, METHOD ENZYMOL, V583, P143, DOI 10.1016/bs.mie.2016.09.008; Vadas O, 2015, BIOCHEM SOC T, V43, P773, DOI 10.1042/BST20150065; Vadas O, 2013, P NATL ACAD SCI USA, V110, P18862, DOI 10.1073/pnas.1304801110; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; van der Schaar HM, 2016, TRENDS MICROBIOL, V24, P535, DOI 10.1016/j.tim.2016.02.017; Vetter M, 2015, NAT STRUCT MOL BIOL, V22, P695, DOI 10.1038/nsmb.3065; Walser R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001587; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335	79	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3872	3880		10.1074/jbc.AW118.003236	http://dx.doi.org/10.1074/jbc.AW118.003236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30692197	hybrid, Green Published			2022-12-28	WOS:000461854400006
J	Koyama, Y; Sumie, S; Nakano, Y; Nagao, T; Tokumaru, S; Michinaga, S				Koyama, Yutaka; Sumie, Satoshi; Nakano, Yasutaka; Nagao, Tomoya; Tokumaru, Shiho; Michinaga, Shotaro			Endothelin-1 stimulates expression of cyclin D1 and S-phase kinase-associated protein 2 by activating the transcription factor STAT3 in cultured rat astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; STAT3; cell cycle; cyclin D1; gene transcription; endothelin; neurobiology; astrocytic activation; SKP2; G1; S phase transition; brain injury; nerve damage	SPINAL-CORD; SCAR FORMATION; SERINE PHOSPHORYLATION; REACTIVE ASTROCYTES; CEREBRAL-ISCHEMIA; NEUROPATHIC PAIN; D3 EXPRESSION; DUAL ROLE; IN-VITRO; PROLIFERATION	Brain injury-mediated induction of reactive astrocytes often leads to glial scar formation in damaged brain regions. Activation of signal transducer and activator of transcription 3 (STAT3), a member of the STAT family of transcription factors, plays a pivotal role in inducing reactive astrocytes and glial scar formation. Endothelin-1 (ET-1) is a vasoconstrictor peptide, and its levels increase in brain disorders and promote astrocytic proliferation through ETB receptors. To clarify the mechanisms underlying ET-1-mediated astrocytic proliferation, here we examined its effects on STAT3 in cultured rat astrocytes. ET-1 treatment stimulated Ser-727 phosphorylation of STAT3 in the astrocytes, but Tyr-705 phosphorylation was unaffected, and ET-induced STAT3 Ser-727 phosphorylation was reduced by the ETB antagonist BQ788. ET-1 stimulated STAT3 binding to its consensus DNA-binding motifs. Monitoring G(1)/S phase cell cycle transition through bromodeoxyuridine (BrdU) incorporation, we found that ET-1 increases BrdU incorporation into the astrocytic nucleus, indicating cell cycle progression. Of note, STAT3 chemical inhibition (with stattic or 5,15-diphenyl-porphine (5,15-DPP)) or siRNA-mediated STAT3 silencing reduced ET-induced BrdU incorporation. Moreover, ET-1 increased astrocytic expression levels of cyclin D1 and S-phase kinase-associated protein 2 (SKP2), which were reduced by stattic, 5,15-DPP, and STAT3 siRNA. ChIP-based PCR analysis revealed that ET-1 promotes the binding of SAT3 to the 5-flanking regions of rat cyclin D1 and SKP2 genes. Our results suggest that STAT3-mediated regulation of cyclin D1 and SKP2 expression underlies ET-induced astrocytic proliferation.	[Koyama, Yutaka] Kobe Pharmaceut Univ, Pharmacol Lab, Higashinada Ku, 4-19-1 Motoyamakita, Kobe, Hyogo 6588558, Japan; [Sumie, Satoshi; Nakano, Yasutaka; Nagao, Tomoya; Tokumaru, Shiho; Michinaga, Shotaro] Osaka Ohtani Univ, Fac Pharm, Pharmacol Lab, Kita Ku, 3-11-1 Nishikiori, Tondabayashi, Osaka 5848540, Japan	Kobe Pharmaceutical University	Koyama, Y (corresponding author), Kobe Pharmaceut Univ, Pharmacol Lab, Higashinada Ku, 4-19-1 Motoyamakita, Kobe, Hyogo 6588558, Japan.	koyama-y@kobepharma-u.ac.jp		Koyama, Yutaka/0000-0002-6508-0094	MEXT/Japan Society for the Promotion of Science (JSPS) [15K07981]	MEXT/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by MEXT/Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) 15K07981 (to Y. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Ben Haim L, 2015, J NEUROSCI, V35, P2817, DOI 10.1523/JNEUROSCI.3516-14.2015; Booz GW, 2002, MOL CELL BIOCHEM, V240, P39, DOI 10.1023/A:1020648425895; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Chelsky ZL, 2015, MOL PHARMACOL, V88, P524, DOI 10.1124/mol.115.099093; Choi JS, 2003, GLIA, V41, P237, DOI 10.1002/glia.10186; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Gorshkov K, 2018, DRUG DISCOV TODAY, V23, P673, DOI 10.1016/j.drudis.2018.01.011; Hernandez-Negrete I, 2011, BIOCHEM J, V436, P133, DOI 10.1042/BJ20101798; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hostenbach S, 2016, PROG NEUROBIOL, V144, P88, DOI 10.1016/j.pneurobio.2016.04.009; Huang HH, 2012, BIOCHEM BIOPH RES CO, V418, P186, DOI 10.1016/j.bbrc.2012.01.004; Ishikawa N, 1997, EUR J NEUROSCI, V9, P895, DOI 10.1111/j.1460-9568.1997.tb01440.x; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Koyama Y, 2004, J NEUROCHEM, V90, P904, DOI 10.1111/j.1471-4159.2004.02546.x; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Koyama Y, 2012, GLIA, V60, P1954, DOI 10.1002/glia.22411; Koyama Y, 2012, J PHARMACOL SCI, V118, P401, DOI 10.1254/jphs.11R13CP; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Lu JQ, 2013, J NEUROPATH EXP NEUR, V72, P1135, DOI 10.1097/NEN.0000000000000011; Michinaga S, 2018, J NEUROTRAUM, V35, P1481, DOI 10.1089/neu.2017.5421; Michinaga S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102009; Morga E, 2000, J NEUROCHEM, V74, P603, DOI 10.1046/j.1471-4159.2000.740603.x; Naito Y, 2014, LIFE SCI, V118, P340, DOI 10.1016/j.lfs.2014.03.012; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Qin AC, 2015, BIOCHEM BIOPH RES CO, V457, P681, DOI 10.1016/j.bbrc.2015.01.048; Renault-Mihara F, 2017, J CELL BIOL, V216, P2533, DOI 10.1083/jcb.201610102; Rogers SD, 2003, GLIA, V41, P180, DOI 10.1002/glia.10173; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Shi SX, 2007, J MOL NEUROSCI, V32, P64, DOI 10.1007/s12031-007-0015-6; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Teixeira A, 2000, J NEUROCHEM, V74, P1034, DOI 10.1046/j.1471-4159.2000.0741034.x; Tkach M, 2013, ENDOCR-RELAT CANCER, V20, P197, DOI 10.1530/ERC-12-0194; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Washburn KB, 2006, NEUROSCIENCE, V142, P411, DOI 10.1016/j.neuroscience.2006.06.034; Wei Z, 2013, CELL SIGNAL, V25, P931, DOI 10.1016/j.cellsig.2013.01.011; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Yamasaki R, 2016, J NEUROSCI, V36, P11929, DOI 10.1523/JNEUROSCI.1981-16.2016; Yeo S, 2013, GLIA, V61, P1488, DOI 10.1002/glia.22536; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	59	13	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3920	3933		10.1074/jbc.RA118.005614	http://dx.doi.org/10.1074/jbc.RA118.005614			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30670587	hybrid, Green Published			2022-12-28	WOS:000461854400010
J	Masuda, Y; Kanao, R; Kawai, H; Kukimoto, I; Masutani, C				Masuda, Yuji; Kanao, Rie; Kawai, Hidehiko; Kukimoto, Iwao; Masutani, Chikahide			Preferential digestion of PCNA-ubiquitin and p53-ubiquitin linkages by USP7 to remove polyubiquitin chains from substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); DNA damage response; enzyme kinetics; p53; proliferating cell nuclear antigen (PCNA)	MONOUBIQUITINATED PCNA; BINDING; DOMAIN; RECOGNITION; P53; DEUBIQUITINATION; MECHANISM; REVEALS; ZRANB3; LIGASE	Ubiquitin-specific protease 7 (USP7) regulates various cellular pathways through its deubiquitination activity. Despite the identification of a growing number of substrates of USP7, the molecular mechanism by which USP7 removes ubiquitin chains from polyubiquitinated substrates remains unexplored. The present study investigated the mechanism underlying the deubiquitination of Lys(63)-linked polyubiquitinated proliferating cell nuclear antigen (PCNA). Biochemical analyses demonstrated that USP7 efficiently removes polyubiquitin chains from polyubiquitinated PCNA by preferential cleavage of the PCNA-ubiquitin linkage. This property was largely attributed to the poor activity toward Lys(63)-linked ubiquitin chains. The preferential cleavage of substrate-ubiquitin linkages was also observed for Lys(48)-linked polyubiquitinated p53 because of the inefficient cleavage of the Lys(48)-linked ubiquitin chains. The present findings suggest a mechanism underlying the removal of polyubiquitin signals by USP7.	[Masuda, Yuji; Kanao, Rie; Masutani, Chikahide] Nagoya Univ, Res Inst Environm Med, Dept Genome Dynam, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Masuda, Yuji; Kanao, Rie; Masutani, Chikahide] Nagoya Univ, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan; [Kawai, Hidehiko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan; [Kukimoto, Iwao] Natl Inst Infect Dis, Pathogen Genom Ctr, 4-7-1 Gakuen, Tokyo 2080011, Japan	Nagoya University; Nagoya University; Hiroshima University; National Institute of Infectious Diseases (NIID)	Masuda, Y (corresponding author), Nagoya Univ, Res Inst Environm Med, Dept Genome Dynam, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	masuda@riem.nagoya-u.ac.jp	Masuda, Yuji/I-6315-2014; Masutani, Chikahide/I-6160-2014	Masuda, Yuji/0000-0002-6229-1988; Kawai, Hidehiko/0000-0003-2213-7166; Masutani, Chikahide/0000-0002-8600-8227	Japan Society for the Promotion of Science (JSPS) KAKENHI [15H02818, 18H03371, 16K12594, 18K11638]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [16H01775]; Takeda Science Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI 15H02818, 18H03371, and 16K12594 (to Y. M.) and 18K11638 (to R. K.); by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI 16H01775 (to C. M.); and by the Takeda Science Foundation (to R. K. and C. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bozza WP, 2012, BIOCHEMISTRY-US, V51, P10075, DOI 10.1021/bi3009104; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Cheng JD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8023; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; FUKUDA K, 1995, J BIOL CHEM, V270, P22527, DOI 10.1074/jbc.270.38.22527; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang AD, 2011, J MOL BIOL, V410, P424, DOI 10.1016/j.jmb.2011.04.051; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kashiwaba S, 2015, CELL REP, V13, P2072, DOI 10.1016/j.celrep.2015.11.014; Kategaya L, 2017, NATURE, V550, P534, DOI 10.1038/nature24006; Kim RQ, 2017, J MOL BIOL, V429, P3395, DOI 10.1016/j.jmb.2017.05.028; Kim RQ, 2016, J STRUCT BIOL, V195, P11, DOI 10.1016/j.jsb.2016.05.005; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Masuda Y, 2015, NUCLEIC ACIDS RES, V43, P7898, DOI 10.1093/nar/gkv712; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P10394, DOI 10.1093/nar/gks763; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Masuda Y, 2010, J MOL BIOL, V396, P487, DOI 10.1016/j.jmb.2010.01.003; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Pfoh R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004950; Piao JH, 2015, J BIOCHEM, V158, P477, DOI 10.1093/jb/mvv063; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rouge L, 2016, STRUCTURE, V24, P1335, DOI 10.1016/j.str.2016.05.020; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2013, J BIOL CHEM, V288, P16975, DOI 10.1074/jbc.M113.469262; Schaefer JB, 2011, J BIOL CHEM, V286, P45186, DOI 10.1074/jbc.M111.310094; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Zhang WF, 2011, BIOCHEMISTRY-US, V50, P4775, DOI 10.1021/bi101958h	42	9	10	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4177	4187		10.1074/jbc.RA118.005167	http://dx.doi.org/10.1074/jbc.RA118.005167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30647135	hybrid, Green Published			2022-12-28	WOS:000461854400029
J	Cal, S; Arguelles, JM; Fernandez, PL; Lopez-Otin, C				Cal, Santiago; Arguelles, Jose M.; Fernandez, Pedro L.; Lopez-Otin, Carlos			RETRACTION: Withdrawal: Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeats. (Retraction of Vol 276, Pg 17932, 2001)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													; Lopez-Otin, Carlos/AAB-2106-2020	Fernandez, Pedro Luis/0000-0002-8618-4597; Lopez-Otin, Carlos/0000-0001-6964-1904				CAI S, 2001, J BIOL CHEM, V276, P17932	1	0	0	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1429	1429		10.1074/jbc.W118.007323	http://dx.doi.org/10.1074/jbc.W118.007323			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30808000	Green Published, hybrid			2022-12-28	WOS:000457879500032
J	Addison, WN; Pellicelli, M; St-Arnaud, R				Addison, William N.; Pellicelli, Martin; St-Arnaud, Rene			Dephosphorylation of the transcriptional cofactor NACA by the PP1A phosphatase enhances cJUN transcriptional activity and osteoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; c-Jun transcription factor; AP1 transcription factor (AP-1); cell signaling; cell differentiation; NAC; nascent polypeptide-associated complex and co-regulator alpha (NACA); osteoblast; PP1A; Protein phosphatase 1 catalytic subunit alpha (PP1A); JUN; transcription	POLYPEPTIDE-ASSOCIATED COMPLEX; ALPHA-NAC; C-JUN; PROTEIN PHOSPHATASE-1; SUBCELLULAR-LOCALIZATION; PHOSPHORYLATION DYNAMICS; MASS-SPECTROMETRY; DOCKING MOTIF; DNA-BINDING; KINASE	The transcriptional cofactor nascent polypeptide-associated complex and co-regulator (NACA) regulates osteoblast maturation and activity. NACA functions, at least in part, by binding to Jun proto-oncogene, AP-1 transcription factor subunit (cJUN) and potentiating the transactivation of AP-1 targets such as osteocalcin (Bglap) and matrix metallopeptidase 9 (Mmp9). NACA activity is modulated by phosphorylation carried out by several kinases, but a phosphatase regulating NACA's activity remains to be identified. Here, we used affinity purification with MS in HEK293T cells to isolate NACA complexes and identified protein phosphatase 1 catalytic subunit (PP1A) as a NACA-associated Ser/Thr phosphatase. NACA interacted with multiple components of the PP1A holoenzyme complex: the PPP1CA catalytic subunit and the regulatory subunits PPP1R9B, PPP1R12A and PPP1R18. MS analysis revealed that NACA co-expression with PPP1CA causes dephosphorylation of NACA at Thr-89, Ser-151, and Thr-174. NACA Ser/Thr-to-alanine variants displayed increased nuclear localization, and NACA dephosphorylation was associated with specific recruitment of novel NACA interactants, such as basic transcription factor 3 (BTF3) and its homolog BTF3L4. NACA and PP1A cooperatively potentiated cJUN transcriptional activity of the AP-1-responsive MMP9-luciferase reporter, which was abolished when Thr-89, Ser-151, or Thr-174 were substituted with phosphomimetic aspartate residues. We confirmed the NACA-PP1A interaction in MC3T3-E1 osteoblastic cells and observed that NACA phosphorylation status at PP1A-sensitive sites is important for the regulation of AP-1 pathway genes and for osteogenic differentiation and matrix mineralization. These results suggest that PP1A dephosphorylates NACA at specific residues, impacting cJUN transcriptional activity and osteoblast differentiation and function.	[Addison, William N.; Pellicelli, Martin; St-Arnaud, Rene] Shriners Hosp Children Canada, Montreal, PQ, Canada; [St-Arnaud, Rene] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [St-Arnaud, Rene] McGill Univ, Dept Surg, Montreal, PQ, Canada; [St-Arnaud, Rene] McGill Univ, Dept Med, Montreal, PQ, Canada; [St-Arnaud, Rene] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Addison, William N.] Kyushu Dent Univ, Div Mol Signaling & Biochem, Kitakyushu, Fukuoka 8030844, Japan	McGill University; McGill University; McGill University; McGill University; Kyushu Dental University	St-Arnaud, R (corresponding author), 1003 Decarie Blvd, Montreal, PQ H4A 0A9, Canada.	rst-arnaud@shriners.mcgill.ca		Addison, William/0000-0002-8587-8028	Shriners Hospitals for Children Grants [86400, 85100]	Shriners Hospitals for Children Grants	This work was supported by Shriners Hospitals for Children Grants 86400 and 85100 (to R. St-A.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhouayri O, 2007, CALCIFIED TISSUE INT, V80, P123, DOI 10.1007/s00223-006-0102-7; Akhouayri O, 2005, MOL CELL BIOL, V25, P3452, DOI 10.1128/MCB.25.9.3452-3460.2005; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Beatrix B, 2000, J BIOL CHEM, V275, P37838, DOI 10.1074/jbc.M006368200; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOHMANN D, 1989, CELL, V59, P709, DOI 10.1016/0092-8674(89)90017-2; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cohen PTW, 2002, J CELL SCI, V115, P241; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hekmatnejad B, 2014, J CELL BIOCHEM, V115, P866, DOI 10.1002/jcb.24729; Hekmatnejad B, 2014, GENE, V538, P328, DOI 10.1016/j.gene.2014.01.009; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hotokezaka Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.90; Hotokezaka Y, 2009, CELL DEATH DIFFER, V16, P1505, DOI 10.1038/cdd.2009.90; HU GZ, 1994, NUCLEIC ACIDS RES, V22, P2740, DOI 10.1093/nar/22.14.2740; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; KURET J, 1986, FEBS LETT, V203, P197, DOI 10.1016/0014-5793(86)80741-4; Li TB, 2018, NAT METHODS, V15, P543, DOI 10.1038/s41592-018-0039-6; Liu YW, 2010, BIOCHEMISTRY-US, V49, P2890, DOI 10.1021/bi902050p; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Meury T, 2010, MOL CELL BIOL, V30, P43, DOI 10.1128/MCB.00378-09; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Moreau A, 1998, MOL CELL BIOL, V18, P1312, DOI 10.1128/MCB.18.3.1312; Nyathi Y, 2015, J CELL BIOL, V210, P287, DOI 10.1083/jcb.201410086; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PARTHUN MR, 1992, MOL CELL BIOL, V12, P5683, DOI 10.1128/MCB.12.12.5683; Pellicelli M, 2018, BBA-GENE REGUL MECH, V1861, P61, DOI 10.1016/j.bbagrm.2018.01.008; Pellicelli M, 2014, MOL CELL BIOL, V34, P1622, DOI 10.1128/MCB.01434-13; Quelo I, 2005, GENE EXPRESSION, V12, P151, DOI 10.3727/000000005783992070; Quelo I, 2004, J BIOL CHEM, V279, P43893, DOI 10.1074/jbc.M406310200; Quelo I, 2004, BIOCHEMISTRY-US, V43, P2906, DOI 10.1021/bi036256+; Quelo I, 2002, GENE EXPRESSION, V10, P255, DOI 10.3727/000000002783992433; Rajgopal A, 2007, J CELL BIOCHEM, V100, P1509, DOI 10.1002/jcb.21137; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; St-Arnaud R, 2011, ANN NY ACAD SCI, V1237, P11, DOI 10.1111/j.1749-6632.2011.06197.x; St-Arnaud Rene, 1998, Frontiers in Bioscience, V3, pD838; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang LF, 2010, PROTEIN CELL, V1, P406, DOI 10.1007/s13238-010-0049-3; Whitby MC, 2001, J MOL BIOL, V306, P703, DOI 10.1006/jmbi.2000.4407; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Yoshida K, 2005, GENES CELLS, V10, P465, DOI 10.1111/j.1365-2443.2005.00848.x; Yotov WV, 1998, MOL CELL BIOL, V18, P1303, DOI 10.1128/MCB.18.3.1303; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763; Yu VWC, 2005, J CELL BIOL, V169, P591, DOI 10.1083/jcb.200412139; ZHENG XM, 1990, NATURE, V344, P556, DOI 10.1038/344556a0; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9	59	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8184	8196		10.1074/jbc.RA118.006920	http://dx.doi.org/10.1074/jbc.RA118.006920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30948508	hybrid, Green Published			2022-12-28	WOS:000470656500017
J	Richetta, C; Thierry, S; Thierry, E; Lesbats, P; Lapaillerie, D; Munir, S; Subra, F; Leh, H; Deprez, E; Parissi, V; Delelis, O				Richetta, Clemence; Thierry, Sylvain; Thierry, Eloise; Lesbats, Paul; Lapaillerie, Delphine; Munir, Soundasse; Subra, Frederic; Leh, Herve; Deprez, Eric; Parissi, Vincent; Delelis, Olivier			Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrase; viral replication; retrovirus; human immunodeficiency virus (HIV); infectious disease; 2-LTR circles; circular DNA; HIV-1 integration; palindromic sequence; strand-transfer inhibitors	IN-VITRO; RALTEGRAVIR; CLEAVAGE; TRANSCRIPTION; INHIBITORS; MUTATIONS; INFECTION; REPAIR; CELLS; ASSAY	Integration of the HIV-1 DNA into the host genome is essential for viral replication and is catalyzed by the retroviral integrase. To date, the only substrate described to be involved in this critical reaction is the linear viral DNA produced in reverse transcription. However, during HIV-1 infection, two-long terminal repeat DNA circles (2-LTRcs) are also generated through the ligation of the viral DNA ends by the host cell's nonhomologous DNA end-joining pathway. These DNAs contain all the genetic information required for viral replication, but their role in HIV-1's life cycle remains unknown. We previously showed that both linear and circular DNA fragments containing the 2-LTR palindrome junction can be efficiently cleaved in vitro by recombinant integrases, leading to the formation of linear 3-processed-like DNA. In this report, using in vitro experiments with purified proteins and DNAs along with DNA endonuclease and in vivo integration assays, we show that this circularized genome can also be efficiently used as a substrate in HIV-1 integrase-mediated integration both in vitro and in eukaryotic cells. Notably, we demonstrate that the palindrome cleavage occurs via a two-step mechanism leading to a blunt-ended DNA product, followed by a classical 3-processing reaction; this cleavage leads to integrase-dependent integration, highlighted by a 5-bp duplication of the host genome. Our results suggest that 2-LTRc may constitute a reserve supply of HIV-1 genomes for proviral integration.	[Richetta, Clemence; Thierry, Sylvain; Thierry, Eloise; Munir, Soundasse; Subra, Frederic; Leh, Herve; Deprez, Eric; Delelis, Olivier] ENS Cachan, CNRS, UMR8113, Lab Biol & Pharmacol Appl, F-94235 Cachan, France; [Lesbats, Paul; Lapaillerie, Delphine; Parissi, Vincent] Univ Victor Segalen Bordeaux 2, CNRS, UMR5234, Lab Microbiol Fondamentale & Pathogen, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Delelis, O (corresponding author), ENS Cachan, CNRS, UMR8113, Lab Biol & Pharmacol Appl, F-94235 Cachan, France.	delelis@lbpa.ens-cachan.fr	Richetta, Clémence/AAN-5864-2020	bouaziz, serge/0000-0001-7792-8307; Lesbats, Paul/0000-0002-4623-0675	French National Research Agency against AIDS (ANRS) [EOTP 342901]; Centre National de la Recherche Scientifique	French National Research Agency against AIDS (ANRS)(ANRSFrench National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by French National Research Agency against AIDS (ANRS) Grant EOTP 342901 (to O. D.). and the Centre National de la Recherche Scientifique. The authors declare that they have no conflicts of interest with the contents of this article.	Bona R, 2013, AIDS RES HUM RETROV, V29, P1365, DOI [10.1089/aid.2013.0047, 10.1089/AID.2013.0047]; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2525, DOI 10.1073/pnas.86.8.2525; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chan CN, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-015-0234-9; CHEN JW, 1992, MOL CELL BIOL, V12, P3757, DOI 10.1128/MCB.12.9.3757; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Delelis O, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-31; Delelis O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000608; Delelis O, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-114; Desfarges S, 2006, NUCLEIC ACIDS RES, V34, P6215, DOI 10.1093/nar/gkl843; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Fischer M, 2003, ANTIVIR THER, V8, P97; Hazuda D, 2009, ANNU REV PHARMACOL, V49, P377, DOI 10.1146/annurev.pharmtox.011008.145553; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Kilzer JM, 2003, VIROLOGY, V314, P460, DOI 10.1016/S0042-6822(03)00455-0; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Lesbats P, 2008, NUCLEIC ACIDS RES, V36, P7043, DOI 10.1093/nar/gkn796; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2009, METHODS, V47, P237, DOI 10.1016/j.ymeth.2009.02.001; Maillot B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060734; Munir S, 2015, J ANTIMICROB CHEMOTH, V70, P739, DOI 10.1093/jac/dku474; Munir S, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-87; Parissi V, 2003, GENE, V322, P157, DOI 10.1016/j.gene.2003.08.020; Reigadas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010311; Reigadas S, 2010, J ANTIMICROB CHEMOTH, V65, P434, DOI 10.1093/jac/dkp473; Sinha S, 2005, J VIROL, V79, P8208, DOI 10.1128/JVI.79.13.8208-8216.2005; Sloan RD, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-52; Svarovskaia ES, 2004, J VIROL, V78, P3210, DOI 10.1128/JVI.78.7.3210-3222.2004; Thierry S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0153-9; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Yoder K, 2006, P NATL ACAD SCI USA, V103, P4622, DOI 10.1073/pnas.0509828103; Zhang DW, 2014, ANAL BIOCHEM, V460, P36, DOI 10.1016/j.ab.2014.05.010	34	2	2	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8286	8295		10.1074/jbc.RA118.006755	http://dx.doi.org/10.1074/jbc.RA118.006755			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30971426	hybrid, Green Published			2022-12-28	WOS:000470656500024
J	Barnum, KJ; Nguyen, YT; O'Connell, MJ				Barnum, Kevin J.; Nguyen, Y. Tram; O'Connell, Matthew J.			XPG-related nucleases are hierarchically recruited for double-stranded rDNA break resection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; chromosomes; DNA repair; DNA recombination; Schizosaccharomyces pombe; DNA damage response; Checkpoint; DNA Damage Response; DNA Repair; Schizosaccharomyces pombe; XPG-Related Nuclease	DNA-DAMAGE CHECKPOINT; MUTATION AVOIDANCE; MOLECULAR CHARACTERIZATION; MISMATCH REPAIR; EXCISION-REPAIR; RAD51 FILAMENT; PROTEIN-KINASE; END RESECTION; RECOMBINATION; POMBE	dsDNA breaks (DSBs) are resected in a 53 direction, generating single-stranded DNA (ssDNA). This promotes DNA repair by homologous recombination and also assembly of signaling complexes that activate the DNA damage checkpoint effector kinase Chk1. In fission yeast (Schizosaccharomyces pombe), genetic screens have previously uncovered a family of three xeroderma pigmentosum G (XPG)-related nucleases (XRNs), known as Ast1, Exo1, and Rad2. Collectively, these XRNs are recruited to a euchromatic DSB and are required for ssDNA production and end resection across the genome. Here, we studied why there are three related but distinct XRN enzymes that are all conserved across a range of species, including humans, whereas all other DSB response proteins are present as single species. Using S. pombe as a model, ChIP and DSB resection analysis assays, and highly efficient I-PpoI-induced DSBs in the 28S rDNA gene, we observed a hierarchy of recruitment for each XRN, with a progressive compensatory recruitment of the other XRNs as the responding enzymes are deleted. Importantly, we found that this hierarchy reflects the requirement for different XRNs to effect efficient DSB resection in the rDNA, demonstrating that the presence of three XRN enzymes is not a simple division of labor. Furthermore, we uncovered a specificity of XRN function with regard to the direction of transcription. We conclude that the DSB-resection machinery is complex, is nonuniform across the genome, and has built-in fail-safe mechanisms, features that are in keeping with the highly pathological nature of DSB lesions.	[Barnum, Kevin J.; Nguyen, Y. Tram; O'Connell, Matthew J.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1425 Madison Ave, New York, NY 10029 USA; [Barnum, Kevin J.; Nguyen, Y. Tram; O'Connell, Matthew J.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	O'Connell, MJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1425 Madison Ave, New York, NY 10029 USA.	matthew.oconnell@mssm.edu			National Institutes of Health [T32 CA078207, GM124079, GM087326]; NATIONAL CANCER INSTITUTE [T32CA078207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM124079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was support by National Institutes of Health Grants T32 CA078207, GM124079, and GM087326. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akamatsu Y, 2008, MOL CELL BIOL, V28, P3639, DOI 10.1128/MCB.01828-07; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Barnum KJ, 2014, METHODS MOL BIOL, V1170, P29, DOI 10.1007/978-1-4939-0888-2_2; Calonge TM, 2006, GENETICS, V174, P113, DOI 10.1534/genetics.106.060970; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Cohen-Fix O, 1997, P NATL ACAD SCI USA, V94, P14361, DOI 10.1073/pnas.94.26.14361; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Farah JA, 2009, P NATL ACAD SCI USA, V106, P9356, DOI 10.1073/pnas.0902793106; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Hartsuiker E, 2001, EMBO J, V20, P6660, DOI 10.1093/emboj/20.23.6660; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; IVANOV EL, 1995, MOL CELL BIOL, V15, P2245; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kuntz K, 2013, EMBO J, V32, P290, DOI 10.1038/emboj.2012.322; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Latif C, 2004, J CELL SCI, V117, P3489, DOI 10.1242/jcs.01204; Lee KM, 2007, GENETICS, V175, P1585, DOI 10.1534/genetics.106.067801; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Limbo O, 2011, MOL CELL BIOL, V31, P573, DOI 10.1128/MCB.00994-10; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Liu J, 2011, P NATL ACAD SCI USA, V108, P441, DOI 10.1073/pnas.1016614108; Liu QH, 2000, GENE DEV, V14, P1448; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Memisoglu A, 2000, J BACTERIOL, V182, P2104, DOI 10.1128/JB.182.8.2104-2112.2000; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mortensen UH, 2009, CURR BIOL, V19, pR676, DOI 10.1016/j.cub.2009.06.001; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MURRAY JM, 1994, MOL CELL BIOL, V14, P4878, DOI 10.1128/MCB.14.7.4878; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; O'Connell MJ, 2005, J CELL SCI, V118, P1, DOI 10.1242/jcs.01626; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Osman F, 1996, GENETICS, V142, P341; Prudden J, 2003, EMBO J, V22, P1419, DOI 10.1093/emboj/cdg119; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Short JM, 2016, NUCLEIC ACIDS RES, V44, P9017, DOI 10.1093/nar/gkw783; Sun XM, 2003, DNA REPAIR, V2, P925, DOI 10.1016/S1568-7864(03)00093-4; Sunder S, 2012, YEAST, V29, P275, DOI 10.1002/yea.2908; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Tapia-Alveal C, 2014, MOL CELL BIOL, V34, P2092, DOI 10.1128/MCB.00193-14; Thorslund T, 2007, ONCOGENE, V26, P7720, DOI 10.1038/sj.onc.1210870; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Toh GWL, 2010, DNA REPAIR, V9, P718, DOI 10.1016/j.dnarep.2010.02.013; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Ueno M, 2003, MOL CELL BIOL, V23, P6553, DOI 10.1128/MCB.23.18.6553-6563.2003; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wilson S, 1999, NUCLEIC ACIDS RES, V27, P2655, DOI 10.1093/nar/27.13.2655; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Zhang HM, 2016, J BIOL CHEM, V291, P24961, DOI 10.1074/jbc.M116.755991; Zhao LY, 2018, METHOD ENZYMOL, V600, P179, DOI 10.1016/bs.mie.2017.12.002; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	68	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7632	7643		10.1074/jbc.RA118.005415	http://dx.doi.org/10.1074/jbc.RA118.005415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30885940	hybrid, Green Published			2022-12-28	WOS:000470153300010
J	Gau, D; Veon, W; Shroff, SG; Roy, P				Gau, David; Veon, William; Shroff, Sanjeev G.; Roy, Partha			The VASP-profilin1 (Pfn1) interaction is critical for efficient cell migration and is regulated by cell-substrate adhesion in a PKA-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						profilin; PKA; cell adhesion; cell motility; phosphorylation; cytoskeleton; kinase signaling; Mena; vasodilator-stimulated phosphoprotein (VASP)	MICROFILAMENT PROTEIN VASP; F-ACTIN BINDING; ENA/VASP PROTEINS; FOCAL ADHESION; LEADING-EDGE; KINASE-A; PHOSPHORYLATION; PROFILIN; MOTILITY; POLYMERIZATION	Dynamic regulation of the actin cytoskeleton is an essential feature of cell motility. Action of Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP), a family of conserved actin-elongating proteins, is an important aspect of regulation of the actin cytoskeletal architecture at the leading edge that controls membrane protrusion and cell motility. In this study, we performed mutagenesis experiments in overexpression and knockdown-rescue settings to provide, for the first time, direct evidence of the role of the actin-binding protein profilin1 (Pfn1) in VASP-mediated regulation of cell motility. We found that VASP's interaction with Pfn1 is promoted by cell-substrate adhesion and requires down-regulation of PKA activity. Our experimental data further suggest that PKA-mediated Ser(137) phosphorylation of Pfn1 potentially negatively regulates the Pfn1-VASP interaction. Finally, Pfn1's ability to be phosphorylated on Ser(137) was partly responsible for the anti-migratory action elicited by exposing cells to a cAMP/PKA agonist. On the basis of these findings, we propose a mechanism of adhesion-protrusion coupling in cell motility that involves dynamic regulation of Pfn1 by PKA activity.	[Gau, David; Veon, William; Shroff, Sanjeev G.; Roy, Partha] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA; [Roy, Partha] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roy, P (corresponding author), Univ Pittsburgh, 306 CNBIO,300 Technol Dr, Pittsburgh, PA 15219 USA.	par19@pitt.edu		Roy, Partha/0000-0002-4946-8531	NCI, National Institutes of Health [2R01CA108607]; National Science Foundation Predoctoral Fellowship [2012139050]; NHLBI, National Institutes of Health [2T32HL076124]; NATIONAL CANCER INSTITUTE [R01CA108607] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076124] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Predoctoral Fellowship(National Science Foundation (NSF)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NCI, National Institutes of Health Grant 2R01CA108607 (to P. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Science Foundation Predoctoral Fellowship 2012139050 and NHLBI, National Institutes of Health Grant 2T32HL076124.; Supported by NHLBI, National Institutes of Health Grant 2T32HL076124.	Alasbahi RH, 2012, PHARMAZIE, V67, P5, DOI 10.1691/ph.2012.1642; Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Carmona G, 2016, ONCOGENE, V35, P5155, DOI 10.1038/onc.2016.47; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Chen XJ, 2014, DEV CELL, V30, P569, DOI 10.1016/j.devcel.2014.08.001; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Gau D, 2011, CELL MOL BIOENG, V4, P1, DOI 10.1007/s12195-010-0133-z; Gau D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156313; Geese M, 2002, MOL BIOL CELL, V13, P2383, DOI 10.1091/mbc.E02-01-0058; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Howe AK, 2002, J BIOL CHEM, V277, P38121, DOI 10.1074/jbc.M205379200; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li Y, 2008, EUR J CELL BIOL, V87, P893, DOI 10.1016/j.ejcb.2008.06.003; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lindsay SL, 2007, J CELL SCI, V120, P3011, DOI 10.1242/jcs.003061; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Padilla-Rodriguez M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05367-2; Pernier J, 2016, DEV CELL, V36, P201, DOI 10.1016/j.devcel.2015.12.024; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schweinhuber SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117244; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Sheetz Michael P., 1999, P233; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Tian YH, 2018, ONCOL LETT, V16, P2151, DOI 10.3892/ol.2018.8930; Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	53	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6972	6985		10.1074/jbc.RA118.005255	http://dx.doi.org/10.1074/jbc.RA118.005255			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30814249	Green Published, hybrid			2022-12-28	WOS:000467394700030
J	Sueyoshi, K; Ledderose, C; Shen, Y; Lee, AH; Shapiro, NI; Junger, WG				Sueyoshi, Koichiro; Ledderose, Carola; Shen, Yong; Lee, Albert H.; Shapiro, Nathan I.; Junger, Wolfgang G.			Lipopolysaccharide suppresses T cells by generating extracellular ATP that impairs their mitochondrial function via P2Y11 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T cell; lipopolysaccharide (LPS); monocyte; purinergic receptor; sepsis; adaptive immunity; ATP release; immune dysregulation; purinergic signaling; T cell suppression	IMPROVES SURVIVAL; SEPTIC SHOCK; SEPSIS; ACTIVATION; MONOCYTES; NUCLEOTIDES; RELEASE; IMMUNOPATHOLOGY; DYSFUNCTION; IL-1-BETA	T cell suppression contributes to immune dysfunction in sepsis. However, the underlying mechanisms are not well-defined. Here, we show that exposure of human peripheral blood mononuclear cells to bacterial lipopolysaccharide (LPS) can rapidly and dose-dependently suppress interleukin-2 (IL-2) production and T cell proliferation. We also report that these effects depend on monocytes. LPS did not prevent the interaction of monocytes with T cells, nor did it induce programmed cell death protein 1 (PD-1) signaling that causes T cell suppression. Instead, we found that LPS stimulation of monocytes led to the accumulation of extracellular ATP that impaired mitochondrial function, cell migration, IL-2 production, and T cell proliferation. Mechanistically, LPS-induced ATP accumulation exerted these suppressive effects on T cells by activating the purinergic receptor P2Y11 on the cell surface of T cells. T cell functions could be partially restored by enzymatic removal of extracellular ATP or pharmacological blocking of P2Y11 receptors. Plasma samples obtained from sepsis patients had similar suppressive effects on T cells from healthy subjects. Our findings suggest that LPS and ATP accumulation in the circulation of sepsis patients suppresses T cells by promoting inappropriate P2Y11 receptor stimulation that impairs T cell metabolism and functions. We conclude that inhibition of LPS-induced ATP release, removal of excessive extracellular ATP, or P2Y11 receptor antagonists may be potential therapeutic strategies to prevent T cell suppression and restore host immune function in sepsis.	[Sueyoshi, Koichiro; Ledderose, Carola; Shen, Yong; Lee, Albert H.; Junger, Wolfgang G.] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA; [Shapiro, Nathan I.] Harvard Med Sch, Dept Emergency Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Junger, Wolfgang G.] Ludwig Boltzmann Inst Traumatol, A-1200 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Ludwig Boltzmann Institute	Ledderose, C; Junger, WG (corresponding author), Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	cleddero@bidmc.harvard.edu; wjunger@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013	Junger, Wolfgang G/0000-0003-3350-8452; Shen, Yong/0000-0002-4866-838X	NIAID, National Institutes of Health [AI-080582]; NIGMS, National Institutes of Health [GM-51477, GM-60475, GM-116162, T32 GM-103702]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051477, T32GM103702, R01GM060475, R01GM116162] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIAID, National Institutes of Health, Grant AI-080582 and NIGMS, National Institutes of Health, Grants GM-51477, GM-60475, GM-116162, and T32 GM-103702. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296; Bryn T, 2008, INT IMMUNOL, V20, P235, DOI 10.1093/intimm/dxm134; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Carson WF, 2010, EUR J IMMUNOL, V40, P998, DOI 10.1002/eji.200939739; Cauwels A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.70; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Communi D, 1999, BRIT J PHARMACOL, V128, P1199, DOI 10.1038/sj.bjp.0702909; Csoka B, 2015, FASEB J, V29, P25, DOI 10.1096/fj.14-253567; De Ita M, 2016, LIFE SCI, V145, P85, DOI 10.1016/j.lfs.2015.12.013; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; Dreisig K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01159; Dreisig K, 2016, PURINERG SIGNAL, V12, P427, DOI 10.1007/s11302-016-9514-7; Duhant X, 2002, J IMMUNOL, V169, P15, DOI 10.4049/jimmunol.169.1.15; Fallon EA, 2018, J LEUKOCYTE BIOL, V103, P1151, DOI 10.1002/JLB.2MIR0917-377R; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Hawkins RB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01511; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jensen IJ, 2018, J IMMUNOL, V200, P1543, DOI 10.4049/jimmunol.1701618; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Kurishita Y, 2012, J AM CHEM SOC, V134, P18779, DOI 10.1021/ja308754g; Lachmandas E, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.246; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Ledderose C, 2018, J CLIN INVEST, V128, P3583, DOI 10.1172/JCI120972; Ledderose C, 2016, J INFECT DIS, V213, P456, DOI 10.1093/infdis/jiv373; Ledderose C, 2014, J BIOL CHEM, V289, P25936, DOI 10.1074/jbc.M114.575308; Lee AH, 2018, CRIT CARE MED, V46, pE1183, DOI 10.1097/CCM.0000000000003446; Li Xiaoou, 2017, Crit Care Med, V45, pe97; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Poujol F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144375; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Shindo Y, 2017, J SURG RES, V208, P33, DOI 10.1016/j.jss.2016.08.099; Shinohara Y, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00986; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sumi Y, 2014, SHOCK, V42, P142, DOI 10.1097/SHK.0000000000000180; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Venet F, 2018, NAT REV NEPHROL, V14, P121, DOI 10.1038/nrneph.2017.165; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang CM, 2014, EMBO J, V33, P1354, DOI 10.15252/embj.201386666; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Weiler M, 2016, EXP CELL RES, V349, P1, DOI 10.1016/j.yexcr.2016.05.017; Wenzel RP, 2012, NEW ENGL J MED, V366, P2122, DOI 10.1056/NEJMe1203412; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yegutkin GG, 2014, CRIT REV BIOCHEM MOL, V49, P473, DOI 10.3109/10409238.2014.953627; Zanin-Zhorov A, 2007, J IMMUNOL, V179, P41, DOI 10.4049/jimmunol.179.1.41	58	17	18	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6283	6293		10.1074/jbc.RA118.007188	http://dx.doi.org/10.1074/jbc.RA118.007188			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30787105	Green Published, hybrid			2022-12-28	WOS:000468402000007
J	Ren, LL; Ding, SY; Song, YH; Li, B; Ramanathan, M; Co, J; Amieva, MR; Khavari, PA; Greenberg, HB				Ren, Lili; Ding, Siyuan; Song, Yanhua; Li, Bin; Ramanathan, Muthukumar; Co, Julia; Amieva, Manuel R.; Khavari, Paul A.; Greenberg, Harry B.			Profiling of rotavirus 3UTR-binding proteins reveals the ATP synthase subunit ATP5B as a host factor that supports late-stage virus replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA virus; RNA-binding protein; virus assembly; virology; proteomics; ATP synthase; RNA-protein interaction; biotin proximity ligation; nonenveloped double-stranded RNA virus; rotavirus; viral gastroenteritis; virus-host interaction	PURIFICATION-MASS-SPECTROMETRY; RNA-BINDING; MESSENGER-RNA; GENOME REPLICATION; STRAND RNA; POLYMERASE; MODEL; MECHANISM; SEQUENCE; IDENTIFICATION	Genome replication and virion assembly of segmented RNA viruses are highly coordinated events, tightly regulated by sequence and structural elements in the UTRs of viral RNA. This process is poorly defined and likely requires the participation of host proteins in concert with viral proteins. In this study, we employed a proteomics-based approach, named RNA-protein interaction detection (RaPID), to comprehensively screen for host proteins that bind to a conserved motif within the rotavirus (RV) 3 terminus. Using this assay, we identified ATP5B, a core subunit of the mitochondrial ATP synthase, as having high affinity to the RV 3UTR consensus sequences. During RV infection, ATP5B bound to the RV 3UTR and co-localized with viral RNA and viroplasm. Functionally, siRNA-mediated genetic depletion of ATP5B or other ATP synthase subunits such as ATP5A1 and ATP5O reduced the production of infectious viral progeny without significant alteration of intracellular viral RNA levels or RNA translation. Chemical inhibition of ATP synthase diminished RV yield in both conventional cell culture and in human intestinal enteroids, indicating that ATP5B positively regulates late-stage RV maturation in primary intestinal epithelial cells. Collectively, our results shed light on the role of host proteins in RV genome assembly and particle formation and identify ATP5B as a novel pro-RV RNA-binding protein, contributing to our understanding of how host ATP synthases may galvanize virus growth and pathogenesis.	[Ren, Lili; Ding, Siyuan; Song, Yanhua; Li, Bin; Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Ren, Lili; Ding, Siyuan; Song, Yanhua; Li, Bin; Co, Julia; Amieva, Manuel R.; Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Ren, Lili; Ding, Siyuan; Song, Yanhua; Li, Bin; Khavari, Paul A.; Greenberg, Harry B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA; [Ren, Lili] Nanjing Tech Univ, Sch Pharmaceut Sci, Nanjing 211816, Jiangsu, Peoples R China; [Song, Yanhua; Li, Bin] Jiangsu Acad Agr Sci, Inst Vet Med, Nanjing 210014, Peoples R China; [Ramanathan, Muthukumar; Khavari, Paul A.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Nanjing Tech University; Jiangsu Academy of Agricultural Sciences; Stanford University	Ding, SY; Greenberg, HB (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.; Ding, SY; Greenberg, HB (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Ding, SY; Greenberg, HB (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA.	syding@stanford.edu; hbgreen@stanford.edu	Ramanathan, Muthukumar/ABE-7524-2020; Amieva, Manuel/U-2581-2017	greenberg, harry/0000-0002-2128-9080; Ding, Siyuan/0000-0002-5338-260X; Amieva, Manuel/0000-0002-5601-4490	Early Career Award (Thrasher Research Fund); Instructor Support Program (Stanford Maternal and Child Health Research Institute); National Institutes of Health [K99 AI135031, R01 AR49737, R01 AR43799, R01 AI021362, R56 AI021362, U19 AI116484]; VA Merit Review Grant [GRH0022]; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125249, U19AI116484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049737, R01AR043799] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000158] Funding Source: NIH RePORTER	Early Career Award (Thrasher Research Fund); Instructor Support Program (Stanford Maternal and Child Health Research Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by an Early Career Award (Thrasher Research Fund), Instructor Support Program (Stanford Maternal and Child Health Research Institute), National Institutes of Health Grant K99 AI135031 (to S. D.), and National Institutes of Health Grants R01 AR49737 and R01 AR43799 (to P. A. K.), National Institutes of Health Grants R01 AI021362, R56 AI021362, and U19 AI116484 and VA Merit Review Grant GRH0022 (to H. B. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Austin RJ, 2002, J AM CHEM SOC, V124, P10966, DOI 10.1021/ja026610b; Bachler M, 1999, RNA, V5, P1509, DOI 10.1017/S1355838299991574; Bagaria A, 2012, PROTEIN SCI, V21, P229, DOI 10.1002/pro.2007; Ball JM, 2005, VIRAL IMMUNOL, V18, P27, DOI 10.1089/vim.2005.18.27; BASS DM, 1990, J VIROL, V64, P322, DOI 10.1128/JVI.64.1.322-330.1990; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Borodavka A, 2017, ELIFE, V6, DOI 10.7554/eLife.27453; Boudreaux CE, 2015, VIROLOGY, V477, P32, DOI 10.1016/j.virol.2015.01.003; Boudreaux CE, 2013, J GEN VIROL, V94, P1818, DOI 10.1099/vir.0.052951-0; Bowman GD, 2000, J MOL BIOL, V304, P861, DOI 10.1006/jmbi.2000.4250; Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243; Chen D, 2001, VIROLOGY, V282, P221, DOI 10.1006/viro.2001.0825; Chen DY, 2000, RNA, V6, P1455, DOI 10.1017/S1355838200001187; De Lorenzo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166719; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Din SY, 2018, ELIFE, V7, DOI 10.7554/eLife.39494; Ding SY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03782-z; Ding SY, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005929; Ding SY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001758; Estes MK, 2013, ROTAVIRUSES FIELDS V, P1347; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Fajardo T, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070167; Fajardo T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005321; Feng NG, 1997, J INFECT DIS, V175, P330, DOI 10.1093/infdis/175.2.330; Fongsaran C, 2014, ARCH VIROL, V159, P3353, DOI 10.1007/s00705-014-2210-4; Foulke-Abel J, 2014, EXP BIOL MED, V239, P1124, DOI 10.1177/1535370214529398; GALLEGOS CO, 1989, VIROLOGY, V172, P616, DOI 10.1016/0042-6822(89)90204-3; Graindorge A, 2008, NUCLEIC ACIDS RES, V36, P1861, DOI 10.1093/nar/gkn031; Gratia M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145998; Green VA, 2016, CELL HOST MICROBE, V20, P107, DOI 10.1016/j.chom.2016.06.005; Gridley CL, 2014, CURR OPIN VIROL, V9, P31, DOI 10.1016/j.coviro.2014.08.008; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Hilbert BJ, 2015, P NATL ACAD SCI USA, V112, pE3792, DOI 10.1073/pnas.1506951112; Hyser JM, 2010, MBIO, V1, DOI 10.1128/mBio.00265-10; KAPAHNKE R, 1986, NUCLEIC ACIDS RES, V14, P3215, DOI 10.1093/nar/14.8.3215; Leveque N, 2017, J VIROL, V91, DOI 10.1128/JVI.00423-17; Li B, 2017, P NATL ACAD SCI USA, V114, pE3642, DOI 10.1073/pnas.1619266114; Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663; Long CP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006242; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lu X, 2008, STRUCTURE, V16, P1678, DOI 10.1016/j.str.2008.09.006; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; McDonald SM, 2011, TRENDS MICROBIOL, V19, P136, DOI 10.1016/j.tim.2010.12.002; McHugh CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4152; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oeffinger M, 2012, PROTEOMICS, V12, P1591, DOI 10.1002/pmic.201100509; Patton JT, 1996, J VIROL, V70, P3961, DOI 10.1128/JVI.70.6.3961-3971.1996; Patton JT, 1999, J VIROL, V73, P1382, DOI 10.1128/JVI.73.2.1382-1391.1999; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; Pennington JD, 2002, ORG LETT, V4, P3823, DOI 10.1021/ol026829v; PONCET D, 1994, EMBO J, V13, P4165, DOI 10.1002/j.1460-2075.1994.tb06734.x; Ramanathan M, 2018, NAT METHODS, V15, P207, DOI [10.1038/NMETH.4601, 10.1038/nmeth.4601]; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rialdi A, 2017, CELL, V169, P679, DOI 10.1016/j.cell.2017.04.021; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sanchez-Tacuba L, 2015, J VIROL, V89, P12145, DOI 10.1128/JVI.01874-15; Saxena K, 2016, J VIROL, V90, P43, DOI 10.1128/JVI.01930-15; SHAW RD, 1986, VIROLOGY, V155, P434, DOI 10.1016/0042-6822(86)90205-9; Silva-Ayala D, 2013, P NATL ACAD SCI USA, V110, P10270, DOI 10.1073/pnas.1304932110; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Stauber N, 1997, J VIROL, V71, P7220; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Uzri D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069825; van den Pol AN, 2014, J VIROL, V88, P3695, DOI 10.1128/JVI.03509-13; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Wentz MJ, 1996, J VIROL, V70, P7833, DOI 10.1128/JVI.70.11.7833-7841.1996; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhu S, 2017, NATURE, V546, P667, DOI 10.1038/nature22967	76	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5993	6006		10.1074/jbc.RA118.006004	http://dx.doi.org/10.1074/jbc.RA118.006004			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30770472	hybrid, Green Published			2022-12-28	WOS:000465077500030
J	Moss, DL; Park, HW; Mettu, RR; Landry, SJ				Moss, Daniel L.; Park, Hee-Won; Mettu, Ramgopal R.; Landry, Samuel J.			Deimmunizing substitutions in Pseudomonas exotoxin domain III perturb antigen processing without eliminating T-cell epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen processing; T-helper cells; T cell; antigen presentation; antibody; protein structure; protein stability; proteomics; proteolysis; cancer; CD4+T cells; deimmunization; immunotoxin; vaccine	CLASS-I; 3-DIMENSIONAL STRUCTURE; FLANKING REGION; NEURAL-NETWORKS; GERMINAL CENTER; PEPTIDES; IMMUNODOMINANCE; IMMUNOGENICITY; IDENTIFICATION; SELECTION	Effective adaptive immune responses depend on activation of CD4+ T cells via the presentation of antigen peptides in the context of major histocompatibility complex (MHC) class II. The structure of an antigen strongly influences its processing within the endolysosome and potentially controls the identity of peptides that are presented to T cells. A recombinant immunotoxin, comprising exotoxin A domain III (PE-III) from Pseudomonas aeruginosa and a cancer-specific antibody fragment, has been developed to manage cancer, but its effectiveness is limited by the induction of neutralizing antibodies. Here, we observed that this immunogenicity is substantially reduced by substituting six residues within PE-III. Although these substitutions targeted T-cell epitopes, we demonstrate that reduced conformational stability and protease resistance were responsible for the reduced antibody titer. Analysis of mouse T-cell responses coupled with biophysical studies on single-substitution versions of PE-III suggested that modest but comprehensible changes in T-cell priming can dramatically perturb antibody production. The most strongly responsive PE-III epitope was well-predicted by a structure-based algorithm. In summary, single-residue substitutions can drastically alter the processing and immunogenicity of PE-III but have only modest effects on CD4+ T-cell priming in mice. Our findings highlight the importance of structure-based processing constraints for accurate epitope prediction.	[Moss, Daniel L.; Park, Hee-Won; Landry, Samuel J.] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Mettu, Ramgopal R.] Tulane Univ, Dept Comp Sci, New Orleans, LA 70118 USA	Tulane University; Tulane University	Landry, SJ (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	landry@tulane.edu	Landry, Samuel/AAK-5778-2020	Landry, Samuel/0000-0002-4082-0543; Moss, Daniel/0000-0001-7639-7276	National Institutes of Health [P20 RR018766, P20 GM103514, P30 GM103514]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Jessie Guidry for assisting with the proteomics work. Proteomics work was supported by National Institutes of Health Grants P20 RR018766, P20 GM103514, and P30 GM103514 and a special appropriation from the Louisiana State University School of Medicine Office of the Dean.	Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; BOND JS, 1980, BIOCHEM J, V189, P17, DOI 10.1042/bj1890017; Carmicle S, 2002, J BIOL CHEM, V277, P155, DOI 10.1074/jbc.M107624200; Carmicle S, 2007, MOL IMMUNOL, V44, P1159, DOI 10.1016/j.molimm.2006.06.014; CHAUDHARY VK, 1988, NATURE, V335, P369, DOI 10.1038/335369a0; Dai GX, 2002, J BIOL CHEM, V277, P161, DOI 10.1074/jbc.M102259200; Dai GX, 2001, J BIOL CHEM, V276, P41913, DOI 10.1074/jbc.M106018200; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fraternali F, 1996, J MOL BIOL, V256, P939, DOI 10.1006/jmbi.1996.0139; Friedman David B, 2007, Methods Mol Biol, V367, P219; Gebreselassie D, 2006, HUM IMMUNOL, V67, P894, DOI 10.1016/j.humimm.2006.08.294; Gelder C, 1998, INT IMMUNOL, V10, P211, DOI 10.1093/intimm/10.2.211; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hassan C, 2014, J PROTEOMICS, V109, P240, DOI 10.1016/j.jprot.2014.07.009; Hilser VJ, 2014, METHODS MOL BIOL, V1084, P255, DOI 10.1007/978-1-62703-658-0_14; Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karunakaran KP, 2017, J PROTEOME RES, V16, P298, DOI 10.1021/acs.jproteome.6b00926; Karunakaran KP, 2015, VACCINE, V33, P2159, DOI 10.1016/j.vaccine.2015.02.055; Kim J, 1997, J IMMUNOL, V159, P335; KONDO T, 1988, J BIOL CHEM, V263, P9470; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kreitman RJ, 1997, BLOOD, V90, P252; Landry SJ, 1997, IMMUNOL TODAY, V18, P527, DOI 10.1016/S0167-5699(97)01152-3; Latek RR, 1999, IMMUNOL REV, V172, P209, DOI 10.1111/j.1600-065X.1999.tb01367.x; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Ma CL, 1999, J IMMUNOL, V163, P6413; Machado Y, 2016, J ALLERGY CLIN IMMUN, V137, P1525, DOI 10.1016/j.jaci.2015.09.026; Manyusa S, 1999, BIOCHEMISTRY-US, V38, P9533, DOI 10.1021/bi990550d; Mazor R, 2017, CELL MOL IMMUNOL, V14, P432, DOI 10.1038/cmi.2015.91; Mazor R, 2016, IMMUNOL REV, V270, P152, DOI 10.1111/imr.12390; Mazor R, 2014, P NATL ACAD SCI USA, V111, P8571, DOI 10.1073/pnas.1405153111; Mazor R, 2012, P NATL ACAD SCI USA, V109, pE3597, DOI 10.1073/pnas.1218138109; Mettu RR, 2016, J IMMUNOL METHODS, V432, P72, DOI 10.1016/j.jim.2016.02.013; Mirano-Bascos D, 2008, EUR J IMMUNOL, V38, P1231, DOI 10.1002/eji.200738011; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nguyen HNP, 2015, VACCINE, V33, P2887, DOI 10.1016/j.vaccine.2015.04.082; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Norton EB, 2015, VACCINE, V33, P1909, DOI 10.1016/j.vaccine.2015.02.069; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Phelps RG, 1998, J BIOL CHEM, V273, P11440, DOI 10.1074/jbc.273.19.11440; Schneider SC, 2000, J IMMUNOL, V165, P20, DOI 10.4049/jimmunol.165.1.20; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; So T, 1997, J BIOL CHEM, V272, P32136, DOI 10.1074/jbc.272.51.32136; STORKUS WJ, 1993, J IMMUNOTHER, V14, P94, DOI 10.1097/00002371-199308000-00003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480; Zhu H, 2005, J IMMUNOL, V175, P2252, DOI 10.4049/jimmunol.175.4.2252	60	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4667	4681		10.1074/jbc.RA118.006704	http://dx.doi.org/10.1074/jbc.RA118.006704			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30683694	Green Published, hybrid			2022-12-28	WOS:000462969500032
J	Wang, PF; Zuo, YN; Sun, JF; Zuo, T; Zhang, SY; Guo, SC; Shi, XL; Liang, MF; Zhou, P; Zhang, LQ; Wang, XQ				Wang, Pengfei; Zuo, Yanan; Sun, Jianfeng; Zuo, Teng; Zhang, Senyan; Guo, Shichun; Shi, Xuanling; Liang, Mifang; Zhou, Paul; Zhang, Linqi; Wang, Xinquan			Structural and functional definition of a vulnerable site on the hemagglutinin of highly pathogenic avian influenza A virus H5N1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza; influenza virus; monoclonal antibody; structural biology; X-ray crystallography; vaccine development; virology; mutagenesis; infectious disease; epitope; H5N1; HPAI; neutralizing antibody; vulnerable site	CONSERVED EPITOPE; MONOCLONAL-ANTIBODIES; IDENTIFICATION; TRANSMISSION; MOLECULE; BINDING; PLASMA; CELLS	Most neutralizing antibodies against highly pathogenic avian influenza A virus H5N1 recognize the receptor-binding site (RBS) on the globular head domain and the stem of H5N1 hemagglutinin (HA). Through comprehensive analysis of multiple human protective antibodies, we previously identified four vulnerable sites (VS1-VS4) on the globular head domain. Among them, the VS1, occupying the opposite side of the RBS on the same HA, was defined by the epitope of antibody 65C6. In this study, we report the crystal structures of two additional human H5N1 antibodies isolated from H5N1-infected individuals, 3C11 and AVFluIgG01, bound to the head at 2.33- and 2.30-angstrom resolution, respectively. These two new antibody epitopes have large overlap with and extend beyond the original VS1. Site-directed mutagenesis experiments identified eight pivotal residues (Ser-126b, Lys-165, Arg-166, Ser-167, Tyr-168, Asn-169, Thr-171, and Asn-172) critical for 65C6-, 3C11-, and AVFluIgG01-binding and neutralization activities. These residues formed a unique Y-shaped surface on H5N1 globular head and are highly conserved among H5N1 viruses. Our results further support the existence of a vulnerable site distinct from the RBS and the stem region of H5N1 HA, and future design of immunogens should take this particular site into consideration.	[Wang, Pengfei; Sun, Jianfeng; Zhang, Senyan; Wang, Xinquan] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Collaborat Innovat Ctr Biotherapy, Key Lab Prot Sci,Sch Life Sci,Minist Educ, Beijing 100084, Peoples R China; [Zuo, Yanan; Zuo, Teng; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing Adv Innovat Ctr Struct Biol,Sch Med, Dept Basic Med Sci,Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Guo, Shichun] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China; [Liang, Mifang] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Control & Prevent, Beijing 102206, Peoples R China; [Zhou, Paul] Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China	Tsinghua University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Tsinghua University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Wang, XQ (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Collaborat Innovat Ctr Biotherapy, Key Lab Prot Sci,Sch Life Sci,Minist Educ, Beijing 100084, Peoples R China.; Zhang, LQ (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing Adv Innovat Ctr Struct Biol,Sch Med, Dept Basic Med Sci,Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China.	zhanglinqi@tsinghua.edu.cn; xinquanwang@mail.tsinghua.edu.cn	zhang, sen/GXH-3513-2022; ZHANG, LIN/GYD-9123-2022		Ministry of Science and Technology of the People's Republic of China (MOST) [2018ZX10731101-002, 2017ZX10201101, 2016YFD0500307, 2014CB542500-03]; National Natural Science Foundation of China (NSFC) [31470751, U1405228, 81530065, 81661128042]	Ministry of Science and Technology of the People's Republic of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of the People's Republic of China (MOST) Grants 2018ZX10731101-002, 2017ZX10201101, 2016YFD0500307, and 2014CB542500-03 (to L.Z. and X.W.) and National Natural Science Foundation of China (NSFC) Grants 31470751, U1405228, 81530065, and 81661128042 (to L.Z. and X.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Benjamin E, 2014, J VIROL, V88, P6743, DOI 10.1128/JVI.03562-13; Cao ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038126; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu C, 2015, CURR TOP MICROBIOL, V386, P381, DOI 10.1007/82_2014_425; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Du LY, 2013, J VIROL, V87, P2215, DOI 10.1128/JVI.02344-12; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gronsang D, 2017, ARCH VIROL, V162, P2257, DOI 10.1007/s00705-017-3350-0; Han T, 2011, BIOCHEM BIOPH RES CO, V409, P253, DOI 10.1016/j.bbrc.2011.04.139; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hu HX, 2012, J VIROL, V86, P2978, DOI 10.1128/JVI.06665-11; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kallewaard NL, 2016, CELL, V166, P596, DOI 10.1016/j.cell.2016.05.073; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Li Y, 2013, J EXP MED, V210, P1493, DOI 10.1084/jem.20130212; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian MR, 2013, J VIROL, V87, P3571, DOI 10.1128/JVI.01292-12; Raymond DD, 2018, P NATL ACAD SCI USA, V115, P168, DOI 10.1073/pnas.1715471115; Rockman S, 2013, MOL IMMUNOL, V53, P435, DOI 10.1016/j.molimm.2012.10.001; Rudneva IA, 2010, VIRAL IMMUNOL, V23, P181, DOI 10.1089/vim.2009.0086; Sano K, 2017, VACCINE, V35, P5388, DOI 10.1016/j.vaccine.2017.08.034; Schrauwen EJA, 2012, J VIROL, V86, P3975, DOI 10.1128/JVI.06828-11; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Wang QS, 2018, NUCL SCI TECH, V29, DOI 10.1007/s41365-018-0398-9; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8708; Xiong XL, 2015, P NATL ACAD SCI USA, V112, P9430, DOI 10.1073/pnas.1510816112; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zuo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9855; Zuo YA, 2018, J BIOL CHEM, V293, P16503, DOI 10.1074/jbc.RA118.004604	44	3	3	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4290	4303		10.1074/jbc.RA118.007008	http://dx.doi.org/10.1074/jbc.RA118.007008			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30737282	Green Published, hybrid			2022-12-28	WOS:000462969500002
J	Theofilopoulos, S; de Oliveira, WAA; Yang, SS; Yutuc, E; Saeed, A; Abdel-Khalik, J; Ullgren, A; Cedazo-Minguez, A; Bjorkhem, I; Wang, YQ; Griffiths, WJ; Arenas, E				Theofilopoulos, Spyridon; de Oliveira, Willy Antoni Abreu; Yang, Shanzheng; Yutuc, Eylan; Saeed, Ahmed; Abdel-Khalik, Jonas; Ullgren, Abbe; Cedazo-Minguez, Angel; Bjorkhem, Ingemar; Wang, Yuqin; Griffiths, William J.; Arenas, Ernest			24(S),25-Epoxycholesterol and cholesterol 24S-hydroxylase (CYP46A1) overexpression promote midbrain dopaminergic neurogenesis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; lipid metabolism; MS; neurodegenerative disease; neurogenesis; CYP46A1; dopamine neuron; liver X receptor; midbrain; oxysterol	CHOLESTEROL 24-HYDROXYLASE; NUCLEAR RECEPTORS; CYTOCHROME-P450 46A1; BRAIN; OXYSTEROLS; ENZYME; MOUSE; 24S-HYDROXYCHOLESTEROL; DEGRADATION; TURNOVER	The liver X receptors Lxr/NR1H3 and Lxr/NR1H2 are ligand-dependent nuclear receptors critical for midbrain dopaminergic (mDA) neuron development. We found previously that 24(S),25-epoxycholesterol (24,25-EC), the most potent and abundant Lxr ligand in the developing mouse midbrain, promotes mDA neurogenesis in vitro. In this study, we demonstrate that 24,25-EC promotes mDA neurogenesis in an Lxr-dependent manner in the developing mouse midbrain in vivo and also prevents toxicity induced by the Lxr inhibitor geranylgeranyl pyrophosphate. Furthermore, using MS, we show that overexpression of human cholesterol 24S-hydroxylase (CYP46A1) increases the levels of both 24(S)-hydroxycholesterol (24-HC) and 24,25-EC in the developing midbrain, resulting in a specific increase in mDA neurogenesis in vitro and in vivo, but has no effect on oculomotor or red nucleus neurogenesis. 24-HC, unlike 24,25-EC, did not affect in vitro neurogenesis, indicating that the neurogenic effect of 24,25-EC on mDA neurons is specific. Combined, our results indicate that increased levels of 24,25-EC in vivo, by intracerebroventricular delivery in WT mice or by overexpression of its biosynthetic enzyme CYP46A1, specifically promote mDA neurogenesis. We propose that increasing the levels of 24,25-EC in vivo may be a useful strategy to combat the loss of mDA neurons in Parkinson's disease.	[Theofilopoulos, Spyridon; de Oliveira, Willy Antoni Abreu; Yang, Shanzheng; Ullgren, Abbe; Arenas, Ernest] Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, S-17177 Stockholm, Sweden; [Theofilopoulos, Spyridon] Swansea Univ, Med Sch, Inst Life Sci, Regenerat Neurobiol Lab, 1 Singleton Pk, Swansea SA2 8PP, W Glam, Wales; [Yutuc, Eylan; Abdel-Khalik, Jonas; Wang, Yuqin; Griffiths, William J.] Swansea Univ, Med Sch, Inst Life Sci, ILS1 Bldg,Singleton Pk, Swansea SA2 8PP, W Glam, Wales; [Saeed, Ahmed; Bjorkhem, Ingemar] Karolinska Inst, Dept Lab Med, Div Clin Chem, S-14157 Stockholm, Sweden; [Saeed, Ahmed; Bjorkhem, Ingemar] Karolinska Univ, Huddinge Hosp, S-14157 Stockholm, Sweden; [Ullgren, Abbe; Cedazo-Minguez, Angel] Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, S-14157 Stockholm, Sweden	Karolinska Institutet; Swansea University; Swansea University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Theofilopoulos, S; Arenas, E (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Lab Mol Neurobiol, S-17177 Stockholm, Sweden.	s.theofilopoulos@swansea.ac.uk; ernest.arenas@ki.se	Yutuc, Eylan/AAD-7282-2019; Yutuc, Eylan/G-7360-2019; Theofilopoulos, Spyridon/B-2075-2015; Arenas, Ernest/AAO-5231-2020; Griffiths, William/N-4641-2016; Cedazo-Minguez, Angel/C-6707-2012	Yutuc, Eylan/0000-0001-9971-1950; Yutuc, Eylan/0000-0001-9971-1950; Theofilopoulos, Spyridon/0000-0003-1986-0943; Arenas, Ernest/0000-0003-0197-6577; Griffiths, William/0000-0002-4129-6616; Bjorkhem, Ingemar/0000-0002-0575-9425; Cedazo-Minguez, Angel/0000-0003-4626-4864; Abreu de Oliveira, Willy Antoni/0000-0003-1783-4522	Swedish Research Council (VR projects: DBRM) [2011-3116, 2011-3318, 2016-01526]; European Union (NeuroStemcellRepair); European Union (DDPD); Swedish Foundation for Strategic Research (DBRM); Swedish Foundation for Strategic Research (SRL program); Swedish Foundation for Strategic Research [SB16-0065]; Hjarnfonden [FO2015: 0202, FO2017-0059]; Cancerfonden [CAN 2016/572]; Karolinska Institutet (SFO Strat Regen, senior grant 2018); Ser Cymru II Rising Stars grant from the Welsh Government; Biotechnology and Biological Sciences Research Council [BB/I001735/1, B/N015932/1, BB/L001942/1]; Imperial College Healthcare Charities; Hjarnfonden; Stockholm County Council (ALF); Stiftelsen for Gamla Tjanarinnor; BBSRC [BB/I001735/1, BB/N015932/1, BB/L001942/1] Funding Source: UKRI	Swedish Research Council (VR projects: DBRM)(Swedish Research Council); European Union (NeuroStemcellRepair); European Union (DDPD); Swedish Foundation for Strategic Research (DBRM)(Swedish Foundation for Strategic Research); Swedish Foundation for Strategic Research (SRL program)(Swedish Foundation for Strategic Research); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Hjarnfonden; Cancerfonden(Swedish Cancer Society); Karolinska Institutet (SFO Strat Regen, senior grant 2018); Ser Cymru II Rising Stars grant from the Welsh Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Imperial College Healthcare Charities; Hjarnfonden; Stockholm County Council (ALF)(Stockholm County Council); Stiftelsen for Gamla Tjanarinnor; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Swedish Research Council (VR projects: DBRM, 2011-3116, 2011-3318, and 2016-01526), the European Union (NeuroStemcellRepair and DDPD), the Swedish Foundation for Strategic Research (DBRM, SRL program, and SB16-0065), Hjarnfonden (FO2015: 0202 and FO2017-0059), Cancerfonden (CAN 2016/572), and Karolinska Institutet (SFO Strat Regen, senior grant 2018) (to E. A.); by a Ser Cymru II Rising Stars grant from the Welsh Government (to S. T.); by the Biotechnology and Biological Sciences Research Council (BB/I001735/1 and B/N015932/1 to W. J. G. and BB/L001942/1 to Y. W.); by a PhD studentship from Imperial College Healthcare Charities (to J. A.-K.); and by Hjarnfonden, the Stockholm County Council (ALF), and Stiftelsen for Gamla Tjanarinnor (to I. B.). The derivatization method used for the LC-MS analysis of sterols has been licensed to Avanti Polar Lipids Inc. and Cayman Chemical by Swansea Innovations Ltd., a wholly owned subsidiary of Swansea University.	Ayciriex S, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00211; Boussicault L, 2016, BRAIN, V139, P953, DOI 10.1093/brain/awv384; Bryleva EY, 2010, P NATL ACAD SCI USA, V107, P3081, DOI 10.1073/pnas.0913828107; Burlot MA, 2015, HUM MOL GENET, V24, P5965, DOI 10.1093/hmg/ddv268; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Crick PJ, 2015, CLIN CHEM, V61, P400, DOI 10.1373/clinchem.2014.231332; Dai YB, 2012, P NATL ACAD SCI USA, V109, P13112, DOI 10.1073/pnas.1210833109; Djelti F, 2015, BRAIN, V138, P2383, DOI 10.1093/brain/awv166; Fakheri RJ, 2012, STEROIDS, V77, P575, DOI 10.1016/j.steroids.2012.02.006; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Forthmann B, 2015, J CELL PHYSIOL, V230, P2875, DOI 10.1002/jcp.25036; Goyal S, 2014, J LIPID RES, V55, P1933, DOI 10.1194/jlr.M051508; Griffiths WJ, 2016, BIOCHEM SOC T, V44, P652, DOI 10.1042/BST20150255; Griffiths WJ, 2011, BBA-MOL CELL BIOL L, V1811, P784, DOI 10.1016/j.bbalip.2011.05.012; Hudry E, 2010, MOL THER, V18, P44, DOI 10.1038/mt.2009.175; Katayama K, 2005, J PHARMACOL SCI, V97, P171, DOI 10.1254/jphs.FMJ04008X3; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Maioli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068534; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2017, NEUROPHARMACOLOGY, V123, P465, DOI 10.1016/j.neuropharm.2017.06.026; Meljon A, 2014, BIOCHEM BIOPH RES CO, V446, P768, DOI 10.1016/j.bbrc.2014.01.153; NELSON JA, 1981, J BIOL CHEM, V256, P1067; Ogundare M, 2010, J BIOL CHEM, V285, P4666, DOI 10.1074/jbc.M109.086678; Pikuleva IA, 2006, DRUG METAB DISPOS, V34, P513, DOI 10.1124/dmd.105.008789; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Shafaati M, 2011, J INTERN MED, V270, P377, DOI 10.1111/j.1365-2796.2011.02389.x; Smith JS, 2014, PROTEOMICS, V14, P1102, DOI 10.1002/pmic.201300241; Theofilopoulos Spyridon, 2015, F1000Prime Rep, V7, P37, DOI 10.12703/P7-37; Theofilopoulos S, 2014, J CLIN INVEST, V124, P4829, DOI 10.1172/JCI68506; Theofilopoulos S, 2013, NAT CHEM BIOL, V9, P126, DOI [10.1038/NCHEMBIO.1156, 10.1038/nchembio.1156]; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Wang YQ, 2009, MOL BIOSYST, V5, P529, DOI 10.1039/b819502a; Yang SZ, 2013, DEVELOPMENT, V140, P4554, DOI 10.1242/dev.098145	38	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4169	4176		10.1074/jbc.RA118.005639	http://dx.doi.org/10.1074/jbc.RA118.005639			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655290	Green Published, hybrid			2022-12-28	WOS:000461854400028
J	Kim, SH; Das, A; Choi, HI; Kim, KH; Chai, JC; Choi, MR; Binas, B; Park, KS; Lee, YS; Jung, KH; Chai, YG				Kim, Sun Hwa; Das, Amitabh; Choi, Hae In; Kim, Ki Hoon; Chai, Jin Choul; Choi, Mi Ran; Binas, Bert; Park, Kyoung Sun; Lee, Young Seek; Jung, Kyoung Hwa; Chai, Young Gyu			Forkhead box O1 (FOXO1) controls the migratory response of Toll-like receptor (TLR3)-stimulated human mesenchymal stromal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mesenchymal stem cells (MSCs); Toll-like receptor (TLR); gene expression; cell migration; transcriptomics; forkhead box protein O; polyinosinic:polycytidylic acid; RNA-sequencing	STEM-CELLS; BONE-MARROW; TRANSCRIPTION FACTOR; TNF-ALPHA; IMMUNOSUPPRESSIVE PROPERTIES; THERAPEUTIC-EFFICACY; INDUCED COLITIS; LINKING INNATE; IMMUNOMODULATION; ACTIVATION	Mesenchymal stromal cells (MSCs) can potently regulate the functions of immune cells and are being investigated for the management of inflammatory diseases. Toll-like receptor 3 (TLR3)-stimulated human MSCs (hMSCs) exhibit increased migration and chemotaxis within and toward damaged tissues. However, the regulatory mechanisms underlying these migratory activities are unclear. Therefore, we analyzed the migration capability and gene expression profiles of TLR3-stimulated hMSCs using RNA-Seq, wound healing, and transwell cell migration assay. Along with increased cell migration, the TLR3 stimulation also increased the expression of cytokines, chemokines, and cell migration-related genes. The promoter regions of the latter showed an enrichment of putative motifs for binding the transcription factors forkhead box O1 (FOXO1), FOXO3, NF-B (NF-B1), and RELA proto-oncogene and NF-B subunit. Of note, FOXO1 inhibition by the FOXO1-selective inhibitor AS1842856 significantly reduced both migration and the expression of migration-related genes. In summary, our results indicate that TLR3 stimulation induces hMSC migration through the expression of FOXO1-activated genes.	[Kim, Sun Hwa; Kim, Ki Hoon; Chai, Jin Choul; Binas, Bert; Lee, Young Seek; Chai, Young Gyu] Hanyang Univ, Dept Mol & Life Sci, Ansan 15588, South Korea; [Das, Amitabh; Choi, Mi Ran; Park, Kyoung Sun; Jung, Kyoung Hwa] Hanyang Univ, Inst Nat Sci & Technol, Ansan 15588, South Korea; [Choi, Hae In; Chai, Young Gyu] Hanyang Univ, Dept Bionanotechnol, Seoul 04673, South Korea; [Das, Amitabh] Univ Maryland, Sch Dent, Div Periodontol, Baltimore, MD 21201 USA; [Chai, Jin Choul] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Choi, Mi Ran] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Psychiat, Seoul, South Korea; [Park, Kyoung Sun] Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Hongcheon 25159, South Korea	Hanyang University; Hanyang University; Hanyang University; University System of Maryland; University of Maryland Baltimore; Yeshiva University; Albert Einstein College of Medicine; Catholic University of Korea; Seoul St. Mary's Hospital; Seoul National University (SNU)	Chai, YG (corresponding author), Hanyang Univ, Dept Mol & Life Sci, Ansan 15588, South Korea.; Jung, KH (corresponding author), Korea Polytech II, Convergence Technol Campus, Incheon 21417, South Korea.	khjung@kopo.ac.kr; ygchai@hanyang.ac.kr	Kim, Sun/GSN-4867-2022		National Research Foundation of Korea (NRF) from the Korean government [2017M3A9G7073033, 2017R1A2B4012905, 2011-0030049, 2016R1D1A1B04934970]	National Research Foundation of Korea (NRF) from the Korean government	This work was supported by National Research Foundation of Korea (NRF) Grants 2017M3A9G7073033, 2017R1A2B4012905, and 2011-0030049 (to Y. G. C.) and 2016R1D1A1B04934970 (to K. H. J.) from the Korean government. The authors declare that they have no conflicts of interest with the contents of this article.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Almalki SG, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0393-1; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bunnell BA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt34; Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen X, 2014, DEV GROWTH DIFFER, V56, P233, DOI 10.1111/dgd.12124; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Chung S, 2016, ONCOTARGET, V7, P17532, DOI 10.18632/oncotarget.8162; Das A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1728-5; De Miguel MP, 2012, CURR MOL MED, V12, P574; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; DelaRosa O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/865601; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Fuenzalida P, 2016, CYTOTHERAPY, V18, P630, DOI 10.1016/j.jcyt.2016.02.002; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Hameedaldeen A, 2014, INT J MOL SCI, V15, P16257, DOI 10.3390/ijms150916257; Hinden L, 2015, STEM CELLS, V33, P2256, DOI 10.1002/stem.2026; Ho IAW, 2009, STEM CELLS, V27, P1366, DOI 10.1002/stem.50; Hu CJ, 2013, J SURG RES, V183, P427, DOI 10.1016/j.jss.2013.01.019; Hu Y, 2008, J LEUKOCYTE BIOL, V84, P1353, DOI 10.1189/jlb.0107040; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jung KH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0260-5; Kaplan JM, 2011, CURR STEM CELL RES T, V6, P297; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kasashima H, 2016, AM J PATHOL, V186, P3028, DOI 10.1016/j.ajpath.2016.07.024; Katanov C, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0080-7; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kim DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083363; Kim SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep30311; Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367; Krampera Mauro, 2007, Blood Transfus, V5, P120, DOI 10.2450/2007.0029-07; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Lee MW, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0178-y; Lee MW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/154919; Lin Q, 2012, J INVEST DERMATOL, V132, P2085, DOI 10.1038/jid.2012.120; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maijenburg MW, 2012, STEM CELLS DEV, V21, P19, DOI 10.1089/scd.2011.0270; Mastri M, 2012, AM J PHYSIOL-CELL PH, V303, pC1021, DOI 10.1152/ajpcell.00191.2012; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Monsel A, 2014, ANESTHESIOLOGY, V121, P1099, DOI 10.1097/ALN.0000000000000446; Murray IR, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0212-7; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Patel SA, 2008, ARCH IMMUNOL THER EX, V56, P1, DOI 10.1007/s00005-008-0001-x; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Pu YF, 2017, J CELL MOL MED, V21, P1411, DOI 10.1111/jcmm.13070; Qiu Y, 2017, MUCOSAL IMMUNOL, V10, P727, DOI 10.1038/mi.2016.78; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Ren GW, 2011, CELL ADHES MIGR, V5, P20, DOI 10.4161/cam.5.1.13491; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x; Suzuki K, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3296498; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Xiao Q, 2012, CELL BIOCHEM BIOPHYS, V62, P409, DOI 10.1007/s12013-011-9317-y; Xu F, 2010, ONCOL REP, V23, P1561, DOI 10.3892/or_00000796; Yan CH, 2016, TUMOR BIOL, V37, P8425, DOI 10.1007/s13277-015-4746-7; Yu Y, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12309; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang CY, 2015, J CELL BIOL, V209, P289, DOI 10.1083/jcb.201409032; Zhao XY, 2014, STEM CELLS, V32, P521, DOI 10.1002/stem.1543	78	3	4	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8424	8437		10.1074/jbc.RA119.008673	http://dx.doi.org/10.1074/jbc.RA119.008673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30944148	Green Published, hybrid			2022-12-28	WOS:000471108200013
J	Chua, NK; Hart-Smith, G; Brown, AJ				Chua, Ngee Kiat; Hart-Smith, Gene; Brown, Andrew J.			Non-canonical ubiquitination of the cholesterol-regulated degron of squalene monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cholesterol regulation; ubiquitin; protein degradation; endoplasmic-reticulum-associated protein degradation (ERAD); degron; lipid homeostasis; membrane-associated ring-CH-type finger 6 (MARCH6); SQLE; squalene monooxygenase	COENZYME-A REDUCTASE; HMG-COA REDUCTASE; CONJUGATING ENZYMES; SACCHAROMYCES-CEREVISIAE; FEEDBACK-REGULATION; DISORDERED REGION; E2 ENZYMES; WEB SERVER; PROTEIN; DEGRADATION	Squalene monooxygenase (SM) is a rate-limiting enzyme in cholesterol synthesis. The region comprising the first 100 amino acids, termed SM N100, represents the shortest cholesterol-responsive degron and enables SM to sense excess cholesterol in the endoplasmic reticulum (ER) membrane. Cholesterol accelerates the ubiquitination of SM by membrane-associated ring-CH type finger 6 (MARCH6), a key E3 ubiquitin ligase involved in ER-associated degradation. However, the ubiquitination site required for cholesterol regulation of SM N100 is unknown. Here, we used SM N100 fused to GFP as a model degron to recapitulate cholesterol-mediated SM degradation and show that neither SM lysine residues nor the N terminus impart instability. Instead, we discovered four serines (Ser-59, Ser-61, Ser-83, and Ser-87) that are critical for cholesterol-accelerated degradation, with MS analysis confirming Ser-83 as a ubiquitination site. Notably, these two clusters of closely spaced serine residues are located in disordered domains flanking a 12-amino acid-long amphipathic helix (residues Gln-62-Leu-73) that together confer cholesterol responsiveness. In summary, our findings reveal the degron architecture of SM N100, introducing the role of non-canonical ubiquitination sites and deepening our molecular understanding of how SM is degraded in response to cholesterol.	[Chua, Ngee Kiat; Hart-Smith, Gene; Brown, Andrew J.] UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au	Chua, Ngee Kiat/AAG-6793-2021	Chua, Ngee Kiat/0000-0003-2785-2767; Hart-Smith, Gene/0000-0003-3907-0367	National Health and Medical Research Council [1060515]; Australian Research Council [DP170101178]; Gold Star award from University of New South Wales Sydney	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Gold Star award from University of New South Wales Sydney	This work was supported by National Health and Medical Research Council Grant 1060515, Australian Research Council Grant DP170101178, and a Gold Star award from University of New South Wales Sydney (to A. J. B). The authors declare that they have no conflicts of interest with the contents of this article.	Akimov V, 2018, NAT STRUCT MOL BIOL, V25, P631, DOI 10.1038/s41594-018-0084-y; Aufderheide A, 2015, FEBS LETT, V589, P2552, DOI 10.1016/j.febslet.2015.07.034; Belter A, 2011, BIOL CHEM, V392, P1053, DOI [10.1515/BC-2011-195, 10.1515/BC.2011.195]; Boban M, 2015, J BIOL CHEM, V290, P2489, DOI 10.1074/jbc.M114.600593; Boeing S, 2016, CELL REP, V15, P1597, DOI 10.1016/j.celrep.2016.04.047; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; BROWN MS, 1980, J LIPID RES, V21, P505; Brown NG, 2016, CELL, V165, P1440, DOI 10.1016/j.cell.2016.05.037; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Chua NK, 2017, J BIOL CHEM, V292, P19959, DOI 10.1074/jbc.M117.794230; Chugh A, 2003, PROG LIPID RES, V42, P37, DOI 10.1016/S0163-7827(02)00029-2; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Cirmena G, 2018, CANCER LETT, V425, P13, DOI 10.1016/j.canlet.2018.03.034; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Dai ZB, 2013, METAB ENG, V20, P146, DOI 10.1016/j.ymben.2013.10.004; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Garaiova M, 2014, FEMS YEAST RES, V14, P310, DOI 10.1111/1567-1364.12107; Garcia-Bermudez J, 2019, NATURE, V567, P118, DOI 10.1038/s41586-019-0945-5; Garner, 1999, Genome Inform Ser Workshop Genome Inform, V10, P41; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gimenez-Andres M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030045; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guharoy M, 2016, J BIOL CHEM, V291, P6723, DOI 10.1074/jbc.R115.692665; Hart-Smith G, 2014, J PROTEOME RES, V13, P1744, DOI 10.1021/pr401251k; Hart-Smith G, 2012, J AM SOC MASS SPECTR, V23, P124, DOI 10.1007/s13361-011-0273-y; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; HIDAKA Y, 1991, J BIOL CHEM, V266, P13171; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Howe V, 2015, J BIOL CHEM, V290, P27533, DOI 10.1074/jbc.M115.675181; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Kristiana I, 2012, J BIOL CHEM, V287, P33897, DOI 10.1074/jbc.M112.360537; Kuzu OF, 2016, CANCER RES, V76, P2063, DOI 10.1158/0008-5472.CAN-15-2613; Lam SY, 2014, BIOCHEM BIOPH RES CO, V451, P361, DOI 10.1016/j.bbrc.2014.07.099; Lenk U, 2002, J CELL SCI, V115, P3007; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu DB, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9840; Liu YF, 2014, ELIFE, V3, DOI 10.7554/eLife.01369; Lumpkin RJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01271-3; Luu W, 2014, J LIPID RES, V55, P410, DOI 10.1194/jlr.M043257; Mahoney CE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07959-4; Mattiroli F, 2014, NAT STRUCT MOL BIOL, V21, P308, DOI 10.1038/nsmb.2792; McDowell GS, 2013, INT J BIOCHEM CELL B, V45, P1833, DOI 10.1016/j.biocel.2013.05.026; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mullen PJ, 2016, NAT REV CANCER, V16, P718, DOI 10.1038/nrc.2016.76; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Pao KC, 2018, NATURE, V556, P381, DOI 10.1038/s41586-018-0026-1; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Prabhu AV, 2017, J STEROID BIOCHEM, V165, P363, DOI 10.1016/j.jsbmb.2016.08.003; Prabhu AV, 2014, BBA-MOL CELL BIOL L, V1841, P1431, DOI 10.1016/j.bbalip.2014.07.006; Prinz WA, 2017, J BIOL CHEM, V292, P19974, DOI 10.1074/jbc.H117.794230; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Smith DL, 2018, ANAL CHEM, V90, P9101, DOI 10.1021/acs.analchem.8b01525; Stefanovic-Barrett S, 2018, EMBO REP, V19, DOI 10.15252/embr.201745603; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Stopsack KH, 2016, CANCER RES, V76, P4785, DOI 10.1158/0008-5472.CAN-16-0903; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tan JME, 2019, ATHEROSCLEROSIS, V281, P137, DOI 10.1016/j.atherosclerosis.2018.12.008; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wang YJ, 2017, NAT CELL BIOL, V19, P808, DOI 10.1038/ncb3551; Weber A, 2016, MOL CELL, V63, P827, DOI 10.1016/j.molcel.2016.07.020; Wood WG, 2014, J NEUROCHEM, V129, P559, DOI 10.1111/jnc.12637; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep09520; Xiao X, 2017, MOL CELL, V66, P154, DOI 10.1016/j.molcel.2017.02.015; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13	97	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8134	8147		10.1074/jbc.RA119.007798	http://dx.doi.org/10.1074/jbc.RA119.007798			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30940729	Green Published, hybrid			2022-12-28	WOS:000470656500013
J	Andrade, H; Lin, WL; Zhang, YX				Andrade, Helena; Lin, Weilin; Zhang, Yixin			Specificity from nonspecific interaction: regulation of tumor necrosis factor- activity by DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); DNA-protein interaction; circular dichroism (CD); allosteric regulation; protein-nucleic acid interaction; activity regulation; biolayer interferometry; homoquenching; nonspecific interaction; photo-switchable protein	T-CELL REPERTOIRE; TNF-ALPHA; SERUM-LEVELS; CANCER; DEOLIGOMERIZATION; IDENTIFICATION; AUTOIMMUNITY; SELECTION; PLASMA; IL-6	As anionic biopolymers, oligonucleotides can have biological functions independent from their roles as the medium for the storage and flow of genetic information. In this paper, we investigated the interaction between DNA and the pro-inflammatory cytokine tumor necrosis factor- (TNF). Although various forms of DNA bind to TNF with low m dissociation constants, the interaction stabilizes the trimeric form of TNF and enhances its cytotoxic effect. Based on this mechanism, a photoswitchable TNF (TNF-2-nitroveratryloxycarbonyl) has been designed whose sensitivity to DNA-mediated up-regulation of TNF activity can be tuned by light irradiation. The mechanism described in this study represents a general model to understand the involvement of nonspecific interactions among biomolecules in regulating their biological functions. Because the interaction is not DNA sequence-specific, the resulting effect should be considered for oligonucleotide-based therapeutics in general.	[Andrade, Helena; Lin, Weilin; Zhang, Yixin] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, D-01307 Dresden, Germany; [Andrade, Helena] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam IBP, CH-8092 Zurich, Switzerland	Technische Universitat Dresden; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zhang, YX (corresponding author), Tech Univ Dresden, B CUBE Ctr Mol Bioengn, D-01307 Dresden, Germany.	yixin.zhang1@tu-dresden.de		Andrade, Helena/0000-0003-4127-8087; Lin, Weilin/0000-0002-2262-5859; Zhang, Yixin/0000-0002-6669-4995	Bundesministerium fur Bildung und Forschung [03Z2EN12, 03Z2E511]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by Bundesministerium fur Bildung und Forschung Grants 03Z2EN12 and 03Z2E511. The authors declare that they have no conflicts of interest with the contents of this article.	ALZANI R, 1993, J BIOL CHEM, V268, P12526; ALZANI R, 1995, BIOCHEMISTRY-US, V34, P6344, DOI 10.1021/bi00019a012; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chatterjee S, 2012, NANOSCALE, V4, P1568, DOI 10.1039/c2nr12039a; Cheng C, 2009, CANCER SCI, V100, P303, DOI 10.1111/j.1349-7006.2008.01021.x; CORTI A, 1992, BIOCHEM J, V284, P905, DOI 10.1042/bj2840905; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Fulda S, 2014, SEMIN CELL DEV BIOL, V35, P51, DOI 10.1016/j.semcdb.2014.07.002; Haugbro K, 2004, ANN RHEUM DIS, V63, P386, DOI 10.1136/ard.2003.016303; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hoffmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031298; Humphreys DT, 1999, CYTOKINE, V11, P773, DOI 10.1006/cyto.1998.0492; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Intiso D, 2004, NEUROL SCI, V24, P390, DOI 10.1007/s10072-003-0194-z; Ishihara J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04525-w; Kenig M, 2008, J CHROMATOGR B, V867, P119, DOI 10.1016/j.jchromb.2008.03.023; Kimoto M, 2016, NUCLEIC ACIDS RES, V44, P7487, DOI 10.1093/nar/gkw619; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kosmrlj A, 2008, P NATL ACAD SCI USA, V105, P16671, DOI 10.1073/pnas.0808081105; Ledford H, 2018, NATURE, V560, P291, DOI 10.1038/d41586-018-05867-7; Li P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00460; Li SP, 2018, NAT BIOTECHNOL, V36, P258, DOI 10.1038/nbt.4071; Mannocci L, 2008, P NATL ACAD SCI USA, V105, P17670, DOI 10.1073/pnas.0805130105; Measey TJ, 2012, LANGMUIR, V28, P12588, DOI 10.1021/la302626d; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Organick L, 2018, NAT BIOTECHNOL, V36, P242, DOI 10.1038/nbt.4079; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; SMITH RA, 1987, J BIOL CHEM, V262, P6951; Stull R A, 1993, Antisense Res Dev, V3, P295; Su KY, 2009, SCAND J IMMUNOL, V70, P175, DOI 10.1111/j.1365-3083.2009.02300.x; Szpechcinski A, 2015, BRIT J CANCER, V113, P476, DOI 10.1038/bjc.2015.225; Tamkovich SN, 2005, CLIN CHEM, V51, P1317, DOI 10.1373/clinchem.2004.045062; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vrisekoop N, 2014, IMMUNITY, V41, P181, DOI 10.1016/j.immuni.2014.07.007; Zeraati M, 2018, NAT CHEM, V10, P631, DOI 10.1038/s41557-018-0046-3; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	41	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6397	6404		10.1074/jbc.RA119.007586	http://dx.doi.org/10.1074/jbc.RA119.007586			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30814250	hybrid, Green Published			2022-12-28	WOS:000468402000017
J	Chen, QH; Guo, XX; Deng, NS; Liu, LL; Chen, S; Wang, AL; Li, RY; Huang, Y; Ding, XH; Yu, HY; Hu, SP; Nie, HX				Chen, Qianhui; Guo, Xuxue; Deng, Nishan; Liu, Linlin; Chen, Shuo; Wang, Ailing; Li, Ruiyun; Huang, Yi; Ding, Xuhong; Yu, Hongying; Hu, Suping; Nie, Hanxiang			alpha-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						asthma; cellular immune response; allergen; antibody; antigen; alpha-galactosylceramide; asthma; inflammation; allergy; cytokine response; lung disease; invariant NKT cells; regulatory T cells; Th2 cell response	REGULATORY T-CELLS; LUNG DENDRITIC CELLS; NKT CELLS; AIRWAY INFLAMMATION; CUTTING EDGE; TOLERANCE; AUTOIMMUNE; MATURATION; MAINTENANCE; MECHANISMS	Asthma is a common inflammatory pulmonary disorder involving a diverse array of immune cells such as proinflammatory T helper 2 (Th2) cells. We recently reported that intraperitoneal injection of -galactosylceramide (-GalCer) can stimulate the lung invariant natural killer T (iNKT) cells and does not lead to airway inflammation in WT mice. Other studies indicate that iNKT cells play an important role in inducing regulatory T cells (Treg cells) and peripheral tolerance. Using iNKT cell- knockout mice, functional inactivation of Treg cells, and co-culture experiments in murine asthma models, we investigated the immunoregulatory effects of -GalCer treatment before allergen sensitization on Th2 cell responses. We also studied whether -GalCer's effects require lung Treg cells induced by activated iNKT cells. Our results disclosed that intraperitoneal administration of -GalCer before allergen sensitization could promote the expansion and suppressive activity of lung CD4(+)FoxP3(+) Treg cells. These effects were accompanied by down-regulated Th2 cell responses and decreased immunogenic maturation of lung dendritic cells in WT mice. However, these changes were absent in CD1d(-/-) mice immunized and challenged with ovalbumin or house dust mites, indicating that the effects of -GalCer on Treg cells mainly require iNKT cells. Moreover, functional inactivation of Treg cells could reverse the inhibitory ability of this -GalCer therapy on Th2 cell responses in a murine asthma model. Our findings indicate that intraperitoneal administration of -GalCer before the development of asthma symptoms induces the generation of lung Treg cells via iNKT cells and may provide a potential therapeutic strategy to prevent allergic asthma.	[Chen, Qianhui; Guo, Xuxue; Deng, Nishan; Liu, Linlin; Chen, Shuo; Li, Ruiyun; Huang, Yi; Ding, Xuhong; Yu, Hongying; Hu, Suping; Nie, Hanxiang] Wuhan Univ, Dept Resp & Crit Med, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China; [Wang, Ailing] Wuhan Univ, Dept Nursing, Sch Hlth Sci, Wuhan 430060, Hubei, Peoples R China	Wuhan University; Wuhan University	Nie, HX (corresponding author), Wuhan Univ, Dept Resp & Crit Med, Renmin Hosp, 238 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China.	nhxbj@sohu.com			National Natural Science Foundation of China [81770036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 81770036. The authors declare that they have no conflicts of interest with the contents of this article.	Afshar R, 2008, CLIN EXP ALLERGY, V38, P1847, DOI 10.1111/j.1365-2222.2008.03119.x; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Barron L, 2010, J IMMUNOL, V185, P6426, DOI 10.4049/jimmunol.0903940; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Caielli S, 2010, J IMMUNOL, V185, P7317, DOI 10.4049/jimmunol.1000400; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Dalod M, 2014, EMBO J, V33, P1104, DOI 10.1002/embj.201488027; Dascher CC, 2003, TRENDS IMMUNOL, V24, P412, DOI 10.1016/S1471-4906(03)00179-0; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Gregory LG, 2011, TRENDS IMMUNOL, V32, P402, DOI 10.1016/j.it.2011.06.006; Grindebacke H, 2004, CLIN EXP ALLERGY, V34, P1364, DOI 10.1111/j.1365-2222.2004.02067.x; Hachem P, 2005, EUR J IMMUNOL, V35, P2793, DOI 10.1002/eji.200535268; He Q, 2017, AM J PHYSIOL-LUNG C, V313, pL973, DOI 10.1152/ajplung.00340.2016; Hoffmann F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00107; Jiang SP, 2005, EUR J IMMUNOL, V35, P1193, DOI 10.1002/eji.200425899; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Kearley J, 2008, J ALLERGY CLIN IMMUN, V122, P617, DOI 10.1016/j.jaci.2008.05.048; Kim S, 2008, EXPERT REV VACCINES, V7, P1519, DOI 10.1586/14760584.7.10.1519; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lee JH, 2007, CLIN EXP IMMUNOL, V148, P53, DOI 10.1111/j.1365-2249.2007.03329.x; Li P, 2015, CLIN EXP ALLERGY, V45, P1126, DOI 10.1111/cea.12521; Liu RL, 2005, J IMMUNOL, V175, P7898, DOI 10.4049/jimmunol.175.12.7898; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Ly D, 2006, J IMMUNOL, V177, P3695, DOI 10.4049/jimmunol.177.6.3695; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Matsuda H, 2005, AM J RESP CELL MOL, V33, P22, DOI 10.1165/rcmb.2004-0010OC; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Nie HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119901; Novak J, 2011, CYTOKINE, V53, P263, DOI 10.1016/j.cyto.2010.11.001; Palomares O, 2014, GENES IMMUN, V15, P511, DOI 10.1038/gene.2014.45; Pham MN, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00651; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Ronet C, 2005, J IMMUNOL, V175, P899, DOI 10.4049/jimmunol.175.2.899; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Thorburn AN, 2010, AM J RESP CELL MOL, V43, P511, DOI 10.1165/rcmb.2009-0342TR; Tomura M, 1999, J IMMUNOL, V163, P93; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zhang GQ, 2011, AM J PHYSIOL-LUNG C, V301, pL975, DOI 10.1152/ajplung.00114.2011	53	6	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5438	5455		10.1074/jbc.RA118.005418	http://dx.doi.org/10.1074/jbc.RA118.005418			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30745361	Green Published, hybrid			2022-12-28	WOS:000464517500017
J	Zhang, ZL; Zhan, XM; Kim, B; Wu, J				Zhang, Zilai; Zhan, Xiaoming; Kim, Bongwoo; Wu, Jiang			A proteomic approach identifies SAFB-like transcription modulator (SLTM) as a bidirectional regulator of GLI family zinc finger transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Sonic hedgehog (SHH); gene transcription; signaling; mouse genetics; chromatin; proteomics; GLI transcription factors; SAFB-like transcription modulator (SLTM); GLI family zinc finger; transcription activation; transcription repression; epigenetics; cell differentiation	SONIC HEDGEHOG; OSTEOBLAST DIFFERENTIATION; SUFU; SHH; SPECIFICATION; SUPPRESSOR; PROTEINS; GENE; PHOSPHORYLATION; ASSOCIATION	In Sonic hedgehog (SHH) signaling, GLI family zinc finger (GLI)-mediated diverse gene transcription outcomes are strictly regulated and are important for SHH function in both development and disease. However, how the GLI factors differentially regulate transcription in response to variable SHH activities is incompletely understood. Here, using a newly generated, tagged Gli3 knock-in mouse (Gli3(TAP)), we performed proteomic analyses and identified the chromatin-associated SAFB-like transcription modulator (SLTM) as a GLI-interacting protein that context-dependently regulates GLI activities. Using immunoprecipitation and immunoblotting, RT-quantitative PCR, and ChIP assays, we show that SLTM interacts with all three GLI proteins and that its cellular levels are regulated by SHH. We also found that SLTM enhances GLI3 binding to chromatin and increases GLI3 repressor (GLI3R) form protein levels. In a GLI3-dependent manner, SLTM promoted the formation of a repressive chromatin environment and functioned as a GLI3 co-repressor. In the absence of GLI3 or in the presence of low GLI3 levels, SLTM co-activated GLI activator (GLIA)-mediated target gene activation and cell differentiation. Moreover, in vivo Sltm deletion generated through CRISPR/Cas9-mediated gene editing caused perinatal lethality and SHH-related abnormal ventral neural tube phenotypes. We conclude that SLTM regulates GLI factor binding to chromatin and contributes to the transcriptional outcomes of SHH signaling via a novel molecular mechanism.	[Zhang, Zilai; Zhan, Xiaoming; Kim, Bongwoo; Wu, Jiang] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Zhan, Xiaoming] Univ Texas Southwestern Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wu, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jiang9.wu@utsouthwestern.edu			March of Dimes Foundation; Welch Foundation [I-1940-20170325]; National Institutes of Health [R01NS09606, R21NS104596]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS104596, R01NS096068] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the March of Dimes Foundation, Welch Foundation Grant I-1940-20170325 (to J. W.), and National Institutes of Health Grants R01NS09606 and R21NS104596 (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aberger F, 2014, SEMIN CELL DEV BIOL, V33, P93, DOI 10.1016/j.semcdb.2014.05.003; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4127; Chan CW, 2007, BIOCHEM J, V407, P355, DOI 10.1042/BJ20070170; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Ding Q, 1998, DEVELOPMENT, V125, P2533; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Falkenstein KN, 2014, SEMIN CELL DEV BIOL, V33, P73, DOI 10.1016/j.semcdb.2014.05.010; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Garee JP, 2010, J CELL BIOCHEM, V109, P312, DOI 10.1002/jcb.22420; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Han YH, 2015, P NATL ACAD SCI USA, V112, P6383, DOI 10.1073/pnas.1421628112; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Lin CW, 2014, GENE DEV, V28, P2547, DOI 10.1101/gad.249425.114; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Lopez-Rios J, 2014, NATURE, V511, P46, DOI 10.1038/nature13289; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Niewiadomski P, 2014, CELL REP, V6, P168, DOI 10.1016/j.celrep.2013.12.003; Norman M, 2016, BIOCHEM J, V473, P4271, DOI 10.1042/BCJ20160649; Oosterveen T, 2012, DEV CELL, V23, P1006, DOI 10.1016/j.devcel.2012.09.015; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Peterson KA, 2012, GENE DEV, V26, P2802, DOI 10.1101/gad.207142.112; Rallu M, 2002, DEVELOPMENT, V129, P4963; Shi XM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6425; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Yuasa T, 2002, J CELL PHYSIOL, V193, P225, DOI 10.1002/jcp.10166; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108; Zhang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3608	52	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5549	5561		10.1074/jbc.RA118.007018	http://dx.doi.org/10.1074/jbc.RA118.007018			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30782847	hybrid, Green Published			2022-12-28	WOS:000464517500025
J	Bowie, AG				Bowie, Andrew G.			Harnessing poxviral know-how for anti-cytokine therapies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Poxviruses have evolved efficient proteins that bind mammalian cytokines and chemokines to suppress host immunity. Here Pontejo et al. examine in detail how one such poxviral protein, CrmD, that has activity against both mammalian tumor necrosis factor and chemokines, interacts with its host targets. They apply their findings to refine a human anti-cytokine therapeutic and increase its specificity, providing an elegant example of the benefits of mining viral proteins for therapeutically useful information.	[Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland [16/IA/4376]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland Grant 16/IA/4376. The author declares that he has no conflicts of interest with the contents of this article.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Murray KM, 1997, ANN PHARMACOTHER, V31, P1335, DOI 10.1177/106002809703101111; Pontejo SM, 2019, J BIOL CHEM, V294, P5214, DOI 10.1074/jbc.RA118.005828; Pontejo SM, 2015, J BIOL CHEM, V290, P15973, DOI 10.1074/jbc.M115.650119; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Zhang GY, 2004, CURR OPIN STRUC BIOL, V14, P154, DOI 10.1016/j.sbi.2004.03.003	7	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5228	5229		10.1074/jbc.H119.008151	http://dx.doi.org/10.1074/jbc.H119.008151			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30926761	Green Published, hybrid			2022-12-28	WOS:000463985600046
J	Bialas, J; Boehm, AN; Catone, N; Aichem, A; Groettrup, M				Bialas, Johanna; Boehm, Annika N.; Catone, Nicola; Aichem, Annette; Groettrup, Marcus			The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin; ubiquitin thioesterase (OTUB1); ubiquitin-conjugating enzyme (E2 enzyme); ubiquitylation (ubiquitination); proteasome; enzyme activity; FAT10; inflammation; ubiquitin-like protein; USE1	PROTEIN FAT10; IDENTIFICATION; SPECIFICITY; SUBSTRATE; BINDING; INHIBITION; ACTIVATION; MECHANISM; OTUBAIN-1; INTERACTS	The deubiquitylation of target proteins is mediated by deubiquitylating enzymes (DUB) such as OTUB1, which plays an important role in immune response, cell cycle progression, and DNA repair. Within these processes, OTUB1 reduces the ubiquitylation of target proteins in two distinct ways, either by using its catalytic DUB activity or in a noncatalytic manner by inhibiting the E2-conjugating enzyme. Here, we show that the ubiquitin-like modifier FAT10 regulates OTUB1 stability and functionality in different ways. Covalent FAT10ylation of OTUB1 resulted in its proteasomal degradation, whereas a noncovalent interaction stabilized OTUB1. We provide evidence that OTUB1 interacts directly with FAT10 and the E2-conjugating enzyme USE1. This interaction strongly stimulated OTUB1 DUB activity toward Lys-48-linked diubiquitin. Furthermore, the noncovalent interaction between FAT10 and OTUB1 not only enhanced its isopeptidase activity toward Lys-48-linked ubiquitin moieties but also strengthened its noncatalytic activity in reducing Lys-63 polyubiquitylation of its target protein TRAF3 (TNF receptor-associated factor 3). Additionally, the cellular clearance of overall polyubiquitylation by OTUB1 was strongly stimulated through the presence of FAT10. The addition of FAT10 also led to an increased interaction between OTUB1 and its cognate E2 UbcH5B, implying a function of FAT10 in the inhibition of polyubiquitylation. Overall, these data indicate that FAT10 not only plays a role in covalent modification, leading its substrates to proteasomal degradation, but also regulates the stability and functionality of target proteins by interacting in a noncovalent manner. FAT10 is thereby able to exert a major influence on ubiquitylation processes.	[Bialas, Johanna; Boehm, Annika N.; Aichem, Annette; Groettrup, Marcus] Univ Konstanz, Div Immunol, Dept Biol, D-78464 Constance, Germany; [Bialas, Johanna; Boehm, Annika N.; Catone, Nicola; Aichem, Annette; Groettrup, Marcus] Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland; [Boehm, Annika N.] Univ Konstanz, Grad Sch Biol Sci, Constance, Germany	University of Konstanz; University of Konstanz	Aichem, A (corresponding author), Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland.	Annette.Aichem@bitg.ch	Groettrup, Marcus/AAT-2623-2020	Groettrup, Marcus/0000-0002-5423-6399	German Research Foundation (DFG) Collaborative Research Center [SFB969, 1029]; Velux Foundation; Graduate School Chemical Biology at the University of Konstanz	German Research Foundation (DFG) Collaborative Research Center(German Research Foundation (DFG)); Velux Foundation(Velux Fonden); Graduate School Chemical Biology at the University of Konstanz	This work was supported by the German Research Foundation (DFG) Collaborative Research Center SFB969, project C01 (to M. G.) and by Grant 1029 from the Velux Foundation (to A. A. and M. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a stipend from the Graduate School Chemical Biology at the University of Konstanz.	Aichem A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05776-3; Aichem A, 2016, INT J BIOCHEM CELL B, V79, P451, DOI 10.1016/j.biocel.2016.07.001; Aichem A, 2014, FEBS J, V281, P1848, DOI 10.1111/febs.12745; Aichem A, 2012, J CELL SCI, V125, P4576, DOI 10.1242/jcs.107789; Aichem A, 2012, METHODS MOL BIOL, V832, P125, DOI 10.1007/978-1-61779-474-2_7; Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; Bialas J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120329; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; Gavin JM, 2012, J BIOL CHEM, V287, P15512, DOI 10.1074/jbc.M111.336198; Groettrup M, 2008, TRENDS BIOCHEM SCI, V33, P230, DOI 10.1016/j.tibs.2008.01.005; Herrador A, 2013, J BIOL CHEM, V288, P16206, DOI 10.1074/jbc.C113.452250; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Juris SJ, 2006, FEBS LETT, V580, P179, DOI 10.1016/j.febslet.2005.11.071; Kalveram B, 2008, J CELL SCI, V121, P4079, DOI 10.1242/jcs.035006; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li TW, 2011, ARCH BIOCHEM BIOPHYS, V509, P164, DOI 10.1016/j.abb.2011.02.017; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nguyen NTH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23377; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Peng YY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004041; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schelpe J, 2016, J BIOL CHEM, V291, P630, DOI 10.1074/jbc.M115.671545; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Theng SS, 2014, P NATL ACAD SCI USA, V111, pE5282, DOI 10.1073/pnas.1403383111; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Zhang YL, 2016, J IMMUNOL, V197, P824, DOI 10.4049/jimmunol.1501563; Zou WG, 2005, BIOCHEM BIOPH RES CO, V336, P61, DOI 10.1016/j.bbrc.2005.08.038	50	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4315	4330		10.1074/jbc.RA118.005406	http://dx.doi.org/10.1074/jbc.RA118.005406			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30718280	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000462969500004
J	Chernyavsky, A; Amber, KT; Agnoletti, AF; Wang, C; Grando, SA				Chernyavsky, Alex; Amber, Kyle T.; Agnoletti, Arianna F.; Wang, Candice; Grando, Sergei A.			Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; antibody; antigen; pemphigus; apoptosis; acantholysis; cell-cell detachment; immune dysfunction; keratinocyte; non-desmoglein pemphigus antibodies	CELL-DEATH; ANTIMITOCHONDRIAL AUTOANTIBODIES; INTRACELLULAR CALCIUM; SIGNALING PATHWAYS; CLINICAL PHENOTYPE; DESMOCOLLIN 3; CROSS-TALK; DISEASE; ATP2C1; GOLGI	Pemphigus vulgaris (PV) is a potentially lethal mucocutaneous blistering disease characterized by IgG autoantibodies (AuAbs) binding to epidermal keratinocytes and inducing this devastating disease. Here, we observed that non-desmoglein (Dsg) AuAbs in the sera of patients with Dsg1/3 AuAb-negative acute PV are pathogenic, because IgGs from these individuals induced skin blistering in neonatal mice caused by suprabasal acantholysis. Serum levels of AuAbs to desmocollin 3 (Dsc3), M3 muscarinic acetylcholine receptor (M3AR), and secretory pathway Ca2+/Mn2+-ATPase isoform 1 (SPCA1) correlated with the disease stage of PV. Moreover, AuAb absorption on recombinant Dsc3, M3AR, or SPCA1 both prevented skin blistering in the passive transfer of AuAbs model of PV in BALB/c mice and significantly decreased the extent of acantholysis in a neonatal mouse skin explant model. Although acantholytic activities of each of these immunoaffinity-purified AuAbs could not induce a PV-like phenotype, their mixture produced a synergistic effect manifested by a positive Nikolskiy sign in the skin of neonatal mice. The downstream signaling of all pathogenic non-Dsg AuAbs involved p38 mitogen-activated protein kinase (MAPK)-mediated phosphorylation and elevation of cytochrome c release and caspase 9 activity. Anti-Dsc3 and anti-SPCA1 AuAbs also activated SRC proto-oncogene, nonreceptor tyrosine kinase (SRC). Of note, although a constellation of non-Dsg AuAbs apparently disrupted epidermal integrity, elimination of a single pathogenic AuAb could prevent keratinocyte detachment and blistering. Therefore, anti-Dsg1/3 AuAb-free PV can be a model for elucidating the roles of non-Dsg antigen-specific AuAbs in the physiological regulation of keratinocyte cell-cell adhesion and blister development.	[Chernyavsky, Alex; Amber, Kyle T.; Agnoletti, Arianna F.; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; [Grando, Sergei A.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Grando, Sergei A.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Amber, Kyle T.] Univ Illinois, Dept Dermatol, Chicago, IL 60607 USA; [Agnoletti, Arianna F.] San Martino Policlin Hosp, DISSAL Sect Dermatol, I-16132 Genoa, Italy; [Wang, Candice] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Western University of Health Sciences	Grando, SA (corresponding author), Univ Calif Irvine, 134 Sprague Hall, Irvine, CA 92697 USA.	sgrando@uci.edu		Grando, Sergei/0000-0001-5769-8938	International Pemphigus and Pemphigoid Foundation; Department of Dermatology of University of California-Irvine	International Pemphigus and Pemphigoid Foundation; Department of Dermatology of University of California-Irvine	This work was supported, in part, by a research grant from the International Pemphigus and Pemphigoid Foundation (to K. T. A.) and internal funds from the Department of Dermatology of University of California-Irvine. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed AR, 2016, EXP DERMATOL, V25, P839, DOI 10.1111/exd.13106; AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; Amber KT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01190; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; Belloni-Fortina A, 2009, CLIN DEV IMMUNOL, P1, DOI 10.1155/2009/187864; Carraro M, 2016, CELL CALCIUM, V60, P102, DOI 10.1016/j.ceca.2016.03.005; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Chen YM, 2015, J BIOL CHEM, V290, P23826, DOI 10.1074/jbc.M115.668061; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Cozzani E, 2013, EUR J DERMATOL, V23, P40, DOI 10.1684/ejd.2012.1903; Di Zenzo G, 2016, SEMIN IMMUNOPATHOL, V38, P57, DOI 10.1007/s00281-015-0541-1; Didier K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00541; DMOCHOWSKI M, 1995, BRIT J DERMATOL, V133, P519, DOI 10.1111/j.1365-2133.1995.tb02698.x; DMOCHOWSKI M, 1993, J INVEST DERMATOL, V100, P380, DOI 10.1111/1523-1747.ep12471934; Espana A, 2013, EXP DERMATOL, V22, P125, DOI 10.1111/exd.12088; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; Giurdanella F, 2016, BRIT J DERMATOL, V175, P185, DOI 10.1111/bjd.14408; Grando S. A., 1993, J EUR ACAD DERMATOL, V2, P72; Grando SA, 2019, INT J DERMATOL, V58, P114, DOI 10.1111/ijd.14143; Grando Sergei A, 2012, Handb Exp Pharmacol, P429, DOI 10.1007/978-3-642-23274-9_18; Grando SA, 2012, AUTOIMMUNITY, V45, P7, DOI 10.3109/08916934.2011.606444; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Hirata Y, 2004, BRAIN RES, V1021, P241, DOI 10.1016/j.brainres.2004.06.064; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Jamora MJJ, 2003, J AM ACAD DERMATOL, V48, P976, DOI 10.1067/mjd.2003.438; Jolly PS, 2010, J BIOL CHEM, V285, P8936, DOI 10.1074/jbc.M109.087999; Kalantari-Dehaghi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057587; Lakshmi MJD, 2017, J AM ACAD DERMATOL, V76, P895, DOI 10.1016/j.jaad.2016.11.039; Lehotsky J, 2009, GEN PHYSIOL BIOPHYS, V28, pF104; Madala Jayakiran, 2017, J Oral Maxillofac Pathol, V21, P260, DOI 10.4103/jomfp.JOMFP_143_17; Mao XM, 2011, J BIOL CHEM, V286, P1283, DOI 10.1074/jbc.M110.172874; Mao XM, 2010, AM J PATHOL, V177, P2724, DOI 10.2353/ajpath.2010.100483; Marchenko S, 2010, J BIOL CHEM, V285, P3695, DOI 10.1074/jbc.M109.081570; Nguyen VT, 2000, J BIOL CHEM, V275, P29466, DOI 10.1074/jbc.M003174200; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 2000, J CLIN INVEST, V106, P1467, DOI 10.1172/JCI10305; Nguyen VT, 1998, ARCH DERMATOL, V134, P971, DOI 10.1001/archderm.134.8.971; Okunade GW, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703029200; Rafei D, 2011, AM J PATHOL, V178, P718, DOI 10.1016/j.ajpath.2010.10.016; Sajda T, 2015, J INVEST DERMATOL, V135, pS12; Sajda T, 2014, J INVEST DERMATOL, V134, pS13; Sajda T, 2016, P NATL ACAD SCI USA, V113, P1859, DOI 10.1073/pnas.1525448113; Sardana K, 2013, BRIT J DERMATOL, V168, P669, DOI 10.1111/bjd.12012; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P33, DOI 10.1111/1523-1747.ep12613469; Sepulveda MR, 2009, J NEUROSCI, V29, P12174, DOI 10.1523/JNEUROSCI.2014-09.2009; Sharma VK, 2006, INT J DERMATOL, V45, P518, DOI 10.1111/j.1365-4632.2006.02593.x; Shull GE, 2011, BIOFACTORS, V37, P150, DOI 10.1002/biof.141; Sinha AA, 2012, AUTOIMMUNITY, V45, P36, DOI 10.3109/08916934.2011.606445; Spindler V, 2010, J IMMUNOL, V185, P6831, DOI 10.4049/jimmunol.1002675; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Zagorodniuk I, 2005, INT J DERMATOL, V44, P541, DOI 10.1111/j.1365-4632.2004.02541.x	56	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4520	4528		10.1074/jbc.RA118.006743	http://dx.doi.org/10.1074/jbc.RA118.006743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30692201	hybrid, Green Published			2022-12-28	WOS:000462969500020
J	Woeste, MA; Stern, S; Raju, DN; Grahn, E; Dittmann, D; Gutbrod, K; Dormann, P; Hansen, JN; Schonauer, S; Marx, CE; Hamzeh, H; Korschen, HG; Aerts, JMFG; Bonigk, W; Endepols, H; Sandhoff, R; Geyer, M; Berger, TK; Bradke, F; Wachten, D				Woeste, Marina A.; Stern, Sina; Raju, Diana N.; Grahn, Elena; Dittmann, Dominik; Gutbrod, Katharina; Doermann, Peter; Hansen, Jan N.; Schonauer, Sophie; Marx, Carina E.; Hamzeh, Hussein; Koerschen, Heinz G.; Aerts, Johannes M. F. G.; Boenigk, Wolfgang; Endepols, Heike; Sandhoff, Roger; Geyer, Matthias; Berger, Thomas K.; Bradke, Frank; Wachten, Dagmar			Species-specific differences in nonlysosomal glucosylceramidase GBA2 function underlie locomotor dysfunction arising from loss-of-function mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycerosphingolipid; ataxia; neuroscience; neurite outgrowth; cytoskeleton; actin cytoskeleton; -glucosidases; cerebellar ataxia; GBA2; glucosylceramide	DISEASE; MICE; BETA-GLUCOSIDASE-2; IDENTIFICATION; CHOLESTEROL; INHIBITION; MIGLUSTAT; DEFECTS; THERAPY; ATAXIA	The nonlysosomal glucosylceramidase 2 (GBA2) catalyzes the hydrolysis of glucosylceramide to glucose and ceramide. Mutations in the human GBA2 gene have been associated with hereditary spastic paraplegia (HSP), autosomal-recessive cerebellar ataxia (ARCA), and the Marinesco-Sjogren-like syndrome. However, the underlying molecular mechanisms are ill-defined. Here, using biochemistry, immunohistochemistry, structural modeling, and mouse genetics, we demonstrate that all but one of the spastic gait locus #46 (SPG46)-connected mutations cause a loss of GBA2 activity. We demonstrate that GBA2 proteins form oligomeric complexes and that protein-protein interactions are perturbed by some of these mutations. To study the pathogenesis of GBA2-related HSP and ARCA in vivo, we investigated GBA2-KO mice as a mammalian model system. However, these mice exhibited a high phenotypic variance and did not fully resemble the human phenotype, suggesting that mouse and human GBA2 differ in function. Whereas some GBA2-KO mice displayed a strong locomotor defect, others displayed only mild alterations of the gait pattern and no signs of cerebellar defects. On a cellular level, inhibition of GBA2 activity in isolated cerebellar neurons dramatically affected F-actin dynamics and reduced neurite outgrowth, which has been associated with the development of neurological disorders. Our results shed light on the molecular mechanism underlying the pathogenesis of GBA2-related HSP and ARCA and reveal species-specific differences in GBA2 function in vivo.	[Woeste, Marina A.; Raju, Diana N.; Dittmann, Dominik; Hansen, Jan N.; Wachten, Dagmar] Univ Bonn, Univ Hosp, Inst Innate Immun, D-53127 Bonn, Germany; [Stern, Sina; Bradke, Frank] German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany; [Grahn, Elena; Schonauer, Sophie; Marx, Carina E.; Hamzeh, Hussein; Koerschen, Heinz G.; Boenigk, Wolfgang; Berger, Thomas K.; Wachten, Dagmar] Ctr Adv European Studies & Res Caesar, D-53175 Bonn, Germany; [Gutbrod, Katharina; Doermann, Peter] Univ Bonn, Inst Mol Physiol & Biotechnol Plants, Bonn, Germany; [Aerts, Johannes M. F. G.] Leiden Univ, Leiden Inst Chem, NL-2333 CD Leiden, Netherlands; [Endepols, Heike] Univ Hosp Cologne, Inst Radiochem & Expt Mol Imaging IREMB, D-50937 Cologne, Germany; [Endepols, Heike] Univ Hosp Cologne, Dept Nucl Med, D-50937 Cologne, Germany; [Sandhoff, Roger] German Canc Res Ctr, Dept Cellular & Mol Pathol, Heidelberg, Germany; [Sandhoff, Roger] German Canc Res Ctr, Lipid Pathobiochem Grp, D-69120 Heidelberg, Germany; [Geyer, Matthias] Univ Bonn, Univ Hosp, Inst Biol Struct, D-53127 Bonn, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR); University of Bonn; Leiden University; Leiden University - Excl LUMC; University of Cologne; University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Bonn	Wachten, D (corresponding author), Univ Bonn, Univ Hosp, Inst Innate Immun, Ctr Adv European Studies & Res Caesar, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	dwachten@uni-bonn.de	Aerts, Johannes/A-1028-2009; Endepols, Heike/AAG-7794-2020	Aerts, Johannes/0000-0001-8168-2565; Endepols, Heike/0000-0002-6166-4818; Raju, Diana/0000-0002-0482-0941; Dormann, Peter/0000-0002-5845-9370; HAMZEH, Hussein/0000-0002-3056-788X; Berger, Thomas/0000-0001-9358-1315; Grahn, Elena/0000-0002-8161-5837; Geyer, Matthias/0000-0002-7718-5002; Bradke, Frank/0000-0002-0345-3772	Deutsche Forschungsgemeinschaft (DFG) [SFB645, TRR83, SPP1926, SPP1726, FOR2743]; Fritz-Thyssen Foundation; Boehringer Ingelheim Stiftung; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC2151 390873048]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fritz-Thyssen Foundation; Boehringer Ingelheim Stiftung(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB645 (to D. W. and P. D.), TRR83 (to D. W.), SPP1926 (to D. W.), SPP1726 (to D. W.), and FOR2743 (to D. W.), the Fritz-Thyssen Foundation (to D. W.), and the Boehringer Ingelheim Stiftung (to D. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy - EXC2151 390873048.	Akiyama H, 2011, BBA-MOL CELL BIOL L, V1811, P314, DOI 10.1016/j.bbalip.2011.02.005; Artola M, 2017, ACS CENTRAL SCI, V3, P784, DOI 10.1021/acscentsci.7b00214; Aureli M, 2012, NEUROCHEM RES, V37, P1344, DOI 10.1007/s11064-012-0719-z; Bone W, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-1; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Chao DHM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138107; Charoenwattanasatien R, 2016, ACS CHEM BIOL, V11, P1891, DOI 10.1021/acschembio.6b00192; Chia PH, 2014, CELL, V156, P208, DOI 10.1016/j.cell.2013.12.009; Chiricozzi E, 2017, J NEUROCHEM, V143, P645, DOI 10.1111/jnc.14146; Citterio A, 2014, J NEUROL, V261, P373, DOI 10.1007/s00415-013-7206-6; Coarelli G, 2018, CLIN NEUROL NEUROSUR, V168, P60, DOI 10.1016/j.clineuro.2018.02.042; ESEN A, 1991, Applied and Theoretical Electrophoresis, V2, P63; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Flynn KC, 2009, DEV NEUROBIOL, V69, P761, DOI 10.1002/dneu.20734; FURUYA S, 1995, J NEUROCHEM, V65, P1551; Gudmundsson M, 2016, ACTA CRYSTALLOGR D, V72, P860, DOI 10.1107/S2059798316008482; Halling KK, 2008, BBA-BIOMEMBRANES, V1778, P1100, DOI 10.1016/j.bbamem.2008.01.001; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012; HARDING AE, 1983, LANCET, V1, P1151; HAREL R, 1993, J BIOL CHEM, V268, P14476; Haugarvoll K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169309; Hu JL, 2012, CURR BIOL, V22, P1109, DOI 10.1016/j.cub.2012.04.019; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Kuo CL, 2018, METHOD ENZYMOL, V598, P217, DOI 10.1016/bs.mie.2017.06.039; Kuter DJ, 2013, BLOOD CELL MOL DIS, V51, P116, DOI 10.1016/j.bcmd.2013.04.005; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Ly PTT, 2007, J NEUROSCI RES, V85, P231, DOI 10.1002/jnr.21147; Marques ARA, 2016, J LIPID RES, V57, P451, DOI 10.1194/jlr.M064923; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Nowak A, 2018, MOL GENET METAB, V123, P148, DOI 10.1016/j.ymgme.2017.07.002; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Pastores GM, 2009, CURR MED RES OPIN, V25, P23, DOI 10.1185/03007990802576518 ; Raju D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005063; Sandhoff R, 2002, J BIOL CHEM, V277, P20386, DOI 10.1074/jbc.M110641200; Schonauer S, 2017, J BIOL CHEM, V292, P6177, DOI 10.1074/jbc.M116.762831; Schule R, 2011, SEMIN NEUROL, V31, P484, DOI 10.1055/s-0031-1299787; Schwarz A, 1997, J NEUROSCI, V17, P2929; Shemesh E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010324.pub2; Soderblom C, 2010, NEUROGENETICS, V11, P369, DOI 10.1007/s10048-010-0252-7; Spillane Mirela, 2014, Small GTPases, V5, pe27974, DOI 10.4161/sgtp.27974; Sultana S, 2015, BIOCHEM BIOPH RES CO, V465, P35, DOI 10.1016/j.bbrc.2015.07.112; van der Spoel AC, 2008, PHARMACOGENOMICS, V9, P717, DOI 10.2217/14622416.9.6.717; van der Spoel AC, 2002, P NATL ACAD SCI USA, V99, P17173, DOI 10.1073/pnas.262586099; Votsi C, 2014, ANN HUM GENET, V78, P13, DOI 10.1111/ahg.12045; Vu HS, 2014, METHODS MOL BIOL, V1166, P199, DOI 10.1007/978-1-4939-0844-8_15; Walden CM, 2007, J BIOL CHEM, V282, P32655, DOI 10.1074/jbc.M702387200; Walden CM, 2006, HUM REPROD, V21, P1309, DOI 10.1093/humrep/dei463; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Woeste MA, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00386; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Yildiz Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-151	53	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					3853	3871		10.1074/jbc.RA118.006311	http://dx.doi.org/10.1074/jbc.RA118.006311			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30662006	Green Published, hybrid			2022-12-28	WOS:000461854400005
J	Wu, Y; Zhang, JZ; Fang, L; Lee, HC; Zhao, YJ				Wu, Yang; Zhang, Jingzi; Fang, Lei; Lee, Hon Cheung; Zhao, Yong Juan			A cytosolic chaperone complex controls folding and degradation of type III CD38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD38; chaperone; heat shock protein (HSP); protein degradation; protein folding; cyclic ADP ribose (cADPR); heat shock protein 90 (Hsp90); cytosolic soluble CD38; hsp70; Hsp70-interacting protein (Hip); lysosomal degradation; type III CD38	CYCLIC ADP-RIBOSE; HEAT-SHOCK-PROTEIN; ACTIVATION; HIP; INHIBITION; HYDROLYSIS; EXPRESSION; MATURATION; HSP90; HSP70	Cluster of differentiation 38 (CD38) is the best-studied enzyme catalyzing the synthesis of the Ca2+ messenger cyclic ADP-ribose. It is a single-pass transmembrane protein, but possesses dual orientations. We have documented the natural existence of type III CD38 in cells and shown that it is regulated by a cytosolic activator, calcium- and integrin-binding 1 (CIB1). However, how type III CD38 can be folded correctly in the reductive cytosol has not been addressed. Using the yeast two-hybrid technique with CD38's catalytic domain (sCD38) as bait, here we identified a chaperone, Hsp70-interacting protein (Hip), that specifically interacts with both the type III CD38 and sCD38. Immunoprecipitation coupled with MS identified a chaperone complex associated specifically with sCD38. Pharmacological and siRNA-mediated knockdown of Hsp90 chaperones decreased the expression levels of both sCD38 and type III CD38, suggesting that these chaperones facilitate their folding. Moreover, knockdown of Hsc70 or DNAJA2 increased the levels of both CD38 types, consistent with the roles of these proteins in mediating CD38 degradation. Notably, Hip knockdown decreased type III CD38 substantially, but only marginally affected sCD38, indicating that Hip was selective for the former. More remarkably, DNAJA1 knockdown decreased sCD38 but increased type III CD38 levels. Mechanistically, we show that Hsc70 mediates lysosomal degradation of type III CD38, requiring the lysosomal receptor Lamp2A and the C19-motif in the C terminus of CD38. Our results indicate that folding and degradation of type III CD38 is effectively controlled in cells, providing further strong support of its physiological relevance.	[Wu, Yang; Lee, Hon Cheung; Zhao, Yong Juan] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Gen, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China; [Zhang, Jingzi; Fang, Lei] Nanjing Univ, Med Sch, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China	Peking University; University Town of Shenzhen; Nanjing University	Lee, HC; Zhao, YJ (corresponding author), Peking Univ, Shenzhen Grad Sch, Key Lab Chem Gen, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China.; Fang, L (corresponding author), Nanjing Univ, Med Sch, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China.	njfanglei@nju.edu.cn; leehoncheung@gmail.com; zhaoyongjuan@pku.edu.cn	Lee, Hon Cheung/C-4329-2009; Zhao, Yongjuan/AAS-9919-2021	Zhao, Yong Juan/0000-0003-4564-1912; Fang, Lei/0000-0002-2582-4845	Shenzhen Governments Grants [JCYJ20160608091848749, JCYJ20170412150609690]; National Science Foundation of China [31571438, 31671463, 31500664, 31770838]; Natural Science Foundation of Jiangsu Province [BK20171338]; Fundamental Research Funds for the Central Universities [021414380334]	Shenzhen Governments Grants; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by Shenzhen Governments Grants JCYJ20160608091848749 (to Y. J. Z.) and JCYJ20170412150609690 (to H. C. L.); National Science Foundation of China Grants 31571438 (to Y. J. Z.), 31671463 (to H. C. L.), and 31500664 and 31770838 (to L. F.); Natural Science Foundation of Jiangsu Province Grant BK20171338 (to L. F.); and the Fundamental Research Funds for the Central Universities Grant 021414380334 (to L. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abisambra JF, 2012, J MOL BIOL, V421, P653, DOI 10.1016/j.jmb.2012.02.003; Avci D, 2015, TRENDS CELL BIOL, V25, P611, DOI 10.1016/j.tcb.2015.07.003; Craig EA, 2017, TRENDS BIOCHEM SCI, V42, P355, DOI 10.1016/j.tibs.2017.02.007; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; DICE JF, 1982, J BIOL CHEM, V257, P4624; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Durig J, 2002, LEUKEMIA, V16, P30, DOI 10.1038/sj.leu.2402339; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Fang L, 2012, MOL CELL PROTEOMICS, V11, P138, DOI 10.1074/mcp.M111.016352; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; HOHFELD J, 1995, CELL, V83, P589; Hoshino S, 1997, J IMMUNOL, V158, P741; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liu J, 2017, P NATL ACAD SCI USA, V114, P8283, DOI 10.1073/pnas.1703718114; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; Mo Y, 1996, Zhonghua Zhong Liu Za Zhi, V18, P241; Nelson GM, 2004, MOL ENDOCRINOL, V18, P1620, DOI 10.1210/me.2004-0054; Noormohammadi A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13649; Orthwein A, 2012, EMBO J, V31, P679, DOI 10.1038/emboj.2011.417; Parrales A, 2016, NAT CELL BIOL, V18, P1233, DOI 10.1038/ncb3427; Pedrozo Z, 2013, CARDIOVASC RES, V98, P277, DOI 10.1093/cvr/cvt029; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; RUIZARGUELLES GJ, 1994, MAYO CLIN PROC, V69, P684, DOI 10.1016/S0025-6196(12)61350-0; Shen SS, 2009, J CELL BIOL, V185, P629, DOI 10.1083/jcb.200810183; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Terada K, 2010, J BIOL CHEM, V285, P16789, DOI 10.1074/jbc.M110.101501; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zhao YJ, 2015, BBA-MOL CELL RES, V1853, P2095, DOI 10.1016/j.bbamcr.2014.10.028; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700; Zhao YJ, 2011, J BIOL CHEM, V286, P22170, DOI 10.1074/jbc.M111.228379	44	5	5	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4247	4258		10.1074/jbc.RA118.005844	http://dx.doi.org/10.1074/jbc.RA118.005844			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30670591	Green Published, hybrid			2022-12-28	WOS:000461854400034
J	Gierasch, LM; Guengerich, FP				Gierasch, Lila M.; Guengerich, F. Peter			Celebrating the scientific legacy of Herbert Tabor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item							ESCHERICHIA-COLI; ROLES		[Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Vanderbilt University	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.; Gierasch, LM (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.			Gierasch, Lila/0000-0002-5706-115X				Bond JS, 2019, J BIOL CHEM, V294, P1643, DOI 10.1074/jbc.TM118.004156; Carman GM, 2019, J BIOL CHEM, V294, P1681, DOI 10.1074/jbc.TM118.004159; Chattopadhyay MK, 2015, J BIOL CHEM, V290, P17809, DOI 10.1074/jbc.M115.655688; Gierasch LM, 2018, J BIOL CHEM, V293, P18803, DOI 10.1074/jbc.E118.006720; Gottesfeld JM, 2019, J BIOL CHEM, V294, P1652, DOI 10.1074/jbc.TM118.004162; Guengerich FP, 2019, J BIOL CHEM, V294, P1671, DOI 10.1074/jbc.TM118.004144; Hascall VC, 2019, J BIOL CHEM, V294, P1690, DOI 10.1074/jbc.TM118.005836; Mushegian S., 2018, ASBMB TODAY; Oldach L., 2018, ASBMB TODAY; Pegg AE, 2018, J BIOL CHEM, V293, P18681, DOI 10.1074/jbc.TM118.006291; Pfeffer SR, 2019, J BIOL CHEM, V294, P1706, DOI 10.1074/jbc.TM118.004165; Sack J, 2019, J BIOL CHEM, V294, P1721, DOI 10.1074/jbc.TME118.005088; Samuel CE, 2019, J BIOL CHEM, V294, P1710, DOI 10.1074/jbc.TM118.004166; Smith WL, 2019, J BIOL CHEM, V294, P1697, DOI 10.1074/jbc.TM118.006295; TABOR CW, 1987, J BIOL CHEM, V262, P16037; Tabor CW, 1999, ANNU REV BIOCHEM, V68, P1, DOI 10.1146/annurev.biochem.68.1.1; TABOR H, 1958, J BIOL CHEM, V233, P907; Wickner RB, 2019, J BIOL CHEM, V294, P1729, DOI 10.1074/jbc.TM118.004168; Worby CA, 2019, J BIOL CHEM, V294, P1638, DOI 10.1074/jbc.TME118.004161; Zurawski Z, 2019, J BIOL CHEM, V294, P1661, DOI 10.1074/jbc.TM118.004163	20	1	1	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1635	1637		10.1074/jbc.TME119.007427	http://dx.doi.org/10.1074/jbc.TME119.007427			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710010	Green Published, hybrid			2022-12-28	WOS:000457879200021
J	Wickner, RB				Wickner, Reed B.			Anti-prion systems in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						amyloid; inositol phosphate; prion; chaperone; innate immunity; in-register parallel; Upf proteins; Siw14; Hsp104; Btn2; Cur1; [URE3]; [PSI plus ]	MESSENGER-RNA DECAY; PARALLEL BETA-SHEET; PSI+ PRION; SACCHAROMYCES-CEREVISIAE; URE3 PRION; IN-VITRO; GUANIDINE-HYDROCHLORIDE; ALZHEIMERS-DISEASE; TRANSLATION TERMINATION; PROTEIN DISAGGREGATION	Yeast prions have become important models for the study of the basic mechanisms underlying human amyloid diseases. Yeast prions are pathogenic (unlike the [Het-s] prion of Podospora anserina), and most are amyloid-based with the same in-register parallel beta-sheet architecture as most of the disease-causing human amyloids studied. Normal yeast cells eliminate the large majority of prion variants arising, and several anti-prion/anti-amyloid systems that eliminate them have been identified. It is likely that mammalian cells also have anti-amyloid systems, which may be useful in the same way humoral, cellular, and innate immune systems are used to treat or prevent bacterial and viral infections.	[Wickner, Reed B.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wickner, RB (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.	wickner@helix.nih.gov			Intramural Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024950] Funding Source: NIH RePORTER	Intramural Program of the NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Program of the NIDDK, National Institutes of Health. This JBC Review is part of a collection honoring Herbert Tabor on the occasion of his 100th birthday. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; Amor AJ, 2015, PRION, V9, P144, DOI 10.1080/19336896.2015.1022022; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Ayers JI, 2016, ACTA NEUROPATHOL, V131, P103, DOI 10.1007/s00401-015-1514-0; Barbitoff YA, 2017, MOL MICROBIOL, V105, P242, DOI 10.1111/mmi.13697; Bateman DA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003257; Bateman DA, 2012, GENETICS, V190, P569, DOI 10.1534/genetics.111.136655; Bateman DA, 2011, BIOPHYS J, V101, P2485, DOI 10.1016/j.bpj.2011.10.009; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bradley ME, 2004, MOL MICROBIOL, V51, P1649, DOI 10.1111/j.1365-2958.2003.03955.x; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Chacinska A, 2001, CURR GENET, V39, P62, DOI 10.1007/s002940000180; Chang HY, 2008, P NATL ACAD SCI USA, V105, P13345, DOI 10.1073/pnas.0802215105; Chattopadhyay S, 2002, EUKARYOT CELL, V1, P606, DOI 10.1128/EC.1.4.606-612.2002; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chernoff YO, 2016, CURR GENET, V62, P677, DOI 10.1007/s00294-016-0586-2; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Cox B, 2003, GENETICS, V165, P23; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; DOEL SM, 1994, GENETICS, V137, P659; Du ZQ, 2017, MOL MICROBIOL, V104, P105, DOI 10.1111/mmi.13616; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Edskes HK, 2018, GENETICS, V209, P789, DOI 10.1534/genetics.118.300981; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Gorkovskiy A, 2017, P NATL ACAD SCI USA, V114, pE4193, DOI 10.1073/pnas.1704016114; Gorkovskiy A, 2014, P NATL ACAD SCI USA, V111, pE4615, DOI 10.1073/pnas.1417974111; Greene LE, 2018, PRION, V12, P9, DOI 10.1080/19336896.2017.1412911; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hatch Ace J., 2017, Advances in Biological Regulation, V64, P9, DOI 10.1016/j.jbior.2017.03.001; He F, 2015, ANNU REV GENET, V49, P339, DOI 10.1146/annurev-genet-112414-054639; He F, 2013, MOL CELL BIOL, V33, P4672, DOI 10.1128/MCB.01136-13; Helsen CW, 2012, J BIOL CHEM, V287, P542, DOI 10.1074/jbc.M111.302869; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jonkers W, 2009, EUKARYOT CELL, V8, P677, DOI 10.1128/EC.00386-08; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kama R, 2007, MOL CELL BIOL, V27, P605, DOI 10.1128/MCB.00699-06; Kanneganti V, 2011, MOL BIOL CELL, V22, P1648, DOI 10.1091/mbc.E10-11-0878; Kelly AC, 2012, P NATL ACAD SCI USA, V109, pE2683, DOI 10.1073/pnas.1213449109; Kiktev DA, 2015, MOL MICROBIOL, V96, P621, DOI 10.1111/mmi.12960; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kirkland PA, 2011, GENETICS, V188, P565, DOI 10.1534/genetics.111.129460; KISILEVSKY R, 1983, LAB INVEST, V48, P53; Kisilevsky R, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00017; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Kryndushkin D, 2012, MOL MICROBIOL, V86, P1531, DOI 10.1111/mmi.12075; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Ladner CL, 2010, J BIOL CHEM, V285, P17137, DOI 10.1074/jbc.M110.117234; Li X, 2014, MOL CELL, V55, P305, DOI 10.1016/j.molcel.2014.05.027; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Masison DC, 2015, PRION, V9, P174, DOI 10.1080/19336896.2015.1027856; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Matveenko AG, 2018, CURR GENET, V64, P317, DOI 10.1007/s00294-017-0750-3; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Mogk A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00022; Moreno-Gonzalez I, 2017, MOL PSYCHIATR, V22, P1327, DOI 10.1038/mp.2016.230; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Mukherjee A, 2017, J EXP MED, V214, P2591, DOI 10.1084/jem.20161134; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Ness F, 2017, MOL MICROBIOL, V104, P125, DOI 10.1111/mmi.13617; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; Roberts BT, 2004, YEAST, V21, P107, DOI 10.1002/yea.1062; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Serag AA, 2002, NAT STRUCT BIOL, V9, P734, DOI 10.1038/nsb838; Shears SB, 2018, J CELL PHYSIOL, V233, P1897, DOI 10.1002/jcp.26017; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Shewmaker F, 2007, GENETICS, V176, P1557, DOI 10.1534/genetics.107.074153; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Son M, 2018, P NATL ACAD SCI USA, V115, pE1184, DOI 10.1073/pnas.1717495115; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Steidle EA, 2016, J BIOL CHEM, V291, P6772, DOI 10.1074/jbc.M116.714907; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Toombs JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021953; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Westermark GT, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024323; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2008, BIOESSAYS, V30, P955, DOI 10.1002/bies.20821; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wickner RB, 2018, BIOCHEMISTRY-US, V57, P1285, DOI 10.1021/acs.biochem.7b01285; Wickner RB, 2017, P NATL ACAD SCI USA, V114, pE8402, DOI 10.1073/pnas.1714361114; Wickner RB, 2015, MICROBIOL MOL BIOL R, V79, P1, DOI 10.1128/MMBR.00041-14; Wickner RB, 2014, P NATL ACAD SCI USA, V111, pE2711, DOI 10.1073/pnas.1409582111; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Winkler J, 2012, J STRUCT BIOL, V179, P152, DOI 10.1016/j.jsb.2012.05.002; Wu MX, 2016, P NATL ACAD SCI USA, V113, pE6757, DOI 10.1073/pnas.1606853113; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	142	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2019	294	5					1729	1738		10.1074/jbc.TM118.004168	http://dx.doi.org/10.1074/jbc.TM118.004168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GC	30710020	Green Published, hybrid			2022-12-28	WOS:000457879200033
J	Dong, XF; Yu, SR; Wang, Y; Yang, M; Xiong, J; Hei, N; Dong, B; Su, Q; Chen, J				Dong, Xuefei; Yu, Shiran; Wang, Ying; Yang, Min; Xiong, Jie; Hei, Naier; Dong, Bo; Su, Qing; Chen, Jing			(Pro)renin receptor-mediated myocardial injury, apoptosis, and inflammatory response in rats with diabetic cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; cardiomyopathy; apoptosis; oxidative stress; inflammation; (pro)renin receptor; myocardial injury	ACTIVATION; SYSTEM	Excessive activation of the renin-angiotensin system (RAS) in diabetic cardiomyopathy (DCM) provokes a series of structural and functional abnormalities, and causes ventricular remodeling and heart failure in diabetes. (Pro)renin receptor (PRR) is a component of the RAS and has been reported to be up-regulated in some cardiovascular diseases. Furthermore, PRR blockade in some cardiovascular diseases, such as myocardial infarction and hypertension, has been demonstrated to reverse their pathogenesis. However, there have been few studies about the function of PRR in the pathogenesis of DCM. In this study, we hypothesized that PRR is involved in the pathogenesis of DCM and mediates myocardial injury in DCM. To explore the role of PRR in DCM, we evaluated the effects of PRR overexpression and knockdown on the DCM phenotype in vivo and in vitro. The results show that PRR overexpression exacerbates myocardial injury and the inflammatory response in rats with DCM. Conversely, PRR knockdown alleviates myocardial fibrosis, apoptosis, and the inflammatory response, reversing the cardiac dysfunction in rats with DCM. In cell experiments, PRR overexpression also up-regulated the protein expression of collagen I and fibronectin, aggravated the inflammatory response, and increased the production of reactive oxygen species, whereas PRR knockdown had the opposite effect. Thus, PRR mediates myocardial injury, apoptosis, and the inflammatory response, likely through a PRR/extracellular signal-regulated kinase/reactive oxygen species pathway.	[Dong, Xuefei; Yu, Shiran; Wang, Ying; Yang, Min; Xiong, Jie; Hei, Naier; Dong, Bo] Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan 250012, Shandong, Peoples R China; [Yu, Shiran; Dong, Bo] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Dong, Xuefei] Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England; [Yang, Min] Third Hosp Jinan, Dept Lab, Jinan 250132, Shandong, Peoples R China; [Su, Qing] Shanghai Jiao Tong Univ, Dept Endocrinol, Sch Med, Xinhua Hosp, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China; [Chen, Jing] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Chen, Jing] Jining Med Univ, Jining 272113, Peoples R China; [Wang, Ying] Dezhou Municipal Hosp, Dezhou City 253012, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; University of Hull; Shanghai Jiao Tong University; University of Warwick; Jining Medical University	Su, Q (corresponding author), Shanghai Jiao Tong Univ, Dept Endocrinol, Sch Med, Xinhua Hosp, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.; Chen, J (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.; Dong, B (corresponding author), Shandong Univ, Shandong Prov Hosp, 324,Jing 5 Rd, Jinan 250012, Shandong, Peoples R China.	bodong@sdu.edu.cn; suqing@xinhuamed.com.cn; Jing.Chen@warwick.ac.uk		Chen, Jing/0000-0002-9636-9034	National Natural Science Foundation of China [81870283, 81570729, 81170207]; Program of State Chinese Medicine Administration Bureau [JDZX2012113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of State Chinese Medicine Administration Bureau	This work was supported by National Natural Science Foundation of China Grants 81870283, 81570729, and 81170207 and Program of State Chinese Medicine Administration Bureau Grant JDZX2012113. The authors declare that they have no conflicts of interest with the contents of this article.	Batenburg WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100954; Connelly KA, 2011, J HYPERTENS, V29, P1175, DOI 10.1097/HJH.0b013e3283462674; Danser AHJ, 2015, AM J HYPERTENS, V28, P1187, DOI 10.1093/ajh/hpv045; Ellmers LJ, 2016, J CARD FAIL, V22, P64, DOI 10.1016/j.cardfail.2015.08.341; Gong LH, 2019, PEPTIDES, V111, P152, DOI 10.1016/j.peptides.2018.04.010; Gonzalez AA, 2017, CLIN EXP PHARMACOL P, V44, P1134, DOI 10.1111/1440-1681.12813; He M, 2009, EUR J PHARMACOL, V606, P155, DOI 10.1016/j.ejphar.2008.12.050; Huber MJ, 2015, AM J PHYSIOL-HEART C, V309, pH880, DOI 10.1152/ajpheart.00095.2015; Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586; Kanda A, 2019, J DIABETES INVEST, V10, P6, DOI 10.1111/jdi.12842; Mizamtsidi M, 2016, EUR J CLIN INVEST, V46, P947, DOI 10.1111/eci.12673; Palomer X, 2018, TRENDS PHARMACOL SCI, V39, P452, DOI 10.1016/j.tips.2018.02.010; Rafiq K, 2013, MOL CELL ENDOCRINOL, V378, P41, DOI 10.1016/j.mce.2012.05.016; Rani MRP, 2018, BIOMED PHARMACOTHER, V100, P467, DOI 10.1016/j.biopha.2018.02.027; Ribeiro AA, 2018, INT J BIOL MACROMOL, V108, P817, DOI 10.1016/j.ijbiomac.2017.10.179; Singh VP, 2008, AM J PHYSIOL-HEART C, V294, pH1675, DOI 10.1152/ajpheart.91493.2007; Sivasankar D, 2018, BIOMED PHARMACOTHER, V106, P1039, DOI 10.1016/j.biopha.2018.07.051; Tian JF, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8214541; Xu QB, 2016, PHARMACOL THERAPEUT, V164, P126, DOI 10.1016/j.pharmthera.2016.04.006; Zhang L, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0849-1; Zhang L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00758	21	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8218	8226		10.1074/jbc.RA119.007648	http://dx.doi.org/10.1074/jbc.RA119.007648			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30952701	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000470656500019
J	Gyimesi, G; Albano, G; Fuster, DG; Hediger, MA; Pujol-Gimenez, J				Gyimesi, Gergely; Albano, Giuseppe; Fuster, Daniel G.; Hediger, Matthias A.; Pujol-Gimenez, Jonai			Unraveling the structural elements of pH sensitivity and substrate binding in the human zinc transporter SLC39A2 (ZIP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						zinc; membrane transport; homology modeling; structure-function; site-directed mutagenesis; metal homeostasis; SLC; ZIP	PROSTATE-CANCER; PROTEIN; EXPRESSION; FAMILY; ROLES	The transport and ion-coupling mechanisms of ZIP transporters remain largely uncharacterized. Previous work in our laboratory has revealed that the solute carrier family 39 member A2 (SLC39A2/ZIP2) increases its substrate transport rate in the presence of extracellular H+. Here, we used a combination of in silico and in vitro techniques involving structural modeling, mutagenesis, and functional characterization in HEK293 cells to identify amino acid residues potentially relevant for both the ZIP2-H+ interaction and substrate binding. Our ZIP2 models revealed a cluster of charged residues close to the substrate-translocation pore. Interestingly, the H63A substitution completely abrogated pH sensitivity, and substitutions of Glu-67 and Phe-269 altered the pH and voltage modulation of transport. In contrast, substitution of Glu-106, which might be part of a dimerization interface, altered pH but not voltage modulation. Substitution of Phe-269, located close to the substrate-binding site, also affected substrate selectivity. These findings were supported by an additional model of ZIP2 that was based on the structure of a prokaryotic homolog, Bordetella bronchiseptica ZrT/Irt-like protein (bbZIP), and in silico pK(a) calculations. We also found that residues Glu-179, His-175, His-202, and Glu-276 are directly involved in the coordination of the substrate metal ion. We noted that, unlike bbZIP, human ZIP2 is predicted to harbor a single divalent metal-binding site, with the charged side chain of Lys-203 replacing the second bound ion. Our results provide the first structural evidence for the previously observed pH and voltage modulation of ZIP2-mediated metal transport, identify the substrate-binding site, and suggest a structure-based transport mechanism for the ZIP2 transporter.	[Gyimesi, Gergely; Albano, Giuseppe; Fuster, Daniel G.; Hediger, Matthias A.; Pujol-Gimenez, Jonai] Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland; [Gyimesi, Gergely; Albano, Giuseppe; Fuster, Daniel G.; Hediger, Matthias A.; Pujol-Gimenez, Jonai] NCCR TransCure, Natl Ctr Competence Res, Buhlstr 28, CH-3012 Bern, Switzerland; [Gyimesi, Gergely; Albano, Giuseppe; Fuster, Daniel G.; Hediger, Matthias A.; Pujol-Gimenez, Jonai] Univ Bern, Univ Hosp Bern, Dept Hypertens & Nephrol, Inselspital, Freiburgstr 18, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Hediger, MA; Pujol-Gimenez, J (corresponding author), Univ Bern, Univ Hosp Bern, Dept Hypertens & Nephrol, Inselspital, Freiburgstr 18, CH-3010 Bern, Switzerland.	matthias.hediger@ibmm.unibe.ch; jonai.pujol@dbmr.unibe.ch	Gyimesi, Gergely/AAL-7340-2021; Fuster, Daniel G/AAA-7079-2021	Gyimesi, Gergely/0000-0002-2054-4633; Fuster, Daniel G/0000-0001-7220-1803; Hediger, Matthias/0000-0003-1946-027X; Pujol, Jonai/0000-0002-9951-1390	Swiss National Centre of Competence in Research (NCCR); Swiss National Science Foundation (SNF) [31003A_156376, 310030_18272]	Swiss National Centre of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Centre of Competence in Research (NCCR) and Swiss National Science Foundation (SNF) Grants 31003A_156376 and 310030_18272 (to M. A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; Antala S, 2015, J BIOL CHEM, V290, P17796, DOI 10.1074/jbc.M114.617613; Bafaro E, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.29; Baltaci AK, 2018, NEUROCHEM RES, V43, P517, DOI 10.1007/s11064-017-2454-y; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cao J, 2001, J LEUKOCYTE BIOL, V70, P559; Cong Q, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-82; Costello LC, 2011, CANCER BIOL THER, V12, P1078, DOI 10.4161/cbt.12.12.18367; Cousins RJ, 2003, P NATL ACAD SCI USA, V100, P6952, DOI 10.1073/pnas.0732111100; Desouki MM, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-37; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Franklin RB, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-32; Franz MC, 2013, MOL ASPECTS MED, V34, P735, DOI 10.1016/j.mam.2012.11.007; Franz MC, 2018, BIOCHEMISTRY-US, V57, P3976, DOI 10.1021/acs.biochem.8b00511; Franz MC, 2014, J BIOMOL SCREEN, V19, P909, DOI 10.1177/1087057114526781; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Hamon R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110056; Hara T, 2017, J PHYSIOL SCI, V67, P283, DOI 10.1007/s12576-017-0521-4; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Inoue Y, 2014, J BIOL CHEM, V289, P21451, DOI 10.1074/jbc.M114.560821; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Johnson LA, 2010, METHODS, V52, P316, DOI 10.1016/j.ymeth.2010.08.004; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Marcoline FV, 2015, STRUCTURE, V23, P1526, DOI 10.1016/j.str.2015.05.014; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pujol-Gimenez J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06446-y; Rishi I, 2003, APPL IMMUNOHISTO M M, V11, P253; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057731; Tao YT, 2013, MOL BIOL REP, V40, P4979, DOI 10.1007/s11033-013-2598-z; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344	47	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8046	8063		10.1074/jbc.RA118.006113	http://dx.doi.org/10.1074/jbc.RA118.006113			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30914478	Green Published, hybrid			2022-12-28	WOS:000470656500008
J	Hong, SM; Lee, YK; Park, I; Kwon, SM; Min, S; Yoon, G				Hong, Sun Mi; Lee, Young-Kyoung; Park, Imkyong; Kwon, So Mee; Min, Seongki; Yoon, Gyesoon			Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatocellular carcinoma; lactic acid; mitochondria; pyruvate dehydrogenase complex (PDC); liver cancer; mitochondrial respiratory chain complex	MONOCARBOXYLATE TRANSPORTERS MCTS; CANCER; HYPOXIA; DYSFUNCTION; METABOLISM; TARGET; MYC; PROMOTES; ISOENZYMES; SIGNATURE	Aerobic glycolysis and mitochondrial dysfunction are key metabolic features of cancer cells, but their interplay during cancer development remains unclear. We previously reported that human hepatoma cells with mitochondrial defects exhibit down-regulated lactate dehydrogenase subunit B (LDHB) expression. Here, using several molecular and biochemical assays and informatics analyses, we investigated how LDHB suppression regulates mitochondrial respiratory activity and contributes to liver cancer progression. We found that transcriptional LDHB down-regulation is an upstream event during suppressed oxidative phosphorylation. We also observed that LDHB knockdown increases inhibitory phosphorylation of pyruvate dehydrogenase (PDH) via lactate-mediated PDH kinase (PDK) activation and thereby attenuates oxidative phosphorylation activity. Interestingly, monocarboxylate transporter 1 was the major lactate transporter in hepatoma cells, and its expression was essential for PDH phosphorylation by modulating intracellular lactate levels. Finally, bioinformatics analysis of the hepatocellular carcinoma cohort from The Cancer Genome Atlas revealed that a low LDHB/LDHA ratio is statistically significantly associated with poor prognostic outcomes. A low ratio was also associated with a significant enrichment in glycolysis genes and negatively correlated with PDK1 and 2 expression, supporting a close link between LDHB suppression and the PDK-PDH axis. These results suggest that LDHB suppression is a key mechanism that enhances glycolysis and is critically involved in the maintenance and propagation of mitochondrial dysfunction via lactate release in liver cancer progression.	[Hong, Sun Mi; Lee, Young-Kyoung; Park, Imkyong; Kwon, So Mee; Min, Seongki; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea; [Hong, Sun Mi; Park, Imkyong; Min, Seongki; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biomed Sci BK21 Plus, Suwon 16499, South Korea	Ajou University; Ajou University	Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea.	ypeace@ajou.ac.kr			Basic Science Research Program through the National Research Foundation - Ministry of Science, ICT, and Future Planning of Korea [2012R1A5A2048183, 2015R1A2 A1A10055038, 2016R1A6A3A11932420]	Basic Science Research Program through the National Research Foundation - Ministry of Science, ICT, and Future Planning of Korea	This work was supported by Grants 2012R1A5A2048183, 2015R1A2 A1A10055038, and 2016R1A6A3A11932420 from the Basic Science Research Program through the National Research Foundation funded by the Ministry of Science, ICT, and Future Planning of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Chang CJ, 2009, CELL MOL LIFE SCI, V66, P1755, DOI 10.1007/s00018-009-8767-5; Chen EI, 2012, J BIOENERG BIOMEMBR, V44, P619, DOI 10.1007/s10863-012-9465-9; Cuezva JM, 2002, CANCER RES, V62, P6674; Cui JJ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0589-8; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 1999, MOL CELL BIOL, V19, P1; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; Enerson BE, 2003, J PHARM SCI-US, V92, P1531, DOI 10.1002/jps.10389; Fan J, 2014, J BIOL CHEM, V289, P26533, DOI 10.1074/jbc.M114.593970; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Guo M, 2006, APOPTOSIS, V11, P67, DOI 10.1007/s10495-005-3085-3; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Hsu CC, 2016, EXP BIOL MED, V241, P1281, DOI 10.1177/1535370216641787; Hung WY, 2012, BBA-GEN SUBJECTS, V1820, P1102, DOI 10.1016/j.bbagen.2012.04.016; Ji YP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15308; Jin L, 2017, ONCOGENE, V36, P3797, DOI 10.1038/onc.2017.6; Kamp WM, 2016, CURR OPIN GENET DEV, V38, P16, DOI 10.1016/j.gde.2016.02.007; Kato Y, 2018, JPN DENT SCI REV, V54, P8, DOI 10.1016/j.jdsr.2017.08.003; Kim JH, 2011, AUTOPHAGY, V7, P1187, DOI 10.4161/auto.7.10.16643; Kim JH, 2011, EXP CELL RES, V317, P1108, DOI 10.1016/j.yexcr.2011.02.011; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2005, CLIN EXP METASTAS, V22, P25, DOI 10.1007/s10585-005-2343-7; Lee DC, 2015, CELL, V161, P595, DOI 10.1016/j.cell.2015.03.011; Lee YK, 2017, J BIOL CHEM, V292, P20208, DOI 10.1074/jbc.M117.809012; Lee YK, 2015, HEPATOLOGY, V62, P1174, DOI 10.1002/hep.27976; Lewis BC, 2000, CANCER RES, V60, P6178; Lutz NW, 2013, CANCER RES, V73, P4616, DOI 10.1158/0008-5472.CAN-13-0767; Ma JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064912; Maekawa M, 2003, CLIN CHEM, V49, P1518, DOI 10.1373/49.9.1518; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Miranda-Goncalves V, 2013, NEURO-ONCOLOGY, V15, P172, DOI 10.1093/neuonc/nos298; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Perez-Escuredo J, 2016, BBA-MOL CELL RES, V1863, P2481, DOI 10.1016/j.bbamcr.2016.03.013; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Romero-Garcia S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00052; Ruan GX, 2013, J BIOL CHEM, V288, P21161, DOI 10.1074/jbc.M113.474619; San-Millan I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127; Saunier E, 2016, INT J CANCER, V138, P809, DOI 10.1002/ijc.29564; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043; Srinivasan S, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1085120; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Valvona CJ, 2016, BRAIN PATHOL, V26, P3, DOI 10.1111/bpa.12299; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	55	15	16	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7810	7820		10.1074/jbc.RA118.006095	http://dx.doi.org/10.1074/jbc.RA118.006095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30923124	Green Published, hybrid			2022-12-28	WOS:000470153300023
J	Ali, A; Farooqui, SR; Banerjea, AC				Ali, Amjad; Farooqui, Sabihur Rahman; Banerjea, Akhil C.			The host cell ubiquitin ligase protein CHIP is a potent suppressor of HIV-1 replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral replication; viral protein; ubiquitylation (ubiquitination); protein degradation; proteasome	INHIBITS HIV-1; TAT PROTEIN; PROTEASOME; CHAPERONE; P53; IDENTIFICATION; DEGRADATION; EXPRESSION; INFECTION; APOPTOSIS	Human immunodeficiency virus-1 (HIV-1) Tat is degraded in the host cell both by proteasomal and lysosomal pathways, but the specific molecules that engage with Tat from these pathways are not known. Because E3 ubiquitin ligases are the primary determinants of substrate specificity within the ubiquitin-dependent proteasomal degradation of proteins, we first sought to identify the E3 ligase associated with Tat degradation. Based on the intrinsic disordered nature of Tat protein, we focused our attention on host cell E3 ubiquitin ligase CHIP (C terminus of HSP70-binding protein). Co-transfection of Tat with a CHIP-expressing plasmid decreased the levels of Tat protein in a dose-dependent manner, without affecting the corresponding mRNA levels. Additionally, the rate of Tat protein degradation as measured by cycloheximide (CHX) chase assay was increased in the presence of CHIP. A CHIP mutant lacking the U-box domain, which is responsible for protein ubiquitination (CHIPU-box), was unable to degrade Tat protein. Furthermore, CHIP promoted ubiquitination of Tat by both WT as well as Lys-48-ubiquitin, which has only a single lysine residue at position 48. CHIP transfection in HIV-1 reporter TZM-bl cells resulted in decreased Tat-dependent HIV-1 long-terminal repeat (LTR) promoter transactivation as well as HIV-1 virion production. CHIP knockdown in HEK-293T cells using CRISPR-Cas9 led to higher virion production and enhanced Tat-mediated HIV-1 LTR promoter transactivation, along with stabilization of Tat protein. Together, these results suggest a novel role of host cell E3 ubiquitin ligase protein CHIP in regulating HIV-1 replication through ubiquitin-dependent degradation of its regulatory protein Tat.	[Ali, Amjad; Farooqui, Sabihur Rahman; Banerjea, Akhil C.] Natl Inst Immunol, Virol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India; [Ali, Amjad; Farooqui, Sabihur Rahman] Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jamia Millia Islamia	Ali, A; Banerjea, AC (corresponding author), Natl Inst Immunol, Virol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.; Ali, A (corresponding author), Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India.	amjad139@gmail.com; akhil@nii.res.in		FAROOQUI, SABIHUR/0000-0003-3779-4644	Indian Council of Medical Research of Government of India [BT/PR8322/Med/-14/1245/2006, BT/PR1800/AGR/36/676/2011, HIV/50/142/9/2011-ECD-II]; Department of Biotechnology	Indian Council of Medical Research of Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology	This work was supported by Department of Biotechnology and Indian Council of Medical Research of Government of India Grants BT/PR8322/Med/-14/1245/2006, BT/PR1800/AGR/36/676/2011, and HIV/50/142/9/2011-ECD-II. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27539; Arora S, 2014, J VIROL, V88, P9141, DOI 10.1128/JVI.00619-14; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Boban M, 2015, J BIOL CHEM, V290, P2489, DOI 10.1074/jbc.M114.600593; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Faust TB, 2018, ELIFE, V7, DOI 10.7554/eLife.31879; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Germini D, 2017, LEUKEMIA, V31, P2515, DOI 10.1038/leu.2017.106; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Harwig A, 2016, NUCLEIC ACIDS RES, V44, P4340, DOI 10.1093/nar/gkw167; Hategan A, 2017, NAT STRUCT MOL BIOL, V24, P379, DOI 10.1038/nsmb.3379; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Izumi T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-1; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Kim JM, 2017, RNA BIOL, V14, P926, DOI 10.1080/15476286.2017.1311455; Lata S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8244; Li J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11730; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Minami R, 2006, CELL IMMUNOL, V243, P41, DOI 10.1016/j.cellimm.2006.11.003; Mueller N, 2018, J VIROL, V92, DOI 10.1128/JVI.01855-17; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Raja R, 2017, BIOCHEM J, V474, P2449, DOI 10.1042/BCJ20160825; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Remoli AL, 2016, MBIO, V7, DOI 10.1128/mBio.01528-16; Sagnier S, 2015, J VIROL, V89, P615, DOI 10.1128/JVI.02174-14; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Shojania S, 2010, PROTEIN PEPTIDE LETT, V17, P999, DOI 10.2174/092986610791498993; Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023; Verhoef K, 1997, VIROLOGY, V237, P228, DOI 10.1006/viro.1997.8786; Verma S, 2011, BLOOD, V117, P6600, DOI 10.1182/blood-2011-01-333427; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhang LL, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-61	53	7	8	6	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7283	7295		10.1074/jbc.RA118.007257	http://dx.doi.org/10.1074/jbc.RA118.007257			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30885946	hybrid, Green Published			2022-12-28	WOS:000468402900017
J	Lebowitz, JJ; Pino, JA; Mackie, PM; Lin, M; Hurst, C; Divita, K; Collins, AT; Koutzoumis, DN; Torres, GE; Khoshbouei, H				Lebowitz, Joseph J.; Pino, Jose A.; Mackie, Phillip M.; Lin, Min; Hurst, Cheyenne; Divita, Keeley; Collins, Anthony T.; Koutzoumis, Dimitri N.; Torres, Gonzalo E.; Khoshbouei, Habibeh			Clustered Kv2.1 decreases dopamine transporter activity and internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine transporter; protein-protein interaction; neurotransmitter transport; voltage-dependent anion channel; trafficking	AXON INITIAL SEGMENT; SUBSTANTIA-NIGRA; K+ CHANNEL; POTASSIUM CHANNELS; ENERGY-TRANSFER; AMPHETAMINE; LOCALIZATION; NEURONS; COCAINE; TRAFFICKING	The dopamine transporter (DAT) regulates dopamine neurotransmission via reuptake of dopamine released into the extracellular space. Interactions with partner proteins alter DAT function and thereby dynamically shape dopaminergic tone important for normal brain function. However, the extent and nature of these interactions are incompletely understood. Here, we describe a novel physical and functional interaction between DAT and the voltage-gated K+ channel Kv2.1 (potassium voltage-gated channel subfamily B member 1 or KCNB1). To examine the functional consequences of this interaction, we employed a combination of immunohistochemistry, immunofluorescence live-cell microscopy, co-immunoprecipitation, and electrophysiological approaches. Consistent with previous reports, we found Kv2.1 is trafficked to membrane-bound clusters observed both in vivo and in vitro in rodent dopamine neurons. Our data provide evidence that clustered Kv2.1 channels decrease DAT's lateral mobility and inhibit its internalization, while also decreasing canonical transporter activity by altering DAT's conformational equilibrium. These results suggest that Kv2.1 clusters exert a spatially discrete homeostatic braking mechanism on DAT by inducing a relative increase in inward-facing transporters. Given recent reports of Kv2.1 dysregulation in neurological disorders, it is possible that alterations in the functional interaction between DAT and Kv2.1 affect dopamine neuron activity.	[Lebowitz, Joseph J.; Mackie, Phillip M.; Lin, Min; Hurst, Cheyenne; Divita, Keeley; Collins, Anthony T.; Khoshbouei, Habibeh] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Pino, Jose A.; Koutzoumis, Dimitri N.; Torres, Gonzalo E.] Univ Florida, Coll Med, Dept Pharmacol & Expt Therapeut, Gainesville, FL 32610 USA; [Lebowitz, Joseph J.; Khoshbouei, Habibeh] UF Hlth, Fixel Ctr Neurol Dis, T32 Movement Disorders & Neurorestorat, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Khoshbouei, H (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA.; Khoshbouei, H (corresponding author), UF Hlth, Fixel Ctr Neurol Dis, T32 Movement Disorders & Neurorestorat, Gainesville, FL 32610 USA.	habibeh@ufl.edu	Pino, José/AAF-4359-2021	Pino, José/0000-0002-1542-0660; Mackie, Phillip/0000-0002-8556-9807; Lebowitz, Joseph/0000-0002-2923-7103	National Institutes of Health NINDS Training Grants [5T32NS082168-04, 2R01NS071122-07A1]; NIDA [5T32NS082168-04, 5R01DA038598-05]; National Institutes of Health Office of the Director Grant [1S10OD020026-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS082168, R01NS071122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038598, R01DA026947] Funding Source: NIH RePORTER	National Institutes of Health NINDS Training Grants; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health Office of the Director Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health NINDS Training Grants 5T32NS082168-04 (to J. J. L.) and 2R01NS071122-07A1 (to H. K.), NIDA Grant 5R01DA026947-10, National Institutes of Health Office of the Director Grant 1S10OD020026-01 (to H. K.), and NIDA Grant 5R01DA038598-05 (to G. E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Butler B, 2015, J BIOL CHEM, V290, P29542, DOI 10.1074/jbc.M115.691592; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Chao RY, 2018, J NEUROCHEM, V144, P483, DOI 10.1111/jnc.14282; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Deutsch E, 2012, MOL BIOL CELL, V23, P2917, DOI 10.1091/mbc.E12-01-0047; Dufour MA, 2014, J NEUROSCI RES, V92, P981, DOI 10.1002/jnr.23382; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Feinshreiber L, 2010, J CELL SCI, V123, P1940, DOI 10.1242/jcs.063719; Fox PD, 2015, J CELL SCI, V128, P2096, DOI 10.1242/jcs.166009; Fox PD, 2013, J NEUROSCI, V33, P1259, DOI 10.1523/JNEUROSCI.3008-12.2013; Frazzini V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.18; Gabriel LR, 2013, J NEUROSCI, V33, P17836, DOI 10.1523/JNEUROSCI.3284-13.2013; Gantz SC, 2018, ANNU REV PHYSIOL, V80, P219, DOI 10.1146/annurev-physiol-021317-121615; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; Hong WMC, 2013, FASEB J, V27, P2995, DOI 10.1096/fj.12-218727; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Hong WC, 2017, J BIOL CHEM, V292, P11250, DOI 10.1074/jbc.M116.774075; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Jensen CS, 2017, J NEUROSCI, V37, P11523, DOI 10.1523/JNEUROSCI.3510-16.2017; Justice JA, 2017, NEUROSCIENCE, V354, P158, DOI 10.1016/j.neuroscience.2017.04.034; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Karpowicz RJ, 2013, ACS CHEM NEUROSCI, V4, P858, DOI 10.1021/cn400038u; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Kimm T, 2015, J NEUROSCI, V35, P16404, DOI 10.1523/JNEUROSCI.5291-14.2015; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Melikian HE, 1999, J NEUROSCI, V19, P7699; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Ng J, 2014, BRAIN, V137, P1107, DOI 10.1093/brain/awu022; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Plant LD, 2011, J GEN PHYSIOL, V137, P441, DOI 10.1085/jgp.201110604; Rahbek-Clemmensen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00790-3; Reith MEA, 2001, J BIOL CHEM, V276, P29012, DOI 10.1074/jbc.M011785200; Richardson BD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10423; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Saha K, 2014, J BIOL CHEM, V289, P22246, DOI 10.1074/jbc.M114.563056; Sambo DO, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02087-x; Sarmiere PD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-112; Shah NH, 2014, J NEUROSCI, V34, P4326, DOI 10.1523/JNEUROSCI.5184-13.2014; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; Wouters FS, 1998, EMBO J, V17, P7179, DOI 10.1093/emboj/17.24.7179	56	7	7	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6957	6971		10.1074/jbc.RA119.007441	http://dx.doi.org/10.1074/jbc.RA119.007441			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30824538	hybrid, Green Published			2022-12-28	WOS:000467394700029
J	Matern, A; Bottcher, C; Eschen-Lippold, L; Westermann, B; Smolka, U; Doll, S; Trempel, F; Aryal, B; Scheel, D; Geisler, M; Rosahl, S				Matern, Andreas; Boettcher, Christoph; Eschen-Lippold, Lennart; Westermann, Bernhard; Smolka, Ulrike; Doell, Stefanie; Trempel, Fabian; Aryal, Bibek; Scheel, Dierk; Geisler, Markus; Rosahl, Sabine			A substrate of the ABC transporter PEN3 stimulates bacterial flagellin (flg22)-induced callose deposition in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; host-pathogen interaction; Arabidopsis thaliana; calcium; plant; metabolomics; flagellin; indole glucosinolates; nonhost resistance; oomycete; Phytophthora infestans	BINDING CASSETTE TRANSPORTER; NONHOST RESISTANCE; PHYTOCHELATIN SYNTHASE; ENDOPLASMIC-RETICULUM; PLANT; DEFENSE; COMPLEX; ACID; PHYTOPHTHORA; METABOLISM	Nonhost resistance of Arabidopsis thaliana against Phytophthora infestans, a filamentous eukaryotic microbe and the causal agent of potato late blight, is based on a multilayered defense system. Arabidopsis thaliana controls pathogen entry through the penetration-resistance genes PEN2 and PEN3, encoding an atypical myrosinase and an ABC transporter, respectively, required for synthesis and export of unknown indole compounds. To identify pathogen-elicited leaf surface metabolites and further unravel nonhost resistance in Arabidopsis, we performed untargeted metabolite profiling by incubating a P. infestans zoospore suspension on leaves of WT or pen3 mutant Arabidopsis plants. Among the plant-secreted metabolites, 4-methoxyindol-3-yl-methanol and S-(4-methoxy-indol-3-yl-methyl) cysteine were detected in spore suspensions recollected from WT plants, but at reduced levels from the pen3 mutant plants. In both whole-cell and microsome-based assays, 4-methoxyindol-3-yl-methanol was transported in a PEN3-dependent manner, suggesting that this compound is a PEN3 substrate. The syntheses of both compounds were dependent on functional PEN2 and phytochelatin synthase 1. None of these compounds inhibited mycelial growth of P. infestans in vitro. Of note, exogenous application of 4-methoxyindol-3-yl methanol slightly elevated cytosolic Ca2+ levels and enhanced callose deposition in hydathodes of seedlings treated with a bacterial pathogen-associated molecular pattern (PAMP), flagellin (flg22). Loss of flg22-induced callose deposition in leaves of pen3 seedlings was partially reverted by the addition of 4-methoxyindol-3-yl methanol. In conclusion, we have identified a specific indole compound that is a substrate for PEN3 and contributes to the plant defense response against microbial pathogens.	[Matern, Andreas; Boettcher, Christoph; Eschen-Lippold, Lennart; Smolka, Ulrike; Doell, Stefanie; Trempel, Fabian; Scheel, Dierk; Rosahl, Sabine] Leibniz Inst Plant Biochem, Dept Stress & Dev Biol, Weinberg 3, D-06120 Halle, Saale, Germany; [Westermann, Bernhard] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Weinberg 3, D-06120 Halle, Saale, Germany; [Aryal, Bibek; Geisler, Markus] Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland; [Boettcher, Christoph] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants Ecol Chem Plant Ana, Konigin Luise Str 19, D-14195 Berlin, Germany	Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie; University of Fribourg; Julius Kuhn-Institut	Rosahl, S (corresponding author), Leibniz Inst Plant Biochem, Dept Stress & Dev Biol, Weinberg 3, D-06120 Halle, Saale, Germany.	srosahl@ipb-halle.de	Geisler, Markus M/B-3921-2012	Geisler, Markus M/0000-0002-6641-5810	DFG (SPP1212 Microbial Reprogramming of Plant Development) [SCHE 235/14-3]	DFG (SPP1212 Microbial Reprogramming of Plant Development)(German Research Foundation (DFG))	This work was supported by the DFG (SPP1212 Microbial Reprogramming of Plant Development, SCHE 235/14-3). The authors declare that they have no conflicts of interest with the contents of this article.	Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Albert I, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.140, 10.1038/nplants.2015.140]; Beck A, 2003, PHYTOCHEMISTRY, V62, P423, DOI 10.1016/S0031-9422(02)00565-4; Beck M, 2014, J EXP BOT, V65, P6487, DOI 10.1093/jxb/eru366; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Blum R, 2007, PLANT J, V49, P740, DOI 10.1111/j.1365-313X.2006.02993.x; Bottcher C, 2014, PLANT PHYSIOL, V165, P841, DOI 10.1104/pp.114.235630; Bottcher C, 2009, PLANT CELL, V21, P1830, DOI 10.1105/tpc.109.066670; Cerutti A, 2017, PLANT PHYSIOL, V174, P700, DOI 10.1104/pp.16.01852; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Clemens S, 2001, EUR J BIOCHEM, V268, P3640, DOI 10.1046/j.1432-1327.2001.02293.x; Dastmalchi M, 2016, PLANT J, V85, P689, DOI 10.1111/tpj.13137; Dobritzsch M, 2016, PLANT CELL, V28, P583, DOI 10.1105/tpc.15.00706; Eschen-Lippold L, 2009, J AGR FOOD CHEM, V57, P9607, DOI 10.1021/jf902067k; Fan J, 2012, CURR OPIN PLANT BIOL, V15, P400, DOI 10.1016/j.pbi.2012.03.001; Fuchs R, 2016, PLANT CELL, V28, P130, DOI 10.1105/tpc.15.00887; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Henrichs S, 2012, EMBO J, V31, P2965, DOI 10.1038/emboj.2012.120; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Johansson ON, 2014, PLANT J, V79, P466, DOI 10.1111/tpj.12571; Kamoun S, 2001, CURR OPIN PLANT BIOL, V4, P295, DOI 10.1016/S1369-5266(00)00176-X; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kobae Y, 2006, PLANT CELL PHYSIOL, V47, P309, DOI 10.1093/pcp/pcj001; Kronbak R, 2010, J AGR FOOD CHEM, V58, P8453, DOI 10.1021/jf101806t; Kuhnlenz T, 2015, PLANT CELL ENVIRON, V38, P2239, DOI 10.1111/pce.12534; Lallemand B, 2013, PLANT PHYSIOL, V162, P616, DOI 10.1104/pp.112.213124; Laursen T, 2016, SCIENCE, V354, P890, DOI 10.1126/science.aag2347; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Lu XL, 2015, PLANT PHYSIOL, V168, P814, DOI 10.1104/pp.15.00182; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nielsen KA, 2008, PHYTOCHEMISTRY, V69, P88, DOI 10.1016/j.phytochem.2007.06.033; Pfalz M, 2011, PLANT CELL, V23, P716, DOI 10.1105/tpc.110.081711; Pislewska-Bednarek M, 2018, PLANT PHYSIOL, V176, P538, DOI 10.1104/pp.17.01455; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Rajniak J, 2015, NATURE, V525, P376, DOI 10.1038/nature14907; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; RUANGYUTTIKARN W, 1992, CHEM RES TOXICOL, V5, P713, DOI 10.1021/tx00029a019; Ruzicka K, 2010, P NATL ACAD SCI USA, V107, P10749, DOI 10.1073/pnas.1005878107; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulze-Lefert P, 2011, TRENDS PLANT SCI, V16, P117, DOI 10.1016/j.tplants.2011.01.001; Si-Ammour A, 2003, MOL PLANT PATHOL, V4, P237, DOI 10.1046/J.1364-3703.2003.00168.X; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stam R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00582; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Strader LC, 2009, PLANT CELL, V21, P1992, DOI 10.1105/tpc.109.065821; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Sweetlove LJ, 2013, ANNU REV PLANT BIOL, V64, P723, DOI 10.1146/annurev-arplant-050312-120233; WALDMANN T, 1988, PLANTA, V173, P88, DOI 10.1007/BF00394492; Westphal L, 2008, PLANT CELL, V20, P824, DOI 10.1105/tpc.107.056895; Xin XF, 2013, MOL PLANT MICROBE IN, V26, P861, DOI 10.1094/MPMI-11-12-0262-R	52	19	19	6	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6857	6870		10.1074/jbc.RA119.007676	http://dx.doi.org/10.1074/jbc.RA119.007676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30833326	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000467394700022
J	Khodayari, N; Oshins, R; Alli, AA; Tuna, KM; Holliday, LS; Krotova, K; Brantly, M				Khodayari, Nazli; Oshins, Regina; Alli, Abdel A.; Tuna, Kubra M.; Holliday, L. Shannon; Krotova, Karina; Brantly, Mark			Modulation of calreticulin expression reveals a novel exosome-mediated mechanism of Z variant (1)-antitrypsin disposal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver injury; protein misfolding; protein secretion; extracellular vesicles; chaperone; chaperone DnaJ (DnaJ)	ENDOPLASMIC-RETICULUM; BREFELDIN-A; EXTRACELLULAR CHAPERONES; SECRETION; DEGRADATION; ERDJ3; BIOGENESIS; CELLS; RELEASE; DISEASE	(1)-Antitrypsin deficiency (AATD) is an inherited disease characterized by emphysema and liver disease. AATD is most often caused by a single amino acid substitution at position 342 in the mature protein, resulting in the Z mutation of the AAT gene (ZAAT). This substitution is associated with misfolding and accumulation of ZAAT in the endoplasmic reticulum (ER) of hepatocytes, causing a toxic gain of function. ERdj3 is an ER luminal DnaJ homologue, which, along with calreticulin, directly interacts with misfolded ZAAT. We hypothesize that depletion of each of these chaperones will change the fate of ZAAT polymers. Our study demonstrates that calreticulin modulation reveals a novel ZAAT degradation mechanism mediated by exosomes. Using human PiZZ hepatocytes and K42, a mouse calreticulin-deficient fibroblast cell line, our results show ERdj3 and calreticulin directly interact with ZAAT in PiZZ hepatocytes. Silencing calreticulin induces calcium independent ZAAT-ERdj3 secretion through the exosome pathway. This co-secretion decreases ZAAT aggregates within the ER of hepatocytes. We demonstrate that calreticulin has an inhibitory effect on exosome-mediated ZAAT-ERdj3 secretion. This is a novel ZAAT degradation process that involves a DnaJ homologue chaperone bound to ZAAT. In this context, calreticulin modulation may eliminate the toxic gain of function associated with aggregation of ZAAT in lung and liver, thus providing a potential new therapeutic approach to the treatment of AATD-related liver disease.	[Khodayari, Nazli; Oshins, Regina; Brantly, Mark] Univ Florida, Dept Med, Coll Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32610 USA; [Alli, Abdel A.; Tuna, Kubra M.] Univ Florida, Dept Med, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Holliday, L. Shannon] Univ Florida, Dept Orthodont, Coll Dent, Gainesville, FL 32610 USA; [Krotova, Karina] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Minnesota System	Brantly, M (corresponding author), Univ Florida, Coll Med, Div Pulm Crit Care & Sleep Med, JHMHC, 1600 SW Archer Rd,Rm M454A,POB 100225, Gainesville, FL 32610 USA.	mbrantly@ufl.edu	Holliday, Lexie/GYQ-4972-2022; Brantly, Mark/AAH-2922-2020	Holliday, Lexie/0000-0002-0844-1965; Krotova, Karina/0000-0002-2248-1277	Alpha-1 Foundation; National Institutes of Health National Center for Advancing Translational Sciences [UL1 TR000064]	Alpha-1 Foundation; National Institutes of Health National Center for Advancing Translational Sciences	This work was supported by a grant from the Alpha-1 Foundation and National Institutes of Health National Center for Advancing Translational Sciences Grant UL1 TR000064. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aalberts M, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095760; Baixauli F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00403; Bals R, 2010, BEST PRACT RES CL GA, V24, P629, DOI 10.1016/j.bpg.2010.08.006; Bergmann TJ, 2018, J BIOL CHEM, V293, P5600, DOI 10.1074/jbc.RA117.001484; Bobrie A, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18397; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cabral CM, 2002, MOL BIOL CELL, V13, P2639, DOI 10.1091/mbc.E02-02-0068; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Dang VD, 2017, FASEB J, V31, P5399, DOI 10.1096/fj.201700417R; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Eitan E, 2016, AGEING RES REV, V32, P65, DOI 10.1016/j.arr.2016.05.001; Fairbanks KD, 2008, AM J GASTROENTEROL, V103, P2136, DOI 10.1111/j.1572-0241.2008.01955.x; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fra A, 2016, EUR RESPIR J, V47, P1005, DOI 10.1183/13993003.00940-2015; Fregonese L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-16; Genereux JC, 2015, PRION, V9, P10, DOI 10.1080/19336896.2015.1011887; Genereux JC, 2015, EMBO J, V34, P4, DOI 10.15252/embj.201488896; Gooptu B, 2014, TRENDS MOL MED, V20, P116, DOI 10.1016/j.molmed.2013.10.007; Greene Catherine M, 2010, World J Gastrointest Pharmacol Ther, V1, P94, DOI 10.4292/wjgpt.v1.i5.94; HUNZIKER W, 1992, FEBS LETT, V307, P93, DOI 10.1016/0014-5793(92)80908-Y; Khodayari N, 2017, J CELL BIOCHEM, V118, P3090, DOI 10.1002/jcb.26069; Khodayari N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172983; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Meister M, 2014, MEMBRANES-BASEL, V4, P356, DOI 10.3390/membranes4030356; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Mohamed NV, 2013, EUR J NEUROSCI, V37, P1939, DOI 10.1111/ejn.12229; Novoradovskaya N, 1998, J CLIN INVEST, V101, P2693, DOI 10.1172/JCI549; Palma J, 2012, NUCLEIC ACIDS RES, V40, P9125, DOI 10.1093/nar/gks656; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Phuyal S, 2014, FEBS J, V281, P2214, DOI 10.1111/febs.12775; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Rabouille C, 2017, TRENDS CELL BIOL, V27, P230, DOI 10.1016/j.tcb.2016.11.007; Roberts RL, 1999, J CELL SCI, V112, P3667; Rossner M, 2004, J CELL BIOL, V166, P11, DOI 10.1083/jcb.200406019; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Sifers Richard N, 2010, Proc Am Thorac Soc, V7, P376, DOI 10.1513/pats.201001-011AW; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Takeuchi T, 2015, P NATL ACAD SCI USA, V112, pE2497, DOI 10.1073/pnas.1412651112; Tan YL, 2014, CHEM BIOL, V21, P967, DOI 10.1016/j.chembiol.2014.06.008; Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Willms E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22519; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904; Wyatt AR, 2012, J MOL BIOL, V421, P499, DOI 10.1016/j.jmb.2012.01.004; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	49	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6240	6252		10.1074/jbc.RA118.006142	http://dx.doi.org/10.1074/jbc.RA118.006142			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30833329	hybrid, Green Published			2022-12-28	WOS:000468402000004
J	Li, LS; Baxter, SS; Zhao, P; Gu, N; Zhan, X				Li, Lushen; Baxter, Shaneen S.; Zhao, Peng; Gu, Ning; Zhan, Xi			Differential interactions of missing in metastasis and insulin receptor tyrosine kinase substrate with RAB proteins in the endocytosis of CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; Rab; chemotaxis; chemokine; C-X-C chemokine receptor type 4 (CXCR-4); cell signaling; endosome; insulin receptor tyrosine kinase substrate (IRTKS); missing in metastasis (MIM); RAB11; RAB7; SH3	IN-METASTASIS; BAR DOMAINS; MEMBRANE; IRTKS; MIM; IRSP53; TRAFFICKING; EXPRESSION; ENDOSOMES; CELLS	Missing in metastasis (MIM), an inverse Bin-Amphiphysin-Rvs (I-BAR) domain protein, promotes endocytosis of C-X-C chemokine receptor 4 (CXCR4) in mammalian cells. In response to the CXCR4 ligand stromal cell-derived factor 1 (SDF-1 or CXCL12), MIM associates with RAS-related GTP-binding protein 7 (RAB7) 30 min after stimulation. However, RAB7's role in MIM function remains undefined. Here we show that RNAi-mediated suppression of RAB7 expression in human HeLa cells has little effect on the binding of MIM to RAB5 and on the recruitment of CXCR4 to early endosomes but effectively abolishes MIM-mediated CXCR4 degradation, chemotactic response, and sorting into late endosomes and lysosomes. To determine whether I-BAR domain proteins interact with RAB7, we examined cells expressing insulin receptor tyrosine kinase substrate (IRTKS), an I-BAR domain protein bearing an Src homology 3 (SH3) domain. We observed that both MIM and IRTKS interact with RAB5 at an early response to SDF-1 and that IRTKS binds poorly to RAB7 but strongly to RAB11 at a later time point. Moreover, IRTKS overexpression reduced CXCR4 internalization and enhanced the chemotactic response to SDF-1. Interestingly, deletion of the SH3 domain in IRTKS abolished the IRTKS-RAB11 interaction and promoted CXCR4 degradation. Furthermore, the SH3 domain was required for selective targeting of MIM-IRTKS fusion proteins by both RAB7 and RAB11. Hence, to the best of our knowledge, our results provide first evidence that the SH3 domain is critical in the regulation of specific endocytic pathways by I-BAR domain proteins.	[Li, Lushen; Baxter, Shaneen S.; Zhan, Xi] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Zhan, Xi] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Zhan, Xi] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Zhao, Peng; Gu, Ning] Southeast Univ, Sch Biol Sci & Med Engn, Jiangsu Key Lab Biomat & Devices, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Southeast University - China	Zhan, X (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.; Zhan, X (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Zhan, X (corresponding author), Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.	xzhan@som.umaryland.edu		Li, lushen/0000-0002-6701-7937	NCI, National Institutes of Health [R01 CA113809]; National Natural Science Foundation of China [61420106012]; NATIONAL CANCER INSTITUTE [R01CA113809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health Grant R01 CA113809 (to X.Z.) and National Natural Science Foundation of China for Key Project of International Cooperation Grant 61420106012 (to N.G). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Brown AS, 2018, P NATL ACAD SCI USA, V115, pE12407, DOI 10.1073/pnas.1816177115; Chou AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40485; Dawson JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031141; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Goh WI, 2011, J BIOL CHEM, V286, P13681, DOI 10.1074/jbc.M110.182683; Itoh Y, 2016, CELL STRUCT FUNCT, V41, P1, DOI 10.1247/csf.15014; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lazar T, 2002, EUR J CELL BIOL, V81, P635, DOI 10.1078/0171-9335-00290; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Li LS, 2017, J CELL SCI, V130, P1475, DOI 10.1242/jcs.198937; Li LS, 2016, BIOCHEM BIOPH RES CO, V479, P787, DOI 10.1016/j.bbrc.2016.09.131; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Numrich J, 2015, J CELL SCI, V128, P2278, DOI 10.1242/jcs.164905; Oikawa Tsukasa, 2012, Commun Integr Biol, V5, P511, DOI 10.4161/cib.21252; Oikawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060528; Patel A, 2012, EUR J CELL BIOL, V91, P171, DOI 10.1016/j.ejcb.2011.11.006; Quinones GA, 2010, J CELL BIOL, V189, P353, DOI 10.1083/jcb.200910136; Saarikangas J, 2015, DEV CELL, V33, P644, DOI 10.1016/j.devcel.2015.04.014; Saarikangas J, 2011, J CELL SCI, V124, P1245, DOI 10.1242/jcs.082610; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Sakaguchi Aisa, 2016, Commun Integr Biol, V9, pe1208325, DOI 10.1080/19420889.2016.1208325; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sudhaharan T, 2016, J CELL SCI, V129, P2829, DOI 10.1242/jcs.179655; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Veltman DM, 2011, BIOCHEM J, V436, P45, DOI 10.1042/BJ20101684; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Wild PS, 2017, J CLIN INVEST, V127, P1798, DOI 10.1172/JCI84840; Xia S, 2010, DEVELOPMENT, V137, P1075, DOI 10.1242/dev.049437; Yu D, 2012, ONCOGENE, V31, P3561, DOI 10.1038/onc.2011.509; Zhan T, 2016, LEUKEMIA, V30, P1327, DOI 10.1038/leu.2016.39; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005; Zheng DT, 2010, BIOCHEM BIOPH RES CO, V401, P527, DOI 10.1016/j.bbrc.2010.09.087; Zhi D., 2012, Frontiers in Genetics, V3, P92, DOI 10.3389/fgene.2012.00092; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	40	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6494	6505		10.1074/jbc.RA118.006071	http://dx.doi.org/10.1074/jbc.RA118.006071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30808710	Green Published, hybrid			2022-12-28	WOS:000468402000025
J	Au, DF; Ostrovsky, D; Fu, RQ; Vugmeyster, L				Au, Dan Fai; Ostrovsky, Dmitry; Fu, Riqiang; Vugmeyster, Liliya			Solid-state NMR reveals a comprehensive view of the dynamics of the flexible, disordered N-terminal domain of amyloid- fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; nuclear magnetic resonance (NMR); solid state NMR; intrinsically disordered protein; fibril; neurodegeneration; protein misfolding; protein dynamics; R1 relaxation; zinc	NUCLEAR-MAGNETIC-RESONANCE; FAMILIAL ALZHEIMERS-DISEASE; A-BETA-PEPTIDES; HYDROPHOBIC CORE; SIDE-CHAIN; CONFORMATIONAL DYNAMICS; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; PROTEIN DYNAMICS; METHYL-GROUPS	Amyloid fibril deposits observed in Alzheimer's disease comprise amyloid- (A) protein possessing a structured hydrophobic core and a disordered N-terminal domain (residues 1-16). The internal flexibility of the disordered domain is likely essential for A aggregation. Here, we used H-2 static solid-state NMR methods to probe the dynamics of selected side chains of the N-terminal domain of A(1-40) fibrils. Line shape and relaxation data suggested a two-state model in which the domain's free state undergoes a diffusive motion that is quenched in the bound state, likely because of transient interactions with the structured C-terminal domain. At 37 degrees C, we observed freezing of the dynamics progressively along the A sequence, with the fraction of the bound state increasing and the rate of diffusion decreasing. We also found that without solvation, the diffusive motion is quenched. The solvent acted as a plasticizer reminiscent of its role in the onset of global dynamics in globular proteins. As the temperature was lowered, the fraction of the bound state exhibited sigmoidal behavior. The midpoint of the freezing curve coincided with the bulk solvent freezing for the N-terminal residues and increased further along the sequence. Using H-2 R-1 measurements, we determined the conformational exchange rate constant between the free and bound states under physiological conditions. Zinc-induced aggregation leads to the enhancement of the dynamics, manifested by the faster conformational exchange, faster diffusion, and lower freezing-curve midpoints.	[Au, Dan Fai; Vugmeyster, Liliya] Univ Colorado, Dept Chem, 1201 Laurimer St, Denver, CO 80204 USA; [Ostrovsky, Dmitry] Univ Colorado, Dept Math, Denver, CO 80204 USA; [Fu, Riqiang] Natl High Field Magnet Lab, Tallahassee, FL 32310 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver	Vugmeyster, L (corresponding author), Univ Colorado, Dept Chem, 1201 Laurimer St, Denver, CO 80204 USA.	liliya.vugmeyster@ucdenver.edu			National Institutes of Health [1R15-GM111681]; National Science Foundation [1726947]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM111681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R15-GM111681 and National Science Foundation Grant 1726947. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Ayton S, 2015, NEUROTHERAPEUTICS, V12, P109, DOI 10.1007/s13311-014-0312-z; Bauer T, 2017, J BIOMOL NMR, V67, P51, DOI 10.1007/s10858-016-0083-4; Berlow RB, 2018, J MOL BIOL, V430, P2309, DOI 10.1016/j.jmb.2018.04.003; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Brannstrom K, 2014, J AM CHEM SOC, V136, P10956, DOI 10.1021/ja503535m; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011; Delgado DA, 2016, J BIOL CHEM, V291, P12233, DOI 10.1074/jbc.M116.720656; Doster W, 2008, EUR BIOPHYS J BIOPHY, V37, P591, DOI 10.1007/s00249-008-0274-3; Dubochet J, 1982, ADV OPTICAL ELECT MI, P107; Fawzi NL, 2014, ANGEW CHEM INT EDIT, V53, P10345, DOI 10.1002/anie.201405180; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fukuda H, 1999, BIOORG MED CHEM LETT, V9, P953, DOI 10.1016/S0960-894X(99)00121-3; GALL CM, 1982, P NATL ACAD SCI-BIOL, V79, P101, DOI 10.1073/pnas.79.1.101; Gauto DF, 2017, SOLID STATE NUCL MAG, V87, P86, DOI 10.1016/j.ssnmr.2017.04.002; Gor'kov PL, 2007, J MAGN RESON, V185, P77, DOI 10.1016/j.jmr.2006.11.008; Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994; Harris Jonathan Gil, 1994, ELECT MICROSCOPY BIO, P203; HIRSCHINGER J, 1990, MACROMOLECULES, V23, P2153, DOI 10.1021/ma00210a009; HIYAMA Y, 1986, J AM CHEM SOC, V108, P2715, DOI 10.1021/ja00270a034; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hu ZW, 2017, J BIOL CHEM, V292, P2611, DOI 10.1074/jbc.M116.757179; Hubin E, 2014, CELL MOL LIFE SCI, V71, P3507, DOI 10.1007/s00018-014-1634-z; Hubin E, 2015, CELL MOL LIFE SCI, V72, P4899, DOI 10.1007/s00018-015-1983-2; Iannuzzi C, 2014, PROTEIN SCI, V23, P1208, DOI 10.1002/pro.2501; Istrate AN, 2016, SCI REP-UK, V6, DOI 10.1038/srep21734; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Jawhar S, 2011, J BIOL CHEM, V286, P38825, DOI 10.1074/jbc.R111.288308; Karamanos TK, 2015, PROG NUCL MAG RES SP, V88-89, P86, DOI 10.1016/j.pnmrs.2015.05.002; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Krushelnitsky A, 2018, J BIOMOL NMR, V71, P53, DOI 10.1007/s10858-018-0191-4; Krushelnitsky A, 2014, J MAGN RESON, V248, P8, DOI 10.1016/j.jmr.2014.09.007; Kulikova AA, 2015, MOL BIOL+, V49, P217, DOI 10.1134/S0026893315020065; Kumar S, 2012, J BIOL CHEM, V287, P8641, DOI 10.1074/jbc.M111.279133; Kumar S, 2011, AGING-US, V3, P803, DOI 10.18632/aging.100362; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Kurauskas V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00165-8; Kussell E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.168101; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lakomek NA, 2017, CHEM-EUR J, V23, P9425, DOI 10.1002/chem.201701738; Larion Mioara, 2015, Intrinsically Disord Proteins, V3, pe1011008, DOI 10.1080/21690707.2015.1011008; Larsen FH, 1998, MOL PHYS, V95, P1185, DOI 10.1080/00268979809483250; Lewandowski JR, 2015, SCIENCE, V348, P578, DOI 10.1126/science.aaa6111; Linser R, 2014, J BIOMOL NMR, V59, P1, DOI 10.1007/s10858-014-9822-6; Liu HY, 2018, ANGEW CHEM INT EDIT, V57, P8017, DOI 10.1002/anie.201802490; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma PX, 2014, ANGEW CHEM INT EDIT, V53, P4312, DOI 10.1002/anie.201311275; Malinska M, 2015, ACTA CRYSTALLOGR D, V71, P1444, DOI 10.1107/S1399004715007816; Viet MH, 2013, ACS CHEM NEUROSCI, V4, P1446, DOI 10.1021/cn400110d; Mazzitelli S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0381-9; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Meints GA, 2008, J AM CHEM SOC, V130, P7305, DOI 10.1021/ja075775n; Miller Y, 2012, COORDIN CHEM REV, V256, P2245, DOI 10.1016/j.ccr.2011.12.022; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Miura T, 2010, YAKUGAKU ZASSHI, V130, P495, DOI 10.1248/yakushi.130.495; Molugu TR, 2017, CHEM REV, V117, P12087, DOI 10.1021/acs.chemrev.6b00619; Morris C, 2018, CHEM-EUR J, V24, P9494, DOI 10.1002/chem.201801805; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Persson PO, 2004, SIAM REV, V46, P329, DOI 10.1137/S0036144503429121; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Quinn CM, 2012, J MAGN RESON, V222, P1, DOI 10.1016/j.jmr.2012.05.014; Quinn CM, 2009, J BIOMOL NMR, V45, P5, DOI 10.1007/s10858-009-9346-7; Rezaei-Ghaleh N, 2016, J BIOL CHEM, V291, P16059, DOI 10.1074/jbc.M116.728956; Rezaei-Ghaleh N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11359; Ringe D, 2003, BIOPHYS CHEM, V105, P667, DOI 10.1016/S0301-4622(03)00096-6; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Rovo P, 2018, CHEMPHYSCHEM, V19, P34, DOI 10.1002/cphc.201701238; Rovo P, 2017, J PHYS CHEM B, V121, P6117, DOI 10.1021/acs.jpcb.7b03333; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheidt HA, 2012, J BIOL CHEM, V287, P2017, DOI 10.1074/jbc.M111.308619; Serra-Vidal B, 2014, ACS CHEM BIOL, V9, P2678, DOI 10.1021/cb500621x; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shannon MD, 2019, CHEMPHYSCHEM, V20, P311, DOI 10.1002/cphc.201800779; Shimizu T, 2002, J NEUROSCI RES, V70, P451, DOI 10.1002/jnr.10350; Smith AA, 2016, J BIOMOL NMR, V65, P171, DOI 10.1007/s10858-016-0047-8; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Thirumalai D, 2012, ACCOUNTS CHEM RES, V45, P83, DOI 10.1021/ar2000869; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tougu V, 2011, METALLOMICS, V3, P250, DOI 10.1039/c0mt00073f; Tsvetkov PO, 2010, BIOPHYS J, V99, pL84, DOI 10.1016/j.bpj.2010.09.015; Vold R. R., 1991, ADV MAGN OPT RESON, V16, P85; Vold R.R., 1994, NUCL MAGNETIC RESONA, P27; Vold RL, 2009, PHYS CHEM CHEM PHYS, V11, P7008, DOI 10.1039/b907343d; Vold RL, 2009, J MAGN RESON, V198, P57, DOI 10.1016/j.jmr.2009.01.008; Vugmeyster L, 2019, CHEMPHYSCHEM, V20, P333, DOI 10.1002/cphc.201800454; Vugmeyster L, 2018, METHODS, V148, P136, DOI 10.1016/j.ymeth.2018.04.030; Vugmeyster L, 2017, PROG NUCL MAG RES SP, V101, P1, DOI 10.1016/j.pnmrs.2017.02.001; Vugmeyster L, 2017, J PHYS CHEM B, V121, P7267, DOI 10.1021/acs.jpcb.7b04726; Vugmeyster L, 2016, BIOPHYS J, V111, P2135, DOI 10.1016/j.bpj.2016.10.001; Vugmeyster L, 2016, J BIOL CHEM, V291, P18484, DOI 10.1074/jbc.M116.740530; Vugmeyster L, 2011, BIOCHEMISTRY-US, V50, P10637, DOI 10.1021/bi201515b; Vugmeyster L, 2010, J PHYS CHEM B, V114, P15799, DOI 10.1021/jp1082467; Wang SSS, 2003, BIOCHEMISTRY-US, V42, P9507, DOI 10.1021/bi0342766; Wang T, 2017, J AM CHEM SOC, V139, P6242, DOI 10.1021/jacs.7b02089; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xu L, 2016, CHEM COMMUN, V52, P1733, DOI 10.1039/c5cc08107f; Xu L, 2014, PROTEINS, V82, P3286, DOI 10.1002/prot.24669; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039	116	15	15	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5840	5853		10.1074/jbc.RA118.006559	http://dx.doi.org/10.1074/jbc.RA118.006559			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30737281	hybrid, Green Published			2022-12-28	WOS:000465077500016
J	Folk, WP; Kumari, A; Iwasaki, T; Pyndiah, S; Johnson, JC; Cassimere, EK; Abdulovic-Cui, AL; Sakamuro, D				Folk, Watson P.; Kumari, Alpana; Iwasaki, Tetsushi; Pyndiah, Slovenie; Johnson, Joanna C.; Cassimere, Erica K.; Abdulovic-Cui, Amy L.; Sakamuro, Daitoku			Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ataxia telangiectasia; E2F transcription factor; DNA damage response; tumor suppressor gene; chemoresistance; genomic instability; cancer; p53; BIN1; double-stranded DNA breaks; MRN complex	DNA-DAMAGE-RESPONSE; ESCHERICHIA-COLI; MRE11 COMPLEX; HISTONE H2AX; REPAIR; PHOSPHORYLATION; INHIBITION; GAMMA-H2AX; MECHANISMS; APOPTOSIS	The tumor suppressor bridging integrator 1 (BIN1) is a corepressor of the transcription factor E2F1 and inhibits cell-cycle progression. BIN1 also curbs cellular poly(ADP-ribosyl)ation (PARylation) and increases sensitivity of cancer cells to DNA-damaging therapeutic agents such as cisplatin. However, how BIN1 deficiency, a hallmark of advanced cancer cells, increases cisplatin resistance remains elusive. Here, we report that BIN1 inactivates ataxia telangiectasia-mutated (ATM) serine/threonine kinase, particularly when BIN1 binds E2F1. BIN1 + 12A (a cancer-associated BIN1 splicing variant) also inhibited cellular PARylation, but only BIN1 increased cisplatin sensitivity. BIN1 prevented E2F1 from transcriptionally activating the human ATM promoter, whereas BIN1 + 12A did not physically interact with E2F1. Conversely, BIN1 loss significantly increased E2F1-dependent formation of MRE11A/RAD50/NBS1 DNA end-binding protein complex and efficiently promoted ATM autophosphorylation. Even in the absence of dsDNA breaks (DSBs), BIN1 loss promoted ATM-dependent phosphorylation of histone H2A family member X (forming H2AX, a DSB biomarker) and mediator of DNA damage checkpoint 1 (MDC1, a H2AX-binding adaptor protein for DSB repair). Of note, even in the presence of transcriptionally active (i.e. proapoptotic) TP53 tumor suppressor, BIN1 loss generally increased cisplatin resistance, which was conversely alleviated by ATM inactivation or E2F1 reduction. However, E2F2 or E2F3 depletion did not recapitulate the cisplatin sensitivity elicited by E2F1 elimination. Our study unveils an E2F1-specific signaling circuit that constitutively activates ATM and provokes cisplatin resistance in BIN1-deficient cancer cells and further reveals that H2AX emergence may not always reflect DSBs if BIN1 is absent.	[Folk, Watson P.; Sakamuro, Daitoku] Augusta Univ, Biochem & Canc Biol Grad Program, Augusta, GA 30912 USA; [Folk, Watson P.; Kumari, Alpana; Iwasaki, Tetsushi; Sakamuro, Daitoku] Augusta Univ, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30912 USA; [Folk, Watson P.; Kumari, Alpana; Iwasaki, Tetsushi; Sakamuro, Daitoku] Augusta Univ, Tumor Signaling & Angiogenesis Program, Georgia Canc Ctr, Augusta, GA 30912 USA; [Iwasaki, Tetsushi] Kobe Univ, Div Signal Pathways, Biosignal Res Ctr, Kobe, Hyogo 657, Japan; [Pyndiah, Slovenie; Cassimere, Erica K.] Louisiana State Univ, Mol Signaling Program, Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Johnson, Joanna C.; Cassimere, Erica K.] Purdue Univ, Med Chem & Mol Pharmacol Grad Program, W Lafayette, IN 47907 USA; [Abdulovic-Cui, Amy L.] Augusta Univ, Dept Biol Sci, Coll Sci & Math, Augusta, GA 30904 USA; [Pyndiah, Slovenie] Univ Paris Diderot, INSERM, UMRS1162, F-75010 Paris, France; [Cassimere, Erica K.] Texas Southern Univ, Dept Biol, Coll Sci Engn & Technol, Houston, TX 77004 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Kobe University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Georgia; Augusta University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Texas Southern University	Sakamuro, D (corresponding author), 1410 Laney Walker Blvd, Augusta, GA 30912 USA.	dsakamuro@augusta.edu			National Institutes of Health [R01CA140379]; United States Army Department of Defense Prostate Cancer Program [DAMD 17-02-1-0131]; first Georgia Cancer Center Polatty Award for Innovative Cancer Research (2018 -2019); Augusta University Graduate School (2014-2015); R. August Roesel Memorial Award Research Excellence for Biochemistry and Cancer Biology (2016); Georgia Cancer Center Postdoctoral Award (2015-2016); International Education and Research Scholarship by Kobe University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Department of Defense Prostate Cancer Program; first Georgia Cancer Center Polatty Award for Innovative Cancer Research (2018 -2019); Augusta University Graduate School (2014-2015); R. August Roesel Memorial Award Research Excellence for Biochemistry and Cancer Biology (2016); Georgia Cancer Center Postdoctoral Award (2015-2016); International Education and Research Scholarship by Kobe University	This work was supported in part by National Institutes of Health Grant R01CA140379, United States Army Department of Defense Prostate Cancer Program DAMD 17-02-1-0131, and the first Georgia Cancer Center Polatty Award for Innovative Cancer Research (2018 -2019) (to D.S.). D. S. holds a 1999 United States Patent with G. Prendergast, Patent No. 6,410,238, "Box-dependent Myc-interacting protein (Bin1) compositions and uses thereof" (The Wistar Institute of Anatomy and Biology, Philadelphia, PA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a fellowship from Augusta University Graduate School (2014-2015) and the R. August Roesel Memorial Award Research Excellence for Biochemistry and Cancer Biology (2016).; First recipient of the Georgia Cancer Center Postdoctoral Award (2015-2016).; Supported by an International Education and Research Scholarship provided by the President of Kobe University (2013-2014).	Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Basourakos SP, 2017, CURR MED CHEM, V24, P1586, DOI 10.2174/0929867323666161214114948; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bowden NA, 2014, CANCER LETT, V346, P163, DOI 10.1016/j.canlet.2014.01.005; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Burkle A, 2001, CANCER LETT, V163, P1, DOI 10.1016/S0304-3835(00)00694-7; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carnevale J, 2012, MOL CELL BIOL, V32, P900, DOI 10.1128/MCB.06286-11; Cassimere EK, 2009, CELL DEATH DIFFER, V16, P1641, DOI 10.1038/cdd.2009.98; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CAN-07-1100; Chen J, 2011, CELL CYCLE, V10, P1287, DOI 10.4161/cc.10.8.15341; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cunningham LL, 2017, NEW ENGL J MED, V377, P2465, DOI 10.1056/NEJMra1616601; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Earley JN, 2011, ANTIOXID REDOX SIGN, V14, P2465, DOI 10.1089/ars.2010.3369; EINHORN LH, 1977, ANN INTERN MED, V87, P293, DOI 10.7326/0003-4819-87-3-293; EINHORN LH, 1979, NEW ENGL J MED, V300, P289, DOI 10.1056/NEJM197902083000605; Frame FM, 2006, ONCOGENE, V25, P3258, DOI 10.1038/sj.onc.1209352; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Ge K, 2000, INT J CANCER, V86, P155, DOI 10.1002/(SICI)1097-0215(20000415)86:2<155::AID-IJC2>3.0.CO;2-M; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Ge K, 2000, INT J CANCER, V85, P376; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Kinney EL, 2008, J CELL PHYSIOL, V216, P621, DOI 10.1002/jcp.21437; Kumari A, 2015, CELL DEATH DIFFER, V22, P311, DOI 10.1038/cdd.2014.146; Kumari A, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060158; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Lin WC, 2001, GENE DEV, V15, P1833; Liu YG, 2001, CARCINOGENESIS, V22, P851, DOI 10.1093/carcin/22.6.851; Lundgaard GL, 2011, J CELL BIOCHEM, V112, P2992, DOI 10.1002/jcb.23222; Manohar S, 2018, J NEPHROL, V31, P15, DOI 10.1007/s40620-017-0392-z; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Ramalingam A, 2007, CELL CYCLE, V6, P1914, DOI 10.4161/cc.6.15.4514; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; ROSENBERG B, 1967, J BIOL CHEM, V242, P1347; Routhier EL, 2003, ONCOGENE, V22, P637, DOI 10.1038/sj.onc.1206162; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Sakamuro D, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.981447; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Weber AM, 2015, PHARMACOL THERAPEUT, V149, P124, DOI 10.1016/j.pharmthera.2014.12.001; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453	60	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5700	5719		10.1074/jbc.RA118.005699	http://dx.doi.org/10.1074/jbc.RA118.005699			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30733337	Green Published, hybrid			2022-12-28	WOS:000464517500037
J	Nagappa, LK; Satha, P; Govindaraju, T; Balaram, H				Nagappa, Lakshmeesha Kempaiah; Satha, Pardhasaradhi; Govindaraju, Thimmaiah; Balaram, Hemalatha			Phosphoglycolate phosphatase is a metabolic proofreading enzyme essential for cellular function in Plasmodium berghei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; glycolysis; gene knockout; malaria; protozoan; metabolic regulation; 2-phospho-L-lactate; 2-phosphoglycolate; 4-phosphoerythronate; phosphoglycolate phosphatase (PGP); Plasmodium berghei	ESCHERICHIA-COLI; 2-PHOSPHOGLYCOLATE PHOSPHATASE; HAD SUPERFAMILY; NUCLEOTIDASES; DIVERSITY; YJJG	Plasmodium falciparum (Pf) 4-nitrophenylphosphatase has been shown previously to be involved in vitamin B1 metabolism. Here, conducting a BLASTp search, we found that 4-nitrophenylphosphatase from Pf has significant homology with phosphoglycolate phosphatase (PGP) from mouse, human, and yeast, prompting us to reinvestigate the biochemical properties of the Plasmodium enzyme. Because the recombinant PfPGP enzyme is insoluble, we performed an extended substrate screen and extensive biochemical characterization of the recombinantly expressed and purified homolog from Plasmodium berghei (Pb), leading to the identification of 2-phosphoglycolate and 2-phospho-L-lactate as the relevant physiological substrates of PbPGP. 2-Phosphoglycolate is generated during repair of damaged DNA ends, 2-phospho-L-lactate is a product of pyruvate kinase side reaction, and both potently inhibit two key glycolytic enzymes, triosephosphate isomerase and phosphofructokinase. Hence, PGP-mediated clearance of these toxic metabolites is vital for cell survival and functioning. Our results differ significantly from those in a previous study, wherein the PfPGP enzyme has been inferred to act on 2-phospho-D-lactate and not on the L isomer. Apart from resolving the substrate specificity conflict through direct in vitro enzyme assays, we conducted PGP gene knockout studies in P. berghei, confirming that this conserved metabolic proofreading enzyme is essential in Plasmodium. In summary, our findings establish PbPGP as an essential enzyme for normal physiological function in P. berghei and suggest that drugs that specifically inhibit Plasmodium PGP may hold promise for use in anti-malarial therapies.	[Nagappa, Lakshmeesha Kempaiah; Balaram, Hemalatha] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Jakkur PO, Bengaluru 560064, Karnataka, India; [Satha, Pardhasaradhi; Govindaraju, Thimmaiah] Jawaharlal Nehru Ctr Adv Sci Res, New Chem Unit, Bioorgan Chem Lab, Bengaluru 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Balaram, H (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Jakkur PO, Bengaluru 560064, Karnataka, India.	hb@jncasr.ac.in	Govindaraju, Thimmaiah/H-1471-2012	Govindaraju, Thimmaiah/0000-0002-9423-4275; Satha, Pardhasaradhi/0000-0002-8924-2510; KN, Lakshmeesha/0000-0002-7034-2378; Balaram, Hemalatha/0000-0002-8821-1288	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR11294/BRB/10/1291/2014, BT/PR13760/COE/34/42/2015, BT/INF/22/SP27679/2018]; Science and Engineering Research Board, Department of Science and Technology, Government of India [EMR/2014/001276, 2017/000920]; Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India; Council of Scientific and Industrial Research; Department of Science and Technology, Government of India [DST/SJF/CSA-02/2015-2016]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Science and Engineering Research Board, Department of Science and Technology, Government of India; Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This project was funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India Grants BT/PR11294/BRB/10/1291/2014, BT/PR13760/COE/34/42/2015, and BT/INF/22/SP27679/2018; Science and Engineering Research Board, Department of Science and Technology, Government of India Grant EMR/2014/001276; and institutional funding from the Jawaharlal Nehru Centre of Advanced Scientific Research, Department of Science and Technology, India. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Council of Scientific and Industrial Research for junior and senior research fellowships.; Supported by a Science and Engineering Research Board, Department of Science and Technology, Government of India for postdoctoral fellowship (Grant 2017/000920).; Supported by Department of Science and Technology, Government of India Grant DST/SJF/CSA-02/2015-2016.	Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Collard F, 2016, NAT CHEM BIOL, V12, P601, DOI [10.1038/NCHEMBIO.2104, 10.1038/nchembio.2104]; Dumont L., 2018, METABOLIC REPAIR ENZ, DOI [10.1101/415505, DOI 10.1101/415505]; Godiska R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1181; GUGGISBERG A, 2018, A R, V9, pe0119, DOI DOI 10.1128/MBIO.01193-18; Guggisberg AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5467; Huang H, 2015, P NATL ACAD SCI USA, V112, pE1974, DOI 10.1073/pnas.1423570112; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Knockel J, 2008, MOL BIOCHEM PARASIT, V157, P241, DOI 10.1016/j.molbiopara.2007.10.010; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Kuznetsova E, 2015, J BIOL CHEM, V290, P18678, DOI 10.1074/jbc.M115.657916; Mehta Monika, 2006, Journal of Vector Borne Diseases, V43, P95; Michaelis L, 1913, BIOCHEM Z, V49, P333; Mony BM, 2009, INT J PARASITOL, V39, P1441, DOI 10.1016/j.ijpara.2009.05.011; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; NOWAK T, 1972, BIOCHEMISTRY-US, V11, P2819, DOI 10.1021/bi00765a014; Pei Y, 2013, CELL MICROBIOL, V15, P1508, DOI 10.1111/cmi.12124; Pellicer MT, 2003, J BACTERIOL, V185, P5815, DOI 10.1128/JB.185.19.5815-5821.2003; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Roberts A, 2005, PROTEINS, V58, P790, DOI 10.1002/prot.20267; Schwarte S, 2007, PLANT PHYSIOL, V144, P1580, DOI 10.1104/pp.107.099192; Segerer G, 2016, SCI REP-UK, V6, DOI 10.1038/srep35160; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smialowski P, 2012, FEBS J, V279, P2192, DOI 10.1111/j.1742-4658.2012.08603.x; Srinivasan B, 2015, EXP PARASITOL, V151, P56, DOI 10.1016/j.exppara.2015.01.013; Srinivasan Bharath, 2007, In Silico Biology, V7, P187; Titz B, 2007, FEMS MICROBIOL LETT, V270, P49, DOI 10.1111/j.1574-6968.2007.00646.x; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; VANDERJAGT DL, 1990, MOL BIOCHEM PARASIT, V42, P277, DOI 10.1016/0166-6851(90)90171-H; Weiss B, 2007, J BACTERIOL, V189, P2186, DOI 10.1128/JB.01645-06	34	4	4	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					4997	5007		10.1074/jbc.AC118.007143	http://dx.doi.org/10.1074/jbc.AC118.007143			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30700551	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000463985600023
J	Michael, ES; Covic, L; Kuliopulos, A				Michael, Emily S.; Covic, Lidija; Kuliopulos, Athan			Trace amine-associated receptor 1 (TAAR1) promotes anti-diabetic signaling in insulin-secreting cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; calcium; pancreas; G protein-coupled receptor (GPCR); insulin secretion	GLUCAGON-LIKE PEPTIDE-1; PROTEIN-KINASE; BETA-CELLS; ACTIVATION; GLUCOSE; CAMP; LISDEXAMFETAMINE; PROLIFERATION; AMPHETAMINE; DYSFUNCTION	Pancreatic -cell failure in type 2 diabetes mellitus is a serious challenge that results in an inability of the pancreas to produce sufficient insulin to properly regulate blood glucose levels. Trace amine-associated receptor 1 (TAAR1) is a G protein-coupled receptor expressed by -cells that has recently been proposed as a potential target for improving glycemic control and suppressing binge eating behaviors. We discovered that TAAR1 is coupled to G(s)-signaling pathways in insulin-secreting -cells to cause protein kinase A (PKA)/exchange protein activated by cAMP (Epac)-dependent release of insulin, activation of RAF proto-oncogene, Ser/Thr kinase (Raf)-mitogen-activated protein kinase (MAPK) signaling, induction of cAMP response element-binding protein (CREB)-insulin receptor substrate 2 (Irs-2), and increased -cell proliferation. Interestingly, TAAR1 triggered cAMP-mediated calcium influx and release from internal stores, both of which were required for activation of a MAPK cascade utilizing calmodulin-dependent protein kinase II (CaMKII), Raf, and MAPK/ERK kinase 1/2 (MEK1/2). Together, these data identify TAAR1/G(s)-mediated signaling pathways that promote insulin secretion, improved -cell function and proliferation, and highlight TAAR1 as a promising new target for improving -cell health in type 2 diabetes mellitus.	[Michael, Emily S.; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Dept Med,Sch Grad Biomed Sci Biochem, Ctr Hemostasis & Thrombosis Res,Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Kuliopulos, A (corresponding author), Box 7510,800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu			NIDDK, National Institutes of Health [DK101240]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK101240] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in whole or in part by NIDDK, National Institutes of Health Grant DK101240 (to A. K. and L. C.). Dr. Kuliopulos and Dr. Covic serve as scientific founders of Oasis Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alenkvist I, 2017, DIABETES, V66, P2610, DOI 10.2337/db17-0050; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bradaia A, 2009, P NATL ACAD SCI USA, V106, P20081, DOI 10.1073/pnas.0906522106; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Drucker DJ, 2003, DIABETES CARE, V26, P2929, DOI 10.2337/diacare.26.10.2929; Duan LL, 2010, P NATL ACAD SCI USA, V107, P22314, DOI 10.1073/pnas.1016630108; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Ferragud A, 2017, NEUROPSYCHOPHARMACOL, V42, P1458, DOI 10.1038/npp.2016.233; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; FRODIN M, 1995, J BIOL CHEM, V270, P7882, DOI 10.1074/jbc.270.14.7882; Fu Z, 2010, ENDOCRINOLOGY, V151, P3026, DOI 10.1210/en.2009-1294; Galley G, 2016, ACS MED CHEM LETT, V7, P192, DOI 10.1021/acsmedchemlett.5b00449; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Ha TY, 2014, ARCH PHARM RES, V37, P671, DOI 10.1007/s12272-013-0209-0; Hermansen K, 2007, DRUG SAFETY, V30, P1127, DOI 10.2165/00002018-200730120-00005; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Lee YS, 2014, METABOLISM, V63, P9, DOI 10.1016/j.metabol.2013.09.010; Leech CA, 2010, ISLETS, V2, P72, DOI 10.4161/isl.2.2.10582; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; McElroy SL, 2015, JAMA PSYCHIAT, V72, P235, DOI 10.1001/jamapsychiatry.2014.2162; Meece J, 2007, CURR MED RES OPIN, V23, P933, DOI 10.1185/030079906X167336; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Michael ES, 2013, AM J PHYSIOL-GASTR L, V304, pG516, DOI 10.1152/ajpgi.00296.2012; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Panse M, 2015, CELL PHYSIOL BIOCHEM, V35, P1537, DOI 10.1159/000373969; PRENTKI M, 1987, FEBS LETT, V220, P103, DOI 10.1016/0014-5793(87)80884-0; Raab S, 2016, MOL METAB, V5, P47, DOI 10.1016/j.molmet.2015.09.015; Reese EA, 2007, J PHARMACOL EXP THER, V321, P178, DOI 10.1124/jpet.106.115402; Revel FG, 2013, MOL PSYCHIATR, V18, P543, DOI 10.1038/mp.2012.57; Revel FG, 2011, P NATL ACAD SCI USA, V108, P8485, DOI 10.1073/pnas.1103029108; Scanlan TS, 2009, ENDOCRINOLOGY, V150, P1108, DOI 10.1210/en.2008-1596; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Shearer AM, 2016, J BIOL CHEM, V291, P23188, DOI 10.1074/jbc.M116.732743; Tengholm A, 2012, UPSALA J MED SCI, V117, P355, DOI 10.3109/03009734.2012.724732; Trumper J, 2005, DIABETOLOGIA, V48, P1534, DOI 10.1007/s00125-005-1820-5; Vickers SP, 2015, J PSYCHOPHARMACOL, V29, P1290, DOI 10.1177/0269881115615107; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Ward K, 2018, EXPERT OPIN DRUG MET, V14, P229, DOI 10.1080/17425255.2018.1420163; WAUGH N, 2010, HEALTH TECHNOL ASSES, V14, P1; Yang HH, 2016, J MOL ENDOCRINOL, V57, pR93, DOI 10.1530/JME-15-0316; Zucchi R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00402	56	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4401	4411		10.1074/jbc.RA118.005464	http://dx.doi.org/10.1074/jbc.RA118.005464			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30670596	Green Published, hybrid			2022-12-28	WOS:000462969500010
J	Yamamoto, N; Kashiwagi, M; Ishihara, M; Kojima, T; Maturana, AD; Kuroda, S; Niimi, T				Yamamoto, Naoka; Kashiwagi, Manabu; Ishihara, Manami; Kojima, Takaaki; Maturana, Andres D.; Kuroda, Shun'ichi; Niimi, Tomoaki			Robo2 contains a cryptic binding site for neural EGFL-like (NELL) protein 1/2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface receptor; protein conformation; protein domain; protein-protein interaction; structural model	CHONDROGENIC DIFFERENTIATION; CELL-ADHESION; AXON GUIDANCE; EXPRESSION; SMART; SLIT; CRANIOSYNOSTOSIS; ROUNDABOUT; MOLECULES; MICE	The signaling pathways that are mediated by Slit ligands and their Roundabout (Robo) family of receptors play multifunctional roles in the development of the nervous system and other organs. A recent study identified neural epidermal growth factor-like (NEL)-like 2 (NELL2) as a novel ligand for Robo3. In this study, we carried out a comprehensive analysis of the interaction between NELL1 and the Robo family of receptors and demonstrated that Robo2 contains a cryptic binding site for both NELL1 and NELL2. NELL1/2 binds to the first fibronectin type III (FNIII) domain of Robo2 but not to intact Robo2. Mutation analysis revealed that several amino acids within the first FNIII domain are critical for NELL1 binding to Robo2 but not to Robo1. The Robo2 deletion mutants without the fourth immunoglobulin domain and single amino acid substitution mutants that can influence the architecture of the ectodomain facilitated binding to NELL1/2. Acidic conditions increased the binding affinity of Robo2 for NELL1. These results suggest that Robo2 functions as a receptor for NELL1/2, particularly under circumstances where Robo2 undergoes proteolytic digestion. If this is not the case, conformational changes of the ectodomain of Robo2 may unmask the binding site for NELL1/2.	[Yamamoto, Naoka; Kashiwagi, Manabu; Ishihara, Manami; Kojima, Takaaki; Maturana, Andres D.; Niimi, Tomoaki] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kuroda, Shun'ichi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Nagoya University; Osaka University	Niimi, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	tniimi@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [26350959, 17K01946]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 26350959 and 17K01946. The authors declare that they have no conflicts of interest with the contents of this article.	Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; Arnett TR, 2010, ARCH BIOCHEM BIOPHYS, V503, P103, DOI 10.1016/j.abb.2010.07.021; Ballard MS, 2012, ADV CANCER RES, V114, P187, DOI 10.1016/B978-0-12-386503-8.00005-3; Bokui N, 2008, FEBS LETT, V582, P365, DOI 10.1016/j.febslet.2007.12.006; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; Hasebe A, 2012, MOL BIOTECHNOL, V51, P58, DOI 10.1007/s12033-011-9440-4; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Hohenester E, 2008, BIOCHEM SOC T, V36, P251, DOI 10.1042/BST0360251; James AW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8362; Jaworski A, 2015, SCIENCE, V350, P961, DOI 10.1126/science.aad2615; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Kim BJ, 2018, J CLIN INVEST, V128, P1429, DOI 10.1172/JCI91086; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li CS, 2016, TISSUE ENG PT A, V22, P272, DOI [10.1089/ten.tea.2015.0250, 10.1089/ten.TEA.2015.0250]; Li CS, 2018, AM J PATHOL, V188, P392, DOI 10.1016/j.ajpath.2017.09.020; Li CS, 2017, AM J PATHOL, V187, P963, DOI 10.1016/j.ajpath.2016.12.026; Li Y, 2017, EXP CELL RES, V361, P73, DOI 10.1016/j.yexcr.2017.10.002; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; Maruyama IN, 2015, BIOESSAYS, V37, P959, DOI 10.1002/bies.201500041; Nakamura Y, 2014, J BIOL CHEM, V289, P9781, DOI 10.1074/jbc.M113.507020; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Okajima F, 2013, CELL SIGNAL, V25, P2263, DOI 10.1016/j.cellsig.2013.07.022; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; Phan HP, 2009, PROTEIN EXPRES PURIF, V68, P79, DOI 10.1016/j.pep.2009.07.005; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seiradake E, 2016, ANNU REV CELL DEV BI, V32, P577, DOI 10.1146/annurev-cellbio-111315-125008; Seki M, 2010, FEBS LETT, V584, P2909, DOI 10.1016/j.febslet.2010.05.009; Shen J, 2012, J CELL BIOCHEM, V113, P3620, DOI 10.1002/jcb.24253; Takahashi K, 2015, FEBS LETT, V589, P4026, DOI 10.1016/j.febslet.2015.11.032; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ting K, 1999, J BONE MINER RES, V14, P80, DOI 10.1359/jbmr.1999.14.1.80; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Yom-Tov G, 2017, J MOL BIOL, V429, P3606, DOI 10.1016/j.jmb.2017.10.002; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zakrys L, 2014, BIOCHEM J, V461, P61, DOI 10.1042/BJ20140190; Zhang X, 2010, J DENT RES, V89, P865, DOI 10.1177/0022034510376401; Zhang XL, 2012, J CRANIOFAC SURG, V23, P61, DOI 10.1097/SCS.0b013e318240c8c4; Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375; Zhao JJ, 2018, CARDIOVASC RES, V114, P794, DOI 10.1093/cvr/cvy061	43	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4693	4703		10.1074/jbc.RA118.005819	http://dx.doi.org/10.1074/jbc.RA118.005819			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30700556	Green Published, hybrid			2022-12-28	WOS:000462969500034
J	Saleeb, RS; Kavanagh, DM; Dun, AR; Dalgarno, PA; Duncan, RR				Saleeb, Rebecca S.; Kavanagh, Deirdre M.; Dun, Alison R.; Dalgarno, Paul A.; Duncan, Rory R.			A VPS33A-binding motif on syntaxin 17 controls autophagy completion in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; SNARE proteins; imaging; fluorescence resonance energy transfer (FRET); membrane; syntaxin 17; FLIM-FRET; membrane trafficking; protein degradation; lysosome; phagosome; VPS33A	SNARE COMPLEXES; HOMOTYPIC FUSION; ENERGY-TRANSFER; PROTEIN VPS33; HOPS COMPLEX; BINDS; MATURATION; LYSOSOME; FEATURES; PLATFORM	Autophagy is an intracellular degradation pathway that transports cytoplasmic material to the lysosome for hydrolysis. It is completed by SNARE-mediated fusion of the autophagosome and endolysosome membranes. This process must be carefully regulated to maintain the organization of the membrane system and prevent mistargeted degradation. As yet, models of autophagosomal fusion have not been verified within a cellular context because of difficulties with assessing protein interactions in situ. Here, we used high-resolution fluorescence lifetime imaging (FLIM)-FRET of HeLa cells to identify protein interactions within the spatiotemporal framework of the cell. We show that autophagosomal syntaxin 17 (Stx17) heterotrimerizes with synaptosome-associated protein 29 (SNAP29) and vesicle-associated membrane protein 7 (VAMP7) in situ, highlighting a functional role for VAMP7 in autophagosome clearance that has previously been sidelined in favor of a role for VAMP8. Additionally, we identified multimodal regulation of SNARE assembly by the Sec1/Munc18 (SM) protein VPS33A, mirroring other syntaxin-SM interactions and therefore suggesting a unified model of SM regulation. Contrary to current theoretical models, we found that the Stx17 N-peptide appears to interact in a positionally conserved, but mechanistically divergent manner with VPS33A, providing a late go, no-go step for autophagic fusion via a phosphoserine master-switch. Our findings suggest that Stx17 fusion competency is regulated by a phosphosite in its N-peptide, representing a previously unknown regulatory step in mammalian autophagy.	[Saleeb, Rebecca S.; Kavanagh, Deirdre M.; Dun, Alison R.; Dalgarno, Paul A.; Duncan, Rory R.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh Super Resolut Imaging Consortium, Inst Biol Chem Biophys & Bioengn, Edinburgh EH14 4AS, Midlothian, Scotland; [Kavanagh, Deirdre M.] Univ Birmingham, Ctr Membrane Proteins & Receptors COMPARE, Birmingham B15 2TT, W Midlands, England	Heriot Watt University; University of Birmingham	Saleeb, RS (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Charterhouse Sq, London EC1M 6BQ, England.; Duncan, RR (corresponding author), Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.	r.saleeb@qmul.ac.uk; r.r.duncan@hw.ac.uk		Dalgarno, Paul/0000-0001-7701-373X; Duncan, Rory/0000-0003-0693-910X; Kavanagh, Deirdre/0000-0003-1531-6617	Medical Research Council [MR/K01563X/1]; MRC [G0901607, MR/K01563X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Award MR/K01563X/1 (to R. R. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbe E., 1881, J ROYAL MICROSCOPICA, V1, P388, DOI DOI 10.1111/J.1365-2818.1881.TB05909.X; Akrap N, 2010, ANAL BIOCHEM, V402, P105, DOI 10.1016/j.ab.2010.03.026; Baker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067409; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Carlsson SR, 2015, J CELL SCI, V128, P193, DOI 10.1242/jcs.141036; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Dilcher M, 2001, J BIOL CHEM, V276, P34537, DOI 10.1074/jbc.M101551200; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Graham SC, 2013, P NATL ACAD SCI USA, V110, P13345, DOI 10.1073/pnas.1307074110; Groenewoud MJ, 2013, BIOCHEM SOC T, V41, P951, DOI 10.1042/BST20130037; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kavanagh DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6774; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Matsui T, 2018, J CELL BIOL, V217, P2633, DOI 10.1083/jcb.201712058; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; McLelland GL, 2016, J CELL BIOL, V214, P275, DOI 10.1083/jcb.201603105; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Ossig R, 2000, EMBO J, V19, P6000, DOI 10.1093/emboj/19.22.6000; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rickman C, 2010, J BIOL CHEM, V285, P3965, DOI 10.1074/jbc.M109.040402; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Uematsu M, 2017, AUTOPHAGY, V13, P1452, DOI 10.1080/15548627.2017.1327940; Vicidomini G, 2011, NAT METHODS, V8, P571, DOI [10.1038/NMETH.1624, 10.1038/nmeth.1624]; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97	64	13	13	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2019	294	11					4188	4201		10.1074/jbc.RA118.005947	http://dx.doi.org/10.1074/jbc.RA118.005947			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HP7FZ	30655294	hybrid, Green Published			2022-12-28	WOS:000461854400030
J	Hoffmeister, H; Fuchs, A; Strobl, L; Sprenger, F; Grobner-Ferreira, R; Michaelis, S; Hoffmann, P; Nazet, J; Merkl, R; Langst, G				Hoffmeister, Helen; Fuchs, Andreas; Strobl, Laura; Sprenger, Frank; Groebner-Ferreira, Regina; Michaelis, Stefanie; Hoffmann, Petra; Nazet, Julian; Merkl, Rainer; Laengst, Gernot			Elucidation of the functional roles of the Q and I motifs in the human chromatin-remodeling enzyme BRG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; chromatin remodeling; ATPase; nucleosome; tumor suppressor gene; ATP; cell proliferation; ATPase domain; BRG1; SF2 helicase family	SWI-SNF COMPLEX; ATP-HYDROLYSIS; RETINOBLASTOMA PROTEIN; TUMOR-SUPPRESSOR; DNA; BINDING; CYCLE; IDENTIFICATION; HELICASES; GROWTH	The Snf2 proteins, comprising 53 different enzymes in humans, belong to the SF2 family. Many Snf2 enzymes possess chromatin-remodeling activity, requiring a functional ATPase domain consisting of conserved motifs named Q and I-VII. These motifs form two recA-like domains, creating an ATP-binding pocket. Little is known about the function of the conserved motifs in chromatin-remodeling enzymes. Here, we characterized the function of the Q and I (Walker I) motifs in hBRG1 (SMARCA4). The motifs are in close proximity to the bound ATP, suggesting a role in nucleotide binding and/or hydrolysis. Unexpectedly, when substituting the conserved residues Gln(758) (Q motif) or Lys(785) (I motif) of both motifs, all variants still bound ATP and exhibited basal ATPase activity similar to that of wildtype BRG1 (wtBRG1). However, all mutants lost the nucleosome-dependent stimulation of the ATPase domain. Their chromatin-remodeling rates were impaired accordingly, but nucleosome binding was retained and still comparable with that of wtBRG1. Interestingly, a cancer-relevant substitution, L754F (Q motif), displayed defects similar to the Gln(758) variant(s), arguing for a comparable loss of function. Because we excluded a mutual interference of ATP and nucleosome binding, we postulate that both motifs stimulate the ATPase and chromatin-remodeling activities upon binding of BRG1 to nucleosomes, probably via allosteric mechanisms. Furthermore, mutations of both motifs similarly affect the enzymatic functionality of BRG1 in vitro and in living cells. Of note, in BRG1-deficient H1299 cells, exogenously expressed wtBRG1, but not BRG1 Q758A and BRG1 K785R, exhibited a tumor suppressor-like function.	[Hoffmeister, Helen; Fuchs, Andreas; Strobl, Laura; Groebner-Ferreira, Regina; Laengst, Gernot] Univ Regensburg, Dept Biochem 3, D-93053 Regensburg, Germany; [Nazet, Julian; Merkl, Rainer] Univ Regensburg, Dept Biochem 2, D-93053 Regensburg, Germany; [Sprenger, Frank] Univ Regensburg, Inst Biochem Genet & Microbiol, Cell Cycle Control, D-93053 Regensburg, Germany; [Michaelis, Stefanie] Univ Regensburg, Inst Analyt Chem Chemo & Biosensors, Fraunhofer Res Inst Microsyst & Solid State Techn, Fraunhofer Einrichtung Mikrosyst & Festkorper Tec, D-93053 Regensburg, Germany; [Hoffmann, Petra] Univ Regensburg, Cent FACS Facil, Regensburg Ctr Intervent Immunol, D-93053 Regensburg, Germany; [Hoffmann, Petra] Univ Hosp Regensburg, Dept Internal Med 3, D-93059 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg; University of Regensburg	Hoffmeister, H; Langst, G (corresponding author), Univ Regensburg, Dept Biochem 3, D-93053 Regensburg, Germany.	Helen.Hoffmeister@vkl.uni-regensburg.de; Gernot.Laengst@vkl.uni-regensburg.de	Langst, Gernot/G-5287-2015; Merkl, Rainer/A-4534-2008	Langst, Gernot/0000-0002-8232-1179; Fuchs, Andreas/0000-0002-7230-4121; Merkl, Rainer/0000-0002-3521-2957	Die Bildung von Ribosomen, Grundlagen der RNP-Biogenese und Kontrolle ihrer Funktion of the Deutsche Forschungsgemeinschaf [SFB 960]	Die Bildung von Ribosomen, Grundlagen der RNP-Biogenese und Kontrolle ihrer Funktion of the Deutsche Forschungsgemeinschaf	This work was supported by Grant SFB 960 from Die Bildung von Ribosomen, Grundlagen der RNP-Biogenese und Kontrolle ihrer Funktion of the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Brahma S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15616; Breiling A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0016-6; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Ding H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140755; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Eustermann S, 2018, NATURE, V556, P386, DOI 10.1038/s41586-018-0029-y; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hoffmeister H, 2017, NUCLEIC ACIDS RES, V45, P10534, DOI 10.1093/nar/gkx711; HUANG RCC, 1969, J MOL BIOL, V39, P365, DOI 10.1016/0022-2836(69)90323-4; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Khan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113293; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Knudsen Erik S, 2003, Methods Mol Biol, V218, P3; Kovac K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04503-2; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Naidu SR, 2009, ONCOGENE, V28, P2492, DOI 10.1038/onc.2009.121; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Nongkhlaw M, 2012, BIOCHEMISTRY-US, V51, P3711, DOI 10.1021/bi2014757; Nongkhlaw M, 2009, NUCLEIC ACIDS RES, V37, P3332, DOI 10.1093/nar/gkp178; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Porter IM, 2004, CURR BIOL, V14, pR554, DOI 10.1016/j.cub.2004.07.009; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; Reiter A, 2012, EMBO J, V31, P3480, DOI 10.1038/emboj.2012.185; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rodriguez-Campos A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001182; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Smith CL, 2005, MOL CELL BIOL, V25, P5880, DOI 10.1128/MCB.25.14.5880-5892.2005; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tong YK, 1999, CHINESE SCI BULL, V44, P1157, DOI 10.1007/BF02885957; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Wong AKC, 2000, CANCER RES, V60, P6171; Wu YL, 2012, J BIOL CHEM, V287, P21699, DOI 10.1074/jbc.M112.351338; Xie WB, 2012, P NATL ACAD SCI USA, V109, P8161, DOI 10.1073/pnas.1201262109; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003	56	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2019	294	9					3294	3310		10.1074/jbc.RA118.005685	http://dx.doi.org/10.1074/jbc.RA118.005685			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU0SA	30647132	Green Published, hybrid			2022-12-28	WOS:000464980100026
J	Godin, E; Nguyen, PT; Zottig, X; Bourgault, S				Godin, Elizabeth; Phuong Trang Nguyen; Zottig, Ximena; Bourgault, Steve			Identification of a hinge residue controlling islet amyloid polypeptide self-assembly and cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; aggregation; peptides; amino acid; apoptosis; aggregation; amyloid; cytotoxicity; islet amyloid polypeptide (IAPP); self-assembly; beta-cell; membrane disruption; molecular hinge	BETA-CELL APOPTOSIS; MEMBRANE DISRUPTION; FIBER FORMATION; HUMAN IAPP; PROTEIN; TOXICITY; PEPTIDE; AMYLIN; TYPE-2; MECHANISM	The islet amyloid polypeptide (IAPP) is a 37-residue peptide hormone whose deposition as amyloid fibrils in the pancreatic islets is associated with type 2 diabetes. Previous studies have suggested that residue Asn-21 plays a critical role in the in vitro self-assembly of IAPP. Herein, we studied structure-self-assembly relationships focusing on position 21 to gain detailed insights into the molecular mechanisms of IAPP self-assembly and to probe the conformational nature of the toxic assemblies associated with -cell death. Thioflavin T (ThT) fluorescence, CD spectroscopy, and transmission EM analysis revealed that the Asn-21 amide side chain is not required for IAPP nucleation and amyloid elongation, as N21A and N21G variants assembled into prototypical fibrils. In contrast, Asn-21 substitution with the conformationally constrained and turn-inducing residue Pro accelerated IAPP self-assembly. Successive substitutions with hydrophobic residues led to the formation of ThT-negative -sheet-rich aggregates having high surface hydrophobicity. Cell-based assays revealed no direct correlation between the in vitro amyloidogenicity of these variants and their toxicity. In contrast, leakage of anionic lipid vesicles disclosed that membrane disruption is closely associated with cytotoxicity. We observed that the N21F variant self-assembles into worm-like aggregates, causing loss of lipid membrane structural integrity and inducing -cell apoptosis. These results indicate that specific intra- and intermolecular interactions involving Asn-21 promote IAPP primary nucleation events by modulating the conformational conversion of the oligomeric intermediates into amyloid fibrils. Our study identifies position 21 as a hinge residue that modulates IAPP amyloidogenicity and cytotoxicity.	[Godin, Elizabeth; Phuong Trang Nguyen; Zottig, Ximena; Bourgault, Steve] Univ Quebec Montreal, Pharmaqam, Dept Chem, Montreal, PQ H3C 3P8, Canada; [Godin, Elizabeth; Phuong Trang Nguyen; Zottig, Ximena; Bourgault, Steve] PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ G1V 0A6, Canada	University of Quebec; University of Quebec Montreal	Bourgault, S (corresponding author), Univ Quebec Montreal, Dept Chem, CP 8888,Succursale Ctr Ville, Montreal, PQ H3C 3P8, Canada.	bourgault.steve@uqam.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [06209]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 06209 (to S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Abedini A, 2006, J MOL BIOL, V355, P274, DOI 10.1016/j.jmb.2005.10.052; Abedini A, 2005, ORG LETT, V7, P693, DOI 10.1021/ol047480+; Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Abedini A, 2016, ELIFE, V5, DOI 10.7554/eLife.12977; Abedini A, 2013, FEBS LETT, V587, P1119, DOI 10.1016/j.febslet.2013.01.017; Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Birol M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03651-9; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bourgault S, 2009, J MED CHEM, V52, P3308, DOI 10.1021/jm900291j; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; Brender JR, 2015, J PHYS CHEM B, V119, P2886, DOI 10.1021/jp511758w; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Camargo DCR, 2017, ELIFE, V6, DOI 10.7554/eLife.31226; Cao P, 2013, P NATL ACAD SCI USA, V110, P19279, DOI 10.1073/pnas.1305517110; Cao P, 2013, FEBS LETT, V587, P1106, DOI 10.1016/j.febslet.2013.01.046; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; De Carufel CA, 2015, ANGEW CHEM INT EDIT, V54, P14383, DOI 10.1002/anie.201507092; De Carufel CA, 2013, BIOPOLYMERS, V100, P645, DOI 10.1002/bip.22243; Doran TM, 2012, PROTEINS, V80, P1053, DOI 10.1002/prot.24007; Fox A, 2010, BIOCHEMISTRY-US, V49, P7783, DOI 10.1021/bi100337p; Grigolato F, 2017, ACS NANO, V11, P11358, DOI 10.1021/acsnano.7b05895; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Hruby VJ, 2002, NAT REV DRUG DISCOV, V1, P847, DOI 10.1038/nrd939; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Karle IL, 2001, BIOPOLYMERS, V60, P351, DOI 10.1002/1097-0282(2001)60:5<351::AID-BIP10174>3.0.CO;2-U; Khemtemourian L, 2017, BIOCHIMIE, V142, P22, DOI 10.1016/j.biochi.2017.07.015; Koo BW, 2008, PROTEIN ENG DES SEL, V21, P147, DOI 10.1093/protein/gzm076; Koo BW, 2005, PROTEIN SCI, V14, P231, DOI 10.1110/ps.041051205; Kraus A, 2016, PRION, V10, P57, DOI 10.1080/19336896.2015.1132138; Krotee P, 2017, ELIFE, V6, DOI 10.7554/eLife.19273; LeVine III H., 1995, INT J EXP CLIN INVES, V2, P1, DOI DOI 10.3109/13506129509031881; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Maj M, 2018, CHEM SCI, V9, P463, DOI 10.1039/c7sc03789a; Mannini B, 2014, ACS CHEM BIOL, V9, P2309, DOI 10.1021/cb500505m; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Nanga RPR, 2008, BIOCHEMISTRY-US, V47, P12689, DOI 10.1021/bi8014357; Opie EL, 1901, J EXP MED, V5, P397, DOI 10.1084/jem.5.4.397; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Nguyen PT, 2017, BIOCHEMISTRY-US, V56, P3808, DOI 10.1021/acs.biochem.7b00209; Nguyen PT, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/515307; Raleigh D, 2017, J MOL ENDOCRINOL, V59, pR121, DOI 10.1530/JME-17-0105; Sakagashira S, 2000, AM J PATHOL, V157, P2101, DOI 10.1016/S0002-9440(10)64848-1; Sebastiao M, 2017, ANAL BIOCHEM, V532, P83, DOI 10.1016/j.ab.2017.06.007; Serrano AL, 2017, J AM CHEM SOC, V139, P16748, DOI 10.1021/jacs.7b08830; Tu LH, 2013, BIOCHEMISTRY-US, V52, P333, DOI 10.1021/bi3014278; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Williamson JA, 2007, PROTEIN SCI, V16, P110, DOI 10.1110/ps.062486907; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Wu C, 2005, J AM CHEM SOC, V127, P13530, DOI 10.1021/ja050767x; Young LM, 2014, J AM CHEM SOC, V136, P660, DOI 10.1021/ja406831n; Zhang SP, 2003, J BIOL CHEM, V278, P52810, DOI 10.1074/jbc.M308244200; Zhu SS, 2016, DIABETES, V65, P699, DOI 10.2337/db15-1264	61	20	21	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8452	8463		10.1074/jbc.RA118.006454	http://dx.doi.org/10.1074/jbc.RA118.006454			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30975901	Green Published, hybrid			2022-12-28	WOS:000471108200015
J	Li, KS; Hou, XB; Li, RR; Bi, WX; Yang, F; Chen, X; Xiao, P; Liu, TT; Lu, TG; Zhou, Y; Tian, ZM; Shen, YM; Zhang, YK; Wang, JY; Fang, H; Sun, JP; Yu, X				Li, Kangshuai; Hou, Xuben; Li, Ruirui; Bi, Wenxiang; Yang, Fan; Chen, Xu; Xiao, Peng; Liu, Tiantian; Lu, Tiange; Zhou, Yuan; Tian, Zhaomei; Shen, Yuemao; Zhang, Yingkai; Wang, Jiangyun; Fang, Hao; Sun, Jinpeng; Yu, Xiao			Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; enzyme inhibitor; enzyme; inhibitor; nuclear magnetic resonance (NMR); autoimmunity; lymphoid-specific tyrosine phosphatase (LYP); protein-tyrosine phosphatase nonreceptor type 22 (PTPN22); tyrosine phosphatase inhibitor; WPD-loop	PARTICLE MESH EWALD; CRYSTAL-STRUCTURE; PROTEIN PHOSPHATASE; R620W POLYMORPHISM; POTENT; LYP; ACCURACY; ASSOCIATION; STRATEGIES; MECHANISM	Protein-tyrosine phosphatase nonreceptor type 22 (PTPN22) is a lymphoid-specific tyrosine phosphatase (LYP), and mutations in the PTPN22 gene are highly correlated with a spectrum of autoimmune diseases. However, compounds and mechanisms that specifically inhibit LYP enzymes to address therapeutic needs to manage these diseases remain to be discovered. Here, we conducted a similarity search of a commercial database for PTPN22 inhibitors and identified several LYP inhibitor scaffolds, which helped identify one highly active inhibitor, NC1. Using noncompetitive inhibition curve and phosphatase assays, we determined NC1's inhibition mode toward PTPN22 and its selectivity toward a panel of phosphatases. We found that NC1 is a noncompetitive LYP inhibitor and observed that it exhibits selectivity against other protein phosphatases and effectively inhibits LYP activity in lymphoid T cells and modulates T-cell receptor signaling. Results from site-directed mutagenesis, fragment-centric topographic mapping, and molecular dynamics simulation experiments suggested that NC1, unlike other known LYP inhibitors, concurrently binds to a WPD pocket and a second pocket surrounded by an LYP-specific insert, which contributes to its selectivity against other phosphatases. Moreover, using a newly developed method to incorporate the unnatural amino acid 2-fluorine-tyrosine and F-19 NMR spectroscopy, we provide direct evidence that NC1 allosterically regulates LYP activity by restricting WPD-loop movement. In conclusion, our approach has identified a new allosteric binding site in LYP useful for selective LYP inhibitor development; we propose that the F-19 NMR probe developed here may also be useful for characterizing allosteric inhibitors of other tyrosine phosphatases.	[Li, Kangshuai; Li, Ruirui; Bi, Wenxiang; Xiao, Peng; Liu, Tiantian; Lu, Tiange; Tian, Zhaomei; Sun, Jinpeng] Shandong Univ, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China; [Li, Kangshuai; Li, Ruirui; Bi, Wenxiang; Xiao, Peng; Liu, Tiantian; Lu, Tiange; Tian, Zhaomei; Sun, Jinpeng] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China; [Hou, Xuben; Fang, Hao] Shandong Univ, Sch Pharm, Dept Med Chem, Jinan 250012, Shandong, Peoples R China; [Hou, Xuben; Fang, Hao] Shandong Univ, Sch Pharm, Key Lab Chem Biol Nat Prod MOE, Jinan 250012, Shandong, Peoples R China; [Yang, Fan; Chen, Xu; Yu, Xiao] Shandong Univ, Sch Med, Dept Physiol, Jinan 250012, Shandong, Peoples R China; [Hou, Xuben; Zhang, Yingkai] NYU, Dept Chem, New York, NY 10003 USA; [Zhang, Yingkai] NYU Shanghai, NYU ECNU Ctr Computat Chem, Shanghai 200062, Peoples R China; [Wang, Jiangyun] Chinese Acad Sci, Inst Biophys, Lab Quantum Biophys, 15 Datun Rd, Chaoyang Dist 100101, Peoples R China; [Wang, Jiangyun] Chinese Acad Sci, Inst Biophys, Lab RNA Biol, 15 Datun Rd, Chaoyang Dist 100101, Peoples R China; [Zhou, Yuan; Shen, Yuemao] Shandong Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Chem Biol, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; New York University; NYU Shanghai; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Shandong University	Sun, JP (corresponding author), Shandong Univ, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China.; Sun, JP (corresponding author), Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China.; Yu, X (corresponding author), Shandong Univ, Sch Med, Dept Physiol, Jinan 250012, Shandong, Peoples R China.	sunjinpeng@sdu.edu.cn; yuxiao@sdu.edu.cn	sun, Jinpeng/AAR-9196-2020; HOU, XUBEN/ABB-5086-2020; Zhang, Yingkai/A-3173-2008	Zhang, Yingkai/0000-0002-4984-3354; Hou, Xuben/0000-0002-8346-9001	National Key Basic Research Program of China [2018YFC1003600]; National Natural Science Foundation of China [81773704, 31700692, 81874288]; National Science Fund for Distinguished Young Scholars [81825022]; National Science Fund for Excellent Young Scholars Grant [81822008]; Shandong Natural Science Fund [ZR2016CQ07]; Key Research and Development Program of Shandong Province [2017GSF218023, 2018GSF118147]; Fundamental Research Funds of Shandong University [2019GN045]; National Institutes of Health [R01GM120736]; Rolling program of ChangJiang Scholars and Innovative Research Team in University [IRT_17R68]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120736] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science Fund for Excellent Young Scholars Grant; Shandong Natural Science Fund; Key Research and Development Program of Shandong Province; Fundamental Research Funds of Shandong University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rolling program of ChangJiang Scholars and Innovative Research Team in University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Key Basic Research Program of China Grant 2018YFC1003600 (to X.Y. and J.S.), the National Natural Science Foundation of China Grant 81773704 (to J.S.), Grant 31700692 (to P.X.), and Grant 81874288 (to H.F.), the National Science Fund for Distinguished Young Scholars Grant 81825022 (to J.S.), the National Science Fund for Excellent Young Scholars Grant 81822008 (to X.Y.), the Shandong Natural Science Fund Grant ZR2016CQ07 (to P.X.), the Key Research and Development Program of Shandong Province Grant 2017GSF218023 (to W.B.) and Grant 2018GSF118147 (to P.X.), the Fundamental Research Funds of Shandong University Grant 2019GN045 (to X.H.), National Institutes of Health Grant R01GM120736 (to Y.Z.), and the Rolling program of ChangJiang Scholars and Innovative Research Team in University Grant IRT_17R68 (to Y.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ala PJ, 2006, J BIOL CHEM, V281, P38013, DOI 10.1074/jbc.M607913200; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Combs AP, 2006, J MED CHEM, V49, P3774, DOI 10.1021/jm0600904; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diaz-Gallo LM, 2011, INFLAMM BOWEL DIS, V17, P2287, DOI 10.1002/ibd.21630; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Elghzaly AA, 2015, HUM IMMUNOL, V76, P525, DOI 10.1016/j.humimm.2015.06.001; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fortanet JG, 2016, J MED CHEM, V59, P7773, DOI 10.1021/acs.jmedchem.6b00680; Frisch M. J., 2009, GAUSSIAN 09 REVISION; He YT, 2013, J MED CHEM, V56, P4990, DOI 10.1021/jm400248c; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hou XB, 2014, J MED CHEM, V57, P9309, DOI 10.1021/jm500692u; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Latorraca NR, 2017, CHEM REV, V117, P139, DOI 10.1021/acs.chemrev.6b00177; Li FH, 2013, ANGEW CHEM INT EDIT, V52, P3958, DOI 10.1002/anie.201300463; Li KS, 2015, CHEMMEDCHEM, V10, P1980, DOI 10.1002/cmdc.201500454; Li R, 2014, J NEUROCHEM, V128, P315, DOI 10.1111/jnc.12463; Li R, 2013, FEBS J, V280, P2700, DOI 10.1111/febs.12275; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043631; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363; Pan C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02333; Perron MD, 2014, MOL PHARMACOL, V85, P553, DOI 10.1124/mol.113.089847; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodriguez-Rodriguez L, 2011, ARTHRITIS RHEUM-US, V63, P365, DOI 10.1002/art.30145; Rooklin D, 2017, J AM CHEM SOC, V139, P15560, DOI 10.1021/jacs.7b05960; Rooklin D, 2015, J CHEM INF MODEL, V55, P1585, DOI 10.1021/acs.jcim.5b00103; Ruiz-Noa Y, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/8753498; Seldin MF, 2015, MOL MED, V21, P769, DOI 10.2119/molmed.2015.00232; Stanford SM, 2011, J MED CHEM, V54, P1640, DOI 10.1021/jm101202j; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Sun JP, 2003, J BIOL CHEM, V278, P33392, DOI 10.1074/jbc.M304693200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; Vandiedonck C, 2006, ANN NEUROL, V59, P404, DOI 10.1002/ana.20751; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Vang T, 2011, J MED CHEM, V54, P562, DOI 10.1021/jm101004d; Wang HM, 2014, CELL RES, V24, P1067, DOI 10.1038/cr.2014.99; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Xiong XB, 2015, MED SCI MONITOR, V21, P2567, DOI 10.12659/MSM.894307; Xu J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001923; Yang F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9202; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Yu X, 2011, J BIOL CHEM, V286, P30526, DOI 10.1074/jbc.M111.254722; Zhang HY, 2016, CURR OPIN STRUC BIOL, V38, P75, DOI 10.1016/j.sbi.2016.05.008; Zhang ZY, 2017, ACCOUNTS CHEM RES, V50, P122, DOI 10.1021/acs.accounts.6b00537; Zheng PL, 2013, DIABETES, V62, P896, DOI 10.2337/db12-0929	60	7	8	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2019	294	21					8653	8663		10.1074/jbc.RA118.007129	http://dx.doi.org/10.1074/jbc.RA118.007129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC6UQ	30979725	hybrid, Green Published			2022-12-28	WOS:000471108200031
J	Van Krieken, R; Mehta, N; Wang, T; Zheng, MY; Li, RZ; Gao, B; Ayaub, E; Ask, K; Paton, JC; Paton, AW; Austin, RC; Krepinsky, JC				Van Krieken, Richard; Mehta, Neel; Wang, Tony; Zheng, Mengyu; Li, Renzhong; Gao, Bo; Ayaub, Ehab; Ask, Kjetil; Paton, James C.; Paton, Adrienne W.; Austin, Richard C.; Krepinsky, Joan C.			Cell surface expression of 78-kDa glucose-regulated protein (GRP78) mediates diabetic nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibrosis; diabetic nephropathy; integrin; extracellular matrix; chaperone; 78-kDa glucose-regulated protein (GRP78); cell stress; kidney disease	ENDOPLASMIC-RETICULUM STRESS; RECEPTOR-RECOGNIZED FORMS; GROWTH-FACTOR RECEPTOR; COOH-TERMINAL DOMAIN; SIGNAL-TRANSDUCTION; ACTIVATION; APOPTOSIS; LIGATION; ANTIBODIES; BINDING	The 78-kDa glucose-regulated protein (GRP78) is a well-established endoplasmic reticulum (ER)-resident chaperone that maintains protein homeostasis and regulates the unfolded protein response. Under conditions of ER stress, GRP78 is also expressed at the cell surface and implicated in tumorigenesis, immunity, and cellular signaling events. The role of cell surface-associated GRP78 (csGRP78) in the pathogenesis of diabetic nephropathy has not yet been defined. Here we explored the role of csGRP78 in regulating high glucose (HG)-induced profibrotic AKT Ser/Thr kinase (AKT) signaling and up-regulation of extracellular matrix proteins. Using primary kidney mesangial cells, we show that HG treatment, but not the osmotic control mannitol, induces csGRP78 expression through an ER stress-dependent mechanism. We found that csGRP78, known to be located on the outer membrane leaflet, interacts with the transmembrane protein integrin 1 and activates focal adhesion kinase and downstream PI3K/AKT signaling. Localization of GRP78 at the cell surface and its interaction with integrin 1 were also required for extracellular matrix protein synthesis in response to HG. Surprisingly, both the N and C termini of csGRP78 were necessary for this profibrotic response. Increased localization of GRP78 at the plasma membrane was also found in the glomerular mesangial area of type 1 diabetic mice in two different models (streptozotocin-induced and Akita). In freshly isolated glomeruli from Akita mice, csGRP78 co-localized with the mesangial cell surface marker 8-integrin. In conclusion, our work reveals a role for csGRP78 in HG-induced profibrotic responses in mesangial cells, informing a potential approach to treating diabetic nephropathy.	[Van Krieken, Richard; Mehta, Neel; Wang, Tony; Zheng, Mengyu; Li, Renzhong; Gao, Bo; Austin, Richard C.; Krepinsky, Joan C.] McMaster Univ, Dept Nephrol, Hamilton, ON L8N 4A6, Canada; [Van Krieken, Richard; Mehta, Neel; Wang, Tony; Zheng, Mengyu; Li, Renzhong; Gao, Bo; Austin, Richard C.; Krepinsky, Joan C.] St Josephs Healthcare, Hamilton, ON L8N 4A6, Canada; [Ayaub, Ehab; Ask, Kjetil] McMaster Univ, Firestone Inst Resp Hlth, Dept Med, Hamilton, ON L8N 4A6, Canada; [Ayaub, Ehab; Ask, Kjetil] St Joes Hosp, Res Inst, Hamilton, ON L8N 4A6, Canada; [Ayaub, Ehab; Ask, Kjetil] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada; [Paton, James C.; Paton, Adrienne W.] Univ Adelaide, Dept Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia	McMaster University; McMaster University; McMaster University; University of Adelaide	Krepinsky, JC (corresponding author), St Josephs Hosp, 50 Charlton Ave E,Rm T3311, Hamilton, ON L8N 4A6, Canada.	krepinj@mcmaster.ca	Ask, Kjetil/AGE-0063-2022; Ask, Kjetil/B-6833-2015	Mehta, Neel/0000-0001-6143-9840; Ask, Kjetil/0000-0002-0202-735X	Canadian Institutes of Health Research Grant [PJT-148628]; Heart and Stroke Foundation of Canada [G-15-0009389]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by Canadian Institutes of Health Research Grant PJT-148628 (to J.C.K.) and Heart and Stroke Foundation of Canada Grant G-15-0009389 (to R.C.A.). The authors declare that they have no conflicts of interest with the contents of this article.	Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; AYO SH, 1990, AM J PATHOL, V136, P1339; Brosius FC, 2008, REV ENDOCR METAB DIS, V9, P245, DOI 10.1007/s11154-008-9100-6; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; Cohen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080231; Crane ED, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99363; Fan Y, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0842-y; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gray PC, 2012, FEBS LETT, V586, P1836, DOI 10.1016/j.febslet.2012.01.051; Hartner A, 2008, AM J NEPHROL, V28, P168, DOI 10.1159/000110022; Hartner A, 2010, AM J PHYSIOL-RENAL, V299, pF1151, DOI 10.1152/ajprenal.00058.2010; Hathaway CK, 2015, P NATL ACAD SCI USA, V112, P5815, DOI 10.1073/pnas.1504777112; Holman D, 2007, J NEUROSCI METH, V160, P302, DOI 10.1016/j.jneumeth.2006.09.018; Li JH, 2003, KIDNEY INT, V63, P2010, DOI 10.1046/j.1523-1755.2003.00016.x; Li RZ, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208629; Li ZW, 2013, INT J BIOCHEM CELL B, V45, P987, DOI 10.1016/j.biocel.2013.02.002; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu C, 2003, AM J PATHOL, V163, P1859, DOI 10.1016/S0002-9440(10)63545-6; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Liu MF, 2010, J CLIN INVEST, V120, P1914, DOI 10.1172/JCI42164; Miller CG, 2014, MOL BIOL CELL, V25, P2342, DOI 10.1091/mbc.E14-03-0800; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J IMMUNOL, V175, P2525, DOI 10.4049/jimmunol.175.4.2525; Misra UK, 2005, J IMMUNOL, V174, P2092, DOI 10.4049/jimmunol.174.4.2092; Misra UK, 2004, CELL SIGNAL, V16, P487, DOI 10.1016/j.cellsig.2003.09.010; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Nakatsuka A, 2012, DIABETES, V61, P2823, DOI 10.2337/db12-0232; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Raiter A, 2016, EXP CLIN ENDOCR DIAB, V124, P239, DOI 10.1055/s-0035-1569356; Raiter A, 2010, J VASC RES, V47, P399, DOI 10.1159/000281580; Ray R, 2012, J BIOL CHEM, V287, P32755, DOI 10.1074/jbc.M112.399808; Rondas Dieter, 2015, Diabetes, V64, P573, DOI 10.2337/db14-0621; Sanchez-Nino MD, 2010, KIDNEY INT, V78, P737, DOI 10.1038/ki.2010.270; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Shimizu F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai9111; Steiner N, 2017, ONCOTARGET, V8, P56243, DOI 10.18632/oncotarget.17353; Tsai YL, 2018, P NATL ACAD SCI USA, V115, pE4245, DOI 10.1073/pnas.1714866115; Tsai YL, 2015, J BIOL CHEM, V290, P8049, DOI 10.1074/jbc.M114.618736; Uttarwar L, 2011, AM J PHYSIOL-RENAL, V300, pF921, DOI 10.1152/ajprenal.00436.2010; Uttarwar L, 2012, AM J PHYSIOL-RENAL, V302, pF329, DOI 10.1152/ajprenal.00136.2011; Van Krieken R, 2018, ENDOCRINOLOGY, V159, P1479, DOI 10.1210/en.2018-00093; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; Wu D, 2007, DIABETOLOGIA, V50, P2008, DOI 10.1007/s00125-007-0721-1; Wu DC, 2009, J AM SOC NEPHROL, V20, P554, DOI 10.1681/ASN.2008040445; Xu Z, 2017, ONCOTARGET, V8, P32655, DOI 10.18632/oncotarget.15948; Yao F, 2015, MOL CELL ENDOCRINOL, V411, P232, DOI 10.1016/j.mce.2015.05.003; Zhang Y, 2012, AM J PHYSIOL-RENAL, V302, pF159, DOI 10.1152/ajprenal.00749.2010; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Zhang Y, 2010, ANTIOXID REDOX SIGN, V13, P959, DOI 10.1089/ars.2009.2908; Zhang Y, 2017, CELL SIGNAL, V31, P31, DOI 10.1016/j.cellsig.2016.12.009; Zhu M, 2014, ENDOCRINE, V47, P129, DOI 10.1007/s12020-013-0132-7	58	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7755	7768		10.1074/jbc.RA118.006939	http://dx.doi.org/10.1074/jbc.RA118.006939			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30914477	Green Published, hybrid			2022-12-28	WOS:000470153300019
J	Chan, M; Lim, YC; Yang, J; Namwanje, M; Liu, LH; Qiang, L				Chan, Michelle; Lim, Yen Ching; Yang, Jing; Namwanje, Maria; Liu, Longhua; Qiang, Li			Identification of a natural beige adipose depot in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; obesity; peroxisome proliferator-activated receptor (PPAR); adipose tissue; metabolic regulation; beige fat; browning	ACTIVATED RECEPTOR-ALPHA; WHITE FAT; BROWN ADIPOCYTES; LIPID-METABOLISM; TISSUE; GENE; OBESITY; EXPRESSION; BRITE	Beige fat is a potential therapeutic target for obesity and other metabolic diseases due to its inducible brown fat-like functions. Inguinal white adipose tissue (iWAT) can undergo robust brown remodeling with appropriate stimuli and is therefore widely considered as a representative beige fat depot. However, adipose tissues residing in different anatomic depots exhibit a broad range of plasticity, raising the possibility that better beige fat depots with greater plasticity may exist. Here we identified and characterized a novel, naturally-existing beige fat depot, thigh adipose tissue (tAT). Unlike classic WATs, tAT maintains beige fat morphology at room temperature, whereas high-fat diet (HFD) feeding or aging promotes the development of typical WAT features, namely unilocular adipocytes. The brown adipocyte gene expression in tAT is consistently higher than in iWAT under cold exposure, HFD feeding, and rosiglitazone treatment conditions. Our molecular profiling by RNA-Seq revealed up-regulation of energy expenditure pathways and repressed inflammation in tAT relative to eWAT and iWAT. Furthermore, we demonstrated that the master fatty acid oxidation regulator peroxisome proliferator-activated receptor is dispensable for maintaining and activating the beige character of tAT. Therefore, we have identified tAT as a natural beige adipose depot in mice with a unique molecular profile that does not require peroxisome proliferator-activated receptor .	[Chan, Michelle; Yang, Jing; Namwanje, Maria; Liu, Longhua; Qiang, Li] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Chan, Michelle] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Lim, Yen Ching] Duke NUS Med Sch, Cardiovasc & Metab Disorders Program, Singapore 169857, Singapore; [Yang, Jing] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Endocrinol, Xian, Shaanxi, Peoples R China	Columbia University; Columbia University; National University of Singapore; Xi'an Jiaotong University	Qiang, L (corresponding author), Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.	lq2123@cumc.columbia.edu	Namwanje, Maria/AAF-2020-2021	Qiang, Li/0000-0001-8322-1797; Chan, Michelle/0000-0001-6037-7051; Liu, Longhua/0000-0001-6501-863X	National Institutes of Health [R00DK97455, R01DK112943]; Pilot and Feasibility Center Grant [P30DK063608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK112943, R00DK097455, P30DK063608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot and Feasibility Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R00DK97455 (to L. Q.) and R01DK112943 (to L. Q.), and Pilot and Feasibility Center Grant P30DK063608 (to L. Q.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; COUSIN B, 1992, J CELL SCI, V103, P931; de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; Defour M, 2018, MOL METAB, V10, P39, DOI 10.1016/j.molmet.2018.01.023; Farmer SR, 2009, NATURE, V458, P839, DOI 10.1038/458839a; Ferrannini G, 2016, MOL METAB, V5, P948, DOI 10.1016/j.molmet.2016.08.013; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikeda K, 2018, TRENDS ENDOCRIN MET, V29, P191, DOI 10.1016/j.tem.2018.01.001; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Mulya A, 2016, ENDOCRIN METAB CLIN, V45, P605, DOI 10.1016/j.ecl.2016.04.010; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Poher AL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00004; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang F, 2018, CELL METAB, V27, P252, DOI 10.1016/j.cmet.2017.12.004	40	11	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6751	6761		10.1074/jbc.RA118.006838	http://dx.doi.org/10.1074/jbc.RA118.006838			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30824545	hybrid, Green Published			2022-12-28	WOS:000467394700013
J	DeLalio, LJ; Billaud, M; Ruddiman, CA; Johnstone, SR; Butcher, JT; Wolpe, AG; Jin, XY; Keller, TCS; Keller, AS; Riviere, T; Good, ME; Best, AK; Lohman, AW; Swayne, LA; Penuela, S; Thompson, RJ; Lampe, PD; Yeager, M; Isakson, BE				DeLalio, Leon J.; Billaud, Marie; Ruddiman, Claire A.; Johnstone, Scott R.; Butcher, Joshua T.; Wolpe, Abigail G.; Jin, Xueyao; Keller, T. C. Stevenson; Keller, Alexander S.; Riviere, Thibaud; Good, Miranda E.; Best, Angela K.; Lohman, Alexander W.; Swayne, Leigh Anne; Penuela, Silvia; Thompson, Roger J.; Lampe, Paul D.; Yeager, Mark; Isakson, Brant E.			Constitutive SRC-mediated phosphorylation of pannexin 1 at tyrosine 198 occurs at the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pannexin 1 (PANX1); SRC; smooth muscle; ATP; ATP release; vascular biology; adrenergic receptor; hypertension; vasoconstriction; SRC family kinase (SFK); kinase signaling; muscle contraction; membrane channel	FOCAL ADHESION KINASE; SMOOTH-MUSCLE; ATP RELEASE; ANGIOTENSIN-II; GROWTH-FACTOR; RECEPTOR ACTIVATION; INDUCED CONTRACTION; CA2+ SENSITIVITY; FAMILY KINASES; G-PROTEINS	Pannexin 1 (PANX1)-mediated ATP release in vascular smooth muscle coordinates 1-adrenergic receptor (1-AR) vasoconstriction and blood pressure homeostasis. We recently identified amino acids 198-200 (YLK) on the PANX1 intracellular loop that are critical for 1-AR-mediated vasoconstriction and PANX1 channel function. We report herein that the YLK motif is contained within an SRC homology 2 domain and is directly phosphorylated by SRC proto-oncogene, nonreceptor tyrosine kinase (SRC) at Tyr(198). We demonstrate that PANX1-mediated ATP release occurs independently of intracellular calcium but is sensitive to SRC family kinase (SFK) inhibition, suggestive of channel regulation by tyrosine phosphorylation. Using a PANX1 Tyr(198)-specific antibody, SFK inhibitors, SRC knockdown, temperature-dependent SRC cells, and kinase assays, we found that PANX1-mediated ATP release and vasoconstriction involves constitutive phosphorylation of PANX1 Tyr(198) by SRC. We specifically detected SRC-mediated Tyr(198) phosphorylation at the plasma membrane and observed that it is not enhanced or induced by 1-AR activation. Last, we show that PANX1 immunostaining is enriched in the smooth muscle layer of arteries from hypertensive humans and that Tyr(198) phosphorylation is detectable in these samples, indicative of a role for membrane-associated PANX1 in small arteries of hypertensive humans. Our discovery adds insight into the regulation of PANX1 by post-translational modifications and connects a significant purinergic vasoconstriction pathway with a previously identified, yet unexplored, tyrosine kinase-based 1-AR constriction mechanism. This work implicates SRC-mediated PANX1 function in normal vascular hemodynamics and suggests that Tyr(198)-phosphorylated PANX1 is involved in hypertensive vascular pathology.	[DeLalio, Leon J.; Ruddiman, Claire A.; Johnstone, Scott R.; Wolpe, Abigail G.; Keller, T. C. Stevenson; Keller, Alexander S.; Good, Miranda E.; Best, Angela K.; Isakson, Brant E.] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, POB 801394, Charlottesville, VA 22908 USA; [DeLalio, Leon J.; Ruddiman, Claire A.; Keller, Alexander S.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Wolpe, Abigail G.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Jin, Xueyao; Keller, T. C. Stevenson; Yeager, Mark; Isakson, Brant E.] Univ Virginia, Sch Med, Dept Mol Physiol & Biophys, Charlottesville, VA 22908 USA; [Billaud, Marie] Univ Pittsburgh, Sch Med, Dept Cardiothorac Surg, Pittsburgh, PA 15213 USA; [Butcher, Joshua T.] Augusta Univ, Dept Physiol, Augusta, GA 30912 USA; [Riviere, Thibaud] Univ Bordeaux, Dept Life & Hlth Sci, F-33000 Bordeaux, France; [Lohman, Alexander W.; Thompson, Roger J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Lohman, Alexander W.; Thompson, Roger J.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Swayne, Leigh Anne] Univ Victoria, Ctr Biomed Res, Div Med Sci, Victoria, BC V8P 5C2, Canada; [Penuela, Silvia] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat, London, ON N6A 3K7, Canada; [Penuela, Silvia] Univ Western Ontario, Schulich Sch Med & Dent, Dept Cell Biol, London, ON N6A 3K7, Canada; [Penuela, Silvia] Univ Western Ontario, Schulich Sch Med & Dent, Dept Oncol, London, ON N6A 3K7, Canada; [Lampe, Paul D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Augusta University; UDICE-French Research Universities; Universite de Bordeaux; University of Calgary; University of Calgary; University of Victoria; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Fred Hutchinson Cancer Center	Isakson, BE (corresponding author), Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, POB 801394, Charlottesville, VA 22908 USA.	brant@virginia.edu	Johnstone, Scott R/E-5032-2013; Penuela, Silvia/A-6961-2010; Billaud, Marie/N-7609-2017; Butcher, Joshua/ABH-7212-2022	Johnstone, Scott R/0000-0003-1920-5033; Penuela, Silvia/0000-0003-4829-5517; Billaud, Marie/0000-0002-7591-0362; Wolpe, Abigail/0000-0002-4169-3697; Butcher, Joshua/0000-0002-7341-1949; Good, Miranda/0000-0001-7775-1863; DeLalio, Leon/0000-0002-9251-0109	NIGMS, National Institutes of Health [F31 HL137270]; National Institutes of Health [T32 GM00813]; NHLBI, National Institutes of Health [P01 HL120840]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL137270, P01HL120840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIGMS, National Institutes of Health, Grant F31 HL137270 (to L. J. D.), National Institutes of Health Grant T32 GM00813 (to L. J. D.), and NHLBI, National Institutes of Health, Grant P01 HL120840 (to B. E. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABEBE W, 1995, J CARDIOVASC PHARM, V26, P153, DOI 10.1097/00005344-199507000-00024; Angus JA, 2016, EUR J PHARMACOL, V791, P179, DOI 10.1016/j.ejphar.2016.08.035; ATKINSON MM, 1981, J CELL BIOL, V91, P573, DOI 10.1083/jcb.91.2.573; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Billaud M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005824; Billaud M, 2012, MICROCIRCULATION, V19, P360, DOI 10.1111/j.1549-8719.2012.00172.x; Billaud M, 2011, CIRC RES, V109, P80, DOI 10.1161/CIRCRESAHA.110.237594; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bokemeyer D, 2000, KIDNEY INT, V58, P549, DOI 10.1046/j.1523-1755.2000.t01-1-00201.x; Bolen JB, 1997, ANNU REV IMMUNOL, V15, P371, DOI 10.1146/annurev.immunol.15.1.371; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Bond SR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00058; Boyce AKJ, 2017, BIOCHEM J, V474, P2133, DOI 10.1042/BCJ20170257; Burnstock G, 2010, BRIT J PHARMACOL, V161, P527, DOI 10.1111/j.1476-5381.2010.00937.x; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chiu YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14324; DeLalio LJ, 2018, ARTERIOSCL THROM VAS, V38, P2065, DOI 10.1161/ATVBAHA.118.311290; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; DISALVO J, 1993, ARCH BIOCHEM BIOPHYS, V304, P386, DOI 10.1006/abbi.1993.1366; DISALVO J, 1993, BIOCHEM BIOPH RES CO, V190, P968, DOI 10.1006/bbrc.1993.1144; DISALVO J, 1989, J BIOL CHEM, V264, P10773; DISALVO J, 1994, CAN J PHYSIOL PHARM, V72, P1434; Fisher SA, 2010, PHYSIOL GENOMICS, V42A, P169, DOI 10.1152/physiolgenomics.00111.2010; Godecke S, 2012, AM J PHYSIOL-CELL PH, V302, pC915, DOI 10.1152/ajpcell.00283.2010; Gomez GI, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040957; Gottlieb-Abraham E, 2013, MOL BIOL CELL, V24, P3881, DOI 10.1091/mbc.E13-03-0163; Grassi G, 2015, CIRC RES, V116, P976, DOI 10.1161/CIRCRESAHA.116.303604; Grassi G, 2009, HYPERTENSION, V54, P690, DOI 10.1161/HYPERTENSIONAHA.108.119883; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Han C, 2008, J CELL PHYSIOL, V216, P486, DOI 10.1002/jcp.21420; Hughes AD, 1998, ACTA PHYSIOL SCAND, V164, P457; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Jackson WF, 2008, BRIT J PHARMACOL, V155, P514, DOI 10.1038/bjp.2008.276; Jin N, 1996, AM J PHYSIOL-HEART C, V271, pH1348, DOI 10.1152/ajpheart.1996.271.4.H1348; Li L, 2010, PEPTIDES, V31, P1159, DOI 10.1016/j.peptides.2010.03.014; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Lohman AW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8965; Lohman AW, 2012, J VASC RES, V49, P405, DOI 10.1159/000338758; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; McGarrigle Deirdre, 2007, Sci STKE, V2007, ppe35, DOI 10.1126/stke.3922007pe35; Min JH, 2012, J CELL PHYSIOL, V227, P3585, DOI 10.1002/jcp.24062; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Murali S, 2017, J PHYSIOL-LONDON, V595, P4261, DOI 10.1113/JP273473; Murali S, 2014, J PHYSIOL-LONDON, V592, P4747, DOI 10.1113/jphysiol.2014.279299; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Nyberg M, 2018, HYPERTENSION, V71, P151, DOI 10.1161/HYPERTENSIONAHA.117.10251; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2014, BIOCHEM J, V461, P371, DOI 10.1042/BJ20140447; Penuela S, 2014, CHANNELS, V8, P124, DOI 10.4161/chan.27422; Penuela S, 2014, FEBS LETT, V588, P1411, DOI 10.1016/j.febslet.2014.01.028; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Pinheiro AR, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-70; Pinheiro AR, 2013, J BIOL CHEM, V288, P27571, DOI 10.1074/jbc.M113.460865; Poornima V, 2015, NITRIC OXIDE-BIOL CH, V47, P77, DOI 10.1016/j.niox.2015.04.005; POSTE G, 1979, CELL, V17, P789, DOI 10.1016/0092-8674(79)90319-2; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Riquelme MA, 2013, NEUROPHARMACOLOGY, V75, P594, DOI 10.1016/j.neuropharm.2013.03.022; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Shah BH, 2002, MOL PHARMACOL, V61, P343, DOI 10.1124/mol.61.2.343; Shao Q, 2016, J BIOL CHEM, V291, P12432, DOI 10.1074/jbc.M116.717934; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Solan JL, 2008, CELL COMMUN ADHES, V15, P75, DOI 10.1080/15419060802014016; Somlyo AP, 1998, ACTA PHYSIOL SCAND, V164, P437; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sumi Y, 2010, AM J PHYSIOL-CELL PH, V299, pC1118, DOI 10.1152/ajpcell.00122.2010; Tanoue A, 2002, J CLIN INVEST, V109, P765, DOI 10.1172/JCI200214001; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Ward D, 2002, J VASC RES, V39, P1, DOI 10.1159/000048988; Weilinger NL, 2016, NAT NEUROSCI, V19, P432, DOI 10.1038/nn.4236; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; Weng YI, 2002, BBA-MOL CELL RES, V1589, P285, DOI 10.1016/S0167-4889(02)00189-1; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858; Yun HM, 2007, J BIOL CHEM, V282, P5496, DOI 10.1074/jbc.M606215200; Zhang M, 2012, J PHYSIOL-LONDON, V590, P4335, DOI 10.1113/jphysiol.2012.236265	88	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6940	6956		10.1074/jbc.RA118.006982	http://dx.doi.org/10.1074/jbc.RA118.006982			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30814251	hybrid, Green Published			2022-12-28	WOS:000467394700028
J	Denu, RA; Sass, MM; Johnson, JM; Potts, GK; Choudhary, A; Coon, JJ; Burkard, ME				Denu, Ryan A.; Sass, Madilyn M.; Johnson, James M.; Potts, Gregory K.; Choudhary, Alka; Coon, Joshua J.; Burkard, Mark E.			Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centrosome; centriole; microtubule; phosphoproteomics; mass spectrometry (MS); chemical biology; cell division; centriole duplication; chemical genetics; chromosome segregation; PLK4; CEP131; centriolar satellite	PLK4; DUPLICATION; PROMOTES; CILIOGENESIS; INSTABILITY; RECRUITMENT; BIOGENESIS; REGULATORS; OVERDUPLICATION; CYTOKINESIS	The centrosome, consisting of two centrioles surrounded by a dense network of proteins, is the microtubule-organizing center of animal cells. Polo-like kinase 4 (PLK4) is a Ser/Thr protein kinase and the master regulator of centriole duplication, but it may play additional roles in centrosome function. To identify additional proteins regulated by PLK4, we generated an RPE-1 human cell line with a genetically engineered analog-sensitive PLK4(AS), which genetically encodes chemical sensitivity to competitive inhibition via a bulky ATP analog. We used this transgenic line in an unbiased multiplex phosphoproteomic screen. Several hits were identified and validated as direct PLK4 substrates by in vitro kinase assays. Among them, we confirmed Ser-78 in centrosomal protein 131 (CEP131, also known as AZI1) as a direct substrate of PLK4. Using immunofluorescence microscopy, we observed that although PLK4-mediated phosphorylation of Ser-78 is dispensable for CEP131 localization, ciliogenesis, and centriole duplication, it is essential for maintaining the integrity of centriolar satellites. We also found that PLK4 inhibition or use of a nonphosphorylatable CEP131 variant results in dispersed centriolar satellites. Moreover, replacement of endogenous WT CEP131 with an S78D phosphomimetic variant promoted aggregation of centriolar satellites. We conclude that PLK4 phosphorylates CEP131 at Ser-78 to maintain centriolar satellite integrity.	[Denu, Ryan A.] Univ Wisconsin, Med Scientist Training Program, Madison, WI 53705 USA; [Denu, Ryan A.; Sass, Madilyn M.; Johnson, James M.; Choudhary, Alka; Burkard, Mark E.] Univ Wisconsin, Dept Med, Div Hematol Oncol, Madison, WI 53705 USA; [Potts, Gregory K.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53705 USA; [Potts, Gregory K.; Coon, Joshua J.] Univ Wisconsin, Genome Ctr, Madison, WI 53705 USA; [Denu, Ryan A.; Sass, Madilyn M.; Johnson, James M.; Choudhary, Alka; Burkard, Mark E.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burkard, ME (corresponding author), 6059 WIMR,1111 Highland Ave, Madison, WI 53705 USA.	meburkard@medicine.wisc.edu		Burkard, Mark/0000-0002-4215-7722; Sass, Madilyn/0000-0002-3084-1084; Denu, Ryan/0000-0001-9698-9201	National Institutes of Health (NIH) [R01 GM097245, F30CA203271]; National Center for Quantitative Biology of Complex Systems (NIH) [P41 GM108538]; University of Wisconsin Carbone Cancer Center [P30 CA014520]; Abbvie; Genentech; Loxo Oncology; Puma; NATIONAL CANCER INSTITUTE [P30CA014520, F30CA203271] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000429, UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM108538, T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Quantitative Biology of Complex Systems (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Carbone Cancer Center; Abbvie(AbbVie); Genentech(Roche HoldingGenentech); Loxo Oncology; Puma; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health (NIH) Grants R01 GM097245 (to M. E. B.), F30CA203271 (to R. A. D.), the National Center for Quantitative Biology of Complex Systems (NIH Grant P41 GM108538 to J. J. C.), and University of Wisconsin Carbone Cancer Center Support Grant P30 CA014520. M. E. B. is on the medical advisory board of Strata Oncology and receives research funding from Abbvie, Genentech, Puma, and Loxo Oncology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai RN, 2016, CANCER BIOL THER, V17, P943, DOI 10.1080/15384047.2016.1210734; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bahtz R, 2012, J CELL SCI, V125, P486, DOI 10.1242/jcs.093930; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783; Bedard P. L., 2016, CANCER RES, DOI [10.1158/1538-7445, 10.1158/1538-7445.AM2016-CT066, DOI 10.1158/1538-7445]; Berdougo E, 2009, METHODS MOL BIOL, V545, P21, DOI 10.1007/978-1-60327-993-2_2; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Bonni S, 2008, CELL CYCLE, V7, P545, DOI 10.4161/cc.7.4.5387; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Chang J, 2010, EMBO J, V29, P2395, DOI 10.1038/emboj.2010.118; Cunha-Ferreira I, 2013, CURR BIOL, V23, P2245, DOI 10.1016/j.cub.2013.09.037; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Denu RA, 2018, MOL CANCER RES, V16, P517, DOI 10.1158/1541-7786.MCR-17-0197; Denu RA, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2083-x; Dzhindzhev NS, 2014, CURR BIOL, V24, P2526, DOI 10.1016/j.cub.2014.08.061; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Firat-Karalar EN, 2014, CURR BIOL, V24, P664, DOI 10.1016/j.cub.2014.01.067; Flanagan AM, 2017, MOL BIOL CELL, V28, P736, DOI 10.1091/mbc.E16-05-0325; Gaillard CLB, 2011, MOL BIOL CELL, V22, P4549, DOI 10.1091/mbc.E11-05-0405; Galletta BJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12476; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Hall EA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003928; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hoang-Minh LB, 2016, TRANSL ONCOL, V9, P392, DOI 10.1016/j.tranon.2016.08.006; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Holland AJ, 2012, MOL BIOL CELL, V23, P1838, DOI 10.1091/mbc.E11-12-1043; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Hori A, 2017, CELL MOL LIFE SCI, V74, P213, DOI 10.1007/s00018-016-2315-x; Hori A, 2016, EMBO REP, V17, P326, DOI 10.15252/embr.201541432; Kazazian K, 2017, CANCER RES, V77, P434, DOI 10.1158/0008-5472.CAN-16-2060; Kim TS, 2013, P NATL ACAD SCI USA, V110, pE4849, DOI 10.1073/pnas.1319656110; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002; Klebba JE, 2013, CURR BIOL, V23, P2255, DOI 10.1016/j.cub.2013.09.019; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kodani A, 2015, ELIFE, V4, DOI 10.7554/eLife.07519; Korzeniewski N, 2010, MOL BIOL CELL, V21, P3942, DOI 10.1091/mbc.E09-12-1049; Kratz AS, 2015, BIOL OPEN, V4, P370, DOI 10.1242/bio.201411023; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Lambrus BG, 2015, J CELL BIOL, V210, P63, DOI 10.1083/jcb.201502089; Lasek AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150225; Lee M, 2017, CELL CYCLE, V16, P1225, DOI 10.1080/15384101.2017.1325555; Lera RF, 2012, J BIOL CHEM, V287, P42812, DOI 10.1074/jbc.M112.412544; Leung GC, 2007, FEBS LETT, V581, P77, DOI 10.1016/j.febslet.2006.11.080; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14866; Liu XH, 2017, INT J BIOCHEM CELL B, V90, P1, DOI 10.1016/j.biocel.2017.07.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Mahjoub MR, 2013, ORGANOGENESIS, V9, P61, DOI 10.4161/org.25144; Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Mason JM, 2014, CANCER CELL, V26, P163, DOI 10.1016/j.ccr.2014.05.006; McLamarrah TA, 2018, J CELL BIOL, V217, P1217, DOI 10.1083/jcb.201605106; Merrill AE, 2013, CURR OPIN CHEM BIOL, V17, P779, DOI 10.1016/j.cbpa.2013.06.011; Mori Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140968; Moyer TC, 2015, J CELL BIOL, V209, P863, DOI 10.1083/jcb.201502088; Petrinac S, 2009, CELL CYCLE, V8, P327, DOI 10.4161/cc.8.2.7355; Pihan GA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00277; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Richards AL, 2015, CURR OPIN CHEM BIOL, V24, P11, DOI 10.1016/j.cbpa.2014.10.017; Riley NM, 2016, CELL SYST, V2, P142, DOI 10.1016/j.cels.2016.03.002; Riley NM, 2016, ANAL CHEM, V88, P74, DOI 10.1021/acs.analchem.5b04123; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Sir JH, 2013, J CELL BIOL, V203, P747, DOI 10.1083/jcb.201309038; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; Staples CJ, 2012, J CELL SCI, V125, P4770, DOI 10.1242/jcs.104059; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Tollenaere MAX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10075; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Villumsen BH, 2013, EMBO J, V32, P3029, DOI 10.1038/emboj.2013.223; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Wong YL, 2015, SCIENCE, V348, P1155, DOI 10.1126/science.aaa5111	82	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6531	6549		10.1074/jbc.RA118.004867	http://dx.doi.org/10.1074/jbc.RA118.004867			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30804208	Green Published, hybrid			2022-12-28	WOS:000468402000028
J	Hyeon, DY; Kim, JH; Ahn, TJ; Cho, Y; Hwang, D; Kim, S				Hyeon, Do Young; Kim, Jong Hyun; Ahn, Tae Jin; Cho, Yeshin; Hwang, Daehee; Kim, Sunghoon			Evolution of the multi-tRNA synthetase complex and its role in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						aminoacyl tRNA synthetase; protein synthesis; intracellular processing; pathology; cancer biology; Aminoacyl-tRNA synthetases; Cancer; multi-tRNA synthetase complex; network analysis; protein-protein interaction	PROTEIN-PROTEIN INTERACTIONS; MULTISYNTHETASE COMPLEX; TRANSLATIONAL CONTROL; GENE; IDENTIFICATION; AUTOANTIBODIES; DISSECTION; PHOSPHORYLATION; DERMATOMYOSITIS; HETEROGENEITY	Aminoacyl-tRNA synthetases (ARSs) are enzymes that ligate their cognate amino acids to tRNAs for protein synthesis. However, recent studies have shown that their functions are expanded beyond protein synthesis through the interactions with diverse cellular factors. In this review, we discuss how ARSs have evolved to expand and control their functions by forming protein assemblies. We particularly focus on a macromolecular ARS complex in eukaryotes, named multi-tRNA synthetase complex (MSC), which is proposed to provide a channel through which tRNAs reach bound ARSs to receive their cognate amino acid and transit further to the translation machinery. Approximately half of the ARSs assemble into the MSC through cis-acting noncatalytic domains attached to their catalytic domains and trans-acting factors. Evolution of the MSC included its functional expansion, during which the MSC interaction network was augmented by additional cellular pathways present in higher eukaryotes. We also discuss MSC components that could be functionally involved in the pathophysiology of tumorigenesis. For example, the activities of some trans-acting factors have tumor-suppressing effects or maintain DNA integrity and are functionally compromised in cancer. On the basis of Gene Ontology analyses, we propose that the regulatory activities of the MSC-associated ARSs mainly converge on five biological processes, including mammalian target of rapamycin (mTOR) and DNA repair pathways. Future studies are needed to investigate how the MSC-associated and free-ARSs interact with each other and other factors in the control of multiple cellular pathways, and how aberrant or disrupted interactions in the MSC can cause disease.	[Hyeon, Do Young; Hwang, Daehee] Daegu Gyeongbuk Inst Sci & Technol, Inst Basic Sci, Ctr Plant Aging Res, Daegu 711873, South Korea; [Kim, Jong Hyun; Kim, Sunghoon] Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul 151742, South Korea; [Kim, Jong Hyun; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea; [Kim, Jong Hyun; Kim, Sunghoon] Seoul Natl Univ, Grad Sch Convergence Technol, Seoul 151742, South Korea; [Ahn, Tae Jin; Cho, Yeshin] Handong Global Univ, Nehemiah 316,Handong Ro 558, Pohang, South Korea; [Hwang, Daehee] Daegu Gyeongbuk Inst Sci & Technol, Dept New Biol, Daegu 711873, South Korea; [Hyeon, Do Young] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Handong Global University; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Med Bioconvergence Res Ctr, Seoul 151742, South Korea.; Hwang, D (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea.; Kim, S (corresponding author), Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea.	daehee@snu.ac.kr; sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	Hyeon, Do Young/0000-0002-6870-4827; kim, sunghoon/0000-0002-1570-3230	Global Frontier Project [NRF-M1AXA002-2010-0029785]; Institute for Basic Science Grant - Korean Ministry of Science, ICT, and Future Planning [IBS-R013-G1]	Global Frontier Project; Institute for Basic Science Grant - Korean Ministry of Science, ICT, and Future Planning	This work was supported by Global Frontier Project Grant NRF-M1AXA002-2010-0029785 and the Institute for Basic Science Grant IBS-R013-G1 funded by Korean Ministry of Science, ICT, and Future Planning. This is the fourth article in the "tRNAs and aminoacyl-tRNA synthetases in human disease" JBC Reviews series. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott JA, 2018, HUM MUTAT, V39, P415, DOI 10.1002/humu.23380; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Arif A, 2017, NATURE, V542, P357, DOI 10.1038/nature21380; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Betteridge Z, 2007, RHEUMATOLOGY, V46, P1005, DOI 10.1093/rheumatology/kem045; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; Choi JW, 2009, CARCINOGENESIS, V30, P1638, DOI 10.1093/carcin/bgp170; Choi JW, 2009, J CELL SCI, V122, P2710, DOI 10.1242/jcs.049767; DELARUE M, 1995, CURR OPIN STRUC BIOL, V5, P48, DOI 10.1016/0959-440X(95)80008-O; Eswarappa SM, 2018, J BIOL CHEM, V293, P19148, DOI 10.1074/jbc.RA118.004276; Eswarappa SM, 2013, TRENDS BIOCHEM SCI, V38, P222, DOI 10.1016/j.tibs.2013.01.005; Francin M, 2003, J BIOL CHEM, V278, P1472, DOI 10.1074/jbc.M208802200; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Galani K, 2001, EMBO J, V20, P6889, DOI 10.1093/emboj/20.23.6889; Gonzalez M, 2013, J NEUROL NEUROSUR PS, V84, P1247, DOI 10.1136/jnnp-2013-305049; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Han JM, 2008, P NATL ACAD SCI USA, V105, P11206, DOI 10.1073/pnas.0800297105; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Han JM, 2010, CANCER LETT, V287, P157, DOI 10.1016/j.canlet.2009.06.005; Hashish L, 2005, ARTHRITIS RHEUM-US, V52, pS312; Hirakata M, 1999, J IMMUNOL, V162, P2315; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Kang T, 2012, J MOL BIOL, V423, P475, DOI 10.1016/j.jmb.2012.07.020; Kim DG, 2014, NAT CHEM BIOL, V10, P29, DOI [10.1038/nchembio.1381, 10.1038/NCHEMBIO.1381]; Kim DG, 2012, FASEB J, V26, P4142, DOI 10.1096/fj.12-207639; Kim D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33303-3; Kim JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00785-0; Kim JH, 2014, TOP CURR CHEM, V344, P119, DOI 10.1007/128_2013_479; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; KIM S, 1993, BIOCHEMISTRY-US, V32, P13026, DOI 10.1021/bi00211a011; Kim SB, 2017, J CELL BIOL, V216, P2201, DOI 10.1083/jcb.201605118; Kim SM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1037-4; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Kwon NH, 2018, ACS PHARMACOL TRANSL, V1, P21, DOI 10.1021/acsptsci.8b00001; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Labirua-Iturburu A, 2012, MEDICINE, V91, P206, DOI 10.1097/MD.0b013e318260977c; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Lee YS, 2006, MOL CELLS, V21, P213; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; Liang D, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01801; MCCLAIN WH, 1993, J MOL BIOL, V234, P257, DOI 10.1006/jmbi.1993.1582; McLaughlin HM, 2012, HUM MUTAT, V33, P244, DOI 10.1002/humu.21635; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Nathanson L, 2000, J BIOL CHEM, V275, P31559, DOI 10.1074/jbc.C000385200; NISHIKAI M, 1980, ARTHRITIS RHEUM, V23, P881, DOI 10.1002/art.1780230802; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Park BJ, 2006, CANCER RES, V66, P6913, DOI 10.1158/0008-5472.CAN-05-3740; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Park SG, 1999, J BIOL CHEM, V274, P16673, DOI 10.1074/jbc.274.24.16673; Quevillon S, 1996, FEBS LETT, V395, P63, DOI 10.1016/0014-5793(96)01005-8; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Ray PS, 2011, MOL BIOL EVOL, V28, P437, DOI 10.1093/molbev/msq246; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Stephens PJ, 2013, J CLIN INVEST, V123, P2965, DOI 10.1172/JCI67201; SWANSON R, 1988, SCIENCE, V242, P1548, DOI 10.1126/science.3144042; TARGOFF IN, 1990, J IMMUNOL, V144, P1737; Vester A, 2013, HUM MUTAT, V34, P191, DOI 10.1002/humu.22210; Witt Leah J, 2016, Clin Pulm Med, V23, P218; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Yum MK, 2016, CANCER RES, V76, P4559, DOI 10.1158/0008-5472.CAN-15-3357	85	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5340	5351		10.1074/jbc.REV118.002958	http://dx.doi.org/10.1074/jbc.REV118.002958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30782841	Green Published, hybrid			2022-12-28	WOS:000464517500009
J	Ahmed, BA; Jeffus, BC; Bukhari, SIA; Harney, JT; Unal, R; Lupashin, VV; van der Sluijs, P; Kilic, F				Ahmed, Billow A.; Jeffus, Brandon C.; Bukhari, Syed I. A.; Harney, Justin T.; Unal, Resat; Lupashin, Vladimir V.; van der Sluijs, Peter; Kilic, Fusun			Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter (Expression of Concern of Vol 283, Pg 9388, 2008)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Ahmed BA, 2008, J BIOL CHEM, V283, P9388, DOI 10.1074/jbc.M706367200	1	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5209	5209		10.1074/jbc.EC119.008296	http://dx.doi.org/10.1074/jbc.EC119.008296			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30926757	Green Published, hybrid			2022-12-28	WOS:000463985600041
J	Li, YC; Cooper, A; Odibo, IN; Ahmed, A; Murphy, P; Koonce, R; Dajani, NK; Lowery, CL; Roberts, DJ; Maroteaux, L; Kilic, F				Li, Yicong; Cooper, Anthonya; Odibo, Imelda N.; Ahmed, Asli; Murphy, Pamela; Koonce, Ruston; Dajani, Nafisa K.; Lowery, Curtis L.; Roberts, Drucilla J.; Maroteaux, Luc; Kilic, Fusun			Discrepancy in insulin regulation between gestational diabetes mellitus (GDM) platelets and placenta (Expression of Concern of Vol 291, Pg 9657, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern													Maroteaux, Luc/H-4585-2019; Roberts, Drucilla/AAB-6379-2022	Maroteaux, Luc/0000-0002-9499-8603; 				Li YC, 2016, J BIOL CHEM, V291, P9657, DOI 10.1074/jbc.M116.713693	1	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2019	294	13					5208	5208		10.1074/jbc.EC119.008295	http://dx.doi.org/10.1074/jbc.EC119.008295			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HS6MI	30926756	hybrid, Green Published			2022-12-28	WOS:000463985600040
J	Ohm, AM; Affandi, T; Reyland, ME				Ohm, Angela M.; Affandi, Trisiani; Reyland, Mary E.			EGF receptor and PKC kinase activate DNA damage-induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; protein kinase C (PKC); signal transduction; mitogen-activated protein kinase (MAPK); DNA damage; epidermal growth factor receptor (EGFR); extracellular signal-regulated kinase (ERK); cell signaling; kinase cascade; mitogen-sensitive kinase (MSK)	C-DELTA; SALIVARY-GLAND; DRUG-SENSITIVITY; NUCLEAR IMPORT; PHOSPHORYLATION; CISPLATIN; DEATH; INHIBITION; REPAIR; MKP-1	DNA damage-mediated activation of extracellular signal-regulated kinase (ERK) can regulate both cell survival and cell death. We show here that ERK activation in this context is biphasic and that early and late activation events are mediated by distinct upstream signals that drive cell survival and apoptosis, respectively. We identified the nuclear kinase mitogen-sensitive kinase 1 (MSK1) as a downstream target of both early and late ERK activation. We also observed that activation of ERKMSK1 up to 4 h after DNA damage depends on epidermal growth factor receptor (EGFR), as EGFR or mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)/ERK inhibitors or short hairpin RNA-mediated MSK1 depletion enhanced cell death. This prosurvival response was partially mediated through enhanced DNA repair, as EGFR or MEK/ERK inhibitors delayed DNA damage resolution. In contrast, the second phase of ERKMSK1 activation drove apoptosis and required protein kinase C (PKC) but not EGFR. Genetic disruption of PKC reduced ERK activation in an in vivo irradiation model, as did short hairpin RNA-mediated depletion of PKC in vitro. In both models, PKC inhibition preferentially suppressed late activation of ERK. We have shown previously that nuclear localization of PKC is necessary and sufficient for apoptosis. Here we identified a nuclear PKCERKMSK1 signaling module that regulates apoptosis. We also show that expression of nuclear PKC activates ERK and MSK1, that ERK activation is required for MSK1 activation, and that both ERK and MSK1 activation are required for apoptosis. Our findings suggest that location-specific activation by distinct upstream regulators may enable distinct functional outputs from common signaling pathways.	[Ohm, Angela M.; Affandi, Trisiani; Reyland, Mary E.] Univ Colorado Anschutz Med Campus, Dept Craniofacial Biol, Sch Dent Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado Anschutz Med Campus, Dept Craniofacial Biol, Aurora, CO 80045 USA.	Mary.Reyland@ucdenver.edu		Affandi, Trisiani/0000-0002-2307-0357; Ohm, Angela/0000-0002-4495-5103	NIDCR, National Institutes of Health [R01DE027517, R01 DE015648]; NATIONAL CANCER INSTITUTE [T32CA190216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE027517, R01DE015648] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIDCR, National Institutes of Health Grants R01DE027517 and R01 DE015648 (to A. M. O., T. A., and M. E. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adewumi Ifeoluwa, 2019, Advances in Biological Regulation, V71, P147, DOI 10.1016/j.jbior.2018.09.010; Adwan TS, 2011, J BIOL CHEM, V286, P35716, DOI 10.1074/jbc.M111.255950; Allen-Petersen BL, 2014, ONCOGENE, V33, P1306, DOI 10.1038/onc.2013.59; Allen-Petersen BL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.20; Arany S, 2013, MOL THER, V21, P1182, DOI 10.1038/mt.2013.42; Bagnyukova TV, 2013, BRIT J CANCER, V109, P1063, DOI 10.1038/bjc.2013.353; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chou RH, 2014, DEV CELL, V30, P224, DOI 10.1016/j.devcel.2014.06.008; DeVries TA, 2004, J BIOL CHEM, V279, P45603, DOI 10.1074/jbc.M407448200; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kolb RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050281; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; Lang E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17316; Leitges M, 2001, J CLIN INVEST, V108, P1505; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Liu H, 2007, MOL CELL BIOL, V27, P8480, DOI 10.1128/MCB.01126-07; Lomonaco SL, 2008, J BIOL CHEM, V283, P17731, DOI 10.1074/jbc.M801727200; Matassa A, 2003, CELL DEATH DIFFER, V10, P269, DOI 10.1038/sj.cdd.4401149; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Nyati MK, 2006, CANCER RES, V66, P11554, DOI 10.1158/0008-5472.CAN-06-1935; Ohm AM, 2017, ONCOGENE, V36, P4370, DOI 10.1038/onc.2017.27; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Quissell DO, 1998, IN VITRO CELL DEV-AN, V34, P58; Reyland ME, 2016, PHARMACOL THERAPEUT, V165, P1, DOI 10.1016/j.pharmthera.2016.05.001; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Reyskens KMSE, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00056; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Sawicka A, 2014, GENOME RES, V24, P1808, DOI 10.1101/gr.176255.114; Shi GX, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.384248; Symonds JM, 2011, CANCER RES, V71, P2087, DOI 10.1158/0008-5472.CAN-10-1511; Tentner AR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.1; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Wei F, 2011, CURR MED CHEM, V18, P5476, DOI 10.2174/092986711798194388; Wie SM, 2017, MOL CANCER THER, V16, P1989, DOI 10.1158/1535-7163.MCT-17-0267; Wie SM, 2014, J BIOL CHEM, V289, P10900, DOI 10.1074/jbc.M114.551366; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	45	14	16	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 22	2019	294	12					4488	4497		10.1074/jbc.RA118.006944	http://dx.doi.org/10.1074/jbc.RA118.006944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HR2LY	30679314	Green Published, hybrid			2022-12-28	WOS:000462969500017
J	Liu, H; Yue, JP; Huang, H; Gou, XW; Chen, SY; Zhao, YM; Wu, XY				Liu, Han; Yue, Jiping; Huang, He; Gou, Xuewen; Chen, Shao-Yu; Zhao, Yingming; Wu, Xiaoyang			Regulation of focal adhesion dynamics and cell motility by the EB2 and Hax1 protein complex (vol 290, pg 30771, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Liu H, 2015, J BIOL CHEM, V290, P30771, DOI 10.1074/jbc.M115.671743	1	0	0	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2019	294	8					2948	2948		10.1074/jbc.AAC119.007825	http://dx.doi.org/10.1074/jbc.AAC119.007825			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HM6QC	30796176	Green Published, hybrid			2022-12-28	WOS:000459601600032
